PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Du, XY; Zhou, Y; Song, LL; Wang, X; Zhang, SC				Du, Xiaoyuan; Zhou, Yang; Song, Lili; Wang, Xia; Zhang, Shicui			Zinc finger protein 365 is a new maternal LPS-binding protein that defends zebrafish embryos against gram-negative bacterial infections	FASEB JOURNAL			English	Article						embryonic immunity; transcriptional factor; antibacterial activity	GENOME-WIDE ASSOCIATION; NF-KAPPA-B; SUSCEPTIBILITY LOCI; ATOPIC-DERMATITIS; RECOGNITION; IMMUNITY; RECEPTOR; POPULATION; EFFECTOR; RNA	Zinc finger protein 365 (ZNF365) is widespread in animals, but its function and mechanism remains poorly defined. Here we clearly demonstrate that zebrafish ZNF365 is a newly identified LPS-binding protein capable of interacting with the gram-negative bacteria Escherichia coli, Vibrio anguillarum, and Aeromonas hydrophila, and functions as an antibacterial effector molecule capable of directly killing the bacteria. We also reveal that N-terminal residues 30-55 consisting of the ZnF_C2H2 domain are indispensable for ZNF365 antimicrobial activity. Importantly, microinjection of recombinant ZNF365 into early embryos significantly enhanced the resistance of the embryos against pathogenic A. hydrophila challenge, whereas down-regulation of ZNF365 by injection of znf365 morpholino into embryos considerably lowered their resistance against A. hydrophila challenge. Furthermore, the N-terminal peptide Z(30-55) with in vitro antibacterial activity also promoted the resistance of embryos against A. hydrophila, but the peptide Z(56-345) without in vitro antibacterial activity did not. Collectively, these results indicate that ZNF365 is a maternal LPS-binding protein that can protect the early embryos of zebrafish against pathogenic attacks, a novel role to be assigned to ZNF365 proteins. This work also provides new insights into the immunologic function of the zinc finger proteins that are widely distributed in various animals.	[Du, Xiaoyuan; Zhou, Yang; Song, Lili; Wang, Xia; Zhang, Shicui] Ocean Univ China, Inst Evolut & Marine Biodivers, Dept Marine Biol, Qingdao, Peoples R China; [Du, Xiaoyuan; Zhou, Yang; Song, Lili; Wang, Xia; Zhang, Shicui] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Wang, X (corresponding author), Ocean Univ China, Dept Marine Biol, 5 Yushan Rd, Qingdao 266003, Peoples R China.; Zhang, SC (corresponding author), Ocean Univ China, Dept Marine Biol Evolut & Marine Biodivers, 5 Yushan Rd, Qingdao 266003, Peoples R China.	wx_fajiao163@163.com; sczhang@ouc.edu.cn			National Natural Science Foundation of China [31372505, U1401211]; Fundamental Research Funds for Central Universities [201762003]; Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, China	The authors thank M. Zhu (Institute of Evolution & Marine Biodiversity, Ocean University of China) for technical aid in flow cytometry and D. Feng (Institute of Evolution & Marine Biodiversity, Ocean University of China) for help with immunohistochemistry. This work was supported by the National Natural Science Foundation of China (31372505 and U1401211), by the Fundamental Research Funds for Central Universities (201762003), and by the Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, China. The authors declare no conflicts of interest.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gao Z, 2014, EUR J IMMUNOL, V44, P3680, DOI 10.1002/eji.201444734; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; KLUG A, 1987, COLD SPRING HARB SYM, V52, P473, DOI 10.1101/SQB.1987.052.01.054; Klug A, 1999, J MOL BIOL, V293, P215, DOI 10.1006/jmbi.1999.3007; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee H, 2015, BBA-BIOMEMBRANES, V1848, P634, DOI 10.1016/j.bbamem.2014.11.016; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; Liang YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004234; Liu B, 2013, J SURG RES, V185, P717, DOI 10.1016/j.jss.2013.06.031; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Nagase T, 1998, DNA Res, V5, P277, DOI 10.1093/dnares/5.5.277; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P1502, DOI 10.1016/j.jaci.2014.10.033; Sharif-Askari E, 2010, MOL CELL BIOL, V30, P3929, DOI 10.1128/MCB.00087-10; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Sun RL, 2011, GENET MOL RES, V10, P3712, DOI 10.4238/2011.December.8.6; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Wang CM, 2013, J BIOL CHEM, V288, P24600, DOI 10.1074/jbc.M113.473397; Wang SH, 2011, J BIOL CHEM, V286, P22653, DOI 10.1074/jbc.M111.247635; Wang X, 2016, J BIOL CHEM, V291, P4019, DOI 10.1074/jbc.M115.679167; Wang ZP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004498; Zhang HJ, 2016, PLANT CELL PHYSIOL, V57, P2472, DOI 10.1093/pcp/pcw160; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]; Zhang YQ, 2013, CELL CYCLE, V12, P2817, DOI 10.4161/cc.25882	32	7	7	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					979	994		10.1096/fj.201700694R	http://dx.doi.org/10.1096/fj.201700694R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29042450	Bronze			2022-12-26	WOS:000425146900038
J	Ma, LQ; Hu, JB; Li, JY; Yang, Y; Zhang, LK; Zou, LY; Gao, RF; Peng, C; Wang, Y; Luo, T; Xiang, XJ; Qing, H; Xiao, XQ; Wu, CD; Wang, ZH; He, JC; Li, QF; Yang, SM				Ma, Linqiang; Hu, Jinbo; Li, Jiayu; Yang, Yi; Zhang, Linkun; Zou, Lingyun; Gao, Rufei; Peng, Chuan; Wang, Yue; Luo, Ting; Xiang, Xiaojiao; Qing, Hua; Xiao, Xiaoqiu; Wu, Chaodong; Wang, Zhihong; He, John Cijiang; Li, Qifu; Yang, Shumin			Bisphenol A promotes hyperuricemia via activating xanthine oxidase	FASEB JOURNAL			English	Article						uric acid; synthesis; direct binding; enzyme; liver	URIC-ACID; OXIDATIVE STRESS; GENE-EXPRESSION; ESTROGEN; MECHANISM; EXPOSURE; DOCKING; DISEASE; HEALTH; SERUM	The prevalence of hyperuricemia has increased rapidly over the past decades. Bisphenol A (BPA) is an environmental endocrine disruptor. We investigated the effects of BPA on uric acid metabolism and its potential mechanisms. Experiments were performed in different animal models, cell cultures, and humans. In 3 different animal models, BPA exposure increased serum and hepatic uric acid with enhanced activity of xanthine oxidase (XO) in liver, whereas the excretion of uric acid was unchanged. Both in vivo and in vitro, BPA-induced uric acid production was decreased after treatment with allopurinol, which is a XO inhibitor. XO led to the accumulation of uric acid after xanthine was added, with the enzyme-catalyzed reaction, which was enhanced by BPA. Altered secondary structures of XO were found by circular dichroism analysis in the conditions of different BPA concentrations. Molecular docking portrayed Asp360 and Lys422 of XO to be the preferred binding sites for BPA. Mutation of both sites significantly blocked the effect of BPA on XO activity. In humans, patients with hyperuricemia exhibited higher levels of serum BPA than subjects without hyperuricemia. These findings demonstrate BPA promotes hyperuricemia by increasing hepatic uric acid synthesis via the activation of XO, probably through direct binding.	[Ma, Linqiang; Hu, Jinbo; Yang, Yi; Zhang, Linkun; Gao, Rufei; Wang, Yue; Luo, Ting; Xiang, Xiaojiao; Qing, Hua; Xiao, Xiaoqiu; Wang, Zhihong; Li, Qifu; Yang, Shumin] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, 1 Youyi St, Chongqing 400016, Peoples R China; [Li, Jiayu; Peng, Chuan; Xiao, Xiaoqiu] Chongqing Med Univ, Affiliated Hosp 1, Lab Lipid & Glucose Metab, Chongqing, Peoples R China; [Zhang, Linkun] Third Mil Med Univ, Bioinformat Ctr, Dept Microbiol, Chongqing, Peoples R China; [Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA; [Wang, Zhihong; He, John Cijiang] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA; [Wang, Zhihong] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA	Chongqing Medical University; Chongqing Medical University; Army Medical University; Texas A&M University System; Texas A&M University College Station; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Li, QF; Yang, SM (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, 1 Youyi St, Chongqing 400016, Peoples R China.	liqifu@yeah.net; 443068494@qq.com	Xiao, Xiaoqiu/AAA-3869-2022; Hu, Jinbo/AAB-7109-2021; Xiao, Xiaoqiu/K-7672-2019	Xiao, Xiaoqiu/0000-0002-4568-8772; Li, Qifu/0000-0003-3904-410X; Hu, Jinbo/0000-0003-2925-0583	National Key Clinical Specialties Construction Program of China; National Natural Science Foundation of China [81370954, 81670785]; Fundamental Science and Advanced Technology Research of Chongqing Major Project [cstc2015jcyjBX0096]; Chongqing Science and Technology Committee Innovation Project, Technology Development and Application of Precision Medicine [cstc2016shms-ztzx1003]	National Key Clinical Specialties Construction Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Science and Advanced Technology Research of Chongqing Major Project; Chongqing Science and Technology Committee Innovation Project, Technology Development and Application of Precision Medicine	The authors thank the Endocrinology Laboratory and the Laboratory of Lipid and Glucose Metabolism, First Affiliated Hospital of Chongqing Medical University. Support was provided by the National Key Clinical Specialties Construction Program of China to the Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University; National Natural Science Foundation of China Grants 81370954, 81670785 (to Q.L.); Fundamental Science and Advanced Technology Research of Chongqing Major Project, cstc2015jcyjBX0096 (to Q.L.); Chongqing Science and Technology Committee Innovation Project, Technology Development and Application of Precision Medicine, cstc2016shms-ztzx1003 (to Q.L.) L. Ma and J. Hu are co-first authors. The authors declare no conflicts of interest.	Alonso-Magdalena P, 2012, MOL CELL ENDOCRINOL, V355, P201, DOI 10.1016/j.mce.2011.12.012; Amaral GP, 2012, TOXICOL IN VITRO, V26, P125, DOI 10.1016/j.tiv.2011.10.006; Arden C, 2011, DIABETES, V60, P3110, DOI 10.2337/db11-0061; Attia AM, 2011, INDIAN J BIOCHEM BIO, V48, P184; Bae S, 2015, HYPERTENSION, V65, P313, DOI 10.1161/HYPERTENSIONAHA.114.04261; Bellanti F, 2013, REDOX BIOL, V1, P340, DOI 10.1016/j.redox.2013.05.003; Budhiraja R, 2003, ANTIOXID REDOX SIGN, V5, P705, DOI 10.1089/152308603770380007; Cao HN, 2010, J BIOL CHEM, V285, P28044, DOI 10.1074/jbc.M110.128561; Duda M, 2007, J MOL CELL CARDIOL, V42, P400, DOI 10.1016/j.yjmcc.2006.10.014; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Gassman NR, 2016, ENVIRON HEALTH PERSP, V124, P1241, DOI 10.1289/EHP237; Hadizadeh M, 2009, ACTA BIOCH BIOPH SIN, V41, P603, DOI 10.1093/abbs/gmp048; Hassan ZK, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/194829; Hu JB, 2016, J HYPERTENS, V34, P332, DOI 10.1097/HJH.0000000000000780; Hu JB, 2015, ACTA DIABETOL, V52, P1135, DOI 10.1007/s00592-015-0801-5; Kataria A, 2015, NAT REV NEPHROL, V11, P610, DOI 10.1038/nrneph.2015.94; Kaur K, 2014, FREE RADICAL BIO MED, V76, P25, DOI 10.1016/j.freeradbiomed.2014.07.030; Kuo CC, 2015, ENVIRON INT, V76, P32, DOI 10.1016/j.envint.2014.11.015; Lee CI, 2000, J BIOL CHEM, V275, P9369, DOI 10.1074/jbc.275.13.9369; Lee YM, 2013, ATHEROSCLEROSIS, V230, P1, DOI 10.1016/j.atherosclerosis.2013.06.012; Liang Q, 2014, ENVIRON HEALTH PERSP, V122, P601, DOI 10.1289/ehp.1307491; Liu R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/762820; Liu X, 2007, FEBS J, V274, P6340, DOI 10.1111/j.1742-4658.2007.06152.x; Macczak A, 2017, TOXICOL IN VITRO, V41, P143, DOI 10.1016/j.tiv.2017.02.018; Mandal AK, 2015, ANNU REV PHYSIOL, V77, P323, DOI 10.1146/annurev-physiol-021113-170343; Marmugi A, 2012, HEPATOLOGY, V55, P395, DOI 10.1002/hep.24685; Melzer D, 2012, CIRCULATION, V125, P1482, DOI 10.1161/CIRCULATIONAHA.111.069153; Ning G, 2011, ANN INTERN MED, V155, P368, DOI 10.7326/0003-4819-155-6-201109200-00005; Nipic D, 2010, HEPATOLOGY, V51, P2140, DOI 10.1002/hep.23598; Ohtsubo T, 2004, CIRC RES, V95, P1118, DOI 10.1161/01.RES.0000149571.96304.36; Olea-Herrero N, 2014, J CELL PHYSIOL, V229, P2057, DOI 10.1002/jcp.24665; Petrie JL, 2013, AM J PHYSIOL-ENDOC M, V305, pE1255, DOI 10.1152/ajpendo.00214.2013; RIESELBACH RE, 1974, AM J MED, V56, P665, DOI 10.1016/0002-9343(74)90633-0; Sakuma S, 2010, FOOD CHEM TOXICOL, V48, P2217, DOI 10.1016/j.fct.2010.05.051; Shankar A, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/481641; Strasak A, 2008, CLIN CHEM, V54, P273, DOI 10.1373/clinchem.2007.094425; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Xu CF, 2015, J HEPATOL, V62, P1412, DOI 10.1016/j.jhep.2015.01.019; Yan JK, 2013, FOOD CHEM, V141, P3766, DOI 10.1016/j.foodchem.2013.06.092; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	40	19	20	7	41	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1007	1016		10.1096/fj.201700755R	http://dx.doi.org/10.1096/fj.201700755R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29042453				2022-12-26	WOS:000425146900040
J	Casasanta, MA; Yoo, CC; Smith, HB; Duncan, AJ; Cochrane, K; Varano, AC; Allen-Vercoe, E; Slade, DJ				Casasanta, Michael A.; Yoo, Christopher C.; Smith, Hans B.; Duncan, Alison J.; Cochrane, Kyla; Varano, Ann C.; Allen-Vercoe, Emma; Slade, Daniel J.			A chemical and biological toolbox for Type Vd secretion: Characterization of the phospholipase A1 autotransporter FplA from Fusobacterium nucleatum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemical biology; colorectal cancer; host-pathogen interaction; phospholipase A; protein secretion; Fusobacterium; autotransporter	INFECTIVE ENDOCARDITIS; BRAIN ABSCESSES; FAD-I; PROTEIN; INHIBITION; VIRULENCE; BINDING; MODEL; FAP2; A(2)	Fusobacterium nucleatum is an oral pathogen that is linked to multiple human infections and colorectal cancer. Strikingly, F. nucleatum achieves virulence in the absence of large, multiprotein secretion systems (Types I, II, III, IV, and VI), which are widely used by Gram-negative bacteria for pathogenesis. By contrast, F. nucleatum strains contain genomic expansions of Type V secreted effectors (autotransporters) that are critical for host cell adherence, invasion, and biofilm formation. Here, we present the first characterization of an F. nucleatum Type Vd phospholipase class A1 autotransporter (strain ATCC 25586, gene FN1704) that we hereby rename Fusobacterium phospholipase autotransporter (FplA). Biochemical analysis of multiple Fusobacterium strains revealed that FplA is expressed as a full-length 85-kDa outer membrane-embedded protein or as a truncated phospholipase domain that remains associated with the outer membrane. Whereas the role of Type Vd secretion in bacteria remains unidentified, we show that FplA binds with high affinity to host phosphoinositide-signaling lipids, revealing a potential role for this enzyme in establishing an F. nucleatum intracellular niche. To further analyze the role of FplA, we developed an fplA gene knock-out strain, which will guide future in vivo studies to determine its potential role in F. nucleatum pathogenesis. In summary, using recombinant FplA constructs, we have identified a biochemical toolbox that includes lipid substrates for enzymatic assays, potent inhibitors, and chemical probes to detect, track, and characterize the role of Type Vd secreted phospholipases in Gram-negative bacteria.	[Casasanta, Michael A.; Yoo, Christopher C.; Smith, Hans B.; Duncan, Alison J.; Slade, Daniel J.] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Cochrane, Kyla] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Cochrane, Kyla] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; [Cochrane, Kyla] Simon Fraser Univ, Dept Biochem & Mol Biol, Burnaby, BC V5A 1S6, Canada; [Varano, Ann C.] Virginia Tech Caril Res Inst, Roanoke, VA 24016 USA; [Allen-Vercoe, Emma] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	Virginia Polytechnic Institute & State University; British Columbia Cancer Agency; University of British Columbia; Simon Fraser University; University of Guelph	Slade, DJ (corresponding author), Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA.	dslade@vt.edu	Slade, Daniel/E-1329-2015	Slade, Daniel/0000-0001-5634-7220; Casasanta, Michael/0000-0001-6614-9623; Yoo, Christopher/0000-0003-0274-7960	Virginia Tech new faculty start-up funds; Institute for Critical Technology and Applied Science (ICTAS, Virginia Tech); Canadian Cancer Society Research Institute	Virginia Tech new faculty start-up funds; Institute for Critical Technology and Applied Science (ICTAS, Virginia Tech); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported in part by Virginia Tech new faculty start-up funds and a seed grant from the Institute for Critical Technology and Applied Science (ICTAS, Virginia Tech) (to D. J. S.). This work was also supported in part through an Innovation grant from the Canadian Cancer Society Research Institute (to E. A. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Abed J, 2016, CELL HOST MICROBE, V20, P215, DOI 10.1016/j.chom.2016.07.006; ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Adibekian A., 2013, PROBE REPORTS NIH MO; Afra K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-264; Ahmed Z, 2015, WORLD J GASTROENTERO, V21, P3731, DOI 10.3748/wjg.v21.i12.3731; Albenne C, 2017, MOL MICROBIOL, V106, P505, DOI 10.1111/mmi.13832; Allewelt M, 2000, INFECT IMMUN, V68, P3998, DOI 10.1128/IAI.68.7.3998-4004.2000; Andersen KR, 2013, PROTEINS, V81, P1857, DOI 10.1002/prot.24364; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BANNAM TL, 1993, PLASMID, V29, P233, DOI 10.1006/plas.1993.1025; BENNETT CF, 1987, MOL PHARMACOL, V32, P587; Bhattacharyya S, 2016, INFECT IMMUN, V84, P1446, DOI 10.1128/IAI.01311-15; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Brook I, 2008, ARCH CARDIOVASC DIS, V101, P665, DOI 10.1016/j.acvd.2008.08.008; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Coppenhagen-Glazer S, 2015, INFECT IMMUN, V83, P1104, DOI 10.1128/IAI.02838-14; Madeira PVD, 2016, J MOL BIOL, V428, P1790, DOI 10.1016/j.jmb.2016.03.012; Dahya V, 2015, AM J MED SCI, V349, P284, DOI 10.1097/MAJ.0000000000000388; Dekker N, 1997, J BIOL CHEM, V272, P3179, DOI 10.1074/jbc.272.6.3179; Desvaux M, 2005, BBA-BIOMEMBRANES, V1713, P92, DOI 10.1016/j.bbamem.2005.05.002; Dorrell N, 1999, GASTROENTEROLOGY, V117, P1098, DOI 10.1016/S0016-5085(99)70394-X; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fan EG, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0009-2015; Flanagan L, 2014, EUR J CLIN MICROBIOL, V33, P1381, DOI 10.1007/s10096-014-2081-3; Flores-Diaz M, 2016, MICROBIOL MOL BIOL R, V80, P597, DOI 10.1128/MMBR.00082-15; Gauthier S, 2011, J MATERN-FETAL NEO M, V24, P1329, DOI 10.3109/14767058.2010.550977; Gedik AH, 2014, PEDIATR PULM, V49, pE63, DOI 10.1002/ppul.22834; Gupta S, 2010, J BIOL CHEM, V285, P36523, DOI 10.1074/jbc.M110.133140; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; Haake SK, 2006, PLASMID, V55, P27, DOI 10.1016/j.plasmid.2005.06.002; Han YPW, 2015, CURR OPIN MICROBIOL, V23, P141, DOI 10.1016/j.mib.2014.11.013; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Heckmann JG, 2003, CAN J NEUROL SCI, V30, P266, DOI 10.1017/S0317167100002717; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Howell HA, 2013, MBIO, V4, DOI 10.1128/mBio.00032-13; Huang Z., 1994, MEDIAT INFLAMM, V3, P307; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Istivan TS, 2006, MICROBIOL-SGM, V152, P1263, DOI 10.1099/mic.0.28609-0; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Kaplan CW, 2010, INFECT IMMUN, V78, P4773, DOI 10.1128/IAI.00567-10; Kaplan CW, 2009, MOL MICROBIOL, V71, P35, DOI 10.1111/j.1365-2958.2008.06503.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Lio YC, 1996, BBA-LIPID LIPID MET, V1302, P55, DOI 10.1016/0005-2760(96)00002-1; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Machado GBS, 2010, SHOCK, V33, P315, DOI 10.1097/SHK.0b013e3181b2b0f4; McGuire AM, 2014, MBIO, V5, DOI 10.1128/mBio.01864-14; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nomura DK, 2008, NAT CHEM BIOL, V4, P373, DOI 10.1038/nchembio.86; Perez Y., 2013, PROTOCOL EXCHANGE, DOI [10.1038/protex.2013.094, DOI 10.1038/PROTEX.2013.094]; Pizarro-Cerda J, 2004, NAT CELL BIOL, V6, P1026, DOI 10.1038/ncb1104-1026; Randazzo A, 1998, J NAT PROD, V61, P571, DOI 10.1021/np9704922; Rashidi A, 2012, INDIAN J GASTROENTER, V31, P198, DOI 10.1007/s12664-012-0233-x; Rossiter AE, 2011, J BACTERIOL, V193, P4250, DOI 10.1128/JB.00192-11; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Salacha R, 2010, ENVIRON MICROBIOL, V12, P1498, DOI 10.1111/j.1462-2920.2010.02174.x; SCHEVITZ RW, 1995, NAT STRUCT BIOL, V2, P458, DOI 10.1038/nsb0695-458; Segall Y, 2003, TOXICOL SCI, V76, P131, DOI 10.1093/toxsci/kfg216; SHAMMAS NW, 1993, CLIN CARDIOL, V16, P72, DOI 10.1002/clc.4960160116; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Tannaes T, 2005, FEMS IMMUNOL MED MIC, V44, P17, DOI 10.1016/j.femsim.2004.10.003; Warren RL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-16; Wells TJ, 2007, FEMS MICROBIOL LETT, V274, P163, DOI 10.1111/j.1574-6968.2007.00833.x; Wilson MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117732; Xu MH, 2007, J BIOL CHEM, V282, P25000, DOI 10.1074/jbc.M611567200	73	12	13	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20240	20254		10.1074/jbc.M117.819144	http://dx.doi.org/10.1074/jbc.M117.819144			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29021252	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000417696400028
J	Zhang, K; Chen, XL; Guo, WC; Luo, HJ; Gong, ZJ; Li, BW; Wu, WF				Zhang, Kai; Chen, Xiu Li; Guo, Wen Chao; Luo, Hui Juan; Gong, Zhi Jun; Li, Bao Wei; Wu, Wen Fei			Effects of biomass reducing agent on magnetic properties and phase transformation of Baotou low-grade limonite during magnetizing-roasting	PLOS ONE			English	Article							CARBOTHERMIC REDUCTION; ORE; SEPARATION	Biomass was used as reducing agent to roast the Baotou low-grade limonite in a high temperature vacuum atmosphere furnace. The effect of calcination temperature, time and ratio of reducing agent on the magnetic properties of calcined ore was studied by VSM. The phase and microstructure changes of limonite before and after calcination were analyzed by XRD and SEM. The results show that in the roasting process the phase transition process of the ferrous material in limonite is first dehydrated at high temperature to form alpha-Fe2O3, and then it is converted into Fe3O4 by the reduction of biomass. With the increase of calcination temperature, the magnetic properties of the calcined ore first increase and then decrease. When the temperature is higher than 650 degrees C, Fe3O4 will become Fe2SiO4, resulting in reduced the magnetic material in calcined ore and the magnetic weakened. The best magnetization effect was obtained when the roasting temperature is 550 degrees C, the percentage of biomass was 15% and the roasting time was 30min. The saturation magnetization can reach 60.13emu.g(-1), the recovery of iron was 72% and the grade of iron was 58%.	[Zhang, Kai; Guo, Wen Chao; Luo, Hui Juan; Gong, Zhi Jun; Wu, Wen Fei] Inner Mongolia Univ Sci & Technol, Sch Energy & Environm, Baotou, Inner Mongolia, Peoples R China; [Zhang, Kai; Luo, Hui Juan; Gong, Zhi Jun; Li, Bao Wei; Wu, Wen Fei] Key Lab Integrated Explorat Bayun Obo Multi Metal, Baotou, Inner Mongolia, Peoples R China; [Chen, Xiu Li] Baotou Teachers Coll, Fac Biol Sci & Technol, Baotou, Inner Mongolia, Peoples R China	Inner Mongolia University of Science & Technology; Baotou Teachers College	Wu, WF (corresponding author), Inner Mongolia Univ Sci & Technol, Sch Energy & Environm, Baotou, Inner Mongolia, Peoples R China.; Wu, WF (corresponding author), Key Lab Integrated Explorat Bayun Obo Multi Metal, Baotou, Inner Mongolia, Peoples R China.	wwf@imust.cn			natural science foundation of Inner Mongolia Autonomous Region [2015MS0546, 2017MSLH0529]	natural science foundation of Inner Mongolia Autonomous Region	The investigation was financially supported by natural science foundation of Inner Mongolia Autonomous Region (http://nsbr.nmkjt.gov.cn/nsbr/passport/login) (2015MS0546, 2017MSLH0529 to KZ).; The investigation was financially supported by natural science foundation of Inner Mongolia Autonomous Region (2015MS0546, 2017MSLH0529).	Abd Rashid RZ, 2014, ISIJ INT, V54, P994, DOI 10.2355/isijinternational.54.994; Bai SJ, 2012, ISIJ INT, V52, P1757, DOI 10.2355/isijinternational.52.1757; Beuria PC, 2017, INT J MINING SCI TEC; Bing HU, 2009, INT C SCI TECHN IR; [曹晓恩 Cao Xiaoen], 2016, [矿冶工程, Mining and Metallurgical Engineering], V36, P67; Chen LZ, 2015, MINER ENG, V78, P122, DOI 10.1016/j.mineng.2015.04.018; Feinman J, 1999, IRON STEEL ENG, P75; Frost RL, 2006, J THERM ANAL CALORIM, V84, P489, DOI 10.1007/s10973-005-6953-8; Pan Wen, 2013, Journal of Northeastern University. Natural Science, V34, P1277; Pickles CA, 2014, MINER ENG, V65, P33, DOI 10.1016/j.mineng.2014.05.006; Wang C., 2009, RES MAGNETIZING ROAS; [汪永斌 WANG Yong-bin], 2009, [过程工程学报, The Chinese Journal of Process Engineering], V9, P508; Wu F, 2017, J ALLOY COMPD, P722; Wu Y, 2012, SEP PURIF TECHNOL, V94, P34, DOI 10.1016/j.seppur.2012.04.008; Yan WU, 2013, ACTA MINERALOGIC SIN, P113; Yongfu YU, 2010, APPL FLASH MAGNETIZI; Zhang GF, 2013, CAN METALL QUART, V52, P153, DOI 10.1179/1879139512Y.0000000055; [张汉泉 ZHANG Han-quan], 2009, [钢铁, Iron and Steel], V44, P11	18	13	14	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186274	10.1371/journal.pone.0186274	http://dx.doi.org/10.1371/journal.pone.0186274			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040307	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500030
J	Persson, K; Eldholm, RS; Barca, ML; Cavallin, L; Ferreira, D; Knapskog, AB; Selbaek, G; Braekhus, A; Saltvedt, I; Westman, E; Engedal, K				Persson, Karin; Eldholm, Rannveig Sakshaug; Barca, Maria Lage; Cavallin, Lena; Ferreira, Daniel; Knapskog, Anne-Brita; Selbaek, Geir; Braekhus, Anne; Saltvedt, Ingvild; Westman, Eric; Engedal, Knut			MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis	PLOS ONE			English	Article							BRAIN ATROPHY; CORTICAL THICKNESS; DEFINED SUBTYPES; LEWY BODIES; DEMENTIA; DIAGNOSIS; EDUCATION; ASSOCIATION; DECLINE; AD	Background/Aims MRI assessment of the brain has demonstrated four different patterns of atrophy in patients with Alzheimer's disease dementia (AD): typical AD, limbic-predominant AD, hippocampalsparing AD, and a subtype with minimal atrophy, previously referred to as no-atrophy AD. The aim of the present study was to identify and describe the differences between these four AD subtypes in a longitudinal memory-clinic study. Methods The medial temporal lobes, the frontal regions, and the posterior regions were assessed with MRI visual rating scales to categorize 123 patients with mild AD according to ICD-10 and NINCDS-ADRDA criteria and the clinical dementia rating scale (CDR) into atrophy subtypes. Demographic data, neuropsychological measures, cerebrospinal-fluid biomarkers, and progression rate of dementia at two-year follow-up were compared between the groups. Results Typical AD was found in 59 patients (48%); 29 (24%) patients had limbic-predominant AD; 19 (15%) had hippocampal-sparing AD; and 16 (13%) belonged to the group with minimal atrophy. No differences were found regarding cognitive test results or progression rates between the different subtypes. Using adjusted logistic regression analysis, we found that the patients in the minimal-atrophy group were less educated, had a lower baseline CDR sum of boxes score, and had higher levels of amyloid beta in the cerebrospinal fluid. Conclusion Previous results concerning the prevalence and the similar phenotypic expressions of the four AD subtypes were confirmed. The main finding was that patients with minimal atrophy as assessed by MRI had less education than the other AD subtypes and that this could support the cognitive reserve hypothesis and, at least in part, explain the lower degree of atrophy in this group. Patients with less formal education might present with clinically typical AD symptoms before they have positive biomarkers of AD and this finding might challenge suggested biomarker-based criteria for AD.	[Persson, Karin; Barca, Maria Lage; Selbaek, Geir; Braekhus, Anne; Engedal, Knut] Vestfold Hosp Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway; [Persson, Karin; Barca, Maria Lage; Braekhus, Anne; Engedal, Knut] Oslo Univ Hosp, Dept Geriatr Med, Oslo, Norway; [Persson, Karin; Knapskog, Anne-Brita; Braekhus, Anne] Oslo Univ Hosp, Dept Geriatr Med, Memory Clin, Oslo, Norway; [Eldholm, Rannveig Sakshaug; Saltvedt, Ingvild] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Cavallin, Lena] Karolinska Inst, Div Med Imaging & Technol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Cavallin, Lena] Karolinska Univ Hosp, Dept Radiol, Stockholm, Sweden; [Ferreira, Daniel; Westman, Eric] Karolinska Inst, Div Clin Geriatr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Selbaek, Geir] Innlandet Hosp Trust, Ctr Old Age Psychiat Res, Ottestad, Norway; [Selbaek, Geir] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Braekhus, Anne] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Saltvedt, Ingvild] Univ Hosp Trondheim, St Olav Hosp, Dept Geriatr, Trondheim, Norway	University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Innlandet Hospital Trust; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU)	Persson, K (corresponding author), Vestfold Hosp Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway.; Persson, K (corresponding author), Oslo Univ Hosp, Dept Geriatr Med, Oslo, Norway.; Persson, K (corresponding author), Oslo Univ Hosp, Dept Geriatr Med, Memory Clin, Oslo, Norway.	Karin.persson@aldringoghelse.no	Saltvedt, Ingvild/AAD-9674-2022; Ferreira, Daniel/L-8974-2014; Eldholm, Rannveig/AAK-1725-2020; Westman, Eric/H-5771-2011	Saltvedt, Ingvild/0000-0002-7897-9808; Ferreira, Daniel/0000-0001-9522-4338; Eldholm, Rannveig/0000-0002-5585-0446; Westman, Eric/0000-0002-3115-2977; Selbaek, Geir/0000-0001-6511-8219	Southern and Eastern Norway Regional Health Authority [2013058]; Norwegian ExtraFoundation for Health and Rehabilitation through Norwegian Health Association; Central Norway Regional Health Authority; Norwegian University of Science and Technology (NTNU)	Southern and Eastern Norway Regional Health Authority; Norwegian ExtraFoundation for Health and Rehabilitation through Norwegian Health Association; Central Norway Regional Health Authority; Norwegian University of Science and Technology (NTNU)	Southern and Eastern Norway Regional Health Authority for providing funding for KP with an unrestricted grant, grant number 2013058 (https://www.helse-sorost.no/south-eastern-norway-regional-health-authority). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Norwegian ExtraFoundation for Health and Rehabilitation through the Norwegian Health Association for funding of coauthors RSE and MLB. (https://www.extrastiftelsen.no/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Liason Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (NTNU) for funding of coauthor RSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; Barber R, 2000, NEUROLOGY, V54, P1304, DOI 10.1212/WNL.54.6.1304; Bennett DA, 2005, NEUROLOGY, V65, P953, DOI 10.1212/01.wnl.0000176286.17192.69; Bennett DA, 2003, NEUROLOGY, V60, P1909, DOI 10.1212/01.WNL.0000069923.64550.9F; Benton AL, 1976, MULTILINGUAL APHASIA; Blennow K, 2015, ALZHEIMERS DEMENT, V11, P58, DOI 10.1016/j.jalz.2014.02.004; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Brakhus Anne, 2011, Tidsskr Nor Laegeforen, V131, P2254, DOI 10.4045/tidsskr.11.0786; Byun MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142756; Cavallin L, 2012, ACTA RADIOL, V53, P318, DOI 10.1258/ar.2012.110552; Claus JJ, 2017, PRACTICAL USE VISUAL, V27, P3147; Csernansky JG, 2004, ALZ DIS ASSOC DIS, V18, P190; Dickerson B. C., 2017, CNS SPECTRUMS, P1; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Engedal K, 1988, Compr Gerontol A, V2, P87; Ferreira D, 2015, J INTERN MED, V278, P277, DOI 10.1111/joim.12358; Ferreira D, 2017, SCI REP-UK, V7, DOI 10.1038/srep46263; Ferreira D, 2016, EUR RADIOL, V26, P2597, DOI 10.1007/s00330-015-4101-9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goodglass H., 1983, BOSTON NAMING TEST; Goodglass H., 2001, ASSESSMENT APHASIA R; Guo H, 2014, AM J NEURORADIOL, V35, P504, DOI 10.3174/ajnr.A3709; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Hwang Jihye, 2016, Alzheimers Dement (Amst), V2, P58, DOI 10.1016/j.dadm.2015.11.008; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Koedam ELGE, 2011, EUR RADIOL, V21, P2618, DOI 10.1007/s00330-011-2205-4; Koedam ELGE, 2010, J ALZHEIMERS DIS, V19, P1401, DOI 10.3233/JAD-2010-1337; Kramberger MG, 2017, J ALZHEIMERS DIS, V57, P787, DOI 10.3233/JAD-161109; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liu YW, 2012, NEURORADIOLOGY, V54, P929, DOI 10.1007/s00234-012-1005-0; Maia LF, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006446; Manly JJ, 2003, J CLIN EXP NEUROPSYC, V25, P680, DOI 10.1076/jcen.25.5.680.14579; Mattsson N, 2013, ALZHEIMERS DEMENT, V9, P251, DOI 10.1016/j.jalz.2013.01.010; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mondragon JD, 2016, DEMENT GER COGN D EX, V6, P486, DOI 10.1159/000449424; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; Noh Y, 2014, NEUROLOGY, V83, P1936, DOI 10.1212/WNL.0000000000001003; Pasquier F, 1996, EUR NEUROL, V36, P268, DOI 10.1159/000117270; Persson K, 2017, DEMENT GERIATR COGN; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rhodius-Meester HFM, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00117; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Schweizer TA, 2012, CORTEX, V48, P991, DOI 10.1016/j.cortex.2011.04.009; Seo SW, 2011, NEUROBIOL AGING, V32, P200, DOI 10.1016/j.neurobiolaging.2009.02.004; Shpanskaya KS, 2014, J NEURORADIOLOGY, V41, P350, DOI 10.1016/j.neurad.2013.11.004; Shulman K. I., 1986, INT J GERIATR PSYCH, V1, P135, DOI [10.1002/gps.930010209, DOI 10.1002/GPS.930010209]; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Teipel SJ, 2009, J ALZHEIMERS DIS, V17, P571, DOI 10.3233/JAD-2009-1077; Whitwell JL, 2008, NEUROLOGY, V71, P743, DOI 10.1212/01.wnl.0000324924.91351.7d; Whitwell JL, 2012, LANCET NEUROL, V11, P868, DOI 10.1016/S1474-4422(12)70200-4; WHO, 2012, ICD 10 CLASS MENT BE	56	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186595	10.1371/journal.pone.0186595	http://dx.doi.org/10.1371/journal.pone.0186595			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036183	Green Published, gold, Green Submitted			2022-12-26	WOS:000413054800049
J	Morales, I; Sanchez, A; Rodriguez-Sabate, C; Rodriguez, M				Morales, Ingrid; Sanchez, Alberto; Rodriguez-Sabate, Clara; Rodriguez, Manuel			Striatal astrocytes engulf dopaminergic debris in Parkinson's disease: A study in an animal model	PLOS ONE			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; ALPHA-SYNUCLEIN; MONITORING AUTOPHAGY; SUBSTANTIA-NIGRA; NEURONS; DEGENERATION; GUIDELINES; ASSAYS; GLIA; RAT	The role of astrocytes in Parkinson's disease is still not well understood. This work studied the astrocytic response to the dopaminergic denervation. Rats were injected in the lateral ventricles with 6-hydroxydopamine (25 mu g), inducing a dopaminergic denervation of the striatum not accompanied by non-selective tissue damage. The dopaminergic debris were found within spheroids (free-spheroids) which retained some proteins of dopaminergic neurons (e. g., tyrosine hydroxylase, the dopamine transporter protein, and APP) but not others (e.g., a-synuclein). Free-spheroids showed the initial (LC3-autophagosomes) but not the late (Lamp1/Lamp2-lysosomes) components of autophagy (incomplete autophagy), preparing their autophagosomes for an external phagocytosis (accumulation of phosphatidylserine). Free-spheroids were penetrated by astrocyte processes (fenestrated-spheroids) which made them immunoreactive for GFAP and S100 beta, and which had some elements needed to continue the debris degradation (Lamp1/Lamp2). Finally, proteins normally found in neurons (TH, DAT and a-synuclein) were observed within astrocytes 2-5 days after the dopaminergic degeneration, suggesting that the intracellular contents of degenerated cells had been transferred to astrocytes. Taken together, present data suggest phagocytosis as a physiological role of striatal astrocytes, a role which could be critical for cleaning striatal debris during the initial stages of Parkinson's disease.	[Morales, Ingrid; Sanchez, Alberto; Rodriguez, Manuel] Univ La Laguna, Fac Med, Dept Basic Med Sci, Lab Neurobiol & Expt Neurol, Tenerife, Canary Islands, Spain; [Morales, Ingrid; Rodriguez-Sabate, Clara; Rodriguez, Manuel] Ctr Networked Biomed Res Neurodegenerat Dis CIBER, Madrid, Spain	Universidad de la Laguna	Rodriguez, M (corresponding author), Univ La Laguna, Fac Med, Dept Basic Med Sci, Lab Neurobiol & Expt Neurol, Tenerife, Canary Islands, Spain.; Rodriguez, M (corresponding author), Ctr Networked Biomed Res Neurodegenerat Dis CIBER, Madrid, Spain.	mrdiaz@ull.es	Rodriguez, Manuel/L-1024-2014	Rodriguez, Manuel/0000-0001-7569-2898; SANCHEZ FERNANDEZ, ALBERTO/0000-0001-7741-7515	Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain [PI2014/06]	Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain	This work was supported by the Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain (PI2014/06) to Manuel Rodriguez. The authors declare no competing financial interests.	Baba M, 1998, AM J PATHOL, V152, P879; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Bates CA, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-17; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Braak H, 2007, ACTA NEUROPATHOL, V114, P231, DOI 10.1007/s00401-007-0244-3; Bruck D, 2016, NEUROBIOL DIS, V85, P262, DOI 10.1016/j.nbd.2015.03.003; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cavaliere F, 2017, NEUROBIOL DIS, V103, P101, DOI 10.1016/j.nbd.2017.04.011; Chen YH, 2015, CELL, V160, P619, DOI 10.1016/j.cell.2015.01.032; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2011, NAT REV MOL CELL BIO, V12, P535, DOI 10.1038/nrm3150; Deierborg T, 2008, PROG NEUROBIOL, V85, P407, DOI 10.1016/j.pneurobio.2008.05.001; Doorn KJ, 2012, PROG NEUROBIOL, V98, P222, DOI 10.1016/j.pneurobio.2012.06.005; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; Hammill AK, 1999, EXP CELL RES, V251, P16, DOI 10.1006/excr.1999.4581; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kim HY, 2014, PROG LIPID RES, V56, P1, DOI 10.1016/j.plipres.2014.06.002; Kim JN, 2013, BIOMOL THER, V21, P222, DOI 10.4062/biomolther.2013.006; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Kitamura Y, 2010, GLIA, V58, P1686, DOI 10.1002/glia.21040; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lee HJ, 2010, OXID MED CELL LONGEV, V3, P283, DOI 10.4161/oxim.3.4.12809; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lowe J, 2005, METHOD ENZYMOL, V399, P86, DOI 10.1016/S0076-6879(05)99007-1; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Morales I, 2016, J NEUROCHEM, V139, P81, DOI 10.1111/jnc.13684; Morales I, 2015, BEHAV BRAIN RES, V289, P19, DOI 10.1016/j.bbr.2015.04.019; Morales I, 2013, EUR J NEUROSCI, V38, P2172, DOI 10.1111/ejn.12205; Morales I, 2012, GLIA, V60, P1481, DOI 10.1002/glia.22368; Rappold PM, 2010, NEUROTHERAPEUTICS, V7, P413, DOI 10.1016/j.nurt.2010.07.001; Rodriguez M, 2015, AGING CELL, V14, P293, DOI 10.1111/acel.12312; Rodriguez M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00080; Saavedra A, 2006, NEUROBIOL DIS, V23, P533, DOI 10.1016/j.nbd.2006.04.008; Song YJC, 2009, J NEUROPATH EXP NEUR, V68, P1073, DOI 10.1097/NEN.0b013e3181b66f1b; Tagliaferro P, 2016, J PARKINSON DIS, V6, P1, DOI 10.3233/JPD-150769; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Walsh S, 2011, NEUROSCIENCE, V175, P251, DOI 10.1016/j.neuroscience.2010.12.005; Wang L, 2013, AUTOPHAGY, V9, P756, DOI 10.4161/auto.23814; ZIGMOND MJ, 1990, TRENDS NEUROSCI, V13, P290, DOI 10.1016/0166-2236(90)90112-N	48	24	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0185989	10.1371/journal.pone.0185989	http://dx.doi.org/10.1371/journal.pone.0185989			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028815	Green Submitted, Green Published, gold			2022-12-26	WOS:000412980300017
J	Mailybayeva, A; Yespembetov, B; Ryskeldinova, S; Zinina, N; Sansyzbay, A; Renukaradhya, GJ; Petrovsky, N; Tabynov, K				Mailybayeva, Aigerim; Yespembetov, Bolat; Ryskeldinova, Sholpan; Zinina, Nadezhda; Sansyzbay, Abylai; Renukaradhya, Gourapura J.; Petrovsky, Nikolai; Tabynov, Kaissar			Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats	PLOS ONE			English	Article							IMMUNE-RESPONSE; OMP16 PROTEINS; STRAIN RB51; HEIFERS; EFFICACY; FUTURE; L7/L12; SAFETY; VIRUS; LIVE	We previously developed a potent candidate vaccine against bovine brucellosis caused by Brucella abortus using the influenza viral vector expressing Brucella Omp16 and L7/L12 proteins (Flu-BA). Our success in the Flu-BA vaccine trial in cattle and results of a pilot study in non-pregnant small ruminants prompted us in the current study to test its efficacy against B. melitensis infection in pregnant sheep and goats. In this study, we improved the Flu-BA vaccine formulation and immunization method to achieve maximum efficacy and safety. The Flu-BA vaccine formulation had two additional proteins Omp19 and SOD, and administered thrice with 20% Montanide Gel01 adjuvant, simultaneously by both subcutaneous and conjunctival routes at 21 days intervals in pregnant sheep and goats. At 42 days post-vaccination (DPV) we detected antigen-specific IgG antibodies predominantly of IgG2a isotype but also IgG1, and also detected a strong lymphocyte recall response with IFN-gamma production. Importantly, our candidate vaccine prevented abortion in 66.7% and 77.8% of pregnant sheep and goats, respectively. Furthermore, complete protection (absence of live B. melitensis 16M) was observed in 55.6% and 66.7% of challenged sheep and goats, and 72.7% and 90.0% of their fetuses (lambs/yeanlings), respectively. The severity of B. melitensis 16M infection in vaccinated sheep and goats and their fetuses (index of infection and rates of Brucella colonization in tissues) was significantly lower than in control groups. None of the protection parameters after vaccination with Flu-BA vaccine were statistically inferior to protection seen with the commercial B. melitensis Rev. 1 vaccine (protection against abortion and vaccination efficacy, alpha = 0.18-0.34, infection index, P = 0.37-0.77, Brucella colonization, P = 0.16 to P > 0.99). In conclusion, our improved Flu-BA vaccine formulation and delivery method were found safe and effective in protecting pregnant sheep and goats against adverse consequences of B. melitensis infection.	[Mailybayeva, Aigerim; Ryskeldinova, Sholpan; Sansyzbay, Abylai; Tabynov, Kaissar] Res Inst Biol Safety Problems, Lab Infect Dis Prevent, Kordaiskiy Rayon, Gvardeiskiy, Kazakhstan; [Yespembetov, Bolat; Zinina, Nadezhda] Res Inst Biol Safety Problems, Lab Microbiol, Kordaiskiy Rayon, Gvardeiskiy, Kazakhstan; [Renukaradhya, Gourapura J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Vet Prevent Med, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Petrovsky, Nikolai; Tabynov, Kaissar] Vaxine Pty Ltd, Bedford Pk, SA, Australia; [Petrovsky, Nikolai; Tabynov, Kaissar] Flinders Univ S Australia, Bedford Pk, SA, Australia	Research Institute for Biological Safety Problems in Kazakhstan; Research Institute for Biological Safety Problems in Kazakhstan; University System of Ohio; Ohio State University; Flinders University South Australia	Tabynov, K (corresponding author), Res Inst Biol Safety Problems, Lab Infect Dis Prevent, Kordaiskiy Rayon, Gvardeiskiy, Kazakhstan.; Tabynov, K (corresponding author), Vaxine Pty Ltd, Bedford Pk, SA, Australia.; Tabynov, K (corresponding author), Flinders Univ S Australia, Bedford Pk, SA, Australia.	tabynov_81@mail.ru	Petrovsky, Nikolai/P-1912-2017; Tabynov, Kaissar/J-4155-2015; Mailybaeva, Aigerim/GPG-1181-2022; Yespembetov, Bolat Amanbay/M-7855-2015; Kulbekov, Erzhan/AAD-8684-2022; Ryskeldinova, Sholpan/GPG-3635-2022; Mailybayeva, Aigerim/GPG-3523-2022	Petrovsky, Nikolai/0000-0002-1580-5245; Tabynov, Kaissar/0000-0001-5823-1280; Mailybaeva, Aigerim/0000-0002-4722-0495; Yespembetov, Bolat Amanbay/0000-0003-3312-4045; 	Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan [1296/GF4]; Vaxine Pty Ltd	Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan); Vaxine Pty Ltd	This work was supported by a grant from the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (grant no.1296/GF4) (http://sc.edu.gov.kz/ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NP and KT are employed by Vaxine Pty Ltd. Vaxine Pty Ltd provided support in the form of salaries for authors NP and KT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Barrio MB, 2009, VACCINE, V27, P1741, DOI 10.1016/j.vaccine.2009.01.025; Blasco JM, 1990, MONOGR OVIS, V8, P65; BRICKER BJ, 1990, INFECT IMMUN, V58, P2935, DOI 10.1128/IAI.58.9.2935-2939.1990; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Duran-Ferrer M, 2004, VET MICROBIOL, V100, P219, DOI 10.1016/j.vetmic.2004.02.008; Edmonds MD, 2002, RES VET SCI, V72, P235, DOI 10.1053/rvsc.2002.0555; El Idrissi AH, 2001, REV SCI TECH OIE, V20, P741, DOI 10.20506/rst.20.3.1305; Garin-Bastuji B, 1998, VET RES, V29, P255; Ivanov NP, 2007, BRUCELLOSIS ANIMALS; Jacques I, 2007, VACCINE, V25, P794, DOI 10.1016/j.vaccine.2006.09.051; JIANG XS, 1993, INFECT IMMUN, V61, P124, DOI 10.1128/IAI.61.1.124-134.1993; Ko JY, 2003, CLIN MICROBIOL REV, V16, P65, DOI 10.1128/CMR.16.1.65-78.2003; Kolar J., 1995, FAO WHO OIE ROUND TA, V1, P77; Moriyon I, 2004, VET RES, V35, P1, DOI 10.1051/vetres:2003037; O'Callaghan D, 2011, BRIEF FUNCT GENOMICS, V10, P334, DOI 10.1093/bfgp/elr026; OLIVEIRA SC, 1995, EUR J IMMUNOL, V25, P2551, DOI 10.1002/eji.1830250922; OLIVEIRA SC, 1994, GENE, V140, P137, DOI 10.1016/0378-1119(94)90744-7; Schurig G, 1995, ARCH MED VET, V27, P19; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Tabynov K, 2014, AUST VET J, V92, P450, DOI 10.1111/avj.12248; Tabynov K, 2014, J VACCINES IMMUN, V1, P101; Tabynov K, 2016, VET MICROBIOL, V197, P15, DOI 10.1016/j.vetmic.2016.11.001; Tabynov K, 2016, VACCINE, V34, P5049, DOI 10.1016/j.vaccine.2016.08.072; Tabynov K, 2016, EXPERT REV VACCINES, V15, P1237, DOI 10.1080/14760584.2016.1208089; Tabynov K, 2016, VACCINE, V34, P438, DOI 10.1016/j.vaccine.2015.12.028; Tabynov K, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-69; Tabynov K, 2016, CIENC RURAL, V46, P114, DOI 10.1590/0103-8478cr20150497; Tabynov K, 2015, VACCINE, V33, P3619, DOI 10.1016/j.vaccine.2015.06.045; Tabynov K, 2014, VACCINE, V32, P5889, DOI 10.1016/j.vaccine.2014.08.073; Tabynov K, 2014, VACCINE, V32, P2034, DOI 10.1016/j.vaccine.2014.02.058; Tibor A, 1999, INFECT IMMUN, V67, P4960, DOI 10.1128/IAI.67.9.4960-4962.1999; Vialle R, 2010, PROCEDIA VACCINOL, V2, P12, DOI 10.1016/j.provac.2010.03.003; Zinsstag J, 2007, EMERG INFECT DIS, V13, P527, DOI 10.3201/eid1304.060381	33	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186484	10.1371/journal.pone.0186484	http://dx.doi.org/10.1371/journal.pone.0186484			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023541	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100133
J	Borths, MR; Stevens, NJ				Borths, Matthew R.; Stevens, Nancy J.			The first hyaenodont from the late Oligocene Nsungwe Formation of Tanzania: Paleoecological insights into the Paleogene-Neogene carnivore transition	PLOS ONE			English	Article							TOOTH ERUPTION SEQUENCE; CREODONT MAMMALIA; EVOLUTION; FOSSIL; DIVERSIFICATION; DIVERSITY; RADIATION; AFRICA; ORIGIN	Throughout the Paleogene, most terrestrial carnivore niches in Afro-Arabia were occupied by Hyaenodonta, an extinct lineage of placental mammals. By the end of the Miocene, terrestrial carnivore niches had shifted to members of Carnivora, a clade with Eurasian origins. The transition from a hyaenodont-carnivore fauna to a carnivoran-carnivore fauna coincides with other ecological changes in Afro-Arabia as tectonic conditions in the African Rift System altered climatic conditions and facilitated faunal exchange with Eurasia. Fossil bearing deposits in the Nsungwe Formation in southwestern Tanzania are precisely dated to similar to 25.2 Ma (late Oligocene), preserving a late Paleogene Afro-Arabian fauna on the brink of environmental transition, including the earliest fossil evidence of the split between Old World monkeys and apes. Here we describe a new hyaenodont from the Nsungwe Formation, Pakakali rukwaensis gen. et sp. nov., a bobcat-sized taxon known from a portion of the maxilla that preserves a deciduous third premolar and alveoli of dP(4) and M-1. The crown of dP(3) bears an elongate parastyle and metastyle and a small, blade-like metacone. Based on alveolar morphology, the two more distal teeth successively increased in size and had relatively large protocones. Using a hyaenodont character-taxon matrix that includes deciduous dental characters, Bayesian phylogenetic methods resolve Pakakali within the clade Hyainailouroidea. A Bayesian biogeographic analysis of phylogenetic results resolve the Pakakali clade as Afro-Arabian in origin, demonstrating that this small carnivorous mammal was part of an endemic Afro-Arabian lineage that persisted into the Miocene. Notably, Pakakali is in the size range of carnivoran forms that arrived and began to diversify in the region by the early Miocene. The description of Pakakali is important for exploring hyaenodont ontogeny and potential influences of Afro-Arabian tectonic events upon mammalian evolution, providing a deep time perspective on the stability of terrestrial carnivore niches through time.	[Borths, Matthew R.; Stevens, Nancy J.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Borths, Matthew R.; Stevens, Nancy J.] Ohio Univ, Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Stevens, NJ (corresponding author), Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA.; Stevens, NJ (corresponding author), Ohio Univ, Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA.	stevensn@ohio.edu	Stevens, Nancy J/E-6928-2013		National Science Foundation of the United States [DBI-1612062, EAR 0617561, EAR/IF 0933619, BCS 1127164, BCS-1313679, EAR-1349825, BCS-1638796]; Belgian Science Policy Office [BR/121/A3/PALEURAFRICA]; National Geographic Society Committee for Research Exploration; LSB Leakey Foundation; Ohio University Research Council; Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee; Div Of Biological Infrastructure [1612062] Funding Source: National Science Foundation	National Science Foundation of the United States(National Science Foundation (NSF)); Belgian Science Policy Office(Belgian Federal Science Policy Office); National Geographic Society Committee for Research Exploration(National Geographic Society); LSB Leakey Foundation; Ohio University Research Council; Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support for this study was provided by: the National Science Foundation of the United States <https://www.nsf.gov/> (DBI-1612062 to MRB; EAR 0617561 to NJS; EAR/IF 0933619 to NJS; BCS 1127164 to NJS; BCS-1313679 to NJS; EAR-1349825 to NJS; BCS-1638796 to NJS), the Belgian Science Policy Office <http://www.belspo.be/belspo/fedra/proj.asp?vertical bar=en&COD=BR/121/A3/PALEURAFRICA> to NJS as (Project BR/121/A3/PALEURAFRICA), the National Geographic Society Committee for Research Exploration <http://www.nationalgeographic.com/explorers/grants-programs/cre/> to NJS, the LSB Leakey Foundation <https://leakeyfoundation.org/> to NJS, the Ohio University Research Council <https://www.ohio.edu/standingcommittees/committee.cfm?customel_datapageid_1748687=1749816> to NJS, Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee <https://www.ohio.edu/medicine/about/offices/research-and-grants/faculty-resources/rsac.cfm> to NJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders U, 2011, PALAEONTOL Z, V85, P321, DOI 10.1007/s12542-011-0098-9; Arcila D, 2015, MOL PHYLOGENET EVOL, V82, P131, DOI 10.1016/j.ympev.2014.10.011; Barry J.C., 1988, Journal of Vertebrate Paleontology, V8, P25; BARRY JC, 1980, J PALEONTOL, V54, P1128; Bastl K, 2014, PALAEONTOL Z, V88, P481, DOI 10.1007/s12542-013-0207-z; Bastl K, 2014, PALAEONTOGR ABT A, V303, P61; Bastl K, 2011, J VERTEBR PALEONTOL, V31, P181, DOI 10.1080/02724634.2011.540052; Beck RMD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1278; Blackburn DC, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.907174; Borths MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173527; Borths MR, 2016, PEERJ, V4, DOI 10.7717/peerj.2639; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Close RA, 2015, CURR BIOL, V25, P2137, DOI 10.1016/j.cub.2015.06.047; Collard M., 2015, P ROYAL SOC B, V282; De Muizon C, 1997, LETHAIA, V30, P353; Egi N, 2007, J PALEONTOL, V81, P770, DOI 10.1666/pleo0022-3360(2007)081[0770:SSOAPA]2.0.CO;2; Eizirik E, 2010, MOL PHYLOGENET EVOL, V56, P49, DOI 10.1016/j.ympev.2010.01.033; Friscia AR, 2007, J ZOOL, V272, P82, DOI 10.1111/j.1469-7998.2006.00246.x; Friscia Anthony R., 2010, P311; Gaina C, 2013, TECTONOPHYSICS, V604, P4, DOI 10.1016/j.tecto.2013.05.037; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; Gheerbrant E, 2006, GEOL MAG, V143, P475, DOI 10.1017/S0016756806002032; Gorscak E, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.1047; Grohe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049054; Halliday TJD, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3026; Harzhauser M, 2007, ZOOL ANZ, V246, P241, DOI 10.1016/j.jcz.2007.05.001; Holliday JA, 2004, PALEOBIOLOGY, V30, P108, DOI 10.1666/0094-8373(2004)030<0108:EOHTEO>2.0.CO;2; Holroyd P. A., 2010, CENOZOIC MAMMALS AFR, P851; Holroyd Patricia A., 1999, Paleobios, V19, P1; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Lee MSY, 2014, SYST BIOL, V63, P442, DOI 10.1093/sysbio/syt110; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Lewis Margaret E., 2010, P543; Lihoreau Fabrice, 2007, P89; Lund EK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154403; Maddison W.P., 2016, MESQUITE MODULAR SYS; McCartney JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090415; Mellett J.S., 1977, CONTRIBUTIONS TO VERTEBRATE EVOLUTION, V1, P1; Miles AEW, 1990, COLYERS VARIATIONS D; Morales J., 2003, Geological Survey of Namibia Memoir, V19, P177; Morales J., 2008, MEMOIR GEOLOGICAL SU, V20, P291; Morlo M, 1999, GEOBIOS-LYON, V32, P297, DOI 10.1016/S0016-6995(99)80043-6; Morlo M, 2007, J VERTEBR PALEONTOL, V27, P145, DOI 10.1671/0272-4634(2007)27[145:CACFWM]2.0.CO;2; Nowak R. M., 2005, WALKERS CARNIVORES W; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Owen R., 1837, ENCY ANATOMY PHYSL, V4, P864; Painter LE, 2015, ECOLOGY, V96, P252, DOI 10.1890/14-0712.1; Partridge TC., 2010, CENOZOIC MAMMALS AFR, P3, DOI DOI 10.1525/CALIFORNIA/9780520257214.003.0001; Prevosti FJ, 2013, J MAMM EVOL, V20, P3, DOI 10.1007/s10914-011-9175-9; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Rana RS, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.965308; Rao M, 2001, SCIENCE, V294, P1923; Rasmussen DT, 2009, PALAEONTOGR ABT A, V288, P1; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roberts EM, 2012, NAT GEOSCI, V5, P289, DOI [10.1038/ngeo1432, 10.1038/NGEO1432]; Roberts EM, 2010, J AFR EARTH SCI, V57, P179, DOI 10.1016/j.jafrearsci.2009.09.002; Rolland J, 2015, GLOBAL ECOL BIOGEOGR, V24, P1059, DOI 10.1111/geb.12354; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; ROSE KD, 2006, BEGINNING AGE MAMMAL; Sallam HM, 2009, P NATL ACAD SCI USA, V106, P16722, DOI 10.1073/pnas.0908702106; Savage R. J. G., 1965, Bulletin of the British Museum (Natural History) Geology, V10, P239; Schlosser M., 1911, Beitreage zur Palaeontologie u Geologie Oesterreich-Ungarns u des Orients Wien u Leipzig, V24; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrago CG, 2013, J EVOLUTION BIOL, V26, P2438, DOI 10.1111/jeb.12237; Seiffert ER, 2012, EVOL ANTHROPOL, V21, P239, DOI 10.1002/evan.21335; Seiffert ER, 2010, ACTA PALAEONTOL POL, V55, P599, DOI 10.4202/app.2010.0023; Sen S, 2013, GEOBIOS-LYON, V46, P159, DOI 10.1016/j.geobios.2012.10.012; Sepulchre P, 2006, SCIENCE, V313, P1419, DOI 10.1126/science.1129158; Sige A B, 1990, PALAEONTOGR ABT A, pA214; Simons E.L., 1974, Annals of the Geological Survey of Egypt, V4, P157; SLAUGHTER BH, 1974, J MAMMAL, V55, P115, DOI 10.2307/1379261; SLOWINSKI JB, 1993, SYST BIOL, V42, P155, DOI 10.2307/2992538; Sole A F, 2015, PLOS ONE, V10; Sole F, 2016, PALAEONTOL ELECTRON, V19; Sole F, 2014, J SYST PALAEONTOL, V12, P303, DOI 10.1080/14772019.2013.795196; Sole F, 2009, ZOOL J LINN SOC-LOND, V156, P827, DOI 10.1111/j.1096-3642.2008.00501.x; Springer MS, 2011, PHILOS T R SOC B, V366, P2478, DOI 10.1098/rstb.2011.0023; Stevens NJ, 2013, NATURE, V497, P611, DOI 10.1038/nature12161; Stevens WN, 2016, RUKWA RIFT BASIN TAN, V36; Ungar PS., 2010, MAMMAL TEETH; Van Valen L., 1967, Bulletin of the American Museum of Natural History, V135, P217; van Valkenburgh B., 1990, P181; VANVALKENBURGH B, 1988, PALEOBIOLOGY, V14, P155, DOI 10.1017/S0094837300011891; Werdelin L, 2010, CENOZOIC MAMMALS AFR, P603, DOI DOI 10.1525/CALIF0RNIA/9780520257214.003.0032; Winkler A.J., 2010, CENOZOIC MAMMALS AFR, P263; Wood HM, 2013, SYST BIOL, V62, P264, DOI 10.1093/sysbio/sys092; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Zack SP, 2012, J MAMMAL, V93, P808, DOI 10.1644/11-MAMM-A-245.1	89	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185301	10.1371/journal.pone.0185301	http://dx.doi.org/10.1371/journal.pone.0185301			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020030	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400025
J	Karampetsou, MP; Comte, D; Kis-Toth, K; Kyttaris, VC; Tsokos, GC				Karampetsou, Maria P.; Comte, Denis; Kis-Toth, Katalin; Kyttaris, Vasileios C.; Tsokos, George C.			Expression patterns of signaling lymphocytic activation molecule family members in peripheral blood mononuclear cell subsets in patients with systemic lupus erythematosus	PLOS ONE			English	Article							T-CELLS; DIFFERENTIAL EXPRESSION; SUSCEPTIBILITY LOCI; CD229 LY9; SLAM; CD244; CONTRIBUTES; ENGAGEMENT; RECEPTORS; SAP	Genome-wide linkage analysis studies (GWAS) studies in systemic lupus erythematosus (SLE) identified the 1q23 region on human chromosome 1, containing the Signaling Lymphocytic Activation Molecule Family (SLAMF) cluster of genes, as a lupus susceptibility locus. The SLAMF molecules (SLAMF1-7) are immunoregulatory receptors expressed predominantly on hematopoietic cells. Activation of cells of the adaptive immune system is aberrant in SLE and dysregulated expression of certain SLAMF molecules has been reported. We examined the expression of SLAMF1-7 on peripheral blood T cells, B cells, monocytes, and their respective differentiated subsets, in patients with SLE and healthy controls in a systematic manner. SLAMF1 levels were increased on both T cell and B cells and their differentiated subpopulations in patients with SLE. SLAMF2 was increased on SLE CD4+ and CD8+ T cells. The frequency of SLAMF4+ and SLAMF7+ central memory and effector memory CD8+ T cells was reduced in SLE patients. Naive CD4+ and CD8+ SLE T cells showed a slight increase in SLAMF3 levels. No differences were seen in the expression of SLAMF5 and SLAMF6 among SLE patients and healthy controls. Overall, the expression of various SLAMF receptors is dysregulated in SLE and may contribute to the immunopathogenesis of the disease.	[Karampetsou, Maria P.; Comte, Denis; Kis-Toth, Katalin; Kyttaris, Vasileios C.; Tsokos, George C.] Harvard Med Sch, Div Rheumatol, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Comte, Denis] CHU Vaudois, Div Immunol & Allergy, Lausanne, Switzerland	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Tsokos, GC (corresponding author), Harvard Med Sch, Div Rheumatol, Beth Israel Deaconess Med Ctr, Boston, MA USA.	gtsokos@bidmc.harvard.edu	Comte, Denis/ABF-4743-2020; Kyttaris, Vasileios/AAR-4507-2020; tsokos, george C/O-3360-2013	Comte, Denis/0000-0002-6605-1498; Kyttaris, Vasileios/0000-0001-7652-3826; tsokos, george C/0000-0001-9589-2360; Karampetsou, Maria/0000-0002-6567-7253	United States National Institutes of Health [P01 A1065687, R01 A142269, R37 A149954]; SICPA Foundation	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SICPA Foundation	This work was funded by the United States National Institutes of Health (https://www.nih.gov) with grant numbers P01 A1065687, R01 A142269 and R37 A149954 (to G.C.T.). This work was also supported by a SICPA Foundation grant (http://www.sicpa.com/company-heritage/communities) to D.C.	Aversa G, 1997, J IMMUNOL, V158, P4036; Balada E, 2011, IMMUNOBIOLOGY, V216, P1034, DOI 10.1016/j.imbio.2011.03.004; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Chatterjee M, 2012, J IMMUNOL, V188, P1206, DOI 10.4049/jimmunol.1102773; Chatterjee M, 2011, AUTOIMMUNITY, V44, P211, DOI 10.3109/08916934.2010.530627; Comte D, 2015, LUPUS, V24, P351, DOI 10.1177/0961203314556139; Comte D, 2016, P NATL ACAD SCI US; Comte D, 2016, ARTHRITIS RHEUM; Comte D, 2016, P NATL ACAD SCI USA, V113, P9321, DOI 10.1073/pnas.1605081113; Detre C, 2010, SEMIN IMMUNOPATHOL, V32, P157, DOI 10.1007/s00281-009-0193-0; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Hagberg N, 2013, J IMMUNOL, V191, P2989, DOI 10.4049/jimmunol.1301022; Hogarth MB, 1998, J IMMUNOL, V161, P2753; Karampetsou MP, 2016, J IMMUNOL, V196, P4915, DOI 10.4049/jimmunol.1501523; Kim JR, 2010, CLIN EXP IMMUNOL, V160, P348, DOI 10.1111/j.1365-2249.2010.04116.x; Kis-Toth K, 2015, ARTHRITIS RHEUMATOL; Kis-Toth K, 2016, ARTHRITIS RHEUMATOL, V68, P164, DOI 10.1002/art.39410; KONO DH, 1994, P NATL ACAD SCI USA, V91, P10168, DOI 10.1073/pnas.91.21.10168; Krishnan S, 2004, J IMMUNOL, V172, P7821, DOI 10.4049/jimmunol.172.12.7821; Linan-Rico L, 2015, LUPUS, V24, P1184, DOI 10.1177/0961203315584412; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Margraf S, 2015, IMMUNOLOGY, V146, P392, DOI 10.1111/imm.12513; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; Ota Y, 2010, MOD RHEUMATOL, V20, P427, DOI 10.1007/s10165-010-0302-x; Puliaeva I, 2009, AUTOIMMUN REV, V8, P219, DOI 10.1016/j.autrev.2008.07.045; Punnonen J, 1997, J EXP MED, V185, P993, DOI 10.1084/jem.185.6.993; Rodriguez-Bayona B, 2011, IMMUNOL LETT, V134, P122, DOI 10.1016/j.imlet.2010.09.015; Romero X, 2004, TISSUE ANTIGENS, V64, P132, DOI 10.1111/j.1399-0039.2004.00247.x; Rozzo SJ, 1996, P NATL ACAD SCI USA, V93, P15164, DOI 10.1073/pnas.93.26.15164; Shin JS, 2001, FEMS MICROBIOL LETT, V197, P131, DOI 10.1016/S0378-1097(01)00108-2; Suzuki A, 2008, NAT GENET, V40, P1224, DOI 10.1038/ng.205; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tsao BP, 2003, TRENDS IMMUNOL, V24, P595, DOI 10.1016/j.it.2003.09.006; TSOKOS GC, 1983, J IMMUNOL, V131, P1797; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Wang A, 2010, CURR OPIN IMMUNOL, V22, P706, DOI 10.1016/j.coi.2010.10.014	36	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186073	10.1371/journal.pone.0186073	http://dx.doi.org/10.1371/journal.pone.0186073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020082	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400065
J	Jasinska-Konior, K; Pochylczuk, K; Czajka, E; Michalik, M; Romanowska-Dixon, B; Swakon, J; Urbanska, K; Elas, M				Jasinska-Konior, Katarzyna; Pochylczuk, Katarzyna; Czajka, Elibieta; Michalik, Marta; Romanowska-Dixon, Boiena; Swakon, Jan; Urbanska, Krystyna; Elas, Martyna			Proton beam irradiation inhibits the migration of melanoma cells	PLOS ONE			English	Article							RELATIVE BIOLOGICAL EFFECTIVENESS; UVEAL MELANOMA; SURVIVAL; RADIOTHERAPY; PROGRESSION; EXPRESSION; FIBROBLASTS; APOPTOSIS; SYSTEM; DAMAGE	Purpose In recent years experimental data have indicated that low-energy proton beam radiation might induce a difference in cellular migration in comparison to photons. We therefore set out to compare the effect of proton beam irradiation and X-rays on the survival and long-term migratory properties of two cell lines: uveal melanoma Mel270 and skin melanoma BLM. Materials and methods Cells treated with either proton beam or X-rays were analyzed for their survival using clonogenic assay and MTT test. Long-term migratory properties were assessed with time-lapse monitoring of individual cell movements, wound test and transpore migration, while the expression of the related proteins was measured with western blot. Results Exposure to proton beam and X-rays led to similar survival but the quality of the cell colonies was markedly different. More paraclones with a low proliferative activity and fewer highly-proliferative holoclones were found after proton beam irradiation in comparison to X-rays. At 20 or 40 days post-irradiation, migratory capacity was decreased more by proton beam than by X-rays. The beta-1-integrin level was decreased in Mel270 cells after both types of radiation, while vimentin, a marker of EMT, was increased in BLM cells only. Conclusions We conclude that proton beam irradiation induced long-term inhibition of cellular motility, as well as changes in the level of beta-1 integrin and vimentin. If confirmed, the change in the quality, but not in the number of colonies after proton beam irradiation might favor tumor growth inhibition after fractionated proton therapy.	[Jasinska-Konior, Katarzyna; Pochylczuk, Katarzyna; Czajka, Elibieta; Urbanska, Krystyna; Elas, Martyna] Fac Biochem Biophys & Biotechnol, Dept Biophys, Krakow, Poland; [Michalik, Marta] Fac Biochem Biophys & Biotechnol, Dept Cell Biol, Krakow, Poland; [Romanowska-Dixon, Boiena] Jagiellonian Univ, Med Coll, Dept Ophthalmol & Ophthalm Oncol, Krakow, Poland; [Swakon, Jan] PAS, Inst Nucl Phys, Krakow, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences	Elas, M (corresponding author), Fac Biochem Biophys & Biotechnol, Dept Biophys, Krakow, Poland.	martyna.elas@uj.edu.pl	Swakoń, Jan/M-5808-2018; Elas, Martyna/E-3584-2017	Swakoń, Jan/0000-0001-9262-7326; Elas, Martyna/0000-0001-6296-2844; Jasinska-Konior, Katarzyna/0000-0003-3795-1590; Urbanska, Krystyna/0000-0001-9643-4740	National Science Centre, Cracow, Poland [2012/07/B/NZ4/01657]; Ministry of Science and Higher Education	National Science Centre, Cracow, Poland(National Science Centre, Poland); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This project was supported by grant 2012/07/B/NZ4/01657 from National Science Centre, Cracow, Poland (https://www.ncn.gov.pl/?languag=en). Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agemy L, 2008, PROSTATE, V68, P530, DOI 10.1002/pros.20702; Antoccia A, 2009, J RADIAT RES, V50, P457, DOI 10.1269/jrr.09008; Aypar U, 2011, MUTAT RES-FUND MOL M, V707, P24, DOI 10.1016/j.mrfmmm.2010.12.003; Beaver CM, 2014, CLONOGENICITY HOLOCL, V9; Boberek M, 2014, ROM REP PHYS, V66, P5; Burotto M, 2014, MAPK PATHWAY ACROSS, DOI [10.1002/cncr.28864, DOI 10.1002/CNCR.28864]; Chang PY, 2007, RADIAT ENVIRON BIOPH, V46, P187, DOI 10.1007/s00411-006-0087-7; Chaudhary P, 2016, INT J RAD ONCOL BIOL, V95; Chaudhary P, 2014, INT J RADIAT ONCOL, V90, P27, DOI 10.1016/j.ijrobp.2014.05.010; Chen PW, 1997, CLIN EXP METASTAS, V15, P509, DOI 10.1023/A:1018479011340; Damato B, 2010, BRIT J CANCER, V103, P285, DOI 10.1038/sj.bjc.6605765; Dasu A, 2013, MED PHYS, V40, DOI 10.1118/1.4769417; Dendale R, 2006, INT J RADIAT ONCOL, V65, P780, DOI 10.1016/j.ijrobp.2006.01.020; Dhillon AS, 2007, MAP KINASE SIGNALLIN, P3279; Dogrusoz M, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20212; Durante M, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/9/096702; Egger E, 2001, INT J RADIAT ONCOL, V51, P138, DOI 10.1016/S0360-3016(01)01560-7; Fokas E, 2009, BBA-REV CANCER, V1796, P216, DOI 10.1016/j.bbcan.2009.07.005; Frese MC, 2011, INT J RAD ONCOL BIOL; Friedrich T, 2012, INT J RADIAT BIOL, V88, P103, DOI 10.3109/09553002.2011.611213; Galanty A, 2008, CELL MOL BIOL LETT, V13, P585, DOI 10.2478/s11658-008-0013-x; Gerelchuluun A, 2011, INT J RADIAT BIOL, V87, P57, DOI 10.3109/09553002.2010.518201; Girdhani S, 2013, RADIAT RES, V179, P257, DOI 10.1667/RR2839.1; Green LM, 2001, RADIAT RES, V155, P32, DOI 10.1667/0033-7587(2001)155[0032:ROTFCT]2.0.CO;2; Grosse N, 2014, INT J RADIAT ONCOL, V88, P175, DOI 10.1016/j.ijrobp.2013.09.041; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; IAEA, 2000, IAEA TECHN REP SER, V398, P1; Jiang WG, 2015, SEMIN CANCER BIOL, V35, pS244, DOI 10.1016/j.semcancer.2015.03.008; Kawamoto A, 2012, ONCOL REP, V27, P51, DOI 10.3892/or.2011.1485; Kemper K, 2014, CANCER RES, V74, P5937, DOI 10.1158/0008-5472.CAN-14-1174; Komiya Yuko, 2008, Organogenesis, V4, P68; Kruger N J, 1994, Methods Mol Biol, V32, P9; Lane AM, 2015, JAMA OPHTHALMOL, V133, P792, DOI 10.1001/jamaophthalmol.2015.0887; Li FZ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00031; Lindberg U, 2008, SEMIN CANCER BIOL, V18, P2, DOI 10.1016/j.semcancer.2007.10.002; Madeja Z, 2001, BIOCHEM CELL BIOL, V79, P425, DOI 10.1139/bcb-79-4-425; McNamara AL, 2015, PHYS MED BIOL, V60, P8399, DOI 10.1088/0031-9155/60/21/8399; Moncharmont C, 2012, CANCER LETT, V322, P139, DOI 10.1016/j.canlet.2012.03.024; Ogata T, 2005, CANCER RES, V65, P113; Paganetti H, 2002, INT J RADIAT ONCOL, V53, P407, DOI 10.1016/S0360-3016(02)02754-2; Paganetti H, 2013, SEMIN RADIAT ONCOL, V23, P77, DOI 10.1016/j.semradonc.2012.11.002; Petrovic I, 2006, INT J RADIAT BIOL, V82, P251, DOI 10.1080/09553000600669859; Petrovic I, 2010, INT J RADIAT BIOL, V86, P742, DOI 10.3109/09553002.2010.481322; Rietschel P, 2005, J CLIN ONCOL, V23, P8076, DOI 10.1200/JCO.2005.02.6534; Sage E., 2016, FREE RADIC BIOL MED; Shay G, 2015, MATRIX BIOL, V44-46, P200, DOI 10.1016/j.matbio.2015.01.019; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Todorovic D, 2008, J MICROSC-OXFORD, V232, P517, DOI 10.1111/j.1365-2818.2008.02151.x; Tommasino F, 2015, CANCERS, V7, P353, DOI 10.3390/cancers7010353; Underwood T, 2016, INT J RADIAT ONCOL, V95, P56, DOI 10.1016/j.ijrobp.2015.10.006; VANMUIJEN GNP, 1989, ANTICANCER RES, V9, P879; Wedenberg M, 2013, MODEL RELATIVE BIOL; Zheng Q, 2015, HUM EXP TOXICOL, P4	53	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186002	10.1371/journal.pone.0186002	http://dx.doi.org/10.1371/journal.pone.0186002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016654	gold, Green Published, Green Submitted			2022-12-26	WOS:000412627400047
J	Suzuki, Y; Tsutsumi, K; Miyamoto, T; Yamamura, H; Imaizumi, Y				Suzuki, Yoshiaki; Tsutsumi, Kanako; Miyamoto, Tatsuya; Yamamura, Hisao; Imaizumi, Yuji			Heterodimerization of two pore domain K+ channel TASK1 and TALK2 in living heterologous expression systems	PLOS ONE			English	Article							2-PORE DOMAIN; POTASSIUM CHANNELS; FUNCTIONAL-CHARACTERISTICS; ENDOPLASMIC-RETICULUM; DISULFIDE-BRIDGE; CALCIUM-ENTRY; SUBUNITS; CONDUCTANCE; PH; ANESTHETICS	Two-pore-domain K+ (K-2P) channels sense a wide variety of stimuli such as mechanical stress, inhalational anesthetics, and changes in extracellular pH or temperature. The K-2P channel activity forms a background K+ current and, thereby, contributes to resting membrane potentials. Six subfamilies including fifteen subtypes of K-2P channels have been identified. Each K-2P channel molecule with two pores consists of a homodimer of each subtype. In addition, a few heterodimers mainly within the same subfamilies have been found recently. In the present study, the possibility of heterodimerization between TASK1 (TWIK-Related Acid-Sensitive K+ channel) and TALK2 (TWIK-Related Alkaline pH-Activated K+ channel) was examined. These channels belong to separate subfamilies and show extremely different channel properties. Surprisingly, single molecular imaging analyses in this study using a total internal reflection microscope suggested the heterodimerization of TASK1 and TALK2 in a pancreatic cell line, QGP-1. This heterodimer was also detected using a bimolecular fluorescence complementation assay in a HEK293 heterologous expression system. Fluorescence resonance energy transfer analyses showed that the affinity between TASK1 and TALK2 appeared to be close to those of homodimers. Whole-cell patch-clamp recordings revealed that TASK1 currents in HEK293 cells were significantly attenuated by co-expression of a dominant-negative form of TALK2 in comparison with that of wild-type TALK2. The sensitivities of TASK1-TALK2 tandem constructs to extracellular pH and halothane were characterized as a unique hybrid of TASK1 and TALK2. These results suggested that heterodimerization of TASK1 and TALK2 provides cells with the ability to make multiple responses to a variety of physiological and pharmacological stimuli.	[Suzuki, Yoshiaki; Tsutsumi, Kanako; Miyamoto, Tatsuya; Yamamura, Hisao; Imaizumi, Yuji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Nagoya, Aichi, Japan	Nagoya City University	Imaizumi, Y (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Nagoya, Aichi, Japan.	yimaizum@phar.nagoya-cu.ac.jp	Imaizumi, Yuji/AAF-6585-2020; Suzuki, Yoshiaki/ABH-5320-2020	Suzuki, Yoshiaki/0000-0002-7879-6059; Imaizumi, Yuji/0000-0001-9431-688X	JSPS KAKENHI [16H06215, 16K15127, 16K08278, 17H05537, 26293021, 16K15128]; Takeda Science Foundation; Salt Science Research Foundation [1637]; Nakatomi Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [16K08278] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Salt Science Research Foundation; Nakatomi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI [https://www.jsps.go.jp/english/] Grant Numbers, 16H06215 and 16K15127 to Y.S., 16K08278 and 17H05537 to H.Y. 26293021 and 16K15128 to Y.I. This work was also supported by a Grant-in-Aid from Takeda Science Foundation [http://www.takeda-sci.or.jp/] (to Y.S.), Salt Science Research Foundation [Grant 1637, http://www.saltscience.or.jp/english.html] (to Y.S.), the Nakatomi Foundation [http://www.nakatomi.or.jp/en/index.html] (to Y.S.) and The Uehara Memorial Foundation [http://www.ueharazadan.or.jp/] (to Y. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmole I, 2001, PFLUG ARCH EUR J PHY, V442, P828, DOI 10.1007/s004240100620; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; Blin S, 2016, P NATL ACAD SCI USA, V113, P4200, DOI 10.1073/pnas.1522748113; Blin S, 2014, J BIOL CHEM, V289, P28202, DOI 10.1074/jbc.M114.600437; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Dadi PK, 2015, MOL ENDOCRINOL, V29, P777, DOI 10.1210/me.2014-1321; Dadi PK, 2014, ENDOCRINOLOGY, V155, P3757, DOI 10.1210/en.2013-2051; Decher N, 2001, FEBS LETT, V492, P84, DOI 10.1016/S0014-5793(01)02222-0; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Friedrich C, 2014, EMBO MOL MED, V6, P937, DOI 10.15252/emmm.201303783; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Goldstein M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19492; Hwang EM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4227; Inayama M, 2015, CELL CALCIUM, V57, P337, DOI 10.1016/j.ceca.2015.02.005; Kang DW, 2004, BIOCHEM BIOPH RES CO, V315, P836, DOI 10.1016/j.bbrc.2004.01.137; Kiyoshi H, 2006, AM J PHYSIOL-HEART C, V291, pH2723, DOI 10.1152/ajpheart.00894.2005; Leithner K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157453; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Marionneau C, 2008, CIRC RES, V102, P1406, DOI 10.1161/CIRCRESAHA.107.170050; Niemeyer MI, 2007, P NATL ACAD SCI USA, V104, P666, DOI 10.1073/pnas.0606173104; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Plant LD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003431; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Renigunta V, 2014, MOL BIOL CELL, V25, P1877, DOI [10.1091/mbc.E13-0592, 10.1091/mbc.E13-10-0592]; Streit AK, 2011, J BIOL CHEM, V286, P13977, DOI 10.1074/jbc.M111.227884; Suzuki Y, 2016, J BIOL CHEM, V291, P24247, DOI 10.1074/jbc.M116.743302; Suzuki Y, 2013, J BIOL CHEM, V288, P36750, DOI 10.1074/jbc.M113.511485; Talley EM, 2002, J BIOL CHEM, V277, P17733, DOI 10.1074/jbc.M200502200; Wilke BU, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6540; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	35	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186252	10.1371/journal.pone.0186252	http://dx.doi.org/10.1371/journal.pone.0186252			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016681	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400064
J	Kanno, T; Yasutake, K; Tanaka, K; Hadano, S; Ikeda, JE				Kanno, Takuya; Yasutake, Kaori; Tanaka, Kazunori; Hadano, Shinji; Ikeda, Joh-E			A novel function of N-linked glycoproteins, alpha-2-HS-glycoprotein and hemopexin: Implications for small molecule compound-mediated neuroprotection	PLOS ONE			English	Article							PROTEIN-SYNTHESIS SYSTEM; OXIDATIVE STRESS; BRAIN; PEPTIDE; PROGRESSION; EXPRESSION; CLEARANCE; SUBSTRATE; MODEL	Therapeutic agents to the central nervous system (CNS) need to be efficiently delivered to the target site of action at appropriate therapeutic levels. However, a limited number of effective drugs for the treatment of neurological diseases has been developed thus far. Further, the pharmacological mechanisms by which such therapeutic agents can protect neurons from cell death have not been fully understood. We have previously reported the novel small-molecule compound, 2-[mesityl(methyl)amino]-N-[4-(pyridin-2-yl)-1H-imidazol-2-yl] acetamide trihydrochloride (WN1316), as a unique neuroprotectant against oxidative injury and a highly promising remedy for the treatment of amyotrophic lateral sclerosis (ALS). One of the remarkable characteristics of WN1316 is that its efficacious doses in ALS mouse models are much less than those against oxidative injury in cultured human neuronal cells. It is also noted that the WN1316 cytoprotective activity observed in cultured cells is totally dependent upon the addition of fetal bovine serum in culture medium. These findings led us to postulate some serum factors being tightly linked to the WN1316 efficacy. In this study, we sieved through fetal bovine serum proteins and identified two N-linked glycoproteins, alpha-2-HS-glycoprotein (AHSG) and hemopexin (HPX), requisites to exert the WN1316 cytoprotective activity against oxidative injury in neuronal cells in vitro. Notably, the removal of glycan chains from these molecules did not affect the WN1316 cytoprotective activity. Thus, two glycoproteins, AHSG and HPX, represent a pivotal glycoprotein of the cytoprotective activity for WN1316, showing a concrete evidence for the novel glycan-independent function of serum glycoproteins in neuroprotective drug efficacy.	[Kanno, Takuya; Yasutake, Kaori; Tanaka, Kazunori; Ikeda, Joh-E] Neugen Pharma Inc, NGP Biomed Res Inst, Meguro Ku, Tokyo, Japan; [Hadano, Shinji] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa, Japan; [Hadano, Shinji] Tokai Univ, Inst Med Sci, Isehara, Kanagawa, Japan; [Ikeda, Joh-E] Kitasato Univ, Fac Med, Dept Mol Neurol, Sagamihara, Kanagawa, Japan; [Ikeda, Joh-E] Univ Ottawa, Fac Med, Dept Pediat, Childrens Hosp Eastern Ontario,Apoptosis Res Ctr, Ottawa, ON, Canada	Tokai University; Tokai University; Kitasato University; University of Ottawa; Children's Hospital of Eastern Ontario	Ikeda, JE (corresponding author), Neugen Pharma Inc, NGP Biomed Res Inst, Meguro Ku, Tokyo, Japan.; Ikeda, JE (corresponding author), Kitasato Univ, Fac Med, Dept Mol Neurol, Sagamihara, Kanagawa, Japan.; Ikeda, JE (corresponding author), Univ Ottawa, Fac Med, Dept Pediat, Childrens Hosp Eastern Ontario,Apoptosis Res Ctr, Ottawa, ON, Canada.	joh-e@mgcheo.med.uottawa.ca	Hadano, Shinji/ABA-5052-2021	Hadano, Shinji/0000-0002-4997-3968	Target-driven R&D (A-STEP) from the Japan Science and Technology Agency (JST); Neugen Pharma	Target-driven R&D (A-STEP) from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Neugen Pharma	This work was supported by the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from the Japan Science and Technology Agency (JST) (JEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TK, KY and KT were employees of Neugen Pharma at the time this research was performed. JEI owns stocks or shares in Neugen Pharma. Neugen Pharma provided financial support in the form of salaries for authors (TK, KY and KT), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in study design (JEI), data collection (TK, KY and KT) and analysis section (TK, KT and JEI).	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Benchenane K, 2005, STROKE, V36, P1059, DOI 10.1161/01.STR.0000163050.39122.4f; Brylka L, 2013, CALCIFIED TISSUE INT, V93, P355, DOI 10.1007/s00223-012-9690-6; CAYATTE AJ, 1990, J BIOL CHEM, V265, P5883; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; Endo Y, 2006, CURR OPIN BIOTECH, V17, P373, DOI 10.1016/j.copbio.2006.06.009; Goustin AS, 2013, CELL SIGNAL, V25, P981, DOI 10.1016/j.cellsig.2012.12.011; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Kanno T, 2012, FREE RADICAL BIO MED, V53, P2028, DOI 10.1016/j.freeradbiomed.2012.09.010; Koutsioulis D, 2008, GLYCOBIOLOGY, V18, P799, DOI 10.1093/glycob/cwn069; KUMBLA L, 1989, FASEB J, V3, P2075, DOI 10.1096/fasebj.3.9.2472993; KUMBLA L, 1991, FASEB J, V5, P2971, DOI 10.1096/fasebj.5.14.1721594; Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Nga BL, 2014, J EXP MED, V211, P233, DOI 10.1084/jem.20131660; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Okada Y, 2005, J CEREBR BLOOD F MET, V25, P794, DOI 10.1038/sj.jcbfm.9600078; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; PU XP, 1994, BBA-PROTEIN STRUCT M, V1208, P338, DOI 10.1016/0167-4838(94)90122-8; Rushworth JV, 2013, J BIOL CHEM, V288, P8935, DOI 10.1074/jbc.M112.400358; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Shi NY, 2001, P NATL ACAD SCI USA, V98, P12754, DOI 10.1073/pnas.221450098; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Smith DA, 2010, NAT REV DRUG DISCOV, V9, P929, DOI 10.1038/nrd3287; Tanaka K, 2008, EXP NEUROL, V211, P378, DOI 10.1016/j.expneurol.2008.02.004; Tanaka K, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087728, 10.1371/journal.pone.0096410]; Tanaka K, 2011, EXP NEUROL, V232, P41, DOI 10.1016/j.expneurol.2011.08.001; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Tozawa Y, 2007, J BIOL CHEM, V282, P35536, DOI 10.1074/jbc.M703820200; Yu YJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009835	36	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186227	10.1371/journal.pone.0186227	http://dx.doi.org/10.1371/journal.pone.0186227			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016670	gold, Green Published, Green Submitted			2022-12-26	WOS:000412601800047
J	Li, ZW; Yuan, X; Cui, XR; Liu, X; Wang, LQ; Zhang, WS; Lu, QH; Zhu, H				Li, Zhongwei; Yuan, Xiang; Cui, Xuerong; Liu, Xin; Wang, Leiquan; Zhang, Weishan; Lu, Qinghua; Zhu, Hu			Optimal experimental conditions for Welan gum production by support vector regression and adaptive genetic algorithm	PLOS ONE			English	Article							NEURAL P SYSTEMS; MACHINE CLASSIFIERS; PREDICTION; IDENTIFICATION; VALIDATION	Welan gum is a kind of novel microbial polysaccharide, which is widely produced during the process of microbial growth and metabolism in different external conditions. Welan gum can be used as the thickener, suspending agent, emulsifier, stabilizer, lubricant, film-forming agent and adhesive usage in agriculture. In recent years, finding optimal experimental conditions to maximize the production is paid growing attentions. In this work, a hybrid computational method is proposed to optimize experimental conditions for producing Welan gum with data collected from experiments records. Support Vector Regression (SVR) is used to model the relationship between Welan gum production and experimental conditions, and then adaptive Genetic Algorithm (AGA, for short) is applied to search optimized experimental conditions. As results, a mathematic model of predicting production of Welan gum from experimental conditions is obtained, which achieves accuracy rate 88.36%. As well, a class of optimized experimental conditions is predicted for producing Welan gum 31.65g/L. Comparing the best result in chemical experiment 30.63g/L, the predicted production improves it by 3.3%. The results provide potential optimal experimental conditions to improve the production of Welan gum.	[Li, Zhongwei; Yuan, Xiang; Cui, Xuerong; Liu, Xin; Wang, Leiquan; Zhang, Weishan; Lu, Qinghua] China Univ Petr, Coll Comp & Commun Engn, Qingdao 266580, Shandong, Peoples R China; [Zhu, Hu] Fujian Normal Univ, Coll Chem & Mat, Fuzhou 350007, Fujian, Peoples R China	China University of Petroleum; Fujian Normal University	Zhu, H (corresponding author), Fujian Normal Univ, Coll Chem & Mat, Fuzhou 350007, Fujian, Peoples R China.	zhuhu@fjnu.edu.cn	zhu, hu/GQQ-8365-2022	Wang, Leiquan/0000-0003-4314-0030	863 program [2015AA020925]; National Natural Science Foundation of China [61402187, 61502535, 61572522, 61572523, 61672033, 61672248]; Key Research and Development Program of Shandong Province [2017GGX10147]; China Postdoctoral Science Foundation [2016M592267]; PetroChina Innovation Foundation [2016D-5007-0305]; Fundamental Research Funds for the Central Universities [R1607005A]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R03AA020925] Funding Source: NIH RePORTER	863 program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Shandong Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); PetroChina Innovation Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by 863 program (2015AA020925), National Natural Science Foundation of China (61402187, 61502535, 61572522, 61572523, 61672033 and 61672248), Key Research and Development Program of Shandong Province (No. 2017GGX10147), China Postdoctoral Science Foundation funded project (2016M592267), PetroChina Innovation Foundation (2016D-5007-0305), and Fundamental Research Funds for the Central Universities (R1607005A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amari S, 1999, NEURAL NETWORKS, V12, P783, DOI 10.1016/S0893-6080(99)00032-5; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Burges CJC, 1999, ADVANCES IN KERNEL METHODS, P89; Cai SX, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/904267; Chen B, 2017, NEUROCOMPUTING; Chen W, 2017, SCI REP-UK, V7, DOI 10.1038/srep40242; Fu ZJ, 2017, IEEE T INF FOREN SEC, V12, P1874, DOI 10.1109/TIFS.2017.2692728; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Li H, 2011, PROCESS BIOCHEM, V46, P1172, DOI 10.1016/j.procbio.2011.02.007; [李会 Li Hui], 2009, [食品与发酵工业, Food and Fermentation Industries], V35, P1; Li Z, 2016, BIOMED RES INT, V2016; Liang J, 2016, FOOD RES DEV, V37, P104; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu Q, 2016, SECUR COMMUN NETW, V9, P4002, DOI 10.1002/sec.1582; Liu X, 2012, DISCRETE DYN NAT SOC, V2012, P132; Liu X., 2017, DISCRETE DYNAMICS NA, V2017; Liu XY, 2007, ADV ENG SOFTW, V38, P668, DOI 10.1016/j.advengsoft.2006.10.009; Liu XY, 2017, NEURAL PROCESS LETT, V46, P171, DOI 10.1007/s11063-016-9577-z; Long K, 2014, CHEM ENG, V8; Ma TH, 2015, COMPUTING, V97, P1165, DOI 10.1007/s00607-015-0453-x; Ouyang S., 2003, COMPUTER ENG APPL; Scholkopf B., 1999, ADV KERNEL METHODS S; Shen J, 2017, IEEE T INF FOREN SEC, V12, P2402, DOI 10.1109/TIFS.2017.2705620; Shevade SK, 2000, IEEE T NEURAL NETWOR, V11, P1188, DOI 10.1109/72.870050; Song T, 2014, NEURAL COMPUTING APP, V24; Song T, 2016, IEEE T NANOBIOSCI, V15, P666, DOI 10.1109/TNB.2016.2598879; Song T, 2016, INFORM SCIENCES, V372, P380, DOI 10.1016/j.ins.2016.08.055; Song T, 2016, NEUROCOMPUTING, V193, P193, DOI 10.1016/j.neucom.2016.02.023; Song T, 2015, IEEE T NANOBIOSCI, V14, P960, DOI 10.1109/TNB.2015.2503603; SRINIVAS M, 1994, IEEE T SYST MAN CYB, V24, P656, DOI 10.1109/21.286385; van Gestel T, 2004, MACH LEARN, V54, P5, DOI 10.1023/B:MACH.0000008082.80494.e0; Vapnik V., 2013, NATURE STAT LEARNING; Vapnik V. N., 1998, STAT LEARNING THEORY, V1; Wang R, 2015, IEEE T CYBERNETICS, V45, P1262, DOI 10.1109/TCYB.2014.2348012; Wang X, 2017, ROM J INF SCI TECH, V20, P32; Wang XS, 2014, CURR BIOINFORM, V9, P140, DOI 10.2174/1574893608999140109115649; Wang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep27624; Wang X, 2014, J COMPUT BIOL, V21, P320, DOI 10.1089/cmb.2013.0054; Wei G, 2014, J SYST ENG ELECTRON, V25, P115, DOI 10.1109/JSEE.2014.00013; Wu TF, 2016, J BIOINF COMPUT BIOL, V14, DOI 10.1142/S021972001650013X; Wu Y, 2014, MATH PROBLEMS ENG, V2014; Wu YF, 2011, J EXP THEOR ARTIF IN, V23, P63, DOI 10.1080/0952813X.2010.506288; Xia ZH, 2016, IEEE T INF FOREN SEC, V11, P2594, DOI 10.1109/TIFS.2016.2590944; Xia ZH, 2016, IEEE T PARALL DISTR, V27, P340, DOI 10.1109/TPDS.2015.2401003; Xue Y, 2018, SOFT COMPUT, V22, P2935, DOI 10.1007/s00500-017-2547-1; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zeng XX, 2016, BBA-GEN SUBJECTS, V1860, P2735, DOI 10.1016/j.bbagen.2016.03.016; Zeng XX, 2015, FRONT COMPUT SCI-CHI, V9, P643, DOI 10.1007/s11704-014-4089-3; Zhang L, 2017, IEEE T CYBERNETICS, V47, P2703, DOI 10.1109/TCYB.2017.2711038; Zhang X, PATTERN RECOMMENDATI; Zhang X, 2016, IEEE T EVOLUTIONARY; Zhang X.G., 2000, ACTA AUTOM SIN, V26, P32; Zhang XY, 2015, IEEE T EVOLUT COMPUT, V19, P761, DOI 10.1109/TEVC.2014.2378512; Zhao YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162882	55	4	4	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185942	10.1371/journal.pone.0185942	http://dx.doi.org/10.1371/journal.pone.0185942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016652	Green Published, gold, Green Submitted			2022-12-26	WOS:000412601800027
J	Agrawal, S; Jaswal, K; Shiver, AL; Balecha, H; Patra, T; Chaba, R				Agrawal, Shashank; Jaswal, Kanchan; Shiver, Anthony L.; Balecha, Himanshi; Patra, Tapas; Chaba, Rachna			A genome-wide screen in Escherichia coli reveals that ubiquinone is a key antioxidant for metabolism of long-chain fatty acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial genetics; electron transport; fatty acid metabolism; oxidative stress; quinone; respiratory chain; long chain fatty acids; non-fermentable carbon sources; ubiI; ubiK	COENZYME-Q BIOSYNTHESIS; OXIDATIVE STRESS; NADH DEHYDROGENASE; ISOCITRATE LYASE; GENETIC-ANALYSIS; MEMBRANE; GROWTH; REDUCTION; MUTANTS; OPERON	Long-chain fatty acids (LCFAs) are used as a rich source of metabolic energy by several bacteria including important pathogens. Because LCFAs also induce oxidative stress, which may be detrimental to bacterial growth, it is imperative to understand the strategies employed by bacteria to counteract such stresses. Here, we performed a genetic screen in Escherichia coli on the LCFA, oleate, and compared our results with published genome-wide screens of multiple non-fermentable carbon sources. This large-scale analysis revealed that among components of the aerobic electron transport chain (ETC), only genes involved in the biosynthesis of ubiquinone, an electron carrier in the ETC, are highly required for growth in LCFAs when compared with other carbon sources. Using genetic and biochemical approaches, we show that this increased requirement of ubiquinone is to mitigate elevated levels of reactive oxygen species generated by LCFA degradation. Intriguingly, we find that unlike other ETC components whose requirement for growth is inversely correlated with the energy yield of non-fermentable carbon sources, the requirement of ubiquinone correlates with oxidative stress. Our results therefore suggest that a mechanism in addition to the known electron carrier function of ubiquinone is required to explain its antioxidant role in LCFA metabolism. Importantly, among the various oxidative stress combat players in E. coli, ubiquinone acts as the cell's first line of defense against LCFA-induced oxidative stress. Taken together, our results emphasize that ubiquinone is a key antioxidant during LCFA metabolism and therefore provides a rationale for investigating its role in LCFA-utilizing pathogenic bacteria.	[Agrawal, Shashank; Jaswal, Kanchan; Balecha, Himanshi; Patra, Tapas; Chaba, Rachna] Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Sas Nagar 140306, Punjab, India; [Shiver, Anthony L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Indian Institute of Science Education & Research (IISER) - Mohali; Stanford University	Chaba, R (corresponding author), Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Sas Nagar 140306, Punjab, India.	rachnachaba@iisermohali.ac.in	Patra, Tapas/W-3194-2019; Patra, Tapas/AAE-8231-2021	Patra, Tapas/0000-0002-3388-1719; Chaba, Rachna/0000-0002-9156-4543	Indian Institute of Science Education and Research Mohali (IISER-Mohali); Council of Scientific and Industrial Research, Government of India [37(1623)/14/EMR-II]; IISER-Mohali; Department of Science and Technology (DST)-Inspire fellowship; DST-Inspire	Indian Institute of Science Education and Research Mohali (IISER-Mohali); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); IISER-Mohali; Department of Science and Technology (DST)-Inspire fellowship(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); DST-Inspire(Department of Science & Technology (India))	This work was supported in part by start-up funds from Indian Institute of Science Education and Research Mohali (IISER-Mohali) (to R. C.) and Council of Scientific and Industrial Research project number 37(1623)/14/EMR-II, Government of India (to R. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from IISER-Mohali for doctoral work.; Recipient of a Department of Science and Technology (DST)-Inspire fellowship for doctoral work.; Supported by a fellowship from DST-Inspire for undergraduate studies.	Al-Attar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27631; Albesa I, 2004, BIOCHEM BIOPH RES CO, V317, P605, DOI 10.1016/j.bbrc.2004.03.085; AU DCT, 1987, J BACTERIOL, V169, P3237, DOI 10.1128/jb.169.7.3237-3242.1987; Aussel L, 2014, BBA-BIOENERGETICS, V1837, P1004, DOI 10.1016/j.bbabio.2014.01.015; Aussel L, 2014, J BACTERIOL, V196, P70, DOI 10.1128/JB.01065-13; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BERGER EA, 1973, P NATL ACAD SCI USA, V70, P1514, DOI 10.1073/pnas.70.5.1514; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Booth I. R., 2005, ECOSAL ESCHERICHIA C; Campbell JW, 2003, MOL MICROBIOL, V47, P793, DOI 10.1046/j.1365-2958.2003.03341.x; Campbell JW, 2002, J BACTERIOL, V184, P3759, DOI 10.1128/JB.184.13.3759-3764.2002; Carrica MC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-95; Chehade MH, 2013, J BIOL CHEM, V288, P20085, DOI 10.1074/jbc.M113.480368; CLARK D, 1981, J BACTERIOL, V148, P521, DOI 10.1128/JB.148.2.521-526.1981; Clark D. P., 2005, ECOSAL ESCHERICHIA C; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; COX GB, 1970, BIOCHEM J, V117, P551, DOI 10.1042/bj1170551; Cronan J. E., 2006, ECOSAL ESCHERICHIA C; Dharmadi Y, 2006, BIOTECHNOL BIOENG, V94, P821, DOI 10.1002/bit.21025; Doi H, 2014, APPL MICROBIOL BIOT, V98, P629, DOI 10.1007/s00253-013-5327-6; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Erental A, 2014, MBIO, V5, DOI 10.1128/mBio.01426-14; Falk-Krzesinski HJ, 1998, J BACTERIOL, V180, P1174, DOI 10.1128/JB.180.5.1174-1184.1998; Fang FC, 2005, INFECT IMMUN, V73, P2547, DOI 10.1128/IAI.73.4.2547-2549.2005; Feng YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046275; Friedrich T., 2007, ECOSAL ESCHERICHIA C; GIBERT I, 1988, J BACTERIOL, V170, P1346, DOI 10.1128/jb.170.3.1346-1349.1988; Goswami M, 2006, ANTIMICROB AGENTS CH, V50, P949, DOI 10.1128/AAC.50.3.949-954.2006; Gulmezian M, 2007, ARCH BIOCHEM BIOPHYS, V467, P144, DOI 10.1016/j.abb.2007.08.009; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Kotnik D., 2013, RES PRECISION INSTRU, V2, P6; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kwon O, 2005, CURR MICROBIOL, V50, P180, DOI 10.1007/s00284-004-4417-1; Lee PT, 1997, J BACTERIOL, V179, P1748, DOI 10.1128/jb.179.5.1748-1754.1997; Lepore BW, 2011, P NATL ACAD SCI USA, V108, P10121, DOI 10.1073/pnas.1018532108; Loiseau L, 2017, J BIOL CHEM, V292, P11937, DOI 10.1074/jbc.M117.789164; Marathe SA, 2013, J ANTIMICROB CHEMOTH, V68, P139, DOI 10.1093/jac/dks375; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Pech-Canul A, 2011, J BACTERIOL, V193, P6295, DOI 10.1128/JB.05450-11; Pelosi L, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00091-16; Perez-Pantoja D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003764; PETITKOSKAS E, 1976, MOL GEN GENET, V143, P203, DOI 10.1007/BF00266923; Pipe LZ, 2008, MOL BIOSYST, V4, P192, DOI 10.1039/b708241j; Pradenas GA, 2012, MICROBIOL-SGM, V158, P1279, DOI 10.1099/mic.0.056903-0; PRUSS BM, 1994, J BACTERIOL, V176, P2143; Sharma P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075412; Shimada T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020081; Shiver AL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006124; Soballe B, 1997, FEBS LETT, V414, P373, DOI 10.1016/S0014-5793(97)01041-7; Soballe B, 2000, MICROBIOL-SGM, V146, P787, DOI 10.1099/00221287-146-4-787; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; STROOBAN.P, 1972, J BACTERIOL, V109, P134, DOI 10.1128/JB.109.1.134-139.1972; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tran QH, 1997, EUR J BIOCHEM, V244, P155, DOI 10.1111/j.1432-1033.1997.00155.x; Unden G., 2004, ECOSAL ESCHERICHIA C; Unden G., 2008, ECOSAL ESCHERICHIA C; Wang KC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01614; WU GH, 1993, J GEN MICROBIOL, V139, P1795, DOI 10.1099/00221287-139-8-1795; Zhang HT, 2003, FEMS MICROBIOL LETT, V223, P67, DOI 10.1016/S0378-1097(03)00343-4; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhu JF, 2011, METAB ENG, V13, P704, DOI 10.1016/j.ymben.2011.09.006	66	23	23	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20086	20099		10.1074/jbc.M117.806240	http://dx.doi.org/10.1074/jbc.M117.806240			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29042439	hybrid, Green Published			2022-12-26	WOS:000417696400016
J	Dapp, MJ; Kober, KM; Chen, LN; Westfall, DH; Wong, K; Zhao, H; Hall, BM; Deng, WJ; Sibley, T; Ghorai, S; Kim, K; Chen, N; McHugh, S; Au, L; Cohen, M; Anastos, K; Mullins, JI				Dapp, Michael J.; Kober, Kord M.; Chen, Lennie; Westfall, Dylan H.; Wong, Kim; Zhao, Hong; Hall, Breana M.; Deng, Wenjie; Sibley, Thomas; Ghorai, Suvankar; Kim, Katie; Chen, Natalie; McHugh, Sarah; Au, Lily; Cohen, Mardge; Anastos, Kathryn; Mullins, James I.			Patterns and rates of viral evolution in HIV-1 subtype B infected females and males	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PHYLOGENETIC ANALYSIS; DISEASE PROGRESSION; HETEROSEXUAL TRANSMISSION; BIOLOGICAL PHENOTYPE; GENDER-DIFFERENCES; GENETIC DIVERSITY; CORECEPTOR USAGE; SEX-DIFFERENCES; GENITAL-TRACT	Biological sex differences affect the course of HIV infection, with untreated women having lower viral loads compared to their male counterparts but, for a given viral load, women have a higher rate of progression to AIDS. However, the vast majority of data on viral evolution, a process that is clearly impacted by host immunity and could be impacted by sex differences, has been derived from men. We conducted an intensive analysis of HIV-1 gag and env-gp120 evolution taken over the first 6-11 years of infection from 8 Women's Interagency HIV Study (WIHS) participants who had not received combination antiretroviral therapy (ART). This was compared to similar data previously collected from men, with both groups infected with HIV-1 subtype B. Early virus populations in men and women were generally homogenous with no differences in diversity between sexes. No differences in ensuing nucleotide substitution rates were found between the female and male cohorts studied herein. As previously reported for men, time to peak diversity in env-gp120 in women was positively associated with time to CD4+ cell count below 200 (P = 0.017), and the number of predicted N- linked glycosylation sites generally increased over time, followed by a plateau or decline, with the majority of changes localized to the V1-V2 region. These findings strongly suggest that the sex differences in HIV-1 disease progression attributed to immune system composition and sensitivities are not revealed by, nor do they impact, global patterns of viral evolution, the latter of which proceeds similarly in women and men.	[Dapp, Michael J.; Chen, Lennie; Westfall, Dylan H.; Wong, Kim; Zhao, Hong; Hall, Breana M.; Deng, Wenjie; Sibley, Thomas; Ghorai, Suvankar; Kim, Katie; Chen, Natalie; McHugh, Sarah; Au, Lily; Mullins, James I.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Kober, Kord M.] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA; [Cohen, Mardge] Bur Hlth Serv Cook Cty, Core Ctr, Chicago, IL USA; [Anastos, Kathryn] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Mullins, James I.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Ghorai, Suvankar] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Chen, Natalie] Univ Calif Los Angeles, Los Angeles, CA USA	University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Yeshiva University; Albert Einstein College of Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); University of California System; University of California Los Angeles	Mullins, JI (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.; Mullins, JI (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.; Mullins, JI (corresponding author), Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA 98195 USA.; Mullins, JI (corresponding author), Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA.	jmullins@uw.edu	Kober, Kord/ABF-2657-2020	Kober, Kord/0000-0001-9732-3321; Dapp, Michael/0000-0003-3854-855X; GHORAI, SUVANKAR/0000-0003-0800-3970; Mullins, James I/0000-0002-4461-8158	NIH [R37AI047734]; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Cancer Institute (NCI); National Institute on Drug Abuse (NIDA); National Institute on Mental Health (NIMH); National Institute of Dental and Craniofacial Research (NIDCR); National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Deafness and other Communication Disorders (NIDCD); NIH Office of Research on Women's Health; UCSF CTSA [UL1-TR000004]; Atlanta CTSA [UL1-TR000454];  [F32AI104318]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, UL1TR000004, UL1TR002378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034993, R37AI047734, F32AI104318, U01AI035004, U01AI034989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); UCSF CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Atlanta CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant R37AI047734. M.J.D. is supported by F32AI104318. Data in this manuscript were collected by the Women's Interagency HIV Study (WIHS). WIHS (Principal Investigators): Bronx WIHS (Kathryn Anastos), U01-AI-035004; Chicago WIHS (Mardge Cohen and Audrey French), U01-AI-034993; Connie Wofsy Women's HIV Study, Northern California (Ruth Greenblatt, Bradley Aouizerat, and Phyllis Tien), U01-AI-034989. The WIHS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute on Mental Health (NIMH). Targeted supplemental funding for specific projects is also provided by the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Deafness and other Communication Disorders (NIDCD), and the NIH Office of Research on Women's Health. WIHS data collection is also supported by UL1-TR000004 (UCSF CTSA) and UL1-TR000454 (Atlanta CTSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Alizon S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-49; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Baan E, 2013, J GEN VIROL, V94, P20, DOI 10.1099/vir.0.046185-0; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Berry IM, 2007, J VIROL, V81, P10625, DOI 10.1128/JVI.00985-07; Bjorndal A, 1997, J VIROL, V71, P7478; Boeras DI, 2011, P NATL ACAD SCI USA, V108, pE1156, DOI 10.1073/pnas.1103764108; CALVELLI T, 1993, CYTOMETRY, V14, P702, DOI 10.1002/cyto.990140703; Carlson JM, 2014, SCIENCE, V345, DOI 10.1126/science.1254031; Chang JJ, 2013, J INFECT DIS, V208, P830, DOI 10.1093/infdis/jit262; Chohan B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005; Chomont N, 2007, AIDS, V21, P153, DOI 10.1097/QAD.0b013e328011f94b; Curlin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001228; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Mendoza C, 2008, JAIDS-J ACQ IMM DEF, V48, P241, DOI 10.1097/QAI.0b013e3181734f0e; de Mendoza C, 2007, J ANTIMICROB CHEMOTH, V59, P698, DOI 10.1093/jac/dkm012; Delmas MC, 1997, AIDS, V11, P1071; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Deymier MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005154; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edo-Matas D, 2011, MOL BIOL EVOL, V28, P1605, DOI 10.1093/molbev/msq326; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; Eshleman SH, 2007, AIDS, V21, P1165, DOI 10.1097/QAD.0b013e32810fd72e; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; FISCHER W, 2010, PLOS ONE, V5; Frenkel LM, 2003, J VIROL, V77, P5721, DOI 10.1128/JVI.77.10.5721-5730.2003; Frenkel LM, 1998, SCIENCE, V280, P1073, DOI 10.1126/science.280.5366.1073; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Frost SDW, 2005, J VIROL, V79, P6523, DOI 10.1128/JVI.79.10.6523-6527.2005; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; Gange SJ, 1998, P NATL ACAD SCI USA, V95, P10848, DOI 10.1073/pnas.95.18.10848; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gottlieb GS, 2008, J INFECT DIS, V197, P1011, DOI 10.1086/529206; Gouveia NL, 2014, VIRUS GENES, V48, P421, DOI 10.1007/s11262-014-1048-x; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hatzakis AE, 2004, AIDS, V18, P2261, DOI 10.1097/00002030-200411190-00006; Herbeck JT, 2011, J VIROL, V85, P7523, DOI 10.1128/JVI.02697-10; Herbeck JT, 2006, J VIROL, V80, P1637, DOI 10.1128/JVI.80.4.1637-1644.2006; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Jensen MA, 2003, 10 C RETR OPP INF BO; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kent SJ, 2005, TRENDS MICROBIOL, V13, P243, DOI 10.1016/j.tim.2005.03.011; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lau B, 2003, AIDS, V17, P2035, DOI 10.1097/00002030-200309260-00004; Leitner T, 1999, P NATL ACAD SCI USA, V96, P10752, DOI 10.1073/pnas.96.19.10752; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Lemey P, 2006, AIDS REV, V8, P125; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Liu SL, 2002, J VIROL, V76, P10674, DOI 10.1128/JVI.76.21.10674-10684.2002; Liu Y, 2008, VIROLOGY, V374, P229, DOI 10.1016/j.virol.2008.01.029; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Liu Y, 2013, J VIROL METHODS, V189, P157, DOI 10.1016/j.jviromet.2012.10.016; Long EM, 2000, NAT MED, V6, P71; Lythgoe KA, 2012, P ROY SOC B-BIOL SCI, V279, P3367, DOI 10.1098/rspb.2012.0595; Maldarelli F, 2013, J VIROL, V87, P10313, DOI 10.1128/JVI.01225-12; MARGOLICK JB, 1995, NAT MED, V1, P674, DOI 10.1038/nm0795-674; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Novitsky V, 2013, INFECT GENET EVOL, V19, P361, DOI 10.1016/j.meegid.2013.02.023; Piantadosi A, 2009, AIDS, V23, P579, DOI 10.1097/QAD.0b013e328328f76e; Pinheiro J., LINEAR NONLINEAR MIX; Rademeyer C, 2004, AIDS, V18, P2096, DOI 10.1097/00002030-200410210-00019; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Redd AD, 2012, J INFECT DIS, V206, P1433, DOI 10.1093/infdis/jis503; Revell LJ, 2012, PHYTOOLS V0 4 31 R P; Rinaldo CR, 1998, AIDS RES HUM RETROV, V14, P1423, DOI 10.1089/aid.1998.14.1423; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sagar M, 2004, J VIROL, V78, P7279, DOI 10.1128/JVI.78.13.7279-7283.2004; Sagar M, 2004, AIDS, V18, P615, DOI 10.1097/00002030-200403050-00005; Sagar M, 2009, J INFECT DIS, V199, P580, DOI 10.1086/596557; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Salazar-Gonzalez JF, 1998, J INFECT DIS, V178, P423, DOI 10.1086/515629; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Schuitemaker H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S5; Seo TK, 2002, GENETICS, V160, P1283; Shankarappa R, 1998, VIROLOGY, V241, P251, DOI 10.1006/viro.1997.8996; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shepherd JC, 2008, J INFECT DIS, V198, P1104, DOI 10.1086/591623; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Song HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102734; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Sunshine JE, 2015, J VIROL, V89, P10303, DOI 10.1128/JVI.01876-15; TERSMETTE M, 1989, J VIROL, V63, P2118, DOI 10.1128/JVI.63.5.2118-2125.1989; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Vrancken B, 2015, AIDS, V29, P1549, DOI 10.1097/QAD.0000000000000731; Vrancken B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003505; Williamson S, 2005, MOL BIOL EVOL, V22, P456, DOI 10.1093/molbev/msi029; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zanini F, 2015, ELIFE, V4, DOI 10.7554/eLife.11282; ZHANG LQ, 1993, J VIROL, V67, P3345, DOI 10.1128/JVI.67.6.3345-3356.1993; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	112	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0182443	10.1371/journal.pone.0182443	http://dx.doi.org/10.1371/journal.pone.0182443			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045410	Green Submitted, gold, Green Published			2022-12-26	WOS:000413168100003
J	Jones, IL; Peres, CA; Benchimol, M; Bunnefeld, L; Dent, DH				Jones, Isabel L.; Peres, Carlos A.; Benchimol, Maria; Bunnefeld, Lynsey; Dent, Daisy H.			Woody lianas increase in dominance and maintain compositional integrity across an Amazonian dam-induced fragmented landscape	PLOS ONE			English	Article							REDUCE CARBON ACCUMULATION; GREENHOUSE-GAS EMISSIONS; BARRO-COLORADO ISLAND; FOREST FRAGMENTATION; TREE REGENERATION; TROPICAL FORESTS; SEED DISPERSAL; DIVERSITY; ABUNDANCE; RESPONSES	Tropical forest fragmentation creates insular biological communities that undergo species loss and changes in community composition over time, due to area-and edge-effects. Woody lianas thrive in degraded and secondary forests, due to their competitive advantage over trees in these habitats. Lianas compete both directly and indirectly with trees, increasing tree mortality and turnover. Despite our growing understanding of liana-tree dynamics, we lack detailed knowledge of the assemblage-level responses of lianas themselves to fragmentation, particularly in evergreen tropical forests. We examine the responses of both sapling and mature liana communities to landscape-scale forest insularization induced by a mega hydroelectric dam in the Brazilian Amazon. Detailed field inventories were conducted on islands created during reservoir filling, and in nearby mainland continuous forest. We assess the relative importance of variables associated with habitat fragmentation such as area, isolation, surrounding forest cover, fire and wind disturbance, on liana community attributes including abundance, basal area, diversity, and composition. We also explore patterns of liana dominance relative to tree saplings and adults >= 10 cm diameter at breast height. We find that 1) liana community composition remains remarkably similar across mainland continuous forest and islands, regardless of extreme area-and edge-effects and the loss of vertebrate dispersers in the latter; and 2) lianas are increasing in dominance relative to trees in the sapling layer in the most degraded islands, with both the amount of forest cover surrounding islands and fire disturbance history predicting liana dominance. Our data suggest that liana communities persist intact in isolated forests, regardless of extreme area-and edge-effects; while in contrast, tree communities simultaneously show evidence of increased turnover and supressed recruitment. These processes may lead to lianas becoming a dominant component of this dam-induced fragmented landscape in the future, due to their competitive advantage over trees in degraded forest habitats. Additional loss of tree biomass and diversity brought about through competition with lianas, and the concurrent loss of carbon storage, should be accounted for in impact assessments of future dam development.	[Jones, Isabel L.; Bunnefeld, Lynsey; Dent, Daisy H.] Univ Stirling, Biol & Environm Sci, Stirling, Scotland; [Peres, Carlos A.] Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England; [Benchimol, Maria] Univ Estadual Santa Cruz, Iiheus, Bahia, Brazil; [Dent, Daisy H.] Smithsonian Trop Res Inst, Balboa, Panama	University of Stirling; University of East Anglia; Universidade Estadual de Santa Cruz; Smithsonian Institution; Smithsonian Tropical Research Institute	Jones, IL (corresponding author), Univ Stirling, Biol & Environm Sci, Stirling, Scotland.	i.l.jones@stir.ac.uk	Benchimol, Maíra MB/I-7664-2014; Peres, Carlos A./B-1276-2013; Dent, Daisy/L-3549-2016; Peres, Carlos Augusto/N-8275-2019; Peres, Carlos A./ABE-8361-2020	Benchimol, Maíra MB/0000-0002-1238-1619; Peres, Carlos A./0000-0002-1588-8765; Dent, Daisy/0000-0002-1219-7344; Peres, Carlos A./0000-0002-1588-8765; Jones, Isabel/0000-0002-8361-1370	Carnegie Trust for the Universities of Scotland; University of Stirling	Carnegie Trust for the Universities of Scotland; University of Stirling	DD was awarded a Research Grant by the Carnegie Trust for the Universities of Scotland (http://www.carnegie-trust.org/). IJ's PhD studentship is funded by the University of Stirling (https://www.stir.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Cansino L, 2015, ECOLOGY, V96, P39, DOI 10.1890/14-1002.1; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Aurelio-Silva M, 2016, BIOL CONSERV, V199, P101, DOI 10.1016/j.biocon.2016.03.016; Barlow J, 2008, PHILOS T R SOC B, V363, P1787, DOI 10.1098/rstb.2007.0013; Barton K., 2016, MUMIN MULTIMODEL INF; Benchimol M, 2015, BIOL CONSERV, V187, P61, DOI 10.1016/j.biocon.2015.04.005; Benchimol M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129818; Benchimol M, 2015, J ECOL, V103, P408, DOI 10.1111/1365-2745.12371; Benchimol M, 2014, BIOTROPICA, V46, P470, DOI 10.1111/btp.12122; Benitez-Malvido J, 2003, CONSERV BIOL, V17, P389, DOI 10.1046/j.1523-1739.2003.01120.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Cornejo F., 2010, SEEDS AMAZONIAN PLAN; Cramer JM, 2007, BIOL CONSERV, V137, P415, DOI 10.1016/j.biocon.2007.02.019; DeWalt SJ, 2004, BIOTROPICA, V36, P7, DOI 10.1646/02115; Dewalt SJ, 2000, J TROP ECOL, V16, P1, DOI 10.1017/S0266467400001231; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Fearnside PM, 2012, NAT CLIM CHANGE, V2, P382, DOI 10.1038/nclimate1540; Fearnside PM, 2002, WATER AIR SOIL POLL, V133, P69, DOI 10.1023/A:1012971715668; Food and Agriculture Organization-FAO, 2016, GLOB FOR RES ASS 201, V2nd; Franci LD, 2016, J TROP ECOL, V32, P79, DOI 10.1017/S0266467415000553; Gentry A.H., 1993, FIELD GUIDE FAMILIES; Gerwing JJ, 2000, J TROP ECOL, V16, P327, DOI 10.1017/S0266467400001437; Gerwing JJ, 2006, BIOTROPICA, V38, P256, DOI 10.1111/j.1744-7429.2006.00134.x; Gerwing JJ, 2004, FOREST ECOL MANAG, V190, P57, DOI 10.1016/j.foreco.2003.10.006; Gerwing JJ, 2002, FOREST ECOL MANAG, V157, P131, DOI 10.1016/S0378-1127(00)00644-7; Gibson L, 2013, SCIENCE, V341, P1508, DOI 10.1126/science.1240495; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Ingwell LL, 2010, J ECOL, V98, P879, DOI 10.1111/j.1365-2745.2010.01676.x; International Energy Agency, 2006, HYDR GOOD PRACT ENV; Jones IL, 2016, BIOL CONSERV, V199, P75, DOI 10.1016/j.biocon.2016.04.036; Kareiva PM, 2012, P NATL ACAD SCI USA, V109, P5553, DOI 10.1073/pnas.1203263109; Kurzel BP, 2006, BIOTROPICA, V38, P262, DOI 10.1111/j.1744-7429.2006.00135.x; Laurance WF, 2001, ECOLOGY, V82, P105, DOI 10.1890/0012-9658(2001)082[0105:RFFATS]2.0.CO;2; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Laurance WF, 2014, ECOLOGY, V95, P3018, DOI 10.1890/14-0330.1; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lees AC, 2016, BIODIVERS CONSERV, V25, P451, DOI 10.1007/s10531-016-1072-3; Legendre P, 2015, METHODS ECOL EVOL, V6, P1239, DOI 10.1111/2041-210X.12425; LEIGH EG, 1993, EVOL ECOL, V7, P76, DOI 10.1007/BF01237735; Lomolino MV, 2000, GLOBAL ECOL BIOGEOGR, V9, P1, DOI 10.1046/j.1365-2699.2000.00185.x; MacArthur R.H., 1967, THEORY ISLAND BIOGEO, DOI DOI 10.1080/00379271.2014.984955; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Perez-Salicrup DR, 2001, BIOTROPICA, V33, P34, DOI 10.1111/j.1744-7429.2001.tb00155.x; Phillips OL, 2005, ECOLOGY, V86, P1250, DOI 10.1890/04-1446; Phillips OL, 2002, NATURE, V418, P770, DOI 10.1038/nature00926; Poulsen JR, 2017, GLOBAL ECOL BIOGEOGR, V26, P472, DOI 10.1111/geb.12554; PUTZ FE, 1984, ECOLOGY, V65, P1713, DOI 10.2307/1937767; R CORE TEAM, 2016, R LANG ENV STAT COMP; Rao M, 2001, SCIENCE, V294, P1923; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Sayer EJ, 2011, NAT CLIM CHANGE, V1, P304, DOI 10.1038/NCLIMATE1190; Scherer L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161947; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schnitzer SA, 2000, J ECOL, V88, P655, DOI 10.1046/j.1365-2745.2000.00489.x; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Schnitzer SA, 2005, AM NAT, V166, P262, DOI 10.1086/431250; Schnitzer SA, 2005, J ECOL, V93, P1115, DOI 10.1111/j.1365-2745.2005.01056.x; Schnitzer SA, 2014, ECOLOGY, V95, P3008, DOI 10.1890/13-1718.1; Schnitzer SA, 2011, PLANT SIGNAL BEHAV, V6, P598, DOI 10.4161/psb.6.4.15373; Schnitzer SA, 2011, ECOL LETT, V14, P397, DOI 10.1111/j.1461-0248.2011.01590.x; Schnitzer SA, 2010, ECOL LETT, V13, P849, DOI 10.1111/j.1461-0248.2010.01480.x; Magnago LFS, 2017, FUNCT ECOL, V31, P542, DOI 10.1111/1365-2435.12752; Su Y.-S., 2016, DATA ANAL USING REGR; Tobin MF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00322.1; Triantis KA, 2012, J BIOGEOGR, V39, P215, DOI 10.1111/j.1365-2699.2011.02652.x; Trussart S, 2002, ENERG POLICY, V30, P1251, DOI 10.1016/S0301-4215(02)00087-3; van der Heijden GM, 2013, BIOTROPICA, V45, P682, DOI 10.1111/btp.12060; van der Heijden GMF, 2015, P NATL ACAD SCI USA, V112, P13267, DOI 10.1073/pnas.1504869112; Wright A, 2015, OECOLOGIA, V177, P561, DOI 10.1007/s00442-014-3179-0; Wright SJ, 2005, J TROP ECOL, V21, P307, DOI 10.1017/S0266467405002294; Wright SJ, 2004, ECOLOGY, V85, P484, DOI 10.1890/02-0757; Yu MJ, 2012, J BIOGEOGR, V39, P1124, DOI 10.1111/j.1365-2699.2011.02676.x; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	82	10	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0185527	10.1371/journal.pone.0185527	http://dx.doi.org/10.1371/journal.pone.0185527			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040272	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000413167500005
J	Makino, T; Nakamura, R; Terakawa, M; Muneoka, S; Nagahira, K; Nagane, Y; Yamate, J; Motomura, M; Utsugisawa, K				Makino, Tomohiro; Nakamura, Ryuichi; Terakawa, Maki; Muneoka, Satoshi; Nagahira, Kazuhiro; Nagane, Yuriko; Yamate, Jyoji; Motomura, Masakatsu; Utsugisawa, Kimiaki			Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools	PLOS ONE			English	Article							MAIN IMMUNOGENIC REGION; EXPERIMENTAL AUTOIMMUNE MYASTHENIA; MONOCLONAL-ANTIBODIES; FAB FRAGMENTS; EXTRACELLULAR DOMAIN; SERUM ANTIBODIES; BLOCKER THERAPY; ALPHA-SUBUNIT; LINE TE671; SPECIFICITIES	The majority of patients with myasthenia gravis (MG), an organ-specific autoimmune disease, harbor autoantibodies that attack the nicotinic acetylcholine receptor (nAChR-Abs) at the neuromuscular junction of skeletal muscles, resulting in muscle weakness. Single cell manipulation technologies coupled with genetic engineering are very powerful tools to examine T cell and B cell repertoires and the dynamics of adaptive immunity. These tools have been utilized to develop mAbs in parallel with hybridomas, phage display technologies and B-cell immortalization. By applying a single cell technology and novel high-throughput cell-based binding assays, we identified peripheral B cells that produce pathogenic nAChR-Abs in patients with MG. Although anti-nAChR antibodies produced by individual peripheral B cells generally exhibited low binding affinity for the alpha-subunit of the nAChR and great sequence diversity, a small fraction of these antibodies bound with high affinity to native-structured nAChRs on cell surfaces. B12L, one such Ab isolated here, competed with a rat Ab (mAb35) for binding to the human nAChR and thus considered to recognize the main immunogenic region (MIR). By evaluating the Ab in in vitro cell-based assays and an in vivo rat passive transfer model, B12L was found to act as a pathogenic Ab in rodents and presumably in humans. These findings suggest that B cells in peripheral blood may impact MG pathogenicity. Our methodology can be applied not only to validate pathogenic Abs as molecular target of MG treatment, but also to discover and analyze Ab production systems in other human diseases.	[Makino, Tomohiro] Asubio Pharma Co LTD, Drug Discovery Technol Funct, Kobe, Hyogo, Japan; [Nakamura, Ryuichi] Asubio Pharma Co LTD, Regenerat Med Field, Kobe, Hyogo, Japan; [Nakamura, Ryuichi; Yamate, Jyoji] Asubio Pharma Co LTD, Immunol & Inflammatory Dis Field, Kobe, Hyogo, Japan; [Terakawa, Maki; Muneoka, Satoshi; Nagahira, Kazuhiro] Osaka Prefecture Univ, Lab Vet Pathol, Osaka, Japan; [Nagane, Yuriko; Utsugisawa, Kimiaki] Hanamaki Gen Hosp, Dept Neurol, Hanamaki, Iwate, Japan; [Motomura, Masakatsu] Nagasaki Inst Appl Sci, Fac Engn, Dept Engn, Med Engn Course, Nagasaki, Japan	Asubio Pharma Co., Ltd.; Asubio Pharma Co., Ltd.; Asubio Pharma Co., Ltd.; Osaka Metropolitan University; Nagasaki Institute of Applied Science	Makino, T (corresponding author), Asubio Pharma Co LTD, Drug Discovery Technol Funct, Kobe, Hyogo, Japan.	makino.tomohiro.hn@asubio.co.jp	Makino, Tomohiro/GPP-4650-2022	Muneoka, Satoshi/0000-0001-6326-0983	AsubioPharmaCo., LTD; Grants-in-Aid for Scientific Research [17K09787] Funding Source: KAKEN	AsubioPharmaCo., LTD; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study sponsor (AsubioPharmaCo., LTD) provided support in the form of salaries for authors (TM, RN, MT, SM, KN) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Anderson D, 2016, ANN CLIN TRANSL NEUR, V3, P552, DOI 10.1002/acn3.314; Andrew DW CJ, 1980, STRUCTURE ANDFUNCTIO, P1; Arias HR, 2010, NEUROCHEM INT, V56, P642, DOI 10.1016/j.neuint.2010.01.011; Beerli RR, 2010, MABS-AUSTIN, V2, P365, DOI 10.4161/mabs.12187; Beeson D, 1996, NEUROSCI LETT, V207, P57, DOI 10.1016/0304-3940(96)12488-5; BEROUKHIM R, 1995, NEURON, V15, P323, DOI 10.1016/0896-6273(95)90037-3; Berrih-Aknin S, 2014, J AUTOIMMUN, V52, P90, DOI 10.1016/j.jaut.2013.12.011; Berrih-Aknin S, 2014, J AUTOIMMUN, V52, P1, DOI 10.1016/j.jaut.2014.05.001; Bielefeld-Sevigny M, 2009, ASSAY DRUG DEV TECHN, V7, P90, DOI 10.1089/adt.2009.9996; Binks S, 2016, J NEUROL, V263, P826, DOI 10.1007/s00415-015-7963-5; Chihara N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083036; Cox KS, 2016, MABS-AUSTIN, V8, P129, DOI 10.1080/19420862.2015.1109757; De Baets M, 2002, J NEUROL SCI, V202, P5, DOI 10.1016/S0022-510X(02)00200-9; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; Fitch RW, 2003, P NATL ACAD SCI USA, V100, P4909, DOI 10.1073/pnas.0630641100; Fostieri E, 2005, EUR J IMMUNOL, V35, P632, DOI 10.1002/eji.200425671; Franciotta D, 1999, CLIN CHEM, V45, P400; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Gilhus NE, 2016, NAT REV NEUROL; Graus YF, 1997, J IMMUNOL, V158, P1919; Grob D, 2008, MUSCLE NERVE, V37, P141, DOI 10.1002/mus.20950; Heath JR, 2016, NAT REV DRUG DISCOV, V15, P204, DOI 10.1038/nrd.2015.16; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Huijbers MG, 2014, J INTERN MED, V275, P12, DOI 10.1111/joim.12163; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kohler S, 2013, J NEUROIMMUNOL, V264, P114, DOI 10.1016/j.jneuroim.2013.09.006; Kordas G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108327; Kurosawa N, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-80; Kusner LL, 2014, MUSCLE NERVE, V49, P749, DOI 10.1002/mus.24057; Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111; LENNON VA, 1975, J EXP MED, V141, P1365, DOI 10.1084/jem.141.6.1365; Lindstrom J, 2008, ANN NY ACAD SCI, V1132, P29, DOI 10.1196/annals.1405.007; Lindstrom J, 2012, ANN NY ACAD SCI, V1274, P9, DOI 10.1111/j.1749-6632.2012.06766.x; Losen M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01019-5; Losen M, 2015, EXP NEUROL, V270, P18, DOI 10.1016/j.expneurol.2015.03.010; Lozier BK, 2015, AM J CLIN PATHOL, V143, P186, DOI 10.1309/AJCPYEOR6SGE8ZLU; Luo J, 2009, J NEUROSCI, V29, P13898, DOI 10.1523/JNEUROSCI.2833-09.2009; LUTHER MA, 1989, J NEUROSCI, V9, P1082; Masuda T, 2012, J NEUROL NEUROSUR PS, V83, P935, DOI 10.1136/jnnp-2012-302705; Meijer PJ, 2006, J MOL BIOL, V358, P764, DOI 10.1016/j.jmb.2006.02.040; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Papanastasiou D, 2000, J NEUROIMMUNOL, V104, P124, DOI 10.1016/S0165-5728(99)00259-3; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Proserpio V, 2016, IMMUNOLOGY, V147, P133, DOI 10.1111/imm.12553; Protopapadakis E, 2005, EUR J IMMUNOL, V35, P1960, DOI 10.1002/eji.200526173; Psaridi-Linardaki L, 2002, J BIOL CHEM, V277, P26980, DOI 10.1074/jbc.M110731200; Rey E, 2000, CLIN IMMUNOL, V96, P269, DOI 10.1006/clim.2000.4898; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Steinitz Michael, 2009, Human Antibodies, V18, P1, DOI 10.3233/HAB-2009-0196; Tickle S, 2015, J BIOMOL SCREEN, V20, P492, DOI 10.1177/1087057114564760; Tradtrantip L, 2012, ANN NEUROL, V71, P314, DOI 10.1002/ana.22657; Trinh VB, 2014, MOL IMMUNOL, V59, P79, DOI 10.1016/j.molimm.2014.01.002; TZARTOS S, 1987, J NEUROIMMUNOL, V15, P185, DOI 10.1016/0165-5728(87)90092-0; Ullman EF, 1996, CLIN CHEM, V42, P1518; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Verschuuren JJGM, 2013, AUTOIMMUN REV, V12, P918, DOI 10.1016/j.autrev.2013.03.001; Vincent A, 1998, IMMUNOL REV, V164, P157, DOI 10.1111/j.1600-065X.1998.tb01217.x; Vrolix K, 2014, J AUTOIMMUN, V52, P101, DOI 10.1016/j.jaut.2013.12.008; WHITING PJ, 1986, NEUROLOGY, V36, P612, DOI 10.1212/WNL.36.5.612; Wine Y, 2015, CURR OPIN IMMUNOL, V35, P89, DOI 10.1016/j.coi.2015.06.009; Wolfe GI, 2016, NEW ENGL J MED, V375, P511, DOI 10.1056/NEJMoa1602489; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yamagami J, 2010, J CLIN INVEST, V120, P4111, DOI 10.1172/JCI44425; Yao Y, 2002, J BIOL CHEM, V277, P12613, DOI 10.1074/jbc.M108845200; YOSHIOKA M, 2011, BMC BIOTECHNOL, V11; Zenobi R, 2013, SCIENCE, V342, P1201, DOI 10.1126/science.1243259	68	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0185976	10.1371/journal.pone.0185976	http://dx.doi.org/10.1371/journal.pone.0185976			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040265	gold, Green Published, Green Submitted			2022-12-26	WOS:000413167500016
J	Hagglund, S; Blodorn, K; Naslund, K; Vargmar, K; Lind, SB; Mi, J; Arainga, M; Riffault, S; Taylor, G; Pringle, J; Valarcher, JF				Hagglund, Sara; Blodorn, Krister; Naslund, Katarina; Vargmar, Karin; Lind, Sara Bergstrom; Mi, Jia; Arainga, Mariluz; Riffault, Sabine; Taylor, Geraldine; Pringle, John; Valarcher, Jean Francois			Proteome analysis of bronchoalveolar lavage from calves infected with bovine respiratory syncytial virus-Insights in pathogenesis and perspectives for new treatments	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; S100 PROTEINS; INFLAMMATION; PROPHYLAXIS; ACTIVATION; EXPRESSION; PROTECTION; PNEUMONIA; INCREASES; IMMUNITY	Human and bovine respiratory syncytial viruses (HRSV/BRSV) are major causes of severe lower respiratory tract infections in children and calves, respectively. Shared epidemiological, clinical, pathological and genetic characteristics of these viruses make comparative research highly relevant. To characterise the host response against BRSV infection, bronchoalveolar lavage supernatant (BAL) from i) non-vaccinated, BRSV-infected ii) vaccinated, BRSV-infected and iii) non-infected calves was analysed by tandem mass spectrometry. Proteins were semi-quantified and protein expression was validated by immunoblotting. Correlations between selected proteins and pathology, clinical signs and virus shedding were investigated. Calves with BRSV-induced disease had increased total protein concentrations and a decreased number of proteins identified in BAL. The protein profile was characterised by neutrophil activation and a reduction in identified antioxidant enzymes. The presence of neutrophils in alveolar septa, the expression level of neutrophil-related or antioxidant proteins and LZTFL1 correlated significantly with disease. Citrullinated histone 3, an indicator of extracellular traps (ETs), was only detected in non-vaccinated, BRSV-infected animals. By bringing disequilibrium in the release and detoxification of reactive oxygen species, generating ETs and causing elastine degradation, exaggerated neutrophil responses might exacerbate RSV-induced disease. Neutrophil-mitigating or antioxidant treatments should be further explored.	[Hagglund, Sara; Blodorn, Krister; Naslund, Katarina; Pringle, John; Valarcher, Jean Francois] Swedish Univ Agr Sci, Host Pathogen Interact Grp, Dept Clin Sci, Uppsala, Sweden; [Vargmar, Karin] Swedish Univ Agr Sci, Sect Pathol, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Lind, Sara Bergstrom; Mi, Jia] Uppsala Univ, Dept Chem BMC, Sci Life Lab, Analyt Chem, Uppsala, Sweden; [Mi, Jia] Binzhou Med Univ, Med & Pharm Res Ctr, Yantai, Peoples R China; [Arainga, Mariluz] Univ Nebraska Med Ctr, Omaha, NE USA; [Riffault, Sabine] Univ Paris Saclay, INRA, Unite Virol & Immunol Mol, Jouy En Josas, France; [Taylor, Geraldine] Pirbright Inst, Ash Rd, Pirbright, Surrey, England	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Uppsala University; Binzhou Medical University; University of Nebraska System; University of Nebraska Medical Center; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Hagglund, S (corresponding author), Swedish Univ Agr Sci, Host Pathogen Interact Grp, Dept Clin Sci, Uppsala, Sweden.	sara.hagglund@slu.se	Pringle, John/E-8332-2019; Hägglund, Sara/AAE-4867-2020; VALARCHER, JEAN FRANCOIS/AAE-4857-2020; Lind, Sara Bergstrom/D-3723-2013	Pringle, John/0000-0003-4013-0363; Hägglund, Sara/0000-0002-6983-5722; VALARCHER, JEAN FRANCOIS/0000-0002-8564-5603; Lind, Sara Bergstrom/0000-0002-9510-3816; Vargmar, Karin/0000-0002-8013-2761	European Union's Horizon 2020 program for research, technological development and demonstration [633184]; Swedish Research Council (Formas, Sweden); L'Agence Nationale de la Recherche (France); Biotechnology and Biological Sciences Research Council Institute Strategic Programme on Livestock Viral Diseases at The Pirbright Institute (United Kingdom); Formas [2016-01770_3]; Swedish Farmers' Foundation for Agricultural Research [H0750358]; Carl Trygger grant [CST 15:57]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001709, BB/I017216/1] Funding Source: researchfish; BBSRC [BBS/E/I/00001709, BB/I017216/1] Funding Source: UKRI	European Union's Horizon 2020 program for research, technological development and demonstration; Swedish Research Council (Formas, Sweden); L'Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); Biotechnology and Biological Sciences Research Council Institute Strategic Programme on Livestock Viral Diseases at The Pirbright Institute (United Kingdom); Formas(Swedish Research Council Formas); Swedish Farmers' Foundation for Agricultural Research; Carl Trygger grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project received funding from the European Union's Horizon 2020 program for research, technological development and demonstration under the Grant Agreement no633184 (SAPHIR, https://ec.europa/eu/ This publication reflects the views only of the author, and not the European Commission (EC). The EC is not liable for any use that may be made of the information contained herein); the Swedish Research Council (Formas, Sweden), L'Agence Nationale de la Recherche (France) and the Biotechnology and Biological Sciences Research Council Institute Strategic Programme on Livestock Viral Diseases at The Pirbright Institute (United Kingdom), where GT is a Jenner Investigator, through the Emerging and Major Infectious Diseases of Livestock (EMIDA) project in the European Research Area Network (ERA-NET), grant FP#87, https://www.anihwa.eu/; Formas grant 2016-01770_3 http://www.formas.se/; the Swedish Farmers' Foundation for Agricultural Research, grant H0750358 http:/www.lantbruksforskning.se/ and Carl Trygger grant CST 15:57 http:/www.carltryggersstiftelse.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleyd E, 2014, J IMMUNOL, V192, P2374, DOI 10.4049/jimmunol.1300261; Angelis N, 2014, J THORAC DIS, V6, pS167, DOI 10.3978/j.issn.2072-1439.2014.03.07; Angen O, 2009, VET MICROBIOL, V137, P165, DOI 10.1016/j.vetmic.2008.12.024; Blodorn K, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0389-6; Blodorn K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100392; BRYSON DG, 1991, VET PATHOL, V28, P286, DOI 10.1177/030098589102800404; Campisi J, 2016, ANN AM THORAC SOC, V13, pS402, DOI 10.1513/AnnalsATS.201609-703AW; Cavnar PJ, 2012, J BIOL CHEM, V287, P25466, DOI 10.1074/jbc.M112.364562; Chen R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.337; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; Cortjens B, 2016, J PATHOL, V238, P401, DOI 10.1002/path.4660; Dapat C, 2016, EXPERT REV ANTI-INFE, V14, P285, DOI 10.1586/14787210.2016.1141676; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Fornander L, 2011, PROTEOM CLIN APPL, V5, P513, DOI 10.1002/prca.201100016; Funchal GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124082; Geerdink RJ, 2015, J ALLERGY CLIN IMMUN, V136, P838, DOI 10.1016/j.jaci.2015.06.034; Griffin D, 2014, ANIM HEALTH RES REV, V15, P138, DOI 10.1017/S1466252314000255; Hagglund S, 2004, VACCINE, V23, P646, DOI 10.1016/j.vaccine.2004.07.006; Hagglund S, 2014, CLIN VACCINE IMMUNOL, V21, P997, DOI 10.1128/CVI.00162-14; Hagglund S, 2011, VACCINE, V29, P8719, DOI 10.1016/j.vaccine.2011.07.146; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Heegaard PMH, 2000, VET IMMUNOL IMMUNOP, V77, P151, DOI 10.1016/S0165-2427(00)00226-9; Hornaeus K, 2016, DATA BRIEF, V8, P470, DOI 10.1016/j.dib.2016.05.073; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Jiang SN, 2014, J IMMUNOL, V192, P4795, DOI 10.4049/jimmunol.1302764; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; Kessel C, 2013, CLIN IMMUNOL, V147, P229, DOI 10.1016/j.clim.2012.11.008; Korppi M, 2016, PEDIAT PULMONOL; Ledgard AM, 2015, REPROD FERT DEVELOP, V27, P395, DOI 10.1071/RD13144; Garcia-Garcia ML, 2016, ARCH BRONCONEUMOL, V52, P269, DOI 10.1016/j.arbres.2015.11.008; Mayer C, 2016, J CANCER, V7, P546, DOI 10.7150/jca.14169; Meade KG, 2014, PHYSIOL GENOMICS, V46, P17, DOI 10.1152/physiolgenomics.00085.2013; Merriman KE, 2015, J STEROID BIOCHEM, V154, P120, DOI 10.1016/j.jsbmb.2015.08.002; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mukherjee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118153; Pulford K, 1999, IMMUNOLOGY, V96, P262; Rahman I, 2012, EXPERT REV CLIN PHAR, V5, P293, DOI [10.1586/ecp.12.16, 10.1586/ECP.12.16]; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Shifren Adrian, 2006, Proc Am Thorac Soc, V3, P428, DOI 10.1513/pats.200601-009AW; Stoppelenburg AJ, 2014, AM J PATHOL, V184, P1274, DOI 10.1016/j.ajpath.2014.01.033; Stoppelenburg AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078461; TAYLOR G, 1989, RES VET SCI, V47, P231, DOI 10.1016/S0034-5288(18)31211-6; Telcian AG, 2017, ANTIVIR RES, V137, P93, DOI 10.1016/j.antiviral.2016.11.004; Terrazzano G, 2014, BBA-MOL CELL RES, V1843, P265, DOI 10.1016/j.bbamcr.2013.10.020; Valarcher JF, 2007, VET RES, V38, P153, DOI 10.1051/vetres:2006053; van Diepen A, 2015, J VIROL, V89, P5022, DOI 10.1128/JVI.03630-14; Viuff B, 2002, AM J PATHOL, V161, P2195, DOI 10.1016/S0002-9440(10)64496-3; Wagner Claudius J, 2016, Mol Cell Pediatr, V3, P25, DOI 10.1186/s40348-016-0053-7; Wang XF, 2016, JPN J INFECT DIS, V69, P285, DOI 10.7883/yoken.JJID.2015.244; Wei Q, 2016, ONCOGENE, V35, P2655, DOI 10.1038/onc.2015.328; Wenzel SE, 2002, AM J MED, V112, P627, DOI 10.1016/S0002-9343(02)01095-1; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Yi YS, 2016, IMMUNE NETW, V16, P337, DOI 10.4110/in.2016.16.6.337; Yoshihara S, 2013, PEDIATRICS, V132, P811, DOI 10.1542/peds.2013-0982; Zawrotniak M, 2013, ACTA BIOCHIM POL, V60, P277	57	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186594	10.1371/journal.pone.0186594	http://dx.doi.org/10.1371/journal.pone.0186594			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036182	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000413054800048
J	Ramay, BM; Ceron, A; Mendez-Alburez, LP; Lou-Meda, R				Ramay, Brooke M.; Ceron, Alejandro; Mendez-Alburez, Luis Pablo; Lou-Meda, Randall			Factors associated to acceptable treatment adherence among children with chronic kidney disease in Guatemala	PLOS ONE			English	Article							TRANSPLANT RECIPIENTS; CARE; STRATEGIES; BURDEN	Pediatric patients with Chronic Kidney Disease face several barriers to medication adherence that, if addressed, may improve clinical care outcomes. A cross sectional questionnaire was administered in the Foundation for Children with Kidney Disease (FUNDANIER, Guatemala City) from September of 2015 to April of 2016 to identify the predisposing factors, enabling factors and need factors related to medication adherence. Sample size was calculated using simple random sampling with a confidence level of 95%, confidence interval of 0.05 and a proportion of 87%. A total of 103 participants responded to the questionnaire (calculated sample size was 96). Independent variables were defined and described, and the bivariate relationship to dependent variables was determined using Odds Ratio. Multivariate analysis was carried out using logistic regression. The mean adherence of study population was 78% (SD 0.08, max = 96%, min = 55%). The mean adherence in transplant patients was 82% (SD 7.8, max 96%, min 63%), and the mean adherence in dialysis patients was 76% (SD 7.8 max 90%, min 55%). Adherence was positively associated to the mother's educational level and to higher monthly household income. Together predisposing, enabling and need factors illustrate the complexities surrounding adherence in this pediatric CKD population. Public policy strategies aimed at improving access to comprehensive treatment regimens may facilitate treatment access, alleviating economic strain on caregivers and may improve adherence outcomes.	[Ramay, Brooke M.] Univ Valle Guatemala, Dept Pharmaceut Chem, Guatemala City, Guatemala; [Ceron, Alejandro] Univ Denver, Dept Anthropol, Denver, CO USA; [Mendez-Alburez, Luis Pablo; Lou-Meda, Randall] Hosp Roosevelt, Fdn El Nino Enfermo Renal FUNDANIER, Guatemala City, Guatemala	Universidad del Valle de Guatemala; University of Denver	Ramay, BM (corresponding author), Univ Valle Guatemala, Dept Pharmaceut Chem, Guatemala City, Guatemala.	bramay@uvg.edu.gt		Ramay, Brooke/0000-0001-8527-4067	University of Denver's Professional Research Opportunities For Faculty (PROF) Grant	University of Denver's Professional Research Opportunities For Faculty (PROF) Grant	This study was funded by University of Denver's Professional Research Opportunities For Faculty (PROF) Grant to AC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by University of Denver's Professional Research Opportunities for Faculty (PROF) Grant. Study design and logistics were possible thanks to the support of the clinical and administrative staff at FUNDANIER. Oscar de Leon (Universidad del Valle de Guatemala) provided crucial IT support for data collection and Maria PurificaciOn Moreno (Universidad de Granada, Spain) provided support in data processing.	Aday L A, 1974, Health Serv Res, V9, P208; ADAY LA, 1981, MED CARE, V19, P4, DOI 10.1097/00005650-198112001-00004; Almaguer M, 2014, MEDICC REV, V16, P9, DOI 10.37757/MR2014.V16.N2.3; Bahador Z, 2015, INT J TRANSPLANT MED, V6, P25; Barsoum RS, 2016, CLIN NEPHROL, V86, pS14, DOI 10.5414/CNP86S003; Becerril-Montekio Víctor, 2011, Salud pública Méx, V53, ps197; Becherucci F, 2016, CLIN KIDNEY J, V9, P583, DOI 10.1093/ckj/sfw047; Bello AK, 2017, JAMA-J AM MED ASSOC, V317, P1864, DOI 10.1001/jama.2017.4046; de Almeida JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140062; Center for Pharmaceutical Management, 2003, DEF MEAS ACC ESS DRU; Ceron A, 2016, INT J EQUITY HLTH, V15; Ceron A, 2014, REV PANAM SALUD PUBL, V36, P376; Chinchilla J., 2016, ADV NEPHROL, V7179028, P1; CSDH, 2008, CLOS GAP GEN HLTH EQ; Davis MC, 1996, PEDIATR NEPHROL, V10, P160; Dobbels F, 2010, PEDIATR TRANSPLANT, V14, P603, DOI 10.1111/j.1399-3046.2010.01299.x; Eduardo Remor, 2002, PSICOTHEMA, V14; Feinstein S, 2005, PEDIATRICS, V115, P969, DOI 10.1542/peds.2004-0211; Harambat J, 2012, PEDIATR NEPHROL, V27, P363, DOI 10.1007/s00467-011-1939-1; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Ingerski L, 2011, NURS RES, V60, P190, DOI 10.1097/NNR.0b013e318215fdfe; Khanna AK, 2015, INDIAN J PEDIATR, V82, P1006, DOI 10.1007/s12098-015-1762-y; Levin A., 2017, LANCET; Emmerick ICM, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0254-z; Mendez J, 2015, REPUBLICA GUATEMALA; Modi AC, 2012, PEDIATRICS, V129, pE473, DOI 10.1542/peds.2011-1635; Muller AD, 2011, AIDS CARE, V23, P129, DOI 10.1080/09540121003758523; National Kidney Foundation Inc, 2002, KDOQI CLIN PRACT GUI; Ordunez P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003019; Perico N, 2005, KIDNEY INT, V68, pS87, DOI 10.1111/j.1523-1755.2005.09715.x; R Development CT, 2008, R LANG ENV STAT COMP; Tafur-Valderrama E, 2008, ARS PHARM, V49, P183; Tong A, 2010, CHILD CARE HLTH DEV, V36, P549, DOI 10.1111/j.1365-2214.2010.01067.x; United Nations Development Report, 2015, WORK HUM DEV BRIEF N; Vasquez K, REV U VAL GUATEM, V35, P67; Vasylyeva TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069060; Wang V, 2016, SEMIN NEPHROL, V36, P319, DOI 10.1016/j.semnephrol.2016.05.008; World Health Organisation, 2003, ADHERENCE LONG TERM; Zelikovsky N, 2008, PEDIATR TRANSPLANT, V12, P300, DOI 10.1111/j.1399-3046.2007.00886.x	39	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186644	10.1371/journal.pone.0186644	http://dx.doi.org/10.1371/journal.pone.0186644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ8YP	29036228	Green Published, Green Submitted, gold			2022-12-26	WOS:000413054800053
J	Todd, N; Le Fur, S; Bougneres, P; Valleron, AJ				Todd, Nicolas; Le Fur, Sophie; Bougneres, Pierre; Valleron, Alain-Jacques			Impact of social inequalities at birth on the longevity of children born 1914-1916: A cohort study	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; SOCIOECONOMIC-STATUS; MATERNAL AGE; STRESS; EXPOSURE; HEALTH; CONSEQUENCES; ASSOCIATION; CORTISOL; DISEASE	Background Testing whether familial socioeconomic status (SES) in childhood is a predictor of mortality has rarely been done on historical cohorts. Methods The birth certificates of 4,805 individuals born 1914-1916 in 16 districts of the Paris region were retrieved. The handwritten information provided the occupation of parents, the legitimacy status, life events (e.g. marriage, divorce), and the precise date of death when after 1945 (i.e. age 31 years (y) in the cohort). We used the median age at death (MAD) as a global measure of mortality, then studied separately survival to and after 31 y. Multivariate Imputation by Chained Equations (MICE), Generalized Additive Models (GAMs) and mixed effect Cox models were used. Results MAD showed large variations according to paternal occupation. The lowest MAD in both sexes was that of workers' children: it was 56.3 y (95% CI: [48.6-62.7]) in men and 67.4 y (95% CI: [60.8-72.7]) in women, respectively (95% CI: 13.4 y [5.7-21.3]) and 12.3 y (95% CI: [4.0-19.2]) below the highest MAD attained. MAD experienced by illegitimate children was 18.9 y (95% CI: [13.3-32.3]) shorter than of legitimate children. The multivariate analysis revealed that in both sexes survival to age 31 y was predicted independently by legitimacy and paternal occupation. Paternal occupation was found significantly associated with mortality after age 31 y in females only: accordingly difference in life expectancy at age 31 y was 4.4 y (95% CI: [1.2-7.6]) between upper class and workers' daughters. Conclusions Paternal occupation and legitimacy status were strong predictors of offspring longevity in this one-century historical cohort born during World War One.	[Todd, Nicolas; Le Fur, Sophie; Bougneres, Pierre; Valleron, Alain-Jacques] INSERM U1169, Le Kremlin Bicetre, France; [Bougneres, Pierre] Paris Sud Univ, Hop Bicetre, Med Adolescents, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Todd, N (corresponding author), INSERM U1169, Le Kremlin Bicetre, France.	nicolas.todd@inserm.fr			Institut National de la Sante et de la Recherche Medicale (INSERM)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1917, B ACAD NATL MED, V77, P116; Bale TL, 2015, NAT NEUROSCI, V18, P1413, DOI 10.1038/nn.4112; Brunton PJ, 2010, J NEUROENDOCRINOL, V22, P258, DOI 10.1111/j.1365-2826.2010.01969.x; Cohen S, 2010, ANN NY ACAD SCI, V1186, P37, DOI 10.1111/j.1749-6632.2009.05334.x; Crawford AA, 2015, HEART, V101, pA6, DOI 10.1136/heartjnl-2015-308734.19; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Dupaquier Jacques, 1988, HIST POPULATION FRAN; Elo IT, 2014, SOC SCI MED, V119, P198, DOI 10.1016/j.socscimed.2013.11.037; Galobardes B, 2008, J EPIDEMIOL COMMUN H, V62, P387, DOI 10.1136/jech.2007.065508; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; Halligan SL, 2004, BIOL PSYCHIAT, V55, P376, DOI 10.1016/j.biopsych.2003.09.013; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hill C, 1998, PREV MED, V27, P514, DOI 10.1006/pmed.1998.0319; Howerton CL, 2014, P NATL ACAD SCI USA, V111, P9639, DOI 10.1073/pnas.1401203111; Juarez SP, 2016, J EPIDEMIOL COMMUNIT; Kinge JM, 2015, J EPIDEMIOL COMMUN H, V69, P1141, DOI 10.1136/jech-2014-205353; Kirchengast S, 2003, AM J HUM BIOL, V15, P220, DOI 10.1002/ajhb.10139; Maccari S, 2014, J NEUROENDOCRINOL, V26, P707, DOI 10.1111/jne.12175; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mathews T J, 2006, Natl Vital Stat Rep, V54, P1; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P391, DOI 10.1038/nrendo.2014.73; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Phipps MG, 2002, OBSTET GYNECOL, V100, P481, DOI 10.1016/S0029-7844(02)02172-5; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; ROLLET C, 1978, POPULATION, V33, P1189, DOI 10.2307/1531965; Rollet-Echalier Catherine, 1990, POLITIQUE EGARD PETI; Rubin DB, 2004, MULTIPLE IMPUTATION; Schomaker M, BOOTSTRAP INFERENCE; Therneau TM., COXME MIXED EFFECTS; Todd N, 2017, P NATL ACAD SCI USA, V114, P4201, DOI 10.1073/pnas.1617911114; Todd N, 2015, ENVIRON HEALTH PERSP, V123, P659, DOI 10.1289/ehp.1307771; University of California Berkeley (USA); Max Planck Institute for Demographic Research (Germany), HUM MORTALITY DATAB; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259; van Buuren S, 2011, J STAT SOFTW, V45, P1; van de Walle, 1974, POPULATION, V29, P89, DOI [10.2307/1530531, DOI 10.2307/1530531]; van Os J, 1998, BRIT J PSYCHIAT, V172, P324, DOI 10.1192/bjp.172.4.324; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood S., MGCV MIXED GAM COMPU	40	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0185848	10.1371/journal.pone.0185848	http://dx.doi.org/10.1371/journal.pone.0185848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ8YP	29036185	Green Submitted, gold, Green Published			2022-12-26	WOS:000413054800011
J	Higgins, JL; Gonzalez-Juarrero, M; Bowen, RA				Higgins, Jennifer L.; Gonzalez-Juarrero, Mercedes; Bowen, Richard A.			Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1	PLOS ONE			English	Article							FLUORESCENCE POLARIZATION ASSAY; PREGNANT GOATS; DELETION MUTANT; ABORTUS INFECTION; CAPRINE MODEL; EWES; PATHOGENESIS; PLACENTITIS; PERSISTENCE; DIAGNOSIS	Brucella melitensis is the causative agent of brucellosis in small ruminants and is of considerable economic and public health importance in many countries worldwide. The control of disease in humans depends on the control of disease in livestock; however, few counties with endemic B. melitensis infection have been able to successfully eradicate this pathogen. This underscores the need for further research on the pathogenesis of both virulent and vaccine strains of B. melitensis in the small ruminant host. The aim of the present study was to characterize clinical effects, tissue colonization, shedding, and humoral immune response following B. melitensis infection in goats. Both virulent (16M) and reduced virulence (Rev. 1) strains of B. melitensis were studied. Pregnant goats were infected at 11-14 weeks of gestation with 8 x 10(6) or 8 x 10(7) CFU of B. melitensis. Infection of goats with B. melitensis 16M resulted in an 86% abortion rate. This strain disseminated widely in pregnant does postinfection with none of the 15 sampled tissues spared from colonization. Importantly, we report the first isolation of B. melitensis from muscle tissue in ruminants. Pathogenesis of Rev. 1 infection was variable with two does showing minimal colonization and one doe exhibiting disease similar to that of animals infected with fully virulent 16M. Shedding of B. melitensis in milk occurred in all 16M-and Rev. 1-infected goats. In pregnant animals challenged with virulent B. melitensis, median time to seroconversion was 21 days; however, 2 animals did not seroconvert until after abortion.	[Higgins, Jennifer L.; Gonzalez-Juarrero, Mercedes] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Higgins, JL (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.; Bowen, RA (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	Jennifer.Higgins@colostate.edu; Richard.Bowen@colostate.edu		gonzalez-juarrero, mercedes/0000-0002-4045-2365; Higgins, Jennifer/0000-0001-8683-7263	Animal Models Core at Colorado State University	Animal Models Core at Colorado State University	This work was funded by the Animal Models Core at Colorado State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTON G G, 1970, British Veterinary Journal, V126, P61; ALTON GG, 1967, J COMP PATHOL, V77, P293, DOI 10.1016/0021-9975(67)90038-2; ALTON GG, 1968, J COMP PATHOL, V78, P173, DOI 10.1016/0021-9975(68)90093-5; Alton GG, 1990, ANIMAL BRUCELLOSIS, P384; Anderson T. D., 1986, Veterinary Pathology, V23, P219; ANDERSON TD, 1986, VET PATHOL, V23, P227, DOI 10.1177/030098588602300302; Blasco JM, 1997, PREV VET MED, V31, P275, DOI 10.1016/S0167-5877(96)01110-5; Capparelli R, 2009, J APPL MICROBIOL, V106, P2041, DOI 10.1111/j.1365-2672.2009.04177.x; Cheville NF, 1996, INFECT IMMUN, V64, P2431, DOI 10.1128/IAI.64.7.2431-2439.1996; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; DEBAGUES MPJ, 1989, ANN RECH VET, V20, P205; Diaz-Aparicio E, 2004, TROP ANIM HEALTH PRO, V36, P117, DOI 10.1023/B:TROP.0000012106.84833.3b; Edmonds MD, 2002, RES VET SCI, V72, P235, DOI 10.1053/rvsc.2002.0555; El Idrissi AH, 2001, REV SCI TECH OIE, V20, P741, DOI 10.20506/rst.20.3.1305; ELBERG SS, 1957, J BACTERIOL, V73, P211, DOI 10.1128/JB.73.2.211-217.1957; Elzer PH, 2002, VET MICROBIOL, V90, P425, DOI 10.1016/S0378-1135(02)00226-2; Elzer PH, 1998, RES VET SCI, V64, P259, DOI 10.1016/S0034-5288(98)90135-7; ENTESSAR F, 1967, J COMP PATHOL, V77, P367, DOI 10.1016/0021-9975(67)90021-7; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Grillo MJ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-29; Kojan S, 2012, MUSCLE NERVE, V45, P290, DOI 10.1002/mus.22261; MEADOR VP, 1989, VET PATHOL, V26, P357, DOI 10.1177/030098588902600501; MEADOR VP, 1986, AM J VET RES, V47, P2337; MEADOR VP, 1988, AM J VET RES, V49, P274; Nielsen K, 1996, J IMMUNOL METHODS, V195, P161, DOI 10.1016/0022-1759(96)00116-0; Nielsen K, 2001, J IMMUNOASS IMMUNOCH, V22, P183, DOI 10.1081/IAS-100104705; OHARA PJ, 1978, NEW ZEAL VET J, V26, P70, DOI 10.1080/00480169.1978.34499; Olsen SC, 2014, VET PATHOL, V51, P1076, DOI 10.1177/0300985814540545; Olsen SC, 2011, CLIN VACCINE IMMUNOL, V18, P2075, DOI 10.1128/CVI.05383-11; Olsen SC, 1997, INFECT IMMUN, V65, P2987, DOI 10.1128/IAI.65.7.2987-2991.1997; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Perry QL, 2010, VACCINE, V28, pF6, DOI 10.1016/j.vaccine.2010.03.056; Phillips RW, 1997, RES VET SCI, V63, P165, DOI 10.1016/S0034-5288(97)90012-6; Ramirez-Pfeiffer C, 2006, VET IMMUNOL IMMUNOP, V110, P121, DOI 10.1016/j.vetimm.2005.09.011; Refai M, 2002, VET MICROBIOL, V90, P81, DOI 10.1016/S0378-1135(02)00248-1; Reguera JM, 2003, EUR J CLIN MICROBIOL, V22, P647, DOI 10.1007/s10096-003-1026-z; Roop RM, 2001, VET MICROBIOL, V82, P91, DOI 10.1016/S0378-1135(01)00380-7; Shimi A., 1981, Bulletin de l'Office International des Epizooties, V93, P1411; Thomsen A., 1950, BRIT VET J, V106, P41, DOI [10.1016/S0007-1935(17)52976-0, DOI 10.1016/S0007-1935(17)52976-0]; Tittarelli M, 2005, J VET MED B, V52, P403, DOI 10.1111/j.1439-0450.2005.00885.x; Troy SB, 2005, MEDICINE, V84, P174, DOI 10.1097/01.md.0000165659.20988.25; Turan H, 2009, INT J INFECT DIS, V13, pE485, DOI 10.1016/j.ijid.2009.02.002; World Organization for Animal Health, 2009, CAPR OV BRUC MAN DIA; World Organization for Animal Health, 2009, BOV BRUC MAN DIAGN T; ZUNDEL E, 1992, ANN RECH VET, V23, P177	46	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0185823	10.1371/journal.pone.0185823	http://dx.doi.org/10.1371/journal.pone.0185823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028813	Green Submitted, gold, Green Published			2022-12-26	WOS:000412980300013
J	Escobar-Sepulveda, HF; Trejo-Tellez, LI; Garcia-Morales, S; Gomez-Merino, FC				Fernando Escobar-Sepulveda, Hugo; Iris Trejo-Tellez, Libia; Garcia-Morales, Soledad; Carlos Gomez-Merino, Fernando			Expression patterns and promoter analyses of aluminum-responsive NAC genes suggest a possible growth regulation of rice mediated by aluminum, hormones and NAC transcription factors	PLOS ONE			English	Article							ROOT-GROWTH; ARABIDOPSIS-THALIANA; ABIOTIC STRESS; TEA PLANTS; LOW-PH; TOXICITY; RESISTANCE; TOLERANCE; ACID; SOILS	In acid soils, the solubilized form of aluminum, Al+3, decreases root growth and affects the development of most crops. However, like other toxic elements, Al can have hormetic effects on plant metabolism. Rice (Oryza sativa) is one of the most tolerant species to Al toxicity, and when this element is supplied at low doses, growth stimulation has been observed, which could be due to combined mechanisms that are partly triggered by NAC transcription factors. This protein family can regulate vital processes in plants, including growth, development, and response to environmental stimuli, whether biotic or abiotic. Under our experimental conditions, 200 mu M Al stimulated root growth and the formation of tillers; it also caused differential expression of a set of NAC genes. The promoter regions of the genes regulated by Al were analyzed and the cis-acting elements that are potentially involved in the responses to different stimuli, including environmental stress, were identified. Through the Genevestigator platform, data on the expression of NAC genes were obtained by experimental condition, tissue, and vegetative stage. This is the first study on NAC genes where in vivo and in silico data are complementarily analyzed, relating the hormetic effect of Al on plant growth and gene expression with a possible interaction in the response to phytohormones in rice. These findings could help to elucidate the possible convergence between the signaling pathways mediated by phytohormones and the role of the NAC transcription factors in the regulation of growth mediated by low Al doses.	[Fernando Escobar-Sepulveda, Hugo; Carlos Gomez-Merino, Fernando] Colegio Postgrad, Dept Biotechnol, Campus Cordoba, Amatlan De Los Reyes, Veracruz, Mexico; [Iris Trejo-Tellez, Libia] Colegio Postgrad, Lab Plant Nutr, Dept Soil Sci, Campus Montecillo, Texcoco, State Of Mexico, Mexico; [Garcia-Morales, Soledad] CONACYT Ctr Res & Assistance Technol & Design Sta, Dept Plant Biotechnol, Zapopan, Jalisco, Mexico	Colegio de Postgraduados - Mexico; Colegio de Postgraduados - Mexico	Gomez-Merino, FC (corresponding author), Colegio Postgrad, Dept Biotechnol, Campus Cordoba, Amatlan De Los Reyes, Veracruz, Mexico.	fernandg@colpos.mx	Gómez-Merino, Fernando Carlos/D-2224-2014; LIBIA, TREJO-TÉLLEZ/AAV-8118-2021; Gomez-Merino, Fernando Carlos/B-2423-2015	Garcia-Morales, Soledad/0000-0002-2551-2518; Gomez-Merino, Fernando Carlos/0000-0001-8496-2095	Secretary of Foreign Affairs (SRE) of Mexico; Mexico's National Council for Science and Technology (CONACYT); Cordoba campuse of the Colegio de Postgraduados; Montecillo campuse of the Colegio de Postgraduados	Secretary of Foreign Affairs (SRE) of Mexico; Mexico's National Council for Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Cordoba campuse of the Colegio de Postgraduados; Montecillo campuse of the Colegio de Postgraduados	The Secretary of Foreign Affairs (SRE) of Mexico granted an M. Sc. scholarship to HFES. We are also very grateful to Mexico's National Council for Science and Technology (CONACYT) for supporting the Colegio de Postgraduados graduate programs involved in this project (i.e., Agri-Food Sustainable Innovation, Soil Science, Statistics, and Computer Science). We also acknowledge the infrastructure facilities and support provided by the Cordoba and Montecillo campuses of the Colegio de Postgraduados. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Arasimowicz-Jelonek M, 2014, PLANTA, V239, P679, DOI 10.1007/s00425-013-2008-8; Arenhart RA, 2016, PLANT CELL ENVIRON, V39, P645, DOI 10.1111/pce.12655; Arenhart RA, 2014, MOL PLANT, V7, P709, DOI 10.1093/mp/sst160; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Barcelo J, 2002, ENVIRON EXP BOT, V48, P75, DOI 10.1016/S0098-8472(02)00013-8; Bose J, 2013, PLANT CELL PHYSIOL, V54, P1093, DOI 10.1093/pcp/pct064; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cancado GMA, 2008, BIOL PLANTARUM, V52, P475, DOI 10.1007/s10535-008-0093-5; Caniato FF, 2007, THEOR APPL GENET, V114, P863, DOI 10.1007/s00122-006-0485-x; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Christianson JA, 2010, PLANT SIGNAL BEHAV, V5, P428, DOI 10.4161/psb.5.4.10847; Daspute AA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01358; Du BG, 2010, ACTA PHYSIOL PLANT, V32, P883, DOI 10.1007/s11738-010-0476-z; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Famoso AN, 2010, PLANT PHYSIOL, V153, P1678, DOI 10.1104/pp.110.156794; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; FOY CD, 1988, COMMUN SOIL SCI PLAN, V19, P959, DOI 10.1080/00103628809367988; Fung KF, 2008, J SCI FOOD AGR, V88, P1582, DOI 10.1002/jsfa.3254; Garcia-Morales S, 2014, ACTA PHYSIOL PLANT, V36, P1927, DOI 10.1007/s11738-014-1569-x; Garcia-Morales S, 2013, REV FITOTEC MEX, V36, P105; Ghanati F, 2005, PLANT SOIL, V276, P133, DOI 10.1007/s11104-005-3697-y; Gomez-Merino FC, 2014, REV FITOTEC MEX, V37, P243; Gonzalez RM, 2014, PLANTA, V239, P941, DOI 10.1007/s00425-014-2039-9; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hajiboland R, 2014, BIOL PLANTARUM, V58, P717, DOI 10.1007/s10535-014-0425-6; Hajiboland R, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1803-1; Hajiboland R, 2013, J INORG BIOCHEM, V128, P183, DOI 10.1016/j.jinorgbio.2013.07.007; Hajiboland R, 2013, J PLANT NUTR SOIL SC, V176, P616, DOI 10.1002/jpln.201200311; Hande AS, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4066-y; Hao DY, 1998, J BIOL CHEM, V273, P26857, DOI 10.1074/jbc.273.41.26857; Gonzalez-Santana IH, 2012, PHYSIOL PLANTARUM, V144, P134, DOI 10.1111/j.1399-3054.2011.01527.x; Hegedus D, 2003, PLANT MOL BIOL, V53, P383, DOI 10.1023/B:PLAN.0000006944.61384.11; Hernandez-Garcia CM, 2014, PLANT SCI, V217, P109, DOI 10.1016/j.plantsci.2013.12.007; Huang CF, 2009, PLANT CELL, V21, P655, DOI 10.1105/tpc.108.064543; Ibraheem O, 2010, COMPUT BIOL CHEM, V34, P268, DOI 10.1016/j.compbiolchem.2010.09.003; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; JONES TR, 1986, J CELL BIOCHEM, V30, P31, DOI 10.1002/jcb.240300105; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; LeNoble ME, 1996, PLANT CELL ENVIRON, V19, P1132, DOI 10.1111/j.1365-3040.1996.tb00428.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li F, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00147; Ma JF, 2007, INT REV CYTOL, V264, P225, DOI 10.1016/S0074-7696(07)64005-4; Moreno-Alvarado M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00073; Moriyama U, 2016, TREES-STRUCT FUNCT, V30, P405, DOI 10.1007/s00468-015-1252-x; Mossor-Pietraszewska T, 2001, ACTA BIOCHIM POL, V48, P673; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nhan P. P., 2013, AFRIC J PLANT SCI, V7, P208, DOI DOI 10.5897/AJPS11.306; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Olsen AN, 2005, PLANT SCI, V169, P785, DOI 10.1016/j.plantsci.2005.05.035; Osaki M, 1997, SOIL SCI PLANT NUTR, V43, P551, DOI 10.1080/00380768.1997.10414782; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Pilon-Smits EAH, 2009, CURR OPIN PLANT BIOL, V12, P267, DOI 10.1016/j.pbi.2009.04.009; Poschenrieder C, 2008, SCI TOTAL ENVIRON, V400, P356, DOI 10.1016/j.scitotenv.2008.06.003; QUARLES LD, 1994, J CELL BIOCHEM, V56, P106, DOI 10.1002/jcb.240560115; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Ricardi MM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-29; Romero I, 1998, PLANT J, V14, P273, DOI 10.1046/j.1365-313X.1998.00113.x; Rosello M, 2015, J INORG BIOCHEM, V152, P160, DOI 10.1016/j.jinorgbio.2015.08.021; SAS, 2004, SAS STAT R 9 1 US GU; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shahnejat-Bushehri S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00214; Shao HB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00902; Shinwari ZK, 1998, BIOCHEM BIOPH RES CO, V250, P161, DOI 10.1006/bbrc.1998.9267; Sindhu A, 2008, P NATL ACAD SCI USA, V105, P1762, DOI 10.1073/pnas.0711406105; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Sperotto RA, 2009, PLANTA, V230, P985, DOI 10.1007/s00425-009-1000-9; Sun LL, 2016, J EXP BOT, V67, P3655, DOI 10.1093/jxb/erw188; Tomioka R., 2012, American Journal of Plant Sciences, V3, P1619, DOI 10.4236/ajps.2012.311196; Tomioka Ric, 2007, Environmental Sciences, V14, P141; Tomioka Rie, 2007, Environmental Sciences, V14, P157; Trejo-Tellez LI, 2010, PLANT SOIL, V326, P187, DOI 10.1007/s11104-009-9994-0; Tsutsui T, 2011, PLANT PHYSIOL, V156, P925, DOI 10.1104/pp.111.175802; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Wang L, 2015, PLANTA, V242, P1391, DOI 10.1007/s00425-015-2376-3; Wang YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166727; Wani SH, 2016, CROP J, V4, P162, DOI 10.1016/j.cj.2016.01.010; Watanabe T., 2009, P INT PLANT NUTR C 1; Watanabe T, 2006, PLANT CELL ENVIRON, V29, P2124, DOI 10.1111/j.1365-3040.2006.001586.x; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yang ZB, 2017, PLANT PHYSIOL, V173, P1420, DOI 10.1104/pp.16.01756; Yu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep18888; Zhou LB, 2016, J EXP MAR BIOL ECOL, V478, P77, DOI 10.1016/j.jembe.2016.02.009; Zimmermann P, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-18; Zou C, 2011, P NATL ACAD SCI USA, V108, P14992, DOI 10.1073/pnas.1103202108	91	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186084	10.1371/journal.pone.0186084	http://dx.doi.org/10.1371/journal.pone.0186084			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023561	gold, Green Published, Green Submitted			2022-12-26	WOS:000412845100059
J	Huang, XB; Whitman, DW; Ma, JC; McNeill, MR; Zhang, ZH				Huang, Xunbing; Whitman, Douglas W.; Ma, Jingchuan; McNeill, Mark Richard; Zhang, Zehua			Diet alters performance and transcription patterns in Oedaleus asiaticus (Orthoptera: Acrididae) grasshoppers	PLOS ONE			English	Article							HOST-PLANT SELECTION; PHENOTYPIC PLASTICITY; INSECT HERBIVORES; EVOLUTIONARY; RESPONSES; LIFE; IDENTIFICATION; LEPIDOPTERA; MECHANISMS; RESISTANCE	We reared Oedaleus asiaticus grasshoppers under four different single-plant diets to examine the relationships among diet, performance, stress, and transcription patterns. Grasshoppers fed only Artemisia frigida (Asteraceae) were stressed, as indicated by their lower growth, size, development, and survival, in comparison to grasshoppers fed on any of three grasses, Cleistogenes squarrosa, Leymus chinensis, or Stipa krylovii (all Poaceae). We then used transcriptome analysis to examine how gene expression levels in O. asiaticus were altered by feeding on these diets. Nymphs fed A. frigida had the largest variation in gene expression profiles with a total of 299 genes significantly up- or down-regulated compared to those feeding on the three grasses: down-regulated genes included those involved in cuticle biosynthesis, DNA replication, biosynthesis and metabolism of nutrition. The up regulated genes included stress-resistant and detoxifying enzymes. GO and KEGG enrichment analysis also showed that feeding on A. frigida could down-regulate biosynthesis and metabolism related pathways, and up-regulate stress-resistant and detoxification terms and pathways. Our results show that diet significantly altered gene-expression, and that unfavorable, stressful diets induce more transcriptional changes than favorable diets. Altered gene expression represents phenotypic plasticity, and many such changes appear to be evolved, adaptive responses. The ease and regularity by which individuals shift phenotypes via altered transcription suggests that populations consist not of similar, fixed phenotypes, but of a collection of ever-changing, divergent phenotypes.	[Huang, Xunbing; Ma, Jingchuan; Zhang, Zehua] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Huang, Xunbing; Ma, Jingchuan; Zhang, Zehua] Chinese Acad Agr Sci, Sci Observat & Expt Stn Pests Xilin Gol Rangeland, Inst Plant Protect, Xilinhot, Peoples R China; [Whitman, Douglas W.] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA; [McNeill, Mark Richard] AgResearch, Lincoln Res Ctr, Christchurch, New Zealand	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Illinois State University; AgResearch - New Zealand	Zhang, ZH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.; Zhang, ZH (corresponding author), Chinese Acad Agr Sci, Sci Observat & Expt Stn Pests Xilin Gol Rangeland, Inst Plant Protect, Xilinhot, Peoples R China.	zhangzehua@cass.cn		McNeill, Mark/0000-0001-9140-610X	National Natural Science Foundation of China [31672485, 31471824]; Earmarked Fund for China Agriculture Research System [CARS-35-07]; Innovation Project of Chinese Academy of Agricultural Science	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for China Agriculture Research System; Innovation Project of Chinese Academy of Agricultural Science	This study was supported by the National Natural Science Foundation of China, 31672485 and 31471824, the Earmarked Fund for China Agriculture Research System, CARS-35-07, and the Innovation Project of Chinese Academy of Agricultural Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Barbehenn RV, 2004, OECOLOGIA, V140, P96, DOI 10.1007/s00442-004-1555-x; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Bernays E. A., 1994, CONT TOPICS ENTOMOLO, V2, P1754; BERNAYS EA, 1994, ECOLOGY, V75, P1997, DOI 10.2307/1941604; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Blainey P, 2014, NAT METHODS, V11, P879, DOI 10.1038/nmeth.3091; Brechenmacher L, 2015, J PROTEOME RES, V14, P4137, DOI 10.1021/acs.jproteome.5b00146; Cease AJ, 2012, SCIENCE, V335, P467, DOI 10.1126/science.1214433; Chen Z., 2000, TYPICAL STEPPE ECOSY; Czosnek H, 2016, MANAGEMENT INSECT PE; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Enders LS, 2015, G3-GENES GENOM GENET, V5, P261, DOI 10.1534/g3.114.015149; Foyer CH, 2015, J EXP BOT, V66, P495, DOI 10.1093/jxb/eru491; Franzke A, 2010, ECOL ENTOMOL, V35, P126, DOI 10.1111/j.1365-2311.2009.01168.x; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo Zhong-Wei, 2006, Insect Science, V13, P221, DOI 10.1111/j.1744-7917.2006.00086.x; Han JG, 2008, RANGELAND J, V30, P233, DOI 10.1071/RJ08009; Huang X, 2016, ENVIRON ENTOMOL, V45, P163, DOI 10.1093/ee/nvv172; Huang XB, 2017, B ENTOMOL RES; Huang XunBing, 2015, Acta Prataculturae Sinica, V24, P25; Ibanez S, 2013, OECOLOGIA, V173, P1459, DOI 10.1007/s00442-013-2738-0; Ji Rong, 2007, Chinese Bulletin of Entomology, V44, P830; Johnson MTJ, 2015, ANNU REV ECOL EVOL S, V46, P191, DOI 10.1146/annurev-ecolsys-112414-054215; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang Le, 1995, Acta Ecologica Sinica, V15, P1; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu GengShan, 2006, Pratacultural Science, V23, P71; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Hui, 2005, Plant Protection, V31, P55; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Perez-Harguindeguy N, 2003, AUSTRAL ECOL, V28, P642, DOI 10.1046/j.1442-9993.2003.01321.x; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; Prasad AK, 2016, J ASIA-PAC ENTOMOL, V19, P167, DOI 10.1016/j.aspen.2015.12.009; Rath SS, 2003, J INVERTEBR PATHOL, V83, P1, DOI 10.1016/S0022-2011(03)00038-7; Raubenheimer D, 2003, J EXP BIOL, V206, P1669, DOI 10.1242/jeb.00336; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rominger AJ, 2009, OECOLOGIA, V161, P791, DOI 10.1007/s00442-009-1420-z; Roy A, 2016, INSECT BIOCHEM MOLEC, V71, P91, DOI 10.1016/j.ibmb.2016.02.006; Schutz S, 1997, NATURWISSENSCHAFTEN, V84, P212, DOI 10.1007/s001140050381; Scriber JM, 2002, ENTOMOL EXP APPL, V104, P217, DOI 10.1023/A:1021292604205; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Slansky F., 1987, NUTR ECOLOGY INSECTS; Srinivasan A, 2006, CELL MOL BIOL LETT, V11, P132, DOI 10.2478/s11658-006-0012-8; Stam JM, 2014, ANNU REV PLANT BIOL, V65, P689, DOI 10.1146/annurev-arplant-050213-035937; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Unsicker SB, 2008, OECOLOGIA, V156, P313, DOI 10.1007/s00442-008-0973-6; Unsicker SB, 2010, ECOLOGY, V91, P1083, DOI 10.1890/09-0402.1; Valentino J. B., 2013, PHENOTYPIC PLASTICIT; Wang Han, 2010, Shengtaixue Zazhi, V29, P2401; West-Eberhard Mary Jane, 2003, pi; Wetzel WC, 2016, NATURE, V539, P425, DOI 10.1038/nature20140; Whitman D.W., 2009, PHENOTYPIC PLASTICIT, V1st; Whitman DW, 1990, GRASSHOPPER CHEM COM; Williams J, 2009, HEAT SHOCK PROTEINS; Wu Hui-hui, 2012, Scientia Agricultura Sinica, V45, P4178; Wund MA, 2012, INTEGR COMP BIOL, V52, P5, DOI 10.1093/icb/ics050; YAMAMURA T, 1979, ATHEROSCLEROSIS, V34, P53, DOI 10.1016/0021-9150(79)90106-0; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang MC, 2011, ENVIRON ENTOMOL, V40, P541, DOI 10.1603/EN10179; Zhang WeiZhong, 2013, Acta Prataculturae Sinica, V22, P302; Zhang ZJ, 2014, PLOS ONE; Zhu E. L., 2004, OCCURRENCE MANAGEMEN; Zhu-Salzman K, 2015, ANNU REV ENTOMOL, V60, P233, DOI 10.1146/annurev-ento-010814-020816	66	9	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186397	10.1371/journal.pone.0186397	http://dx.doi.org/10.1371/journal.pone.0186397			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023588	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100123
J	Jung, SY; Rohan, T; Strickler, H; Bea, J; Zhang, ZF; Ho, G; Crandall, C				Jung, Su Yon; Rohan, Thomas; Strickler, Howard; Bea, Jennifer; Zhang, Zuo-Feng; Ho, Gloria; Crandall, Carolyn			Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BREAST-CANCER; PHYSICAL-ACTIVITY; GLY972ARG POLYMORPHISM; PROSPECTIVE COHORT; COLON-CANCER; PATHWAY; ASSOCIATION; ESTROGEN; OBESITY	Genetic variants and traits in metabolic signaling pathways may interact with lifestyle factors such as obesity, physical activity, and exogenous estrogen (E), influencing postmenopausal colorectal cancer (CRC) risk, but these interrelated pathways are not fully understood. In this case-cohort study, we examined 33 single-nucleotide polymorphisms (SNPs) in genes related to insulin-like growth factor-I (IGF-I)/insulin resistance (IR) traits and signaling pathways, using data from 704 postmenopausal women in Women's Health Initiative Observation ancillary studies. Stratifying by the lifestyle modifiers, we assessed the effects of IGF-I/IR traits (fasting total and free IGF-I, IGF binding protein-3, insulin, glucose, and homeostatic model assessment-insulin resistance) on CRC risk as a mediator or influencing factor. Six SNPs in the INS, IGF-I, and IGFBP3 genes were associated with CRC risk, and those associations differed between non-obese/active and obese/inactive women and between E nonusers and users. Roughly 30% of the cancer risk due to the SNP was mediated by IGF-I/IR traits. Likewise, carriers of 11 SNPs in the IRS1 and AKT1/2 genes (signaling pathway-related genetic variants) had different associations with CRC risk between strata, and the proportion of the SNP-cancer association explained by traits varied from 30% to 50%. Our findings suggest that IGF-I/IR genetic variants interact with obesity, physical activity, and exogenous E, altering postmenopausal CRC risk, through IGF-I/IR traits, but also through different pathways. Unraveling gene-phenotype-lifestyle interactions will provide data on potential genetic targets in clinical trials for cancer prevention and intervention strategies to reduce CRC risk.	[Jung, Su Yon] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Translat Sci Sect, Sch Nursing, Los Angeles, CA 90024 USA; [Rohan, Thomas; Strickler, Howard] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Bea, Jennifer] Univ Arizona, Canc Ctr, Med & Nutr Sci, Tucson, AZ USA; [Zhang, Zuo-Feng] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Ho, Gloria] Hofstra Northwell Sch Med, Dept Occupat Med Epidemiol & Prevent, Feinstein Inst Med Res, Great Neck, NY USA; [Crandall, Carolyn] Univ Calif Los Angeles, David Geffen Sch Med, Dept Internal Med, Div Gen Internal Med, Los Angeles, CA 90095 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Yeshiva University; Albert Einstein College of Medicine; University of Arizona; University of California System; University of California Los Angeles; Northwell Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Jung, SY (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Translat Sci Sect, Sch Nursing, Los Angeles, CA 90024 USA.	sjung@sonnet.ucla.edu		Zhang, Zuo-Feng/0000-0002-4669-3995; Bea, Jennifer W./0000-0002-9868-1574; Jung, Su Yon/0000-0002-0513-1830	NIDDK NIH HHS [P30 DK020541] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbas Afroze, 2008, Expert Rev Cardiovasc Ther, V6, P1135, DOI 10.1586/14779072.6.8.1135; Al-Ajmi K, 2012, BREAST CANCER-BASIC, V6, P103, DOI 10.4137/BCBCR.S9784; Al-Zahrani A, 2006, HUM MOL GENET, V15, P1, DOI 10.1093/hmg/ddi398; American Cancer Society, 2014, COL CANC FACTS FIG 2; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Beral V, 2002, LANCET, V360, P942, DOI 10.1016/S0140-6736(02)11032-4; CALLE EE, 1995, J NATL CANCER I, V87, P517, DOI 10.1093/jnci/87.7.517; Cleveland RJ, 2006, CARCINOGENESIS, V27, P758, DOI 10.1093/carcin/bgi294; Creighton CJ, 2012, BREAST CANCER RES TR, V132, P993, DOI 10.1007/s10549-011-1595-y; De Marco P, 2014, ENDOCR-RELAT CANCER, V21, P739, DOI 10.1530/ERC-14-0245; DeLellis K, 2004, CANCER EPIDEM BIOMAR, V13, P1444; Feik E, 2010, CANCER CAUSE CONTROL, V21, P91, DOI 10.1007/s10552-009-9438-4; Franks SE, 2012, ONCOGENE, V31, P3298, DOI 10.1038/onc.2011.486; Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Gunter MJ, 2008, CANCER RES, V68, P329, DOI 10.1158/0008-5472.CAN-07-2946; Gunter MJ, 2007, CANCER EPIDEM BIOMAR, V16, P703, DOI 10.1158/1055-9965.EPI-06-0849; Gunter MJ, 2009, JNCI-J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415; Gunter MJ, 2006, J NUTR BIOCHEM, V17, P145, DOI 10.1016/j.jnutbio.2005.06.011; Haiman CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003419; Ho GYF, 2012, CANCER RES, V72, P3029, DOI 10.1158/0008-5472.CAN-11-2771; Iyengar Neil M, 2013, Am Soc Clin Oncol Educ Book, P46, DOI 10.1200/EdBook_AM.2013.33.46; Kabat GC, 2012, EUR J CANCER PREV, V21, P326, DOI 10.1097/CEJ.0b013e32834dbc81; Karimi K, 2013, ASIAN PAC J CANCER P, V14, P5011, DOI 10.7314/APJCP.2013.14.9.5011; Khoury-Shakour S, 2008, CANCER EPIDEM BIOMAR, V17, P3314, DOI 10.1158/1055-9965.EPI-08-0062; Lavasani S, 2015, CANCER-AM CANCER SOC, V121, P3261, DOI 10.1002/cncr.29464; Li P, 2014, TUMOR BIOL, V35, P6581, DOI 10.1007/s13277-014-1900-6; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin KJ, 2012, INT J CANCER, V130, P419, DOI 10.1002/ijc.26026; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Mahmoudi T, 2015, TUMOR BIOL, V36, P3709, DOI 10.1007/s13277-014-3010-x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Morois S, 2012, EUR J EPIDEMIOL, V27, P439, DOI 10.1007/s10654-012-9694-6; National Cancer Institute, 1993, SEER PROGR COMP STAG; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Parekh N, 2015, CANCER CAUSE CONTROL, V26, P1189, DOI 10.1007/s10552-015-0613-5; Pechlivanis S, 2007, ENDOCR-RELAT CANCER, V14, P733, DOI 10.1677/ERC-07-0107; Quan HY, 2014, CELL BIOCHEM BIOPHYS, V69, P169, DOI 10.1007/s12013-013-9784-4; Rose DP, 2012, ENDOCR-RELAT CANCER, V19, pR225, DOI 10.1530/ERC-12-0203; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Simons CCJM, 2014, CANCER EPIDEM BIOMAR, V23, P1852, DOI 10.1158/1055-9965.EPI-13-1285; Slattery ML, 2007, BREAST CANCER RES TR, V104, P197, DOI 10.1007/s10549-006-9403-9; Slattery ML, 2015, NUTR CANCER, V67, P292, DOI 10.1080/01635581.2015.990568; Slattery ML, 2011, NUTR CANCER, V63, P1226, DOI 10.1080/01635581.2011.607545; Slattery ML, 2005, INT J CANCER, V115, P148, DOI 10.1002/ijc.20843; Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P538; Thomson CA, 2014, CANCER PREV RES, V7, P42, DOI 10.1158/1940-6207.CAPR-13-0258; Wagner K, 2004, CARCINOGENESIS, V25, P2473, DOI 10.1093/carcin/bgh263; Wang Q, 2014, NANOTOXICOLOGY, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0108934; Wang YT, 2007, ANTICANCER RES, V27, P589; Wong HL, 2008, GUT, V57, P1090, DOI 10.1136/gut.2007.140855; Yarden RI, 2010, MOL CARCINOGEN, V49, P545, DOI 10.1002/mc.20618; Zhang HT, 2013, TUMOR BIOL, V34, P2929, DOI 10.1007/s13277-013-0855-3	56	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186296	10.1371/journal.pone.0186296	http://dx.doi.org/10.1371/journal.pone.0186296			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023587	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100102
J	Liu, JX; Xu, YQ; Zhang, LG; Li, W; Cai, ZX; Li, F; Peng, M; Li, FL; Hu, BZ				Liu, Jianxin; Xu, Yongqing; Zhang, Liguo; Li, Wei; Cai, Zhenxue; Li, Fei; Peng, Mu; Li, Fenglan; Hu, Baozhong			De novo assembly and analysis of the transcriptome of Rumex patientia L. during cold stress	PLOS ONE			English	Article							ABIOTIC STRESS; GENE-EXPRESSION; LOW-TEMPERATURE; SIGNAL-TRANSDUCTION; REACTIVE OXYGEN; ARABIDOPSIS; METABOLISM; RESPONSES; IDENTIFICATION; CYTOSKELETON	Background Rumex patientia L. is consumed as a green vegetable in several parts of the world, and can withstand extremely low temperatures(-35 degrees C). However, little or no available genomic data for this species has been reported to date. Here, we used Illumina Hiseq technology for transcriptome assembly in R. patientia under normal and cold conditions to evaluate how it responds to cold stress. Results After an in-depth RNA-Seq analysis, 115,589 unigenes were produced from the assembled transcripts. Based on similarity search analysis with seven databases, we obtained and annotated 60,157 assembled unigenes to at least one database. In total, 1,179 unigenes that were identified as differentially expressed genes (DEGs), including up-regulated (925) and down-regulated ones (254), were successfully assigned GO annotations and classified into three major metabolic pathways. Ribosome, carbon metabolism, oxidative phosphorylation and biosynthesis of amino acids were the most highly enriched pathways according to KEGG analysis. Overall, 66 up-regulated genes were identified as putatively involved in the response to cold stress, including members of MYB, AP2/ERF, CBF, Znf, bZIP, NAC and COR families. Conclusion To our knowledge, this investigation was the first to provide a cold-responsive (COR) transcriptome assembly in R. patientia. A large number of potential COR genes were identified, suggesting that this species is suitable for cultivation in northern China. In summary, these data provide valuable information for future research and genomic studies in R. patientia.	[Liu, Jianxin; Xu, Yongqing; Zhang, Liguo; Li, Wei; Cai, Zhenxue; Li, Fei; Li, Fenglan; Hu, Baozhong] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China; [Liu, Jianxin] Heilongjiang Acad Agr Sci, Harbin, Heilongjiang, Peoples R China; [Peng, Mu] Northeast Forestry Univ, Alkali Soil Nat Environm Sci Ctr, Harbin, Peoples R China; [Hu, Baozhong] Harbin Univ, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Heilongjiang Academy of Agricultural Sciences; Northeast Forestry University - China; Harbin University	Li, FL; Hu, BZ (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China.; Hu, BZ (corresponding author), Harbin Univ, Harbin, Heilongjiang, Peoples R China.	lifenglan@neau.edu.cn; wendyliujx@aliyun.com	peng, mugen/D-3023-2012	peng, mugen/0000-0002-4755-7231	National Science Foundation for Fostering Talents in Basic Research and International Cooperation Project [2013DFR30270]	National Science Foundation for Fostering Talents in Basic Research and International Cooperation Project	This research was supported by National Science Foundation for Fostering Talents in Basic Research and International Cooperation Project (Grant no. 2013DFR30270 to BH).	ASHRAF N, 2009, BMC GENOMICS, V10, DOI DOI 10.1093/JXB/ERU426; Aslam M, 2010, ACTA PHYSIOL PLANT, V32, P205, DOI 10.1007/s11738-009-0382-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CHAPMAN HD, 1961, U CALIFORNIA DIVISIO, V93, P68, DOI DOI 10.1186/1471-2164-10-415; CHAURASIA AB, 2007, ETHNOBOTANY PLANTS T, DOI DOI 10.1105/TPC.003483; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Cruz-Mendivil A, 2015, POSTHARVEST BIOL TEC, V109, P137, DOI 10.1016/j.postharvbio.2015.06.015; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; GUY CL, 1992, PLANT PHYSIOL, V100, P502, DOI 10.1104/pp.100.1.502; Hedenec P, 2015, BIOMASS BIOENERG, V78, P92, DOI 10.1016/j.biombioe.2015.04.016; Inaba M, 2003, J BIOL CHEM, V278, P12191, DOI 10.1074/jbc.M212204200; Jiang Q, 2015, MOL GENET GENOMICS, V290, P671, DOI 10.1007/s00438-014-0953-y; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lin SY, 2009, ANTICANCER RES, V29, P327; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu BB, 2005, PLANT SCI, V169, P295, DOI 10.1016/j.plantsci.2004.09.031; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Mirzadeh H, 2005, PLOS GENET, V1, P26; MONROY AF, 1995, PLANT CELL, V7, P321, DOI 10.1105/tpc.7.3.321; Nakashima K, 2006, PHYSIOL PLANTARUM, V126, P62, DOI 10.1111/j.1399-3054.2005.00592.x; Orvar BL, 2000, PLANT J, V23, P785, DOI 10.1046/j.1365-313x.2000.00845.x; Poldervaart MT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072610, 10.1371/journal.pone.0082817]; Qi XJ, 2012, WORLD J MICROB BIOT, V28, P2257, DOI 10.1007/s11274-012-1033-2; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sangwan V, 2001, PLANT J, V27, P1, DOI 10.1046/j.1365-313x.2001.01052.x; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Singh N, 2013, CURR SCI INDIA, V104, P574; Solanke Amolkumar U., 2008, Physiology and Molecular Biology of Plants, V14, P69, DOI 10.1007/s12298-008-0006-2; Wang XM, 2006, PHYSIOL PLANTARUM, V126, P90, DOI 10.1111/j.1399-3054.2005.00622.x; Wingler A, 2015, J EXP BOT, V66, P355, DOI 10.1093/jxb/eru426; Yang F, 1981, J INTEGR PLANT BIOL, V5, P23; Zhang L, 2015, THERAPY MED PLANTS T, V153, P538; Zhang LN, 2015, PHYSIOL PLANTARUM, V153, P538, DOI 10.1111/ppl.12261; ZHANG LS, 2011, HUBEI AGR SCI, V50, P865; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhang X, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0330-4; Zhang ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20300; Zhu JK, 2016, CELL, V167, P313, DOI 10.1016/j.cell.2016.08.029; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010	46	7	7	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186470	10.1371/journal.pone.0186470	http://dx.doi.org/10.1371/journal.pone.0186470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023590	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100132
J	Monroe, MJ; Bokma, F				Monroe, Melanie J.; Bokma, Folmer			Does density-dependent diversification mirror ecological competitive exclusion?	PLOS ONE			English	Article							CHARACTER DISPLACEMENT; MOLECULAR PHYLOGENIES; DIVERSITY-DEPENDENCE; SPECIES-DIVERSITY; FOSSIL RECORD; BODY-MASS; EVOLUTION; SPECIATION; MAMMALS; RATES	Density-dependence is a term used in ecology to describe processes such as birth and death rates that are regulated by the number of individuals in a population. Evolutionary biologists have borrowed the term to describe decreasing rates of species accumulation, suggesting that speciation and extinction rates depend on the total number of species in a clade. If this analogy with ecological density-dependence holds, diversification of clades is restricted because species compete for limited resources. We hypothesize that such competition should not only affect numbers of species, but also prevent species from being phenotypically similar. Here, we present a method to detect whether competitive interactions between species have ordered phenotypic traits on a phylogeny, assuming that competition prevents related species from having identical trait values. We use the method to analyze clades of birds and mammals, with body size as the phenotypic trait. We find no sign that competition has prevented species from having the same body size. Thus, since body size is a key ecological trait and competition does not seem to be responsible for differences in body size between species, we conclude that the diversification slowdown that is prevalent in these clades is unlikely due to the ecological interference implied by the term density dependence.	[Monroe, Melanie J.; Bokma, Folmer] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Monroe, Melanie J.; Bokma, Folmer] Umea Univ, IceLab, Umea, Sweden; [Monroe, Melanie J.] Uppsala Univ, Dept Ecol & Genet, Evolutionary Biol Ctr, Norbyvagen 18D, Uppsala, Sweden; [Monroe, Melanie J.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada; [Monroe, Melanie J.] Simon Fraser Univ, IRMACS Ctr Interdisciplinary Res, Burnaby, BC, Canada	Umea University; Umea University; Uppsala University; Simon Fraser University; Simon Fraser University	Monroe, MJ (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.; Monroe, MJ (corresponding author), Umea Univ, IceLab, Umea, Sweden.; Monroe, MJ (corresponding author), Uppsala Univ, Dept Ecol & Genet, Evolutionary Biol Ctr, Norbyvagen 18D, Uppsala, Sweden.; Monroe, MJ (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada.; Monroe, MJ (corresponding author), Simon Fraser Univ, IRMACS Ctr Interdisciplinary Res, Burnaby, BC, Canada.	melanie.monroe@ebc.uu.se		Monroe, Melanie/0000-0003-1692-7938	Umea University; Swedish Research Council (VR) [90382001, 637-2013-274]; Formas [215-2012-1372]	Umea University; Swedish Research Council (VR)(Swedish Research Council); Formas(Swedish Research Council Formas)	This research was funded by Umea University, the Swedish Research Council (VR) (FB grant number: 90382001, MJM grant number: 637-2013-274) and Formas (FB grant number: 215-2012-1372). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by Umea University, the Swedish Research Council (VR) (FB grant number: 90382001, MJM grant number:637-2013-274) and Formas (FB grant number: 215-2012-1372). Phylogenies for birds can be obtained from Jetz et al. 2014 (http://dx.doi.org/10.1016/j.cub.2014.03.011 or at http://birdtree.orgi) and for mammals from Martyn et al. 2012 (http://www.almob.org/content/7/1/6). Body mass data is available for birds from Dunning 1993 (CRC handbook of avian body masses) and for mammals from Smith et al. 2003 (http://www.esapubs.org/archive/ecol/E084/0941/). Geographical range data is available from the IUCN Red List (http://www.iuenredlist.org/). Converted geographical range data is available from 10.6084/m9.figshare.3379460. Code for this analysis is available upon request.	ABRAMS P, 1983, ANNU REV ECOL SYST, V14, P359, DOI 10.1146/annurev.es.14.110183.002043; [Anonymous], 2009, IUCN RED LIST THREAT; Arnqvist Goran, 2005, pUnpaginated; Benjamini Y, CONTROLLING FALSE DI; Benton MJ, 2007, PALAEONTOLOGY, V50, P23, DOI 10.1111/j.1475-4983.2006.00612.x; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Calder WA., 1984, SIZE FUNCTION LIFE H; Carotenuto F, 2015, PALAEOGEOGR PALAEOCL, V437, P18, DOI 10.1016/j.palaeo.2015.07.013; Carotenuto F, 2010, PALEOBIOLOGY, V36, P399, DOI 10.1666/09059.1; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Cooper N, 2009, J EVOLUTION BIOL, V22, P1024, DOI 10.1111/j.1420-9101.2009.01714.x; Cornell HV, 2013, BIOL REV, V88, P140, DOI 10.1111/j.1469-185X.2012.00245.x; Cusimano N, 2010, SYST BIOL, V59, P458, DOI 10.1093/sysbio/syq032; Darwin C, 1859, ORIGIN SPECIES MEANS; Davies TJ, 2007, ECOL LETT, V10, P146, DOI 10.1111/j.1461-0248.2006.01005.x; Davies TJ, 2012, ECOLOGY, V93, pS44, DOI 10.1890/11-0400.1; Dayan T, 1998, MAMMAL REV, V28, P99, DOI 10.1046/j.1365-2907.1998.00029.x; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Dunning J.B., 2007, CRC HDB AVIAN BODY M, V2nd ed., DOI [10.1201/9781420064452, DOI 10.1201/9781420064452]; Etienne RS, 2012, P ROY SOC B-BIOL SCI, V279, P1300, DOI 10.1098/rspb.2011.1439; Etienne RS, 2012, SYST BIOL, V61, P204, DOI 10.1093/sysbio/syr091; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; GOULD S J, 1977, Paleobiology, V3, P23; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Harmon LJ, 2015, AM NAT, V185, P584, DOI 10.1086/680859; Jetz W, 2014, CURR BIOL, V24, P919, DOI 10.1016/j.cub.2014.03.011; Kraaijeveld K, 2011, BIOL REV, V86, P367, DOI 10.1111/j.1469-185X.2010.00150.x; Martyn I, 2012, ALGORITHM MOL BIOL, V7, DOI 10.1186/1748-7188-7-6; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Moen D, 2014, TRENDS ECOL EVOL, V29, P190, DOI 10.1016/j.tree.2014.01.010; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Quental TB, 2010, TRENDS ECOL EVOL, V25, P434, DOI 10.1016/j.tree.2010.05.002; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky DL, 2013, ANNU REV ECOL EVOL S, V44, P481, DOI 10.1146/annurev-ecolsys-110512-135800; Raia P, 2016, SCI REP-UK, V6, DOI 10.1038/srep30965; Reifova R, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-138; Revell LJ, 2005, SYST BIOL, V54, P973, DOI 10.1080/10635150500354647; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Silvestro D, 2015, P NATL ACAD SCI USA, V112, P8684, DOI 10.1073/pnas.1502803112; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; STANLEY SM, 1973, SYST ZOOL, V22, P486, DOI 10.2307/2412955; Tobias JA, 2014, NATURE, V506, P359, DOI 10.1038/nature12874; Turchin P, 1999, OIKOS, V84, P153, DOI 10.2307/3546876	48	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0184814	10.1371/journal.pone.0184814	http://dx.doi.org/10.1371/journal.pone.0184814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023484	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100009
J	Ong, RH; King, AJC; Kaandorp, JA; Mullins, BJ; Caley, MJ				Ong, Robert H.; King, Andrew J. C.; Kaandorp, Jaap A.; Mullins, Benjamin J.; Caley, M. Julian			The effect of allometric scaling in coral thermal microenvironments	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORALS; MADRACIS-MIRABILIS; BLEACHING EVENT; WATER-FLOW; TEMPERATURE-VARIATION; CLIMATE-CHANGE; SURFACE-AREAS; COLONY SIZE; MORTALITY	A long-standing interest in marine science is in the degree to which environmental conditions of flow and irradiance, combined with optical, thermal and morphological characteristics of individual coral colonies, affects their sensitivity of thermal microenvironments and susceptibility to stress-induced bleaching within and/or among colonies. The physiological processes in Scleractinian corals tend to scale allometrically as a result of physical and geometric constraints on body size and shape. There is a direct relationship between scaling to thermal stress, thus, the relationship between allometric scaling and rates of heating and cooling in coral microenvironments is a subject of great interest. The primary aim of this study was to develop an approximation that predicts coral thermal microenvironments as a function of colony morphology (shape and size), light or irradiance, and flow velocity or regime. To do so, we provided intuitive interpretation of their energy budgets for both massive and branching colonies, and then quantified the heat-size exponent (b*) and allometric constant (m) using logarithmic linear regression. The data demonstrated a positive relationship between thermal rates and changes in irradiance, A/V ratio, and flow, with an interaction where turbulent regime had less influence on overall stress which may serve to ameliorate the effects of temperature rise compared to the laminar regime. These findings indicated that smaller corals have disproportionately higher stress, however they can reach thermal equilibrium quicker. Moreover, excellent agreements between the predicted and simulated microscale temperature values with no significant bias were observed for both the massive and branching colonies, indicating that the numerical approximation should be within the accuracy with which they could be measured. This study may assist in estimating the coral microscale temperature under known conditions of water flow and irradiance, in particular when examining the intra-and inter-colony variability found during periods of bleaching conditions.	[Ong, Robert H.; King, Andrew J. C.; Mullins, Benjamin J.] Curtin Univ, Curtin Inst Computat, Dept Mech Engn, Fluid Dynam Res Grp, Perth, WA, Australia; [Kaandorp, Jaap A.] Univ Amsterdam, Computat Sci Sect, Amsterdam, Netherlands; [Mullins, Benjamin J.] Curtin Univ, Sch Publ Hlth, Occupat & Environm, Perth, WA, Australia; [Caley, M. Julian] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia; [Caley, M. Julian] Australian Res Council Ctr Excellence Math & Stat, Parkville, Vic, Australia; [Ong, Robert H.] Univ Sydney, Ctr Wind Waves & Water, Sch Civil Engn, Sydney, NSW, Australia	Curtin University; University of Amsterdam; Curtin University; Queensland University of Technology (QUT); University of Sydney	Mullins, BJ (corresponding author), Curtin Univ, Curtin Inst Computat, Dept Mech Engn, Fluid Dynam Res Grp, Perth, WA, Australia.; Mullins, BJ (corresponding author), Curtin Univ, Sch Publ Hlth, Occupat & Environm, Perth, WA, Australia.	b.mullins@curtin.edu.au		King, Andrew/0000-0003-0517-3712; Mullins, Benjamin/0000-0002-6722-1073	iVEC/Pawsey high performance computing facility; School of Civil and Mechanical Engineering, Curtin University	iVEC/Pawsey high performance computing facility; School of Civil and Mechanical Engineering, Curtin University	The authors received no specific funding for this work. RHO received financial (salary/stipend) support from the iVEC/Pawsey high performance computing facility and the School of Civil and Mechanical Engineering, Curtin University.	[Anonymous], 2012, BIOPHYSICAL ECOLOGY; BABCOCK RC, 1984, CORAL REEFS, V2, P187; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Bak RPM, 1998, MAR ECOL PROG SER, V162, P301, DOI 10.3354/meps162301; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Bejan A., 2003, HEAT TRANSFER HDB, V1; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; BIEWENER AA, 1990, SCIENCE, V250, P1097, DOI 10.1126/science.2251499; Brandt ME, 2009, CORAL REEFS, V28, P911, DOI 10.1007/s00338-009-0548-y; Brinkman R, 2002, ESTUAR COAST SHELF S, V54, P655, DOI 10.1006/ecss.2001.0850; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; BROWN BE, 1994, MAR ECOL PROG SER, V105, P219, DOI 10.3354/meps105219; CATTI M, 1993, PHYS CHEM MINER, V19, P472; Chang S, 2009, LIMNOL OCEANOGR, V54, P1819, DOI DOI 10.4319/LO.2009.54.5.1819; Chindapol N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002849; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Connell J.H., 1973, P205; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Cooper T.F, 2008, CORAL BIOINDICATORS; Coutis PF, 1999, DEEP-SEA RES PT I, V46, P1633, DOI 10.1016/S0967-0637(99)00007-2; Day T, 2008, AM NAT, V171, pE72, DOI 10.1086/524956; Denny M. W., 1993, AIR WATER BIOL PHYS; Denny M, 2009, INTEGR COMP BIOL, V49, P197, DOI 10.1093/icb/icp070; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Edmunds PJ, 2005, OECOLOGIA, V146, P350, DOI 10.1007/s00442-005-0210-5; Edmunds PJ, 2002, CORAL REEFS, V21, P193, DOI 10.1007/s00338-002-0214-0; Elahi R, 2007, BIOL BULL-US, V212, P20, DOI 10.2307/25066577; Fabricius KE, 2006, LIMNOL OCEANOGR, V51, P30, DOI 10.4319/lo.2006.51.1.0030; FISK DA, 1985, P 5 INT COR REEF C, V0006, P00149; Fitt WK, 1995, BIOL BULL, V189, P298, DOI 10.2307/1542147; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Frankino WA, 2005, SCIENCE, V307, P718, DOI 10.1126/science.1105409; Frith CA, 1982, P 4 INT COR REEF S A, P347; Fujioka Y., 1999, MBE997 IEICE, P41; Gates RD, 1999, AM ZOOL, V39, P30; Gleason DF, 1993, ULTRAVIOLET RAD CORA; Glynn P.W., 1990, Elsevier Oceanography Series, V52, P55; GLYNN PW, 1983, ENVIRON CONSERV, V10, P149, DOI 10.1017/S0376892900012248; GLYNN PW, 1988, ANNU REV ECOL SYST, V19, pU309; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Gould S. J., 1977, ONTOGENY PHYLOGENY; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; HARRIOTT VJ, 1985, MAR ECOL PROG SER, V21, P81, DOI 10.3354/meps021081; Helmuth BST, 1998, ECOL MONOGR, V68, P51, DOI 10.1890/0012-9615(1998)068[0051:IMMPTB]2.0.CO;2; Hench JL, 2013, J GEOPHYS RES-OCEANS, V118, P1142, DOI 10.1002/jgrc.20105; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1995, MAR ECOL PROG SER, V121, P181, DOI 10.3354/meps121181; Holmes G, 2008, J EXP MAR BIOL ECOL, V365, P67, DOI 10.1016/j.jembe.2008.07.045; HUGHES DJ, 1986, PHILOS T R SOC B, V313, P23, DOI 10.1098/rstb.1986.0023; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; HUGHES TP, 1987, AM NAT, V129, P818, DOI 10.1086/284677; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Incropera F.P., 1996, FUNDAMENTALS HEAT MA; Jackson J.B.C., 1979, Systematics Association Special Volume Series, P499; Jimenez I., 2012, MAR BIOL, P1; Jimenez IM, 2008, LIMNOL OCEANOGR, V53, P1548, DOI 10.4319/lo.2008.53.4.1548; Jimenez IM, 2011, J R SOC INTERFACE, V8, P1785, DOI 10.1098/rsif.2011.0144; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; JOKIEL PL, 1986, MAR BIOL, V91, P15, DOI 10.1007/BF00397566; Jones AM, 2008, CORAL REEFS, V27, P521, DOI 10.1007/s00338-008-0354-y; Joshi KB, 2013, MODELING BIOINSPIRED; Kaandorp JA, 2005, P ROY SOC B-BIOL SCI, V272, P127, DOI 10.1098/rspb.2004.2934; Kaandorp JA, 2003, PHILOS T R SOC B, V358, P1551, DOI 10.1098/rstb.2003.1339; Kim K, 1998, FUNCT ECOL, V12, P646, DOI 10.1046/j.1365-2435.1998.00228.x; King ACJ, 2011, 9 AUSTR HEAT MASS TR; Kleiber M., 1932, BODY SIZE METABOLISM, V6; Kleiber M, 1961, FIRE LIFE; LANG JC, 1992, AM ZOOL, V32, P696; Lienhard JH., 2011, HEAT TRANSFER TXB; Loch K, 2002, MAR ECOL-P S Z N I, V23, P219, DOI 10.1046/j.1439-0485.2002.02773.x; Lowe RJ, 2005, J GEOPHYS RES-OCEANS, V110, DOI [10.1029/2004JC002711, 10.1029/2004JC002788]; Lowe RJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003605; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Mass T, 2010, P NATL ACAD SCI USA, V107, P2527, DOI 10.1073/pnas.0912348107; McClanahan TR, 2003, ECOSYSTEMS, V6, P551, DOI 10.1007/s10021-002-0104-x; McClanahan TR, 2005, MAR ECOL PROG SER, V298, P131, DOI 10.3354/meps298131; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; Mumby PJ, 1999, MAR ECOL PROG SER, V190, P27, DOI 10.3354/meps190027; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; Nakamura T, 2003, MAR ECOL PROG SER, V256, P287, DOI 10.3354/meps256287; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; Nakaya F, 2003, P ROY SOC B-BIOL SCI, V270, P1105, DOI 10.1098/rspb.2003.2347; Obura DO, 2001, B MAR SCI, V69, P421; Oliver J., 1985, P 5 INT COR REEF C, V4, P206; Ong RH, 2012, AUSTR FLUID MECH SOC; Ong RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037842; OpenCFD Ltd, 2010, OPENFOAM US GUID OPE; PACKARD GC, 1988, PHYSIOL ZOOL, V61, P1; PATTERSON MR, 1991, LIMNOL OCEANOGR, V36, P936, DOI 10.4319/lo.1991.36.5.0936; PATTERSON MR, 1992, AM ZOOL, V32, P566; PATTERSON MR, 1992, SCIENCE, V255, P1421, DOI 10.1126/science.255.5050.1421; Peters RH, 1986, ECOLOGICAL IMPLICATI, V2; PORTER JW, 1976, AM NAT, V110, P731, DOI 10.1086/283100; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Riegl B, 2002, MAR BIOL, V140, P29, DOI 10.1007/s002270100676; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Rubner M., 1883, Z BIOL, V19, P535; Sakai K, 1998, RES POPUL ECOL, V40, P287, DOI 10.1007/BF02763460; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Schlichting H., 1968, BOUNDARY LAYER THEOR; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; Seebacher F, 2012, PHILOS T R SOC B, V367, P1607, DOI 10.1098/rstb.2012.0036; Shenkar N, 2005, MAR ECOL PROG SER, V294, P181, DOI 10.3354/meps294181; SOONG K, 1993, CORAL REEFS, V12, P77, DOI 10.1007/BF00302106; STRATHMANN RR, 1982, AM NAT, V119, P91, DOI 10.1086/283892; Van Woesik R, 2004, CORAL HEALTH AND DISEASE, P119; Vogel S., 1981, LIFE MOVING FLUIDS P, V2nd; Vollmer SV, 2000, BIOL BULL-US, V199, P21, DOI 10.2307/1542703; White F., 1988, HEAT MASS TRANSFER; Wilkinson C., 2000, GLOBAL CORAL REEF MO, V18, P473; Yamazato K., 1981, 8 SES MAR SCI LAB, P9	121	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0184214	10.1371/journal.pone.0184214	http://dx.doi.org/10.1371/journal.pone.0184214			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023468	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100005
J	Park, SY; Scranton, MA; Stajich, JE; Yee, A; Walling, LL				Park, Sang-Youl; Scranton, Melissa A.; Stajich, Jason E.; Yee, Ashley; Walling, Linda L.			Chlorophyte aspartyl aminopeptidases: Ancient origins, expanded families, new locations, and secondary functions	PLOS ONE			English	Article							INDUCED LEUCINE AMINOPEPTIDASE; ENTERICA SEROVAR TYPHIMURIUM; MULTIPLE SEQUENCE ALIGNMENT; MODEL DATA-ANALYSIS; ARABIDOPSIS-THALIANA; PLASMODIUM-FALCIPARUM; SUBSTRATE-SPECIFICITY; GEL-ELECTROPHORESIS; MOLECULAR-WEIGHTS; TARGETED PROTEINS	M18 aspartyl aminopeptidases (DAPs) are well characterized in microbes and animals with likely functions in peptide processing and vesicle trafficking. In contrast, there is a dearth of knowledge on plant aminopeptidases with a preference for proteins and peptides with N-terminal acidic residues. During evolution of the Plantae, there was an expansion and diversification of the M18 DAPs. After divergence of the ancestral green algae from red and glaucophyte algae, a duplication yielded the DAP1 and DAP2 lineages. Subsequently DAP1 genes were lost in chlorophyte algae. A duplication of DAP2-related genes occurred early in green plant evolution. DAP2 genes were retained in land plants and picoeukaryotic algae and lost in green algae. In contrast, DAP2-like genes persisted in picoeukaryotic and green algae, while this lineage was lost in land plants. Consistent with this evolutionary path, Arabidopsis thaliana has two DAP gene lineages (AtDAP1 and AtDAP2). Similar to animal and yeast DAPs, AtDAP1 is localized to the cytosol or vacuole; while AtDAP2 harbors an N-terminal transit peptide and is chloroplast localized. His(6)-DAP1 and His(6)-DAP2 expressed in Escherichia coli were enzymatically active and dodecameric with masses exceeding 600 kDa. His(6)-DAP1 and His(6)-DAP2 preferentially hydrolyzed Asp-p-nitroanilide and Glu-pnitroanilide. AtDAPs are highly conserved metallopeptidases activated by MnCl2 and inhibited by ZnCl2 and divalent ion chelators. The protease inhibitor PMSF inhibited and DTT stimulated both His(6)-DAP1 and His(6)-DAP2 activities suggesting a role for thiols in the AtDAP catalytic mechanism. The enzymes had distinct pH and temperature optima, as well as distinct kinetic parameters. Both enzymes had high catalytic efficiencies (kcat/Km) exceeding 1.0 x 10(7) M-1 sec(-1). Using established molecular chaperone assays, AtDAP1 and AtDAP2 prevented thermal denaturation. AtDAP1 also prevented protein aggregation and promoted proteinrefolding. Collectively, these data indicate that plant DAPs have a complex evolutionary history and have evolved new biochemical features that may enable their role in vivo.	[Park, Sang-Youl; Scranton, Melissa A.; Yee, Ashley; Walling, Linda L.] Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Stajich, Jason E.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Scranton, Melissa A.] BASF Enzymes LLC, San Diego, CA USA	University of California System; University of California Riverside; University of California System; University of California Riverside; BASF	Walling, LL (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	lwalling@ucr.edu	Stajich, Jason Eric/C-7297-2008	Stajich, Jason Eric/0000-0002-7591-0020	National Science Foundation [IOB 0645230, MCB 0313579, DGE 0504249]; Division Of Integrative Organismal Systems [1450331] Funding Source: National Science Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016290] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation Grants IOB 0645230 and MCB 0313579 (to L.L.W.). M.A.S. was partially supported by the National Science Foundation funded ChemIGERT program (Grant DGE 0504249) and Grant IOB 0645230 (to L.L.W.).	Asano M, 2010, BIOSCI BIOTECH BIOCH, V74, P113, DOI 10.1271/bbb.90617; Banegas I, 2006, J RENIN-ANGIO-ALDO S, V7, P129, DOI 10.3317/jraas.2006.021; BARRETT AJ, 1994, METHOD ENZYMOL, V244, P1; Becker B, 2013, TRENDS PLANT SCI, V18, P180, DOI 10.1016/j.tplants.2012.09.010; Becker B, 2009, ANN BOT-LONDON, V103, P999, DOI 10.1093/aob/mcp044; Broder DH, 2003, J BACTERIOL, V185, P4748, DOI 10.1128/JB.185.16.4748-4754.2003; BRYAN JK, 1977, ANAL BIOCHEM, V78, P513, DOI 10.1016/0003-2697(77)90111-7; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carrie C, 2009, PLANT J, V57, P1128, DOI 10.1111/j.1365-313X.2008.03745.x; CARTER TH, 1984, J BACTERIOL, V159, P453, DOI 10.1128/JB.159.2.453-459.1984; Chaikuad A, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-14; Chen YY, 2012, J BIOL CHEM, V287, P13356, DOI 10.1074/jbc.M112.347518; CHEUNG HS, 1971, BIOCHIM BIOPHYS ACTA, V242, P190, DOI 10.1016/0005-2744(71)90098-2; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Duprez K, 2014, ACTA CRYSTALLOGR D, V70, P1649, DOI 10.1107/S1399004714006245; DuPrez KT, 2016, ACTA CRYSTALLOGR D, V72, P694, DOI 10.1107/S205979831600509X; Durek P, 2010, NUCLEIC ACIDS RES, V38, pD828, DOI 10.1093/nar/gkp810; Nguyen DD, 2014, BIOCHEM BIOPH RES CO, V447, P101, DOI 10.1016/j.bbrc.2014.03.109; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Farrokhi N, 2008, PLANT BIOTECHNOL J, V6, P105, DOI 10.1111/j.1467-7652.2007.00315.x; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Gabriel M, 2012, PLANTA, V235, P1013, DOI 10.1007/s00425-011-1557-y; Gill N, 2009, PLANT PHYSIOL, V151, P1167, DOI 10.1104/pp.109.137935; GLENNER GG, 1962, NATURE, V194, P867, DOI 10.1038/194867a0; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Graciet E, 2010, TRENDS PLANT SCI, V15, P447, DOI 10.1016/j.tplants.2010.04.011; Gu YQ, 1999, EUR J BIOCHEM, V263, P726, DOI 10.1046/j.1432-1327.1999.00548.x; Gu YQ, 2002, EUR J BIOCHEM, V269, P1630, DOI 10.1046/j.1432-1327.2002.02795.x; HEDRICK JL, 1968, ARCH BIOCHEM BIOPHYS, V126, P155, DOI 10.1016/0003-9861(68)90569-9; Hejazi M, 2002, BIOCHEM J, V364, P129, DOI 10.1042/bj3640129; Hirsch-Hoffmann M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00123; IRIBAR C, 1995, BRAIN RES, V687, P211, DOI 10.1016/0006-8993(95)00538-2; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; KELLY JA, 1983, J NEUROCHEM, V40, P1727, DOI 10.1111/j.1471-4159.1983.tb08148.x; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kusumoto KI, 2008, J APPL MICROBIOL, V105, P1711, DOI 10.1111/j.1365-2672.2008.03889.x; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Larsen RA, 2001, J BACTERIOL, V183, P3089, DOI 10.1128/JB.183.10.3089-3097.2001; Lauterbach SB, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-161; Lee A, 2015, AM J PHYSIOL-RENAL, V308, pF784, DOI 10.1152/ajprenal.00322.2014; Lee S, 2009, BMB REP, V42, P812, DOI 10.5483/BMBRep.2009.42.12.812; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Li X, 2013, MOL BIOL CELL, V24, P1163, DOI 10.1091/mbc.E12-10-0730; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mathew Z, 2000, J BACTERIOL, V182, P3383, DOI 10.1128/JB.182.12.3383-3393.2000; METZ G, 1976, BIOCHIM BIOPHYS ACTA, V429, P933, DOI 10.1016/0005-2744(76)90338-7; Michaeli S, 2016, TRENDS PLANT SCI, V21, P134, DOI 10.1016/j.tplants.2015.10.008; Nakamura Y, 2011, MOL CELL BIOL, V31, P3019, DOI 10.1128/MCB.05178-11; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PAUTOT V, 1991, MOL PLANT MICROBE IN, V4, P284, DOI 10.1094/MPMI-4-284; Proost S, 2011, PLANT J, V66, P58, DOI 10.1111/j.1365-313X.2011.04521.x; Reyes-Prieto A, 2007, MOL BIOL EVOL, V24, P2358, DOI 10.1093/molbev/msm186; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Scranton MA, 2012, J BIOL CHEM, V287, P18408, DOI 10.1074/jbc.M111.309500; Shen JB, 2013, MOL PLANT, V6, P1419, DOI 10.1093/mp/sst079; Shimaoka T, 2004, PLANT CELL PHYSIOL, V45, P672, DOI 10.1093/pcp/pch099; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sivaraman KK, 2012, J MOL BIOL, V422, P495, DOI 10.1016/j.jmb.2012.06.006; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Small I, 1998, PLANT MOL BIOL, V38, P265, DOI 10.1023/A:1006081903354; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Suzuki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091651; Teuscher F, 2007, J BIOL CHEM, V282, P30817, DOI 10.1074/jbc.M704938200; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Walker NS, 2007, NUCLEIC ACIDS RES, V35, pD852, DOI 10.1093/nar/gkl795; Walling LL, 2006, CURR OPIN PLANT BIOL, V9, P227, DOI 10.1016/j.pbi.2006.03.009; Watanabe J, 2007, BIOSCI BIOTECH BIOCH, V71, P2557, DOI 10.1271/bbb.70107; Wheeler JI, 2010, FUNCT PLANT BIOL, V37, P382, DOI 10.1071/FP09242; Wilk S, 2002, ARCH BIOCHEM BIOPHYS, V407, P176, DOI 10.1016/S0003-9861(02)00494-0; Wilk S, 1998, J BIOL CHEM, V273, P15961, DOI 10.1074/jbc.273.26.15961; Wright JW, 2011, PROG NEUROBIOL, V95, P49, DOI 10.1016/j.pneurobio.2011.07.001; Yao QM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00186; Yokoyama R, 2006, FEBS J, V273, P192, DOI 10.1111/j.1742-4658.2005.05057.x; Yuga M, 2011, J BIOL CHEM, V286, P13704, DOI 10.1074/jbc.M110.173906	79	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185492	10.1371/journal.pone.0185492	http://dx.doi.org/10.1371/journal.pone.0185492			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023459	Green Submitted, Green Published, gold			2022-12-26	WOS:000412845100020
J	Wamboga, C; Matovu, E; Bessell, PR; Picado, A; Bieler, S; Ndung'u, JM				Wamboga, Charles; Matovu, Enock; Bessell, Paul Richard; Picado, Albert; Bieler, Sylvain; Ndung'u, Joseph Mathu			Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda - Moving towards elimination	PLOS ONE			English	Article							RHODESIENSE SLEEPING SICKNESS; HEALTH FACILITIES; SEEKING BEHAVIOR; EASTERN UGANDA; BRUCEI; CONGO; RISK	Introduction The incidence of gambiense human African trypanosomiasis (gHAT) in Uganda has been declining, from 198 cases in 2008, to only 20 in 2012. Interruption of transmission of the disease by early diagnosis and treatment is core to the control and eventual elimination of gHAT. Until recently, the format of available screening tests had restricted screening and diagnosis to central health facilities (passive screening). We describe a novel strategy that is contributing to elimination of gHAT in Uganda through expansion of passive screening to the entire population at risk. Methodology / Principal findings In this strategy, patients who are clinically suspected of having gHAT at primary health facilities are screened using a rapid diagnostic test (RDT), followed by parasitological confirmation at strategically located microscopy centres. For patients who are positive with the RDT and negative by microscopy, blood samples undergo further testing using loop-mediated isothermal amplification (LAMP), a molecular test that detects parasite DNA. LAMP positive patients are considered strong suspects, and are re-evaluated by microscopy. Location and upgrading of facilities to perform microscopy and LAMP was informed by results of georeferencing and characterization of all public healthcare facilities in the 7 gHAT endemic districts in Uganda. Three facilities were upgraded to perform RDTs, microscopy and LAMP, 9 to perform RDTs and microscopy, and 200 to screen patients with RDTs. This reduced the distance that a sick person must travel to be screened for gHAT to a median distance of 2.5km compared to 23km previously. In this strategy, 9 gHAT cases were diagnosed in 2014, and 4 in 2015. Conclusions This enhanced passive screening strategy for gHAT has enabled full coverage of the population at risk, and is being replicated in other gHAT endemic countries. The improvement in case detection is making elimination of the disease in Uganda an imminent possibility.	[Wamboga, Charles] Minist Hlth, Kampala, Uganda; [Matovu, Enock] Makerere Univ, Coll Vet Med Anim Resources & Biosecur COVAB, Kampala, Uganda; [Bessell, Paul Richard] Epi Intervent Ltd, Edinburgh, Midlothian, Scotland; [Picado, Albert; Bieler, Sylvain; Ndung'u, Joseph Mathu] FIND, Geneva, Switzerland	Makerere University; Foundation For Innovative New Diagnostics	Ndung'u, JM (corresponding author), FIND, Geneva, Switzerland.	Joseph.Ndungu@finddx.org		Picado, Albert/0000-0001-7344-628X	Bill & Melinda Gates Foundation; Republic and Canton of Geneva; German Federal Ministry of Education and Research through KfW; Swiss Government; UK government	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Republic and Canton of Geneva; German Federal Ministry of Education and Research through KfW; Swiss Government; UK government	This project was funded by the Bill & Melinda Gates Foundation, the Republic and Canton of Geneva, the German Federal Ministry of Education and Research through KfW, the Swiss Government and UK aid from the UK government. The funders provided support in the form of salaries for authors JN, SB and AP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2021, LANG ENV STAT COMP; Barrington J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-298; Bieler S, 2012, ACTA TROP, V121, P135, DOI 10.1016/j.actatropica.2011.10.016; Bisser S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004608; Buscher P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000471; Bukachi SA, 2009, ANN TROP MED PARASIT, V103, P211, DOI 10.1179/136485909X398230; Buscher P, 2013, NEW ENGL J MED, V368, P1069, DOI 10.1056/NEJMc1210373; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; de Vries H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005103; Franco JR, 2014, PARASITOLOGY, V141, P748, DOI 10.1017/S0031182013002102; Hasker E, 2011, TROP MED INT HEALTH, V16, P869, DOI 10.1111/j.1365-3156.2011.02772.x; Hasker E, 2010, TROP MED INT HEALTH, V15, P263, DOI 10.1111/j.1365-3156.2009.02446.x; Hayashida K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003578; Holmes P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003244; Jamonneau V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003480; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Matovu E, 2016, STANDARD OPERATING P; Mitashi P, 2015, MICROSC RES TECHNIQ, V03, P17, DOI [DOI 10.4236/MR.2015.32003, 10.4236/mr.2015.32003]; Mitashi P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002504; Mugasa CM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001438; Mukadi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146450; Njiru ZK, 2017, J TROP MED-US, V2017, P1, DOI 10.1155/2017/8630708; Odiit M, 2006, T ROY SOC TROP MED H, V100, P354, DOI 10.1016/j.trstmh.2005.04.022; Odiit M, 2005, TROP MED INT HEALTH, V10, P840, DOI 10.1111/j.1365-3156.2005.01470.x; Odiit M, 2004, ANN TROP MED PARASIT, V98, P339, DOI 10.1179/000349804225003389; Palmer JJ, 2014, SOC SCI MED, V120, P396, DOI 10.1016/j.socscimed.2014.03.012; Palmer JJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002742; Picado A, 2017, LANCET GLOB HEALTH, V5, pE28, DOI 10.1016/S2214-109X(16)30288-1; Rock KS, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1131-8; Shaw APM, 2015, PREV VET MED, V122, P406, DOI 10.1016/j.prevetmed.2015.06.013; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Simarro PP, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-4; Steinmann P, 2015, TROP MED INT HEALTH, V20, P707, DOI 10.1111/tmi.12483; Sternberg JM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003373; Stone CM, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004514; Tirados I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003822; Uganda Bureau of Statistics, 2014, NAT POP HOUS CENS 20; WHO, 2013, WHO TECH REP SER, V984, P1; World Health Organization, 2012, ACC WORK OV GLOB IMP; World Health Organization, 2015, WHO GLOB HLTH OBS DA	41	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186429	10.1371/journal.pone.0186429	http://dx.doi.org/10.1371/journal.pone.0186429			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023573	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100128
J	Wang, DF; Li, LD; Wu, GY; Vasseur, L; Yang, G; Huang, PR				Wang, Dingfeng; Li, Liangde; Wu, Guangyuan; Vasseur, Liette; Yang, Guang; Huang, Pengrong			De novo transcriptome sequencing of Isaria cateniannulata and comparative analysis of gene expression in response to heat and cold stresses	PLOS ONE			English	Article							FUNGUS BEAUVERIA-BASSIANA; METARHIZIUM-ANISOPLIAE; ENTOMOPATHOGENIC FUNGUS; SHOCK PROTEINS; ABIOTIC STRESS; TEMPERATURE; HSP70; THERMOTOLERANCE; PAECILOMYCES; FAMILY	Isaria cateniannulata is a very important and virulent entomopathogenic fungus that infects many insect pest species. Although I. cateniannulata is commonly exposed to extreme environmental temperature conditions, little is known about its molecular response mechanism to temperature stress. Here, we sequenced and de novo assembled the transcriptome of I. cateniannulata in response to high and low temperature stresses using Illumina RNA-Seq technology. Our assembly encompassed 17,514 unigenes (mean length = 1,197 bp), in which 11,445 unigenes (65.34%) showed significant similarities to known sequences in NCBI non-redundant protein sequences (Nr) database. Using digital gene expression analysis, 4,483 differentially expressed genes (DEGs) were identified after heat treatment, including 2,905 up-regulated genes and 1,578 down-regulated genes. Under cold stress, 1,927 DEGs were identified, including 1,245 up-regulated genes and 682 down-regulated genes. The expression patterns of 18 randomly selected candidate DEGs resulting from quantitative real-time PCR (qRT-PCR) were consistent with their transcriptome analysis results. Although DEGs were involved in many pathways, we focused on the genes that were involved in endocytosis: In heat stress, the pathway of clathrin-dependent endocytosis (CDE) was active; however at low temperature stresses, the pathway of clathrin-independent endocytosis (CIE) was active. Besides, four categories of DEGs acting as temperature sensors were observed, including cell-wall-major-components-metabolism-related (CWMCMR) genes, heat shock protein (Hsp) genes, intracellular-compatible-solutesmetabolism- related (ICSMR) genes and glutathione S-transferase (GST). These results enhance our understanding of the molecular mechanisms of I. cateniannulata in response to temperature stresses and provide a valuable resource for the future investigations.	[Wang, Dingfeng; Li, Liangde; Wu, Guangyuan] Fujian Acad Agr Sci, Tea Res Inst, Fuan, Fujian, Peoples R China; [Vasseur, Liette; Yang, Guang; Huang, Pengrong] Minist Agr, Key Lab Integrated Pest Management Fujian Taiwan, Fuzhou, Fujian, Peoples R China; [Vasseur, Liette; Yang, Guang; Huang, Pengrong] Fujian Agr & Forestry Univ, Inst Appl Ecol, State Key Lab Ecol Pest Control Fujian & Taiwan C, Fuzhou, Fujian, Peoples R China; [Vasseur, Liette] Brock Univ, Dept Biol Sci, St Catharines, ON, Canada; [Yang, Guang; Huang, Pengrong] Fujian Prov Univ, Fujian Agr & Forestry Univ, Key Lab Green Control Insect Pests, Fuzhou, Fujian, Peoples R China; [Yang, Guang; Huang, Pengrong] Fujian Agr & Forestry Univ, Fujian Taiwan Joint Ctr Ecol Control Crop Pests, Fuzhou, Fujian, Peoples R China	Fujian Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Fujian Agriculture & Forestry University; Brock University; Fujian Agriculture & Forestry University; Fuzhou University; Fujian Agriculture & Forestry University	Wu, GY (corresponding author), Fujian Acad Agr Sci, Tea Res Inst, Fuan, Fujian, Peoples R China.; Yang, G (corresponding author), Minist Agr, Key Lab Integrated Pest Management Fujian Taiwan, Fuzhou, Fujian, Peoples R China.; Yang, G (corresponding author), Fujian Agr & Forestry Univ, Inst Appl Ecol, State Key Lab Ecol Pest Control Fujian & Taiwan C, Fuzhou, Fujian, Peoples R China.; Yang, G (corresponding author), Fujian Prov Univ, Fujian Agr & Forestry Univ, Key Lab Green Control Insect Pests, Fuzhou, Fujian, Peoples R China.; Yang, G (corresponding author), Fujian Agr & Forestry Univ, Fujian Taiwan Joint Ctr Ecol Control Crop Pests, Fuzhou, Fujian, Peoples R China.	gywupt@163.com; yxg@iae.fjau.edu.cn			programs of Natural Science Foundation of Fujian Province, China [2015J01099]; Modern Agro-Industry Technology Research System [CARS-23]; Key Project of Tea Research Institute of FAAS [2014-cys-02]; Collaborative Innovation Center of Chinese Oolong Tea Industry-Collaborative Innovation Center of Fujian Province	programs of Natural Science Foundation of Fujian Province, China; Modern Agro-Industry Technology Research System; Key Project of Tea Research Institute of FAAS; Collaborative Innovation Center of Chinese Oolong Tea Industry-Collaborative Innovation Center of Fujian Province	This work was financially supported by the programs of Natural Science Foundation of Fujian Province, China (grant no. 2015J01099; http://www.fjkx.org/), Modern Agro-Industry Technology Research System (grant no. CARS-23; http://www.moa.gov.cn/), Key Project of Tea Research Institute of FAAS (grant no. 2014-cys-02; http://www.faas.cn/dept/cys/index.html) and Collaborative Innovation Center of Chinese Oolong Tea Industry-Collaborative Innovation Center (2011) of Fujian Province (http://www.fjedu.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggett JJ, 2001, TRAFFIC, V2, P297, DOI 10.1034/j.1600-0854.2001.002005297.x; Bugeme DM, 2008, EXP APPL ACAROL, V46, P275, DOI 10.1007/s10493-008-9179-1; Chen Ming-jun, 2011, Yingyong Shengtai Xuebao, V22, P1275; Chen YF, 2014, APPL MICROBIOL BIOT, V98, P1349, DOI 10.1007/s00253-013-5001-z; CID VJ, 1995, MICROBIOL REV, V59, P345, DOI 10.1128/MMBR.59.3.345-386.1995; Dal Piaz F, 2015, PLANTA MED, V81, P1223, DOI 10.1055/s-0035-1546251; Georg RD, 2007, GENE, V386, P24, DOI 10.1016/j.gene.2006.07.033; Devi KU, 2005, J INVERTEBR PATHOL, V88, P181, DOI 10.1016/j.jip.2005.02.001; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fan LS, 2015, TRENDS PLANT SCI, V20, P388, DOI 10.1016/j.tplants.2015.03.014; Fang WG, 2010, ENVIRON MICROBIOL, V12, P810, DOI 10.1111/j.1462-2920.2009.02127.x; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FENG MG, 1994, BIOCONTROL SCI TECHN, V4, P3, DOI 10.1080/09583159409355309; Fernandes EKK, 2008, J INVERTEBR PATHOL, V98, P69, DOI 10.1016/j.jip.2007.10.011; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Goettel M.S., 2005, COMPREHENSIVE MOL IN, P361, DOI DOI 10.1016/B0-44-451924-6/00088-0; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hasin N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-194; Hong TD, 2001, MYCOL RES, V105, P597, DOI 10.1017/S0953756201004026; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Krzewska J, 2001, FEBS LETT, V489, P92, DOI 10.1016/S0014-5793(00)02423-6; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Levdansky E, 2010, EUKARYOT CELL, V9, P1403, DOI 10.1128/EC.00126-10; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130526; Liang Zongqi, 1981, Acta Microbiologica Sinica, V21, P31; Liang ZQ, 2005, FUNGAL DIVERS, V20, P83; Liao XG, 2014, APPL MICROBIOL BIOT, V98, P777, DOI 10.1007/s00253-013-5360-5; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Link T, 2005, BIOCHEM J, V389, P289, DOI 10.1042/BJ20050301; Liu DL, 2006, PLANT PHYSIOL BIOCH, V44, P380, DOI 10.1016/j.plaphy.2006.06.011; Liu XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152540; Liu YW, 2012, BIOESSAYS, V34, P643, DOI 10.1002/bies.201200033; Luangsa-Ard JJ, 2005, MYCOL RES, V109, P581, DOI 10.1017/S0953756205002741; MACLEAN DJ, 1976, J GEN MICROBIOL, V97, P83, DOI 10.1099/00221287-97-1-83; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Miaczynska M, 2008, J CELL BIOL, V180, P7, DOI 10.1083/jcb.200711073; MITSUHASHI W, 1992, APPL ENTOMOL ZOOL, V27, P295, DOI 10.1303/aez.27.295; Montero-Barrientos M, 2007, CURR GENET, V52, P45, DOI 10.1007/s00294-007-0140-3; Ocon A, 2007, NEW PHYTOL, V174, P879, DOI 10.1111/j.1469-8137.2007.02048.x; Ouedraogo A, 1997, MYCOPATHOLOGIA, V137, P37, DOI 10.1023/A:1006882621776; Raggam RB, 2011, MYCOSES, V54, pE394, DOI 10.1111/j.1439-0507.2010.01933.x; Rangel DEN, 2005, J INVERTEBR PATHOL, V88, P116, DOI 10.1016/j.jip.2004.11.007; Ren LP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-844; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Rocha LFN, 2011, T ROY SOC TROP MED H, V105, P417, DOI 10.1016/j.trstmh.2011.04.012; Roy SS, 2013, J MOL GRAPH MODEL, V44, P54, DOI 10.1016/j.jmgm.2013.02.008; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Sun PP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1586-1; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; VASSILEV AO, 1992, BIOCHIM BIOPHYS ACTA, V1156, P1, DOI 10.1016/0304-4165(92)90087-B; Veal EA, 2002, J BIOL CHEM, V277, P35523, DOI 10.1074/jbc.M111548200; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Wang DingFeng, 2014, Acta Phytophylacica Sinica, V41, P531; Wang J, 2017, APPL MICROBIOL BIOT, V101, P185, DOI 10.1007/s00253-016-7757-4; Wang J, 2016, ENVIRON MICROBIOL, V18, P1037, DOI 10.1111/1462-2920.13197; Wang Pin, 2013, Journal of Tea Science, V33, P562; Wang Z, 2014, APPL MICROBIOL BIOT, V98, P641, DOI 10.1007/s00253-013-4870-5; Wang ZL, 2012, ENVIRON MICROBIOL, V14, P2139, DOI 10.1111/j.1462-2920.2011.02654.x; Wu JB, 2016, GENE, V575, P675, DOI 10.1016/j.gene.2015.09.044; Wyatt TT, 2015, ENVIRON MICROBIOL, V17, P395, DOI 10.1111/1462-2920.12558; [谢翎 XIE Ling], 2009, [菌物学报, Mygosystema], V28, P806; Yang M, 2011, CURR GENET, V57, P253, DOI 10.1007/s00294-011-0344-4; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Ye SF, 2012, CHINESE SCI BULL, V57, P336, DOI 10.1007/s11434-011-4863-7; Zhang XN, 2016, PEST MANAG SCI, V72, P1059, DOI 10.1002/ps.4233	77	6	8	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186040	10.1371/journal.pone.0186040	http://dx.doi.org/10.1371/journal.pone.0186040			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023475	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100055
J	Asela, I; Noyong, M; Simon, U; Andrades-Lagos, J; Campanini-Salinas, J; Vasquez-Velasquez, D; Kogan, M; Yutronic, N; Sierpe, R				Asela, I.; Noyong, M.; Simon, U.; Andrades-Lagos, J.; Campanini-Salinas, J.; Vasquez-Velasquez, D.; Kogan, M.; Yutronic, N.; Sierpe, R.			Gold nanoparticles stabilized with beta cyclodextrin-2-amino-4-(4-chlorophenyl)thiazole complex: A novel system for drug transport	PLOS ONE			English	Article							BETA-CYCLODEXTRIN; INCLUSION COMPLEXES; ORGANOPHOSPHORUS PESTICIDES; 2,4-DISUBSTITUTED THIAZOLES; PHOTODEGRADATION RATES; ANTIBACTERIAL ACTIVITY; DELIVERY-SYSTEMS; ANTIBIOTICS; ABSORPTION; AGENTS	While 2-amino-4-(4-chlorophenyl)thiazole (AT) drug and thiazole derivatives have several biological applications, these compounds present some drawbacks, such as low aqueous solubility and instability. A new complex of beta CD-AT has been synthesized to increase AT solubility and has been used as a substrate for the deposit of solid-state AuNPs via magnetron sputtering, thus forming the beta CD-AT-AuNPs ternary system, which is stable in solution. Complex formation has been confirmed through powder X-ray diffraction and 1D and 2D nuclear magnetic resonance. Importantly, the amine and sulfide groups of AT remained exposed and can interact with the surfaces of the AuNPs. The complex association constant (970 M-1) has been determined using phase solubility analysis. AuNPs formation (32 nm average diameter) has been studied by UV-Visible spectroscopy, transmission/scanning electron microscopy and energy-dispersive X-ray analysis. The in vitro permeability assays show that effective permeability of AT increased using beta CD. In contrast, the ternary system did not have the capacity to diffuse through the membrane. Nevertheless, the antibacterial assays have demonstrated that AT is transferred from beta CD-AT-AuNPs, being available to exert its antibacterial activity. In conclusion, this novel beta CD-AT-AuNPs ternary system is a promising alternative to improve the delivery of AT drugs in therapy.	[Asela, I.; Yutronic, N.; Sierpe, R.] Univ Chile, Fac Ciencias, Dept Quim, Santiago, Chile; [Noyong, M.; Simon, U.] Rhein Westfal TH Aachen, Inst Inorgan Chem, Aachen, Germany; [Andrades-Lagos, J.; Campanini-Salinas, J.; Vasquez-Velasquez, D.; Kogan, M.; Sierpe, R.] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Quim Farmacol & Toxicol, Santiago, Chile; [Kogan, M.; Sierpe, R.] Univ Chile, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Kogan, M.; Sierpe, R.] Pontificia Univ Catolica Chile, Santiago, Chile	Universidad de Chile; RWTH Aachen University; Universidad de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile	Yutronic, N; Sierpe, R (corresponding author), Univ Chile, Fac Ciencias, Dept Quim, Santiago, Chile.; Kogan, M; Sierpe, R (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Quim Farmacol & Toxicol, Santiago, Chile.; Kogan, M; Sierpe, R (corresponding author), Univ Chile, Adv Ctr Chron Dis ACCDiS, Santiago, Chile.; Kogan, M; Sierpe, R (corresponding author), Pontificia Univ Catolica Chile, Santiago, Chile.	mkogan@ciq.uchile.cl; nyutroni@uchile.cl; rsierpe@ciq.uchile.cl	Campanini-Salinas, Javier./CPX-2835-2022; Simon, Ulrich/K-7737-2013; Velásquez, David R. Vásquez/I-2010-2013; Noyong, Michael/I-6207-2016	Campanini-Salinas, Javier./0000-0002-7358-409X; Simon, Ulrich/0000-0002-6118-0573; Velásquez, David R. Vásquez/0000-0003-0635-4857; Noyong, Michael/0000-0002-3148-1084	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [21130628, 21130643, 1170929, 1160114]; Fondo de Financiamiento de Centros Investigacion en Areas Prioritarias (FONDAP) [15130011]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Financiamiento de Centros Investigacion en Areas Prioritarias (FONDAP)	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), number 21130628 (JA), 21130643 (JC), 1170929 (MK), and 1160114 (NY); http://www.conicyt.cl/fondecyt/. It was also supported by Fondo de Financiamiento de Centros Investigacion en Areas Prioritarias (FONDAP), number 15130011; http://www.conicyt.cl/fondap/.	Abadeer NS, 2016, J PHYS CHEM C, V120, P4691, DOI 10.1021/acs.jpcc.5b11232; Alexander CM, 2012, BIOCONJUGATE CHEM, V23, P2061, DOI 10.1021/bc3002634; Alvarez-Lorenzo C, 2006, BIOTECHNOL ANN REV, V12, P225, DOI 10.1016/S1387-2656(06)12007-4; ATTIOUI F, 1994, BIOL CELL, V82, P161, DOI 10.1016/S0248-4900(94)80018-9; Brewster ME, 2007, INT J PHARMACEUT, V342, P250, DOI 10.1016/j.ijpharm.2007.04.029; Burygin GL, 2009, NANOSCALE RES LETT, V4, P794, DOI 10.1007/s11671-009-9316-8; Caira MR, 2001, REV ROUM CHIM, V46, P371; Challa R, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060243; Chen H, 2014, OPT LETT, V39, P5822, DOI 10.1364/OL.39.005822; Chen M, 2006, CHEMOSPHERE, V63, P522, DOI 10.1016/j.chemosphere.2005.08.033; Chen YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150877; Connors KA, 1997, CHEM REV, V97, P1325, DOI 10.1021/cr960371r; CREIGHTON JA, 1991, J CHEM SOC FARADAY T, V87, P3881, DOI 10.1039/ft9918703881; Dang Z, 2011, CURR ORG CHEM, V15, P848, DOI 10.2174/138527211794518899; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Das B, 2006, J MOL CATAL A-CHEM, V252, P235, DOI 10.1016/j.molcata.2006.02.065; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Fang LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146292; Feng XL, 2010, ACS APPL MATER INTER, V2, P2429, DOI 10.1021/am100435k; Gibson JD, 2007, J AM CHEM SOC, V129, P11653, DOI 10.1021/ja075181k; Herrera B, 2013, J COLLOID INTERF SCI, V389, P42, DOI 10.1016/j.jcis.2012.08.027; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Hinde E, 2017, NAT NANOTECHNOL, V12, P81, DOI [10.1038/nnano.2016.160, 10.1038/NNANO.2016.160]; Holla BS, 2003, EUR J MED CHEM, V38, P313, DOI 10.1016/S0223-5234(02)01447-2; Huang XH, 2010, J ADV RES, V1, P13, DOI 10.1016/j.jare.2010.02.002; KAMIYA M, 1994, CHEMOSPHERE, V28, P1961, DOI 10.1016/0045-6535(94)90146-5; KAMIYA M, 1995, ENVIRON INT, V21, P299, DOI 10.1016/0160-4120(95)00026-H; Kamiya M, 2001, CHEMOSPHERE, V42, P251, DOI 10.1016/S0045-6535(00)00085-0; Kansy M, 1998, J MED CHEM, V41, P1007, DOI 10.1021/jm970530e; Karegoudar P, 2008, EUR J MED CHEM, V43, P261, DOI 10.1016/j.ejmech.2007.03.014; Kogan MJ, 2007, NANOMEDICINE-UK, V2, P287, DOI 10.2217/17435889.2.3.287; Lepretre S, 2009, BIOMATERIALS, V30, P6086, DOI 10.1016/j.biomaterials.2009.07.045; Loftsson T, 2007, J PHARM SCI-US, V96, P2532, DOI 10.1002/jps.20992; Loftsson T, 2010, J PHARM PHARMACOL, V62, P1607, DOI 10.1111/j.2042-7158.2010.01030.x; Manolikar MK, 2003, CHEMOSPHERE, V51, P811, DOI 10.1016/S0045-6535(03)00099-7; Morillo E, 2001, CHEMOSPHERE, V44, P1065, DOI 10.1016/S0045-6535(00)00346-5; Moser F, 2016, BIOPHYS J, V110, P947, DOI 10.1016/j.bpj.2016.01.004; Okamoto T, 2003, J PHYS CHEM B, V107, P10321, DOI 10.1021/jp0345371; Ottaviani G, 2006, J MED CHEM, V49, P3948, DOI 10.1021/jm060230+; Paciotti GF, 2016, BIOCONJUGATE CHEM, V27, P2646, DOI 10.1021/acs.bioconjchem.6b00405; Padukka Indra, 2000, Journal of Food Composition and Analysis, V13, P59, DOI 10.1006/jfca.1999.0820; Pajatsch M, 1998, J BACTERIOL, V180, P2630, DOI 10.1128/JB.180.10.2630-2635.1998; Peng X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118274; Pessine F., 2014, MAGNETIC RESONANCE S, P237; Pinto-Alphandary H, 2000, INT J ANTIMICROB AG, V13, P155, DOI 10.1016/S0924-8579(99)00121-1; Premakumari C, 2014, ARAB J CHEM, V7, P385, DOI 10.1016/j.arabjc.2013.10.024; Rai A, 2010, J MATER CHEM, V20, P6789, DOI 10.1039/c0jm00817f; Rao VM, 2003, J PHARM SCI, V92, P927, DOI 10.1002/jps.10341; Saenger WR, 1998, CHEM REV, V98, P1787, DOI 10.1021/cr9700181; Saha B, 2007, NANOSCALE RES LETT, V2, P614, DOI 10.1007/s11671-007-9104-2; Saikosin R, 2002, J INCL PHENOM MACRO, V44, P191, DOI 10.1023/A:1023099925658; Schmid G., 2006, ENCY INORG CHEM; Schnurch M, 2011, BIOORG MED CHEM LETT, V21, P2149, DOI 10.1016/j.bmcl.2011.01.123; Shi Y, 2013, INORG CHEM, V52, P9418, DOI 10.1021/ic400989v; Shulman M, 2012, PLOS ONE, V7; Siddiqui HL, 2007, CHEM PHARM BULL, V55, P1014, DOI 10.1248/cpb.55.1014; Sierpe R, 2017, CARBOHYDR POLYM; Sierpe R, 2015, ACS APPL MATER INTER, V7, P15177, DOI 10.1021/acsami.5b00186; Silva CO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165419; Sperling RA, 2010, PHILOS T R SOC A, V368, P1333, DOI 10.1098/rsta.2009.0273; Su KH, 2003, NANO LETT, V3, P1087, DOI 10.1021/nl034197f; SZENTE L, 1981, ACTA CHIM HUNG, V107, P195; Thatiparti TR, 2010, MACROMOL BIOSCI, V10, P82, DOI 10.1002/mabi.200900204; Tiwari G, 2010, J PHARM BIOALLIED SC, V2, P72, DOI 10.4103/0975-7406.67003; Venkatachalam TK, 2001, BIOORG MED CHEM LETT, V11, P523, DOI 10.1016/S0960-894X(01)00011-7; Wang SH, 2010, J NANOBIOTECHNOL, V8, DOI 10.1186/1477-3155-8-33; Wayne P.A, 2015, M100S25 CLSI; Wikler M.A., 2009, METHODS DILUTION ANT, V8; Wulf V, 2016, J PHYS CHEM LETT, V7, P4951, DOI 10.1021/acs.jpclett.6b02165; Yokoo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141946	70	7	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185652	10.1371/journal.pone.0185652	http://dx.doi.org/10.1371/journal.pone.0185652			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020065	Green Published, gold, Green Submitted			2022-12-26	WOS:000412754400038
J	Magin, RS; Deng, SB; Zhang, HB; Cooperman, B; Marmorstein, R				Magin, Robert S.; Deng, Sunbin; Zhang, Haibo; Cooperman, Barry; Marmorstein, Ronen			Probing the interaction between NatA and the ribosome for co-translational protein acetylation	PLOS ONE			English	Article							N-TERMINAL ACETYLATION; SIGNAL RECOGNITION PARTICLE; ALPHA-ACETYLTRANSFERASE; MOLECULAR-BASIS; TRIGGER FACTOR; CRYSTAL-STRUCTURE; NASCENT PEPTIDES; COMPLEX REVEALS; GTPASE ARL3P; APOPTOSIS	N-terminal acetylation is among the most abundant protein modifications in eukaryotic cells. Over the last decade, significant progress has been made in elucidating the function of N-terminal acetylation for a number of diverse systems, involved in a wide variety of biological processes. The enzymes responsible for the modification are the N-terminal acetyltransferases (NATs). The NATs are a highly conserved group of enzymes in eukaryotes, which are responsible for acetylating over 80% of the soluble proteome in human cells. Importantly, many of these NATs act co-translationally; they interact with the ribosome near the exit tunnel and acetylate the nascent protein chain as it is being translated. While the structures of many of the NATs have been determined, the molecular basis for the interaction with ribosome is not known. Here, using purified ribosomes and NatA, a very well-studied NAT, we show that NatA forms a stable complex with the ribosome in the absence of other stabilizing factors and through two conserved regions; primarily through an N-terminal domain and an internal basic helix. These regions may orient the active site of the NatA to face the peptide emerging from the exit tunnel. This work provides a framework for understanding how NatA and potentially other NATs interact with the ribosome for co-translational protein acetylation and sets the foundation for future studies to decouple N-terminal acetyltransferase activity from ribosome association.	[Magin, Robert S.; Deng, Sunbin; Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Magin, Robert S.] Univ Penn, Perelman Sch Med, Grad Grp Biochem & Biophys, Philadelphia, PA 19104 USA; [Deng, Sunbin; Zhang, Haibo; Cooperman, Barry; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Zhang, Haibo] Spark Therapeut, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Marmorstein, R (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.; Marmorstein, R (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	marmor@upenn.edu	Deng, Sunbin/AAG-6551-2021	Deng, Sunbin/0000-0001-7798-4317; Magin, Robert/0000-0002-8480-8511; Marmorstein, Ronen/0000-0003-4373-4752	National Institutes of Health [R35GM118090, T32 GM071339]; DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania [NIH P30 CA016520]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118090, T32GM071339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R35GM118090 to R.M and T32 GM071339 to R.S.M. We also acknowledge the support of the DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania (NIH P30 CA016520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institutes of Health grants R35GM118090 to R.M and T32 GM071339 to R.S.M. We acknowledge the support of the DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania (NIH P30 CA016520). We thank Glen Liszczak for guidance in ribosome purification and assay development.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Aksnes H, 2017, J BIOL CHEM, V292, P6821, DOI 10.1074/jbc.M116.770362; Aksnes H, 2016, TRENDS BIOCHEM SCI, V41, P746, DOI 10.1016/j.tibs.2016.07.005; Aksnes H, 2015, CELL REP, V10, P1362, DOI 10.1016/j.celrep.2015.01.053; Arnesen T, 2006, ONCOGENE, V25, P4350, DOI 10.1038/sj.onc.1209469; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bingel-Erlenmeyer R, 2008, NATURE, V452, P108, DOI 10.1038/nature06683; Bornemann T, 2008, NAT STRUCT MOL BIOL, V15, P494, DOI 10.1038/nsmb.1402; Chen D, 2014, PLOS GENET; Dikiy I, 2014, J BIOL CHEM; Ferrandez-Ayela A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080697; Forte GMA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001073; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; Giglione C, 2015, BIOCHIMIE, V114, P134, DOI 10.1016/j.biochi.2014.11.008; Helbig AO, 2010, MOL CELL PROTEOMICS, V9, P928, DOI 10.1074/mcp.M900463-MCP200; Hong HY, 2017, STRUCTURE, V25, P641, DOI 10.1016/j.str.2017.03.003; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Kalvik TV, 2013, ONCOGENE, V32, P269, DOI 10.1038/onc.2012.82; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; Liszczak G, 2011, J BIOL CHEM, V286, P37002, DOI 10.1074/jbc.M111.282863; Magin RS, 2015, STRUCTURE, V23, P332, DOI 10.1016/j.str.2014.10.025; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Marmorstein R, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018762; MATASOVA NB, 1991, ANAL BIOCHEM, V198, P219, DOI 10.1016/0003-2697(91)90416-Q; Myklebust LM, 2015, ONCOTARGET, V6, P34041, DOI 10.18632/oncotarget.5867; Neubauer JL, 2012, THESIS; Pavlou D, 2016, APOPTOSIS, V21, P298, DOI 10.1007/s10495-015-1207-0; PESTANA A, 1974, NATURE, V247, P200, DOI 10.1038/247200a0; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 2008, J CELL BIOCHEM, V103, P492, DOI 10.1002/jcb.21418; Raine A, 2006, J BIOL CHEM, V281, P28033, DOI 10.1074/jbc.M605753200; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; Ree R, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150168; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; Sandikci A, 2013, NAT STRUCT MOL BIOL, V20, P843, DOI 10.1038/nsmb.2615; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Schiza V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003805; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Song OK, 2003, J BIOL CHEM, V278, P38109, DOI 10.1074/jbc.C300355200; Starheim KK, 2009, MOL CELL BIOL, V29, P3569, DOI 10.1128/MCB.01909-08; Stove SI, 2016, STRUCTURE, V24, P1044, DOI 10.1016/j.str.2016.04.020; STROUS GJA, 1974, BIOCHEM BIOPH RES CO, V58, P876, DOI 10.1016/S0006-291X(74)80498-5; STROUS GJAM, 1973, EUR J BIOCHEM, V38, P79, DOI 10.1111/j.1432-1033.1973.tb03036.x; Van Damme P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004580; Wang Y, 2010, DEV DYNAMICS; Wegrzyn RD, 2006, J BIOL CHEM, V281, P2847, DOI 10.1074/jbc.M511420200; Weyer FA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15726; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Yang DX, 2013, NAT STRUCT MOL BIOL, V20, P1116, DOI 10.1038/nsmb.2637; Zhang Z., 2010, EMBO J	58	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186278	10.1371/journal.pone.0186278	http://dx.doi.org/10.1371/journal.pone.0186278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016658	gold, Green Submitted, Green Published			2022-12-26	WOS:000412627400065
J	Jaramillo, CM; de la Hoz, F; Porras, A; di Filippo, D; Choconta-Piraquive, LA; Payares, E; Montes, N; Navas, MC				Mario Jaramillo, Carlos; de la Hoz, Fernando; Porras, Alexandra; di Filippo, Diana; Angela Choconta-Piraquive, Luz; Payares, Edra; Montes, Neyla; Navas, Maria-Cristina			Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State, Colombia	PLOS ONE			English	Article							GENOTYPE-F; GENETIC DIVERSITY; SURFACE-PROTEIN; HIGH-PREVALENCE; VARIANTS; VACCINE; REGION; MUTANT; INFECTION; POPULATION	Background Hepatitis B Virus (HBV) infection is a worldwide public health problem. In the 1980's a highly effective and safe vaccine against HBV was developed, although breakthrough infection still occasionally occurs because of the emergence of escape mutants. The aim of this study was to identify HBV genotypes and escape mutants in children and their mothers in Amerindian communities of the Amazonas State, Southern Colombia. Methods Blood specimens collected from children and mothers belonging to 37 Amerindian communities in Amazonas state, were screened for HBsAg and anti-HBc using ELISA. The partial region containing the S ORF was amplified by nested PCR, and amplicons were sequenced. The phylogenetic analysis was performed using the MEGA 5.05 software. Results Forty-six children (46/1275, 3.6%) and one hundred and seventy-seven mothers (177/572, 30.9%) were tested positive for the anti-HBc serological marker. Among them, 190 samples were tested for viral genome detection; 8.3% (2/31) serum samples obtained from children and 3.1% (5/159) from mothers were positive for the ORF S PCR. The predominant HBV genotype in the study population was F, subgenotype F1b; in addition, subgenotype F1a and genotype A were also characterized. Two HBV escape mutants were identified, G145R, reported worldwide, and W156*; this stop codon was identified in a child with occult HBV infection. Other mutations were found, L109R and G130E, located in critical positions of the HBsAg sequence. Conclusions This study aimed to characterize the HBV genotype F, subgenotypes F1b and F1a, and genotype A in Amerindian communities and for the first time escape mutants in Colombia. Further investigations are necessary to elucidate the frequency and the epidemiological impact of the escape mutants in the country.	[Mario Jaramillo, Carlos; di Filippo, Diana; Navas, Maria-Cristina] Univ Antioquia, UdeA, Fac Med, Grp Gastrohepatol, Medellin, Colombia; [de la Hoz, Fernando; Porras, Alexandra; Angela Choconta-Piraquive, Luz] Univ Nacl Colombia, Grp Epidemiol & Evaluac Salud Publ, Bogota, Colombia; [Payares, Edra] Lab Dept Salud Publ Amazonas, Leticia, Colombia; [Montes, Neyla] Alcaldia Puerto Narino, Coordinac Salud Publ, Puerto Narino, Colombia	Universidad de Antioquia; Universidad Nacional de Colombia	Navas, MC (corresponding author), Univ Antioquia, UdeA, Fac Med, Grp Gastrohepatol, Medellin, Colombia.	maria.navas@udea.edu.co	Navas, Maria Cristina/AAE-2528-2022	Porras-Ramirez, Alexandra/0000-0002-0800-1388; Navas, Maria Cristina/0000-0003-2610-9306	Universidad de Antioquia (Proyecto de Sostenibilidad, Vicerrectoria de Investigacion); Departamento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias [110151929040]	Universidad de Antioquia (Proyecto de Sostenibilidad, Vicerrectoria de Investigacion); Departamento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This study was funded by Universidad de Antioquia (Proyecto de Sostenibilidad, Vicerrectoria de Investigacion) and by Departamento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias (Grant 110151929040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 1981, BIORNEDICA REV I NAC, V1, P182; de la Fuente RA, 2011, WORLD J GASTROENTERO, V17, P1543, DOI [10.3748/wjg.v17.i12.1543, 10.3748/wjg.v17.i12. 1543]; Mora MVA, 2011, INFECT GENET EVOL, V11, P103, DOI 10.1016/j.meegid.2010.10.003; Mora MVA, 2010, J GEN VIROL, V91, P501, DOI 10.1099/vir.0.015958-0; Alvarado-Mora MV, 2013, ANTIVIR THER, V18, P459, DOI 10.3851/IMP2599; Alvarado-Mora MV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-244; Alvarado-Mora MV, 2011, INFECT GENET EVOL, V11, P1462, DOI 10.1016/j.meegid.2011.05.020; Amini-Bavil-Olyaee S, 2010, J VIROL, V84, P1026, DOI 10.1128/JVI.01796-09; Choconta-Piraquive LA, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1542-z; Avellon A, 2006, J MED VIROL, V78, P24, DOI 10.1002/jmv.20516; Campos Rodolfo H, 2005, J Clin Virol, V34 Suppl 2, pS8, DOI 10.1016/S1386-6532(05)80028-9; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Carman WF, 1997, J VIRAL HEPATITIS, V4, P11, DOI 10.1111/j.1365-2893.1997.tb00155.x; Chang MH, 2006, J CLIN VIROL, V36, pS45, DOI 10.1016/S1386-6532(06)80008-9; Chen CY, 2010, VACCINE, V28, P5605, DOI 10.1016/j.vaccine.2010.06.029; Cortes-Mancera Fabian, 2011, Hepat Res Treat, V2011, P363205, DOI 10.1155/2011/363205; Cuestas ML, 2012, J VIRAL HEPATITIS, V19, P754, DOI 10.1111/j.1365-2893.2012.01614.x; Cuestas ML, 2010, ANTIVIR RES, V87, P74, DOI 10.1016/j.antiviral.2010.04.005; David Rios P., 2015, REV COLOMB GASTROENT, V30, P11; de la Hoz F, 2005, TROP MED INT HEALTH, V10, P322, DOI 10.1111/j.1365-3156.2005.01399.x; De la Hoz F., 1992, BIOMEDICA, V12, P5; de la Hoz F, 2008, INT J INFECT DIS, V12, P183, DOI 10.1016/j.ijid.2007.06.010; Devesa M, 2008, J MED VIROL, V80, P20, DOI 10.1002/jmv.21024; Devesa M, 2004, J MED VIROL, V72, P377, DOI 10.1002/jmv.20015; Devesa M, 2007, VIRUS RES, V127, P177, DOI 10.1016/j.virusres.2007.01.004; Villa DD, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0402-5; DUARTE EA, 1994, INFECT AGENT DIS, V3, P201; Crispim MAE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-94; Hsu HY, 2010, J INFECT DIS, V201, P1192, DOI 10.1086/651378; Hsu HY, 2004, GUT, V53, P1499, DOI 10.1136/gut.2003.034223; Kitab B, 2011, J INFECTION, V63, P66, DOI 10.1016/j.jinf.2011.05.007; Lai MW, 2008, ANTIVIR THER, V13, P875; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Lledo JL, 2011, WORLD J GASTROENTERO, V17, P1563, DOI [10.3748/wjg.v17.i12. 1563, 10.3748/wjg.v17.i12.1563]; Martinez M, 1991, BIOMEDICA, V11, P43; Mello FCA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-103; Michel ML, 2010, PATHOL BIOL, V58, P288, DOI 10.1016/j.patbio.2010.01.006; Nakano T, 2001, J GEN VIROL, V82, P359, DOI 10.1099/0022-1317-82-2-359; Pawlotsky JM, 2005, J CLIN VIROL, V34, pS125, DOI 10.1016/S1386-6532(05)80021-6; Quintero A, 2001, J MED VIROL, V64, P356, DOI 10.1002/jmv.1058; Raimondo G, 2013, SEMIN IMMUNOPATHOL, V35, P39, DOI 10.1007/s00281-012-0327-7; Ríos-Ocampo Alfredo, 2013, Acta Med Colomb, V38, P143; Sa-nguanmoo P, 2012, J MED VIROL, V84, P1177, DOI 10.1002/jmv.23260; Salisse J, 2009, J VIROL, V83, P9321, DOI 10.1128/JVI.00678-09; Salud INd, 2013, INF COMP EV HEP NIV; Salud INd, 2008, INF COMP EV HEP NIV; Salud INd, 2015, INF EP EV INF FIN HE; Salud INd, 2012, INF COMP EV HEP NIV; Salud INd, 2014, INF EP EV INF FIN HE; Salud INd, 2011, INF COMP EV HEP NIV; Salud INd, 2010, INF COMP EV HEP NIV; Somi Mohammad Hossein, 2012, ISRN Gastroenterol, V2012, P960413, DOI 10.5402/2012/960413; Szomor KN, 2008, ARCH VIROL, V153, P1885, DOI 10.1007/s00705-008-0206-7; Thuy LTT, 2005, J MED VIROL, V76, P161, DOI 10.1002/jmv.20337; Venegas M, 2011, J MED VIROL, V83, P1530, DOI 10.1002/jmv.22129; Viana S, 2005, AM J TROP MED HYG, V73, P808, DOI 10.4269/ajtmh.2005.73.808; Warner N, 2008, HEPATOLOGY, V48, P88, DOI 10.1002/hep.22295; Wu CC, 2012, J VIROL, V86, P4658, DOI 10.1128/JVI.06353-11; Yamani LN, 2015, J CLIN MICROBIOL, V53, P3165, DOI 10.1128/JCM.00602-15; Zarante IO AO, 2000, I COLOMBIA GEOGRAFIA, V1, P475; Zuckerman JN, 2003, ANTIVIR RES, V60, P75, DOI 10.1016/j.antiviral.2003.08.013	61	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0181643	10.1371/journal.pone.0181643	http://dx.doi.org/10.1371/journal.pone.0181643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016603	Green Published, gold, Green Submitted			2022-12-26	WOS:000412627400001
J	Chen, TL; Bhattacharjee, T; Beer, JM; Ting, LH; Hackney, ME; Rogers, WA; Kemp, CC				Chen, Tiffany L.; Bhattacharjee, Tapomayukh; Beer, Jenay M.; Ting, Lena H.; Hackney, Madeleine E.; Rogers, Wendy A.; Kemp, Charles C.			Older adults' acceptance of a robot for partner dance-based exercise	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; TECHNOLOGY ACCEPTANCE; ARGENTINE TANGO; USER ACCEPTANCE; PARKINSONS-DISEASE; PERCEIVED EASE; BALANCE; HEALTH; PERFORMANCE; CONFIDENCE	Partner dance has been shown to be beneficial for the health of older adults. Robots could potentially facilitate healthy aging by engaging older adults in partner dance-based exercise. However, partner dance involves physical contact between the dancers, and older adults would need to be accepting of partner dancing with a robot. Using methods from the technology acceptance literature, we conducted a study with 16 healthy older adults to investigate their acceptance of robots for partner dance-based exercise. Participants successfully led a human-scale wheeled robot with arms (i. e., a mobile manipulator) in a simple, which we refer to as the Partnered Stepping Task (PST). Participants led the robot by maintaining physical contact and applying forces to the robot's end effectors. According to questionnaires, participants were generally accepting of the robot for partner dance-based exercise, tending to perceive it as useful, easy to use, and enjoyable. Participants tended to perceive the robot as easier to use after performing the PST with it. Through a qualitative data analysis of structured interview data, we also identified facilitators and barriers to acceptance of robots for partner dance-based exercise. Throughout the study, our robot used admittance control to successfully dance with older adults, demonstrating the feasibility of this method. Overall, our results suggest that robots could successfully engage older adults in partner dance-based exercise.	[Chen, Tiffany L.; Bhattacharjee, Tapomayukh; Ting, Lena H.; Kemp, Charles C.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Beer, Jenay M.] Univ South Carolina, Dept Comp Sci & Engn, Columbia, SC USA; [Beer, Jenay M.] Univ South Carolina, Coll Social Work, Columbia, SC USA; [Beer, Jenay M.; Rogers, Wendy A.] Georgia Inst Technol, Sch Psychol, Atlanta, GA 30332 USA; [Ting, Lena H.] Emory Univ, Sch Med, Dept Biomed Engn, Atlanta, GA USA; [Hackney, Madeleine E.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Hackney, Madeleine E.] Atlanta VA Geriatr Res Educ & Clin Ctr, Dept Med, Atlanta, GA USA; [Rogers, Wendy A.] Univ Illinois, Dept Appl Hlth Sci, Champaign, IL USA	University System of Georgia; Georgia Institute of Technology; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; Geriatric Research Education & Clinical Center; University of Illinois System; University of Illinois Urbana-Champaign	Kemp, CC (corresponding author), Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.	charlie.kemp@bme.gatech.edu	Beer, Jenay M/D-9748-2018	Beer, Jenay/0000-0002-6834-6978	NSF Graduate Research Fellowship Program (GRFP); National Science Foundation EFRI-M3C: Partnered Rehabilitative Movement: Cooperative Human-robot Interactions for Motor Assistance, Learning, and Communication Award [1137229]; NSF Emerging Frontiers in Research and Innovation (EFRI) [1137229]; Emerging Frontiers & Multidisciplinary Activities [1137229] Funding Source: National Science Foundation	NSF Graduate Research Fellowship Program (GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Science Foundation EFRI-M3C: Partnered Rehabilitative Movement: Cooperative Human-robot Interactions for Motor Assistance, Learning, and Communication Award; NSF Emerging Frontiers in Research and Innovation (EFRI)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)NSF - Directorate for Engineering (ENG)NSF - Emerging Frontiers in Research & Innovation (EFRI)); Emerging Frontiers & Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the NSF Graduate Research Fellowship Program (GRFP), and National Science Foundation EFRI-M3C: Partnered Rehabilitative Movement: Cooperative Human-robot Interactions for Motor Assistance, Learning, and Communication Award #: 1137229, MH, LT, CK (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1137229&HistoricalAwards=false). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Stacie A. Chvatal, Andrew B. Sawers, J. Lucas McKay, Zackory Erickson, Yash Chitalia, and all the participants. We also thank undergraduate research assistants Inez Raharjo and Jacquelyn Borinski. We used the Human Factors and Aging Laboratory Participant Database at Georgia Tech, which was helpful for our study. We gratefully acknowledge support from NSF Emerging Frontiers in Research and Innovation (EFRI) 1137229 and the NSF Graduate Research Fellowship Program (GRFP).	[Anonymous], 2012, P CHI 12 HUM FACT CO, DOI DOI 10.1145/2212776.2223792; Aoki T, 2007, 2007 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-9, P40, DOI 10.1109/IROS.2007.4399584; Aucouturier JJ, 2008, IEEE INTELL SYST, V23, P74, DOI 10.1109/MIS.2008.22; Bann D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116058; Bethancourt HJ, 2014, CLIN MED RES, V12, P10, DOI 10.3121/cmr.2013.1171; Biedenweg K, 2014, J PRIM PREV, V35, P1, DOI 10.1007/s10935-013-0331-2; Blair CK, 2014, MED SCI SPORT EXER, V46, P1375, DOI 10.1249/MSS.0000000000000241; Brown WJ, 2012, BRIT J SPORT MED, V46, P664, DOI 10.1136/bjsports-2011-090529; Buatois S, 2007, INT J SPORTS MED, V28, P53, DOI 10.1055/s-2006-924054; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Chen K, 2014, ERGONOMICS, V57, P635, DOI 10.1080/00140139.2014.895855; Chen TL, 2011, ADV ROBOTICS, V25, P605, DOI 10.1163/016918611X558243; Cheng TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122837; Cress ME, 1999, J GERONTOL A-BIOL, V54, pM242, DOI 10.1093/gerona/54.5.M242; Czaja SJ, 2006, CREATE TR 2006 03; Czaja SJ, 2006, CREATETR200602 U MIA; Borges EGD, 2012, ARCH GERONTOL GERIAT, V55, P492, DOI 10.1016/j.archger.2011.09.004; DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Duignan Debbie, 2009, Nurs Times, V105, P19; Ezer N, 2009, LECT NOTES COMPUT SC, V5615, P39, DOI 10.1007/978-3-642-02710-9_5; Fasola J, 2013, J HUM-ROBOT INTERACT, V2, P3, DOI 10.5898/JHRI.2.2.Fasola; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Franco MR, 2015, BRIT J SPORTS MED; Gadde P, 2011, J ROBOT, V2011, DOI 10.1155/2011/438514; Gando Y, 2010, HYPERTENSION, V56, P540, DOI 10.1161/HYPERTENSIONAHA.110.156331; Gentry S, 2003, IEEE SYS MAN CYBERN, P3432; Gerling K., 2012, P 2012 ACM ANN C HUM, P1873, DOI [10.1145/2207676.2208324, DOI 10.1145/2207676.2208324]; Goodill SW, 2005, INTRO MED DANCE MOVE; Gorer Binnur, 2013, Ambient Intelligence. 4th International Joint Conference, AmI 2013. Proceedings: LNCS 8309, P124, DOI 10.1007/978-3-319-03647-2_9; Hackney Madeleine E, 2007, J Neurol Phys Ther, V31, P173, DOI 10.1097/NPT.0b013e31815ce78b; Hackney ME, 2010, AM J DANCE THER, V32, P41, DOI 10.1007/s10465-010-9086-y; Hackney ME, 2010, NEUROREHAB NEURAL RE, V24, P384, DOI 10.1177/1545968309353329; Hackney ME, 2007, AM J DANCE THER, V29, P109, DOI 10.1007/s10465-007-9039-2; Hackney ME, 2009, J REHABIL MED, V41, P475, DOI 10.2340/16501977-0362; Hamer M, 2014, AM J PREV MED, V47, P452, DOI 10.1016/j.amepre.2014.05.044; Harley D, 2010, LECT NOTES COMPUT SC, V6389, P156; HART S G, 1988, P139; Heerink M, 2008, P 3 ACMIEEE INT C HU, P113, DOI DOI 10.1145/1349822.1349838; Heerink M, 2010, INT J SOC ROBOT, V2, P361, DOI 10.1007/s12369-010-0068-5; Holldampf Jens, 2010, 2010 RO-MAN: The 19th IEEE International Symposium on Robot and Human Interactive Communication, P527, DOI 10.1109/ROMAN.2010.5598616; Hu PJ, 1999, J MANAGE INFORM SYST, V16, P91, DOI 10.1080/07421222.1999.11518247; Jarrasse N, 2014, ADAPT BEHAV, V22, P70, DOI 10.1177/1059712313481044; Kattenstroth JC, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00005; Krebs HI, 2003, AUTON ROBOT, V15, P7, DOI 10.1023/A:1024494031121; Kudlacek S, 1997, AM J PHYS MED REHAB, V76, P477, DOI 10.1097/00002060-199711000-00009; LaViers Amy, 2014, CONTROLS AND ART, P205, DOI [10.1007/978-3-319-03904-6_9, DOI 10.1007/978-3-319-03904-6_9]; Liu Z, 2008, IEEE ASME INT C ADV, P1070, DOI 10.1109/AIM.2008.4601810; Loprinzi PD, 2015, AM J HEALTH PROMOT, V29, P277, DOI 10.4278/ajhp.130709-QUAN-354; Maclean N, 2000, SOC SCI MED, V50, P495; MAXQDA, 1989, SOFTW QUAL DAT AN VE; McKinley P, 2008, J AGING PHYS ACTIV, V16, P435, DOI 10.1123/japa.16.4.435; Meng QG, 2014, NEURAL COMPUT APPL, V24, P117, DOI 10.1007/s00521-013-1504-x; Michael KM, 2006, J CARDIOVASC NURS, V21, pS21, DOI 10.1097/00005082-200609001-00006; Michalowski MP, 2007, P ACM IEEE HRI, P89, DOI [10.1145/1228716.1228729, DOI 10.1145/1228716.1228729]; Moore A., 2002, BALLROOM DANCING; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Nakaoka S., 2005, 2005 IEEE/RSJ International Conference on Intelligent Robots and Systems, P3157; Nakata T, 2002, J ROBOTICS MECHATRON, V14, P27, DOI DOI 10.20965/JRM.2002.P0027; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Neufeldt C., 2009, INT REPORTS SOCIOINF, V6, P50; New England Research Institutes I, 1991, PASE PHYS ACT SCAL E; Ofli F, 2016, IEEE J BIOMED HEALTH, V20, P201, DOI 10.1109/JBHI.2015.2391671; Oliveira JL, 2015, INT J HUM ROBOT, V12, DOI 10.1142/S0219843615500231; Olson KE, 2013, HFATR1303 GEORG I TE; ONEILL K, 1991, CAN J PUBLIC HEALTH, V82, P392; Peek STM, 2014, INT J MED INFORM, V83, P235, DOI 10.1016/j.ijmedinf.2014.01.004; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Pratt Rosalie Rebollo, 2004, Phys Med Rehabil Clin N Am, V15, P827, DOI 10.1016/j.pmr.2004.03.004; Pulliam J., 2006, NURSING ASSISTANT AC; Ramos OE, 2015, IEEE ROBOT AUTOM MAG, V22, P16, DOI 10.1109/MRA.2015.2415048; Ros R, 2014, ROBOT AUTON SYST, V62, P707, DOI 10.1016/j.robot.2014.03.005; Saldana J., 2012, CODING MANUAL QUALIT, V14; Salichs MA, 2006, 2006 IEEE CONFERENCE ON ROBOTICS, AUTOMATION AND MECHATRONICS, VOLS 1 AND 2, P862; Sawers A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-142; Schutzer KA, 2004, PREV MED, V39, P1056, DOI 10.1016/j.ypmed.2004.04.003; SERAJI H, 1994, IEEE INT CONF ROBOT, P2705, DOI 10.1109/ROBOT.1994.350927; Shinozaki K, 2008, INT FED INFO PROC, V279, P83; Smarr CA, 2013, HFATR1304 GEORG I TE; Smarr CA, 2014, INT J SOC ROBOT, V6, P229, DOI 10.1007/s12369-013-0220-0; Song R, 2004, PUBLIC HEALTH NURS, V21, P361, DOI 10.1111/j.0737-1209.2004.21410.x; Takeda T, 2007, IEEE T IND ELECTRON, V54, P699, DOI 10.1109/TIE.2007.891642; van der Heijden H, 2004, MIS QUART, V28, P695, DOI 10.2307/25148660; van Schijndel-Speet M, 2014, INTELLECT DEV DISAB, V52, P175, DOI 10.1352/1934-9556-52.3.175; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Venkatesh V, 2000, INFORM SYST RES, V11, P342, DOI 10.1287/isre.11.4.342.11872; Venkatesh V, 2000, MIS QUART, V24, P115, DOI 10.2307/3250981; Venkatesh V, 2012, CONSUMER ACCEPTANCE; Wang HB, 2012, IEEE T HAPTICS, V5, P264, DOI 10.1109/TOH.2012.36; Wannamethee SG, 1998, LANCET, V351, P1603, DOI 10.1016/S0140-6736(97)12355-8; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4	92	28	28	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0182736	10.1371/journal.pone.0182736	http://dx.doi.org/10.1371/journal.pone.0182736			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KG	29045408	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100005
J	Abrahams, MI; Peres, CA; Costa, HCM				Abrahams, Mark I.; Peres, Carlos A.; Costa, Hugo C. M.			Measuring local depletion of terrestrial game vertebrates by central-place hunters in rural Amazonia	PLOS ONE			English	Article							MANU NATIONAL-PARK; INDIGENOUS PEOPLES; MBARACAYU RESERVE; TROPICAL FORESTS; TAYASSU-PECARI; BRINGING HOME; BIOKO ISLAND; SUSTAINABILITY; CONSERVATION; POPULATION	The degree to which terrestrial vertebrate populations are depleted in tropical forests occupied by human communities has been the subject of an intense polarising debate that has important conservation implications. Conservation ecologists and practitioners are divided over the extent to which community-based subsistence offtake is compatible with ecologically functional populations of tropical forest game species. To quantify depletion envelopes of forest vertebrates around human communities, we deployed a total of 383 camera trap stations and 78 quantitative interviews to survey the peri-community areas controlled by 60 semi-subsistence communities over a combined area of over 3.2 million hectares in the Medio Jurua and Uatuma regions of Central-Western Brazilian Amazonia. Our results largely conform with prior evidence that hunting large-bodied vertebrates reduces wildlife populations near settlements, such that they are only found at a distance to settlements where they are hunted less frequently. Camera trap data suggest that a select few harvest-sensitive species, including lowland tapir, are either repelled or depleted by human communities. Nocturnal and cathemeral species were detected relatively more frequently in disturbed areas close to communities, but individual species did not necessarily shift their activity patterns. Group biomass of all species was depressed in the wider neighbourhood of urban areas rather than communities. Interview data suggest that species traits, especially group size and body mass, mediate these relationships. Large-bodied, large-group-living species are detected farther from communities as reported by experienced informants. Long-established communities in our study regions have not "emptied" the surrounding forest. Low human population density and low hunting offtake due to abundant sources of alternative aquatic protein, suggest that these communities represent a best-case scenario for sustainable hunting of wildlife for food, thereby providing a conservative assessment of game depletion. Given this 'best-case' camera trap and interview-based evidence for hunting depletion, regions with higher human population densities, external trade in wildlife and limited access to alternative protein will likely exhibit more severe depletion.	[Abrahams, Mark I.; Peres, Carlos A.] Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England; [Costa, Hugo C. M.] Univ Estadual Santa Cruz, PPG Ecol & Conservacao Biodiversidade, Ilheus, Brazil; [Abrahams, Mark I.] Bristol Zool Soc, Field Conservat & Sci Dept, Bristol, Avon, England	University of East Anglia; Universidade Estadual de Santa Cruz	Abrahams, MI (corresponding author), Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England.; Abrahams, MI (corresponding author), Bristol Zool Soc, Field Conservat & Sci Dept, Bristol, Avon, England.	mabrahams@bristolzoo.org.uk	Peres, Carlos Augusto/N-8275-2019; Peres, Carlos A./B-1276-2013; Peres, Carlos A./ABE-8361-2020	Peres, Carlos A./0000-0002-1588-8765; Peres, Carlos A./0000-0002-1588-8765; abrahams, mark/0000-0002-6424-187X	School of Environmental Science at University of East Anglia; Darwin Initiative for the Survival of Species grant; Explorers Club; Idea Wild; Rufford Foundation Small Grants; Smithsonian Manson School of Conservation partial scholarship award	School of Environmental Science at University of East Anglia; Darwin Initiative for the Survival of Species grant; Explorers Club; Idea Wild; Rufford Foundation Small Grants; Smithsonian Manson School of Conservation partial scholarship award	The PhD studentship of MIA was funded by the School of Environmental Science at University of East Anglia (https://wm.uea.ac.uk/environmental-sciences). Fieldwork and equipment funding were provided by a Darwin Initiative for the Survival of Species grant (http://www.darwininitiative.org.uk/ DEFRA no. 20-001) to CAP; the Explorers Club (https://explorers.org/); Idea Wild (http://Aqww.ideawild.org/); the Rufford Foundation Small Grants (http://www.rufford.org/12231-1) and the Smithsonian Manson School of Conservation partial scholarship award (http//smconservation.gmu.edu/ MCCS 0501) to HCMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MI, J WILDLIFE MANAGEMEN; ALCORN JB, 1993, CONSERV BIOL, V7, P424, DOI 10.1046/j.1523-1739.1993.07020424.x; Altrichter M, 2005, BIOL CONSERV, V126, P351, DOI 10.1016/j.biocon.2005.06.024; ALVARD MS, 1993, HUM ECOL, V21, P355, DOI 10.1007/BF00891140; Alvard MS, 1997, CONSERV BIOL, V11, P977, DOI 10.1046/j.1523-1739.1997.96047.x; Antunes AP, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600936; Baptista L. F., 1997, HDB BIRDS WORLD, V4, P60; Bar-Oz G, 2011, P NATL ACAD SCI USA, V108, P7345, DOI 10.1073/pnas.1017647108; Becher H, 1996, AMAZONIA MAN CULTURE; Bennett EL, 2000, BIOL RESOURCE MANAGE, P305; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Berkes F., 1995, Biodiversity conservation: problems and policies. Papers from the Biodiversity Programme, Beijer International Institute of Ecological Economics, Royal Swedish Academy of Sciences., P281; BODMER RE, 1990, J TROP ECOL, V6, P191, DOI 10.1017/S0266467400004314; Bodmer RE, 1997, CONSERV BIOL, V11, P460, DOI 10.1046/j.1523-1739.1997.96022.x; Borner J., 2013, PROMOTING FOREST STE; Bowen-Jones E, 1999, ORYX, V33, P233, DOI 10.1046/j.1365-3008.1999.00066.x; Branch TA, 2013, TRENDS ECOL EVOL, V28, P409, DOI 10.1016/j.tree.2013.03.003; Brandon K., 1998, PARKS PERIL PEOPLE P; Burnham KP, 2003, MODEL SELECTION MULT; Carboneras C., 1992, HDB BIRDS WORLD OSTR, V1, P536; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Clayton L, 1997, ECOL APPL, V7, P642, DOI 10.1890/1051-0761(1997)007[0642:BHTBAS]2.0.CO;2; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; da Silva Maria N.F., 2005, Neotropical Primates, V13, P31, DOI 10.1896/1413-4705.13.2.31; Datta A, 2008, BIOL CONSERV, V141, P1429, DOI 10.1016/j.biocon.2008.02.022; Denevan WM, 1996, ANN ASSOC AM GEOGR, V86, P654, DOI 10.1111/j.1467-8306.1996.tb01771.x; Dunning Jr JB, 1992, CRC HDB AVIAN BODY M; EMMONS LH, 1984, BIOTROPICA, V16, P210, DOI 10.2307/2388054; Emmons LH, 1997, NEOTROPICAL RAINFORE, P2; Endo W, 2016, BIOL CONSERV, V201, P129, DOI 10.1016/j.biocon.2016.07.006; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fa JE, 2000, CONSERV BIOL, V14, P1602, DOI [10.1111/j.1523-1739.2000.99067.x, 10.1046/j.1523-1739.2000.99067.x]; Fragoso J.M.V., 1991, P154; Fragoso JMV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152659; Garcia-Fernandez C, 2008, FOREST ECOL MANAG, V256, P1468, DOI 10.1016/j.foreco.2008.04.029; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Geisler C, 2003, INT SOC SCI J, V55, P69, DOI 10.1111/1468-2451.5501007; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Gompper ME, 2006, WILDLIFE SOC B, V34, P1142, DOI 10.2193/0091-7648(2006)34[1142:ACONTT]2.0.CO;2; Vega MG, 2013, CONSERV BIOL, V27, P576, DOI 10.1111/cobi.12067; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harrison RD, 2013, ECOL LETT, V16, P687, DOI 10.1111/ele.12102; Harrison RD, 2011, BIOSCIENCE, V61, P919, DOI 10.1525/bio.2011.61.11.11; Hart John A., 2000, P106; HAWKES K, 1982, AM ETHNOL, V9, P379, DOI 10.1525/ae.1982.9.2.02a00100; Hill K, 2003, CONSERV BIOL, V17, P1312, DOI 10.1046/j.1523-1739.2003.01135.x; Hill K, 2000, BIOL RESOURCE MANAGE, P79; Holt Flora L, 2004, OCCASIONAL PAPER, P87; Instituto Nacional de Pesquisas Espaciais [INPE], 2009, MON FLOR AM BRAS STA; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; JOHNS AD, 1985, AM J PRIMATOL, V8, P31, DOI 10.1002/ajp.1350080104; Kern DC, 2007, AMAZONIAN DARK EARTH; Kramer R, 1997, LAST STAND PROTECTED; Lahm S., 2001, WHY CONSERVATION SHO; Leendertz SAJ, 2017, MAMMAL REV, V47, P98, DOI 10.1111/mam.12082; Lehner B, 2013, HYDROL PROCESS, V27, P2171, DOI 10.1002/hyp.9740; Leuwenberg FT, 2013, HUNTING SUSTAINABILI, P375; Levi T, 2009, J APPL ECOL, V46, P804, DOI 10.1111/j.1365-2664.2009.01661.x; LOW BS, 1993, POPUL ENVIRON, V15, P7, DOI 10.1007/BF02207996; Madhusudan MD, 2002, AMBIO, V31, P49, DOI 10.1639/0044-7447(2002)031[0049:LHATCO]2.0.CO;2; Martin P. S., 1967, P75; Martinez D., 1996, SIERRA MAGAZINE SIER, V81; MCDONALD DR, 1977, ANTHROPOS, V72, P734; MCGRATH DG, 1993, HUM ECOL, V21, P167, DOI 10.1007/BF00889358; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Milner-Gulland EJ, 2001, TRENDS ECOL EVOL, V16, P686, DOI 10.1016/S0169-5347(01)02278-9; Mitlermeier R.A., 1987, Monographs in Primatology, V9, P109; Muller-Landau HC, 2007, BIOTROPICA, V39, P372, DOI 10.1111/j.1744-7429.2007.00290.x; Munari DP, 2011, MAMMALIAN BIOL Z SAU, V76; NEPAL SK, 1995, ENVIRON MANAGE, V19, P853, DOI 10.1007/BF02471937; Nichols JD, 2010, ANIM CONSERV, V13, P344, DOI 10.1111/j.1469-1795.2010.00382.x; NORTONGRIFFITHS M, 1995, ECOL ECON, V12, P125, DOI 10.1016/0921-8009(94)00041-S; Noss A, 2000, BIOL RESOURCE MANAGE, P282; Novaro AJ, 2000, CONSERV BIOL, V14, P713, DOI 10.1046/j.1523-1739.2000.98452.x; Nowak R.M, 1999, WALKERS MAMMALS WORL, V6th; Ntiamoa-Baidu Y., 2008, J STUDY RELIG NATURE, V2; Nuno A, 2015, BIOL CONSERV, V189, P5, DOI 10.1016/j.biocon.2014.09.047; O'Donnell KP, 2010, ANIM CONSERV, V13, P526, DOI 10.1111/j.1469-1795.2010.00377.x; OBrien T., 2010, WILDLIFE PICTURE IND; Ohl-Schacherer J, 2007, CONSERV BIOL, V21, P1174, DOI 10.1111/j.1523-1739.2007.00759.x; Oliveira-Santos LGR, 2010, MAMM BIOL, V75, P219, DOI 10.1016/j.mambio.2009.05.006; Parry L, 2015, ECOL SOC, V20, DOI 10.5751/ES-07601-200315; Parry L, 2010, POPUL ENVIRON, V32, P137, DOI 10.1007/s11111-010-0127-8; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; PERES CA, 1995, CONSERV BIOL, V9, P34, DOI 10.1046/j.1523-1739.1995.09010034.x; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Peres CA, 1996, BIOL CONSERV, V77, P115, DOI 10.1016/0006-3207(96)00010-9; PERES CA, 1990, BIOL CONSERV, V54, P47, DOI 10.1016/0006-3207(90)90041-M; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; Peres CA, 2000, OECOLOGIA, V122, P175, DOI 10.1007/PL00008845; Peres CA, 2008, HUMAN EXPLOITATION B, P287; Peres CA, 2011, TROPICAL FOREST COMM, P349; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Peres CA, 2011, CONSERV BIOL, V25, P1124, DOI 10.1111/j.1523-1739.2011.01770.x; Porter-Bolland L, 2012, FOREST ECOL MANAG, V268, P6, DOI 10.1016/j.foreco.2011.05.034; Radar na Amazo A nia (RADAMBRASIL), 1976, LEVANTAMENTO RECURSO; Read JM, 2010, J LAT AM GEOGR, V9, P213, DOI 10.1353/lag.2010.0030; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Renno CD, 2008, REMOTE SENS ENVIRON, V112, P3469, DOI 10.1016/j.rse.2008.03.018; Reyna-Hurtado R, 2010, ORYX, V44, P89, DOI 10.1017/S0030605309990664; Ripple WJ, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160498; Robinson J.G., 1991, P415; Robinson John G., 1994, Oryx, V28, P249, DOI 10.1017/S0030605300028647; Ruggiero R., 1990, PACHYDERM, V13, P42; Rushton J, 2005, ODI WILDLIFE POLICY, V11; Schwartzman S, 2000, CONSERV BIOL, V14, P1351, DOI 10.1046/j.1523-1739.2000.99329.x; Sequin ES, 2003, CAN J ZOOL, V81, P2015, DOI 10.1139/Z03-204; Siren A, 2004, CONSERV BIOL, V18, P1315, DOI 10.1111/j.1523-1739.2004.00024.x; Sollmann R, 2013, BIOL CONSERV, V159, P405, DOI 10.1016/j.biocon.2012.12.025; Sreekar R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117920; Steinmetz R, 2013, BIOL CONSERV, V163, P68, DOI 10.1016/j.biocon.2012.12.016; Struebig MJ, 2007, ORYX, V41, P390, DOI 10.1017/S0030605307000310; Thurfjell H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178082; van Vliet N, 2008, ORYX, V42, P392, DOI 10.1017/S0030605308000288; Van Vliet N, 2010, CONSERV BIOL, V24, P1327, DOI 10.1111/j.1523-1739.2010.01484.x; Veloso HP, FITOGEOGRAFIA BRASIL; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; Wright SJ, 2003, PERSPECT PLANT ECOL, V6, P73, DOI 10.1078/1433-8319-00043; Zuur Alain F., 2009, P1	120	22	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186653	10.1371/journal.pone.0186653	http://dx.doi.org/10.1371/journal.pone.0186653			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KA	29040340	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000413167500068
J	Lee, YK; Landuyt, AE; Lobionda, S; Sittipo, P; Zhao, Q; Maynard, CL				Lee, Yun Kyung; Landuyt, Ashley E.; Lobionda, Stefani; Sittipo, Panida; Zhao, Qing; Maynard, Craig L.			TCR-independent functions of Th17 cells mediated by the synergistic actions of cytokines of the IL-12 and IL-1 families	PLOS ONE			English	Article							T-HELPER-CELLS; INTERFERON-GAMMA PRODUCTION; IN-VIVO; TRANSCRIPTION FACTOR; ROR-GAMMA; TGF-BETA; DIFFERENTIATION; LINEAGE; GENERATION; EXPRESSION	The development of Th17 cells is accompanied by the acquisition of responsiveness to both IL-12 and IL-23, cytokines with established roles in the development and/or function of Th1 and Th17 cells, respectively. IL-12 signaling promotes antigen-dependent Th1 differentiation but, in combination with IL-18, allows the antigen-independent perpetuation of Th1 responses. On the other hand, while IL-23 is dispensable for initial commitment to the Th17 lineage, it promotes the pathogenic function of the Th17 cells. In this study, we have examined the overlap between Th1 and Th17 cells in their responsiveness to common pro-inflammatory cytokines and how this affects the antigen-independent cytokine responses of Th17 cells. We found that in addition to the IL-1 receptor, developing Th17 cells also up-regulate the IL-18 receptor. Consequently, in the presence of IL-1 beta or IL-18, and in the absence of TCR activation, Th17 cells produce Th17 lineage cytokines in a STAT3-dependent manner when stimulated with IL-23, and IFN (c) via a STAT4-dependent mechanism when stimulated with IL-12. Thus, building on previous findings of antigen-induced plasticity of Th17 cells, our results indicate that this potential of Th17 cells extends to their cytokine-dependent antigen-independent responses. Collectively, our data suggest a model whereby signaling via either IL-1 beta or IL-18 allows for bystander responses of Th17 cells to pathogens or pathogen products that differentially activate innate cell production of IL-12 or IL-23.	[Lee, Yun Kyung; Landuyt, Ashley E.; Maynard, Craig L.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Lee, Yun Kyung; Lobionda, Stefani; Sittipo, Panida] Soonchunhyang Univ, Soonchunhyang Inst Medibiosci SIMS, Cheonan Si, South Korea; [Zhao, Qing] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Soonchunhyang University; University of Alabama System; University of Alabama Birmingham	Lee, YK; Maynard, CL (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.; Lee, YK (corresponding author), Soonchunhyang Univ, Soonchunhyang Inst Medibiosci SIMS, Cheonan Si, South Korea.	yunklee@sch.ac.kr; craigmaynard@uabmc.edu		Zhao, Qing/0000-0003-2862-3886	University of Alabama at Birmingham; Soonchunyang University; National Research Foundation of Korea [NRF-2017-M2A2A6A01020874, 2017M3A9F3043849, 2016K1A4A3914725, 2015R1D1A1A 01060760]; Crohn's and Colitis Foundation; Ministry of Science, ICT and Future Planning [2017K000492]	University of Alabama at Birmingham; Soonchunyang University; National Research Foundation of Korea(National Research Foundation of Korea); Crohn's and Colitis Foundation; Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the University of Alabama at Birmingham to CLM, Soonchunyang University, National Research Foundation of Korea grants NRF-2017-M2A2A6A01020874, 2017M3A9F3043849, 2016K1A4A3914725, and 2015R1D1A1A 01060760 to YKL, Crohn's and Colitis Foundation (http://www.crohnscolitisfoundation.org) to CLM and the Ministry of Science, ICT and Future Planning grant 2017K000492 to YKL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Ikeda S, 2014, J IMMUNOL, V192, P1449, DOI 10.4049/jimmunol.1300387; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Koenders MI, 2008, ARTHRITIS RHEUM-US, V58, P3461, DOI 10.1002/art.23957; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lertmemongkolchai G, 2001, J IMMUNOL, V166, P1097, DOI 10.4049/jimmunol.166.2.1097; Lexberg MH, 2008, EUR J IMMUNOL, V38, P2654, DOI 10.1002/eji.200838541; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Murphy KM, 1999, CURR TOP MICROBIOL, V238, P13; Nakae S, 2007, J LEUKOCYTE BIOL, V81, P1258, DOI 10.1189/jlb.1006610; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Garra A, 1997, RES IMMUNOL, V148, P413, DOI 10.1016/S0923-2494(97)82874-X; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Roses RE, 2008, J IMMUNOL, V181, P5120, DOI 10.4049/jimmunol.181.7.5120; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	40	8	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186351	10.1371/journal.pone.0186351	http://dx.doi.org/10.1371/journal.pone.0186351			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023599	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100114
J	Peng, EX; Todorova, N; Yarovsky, I				Peng, Enxi; Todorova, Nevena; Yarovsky, Irene			Effects of forcefield and sampling method in all-atom simulations of inherently disordered proteins: Application to conformational preferences of human amylin	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FREE-ENERGY LANDSCAPE; REPLICA-EXCHANGE; WATER MODEL; FIELD; VALIDATION; PEPTIDES; INSIGHTS; RESPECT; SURFACE	Although several computational modelling studies have investigated the conformational behaviour of inherently disordered protein (IDP) amylin, discrepancies in identifying its preferred solution conformations still exist between various forcefields and sampling methods used. Human islet amyloid polypeptide has long been a subject of research, both experimentally and theoretically, as the aggregation of this protein is believed to be the lead cause of type-II diabetes. In this work, we present a systematic forcefield assessment using one of the most advanced non-biased sampling techniques, Replica Exchange with Solute Tempering (REST2), by comparing the secondary structure preferences of monomeric amylin in solution. This study also aims to determine the ability of common forcefields to sample a transition of the protein from a helical membrane bound conformation into the disordered solution state of amylin. Our results demonstrated that the CHARMM22* forcefield showed the best ability to sample multiple conformational states inherent for amylin. It is revealed that REST2 yielded results qualitatively consistent with experiments and in quantitative agreement with other sampling methods, however far more computationally efficiently and without any bias. Therefore, combining an unbiased sampling technique such as REST2 with a vigorous forcefield testing could be suggested as an important step in developing an efficient and robust strategy for simulating IDPs.	[Peng, Enxi; Todorova, Nevena; Yarovsky, Irene] RMIT Univ, Sch Engn, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Yarovsky, I (corresponding author), RMIT Univ, Sch Engn, Melbourne, Vic, Australia.	irene.yarovsky@rmit.edu.au	Todorova, Nevena/L-5190-2016	Todorova, Nevena/0000-0001-6358-2974; Yarovsky, Irene/0000-0002-4033-5150	Australian Research Council Discovery grant [DP140101888, DP170100511]	Australian Research Council Discovery grant(Australian Research Council)	This work was funded by Australian Research Council (http://www.arc.gov.au) Discovery grant DP140101888 and DP170100511 awarded to IY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal JLF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121687; Andrews MN, 2011, BIOPHYS CHEM, V156, P43, DOI 10.1016/j.bpc.2010.12.007; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2010, J PHYS CHEM B, V114, P14916, DOI 10.1021/jp108618d; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Boonstra S, 2016, J PHYS CHEM B, V120, P3692, DOI 10.1021/acs.jpcb.6b01316; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Bussi G, 2006, J AM CHEM SOC, V128, P13435, DOI 10.1021/ja062463w; Chun Wu J-ES, 2013, PLOS COMPUT BIOL, V9; Cort JR, 2009, PROTEIN ENG DES SEL, V22, P497, DOI 10.1093/protein/gzp029; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268; Henriques J, 2016, J CHEM THEORY COMPUT, V12, P3407, DOI 10.1021/acs.jctc.6b00429; Henriques J, 2015, J CHEM THEORY COMPUT, V11, P3420, DOI 10.1021/ct501178z; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hoffmann KQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134091; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Huang W, 2011, J CHEM THEORY COMPUT, V7, P1237, DOI 10.1021/ct100747y; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Latour RA, 2014, COLLOID SURFACE B, V124, P25, DOI 10.1016/j.colsurfb.2014.06.050; Leach A. R., 2001, MOL MODELLING PRINCI; Liang GZ, 2013, BIOCHEMISTRY-US, V52, P1089, DOI 10.1021/bi301525e; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu P, 2005, P NATL ACAD SCI USA, V102, P13749, DOI 10.1073/pnas.0506346102; Lundborg M, 2015, J PHYS CHEM B, V119, P810, DOI 10.1021/jp505332p; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Morriss-Andrews A, 2014, J PHYS CHEM LETT, V5, P1899, DOI 10.1021/jz5006847; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; Palafox-Hernandez JP, 2014, CHEM MATER, V26, P4960, DOI 10.1021/cm501529u; Piana S, 2015, J PHYS CHEM B, V119, P5113, DOI 10.1021/jp508971m; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Qiao Q, 2013, J AM CHEM SOC, V135, P16092, DOI 10.1021/ja403147m; Reddy AS, 2010, BIOPHYS J, V99, P2208, DOI 10.1016/j.bpj.2010.07.014; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Terakawa T, 2011, J COMPUT CHEM, V32, P1228, DOI 10.1002/jcc.21703; Todorova N, 2008, J PHYS CHEM B, V112, P11137, DOI 10.1021/jp076825d; Todorova N, 2009, J PHYS CHEM B, V113, P3556, DOI 10.1021/jp809776v; Wang LL, 2011, J PHYS CHEM B, V115, P9431, DOI 10.1021/jp204407d; Wright LB, 2013, PHYS CHEM CHEM PHYS, V15, P4715, DOI 10.1039/c3cp42921k; Yonemoto IT, 2008, BIOCHEMISTRY-US, V47, P9900, DOI 10.1021/bi800828u; Zerze GH, 2015, J CHEM THEORY COMPUT, V11, P2776, DOI 10.1021/acs.jctc.5b00047	50	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e186219	10.1371/journal.pone.0186219	http://dx.doi.org/10.1371/journal.pone.0186219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023509	gold, Green Published, Green Submitted			2022-12-26	WOS:000412845100084
J	Sieminski, M; Chwojnicki, K; Sarkanen, T; Partinen, M				Sieminski, Mariusz; Chwojnicki, Kamil; Sarkanen, Tomi; Partinen, Markku			The relationship between orexin levels and blood pressure changes in patients with narcolepsy	PLOS ONE			English	Article							PULSE TRANSIT-TIME; HEART-RATE; HYPOCRETIN DEFICIENCY; CARDIOVASCULAR RISK; AUTONOMIC CONTROL; DEFENSE RESPONSE; SLEEP; MICE; INCREASES; CATAPLEXY	Study objective Narcolepsy type 1 (NT1) is caused by a deficiency or absence of the neurotransmitter orexin. NT1 is also associated with a reduced nocturnal "dipping" of blood pressure (BP). The study objective was to analyze whether nocturnal BP values differed in patients depleted of orexin, versus those in whom production was preserved. Methods We performed a retrospective analysis of the polysomnographic recordings, orexin levels, and BP values of patients with NT1. Data was collected from a total of 21 patients, divided into two groups as follows: those with a complete depletion of orexin (n = 11) (Group1), and those with a remaining, limited presence of orexin (n = 10) (Group 2). Results The groups did not differ in terms of the clinical features of NT1 or sleep characteristics, with an exception of increased number of cataplexy episodes and increased percentage of sleep stage 2 in the Group 1. Daytime and nocturnal BP did not differ between the groups. Most patients, regardless of group, had a non-dipping blood pressure pattern, and no difference in dipping prevalence was observed between groups. The amplitude of the daytime to night-time change in BP did not differ between the groups. Conclusions Non-dipping BP patterns are frequent among patients with narcolepsy type 1, but we saw no evidence that they depended on whether orexin levels were above or below the assay detection threshold. Therefore, our results do not support the hypothesis that in patients with narcolepsy type 1 residual orexin levels play a role in the control of nocturnal BP dipping.	[Sieminski, Mariusz; Chwojnicki, Kamil] Med Univ Gdansk, Dept Adults Neurol, Gdansk, Poland; [Sarkanen, Tomi; Partinen, Markku] Vitalmed Helsinki Sleep Clin, Helsinki, Finland	Fahrenheit Universities; Medical University Gdansk	Sieminski, M (corresponding author), Med Univ Gdansk, Dept Adults Neurol, Gdansk, Poland.	msiem@wp.pl	Chwojnicki, Kamil/AAK-6739-2020	Chwojnicki, Kamil/0000-0002-1361-8796; Sarkanen, Tomi/0000-0001-8815-2807; Partinen, Markku/0000-0002-8182-9368; Sieminski, Mariusz/0000-0001-8219-2912				Ahmed I, 2010, CLIN CHEST MED, V31, P371, DOI 10.1016/j.ccm.2010.02.014; BAKER TL, 1986, SLEEP, V9, P232, DOI 10.1093/sleep/9.1.232; Bastianini S, 2011, SLEEP, V34, P213, DOI 10.1093/sleep/34.2.213; Bendzala M, 2015, BLOOD PRESSURE, V24, P103, DOI 10.3109/08037051.2014.992198; Bilo G, 2015, BLOOD PRESS MONIT, V20, P291, DOI 10.1097/MBP.0000000000000124; Chen CT, 2000, AM J PHYSIOL-REG I, V278, pR692, DOI 10.1152/ajpregu.2000.278.3.R692; Dauvilliers Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038977; Donadio V, 2014, SLEEP MED, V15, P315, DOI 10.1016/j.sleep.2013.12.005; Draman MS, 2015, J HYPERTENS, V33, P1373, DOI 10.1097/HJH.0000000000000576; Gesche H, 2012, EUR J APPL PHYSIOL, V112, P309, DOI 10.1007/s00421-011-1983-3; Grimaldi D, 2014, NEUROLOGY, V82, P271, DOI 10.1212/WNL.0000000000000045; Grimaldi D, 2012, SLEEP, V35, P519, DOI 10.5665/sleep.1738; Hermida RC, 2013, CHRONOBIOL INT, V30, P87, DOI 10.3109/07420528.2012.701127; Hermida RC, 2011, J AM COLL CARDIOL, V58, P1165, DOI 10.1016/j.jacc.2011.04.043; Iber C., 2007, AASM MANUAL SCORING; Kayaba Y, 2003, AM J PHYSIOL-REG I, V285, pR581, DOI 10.1152/ajpregu.00671.2002; Leschziner Guy, 2014, Pract Neurol, V14, P323, DOI 10.1136/practneurol-2014-000837; Liblau RS, 2015, LANCET NEUROL, V14, P318, DOI 10.1016/S1474-4422(14)70218-2; Lo Martire V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047032; Luong LNL, 2012, NEUROSCIENCE, V202, P209, DOI 10.1016/j.neuroscience.2011.11.073; Mancia G, 2014, BLOOD PRESSURE, V23, P3, DOI 10.3109/08037051.2014.868629; Matsumura K, 2001, HYPERTENSION, V37, P1382, DOI 10.1161/01.HYP.37.6.1382; Nisbet LC, 2014, SLEEP MED, V15, P464, DOI 10.1016/j.sleep.2013.11.787; Pepin JL, 2014, SLEEP MED REV, V18, P509, DOI 10.1016/j.smrv.2014.03.003; Schmalgemeier H, 2012, SLEEP BREATH, V16, P1105, DOI 10.1007/s11325-011-0609-7; Schwimmer H, 2010, J APPL PHYSIOL, V109, P1053, DOI 10.1152/japplphysiol.00516.2010; Shirasaka T, 1999, AM J PHYSIOL-REG I, V277, pR1780, DOI 10.1152/ajpregu.1999.277.6.R1780; Sieminski M, 2016, SLEEP BIOL RHYTHMS, V14, P31, DOI 10.1007/s41105-015-0004-z; Silvani A, 2012, J SLEEP RES; Silvani A, 2014, J SLEEP RES, V23, P98, DOI 10.1111/jsr.12081; Silvani A, 2013, AM J PHYSIOL-HEART C, V305, pH1683, DOI 10.1152/ajpheart.00554.2013; Smith PM, 2002, BRAIN RES, V950, P261, DOI 10.1016/S0006-8993(02)03048-2; Sorensen GL, 2013, SLEEP, V36, P91, DOI 10.5665/sleep.2308; van der Meijden WP, 2015, J SLEEP RES, V24, P206, DOI 10.1111/jsr.12253; Yano Y, 2012, HYPERTENS RES, V35, P695, DOI 10.1038/hr.2012.26; Zhang W, 2006, AM J PHYSIOL-REG I, V290, pR1654, DOI 10.1152/ajpregu.00704.2005	36	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185975	10.1371/journal.pone.0185975	http://dx.doi.org/10.1371/journal.pone.0185975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023559	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100048
J	Zschaeck, S; Blumke, B; Wust, P; Kaul, D; Bahra, M; Riess, H; Klein, F; Sinn, M; Pelzer, U; Budach, V; Ghadjar, P				Zschaeck, Sebastian; Bluemke, Bibiana; Wust, Peter; Kaul, David; Bahra, Marcus; Riess, Hanno; Klein, Fritz; Sinn, Marianne; Pelzer, Uwe; Budach, Volker; Ghadjar, Pirus			Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients	PLOS ONE			English	Article							INDUCTION CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; DUCTAL ADENOCARCINOMA; RADIATION-THERAPY; PHASE-II; CHEMORADIOTHERAPY; GEMCITABINE; CONCURRENT; SURVIVAL; TRIAL	Purpose The role of radiotherapy for unresectable pancreatic cancer is controversial. A benefit of additional radiotherapy is supported by some observations. A dose-effect relationship was recently found by dose escalation employing image guided and intensity modulated radiotherapy. Methods We retrospectively evaluated 28 consecutive patients, all with history of extensive prior therapies for unresectable locally advanced/recurrent pancreatic cancer (LAPC/LRPC). Treatment was delivered by helical tomotherapy after daily position verification with computed tomography. Dose to the planned target volume (PTV) was 51 Gy, while the dose to the macroscopic tumor was escalated by a simultaneous integrated boost to a median cumulative dose of 66 Gy (60-66 Gy). Concomitant chemotherapy consisted mainly of capecitabine (n = 23). Results 10 of 28 patients presented acute toxicities > grade 2, one patient succumbed to gastrointestinal bleeding after treatment. No correlations of toxicities and dose volume histograms (DVH) of retrospectively delineated small bowel loops were observed, although average small bowel volume receiving >= 20 Gy was 374 ml. DVH analyses revealed a correlation of splenic parameters and acute toxicity: Vomiting, anorexia, dehydration, hematologic toxicity, fatigue, combined gastro-intestinal toxicity wit R-values between 0.392 and 0.561 (all p-values > 0.05). Only one patient developed late toxicities > grade 2. With an average follow-up time in surviving patients of 14 months median overall survival time was 19 months and median time to local recurrence 13 months. In 8 patients with available imaging of local recurrence: 5 in field recurrences, 2 marginal recurrences and one lymph node recurrence outside the high dose radiation field were observed. In univariate analysis only Delta CA-19-9 during radiotherapy was associated with local control (p = 0.029) and overall survival (p = 0.049). Conclusion Dose escalated normo-fractionated radiotherapy for LAPC/LRPC seems feasible and suitable to prolong local control and in consequence long-term survival. However, in-field local progression is still frequently observed and possibilities to increase the local effectiveness should be evaluated. Exposure of the spleen was predictive for acute toxicity and should be further investigated.	[Zschaeck, Sebastian; Bluemke, Bibiana; Wust, Peter; Kaul, David; Budach, Volker; Ghadjar, Pirus] Charite, Dept Radiat Oncol, Berlin, Germany; [Bahra, Marcus; Klein, Fritz] Charite, Dept Gen Visceral & Transplantat Surg, Berlin, Germany; [Riess, Hanno; Sinn, Marianne; Pelzer, Uwe] Charite, Dept Hematol Oncol Tumorimmunol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Zschaeck, S (corresponding author), Charite, Dept Radiat Oncol, Berlin, Germany.	Sebastian.Zschaeck@charite.de	Ghadjar, Pirus/V-5616-2019; Pelzer, Uwe/AAX-1957-2020	Pelzer, Uwe/0000-0001-9213-2737; Zschaeck, Sebastian/0000-0003-3109-0662; Ghadjar, Pirus/0000-0002-2747-165X; Budach, Volker/0000-0002-2191-9871				Akimoto M, 2017, INT J RAD ONCOLOGY B; Bahra M, 2015, PANCREAS, V44, P930, DOI 10.1097/MPA.0000000000000365; Ben-Josef E, 2012, INT J RADIAT ONCOL, V84, P1166, DOI 10.1016/j.ijrobp.2012.02.051; Chadha AS, 2016, INT J RAD ONCOLOGY B; Chadha AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156910; Chauffert B, 2008, ANN ONCOL, V19, P1592, DOI 10.1093/annonc/mdn281; Chung SY, 2017, RADIOTHERAPY ONCOLOG; Diener MK, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006053.pub3, 10.1002/14651858.CD006053.pub4]; Fiore M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45845; Hammel P, 2016, JAMA-J AM MED ASSOC, V315, P1844, DOI 10.1001/jama.2016.4324; Huguet F, 2014, CLIN ONCOL-UK, V26, P560, DOI 10.1016/j.clon.2014.06.002; Huguet F, 2007, J CLIN ONCOL, V25, P326, DOI 10.1200/JCO.2006.07.5663; Jin L, 2016, CURR ONCOL, V23, pE41, DOI 10.3747/co.23.2771; Kavanagh BD, 2010, INT J RADIAT ONCOL, V76, pS101, DOI 10.1016/j.ijrobp.2009.05.071; Kelly P, 2013, INT J RADIAT ONCOL, V85, pE143, DOI 10.1016/j.ijrobp.2012.09.035; Kishi T, 2016, RADIOTHER ONCOL, V120, P217, DOI 10.1016/j.radonc.2016.07.012; KLAASSEN DJ, 1985, J CLIN ONCOL, V3, P373, DOI 10.1200/JCO.1985.3.3.373; Koom WS, 2009, INT J RADIAT ONCOL, V73, P1148, DOI 10.1016/j.ijrobp.2008.06.1483; Krishnan S, 2007, CANCER-AM CANCER SOC, V110, P47, DOI 10.1002/cncr.22735; Krishnan S, 2016, INT J RADIAT ONCOL, V94, P755, DOI 10.1016/j.ijrobp.2015.12.003; Lee KJ, 2016, GUT LIVER, V10, P303, DOI 10.5009/gnl15186; Lens E, 2016, RADIOTHER ONCOL, V121, P268, DOI 10.1016/j.radonc.2016.09.012; Loehrer PJ, 2011, J CLIN ONCOL, V29, P4105, DOI 10.1200/JCO.2011.34.8904; Maluta S, 2011, STRAHLENTHER ONKOL, V187, P619, DOI 10.1007/s00066-011-2226-6; Micke O, 2003, INT J RADIAT ONCOL, V57, P90, DOI 10.1016/S0360-3016(03)00524-8; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Park JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052481; Rutter CE, 2015, CANCER-AM CANCER SOC, V121, P4141, DOI 10.1002/cncr.29652; Sinn M, 2014, THESCIENTIFICWORLDJO, V2014; Sperti C, 1997, WORLD J SURG, V21, P195, DOI 10.1007/s002689900215; Sperti C, 2015, WORLD J GASTRO ONCOL, V7, P375, DOI 10.4251/wjgo.v7.i12.375; Sun WJ, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-28; Thomas RM, 2012, J GASTROINTEST SURG, V16, P1696, DOI 10.1007/s11605-012-1912-8; Trip AK, 2015, RADIOTHER ONCOL, V116, P239, DOI 10.1016/j.radonc.2015.07.036; Uesaka K, 2016, LANCET, V388, P248, DOI 10.1016/S0140-6736(16)30583-9; Vainshtein JM, 2013, INT J RADIAT ONCOL, V86, P96, DOI 10.1016/j.ijrobp.2012.11.020; Verma V, 2017, RADIOTHER ONCOL, V122, P464, DOI 10.1016/j.radonc.2016.12.030; Wang LS, 2015, PRACT RADIAT ONCOL, V5, pE457, DOI 10.1016/j.prro.2015.04.004; Xu BH, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0566-6	40	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186341	10.1371/journal.pone.0186341	http://dx.doi.org/10.1371/journal.pone.0186341			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023527	Green Submitted, gold, Green Published			2022-12-26	WOS:000412845100109
J	Nishitani, K; Mietus, Z; Beck, CA; Ito, H; Matsuda, S; Awad, HA; Ehrhart, N; Schwarz, EM				Nishitani, Kohei; Mietus, Zachary; Beck, Christopher A.; Ito, Hiromu; Matsuda, Shuichi; Awad, Hani A.; Ehrhart, Nicole; Schwarz, Edward M.			High dose teriparatide (rPTH1-34) therapy increases callus volume and enhances radiographic healing at 8-weeks in a massive canine femoral allograft model	PLOS ONE			English	Article							PARATHYROID-HORMONE 1-34; POSTMENOPAUSAL WOMEN; BONE REGENERATION; FRACTURES; GRAFT; UNION; RECONSTRUCTION; ABALOPARATIDE; AMPUTATION; DEFECTS	Small animal studies have demonstrated significant high-dose recombinant parathyroid hormone1-34 (rPTH1-34) effects on intercalary allograft healing. Towards a human adjuvant therapy to decrease non-unions, we evaluated rPTH1-34 safety and efficacy in a clinically relevant canine femoral allograft model. Adult female mongrel hounds (n = 20) received a 5cm mid-diaphyseal osteotomy reconstructed with a plated allograft, and were randomized to: 1) Placebo (n = 5; daily saline), 2) Continuous rPTH1-34 (n = 7; 5 mu g/kg/day s.c. from day 1-55 post-op), or 3) Delayed rPTH1-34 (n = 8; 5 mu g/kg/day s.c. from day 14-28 post-op). Safety was assessed by physical behavior and blood calcium monitoring. Cone beam CT (CB-CT) was performed on days 14, 28 and 56 post-op to assess 2D cortical healing, 3D bone volume, and Union Ratio. Biomechanical testing and dynamic histomorphometry were also performed. The high drug dose was poorly tolerated, as most dogs receiving rPTH1-34 had to be given intravenous saline, and one dog died from hypercalcemia. Continuous rPTH1-34 significantly increased 2D healing and callus volumes at 4-weeks versus Placebo, and sustained the significant increase in cortical union at 8-week (p<0.05). These rPTH1-34 effects were confirmed by histomorphometry, revealing significant increases in mineral apposition rates (MAR) on host bone and graft-host junctions (p<0.05). Delayed rPTH1-34 significantly increased callus volume and MAR at 8 weeks (p<0.05). Although no biomechanical differences were observed, as expected for early healing, the results demonstrated that 2D RUST scoring significantly correlated with torsional biomechanics (p<0.01). In conclusion, 8-weeks of intermittent high-dose rPTH1-34 treatment significantly increases callus formation and accelerates bony union of intercalary massive allografts in a clinically relevant canine model, but with serious side-effects from hypercalcemia.	[Nishitani, Kohei; Beck, Christopher A.; Awad, Hani A.; Schwarz, Edward M.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY USA; [Nishitani, Kohei; Ito, Hiromu; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Mietus, Zachary; Awad, Hani A.; Schwarz, Edward M.] Univ Rochester, Dept Biomed Engn, Rochester, NY 14611 USA; [Beck, Christopher A.; Awad, Hani A.; Schwarz, Edward M.] Univ Rochester, Med Ctr, Dept Orthoped, Rochester, NY 14642 USA; [Beck, Christopher A.] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Ehrhart, Nicole] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA	University of Rochester; Kyoto University; University of Rochester; University of Rochester; University of Rochester; Colorado State University	Schwarz, EM (corresponding author), Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY USA.; Schwarz, EM (corresponding author), Univ Rochester, Dept Biomed Engn, Rochester, NY 14611 USA.; Schwarz, EM (corresponding author), Univ Rochester, Med Ctr, Dept Orthoped, Rochester, NY 14642 USA.	Edward_Schwarz@URMC.Rochester.edu	Nishitani, Kohei/ABB-1788-2021; Mostafa, Taymour/H-6834-2019; Awad, Hani/G-6976-2014	Mostafa, Taymour/0000-0003-3627-0662; Nishitani, Kohei/0000-0002-8327-3826; Awad, Hani/0000-0003-2197-2610	National Institutes of Health [P30 AR069655, P50 AR054041, R01 DE019902, R01 AR070613]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from the National Institutes of Health (grant no. P30 AR069655, P50 AR054041, R01 DE019902 and R01 AR070613). Research material support for this study was provided by Lilly Inc., DePuy-Synthes Inc., and Stryker Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2007, BONE, V41, P775, DOI 10.1016/j.bone.2007.06.025; Alkhiary YM, 2005, J BONE JOINT SURG AM, V87A, P731, DOI 10.2106/JBJS.D.02115; Andreassen TT, 2004, J CRANIOFAC SURG, V15, P424, DOI 10.1097/00001665-200405000-00014; Andrews EB, 2012, J BONE MINER RES, V27, P2429, DOI 10.1002/jbmr.1768; Aspenberg P, 2010, J BONE MINER RES, V25, P404, DOI 10.1359/jbmr.090731; Awad HA, 2007, TISSUE ENG, V13, P1973, DOI 10.1089/ten.2006.0107; Bertolini F, 2015, NAT REV CLIN ONCOL, V12, P732, DOI 10.1038/nrclinonc.2015.169; Bosse MJ, 2002, NEW ENGL J MED, V347, P1924, DOI 10.1056/NEJMoa012604; Busse JW, 2007, J ORTHOP TRAUMA, V21, P70, DOI 10.1097/BOT.0b013e31802cbc43; Chiavaras MM, 2013, SKELETAL RADIOL, V42, P1079, DOI 10.1007/s00256-013-1605-8; Coppola C, 2015, TRANSL MED UNISA, V12, P47; Cosman F, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.28; Daugaard H, 2011, J BONE JOINT SURG BR, V93B, P131, DOI 10.1302/0301-620X.93B1.24261; Daugaard H, 2012, ACTA ORTHOP, V83, P411, DOI 10.3109/17453674.2012.702388; Daugaard H, 2011, CALCIFIED TISSUE INT, V88, P294, DOI 10.1007/s00223-010-9458-9; Ehrhart N, 2008, CLIN ORTHOP RELAT R, V466, P1897, DOI 10.1007/s11999-008-0293-5; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Fox J, 2007, J BONE MINER RES, V22, P260, DOI 10.1359/JBMR.061101; Gardner MJ, 2007, J ORTHOP RES, V25, P1474, DOI 10.1002/jor.20427; Grayson WL, 2015, NAT REV ENDOCRINOL, V11, P140, DOI 10.1038/nrendo.2014.234; Halim AS, 2015, J PLAST RECONSTR AES, V68, P1755, DOI 10.1016/j.bjps.2015.08.013; Harada Y, 2012, J BONE MINER METAB, V30, P388, DOI 10.1007/s00774-011-0329-x; Hattersley G, 2016, ENDOCRINOLOGY, V157, P141, DOI 10.1210/en.2015-1726; Kim PD, 2008, ARCH OTOLARYNGOL, V134, P1324, DOI 10.1001/archotol.134.12.1324; Kooistra BW, 2010, J ORTHOP TRAUMA, V24, pS81, DOI 10.1097/BOT.0b013e3181ca3fd1; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; O'Loughlin PF, 2009, SPINE, V34, P121, DOI 10.1097/BRS.0b013e318191e687; Reynolds DG, 2007, J BIOMECH, V40, P3178, DOI 10.1016/j.jbiomech.2007.04.004; Reynolds DG, 2011, BONE, V48, P562, DOI 10.1016/j.bone.2010.10.003; Reynolds DG, 2009, J BONE MINER RES, V24, P899, DOI 10.1359/JBMR.081232; Rubery PT, 2010, J SPINAL DISORD TECH, V23, P151, DOI 10.1097/BSD.0b013e31819a8b7a; Sakals S, 2006, CAN VET J, V47, P819; Santoni BG, 2012, CLIN ORTHOP RELAT R, V470, P2478, DOI 10.1007/s11999-012-2349-9; Schwietert HR, 1997, CLIN PHARMACOL THER, V61, P360, DOI 10.1016/S0009-9236(97)90169-7; Sheyn D, 2013, MOL PHARMACEUT, V10, P4462, DOI 10.1021/mp400292p; Takahata M, 2012, J BONE MINER RES, V27, P26, DOI 10.1002/jbmr.518; Zhang DF, 2014, J ORTHOP TRAUMA, V28, P57, DOI 10.1097/BOT.0b013e31828e13fe	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185446	10.1371/journal.pone.0185446	http://dx.doi.org/10.1371/journal.pone.0185446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020057	gold, Green Published, Green Submitted			2022-12-26	WOS:000412754400032
J	Palluzzi, F; Ferrari, R; Graziano, F; Novelli, V; Rossi, G; Galimberti, D; Rainero, I; Benussi, L; Nacmias, B; Bruni, AC; Cusi, D; Salvi, E; Borroni, B; Grassi, M				Palluzzi, Fernando; Ferrari, Raffaele; Graziano, Francesca; Novelli, Valeria; Rossi, Giacomina; Galimberti, Daniela; Rainero, Innocenzo; Benussi, Luisa; Nacmias, Benedetta; Bruni, Amalia C.; Cusi, Daniele; Salvi, Erika; Borroni, Barbara; Grassi, Mario			A novel network analysis approach reveals DNA damage, oxidative stress and calcium/cAMP homeostasis-associated biomarkers in frontotemporal dementia	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-INTERACTION NETWORKS; LOBAR DEGENERATION; R PACKAGE; KINASE-C; ACTIVATION; DISEASE; TRANSCRIPTION; MOUSE; PHOSPHORYLATION	Frontotemporal Dementia (FTD) is the form of neurodegenerative dementia with the highest prevalence after Alzheimer's disease, equally distributed in men and women. It includes several variants, generally characterized by behavioural instability and language impairments. Although few mendelian genes (MAPT, GRN, and C9orf72) have been associated to the FTD phenotype, in most cases there is only evidence of multiple risk loci with relatively small effect size. To date, there are no comprehensive studies describing FTD at molecular level, highlighting possible genetic interactions and signalling pathways at the origin FTD-associated neurodegeneration. In this study, we designed a broad FTD genetic interaction map of the Italian population, through a novel network-based approach modelled on the concepts of disease-relevance and interaction perturbation, combining Steiner tree search and Structural Equation Model (SEM) analysis. Our results show a strong connection between Calcium/cAMP metabolism, oxidative stress-induced Serine/Threonine kinases activation, and postsynaptic membrane potentiation, suggesting a possible combination of neuronal damage and loss of neuroprotection, leading to cell death. In our model, Calcium/cAMP homeostasis and energetic metabolism impairments are primary causes of loss of neuroprotection and neural cell damage, respectively. Secondly, the altered postsynaptic membrane potentiation, due to the activation of stress-induced Serine/Threonine kinases, leads to neurodegeneration. Our study investigates the molecular underpinnings of these processes, evidencing key genes and gene interactions that may account for a significant fraction of unexplained FTD aetiology. We emphasized the key molecular actors in these processes, proposing them as novel FTD biomarkers that could be crucial for further epidemiological and molecular studies.	[Palluzzi, Fernando; Graziano, Francesca; Grassi, Mario] Univ Pavia, Dept Brain & Behav Sci, Med & Genom Stat Unit, Pavia, Italy; [Ferrari, Raffaele] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Novelli, Valeria] Fdn Policlin A Gemelli, Dept Genet, Rome, Italy; [Rossi, Giacomina] Fdn IRCCS Ist Neurol Carlo Besta, Div Neurol & Neuropathol 5, Milan, Italy; [Galimberti, Daniela] Univ Milan, Dino Ferrari Inst, Dept Neurol Sci, Milan, Italy; [Rainero, Innocenzo] Univ Torino & Citta Salute & Sci Torino, Dept Neurosci, Neurol 1, Turin, Italy; [Benussi, Luisa] IRCCS Ist Ctr San Giovanni Dio Fatebenefratell, Mol Markers Lab, Brescia, Italy; [Nacmias, Benedetta] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Florence, Italy; [Bruni, Amalia C.] Neurogenet Reg Ctr ASPCZ Lamezia Terme, Lamezia Terme, CZ, Italy; [Cusi, Daniele] Univ Milan, San Paolo Hosp, Dept Hlth Sci, Milan, Italy; [Cusi, Daniele; Salvi, Erika] Italian Natl Res Council, Inst Biomed Technol, Milan, Italy; [Grassi, Mario] Univ Brescia, Dept Med Sci, Neurol Clin, Brescia, Italy	University of Pavia; University of London; University College London; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Istituto Neurologico Besta; University of Milan; A.O.U. Citta della Salute e della Scienza di Torino; University of Florence; San Paolo-Polo Universitaria Hospital; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Brescia	Palluzzi, F (corresponding author), Univ Pavia, Dept Brain & Behav Sci, Med & Genom Stat Unit, Pavia, Italy.	fernando.palluzzi@gmail.com	Rossi, Giacomina/I-2783-2012; Salvi, Erika/AAA-1415-2019; Benussi, Luigi/O-9684-2014; Nacmias, Benedetta/J-5084-2018; Galimberti, Daniela/N-7209-2019; BENUSSI, LUISA/K-4409-2016; Borroni, Barbara/AAN-4105-2020; Bruni, Amalia/K-5038-2016	Rossi, Giacomina/0000-0001-6680-2725; Salvi, Erika/0000-0002-2724-2291; Benussi, Luigi/0000-0002-2363-8889; Nacmias, Benedetta/0000-0001-9338-9040; Galimberti, Daniela/0000-0002-9284-5953; BENUSSI, LUISA/0000-0003-2836-8141; Bruni, Amalia/0000-0003-3471-3343; Palluzzi, Fernando/0000-0003-0861-5512; Cusi, Daniele/0000-0002-1006-7597; novelli, valeria/0000-0002-4859-0826; Grassi, Mario/0000-0001-6612-8566; Graziano, Francesca/0000-0003-1825-3527	European Union [FP7-HEALTH-F4-2007-201550, HYPER-GENES]; InterOmics [PB05 MIUR-CNR Italian Flagship Project]; National Institute of Neurological Disorders and Stroke (NINDS); National Institute on Aging (NIA)	European Union(European Commission); InterOmics; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the European Union [grant FP7-HEALTH-F4-2007-201550, HYPER-GENES]; InterOmics [PB05 MIUR-CNR Italian Flagship Project]; Intramural funding from the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (NIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers DS, 2000, J NEURAL TRANSM-SUPP, P133; Arrazola MS, 2009, J CELL PHYSIOL, V221, P658, DOI 10.1002/jcp.21902; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; Bengoa-Vergniory N, 2014, STEM CELLS, V32, P3196, DOI 10.1002/stem.1807; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Blom Elin S, 2010, Int J Alzheimers Dis, V2011, P936580, DOI 10.4061/2011/936580; Bo-Yeong C LY, 2016, J PROTEOM BIOINFORM, V9; Bollen E, 2012, IUBMB LIFE, V64, P965, DOI 10.1002/iub.1104; Caberlotto L, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-65; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Catarzi S, 2011, BBA-GEN SUBJECTS, V1810, P446, DOI 10.1016/j.bbagen.2011.01.005; Chalmers RP, 2012, J STAT SOFTW, V48, P1; CHUA JK, 1991, ELECTRON LETT, V27, P1139, DOI 10.1049/el:19910710; Clark CEJ, 2012, NEUROSIGNALS, V20, P202, DOI 10.1159/000332153; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen-Armon M, 2016, GENE TRANSLATIONAL B, P2; Correa Sonia A L, 2012, J Signal Transduct, V2012, P649079, DOI 10.1155/2012/649079; Correia C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112399; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Cui Qi, 2004, Anatomical Science International, V79, P209, DOI 10.1111/j.1447-073x.2004.00089.x; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Duan SW, 2013, GENE, V531, P347, DOI 10.1016/j.gene.2013.08.059; Dubruc E, 2014, AM J MED GENET A, V164, P1571, DOI 10.1002/ajmg.a.36484; Ferrari R, 2017, J PROTEOME RES, V16, P999, DOI 10.1021/acs.jproteome.6b00934; Ferrari R, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0085-4; Ferrari R, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.06.005; Ferrari R, 2014, LANCET NEUROL, V13, P686, DOI 10.1016/S1474-4422(14)70065-1; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; GAMOU S, 1995, FEBS LETT, V357, P161, DOI 10.1016/0014-5793(94)01335-X; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Gerst JL, 1999, DEMENT GERIATR COGN, V10, P85, DOI 10.1159/000051220; Ghiassian SD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004120; Gillis J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002444; Goldkorn T, 1998, AM J RESP CELL MOL, V19, P786, DOI 10.1165/ajrcmb.19.5.3249; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th; Hallock P, 2012, OMICS, V16, P37, DOI 10.1089/omi.2011.0054; Han SZ, 2013, AM J HUM GENET, V93, P1027, DOI 10.1016/j.ajhg.2013.10.021; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hershberger SL, 2001, STRUCT EQU MODELING, V8, P646, DOI 10.1207/S15328007SEM0804_08; Himmelstein DS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004259; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070412; Huddleston AT, 2008, J NEUROPHYSIOL, V99, P1565, DOI 10.1152/jn.00659.2007; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; Jahid MJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S8; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KEISARI Y, 1983, IMMUNOBIOLOGY, V165, P78, DOI 10.1016/S0171-2985(83)80048-5; Kiritoshi T, 2010, BRAIN RES, V1349, P32, DOI 10.1016/j.brainres.2010.06.039; Kitaoka Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.391; KLANN E, 1993, P NATL ACAD SCI USA, V90, P8337, DOI 10.1073/pnas.90.18.8337; Klann E, 1999, PROG NEURO-PSYCHOPH, V23, P359, DOI 10.1016/S0278-5846(99)00002-0; KLANN E, 1991, J BIOL CHEM, V266, P24253; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; Knapp LT, 2002, J NEUROSCI, V22, P674, DOI 10.1523/JNEUROSCI.22-03-00674.2002; Knott EP, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/651625; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kwan V, 2016, J NEURODEV DISORD, V8, DOI 10.1186/s11689-016-9176-3; Lau CG, 2009, BIOCHEM SOC T, V37, P1369, DOI 10.1042/BST0371369; Li J, 2013, INT J MOL SCI, V14, P24438, DOI 10.3390/ijms141224438; Liu GY, 2012, J NEUROCHEM, V120, P190, DOI 10.1111/j.1471-4159.2011.07547.x; Ljungberg MC, 2012, HUM MOL GENET, V21, P251, DOI 10.1093/hmg/ddr492; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Makinen VP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004502; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Martinez A, 2008, J NEUROPATH EXP NEUR, V67, P1122, DOI 10.1097/NEN.0b013e31818e06f3; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Nagalski A, 2013, BRAIN STRUCT FUNCT, V218, P1531, DOI 10.1007/s00429-012-0474-6; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Ouyang Y, 1997, J NEUROSCI, V17, P5416; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Paul C, 2010, NEUROSCI LETT, V473, P82, DOI 10.1016/j.neulet.2010.02.020; Pepe D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-132; Phatnani H, 2015, COLD SPRING HARBOR P, P7; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rhrissorrakrai K, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0929-5; Richardson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031627; Rohrer JD, 2011, CURR OPIN NEUROL, V24, P542, DOI 10.1097/WCO.0b013e32834cd442; Rosa GJM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-6; Rosso SB, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00103; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Sadeghi A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-144; Sales G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-20; Salinas PC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008003; Salvi E, 2012, HYPERTENSION, V59, P248, DOI 10.1161/HYPERTENSIONAHA.111.181990; Sanabra C, 2011, J CHEM NEUROANAT, V41, P43, DOI 10.1016/j.jchemneu.2010.11.001; Scott MS, 2005, MOL CELL PROTEOMICS, V4, P683, DOI 10.1074/mcp.M400110-MCP200; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; Villa C, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00081; Villers A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040823; Visser JE, 2007, MOVEMENT DISORD, V22, P1024, DOI 10.1002/mds.21414; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; WINTER P, 1992, ALGORITHMICA, V7, P309, DOI 10.1007/BF01758765; Yu GC, 2015, BIOINFORMATICS, V31, P608, DOI 10.1093/bioinformatics/btu684; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zhang L., 2015, SCI REP, V5, P1, DOI DOI 10.1002/aenm.201400930; Zhao HF, 2015, INT J ONCOL, V47, P429, DOI 10.3892/ijo.2015.3052; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	115	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185797	10.1371/journal.pone.0185797	http://dx.doi.org/10.1371/journal.pone.0185797			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020091	Green Published, gold			2022-12-26	WOS:000412754400046
J	Cicalese, L; Curcuru, G; Montalbano, M; Shirafkan, A; Georgiadis, J; Rastellini, C				Cicalese, Luca; Curcuru, Giuseppe; Montalbano, Mauro; Shirafkan, Ali; Georgiadis, Jeremias; Rastellini, Cristiana			Hazardous air pollutants and primary liver cancer in Texas	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; HEPATOCELLULAR-CARCINOMA; UNLEADED GASOLINE; B6C3F1 MICE; RATS; 2,2,4-TRIMETHYLPENTANE; FORMALDEHYDE; MORTALITY; CARCINOGENICITY; IDENTIFICATION	The incidence of hepatocellular carcinoma (HCC), the most common primary liver cancer, is increasing in the US and tripled during the past two decades. The reasons for such phenomenon remain poorly understood. Texas is among continental states with the highest incidence of liver cancer with an annual increment of 5.7%. Established risk factors for HCC include Hepatitis B and C (HBV, HCV) viral infection, alcohol, tobacco and suspected risk factors include obesity and diabetes. While distribution of these risk factors in the state of Texas is similar to the national data and homogeneous, the incidence of HCC in this state is exceptionally higher than the national average and appears to be dishomogeneous in various areas of the state suggesting that other non-recognized risk factors might play a role. No population-based studies are currently available investigating the effect of exposure to Hazardous Air Pollutants (HAPs) as a contributing risk factor for liver cancer. Incidence rate of liver cancer in Texas by counties for the time period between 2002 and 2012 was obtained from the Texas Cancer Registry (TCR). Through Principal Component Analysis (PCA) a subgroup of pollutants, explaining almost all the dataset variability, were identified and used to cluster Texas counties. The analysis generated 4 clusters showing liver cancer rate either higher or lower than national average in association with either high or low levels of HAPs emission in the environment. The study shows that the selected relevant HAPs, 10 among 253 analyzed, produce a significant correlation (P = 0.01-0.05) and some of these have been previously identified as carcinogens. An association between the increased production and consequent exposure to these HAPs and a higher presence of liver cancer in certain counties is suggested. This study provides a new insight on this complex multifactorial disease suggesting that environmental substances might play a role in the etiology of this cancer.	[Cicalese, Luca; Montalbano, Mauro; Shirafkan, Ali; Georgiadis, Jeremias; Rastellini, Cristiana] Univ Texas Med Branch, Dept Surg, Texas Transplant Ctr, Galveston, TX 77555 USA; [Curcuru, Giuseppe] Univ Palermo, Dept Chem Management Informat & Mech Engn, Palermo, Italy; [Curcuru, Giuseppe] Ist EuroMediterraneo Sci & Tecnol IE MEST, Palermo, Italy; [Montalbano, Mauro] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Palermo; University of Texas System; University of Texas Medical Branch Galveston	Cicalese, L (corresponding author), Univ Texas Med Branch, Dept Surg, Texas Transplant Ctr, Galveston, TX 77555 USA.	lucicale@utmb.edu	Montalbano, Mauro/AAA-6833-2021	Montalbano, Mauro/0000-0002-0456-452X	Department of Surgery of University of Texas Medical Branch; Department of Chemical, Management, Informatics and Mechanical Engineering, University of Palermo	Department of Surgery of University of Texas Medical Branch; Department of Chemical, Management, Informatics and Mechanical Engineering, University of Palermo	The study was supported by departmental funds, in particular by the Department of Surgery of University of Texas Medical Branch and Department of Chemical, Management, Informatics and Mechanical Engineering, University of Palermo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11; ATSDR, 2000, TOX PROF TOL; BESTERVELT LL, 1995, P NATL ACAD SCI USA, V92, P3764, DOI 10.1073/pnas.92.9.3764; Bird MG, 1997, J APPL TOXICOL, V17, pS45, DOI 10.1002/(SICI)1099-1263(199705)17:1+<S45::AID-JAT410>3.3.CO;2-B; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Centers for Disease Control and Prevention Division of Nutrition, PHYS ACTIVITY OBESIT; Chan PC, 1998, TOXICOL LETT, V99, P23, DOI 10.1016/S0378-4274(98)00133-7; Cogliano VJ, 2005, ENVIRON HEALTH PERSP, V113, P1205, DOI 10.1289/ehp.7542; Davila JA, 2004, GASTROENTEROLOGY, V127, P1372, DOI 10.1053/j.gastro.2004.07.020; ENGSTROM KM, 1984, SCAND J WORK ENV HEA, V10, P83, DOI 10.5271/sjweh.2354; Esposti Davide Degli, 2012, HEPATOCELLULAR CARCI; Everitt Brian S., WILEY SERIES PROBABI; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; FOWLIE AJ, 1987, J APPL TOXICOL, V7, P335, DOI 10.1002/jat.2550070508; Guyton KZ, 2009, MUTAT RES-REV MUTAT, V681, P230, DOI 10.1016/j.mrrev.2008.10.001; Hair J. F., 2006, HDB RES SCI ED, P125; Huff J, 2007, INT J OCCUP ENV HEAL, V13, P213, DOI 10.1179/oeh.2007.13.2.213; Im H, 2006, J PROTEOME RES, V5, P1354, DOI 10.1021/pr050437b; International Agency for Research on Cancer, 2012, PERS HAB IND COMB, V100; Jung KH, 2013, TOXICOL LETT, V216, P1, DOI 10.1016/j.toxlet.2012.11.001; Lee YCA, 2009, INT J EPIDEMIOL, V38, P1497, DOI 10.1093/ije/dyp280; LOCK EA, 1987, XENOBIOTICA, V17, P513, DOI 10.3109/00498258709043958; London WT, 2006, CANC EPIDEMIOLOGY PR, P763, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0039; LOURY DJ, 1986, TOXICOL APPL PHARM, V85, P11, DOI 10.1016/0041-008X(86)90383-2; Lu K, 2008, CHEM RES TOXICOL, V21, P1586, DOI 10.1021/tx8000576; MALTONI C, 1989, ENVIRON HEALTH PERSP, V82, P109, DOI 10.2307/3430768; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Mennear JH, 1997, RISK ANAL, V17, P673, DOI 10.1111/j.1539-6924.1997.tb01274.x; National Toxicology Program (NTP), 2011, CHEM ASS SIT SPEC TU; Persson EC, 2013, CANCER EPIDEM BIOMAR, V22, P415, DOI 10.1158/1055-9965.EPI-12-1169; Porru S, 2001, INT J CANCER, P94; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Robin LA, 2011, APPARENT CAPITA ALCO; Song MK, 2012, TOXICOL LETT, V212, P18, DOI 10.1016/j.toxlet.2012.04.013; STANDEVEN AM, 1994, J TOXICOL ENV HEALTH, V43, P213, DOI 10.1080/15287399409531916; U.S. Department of Health and Human Services, 1993, HAZ SUBST DAT BANK H; U. S. Environmenal Protection Agency, 1999, NAT CTR ENV ASS OFF; U. S. Environmental Protection Agency, 2005, NAT CTR ENV ASS OFF; U. S. Environmental Protection Agency, 1987, N HEX HLTH ADV; United States Environmental Protection Agency (IRIS-US EPA), 1999, INT RISK INF SYST IR; US Cancer statistics Working Group, 2014, INC MORT WEB BAS REP; Yalamanchili Kanthi, 2005, Proc (Bayl Univ Med Cent), V18, P3	42	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185610	10.1371/journal.pone.0185610	http://dx.doi.org/10.1371/journal.pone.0185610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016628	gold, Green Submitted, Green Published			2022-12-26	WOS:000412627400025
J	Dai, YC; Wang, SC; Hague, MM; Lin, WH; Lin, LC; Chen, CH; Liu, YW				Dai, Yuan-Chang; Wang, Shou-Chieh; Hague, Mohammad Mezbahul; Lin, Wei-Han; Lin, Lei-Chen; Chen, Ching-Hsein; Liu, Yi-Wen			The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice	PLOS ONE			English	Article							URINARY-BLADDER CARCINOGENESIS; S-TRANSFERASE M1; DRINKING-WATER; DIMETHYLARSINIC ACID; LUNG-CANCER; CIGARETTE-SMOKING; POOLED ANALYSIS; ORAL-EXPOSURE; DAMAGE; METHYLATION	The bladder is an important organ for the storage of excreted water and metabolites. If metabolites with carcinogenic characteristics are present in urine, the urothelial lining of the bladder could be damaged and genetically altered. In this study, we analyzed the interaction of arsenic and N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) on mouse bladder carcinogenesis. Our previous study found that arsenic affects BBN-altered urothelial enzymatic activity, protein expression, DNA oxidation and global DNA CpG methylation levels. In this study, two mouse models were used. First, after administering a co-treatment of BBN and arsenic for 20 weeks, BBN alone led to a urothelial carcinoma formation of 20%, and arsenic promoted a BBN-induced urothelial carcinoma formation of 10%. The protein expression of GSTM1, GSTO1, NQO1, and p21 did not change by arsenic along with the BBN co-treatment, but the Sp1 expression increased. In the second mouse model, BBN was a pretreatment promoter; arsenic dose-dependently deteriorated BBN-promoted dysplasia by 10% and 40% at 10 ppm and 100 ppm, respectively. Conversely, BBN pretreatment also accelerated arsenic-induced dysplasia by 30%. The urothelial carcinogenic effect reversed after ceasing BBN for a period of 20 weeks. In summary, three conclusions were drawn from this study. The first is the mutual promotion of arsenic and BBN in bladder carcinogenesis. Second, arsenic dosages without bladder carcinogenicity (10 ppm) or with slight carcinogenicity (100 ppm) promote BBN-induced mice bladder cancer progression. Finally, the dysplastic urothelium had reverted to near-normal morphology after ceasing BBN intake for 20 weeks, providing a good suggestion for people who want to quit smoking.	[Dai, Yuan-Chang; Hague, Mohammad Mezbahul; Lin, Wei-Han; Chen, Ching-Hsein; Liu, Yi-Wen] Natl Chiayi Univ, Coll Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan; [Dai, Yuan-Chang] Chiayi Christian Hosp, Dept Pathol, Chiayi, Taiwan; [Wang, Shou-Chieh] Kuang Tien Gen Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan; [Wang, Shou-Chieh] Natl Chiayi Univ, Coll Life Sci, Dept Food Sci, Chiayi, Taiwan; [Lin, Lei-Chen] Natl Chiayi Univ, Coll Agr, Dept Forestry & Nat Resources, Chiayi, Taiwan	National Chiayi University; Chia-Yi Christian Hospital; National Chiayi University; National Chiayi University	Liu, YW (corresponding author), Natl Chiayi Univ, Coll Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan.	ywlss@mail.ncyu.edu.tw		Liu, Yi-Wen/0000-0002-4715-3800	Ministry of Science and Technology Republic of China, Taiwan [MOST1042320-6-415-001-MY3]	Ministry of Science and Technology Republic of China, Taiwan	This work is supported by grants from the Ministry of Science and Technology MOST1042320-6-415-001-MY3 of the Republic of China, Taiwan.; This work is supported by grants from the Ministry of Science and Technology MOST104-2320-B-415-001-MY3 of the Republic of China, Taiwan.	Ameer SS, 2017, TOXICOL APPL PHARM, V321, P57, DOI 10.1016/j.taap.2017.02.019; Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Baris D, 2009, JNCI-J NATL CANCER I, V101, P1553, DOI 10.1093/jnci/djp361; Brennan P, 2000, INT J CANCER, V86, P289, DOI 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M; Bustaffa E, 2014, ARCH TOXICOL, V88, P1043, DOI 10.1007/s00204-014-1233-7; Chiou HY, 2001, AM J EPIDEMIOL, V153, P411, DOI 10.1093/aje/153.5.411; Chuang JJ, 2014, TOXICOL APPL PHARM, V279, P322, DOI 10.1016/j.taap.2014.06.018; Cohen SM, 2007, TOXICOL APPL PHARM, V222, P258, DOI 10.1016/j.taap.2006.10.010; Cui X, 2006, TOXICOL SCI, V91, P372, DOI 10.1093/toxsci/kfj159; Engel LS, 2002, AM J EPIDEMIOL, V156, P95, DOI 10.1093/aje/kwf018; He ZM, 2012, MUTAT RES-GEN TOX EN, V742, P92, DOI 10.1016/j.mrgentox.2011.11.015; Jiang T, 2009, TOXICOL APPL PHARM, V240, P8, DOI 10.1016/j.taap.2009.06.010; Joehanes R, 2016, CIRC-CARDIOVASC GENE, V9, P436, DOI 10.1161/CIRCGENETICS.116.001506; Kinoshita A, 2007, CANCER SCI, V98, P803, DOI 10.1111/j.1349-7006.2007.00475.x; Lee CH, 2013, J INVEST DERMATOL, V133, P1890, DOI 10.1038/jid.2013.55; Lin PY, 2012, TOXICOL APPL PHARM, V259, P27, DOI 10.1016/j.taap.2011.11.016; Mandal P, 2017, N-S ARCH PHARMACOL, V390, P443, DOI 10.1007/s00210-017-1351-x; Michaud DS, 2006, AM J CLIN NUTR, V84, P1177, DOI 10.1093/ajcn/84.5.1177; Mitacek EJ, 1999, CARCINOGENESIS, V20, P133, DOI 10.1093/carcin/20.1.133; Ng JC, 2003, CHEMOSPHERE, V52, P1353, DOI 10.1016/S0045-6535(03)00470-3; Oliveira P. A., 2006, Experimental Oncology, V28, P2; Oliveira PA, 2005, J EXP CLIN CANC RES, V24, P609; Phookphan P, 2017, TOXICOL APPL PHARM, V316, P36, DOI 10.1016/j.taap.2016.12.015; Reuter VE., 2016, WHO CLASSIFICATION T; Salim EI, 2003, CARCINOGENESIS, V24, P335, DOI 10.1093/carcin/24.2.335; Samanic C, 2006, CANCER EPIDEM BIOMAR, V15, P1348, DOI 10.1158/1055-9965.EPI-06-0021; Shen J, 2003, CARCINOGENESIS, V24, P1827, DOI 10.1093/carcin/bgg143; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Smith AH, 1998, AM J EPIDEMIOL, V147, P660, DOI 10.1093/oxfordjournals.aje.a009507; Steinmaus C, 2003, AM J EPIDEMIOL, V158, P1193, DOI 10.1093/aje/kwg281; Straif K, 2009, LANCET ONCOL, V10, P453, DOI 10.1016/S1470-2045(09)70134-2; Tang FQ, 2006, MOL CARCINOGEN, V45, P861, DOI 10.1002/MC.20245; Tokar EJ, 2010, CRIT REV TOXICOL, V40, P912, DOI 10.3109/10408444.2010.506641; Tyagi A, 2007, MOL CANCER THER, V6, P3248, DOI 10.1158/1535-7163.MCT-07-2006; Wang SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159102; Wanibuchi H, 1996, CARCINOGENESIS, V17, P2435, DOI 10.1093/carcin/17.11.2435; Wanibuchi H, 2004, TOXICOL APPL PHARM, V198, P366, DOI 10.1016/j.taap.2003.10.032; Wauson EM, 2002, TOXICOL SCI, V65, P211, DOI 10.1093/toxsci/65.2.211; Wu CC, 2012, J UROLOGY, V188, P1701, DOI 10.1016/j.juro.2012.07.025; Yamanaka K, 2001, BIOCHEM BIOPH RES CO, V287, P66, DOI 10.1006/bbrc.2001.5551; Yu MC, 2002, MUTAT RES-FUND MOL M, V506, P21, DOI 10.1016/S0027-5107(02)00148-3	41	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186214	10.1371/journal.pone.0186214	http://dx.doi.org/10.1371/journal.pone.0186214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016672	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400061
J	Neves, FM; Viana, RL; Pie, MR				Neves, Felipe Marcel; Viana, Ricardo Luiz; Pie, Marcio Roberto			Recurrence analysis of ant activity patterns	PLOS ONE			English	Article							TIME-SERIES; PHEIDOLE-PALLIDULA; LOCOMOTOR-ACTIVITY; MOVEMENT ACTIVITY; FOOD RECRUITMENT; ANIMAL BEHAVIOR; EVOLUTION; HYMENOPTERA; PLOTS; SYNCHRONIZATION	In this study, we used recurrence quantification analysis (RQA) and recurrence plots (RPs) to compare the movement activity of individual workers of three ant species, as well as a gregarious beetle species. RQA and RPs quantify the number and duration of recurrences of a dynamical system, including a detailed quantification of signals that could be stochastic, deterministic, or both. First, we found substantial differences between the activity dynamics of beetles and ants, with the results suggesting that the beetles have quasi-periodic dynamics and the ants do not. Second, workers from different ant species varied with respect to their dynamics, presenting degrees of predictability as well as stochastic signals. Finally, differences were found among minor and major caste of the same (dimorphic) ant species. Our results underscore the potential of RQA and RPs in the analysis of complex behavioral patterns, as well as in general inferences on animal behavior and other biological phenomena.	[Neves, Felipe Marcel; Pie, Marcio Roberto] Univ Fed Parana, Dept Zool, Curitiba, Parana, Brazil; [Viana, Ricardo Luiz] Univ Fed Parana, Dept Fis, Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana	Neves, FM (corresponding author), Univ Fed Parana, Dept Zool, Curitiba, Parana, Brazil.	fmarcelneves@gmail.com	Neves, Felipe Marcel/L-1382-2019; Viana, Ricardo Luiz/AAK-7722-2021; Neves, Felipe/G-4492-2013	Neves, Felipe Marcel/0000-0002-1586-6929; Viana, Ricardo Luiz/0000-0001-7298-9370; Neves, Felipe/0000-0002-1586-6929	CNPq/MCT [571334/2008-3];  [141355/2012-3]	CNPq/MCT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	CNPq/MCT (http://cnpq.br/) provided support for this study through research fellowships to MRP (571334/2008-3), as well as a graduate fellowship to FMN (141355/2012-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler FR, 2003, AM NAT, V162, P529, DOI 10.1086/378856; [Anonymous], 1992, ECOL SOCIOBIOL, V31, P181; Bender JA, 2011, J EXP BIOL, V214, P2057, DOI 10.1242/jeb.056481; Biro PA, 2010, P ROY SOC B-BIOL SCI, V277, P71, DOI 10.1098/rspb.2009.1346; Boi S, 1999, P ROY SOC B-BIOL SCI, V266, P371, DOI 10.1098/rspb.1999.0647; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Brodin T, 2009, BEHAV ECOL, V20, P30, DOI 10.1093/beheco/arn111; Chapman BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059437; Christensen K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0985; COLE BJ, 1991, P ROY SOC B-BIOL SCI, V244, P253, DOI 10.1098/rspb.1991.0079; COLE BJ, 1995, ANIM BEHAV, V50, P1317, DOI 10.1016/0003-3472(95)80047-6; COLE BJ, 1991, J INSECT BEHAV, V4, P129, DOI 10.1007/BF01054607; COTTON R. T., 1927, ANN ENT SOC AMER, V20, P81, DOI 10.1093/aesa/20.1.81; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; DENEUBOURG JL, 1986, PHYSICA D, V22, P176, DOI 10.1016/0167-2789(86)90239-3; DETRAIN C, 1991, J INSECT BEHAV, V4, P157, DOI 10.1007/BF01054609; DETRAIN C, 1992, BEHAV ECOL SOCIOBIOL, V29, P405, DOI 10.1007/BF00170170; Dinno A., DUNN TEST DUNNS TEST; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; FONDACARO JD, 1970, ANN ENTOMOL SOC AM, V63, P952, DOI 10.1093/aesa/63.4.952; Giraud T, 2000, MOL ECOL, V9, P1835, DOI 10.1046/j.1365-294x.2000.01085.x; GORDON DM, 1992, J THEOR BIOL, V156, P293, DOI 10.1016/S0022-5193(05)80677-0; Grimaldi D, 2000, P NATL ACAD SCI USA, V97, P13678, DOI 10.1073/pnas.240452097; Guimaraes ZO, 2008, PHYS LETT A, V372, P1088, DOI 10.1016/j.physleta.2007.07.088; Holldobler B., 1990, pi; Holyst JA, 2001, EUR PHYS J B, V20, P531, DOI 10.1007/PL00011109; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Korb J, 2004, NATURWISSENSCHAFTEN, V91, P291, DOI 10.1007/s00114-004-0529-5; Koto A, 2015, BEHAV ECOL SOCIOBIOL, V69, P583, DOI 10.1007/s00265-014-1869-6; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lattke JE, 1990, ACTA TERROMORIA, V2, P1; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lommelen E, 2006, J CHEM ECOL, V32, P2023, DOI 10.1007/s10886-006-9126-8; Lone SR, 2011, CHRONOBIOL INT, V28, P862, DOI 10.3109/07420528.2011.622676; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marwan N, 2005, PHYS LETT A, V336, P349, DOI 10.1016/j.physleta.2004.12.056; Marwan N, 2003, CLIM DYNAM, V21, P317, DOI 10.1007/s00382-003-0335-3; Marwan N, 2002, NONLINEAR PROC GEOPH, V9, P325, DOI 10.5194/npg-9-325-2002; Marwan N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026702; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Marwan N, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0624; Marwan N, 2011, INT J BIFURCAT CHAOS, V21, P1003, DOI 10.1142/S0218127411029008; MATLAB, 2010, MATLAB STAT TOOLB RE; Miramontes O., 1992, THESIS; Neves FM, 2012, AIP CONF PROC, V1479, P658, DOI 10.1063/1.4756220; Nicolis SC, 1999, J THEOR BIOL, V198, P575, DOI 10.1006/jtbi.1999.0934; Oster GF, CASTE ECOLOGY SOCIAL; Pie MR, 2007, J ZOOL, V271, P99, DOI 10.1111/j.1469-7998.2006.00239.x; R Development Core Team, 2015, R LANG ENV STAT COMP; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Reid CR, 2011, J EXP BIOL, V214, P50, DOI 10.1242/jeb.048173; Riley MA, 1999, GAIT POSTURE, V9, P65, DOI 10.1016/S0966-6362(98)00044-7; SOLE RV, 1993, J THEOR BIOL, V161, P343, DOI 10.1006/jtbi.1993.1060; Sweeney K, 2013, BEHAV ECOL, V24, P1205, DOI 10.1093/beheco/art052; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Webber CL, 2009, PHYS LETT A, V373, P3753, DOI 10.1016/j.physleta.2009.08.052; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; WILD A., 2007, ENTOMOLOGY, V126, P1; Wild AL, 2009, SYST ENTOMOL, V34, P49, DOI 10.1111/j.1365-3113.2008.00435.x; Wilson E.O., 2003, PHEIDOLE NEW WORLD D, V1; WILSON EO, 1985, SCIENCE, V228, P1489, DOI 10.1126/science.228.4707.1489; ZBILUT JP, 1992, PHYS LETT A, V171, P199, DOI 10.1016/0375-9601(92)90426-M	62	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185968	10.1371/journal.pone.0185968	http://dx.doi.org/10.1371/journal.pone.0185968			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016648	Green Published, gold, Green Submitted			2022-12-26	WOS:000412601800032
J	Poljak, K; Breitling, J; Gauss, R; Rugarabamu, G; Pellanda, M; Aebi, M				Poljak, Kristina; Breitling, Joerg; Gauss, Robert; Rugarabamu, George; Pellanda, Mauro; Aebi, Markus			Analysis of substrate specificity of Trypanosoma brucei oligosaccharyltransferases (OSTs) by functional expression of domain-swapped chimeras in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-linked glycosylation; oligosaccharide; oligosaccharyltransferase; Trypanosoma brucei; yeast; glycosylation occupancy analysis; lipid-linked oligosaccharide specificity	LIPID-LINKED OLIGOSACCHARIDE; N-GLYCOSYLATION; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PROTEIN GLYCOSYLATION; TRANSFERASE-ACTIVITY; LEISHMANIA-MAJOR; SWATH-MS; IN-VIVO; SUBUNIT	N-Linked protein glycosylation is an essential and highly conserved post-translational modification in eukaryotes. The transfer of a glycan from a lipid-linked oligosaccharide (LLO) donor to the asparagine residue of a nascent polypeptide chain is catalyzed by an oligosaccharyltransferase (OST) in the lumen of the endoplasmic reticulum (ER). Trypanosoma brucei encodes three paralogue single-protein OSTs called TbSTT3A, TbSTT3B, and TbSTT3C that can functionally complement the Saccharomyces cerevisiae OST, making it an ideal experimental system to study the fundamental properties of OST activity. We characterized the LLO and polypeptide specificity of all three TbOST isoforms and their chimeric forms in the heterologous expression host S. cerevisiae where we were able to apply yeast genetic tools and newly developed glycoproteomics methods. We demonstrated that TbSTT3A accepted LLO substrates ranging from Man(5)GlcNAc(2) to Man(7)GlcNAc(2). In contrast, TbSTT3B required more complex precursors ranging from Man(6)GlcNAc(2) to Glc(3)Man(9)GlcNAc(2) structures, and TbSTT3C did not display any LLO preference. Sequence differences between the isoforms cluster in three distinct regions. We have swapped the individual regions between different OST proteins and identified region 2 to influence the specificity toward the LLO and region 1 to influence polypeptide substrate specificity. These results provide a basis to further investigate the molecular mechanisms and contribution of single amino acids in OST interaction with its substrates.	[Poljak, Kristina; Breitling, Joerg; Gauss, Robert; Rugarabamu, George; Pellanda, Mauro; Aebi, Markus] ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland; [Poljak, Kristina] Life Sci Zurich Grad Program Mol Life Sci, Zurich, Switzerland; [Gauss, Robert] Freies Gymnasium Zurich, Arbenzstr 19, CH-8008 Zurich, Switzerland; [Rugarabamu, George] Policy Cures Res, Paramount House,55 Brisbane St, Sydney, NSW 2010, Australia; [Pellanda, Mauro] Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Aebi, M (corresponding author), ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland.	markus.aebi@micro.biol.ethz.ch		Poljak, Kristina/0000-0002-0199-3812	Swiss National Science Foundation [310030B_144083, 310030_162636]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	This work was supported by Swiss National Science Foundation Grants 310030B_144083 and 310030_162636 (to M. A.) and ETH Zurich. The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1991, Methods Enzymol, V194, P1; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Burda P, 1999, GLYCOBIOLOGY, V9, P617, DOI 10.1093/glycob/9.6.617; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Castillo-Acosta VM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005851; Castillo-Acosta VM, 2013, MOL MICROBIOL, V90, P665, DOI 10.1111/mmi.12359; Castro O, 2006, P NATL ACAD SCI USA, V103, P14756, DOI 10.1073/pnas.0607086103; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DELACANAL L, 1987, J BIOL CHEM, V262, P11128; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; HEESEN ST, 1992, EMBO J, V11, P2071, DOI 10.1002/j.1460-2075.1992.tb05265.x; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Izquierdo L, 2012, GLYCOBIOLOGY, V22, P696, DOI 10.1093/glycob/cws003; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Jakob CA, 1998, GLYCOBIOLOGY, V8, P155, DOI 10.1093/glycob/8.2.155; Jinnelov A, 2017, J BIOL CHEM, V292, P20328, DOI 10.1074/jbc.M117.810945; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; Mueller S, 2015, MOL BIOL CELL, V26, P2596, DOI 10.1091/mbc.E15-03-0168; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; PARODI AJ, 1981, P NATL ACAD SCI-BIOL, V78, P6201, DOI 10.1073/pnas.78.10.6201; PATHAK R, 1995, BIOCHEMISTRY-US, V34, P4179, DOI 10.1021/bi00013a005; Poljak K., 2017, MOL CELL PROTEOMICS; Ramirez AS, 2017, GLYCOBIOLOGY, V27, P525, DOI 10.1093/glycob/cwx017; Roboti P, 2012, J CELL SCI, V125, P220, DOI 10.1242/jcs.094599; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schulz BL, 2009, MOL CELL PROTEOMICS, V8, P357, DOI 10.1074/mcp.M800219-MCP200; Spirig U, 2005, GLYCOBIOLOGY, V15, P1396, DOI 10.1093/glycob/cwj025; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wilson CM, 2008, P NATL ACAD SCI USA, V105, P9534, DOI 10.1073/pnas.0711846105; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu Y, 2015, PROTEOMICS, V15, P2177, DOI 10.1002/pmic.201400465; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; Zacchi LF, 2016, MOL CELL PROTEOMICS, V15, P2435, DOI 10.1074/mcp.M115.056366; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	47	5	5	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20342	20352		10.1074/jbc.M117.811133	http://dx.doi.org/10.1074/jbc.M117.811133			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29042445	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000417696400036
J	Adachi, A; Koizumi, M; Ohsumi, Y				Adachi, Atsuhiro; Koizumi, Michiko; Ohsumi, Yoshinori			Autophagy induction under carbon starvation conditions is negatively regulated by carbon catabolite repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; autophagy; energy metabolism; glucose; yeast	DEPENDENT PROTEIN-KINASE; VACUOLE TARGETING PATHWAY; SACCHAROMYCES-CEREVISIAE; SELECTIVE AUTOPHAGY; TRANSCRIPTIONAL REGULATION; NITROGEN STARVATION; SIGNALING PATHWAYS; INHIBITS AUTOPHAGY; BUDDING YEAST; RECEPTOR	Autophagy is a conserved process in which cytoplasmic components are sequestered for degradation in the vacuole/lysosomes in eukaryotic cells. Autophagy is induced under a variety of starvation conditions, such as the depletion of nitrogen, carbon, phosphorus, zinc, and others. However, apart from nitrogen starvation, it remains unclear how these stimuli induce autophagy. In yeast, for example, it remains contentious whether autophagy is induced under carbon starvation conditions, with reports variously suggesting both induction and lack of induction upon depletion of carbon. We therefore undertook an analysis to account for these inconsistencies, concluding that autophagy is induced in response to abrupt carbon starvation when cells are grown with glycerol but not glucose as the carbon source. We found that autophagy under these conditions is mediated by nonselective degradation that is highly dependent on the autophagosome-associated scaffold proteins Atg11 and Atg17. We also found that the extent of carbon starvation-induced autophagy is positively correlated with cells' oxygen consumption rate, drawing a link between autophagy induction and respiratory metabolism. Further biochemical analyses indicated that maintenance of intracellular ATP levels is also required for carbon starvation-induced autophagy and that autophagy plays an important role in cell viability during prolonged carbon starvation. Our findings suggest that carbon starvation-induced autophagy is negatively regulated by carbon catabolite repression.	[Adachi, Atsuhiro; Koizumi, Michiko; Ohsumi, Yoshinori] Tokyo Inst Technol, Ctr Cell Biol, Inst Innovat Res, Midori Ku, 4259-S2-12 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology	Ohsumi, Y (corresponding author), Tokyo Inst Technol, Ctr Cell Biol, Inst Innovat Res, Midori Ku, 4259-S2-12 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	yohsumi@iri.titech.ac.jp	Ohsumi, Yoshinori/C-6449-2009	Ohsumi, Yoshinori/0000-0003-2384-2166	Ministry of Education, Culture, Sports, Science and Technology of Japan [23000015, 16H06375]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research 23000015 (to Y. O.) and 16H06375 (to Y. O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	An ZY, 2014, AUTOPHAGY, V10, P1702, DOI 10.4161/auto.32122; Aoh QL, 2011, MOL BIOL CELL, V22, P3671, DOI 10.1091/mbc.E11-04-0309; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Bartholomew CR, 2012, P NATL ACAD SCI USA, V109, P11206, DOI 10.1073/pnas.1200313109; Bernard A, 2015, CURR BIOL, V25, P546, DOI 10.1016/j.cub.2014.12.049; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Dechant R, 2014, MOL CELL, V55, P409, DOI 10.1016/j.molcel.2014.06.002; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fendt SM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-12; Fujioka Y, 2014, NAT STRUCT MOL BIOL, V21, P513, DOI 10.1038/nsmb.2822; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Hagman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068734; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jin MY, 2014, CURR BIOL, V24, P1314, DOI 10.1016/j.cub.2014.04.048; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kawamata T, 2005, BIOCHEM BIOPH RES CO, V338, P1884, DOI 10.1016/j.bbrc.2005.10.163; Kawamata T, 2017, J BIOL CHEM, V292, P8520, DOI 10.1074/jbc.M116.762948; Kayikci O, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov068; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kira S, 2014, AUTOPHAGY, V10, P1565, DOI 10.4161/auto.29397; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lang MJ, 2014, J BIOL CHEM, V289, P16736, DOI 10.1074/jbc.M113.525782; Mao K, 2013, P NATL ACAD SCI USA, V110, pE2875, DOI 10.1073/pnas.1300064110; Matsui A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003245; Meijer MMC, 1998, J BIOL CHEM, V273, P24102, DOI 10.1074/jbc.273.37.24102; Miller-Fleming L, 2014, P NATL ACAD SCI USA, V111, P7012, DOI 10.1073/pnas.1319221111; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Pilatus U, 2001, MAGNET RESON MED, V45, P749, DOI 10.1002/mrm.1102; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Seo AY, 2017, ELIFE, V6, DOI 10.7554/eLife.21690; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Stephan JS, 2010, AUTOPHAGY, V6, P294, DOI 10.4161/auto.6.2.11129; Sun LL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003715; Sutter BM, 2013, CELL, V154, P403, DOI 10.1016/j.cell.2013.06.041; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanaka C, 2014, J CELL BIOL, V207, P91, DOI 10.1083/jcb.201402128; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Turcotte B, 2010, FEMS YEAST RES, V10, P2, DOI 10.1111/j.1567-1364.2009.00555.x; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Welter E, 2010, AUTOPHAGY, V6, P794, DOI 10.4161/auto.6.6.12348; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yamamoto H, 2015, J BIOL CHEM, V290, P29506, DOI 10.1074/jbc.M115.684233; Yi C, 2017, DEV CELL, V41, P59, DOI 10.1016/j.devcel.2017.03.007; Yokota H, 2017, BIOCHEM BIOPH RES CO, V483, P522, DOI 10.1016/j.bbrc.2016.12.112; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Zaffagnini G, 2016, J MOL BIOL, V428, P1714, DOI 10.1016/j.jmb.2016.02.004	69	31	31	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19905	19918		10.1074/jbc.M117.817510	http://dx.doi.org/10.1074/jbc.M117.817510			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29042435	hybrid, Green Published			2022-12-26	WOS:000416911300032
J	Abrahams, N; Mathews, S; Lombard, C; Martin, LJ; Jewkes, R				Abrahams, Naeemah; Mathews, Shanaaz; Lombard, Carl; Martin, Lorna J.; Jewkes, Rachel			Sexual homicides in South Africa: A national cross-sectional epidemiological study of adult women and children	PLOS ONE			English	Article							VIOLENCE	Sexual homicides of women and children are extreme forms of violence against women and children and are located within the broader context of gender inequality and social norms that condone sexual violence and gender based violence against women and children. The aim of this study is to describe the prevalence and characteristics of sexual homicide of women and children nationally in South Africa. Methods We conducted a retrospective national mortuary based study to identify all adult female homicides (18 years and older) and all child homicides (boys and girls < 18 years) in 2009 in a randomly selected, proportionate sample of mortuaries. Victim, perpetrator and crime data were collected in three processes: from the mortuary register, the autopsy report and from police with the identification of sexual homicides validated across the data collection processes. Findings Among the 2670 (95% CI: 2311-2979) adult women killed in 2009, 494 (95% CI: 406-574) were identified as sexual homicides which was 19.8% (95% CI: 17.6-22.0) of all adult female homicides and among 1277 (95% CI: 1091-1462) children killed in SA, sexual homicides were found in 104 (95% CI: 77-132) of the child homicides which was 8.7% (95% CI: 10.9-11.2%) of these murders. Strangulation was the most common cause of death for both children and adult females. A distinct age and sex pattern was found among children with only 1% boy child death identified as a sexual homicide and 92% of all the child sexual homicides were among girls. Strangulation was the most common manner of death among children (35.5%) and perpetrators were seldom strangers. However, no difference in the proportion of convictions between the sexual homicides and non-sexual homicides were found for both adult females and children. Conclusion Rape homicide is not a rare event in South Africa, with one in five female homicides and nearly one in ten child homicides identified with an associated sexual crime. These high prevalences are amongst the highest levels reported in the literature with our study among the few reporting on the epidemiology of child sexual homicide. Reducing mortality is an important policy goal for South Africa and for the rest of the world and the prevention of female and child homicide is an important part of attaining this goal.	[Abrahams, Naeemah; Jewkes, Rachel] South African Med Res Council, Gender & Hlth Res Unit, Cape Town, South Africa; [Abrahams, Naeemah; Jewkes, Rachel] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Mathews, Shanaaz] Univ Cape Town, Childrens Inst, Fac Hlth Sci, Cape Town, South Africa; [Lombard, Carl] South African Med Res Council, Biostat Unit, Cape Town, South Africa; [Martin, Lorna J.] Univ Cape Town, Forens Pathol Serv, Western Cape Forens Med & Toxicol, Cape Town, South Africa	South African Medical Research Council; South African Medical Research Council; University of Cape Town; South African Medical Research Council; University of Cape Town	Abrahams, N (corresponding author), South African Med Res Council, Gender & Hlth Res Unit, Cape Town, South Africa.; Abrahams, N (corresponding author), South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa.	naeemah.abrahams@mrc.ac.za	Abrahams, Naeemah/AAF-1144-2020; Martin, Lorna J/C-5233-2009	Martin, Lorna J/0000-0002-1231-7932; Jewkes, Rachel/0000-0002-4330-6267; Lombard, Carl/0000-0002-2136-6533; Abrahams, Naeemah/0000-0002-6138-6256; Mathews, Shanaaz/0000-0002-4743-3829	South African Medical Research Council; Open Society Foundation - South Africa	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Open Society Foundation - South Africa	The study was funded by the South African Medical Research Council, http://www.mrc.ac.za/home.htm, and Open Society Foundation - South Africa, http://www.osf.org.za/.	Abrahams N, 2008, FORENSIC SCI INT, V178, P132, DOI 10.1016/j.forsciint.2008.03.006; Abrahams N, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001412; Abrahams N, 2009, VIOLENCE VICTIMS, V24, P546, DOI 10.1891/0886-6708.24.4.546; [Anonymous], CENS 2001 STAT S AFR; Benson B., 2015, ACTA CRIMINOLOGICA, V28, P62; Burton P, 2015, OPTIMUS STUDY CHILD; Byard R., 2010, SUDDEN DEATH YOUNG, P1, DOI [10.1017/CBO9780511777783, DOI 10.1017/CBO9780511777783]; Chan HC, 2009, TRAUMA VIOLENCE ABUS, V10, P31, DOI 10.1177/1524838008326478; DEMING JE, 1983, J FORENSIC SCI, V28, P572; Heide KM, 2009, VICTIMS OFFENDERS, V4, P58, DOI 10.1080/15564880802561770; Henry Tara, 2010, J Forensic Nurs, V6, P57, DOI 10.1111/j.1939-3938.2010.01069.x; Jewkes R, 2013, LANCET; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024256; Kerr KJ, 2013, AGGRESS VIOLENT BEH, V18, P1, DOI 10.1016/j.avb.2012.05.006; Martin L. C., 1999, THESIS; Mathews S, 2016, SAMJ, S. Afr. med. j., V106, P895, DOI [10.7196/samj.2016.v106i9.11234, 10.7196/SAMJ.2016.v106i9.11234]; Mcquown C, 2016, AM J EMERG MED, V34, P1281, DOI 10.1016/j.ajem.2016.04.029; Meintjes-vander Walt L, 2008, S AFR J CRIM JUST, V21, P22; Meloy JR, 2000, AGGRESS VIOLENT BEH, V5, P1, DOI 10.1016/S1359-1789(99)00006-3; Molefe I, 2015, EPIDEMIOLOGY PATHOLO; Pinheiro P.S., 2006, WORLD REPORT VIOLENC; Schmidt P, 1999, J Clin Forensic Med, V6, P90, DOI 10.1016/S1353-1131(99)90206-7; South African Police Service, 2010, CRIM SIT S AFR PRET; StataCorp, 2012, INT STAT VERS 13; UNODC, 2011, 2011 GLOB STUD HOM; Vetten L, 2008, TRACKING JUSTICE ATT; Watson J, 2013, DISRUPTING NORMS SOC	27	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186432	10.1371/journal.pone.0186432	http://dx.doi.org/10.1371/journal.pone.0186432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KA	29040329	Green Published, gold			2022-12-26	WOS:000413167500045
J	Fernandez, AG; Hielpos, MS; Ferrero, MC; Fossati, CA; Baldi, PC				Fernandez, Andrea G.; Soledad Hielpos, M.; Ferrero, Mariana C.; Fossati, Carlos A.; Baldi, Pablo C.			Proinflammatory response of canine trophoblasts to Brucella canis infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ABORTUS INFECTION; ACTIVATION; CELLS; LIPOPOLYSACCHARIDE; INFLAMMATION; EXPRESSION; KENNEL	Brucella canis infection is an important cause of late-term abortion in pregnant bitches. The pathophysiological mechanisms leading to B. canis-induced abortion are unknown, but heavily infected trophoblasts are consistently observed. As trophoblasts responses to other pathogens contribute to placental inflammation leading to abortion, the aim of the present study was to characterize the cytokine response of canine trophoblasts to B. canis infection. To achieve this, trophoblasts isolated from term placenta of healthy female dogs were infected with B. canis, culture supernatants were harvested for cytokine determinations, and the load of intracellular viable B. canis was determined at different times post-infection. Additionally, cytokine responses were assessed in non-infected trophoblasts stimulated with conditioned media (CM) from B. canis-infected canine monocytes and neutrophils. Finally, cytokine response and bacteria replication were assessed in canine placental explants infected ex vivo. B. canis successfully infected and replicated in primary canine trophoblasts, eliciting an increase in IL-8 and RANTES (CCL5) secretion. Moreover, the stimulation of trophoblasts with CM from B. canis-infected monocytes and neutrophils induced a significant increase in IL-8, IL-6 and RANTES secretion. B. canis replication was confirmed in infected placental explants and the infection elicited an increased secretion of TNF-alpha, IL-8, IL-6 and RANTES. This study shows that canine trophoblasts produce proinflammatory cytokines in response to B. canis infection and/or to stimulation with factors produced by infected monocytes and neutrophils. These cytokines may contribute to placental inflammation leading to abortion in B. canis-infected pregnant bitches.	[Fernandez, Andrea G.; Soledad Hielpos, M.; Ferrero, Mariana C.; Baldi, Pablo C.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Inmunol, Buenos Aires, DF, Argentina; [Fernandez, Andrea G.; Soledad Hielpos, M.; Ferrero, Mariana C.; Baldi, Pablo C.] Univ Buenos Aires, CONICET, Inst Estudios Inmunidad Humoral IDEHU, Buenos Aires, DF, Argentina; [Fossati, Carlos A.] Univ Nacl La Plata, Inst Estudios Inmunol & Fisiopatol IIFP, Fac Ciencias Exactas, CONICET UNLP, La Plata, Buenos Aires, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Baldi, PC (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Inmunol, Buenos Aires, DF, Argentina.; Baldi, PC (corresponding author), Univ Buenos Aires, CONICET, Inst Estudios Inmunidad Humoral IDEHU, Buenos Aires, DF, Argentina.	pablobal@ffyb.uba.ar	Baldi, Pablo/AAS-4736-2020	Baldi, Pablo/0000-0002-2500-6682	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-0494]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica, http://www.agencia.mincyt.gob.ar, PICT 2010-0494 awarded to CAF. The funders had no role in study desing, data collection and analysis, decision to publish, or preparation of the manuscript.	Bildfell RJ, 2000, J VET DIAGN INVEST, V12, P419, DOI 10.1177/104063870001200505; Boschiroli ML, 2002, VET MICROBIOL, V90, P341, DOI 10.1016/S0378-1135(02)00219-5; Brennan SJ, 2008, CAN VET J, V49, P703; Burrough ER, 2011, VET PATHOL, V48, P381, DOI 10.1177/0300985810375809; Buxton D, 2002, J COMP PATHOL, V127, P133, DOI 10.1053/jcpa.2002.0573; Cardenas I, 2011, J IMMUNOL, V187, P980, DOI 10.4049/jimmunol.1100578; CARMICHAEL LE, 1968, J AM VET MED ASSOC, V152, P605; Chacon-Diaz C, 2015, INFECT IMMUN, V83, P4861, DOI 10.1128/IAI.00995-15; Chattopadhyay A, 2010, INFECT IMMUN, V78, P2292, DOI 10.1128/IAI.01186-09; de la Torre E, 2009, J IMMUNOL, V182, P3735, DOI 10.4049/jimmunol.0800764; Dubey JP, 2006, J COMP PATHOL, V134, P267, DOI 10.1016/j.jcpa.2005.11.004; Fernandez AG, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.131706; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; Gierman LM, 2015, PLACENTA, V36, P1246, DOI 10.1016/j.placenta.2015.09.004; Griesinger G, 2001, J SOC GYNECOL INVEST, V8, P334, DOI 10.1016/S1071-5576(01)00135-6; Holmlund U, 2002, IMMUNOLOGY, V107, P145, DOI 10.1046/j.1365-2567.2002.01491.x; Lucero NE, 2010, EPIDEMIOL INFECT, V138, P280, DOI 10.1017/S0950268809990525; Miklos G, 2011, J VET DIAGN INVEST, V23, P143, DOI 10.1177/104063871102300127; Neta AVC, 2010, VET J, V184, P146, DOI 10.1016/j.tvjl.2009.04.010; Nomura A, 2010, EMERG INFECT DIS, V16, P1183, DOI 10.3201/eid1607.090209; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Potter JA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124032; Renaud SJ, 2009, PLACENTA, V30, P313, DOI 10.1016/j.placenta.2009.01.001; Riewe SD, 2010, MOL ORAL MICROBIOL, V25, P252, DOI 10.1111/j.2041-1014.2010.00573.x; Sahlfeld L, 2012, THESIS; Samartino LE, 1996, COMP IMMUNOL MICROB, V19, P55, DOI 10.1016/0147-9571(95)00018-6; Shimoya K, 1999, MOL HUM REPROD, V5, P885, DOI 10.1093/molehr/5.9.885; Tangeras LH, 2014, J REPROD IMMUNOL, V106, P89, DOI 10.1016/j.jri.2014.04.004; Wanke MM, 2006, THERIOGENOLOGY, V66, P1573, DOI 10.1016/j.theriogenology.2006.01.034; Wanke MM, 2004, ANIM REPROD SCI, V82-3, P195, DOI 10.1016/j.anireprosci.2004.05.005; Watanabe K, 2008, J VET MED SCI, V70, P681, DOI 10.1292/jvms.70.681; Wheelhouse N, 2009, J REPROD IMMUNOL, V80, P49, DOI 10.1016/j.jri.2008.12.003	32	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186561	10.1371/journal.pone.0186561	http://dx.doi.org/10.1371/journal.pone.0186561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036184	gold, Green Published			2022-12-26	WOS:000413054800047
J	Ward, C; Maselko, M; Lupfer, C; Prescott, M; Pastey, MK				Ward, Casey; Maselko, Maciej; Lupfer, Christopher; Prescott, Meagan; Pastey, Manoj K.			Interaction of the Human Respiratory Syncytial Virus matrix protein with cellular adaptor protein complex 3 plays a critical role in trafficking	PLOS ONE			English	Article							LYSOSOMAL MEMBRANE-PROTEINS; COATED VESICLE PROTEINS; EPITHELIAL-CELLS; HIV-1 NEF; AP-3; ASSOCIATION; GLYCOPROTEINS; LOCALIZATION; REPLICATION; EXPRESSION	Human Respiratory Syncytial Virus (HRSV) is a leading cause of bronchopneumonia in infants and the elderly. To date, knowledge of viral and host protein interactions within HRSV is limited and are critical areas of research. Here, we show that HRSV Matrix (M) protein interacts with the cellular adaptor protein complex 3 specifically via its medium subunit (AP-3Mu3A). This novel protein-protein interaction was first detected via yeast-two hybrid screen and was further confirmed in a mammalian system by immunofluorescence colocalization and co-immunoprecipitation. This novel interaction is further substantiated by the presence of a known tyrosine-based adaptor protein MU subunit sorting signal sequence, YXX.: where. is a bulky hydrophobic residue, which is conserved across the related RSV M proteins. Analysis of point-mutated HRSV M derivatives indicated that AP-3Mu3A-mediated trafficking is contingent on the presence of the tyrosine residue within the YXXL sorting sequence at amino acids 197-200 of the M protein. AP-3Mu3A is up regulated at 24 hours post-infection in infected cells versus mock-infected HEp2 cells. Together, our data suggests that the AP-3 complex plays a critical role in the trafficking of HRSV proteins specifically matrix in epithelial cells. The results of this study add new insights and targets that may lead to the development of potential antivirals and attenuating mutations suitable for candidate vaccines in the future.	[Ward, Casey; Maselko, Maciej; Lupfer, Christopher; Prescott, Meagan; Pastey, Manoj K.] Oregon State Univ, Dept Vet Biomed Sci, Corvallis, OR 97331 USA	Oregon State University	Pastey, MK (corresponding author), Oregon State Univ, Dept Vet Biomed Sci, Corvallis, OR 97331 USA.	manoj.pastey@oregonstate.edu		Pastey, Manoj/0000-0001-7468-0406; Maselko, Maciej/0000-0001-7831-848X	Medical Research Foundation; Oregon Health and Science University; Oregon AND College of Veterinary Medicine internal grant from Oregon State University	Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oregon Health and Science University; Oregon AND College of Veterinary Medicine internal grant from Oregon State University	This research was funded in part by Medical Research Foundation, Oregon Health and Science University, Oregon AND College of Veterinary Medicine internal grant from Oregon State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Bajorek M, 2014, J VIROL, V88, P6380, DOI 10.1128/JVI.03856-13; Batonick M, 2008, J VIROL, V82, P8664, DOI 10.1128/JVI.00827-08; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Coleman SH, 2005, J VIROL, V79, P2066, DOI 10.1128/JVI.79.4.2066-2078.2005; Craig HM, 2000, VIROLOGY, V271, P9, DOI 10.1006/viro.2000.0277; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Ghildyal R, 2005, J GEN VIROL, V86, P1879, DOI 10.1099/vir.0.80829-0; Ghildyal R, 2003, ARCH VIROL, V148, P1419, DOI 10.1007/s00705-003-0112-y; Ghildyal R, 2006, FEMS MICROBIOL REV, V30, P692, DOI 10.1111/j.1574-6976.2006.00025.x; Ghildyal R, 2009, J VIROL, V83, P5353, DOI 10.1128/JVI.02374-08; Henderson G, 2002, VIROLOGY, V300, P244, DOI 10.1006/viro.2002.1540; Ihrke G, 2004, TRAFFIC, V5, P946, DOI 10.1111/j.1600-0854.2004.00236.x; Janvier K, 2003, J BIOL CHEM, V278, P8725, DOI 10.1074/jbc.M210115200; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Kipper S, 2015, MOL CELL PROTEOMICS, V14, P532, DOI 10.1074/mcp.M114.044107; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Li DS, 2008, J VIROL, V82, P8863, DOI 10.1128/JVI.00343-08; Lupfer C, 2010, VIRUS RES, V149, P36, DOI 10.1016/j.virusres.2009.12.010; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Newell-Litwa K, 2007, J CELL SCI, V120, P531, DOI 10.1242/jcs.03365; Nishimura N, 2002, P NATL ACAD SCI USA, V99, P6755, DOI 10.1073/pnas.092150699; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; ROBINSON MS, 1986, J CELL BIOL, V102, P48, DOI 10.1083/jcb.102.1.48; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; Utley TJ, 2008, P NATL ACAD SCI USA, V105, P10209, DOI 10.1073/pnas.0712144105; Wright PF, 2005, J VIROL, V79, P8651, DOI 10.1128/JVI.79.13.8651-8654.2005; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	34	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0184629	10.1371/journal.pone.0184629	http://dx.doi.org/10.1371/journal.pone.0184629			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028839	Green Submitted, Green Published, gold			2022-12-26	WOS:000412980300005
J	Muncy, NM; Hedges-Muncy, AM; Kirwan, CB				Muncy, Nathan M.; Hedges-Muncy, Ariana M.; Kirwan, C. Brock			Discrete pre-processing step effects in registration-based pipelines, a preliminary volumetric study on T1-weighted images	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; ALZHEIMERS-DISEASE; CORTICAL THICKNESS; BRAIN STRUCTURES; MRI DATA; AUTOMATED SEGMENTATION; HIPPOCAMPAL VOLUME; OLDER-ADULTS; VALIDATION; PERFORMANCE	Pre-processing MRI scans prior to performing volumetric analyses is common practice in MRI studies. As pre-processing steps adjust the voxel intensities, the space in which the scan exists, and the amount of data in the scan, it is possible that the steps have an effect on the volumetric output. To date, studies have compared between and not within pipelines, and so the impact of each step is unknown. This study aims to quantify the effects of preprocessing steps on volumetric measures in T1-weighted scans within a single pipeline. It was our hypothesis that pre-processing steps would significantly impact ROI volume estimations. One hundred fifteen participants from the OASIS dataset were used, where each participant contributed three scans. All scans were then pre-processed using a step-wise pipeline. Bilateral hippocampus, putamen, and middle temporal gyrus volume estimations were assessed following each successive step, and all data were processed by the same pipeline 5 times. Repeated-measures analyses tested for a main effects of pipeline step, scan-rescan (for MRI scanner consistency) and repeated pipeline runs (for algorithmic consistency). A main effect of pipeline step was detected, and interestingly an interaction between pipeline step and ROI exists. No effect for either scan-rescan or repeated pipeline run was detected. We then supply a correction for noise in the data resulting from preprocessing.	[Muncy, Nathan M.; Hedges-Muncy, Ariana M.; Kirwan, C. Brock] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Kirwan, C. Brock] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA	Brigham Young University; Brigham Young University	Kirwan, CB (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.; Kirwan, CB (corresponding author), Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA.	kirwan@byu.edu	Kirwan, Brock/B-1520-2014	Kirwan, Brock/0000-0003-0768-1446	National Institutes of Health (US) [R01 AG021910, P50 MH071616, U24 RR021382, R01 MH56584, P50 AG05681, P01 AG03991]	National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (US) R01 AG021910, P50 MH071616, U24 RR021382, R01 MH56584, P50 AG05681, P01 AG03991.	Aarnink SH, 2014, NEUROIMAGE, V86, P404, DOI 10.1016/j.neuroimage.2013.10.026; Acosta-Cabronero J, 2008, NEUROIMAGE, V39, P1654, DOI 10.1016/j.neuroimage.2007.10.051; Andronache A, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00016; [Anonymous], 2008, 3 INT WORKSH BIOM IM, V12, P26; Aubert-Broche B, 2013, NEUROIMAGE, V82, P393, DOI 10.1016/j.neuroimage.2013.05.065; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Baare WFC, 2010, J PSYCHIATR RES, V44, P655, DOI 10.1016/j.jpsychires.2009.12.009; BARTKO JJ, 1991, SCHIZOPHRENIA BULL, V17, P483, DOI 10.1093/schbul/17.3.483; Bazin PL, 2014, NEUROIMAGE, V93, P201, DOI 10.1016/j.neuroimage.2013.03.077; Cha S.H., 2007, INT J MATH MODEL MET, V1, P1; Cheng YQ, 2010, NEUROSCI LETT, V480, P30, DOI 10.1016/j.neulet.2010.05.075; Chiverton J, 2007, COMPUT BIOL MED, V37, P342, DOI 10.1016/j.compbiomed.2006.04.001; Chupin M, 2007, NEUROIMAGE, V34, P996, DOI 10.1016/j.neuroimage.2006.10.035; Collins DL, 1999, BIENN INT C INF PROC; Coupe P, 2011, NEUROIMAGE, V54, P940, DOI 10.1016/j.neuroimage.2010.09.018; Crum WR, 2006, IEEE T MED IMAGING, V25, P1451, DOI 10.1109/TMI.2006.880587; Crum WR, 2001, NEUROIMAGE, V13, P847, DOI 10.1006/nimg.2001.0744; Crum WR, 2004, INT C MED IM COMP CO; Csernansky JG, 2004, NEUROIMAGE, V23, pS56, DOI 10.1016/j.neuroimage.2004.07.025; Csernansky JG, 2005, NEUROIMAGE, V25, P783, DOI 10.1016/j.neuroimage.2004.12.036; Csernansky JG, 2002, AM J PSYCHIAT, V159, P2000, DOI 10.1176/appi.ajp.159.12.2000; de Boer R, 2010, NEUROIMAGE, V51, P1047, DOI 10.1016/j.neuroimage.2010.03.012; De Flores R, 2015, NEUROSCIENCE, V309, P29, DOI 10.1016/j.neuroscience.2015.08.033; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Droby A, 2015, NEUROIMAGE, V110, P11, DOI 10.1016/j.neuroimage.2015.01.028; Ebdrup BH, 2010, J PSYCHIATR NEUROSCI, V35, P95, DOI 10.1503/jpn.090049; Eskildsen SF, 2012, NEUROIMAGE, V59, P2362, DOI 10.1016/j.neuroimage.2011.09.012; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Focke NK, 2011, NEUROIMAGE, V56, P1164, DOI 10.1016/j.neuroimage.2011.02.029; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [DOI 10.1016/S1053-8119(09)70884-5, 10.1016/s1053-8119(09)70884-5]; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Ghosh SS, 2010, NEUROIMAGE, V53, P85, DOI 10.1016/j.neuroimage.2010.05.075; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Hodgetts CJ, 2017, J NEUROSCI, V37, P3150, DOI 10.1523/JNEUROSCI.3225-16.2017; HUMMEL TJ, 1971, PSYCHOL BULL, V76, P49, DOI 10.1037/h0031323; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Keihaninejad S, 2010, NEUROIMAGE, V50, P1427, DOI 10.1016/j.neuroimage.2010.01.064; Khan AR, 2008, NEUROIMAGE, V41, P735, DOI 10.1016/j.neuroimage.2008.03.024; Klein A, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005350; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Klein A, 2010, NEUROIMAGE, V51, P214, DOI 10.1016/j.neuroimage.2010.01.091; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Lee JM, 2003, COMPUT BIOL MED, V33, P495, DOI 10.1016/S0010-4825(03)00022-2; Machado-de-Sousa JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088523; Mak E, 2015, NEUROIMAGE-CLIN, V7, P456, DOI 10.1016/j.nicl.2015.01.017; Maltbie E, 2012, NEUROIMAGE, V59, P1315, DOI 10.1016/j.neuroimage.2011.08.025; Malykhin NV, 2010, J PSYCHIAT NEUROSCIE, V35; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Meisenzahl E, 2011, J PSYCHIAT NEUROSCIE, V36; Meisenzahl E, 2010, EUR ARCH PSY CLIN N, V260, P127, DOI 10.1007/s00406-009-0023-3; Moreno-Alcazar A, 2016, PSYCHIAT RES-NEUROIM, V254, P41, DOI 10.1016/j.pscychresns.2016.06.002; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Mulder ER, 2014, NEUROIMAGE, V92, P169, DOI 10.1016/j.neuroimage.2014.01.058; Nakamura K, 2011, NEUROIMAGE, V54, P278, DOI 10.1016/j.neuroimage.2010.07.052; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Pangelinan MM, 2011, NEUROIMAGE, V54, P3093, DOI 10.1016/j.neuroimage.2010.11.021; Rencher A.C., 2012, METHODS MULTIVARIATE, DOI DOI 10.1002/9781118391686; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Sandman CA, 2014, NEUROIMAGE, V99, P93, DOI 10.1016/j.neuroimage.2014.05.020; Schwarz CG, 2016, NEUROIMAGE-CLIN, V11, P802, DOI 10.1016/j.nicl.2016.05.017; Sinanaj I, 2015, CONSCIOUS COGN, V36, P327, DOI 10.1016/j.concog.2015.07.012; Smith SM, 2007, NEUROIMAGE, V36, P1200, DOI 10.1016/j.neuroimage.2007.04.035; Sone D, 2016, NEUROIMAGE-CLIN, V12, P57, DOI 10.1016/j.nicl.2016.06.008; Stewart JC, 2014, NEUROIMAGE, V86, P326, DOI 10.1016/j.neuroimage.2013.10.016; Tustison NJ, 2014, NEUROIMAGE, V99, P166, DOI 10.1016/j.neuroimage.2014.05.044; Tustison Nicholas J, 2013, Front Neurosci, V7, P162, DOI 10.3389/fnins.2013.00162; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van Erp TGM, 2014, PSYCHIAT RES-NEUROIM, V222, P10, DOI 10.1016/j.pscychresns.2014.02.011; Wang HZ, 2013, IEEE T PATTERN ANAL, V35, P611, DOI 10.1109/TPAMI.2012.143; Wang L, 2006, NEUROIMAGE, V30, P52, DOI 10.1016/j.neuroimage.2005.09.017; Yousefi S, 2012, IEEE T BIO-MED ENG, V59, P1808, DOI 10.1109/TBME.2011.2122306; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096	77	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186071	10.1371/journal.pone.0186071	http://dx.doi.org/10.1371/journal.pone.0186071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023597	gold, Green Published, Green Submitted			2022-12-26	WOS:000412845100058
J	Pinna, S; Romagnoli, N				Pinna, Stefania; Romagnoli, Noemi			Radiographic measurement of the quadriceps angle in dogs	PLOS ONE			English	Article							MEDIAL PATELLAR LUXATION; BONE DEFORMITIES; DISLOCATION; TOMOGRAPHY	The direction of the force of the quadriceps muscle group is expressed by the value of the quadriceps angle, between the long axis of the muscle rectus femoris and the patellar ligament. This value is often modified in dogs with patellar luxation, a common orthopaedic disease of the stifle joint in both small and large dogs. The aims of the present study were to give a reference value for the quadriceps angle in healthy small and medium-large breed dogs. The medical records of healthy dogs and their pelvic limb radiographs (2014-2016) were reviewed. The radiographs were then divided into two groups: Group A (small dogs <15 kg body weight) and Group B (medium-large dogs >15 kg). The quadriceps angle of each pelvic limb was assessed using a digital software program in order to compare values between the two groups. The radiographs of 160 dogs, 80 per group were studied along with the assessment of the 320 pelvic limbs. The median quadriceps angle values obtained were in contrast with the literature: in Group A, it was 18.3 degrees and, in Group B, it was 8.7 degrees; moreover, the quadriceps angle value for Group A was statistically higher than for Group B (p<0.0001). No significant difference was present between males and females, or between right and left hindlimbs. In Group B, the Labrador Retriever breed influenced the quadriceps angle (p = 0.0005). The outcome of this survey provides an objective parameter, or additional information, to explain the different quadriceps mechanisms of small and medium-large dogs. In future studies the QA range values assessed in the two size groups may be useful in defining the magnitude of the malalignment of the extensor mechanism in both healthy dogs and ones with patellar luxation.	[Pinna, Stefania; Romagnoli, Noemi] Univ Bologna, Dept Vet Med Sci, Sch Agr & Vet Med, Alma Mater Studiorum, Bologna, Italy	University of Bologna	Pinna, S (corresponding author), Univ Bologna, Dept Vet Med Sci, Sch Agr & Vet Med, Alma Mater Studiorum, Bologna, Italy.	stefania.pinna@unibo.it		Pinna, Stefania/0000-0002-0005-9753				Barone R., 1980, ANATOMIA COMPARATA A, V1; Coulson A., 2002, ATLAS INTERPRETATIVE; Evans HE., 2013, MILLERS ANATOMY DOG, V4th, P140; Gibbons SE, 2006, J SMALL ANIM PRACT, V47, P3, DOI 10.1111/j.1748-5827.2006.00067.x; HAUPTMAN J, 1983, VET SURG, V12, P189, DOI 10.1111/j.1532-950X.1983.tb00740.x; Hayashi K, 2010, MECH DIS SMALL ANIMA, P655; HAYES AG, 1994, J AM VET MED ASSOC, V205, P716; HULSE DA, 1981, VET MED SM ANIM CLIN, V76, P43; Kaiser S, 2001, VET RADIOL ULTRASOUN, V42, P113, DOI 10.1111/j.1740-8261.2001.tb00913.x; Kaiser S, 1997, KLEINTIERPRAXIS, V42, P953; Kaiser S, 2001, VET SURG, V30, P552, DOI 10.1053/jvet.2001.28420; Kowaleski M.P., 2012, VET SURG SMALL ANIMA, P973; Lojszczyk-Szczepaniak A, 2014, MED WETER, V70, P46; Miles JE, 2012, VET SURG, V41, P422, DOI 10.1111/j.1532-950X.2011.00936.x; Mortari AC, 2009, CAN VET J, V50, P1064; Olimpo M, 2016, VET ITAL, V52, P45, DOI 10.12834/VetIt.71.206.3; Piermattei DL, 1997, HDB SMALL ANIMAL ORT, V3rd, P516; Pinna S, 2008, J SMALL ANIM PRACT, V49, P163, DOI 10.1111/j.1748-5827.2007.00532.x; PRIESTER WA, 1972, J AM VET MED ASSOC, V160, P740; RENDANO VT, 1985, VET RADIOLOGY, V26, P170, DOI 10.1111/j.1740-8261.1985.tb01405.x; SINGLETO.WB, 1969, J SMALL ANIM PRACT, V10, P59, DOI 10.1111/j.1748-5827.1969.tb04021.x; Towle HA, 2005, VET SURG, V34, P265, DOI [10.1111/j.1532-950x.2005.00040.x, 10.1111/j.1532-950X.2005.00040.x]; Trotter E.J., 1980, COMPEND CONT ED PRAC, V2, P58; Yasukawa S, 2016, VET COMP ORTHOPAED, V29, P29, DOI 10.3415/VCOT-15-05-0089	24	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185833	10.1371/journal.pone.0185833	http://dx.doi.org/10.1371/journal.pone.0185833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023529	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100034
J	Strong, CJ; Burnside, NG; Llewellyn, D				Strong, Conor J.; Burnside, Niall G.; Llewellyn, Dan			The potential of small-Unmanned Aircraft Systems for the rapid detection of threatened unimproved grassland communities using an Enhanced Normalized Difference Vegetation Index	PLOS ONE			English	Article							STRUCTURE-FROM-MOTION; RED; PHOTOGRAMMETRY; CHANNEL; COLOR; NDVI	The loss of unimproved grassland has led to species decline in a wide range of taxonomic groups. Agricultural intensification has resulted in fragmented patches of remnant grassland habitat both across Europe and internationally. The monitoring of remnant patches of this habitat is critically important, however, traditional surveying of large, remote landscapes is a notoriously costly and difficult task. The emergence of small-Unmanned Aircraft Systems (sUAS) equipped with low-cost multi-spectral cameras offer an alternative to traditional grassland survey methods, and have the potential to progress and innovate the monitoring and future conservation of this habitat globally. The aim of this article is to investigate the potential of sUAS for rapid detection of threatened unimproved grassland and to test the use of an Enhanced Normalized Difference Vegetation Index (ENDVI). A sUAS aerial survey is undertaken at a site nationally recognised as an important location for fragmented unimproved mesotrophic grassland, within the south east of England, UK. A multispectral camera is used to capture imagery in the visible and near-infrared spectrums, and the ENDVI calculated and its discrimination performance compared to a range of more traditional vegetation indices. In order to validate the results of analysis, ground quadrat surveys were carried out to determine the grassland communities present. Quadrat surveys identified three community types within the site; unimproved grassland, improved grassland and rush pasture. All six vegetation indices tested were able to distinguish between the broad habitat types of grassland and rush pasture; whilst only three could differentiate vegetation at a community level. The Enhanced Normalized Difference Vegetation Index (ENDVI) was the most effective index when differentiating grasslands at the community level. The mechanisms behind the improved performance of the ENDVI are discussed and recommendations are made for areas of future research and study.	[Strong, Conor J.; Burnside, Niall G.] Univ Brighton, Ecosyst & Environm Management Res Grp, Sch Environm & Technol, Brighton, E Sussex, England; [Llewellyn, Dan] LDP LLC, Carlstadt, NJ USA	University of Brighton	Burnside, NG (corresponding author), Univ Brighton, Ecosyst & Environm Management Res Grp, Sch Environm & Technol, Brighton, E Sussex, England.	N.G.Burnside@Brighton.ac.uk		Burnside, Niall/0000-0002-0416-1608				Agisoft, 2016, AG PHOTOSCAN US MAN; Alard D, 2000, NITRO DEP NATURA, P154; Amey, 2010, PLANT BIOLOGY; Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; BIRTH GS, 1968, AGRON J, V60, P640, DOI 10.2134/agronj1968.00021962006000060016x; Bulanon DM, 2016, ISPRS INT J GEO-INF, V5, DOI 10.3390/ijgi5060079; Burnside NG, 2003, ENVIRON CONSERV, V30, P52, DOI 10.1017/S0376892903000043; Cole B, 2014, ISPRS J PHOTOGRAMM, V90, P49, DOI 10.1016/j.isprsjprs.2014.01.010; CRIPPEN RE, 1990, REMOTE SENS ENVIRON, V34, P71, DOI 10.1016/0034-4257(90)90085-Z; Critchley CNR, 2004, BIOL CONSERV, V115, P263, DOI 10.1016/S0006-3207(03)00146-0; Cunliffe AM, 2016, REMOTE SENS ENVIRON, V183, P129, DOI 10.1016/j.rse.2016.05.019; Delegido J, 2013, EUR J AGRON, V46, P42, DOI 10.1016/j.eja.2012.12.001; Ding MJ, 2007, J GEOGR SCI, V17, P259, DOI 10.1007/s11442-007-0259-7; Erena M, 2016, INT ARCH PHOTOGRAMM, V41, P809, DOI 10.5194/isprsarchives-XLI-B1-809-2016; Ghazal M, 2015, IEEE INT SYMP SIGNAL, P332, DOI 10.1109/ISSPIT.2015.7394354; Gitelson AA, 1996, REMOTE SENS ENVIRON, V58, P289, DOI 10.1016/S0034-4257(96)00072-7; Harris RB, 2003, MAKING HIGH WEALD IN; High Weald AONB Joint Advisory Committee, 2014, HIGH WEALD AR OUTST; Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]; Hunt ER, 2010, REMOTE SENS-BASEL, V2, P290, DOI 10.3390/rs2010290; Joyce C., 2004, NATL WETLANDS NEWSLE, V26, P11; Kumar P., 2010, REP OPINION, V2, P55; Maxmax, 2015, ENDVI; McCann CN, 2016, THESIS; McGovern S, 2011, J VEG SCI, V22, P346, DOI 10.1111/j.1654-1103.2011.01256.x; Mkhabela MS, 2011, AGR FOREST METEOROL, V151, P385, DOI 10.1016/j.agrformet.2010.11.012; PARUELO JM, 1994, J RANGE MANAGE, V47, P498, DOI 10.2307/4003005; Pettorelli N, 2013, NORMALIZED DIFFERENCE VEGETATION INDEX, P1, DOI 10.1093/acprof:osobl/9780199693160.001.0001; Price EAC, 2003, LOWL GRASSL HEALTHL; Ramsey Elijah W. III, 2002, Wetlands Ecology and Management, V10, P85, DOI 10.1023/A:1014362616119; Rasmussen J, 2016, EUR J AGRON, V74, P75, DOI 10.1016/j.eja.2015.11.026; Redhead JW, 2014, APPL VEG SCI, V17, P408, DOI 10.1111/avsc.12076; Ridding LE, 2015, GLOB ECOL CONSERV, V4, P516, DOI 10.1016/j.gecco.2015.10.004; RODWELL JS, 1990, BRIT PLANT COMMUNITI, V1; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Sarda-Palomera F, 2012, IBIS, V154, P177, DOI 10.1111/j.1474-919X.2011.01177.x; Schuster C, 2012, INT J REMOTE SENS, V33, P5583, DOI 10.1080/01431161.2012.666812; Sripada RP, 2006, AGRON J, V98, P968, DOI 10.2134/agronj2005.0200; Sruthi S, 2015, AQUAT PR, V4, P1258, DOI 10.1016/j.aqpro.2015.02.164; Tommervik H., 2014, EARSeL eProceedings, V13, P47; Tonkin TN, 2014, GEOMORPHOLOGY, V226, P35, DOI 10.1016/j.geomorph.2014.07.021; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Vermeulen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054700; Vicente-Serrano SM, 2006, INT J REMOTE SENS, V27, P511, DOI 10.1080/01431160500296032; Wang D, 2017, SENSORS, V17, P1, DOI DOI 10.3390/S17010180; Watts AC, 2010, J WILDLIFE MANAGE, V74, P1614, DOI 10.2193/2009-425; Westoby MJ, 2012, GEOMORPHOLOGY, V179, P300, DOI 10.1016/j.geomorph.2012.08.021; Whitehead K, 2014, J UNMANNED VEH SYST, V2, P69, DOI 10.1139/juvs-2014-0006	48	19	20	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186193	10.1371/journal.pone.0186193	http://dx.doi.org/10.1371/journal.pone.0186193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023504	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100077
J	Zhu, FJ; Schlupp, I; Tiedemann, R				Zhu, Fangjun; Schlupp, Ingo; Tiedemann, Ralph			Allele-specific expression at the androgen receptor alpha gene in a hybrid unisexual fish, the Amazon molly (Poecilia formosa)	PLOS ONE			English	Article							AMPLIFICATION MUTATION ASSAY; EVOLUTIONARY ORIGIN; POLYPLOIDY; TRANSCRIPTOME; HYBRIDIZATION; PCR; METHYLATION; VERTEBRATES; PRIMERS; TOOLS	The all-female Amazon molly (Poecilia formosa) is the result of a hybridization of the Atlantic molly (P. mexicana) and the sailfin molly (P. latipinna) approximately 120,000 years ago. As a gynogenetic species, P. formosa needs to copulate with heterospecific males including males from one of its bisexual ancestral species. However, the sperm only triggers embryo genesis of the diploid eggs. The genetic information of the sperm donor typically will not contribute to the next generation of P. formosa. Hence, P. formosa possesses generally one allele from each of its ancestral species at any genetic locus. This raises the question whether both ancestral alleles are equally expressed in P. formosa. Allele-specific expression (ASE) has been previously assessed in various organisms, e.g., human and fish, and ASE was found to be important in the context of phenotypic variability and disease. In this study, we utilized Real-Time PCR techniques to estimate ASE of the androgen receptor alpha (ara) gene in several distinct tissues of Amazon mollies. We found an allelic bias favoring the maternal ancestor (P. mexicana) allele in ovarian tissue. This allelic bias was not observed in the gill or the brain tissue. Sequencing of the promoter regions of both alleles revealed an association between an Indel in a known CpG island and differential expression. Future studies may reveal whether our observed cis-regulatory divergence is caused by an ovary-specific trans-regulatory element, preferentially activating the allele of the maternal ancestor.	[Zhu, Fangjun; Tiedemann, Ralph] Univ Potsdam, Inst Biochem & Biol, Univ Evolutionary Biol Systemat Zool, Potsdam, Germany; [Schlupp, Ingo] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA	University of Potsdam; University of Oklahoma System; University of Oklahoma - Norman	Tiedemann, R (corresponding author), Univ Potsdam, Inst Biochem & Biol, Univ Evolutionary Biol Systemat Zool, Potsdam, Germany.	tiedeman@uni-potsdam.de			University of Potsdam	University of Potsdam	Financial support was provided by the University of Potsdam.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; Antequera F., 1993, Experientia Supplementum (Basel), V64, P169; AVISE JC, 1991, EVOLUTION, V45, P1530, DOI 10.1111/j.1558-5646.1991.tb02657.x; Avise JC, 2008, CLONALITY, P237; BERGER L, 1973, Journal of Herpetology, V7, P1, DOI 10.2307/1562822; Cha R S, 1992, PCR Methods Appl, V2, P14; Chamberlain AJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2174-0; Chen Y, 2014, PLOS ONE, V9; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; DARNELL RM, 1968, COPEIA, P354; Dvorakova D, 2009, LEUKEMIA, V23, P793, DOI 10.1038/leu.2008.268; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Garcia TI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100250; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Ghotbi R, 2009, PHARMACOGENOMICS J, V9, P208, DOI 10.1038/tpj.2009.4; Gregg Christopher, 2014, F1000Prime Rep, V6, P75, DOI 10.12703/P6-75; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hasin-Brumshtein Y, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15, 10.1186/1471-2164-15-471]; Hubbs CL, 1932, SCIENCE, V76, P628, DOI 10.1126/science.76.1983.628; Lampert KP, 2008, PHILOS T R SOC B, V363, P2901, DOI 10.1098/rstb.2008.0040; Lampert KP, 2006, J GENET, V85, P67, DOI 10.1007/BF02728973; Latorra D, 2003, HUM MUTAT, V22, P79, DOI 10.1002/humu.10228; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lu Y, 2015, COMP BIOCHEM PHYS C, V178, P86, DOI 10.1016/j.cbpc.2015.07.011; Madlung A, 2013, HEREDITY, V110, P99, DOI 10.1038/hdy.2012.79; Maia AT, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2458; Main BJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-422; Mayba O, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0405-3; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; Mochida K, 2004, MOL GENET GENOMICS, V270, P371, DOI 10.1007/s00438-003-0939-7; Niemeitz Andreas, 2002, Acta Ethologica, V5, P45, DOI 10.1007/s10211-002-0065-2; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Palacios R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004150; Ptacek MB, 2005, ANIM BEHAV, V70, P1339, DOI 10.1016/j.anbehav.2005.03.019; R Development Core Team RFFSC, 2008, R LANG ENV STAT COMP, P2673; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Sabui S, 2012, J CLIN MICROBIOL, V50, P1308, DOI 10.1128/JCM.05424-11; SCHARTL M, 1995, EVOLUTION, V49, P827, DOI 10.1111/j.1558-5646.1995.tb02319.x; Schlupp I, 2005, ANNU REV ECOL EVOL S, V36, P399, DOI 10.1146/annurev.ecolsys.36.102003.152629; Schlupp I, 2002, J BIOGEOGR, V29, P1, DOI 10.1046/j.1365-2699.2002.00651.x; SCHULTZ RJ, 1969, AM NAT, V103, P605, DOI 10.1086/282629; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Shen YJ, 2013, COMP BIOCHEM PHYS D, V8, P11, DOI 10.1016/j.cbd.2012.10.006; Shen YJ, 2012, COMP BIOCHEM PHYS C, V155, P102, DOI 10.1016/j.cbpc.2011.03.012; Stock M, 2010, MOL ECOL, V19, P5204, DOI 10.1111/j.1365-294X.2010.04869.x; Tiedemann R, 2005, MOL ECOL NOTES, V5, P586, DOI 10.1111/j.1471-8286.2005.00993.x; TURNER BJ, 1980, EVOLUTION, V34, P917, DOI 10.1111/j.1558-5646.1980.tb04029.x; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yu AR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-143; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357; Zhang X, 2009, GENETICS, V182, P943, DOI 10.1534/genetics.109.103499; Zhu FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156209	56	3	3	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186411	10.1371/journal.pone.0186411	http://dx.doi.org/10.1371/journal.pone.0186411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023530	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100124
J	Barauskas, O; Xing, WM; Aguayo, E; Willkom, M; Sapre, A; Clarke, M; Birkus, G; Schultz, BE; Sakowicz, R; Kwon, H; Feng, JY				Barauskas, Ona; Xing, Weimei; Aguayo, Esmeralda; Willkom, Madeleine; Sapre, Annapurna; Clarke, Michael; Birkus, Gabriel; Schultz, Brian E.; Sakowicz, Roman; Kwon, HyockJoo; Feng, Joy Y.			Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Polymerase activity and mechanisms of action of nucleotide analogs	PLOS ONE			English	Article							VIRUS RNA-POLYMERASE; T-705 FAVIPIRAVIR; STRUCTURAL BASIS; B VIRUSES; REPLICATION; INHIBITION; EFFICACY; IDENTIFICATION; TRANSCRIPTION; INFECTIONS	Influenza polymerase is a heterotrimer protein with both endonuclease and RNA-dependent RNA polymerase (RdRp) activity. It plays a critical role in viral RNA replication and transcription and has been targeted for antiviral drug development. In this study, we characterized the activity of recombinant RdRp purified at 1:1:1 ratio in both ApG-primed RNA replication and mRNA-initiated RNA transcription. The heterotrimer complex showed comparable activity profiles to that of viral particle derived crude replication complex, and in contrast to the crude replication complex, was suitable for detailed mechanistic studies of nucleotide incorporation. The recombinant RdRp was further used to examine distinct modes of inhibition observed with five different nucleotide analog inhibitors, and the apparent steady-state binding affinity K-app was measured for selected analogs to correlate antiviral activity and enzymatic inhibition with substrate efficiency.	[Barauskas, Ona; Xing, Weimei; Aguayo, Esmeralda; Willkom, Madeleine; Sapre, Annapurna; Clarke, Michael; Birkus, Gabriel; Schultz, Brian E.; Sakowicz, Roman; Kwon, HyockJoo; Feng, Joy Y.] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA; [Aguayo, Esmeralda] Univ Copenhagen, BRIC, Copenhagen N, Denmark; [Birkus, Gabriel] Inst Organ Chem & Biochem, Prague 6, Czech Republic	Gilead Sciences; University of Copenhagen; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Kwon, H; Feng, JY (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	HyockJoo.Kwon@gilead.com; Joy.Feng@gilead.com	Birkus, Gabriel/GNW-3123-2022	Barauskas, Ona/0000-0001-9878-5763	Gilead Sciences Inc.	Gilead Sciences Inc.(Gilead Sciences)	All funding provided by Gilead Sciences Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010372; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Brownlee GG, 2002, J VIROL, V76, P7103, DOI 10.1128/JVI.76.14.7103-7113.2002; Chu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036113; Coats SJ, 2014, ANTIVIR RES, V102, P119, DOI 10.1016/j.antiviral.2013.11.008; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Crow M, 2004, J VIROL, V78, P6263, DOI 10.1128/JVI.78.12.6263-6270.2004; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; De Clercq E, 2011, ANNU REV PHARMACOL, V51, P1, DOI 10.1146/annurev-pharmtox-010510-100228; Eyer L, 2013, VET MED-CZECH, V58, P113, DOI 10.17221/6746-VETMED; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015; Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hayashi T, 2015, J VIROL, V89, P8042, DOI 10.1128/JVI.00901-15; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Hwang JS, 2000, J VIROL, V74, P4074, DOI 10.1128/JVI.74.9.4074-4084.2000; JAKEMAN KJ, 1994, ANTIMICROB AGENTS CH, V38, P1864, DOI 10.1128/AAC.38.8.1864; Jin ZN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068347; Kumaki Y, 2011, ANTIVIR RES, V92, P329, DOI 10.1016/j.antiviral.2011.09.001; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Olson AC, 2010, BIOCHEMISTRY-US, V49, P10208, DOI 10.1021/bi101011j; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; Song JY, 2015, EXPERT REV ANTI-INFE, V13, P1361, DOI 10.1586/14787210.2015.1076334; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; TILEY LS, 1994, J VIROL, V68, P5108, DOI 10.1128/JVI.68.8.5108-5116.1994; TISDALE M, 1995, ANTIMICROB AGENTS CH, V39, P2454, DOI 10.1128/AAC.39.11.2454; TISDALE M, 1993, ANTIVIR CHEM CHEMOTH, V4, P281, DOI 10.1177/095632029300400504; TOMASSINI J, 1994, ANTIMICROB AGENTS CH, V38, P2827, DOI 10.1128/AAC.38.12.2827; Tomassini JE, 1996, METHOD ENZYMOL, V275, P90; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180; Xing WM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181969; Zhang SJ, 2010, BIOCHEM BIOPH RES CO, V391, P570, DOI 10.1016/j.bbrc.2009.11.100	37	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185998	10.1371/journal.pone.0185998	http://dx.doi.org/10.1371/journal.pone.0185998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020100	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400058
J	Cedraz, H; Gromboni, JGG; Garcia, AA; Farias, RV; Souza, TM; de Oliveira, ER; de Oliveira, EB; do Nascimento, CS; Meneghetti, C; Wenceslau, AA				Cedraz, Haniel; Gonzaga Gromboni, Juliana Gracielle; Pinto Garcia Junior, Antonio Amandio; Farias Filho, Ronaldo Vasconcelos; Souza, Teillor Machado; de Oliveira, Eduardo Ribeiro; de Oliveira, Elizangela Bonfim; do Nascimento, Carlos Souza; Meneghetti, Camila; Wenceslau, Amauri Arias			Heat stress induces expression of HSP genes in genetically divergent chickens	PLOS ONE			English	Article							RELATIVE QUANTIFICATION; MOLECULAR CHAPERONES; SHOCK PROTEINS; TRANSCRIPTION; ACTIVATION; CELLS; MODEL; PCR; PERFORMANCE; PROTECTION	Background Chickens are animals that are sensitive to thermal stress, which may decrease their production level in terms that it affects feed intake and thus, decreasing body weight gain. The Heat Shock Factors (HSF) and Heat Shock Proteins (HSP) genes are involved in the key cellular defense mechanisms during exposure in hot environments. Aimed with this study to analyze the expression of HSF1, HSF3, HSP70 and HSP90 genes in two local breeds (Peloco and Caneluda) and a commercial broiler line (Cobb 500 (R)) to verify differences in resistance of these chicken to Heat stress treatment. Chicken were submitted to heat stress under an average temperature of 39 degrees C +/- 1. Results Under stress environment, the HSP70 and HSP90 genes were more expressed in backyard chickens than in broiler. There was a difference in HSP70 and HSP90 expression between Caneluda and Cobb and between Peloco and Cobb under stress and comfort environment respectively. HSP70 expression is higher in local breeds during heat stress than in a commercial broiler line. No significant differences were observed in the expression of HSF1 and HSF3 genes between breeds or environments. Conclusions HSP70 and HSP90 genes are highly expressed, HSF1 and HSF3 genes did not have high expression in all genetic groups. HSP70 and HSP90 are highly expressed in Peloco and Caneluda within heat stress, these breeds proved to be very resistant to high temperature.	[Cedraz, Haniel; Gonzaga Gromboni, Juliana Gracielle; Pinto Garcia Junior, Antonio Amandio; Meneghetti, Camila; Wenceslau, Amauri Arias] Univ Estadual Santa Cruz, Ilheus, BA, Brazil; [Farias Filho, Ronaldo Vasconcelos; de Oliveira, Elizangela Bonfim] UESB, Dept Rural & Anim Technol, Campus Itapetinga, Itapetinga, BA, Brazil; [Souza, Teillor Machado; de Oliveira, Eduardo Ribeiro] Univ Estadual Santa Cruz, Ilheus, BA, Brazil; [do Nascimento, Carlos Souza] Univ Fed Sergipe, Dept Anim Sci, Sao Cristovao, Sergipe, Brazil	Universidade Estadual de Santa Cruz; Universidade Estadual do Sudoeste da Bahia; Universidade Estadual de Santa Cruz; Universidade Federal de Sergipe	Cedraz, H (corresponding author), Univ Estadual Santa Cruz, Ilheus, BA, Brazil.	hanielcedraz@gmail.com	; Cedraz de Oliveira, Haniel/U-6430-2018	do Nascimento, Carlos/0000-0001-8471-4542; Cedraz de Oliveira, Haniel/0000-0001-7317-2004	Fundacao de Amparo a Pesquisa no Estado da Bahia (FAPESB); Universidade Estadual de Santa Cruz (UESC); Universidade Estadual do Sudoeste da Bahia (UESB)	Fundacao de Amparo a Pesquisa no Estado da Bahia (FAPESB); Universidade Estadual de Santa Cruz (UESC); Universidade Estadual do Sudoeste da Bahia (UESB)	This study was financially supported by Fundacao de Amparo a Pesquisa no Estado da Bahia (FAPESB), Universidade Estadual de Santa Cruz (UESC) and Universidade Estadual do Sudoeste da Bahia (UESB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Akbarian A, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0097-5; Al-Batshan HA, 2002, ASIAN AUSTRAL J ANIM, V15, P1502, DOI 10.5713/ajas.2002.1502; ALI N, 1991, BIOCHEM EDUC, V19, P166, DOI 10.1016/0307-4412(91)90087-O; Altan O, 2003, BRIT POULTRY SCI, V44, P545, DOI 10.1080/00071660310001618334; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; CLASSEN HL, 2000, OCCASIONAL PUBLICATI, P63; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; de Oliveira HC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176402; Ding XZ, 1987, MOL CELL BIOCHEM, V158, P189; Duangjinda M, 2017, BRAZ J POULTRY SCI, V19, P7, DOI 10.1590/1806-9061-2016-0245; Federal U, 2013, OTIMIZAC FRANGO CORT; Figueiredo D, 2007, CELL TISSUE RES, V329, P91, DOI 10.1007/s00441-007-0414-6; Fu WJJ, 2006, COMPUT BIOL CHEM, V30, P21, DOI 10.1016/j.compbiolchem.2005.10.005; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Guertin MJ, 2010, COLD SH Q B, V75, P1, DOI 10.1101/sqb.2010.75.039; HARTL FU, 1994, TRENDS BIOCHEM SCI, V19, P20, DOI 10.1016/0968-0004(94)90169-4; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hu WH, 2009, PLANT SCI, V176, P583, DOI 10.1016/j.plantsci.2009.01.016; Inouye S, 2003, MOL CELL BIOL, V23, P5882, DOI 10.1128/MCB.23.16.5882-5895.2003; Lara JL, 2013, ANIMALS; Lei L, 2013, J ANIM SCI, V91, P5194, DOI 10.2527/jas.2013-6538; Lei L, 2009, BRIT POULTRY SCI, V50, P504, DOI 10.1080/00071660903110851; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mariante AD, 2009, LIVEST SCI, V120, P204, DOI 10.1016/j.livsci.2008.07.007; Mello J. L. M., 2015, Archivos de Zootecnia, V64, P339; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Mittal D, 2009, PLANT PHYSIOL BIOCH, V47, P785, DOI 10.1016/j.plaphy.2009.05.003; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Nagaya S, 2010, PLANT CELL PHYSIOL, V51, P328, DOI 10.1093/pcp/pcp188; Nakai A, 2001, EMBO J, V20, P2885, DOI 10.1093/emboj/20.11.2885; Ni L, 2009, GENE DEV, V23, P1351, DOI 10.1101/gad.1781909; PARDUE ML, 1992, ANN NY ACAD SCI, V663, P125, DOI 10.1111/j.1749-6632.1992.tb38656.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porterfield A., 2015, WHAT IS A CT VALUE; Prakasam R, 2013, FEBS LETT, V587, P3541, DOI 10.1016/j.febslet.2013.09.012; Sagrilo Edvaldo, 2003, SOC E COMBAT, P1; Soleimani AF, 2011, POULTRY SCI, V90, P1435, DOI 10.3382/ps.2011-01381; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Takii R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180776; Tanabe M, 1998, EMBO J, V17, P1750, DOI 10.1093/emboj/17.6.1750; Tanabe M, 1997, J BIOL CHEM, V272, P15389, DOI 10.1074/jbc.272.24.15389; Temim S, 2000, J NUTR, V130, P813, DOI 10.1093/jn/130.4.813; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Xie JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102204; Xue HY, 2012, J BIOL CHEM, V287, P40400, DOI 10.1074/jbc.M112.410712; Yeh FL, 2002, J EXP ZOOL, V293, P349, DOI 10.1002/jez.10093; Yu JM, 2008, CELL STRESS CHAPERON, V13, P327, DOI 10.1007/s12192-008-0031-7	52	33	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186083	10.1371/journal.pone.0186083	http://dx.doi.org/10.1371/journal.pone.0186083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020081	Green Published, gold, Green Submitted			2022-12-26	WOS:000412754400067
J	Ding, L; Wo, LK; Du, ZY; Tang, LH; Song, ZY; Dou, XB				Ding, Lei; Wo, Like; Du, Zhongyan; Tang, Lihua; Song, Zhenyuan; Dou, Xiaobing			Danshen protects against early-stage alcoholic liver disease in mice via inducing PPAR alpha activation and subsequent 4-HNE degradation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; GLUTATHIONE S-TRANSFERASES; LIPID-METABOLISM; OXIDATIVE STRESS; RECEPTORS PPARS; INJURY; CELLS; CONTRIBUTES; INHIBITION; MODULATION	Alcoholic liver disease (ALD) is a type of chronic liver disease caused by long-term heavy ethanol consumption. Danshen is one of the most commonly used substances in traditional Chinese medicine and has been widely used for the treatment of various diseases, and most frequently, the ALD. The current study aims to determine the potential beneficial effect of Danshen administration on ALD and to clarify the underlying molecular mechanisms. Danshen administration improved liver pathologies of ALD, attenuated alcohol-induced increment of hepatic 4-Hydroxynonenal (4-HNE) formation, and prevented hepatic Peroxisome proliferators activated receptor alpha (PPAR alpha) suppression in response to chronic alcohol consumption. Cell culture studies revealed that both hepatoprotective effect and increased intracellular 4-HNE clearance instigated by Danshen supplementation are PPAR alpha-dependent. In conclusion, Danshen administration can protect against ALD via inducing PPAR alpha activation and subsequent 4-HNE degradation.	[Ding, Lei; Tang, Lihua; Dou, Xiaobing] Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Wo, Like] Zhejiang Prov Hosp Tradit Chinese Med, Hangzhou, Zhejiang, Peoples R China; [Du, Zhongyan] Zhejiang Chinese Med Univ, Hangzhou, Zhejiang, Peoples R China; [Song, Zhenyuan] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL USA	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Dou, XB (corresponding author), Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.; Song, ZY (corresponding author), Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL USA.	song2008@uic.edu; xbdou77@gmail.com			Natural Science Foundation of China [81473393, 81470845]; National Science Fund for Distinguished Young Scholars [LR15H030003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the Natural Science Foundation of China [grant numbers 81473393 to XD, 81470845 to ZS], http://www.nsfc.gov.cn/; and the National Science Fund for Distinguished Young Scholars [grant number LR15H030003 to XD], http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balogh LM, 2011, DRUG METAB REV, V43, P165, DOI 10.3109/03602532.2011.558092; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; CHAIT A, 1972, LANCET, V2, P62; Cheng JZ, 2001, BIOCHEM BIOPH RES CO, V282, P1268, DOI 10.1006/bbrc.2001.4707; Cheng TO, 2006, INT J CARDIOL, V113, P437, DOI 10.1016/j.ijcard.2005.10.026; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Demozay D, 2008, DIABETES, V57, P1216, DOI 10.2337/db07-0389; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; Donohue TM, 2007, WORLD J GASTROENTERO, V13, P4974; Dou XB, 2012, AM J PATHOL, V181, P1702, DOI 10.1016/j.ajpath.2012.08.004; FELVER ME, 1990, ALCOHOL CLIN EXP RES, V14, P255, DOI 10.1111/j.1530-0277.1990.tb00482.x; Fischer M, 2003, J BIOL CHEM, V278, P27997, DOI 10.1074/jbc.M302140200; Gallagher EP, 2007, TOXICOL IN VITRO, V21, P1365, DOI 10.1016/j.tiv.2007.04.004; Gloerich J, 2006, MOL GENET METAB, V89, P111, DOI 10.1016/j.ymgme.2006.05.009; Guo XH, 2009, CHINESE MED CLIN, V9, P13; Han BK, 2008, EUROPEAN J PHARM, V601, P30; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Katunga LA, 2015, MOL METAB, V4, P493, DOI 10.1016/j.molmet.2015.04.001; Kharbanda KK, 2009, MOL CELL BIOCHEM, V327, P75, DOI 10.1007/s11010-009-0044-2; KHORUTS A, 1991, HEPATOLOGY, V13, P267, DOI 10.1016/0270-9139(91)92439-F; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Krengel U, FEBS LETT; Li HH, 2014, ALCOHOL CLIN EXP RES, V38, P1520, DOI 10.1111/acer.12424; LIEBER CS, 1970, SCIENCE, V170, P78, DOI 10.1126/science.170.3953.78; MCCLAIN CJ, 1989, HEPATOLOGY, V9, P349, DOI 10.1002/hep.1840090302; Miyamura M, 2016, YAKUGAKU ZASSHI, V136, P579, DOI 10.1248/yakushi.15-00264-3; Petersen DR, 2005, ALCOHOL, V35, P243, DOI 10.1016/j.alcohol.2005.03.013; Reichard JF, 2000, BIOCH BIOPHYSICA ACT, V1487; Ronis MJJ, 2015, AM J PHYSIOL-GASTR L, V308, pG403, DOI 10.1152/ajpgi.00154.2014; Rouach H, 1997, HEPATOLOGY, V25, P351; Sampey BP, 2007, J BIOL CHEM, V282, P1925, DOI 10.1074/jbc.M610602200; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Shearn CT, 2012, FREE RADICAL BIO MED, V53, P1, DOI 10.1016/j.freeradbiomed.2012.04.021; Singhal SS, 2015, TOXICOL APPL PHARM, V289, P361, DOI 10.1016/j.taap.2015.10.006; SINGHAL SS, 1995, INVEST OPHTH VIS SCI, V36, P142; Smathers RL, 2011, CHEM-BIOL INTERACT, V192, P107, DOI 10.1016/j.cbi.2011.02.021; Song ZY, 2004, HEPATOLOGY, V40, P989, DOI 10.1002/hep.20412; Wu D, 2009, SEM LIV DIS; Zhang Y, 2012, PHARM RES-DORDR, V29, P1595, DOI 10.1007/s11095-012-0670-3	39	15	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186357	10.1371/journal.pone.0186357	http://dx.doi.org/10.1371/journal.pone.0186357			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020055	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400094
J	Vedula, EM; Alonso, JL; Arnaout, MA; Charest, JL				Vedula, Else M.; Alonso, Jose Luis; Arnaout, M. Amin; Charest, Joseph L.			A microfluidic renal proximal tubule with active reabsorptive function	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; IN-VITRO; BASEMENT-MEMBRANES; GLUCOSE-UPTAKE; SCHWANN-CELLS; SHEAR-STRESS; COCULTURE; MODEL; DIFFERENTIATION	In the kidney, the renal proximal tubule (PT) reabsorbs solutes into the peritubular capillaries through active transport. Here, we replicate this reabsorptive function in vitro by engineering a microfluidic PT. The microfluidic PT architecture comprises a porous membrane with user-defined submicron surface topography separating two microchannels representing a PT filtrate lumen and a peritubular capillary lumen. Human PT epithelial cells and microvascular endothelial cells in respective microchannels created a PT-like reabsorptive barrier. Co-culturing epithelial and endothelial cells in the microfluidic architecture enhanced viability, metabolic activity, and compactness of the epithelial layer. The resulting tissue expressed tight junctions, kidney-specific morphology, and polarized expression of kidney markers. The microfluidic PT actively performed sodium-coupled glucose transport, which could be modulated by administration of a sodium-transport inhibiting drug. The microfluidic PT reproduces human physiology at the cellular and tissue levels, and measurable tissue function which can quantify kidney pharmaceutical efficacy and toxicity.	[Vedula, Else M.; Charest, Joseph L.] Draper, Biomed Microsyst Grp, Cambridge, MA 02139 USA; [Alonso, Jose Luis; Arnaout, M. Amin] Massachusetts Gen Hosp, Leukocyte Biol & Inflammat Program, Dept Med, Nephrol Div, Charlestown, MA 02129 USA; [Alonso, Jose Luis; Arnaout, M. Amin] Harvard Med Sch, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Charest, JL (corresponding author), Draper, Biomed Microsyst Grp, Cambridge, MA 02139 USA.; Arnaout, MA (corresponding author), Massachusetts Gen Hosp, Leukocyte Biol & Inflammat Program, Dept Med, Nephrol Div, Charlestown, MA 02129 USA.; Arnaout, MA (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.	aarnaout1@mgh.harvard.edu; jcharest@draper.com		Charest, Joseph/0000-0002-9062-2473	National Cancer Institute [R33 CA174550]; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK048549, R01 DK088327]; Charles Stark Draper Laboratory: Draper Research and Development Grant; Charles Stark Draper Laboratory: University Research and Development Grant	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Charles Stark Draper Laboratory: Draper Research and Development Grant; Charles Stark Draper Laboratory: University Research and Development Grant	This work was supported by National Cancer Institute, Award: R33 CA174550, Recipient/PI: Joseph Leo Charest, Ph.D.; National Institute of Diabetes and Digestive and Kidney Diseases, Award: R01 DK048549, Recipient/PI: M. Amin Arnaout, M.D.; National Institute of Diabetes and Digestive and Kidney Diseases, Award: R01 DK088327, Recipient/PI: M. Amin Arnaout, M.D.; Charles Stark Draper Laboratory, Award: Draper Research and Development Grant, Recipient/PI: Joseph Leo Charest, Ph.D.; and Charles Stark Draper Laboratory, Award: University Research and Development Grant, Recipient/PI: M. Amin Arnaout, M.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Awqati Q, 2012, STRUCTURE FUNCTION K, P716; Aydin S, 2008, AM J PHYSIOL-CELL PH, V294, pC543, DOI 10.1152/ajpcell.00307.2007; Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179; Blattmann A, 2008, BIOMATERIALS, V29, P2749, DOI 10.1016/j.biomaterials.2008.03.019; Bruggeman LA, 2012, CELL MOL BIOENG, V5, P194, DOI 10.1007/s12195-012-0221-3; Chang HC, 2013, MOL BIOSYST, V9, P2010, DOI 10.1039/c3mb70060g; Charest JL, 2005, J VAC SCI TECHNOL B, V23, P3011, DOI 10.1116/1.2127951; Charest JL, 2006, BIOMATERIALS, V27, P2487, DOI 10.1016/j.biomaterials.2005.11.022; Charest JL, 2004, BIOMATERIALS, V25, P4767, DOI 10.1016/j.biomaterials.2003.12.011; Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020; Chen ZJ, 2009, J NEURO-ONCOL, V92, P121, DOI 10.1007/s11060-008-9742-y; Christensen EI, 2012, COMPR PHYSIOL, V2, P805, DOI 10.1002/cphy.c100073; Duan Y, 2008, P NATL ACAD SCI USA, V105, P11418, DOI 10.1073/pnas.0804954105; Duan Y, 2010, P NATL ACAD SCI USA, V107, P21860, DOI 10.1073/pnas.1015751107; Frohlich EM, 2013, LAB CHIP, V13, P2311, DOI 10.1039/c3lc50199j; Frohlich EM, 2012, INTEGR BIOL-UK, V4, P75, DOI 10.1039/c1ib00096a; Frohlich EM, 2013, MICROFLUIDIC CELL CU, P279; HIRONAKA K, 1993, KIDNEY INT, V43, P334, DOI 10.1038/ki.1993.51; Huang HC, 2013, TISSUE ENG PT A, V19, P2024, DOI [10.1089/ten.tea.2012.0605, 10.1089/ten.TEA.2012.0605]; Humes HD, 1999, KIDNEY INT, V55, P2502, DOI 10.1046/j.1523-1755.1999.00486.x; Jang KJ, 2013, INTEGR BIOL; Jang KJ, 2013, INTEGR BIOL-UK, V5, P1119, DOI 10.1039/c3ib40049b; Jang KJ, 2011, INTEGR BIOL-UK, V3, P134, DOI 10.1039/c0ib00018c; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Kaissling B, 2008, HISTOCHEM CELL BIOL, V130, P247, DOI 10.1007/s00418-008-0452-5; Kanwal A, 2012, ANAL BIOCHEM, V429, P70, DOI 10.1016/j.ab.2012.07.003; Kelly EJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt378; Kim J, 2013, BIOMATERIALS, V34, P7257, DOI 10.1016/j.biomaterials.2013.06.029; Kriz W, 2008, THE KIDNEY, P479; Kumar R, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-27; Li Q, 2013, ARCH MED RES, V44, P504, DOI 10.1016/j.arcmed.2013.09.009; Li XJ, 2009, ARCH BIOL SCI, V61, P703, DOI 10.2298/ABS0904703L; Linas SL, 1999, KIDNEY INT, V55, P1251, DOI 10.1046/j.1523-1755.1999.00360.x; Luyts K, 2015, TOXICOL IN VITRO, V29, P234, DOI 10.1016/j.tiv.2014.10.024; Maunsbach AB, 2011, HDB PHYSL, P41, DOI [10.1002/cphy.cp080102, DOI 10.1002/CPHY.CP080102]; Nguyen ANT, 2007, J AM SOC NEPHROL, V18, P46, DOI 10.1681/ASN.2006010086; Panchapakesan U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054442; Prozialeck WC, 2006, TOXICOL IN VITRO, V20, P942, DOI 10.1016/j.tiv.2005.11.006; Saito K, 2006, WORLD J GASTROENTERO, V12, P6818, DOI 10.3748/wjg.v12.i42.6818; Slater SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020802; Tufro A, 1999, J AM SOC NEPHROL, V10, P2125; Weber EJ, 2016, KIDNEY INT, V90, P627, DOI 10.1016/j.kint.2016.06.011; Weinberg JM, 2009, J AM SOC NEPHROL, V20, P1164, DOI 10.1681/ASN.2009040419; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Yan YL, 2012, MOL CELL BIOCHEM, V367, P175, DOI 10.1007/s11010-012-1331-x; Yuan Q, 2008, ARCH MED SCI, V4, P242; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; Zhang B, 2012, J HUAZHONG U SCI-MED, V32, P173, DOI 10.1007/s11596-012-0031-9; Zhang Y, 2010, CELL MOL BIOL LETT, V15, P517, DOI 10.2478/s11658-010-0026-0	49	43	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0184330	10.1371/journal.pone.0184330	http://dx.doi.org/10.1371/journal.pone.0184330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020011	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400010
J	Yan, YT; Yu, LD; Castro, L; Dixon, D				Yan, Yitang; Yu, Linda; Castro, Lysandra; Dixon, Darlene			ER alpha 36, a variant of estrogen receptor a, is predominantly localized in mitochondria of human uterine smooth muscle and leiomyoma cells	PLOS ONE			English	Article							ADIPOSE-TISSUE; BREAST-CANCER; EXPRESSION; ALPHA; RECEPTOR-ALPHA-36; COLOCALIZATION; MICROSCOPY; INDUCTION; KINASES; BETA	ER alpha 36 is a naturally occurring, membrane-associated, isoform of estrogen receptor a. The expression of ER alpha 36 is due to alternative splicing and different promoter usage. ER alpha 36 is a dominant-negative effector of ERa66-mediated transactivational activities and has the potential to trigger membrane-initiated mitogenic, nongenomic, estrogen signaling; however, the subcellular localization of ER alpha 36 remains controversial. To determine the cellular localization of ER alpha 36 in estrogen-responsive human uterine smooth muscle (ht-UtSMC) and leiomyoma (fibroid; ht-UtLM) cells, we conducted systematic confocal microscopy and subcellular fractionation analysis using ER alpha 36 antibodies. With Image J colocalizaton analysis plugin, confocal images were analyzed to obtain a Pearson's Correlation Coefficient (PCC) to quantify signal colocalization of ER alpha 36 with mitochondrial, endoplasmic reticulum, and cytoskeletal components in both cell lines. When cells were double-stained with an ER alpha 36 antibody and a mitochondrial-specific dye, MitoTracker, the PCC for the two channel signals were both greater than 0.75, indicating strong correlation between ER alpha 36 and mitochondrial signals in the two cell lines. A blocking peptide competition assay confirmed that the mitochondria-associated ER alpha 36 signal detected by confocal analysis was specific for ER alpha 36. In contrast, confocal images double-stained with an ER alpha 36 antibody and endoplasmic reticulum or cytoskeletal markers, had PCCs that were all less than 0.4, indicating no or very weak signal correlation. Fractionation studies showed that ER alpha 36 existed predominantly in membrane fractions, with minimal or undetected amounts in the cytosol, nuclear, chromatin, and cytoskeletal fractions. With isolated mitochondrial preparations, we confirmed that a known mitochondrial protein, prohibitin, was present in mitochondria, and by co-immunoprecipitation analysis that ER alpha 36 was associated with prohibitin in ht-UtLM cells. The distinctive colocalization pattern of ER alpha 36 with mitochondria in ht-UtSMC and ht-UtLM cells, and the association of ER alpha 36 with a mitochondrial-specific protein suggest that ER alpha 36 is localized primarily in mitochondria and may play a pivotal role in non-genomic signaling and mitochondrial functions.	[Yan, Yitang; Yu, Linda; Castro, Lysandra; Dixon, Darlene] NIEHS, Mol Pathogenesis Grp, NTPL, Natl Toxicol Program,NIH, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dixon, D (corresponding author), NIEHS, Mol Pathogenesis Grp, NTPL, Natl Toxicol Program,NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	dixon@niehs.nih.gov			National Toxicology Program (NTP) of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS); Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES021196] Funding Source: NIH RePORTER	National Toxicology Program (NTP) of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS); Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the National Toxicology Program (NTP) and the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370; Carney SA, 2002, LAB INVEST, V82, P719, DOI 10.1097/01.LAB.0000017499.51216.3E; Chakraborty P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058291, 10.1371/journal.pone.0068543]; Chen JQ, 2007, BBA-MOL CELL RES, V1773, P1732, DOI 10.1016/j.bbamcr.2007.05.008; Chigira T, 2015, BIOCHEM BIOPH RES CO, V463, P726, DOI 10.1016/j.bbrc.2015.06.002; Choi M, 2015, MOL CELL BIOCHEM, V407, P181, DOI 10.1007/s11010-015-2468-1; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; Hebert-Chatelain E, 2013, INT J BIOCHEM CELL B, V45, P90, DOI 10.1016/j.biocel.2012.08.014; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Ivanova MM, 2010, AM J RESP CELL MOL, V42, P320, DOI 10.1165/rcmb.2009-0059OC; Li GL, 2013, MOL ONCOL, V7, P611, DOI 10.1016/j.molonc.2013.02.001; Lin SL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-102; Pelekanou V, 2012, STEROIDS, V77, P928, DOI 10.1016/j.steroids.2011.12.016; Psarra AMG, 2008, IUBMB LIFE, V60, P210, DOI 10.1002/iub.37; Sekeris C E, 1990, In Vivo, V4, P317; Simpkins JW, 2008, MOL CELL ENDOCRINOL, V290, P51, DOI 10.1016/j.mce.2008.04.013; Soltysik K, 2015, EUR J CELL BIOL, V94, P611, DOI 10.1016/j.ejcb.2015.10.001; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tibaldi E, 2008, J CELL BIOCHEM, V104, P840, DOI 10.1002/jcb.21670; Tong JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015408; Velickovic K, 2014, J CLIN ENDOCR METAB, V99, P151, DOI 10.1210/jc.2013-2017; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; Wallacides A, 2012, MOL CELL ENDOCRINOL, V350, P61, DOI 10.1016/j.mce.2011.11.021; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Zhang J, 2012, STEROIDS, V77, P666, DOI 10.1016/j.steroids.2012.02.013; Zinchuk, 2008, CURR PROTOC CELL BIO, V39	29	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186078	10.1371/journal.pone.0186078	http://dx.doi.org/10.1371/journal.pone.0186078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020039	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400066
J	Collings, SL; Lefevre, C; Johnson, ME; Evans, D; Hack, G; Stynes, G; Maguire, A				Collings, Shuk-Li; Lefevre, Cinira; Johnson, Michelle E.; Evans, David; Hack, Guido; Stynes, Gillian; Maguire, Andrew			Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany	PLOS ONE			English	Article							WARFARIN DISCONTINUATION; DABIGATRAN; APIXABAN; RISK; RIVAROXABAN; ADHERENCE; STROKE	This study examined characteristics and treatment persistence among patients prescribed oral anticoagulants (OACs) for stroke prevention in non-valvular atrial fibrillation (NVAF). We identified 15,244 patients (51.8% male, 72.7% aged >= 70) with NVAF and no prior OAC therapy who were prescribed apixaban (n = 1,303), rivaroxaban (n = 5,742), dabigatran (n = 1,622) or vitamin-K antagonists (VKAs, n = 6,577) between 1-Dec-2012 and 31-Oct-2014 in German primary care (IMS (R) Disease Analyzer). We compared OAC persistence using Cox regression over patients' entire follow-up and using a data-driven time-partitioned approach (before/after 100 days) to handle non-proportional hazards. History of stroke risk factors (stroke/transient ischaemic attack [TIA] 15.2%; thromboembolism 14.1%; hypertension 84.3%) and high bleeding risk (HAS-BLED score >= 3 68.4%) was common. Apixaban-prescribed patients had more frequent history of stroke/TIA (19.7%) and high bleeding risk (72.6%) than other OACs. 12-month persistence rates were: VKA 57.5% (95% confidence interval (CI) 56.0-59.0%), rivaroxaban 56.6% (54.9-58.2%), dabigatran 50.1% (47.2- 53.1%), apixaban 62.9% (58.8-67.0%). Over entire follow-up, compared to VKA, non-persistence was similar with apixaban (adjusted hazard ratio 1.08, 95% CI 0.95-1.24) but higher with rivaroxaban (1.21, 1.14-1.29) and dabigatran (1.53, 1.40-1.68). Using post-hoc time-partitioned approach: in first 100 days, non-persistence was higher with apixaban (1.37, 1.17-1.59), rivaroxaban (1.41, 1.30-1.53) and dabigatran (1.91, 1.70-2.14) compared to VKA. Compared to apixaban, rivaroxaban non-persistence was similar (1.03, 0.89- 1.20), dabigatran was higher (1.39, 1.17-1.66). After 100 days, apixaban non-persistence was lower than VKA (0.66, 0.52-0.85); rivaroxaban (0.97, 0.87-1.07) and dabigatran (1.10, 0.95-1.28) were similar to VKA. Furthermore, rivaroxaban (1.46, 1.13-1.88) and dabigatran (1.67, 1.26-2.19) non-persistence was higher than apixaban. This study describes real-world observations on OAC use, particularly early apixaban use following approval for NVAF, in Germany. We identified potential differential OAC prescribing and higher persistence with apixaban than other OACs after 100 days' treatment. Larger studies are needed with longer follow-up to establish long-term patterns.	[Collings, Shuk-Li; Johnson, Michelle E.; Maguire, Andrew] OXON Epidemiol, London, England; [Lefevre, Cinira; Evans, David] Bristol Myers Squibb, Ctr Observat Res & Data Sci, Paris, France; [Hack, Guido] Bristol Myers Squibb, Med Dept, Munich, Germany; [Stynes, Gillian] Bristol Myers Squibb, Worldwide Hlth Econ & Outcomes Res, London, England	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Collings, SL (corresponding author), OXON Epidemiol, London, England.	shuk-li.collings@oxonepi.com			Bristol-Myers Squibb, Paris, France; Pfizer; Bristol-Myers Squibb	Bristol-Myers Squibb, Paris, France(Bristol-Myers Squibb); Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb)	This study was funded by Bristol-Myers Squibb, Paris, France (www.bmsfrance.fr) and Pfizer (www.pfizer.com). CL, DE, GH and GS were employed by Bristol-Myers Squibb at the time of the study and contributed to the study design, interpretation of results and manuscript. MJ, SC and AM were employed by OXON Epidemiology Ltd, which has received funding from Bristol-Myers Squibb to develop this study.	[Anonymous], XAR 15MG FILM COAT T; [Anonymous], PRAD 110MG HARD CAPS; [Anonymous], EL 2 5 MG FILM COAT; Bancroft T, 2016, CLIN THER, V38, P545, DOI 10.1016/j.clinthera.2016.01.008; Becher H, 2009, INT J CLIN PHARM TH, V47, P617; Beyer-Westendorf J, 2016, EUROPACE, V18, P1150, DOI 10.1093/europace/euv421; Brown Joshua D, 2016, J Manag Care Spec Pharm, V22, P1319; Camm AJ, 2015, EUROPACE, V17, P1007, DOI 10.1093/europace/euv068; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Coleman CI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157769; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; DeWilde S, 2006, HEART, V92, P1064, DOI 10.1136/hrt.2005.069492; Fang MC, 2010, CIRC-CARDIOVASC QUAL, V3, P624, DOI 10.1161/CIRCOUTCOMES.110.937680; Forslund T, 2016, EUR J CLIN PHARMACOL, V72, P329, DOI 10.1007/s00228-015-1983-z; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hohnloser SH, 2016, EUR HEART J, V37, P513; Hylek EM, 2014, J AM COLL CARDIOL, V63, P2141, DOI 10.1016/j.jacc.2014.02.549; Johnson ME, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011471; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; Lefevre C, 2016, J AM COLL CARDIOL, V67, P769, DOI 10.1016/S0735-1097(16)30770-7; Lip GYH, 2016, INT J CLIN PRACT, V70, P752, DOI 10.1111/ijcp.12863; Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049; National Institute for Health and Clinical Excellence, 2014, ATR FIBR MAN; O'Brien EC, 2014, AM HEART J, V168, P487, DOI 10.1016/j.ahj.2014.07.002; Olesen JB, 2015, EUROPACE, V17, P187, DOI DOI 10.1093/EUR0PACE/; Pan XY, 2014, J AM COLL CARDIOL, V63, pA415, DOI 10.1016/S0735-1097(14)60415-0; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Piccini JP, 2014, EUR HEART J, V35, P250, DOI 10.1093/eurheartj/eht483; Rubboli A, 2015, CURR MED RES OPIN, V31, P1845, DOI 10.1185/03007995.2015.1086993; Savelieva I, 2014, CLIN CARDIOL, V37, P32, DOI 10.1002/clc.22204; Simonin L, 2017, CLIN REV ALLERG IMMU, V53, P14, DOI 10.1007/s12016-016-8568-1; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yao X, 2016, J AM HEART ASS, V5; Zalesak M, 2013, CIRC-CARDIOVASC QUAL, V6, P567, DOI 10.1161/CIRCOUTCOMES.113.000192	36	23	25	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185642	10.1371/journal.pone.0185642	http://dx.doi.org/10.1371/journal.pone.0185642			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016695	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400026
J	Macario, P; Pichorim, M; Doherty, PF; Toledo-Lima, GS; Oliveira, TM; Camara, TPF; Melo, SM; Silveira, JLS; Araujo, JC; Franca, LF				Macario, Phoeve; Pichorim, Mauro; Doherty, Paul F., Jr.; Toledo-Lima, Guilherme S.; Oliveira-Junior, Tonny M.; Camara, Thanyria P. F.; Melo, Shirley Macjane; Silveira, Joao Lucas S.; Araujo, Juliana C.; Franca, Leonardo F.			Apparent survival and cost of reproduction for White-lined Tanager (Tachyphonus rufus, Thraupidae) in the northern Atlantic Rainforest, Brazil	PLOS ONE			English	Article							AFRICAN SYLVIA WARBLERS; LIFE-HISTORY EVOLUTION; NEW-WORLD POPULATIONS; NEOTROPICAL BIRDS; CLUTCH-SIZE; DEMOGRAPHIC PARAMETERS; JUVENILE SURVIVAL; MODEL SELECTION; HABITAT USE; PATTERNS	Understanding latitudinal variation in avian life-history traits has been a focus of many demographic studies around the world. However, we still know little about annual or intra-annual demographic variation within tropical regions or about how factors such as breeding season and precipitation influence demographic rates. In this study, we estimated intra-annual apparent survival of the White-lined Tanager (Tachyphonus rufus) using capture-markrecapture data from northeastern Brazil. We tested whether survival varied seasonally (breeding vs. non-breeding), with rainfall, by age and residence status in our study area. Intra-annual apparent survival was correlated with the reproductive cycle, being lower during the breeding (0.65 +/- 0.16 SE) vs. the non-breeding season (0.97 +/- 0.05 SE). The annual apparent survival (similar to 0.6) was relatively low for a tropical species. In both years, we observed highest abundance in spring (November, 3.1-3.7 birds/ha) and lowest abundance in autumn-winter periods (May-August, 1.1-1.4 bird/ha). The low survival during the breeding season probably reflects the trade-off between survival and reproduction and the cost of reproduction. Our findings represent an advance in the understanding of the demography of tropical birds because we did not find a predicted high annual apparent survival, and we elucidated some aspects of intra-annual variation in survival. Further exploration of latitudinal variation in demographic traits, especially in diverse, but poorly known habitats is needed to fully vet and develop life history theories.	[Macario, Phoeve; Toledo-Lima, Guilherme S.] Univ Fed Rio Grande do Norte, Programa Posgrad Ecol, Natal, RN, Brazil; [Macario, Phoeve; Pichorim, Mauro; Toledo-Lima, Guilherme S.; Oliveira-Junior, Tonny M.; Camara, Thanyria P. F.; Melo, Shirley Macjane; Silveira, Joao Lucas S.; Araujo, Juliana C.] Univ Fed Rio Grande do Norte, Lab Ornitol, Dept Bot & Zool, Natal, RN, Brazil; [Doherty, Paul F., Jr.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Oliveira-Junior, Tonny M.] Univ Fed Rio Grande do Norte, Programa Posgrad Ciencias Biol, Natal, RN, Brazil; [Franca, Leonardo F.] Univ Fed Rural Semi Arido, Lab Ecol Populacaes Anim, Mossoro, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Colorado State University; Universidade Federal do Rio Grande do Norte; Universidade Federal Rural do Semi-Arido (UFERSA)	Macario, P (corresponding author), Univ Fed Rio Grande do Norte, Programa Posgrad Ecol, Natal, RN, Brazil.; Macario, P (corresponding author), Univ Fed Rio Grande do Norte, Lab Ornitol, Dept Bot & Zool, Natal, RN, Brazil.	phoevemacario@gmail.com	Pichorim, Mauro/H-2224-2014	Pichorim, Mauro/0000-0002-9340-9010	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [474945/2010-3, 248588/2013-3]; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)	The long-term field study was financially supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq processes 474945/2010-3, 248588/2013-3), http://cnpq.br/, and the Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES), http://www.capes.gov.br/, granted scholarships to GSTL, PM, and TMO Jr.	Anders AD, 1997, CONSERV BIOL, V11, P698, DOI 10.1046/j.1523-1739.1997.95526.x; Anderson KE, 2012, AUK, V129, P307, DOI 10.1525/auk.2012.11164; [Anonymous], 1982, ESTIMATION ANIMAL AB; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Blake JG, 2002, AUK, V119, P132, DOI 10.1642/0004-8038(2002)119[0132:MPISGA]2.0.CO;2; Blake JG, 2008, BIOTROPICA, V40, P485, DOI 10.1111/j.1744-7429.2007.00395.x; Blake JA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003343; Blomberg EJ, 2014, ECOL EVOL, V4, P4488, DOI 10.1002/ece3.1139; Blomberg EJ, 2013, J AVIAN BIOL, V44, P149, DOI 10.1111/j.1600-048X.2012.00013.x; Boano Giovanni, 2004, Avocetta, V28, P77; Both C, 2000, J AVIAN BIOL, V31, P412, DOI 10.1034/j.1600-048X.2000.310317.x; Brawn JD, 1999, P INT ORN C, V22, P297; BRYANT DM, 1979, J ANIM ECOL, V48, P655, DOI 10.2307/4185; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Silva João Vitor Campos e, 2012, Acta Amaz., V42, P73, DOI 10.1590/S0044-59672012000100009; CHARNOV EL, 1974, IBIS, V116, P217, DOI 10.1111/j.1474-919X.1974.tb00241.x; COLLAR N., 2005, HDB BIRDS WORLD, V10, P514; Conn PB, 2005, ECOLOGY, V86, P2536, DOI 10.1890/04-1799; DIJKSTRA C, 1990, J ANIM ECOL, V59, P269, DOI 10.2307/5172; Faaborg J, 1995, AUK, V112, P503, DOI 10.2307/4088741; FAABORG J, 1984, WILSON BULL, V96, P575; Fleming T.H., 1992, P355; FOGDEN MPL, 1972, IBIS, V114, P307, DOI 10.1111/j.1474-919X.1972.tb00831.x; Franca LF, 2010, J FIELD ORNITHOL, V81, P227, DOI 10.1111/j.1557-9263.2010.00279.x; Ghalambor CK, 2001, SCIENCE, V292, P494, DOI 10.1126/science.1059379; Hernandez-Matias A, 2011, IBIS, V153, P846, DOI 10.1111/j.1474-919X.2011.01158.x; Hilty S.L, 2011, HDB BIRDS WORLD, V16, P46; Hoef JMV, 2012, AM STAT, V66, P124, DOI 10.1080/00031305.2012.687494; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Johnston JP, 1997, AM NAT, V150, P771, DOI 10.1086/286093; Jullien M, 2000, ECOLOGY, V81, P3416, DOI 10.1890/0012-9658(2000)081[3416:TSVOFI]2.0.CO;2; KARR JR, 1990, AM NAT, V136, P277, DOI 10.1086/285098; Kendall WL, 1997, ECOLOGY, V78, P563; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Kostecke RM, 2008, CONDOR, V110, P251, DOI 10.1525/cond.2008.8459; Krebs CJ, 2002, PHILOS T ROY SOC B, V357, P1211, DOI 10.1098/rstb.2002.1122; Lack D., 1954, P343; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Lack D., 1966, POPULATION STUDIES B; LOERY G, 1987, ECOLOGY, V68, P1038, DOI 10.2307/1938375; LOISELLE BA, 1992, BIOSCIENCE, V42, P838, DOI 10.2307/1312083; Marengo JA, 2013, J CLIMATE, V26, P9137, DOI 10.1175/JCLI-D-12-00642.1; MARTIN K, 1995, AM ZOOL, V35, P340; MARTIN TE, 1986, WILSON BULL, V98, P38; Martin TE, 1996, J AVIAN BIOL, V27, P263, DOI 10.2307/3677257; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Merila J, 1997, J ANIM ECOL, V66, P452, DOI 10.2307/5940; Newton I., 1998, POPULATION LIMITATIO; Nicholson AJ, 1933, J ANIM ECOL, V2, P132, DOI 10.2307/954; Nimer E., 1972, REV BRAS GEOGR, V34, P3; Oberg M, 2015, ECOL EVOL, V5, P345, DOI 10.1002/ece3.1345; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Parker TH, 2006, BIOTROPICA, V38, P764, DOI 10.1111/j.1744-7429.2006.00210.x; Pearce-Higgins JW, 2007, CONDOR, V109, P167, DOI 10.1650/0010-5422(2007)109[167:SOBM]2.0.CO;2; Pichorim M, 2010, ANN ZOOL FENN, V47, P123, DOI 10.5735/086.047.0205; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Reid JM, 2003, J ANIM ECOL, V72, P36, DOI 10.1046/j.1365-2656.2003.00673.x; RICKLEFS RE, 1977, CONDOR, V79, P376, DOI 10.2307/1368016; RICKLEFS RE, 1980, AUK, V97, P38; Ricklefs RE, 2005, ECOLOGY, V86, P2541, DOI 10.1890/05-0066; Ricklefs RE, 2000, CONDOR, V102, P3, DOI 10.1650/0010-5422(2000)102[0003:LSAMTE]2.0.CO;2; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; Ricklefs RE, 2007, ECOLOGY, V88, P1408, DOI 10.1890/06-1035; Ricklefs RE, 2011, J ORNITHOL, V152, P481, DOI 10.1007/s10336-010-0614-9; RIDGELY RS, 1989, BIRDS S AM; Robinson RA, 2007, IBIS, V149, P357, DOI 10.1111/j.1474-919X.2006.00648.x; Rodrigues RR, 2014, GEOPHYS RES LETT, V41, P1012, DOI 10.1002/2013GL058703; Ruiz-Gutierrez V, 2008, ECOL APPL, V18, P838, DOI 10.1890/07-1090.1; Ruiz-Gutierrez V, 2012, AUK, V129, P500, DOI 10.1525/auk.2012.11171; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Saino N, 1999, J ANIM ECOL, V68, P999, DOI 10.1046/j.1365-2656.1999.00350.x; Sandercock BK, 2000, ECOLOGY, V81, P1351, DOI 10.2307/177213; Sandercock BK, 2006, J WILDLIFE MANAGE, V70, P1504, DOI 10.2193/0022-541X(2006)70[1504:EODPFL]2.0.CO;2; Sankamethawee W, 2011, ECOL RES, V26, P429, DOI 10.1007/s11284-011-0802-y; Schaefer HC, 2006, IBIS, V148, P411, DOI 10.1111/j.1474-919X.2006.00544.x; Schaefer HC, 2004, IBIS, V146, P427, DOI 10.1111/j.1474-919X.2004.00276.x; Sharp PJ, 1996, ANIM REPROD SCI, V42, P505, DOI 10.1016/0378-4320(96)01556-4; Sick H, 2001, ORNITOLOGIA BRASILEI; SIMONS LS, 1990, ECOLOGY, V71, P869, DOI 10.2307/1937358; Skutch A. F., 1949, Auk, V66, P1; Slagsvold T, 1996, ECOLOGY, V77, P461, DOI 10.2307/2265622; SNOW DW, 1974, CONDOR, V76, P262, DOI 10.2307/1366339; Snow DW, 1962, TRINIDAD ZOOLOGICA, V47, P65; Stanley TR, 2005, WILDLIFE SOC B, V33, P782, DOI 10.2193/0091-7648(2005)33[782:SRAPFT]2.0.CO;2; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Stutchbury BJM, 2001, BEHAV ECOL SOCIOBIOL; Tarwater CE, 2011, ECOLOGY, V92, P1271, DOI 10.1890/10-1386.1; Thomson DL, 1997, J ANIM ECOL, V66, P414, DOI 10.2307/5986; Van der Jeugd HP, 1998, J ANIM ECOL, V67, P953, DOI 10.1046/j.1365-2656.1998.6760953.x; Vitz AC, 2011, CONDOR, V113, P400, DOI 10.1525/cond.2011.100023; Ward DH, 2004, CONDOR, V106, P263, DOI 10.1650/7387; WEIMERSKIRCH H, 1992, OIKOS, V64, P464, DOI 10.2307/3545162; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	99	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185890	10.1371/journal.pone.0185890	http://dx.doi.org/10.1371/journal.pone.0185890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016633	Green Published, gold, Green Submitted			2022-12-26	WOS:000412627400034
J	Pan, J; Li, K; Huang, W; Zhang, XQ				Pan, Jin; Li, Kai; Huang, Wei; Zhang, Xiaoqing			MiR-137 inhibited cell proliferation and migration of vascular smooth muscle cells via targeting IGFBP-5 and modulating the mTOR/STAT3 signaling	PLOS ONE			English	Article							PROMOTES; GROWTH; MICRORNAS; METASTASIS; ACTIVATION; MECHANISMS; PATHWAY; ROLES	Abnormal proliferation of vascular smooth muscle cells (VSMCs) contributes to the development of cardiovascular diseases. Studies have shown the great impact of microRNAs (miRNAs) on the cell proliferation of VSMCs. This study examined the effects of miR-137 on the cell proliferation and migration of VSMCs and also explored the underlying molecular mechanisms. The mRNA and protein expression levels were determined by qRT-PCR and western blot assays, respectively. The CCK-8 assay, wound healing assay and transwell migration assay were performed to measure cell proliferation and migration of VSMCs. The miR-137-targeted 3'untranslated region of insulin-like growth factor-binding protein-5 (IGFBP-5) was confirmed by luciferase reporter assay. Platelet-derived growth factor-bb (PDGF-bb) treatment enhanced cell proliferation and suppressed the expression of miR-137 in VSMCs. The gain-of-function and loss-of-function assays showed that overexpression of miR-137 suppressed the cell proliferation and migration, and also inhibited the expression of matrix genes of VSMCs; down-regulation of miR-137 had the opposite effects on VSMCs. Bioinformatics analysis and luciferase report assay results showed that IGFBP-5 was a direct target of miR-137, and miR-137 overexpression suppressed the IGFBP-5 expression and down-regulation of miR-137 increased the IGFBP-5 expression in VSMCs. PDGF-bb treatment also increased the IGFBP-5 mRNA expression. In addition, enforced expression of IGFBP-5 reversed the inhibitory effects of miR-137 on cell proliferation and migration of VSMCs. More importantly, overexpression of miR-137 also suppressed the activity of mTOR/STAT3 signaling in VSMCs. Taken together, the results suggest that miR-137 may suppress cell proliferation and migration of VSMCs via targeting IGFBP-5 and modulating mTOR/STAT3 signaling pathway.	[Pan, Jin; Huang, Wei; Zhang, Xiaoqing] Xian Med Univ, Clin Med Coll, Xian, Shaanxi, Peoples R China; [Li, Kai] Xian Med Univ, Affiliated Hosp 1, Dept Cardiol, Xian, Shaanxi, Peoples R China	Xi'an Medical University; Xi'an Medical University	Pan, J (corresponding author), Xian Med Univ, Clin Med Coll, Xian, Shaanxi, Peoples R China.	pannjin@126.com			Shaanxi Science and Technology Department [2012KRM64]	Shaanxi Science and Technology Department	This project was supported by Soft Science Project of Shaanxi Science and Technology Department (www.sninfogov.cn/), 2012KRM64 to JP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEDI H, 1995, CARDIOVASC RES, V30, P544, DOI 10.1016/0008-6363(95)00092-5; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bach LA, 2015, BEST PRACT RES CL EN, V29, P713, DOI 10.1016/j.beem.2015.06.002; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Bi R, 2016, BIOMED PHARMACOTHER, V84, P1711, DOI 10.1016/j.biopha.2016.10.081; Bian DH, 2017, AM J TRANSL RES, V9, P1509; Cheng Y, 2014, FEBS LETT, V588, P3274, DOI 10.1016/j.febslet.2014.07.012; Clemmons DR, 2001, ENDOCR REV, V22, P800, DOI 10.1210/er.22.6.800; DU YT, 2016, J INT SOC ONCODEVELO, V37, P13557; Duan C, 2002, J ENDOCRINOL, V175, P41, DOI 10.1677/joe.0.1750041; Fan XM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5135781; Gao Y, 2016, CLIN CHIM ACTA, V460, P164, DOI 10.1016/j.cca.2016.06.044; Guo X, 2016, SCI REP-UK, V6, DOI 10.1038/srep35302; Gurha P, 2016, CURR OPIN CARDIOL, V31, P249, DOI 10.1097/HCO.0000000000000280; Huang YC, 2016, ONCOTARGET, V7, P76852, DOI 10.18632/oncotarget.12719; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Kim S, 2013, BMB REP, V46, P550, DOI 10.5483/BMBRep.2013.46.11.057; Li K, 2017, YONSEI MED J, V58, P234, DOI 10.3349/ymj.2017.58.1.234; Li P, 2014, ARTERIOSCL THROM VAS, V34, P2001, DOI 10.1161/ATVBAHA.113.303145; Li TJ, 2015, INT J CLIN EXP PATHO, V8, P10375; Li XD, 2017, BRIT J CANCER, V116, P66, DOI 10.1038/bjc.2016.379; Li YM, 2014, AM J TRANSL RES, V6, P507; Liu LL, 2014, ONCOTARGET, V5, P5113, DOI 10.18632/oncotarget.2089; Matsuoka T, 2014, CANCERS, V6, P1441, DOI 10.3390/cancers6031441; Millette E, 2006, TRENDS CARDIOVAS MED, V16, P25, DOI 10.1016/j.tcm.2005.11.003; Owens Gary K, 2007, Novartis Found Symp, V283, P174; Porter KE, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0647-9; Pu X, 2014, ASIAN PAC J TROP MED, V7, P368, DOI 10.1016/S1995-7645(14)60057-2; Sun J, 2015, J NEURO-ONCOL, V122, P481, DOI 10.1007/s11060-015-1753-x; Wang HR, 2015, INT J CLIN EXP PATHO, V8, P12901; Wang P, 2016, CELL PROLIFERAT, V49, P484, DOI 10.1111/cpr.12265; Welten SMJ, 2016, CARDIOVASC RES, V110, P6, DOI 10.1093/cvr/cvw039; Wu DC, 2016, ONCOTARGET, V7, P38052, DOI 10.18632/oncotarget.9343; Xie BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141512; Xu QJ, 2004, CIRC RES, V94, pE46, DOI 10.1161/01.RES.0000124761.62846.DF; Yang F, 2016, AM J TRANSL RES, V8, P506; Yu M, 2017, INT J ONCOL, V50, P975, DOI 10.3892/ijo.2017.3852; Zhang MJ, 2016, HISTOCHEM CELL BIOL, V145, P119, DOI 10.1007/s00418-015-1386-3; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	39	19	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186245	10.1371/journal.pone.0186245	http://dx.doi.org/10.1371/journal.pone.0186245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016699	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400062
J	Pertile, RAN; Cui, XY; Hammond, L; Eyles, DW				Pertile, Renata A. N.; Cui, Xiaoying; Hammond, Luke; Eyles, Darryl W.			Vitamin D regulation of GDNF/Ret signaling in dopaminergic neurons	FASEB JOURNAL			English	Article						VDR; C-Ret; SH-SY5Y; GFR alpha 1; DVD-deficiency	D DEFICIENCY ALTERS; BIOLOGICAL-IMAGE-ANALYSIS; C-RET PROTOONCOGENE; NEUROTROPHIC FACTOR; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; BRAIN-DEVELOPMENT; NIGROSTRIATAL SYSTEM; SUBSTANTIA-NIGRA; MESSENGER-RNAS	1,25(OH)(2)D-3 (vitamin D) appears essential for the normal development of dopaminergic neurons. Vitamin D affects dopamine synthesis and metabolism as well as expression of glial cell line-derived neurotrophic factor (GDNF), which is crucial for the survival of dopaminergic neurons. We investigated the role of vitamin D on GDNF and its receptors protooncogene tyrosine-protein kinase receptor Ret (C-Ret) and GDNF family receptor alpha 1 (GFR alpha 1) signaling. To this end, we used a developmental vitamin D-deficient rat model and SH-SY5Y cells transfected with vitamin D receptor (VDR). The absence of vitamin D ligand in gestation reduces C-Ret expression, but not GDNF and GFRa1, in embryo forebrains. Overexpression of VDR in SH-SY5Y in the absence of ligand (mimicking in vivo developmental vitamin D deficiency) also suppressed C-Ret mRNA levels. In the presence of vitamin D, C-Ret mRNA and protein expression were increased. The chromatin immunoprecipitation results suggested that C-Ret is directly regulated by vitamin D via VDR. GDNF was also increased by vitamin D in these cells. Our small interfering RNA studies showed that knocking down VDR leads to an increase in C-Ret in the absence of ligand. Finally, we confirmed the inverse relationship between GFRa1 and C-Ret, as knocking down C-Ret led to increases in GFRa1 expression. These data extend our knowledge of the diverse and important roles played by vitamin D in dopamine physiology.	[Pertile, Renata A. N.; Cui, Xiaoying; Eyles, Darryl W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Hammond, Luke] Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY USA; [Eyles, Darryl W.] Queensland Ctr Mental Hlth Res, Wacol, Qld, Australia	University of Queensland; Columbia University; Queensland Centre for Mental Health Research	Eyles, DW (corresponding author), Univ Queensland, Queensland Brain Inst, Neurobiol Lab, Brisbane, Qld 4072, Australia.	eyles@uq.edu.au	Eyles, Darryl W/X-3386-2018; Hammond, Luke/AAG-2364-2019	Eyles, Darryl W/0000-0002-5023-7095; Hammond, Luke/0000-0002-4065-7619; Pertile, Renata/0000-0003-4699-8817	National Health and Medical Research Council of Australia [APP1057883]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (APP1057883). Imaging was performed at the Queensland Brain Institute's Advanced Microscopy Facility. The authors declare no conflicts of interest.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Burazin TCD, 1999, MOL BRAIN RES, V73, P151, DOI 10.1016/S0169-328X(99)00217-X; Burke RE, 2006, J NEURAL TRANSM-SUPP, P41; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; CHOILUNDBERG DL, 1995, DEV BRAIN RES, V85, P80, DOI 10.1016/0165-3806(94)00197-8; Cui X, 2015, NEUROSCIENCE, V304, P90, DOI 10.1016/j.neuroscience.2015.07.048; Cui X, 2013, NEUROSCIENCE, V236, P77, DOI 10.1016/j.neuroscience.2013.01.035; Cui XY, 2010, NEUROSCI LETT, V486, P220, DOI 10.1016/j.neulet.2010.09.057; Esposito CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001643; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles D W, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS247, DOI 10.1016/j.psyneuen.2009.04.015; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Galleguillos D, 2010, J NEUROCHEM, V114, P1158, DOI 10.1111/j.1471-4159.2010.06841.x; Hawes JE, 2015, BEHAV BRAIN RES, V286, P192, DOI 10.1016/j.bbr.2015.03.008; He DY, 2006, FASEB J, V20, P2420, DOI 10.1096/fj.06-6394fje; Kesby JP, 2009, NEUROSCI LETT, V461, P155, DOI 10.1016/j.neulet.2009.05.070; Kim JY, 2009, MOL ENDOCRINOL, V23, P251, DOI 10.1210/me.2008-0426; Kowsky S, 2007, P NATL ACAD SCI USA, V104, P20049, DOI 10.1073/pnas.0706177104; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Kramer ER, 2015, NEURAL REGEN RES, V10, P1752, DOI 10.4103/1673-5374.165295; Kramer ER, 2015, FEBS LETT, V589, P3760, DOI 10.1016/j.febslet.2015.11.006; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Li L, 2006, NEUROSCIENCE, V142, P391, DOI 10.1016/j.neuroscience.2006.06.018; Li L, 2009, NEUROL RES, V31, P534, DOI 10.1179/174313209X380810; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Luan W., MOL NEUROBI IN PRESS; Marcos C, 1996, Int J Dev Biol, VSuppl 1, p137S; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; MATKOVITS T, 1995, MOL ENDOCRINOL, V9, P232, DOI 10.1210/me.9.2.232; Meyer MB, 2010, J STEROID BIOCHEM, V121, P136, DOI 10.1016/j.jsbmb.2010.02.011; Naveilhan P, 1996, NEUROREPORT, V7, P2171, DOI 10.1097/00001756-199609020-00023; Nosrat CA, 1997, EXP BRAIN RES, V115, P410, DOI 10.1007/PL00005711; Orme RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062040; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Paratcha G, 2008, TRENDS NEUROSCI, V31, P384, DOI 10.1016/j.tins.2008.05.003; Peng CG, 2007, FEBS LETT, V581, P1357, DOI 10.1016/j.febslet.2007.02.054; Pertile RAN, 2016, NEUROSCIENCE, V333, P193, DOI 10.1016/j.neuroscience.2016.07.020; Prufer K, 1999, J CHEM NEUROANAT, V16, P135, DOI 10.1016/S0891-0618(99)00002-2; Sanchez B, 2002, MOL BRAIN RES, V108, P143, DOI 10.1016/S0169-328X(02)00545-4; Satoh J, 2013, MULT SCLER J, V19, P1035, DOI 10.1177/1352458512471873; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sillivan SE, 2011, NEUROSCIENCE, V199, P501, DOI 10.1016/j.neuroscience.2011.10.004; STROMBERG I, 1993, EXP NEUROL, V124, P401, DOI 10.1006/exnr.1993.1214; STUMPF WE, 1982, SCIENCE, V215, P1403, DOI 10.1126/science.6977846; TOMAC A, 1995, P NATL ACAD SCI USA, V92, P8274, DOI 10.1073/pnas.92.18.8274; Towers TL, 1998, J BIOL CHEM, V273, P10338, DOI 10.1074/jbc.273.17.10338; Trinko JR, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0122-15.2016; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; van Heesbeen HJ, 2013, DEVELOPMENT, V140, P1159, DOI 10.1242/dev.089359; Wallen A, 2001, MOL CELL NEUROSCI, V18, P649, DOI 10.1006/mcne.2001.1057; Wang Y, 2000, NEUROPHARMACOLOGY, V39, P873, DOI 10.1016/S0028-3908(99)00255-5; Yen PM, 1996, J BIOL CHEM, V271, P10910, DOI 10.1074/jbc.271.18.10910; Zella LA, 2007, J STEROID BIOCHEM, V103, P435, DOI 10.1016/j.jsbmb.2006.12.019; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	56	36	40	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					819	828		10.1096/fj.201700713R	http://dx.doi.org/10.1096/fj.201700713R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29018141				2022-12-26	WOS:000425146900024
J	Kolodecik, TR; Reed, AM; Date, K; Shugrue, CA; Patel, V; Chung, SL; Desir, GV; Gorelick, FS				Kolodecik, Thomas R.; Reed, Anamika M.; Date, Kimie; Shugrue, Christine A.; Patel, Vikhil; Chung, Shang-Lin; Desir, Gary V.; Gorelick, Fred S.			The serum protein renalase reduces injury in experimental pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE CA2+-ATPASE; ACINAR-CELLS; CA2+; INHIBITION; EXPRESSION; OXIDASE; GROWTH; AKI	Acute pancreatitis is a disease associated with inflammation and tissue damage. One protein that protects against acute injury, including ischemic injury to both the kidney and heart, is renalase, which is secreted into the blood by the kidney and other tissues. However, whether renalase reduces acute injury associated with pancreatitis is unknown. Here, we used both in vitro and in vivo murine models of acute pancreatitis to study renalase's effects on this condition. In isolated pancreatic lobules, pretreatment with recombinanthumanrenalase(rRNLS) blockedzymogen activation causedbycerulein, carbachol, andabileacid. Renalase also blocked cerulein-induced cell injury and histological changes. In the in vivo cerulein model of pancreatitis, genetic deletion of renalase resulted in more severe disease, and administering rRNLS to cerulein-exposed WT mice after pancreatitis onset was protective. Because pathological increases in acinar cell cytosolic calcium levels are central to the initiation of acute pancreatitis, we also investigated whether rRNLS could function through its binding protein, plasma membrane calcium ATPase 4b (PMCA4b), which excretes calcium from cells. We found that PMCA4b is expressed in both murine and human acinar cells and that a PMCA4b-selective inhibitor worsens pancreatitis-induced injury and blocks the protective effects of rRNLS. These findings suggest that renalase is a protective plasmaprotein that reduces acinar cell injury through a plasma membrane calcium ATPase. Because exogenous rRNLS reduces the severity of acute pancreatitis, it has potential as a therapeutic agent.	[Kolodecik, Thomas R.; Reed, Anamika M.; Shugrue, Christine A.; Patel, Vikhil; Chung, Shang-Lin; Desir, Gary V.; Gorelick, Fred S.] Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA; [Kolodecik, Thomas R.; Reed, Anamika M.; Shugrue, Christine A.; Patel, Vikhil; Chung, Shang-Lin; Desir, Gary V.; Gorelick, Fred S.] Vet Affairs Connecticut Healthcare Syst, West Haven, CT 06516 USA; [Date, Kimie] Ochanomizu Univ, Tokyo 1128610, Japan	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Ochanomizu University	Gorelick, FS (corresponding author), VA CT Healthcare Syst, Dept Internal Med & Cell Biol, 950 Campbell Ave, West Haven, CT 06516 USA.; Gorelick, FS (corresponding author), Yale Univ, Sch Med, 950 Campbell Ave, West Haven, CT 06516 USA.	fred.gorelick@yale.edu	Asanuma, Kimie/AAW-2543-2020; Chung, Shang-Lin/GYR-1637-2022	Asanuma, Kimie/0000-0003-4311-0544; 	National Institutes of Health [P30DK079310, P30DK034989]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086402, P30DK034989, RC1DK086465, P30DK079310, R01DK081037, T32DK007356] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank Guy E. Groblewski from the University of Wisconsin for providing the human cDNA used for PCR analysis of PMCA isoforms. We also acknowledge the Yale George M. O'Brien Kidney Center at Yale (supported by National Institutes of Health Grant P30DK079310) and the Yale Silvio O. Conte Digestive Diseases Research Core Center (supported by National Institutes of Health Grant P30DK034989) for technical support.	Alexander RT, 2015, AM J PHYSIOL-RENAL, V309, pF604, DOI 10.1152/ajprenal.00651.2014; Baggaley E, 2007, J BIOL CHEM, V282, P37678, DOI 10.1074/jbc.M703416200; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Bruce JIE, 2007, AM J PHYSIOL-CELL PH, V293, pC938, DOI 10.1152/ajpcell.00582.2006; Duan WJ, 2013, PROTEIN CELL, V4, P286, DOI 10.1007/s13238-013-2116-z; Gerasimenko JV, 2014, J PHYSIOL-LONDON, V592, P269, DOI 10.1113/jphysiol.2013.261784; Guo XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22996; Hollander L, 2016, CANCER RES, V76, P3884, DOI 10.1158/0008-5472.CAN-15-1524; Kim HJ, 2012, J CELL BIOL, V199, P1145, DOI 10.1083/jcb.201204067; Lee HT, 2013, J AM SOC NEPHROL, V24, P445, DOI 10.1681/ASN.2012090943; Li XG, 2015, KIDNEY BLOOD PRESS R, V40, P215, DOI 10.1159/000368497; Mankad P, 2012, J BIOL CHEM, V287, P1823, DOI 10.1074/jbc.M111.326272; Patel R, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108712; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Reed AM, 2011, J BIOL CHEM, V286, P1919, DOI 10.1074/jbc.M110.158329; Roy N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110843; Samad A, 2014, J BIOL CHEM, V289, P23582, DOI 10.1074/jbc.M114.589440; Shah AU, 2009, AM J PHYSIOL-GASTR L, V297, pG967, DOI 10.1152/ajpgi.00181.2009; Strehler EE, 2015, BIOCHEM BIOPH RES CO, V460, P26, DOI 10.1016/j.bbrc.2015.01.121; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122932; Wang L, 2014, J AM SOC NEPHROL, V25, P1226, DOI 10.1681/ASN.2013060665; Wang Y, 2017, J CELL MOL MED, V21, P1260, DOI 10.1111/jcmm.13062; Wildi S, 2007, GUT, V56, P685, DOI 10.1136/gut.2006.105833; Wu YL, 2011, KIDNEY INT, V79, P853, DOI 10.1038/ki.2010.488; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066; Yang YM, 2014, J BIOL CHEM, V289, P24971, DOI 10.1074/jbc.M114.577221	27	16	18	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21047	21059		10.1074/jbc.M117.789776	http://dx.doi.org/10.1074/jbc.M117.789776			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29042438	Green Published, hybrid			2022-12-26	WOS:000418453400020
J	Yano, H; Provasi, D; Cai, NS; Filizola, M; Ferre, S; Javitch, JA				Yano, Hideaki; Provasi, Davide; Cai, Ning Sheng; Filizola, Marta; Ferre, Sergi; Javitch, Jonathan A.			Development of novel biosensors to study receptor-mediated activation of the G-protein subunits G(s) and G(olf)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioluminescence resonance energy transfer (BRET); dopamine receptor; G protein; G-protein-coupled receptor (GPCR); pharmacology	BETA(2) ADRENERGIC-RECEPTOR; ADENYLYL-CYCLASE; NUCLEOTIDE EXCHANGE; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; LIVING CELLS; DOPAMINE; STRIATUM; COMPLEX	G(s) (G(s)) and G(olf) (G(olf)) are highly homologous G-protein subunits that activate adenylate cyclase, thereby serving as crucial mediators of intracellular signaling. Because of their dramatically different brain expression patterns, we studied similarities and differences between their activation processes with the aim of comparing their receptor coupling mechanisms. We engineered novel luciferase- and Venus-fused G constructs that can be used in bioluminescence resonance energy transfer assays. In conjunction with molecular simulations, these novel biosensors were used to determine receptor activation-induced changes in conformation. Relative movements in G(s) were consistent with the crystal structure of (2) adrenergic receptor in complex with G(s). Conformational changes in G(olf) activation are shown to be similar to those in G(s). Overall the current study reveals general similarities between G(s) and G(olf) activation at the molecular level and provides a novel set of tools to search for G(s)- and G(olf)-specific receptor pharmacology. In view of the wide functional and pharmacological roles of G(s)- and G(olf)-coupled dopamine D-1 receptor and adenosine A(2A) receptor in the brain and other organs, elucidating their differential structure-function relationships with G(s) and G(olf) might provide new approaches for the treatment of a variety of neuropsychiatric disorders. In particular, these novel biosensors can be used to reveal potentially therapeutic dopamine D-1 receptor and adenosine A(2A) receptor ligands with functionally selective properties between G(s) and G(olf) signaling.	[Yano, Hideaki; Cai, Ning Sheng; Ferre, Sergi] NIDA, Baltimore, MD 21224 USA; [Provasi, Davide; Filizola, Marta] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; New York State Psychiatry Institute	Yano, H (corresponding author), NIDA, Baltimore, MD 21224 USA.; Javitch, JA (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA.; Javitch, JA (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA.; Javitch, JA (corresponding author), New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA.	yanoh@nih.gov; jaj2@columbia.edu	; Ferre, Sergi/K-6115-2014	Provasi, Davide/0000-0002-2868-303X; Yano, Hideaki/0000-0001-9242-3884; Ferre, Sergi/0000-0002-1747-1779; Javitch, Jonathan/0000-0001-7395-2967	National Institute on Drug Abuse; Japan Society for the Promotion of Science; National Institutes of Health [DA022413, MH54137, DA026434]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, K02DA026434, ZIADA000493] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Intramural funds of the National Institute on Drug Abuse (to S.F.), a fellowship from the Japan Society for the Promotion of Science (to H.Y.), and National Institutes of Health Grants DA022413 and MH54137 (to J.A.J.) and DA026434 (to M.F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Chan P, 2011, J BIOL CHEM, V286, P2625, DOI 10.1074/jbc.M110.178897; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Corradi JP, 2005, MOL PSYCHIATR, V10, P1017, DOI 10.1038/sj.mp.4001713; Corvol JC, 2001, J NEUROCHEM, V76, P1585, DOI 10.1046/j.1471-4159.2001.00201.x; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Frederick AL, 2015, MOL PSYCHIATR, V20, P1373, DOI 10.1038/mp.2014.166; Fuchs T, 2013, NAT GENET, V45, P88, DOI 10.1038/ng.2496; Gabay M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002223; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Herve D, 2001, J NEUROSCI, V21, P4390, DOI 10.1523/JNEUROSCI.21-12-04390.2001; HERVE D, 1993, J NEUROSCI, V13, P2237, DOI 10.1523/jneurosci.13-05-02237.1993; Herve D, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00048; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Kumar KR, 2014, JAMA NEUROL, V71, P490, DOI 10.1001/jamaneurol.2013.4677; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu HY, 2001, J NEUROCHEM, V78, P325, DOI 10.1046/j.1471-4159.2001.00422.x; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Marchi M, 1999, J CHEM PHYS, V110, P3697, DOI 10.1063/1.478259; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schwindinger WF, 2003, J BIOL CHEM, V278, P6575, DOI 10.1074/jbc.M211132200; Schwindinger WF, 2010, J BIOL CHEM, V285, P29787, DOI 10.1074/jbc.M110.142620; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Urizar E, 2011, NAT CHEM BIOL, V7, P624, DOI [10.1038/NCHEMBIO.623, 10.1038/nchembio.623]; Vemula SR, 2013, HUM MOL GENET, V22, P2510, DOI 10.1093/hmg/ddt102; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Xie KQ, 2015, ELIFE, V4, DOI 10.7554/eLife.10451; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200; Zhuang XX, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-16-j0001.2000	41	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					19989	19998		10.1074/jbc.M117.800698	http://dx.doi.org/10.1074/jbc.M117.800698			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29042444	hybrid, Green Published			2022-12-26	WOS:000417696400006
J	Zhang, QS; Kurpad, DS; Mahoney, MG; Steinbeck, MJ; Freeman, TA				Zhang, Qian-Shi; Kurpad, Deepa S.; Mahoney, My G.; Steinbeck, Marla J.; Freeman, Theresa A.			Inhibition of apoptosis signal-regulating kinase 1 alters the wound epidermis and enhances auricular cartilage regeneration	PLOS ONE			English	Article							KERATINOCYTE DIFFERENTIATION; APPENDAGE REGENERATION; INTRACELLULAR CALCIUM; DIGIT AMPUTATION; EXPRESSION; MOUSE; MODEL; MICE; CELL; TRANSCRIPTION	Why regeneration does not occur in mammals remains elusive. In lower vertebrates, epimorphic regeneration of the limb is directed by the wound epidermis, which controls blastema formation to promote regrowth of the appendage. Herein, we report that knockout (KO) or inhibition of Apoptosis Signal-regulated Kinase-1 (ASK1), also known as mitogen-activated protein kinase kinase kinase 5 (MAP3K5), after full thickness ear punch in mice prolongs keratinocyte activation within the wound epidermis and promotes regeneration of auricular cartilage. Histological analysis showed the ASK1 KO ears displayed enhanced protein markers associated with blastema formation, hole closure and regeneration of auricular cartilage. At seven days after punch, the wound epidermis morphology was markedly different in the KO, showing a thickened stratum corneum with rounded cell morphology and a reduction of both the granular cell layer and decreased expression of filament aggregating protein. In addition, cytokeratin 6 was expressed in the stratum spinosum and granulosum. Topical application of inhibitors of ASK1 (NQDI-1), the upstream ASK1 activator, calcium activated mitogen kinase 2 (KN93), or the downstream target, c-Jun N-terminal kinase (SP600125) also resulted in enhanced regeneration; whereas inhibition of the other downstream target, the p38 alpha/beta isoforms, (SB203580) had no effect. The results of this investigation indicate ASK1 inhibition prolongs keratinocyte and blastemal cell activation leading to ear regeneration.	[Zhang, Qian-Shi; Kurpad, Deepa S.; Freeman, Theresa A.] Thomas Jefferson Univ, Dept Orthopaed Surg, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Zhang, Qian-Shi] Cent S Univ, Dept Spine Surg, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Mahoney, My G.; Freeman, Theresa A.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Steinbeck, Marla J.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	Jefferson University; Central South University; Jefferson University; Drexel University	Freeman, TA (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.; Freeman, TA (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.	Theresa.Freeman@jefferson.edu		Freeman, Theresa/0000-0002-5959-5884	National Institute for Craniofacial Research [R03DE20840]; National Institute of Biomedical Imaging and Bioengineering (Freeman) [R01E6013011]	National Institute for Craniofacial Research; National Institute of Biomedical Imaging and Bioengineering (Freeman)	This work was supported by NIH grants R03DE20840 from National Institute for Craniofacial Research and R01E6013011 from National Institute of Biomedical Imaging and Bioengineering (Freeman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedelbaeva K, 2010, P NATL ACAD SCI USA, V107, P5845, DOI 10.1073/pnas.1000830107; Bikle DD, 2012, EXPERT REV ENDOCRINO, V7, P461, DOI 10.1586/EEM.12.34; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Cheng CH, 2013, PHYSIOL GENOMICS, V45, P409, DOI 10.1152/physiolgenomics.00142.2012; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Del Carlo M, 2003, ARTHRITIS RHEUM-US, V48, P3419, DOI 10.1002/art.11338; DENNING MF, 1995, CELL GROWTH DIFFER, V6, P149; DeOliveira D, 2011, INT J RADIAT BIOL, V87, P869, DOI 10.3109/09553002.2011.568575; Eaton GJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.480; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; Fitzgerald J, 2008, OSTEOARTHR CARTILAGE, V16, P1319, DOI 10.1016/j.joca.2008.03.014; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Gourevitch D, 2003, DEV DYNAM, V226, P377, DOI 10.1002/dvdy.10243; Gourevitch DL, 2009, WOUND REPAIR REGEN, V17, P447, DOI 10.1111/j.1524-475X.2009.00492.x; Harada C, 2006, AM J PATHOL, V168, P261, DOI 10.2353/ajpath.2006.050765; Heber-Katz E, 2009, ANN NY ACAD SCI, V1172, P110, DOI 10.1111/j.1749-6632.2009.04499.x; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kawarazaki Y, 2014, EXPERT OPIN THER TAR, V18, P651, DOI 10.1517/14728222.2014.896903; Kench JA, 1999, CLIN IMMUNOL, V92, P300, DOI 10.1006/clim.1999.4754; Li W, 2001, J INVEST DERMATOL, V117, P1601, DOI 10.1046/j.0022-202x.2001.01608.x; NIGAM SK, 1992, P NATL ACAD SCI USA, V89, P6162, DOI 10.1073/pnas.89.13.6162; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; Sayama K, 2005, EUR J IMMUNOL, V35, P1886, DOI 10.1002/eji.200425827; Sayama K, 2001, J BIOL CHEM, V276, P999, DOI 10.1074/jbc.M003425200; Schumacher M, 2014, J INVEST DERMATOL, V134, P1332, DOI 10.1038/jid.2013.535; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Stoll SW, 2003, WOUND REPAIR REGEN, V11, P346, DOI 10.1046/j.1524-475X.2003.11506.x; Stuart RO, 1996, J BIOL CHEM, V271, P13636, DOI 10.1074/jbc.271.23.13636; Takahashi H, 1998, J INVEST DERMATOL, V110, P218, DOI 10.1046/j.1523-1747.1998.00110.x; Tamura K, 2010, DEV GROWTH DIFFER, V52, P89, DOI 10.1111/j.1440-169X.2009.01144.x; Wong PP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008369; Zhang QS, 2015, J CELL PHYSL; Zhang Y, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010228	35	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185803	10.1371/journal.pone.0185803	http://dx.doi.org/10.1371/journal.pone.0185803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045420	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100028
J	Krefft, D; Papkov, A; Zylicz-Stachula, A; Skowron, PM				Krefft, Daria; Papkov, Aliaksei; Zylicz-Stachula, Agnieszka; Skowron, Piotr M.			Thermostable proteins bioprocesses: The activity of restriction endonuclease-methyltransferase from Thermus thermophilus (RM.TthHB27I) cloned in Escherichia coli is critically affected by the codon composition of the synthetic gene	PLOS ONE			English	Article							2 RECOGNITION SITES; WEB SERVER; USAGE; DNA; TAQII; EXPRESSION; BACTERIA; GENOME; TOOL; OPTIMIZATION	Obtaining thermostable enzymes (thermozymes) is an important aspect of biotechnology. As thermophiles have adapted their genomes to high temperatures, their cloned genes' expression in mesophiles is problematic. This is mainly due to their high GC content, which leads to the formation of unfavorable secondary mRNA structures and codon usage in Escherichia coli (E. coli). RM.TthHB27I is a member of a family of bifunctional thermozymes, containing a restriction endonuclease (REase) and a methyltransferase (MTase) in a single polypeptide. Thermus thermophilus HB27 (T. thermophilus) produces low amounts of RM.TthHB27I with a unique DNA cleavage specificity. We have previously cloned the wild type (wt) gene into E. coli, which increased the production of RM.TthHB27I over 100-fold. However, its enzymatic activities were extremely low for an ORF expressed under a T7 promoter. We have designed and cloned a fully synthetic tthHB27IRM gene, using a modified 'codon randomization' strategy. Codons with a high GC content and of low occurrence in E. coli were eliminated. We incorporated a stem-loop circuit, devised to negatively control the expression of this highly toxic gene by partially hiding the ribosome-binding site (RBS) and START codon in mRNA secondary structures. Despite having optimized 59% of codons, the amount of produced RM.TthHB27I protein was similar for both recombinant tthHB27IRM gene variants. Moreover, the recombinant wt RM.TthHB27I is very unstable, while the RM. TthHB27I resulting from the expression of the synthetic gene exhibited enzymatic activities and stability equal to the native thermozyme isolated from T. thermophilus. Thus, we have developed an efficient purification protocol using the synthetic tthHB27IRM gene variant only. This suggests the effect of co-translational folding kinetics, possibly affected by the frequency of translational errors. The availability of active RM. TthHB27I is of practical importance in molecular biotechnology, extending the palette of available REase specificities.	[Krefft, Daria; Papkov, Aliaksei; Zylicz-Stachula, Agnieszka; Skowron, Piotr M.] Univ Gdansk, Fac Chem, Dept Mol Biotechnol, Wita Stwosza 63, Gdansk, Poland	Fahrenheit Universities; University of Gdansk	Skowron, PM (corresponding author), Univ Gdansk, Fac Chem, Dept Mol Biotechnol, Wita Stwosza 63, Gdansk, Poland.	piotr.skowron@ug.edu.pl	Zylicz-Stachula, Agnieszka/G-8000-2011	Zylicz-Stachula, Agnieszka/0000-0003-2479-3634; Skowron, Piotr/0000-0003-1345-3271; Krefft, Daria/0000-0003-3777-0343	University of Gdansk [DS 530-8645-D691-17]; BMN [538-8170-1068-12]; Gdansk University; Chemistry Department; Centre for Preclinical Research and Technology (CePT); European Regional Development Fund and Innovative Economy; National Cohesion Strategy of Poland	University of Gdansk; BMN; Gdansk University; Chemistry Department; Centre for Preclinical Research and Technology (CePT); European Regional Development Fund and Innovative Economy; National Cohesion Strategy of Poland	This work was supported by University of Gdansk task funds no. DS 530-8645-D691-17 (to Piotr Skowron) and BMN Nr 538-8170-1068-12 (to Dada Krefft), Gdansk University, Chemistry Department fund. Both funding bodies had equal contribution in the design of the study, analysis, and interpretation of data and in writing the manuscript.; Custom software GeneOptimizer 1.1.2. was developed by Krzysztof Miaskowski. The software is available free of charge upon request at: pmars44@gmailcom. Marta Skowron is appreciated for critical reading of the manuscript. Mass Spectrometry was conducted at IBB MS Laboratory in Warsaw (Poland). The equipment used was sponsored in part by the Centre for Preclinical Research and Technology (CePT), a project co-sponsored by European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland.	[Anonymous], 1994, PROGRAM MANUAL WISCO; Bath AJ, 2002, J BIOL CHEM, V277, P4024, DOI 10.1074/jbc.M108441200; Bin Pek H, 2015, ENZYME MICROB TECH, V75-76, P57, DOI 10.1016/j.enzmictec.2015.04.008; Chin JX, 2014, BIOINFORMATICS, V30, P2210, DOI 10.1093/bioinformatics/btu192; Chung BKS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-134; Das S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-186; Dutta C, 2012, CURR GENOMICS, V13, P153, DOI 10.2174/138920212799860698; Fuglsang A, 2003, PROTEIN EXPRES PURIF, V31, P247, DOI 10.1016/S1046-5928(03)00213-4; Green MR, 2012, MOL CLONING LAB MANU, V1; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; Krefft D, 2015, J BIOTECHNOL, V194, P67, DOI 10.1016/j.jbiotec.2014.11.030; Lobry JR, 2006, GENE, V385, P128, DOI 10.1016/j.gene.2006.05.033; Lobry JR, 2003, J APPL GENET, V44, P235; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P20, DOI 10.1093/nar/gkt847; Lynn DJ, 2002, NUCLEIC ACIDS RES, V30, P4272, DOI 10.1093/nar/gkf546; Makino T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-32; Marshall JJT, 2007, J MOL BIOL, V367, P419, DOI 10.1016/j.jmb.2006.12.070; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Menzella HG, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-15; Nowak M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-91; Olszewski M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126563; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Raab David, 2010, Syst Synth Biol, V4, P215, DOI 10.1007/s11693-010-9062-3; Rasko T, 2010, NUCLEIC ACIDS RES, V38, P7155, DOI 10.1093/nar/gkq567; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; Skowron PM, 2017, NUCLEIC ACIDS RES, V45, P9005, DOI 10.1093/nar/gkx599; Skowron PM, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng074; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Villalobos Alan, 2012, Methods Mol Biol, V852, P197, DOI 10.1007/978-1-61779-564-0_15; Welch M, 2011, METHOD ENZYMOL, V498, P43, DOI 10.1016/B978-0-12-385120-8.00003-6; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zylicz-Stachula A, 2016, MOL BIOL REP, V43, P269, DOI 10.1007/s11033-016-3949-3; Zylicz-Stachula A, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-7; Zylicz-Stachula A, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-13; Zylicz-Stachula A, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-62; Zylicz-Stachula A, 2011, BIOTECHNIQUES, V50, P397, DOI 10.2144/000113685; Zylicz-Stachula A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-52	43	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186633	10.1371/journal.pone.0186633	http://dx.doi.org/10.1371/journal.pone.0186633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040308	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500065
J	Nishizawa, A; Suemoto, CK; Farias-Itao, DS; Campos, FM; Silva, KCS; Bittencourt, MS; Grinberg, LT; Leite, REP; Ferretti-Rebustini, REL; Farfel, JM; Jacob, W; Pasqualucci, CA				Nishizawa, Aline; Suemoto, Claudia K.; Farias-Itao, Daniela S.; Campos, Fernanda M.; Silva, Karen C. S.; Bittencourt, Marcio S.; Grinberg, Lea T.; Leite, Renata E. P.; Ferretti-Rebustini, Renata E. L.; Farfel, Jose M.; Jacob-Filho, Wilson; Pasqualucci, Carlos A.			Morphometric measurements of systemic atherosclerosis and visceral fat: Evidence from an autopsy study	PLOS ONE			English	Article							EPICARDIAL ADIPOSE-TISSUE; CORONARY-ARTERY-DISEASE; RISK-FACTOR; PERICARDIAL FAT; ECTOPIC FAT; CARDIOVASCULAR-DISEASE; COMPUTED-TOMOGRAPHY; ABDOMINAL FAT; ASSOCIATION; OBESITY	Background Morphometric measurements of systemic atherosclerosis and direct quantification of visceral fat are only possible using materials from autopsy studies. However, the few autopsy studies that have investigated the association of visceral fat with atherosclerosis had small sample sizes and focused on coronary arteries of young or middle-aged White subjects. We aimed to investigate the association of pericardial fat (PF) and abdominal visceral fat (AVF) with atherosclerosis in the aorta, coronary, carotid, and cerebral arteries in a large autopsy study. Materials and methods We evaluated deceased subjects aged 30 years or above. We dissected and weighted the PF and the AVF and evaluated the atherosclerotic burden in the aorta, as well as the carotid, coronary, and cerebral arteries using morphometric measurements. We also investigated the interaction of PF and AVF with age regarding the atherosclerotic burden. Results The mean age of the 240 included subjects was 64.8 +/- 15.3 years, and 63% was male. Greater PF was associated with a higher degree of aortic atherosclerosis after adjusting for confounding variables (coefficient = 4.39, 95% CI = 0.83; 7.94, p = 0.02). Greater AVF was associated with a higher coronary stenosis index (coefficient = 1.49, 95% CI = 0.15; 2.83, p = 0.03) and a greater number of coronary plaques (coefficient = 0.71, 95% CI = 0.24; 1.19, p = 0.003). We did not find an association of PF or AVF with carotid or cerebral atherosclerotic burden. We found a significant interaction of AVF (coefficient = -0.08; 95% CI = -0.14; -0.02, p = 0.009) and PF (coefficient = -0.87, 95% CI = -1.70; -0.04, p = 0.04) with age regarding carotid artery atherosclerotic burden. Conclusions Greater AVF was associated with greater atherosclerotic burden and extent in coronary arteries, while greater PF correlated with a higher degree of atherosclerosis in the aorta.	[Nishizawa, Aline; Suemoto, Claudia K.; Farias-Itao, Daniela S.; Campos, Fernanda M.; Silva, Karen C. S.; Pasqualucci, Carlos A.] Univ Sao Paulo, Lab Cardiovasc Pathol LIM 22, Dept Pathol, Med Sch, Sao Paulo, Brazil; [Nishizawa, Aline; Suemoto, Claudia K.; Farias-Itao, Daniela S.; Silva, Karen C. S.; Grinberg, Lea T.; Leite, Renata E. P.; Ferretti-Rebustini, Renata E. L.; Farfel, Jose M.; Jacob-Filho, Wilson; Pasqualucci, Carlos A.] Univ Sao Paulo, Pathophysiol Aging Lab, Brazilian Aging Brain Study Grp LIM 22, Med Sch, Sao Paulo, Brazil; [Suemoto, Claudia K.; Leite, Renata E. P.; Farfel, Jose M.; Jacob-Filho, Wilson] Univ Sao Paulo, Discipline Geriatr, Med Sch, Sao Paulo, Brazil; [Bittencourt, Marcio S.] Univ Sao Paulo, Div Internal Med, Univ Hosp, Sao Paulo, Brazil; [Bittencourt, Marcio S.] Univ Sao Paulo, State Sao Paulo Canc Inst ICESP, Sao Paulo, Brazil; [Bittencourt, Marcio S.] Hosp Israelita Albert Einstein, Prevent Med Ctr, Sao Paulo, Brazil; [Bittencourt, Marcio S.] Fac Israelita Ciencia Saude Albert Einstein, Sch Med, Sao Paulo, Brazil; [Grinberg, Lea T.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Grinberg, Lea T.; Pasqualucci, Carlos A.] Univ Sao Paulo, Dept Pathol, Med Sch, Sao Paulo, Brazil; [Ferretti-Rebustini, Renata E. L.] Univ Sao Paulo, Dept Med Surg Nursing, Nursing Sch, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Hospital Israelita Albert Einstein; University of California System; University of California San Francisco; Universidade de Sao Paulo; Universidade de Sao Paulo	Nishizawa, A (corresponding author), Univ Sao Paulo, Lab Cardiovasc Pathol LIM 22, Dept Pathol, Med Sch, Sao Paulo, Brazil.; Nishizawa, A (corresponding author), Univ Sao Paulo, Pathophysiol Aging Lab, Brazilian Aging Brain Study Grp LIM 22, Med Sch, Sao Paulo, Brazil.	anishizawa@alumni.usp.br	Suemoto, Claudia K/C-7218-2012; de Lucena Ferretti-Rebustini, Renata Eloah/C-8126-2012; Bittencourt, Marcio Sommer/C-1444-2011; Itao, Daniela Souza Farias/J-7624-2012; Campos, Fernanda/GRR-6776-2022; Suemoto, Claudia Kimie/AAC-7238-2019; Farfel, Jose/C-8936-2012; Jacob-Filho, Wilson WJF/H-5837-2012	Suemoto, Claudia K/0000-0002-5942-4778; de Lucena Ferretti-Rebustini, Renata Eloah/0000-0002-6159-5787; Bittencourt, Marcio Sommer/0000-0002-3711-1754; Farfel, Jose/0000-0003-2057-3669; 	CAPES Foundation, Ministry of Education of Brazil [1074888]; FAPESP (Sao Paulo Research Foundation) [2013/12290-3]	CAPES Foundation, Ministry of Education of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	AN was supported by a scholarship from the CAPES Foundation, Ministry of Education of Brazil (1074888) (http://www.capes.gov.br/). DSF-I was supported by a scholarship from the FAPESP (Sao Paulo Research Foundation, 2013/12290-3) (http://www.fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apolinario D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060084; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; Berg RM, 2015, CALCIFIED TISSUE INT, V97, P40, DOI 10.1007/s00223-015-0008-3; Bertaso AG, 2013, ARQ BRAS CARDIOL, V101, pE18, DOI 10.5935/abc.20130138; Bettencourt N, 2012, INT J CARDIOL, V158, P26, DOI 10.1016/j.ijcard.2010.12.085; Crossley R. P., 1974, POLICE CHIEF, V41, p[65, 85]; Crossley RP, 1974, POLICE CHIEF, V41, P65; Ding JZ, 2009, AM J CLIN NUTR, V90, P499, DOI 10.3945/ajcn.2008.27358; Dolan H, 2010, ANN NEUROL, V68, P231, DOI 10.1002/ana.22055; Efe D, 2015, VASCULAR, V23, P396, DOI 10.1177/1708538114552012; Ferretti Renata Eloah de Lucena, 2010, Dement. neuropsychol., V4, P138, DOI 10.1590/S1980-57642010DN40200011; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Greif M, 2009, ARTERIOSCL THROM VAS, V29, P781, DOI 10.1161/ATVBAHA.108.180653; Grinberg Lea Tenenholz, 2007, Cell and Tissue Banking, V8, P151, DOI 10.1007/s10561-006-9022-z; Higuchi S, 2017, ATHEROSCLEROSIS, V259, P41, DOI 10.1016/j.atherosclerosis.2017.03.001; Hirata Y, 2011, INT HEART J, V52, P139, DOI 10.1536/ihj.52.139; Inomoto Atsushi, 2016, J Phys Ther Sci, V28, P2883; Jeong JW, 2007, CIRC J, V71, P536, DOI 10.1253/circj.71.536; Karcher HS, 2013, CEREBROVASC DIS, V35, P341, DOI 10.1159/000348703; Kocaman SA, 2016, ANATOL J CARDIOL; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kortelainen ML, 1997, ARTERIOSCL THROM VAS, V17, P574, DOI 10.1161/01.ATV.17.3.574; Kortelainen ML, 1999, ARTERIOSCL THROM VAS, V19, P695, DOI 10.1161/01.ATV.19.3.695; Kortelainen ML, 2001, INT J OBESITY, V25, P228, DOI 10.1038/sj.ijo.0801466; Kortelainen ML, 1997, INT J OBESITY, V21, P43, DOI 10.1038/sj.ijo.0800361; Kuipers AL, 2017, ATHEROSCLEROSIS, V263, P198, DOI 10.1016/j.atherosclerosis.2017.06.030; Lajous M, 2015, AM J MED, V128, P334, DOI 10.1016/j.amjmed.2014.10.043; Lear SA, 2007, STROKE, V38, P2422, DOI 10.1161/STROKEAHA.107.484113; Lim S, 2014, ARTERIOSCL THROM VAS, V34, P1820, DOI 10.1161/ATVBAHA.114.303035; Liu JK, 2012, ATHEROSCLEROSIS, V224, P521, DOI 10.1016/j.atherosclerosis.2012.07.042; Liu JK, 2011, ARTERIOSCL THROM VAS, V31, P2715, DOI 10.1161/ATVBAHA.111.234062; Marques MD, 2010, ATHEROSCLEROSIS, V209, P481, DOI 10.1016/j.atherosclerosis.2009.10.023; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Natale F, 2009, EUR J ECHOCARDIOGR, V10, P549, DOI 10.1093/ejechocard/jep002; Nishizawa A, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000433; Ohashi N, 2010, JACC-CARDIOVASC IMAG, V3, P908, DOI 10.1016/j.jcmg.2010.06.014; Rabkin SW, 2007, OBES REV, V8, P253, DOI 10.1111/j.1467-789X.2006.00293.x; Roher AE, 2003, ARTERIOSCL THROM VAS, V23, P2055, DOI 10.1161/01.ATV.0000095973.42032.44; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Seo JA, 2012, J AM GERIATR SOC, V60, P700, DOI 10.1111/j.1532-5415.2012.03887.x; Sequeira DI, 2015, FORENSIC SCI MED PAT, V11, P186, DOI 10.1007/s12024-015-9659-7; Silaghi A, 2008, OBESITY, V16, P2424, DOI 10.1038/oby.2008.379; SOLBERG LA, 1968, LAB INVEST, V18, P604; Suemoto CK, 2011, STROKE, V42, P3614, DOI 10.1161/STROKEAHA.111.628156; Taguchi R, 2001, ATHEROSCLEROSIS, V157, P203, DOI 10.1016/S0021-9150(00)00709-7; VANDERKOOY K, 1993, INT J OBESITY, V17, P187; WHO, 2016, OB OV WORLD HLTH ORG; Wu FZ, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0195-5; Yorgun H, 2012, INT J CARDIOVAS IMAG, V28, P911, DOI 10.1007/s10554-011-9899-x	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186630	10.1371/journal.pone.0186630	http://dx.doi.org/10.1371/journal.pone.0186630			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036197	Green Submitted, Green Published, gold			2022-12-26	WOS:000413054800051
J	Bochimoto, H; Matsuno, N; Ishihara, Y; Shonaka, T; Koga, D; Hira, Y; Nishikawa, Y; Furukawa, H; Watanabe, T				Bochimoto, Hiroki; Matsuno, Naoto; Ishihara, Yo; Shonaka, Tatsuya; Koga, Daisuke; Hira, Yoshiki; Nishikawa, Yuji; Furukawa, Hiroyuki; Watanabe, Tsuyoshi			The ultrastructural characteristics of porcine hepatocytes donated after cardiac death and preserved with warm machine perfusion preservation	PLOS ONE			English	Article							VIVO LIVER PERFUSION; BILE-DUCT INJURY; SCANNING-ELECTRON-MICROSCOPY; CRITERIA DONOR LIVERS; HEART-BEATING DONOR; ISCHEMIC RAT-LIVER; COLD-STORAGE; SUCCESSFUL TRANSPLANTATION; MITOCHONDRIAL AUTOPHAGY; REWARMING PRESERVATION	The effects of warm machine perfusion preservation of liver grafts donated after cardiac death on the intracellular three-dimensional ultrastructure of the organelles in hepatocytes remain unclear. Here we analyzed comparatively the ultrastructure of the endomembrane systems in porcine hepatocytes under warm ischemia and successive hypothermic and midthermic machine perfusion preservation, a type of the warm machine perfusion. Porcine liver grafts which had a warm ischemia time of 60 minutes were perfused for 4 hours with modified University of Wisconsin gluconate solution. Group A grafts were preserved with hypothermic machine perfusion preservation at 8 degrees C constantly for 4 hours. Group B grafts were preserved with rewarming up to 22 degrees C by warm machine perfusion preservation for 4 hours. An analysis of hepatocytes after 60 minutes of warm ischemia by scanning electron microscope revealed the appearance of abnormal vacuoles and invagination of mitochondria. In the hepatocytes preserved by subsequent hypothermic machine perfusion preservation, strongly swollen mitochondria were observed. In contrast, the warm machine perfusion preservation could preserve the functional appearance of mitochondria in hepatocytes. Furthermore, abundant vacuoles and membranous structures sequestrating cellular organelles like autophagic vacuoles were frequently observed in hepatocytes after warm machine perfusion preservation. In conclusion, the ultrastructure of the endomembrane systems in the hepatocytes of liver grafts changed in accordance with the temperature conditions of machine perfusion preservation. In addition, temperature condition of the machine perfusion preservation may also affect the condition of the hepatic graft attributed to autophagy systems, and consequently alleviate the damage of the hepatocytes.	[Bochimoto, Hiroki] Obihiro Univ Agr & Vet Med, Hlth Care Adm Ctr, Obihiro, Hokkaido, Japan; [Matsuno, Naoto; Shonaka, Tatsuya; Furukawa, Hiroyuki] Asahikawa Med Univ, Dept Surg, Asahikawa, Hokkaido, Japan; [Ishihara, Yo; Koga, Daisuke; Watanabe, Tsuyoshi] Asahikawa Med Univ, Dept Microscop Anat & Cell Biol, Asahikawa, Hokkaido, Japan; [Hira, Yoshiki] Asahikawa Med Univ, Dept Nursing, Area Funct Anat, Asahikawa, Hokkaido, Japan; [Nishikawa, Yuji] Asahikawa Med Univ, Dept Pathol, Asahikawa, Hokkaido, Japan	Obihiro University of Agriculture & Veterinary Medicine; Asahikawa Medical College; Asahikawa Medical College; Asahikawa Medical College; Asahikawa Medical College	Matsuno, N (corresponding author), Asahikawa Med Univ, Dept Surg, Asahikawa, Hokkaido, Japan.	mtn@asahikawa-med.ac.jp		Koga, Daisuke/0000-0002-2792-7207; Bochimoto, Hiroki/0000-0002-1708-0348; Watanabe, Tsuyoshi/0000-0002-6094-7728; Ishihara, Yo/0000-0002-3958-706X; Ishihara, Yo/0000-0002-5675-4026	Japan Society for the Promotion of Science [15K18951]; Asahikawa Medical University; Grants-in-Aid for Scientific Research [15K18951] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Asahikawa Medical University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science Award no. 15K18951 to HB (https://www.jsps.go.jp/english/) and a Grant-in-Aid for Innovative Research in Life Science from Asahikawa Medical University to NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir M, 2013, CELL DEATH DIFFER, V20, P878, DOI 10.1038/cdd.2013.21; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Barbas AS, 2016, TRANSPLANT REV-ORLAN, V30, P154, DOI 10.1016/j.trre.2016.03.002; Berendsen TA, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-6; Bessems M, 2005, LIVER TRANSPLANT, V11, P1379, DOI 10.1002/lt.20502; Bhogal RH, 2012, AUTOPHAGY, V8, P545, DOI 10.4161/auto.19012; Boehnert MU, 2013, AM J TRANSPLANT, V13, P1441, DOI 10.1111/ajt.12224; Bruinsma BG, 2014, AM J TRANSPLANT, V14, P1400, DOI 10.1111/ajt.12727; Bruinsma BG, 2015, JOVE-J VIS EXP, DOI 10.3791/52777; Bruinsma BG, 2013, INT J ARTIF ORGANS, V36, P775, DOI 10.5301/ijao.5000250; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; de Rougemont O, 2009, ANN SURG, V250, P674, DOI 10.1097/SLA.0b013e3181bcb1ee; den Dries SO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088521; Ding WX, 2014, HEPATOLOGY, V59, P1235, DOI 10.1002/hep.26736; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dutkowski P, 2008, AM J TRANSPLANT, V8, P917, DOI 10.1111/j.1600-6143.2008.02165.x; Dutkowski P, 2006, ANN SURG, V244, P968, DOI 10.1097/01.sla.0000247056.85590.6b; Echeverri J, 2016, LIVER TRANSPLANT, V22, pS29, DOI 10.1002/lt.24622; Evankovich J, 2012, AM J PHYSIOL-GASTR L, V303, pG189, DOI 10.1152/ajpgi.00051.2012; Fondevila C, 2011, ANN SURG, V254, P1000, DOI 10.1097/SLA.0b013e31822b8b2f; Fontes P, 2015, AM J TRANSPLANT, V15, P381, DOI 10.1111/ajt.12991; Furukori M, 2016, TRANSPL P, V48, P1239, DOI 10.1016/j.transproceed.2015.12.076; Goldaracena N, 2016, LIVER TRANSPLANT, V22, P1573, DOI 10.1002/lt.24603; Goldaracena N, 2016, CURR OPIN ORGAN TRAN, V21, P315, DOI 10.1097/MOT.0000000000000305; Guarrera JV, 2015, AM J TRANSPLANT, V15, P161, DOI 10.1111/ajt.12958; Guarrera JV, 2010, AM J TRANSPLANT, V10, P372, DOI 10.1111/j.1600-6143.2009.02932.x; Guarrera JV, 2005, TRANSPL P, V37, P323, DOI 10.1016/j.transproceed.2004.12.094; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Isola R, 2010, MITOCHONDRION, V10, P472, DOI 10.1016/j.mito.2010.05.007; Jurado F, 1997, HISTOL HISTOPATHOL, V12, P123; Karangwa SA, 2016, AM J TRANSPLANT, V16, P2932, DOI 10.1111/ajt.13843; Kim JS, 2008, HEPATOLOGY, V47, P1725, DOI 10.1002/hep.22187; Kim JS, 1997, TRANSPLANT P, V29, P3452, DOI 10.1016/S0041-1345(97)00975-5; Knaak JM, 2014, LIVER TRANSPLANT, V20, P1296, DOI 10.1002/lt.23986; Koetting M, 2011, TRANSPLANTATION, V91, P42, DOI 10.1097/TP.0b013e3181fed021; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004; Li XT, 2003, TOXICOL PATHOL, V31, P682, DOI 10.1080/714044702; Liu Q, 2014, LIVER TRANSPLANT, V20, P987, DOI 10.1002/lt.23906; Marecki H, 2017, LIVER TRANSPLANT, V23, P679, DOI 10.1002/lt.24751; Matsuno N, 2014, TRANSPL P, V46, P1095, DOI 10.1016/j.transproceed.2013.12.035; Matsuno N, 1998, CLIN TRANSPLANT, V12, P1; Meng L, 2016, TRANSPL P, V48, P2467, DOI 10.1016/j.transproceed.2016.03.059; Minor T, 2006, AM J TRANSPLANT, V6, P1355, DOI 10.1111/j.1600-6143.2006.01338.x; Minor T, 2013, AM J TRANSPLANT, V13, P1450, DOI 10.1111/ajt.12235; Minor T, 2011, AM J TRANSPLANT, V11, P2627, DOI 10.1111/j.1600-6143.2011.03731.x; Minor T, 2009, LIVER TRANSPLANT, V15, P798, DOI 10.1002/lt.21751; Moers C, 2012, NEW ENGL J MED, V366, P770, DOI 10.1056/NEJMc1111038; Monbaliu D, 2005, TRANSPLANTATION, V79, P1226, DOI 10.1097/01.TP.0000153508.71684.99; Monbaliu D, 2008, LIVER TRANSPLANT, V14, P1256, DOI 10.1002/lt.21513; Moussa M E, 1996, Liver Transpl Surg, V2, P461, DOI 10.1002/lt.500020609; Namas RA, 2011, SHOCK, V36, P196, DOI 10.1097/SHK.0b013e3182205e07; Nassar A, 2014, SURG INNOV; Nassar A, 2016, ARTIF ORGANS, V40, P999, DOI 10.1111/aor.12699; Obara H, 2013, TRANSPL P, V45, P1690, DOI 10.1016/j.transproceed.2013.01.087; Olschewski P, 2010, CRYOBIOLOGY, V60, P337, DOI 10.1016/j.cryobiol.2010.03.005; op den Dries S, 2013, AM J TRANSPLANT, V13, P1327, DOI 10.1111/ajt.12187; op den Dries S, 2016, LIVER TRANSPLANT, V22, P994, DOI 10.1002/lt.24436; Peralta C, 2013, J HEPATOL, V59, P1094, DOI 10.1016/j.jhep.2013.06.017; Perk Sinem, 2012, BMC Res Notes, V5, P325, DOI 10.1186/1756-0500-5-325; Perk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028518; SALAS M, 1980, PATHOL RES PRACT, V167, P217, DOI 10.1016/S0344-0338(80)80052-5; SALAS M, 1977, EXPERIENTIA, V33, P612, DOI 10.1007/BF01946531; Schlegel A, 2013, J HEPATOL, V58, P278, DOI 10.1016/j.jhep.2012.10.004; Selzner M, 2016, LIVER TRANSPLANT, V22, P1501, DOI 10.1002/lt.24499; Shigeta T, 2013, TRANSPL P, V45, P1684, DOI 10.1016/j.transproceed.2013.01.098; Siskova Z, 2010, AM J PATHOL, V177, P1411, DOI 10.2353/ajpath.2010.091037; Srinivasan PK, 2012, LIVER TRANSPLANT, V18, P219, DOI 10.1002/lt.22442; TANAKA K, 1984, J MICROSC-OXFORD, V133, P213, DOI 10.1111/j.1365-2818.1984.tb00487.x; Tolboom H, 2008, TRANSPL P, V40, P1306, DOI 10.1016/j.transproceed.2008.03.100; Tolboom H, 2012, J SURG RES, V175, P149, DOI 10.1016/j.jss.2011.03.003; Tolboom H, 2009, TRANSPLANTATION, V87, P170, DOI 10.1097/TP.0b013e318192df6b; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333; Trowell O. A., 1946, JOUR PHYSIOL, V105, P268; Vairetti M, 2009, LIVER TRANSPLANT, V15, P20, DOI 10.1002/lt.21581; Watanabe I, 1996, HISTOL HISTOPATHOL, V11, P103; Westerkamp AC, 2016, TRANSPLANTATION, V100, P825, DOI 10.1097/TP.0000000000001081; Westerkamp AC, 2015, LIVER TRANSPLANT, V21, P1300, DOI 10.1002/lt.24200; Ye H, 2014, J HUAZHONG U SCI-MED, V34, P687, DOI 10.1007/s11596-014-1337-6; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	81	9	9	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186352	10.1371/journal.pone.0186352	http://dx.doi.org/10.1371/journal.pone.0186352			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023512	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100115
J	Choi, SH; Severson, E; Pear, WS; Liu, XLS; Aster, JC; Blacklow, SC				Choi, Sung Hee; Severson, Eric; Pear, Warren S.; Liu, Xiaole S.; Aster, Jon C.; Blacklow, Stephen C.			The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia	PLOS ONE			English	Article							ACTIVATING MUTATIONS; C-MYC; TARGET; SENSITIVITY; EXPRESSION; INDUCTION; REVEALS; BINDING	Notch is a major oncogenic driver in T cell acute lymphoblastic leukemia (T-ALL), in part because it binds to an enhancer that increases expression of MYC. Here, we exploit the capacity of activated NOTCH1 and NOTCH3 to induce T-ALL, despite substantial divergence in their intracellular regions, as a means to elucidate a broad, common Notch-dependent oncogenomic program through systematic comparison of the transcriptomes and Notch-bound genomic regulatory elements of NOTCH1- and NOTCH3-dependent T-ALL cells. ChIP-seq studies show a high concordance of functional NOTCH1 and NOTCH3 genomic binding sites that are enriched in binding motifs for RBPJ, the transcription factor that recruits activated Notch to DNA. The interchangeability of NOTCH1 and NOTCH3 was confirmed by rescue of NOTCH1-dependent T-ALL cells with activated NOTCH3 and vice versa. Despite remarkable overall similarity, there are nuanced differences in chromatin landscapes near critical common Notch target genes, most notably at a Notch-dependent enhancer that regulates MYC, which correlates with responsiveness to Notch pathway inhibitors. Overall, a common oncogenomic program driven by binding of either Notch is sufficient to maintain T-ALL cell growth, whereas cell-context specific differences appear to influence the response of T-ALL cells to Notch inhibition.	[Choi, Sung Hee; Blacklow, Stephen C.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Choi, Sung Hee; Blacklow, Stephen C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Severson, Eric; Aster, Jon C.; Blacklow, Stephen C.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Severson, Eric; Aster, Jon C.; Blacklow, Stephen C.] Harvard Med Sch, Boston, MA 02115 USA; [Severson, Eric; Liu, Xiaole S.] Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA; [Severson, Eric; Liu, Xiaole S.] Dana Farber Canc Inst, Dept Computat Biol, Boston, MA 02115 USA; [Severson, Eric; Liu, Xiaole S.] Harvard Sch Publ Hlth, Boston, MA USA; [Pear, Warren S.] Univ Penn, Dept Pathol & Lab Med, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; Pennsylvania Medicine	Blacklow, SC (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Blacklow, SC (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.; Aster, JC; Blacklow, SC (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Aster, JC; Blacklow, SC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	jaster@rics.bwh.harvard.edu; stephen_blacklow@hms.harvard.edu			National Institutes of Health/National Cancer Institute [5 R01 CA092433, 5 P01 CA119170, 1 R35 CA220340]; Novartis Institutes for BioMedical Research: Novartis-DFCI DDP; NATIONAL CANCER INSTITUTE [R35CA220340] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Novartis Institutes for BioMedical Research: Novartis-DFCI DDP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Institutes of Health/National Cancer Institute: 5 R01 CA092433 (to Stephen C. Blacklow); 5 P01 CA119170 (to Jon C. Aster, Xiaole S. Liu, Warren S. Pear, and Stephen C. Blacklow); 1 R35 CA220340 (to Stephen C. Blacklow); and the Novartis Institutes for BioMedical Research: Novartis-DFCI DDP (to Stephen C. Blacklow). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Aster JC, 2014, J PATHOL, V232, P1, DOI 10.1002/path.4291; Aster JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025645; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bellavia D, 2007, EMBO J, V26, P1670, DOI 10.1038/sj.emboj.7601626; Bernasconi-Elias P, 2016, ONCOGENE, V35, P6077, DOI 10.1038/onc.2016.133; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gerhardt DM, 2014, GENE DEV, V28, P576, DOI 10.1101/gad.227496.113; Gonzalez-Garcia S, 2012, CURR TOP MICROBIOL, V360, P47, DOI 10.1007/82_2012_231; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Medyouf H, 2011, J EXPT MED; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakagawa M, 2006, BLOOD, V108, P3329, DOI 10.1182/blood-2006-04-019570; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roti G, 2013, CANCER CELL, V23, P390, DOI 10.1016/j.ccr.2013.01.015; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terriente-Felix A, 2013, DEVELOPMENT, V140, P926, DOI 10.1242/dev.086785; Trimarchi T, 2014, CELL, V158, P593, DOI 10.1016/j.cell.2014.05.049; Waegemans E, 2014, J IMMUNOL, V193, P5997, DOI 10.4049/jimmunol.1400764; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xu X, 2015, STRUCTURE, V23, P1227, DOI 10.1016/j.str.2015.05.001; Yashiro-Ohtani Y, 2014, P NATL ACAD SCI USA, V111, pE4946, DOI 10.1073/pnas.1407079111	41	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185762	10.1371/journal.pone.0185762	http://dx.doi.org/10.1371/journal.pone.0185762			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023469	gold, Green Published, Green Submitted			2022-12-26	WOS:000412845100028
J	Ficken, CD; Wright, JP				Ficken, Cari D.; Wright, Justin P.			Effects of fire frequency on litter decomposition as mediated by changes to litter chemistry and soil environmental conditions	PLOS ONE			English	Article							LEAF-LITTER; TERRESTRIAL ECOSYSTEMS; MICROBIAL ACTIVITY; PRESCRIBED FIRE; MESIC GRASSLAND; ENZYME-ACTIVITY; LONG-TERM; FOREST; SAVANNA; CLIMATE	Litter quality and soil environmental conditions are well-studied drivers influencing decomposition rates, but the role played by disturbance legacy, such as fire history, in mediating these drivers is not well understood. Fire history may impact decomposition directly, through changes in soil conditions that impact microbial function, or indirectly, through shifts in plant community composition and litter chemistry. Here, we compared early-stage decomposition rates across longleaf pine forest blocks managed with varying fire frequencies (annual burns, triennial burns, fire-suppression). Using a reciprocal transplant design, we examined how litter chemistry and soil characteristics independently and jointly influenced litter decomposition. We found that both litter chemistry and soil environmental conditions influenced decomposition rates, but only the former was affected by historical fire frequency. Litter from annually burned sites had higher nitrogen content than litter from triennially burned and fire suppression sites, but this was correlated with only a modest increase in decomposition rates. Soil environmental conditions had a larger impact on decomposition than litter chemistry. Across the landscape, decomposition differed more along soil moisture gradients than across fire management regimes. These findings suggest that fire frequency has a limited effect on litter decomposition in this ecosystem, and encourage extending current decomposition frameworks into disturbed systems. However, litter from different species lost different masses due to fire, suggesting that fire may impact decomposition through the preferential combustion of some litter types. Overall, our findings also emphasize the important role of spatial variability in soil environmental conditions, which may be tied to fire frequency across large spatial scales, in driving decomposition rates in this system.	[Ficken, Cari D.; Wright, Justin P.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Ficken, CD (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	cari.ficken@duke.edu	Wright, Justin/AAG-6461-2019	Wright, Justin/0000-0002-9102-5347; Ficken, Cari/0000-0003-4132-4354	U.S. Army Engineer Research Development Center, Construction Engineering Research Laboratory (ERDC-CERL) [W9132T-11-2-0008]	U.S. Army Engineer Research Development Center, Construction Engineering Research Laboratory (ERDC-CERL)	Funding for this project was provided by grant W9132T-11-2-0008 from the U.S. Army Engineer Research Development Center, Construction Engineering Research Laboratory (ERDC-CERL) to JPW.	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P2898, DOI 10.1111/j.1365-2486.2008.01716.x; Ames GM, 2016, FUNCT ECOL, V30, P789, DOI 10.1111/1365-2435.12536; Averill C, 2014, NATURE, V505, P543, DOI 10.1038/nature12901; Ayres E, 2009, J ECOL, V97, P901, DOI 10.1111/j.1365-2745.2009.01539.x; Ayres E, 2009, SOIL BIOL BIOCHEM, V41, P606, DOI 10.1016/j.soilbio.2008.12.022; BERG B, 1993, BIOGEOCHEMISTRY, V20, P127, DOI 10.1007/BF00000785; Boerner REJ, 2003, APPL SOIL ECOL, V23, P137, DOI 10.1016/S0929-1393(03)00022-2; Bradford MA, 2016, J ECOL, V104, P229, DOI 10.1111/1365-2745.12507; Bray SR, 2012, SOIL BIOL BIOCHEM, V49, P30, DOI 10.1016/j.soilbio.2012.02.009; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Brockway DG, 1997, FOREST ECOL MANAG, V96, P167, DOI 10.1016/S0378-1127(96)03939-4; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; CHRISTENSEN NL, 1977, OECOLOGIA, V31, P27, DOI 10.1007/BF00348706; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Ficken CD, 2017, BIOGEOSCIENCES, V14, P241, DOI 10.5194/bg-14-241-2017; Fill JM, 2016, PLANT ECOL, V217, P331, DOI 10.1007/s11258-016-0574-0; Gagnon PR, 2015, J ECOL, V103, P1009, DOI 10.1111/1365-2745.12421; Garcia-Palacios P, 2016, J ECOLOGY; Garcia-Palacios P, 2016, FUNCT ECOL, V30, P819, DOI 10.1111/1365-2435.12589; Gomez JD, 2014, EUR J SOIL SCI, V65, P28, DOI 10.1111/ejss.12097; Grady JM, 2012, ECOLOGY, V93, P2052, DOI 10.1890/12-0354.1; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; Jacqmain EI, 1999, AM MIDL NAT, V141, P85, DOI 10.1674/0003-0031(1999)141[0085:IOFCSB]2.0.CO;2; Jones DL, 2012, SOIL BIOL BIOCHEM, V45, P113, DOI 10.1016/j.soilbio.2011.10.012; Keiser AD, 2014, J ECOL, V102, P603, DOI 10.1111/1365-2745.12220; Kirkman KP, 2014, J VEG SCI, V25, P793, DOI 10.1111/jvs.12130; Lavoie M, 2010, NAT AREA J, V30, P82, DOI 10.3375/043.030.0109; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Lett MS, 2003, J VEG SCI, V14, P487, DOI 10.1111/j.1654-1103.2003.tb02175.x; Matulich KL, 2015, ECOLOGY, V96, P154, DOI 10.1890/14-0357.1; Midgley MG, 2015, J ECOL, V103, P1454, DOI 10.1111/1365-2745.12467; OJIMA DS, 1994, BIOGEOCHEMISTRY, V24, P67, DOI 10.1007/BF02390180; Pellegrini AFA, 2014, ECOLOGY, V95, P342, DOI 10.1890/13-0290.1; Pinheiro J., 2011, PACKAGE NLME; Prendergast-Miller MT, 2017, SOIL BIOL BIOCHEM, V109, P1, DOI 10.1016/j.soilbio.2017.01.027; Reed HE, 2009, APPL SOIL ECOL, V42, P79, DOI 10.1016/j.apsoil.2009.01.009; Sorrie BA, 2006, CASTANEA, V71, P129, DOI 10.2179/05-02.1; Staff SS, WEB SOIL SURVEY NATU; Staver AC, 2012, AM NAT, V180, P211, DOI 10.1086/666648; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Steinweg JM, 2012, SOIL BIOL BIOCHEM, V55, P85, DOI 10.1016/j.soilbio.2012.06.015; Strickland MS, 2009, FUNCT ECOL, V23, P627, DOI 10.1111/j.1365-2435.2008.01515.x; Talbot JM, 2012, ECOLOGY, V93, P345, DOI 10.1890/11-0843.1; Team RDC, 2011, LANG ENV STAT COMP; Tharayil N, 2011, NEW PHYTOL, V191, P132, DOI 10.1111/j.1469-8137.2011.03667.x; Varner JM, 2015, CURR FOR REP, V1, P91, DOI 10.1007/s40725-015-0012-x; Veldman JW, 2014, J VEG SCI, V25, P1438, DOI 10.1111/jvs.12195; Wan SQ, 2001, ECOL APPL, V11, P1349, DOI 10.1890/1051-0761(2001)011[1349:FEONPA]2.0.CO;2; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Wieder WR, 2015, NAT GEOSCI, V8, P441, DOI 10.1038/NGEO2413; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]	54	19	19	6	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186292	10.1371/journal.pone.0186292	http://dx.doi.org/10.1371/journal.pone.0186292			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023560	gold, Green Published, Green Submitted			2022-12-26	WOS:000412845100099
J	Sorde, L; Spindeldreher, S; Palmer, E; Karle, A				Sorde, Laetitia; Spindeldreher, Sebastian; Palmer, Ed; Karle, Anette			Massive immune response against IVIg interferes with response against other antigens in mice: A new mode of action?	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN IVIG; T-CELL-ACTIVATION; FC-GAMMA RECEPTOR; ANTIINFLAMMATORY ACTIVITY; MEDIATED AMELIORATION; ADVERSE EVENTS; IN-VIVO; B-CELLS; ANTIIDIOTYPIC ANTIBODIES; THERAPEUTIC-EFFICACY	Administration of high dose intravenous immunoglobulin (IVIg) is widely used in the clinic to treat autoimmune and severe inflammatory diseases. However, its mechanisms of action remain poorly understood. We assessed the impact of IVIg on immune cell populations using an in vivo ovalbumin (Ova)-immunization mouse model. High dose IVIg significantly reduced the Ova-specific antibody response. Intriguingly, the results obtained indicate an immediate and massive immune reaction against IVIg, as shown by the activation and expansion of B cells and CD4+ T cells in the spleen and draining lymph nodes and the production of IVIg-specific antibodies. We propose that IVIg competes at the T-cell level with the response against Ova to explain the immunomodulatory properties of IVIg. Two monoclonal antibodies did not succeeded in reproducing the effects of IVIg. This suggests that in addition to the mouse response against human constant domains, the enormous sequence diversity of IVIg may significantly contribute to this massive immune response against IVIg. While correlation of these findings to IVIg-treated patients remains to be explored, our data demonstrate for the first time that IVIg re-directs the immune response towards IVIg and away from a specific antigen response.	[Sorde, Laetitia; Karle, Anette] Novartis Pharma AG, Integrated Biol Profiling Unit, Immunogen Risk Assessment, Basel, Switzerland; [Spindeldreher, Sebastian] Novartis Inst Biomed Res, Drug Metab & Pharmacokinet, Biol, Basel, Switzerland; [Palmer, Ed] Univ Hosp Basel, Dept Biomed Transplantat Immunol & Nephrol, Basel, Switzerland; [Sorde, Laetitia] Novimmune SA, Exploratory Sci & Translat Med, Plan Les Ouates, Switzerland	Novartis; Novartis; University of Basel; NovImmune SA	Karle, A (corresponding author), Novartis Pharma AG, Integrated Biol Profiling Unit, Immunogen Risk Assessment, Basel, Switzerland.	anette.karle@novartis.com			Novartis Pharma AG	Novartis Pharma AG	This work was funded by Novartis Pharma AG. Laetitia Sorde, Sebastian Spindeldreher and Anette C. Karle are current or former full-time employees at Novartis Pharma AG. The funder provided support in the form of salaries for authors [L.S., S.S. and A.K.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abe J, 2005, J IMMUNOL, V174, P5837, DOI 10.4049/jimmunol.174.9.5837; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Arumugam TV, 2007, P NATL ACAD SCI USA, V104, P14104, DOI 10.1073/pnas.0700506104; Aubin E, 2011, CLIN IMMUNOL, V141, P273, DOI 10.1016/j.clim.2011.06.009; Aubin E, 2010, BLOOD, V115, P1727, DOI 10.1182/blood-2009-06-225417; Basta M, 2003, NAT MED, V9, P431, DOI 10.1038/nm836; BASTA M, 1994, J CLIN INVEST, V94, P1729, DOI 10.1172/JCI117520; Bayry J, 2009, P NATL ACAD SCI USA, V106, pE24, DOI 10.1073/pnas.0900016106; Bazin R, 2006, BRIT J HAEMATOL, V135, P97, DOI 10.1111/j.1365-2141.2006.06245.x; Bleeker WK, 2001, BLOOD, V98, P3136, DOI 10.1182/blood.V98.10.3136; Bouhlal H, 2014, J CLIN IMMUNOL, V34, pS4, DOI 10.1007/s10875-014-0019-2; Brady RO, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.6.e11; BRODY NI, 1969, J EXP MED, V130, P821, DOI 10.1084/jem.130.4.821; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; Bussel JB, 2000, SEMIN HEMATOL, V37, P261, DOI 10.1053/shem.2000.8957; Campbell IK, 2014, J IMMUNOLOGY; COICO RF, 1983, J IMMUNOL, V131, P2254; Crow AR, 2011, BLOOD, V118, P6403, DOI 10.1182/blood-2011-08-374223; Crow AR, 2003, BLOOD, V102, P558, DOI 10.1182/blood-2003-01-0023; de Grandmont MJ, 2003, BLOOD, V101, P3065, DOI 10.1182/blood-2002-06-1684; De Groot AS, 2008, BLOOD, V112, P3303, DOI 10.1182/blood-2008-02-138073; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; Dussault N, 2008, INT IMMUNOL, V20, P1369, DOI 10.1093/intimm/dxn090; Fiebiger BM, 2015, P NATL ACAD SCI US; Fuchs S, 2008, J NEUROIMMUNOL, V194, P89, DOI 10.1016/j.jneuroim.2007.11.020; Gelfand EW, 2012, NEW ENGL J MED, V367, P2015, DOI 10.1056/NEJMra1009433; Gurcan HM, 2007, ANN PHARMACOTHER, V41, P1604, DOI 10.1345/aph.1K198; Hamrock DJ, 2006, INT IMMUNOPHARMACOL, V6, P535, DOI 10.1016/j.intimp.2005.11.015; Hansen RJ, 2002, BLOOD, V100, P2087, DOI 10.1182/blood.V100.6.2087.h81802002087_2087_2093; Hayball JD, 2004, IMMUNOL CELL BIOL, V82, P103, DOI 10.1046/j.0818-9641.2004.01233.x; Hunt JD, 1995, VACCINE, V13, P1649, DOI 10.1016/0264-410X(95)00145-Q; Issekutz AC, 2015, CLIN IMMUNOL, V160, P123, DOI 10.1016/j.clim.2015.05.003; Kaneko Y, 2006, J EXP MED, V203, P789, DOI 10.1084/jem.20051900; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Katz U, 2007, AUTOIMMUN REV, V6, P257, DOI 10.1016/j.autrev.2006.08.011; Kivity S, 2010, CLIN REV ALLERG IMMU, V38, P201, DOI 10.1007/s12016-009-8155-9; Kubisz P, 2015, BLOOD COAGUL FIBRIN, V26, P604, DOI 10.1097/MBC.0000000000000304; Le Pottier L, 2007, ANN NY ACAD SCI, V1110, P426, DOI 10.1196/annals.1423.044; Leong H, 2008, AM J HEALTH-SYST PH, V65, P1815, DOI 10.2146/ajhp070582; Leontyev D, 2012, TRANSFUSION, V52, P1799, DOI 10.1111/j.1537-2995.2011.03517.x; Leontyev D, 2012, BLOOD, V119, P5261, DOI 10.1182/blood-2012-03-415695; Leucht S, 2001, CLIN IMMUNOL, V99, P18, DOI 10.1006/clim.2001.5004; Li N, 2005, J CLIN INVEST, V115, P3440, DOI 10.1172/JCI24394; Massoud A. H., 2013, J ALLERGY CLIN IMMUN; Messinger YH, 2012, GENET MED, V14, P135, DOI 10.1038/gim.2011.4; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Mimouni D, 2010, CLIN EXP IMMUNOL, V162, P543, DOI 10.1111/j.1365-2249.2010.04265.x; Nagelkerke SQ, 2014, BLOOD, V124, P3709, DOI 10.1182/blood-2014-05-576835; Neron S, 2009, ARCH IMMUNOL THER EX, V57, P447, DOI 10.1007/s00005-009-0048-3; Othy S, 2014, EUR J IMMUNOL, V44, P2059, DOI 10.1002/eji.201444440; Othy S, 2013, J IMMUNOL, V190, P4535, DOI 10.4049/jimmunol.1201965; Palabrica FRR, 2013, ASIA PAC ALLERGY, V3, P249, DOI 10.5415/apallergy.2013.3.4.249; Pratama A, 2014, IMMUNOL CELL BIOL, V92, P40, DOI 10.1038/icb.2013.69; RHODES JM, 1972, IMMUNOLOGY, V23, P817; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Schwab I, 2014, EUROPEAN J IMMUNOLOG; Schwab I, 2012, EUR J IMMUNOL, V42, P826, DOI 10.1002/eji.201142260; Shimomura M, 2012, CLIN EXP IMMUNOL, V169, P33, DOI 10.1111/j.1365-2249.2012.04591.x; Shoenfeld Y, 2002, INT IMMUNOL, V14, P1303, DOI 10.1093/intimm/dxf099; Sorde L, 2017, IMMUN INFLAMM DIS; SUNDBLAD A, 1991, J AUTOIMMUN, V4, P325, DOI 10.1016/0896-8411(91)90028-B; Tackenberg B, 2009, P NATL ACAD SCI USA, V106, P4788, DOI 10.1073/pnas.0807319106; Teeling JL, 2001, BLOOD, V98, P1095, DOI 10.1182/blood.V98.4.1095; Tremblay T, 2013, TRANSFUSION, V53, P261, DOI 10.1111/j.1537-2995.2012.03725.x; Vassilev TL, 1999, BLOOD, V93, P3624, DOI 10.1182/blood.V93.11.3624.411a28_3624_3631; Wadhwa M, 2000, IMMUNOLOGY, V99, P113, DOI 10.1046/j.1365-2567.2000.00949.x; Washburn N., 2015, P NATL ACAD SCI USA; Weaver JM, 2009, P NATL ACAD SCI USA, V106, P8647, DOI 10.1073/pnas.0811584106; Willis RA, 2006, P NATL ACAD SCI USA, V103, P12063, DOI 10.1073/pnas.0605130103; Wolpert EZ, 1998, J IMMUNOL, V161, P4499; Yu LL, 2008, INVEST OPHTH VIS SCI, V49, P522, DOI 10.1167/iovs.07-1175	71	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186046	10.1371/journal.pone.0186046	http://dx.doi.org/10.1371/journal.pone.0186046			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023507	gold, Green Published, Green Submitted			2022-12-26	WOS:000412845100056
J	Wang, JL; Zhao, J; Wang, SJ; Gong, R; Zheng, Z; Liu, LQ				Wang, Jianglan; Zhao, Jiao; Wang, Shoujing; Gong, Rui; Zheng, Zhong; Liu, Longqian			Cognitive processing of orientation discrimination in anisometropic amblyopia	PLOS ONE			English	Article							VISUAL CORTICAL RESPONSES; P300 COMPONENT; BOTTOM-UP; TOP-DOWN; ERP; ATTENTION; P3A; AMPLITUDE; UTILITY; TARGET	Cognition is very important in our daily life. However, amblyopia has abnormal visual cognition. Physiological changes of the brain during processes of cognition could be reflected with ERPs. So the purpose of this study was to investigate the speed and the capacity of resource allocation in visual cognitive processing in orientation discrimination task during monocular and binocular viewing conditions of amblyopia and normal control as well as the corresponding eyes of the two groups with ERPs. We also sought to investigate whether the speed and the capacity of resource allocation in visual cognitive processing vary with target stimuli at different spatial frequencies (3, 6 and 9 cpd) in amblyopia and normal control as well as between the corresponding eyes of the two groups. Fifteen mild to moderate anisometropic amblyopes and ten normal controls were recruited. Three-stimulus oddball paradigms of three different spatial frequency orientation discrimination tasks were used in monocular and binocular conditions in amblyopes and normal controls to elicit event-related potentials (ERPs). Accuracy (ACC), reaction time (RT), the latency of novelty P300 and P3b, and the amplitude of novelty P300 and P3b were measured. Results showed that RT was longer in the amblyopic eye than in both eyes of amblyopia and non-dominant eye in control. Novelty P300 amplitude was largest in the amblyopic eye, followed by the fellow eye, and smallest in both eyes of amblyopia. Novelty P300 amplitude was larger in the amblyopic eye than non-dominant eye and was larger in fellow eye than dominant eye. P3b latency was longer in the amblyopic eye than in the fellow eye, both eyes of amblyopia and non-dominant eye of control. P3b latency was not associated with RT in amblyopia. Neural responses of the amblyopic eye are abnormal at the middle and late stages of cognitive processing, indicating that the amblyopic eye needs to spend more time or integrate more resources to process the same visual task. Fellow eye and both eyes in amblyopia are slightly different from the dominant eye and both eyes in normal control at the middle and late stages of cognitive processing. Meanwhile, abnormal extents of amblyopic eye do not vary with three different spatial frequencies used in our study.	[Wang, Jianglan] Sichuan Univ, West China Sch Med, Dept Optometry & Visual Sci, Chengdu, Sichuan, Peoples R China; [Zhao, Jiao] Peoples Hosp Leshan, Dept Ophthalmol, Leshan, Sichuan, Peoples R China; [Wang, Shoujing] Sichuan Univ, West China Hosp, Med Engn Dept, Chengdu, Sichuan, Peoples R China; [Gong, Rui; Liu, Longqian] Sichuan Univ, West China Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China; [Zheng, Zhong] Sichuan Univ, West China Hosp, Neurobiol Lab Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Liu, LQ (corresponding author), Sichuan Univ, West China Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China.; Zheng, Z (corresponding author), Sichuan Univ, West China Hosp, Neurobiol Lab Ctr, Chengdu, Sichuan, Peoples R China.	zhengzhong1963@163.com; b.q15651@hotmail.com			 [321160192]		This work was funded by The Orthokeratology used for Temporary Correction with Grant number 321160192 (LL).	Awh E, 2000, J COGNITIVE NEUROSCI, V12, P840, DOI 10.1162/089892900562444; Banko EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066583; Banko EM, 2013, CORTEX, V49, P1013, DOI 10.1016/j.cortex.2012.03.021; Barrett BT, 2013, PROG RETIN EYE RES, V36, P120, DOI 10.1016/j.preteyeres.2013.05.001; Birch EE, 2013, PROG RETIN EYE RES, V33, P67, DOI 10.1016/j.preteyeres.2012.11.001; Bledowski C, 2004, NEUROIMAGE, V22, P530, DOI 10.1016/j.neuroimage.2003.12.034; Bonneh YS, 2004, VISION RES, V44, P3099, DOI 10.1016/j.visres.2004.07.031; BRYDEN MP, 1977, NEUROPSYCHOLOGIA, V15, P617, DOI 10.1016/0028-3932(77)90067-7; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Dadeya S, 2009, J PEDIAT OPHTH STRAB, V46, P87, DOI 10.3928/01913913-20090301-07; Dejanovic M, 2015, MINERVA END IN PRESS; Demiralp T, 2001, BRAIN TOPOGR, V13, P251, DOI 10.1023/A:1011102628306; Ding J, 2013, J VISION, V13, DOI 10.1167/13.2.14; Dolman P., 1919, AM J OPHTHALMOL, V2, P867, DOI [10.1016/S0002-9394(19)90258-3, DOI 10.1016/S0002-9394(19)90258-3]; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; DUNCANJOHNSON CC, 1981, PSYCHOPHYSIOLOGY, V18, P207; FRIEDMAN D, 1994, COGNITIVE BRAIN RES, V2, P49, DOI 10.1016/0926-6410(94)90020-5; GIEDKE H, 1981, BIOL PSYCHOL, V13, P31, DOI 10.1016/0301-0511(81)90026-0; Guo Q, 2014, SCHIZOPHR RES, V160, P57, DOI 10.1016/j.schres.2014.10.006; Hamm LM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00583; HANSENNE M, 1995, EVOKED POTENTIAL, V96, P194, DOI 10.1016/0168-5597(94)00317-8; Ho CS, 2009, VISION RES, V49, P2891, DOI 10.1016/j.visres.2009.07.012; Ho CS, 2005, VISION RES, V45, P1615, DOI 10.1016/j.visres.2004.12.009; Holmes JM, 2006, LANCET, V367, P1343, DOI 10.1016/S0140-6736(06)68581-4; Hou C, 2008, J VISION, V8, DOI 10.1167/8.4.2; Husk JS, 2012, J VISION, V12, DOI 10.1167/12.4.4; Hussain Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01210; Ilan AB, 1999, CLIN NEUROPHYSIOL, V110, P367, DOI 10.1016/S0168-5597(98)00053-7; Inoue Yuki, 2007, No To Hattatsu, V39, P263; Jimenez-Rodriguez A, 2015, MED BIOL ENG COMPUT, V53, P889, DOI 10.1007/s11517-015-1283-x; JOHNSON R, 1993, PSYCHOPHYSIOLOGY, V30, P90; Joly O, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00062; Joshi M., 2015, J VISION, V15, P193; Kirkil G, 2007, CLIN NEUROL NEUROSUR, V109, P553, DOI 10.1016/j.clineuro.2007.03.013; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Kortvelyes J, 2012, ACTA BIOL HUNG, V63, P65, DOI 10.1556/ABiol.63.2012.Suppl.1.7; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kok A, 1997, BIOL PSYCHOL, V45, P19, DOI 10.1016/S0301-0511(96)05221-0; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Levi DM, 2015, VISION RES, V114, P17, DOI 10.1016/j.visres.2015.01.002; Levi DM, 2002, VISION RES, V42, P1379, DOI 10.1016/S0042-6989(02)00061-5; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; Meier K, 2015, J VIS, V15, P653; Parisi V, 2010, INVEST OPHTH VIS SCI, V51, P5041, DOI 10.1167/iovs.10-5412; Polich J, 1996, PSYCHOPHYSIOLOGY, V33, P747, DOI 10.1111/j.1469-8986.1996.tb02371.x; Polich J, 2003, BRAIN TOPOGR, V15, P141, DOI 10.1023/A:1022637732495; Polich J, 1998, J CLIN NEUROPHYSIOL, V15, P14, DOI 10.1097/00004691-199801000-00004; Polich J, 1996, PSYCHOPHYSIOLOGY, V33, P334, DOI 10.1111/j.1469-8986.1996.tb01058.x; POLICH J, 1987, ELECTROEN CLIN NEURO, V68, P311, DOI 10.1016/0168-5597(87)90052-9; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Polich J., 2003, DETECTION CHANGE EVE, P83, DOI DOI 10.1007/978-1-4615-0294-4_; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pontifex MB, 2009, PSYCHOPHYSIOLOGY, V46, P379, DOI 10.1111/j.1469-8986.2008.00782.x; Rashad MA, 2012, CLIN OPHTHALMOL, V6, P409, DOI 10.2147/OPTH.S29941; Rushby JA, 2005, CLIN NEUROPHYSIOL, V116, P2363, DOI 10.1016/j.clinph.2005.06.008; Samarawickrama C, 2009, J AAPOS, V13, P142, DOI 10.1016/j.jaapos.2008.11.004; Schummers J, 2005, PROG BRAIN RES, V149, P65, DOI 10.1016/S0079-6123(05)49006-8; Seppanen M, 2012, ATTEN PERCEPT PSYCHO, V74, P600, DOI 10.3758/s13414-011-0257-9; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; STANZIONE P, 1991, ELECTROEN CLIN NEURO, V80, P446, DOI 10.1016/0168-5597(91)90093-D; Tsirlin I, 2015, J VIS, V15, P656; Vecchio Fabrizio, 2011, Int J Alzheimers Dis, V2011, P653173, DOI 10.4061/2011/653173; Verleger R, 1997, PSYCHOPHYSIOLOGY, V34, P131, DOI 10.1111/j.1469-8986.1997.tb02125.x; Wang XM, 2012, MOL VIS, V18, P909; Wilson DE, 2016, NAT NEUROSCI, V19, P1003, DOI 10.1038/nn.4323; Zhou B, 2014, J EXP PSYCHOL GEN, V143, P1893, DOI 10.1037/a0037294	67	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186221	10.1371/journal.pone.0186221	http://dx.doi.org/10.1371/journal.pone.0186221			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023501	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100085
J	Xie, FY; Hosany, S; Zhong, S; Jiang, Y; Zhang, F; Lin, LL; Wang, XB; Gao, SM; Hui, XQ				Xie, FeiYan; Hosany, Sumayyah; Zhong, Shen; Jiang, Yang; Zhang, Fen; Lin, LiLi; Wang, XiaoBo; Gao, ShenMeng; Hui, XiaoQu			MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1	PLOS ONE			English	Article							MULTI-CHEMORESISTANCE; TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; LUNG-CANCER; MIR-193A-3P; EXPRESSION; APOPTOSIS; PROMOTES; GROWTH	In many cancers, microRNA-193a (miR-193a) is a suppressor miRNA, but its underlying anti-oncogenic activity in breast cancer is not known. In this study, we found decreased miR-193a (specifically, miR-193a-5p) expression not only in breast cancer cell lines but also in breast cancer tissues as compared with the adjacent non-tumor tissues. Ectopic miR-193a overexpression inhibited the proliferation, colony formation, migration, and invasion of MDA-MB-231 and BT549 cells. miR-193a reduced Wilms' tumor 1 (WT1) expression and repressed luciferase reporter activity by binding WT1 coding region sequences; mutation of the predicted miR-193a binding site abolished this effect. miR-193a and WT1 expression were significantly inversely correlated in breast cancer tissues. Importantly, the anti-cancer activity induced by miR-193a was partially reversed by WT1 overexpression, indicating an important role for WT1 in such activity related to miR-193a. Our results reveal that miR-193a-WT1 interaction plays an important role in breast cancer metastasis, and suggest that restoring miR-193a expression is a therapeutic strategy in breast cancer.	[Xie, FeiYan; Hosany, Sumayyah; Zhong, Shen; Jiang, Yang; Zhang, Fen; Lin, LiLi; Wang, XiaoBo] Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China; [Gao, ShenMeng] Wenzhou Med Univ, Affiliated Hosp 1, Lab Internal Med, Wenzhou, Zhejiang, Peoples R China; [Hui, XiaoQu] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Gao, SM (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Lab Internal Med, Wenzhou, Zhejiang, Peoples R China.; Hui, XQ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Wenzhou, Zhejiang, Peoples R China.	gaoshenmeng77@126.com; drhxj@126.com	Lin, Lili/AHC-1654-2022	Lin, Lili/0000-0002-8694-7486	Natural Science Foundation of China [81572580, 81672087]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China [grant numbers: 81572580 to Xiaoqu Hu and 81672087 to Shen Meng Gao]. The Natural Science Foundation of China can be accessed on the following URL www.nsfc.gov.cn and all the relevant information can be verified. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Deng H, 2015, BBA-MOL BASIS DIS, V1852, P520, DOI 10.1016/j.bbadis.2014.12.014; Deng H, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-234; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fisher JN, 2015, ONCOTARGET, V6, P13176, DOI 10.18632/oncotarget.3759; Gao XN, 2011, ONCOGENE, V30, P3416, DOI 10.1038/onc.2011.62; Iliopoulos D, 2011, CANCER RES, V71, P5144, DOI 10.1158/0008-5472.CAN-11-0425; Kwon JE, 2013, APOPTOSIS, V18, P896, DOI 10.1007/s10495-013-0841-7; Leivonen SK, 2014, MOL ONCOL, V8, P93, DOI 10.1016/j.molonc.2013.10.001; Li Y, 2015, ONCOTARGET, V6, P10195, DOI 10.18632/oncotarget.3555; Liang HW, 2015, J BIOL CHEM, V290, P926, DOI 10.1074/jbc.M114.621409; Lindstedt I, 2014, IN VIVO, V28, P675; Liu LQ, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317711951; LV L, 2014, CELL DEATH DIS, V5; Lv L, 2015, CANCER LETT, V357, P105, DOI 10.1016/j.canlet.2014.11.002; Ma KL, 2012, J BIOL CHEM, V287, P5639, DOI 10.1074/jbc.M111.291229; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Moelans CB, 2011, J PATHOL, V225, P222, DOI 10.1002/path.2930; Nakano H, 2013, INT J ONCOL, V42, P1875, DOI 10.3892/ijo.2013.1896; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Qi XW, 2012, ONCOL REP, V28, P1231, DOI 10.3892/or.2012.1906; Salvi A, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-162; Tahiri A, 2014, CARCINOGENESIS, V35, P76, DOI 10.1093/carcin/bgt333; Toska E, 2014, BIOCHEM J, V461, P15, DOI 10.1042/BJ20131587; Tsai KW, 2016, SCI REP-UK, V6, DOI 10.1038/srep28176; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Wang JL, 2013, CELL PHYSIOL BIOCHEM, V32, P1707, DOI 10.1159/000356605; Wang W, 2015, J ZHEJIANG UNIV-SC B, V16, P18, DOI 10.1631/jzus.B1400184; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Williams M, 2015, ONCOTARGET, V6, P23480, DOI 10.18632/oncotarget.4346; Yang Y, 2013, ONCOGENE, V32, P3432, DOI 10.1038/onc.2012.360; Yong FL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-280; Yu T, 2015, ONCOGENE, V34, P413, DOI 10.1038/onc.2013.574	34	48	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185565	10.1371/journal.pone.0185565	http://dx.doi.org/10.1371/journal.pone.0185565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016617	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400023
J	Horiuchi, K; Ishihara, M; Imanaka, K				Horiuchi, Kentaro; Ishihara, Masami; Imanaka, Kuniyasu			The essential role of optical flow in the peripheral visual field for stable quiet standing: Evidence from the use of a head-mounted display	PLOS ONE			English	Article							POSTURAL RESPONSES; VISION; LOCOMOTION; STANCE	It has long been thought that vision is the most essential factor in maintaining stable quiet standing compared to other sources (i.e., vestibular and somatosensory inputs) of information. Specifically, several vision studies on postural control have shown evidence for the importance of the visual system, particularly peripheral vision rather than central vision, and optical flow. Nevertheless, to date, no study has manipulated both visual field and optical flow concurrently. In the present study, we experimentally manipulated both the visual field (the central and peripheral visual fields) and the occurrence of optical flow during quiet standing, examining the effects of the visual field and optical flow on postural sway measured in terms of the center of pressure (CoP). Stationary random dot stimuli were presented exclusively in either the central or peripheral visual field, while the occurrence of optical flow was manipulated using a desktop (DTD) or a head-mounted (HMD) display. The optical flow that occurred while using the DTD was a function of the postural sway during quiet standing, while for the HMD, no optical flow occurred even when the body/head swayed during quiet standing. Our results show that the extent of postural sway (e.g., CoP area) was smaller when visual stimuli were presented in the peripheral visual field than that in the central visual field; this was the case while using the DTD alone, with no effects of the peripheral vision on the extent of postural sway while using the HMD. It is therefore suggested that the optical flow occurring in the peripheral visual field is essential for stable quiet standing.	[Horiuchi, Kentaro; Imanaka, Kuniyasu] Tokyo Metropolitan Univ, Dept Hlth Promot Sci, Tokyo, Japan; [Horiuchi, Kentaro; Ishihara, Masami] Tokyo Metropolitan Univ, Dept Human Sci, Tokyo, Japan	Tokyo Metropolitan University; Tokyo Metropolitan University	Imanaka, K (corresponding author), Tokyo Metropolitan Univ, Dept Hlth Promot Sci, Tokyo, Japan.	imanaka@tmu.ac.jp			Japan Society for the Promotion of Science [25242060]; Grants-in-Aid for Scientific Research [17H00875] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid for Scientific Research (A), #25242060, awarded to KI by the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLARD B, 1980, PERCEPT MOTOR SKILL, V51, P903, DOI 10.2466/pms.1980.51.3.903; Berencsi A, 2005, HUM MOVEMENT SCI, V24, P689, DOI 10.1016/j.humov.2005.10.014; BRANDT T, 1973, EXP BRAIN RES, V16, P476, DOI 10.1007/BF00234474; Charles C, 2002, J VESTIBUL RES-EQUIL, V12, P135; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Cunningham DW, 2006, P IEEE VIRT REAL ANN, P111, DOI 10.1109/VR.2006.14; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; Dichgans Johannes, 1978, PERCEPTION, P755, DOI DOI 10.1007/978-3-642-46354-9_25; DIJKSTRA TMH, 1992, HUM MOVEMENT SCI, V11, P195, DOI 10.1016/0167-9457(92)90060-O; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Gibson J.J., 1966, SENSES CONSIDERED PE; Gibson J.J., 1966, SENSES CONSIDERED PE; HUFSCHMIDT A, 1980, ARCH PSYCHIAT NERVEN, V228, P135, DOI 10.1007/BF00365601; Kapteyn T S, 1983, Agressologie, V24, P321; Kawakita T, 2000, JPN J PHYSIOL, V50, P315, DOI 10.2170/jjphysiol.50.315; KELLY DH, 1984, J OPT SOC AM A, V1, P107, DOI 10.1364/JOSAA.1.000107; Kelly JW, 2008, PERCEPT PSYCHOPHYS, V70, P158, DOI 10.3758/PP.70.1.158; Kiyota Y, 2011, DISABIL REHABIL, V33, P2567, DOI 10.3109/09638288.2011.579226; Knaut LA, 2009, ARCH PHYS MED REHAB, V90, P793, DOI 10.1016/j.apmr.2008.10.030; LEE DN, 1974, PERCEPT PSYCHOPHYS, V15, P529, DOI 10.3758/BF03199297; Lee DN, 1975, J HUMAN MOVEMENT STU, V1, P87, DOI DOI 10.3758/BF03199297; LISHMAN JR, 1973, PERCEPTION, V2, P287, DOI 10.1068/p020287; Magdalon EC, 2011, ACTA PSYCHOL, V138, P126, DOI 10.1016/j.actpsy.2011.05.015; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Munafo J, 2017, EXP BRAIN RES, V235, P889, DOI 10.1007/s00221-016-4846-7; Nougier V, 1997, GAIT POSTURE, V5, P34, DOI 10.1016/S0966-6362(96)01071-5; Nougier V, 1998, J EXP CHILD PSYCHOL, V68, P202, DOI 10.1006/jecp.1997.2427; Osaka N., 1994, NEW SENSATION PERCEP, P923; Osterberg G, 1935, Acta Ophthalmol., V13, P11; Oullier O, 2002, HUM MOVEMENT SCI, V21, P147, DOI 10.1016/S0167-9457(02)00093-3; Park Du-Jin, 2016, J Phys Ther Sci, V28, P1769, DOI 10.1589/jpts.28.1769; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Piponnier JC, 2009, J VISION, V9, DOI 10.1167/9.1.13; PREVIC FH, 1995, J VESTIBUL RES-EQUIL, V5, P399, DOI 10.1016/0957-4271(95)00019-C; Prokop T, 1997, EXP BRAIN RES, V114, P63, DOI 10.1007/PL00005624; Robert MT, 2016, GAIT POSTURE, V48, P261, DOI 10.1016/j.gaitpost.2016.06.010; Schmidt R.A., 2011, HUMAN KINETICS; STOFFREGEN TA, 1987, PERCEPTION, V16, P113, DOI 10.1068/p160113; Stoffregen TA, 2004, PRESENCE-TELEOP VIRT, V13, P601, DOI 10.1162/1054746042545274; STOFFREGEN TA, 1985, J EXP PSYCHOL HUMAN, V11, P554, DOI 10.1037/0096-1523.11.5.554; Streepey JW, 2007, GAIT POSTURE, V25, P49, DOI 10.1016/j.gaitpost.2005.12.013; Warren WH, 1996, J EXP PSYCHOL HUMAN, V22, P818, DOI 10.1037/0096-1523.22.4.818; WARREN WH, 1991, BIOL CYBERN, V65, P311, DOI 10.1007/BF00216964	43	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0184552	10.1371/journal.pone.0184552	http://dx.doi.org/10.1371/journal.pone.0184552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	28991916	Green Published, gold, Green Submitted			2022-12-26	WOS:000412601800007
J	Liu, Q; Kulak, MV; Borcherding, N; Maina, PK; Zhang, W; Weigel, RJ; Qi, HH				Liu, Q.; Kulak, M. V.; Borcherding, N.; Maina, P. K.; Zhang, W.; Weigel, R. J.; Qi, H. H.			A novel HER2 gene body enhancer contributes to HER2 expression	ONCOGENE			English	Article							BREAST-CANCER CELLS; NEGATIVE REGULATORY ELEMENTS; HUMAN ERBB-2 GENE; TRANSCRIPTION FACTOR; DNA METHYLATION; ACTIVATOR PROTEIN-2; PROMOTER; OVEREXPRESSION; IDENTIFICATION; RECEPTOR	The transcriptional regulation of the human epidermal growth factor receptor-2 (HER2) contributes to an enhanced HER2 expression in HER2-positive breast cancers with HER2 gene amplification and HER2-low or HER2-negative breast cancers following radiotherapy or endocrine therapy, and this drives tumorigenesis and the resistance to therapy. Epigenetic mechanisms are critical for transcription regulation, however, such mechanisms in the transcription regulation of HER2 are limited to the involvement of trimethylated histone 3 lysine 4 (H3K4me3) and acetylated histone 3 lysine 9 (H3K9ac) at the HER2 promoter region. Here, we report the identification of a novel enhancer in the HER2 3' gene body, which we have termed HER2 gene body enhancer (HGE). The HGE starts from the 3' end of intron 19 and extends into intron 22, possesses enhancer histone modification marks in specific cells and enhances the transcriptional activity of the HER2 promoters. We also found that TFAP2C, a known regulator of HER2, binds to HGE and is required for its enhancer function and that DNA methylation in the HGE region inhibits the histone modifications characterizing enhancer and is inversely correlated with HER2 expression in breast cancer samples. The identification of this novel enhancer sheds a light on the roles of epigenetic mechanisms in HER2 transcription, in both HER2-positive breast cancer samples and individuals with HER2-low or HER2-negative breast cancers undergoing radiotherapy or endocrine therapy.	[Liu, Q.; Maina, P. K.; Qi, H. H.] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, 1-632 BSB,51 Newton Rd, Iowa City, IA 52243 USA; [Kulak, M. V.; Weigel, R. J.] Univ Iowa, Dept Surg, Carver Coll Med, Iowa City, IA 52243 USA; [Borcherding, N.; Zhang, W.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52243 USA; [Weigel, R. J.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52243 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Qi, HH (corresponding author), Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, 1-632 BSB,51 Newton Rd, Iowa City, IA 52243 USA.	hank-qi@uiowa.edu		Kulak, Mikhail/0000-0002-4307-5868; Borcherding, Nicholas/0000-0003-1427-6342; Qi, Hank/0000-0002-3401-4940; Maina, Peterson/0000-0002-5909-190X; Weigel, Ronald/0000-0002-9249-0793	Department of Anatomy and Cell Biology, the Carver College of Medicine, University of Iowa; Carver Trust Young Investigator Award from the Roy J Carver Charitable Trust [01-224]; Breast Cancer Research Award by the Holden Comprehensive Cancer Center at University of Iowa; NIH [P30 CA086862, R01CA183702, CA200673, CA203834]; NIH MD/PhD fellowship [F30 CA206255]; V Scholar award from Holden Comprehensive Cancer Center at the University of Iowa; Breast Cancer Research Award from Holden Comprehensive Cancer Center at the University of Iowa; Oberley Award (National Cancer Institute Award) from Holden Comprehensive Cancer Center at the University of Iowa [P30 CA086862]; NATIONAL CANCER INSTITUTE [R00CA158055, P30CA086862, F30CA206255, R01CA200673, R01CA203834, R01CA183702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	Department of Anatomy and Cell Biology, the Carver College of Medicine, University of Iowa; Carver Trust Young Investigator Award from the Roy J Carver Charitable Trust; Breast Cancer Research Award by the Holden Comprehensive Cancer Center at University of Iowa; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH MD/PhD fellowship; V Scholar award from Holden Comprehensive Cancer Center at the University of Iowa; Breast Cancer Research Award from Holden Comprehensive Cancer Center at the University of Iowa; Oberley Award (National Cancer Institute Award) from Holden Comprehensive Cancer Center at the University of Iowa; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Brad Amendt and his lab for helpful discussions, and the ENCODE Consortium and the ENCODE production laboratories for generating the relevant data sets. The results of the bioinformatical analysis are based, in whole or part, upon data generated by The Cancer Genome Atlas Research Network (http://cancergenome.nih.gov/). The K562 cell line was a kind gift from Dr Fenghuang Zhan. We also thank Drs Christine Blaumueller and Marie Gaine for editorial consultation. This work was supported by to HHQ start-up funds from the Department of Anatomy and Cell Biology, the Carver College of Medicine, University of Iowa; Carver Trust Young Investigator Award (01-224 to HHQ) from the Roy J Carver Charitable Trust; a Breast Cancer Research Award (to HHQ) by the Holden Comprehensive Cancer Center at University of Iowa; The NIH grant (P30 CA086862) to the Genomics and Flow Cytometry core facilities at the University of Iowa. NIH grants R01CA183702 (PI: RJW) and by a generous gift from the Kristen Olewine Milke Breast Cancer Research Fund (PI: RJW). NB was supported by NIH MD/PhD fellowship (F30 CA206255); WZ was supported by NIH grants CA200673, and CA203834, the V Scholar award, a Breast Cancer Research Award and an Oberley Award (National Cancer Institute Award P30 CA086862) from Holden Comprehensive Cancer Center at the University of Iowa.	Allouche A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1851; Anido J, 2006, EMBO J, V25, P3234, DOI 10.1038/sj.emboj.7601191; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Begon DY, 2005, J BIOL CHEM, V280, P24428, DOI 10.1074/jbc.M503790200; Benz CC, 2006, GENE CHROMOSOME CANC, V45, P983, DOI 10.1002/gcc.20364; Bofin AM, 2004, AM J CLIN PATHOL, V122, P110, DOI 10.1309/8A2DJFT07NE6EWHE; Bosher JM, 1996, ONCOGENE, V13, P1701; Cao N, 2009, RADIAT RES, V171, P9, DOI 10.1667/RR1472.1; Chen YY, 1997, J BIOL CHEM, V272, P14110, DOI 10.1074/jbc.272.22.14110; Chen YY, 1996, J BIOL CHEM, V271, P5183; CHEN YY, 1994, ONCOGENE, V9, P2269; Choudhury A, 2004, INT J CANCER, V108, P71, DOI 10.1002/ijc.11497; Contino F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-81; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Deblois G, 2010, CANCER RES, V70, P10277, DOI 10.1158/0008-5472.CAN-10-2840; Delacroix L, 2005, DNA CELL BIOL, V24, P582, DOI 10.1089/dna.2005.24.582; Dillon RL, 2007, MOL CELL BIOL, V27, P8648, DOI 10.1128/MCB.00866-07; Dittrich A, 2014, J MAMMARY GLAND BIOL, V19, P253, DOI 10.1007/s10911-014-9329-5; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duru N, 2012, CLIN CANCER RES, V18, P6634, DOI 10.1158/1078-0432.CCR-12-1436; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; GROOTECLAES M, 1994, CANCER RES, V54, P4193; Hua GQ, 2009, MOL CANCER RES, V7, P402, DOI 10.1158/1541-7786.MCR-08-0175; Huang WY, 2015, NUCLEIC ACIDS RES, V43, pD856, DOI 10.1093/nar/gku1151; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; Kulak MV, 2013, ONCOGENE, V32, P4043, DOI 10.1038/onc.2012.400; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; MIZUGUCHI G, 1995, J BIOL CHEM, V270, P9384, DOI 10.1074/jbc.270.16.9384; Moarii M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1994-2; Mungamuri SK, 2013, CELL REP, V5, P302, DOI 10.1016/j.celrep.2013.09.009; Nezu M, 1999, BIOCHEM BIOPH RES CO, V258, P499, DOI 10.1006/bbrc.1999.0634; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; PASLEAU F, 1993, ONCOGENE, V8, P849; Perissi V, 2000, ONCOGENE, V19, P280, DOI 10.1038/sj.onc.1203303; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; RENBAUM P, 1990, NUCLEIC ACIDS RES, V18, P1145, DOI 10.1093/nar/18.5.1145; Rose NR, 2014, BBA-GENE REGUL MECH, V1839, P1362, DOI 10.1016/j.bbagrm.2014.02.007; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Schaefer KA, 2017, NAT METHODS, V14, P547, DOI 10.1038/nmeth.4293; Scott GK, 2000, ONCOGENE, V19, P6490, DOI 10.1038/sj.onc.1204041; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; TAL M, 1987, MOL CELL BIOL, V7, P2597, DOI 10.1128/MCB.7.7.2597; Tata PR, 2011, NUCLEIC ACIDS RES, V39, P3574, DOI 10.1093/nar/gkq1344; Vernimmen D, 2003, BIOCHEM J, V370, P323, DOI 10.1042/BJ20021238; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wang H, 2017, CANCER LETT, V385, P137, DOI 10.1016/j.canlet.2016.10.033; Woodfield GW, 2010, GENE CHROMOSOME CANC, V49, P948, DOI 10.1002/gcc.20807; Woodfield GW, 2009, CLIN CANCER RES, V15, P3672, DOI 10.1158/1078-0432.CCR-08-2343; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Xing XM, 2000, NAT MED, V6, P189, DOI 10.1038/72294; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	53	16	16	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 1	2018	37	5					687	694		10.1038/onc.2017.382	http://dx.doi.org/10.1038/onc.2017.382			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FU4GT	29035388	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000423812200013
J	Chen, SI				Chen, Sheng-I			Economic benefits of sharing and redistributing influenza vaccines when shortages occurred	PLOS ONE			English	Article							COST-EFFECTIVENESS; VACCINATION PROGRAM; CHILDREN; TAIWAN; IMPACT; EFFICACY; OLDER	Background Recurrent influenza outbreak has been a concern for government health institutions in Taiwan. Over 10% of the population is infected by influenza viruses every year, and the infection has caused losses to both health and the economy. Approximately three million free vaccine doses are ordered and administered to high-risk populations at the beginning of flu season to control the disease. The government recommends sharing and redistributing vaccine inventories when shortages occur. While this policy intends to increase inventory flexibility, and has been proven as widely valuable, its impact on vaccine availability has not been previously reported. Material and methods This study developed an inventory model adapted to vaccination protocols to evaluate government recommended polices under different levels of vaccine production. Demands were uncertain and stratified by ages and locations according to the demographic data in Taiwan. Results When vaccine supply is sufficient, sharing pediatric vaccine reduced vaccine unavailability by 43% and overstock by 54%, and sharing adult vaccine reduced vaccine unavailability by 9% and overstock by 15%. Redistributing vaccines obtained greater gains for both pediatrics and adults (by 75%). When the vaccine supply is in short, only sharing pediatric vaccine yielded a 48% reduction of unused inventory, while other polices do not improve performances. Conclusions When implementing vaccination activities for seasonal influenza intervention, it is important to consider mismatches of demand and vaccine inventory. Our model confirmed that sharing and redistributing vaccines can substantially increase availability and reduce unused vaccines.	[Chen, Sheng-I] Natl Chiao Tung Univ, Sch Management, Dept Ind Engn & Management, Hsinchu, Taiwan	National Yang Ming Chiao Tung University	Chen, SI (corresponding author), Natl Chiao Tung Univ, Sch Management, Dept Ind Engn & Management, Hsinchu, Taiwan.	sichen@nctu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 104-2218-E-009-021, MOST 106-2221-E-009-114-MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Funding for this study was provided by the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/) grants MOST 104-2218-E-009-021 and MOST 106-2221-E-009-114-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, TAIW INFL EXPR WEEK; Centers for Disease Control and Prevention, 2015, SEAS INFL VACC DOS A; Centers for Disease Control Taiwan, 2015, TAIW NAT INF DIS STA; Centers for Disease Control Taiwan, 2014, LIST CONTR HOSP CLIN; Centers for Disease Control Taiwan, 2014, INFL VACC VACC PLAN; Chang YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158075; Chang YC, 2013, VACCINE, V31, P410, DOI 10.1016/j.vaccine.2012.10.086; Chen CH, 2015, VACCINE, V33, P1993, DOI 10.1016/j.vaccine.2015.01.032; Chen SC, 2013, EPIDEMIOL INFECT, V141, P2581, DOI 10.1017/S0950268813000423; Chiu PJ, 2013, VACCINE, V31, P632, DOI 10.1016/j.vaccine.2012.11.055; Department of Statistics Ministry of the Interior Taiwan, 2014, MONTHL B INT STAT; Esposito S, 2006, VACCINE, V24, P629, DOI 10.1016/j.vaccine.2005.08.054; Lee C.L., 2013, TAIWAN EPIDEMIOL B, V29, P253; Lu CM, 2008, 2008 JOINT C MED INF, P65; Maciosek MV, 2006, AM J PREV MED, V31, P72, DOI 10.1016/j.amepre.2006.03.008; Meltzer MI, 2005, VACCINE, V23, P1004, DOI 10.1016/j.vaccine.2004.07.040; MULLOOLY JP, 1994, ANN INTERN MED, V121, P947, DOI 10.7326/0003-4819-121-12-199412150-00008; Nichol KL, 2003, VACCINE, V21, P1769, DOI 10.1016/S0264-410X(03)00070-7; Nichol KL, 2008, VACCINE, V26, pD17, DOI 10.1016/j.vaccine.2008.07.048; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Plans-Rubio P, 2012, PREV MED, V55, P72, DOI 10.1016/j.ypmed.2012.02.015; Turner DA, 2006, VACCINE, V24, P1035, DOI 10.1016/j.vaccine.2004.12.033; Wang CS, 2007, VACCINE, V25, P1196, DOI 10.1016/j.vaccine.2006.10.015; Wang CS, 2004, CLIN INFECT DIS, V39, P1604, DOI 10.1086/425323; Wang ST, 2005, VACCINE, V23, P1973, DOI 10.1016/j.vaccine.2004.10.011	25	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186418	10.1371/journal.pone.0186418	http://dx.doi.org/10.1371/journal.pone.0186418			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040317	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500044
J	Majot, AT; Bidwai, AP				Majot, Adam T.; Bidwai, Ashok P.			Analysis of transient hypermorphic activity of E(spl)(D) during R8 specification	PLOS ONE			English	Article							DEVELOPING DROSOPHILA RETINA; CELL FATE DECISIONS; OF-SPLIT GENES; ATONAL EXPRESSION; NOTCH ACTIVITY; BHLH PROTEINS; ROUGHENED EYE; ENHANCER; COMPLEX; REPRESSION	Drosophila atonal (ato) is required for the specification of founding R8 photoreceptors during retinal development. ato is regulated via dual eye-specific enhancers; ato-3' is subject to initial induction whereas 5'-ato facilitates Notch-mediated autoregulation. Notch is further utilized to induce bHLH repressors of the E(spl) locus to restrict Ato from its initial broad expression to individual cells. Although Notch operates in two, distinct phases, it has remained unclear how the two phases maintain independence from one another. The difference in these two phases has attributed to the hypothesized delayed expression of E(spl). However, immunofluorescence data indicate that E(spl) are expressed during early Ato patterning, suggesting a more sophisticated underlying mechanism. To probe this mechanism, we provide evidence that although E(spl) exert no influence on ato-3', E(spl) repress 5'-ato and deletion of the E(spl) locus elicits precocious 5'-ato activity. Thus, E(spl) imposes a delay to the timing in which Ato initiates autoregulation. We next sought to understand this finding in the context of E(spl) D, which encodes a dysregulated variant of E(spl) M8 that perturbs R8 patterning, though, as previously reported, only in conjunction with the mutant receptor N spl. We established a genetic interaction between E(spl) D and roughened eye (roe), a known modulator of Notch signaling in retinogenesis. This link further suggests a dosage-dependence between E(spl) and the proneural activators Ato and Sens, as indicated via interaction assays in which E(spl) D renders aberrant R8 patterning in conjunction with reduced proneural dosage. In total, the biphasicity of Notch signaling relies, to some degree, on the post-translational regulation of individual E(spl) members and, importantly, that post-translational regulation is likely necessary to modulate the level of E(spl) activity throughout the progression of Ato expression.	[Majot, Adam T.; Bidwai, Ashok P.] West Virginia Univ, Dept Biol, Morgantown, WV 26506 USA	West Virginia University	Bidwai, AP (corresponding author), West Virginia Univ, Dept Biol, Morgantown, WV 26506 USA.	abidwai@wvu.edu		Bidwai, Ashok/0000-0002-4297-5629	West Virginia Space Grant Consortium	West Virginia Space Grant Consortium	This study was funded West Virginia Space Grant Consortium to Dr. Adam T Majot. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifragis P, 1997, P NATL ACAD SCI USA, V94, P13099, DOI 10.1073/pnas.94.24.13099; Baker NE, 1996, CURR BIOL, V6, P1290, DOI 10.1016/S0960-9822(02)70715-X; BAKER NE, 1992, DEV BIOL, V150, P381, DOI 10.1016/0012-1606(92)90250-K; Baker NE, 2009, DEV BIOL, V335, P356, DOI 10.1016/j.ydbio.2009.09.008; Bandyopadhyay M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159508; Baonza A, 2001, DEVELOPMENT, V128, P3889; Bose A, 2006, MECH DEVELOP, V123, P649, DOI 10.1016/j.mod.2006.07.003; Bose A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101884; Brand M, 1990, DEV GENES EVOL, V198, P275, DOI DOI 10.1007/BF00377394; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Chanut F, 2000, GENETICS, V156, P1203; Chen KC, 1999, P NATL ACAD SCI USA, V96, P5055, DOI 10.1073/pnas.96.9.5055; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; deCelis JF, 1996, DEVELOPMENT, V122, P2719; del Alamo D, 2008, DEVELOPMENT, V135, P2895, DOI 10.1242/dev.022194; Dokucu ME, 1996, DEVELOPMENT, V122, P4139; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; ELLIS MC, 1994, DEVELOPMENT, V120, P1959; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Frankfort BJ, 2002, DEVELOPMENT, V129, P1295; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Heitzler P, 1996, DEVELOPMENT, V122, P161; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Jones C, 2006, GENETICS, V173, P793, DOI 10.1534/genetics.106.056762; Kahali B, 2010, GENESIS, V48, P44, DOI 10.1002/dvg.20581; Kahali B, 2009, GENESIS, V47, P456, DOI 10.1002/dvg.20521; Karandikar UC, 2004, MECH DEVELOP, V121, P273, DOI 10.1016/j.mod.2004.01.008; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Li YX, 2003, DEVELOPMENT, V130, P2829, DOI 10.1242/dev.00498; Li YX, 2001, CURR BIOL, V11, P330, DOI 10.1016/S0960-9822(01)00093-8; Ligoxygakis P, 1998, DEVELOPMENT, V125, P2893; Ligoxygakis P, 1999, DEVELOPMENT, V126, P2205; Lim J, 2008, EMBO REP; Maeder ML, 2007, GENETICS, V177, P1377, DOI 10.1534/genetics.107.070425; Majot AT, 2015, ADV BIOCHEM HEALTH D, V12, P81, DOI 10.1007/978-3-319-14544-0_6; Melicharek D, 2008, GENETICS, V180, P2095, DOI 10.1534/genetics.108.093302; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Nagel AC, 1999, DEV BIOL, V208, P406, DOI 10.1006/dbio.1999.9203; Nagel AC, 1999, DEV GENET, V25, P168, DOI 10.1002/(SICI)1520-6408(1999)25:2<168::AID-DVG11>3.0.CO;2-0; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; OELLERS N, 1994, MOL GEN GENET, V244, P465, DOI 10.1007/BF00583897; Pappu KS, 2005, DEVELOPMENT, V132, P2895, DOI 10.1242/dev.01869; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; SCHRONS H, 1992, GENETICS, V132, P481; St Pierre SE, 2002, DEVELOPMENT, V129, P1273; Sun Y, 1998, DEVELOPMENT, V125, P3731; TIETZE K, 1992, P NATL ACAD SCI USA, V89, P6152, DOI 10.1073/pnas.89.13.6152; TOMLINSON A, 1988, CELL, V55, P771, DOI 10.1016/0092-8674(88)90133-X; Trott RL, 2001, J BIOL CHEM, V276, P2159, DOI 10.1074/jbc.M005996200; Wang H, 2010, GENOME RES, V20, P981, DOI 10.1101/gr.102921.109; Welshons WJ, 1956, DROS INFORM SERV, V30, P157; White NM, 2000, DEVELOPMENT, V127, P1681; XU T, 1993, DEVELOPMENT, V117, P1223; Zarifi I, 2012, MOL CELL BIOL, V32, P4534, DOI 10.1128/MCB.00827-12	57	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186439	10.1371/journal.pone.0186439	http://dx.doi.org/10.1371/journal.pone.0186439			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036187	gold, Green Submitted, Green Published			2022-12-26	WOS:000413054800033
J	Park, J; Rodionov, D; De Schutter, JW; Lin, YS; Tsantrizos, YS; Berghuis, AM				Park, Jaeok; Rodionov, Dmitry; De Schutter, Joris W.; Lin, Yih-Shyan; Tsantrizos, Youla S.; Berghuis, Albert M.			Crystallographic and thermodynamic characterization of phenylaminopyridine bisphosphonates binding to human farnesyl pyrophosphate synthase	PLOS ONE			English	Article							NITROGEN-CONTAINING BISPHOSPHONATES; STRUCTURAL BASIS; INHIBITION; DESIGN; DRUGS	Human farnesyl pyrophosphate synthase (hFPPS) catalyzes the production of the 15-carbon isoprenoid farnesyl pyrophosphate. The enzyme is a key regulator of the mevalonate pathway and a well-established drug target. Notably, it was elucidated as the molecular target of nitrogen-containing bisphosphonates, a class of drugs that have been widely successful against bone resorption disorders. More recently, research has focused on the anticancer effects of these inhibitors. In order to achieve increased non-skeletal tissue exposure, we created phenylaminopyridine bisphosphonates (PNP-BPs) that have bulky hydrophobic side chains through a structure-based approach. Some of these compounds have proven to be more potent than the current clinical drugs in a number of antiproliferation assays using multiple myeloma cell lines. In the present work, we characterized the binding of our most potent PNP-BPs to the target enzyme, hFPPS. Co-crystal structures demonstrate that the molecular interactions designed to elicit tighter binding are indeed established. We carried out thermodynamic studies as well; the newly introduced protein-ligand interactions are clearly reflected in the enthalpy of binding measured, which is more favorable for the new PNP-BPs than for the lead compound. These studies also indicate that the affinity of the PNP-BPs to hFPPS is comparable to that of the current drug risedronate. Risedronate forms additional polar interactions via its hydroxyl functional group and thus exhibits more favorable binding enthalpy; however, the entropy of binding is more favorable for the PNP-BPs, owing to the greater desolvation effects resulting from their large hydrophobic side chains. These results therefore confirm the overall validity of our drug design strategy. With a distinctly different molecular scaffold, the PNP-BPs described in this report represent an interesting new group of future drug candidates. Further investigation should follow to characterize the tissue distribution profile and assess the potential clinical benefits of these compounds.	[Park, Jaeok; Rodionov, Dmitry; Tsantrizos, Youla S.; Berghuis, Albert M.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [De Schutter, Joris W.; Lin, Yih-Shyan; Tsantrizos, Youla S.] McGill Univ, Dept Chem, Montreal, PQ, Canada; [Rodionov, Dmitry] Formulatrix, Bedford, MA USA; [De Schutter, Joris W.] Putnam Associates, Boston, MA USA; [Lin, Yih-Shyan] APRINOIR Therapeut, Taipei, Taiwan	McGill University; McGill University	Berghuis, AM (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	albert.berghuis@mcgill.ca	Park, Jaeok/U-6904-2019	Park, Jaeok/0000-0002-8180-3950; Berghuis, Albert/0000-0002-2663-025X	Canadian Institutes of Health Research [MOP-126062, MOP-114889]; Fonds de Recherche du Quebec - Nature et Technologies [PR-181227]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec - Nature et Technologies	This work was supported by grants from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) to YST (MOP-126062) and AMB (MOP-114889) and the Fonds de Recherche du Quebec - Nature et Technologies (www.frgnt.gouv.qc.ca.) to both YST and AMB (PR-181227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyar H, 2011, COMPUT THEOR CHEM, V977, P22, DOI 10.1016/j.comptc.2011.09.001; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Cremers S, 2011, BONE, V49, P42, DOI 10.1016/j.bone.2011.01.014; De Schutter JW, 2012, BIOORGAN MED CHEM, V20, P5583, DOI 10.1016/j.bmc.2012.07.019; DEMEIJERE A, 1979, ANGEW CHEM INT EDIT, V18, P809, DOI 10.1002/anie.197908093; Dunford JE, 2008, J MED CHEM, V51, P2187, DOI 10.1021/jm7015733; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GE Healthcare Life Sciences, 2012, MICR ITC200 SYST US; Hosfield DJ, 2004, J BIOL CHEM, V279, P8526, DOI 10.1074/jbc.C300511200; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; Koul HK, 2012, PROSTATE CANCER P D, V15, P111, DOI 10.1038/pcan.2011.41; Lawson MA, 2010, J BIOMED MATER RES B, V92B, P149, DOI 10.1002/jbm.b.31500; Lin YS, 2012, J MED CHEM, V55, P3201, DOI 10.1021/jm201657x; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Park J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14132; Park J, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-32; Rogers MJ, 2011, BONE, V49, P34, DOI 10.1016/j.bone.2010.11.008; Rondeau JM, 2006, CHEMMEDCHEM, V1, P267, DOI 10.1002/cmdc.200500059; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308	22	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186447	10.1371/journal.pone.0186447	http://dx.doi.org/10.1371/journal.pone.0186447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036218	Green Published, gold, Green Submitted			2022-12-26	WOS:000413054800036
J	Vinci, G; Buffat, C; Simoncini, S; Boubred, F; Ligi, I; Dumont, F; Le Bonniec, B; Fournier, T; Vaiman, D; Dignat-George, F; Simeoni, U				Vinci, Giovanna; Buffat, Christophe; Simoncini, Stephanie; Boubred, Farid; Ligi, Isabelle; Dumont, Florent; Le Bonniec, Bernard; Fournier, Thierry; Vaiman, Daniel; Dignat-George, Francoise; Simeoni, Umberto			Gestational age-related patterns of AMOT mleethylation are revealed in preterm infant endothelial progenitors	PLOS ONE			English	Article							BIRTH-WEIGHT; DEVELOPMENTAL ORIGINS; CARDIOVASCULAR RISK; CELL MIGRATION; ADULT DISEASE; HYPERTENSION; METHYLATION; GENE; EXPRESSION; ANGIOMOTIN	Objective Preterm birth is associated with altered angiogenesis and with increased risk of cardiovascular dysfunction and hypertension at adulthood. We previously demonstrated that in preterm newborns circulating cord blood endothelial progenitor cells (ECFC), responsible for angio/vasculogenesis, are reduced in number and display altered angiogenic properties. Altered angiogenic function was associated with a decreased expression of pro-angiogenic genes, among which the AMOT gene which is a strong positive regulator of angiogenesis. Such dysregulation may be related to epigenetic factors. In this study we analyse the methylation profiling of the AMOT gene during development, through a comparative analysis of the cord blood ECFC of preterm newborns and their term counterpart. Methods We used both cloning-sequencing and pyrosequencing experiments to perform a comparative analysis of the DNA methylation profile of the promoter CpG island of AMOT gene in the cord blood ECFC of 16 preterm newborns (28-35 weeks gestational age-GA) and 15 term newborns (>37 weeks GA). Results Twenty nine clones (obtained from 2 term newborns) and forty clones (obtained from 3 preterm newborns) were sequenced. The AMOT gene methylation rate was significantly higher in preterm compared to term newborns (4.5% versus 2.5% respectively:chi(2) = 3.84; P = 1.8 10(-02)). Bisulfite pyrosequencing identified four CpG dinucleotides with significantly higher methylation levels in preterm newborns. This CpG-targeted methylation significantly decreased with increasing gestational age. Conclusions These findings highlight importance of pro-angiogenic AMOT gene methylation in ECFC, suggesting that epigenetic mechanisms may control the regulation of angiogenesis during development. Therefore they pave the way to specific short term and long term complications of preterm birth by altered angiogenesis.	[Vinci, Giovanna; Vaiman, Daniel] Univ Paris 05, CNRS 8104, Inserm U1016, Cochin Inst, 27 Rue Faubourg St Jacques, Paris, France; [Vinci, Giovanna; Fournier, Thierry] Univ Paris 05, UMR Inserm S1139, Fac Pharm, Paris, France; [Buffat, Christophe; Boubred, Farid; Ligi, Isabelle] Hop La Conception, Dept Neonatol, 147 Blvd Baille, Marseille, France; [Simoncini, Stephanie; Boubred, Farid; Ligi, Isabelle; Dignat-George, Francoise] Aix Marseille Univ, UMR INSERM 1076, 27 Blvd Jean Moulin, Marseille, France; [Dumont, Florent] UPSud UFR Pharm, IPSIT, 5 Rue JB Clement, Chatenay Malabry, France; [Le Bonniec, Bernard] Univ Paris 05, UMR Inserm S1140, Paris, France; [Le Bonniec, Bernard] Fac Pharm, Paris, France; [Simeoni, Umberto] CHU Vaudois, Div Pediat, Rue Bugnon 46, Lausanne, Switzerland; [Simeoni, Umberto] CHU Vaudois, DOHaD Lab, Rue Bugnon 46, Lausanne, Switzerland; [Simeoni, Umberto] Univ Lausanne, Rue Bugnon 46, Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Vinci, G (corresponding author), Univ Paris 05, CNRS 8104, Inserm U1016, Cochin Inst, 27 Rue Faubourg St Jacques, Paris, France.; Vinci, G (corresponding author), Univ Paris 05, UMR Inserm S1139, Fac Pharm, Paris, France.	giovanna.vinci@inserm.fr	Vinci, Giovanna/M-1311-2017; Fournier, Thierry C/E-5836-2016; Vaiman, Daniel/O-6030-2015; Le Bonniec, Bernard/ABA-1366-2020; Simeoni, Umberto/GRO-6971-2022; DIGNAT-GEORGE, Françoise/R-1129-2016; SIMEONI, Umberto/AAQ-1870-2021; boubred, farid/D-9831-2014; Le Bonniec, Bernard/S-5756-2016	Vaiman, Daniel/0000-0002-1915-0717; Le Bonniec, Bernard/0000-0002-8432-7363; Simeoni, Umberto/0000-0003-0730-9337; DIGNAT-GEORGE, Françoise/0000-0001-7006-4462; SIMEONI, Umberto/0000-0003-0730-9337; Le Bonniec, Bernard/0000-0002-8432-7363; Boubred, Farid/0000-0003-3039-2036; Fournier, Thierry/0000-0002-7515-339X	Fondation pour la Recherche Medicale; Danone Institute (Paris, France)	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Danone Institute (Paris, France)	This work was supported by grants from the Fondation pour la Recherche Medicale and Danone Institute (Paris, France). We state here that the funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 2006, HYPERTENSION, V48, P357, DOI 10.1161/01.HYP.0000236552.04251.42; Barker DJP, 2006, NAT CLIN PRACT NEPHR, V2, P700, DOI 10.1038/ncpneph0344; Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Borghesi A, 2009, AM J RESP CRIT CARE, V180, P540, DOI 10.1164/rccm.200812-1949OC; Boullu-Ciocca S, 2005, DIABETES, V54, P197, DOI 10.2337/diabetes.54.1.197; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Crudo A, 2013, ENDOCRINOLOGY, V154, P1168, DOI 10.1210/en.2012-1980; Crudo A, 2012, ENDOCRINOLOGY, V153, P3269, DOI 10.1210/en.2011-2160; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Dunn JR, 2006, BRIT J CANCER, V94, P1186, DOI 10.1038/sj.bjc.6603006; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Ingram DA, 2004, BLOOD, V104; Ingram DA, 2008, DIABETES, V57, P724, DOI 10.2337/db07-1507; Irving RJ, 2000, LANCET, V355, P2135, DOI 10.1016/S0140-6736(00)02384-9; Johansson S, 2005, CIRCULATION, V112, P3430, DOI 10.1161/CIRCULATIONAHA.105.540906; Kunes J, 2009, PHYSIOL RES, V58, pS33, DOI 10.33549/physiolres.931913; Lee H, 2012, INT J EPIDEMIOL, V41, P188, DOI 10.1093/ije/dyr237; Levchenko T, 2003, J CELL SCI, V116, P3803, DOI 10.1242/jcs.00694; Ligi I, 2011, BLOOD, V118, P1699, DOI 10.1182/blood-2010-12-325142; Ligi I, 2010, SEMIN PERINATOL, V34, P188, DOI 10.1053/j.semperi.2010.02.002; Marfella CGA, 2008, KIDNEY BLOOD PRESS R, V31, P421, DOI 10.1159/000190788; McKay JA, 2011, GENES NUTR, V6, P189, DOI 10.1007/s12263-010-0199-1; Mitchell P, 2008, CIRCULATION, V118, P518, DOI 10.1161/CIRCULATIONAHA.107.747329; Nadeau JH, 2009, HUM MOL GENET, V18, pR202, DOI 10.1093/hmg/ddp366; Oue N, 2003, ONCOLOGY-BASEL, V64, P423, DOI 10.1159/000070302; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Rodriguez-Iturbe B, 2006, KIDNEY INT, V69, P1104, DOI 10.1038/sj.ki.5000222; Rojas A, 2008, INT J CANCER, V123, P14, DOI 10.1002/ijc.23608; Ross MG, 2007, CURR ALZHEIMER RES, V4, P213, DOI 10.2174/156720507780362056; Schroeder JW, 2011, EPIGENETICS-US, V6, P1498, DOI 10.4161/epi.6.12.18296; Simeoni U, 2009, SEMIN FETAL NEONAT M, V14, P119, DOI 10.1016/j.siny.2009.01.002; Stueve TR, 2016, EPIGENOMICS-UK, V8, P817, DOI 10.2217/epi-2016-0005; Sun YV, 2010, HUM GENET, V127, P651, DOI 10.1007/s00439-010-0810-y; Tauzin L, 2006, PEDIATR RES, V60, P592, DOI 10.1203/01.pdr.0000242264.68586.28; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Yang QW, 2003, CANCER RES, V63, P6299; Yu ZY, 2010, AM J PHYSIOL-RENAL, V298, pF617, DOI 10.1152/ajprenal.00636.2009	44	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186321	10.1371/journal.pone.0186321	http://dx.doi.org/10.1371/journal.pone.0186321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036193	Green Published, Green Submitted, gold			2022-12-26	WOS:000413054800019
J	McLean, ARD; Stanisic, D; McGready, R; Chotivanich, K; Clapham, C; Baiwog, F; Pimanpanarak, M; Siba, P; Mueller, I; King, CL; Nosten, F; Beeson, JG; Rogerson, S; Simpson, JA; Fowkes, FJI				McLean, Alistair R. D.; Stanisic, Danielle; McGready, Rose; Chotivanich, Kesinee; Clapham, Caroline; Baiwog, Francesca; Pimanpanarak, Mupawjay; Siba, Peter; Mueller, Ivo; King, Christopher L.; Nosten, Francois; Beeson, James G.; Rogerson, Stephen; Simpson, Julie A.; Fowkes, Freya J. I.			P. falciparum infection and maternofetal antibody transfer in malaria-endemic settings of varying transmission	PLOS ONE			English	Article							MATERNAL HIV-INFECTION; LOW-BIRTH-WEIGHT; PAPUA-NEW-GUINEA; PLASMODIUM-FALCIPARUM; PLACENTAL MALARIA; MEROZOITE ANTIGENS; CLINICAL MALARIA; GESTATIONAL-AGE; PREGNANT-WOMEN; ACQUIRED ANTIBODIES	Introduction During pregnancy, immunoglobulin G (IgG) is transferred from the mother to the fetus, providing protection from disease in early infancy. Plasmodium falciparum infections may reduce maternofetal antibody transfer efficiency, but mechanisms remain unclear. Methods Mother-cord paired serum samples collected at delivery from Papua New Guinea (PNG) and the Thailand-Myanmar Border Area (TMBA) were tested for IgG1 and IgG3 to four P. falciparum antigens and measles antigen, as well as total serum IgG. Multivariable linear regression was conducted to assess the association of peripheral P. falciparum infection during pregnancy or placental P. falciparum infection assessed at delivery with maternofetal antibody transfer efficiency. Path analysis assessed the extent to which associations between P. falciparum infection and antibody transfer were mediated by gestational age at delivery or levels of maternal total serum IgG. Results Maternofetal antibody transfer efficiency of IgG1 and IgG3 was lower in PNG compared to TMBA (mean difference in cord antibody levels (controlling for maternal antibody levels) ranged from -0.88 to 0.09, median of -0.20 log(2) units). Placental P. falciparum infections were associated with substantially lower maternofetal antibody transfer efficiency in PNG primigravid women (mean difference in cord antibody levels (controlling for maternal antibody levels) ranged from -0.62 to -0.10, median of -0.36 log(2) units), but not multigravid women. The lower antibody transfer efficiency amongst primigravid women with placental infection was only partially mediated by gestational age at delivery (proportion indirect effect ranged from 0% to 18%), whereas no mediation effects of maternal total serum IgG were observed. Discussion Primigravid women may be at risk of impaired maternofetal antibody transport with placental P. falciparum infection. Direct effects of P. falciparum on the placenta, rather than earlier gestational age and elevated serum IgG, are likely responsible for the majority of the reduction in maternofetal antibody transfer efficiency with placental infection.	[McLean, Alistair R. D.; Beeson, James G.; Fowkes, Freya J. I.] Burnet Inst, Melbourne, Vic, Australia; [McLean, Alistair R. D.; Simpson, Julie A.; Fowkes, Freya J. I.] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [McLean, Alistair R. D.] Myanmar Oxford Clin Res Unit, Yangon, Myanmar; [Stanisic, Danielle] Griffith Univ, Inst Glyc, Gold Coast Campus, Southport, Qld, Australia; [McGready, Rose; Pimanpanarak, Mupawjay; Nosten, Francois] Mahidol Univ, SMRU, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Mae Sot, Thailand; [McGready, Rose; Nosten, Francois] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Chotivanich, Kesinee] Mahidol Univ, Dept Clin Trop Med, Fac Trop Med, Bangkok, Thailand; [Clapham, Caroline; Baiwog, Francesca; Siba, Peter] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Mueller, Ivo] WEHI, Populat Hlth & Immun Div, Parkville, Vic, Australia; [Mueller, Ivo] Inst Pasteur, Malaria Parasites & Hosts Unit, Paris, France; [Mueller, Ivo] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [King, Christopher L.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [King, Christopher L.] Vet Affairs Med Ctr, Cleveland, OH USA; [Beeson, James G.; Rogerson, Stephen] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Beeson, James G.] Monash Univ, Dept Microbiol, Melbourne, Vic, Australia; [Beeson, James G.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Fowkes, Freya J. I.] Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic, Australia	Burnet Institute; University of Melbourne; Griffith University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Mahidol University; PNG Institute Of Medical Research; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Melbourne; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Melbourne; Monash University; Monash University; Monash University	Fowkes, FJI (corresponding author), Burnet Inst, Melbourne, Vic, Australia.; Fowkes, FJI (corresponding author), Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.; Fowkes, FJI (corresponding author), Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic, Australia.	freya.fowkes@burnet.edu.au	Nosten, Francois/AAC-5509-2019; McGready, Rose/A-3290-2014	Nosten, Francois/0000-0002-7951-0745; McGready, Rose/0000-0003-1621-3257; Stanisic, Danielle/0000-0003-3908-7468; Fowkes, Freya/0000-0001-5832-9464; McLean, Alistair/0000-0003-3449-7142	National Health and Medical Research Council of Australia; Australian Research Council; Victorian State Government; Australian Postgraduate Award; Wellcome Trust of Great Britain; Christophe and Rodolphe Merieux Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian State Government; Australian Postgraduate Award(Australian Government); Wellcome Trust of Great Britain(Wellcome Trust); Christophe and Rodolphe Merieux Foundation	This work was supported by the National Health and Medical Research Council of Australia (project grant and training award to Freya J. I. Fowkes; Infrastructure for Research Institutes Support Scheme grant, Senior Research Fellowship and Program Grant to JGB and IM, NHMRC Independent Research Institutes Infrastructure Support to the Burnet Institute and WEHI), Australian Research Council (Future Fellowship to Freya J. I. Fowkes), and Victorian State Government Operational Infrastructure Support grant to the Burnet Institute. Alistair R. D. McLean is supported by an Australian Postgraduate Award. Shoklo Malaria Research Unit is part of the Mahidol Oxford University Tropical Medicine Research Unit supported by the Wellcome Trust of Great Britain. The Christophe and Rodolphe Merieux Foundation supported the study through a prize (2008) to Francois Nosten. No individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell JE, 2015, J INFECT DIS; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Beeson JG, 2016, FEMS MICROBIOL REV, V40, P343, DOI 10.1093/femsre/fuw001; Boeuf P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003153; Boyle MJ, 2015, IMMUNITY, V42, P580, DOI 10.1016/j.immuni.2015.02.012; BRAIR ME, 1994, LANCET, V343, P208, DOI 10.1016/S0140-6736(94)90991-1; BRUCECHWATT LJ, 1952, ANN TROP MED PARASIT, V46, P173, DOI 10.1080/00034983.1952.11685522; BULMER JN, 1993, HISTOPATHOLOGY, V22, P211, DOI 10.1111/j.1365-2559.1993.tb00110.x; BULMER JN, 1993, HISTOPATHOLOGY, V22, P219, DOI 10.1111/j.1365-2559.1993.tb00111.x; Chaikitgosiyakul S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-4; Chandrasiri UP, 2014, J INFECT DIS, V209, P1663, DOI 10.1093/infdis/jit803; Chu HY, 2014, CLIN INFECT DIS, V59, P560, DOI 10.1093/cid/ciu327; CostaCarvalho BT, 1996, BRAZ J MED BIOL RES, V29, P201; Cumberland P, 2007, J INFECT DIS, V196, P550, DOI 10.1086/519845; de Moraes-Pinto MI, 1998, ARCH DIS CHILD-FETAL, V79, pF202, DOI 10.1136/fn.79.3.F202; Dechavanne C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145464; Dobbs KR, 2016, PARASITOLOGY, V143, P129, DOI 10.1017/S0031182015001626; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Einarsdottir HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108319; Elliott SR, 2005, INFECT IMMUN, V73, P5903, DOI 10.1128/IAI.73.9.5903-5907.2005; Fowkes FJI, 2012, J INFECT DIS, V206, P1612, DOI 10.1093/infdis/jis566; GARNHAM PCC, 1949, ANN TROP MED PARASIT, V43, P47, DOI 10.1080/00034983.1949.11685394; Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8; Joos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009871; Kangoye D. T., 2014, PLoS ONE, V9, pe107965, DOI 10.1371/journal.pone.0107965; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Malek A, 1996, AM J REPROD IMMUNOL, V36, P248; McGready R, 2004, AM J TROP MED HYG, V70, P398, DOI 10.4269/ajtmh.2004.70.398; McGuinness D, 1998, T ROY SOC TROP MED H, V92, P527, DOI 10.1016/S0035-9203(98)90902-6; Megnekou R, 2005, INFECT IMMUN, V73, P4112, DOI 10.1128/IAI.73.7.4112-4118.2005; Moore KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131025; Moro L, 2015, J INFECT DIS, V211, P1004, DOI 10.1093/infdis/jiu547; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Okoko BJ, 2002, ANN TROP PAEDIATR, V22, P325, DOI 10.1179/027249302125001985; Okoko BJ, 2001, J HEALTH POPUL NUTR, V19, P59; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Osier FHA, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-108; Owens S, 2006, ARCH DIS CHILD, V91, P507, DOI 10.1136/adc.2005.085274; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Plewes K, 2008, INT J STD AIDS, V19, P833, DOI 10.1258/ijsa.2008.008034; Richards JS, 2013, J IMMUNOL, V191, P795, DOI 10.4049/jimmunol.1300778; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Riley EM, 2000, INFECT IMMUN, V68, P5856, DOI 10.1128/IAI.68.10.5856-5863.2000; Riley EM, 2001, PARASITE IMMUNOL, V23, P51, DOI 10.1046/j.1365-3024.2001.00364.x; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Rono J, 2013, CLIN INFECT DIS, V57, P1409, DOI 10.1093/cid/cit556; Scott S, 2005, J INFECT DIS, V191, P1854, DOI 10.1086/429963; Sehgal V M, 1989, Trans R Soc Trop Med Hyg, V83 Suppl, P105, DOI 10.1016/0035-9203(89)90616-0; Souza RM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002071; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Stanisic DI, 2015, T ROY SOC TROP MED H, V109, P313, DOI 10.1093/trstmh/trv019; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Stapleton NM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1608; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Sunjoh F, 2004, J TROP PEDIATRICS, V50, P285, DOI 10.1093/tropej/50.5.285; Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006; Unger HW, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0258-3; Verhoeff FH, 1997, ANN TROP PAEDIATR, V17, P333, DOI 10.1080/02724936.1997.11747907; Villegas L, 2007, TROP MED INT HEALTH, V12, P209, DOI [10.1111/j.1365-3165.2006.01778.x, 10.1111/j.1365-3156.2006.01778.x]; Walker PGT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2605; WALTER PR, 1982, AM J PATHOL, V109, P330; Wylie BJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-183	63	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186577	10.1371/journal.pone.0186577	http://dx.doi.org/10.1371/journal.pone.0186577			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028827	Green Published, gold			2022-12-26	WOS:000412980300042
J	Aradhya, M; Velasco, D; Ibrahimov, Z; Toktoraliev, B; Maghradze, D; Musayev, M; Bobokashvili, Z; Preece, JE				Aradhya, Mallikarjuna; Velasco, Dianne; Ibrahimov, Zakir; Toktoraliev, Biimyrza; Maghradze, David; Musayev, Mirza; Bobokashvili, Zviadi; Preece, John E.			Genetic and ecological insights into glacial refugia of walnut (Juglans regia L.)	PLOS ONE			English	Article							LATE MIOCENE; PALYNOLOGICAL INVESTIGATIONS; QUATERNARY REFUGIA; CLIMATE-CHANGE; R-PACKAGE; MODEL; DIVERSITY; HISTORY; TREE; VEGETATION	The distribution and survival of trees during the last glacial maximum (LGM) has been of interest to paleoecologists, biogeographers, and geneticists. Ecological niche models that associate species occurrence and abundance with climatic variables are widely used to gain ecological and evolutionary insights and to predict species distributions over space and time. The present study deals with the glacial history of walnut to address questions related to past distributions through genetic analysis and ecological modeling of the present, LGM and Last Interglacial (LIG) periods. A maximum entropy method was used to project the current walnut distribution model on to the LGM (21-18 kyr BP) and LIG (130-116 kyr BP) climatic conditions. Model tuning identified the walnut data set filtered at 10 km spatial resolution as the best for modeling the current distribution and to hindcast past (LGM and LIG) distributions of walnut. The current distribution model predicted southern Caucasus, parts of West and Central Asia extending into South Asia encompassing northern Afghanistan, Pakistan, northwestern Himalayan region, and southwestern Tibet, as the favorable climatic niche matching the modern distribution of walnut. The hindcast of distributions suggested the occurrence of walnut during LGM was somewhat limited to southern latitudes from southern Caucasus, Central and South Asian regions extending into southwestern Tibet, northeastern India, Himalayan region of Sikkim and Bhutan, and southeastern China. Both CCSM and MIROC projections overlapped, except that MIROC projected a significant presence of walnut in the Balkan Peninsula during the LGM. In contrast, genetic analysis of the current walnut distribution suggested a much narrower area in northern Pakistan and the surrounding areas of Afghanistan, northwestern India, and southern Tajikistan as a plausible hotspot of diversity where walnut may have survived glaciations. Overall, the findings suggest that walnut perhaps survived the last glaciations in several refugia across a wide geographic area between 30 E and 45 E North latitude. However, humans probably played a significant role in the recent history and modern distribution of walnut.	[Aradhya, Mallikarjuna; Preece, John E.] Univ Calif Davis, Natl Clonal Germplasm Repository, USDA ARS, Davis, CA 95616 USA; [Velasco, Dianne] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Ibrahimov, Zakir] Azerbaijan State Agr Univ, Dept Environm Engn & Forestry, Ganja, Azerbaijan; [Toktoraliev, Biimyrza] Natl Acad Sci Kyrgyz Republ, Bishkek, Kyrgyzstan; [Maghradze, David] Agr Univ Georgia, Inst Hort Viticulture & Oenol, Tbilisi, Georgia; [Musayev, Mirza] Genet Resources Inst, Lab Subtrop Plants & Grapevine, Baku, Azerbaijan; [Bobokashvili, Zviadi] Minist Agr, Sci Res Ctr Agr, Tbilisi, Georgia	United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis; Azerbaijan State Agricultural University; National Academy of Sciences of the Kyrgyz Republic (NAS KR); Azerbaijan National Academy of Sciences (ANAS); Azerbaijan Institute of Genetic Resources	Aradhya, M (corresponding author), Univ Calif Davis, Natl Clonal Germplasm Repository, USDA ARS, Davis, CA 95616 USA.	malli.aradhya@ars.usda.gov	Bobokashvili, Zviad/CAE-9676-2022	Bobokashvili, Zviad/0000-0002-6290-1504; Aradhya, Mallikarjuna/0000-0002-2118-7885; Musayev, Mirza/0000-0002-3904-1227; Maghradze, David/0000-0001-8197-9502; Velasco, Dianne/0000-0003-1432-0630	U.S. Department of Agriculture, Agricultural Research Service (ARS) [2032-21000-020-00]	U.S. Department of Agriculture, Agricultural Research Service (ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was funded by the U.S. Department of Agriculture, Agricultural Research Service (ARS Project Number 2032-21000-020-00; URL: https://www.ars.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2012, ANN NY ACAD SCI, V1260, P66, DOI 10.1111/j.1749-6632.2011.06440.x; [Anonymous], 1909, B SOC DENDROLOGIQUE; [Anonymous], 1994, FOLDTANI KOZLONY; Aradhya MK, 2007, TREE GENET GENOMES, V3, P363, DOI 10.1007/s11295-006-0078-5; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Bai WN, 2010, NEW PHYTOL, V188, P892, DOI 10.1111/j.1469-8137.2010.03407.x; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Beer R, 2008, QUATERNARY SCI REV, V27, P621, DOI 10.1016/j.quascirev.2007.11.012; Bennett KD, 2008, QUATERNARY SCI REV, V27, P2449, DOI 10.1016/j.quascirev.2008.08.019; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Berry EW, 1912, THE PLANT WORLD, V15, P225; Beug H., 1975, PROBLEMS BALKAN FLOR; BEUG H. J., 1962, POLLEN ET SPORES, V4, P333; Blondel J., 1999, Biology and wildlife of the Mediterranean region.; Bolikhovskaya N.S, 1995, EVOLUTION LOESS PALE; Bor N., 1942, INDIAN FOREST RECORD, V3, P153; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; BOTTEMA S, 1980, ACTA BOT NEERL, V29, P343, DOI 10.1111/j.1438-8677.1980.tb01240.x; BOTTEMA S, 1980, REV PALAEOBOT PALYNO, V31, P193, DOI 10.1016/0034-6667(80)90027-5; Bottema S., 2000, PALLAS, V52, P35; Bottema S., 1982, PALAEOHISTORIA, V24, P257; Bottema S., 1984, PALAEOHISTORIA, V26, P123; BOZILOVA E, 1976, Fitologija, V4, P25; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; CARRION JS, 1992, J BIOGEOGR, V19, P623, DOI 10.2307/2845705; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Corneanu C, 2010, ACTA PALEONTOLOGICA, V7, P103; Cuendett RE, 2005, MOL ECOL NOTES, V5, P187; Dabrowski MJ, 2014, MOL ECOL RESOUR, V14, P361, DOI 10.1111/1755-0998.12177; Dangl GS, 2005, J AM SOC HORTIC SCI, V130, P348, DOI 10.21273/JASHS.130.3.348; Denk T, 2001, BIOL J LINN SOC, V72, P287, DOI [10.1006/bijl.2000.0502, 10.1111/j.1095-8312.2001.tb01318.x]; DOPAZO J, 1994, J MOL EVOL, V38, P300, DOI 10.1007/BF00176092; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Egota T., 1966, ERDKUNDE, V20, P110; Ercelj A, 1966, PELODNE ANALIZE PLEI; Erdei B., 2011, Studia Botanica Hungarica, V42, P135; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Filipova-Marinova MV, 2010, VEG HIST ARCHAEOBOT, V19, P351, DOI 10.1007/s00334-010-0257-z; Fithian W, 2012, ANN APPL STAT; Grichuk VP, 1989, FLORA VEGETATION HIS; Grichuk VP, 1984, LATE QUATERNARY ENV, P251; Gulisashvili V., 1964, NATURAL ZONES NATURA; Gunn BF, 2010, AM J BOT, V97, P660, DOI 10.3732/ajb.0900114; HASUMI H, 2004, 1 U TOK CTR CLIM SYS; Hemery GE, 2005, FORESTRY, V78, P121, DOI 10.1093/forestry/cpi012; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt Godfrey M., 1993, Linnean Society Symposium Series, V14, P97; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huntley B., 1983, An atlas of past and present pollen maps of Europe: 0-13 000 years ago.; HUNTLEY B, 1989, J BIOGEOGR, V16, P5, DOI 10.2307/2845307; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Ibrahimov Z, P 6 INT WALN S, V861; Ivanov D, 2012, TURK J EARTH SCI, V21, P187, DOI 10.3906/yer-1004-45; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kolakovsky A, 1976, TRUDY SUKHUM BOT SAD, V22, P98; Kolov O., 1998, BIODIVERSITY SUSTAIN, P59; Kovar-Eder J, 2006, PALAEOGEOGR PALAEOCL, V238, P321, DOI 10.1016/j.palaeo.2006.03.031; Kullman L, 2008, QUATERNARY SCI REV, V27, P2467, DOI 10.1016/j.quascirev.2008.09.004; Laufer B., 1919, SINOIRANICA CHINESE; Leroy SAG, 2007, J BIOGEOGR, V34, P2115, DOI 10.1111/j.1365-2699.2007.01754.x; Lessa EP, 2010, MOL ECOL, V19, P3031, DOI 10.1111/j.1365-294X.2010.04734.x; Mai DH, 1995, METHODEN ERGEBNISSE; Mercuri AM, 2013, ANN BOT-ITALY, V3, P107, DOI 10.4462/annbotrm-10332; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Merzlyakova I., 2002, PHYS GEOGRAPHY NO EU, P377; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NIKLEWSKI J, 1970, Acta Botanica Neerlandica, V19, P737; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Peterson AT, MONOGRAPHS POPULATIO, P49; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pollegioni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135980; Popov K.P., 1994, BIOGEOGRAPHY ECOLOGY, P173, DOI [DOI 10.1007/978-94-011-1116-4_10, 10.1007/978-94-011-1116-4_10]; [POPOV M. G., 1929, [BULL APPL BOT GEN AND PLANT BREED], V22, P241; Pritchard JK, 2000, GENETICS, V155, P945; Renault-Miskovsky J., 1984, REV PALEOBIOLOGIE, P155; ROIRON P, 1991, Palaeontographica Abteilung B Palaeophytologie, V223, P169; Schlutz F, 2004, VEG HIST ARCHAEOBOT, V13, P81, DOI 10.1007/s00334-004-0035-x; SHATILOVA I, 2014, BULL GEORGIAN NATL A, V8, P109; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Suc J. -P., 1986, B CENT RECH EXPL, V10, P477; Svenning JC, 2003, ECOL LETT, V6, P646, DOI 10.1046/j.1461-0248.2003.00477.x; Svenning JC, 2008, J ECOL, V96, P1117, DOI 10.1111/j.1365-2745.2008.01422.x; Taberlet P, 2002, SCIENCE, V297, P2009, DOI 10.1126/science.297.5589.2009; Takhtajan AL., 1986, FLORISTIC REGIONS WO; Tallis J. H., 1991, PLANT COMMUNITY HIST; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tralau H, 1963, ASIATIC DICOTYLEDONO; Tzedakis PC, 2013, TRENDS ECOL EVOL, V28, P696, DOI 10.1016/j.tree.2013.09.001; van der Hammen T, 1971, LATE CENOZOIC GLACIA, P391; van Zeist W, 1975, PALAEOHISTORIA, V17, P55; Vavilov N., 1931, P APPL BOT GENET PLA, V26, P85; Vavilov NJ., 1992, ORIGIN GEOGRAPHY CUL; Volodicheva N., 2002, PHYS GEOGRAPHY NO EU, P350, DOI DOI 10.2307/1774716; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Watts W., 1988, HDB VEGETATION SCI, P155; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; WILLIS KJ, 1994, QUATERNARY SCI REV, V13, P769, DOI 10.1016/0277-3791(94)90104-X; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119; Woeste K, 2002, J HERED, V93, P58, DOI 10.1093/jhered/93.1.58; Xi R. T., 1989, ACTA HORTIC, V284, P353, DOI 10.17660/ActaHortic.1990.284.52; Yao YF, 2011, PALAEOGEOGR PALAEOCL, V304, P291, DOI 10.1016/j.palaeo.2010.04.012; Zapryagaeva V., 1964, WALNUTS TAJIKISTAN; Zeven A. C., 1975, Dictionary of cultivated plants and their centres of diversity. Excluding ornamentals, forest trees and lower plants.; Zohary D., 1970, Genetic resources in plants-their exploration and conservation., P33; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001; Zohary M., 1973, Geobotanical foundations of the Middle East.	121	23	23	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185974	10.1371/journal.pone.0185974	http://dx.doi.org/10.1371/journal.pone.0185974			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023476	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100047
J	Lee, JH; Lee, MY; Lee, WK				Lee, Jae Hyung; Lee, Mee Yon; Lee, Won Ki			Incidence and risk factors of massive subretinal hemorrhage in retinal angiomatous proliferation	PLOS ONE			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; ENDOTHELIAL GROWTH-FACTOR; DEGENERATION TREATMENTS TRIALS; OPTICAL COHERENCE TOMOGRAPHY; MACULAR DEGENERATION; NATURAL-HISTORY; TYPE-3 NEOVASCULARIZATION; INTRAVITREAL RANIBIZUMAB; PHOTODYNAMIC THERAPY; GEOGRAPHIC ATROPHY	Objective To evaluate the incidence and associated risk factors of massive subretinal hemorrhage (SRH) in patients with retinal angiomatous proliferation (RAP). Methods A total of 187 eyes of 135 treatment-naive patients diagnosed with RAP were evaluated retrospectively. Clinical records including the time between the initial visit, last anti-vascular endothelial growth factor (VEGF) treatment, last stable examination, and the date of massive SRH were reviewed. Imaging findings including indocyanine green angiography (ICGA) and optical coherence tomography (OCT) were analyzed. Results Massive SRH developed in 18 eyes (9.6%) a median of 20 months after the initial presentation. Kaplan-Meier survival analysis revealed that the incidence (2.8, 5.8, 13.1, and 21.0% after 1,2,5 and 10 years, respectively) continuously increased. Among 14 eyes with discernable vascular anastomosis on baseline ICGA, 13 (92.8%) showed retinal arteriole involvement. On spectral-domain OCT imaging of the last visit prior to the massive SRH, a layered lamellar tissue complex was noted under the retinal pigment epithelium in 9 of 13 eyes, which was significantly associated with massive SRH[hazard ratio(HR), 5.883; P = .010]. The average time between the last stable examination/last injection and the massive SRH was 2 and 5 months, respectively. The patients were treated with anti-VEGF, gas and recombinant tissue plasminogen activator injection; however, all except one eye had visual acuity worse than 20/1000 at the final visit. Conclusions Massive SRH can occur in RAP in the course of anti-VEGF treatment, resulting in severe vision loss. A proactive dosing regimen may be more appropriate for these RAP eyes.	[Lee, Jae Hyung; Lee, Won Ki] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Lee, Mee Yon] Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Uijongbu, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Lee, WK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	wklee@catholic.ac.kr						Alm A., 1992, ADLERS PHYSL EYE, P212; Avery RL, 1996, RETINA-J RET VIT DIS, V16, P183, DOI 10.1097/00006982-199616030-00001; Axer-Siegel R, 2002, OPHTHALMOLOGY, V109, P1726, DOI 10.1016/S0161-6420(02)01149-1; Bottoni F, 2005, ARCH OPHTHALMOL-CHIC, V123, P1644, DOI 10.1001/archopht.123.12.1644; Cho HJ, 2016, GRAEF ARCH CLIN EXP, V254, P23, DOI 10.1007/s00417-015-2993-3; Fine HF, 2010, RETINA-J RET VIT DIS, V30, P1588, DOI 10.1097/IAE.0b013e3181e2263c; Freund KB, 2008, RETINA-J RET VIT DIS, V28, P201, DOI 10.1097/IAE.0b013e3181669504; Freund KB, 2015, RETINA-J RET VIT DIS, V35, P1489, DOI 10.1097/IAE.0000000000000627; Fung AE, 2007, AM J OPHTHALMOL, V143, P566, DOI 10.1016/j.ajo.2007.01.028; Gharbiya M, 2014, RETINA-J RET VIT DIS, V34, P298, DOI 10.1097/IAE.0b013e3182979e62; Grunwald JE, 2015, OPHTHALMOLOGY, V122, P809, DOI 10.1016/j.ophtha.2014.11.007; Grunwald JE, 2014, OPHTHALMOLOGY, V121, P150, DOI 10.1016/j.ophtha.2013.08.015; Gupta OP, 2010, OPHTHALMOLOGY, V117, P2134, DOI 10.1016/j.ophtha.2010.02.032; HARTNETT ME, 1992, GRAEF ARCH CLIN EXP, V230, P11, DOI 10.1007/BF00166756; Hartnett ME, 1996, OPHTHALMOLOGY, V103, P2042, DOI 10.1016/S0161-6420(96)30389-8; Hassan AS, 1999, OPHTHALMOLOGY, V106, P1900, DOI 10.1016/S0161-6420(99)90399-8; Hirami Y, 2007, RETINA-J RET VIT DIS, V27, P335, DOI 10.1097/01.iae.0000233647.78726.46; Inoue M, 2014, BRIT J OPHTHALMOL, V98, P956, DOI 10.1136/bjophthalmol-2013-304251; KLEIN ML, 1991, JAMA-J AM MED ASSOC, V266, P2279; Kuhn D, 1960, ARCH OPHTHALMOL-CHIC, P113; Mrejen S, 2015, J CLIN MED, V4, P1380, DOI 10.3390/jcm4071380; Nagiel A, 2013, AM J OPHTHALMOL, V156, P981, DOI 10.1016/j.ajo.2013.06.024; Parodi MB, 2013, ACTA OPHTHALMOL, V91, P267, DOI 10.1111/j.1755-3768.2011.02265.x; Rahimy E, 2014, RETINA-J RET VIT DIS, V34, P1289, DOI 10.1097/IAE.0000000000000130; Sacu S, 2009, EYE, V23, P1404, DOI 10.1038/eye.2008.267; Scupola A, 1999, OPHTHALMOLOGICA, V213, P97, DOI 10.1159/000027400; Sho K, 2003, ARCH OPHTHALMOL-CHIC, V121, P1392, DOI 10.1001/archopht.121.10.1392; Slakter JS, 2000, OPHTHALMOLOGY, V107, P742, DOI 10.1016/S0161-6420(00)00009-9; TOTH CA, 1991, ARCH OPHTHALMOL-CHIC, V109, P723, DOI 10.1001/archopht.1991.01080050139046; Tsuchiya D, 2009, RETINA-J RET VIT DIS, V29, P960, DOI 10.1097/IAE.0b013e3181a3b7c5; Uyama M, 2002, AM J OPHTHALMOL, V133, P639, DOI 10.1016/S0002-9394(02)01404-6; Viola F, 2009, RETINA-J RET VIT DIS, V29, P732, DOI 10.1097/IAE.0b013e3181a395cb; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Yannuzzi LA, 2008, RETINA-J RET VIT DIS, V28, P375, DOI 10.1097/IAE.0b013e3181619c55; Ying GS, 2016, OPHTHALMOLOGY, V123, P352, DOI 10.1016/j.ophtha.2015.09.046	35	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186272	10.1371/journal.pone.0186272	http://dx.doi.org/10.1371/journal.pone.0186272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023498	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100096
J	Purse, BV; Masante, D; Golding, N; Pigott, D; Day, JC; Ibanez-Bernal, S; Kolb, M; Jones, L				Purse, Bethan V.; Masante, Dario; Golding, Nicholas; Pigott, David; Day, John C.; Ibanez-Bernal, Sergio; Kolb, Melanie; Jones, Laurence			How will climate change pathways and mitigation options alter incidence of vector-borne diseases? A framework for leishmaniasis in South and Meso-America	PLOS ONE			English	Article							LAND-USE CHANGE; CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; POTENTIAL DISTRIBUTION; DIPTERA PSYCHODIDAE; RISK-FACTORS; SCENARIOS; DISTRIBUTIONS; BIODIVERSITY; TEMPERATURE	The enormous global burden of vector-borne diseases disproportionately affects poor people in tropical, developing countries. Changes in vector-borne disease impacts are often linked to human modification of ecosystems as well as climate change. For tropical ecosystems, the health impacts of future environmental and developmental policy depend on how vector-borne disease risks trade off against other ecosystem services across heterogeneous landscapes. By linking future socio-economic and climate change pathways to dynamic land use models, this study is amongst the first to analyse and project impacts of both land use and climate change on continental-scale patterns in vector-borne diseases. Models were developed for cutaneous and visceral leishmaniasis in the Americas D ecologically complex sand fly borne infections linked to tropical forests and diverse wild and domestic mammal hosts. Both diseases were hypothesised to increase with available interface habitat between forest and agricultural or domestic habitats and with mammal biodiversity. However, landscape edge metrics were not important as predictors of leishmaniasis. Models including mammal richness were similar in accuracy and predicted disease extent to models containing only climate and land use predictors. Overall, climatic factors explained 80% and land use factors only 20% of the variance in past disease patterns. Both diseases, but especially cutaneous leishmaniasis, were associated with low seasonality in temperature and precipitation. Since such seasonality increases under future climate change, particularly under strong climate forcing, both diseases were predicted to contract in geographical extent to 2050, with cutaneous leishmaniasis contracting by between 35% and 50%. Whilst visceral leishmaniasis contracted slightly more under strong than weak management for carbon, biodiversity and ecosystem services, future cutaneous leishmaniasis extent was relatively insensitive to future alternative socio-economic pathways. Models parameterised at narrower geographical scales may be more sensitive to land use pattern and project more substantial changes in disease extent under future alternative socio-economic pathways.	[Purse, Bethan V.; Day, John C.] NERC Ctr Ecol & Hydrol, Crowmarsh Gifford, Oxon, England; [Masante, Dario; Jones, Laurence] Environm Ctr Wales, NERC Ctr Ecol & Hydrol, Bangor, Gwynedd, Wales; [Golding, Nicholas] Univ Melbourne, Sch Biosci, Melbourne, Vic, Australia; [Pigott, David] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA USA; [Ibanez-Bernal, Sergio] AC INECOL Red Ambiente & Sustentabilidad, Inst Ecol, Xalapa, Veracruz, Mexico; [Kolb, Melanie] Univ Nacl Autonoma Mexico, Inst Geog, Mexico City, DF, Mexico	UK Centre for Ecology & Hydrology (UKCEH); UK Centre for Ecology & Hydrology (UKCEH); University of Melbourne; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico	Purse, BV (corresponding author), NERC Ctr Ecol & Hydrol, Crowmarsh Gifford, Oxon, England.	beth@ceh.ac.uk	Day, John/D-2595-2010; Purse, Bethan V/I-6640-2012; Jones, Laurence/A-3900-2011	Day, John/0000-0002-5483-4487; Purse, Bethan V/0000-0001-5140-2710; Jones, Laurence/0000-0002-4379-9006; Golding, Nick/0000-0001-8916-5570	European Union Seventh Framework Programme [283093]; Natural Environment Research Council (NERC) [NEC05100]; NERC [ceh020006] Funding Source: UKRI; Natural Environment Research Council [ceh020006] Funding Source: researchfish	European Union Seventh Framework Programme(European Commission); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 283093 - The Role Of Biodiversity In climate change mitigatioN (ROBIN). BVP received additional support from the Natural Environment Research Council (NERC) Natural Capital allocation to CEH (Natural Hazards HARM project NEC05100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 283093-The Role Of Biodiversity In climate change mitigatioN (ROBIN). BVP received additional support from the Natural Environment Research Council (NERC) Natural Capital allocation to CEH (Natural Hazards HARM project NEC05100).	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Alexander B, 2009, T ROY SOC TROP MED H, V103, P1263, DOI 10.1016/j.trstmh.2009.04.018; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 2016, DISMO SPECIES DISTRI; [Anonymous], 2014, GLOB BRIEF VECT BORN; Assessment ME, 2005, EC HUM WELL BEING SY; Astrom C, 2012, ECOHEALTH, V9, P448, DOI 10.1007/s10393-012-0808-0; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Campbell-Lendrum D., 2005, ECOSYST HUM WELL BEI, P353; Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552; Chaves LF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000176; *CTR INT EARTH SCI, 2005, GRID POP WORLD VERS; Dantas-Torres F, 2007, VET PARASITOL, V149, P139, DOI 10.1016/j.vetpar.2007.07.007; de Almeida PS, 2013, MEM I OSWALDO CRUZ, V108, P992, DOI 10.1590/0074-0276130331; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Donalisio MR, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/642910; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Pinheiro MPG, 2013, J VECTOR ECOL, V38, P307, DOI 10.1111/j.1948-7134.2013.12045.x; Gonzalez C, 2014, ACTA TROP, V129, P83, DOI 10.1016/j.actatropica.2013.08.014; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Gonzalez-Salazar C, 2012, ZOONOSES PUBLIC HLTH, V59, P179, DOI 10.1111/j.1863-2378.2012.01479.x; Harhay MO, 2011, TRENDS PARASITOL, V27, P403, DOI 10.1016/j.pt.2011.04.001; Hartemink N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020817; Hay SI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0250; Hlavacova J, 2013, J MED ENTOMOL, V50, P955, DOI 10.1603/ME13053; Howe C, 2014, GLOBAL ENVIRON CHANG, V28, P263, DOI 10.1016/j.gloenvcha.2014.07.005; IPCC, 2007, CLIMATE CHANGE 2007; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jones L., 2013, SCENARIOS USE ROBIN; Karagiannis-Voules DA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002213; King RJ, 2004, EMERG INFECT DIS, V10, P598, DOI 10.3201/eid1004.030241; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Maroli M, 2013, MED VET ENTOMOL, V27, P123, DOI 10.1111/j.1365-2915.2012.01034.x; Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430; Moo-Llanes D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002421; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Murray KA, 2013, CURR OPIN VIROL, V3, P79, DOI 10.1016/j.coviro.2013.01.006; O'Neill, 2011, M WORKSH NAT US NEW; Pan American Health Organization, 2016, LEISHM EP REP AM; Pigott DM, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.36; Pigott DM, 2014, GLOBAL DISTRIBUTION; Purse BV, 2015, BIOL J LINN SOC, V115, P664, DOI 10.1111/bij.12567; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Quintana M, 2013, MED VET ENTOMOL, V27, P39, DOI 10.1111/j.1365-2915.2012.01033.x; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Ridgeway G., 2006, GEN BOOSTED REGRESSI; Rogers DJ, 2006, ADV PARASIT, V62, P1, DOI 10.1016/S0065-308X(05)62001-5; Roque Andre Luiz R., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P251, DOI 10.1016/j.ijppaw.2014.08.004; Stephens CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005725; Stolar J, 2015, DIVERS DISTRIB, V21, P595, DOI 10.1111/ddi.12279; Thomson MC, 1999, TROP MED INT HEALTH, V4, P105, DOI 10.1046/j.1365-3156.1999.00368.x; Valderrama-Ardila C, 2010, AM J TROP MED HYG, V82, P243, DOI 10.4269/ajtmh.2010.09-0218; van Eupen M, D221 EC ROBIN; van Vuuren DP, 2007, CLIMATIC CHANGE, V81, P119, DOI 10.1007/s10584-006-9172-9; Vanwambeke SO, 2016, EXP APPL ACAROL, V68, P375, DOI 10.1007/s10493-015-0007-0; Vanwambeke SO, 2007, ECOHEALTH, V4, P37, DOI 10.1007/s10393-007-0085-5; WHO, 2008, CLIM CHANG HLTH RES; Wimberly MC, 2008, GLOBAL ECOL BIOGEOGR, V17, P189, DOI 10.1111/j.1466-8238.2007.00353.x; Wood CL, 2014, ECOLOGY, V95, P817, DOI 10.1890/13-1041.1; World Health Organization, 2008, The global burden of disease: 2004 update; Zeimes CB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-370; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	69	27	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0183583	10.1371/journal.pone.0183583	http://dx.doi.org/10.1371/journal.pone.0183583			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020041	Green Published, Green Accepted, gold			2022-12-26	WOS:000412754400005
J	Watanabe, LP; Riddle, NC				Watanabe, Louis Patrick; Riddle, Nicole C.			Characterization of the Rotating Exercise Quantification System (REQS), a novel Drosophila exercise quantification apparatus	PLOS ONE			English	Article							WEIGHT-LOSS; RESISTANCE EXERCISE; INSULIN SENSITIVITY; ENDURANCE EXERCISE; PHYSICAL-EXERCISE; GENETIC-VARIATION; AEROBIC EXERCISE; MELANOGASTER; DISEASE; LIFE	Obesity is a disease that has reached epidemic proportions in the United States and has prompted international legislation in an attempt to curtail its prevalence. Despite the fact that one of the most prescribed treatment options for obesity is exercise, the genetic mechanisms underlying exercise response in individuals are still largely unknown. The fruit fly Drosophila melanogaster is a promising new model for studying exercise genetics. Currently, the lack of an accurate method to quantify the amount of exercise performed by the animals is limiting the utility of the Drosophila model for exercise genetics research. To address this limitation, we developed the Rotational Exercise Quantification System (REQS), a novel apparatus that is able to simultaneously induce exercise in flies while recording their activity levels. Thus, the REQS provides a method to standardize Drosophila exercise and ensure that all animals irrespective of genotype and sex experience the same level of exercise. Here, we provide a basic characterization of the REQS, validate its measurements using video-tracking technology, illustrate its potential use by presenting a comparison of two different exercise regimes, and demonstrate that it can be used to detect genotype-dependent variation in activity levels.	[Watanabe, Louis Patrick; Riddle, Nicole C.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Riddle, NC (corresponding author), Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA.	riddlenc@uab.edu		Riddle, Nicole/0000-0003-1827-9145	National Institute Of Diabetes And Digestive And Kidney Diseases [P30DK056336]; Nutrition and Obesity Research Center at the University of Alabama at Birmingham; Nutrition Obesity Research Center (NORC)	National Institute Of Diabetes And Digestive And Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Nutrition and Obesity Research Center at the University of Alabama at Birmingham; Nutrition Obesity Research Center (NORC)	The project described was supported by Award Number P30DK056336 from the National Institute Of Diabetes And Digestive And Kidney Diseases, https://www.niddk.nih.gov/ (pilot grant from the Nutrition and Obesity Research Center at the University of Alabama at Birmingham to NCR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of Diabetes And Digestive And Kidney Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the assistance that was provided to us by the Biostatistics, Epidemiology, and Research Design (BERD) group with the Center for Clinical and Translational Science (CCTS) for advice on the statistical analyses. We are indebted to the UAB Research Machine Shop for their help in the development and maintenance of the REQS, as well as the Nutrition Obesity Research Center (NORC) for their funding support (Pilot and Feasibility grant to NCR). We would also like to thank the members of the Riddle lab for helpful discussions and support, as well as several anonymous reviewers for their suggestions. For help with fly husbandry specifically, we thank Michael Azar, Anthony Foster, Makayla Nixon, Cameron Gordon, and Lexus Wiley.	Ades PA, 2015, PREV MED, V80, P50, DOI 10.1016/j.ypmed.2015.03.014; Andersen G, 2015, AM J PHYSIOL-REG I, V308, pR123, DOI 10.1152/ajpregu.00321.2014; Balducci S, 2014, DIABETES-METAB RES, V30, P13, DOI 10.1002/dmrr.2514; Blazek AD, 2016, OSTEOARTHR CARTILAGE, V24, P1210, DOI 10.1016/j.joca.2016.02.004; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Bouchard C, 2015, PROG CARDIOVASC DIS, V57, P337, DOI 10.1016/j.pcad.2014.08.005; Breit M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004454; Brocklebank LA, 2015, PREV MED, V76, P92, DOI 10.1016/j.ypmed.2015.04.013; Buresh R, 2014, J SPORT MED PHYS FIT, V54, P373; Cao WH, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0880-8; Chen YW, 2014, ANN MED, V46, P439, DOI 10.3109/07853890.2014.927713; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; Coen PM, 2015, DIABETES, V64, P3737, DOI 10.2337/db15-0809; Coletta DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160327; Cordero Y, 2015, MED SCI SPORT EXER, V47, P1328, DOI 10.1249/MSS.0000000000000547; Denham J, 2015, EPIGENOMICS-UK, V7, P717, DOI 10.2217/epi.15.29; Drenowatz C, 2015, J SCI MED SPORT, V18, P632, DOI 10.1016/j.jsams.2014.09.009; Fock KM, 2013, J GASTROEN HEPATOL, V28, P59, DOI 10.1111/jgh.12407; Glynn EL, 2015, DIABETOLOGIA, V58, P2324, DOI 10.1007/s00125-015-3705-6; Green EW, 2015, P NATL ACAD SCI USA, V112, P8702, DOI 10.1073/pnas.1506093112; Guo R, 2015, HEPATOB PANCREAT DIS, V14, P139, DOI 10.1016/S1499-3872(15)60355-1; Habibi Ehsanollah, 2014, J Educ Health Promot, V3, P55, DOI 10.4103/2277-9531.134751; Hammar M, 2013, BEST PRACT RES CL OB, V27, P741, DOI 10.1016/j.bpobgyn.2013.01.004; Hoffmann K, 2016, J ALZHEIMERS DIS, V50, P443, DOI 10.3233/JAD-150817; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Imayama I, 2013, J PHYS ACT HEALTH, V10, P676, DOI 10.1123/jpah.10.5.676; Ishimoto Hiroshi, 2012, Front Neurol, V3, P24, DOI 10.3389/fneur.2012.00024; Jennings BH, 2011, MATER TODAY, V14, P190, DOI 10.1016/S1369-7021(11)70113-4; Karoly HC, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/540563; Keating SE, 2015, EXPERT REV GASTROENT, V9, P1247, DOI 10.1586/17474124.2015.1075392; Khazaeli AA, 2007, MECH AGEING DEV, V128, P486, DOI 10.1016/j.mad.2007.06.005; Kim HJ, 2015, EXP GERONTOL, V70, P11, DOI 10.1016/j.exger.2015.07.006; Laughlin MH, 2015, J APPL PHYSIOL, V119, P583, DOI 10.1152/japplphysiol.00316.2015; Lavie CJ, 2015, CIRC RES, V117, P207, DOI 10.1161/CIRCRESAHA.117.305205; Lin XC, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002014; Lovell D, 2011, INT J SPORTS MED, V32, P271, DOI 10.1055/s-0030-1269844; Low KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049536; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mann T, 2013, SPORTS MED, V43, P613, DOI 10.1007/s40279-013-0045-x; Mann TN, 2014, SPORTS MED, V44, P1113, DOI 10.1007/s40279-014-0197-3; Portugal EMM, 2013, NEUROPSYCHOBIOLOGY, V68, P1, DOI 10.1159/000350946; Mendez S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164706; Naldi L, 2014, BRIT J DERMATOL, V170, P634, DOI 10.1111/bjd.12735; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Parmenter BJ, 2015, VASC MED, V20, P30, DOI 10.1177/1358863X14559092; Pedersen L, 2015, CANCER J, V21, P111, DOI 10.1097/PPO.0000000000000096; Pfeiffenberger Cory, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5518; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; R Core Team, 2013, R LANG ENV STAT COMP; Rezende EL, 2006, J APPL PHYSIOL, V101, P477, DOI 10.1152/japplphysiol.00042.2006; Ro J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101107; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Rynders CA, 2014, PHYSICIAN SPORTSMED, V42, P7, DOI 10.3810/psm.2014.02.2042; Shete AN, 2014, J CLIN DIAGN RES, V8, pBC1, DOI 10.7860/JCDR/2014/10896.5329; Shiraev T, 2012, AUST FAM PHYSICIAN, V41, P960; Stephens NA, 2015, J CLIN ENDOCR METAB, V100, P43, DOI 10.1210/jc.2014-2545; Sujkowski A, 2015, AGING-US, V7, P535, DOI 10.18632/aging.100789; Svetec N, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0316-2; Szuhany KL, 2015, J PSYCHIATR RES, V60, P56, DOI 10.1016/j.jpsychires.2014.10.003; Tinkerhess MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031633; Tonevitsky Alexander G., 2013, BMC Physiology, V13, P9, DOI 10.1186/1472-6793-13-9; Ugur B, 2016, DIS MODEL MECH, V9, P235, DOI 10.1242/dmm.023762; Upala S, 2015, INT J OBESITY, V39, P1197, DOI 10.1038/ijo.2015.64; Van Huffel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113667; Voet NBM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003907.pub4; Ward B. W., 2013, EARLY RELEASE SELECT; Wegner M, 2014, CNS NEUROL DISORD-DR, V13, P1002, DOI 10.2174/1871527313666140612102841; WOMACK CJ, 1995, J APPL PHYSIOL, V79, P838, DOI 10.1152/jappl.1995.79.3.838; Zheng GH, 2016, BRIT J SPORT MED, V50, P1443, DOI 10.1136/bjsports-2015-095699; Zheng L, 2016, BIOGERONTOLOGY, P1; Zimmerman JE, 2012, SLEEP, V35, P545, DOI 10.5665/sleep.1744	71	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185090	10.1371/journal.pone.0185090	http://dx.doi.org/10.1371/journal.pone.0185090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016615	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400013
J	Li, LY; Wang, P; Hu, KQ; Wang, XY; Cai, WP; Ai, C; Liu, SF; Wang, Z				Li, Liyuan; Wang, Pan; Hu, Kaiqiang; Wang, Xiaoyan; Cai, Wenping; Ai, Chao; Liu, Shangfeng; Wang, Zhao			PFMG1 promotes osteoblast differentiation and prevents osteoporotic bone loss	FASEB JOURNAL			English	Article						nacre; remodeling; osteoporosis	PINCTADA-MAXIMA; NACRE; PEARL; MARROW; CELL; IMPLANTS; PATHWAY; MATRIX; MANTLE; MINERALIZATION	Nacre is a widely used mineral medicine that has been reported to have beneficial effects in bone remodeling without an increase in inflammation. Water-soluble nacre matrix has been demonstrated to be responsible for the effect, yet core active ingredients are unknown. Pinctada fucata mantle gene 1 (PFMG1) was first discovered in the mantle tissue of Pinctada fucata. The protein has 2 EF-hands, a calcium-binding domain. PFMG1 protein can affect the growth of calcium carbonate crystals in vitro. Here, we demonstrate that PFMG1 affects cell-cycle distribution and promotes preosteoblast proliferation. PFMG1 accelerates preosteoblast differentiation and extracellular matrix mineralization. During the differentiation process, PFMG1 increases the expression level of osteoblastic marker genes and activates the Erk signaling pathway. PFMG1 also accelerates calcium crystal aggregation in culture medium and suppresses osteoclast formation. Moreover, PFMG1 prevents bone loss caused by ovariectomy. RNA sequencing analysis demonstrated that PFMG1 stimulates genes that are associated with tissue development and ossification, which indicated new genes that function in bone remodeling. Our findings demonstrate the therapeutic potential of PFMG1 from nacre as a novel medicine for osteoporosis.	[Li, Liyuan; Wang, Pan; Hu, Kaiqiang; Wang, Xiaoyan; Ai, Chao; Wang, Zhao] Tsinghua Univ, Sch Pharmaceut Sci, Prot Sci Key Lab, Minist Educ, Beijing, Peoples R China; [Wang, Xiaoyan] Natl Univ Def Technol, Dept Biol & Chem, Coll Sci, Changsha, Hunan, Peoples R China; [Cai, Wenping; Liu, Shangfeng] Fudan Univ, Huashan Hosp, Dept Stomatol, Shanghai 200040, Peoples R China; [Ai, Chao] Tsinghua Univ, Med Ctr, Beijing Tsinghua Changgung Hosp, Dept Pharm, Beijing, Peoples R China	Tsinghua University; National University of Defense Technology - China; Fudan University; Tsinghua University	Liu, SF (corresponding author), Fudan Univ, Huashan Hosp, Dept Stomatol, Shanghai 200040, Peoples R China.; Wang, Z (corresponding author), Tsinghua Univ, Dept Pharmacol, Sch Pharmaceut Sci, Room C116, Beijing 100084, Peoples R China.	shangfengliufudan@163.com; zwang@tsinghua.edu.cn			Tsinghua University Initiative Scientific Research Program [2011THZ0]; National Natural Science Foundation of China [81270425]	Tsinghua University Initiative Scientific Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Tsinghua University Initiative Scientific Research Program (2011THZ0) and the National Natural Science Foundation of China (81270425). The authors thank the J. Zhou laboratory (Yale University, New Haven, CT, USA) for offering the lentivector with lgk-chain leader sequence built on the basis of the plasmid pCDH-CMV-MCS-T2A. The authors thank Leto Laboratories (Beijing, China) for providing protein purification services. The prediction of the PFMG1 protein structure was completed by X. Lyu and T. Wang (Tsinghua University). The authors declare no conflicts of interest.	Aksay IA, 1996, SCIENCE, V273, P892, DOI 10.1126/science.273.5277.892; Almqvist N, 1999, MAT SCI ENG C-BIO S, V7, P37, DOI 10.1016/S0928-4931(98)00072-1; Amos FF, 2010, CRYST GROWTH DES, V10, P4211, DOI 10.1021/cg100363m; Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8; Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5; Berland S, 2005, BIOMATERIALS, V26, P2767, DOI 10.1016/j.biomaterials.2004.07.019; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chaturvedi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084584; Chen JX, 2014, CELL SIGNAL, V26, P1068, DOI 10.1016/j.cellsig.2013.12.020; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; DeLano W.L., 2002, PYMOL OPEN SOURCE MO; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Duplat D, 2007, BIOMATERIALS, V28, P4769, DOI 10.1016/j.biomaterials.2007.07.036; Evans JS, 2012, BIOINFORMATICS, V28, P3182, DOI 10.1093/bioinformatics/bts604; Falini G, 2011, J STRUCT BIOL, V173, P128, DOI 10.1016/j.jsb.2010.08.002; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Golob AL, 2015, MED CLIN N AM, V99, P587, DOI 10.1016/j.mcna.2015.01.010; Guo J, 2008, BONE, V43, P961, DOI 10.1016/j.bone.2008.06.011; Harborne SPD, 2015, BBA-BIOENERGETICS, V1847, P1245, DOI 10.1016/j.bbabio.2015.07.002; HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Kartsogiannis V, 2004, MOL CELL ENDOCRINOL, V228, P79, DOI 10.1016/j.mce.2003.06.002; Kim H, 2012, BIOMATERIALS, V33, P7489, DOI 10.1016/j.biomaterials.2012.06.098; Komori T, 2003, J BONE MINER METAB, V21, P193, DOI 10.1007/s00774-002-0408-0; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; Lamghari M, 2001, BIOMATERIALS, V22, P555, DOI 10.1016/S0142-9612(00)00213-1; Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6; Lamghari M, 2001, J BONE MINER RES, V16, P2232, DOI 10.1359/jbmr.2001.16.12.2232; Liang P, 2009, J BIOL CHEM, V284, P4960, DOI 10.1074/jbc.M807704200; Liao HH, 2000, BIOMATERIALS, V21, P457, DOI 10.1016/S0142-9612(99)00184-2; Liu HL, 2007, BIOCHEMISTRY-US, V46, P844, DOI 10.1021/bi061881a; LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Perovic I, 2013, BIOCHEMISTRY-US, V52, P5696, DOI 10.1021/bi400808j; Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0; Rousseau M, 2008, J BIOMED MATER RES A, V85A, P487, DOI 10.1002/jbm.a.31553; Sakai A, 1998, BONE, V23, P443, DOI 10.1016/S8756-3282(98)00121-5; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Sshrodinger LLC., 2010, PYMOL MOL GRAPHICS S; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Wang W, 2015, GENET MOL RES, V14, P10507, DOI 10.4238/2015.September.8.12; Wang XY, 2015, BIOSCI BIOTECH BIOCH, V79, P558, DOI 10.1080/09168451.2014.987206; Wang XY, 2011, J BONE MINER RES, V26, P1964, DOI 10.1002/jbmr.394; Wang XY, 2011, BIOSCI BIOTECH BIOCH, V75, P991, DOI 10.1271/bbb.100821; Wang XY, 2011, COMP BIOCHEM PHYS B, V158, P173, DOI 10.1016/j.cbpb.2010.11.004; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Xu HB, 2001, PHARMACOL RES, V44, P1, DOI 10.1006/phrs.2000.0780; Yamamoto T, 2014, FEBS OPEN BIO, V4, P387, DOI 10.1016/j.fob.2014.04.003; Yu B, 2014, NAT MED, V20, P1009, DOI 10.1038/nm.3586; Zhang JX, 2016, J ETHNOPHARMACOL, V181, P229, DOI 10.1016/j.jep.2016.01.039; Zhang NN, 2016, CELL CYCLE, V15, P1009, DOI 10.1080/15384101.2016.1152427	57	7	7	5	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					838	849		10.1096/fj.201700422R	http://dx.doi.org/10.1096/fj.201700422R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29021211	Bronze			2022-12-26	WOS:000425146900026
J	Aboualizadeh, E; Bumah, VV; Masson-Meyers, DS; Eells, JT; Hirschmugl, CJ; Enwemeka, CS				Aboualizadeh, Ebrahim; Bumah, Violet V.; Masson-Meyers, Daniela S.; Eells, Janis T.; Hirschmugl, Carol J.; Enwemeka, Chukuka S.			Understanding the antimicrobial activity of selected disinfectants against methicillin-resistant Staphylococcus aureus (MRSA)	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; HAND HYGIENE; RAPID IDENTIFICATION; FTIR SPECTROSCOPY; HYPOCHLOROUS ACID; ENOYL REDUCTASE; TRICLOSAN; MECHANISMS	Disinfectants and biocidal products have been widely used to combat Methicillin-resistant Staphylococcus aureus (MRSA) infections in homes and healthcare environments. Although disruption of cytoplasmic membrane integrity has been documented as the main bactericidal effect of biocides, little is known about the biochemical alterations induced by these chemical agents. In this study, we used Fourier transform infrared (FT-IR) spectroscopy and chemometric tools as an alternative non-destructive technique to determine the bactericidal effects of commonly used disinfectants against MRSA USA-300. FTIR spectroscopy permits a detailed characterization of bacterial reactivity, allowing an understanding of the fundamental mechanism of action involved in the interaction between bacteria and disinfectants. The disinfectants studied were ethanol 70% (N = 5), isopropanol (N = 5), sodium hypochlorite (N = 5), triclosan (N = 5) and triclocarban (N = 5). Results showed less than 5% colony forming units growth of MRSA treated with triclocarban and no growth in the other groups. Nearly 70,000 mid-infrared spectra from the five treatments and the two control (untreated; N = 4) groups of MRSA (bacteria grown in TSB and incubated at 37 degrees C (Control I)/at ambient temperature (Control II), for 24h) were pre-processed and analyzed using principal component analysis followed by linear discriminant analysis (PCA-LDA). Clustering of strains of MRSA belonging to five treatments and the discrimination between each treatment and two control groups in MRSA (untreated) were investigated. PCA-LDA discriminatory frequencies suggested that ethanol-treated spectra are the most similar to isopropanol-treated spectra biochemically. Also reported here are the biochemical alterations in the structure of proteins, lipid membranes, and phosphate groups of MRSA produced by sodium hypochlorite, triclosan, and triclocarban treatments. These findings provide mechanistic information involved in the interaction between MRSA strains and hygiene products; thereby demonstrating the potential of spectroscopic analysis as an objective, robust, and label-free tool for evaluating the macromolecular changes involved in disinfectant-treated MRSA.	[Aboualizadeh, Ebrahim; Hirschmugl, Carol J.] Univ Wisconsin, Phys Dept, Milwaukee, WI USA; [Bumah, Violet V.] San Diego State Univ, Coll Sci, Dept Chem & Biochem, San Diego, CA 92182 USA; [Masson-Meyers, Daniela S.; Eells, Janis T.; Enwemeka, Chukuka S.] Univ Wisconsin, Coll Hlth Sci, Dept Biomed Sci, Milwaukee, WI 53211 USA; [Enwemeka, Chukuka S.] San Diego State Univ, Off Provost, San Diego, CA 92182 USA; [Aboualizadeh, Ebrahim] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA	University of Wisconsin System; University of Wisconsin Milwaukee; California State University System; San Diego State University; University of Wisconsin System; University of Wisconsin Milwaukee; California State University System; San Diego State University; University of Rochester	Enwemeka, CS (corresponding author), Univ Wisconsin, Coll Hlth Sci, Dept Biomed Sci, Milwaukee, WI 53211 USA.; Enwemeka, CS (corresponding author), San Diego State Univ, Off Provost, San Diego, CA 92182 USA.	enwemeka@mail.sdsu.edu	Masson-Meyers, Daniela/GYU-3472-2022; Aboualizadeh, Ebrahim/K-2559-2019	Aboualizadeh, Ebrahim/0000-0002-8577-7403; Enwemeka, Chukuka/0000-0001-9405-9529	National Science Foundation [CHE-1508240, CHE-1112433]; Stimulus Program to Accelerate Research Clusters (SPARC) of College of Health Sciences, University of Wisconsin-Milwaukee [PRJ73CL]; Direct For Mathematical & Physical Scien [1112433, 1508240] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Stimulus Program to Accelerate Research Clusters (SPARC) of College of Health Sciences, University of Wisconsin-Milwaukee; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the grants CHE-1508240 and CHE-1112433 to C.J.H. from the National Science Foundation and the grant PRJ73CL to J.T.E and V.V.B from the Stimulus Program to Accelerate Research Clusters (SPARC) of College of Health Sciences, University of Wisconsin-Milwaukee.	Aboualizadeh E, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00121; Aboualizadeh E, 2017, ANALYST, V142, P1061, DOI 10.1039/c6an02603f; ANSARI SA, 1989, APPL ENVIRON MICROB, V55, P3113, DOI 10.1128/AEM.55.12.3113-3118.1989; Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8; Barabas ME, 2014, J BIOL CHEM, V289, P34241, DOI 10.1074/jbc.M114.570101; BLOOMFIELD SF, 1979, J APPL BACTERIOL, V46, P65, DOI 10.1111/j.1365-2672.1979.tb02582.x; Bogomolny E, 2008, BBA-GEN SUBJECTS, V1780, P1038, DOI 10.1016/j.bbagen.2008.05.008; Bosch A, 2008, J CLIN MICROBIOL, V46, P2535, DOI 10.1128/JCM.02267-07; Bumah VV, 2017, J PHOTOCH PHOTOBIO B, V167, P150, DOI 10.1016/j.jphotobiol.2016.12.030; CAMPER AK, 1979, APPL ENVIRON MICROB, V37, P633, DOI 10.1128/AEM.37.3.633-641.1979; Chiriboga L, 1998, BIOSPECTROSCOPY, V4, P47, DOI 10.1002/(SICI)1520-6343(1998)4:1<47::AID-BSPY5>3.0.CO;2-P; Daum T, 2015, GENOME ANNOUNC, V3; DENNIS WH, 1979, WATER RES, V13, P357, DOI 10.1016/0043-1354(79)90023-X; Denyer SP, 1998, INT BIODETER BIODEGR, V41, P261, DOI 10.1016/S0964-8305(98)00023-7; Dukan S, 1996, J BACTERIOL, V178, P6145, DOI 10.1128/jb.178.21.6145-6150.1996; Dychdala G.R., 2001, DISINFECTION STERILI, P135; Eklund T, 1991, SOC APPL BACTERIOL T, V27, P225; FITZGERALD KA, 1992, LETT APPL MICROBIOL, V14, P33, DOI 10.1111/j.1472-765X.1992.tb00641.x; Fuller SJ., 1991, SOC APPL BACTERIOL T, V27, P235; GERBA CP, 2001, P C DIS ANT STER PRA, P187; Gilbert P, 1991, SOC APPL BACTERIOL T, V27, P155; Goodacre R, 1996, FEMS MICROBIOL LETT, V140, P233, DOI 10.1016/0378-1097(96)00186-3; Gordin FM, 2005, INFECT CONT HOSP EP, V26, P650, DOI 10.1086/502596; Hamilton WA, 1971, INHIBITION DESTRUCTI, P77; Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316; HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69; Hugo WB, 1999, PRINCIPLES AND PRACTICE OF DISINFECTION, PRESERVATION AND STERILIZATION, 3RD EDITION, P258; Jones RD, 2000, AM J INFECT CONTROL, V28, P184, DOI 10.1016/S0196-6553(00)90027-0; Jumaa PA, 2005, INT J INFECT DIS, V9, P3, DOI 10.1016/j.ijid.2004.05.005; Kirschner C, 2001, J CLIN MICROBIOL, V39, P1763, DOI 10.1128/JCM.39.5.1763-1770.2001; Kroll RG, 1991, SOC APPL BACTERIOL T, V27, P189; KUYYAKANOND T, 1992, FEMS MICROBIOL LETT, V100, P211, DOI 10.1111/j.1574-6968.1992.tb05705.x; Larson E.L., 1991, DISINFECTION STERILI, P191; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; Liao CR, 2013, ANALYST, V138, P3991, DOI 10.1039/c3an00295k; Maillard JY, 2002, J APPL MICROBIOL, V92, p16S, DOI 10.1046/j.1365-2672.92.5s1.3.x; Mariey L, 2001, VIB SPECTROSC, V26, P151, DOI 10.1016/S0924-2031(01)00113-8; Martin FL, 2007, J COMPUT BIOL, V14, P1176, DOI 10.1089/cmb.2007.0057; Mattson EC, 2013, INT J MOL SCI, V14, P22753, DOI 10.3390/ijms141122753; McDonnell G, 2001, CLIN MICROBIOL REV, V14, P227; Morton H.E., 1983, DISINFECTION STERILI, P225; Nobmann P, 2010, J APPL MICROBIOL, V108, P2152, DOI 10.1111/j.1365-2672.2009.04622.x; Pijanka JK, 2010, ANALYST, V135, P3126, DOI 10.1039/c0an00525h; Roujeinikova A, 1999, J MOL BIOL, V294, P527, DOI 10.1006/jmbi.1999.3240; Russell AD, 2002, J ANTIMICROB CHEMOTH, V49, P597, DOI 10.1093/jac/49.4.597; Sickbert-Bennett EE, 2005, AM J INFECT CONTROL, V33, P67, DOI 10.1016/j.ajic.2004.08.005; Stewart MJ, 1999, J MOL BIOL, V290, P859, DOI 10.1006/jmbi.1999.2907; Suller MTE, 2000, J ANTIMICROB CHEMOTH, V46, P11, DOI 10.1093/jac/46.1.11; Trampuz A, 2004, MAYO CLIN PROC, V79, P109, DOI 10.4065/79.1.109; Trevisan J, 2012, ANALYST, V137, P3202, DOI 10.1039/c2an16300d; Tsuboi M., 1961, PROG THEOR PHYS SUPP, V17, P99; Waites WM, 1979, J APPLIED BIOCH, V1, P71; Walsh MJ, 2007, BIOCHEM BIOPH RES CO, V352, P213, DOI 10.1016/j.bbrc.2006.11.005; Walsh SE, 2003, J APPL MICROBIOL, V94, P240, DOI 10.1046/j.1365-2672.2003.01825.x; Wenning M, 2013, APPL MICROBIOL BIOT, V97, P7111, DOI 10.1007/s00253-013-5087-3; Zucchiatti P, 2016, ANAL CHEM, V88, P12090, DOI 10.1021/acs.analchem.6b02744	56	23	24	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							0186375	10.1371/journal.pone.0186375	http://dx.doi.org/10.1371/journal.pone.0186375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036196	Green Published, gold, Green Submitted			2022-12-26	WOS:000413054800027
J	Lagler, C; El-Mesery, M; Kubler, AC; Muller-Richter, UDA; Stuhmer, T; Nickel, J; Muller, TD; Wajant, H; Seher, A				Lagler, Charlotte; El-Mesery, Mohamed; Kuebler, Alexander Christian; Mueller-Richter, Urs Dietmar Achim; Stuehmer, Thorsten; Nickel, Joachim; Mueller, Thomas Dieter; Wajant, Harald; Seher, Axel			The anti-myeloma activity of bone morphogenetic protein 2 predominantly relies on the induction of growth arrest and is apoptosis-independent	PLOS ONE			English	Article							MULTIPLE-MYELOMA; CELL-DEATH; PROGRAMMED NECROSIS; MEDIATED APOPTOSIS; TNF-ALPHA; CYCLOHEXIMIDE; PROLIFERATION; INHIBITOR; AUTOPHAGY; CANCER	Multiple myeloma (MM), a malignancy of the bone marrow, is characterized by a pathological increase in antibody-producing plasma cells and an increase in immunoglobulins (plasmacytosis). In recent years, bone morphogenetic proteins (BMPs) have been reported to be activators of apoptotic cell death in neoplastic B cells in MM. Here, we use bone morphogenetic protein 2 (BMP2) to show that the "apoptotic" effect of BMPs on human neoplastic B cells is dominated by anti-proliferative activities and cell cycle arrest and is apoptosis-independent. The anti-proliferative effect of BMP2 was analysed in the human cell lines KMS12BM and L363 using WST-1 and a Coulter counter and was confirmed using CytoTox assays with established inhibitors of programmed cell death (zVAD-fmk and necrostatin-1). Furthermore, apoptotic activity was compared in both cell lines employing western blot analysis for caspase 3 and 8 in cells treated with BMP2 and FasL. Additionally, expression profiles of marker genes of different cell death pathways were analysed in both cell lines after stimulation with BMP2 for 48h using an RT-PCR-based array. In our experiments we observed that there was rather no reduction in absolute cell number, but cells stopped proliferating following treatment with BMP2 instead. The time frame (48-72 h) after BMP2 treatment at which a reduction in cell number is detectable is too long to indicate a directly BMP2-triggered apoptosis. Moreover, in comparison to robust apoptosis induced by the approved apoptotic factor FasL, BMP2 only marginally induced cell death. Consistently, neither the known inhibitor of apoptotic cell death zVAD-fmk nor the necroptosis inhibitor necrostatin-1 was able to rescue myeloma cell growth in the presence of BMP2.	[Lagler, Charlotte; Kuebler, Alexander Christian; Mueller-Richter, Urs Dietmar Achim; Seher, Axel] Univ Hosp Wuerzburg, Dept Oral & Maxillofacial Plast Surg, Wurzburg, Germany; [El-Mesery, Mohamed] Mansoura Univ, Dept Biochem, Fac Pharm, Mansoura, Egypt; [Stuehmer, Thorsten] Univ Hosp Wuerzburg, Comprehens Canc Ctr Mainfranken CCCMF, Wurzburg, Germany; [Nickel, Joachim] Univ Hosp Wuerzburg, Chair Tissue Engn & Regenerat Med, Wurzburg, Germany; [Nickel, Joachim] Fraunhofer IGB, Translat Ctr Wuerzburg Regenerat Therapies Oncol, Wurzburg, Germany; [Mueller, Thomas Dieter] Univ Wurzburg, Julius Von Sachs Inst, Dept Mol Plant Physiol & Biophys, Wurzburg, Germany; [Wajant, Harald] Univ Hosp Wuerzburg, Div Mol Internal Med, Dept Internal Med 2, Wurzburg, Germany	University of Wurzburg; Egyptian Knowledge Bank (EKB); Mansoura University; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Seher, A (corresponding author), Univ Hosp Wuerzburg, Dept Oral & Maxillofacial Plast Surg, Wurzburg, Germany.	seher_a@ukw.de	El-Mesery, Mohamed/ADM-7145-2022; DA Müller-Richter, Urs/P-5864-2014; El-Mesery, Mohamed/U-7250-2018; Kübler, Alexander/ABA-9297-2021	DA Müller-Richter, Urs/0000-0001-7869-7686; Mueller, Thomas/0000-0003-1862-7357	Deutsche Forschungsgemeinschaft [KFO 216]; University of Wuerzburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by the Deutsche Forschungsgemeinschaft (KFO 216 to TS) and the University of Wuerzburg (funding program Open Access Publishing).	Anguiano A, 2009, J CLIN ONCOL, V27, P4197, DOI 10.1200/JCO.2008.19.1916; Bergsagel PL, 2001, ONCOGENE, V20, P5611, DOI 10.1038/sj.onc.1204641; Cain JE, 2008, DIFFERENTIATION, V76, P831, DOI 10.1111/j.1432-0436.2008.00265.x; Chen S, 2002, J DENT RES, V81, P98, DOI 10.1177/154405910208100203; Craighead MW, 1999, J NEUROSCI RES, V57, P236, DOI 10.1002/(SICI)1097-4547(19990715)57:2<236::AID-JNR9>3.3.CO;2-4; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fan CG, 2002, J CELL SCI, V115, P4843, DOI 10.1242/jcs.00151; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Feig C, 2007, EUR J IMMUNOL, V37, pS61, DOI 10.1002/eji.200737462; Fischer-Posovszky P, 2011, EXP CELL RES, V317, P2200, DOI 10.1016/j.yexcr.2011.06.016; Fukuda N, 2006, ONCOGENE, V25, P3509, DOI 10.1038/sj.onc.1209393; GaleaLauri J, 1996, J IMMUNOL, V157, P4109; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Harousseau JL, 2009, NEW ENGL J MED, V360, P2645, DOI 10.1056/NEJMct0805626; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Heinecke K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-59; Hjertner O, 2001, BLOOD, V97, P516, DOI 10.1182/blood.V97.2.516; Holien T, 2012, LEUKEMIA, V26, P1073, DOI 10.1038/leu.2011.263; ISHII HH, 1995, IMMUNOL CELL BIOL, V73, P463, DOI 10.1038/icb.1995.72; Kawamura C, 2000, BLOOD, V96, P2005, DOI 10.1182/blood.V96.6.2005.h8002005a_2005_2011; Kawamura C, 2002, LEUKEMIA LYMPHOMA, V43, P635, DOI 10.1080/10428190290012182; Kotzsch A, 2008, J BIOL CHEM, V283, P5876, DOI 10.1074/jbc.M706029200; Lalaoui N, 2015, SEMIN CELL DEV BIOL, V39, P63, DOI 10.1016/j.semcdb.2015.02.003; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Long JS, 2012, ONCOGENE, V31, P5045, DOI 10.1038/onc.2012.7; Longo V, 2012, CANCER TREAT REV, V38, P787, DOI 10.1016/j.ctrv.2012.03.004; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Montero JA, 2010, APOPTOSIS, V15, P365, DOI 10.1007/s10495-009-0444-5; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; NISHIHARA T, 1993, BIOCHEM BIOPH RES CO, V197, P985, DOI 10.1006/bbrc.1993.2576; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Olsen OE, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.16; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Quirk SM, 1998, ENDOCRINOLOGY, V139, P4860, DOI 10.1210/en.139.12.4860; Rajkumar SV, 2011, AM J HEMATOL, V86, P57, DOI 10.1002/ajh.21913; Ro TB, 2004, ONCOGENE, V23, P3024, DOI 10.1038/sj.onc.1207386; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Saremba S, 2008, FEBS J, V275, P172, DOI 10.1111/j.1742-4658.2007.06187.x; Seckinger A, 2009, ONCOGENE, V28, P3866, DOI 10.1038/onc.2009.257; Stepanenko AA, 2015, GENE, V574, P193, DOI 10.1016/j.gene.2015.08.009; Tong KK, 2015, DEV GROWTH DIFFER, V57, P121, DOI 10.1111/dgd.12198; Vandenabeele P, 2013, CELL DEATH DIFFER, V20, P185, DOI 10.1038/cdd.2012.151; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wright KM, 2006, CELL CYCLE, V5, P1616, DOI 10.4161/cc.5.15.3129; Yamamoto Y, 2004, NATURWISSENSCHAFTEN, V91, P519, DOI 10.1007/s00114-004-0575-z; Zipori D, 2001, J LEUKOCYTE BIOL, V69, P867	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0185720	10.1371/journal.pone.0185720	http://dx.doi.org/10.1371/journal.pone.0185720			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028819	Green Published, gold, Green Submitted			2022-12-26	WOS:000412980300012
J	Wenke, C; Pospiech, J; Reutter, T; Truyen, U; Speck, S				Wenke, Cindy; Pospiech, Janina; Reutter, Tobias; Truyen, Uwe; Speck, Stephanie			Efficiency of different air filter types for pig facilities at laboratory scale	PLOS ONE			English	Article							RESPIRATORY-SYNDROME-VIRUS; LARGE BREEDING HERDS; LARGE SOW HERDS; FILTRATION SYSTEMS; AIRBORNE SPREAD; PRRSV INFECTION; MOUTH-DISEASE; ACTINOBACILLUS-PLEUROPNEUMONIAE; MYCOPLASMA-HYOPNEUMONIAE; AEROSOL TRANSMISSION	Air filtration has been shown to be efficient in reducing pathogen burden in circulating air. We determined at laboratory scale the retention efficiency of different air filter types either composed of a prefilter (EU class G4) and a secondary fiberglass filter (EU class F9) or consisting of a filter mat (EU class M6 and F8-9). Four filter prototypes were tested for their capability to remove aerosol containing equine arteritis virus (EAV), porcine reproductive and respiratory syndrome virus (PRRSV), bovine enterovirus 1 (BEV), Actinobacillus pleuropneumoniae (APP), and Staphylococcus (S.) aureus from air. Depending on the filter prototype and utilisation, the airflow was set at 1,800 m(3)/h (combination of upstream prefilter and fiberglass filter) or 80 m(3)/h (filter mat). The pathogens were aerosolized and their concentration was determined in front of and behind the filter by culture or quantitative real-time RT-PCR. Furthermore, survival of the pathogens over time in the filter material was determined. Bacteria were most efficiently filtered with a reduction rate of up to 99.9% depending on the filter used. An approximately 98% reduction was achieved for the viruses tested. Viability or infectivity of APP or PRRSV in the filter material decreased below the detection limit after 4 h and 24 h, respectively, whereas S. aureus was still culturable after 4 weeks. Our results demonstrate that pathogens can efficiently be reduced by air filtration. Consequently, air filtration combined with other strict biosecurity measures markedly reduces the risk of introducing airborne transmitted pathogens to animal facilities. In addition, air filtration might be useful in reducing bioaerosols within a pig barn, hence improving respiratory health of pigs.	[Wenke, Cindy; Pospiech, Janina; Truyen, Uwe; Speck, Stephanie] Inst Anim Hyg & Vet Publ Hlth, Leipzig, Germany; [Reutter, Tobias] REVENTA GmbH, Horstmar, Germany		Speck, S (corresponding author), Inst Anim Hyg & Vet Publ Hlth, Leipzig, Germany.	stephanie.speck@vetmed.uni-leipzig.de			German federal government/Federal Ministry of Food and Agriculture by the Landwirtschaftliche Rentenbank (University of Leipzig) [741 120/1]; German federal government/Federal Ministry of Food and Agriculture by the Landwirtschaftliche Rentenbank (REVENTA(R) GmbH) [742 393/1]	German federal government/Federal Ministry of Food and Agriculture by the Landwirtschaftliche Rentenbank (University of Leipzig); German federal government/Federal Ministry of Food and Agriculture by the Landwirtschaftliche Rentenbank (REVENTA(R) GmbH)	This project was funded in part from a special purpose fund of the German federal government/Federal Ministry of Food and Agriculture by the Landwirtschaftliche Rentenbank (University of Leipzig grant number 741 120/1 and REVENTA (R) GmbH grant number 742 393/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2013, PREV VET MED, V112, P109, DOI 10.1016/j.prevetmed.2013.06.001; Alonso C, 2013, PREV VET MED, V111, P268, DOI 10.1016/j.prevetmed.2013.05.001; American Society of Heating, 2007, METH TEST GEN VENT A, V52; Assavacheep P, 2013, RES VET SCI, V94, P22, DOI 10.1016/j.rvsc.2012.07.024; Batista L., 2009, Banff Pork Seminar Proceedings 2009, P151; Chaibenjawong P, 2011, ARCH MICROBIOL, V193, P125, DOI 10.1007/s00203-010-0653-x; CONZELMANN KK, 1993, VIROLOGY, V193, P329, DOI 10.1006/viro.1993.1129; Dee S, 2005, CAN J VET RES, V69, P293; Dee S., 2008, INT PIGLETTER, V28, p9a; Dee SA, 2006, CAN J VET RES, V70, P28; Dee S, 2012, VIRUSES-BASEL, V4, P654, DOI 10.3390/v4050654; Dee S, 2011, J SWINE HEALTH PROD, V19, P292; Dee S, 2010, VIRUS RES, V154, P177, DOI 10.1016/j.virusres.2010.07.022; Dee S, 2009, VET RES, V40, DOI 10.1051/vetres/2009022; Dee S, 2009, VET MICROBIOL, V138, P106, DOI 10.1016/j.vetmic.2009.03.019; Dee SA, 2006, CAN J VET RES, V70, P168; DONALDSON AI, 1982, VET REC, V110, P53, DOI 10.1136/vr.110.3.53; Friese A, 2012, VET MICROBIOL, V158, P129, DOI 10.1016/j.vetmic.2012.01.019; Gloster J, 2005, EPIDEMIOL INFECT, V133, P767, DOI 10.1017/S0950268805004073; Hartung J., 2007, LANDBAUFORSCH VOLK, V308, P111; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Jimenez-Clavero MA, 2005, APPL ENVIRON MICROB, V71, P3536, DOI 10.1128/AEM.71.7.3536-3543.2005; Jobert JL, 2000, CAN J VET RES, V64, P21; Kaerber G., 1921, ARCH EXP PATHOL PH, V162, P480; Mainelis G, 2001, J AEROSOL SCI, V32, P1087, DOI 10.1016/S0021-8502(01)00039-8; MCFERRAN JB, 1962, ANN NY ACAD SCI, V101, P436, DOI 10.1111/j.1749-6632.1962.tb18883.x; Otake S, 2010, VET MICROBIOL, V145, P198, DOI 10.1016/j.vetmic.2010.03.028; Pedersen S, 2000, J Agric Saf Health, V6, P261; ROUNTREE PM, 1963, J HYG-CAMBRIDGE, V61, P265, DOI 10.1017/S0022172400039541; SCOTT FW, 1967, AM J VET RES, V28, P1597; Seedorf J., 2000, LANDTECHNIK, V2, P182; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Spronk G, 2010, VET REC, V166, P758, DOI 10.1136/vr.b4848; Torremorell M, 1997, AM J VET RES, V58, P828; Zhen HJ, 2013, APPL ENVIRON MICROB, V79, P7780, DOI 10.1128/AEM.02859-13	35	11	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186558	10.1371/journal.pone.0186558	http://dx.doi.org/10.1371/journal.pone.0186558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028843	gold, Green Published, Green Submitted			2022-12-26	WOS:000412980300041
J	Asem, D; Leo, VV; Passari, AK; Tonsing, MV; Joshi, JB; Uthandi, S; Hashem, A; Abd Allah, EF; Singh, BP				Asem, Dhaneshwaree; Leo, Vincent Vineeth; Passari, Ajit Kumar; Tonsing, Mary Vanlalhruaii; Joshi, J. Beslin; Uthandi, Sivakumar; Hashem, Abeer; Abd Allah, Elsayed Fathi; Singh, Bhim Pratap			Evaluation of gastrointestinal bacterial population for the production of holocellulose enzymes for biomass deconstruction	PLOS ONE			English	Article							CELLULOLYTIC BACTERIA; XYLANASE PRODUCTION; CELLULASE; PRETREATMENT; DIVERSITY; RUMEN; OPTIMIZATION; PURIFICATION; STRATEGIES; ETHANOL	The gastrointestinal (GI) habitat of ruminant and non-ruminant animals sustains a vast ensemble of microbes that are capable of utilizing lignocellulosic plant biomass. In this study, an indigenous swine (Zovawk) and a domesticated goat (Black Bengal) were investigated to isolate bacteria having plant biomass degrading enzymes. After screening and enzymatic quantification of eighty-one obtained bacterial isolates, Serratia rubidaea strain DBT4 and Aneurinibacillus aneurinilyticus strain DBT87 were revealed as the most potent strains, showing both cellulase and xylanase production. A biomass utilization study showed that submerged fermentation (SmF) of D2 (alkaline pretreated pulpy biomass) using strain DBT4 resulted in the most efficient biomass deconstruction with maximum xylanase (11.98 U/mL) and FPase (0.5 U/mL) activities (55 degrees C, pH 8). The present study demonstrated that bacterial strains residing in the gastrointestinal region of non-ruminant swine are a promising source for lignocellulose degrading microorganisms that could be used for biomass conversion.	[Asem, Dhaneshwaree; Leo, Vincent Vineeth; Passari, Ajit Kumar; Tonsing, Mary Vanlalhruaii; Singh, Bhim Pratap] Mizoram Univ, Dept Biotechnol, Mol Microbiol & Systemat Lab, Aizawl, Mizoram, India; [Joshi, J. Beslin; Uthandi, Sivakumar] Tamil Nadu Agr Univ, Dept Agr Microbiol, Bioctalysts Lab, Coimbatore, Tamil Nadu, India; [Hashem, Abeer] King Saud Univ, Coll Sci, Bot & Microbiol Dept, Riyadh, Saudi Arabia; [Abd Allah, Elsayed Fathi] King Saud Univ, Coll Food & Agr Sci, Plant Prod Dept, Riyadh, Saudi Arabia	Mizoram University; Tamil Nadu Agricultural University; King Saud University; King Saud University	Singh, BP (corresponding author), Mizoram Univ, Dept Biotechnol, Mol Microbiol & Systemat Lab, Aizawl, Mizoram, India.	bhimpratap@gmail.com	Hashem, Abeer/AAX-5952-2021; Abd_Allah, Elsayed Fathi/N-6846-2017; Singh, Bhim Pratap/G-7268-2016; Passari, Ajit Kumar/X-9807-2019; Uthandi, Sivakumar/C-3277-2018	Abd_Allah, Elsayed Fathi/0000-0002-8509-8953; Singh, Bhim Pratap/0000-0002-9911-4125; Passari, Ajit Kumar/0000-0002-1150-8075; Uthandi, Sivakumar/0000-0002-7116-1317; ASEM, DHANESHWAREE/0000-0002-0581-0438; Leo, Vincent Vineeth/0000-0003-1700-2259	Department of Biotechnology, Government of India [BT/323/NE/TBP/2012]; Deanship of Scientific Research at King Saud University [RG-1435-014]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Deanship of Scientific Research at King Saud University(King Saud University)	The funding was received from Department of Biotechnology, Government of India to execute this work (No BT/323/NE/TBP/2012) to BPS.The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding to the Research Group number (RG-1435-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BPS is thankful to the Department of Biotechnology, the Government of India, New Delhi for financial support under DBT's NER-Twinning project (No BT/323/NE/TBP/2012). The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding to the Research Group number (RG-1435-014). The authors are thankful to the DBT, New Delhi, for the establishment of the DBT-BIF center and DBT-state Biotech Hub facility at Mizoram University, which was used for the present study.	Acharya S, 2012, BRAZ ARCH BIOL TECHN, V55, P497, DOI 10.1590/S1516-89132012000400003; Adav SS, 2010, J PROTEOME RES, V9, P3016, DOI 10.1021/pr901174z; Anand AAP, 2004, COMP BIOCHEM PHYS A, V139, P65, DOI 10.1016/j.cbpb.2004.07.006; Archana A, 1997, ENZYME MICROB TECH, V21, P12, DOI 10.1016/S0141-0229(96)00207-4; BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J; Camassola M., 2012, J ANAL BIOANAL TECH, V1, P125, DOI [10.4172/scientificreports.125, DOI 10.4172/SCIENTIFICREP0RTS.125]; Choi IS, 2009, J WOOD SCI, V55, P329, DOI 10.1007/s10086-009-1044-2; Dar MA, 2015, INT BIODETER BIODEGR, V98, P73, DOI 10.1016/j.ibiod.2014.11.016; Dhakal S, 2014, FOOD RES INT, V62, P215, DOI 10.1016/j.foodres.2014.02.021; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; del Pulgar EMG, 2014, CRIT REV MICROBIOL, V40, P236, DOI 10.3109/1040841X.2013.776512; Gupta P., 2012, INT J MICROBIOL, V2012; Han X, 2015, PLOS ONE, V10; Haruta S, 2002, APPL MICROBIOL BIOT, V60, P224, DOI 10.1007/s00253-002-1074-9; HENDRICKS CW, 1995, APPL ENVIRON MICROB, V61, P2016, DOI 10.1128/AEM.61.5.2016-2019.1995; Hong J, 2007, J BIOTECHNOL, V130, P114, DOI 10.1016/j.jbiotec.2007.03.008; Howard R. L., 2003, African Journal of Biotechnology, V2, P602; Immanuel G., 2006, International Journal of Environmental Science and Technology, V3, P25, DOI 10.1007/BF03325904; Jiao JZ, 2015, APPL ENVIRON MICROB, V81, P3502, DOI 10.1128/AEM.00203-15; Jonsson LJ, 2016, BIORESOURCE TECHNOL, V199, P103, DOI 10.1016/j.biortech.2015.10.009; Kim HB, 2015, VET MICROBIOL, V177, P242, DOI 10.1016/j.vetmic.2015.03.014; Ko CH, 2011, INT BIODETER BIODEGR, V65, P334, DOI 10.1016/j.ibiod.2010.12.006; Ko CH, 2010, INT BIODETER BIODEGR, V64, P13, DOI 10.1016/j.ibiod.2009.10.001; Komolwanich Tidarat, 2016, Materials Research Innovations, V20, P259, DOI 10.1080/14328917.2015.1105573; Lalthansanga J, 2015, VET WORLD, V8, P918, DOI 10.14202/vetworld.2015.918-923; Leo VV, 2016, FRONT MICROBIOL, P7; Liang Y, 2009, J IND MICROBIOL BIOT, V36, P961, DOI 10.1007/s10295-009-0575-2; Lopez-Linares JC, 2015, BIORESOURCE TECHNOL, V190, P97, DOI 10.1016/j.biortech.2015.04.066; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; LYND LR, 1991, SCIENCE, V251, P1318, DOI 10.1126/science.251.4999.1318; Maki M, 2009, INT J BIOL SCI, V5, P500; Mawadza C, 2000, J BIOTECHNOL, V83, P177, DOI 10.1016/S0168-1656(00)00305-9; Min BR., 2014, AGR FOOD ANAL BACTER, V4, P195; Mohanram S., 2013, SUSTAINABLE CHEM PRO, V1, P15, DOI [10.1186/2043-7129-1-15, DOI 10.1186/2043-7129-1-15]; Oyeleke SB, 2008, AFR J BIOTECHNOL, V7, P1503; Qin S, 2009, APPL ENVIRON MICROB, V75, P6176, DOI 10.1128/AEM.01034-09; Rastogi G, 2009, J IND MICROBIOL BIOT, V36, P585, DOI 10.1007/s10295-009-0528-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seo JK, 2013, ASIAN AUSTRAL J ANIM, V26, P50, DOI 10.5713/ajas.2012.12506; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Sun JZ, 2010, INSECT SCI, V17, P163, DOI 10.1111/j.1744-7917.2010.01348.x; Sweeney MD, 2012, CATALYSTS, V2, P244, DOI 10.3390/catal2020244; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trivedi N, 2011, CARBOHYD POLYM, V83, P891, DOI 10.1016/j.carbpol.2010.08.069; Wang SR, 2011, J ANAL APPL PYROL, V91, P183, DOI 10.1016/j.jaap.2011.02.006; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Xu JL, 2010, ENERG FUEL, V24, P2113, DOI 10.1021/ef9014718; Yang VW, 1995, J IND MICROBIOL, V15, P434, DOI 10.1007/BF01569971; Yang WP, 2014, ELECTRON J BIOTECHN, V17, P262, DOI 10.1016/j.ejbt.2014.08.002; Yin LJ, 2010, J MAR SCI TECH-TAIW, V18, P466	53	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186355	10.1371/journal.pone.0186355	http://dx.doi.org/10.1371/journal.pone.0186355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023528	Green Submitted, Green Published, gold			2022-12-26	WOS:000412845100116
J	Nakazawa, S; Haramiishi, A; Fukuda, K; Kanayama, Y; Watanabe, T; Yuki, M; Ohkuma, M; Takeda, K; Kimbara, K; Shintani, M				Nakazawa, Shunsuke; Haramiishi, Akira; Fukuda, Kohei; Kanayama, Yukie; Watanabe, Toshinori; Yuki, Masahiro; Ohkuma, Moriya; Takeda, Kazuhiro; Kimbara, Kazuhide; Shintani, Masaki			Different transferability of incompatibility (Inc) P-7 plasmid pCAR1 and IncP-1 plasmid pBP136 in stirring liquid conditions	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; MOBILE GENETIC ELEMENTS; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; PSEUDOMONAS-PUTIDA; TRANSPOSON TN4676; CARBAZOLE; BEHAVIOR; VISUALIZATION; REPLICATION	Self-transmissible plasmids are classified into two types based on their sex pili: short and rigid pili, and long and flexible pili. The transferability of two plasmids with different types of sex pili, pBP136 and pCAR1, was compared in stirring liquid conditions with different cell density. The most probable number method to count transconjugants could detect differences in the transfer frequency with higher resolution in comparison with the conventional CFU counting method. Both plasmids showed higher transfer frequency in high stirring rates than static liquid conditions when the donor and recipient density was 10(6)-10(7) CFU mL(-1). The probability of donor-initiated plasmid transfer was investigated by a single-cell-level analysis using a cell sorter. The probability was >36-fold higher for pBP136 than for pCAR1; thus, the simulated transfer frequency of pBP136 was much higher than that of pCAR1 in stirring liquid conditions. Nevertheless, the transfer frequency of pCAR1 was as high as that of pBP136 when the donor and recipient cell density was 10 6 CFU mL(-1). This fact indicates that the lower probability of the donor pCAR1 to initiate transfer could be overcome by its high tolerance to the shearing force between donor and recipient cells under higher stirring liquid conditions. Our findings can explain the different survival strategies of these two types of plasmids based on their preferences of transfer conditions.	[Nakazawa, Shunsuke; Haramiishi, Akira; Kanayama, Yukie; Watanabe, Toshinori; Takeda, Kazuhiro; Kimbara, Kazuhide; Shintani, Masaki] Shizuoka Univ, Grad Sch Integrated Sci & Technol, Dept Engn, Appl Chem & Biochem Engn Course, Hamamatsu, Shizuoka, Japan; [Fukuda, Kohei; Shintani, Masaki] Shizuoka Univ, Graduated Sch Sci & Technol, Dept Biosci, Hamamatsu, Shizuoka, Japan; [Yuki, Masahiro; Ohkuma, Moriya] RIKEN Ctr Sustainable Resource Sci, Biomass Engn Program Cooperat Div, Biomass Res Platform Team, Tsukuba, Ibaraki, Japan; [Ohkuma, Moriya; Shintani, Masaki] RIKEN BioResource Ctr, Japan Collect Microorganisms, Tsukuba, Ibaraki, Japan	Shizuoka University; Shizuoka University; RIKEN; RIKEN	Shintani, M (corresponding author), Shizuoka Univ, Grad Sch Integrated Sci & Technol, Dept Engn, Appl Chem & Biochem Engn Course, Hamamatsu, Shizuoka, Japan.; Shintani, M (corresponding author), Shizuoka Univ, Graduated Sch Sci & Technol, Dept Biosci, Hamamatsu, Shizuoka, Japan.; Shintani, M (corresponding author), RIKEN BioResource Ctr, Japan Collect Microorganisms, Tsukuba, Ibaraki, Japan.	shintani.masaki@shizuoka.ac.jp	Yuki, Masahiro/C-5419-2017; Shintani, Masaki/L-2091-2019; Shintani, Masaki/A-3219-2012	Shintani, Masaki/0000-0002-6505-9850; Shintani, Masaki/0000-0002-6505-9850	JSPS KAKENHI [15H05618]; Grants-in-Aid for Scientific Research [17H01447, 15H05618] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	his work was supported by JSPS KAKENHI, Grant Number 15H05618 to MS (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-15H05618/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminov RI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00158; Babic A, 2008, SCIENCE, V319, P1533, DOI 10.1126/science.1153498; Beuls E, 2012, APPL ENVIRON MICROB, V78, P7128, DOI 10.1128/AEM.01105-12; BRADLEY DE, 1984, J GEN MICROBIOL, V130, P1489; BRADLEY DE, 1980, J BACTERIOL, V143, P1466, DOI 10.1128/JB.143.3.1466-1470.1980; CARON DA, 1989, MICROBIAL ECOL, V18, P89, DOI 10.1007/BF02030118; Clarke M, 2008, P NATL ACAD SCI USA, V105, P17978, DOI 10.1073/pnas.0806786105; Dunny GM, 2013, ANNU REV GENET, V47, P457, DOI 10.1146/annurev-genet-111212-133449; Ekelund F, 1999, J MICROBIOL METH, V38, P177, DOI 10.1016/S0167-7012(99)00086-X; Guglielmini J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002222; Handel N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123039; Heuer H, 2007, ENVIRON MICROBIOL, V9, P657, DOI 10.1111/j.1462-2920.2006.01185.x; Jarvis B, 2010, J APPL MICROBIOL, V109, P1660, DOI 10.1111/j.1365-2672.2010.04792.x; Kamachi K, 2006, MICROBIOL-SGM, V152, P3477, DOI 10.1099/mic.0.29056-0; Lawley TD, 2002, MOL MICROBIOL, V44, P947, DOI 10.1046/j.1365-2958.2002.02938.x; Maeda K, 2003, J MOL BIOL, V326, P21, DOI 10.1016/S0022-2836(02)01400-6; Rusconi R, 2015, CURR OPIN MICROBIOL, V25, P1, DOI 10.1016/j.mib.2015.03.003; Sambrook J., 2001, MOL CLONING LAB MANU; Schluter A, 2003, MICROBIOL-SGM, V149, P3139, DOI 10.1099/mic.0.26570-0; Schuurmans JM, 2014, PLASMID, V72, P1, DOI 10.1016/j.plasmid.2014.01.002; Shintani M, 2005, BIOTECHNOL LETT, V27, P1847, DOI 10.1007/s10529-005-3892-1; Shintani M, 2005, APPL MICROBIOL BIOT, V67, P370, DOI 10.1007/s00253-004-1778-0; Shintani M, 2008, APPL MICROBIOL BIOT, V80, P485, DOI 10.1007/s00253-008-1564-5; Shintani M, 2006, APPL ENVIRON MICROB, V72, P3206, DOI 10.1128/AEM.72.5.3206-3216.2006; Shintani M, 2017, BIOSCI BIOTECH BIOCH, V81, P854, DOI 10.1080/09168451.2016.1270743; Shintani M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00242; Shintani M, 2014, APPL ENVIRON MICROB, V80, P138, DOI 10.1128/AEM.02571-13; Shintani M, 2010, BIOSCI BIOTECH BIOCH, V74, P343, DOI 10.1271/bbb.90675; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Takahashi Y, 2009, BIOSCI BIOTECH BIOCH, V73, P744, DOI 10.1271/bbb.80665; Verma T, 2002, APPL BIOCHEM BIOTECH, V102, P5, DOI 10.1385/ABAB:102-103:1-6:005; Yanagida K, 2016, BIOSCI BIOTECH BIOCH, V80, P1020, DOI 10.1080/09168451.2015.1127131; Zhong X, 2010, J THEOR BIOL, V262, P711, DOI 10.1016/j.jtbi.2009.10.013	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186248	10.1371/journal.pone.0186248	http://dx.doi.org/10.1371/journal.pone.0186248			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023575	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100091
J	Van Rooij, P; Pasmans, F; Coen, Y; Martel, A				Van Rooij, Pascale; Pasmans, Frank; Coen, Yanaika; Martel, An			Efficacy of chemical disinfectants for the containment of the salamander chytrid fungus Batrachochytrium salamandrivorans	PLOS ONE			English	Article							SP-NOV; DENDROBATIDIS; CHYTRIDIOMYCOSIS; MECHANISMS; STRESS; LIFE	The recently emerged chytrid fungus Batrachochytrium salamandrivorans (Bsal) causes European salamander declines. Proper hygiene protocols including disinfection procedures are crucial to prevent disease transmission. Here, the efficacy of chemical disinfectants in killing Bsal was evaluated. At all tested conditions, Biocidal (R), Chloramine-T (R), Dettol medical (R), Disolol (R), ethanol, F10 (R), Hibiscrub (R), potassium permanganate, Safe4 (R), sodium hypochlorite, and Virkon S (R), were effective at killing Bsal. Concentrations of 5% sodium chloride or lower, 0.01% peracetic acid and 0.001-1% copper sulphate were inactive against Bsal. None of the conditions tested for hydrogen peroxide affected Bsal viability, while it did kill Batrachochytrium dendrobatidis (Bd). For Bsal, enzymatic breakdown of hydrogen peroxide by catalases and specific morphological features (clustering of sporangia, development of new sporangia within the original sporangium), were identified as fungal factors altering susceptibility to several of the disinfectants tested. Based on the in vitro results we recommend 1% Virkon S (R), 4% sodium hypochlorite and 70% ethanol for disinfecting equipment in the field, lab or captive setting, with a minimal contact time of 5 minutes for 1% Virkon S (R) and 1 minute for the latter disinfectants. These conditions not only efficiently target Bsal, but also Bd and Ranavirus.	[Van Rooij, Pascale; Pasmans, Frank; Coen, Yanaika; Martel, An] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium	Ghent University	Martel, A (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	an.martel@ugent.be	Pasmans, Frank/D-3667-2014		Ghent University Special Research Fund [BOF13/PDO/130]	Ghent University Special Research Fund(Ghent University)	Financial support of PVR is funded by the Ghent University Special Research Fund (BOF13/PDO/130). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, CDC GUID DIS STER HE; [Anonymous], 2017, RAVON HYGIENE PROTOC; Berger L, 2010, DIS AQUAT ORGAN, V92, P165, DOI 10.3354/dao02238; Blooi M, 2013, FUNGAL BIOL-UK, V117, P156, DOI 10.1016/j.funbio.2013.01.004; Boisvert SP, 2011, J WILDLIFE DIS, V47, P694, DOI 10.7589/0090-3558-47.3.694; Bryan LK, 2009, DIS AQUAT ORGAN, V84, P89, DOI 10.3354/dao02036; Caldwell B, RESOURCE GUIDE ORGAN; Chinchar VG, 2011, VIRUSES-BASEL, V3, P1959, DOI 10.3390/v3101959; Clarkson RM, 2001, AUST DENT J, V46, P269, DOI 10.1111/j.1834-7819.2001.tb00291.x; Cunningham AA, 2015, VET REC, V176, P468, DOI 10.1136/vr.h2264; Dantas AD, 2015, BIOMOLECULES, V5, P142, DOI 10.3390/biom5010142; Duffus A. L. J., 2015, RANAVIRUSES LETHAL P, P9, DOI DOI 10.1007/978-3-319-13755-1; Fitzpatrick L, 2016, P 12 C EUR WILDL DIS; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Gold KK, 2013, DIS AQUAT ORGAN, V107, P77, DOI 10.3354/dao02670; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; Hangartner S, 2012, AMPHIBIA-REPTILIA, V33, P349, DOI 10.1163/15685381-00002837; HASSETT DJ, 1989, FASEB J, V3, P2574, DOI 10.1096/fasebj.3.14.2556311; Iwase T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03081; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; LANGDON JS, 1989, J FISH DIS, V12, P295, DOI 10.1111/j.1365-2761.1989.tb00318.x; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Mesa-Arango AC, 2016, ANTIMICROB AGENTS CH, V60, P2326, DOI 10.1128/AAC.02681-15; Phillott AD, 2010, DIS AQUAT ORGAN, V92, P175, DOI 10.3354/dao02162; Sabino-Pinto J, 2015, AMPHIBIA-REPTILIA, V36, P411, DOI 10.1163/15685381-00003008; Sanglard D, 2002, LANCET INFECT DIS, V2, P73, DOI 10.1016/S1473-3099(02)00181-0; Schmidt BR, 2009, AMPHIBIA-REPTILIA, V30, P313, DOI 10.1163/156853809788795245; Singh P, 2016, MYCOSES, V59, P628, DOI 10.1111/myc.12512; Spitzen-van der Sluijs A, 2016, EMERG INFECT DIS, V22, P1286, DOI 10.3201/eid2207.160109; Stegen G, 2017, NATURE, V544, P353, DOI 10.1038/nature22059; Swaef E. de, 2016, Reviews in Aquaculture, V8, P321, DOI 10.1111/raq.12096; Van Rooij P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0266-0; Van Rooij P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041481; Webb R, 2007, DIS AQUAT ORGAN, V74, P13, DOI 10.3354/dao074013; Zamocky M, 2014, CELL MOL LIFE SCI, V71, P4681, DOI 10.1007/s00018-014-1643-y	38	25	26	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186269	10.1371/journal.pone.0186269	http://dx.doi.org/10.1371/journal.pone.0186269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023562	Green Published, gold			2022-12-26	WOS:000412845100095
J	Baird, AB; Braun, JK; Engstrom, MD; Holbert, AC; Huerta, MG; Lim, BK; Mares, MA; Patton, JC; Bickham, JW				Baird, Amy B.; Braun, Janet K.; Engstrom, Mark D.; Holbert, Ashlyn C.; Huerta, Maritza G.; Lim, Burton K.; Mares, Michael A.; Patton, John C.; Bickham, John W.			Nuclear and mtDNA phylogenetic analyses clarify the evolutionary history of two species of native Hawaiian bats and the taxonomy of Lasiurini (Mammalia: Chiroptera)	PLOS ONE			English	Article							WHITE-TAILED DEER; MITOCHONDRIAL-DNA ANALYSIS; MULE DEER; INTROGRESSIVE HYBRIDIZATION; ECHOLOCATION CALLS; HOARY BAT; CINEREUS; ODOCOILEUS; SPECIATION; SEQUENCES	Previous studies on genetics of hoary bats produced differing conclusions on the timing of their colonization of the Hawaiian Islands and whether or not North American (Aeorestes cinereus) and Hawaiian (A. semotus) hoary bats are distinct species. One study, using mtDNA COI and nuclear Rag2 and CMA1, concluded that hoary bats colonized the Hawaiian Islands no more than 10,000 years ago based on indications of population expansion at that time using Extended Bayesian Skyline Plots. The other study, using 3 mtDNA and 1 Y-chromosome locus, concluded that the Hawaiian Islands were colonized about 1 million years ago. To address the marked inconsistencies between those studies, we examined DNA sequences from 4 mitochondrial and 2 nuclear loci in lasiurine bats to investigate the timing of colonization of the Hawaiian Islands by hoary bats, test the hypothesis that Hawaiian and North American hoary bats belong to different species, and further investigate the generic level taxonomy within the tribe. Phylogenetic analysis and dating of the nodes of mtDNA haplotypes and of nuclear CMA1 alleles show that A. semotus invaded the Hawaiian Islands approximately 1.35 Ma and that multiple arrivals of A. cinereus occurred much more recently. Extended Bayesian Skyline plots show population expansion at about 20,000 years ago in the Hawaiian Islands, which we conclude does not represent the timing of colonization of the Hawaiian Islands given the high degree of genetic differentiation among A. cinereus and A. semotus (4.2% divergence at mtDNA Cytb) and the high degree of genetic diversity within A. semotus. Rather, population expansion 20,000 years ago could have resulted from colonization of additional islands, expansion after a bottleneck, or other factors. New genetic data also support the recognition of A. semotus and A. cinereus as distinct species, a finding consistent with previous morphological and behavioral studies. The phylogenetic analysis of CMA1 alleles shows the presence of 2 clades that are primarily associated with A. semotus mtDNA haplotypes, and are unique to the Hawaiian Islands. There is evidence for low levels of hybridization between A. semotus and A. cinereus on the Hawaiian Islands, but it is not extensive (<15% of individuals are of hybrid origin), and clearly each species is able to maintain its own genetic distinctiveness. Both mtDNA and nuclear DNA sequences show deep divergence between the 3 groups (genera) of lasiurine bats that correspond to the previously recognized morphological differences between them. We show that the Tribe Lasiurini contains the genera Aeorestes (hoary bats), Lasiurus (red bats), and Dasypterus (yellow bats).	[Baird, Amy B.; Holbert, Ashlyn C.; Huerta, Maritza G.] Univ Houston Downtown, Dept Nat Sci, Houston, TX 77002 USA; [Braun, Janet K.; Mares, Michael A.] Univ Oklahoma, Sam Noble Museum, Norman, OK 73019 USA; [Engstrom, Mark D.; Lim, Burton K.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON, Canada; [Mares, Michael A.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Patton, John C.] Purdue Univ, Dept Forestry & Nat Resources, Lafayette, IN USA; [Bickham, John W.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	University of Houston System; University of Houston; University of Houston Downtown; University of Oklahoma System; University of Oklahoma - Norman; Royal Ontario Museum; University of Oklahoma System; University of Oklahoma - Norman; Purdue University System; Purdue University; Texas A&M University System; Texas A&M University College Station	Baird, AB (corresponding author), Univ Houston Downtown, Dept Nat Sci, Houston, TX 77002 USA.	bairda@uhd.edu	Lim, Burton/A-1148-2011	Lim, Burton/0000-0002-0884-0421	startup funds from University of Houston - Downtown	startup funds from University of Houston - Downtown	Funding was provided through startup funds from University of Houston - Downtown to Amy B. Baird. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen H., 1890, P US NATL MUS, V13, P173; Amador LL, 2016, J MAMM EVOL; Baird AB, 2015, J MAMMAL, V96, P1255, DOI 10.1093/jmammal/gyv135; Baird AB, 2009, MOL PHYLOGENET EVOL, V50, P256, DOI 10.1016/j.ympev.2008.11.001; Baker R.J., 1988, Occasional Papers Museum of Texas Tech University, P1; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; BALLINGER SW, 1992, BIOCHEM GENET, V30, P1, DOI 10.1007/BF00554423; Barclay RMR, 1999, CAN J ZOOL, V77, P530, DOI 10.1139/cjz-77-4-530; BARCLAY RMR, 1986, CAN J ZOOL, V64, P2700, DOI 10.1139/z86-394; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; CARR SM, 1993, J MAMMAL, V74, P331, DOI 10.2307/1382388; CARR SM, 1986, P NATL ACAD SCI USA, V83, P9576, DOI 10.1073/pnas.83.24.9576; Cathey JC, 1998, EVOLUTION, V52, P1224, DOI [10.1111/j.1558-5646.1998.tb01850.x, 10.2307/2411253]; Clement M., 2002, P 16 INT PARALLEL DI, P7; CRONIN MA, 1988, J WILDLIFE MANAGE, V52, P320, DOI 10.2307/3801243; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DERR JN, 1991, J WILDLIFE MANAGE, V55, P228, DOI 10.2307/3809144; Eiting TP, 2009, J MAMM EVOL, V16, P151, DOI 10.1007/s10914-009-9118-x; Fitzinger LJ, 1870, SITZUNGSBERICHTE MAT, V62, P353; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; FUJIOKA KK, 1988, J MAMMAL, V69, P369, DOI 10.2307/1381389; Gardner AL, 2007, MAMMALS S AM, V1, P457, DOI DOI 10.1890/04-0532; Gimenez AL, 2017, CURR ZOOL, V63, P495, DOI 10.1093/cz/zow100; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunnell GF, 2008, J VERTEBR PALEONTOL, V28, P1, DOI 10.1671/0272-4634(2008)28[1:NBMCFT]2.0.CO;2; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hoofer SR, 2003, ACTA CHIROPTEROL, V5, P1, DOI 10.3161/001.005.s101; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jacobs DS, 1996, FUNCT ECOL, V10, P622, DOI 10.2307/2390172; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lyon MW, 1909, B US NATL MUSEUM, V62, P1; MORALES JC, 1995, J MAMMAL, V76, P730, DOI 10.2307/1382744; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; NAUGHTON JJ, 1980, J VOLCANOL GEOTH RES, V7, P339, DOI 10.1016/0377-0273(80)90037-2; Peters W., 1871, MONOGRAPHISCHE UBERS, P900; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Rambaut A, 2012, FIGTREE V1 4; Rambaut A, 2009, TRACER V 1 5; Rodriguez-San Pedro A, 2016, BIODIVERSITY NATURAL, V2, P10; Roehrs ZP, 2010, J MAMMAL, V91, P1073, DOI 10.1644/09-MAMM-A-325.1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russell AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128248; SCHMIDLY D.J., 2016, MAMMALS TEXAS; STUBBLEFIELD SS, 1986, J WILDLIFE MANAGE, V50, P688, DOI 10.2307/3800982; Tate GHH, 1943, B AM MUS NAT HIST, V80, P0221; WHITAKER JO, 1983, J MAMMAL, V64, P151, DOI 10.2307/1380766; Ziegler AC, 2016, AM MUS NOVIT, P1	49	20	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186085	10.1371/journal.pone.0186085	http://dx.doi.org/10.1371/journal.pone.0186085			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020097	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400068
J	Caputi, TL; Leas, E; Dredze, M; Cohen, JE; Ayers, JW				Caputi, Theodore L.; Leas, Eric; Dredze, Mark; Cohen, Joanna E.; Ayers, John W.			They're heating up: Internet search query trends reveal significant public interest in heat-not-burn tobacco products	PLOS ONE			English	Article							ELECTRONIC CIGARETTES; SURVEILLANCE; SMOKE; RISE	Heat-not-burn tobacco products, battery powered devices that heat leaf tobacco to approximately 500 degrees Fahrenheit to produce an inhalable aerosol, are being introduced in markets around the world. Japan, where manufacturers have marketed several heat-not-burn brands since 2014, has been the focal national test market, with the intention of developing global marketing strategies. We used Google search query data to estimate, for the first time, the scale and growth potential of heat-not-burn tobacco products. Average monthly searches for heat-not-burn products rose 1,426% (95% CI: 746,3574) between their first (2015) and second (2016) complete years on the market and an additional 100% (95% CI: 60, 173) between the products second (2016) and third years on the market (Jan-Sep 2017). There are now between 5.9 and 7.5 million heat-not-burn related Google searches in Japan each month based on September 2017 estimates. Moreover, forecasts relying on the historical trends suggest heat-not-burn searches will increase an additional 32% (95% CI: -4 to 79) during 2018, compared to current estimates for 2017 (Jan-Sep), with continued growth thereafter expected. Contrasting heat-not-burn's rise in Japan to electronic cigarettes' rise in the United States we find searches for heat-not-burn eclipsed electronic cigarette searches during April 2016. Moreover, the change in average monthly queries for heat-not-burn in Japan between 2015 and 2017 was 399 (95% CI: 184, 1490) times larger than the change in average monthly queries for electronic cigarettes in the Unites States over the same time period, increasing by 2,956% (95% CI: 1729, 7304) compared to only 7% (95% CI: 3,13). Our findings are a clarion call for tobacco control leaders to ready themselves as heat-not-burn tobacco products will likely garner substantial interest as they are introduced into new markets. Public health practitioners should expand heat-not-burn tobacco product surveillance, adjust existing tobacco control strategies to account for heat-not-burn tobacco products, and preemptively study the health risks/benefits, popular perceptions, and health messaging around heat-not-burn tobacco products.	[Caputi, Theodore L.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Caputi, Theodore L.] Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Caputi, Theodore L.] Univ Florida, Coll Med, Drug Policy Inst, Gainesville, FL USA; [Leas, Eric] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA; [Dredze, Mark] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Cohen, Joanna E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Inst Global Tobacco Control, Baltimore, MD USA; [Ayers, John W.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA	University of Pennsylvania; University College Cork; State University System of Florida; University of Florida; Stanford University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; California State University System; San Diego State University	Ayers, JW (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA.	ayers.john.w@gmail.com	Caputi, Theodore/P-8697-2019; Caputi, Theodore/ADP-8818-2022	Caputi, Theodore/0000-0003-3498-9032; Caputi, Theodore/0000-0003-3498-9032; Dredze, Mark/0000-0002-0422-2474	Joseph Wharton Scholars program; Institute for Global Tobacco Control at the Johns Hopkins Bloomberg School of Public Health; Bloomberg Initiative to Reduce Tobacco Use; George J. Mitchell scholarship program	Joseph Wharton Scholars program; Institute for Global Tobacco Control at the Johns Hopkins Bloomberg School of Public Health; Bloomberg Initiative to Reduce Tobacco Use; George J. Mitchell scholarship program	This work was supported by the Joseph Wharton Scholars program (https://www.wharton.upenn.edu/) and the Institute for Global Tobacco Control at the Johns Hopkins Bloomberg School of Public Health, with funding from the The Bloomberg Initiative to Reduce Tobacco Use (https.//www.bloomberg.org/program/publichealth/tobacco-control/#problem) to TC and the George J. Mitchell scholarship program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funder.	Auer R, 2017, JAMA INTERN MED, V177, P1050, DOI 10.1001/jamainternmed.2017.1419; Ayers JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170702; Ayers John W, 2016, JMIR Public Health Surveill, V2, pe16, DOI 10.2196/publichealth.5304; Ayers JW, 2016, AM J PREV MED, V50, pE173, DOI 10.1016/j.amepre.2015.12.008; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Ayers JW, 2014, NICOTINE TOB RES, V16, P576, DOI 10.1093/ntr/ntt186; Ayers JW, 2014, JAMA INTERN MED, V174, P146, DOI 10.1001/jamainternmed.2013.11933; Ayers JW, 2014, PREV MED, V58, P81, DOI 10.1016/j.ypmed.2013.11.007; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Caputi TL, 2016, TOBACCO CONTROL; Caputi TL, 2017, NICOTINE TOBACCO RES; Cavazos-Rehg PA, 2015, TOB CONTROL, V24, P249, DOI 10.1136/tobaccocontrol-2013-051276; Delnevo CD, 2017, AM J EPIDEMIOL, P1; Du L, BLOOMBERG POLITICS; Farsalinos KE, 2017, NICOTINE TOB RES; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Hyndman RJ, 2008, AUTOMATIC TIME SERIE; Katz MH, 2017, JAMA INTERN MED, V177, P1052, DOI 10.1001/jamainternmed.2017.1425; Levy DT, 2017, ADDICTION, V112, P8, DOI 10.1111/add.13394; Lopez AA, 2016, DRUG ALCOHOL DEPEN, V169, P33, DOI 10.1016/j.drugalcdep.2016.10.005; Philip Morris International, MOD RISK TOB PROD MR; Philip Morris International, WHAT AR RED RISK PRO; Philip Morris International, TOB MEETS TECHN; Protano C, 2016, Ann Ig, V28, P109, DOI 10.7416/ai.2016.2089; Soneji S, 2016, JAMA PEDIATR, V170, P511, DOI 10.1001/jamapediatrics.2015.4501; Tabuchi T, 2016, ADDICTION, V111, P706, DOI 10.1111/add.13231; Yui M, JAPAN TIMES	27	51	53	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185735	10.1371/journal.pone.0185735	http://dx.doi.org/10.1371/journal.pone.0185735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020019	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400042
J	Hajjar, AM; Ernst, RK; Yi, J; Yam, CS; Miller, SI				Hajjar, Adeline M.; Ernst, Robert K.; Yi, Jaehun; Yam, Cathy S.; Miller, Samuel I.			Expression level of human TLR4 rather than sequence is the key determinant of LPS responsiveness	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; RESPIRATORY SYNCYTIAL VIRUS; MONOPHOSPHORYL-LIPID-A; INFECTIOUS-DISEASE; CYTOKINE RELEASE; POLYMORPHISMS; LIPOPOLYSACCHARIDE; ENDOTOXIN; ASSOCIATION; MICE	To address the role of Toll-like receptor 4 (TLR4) single nucleotide polymorphisms (SNP) in lipopolysaccharide (LPS) recognition, we generated mice that differed only in the sequence of TLR4. We used a bacterial artificial chromosome (BAC) transgenic approach and TLR4/MD-2 knockout mice to specifically examine the role of human TLR4 variants in recognition of LPS. Using in vitro and in vivo assays we found that the expression level rather than the sequence of TLR4 played a larger role in recognition of LPS, especially hypoacylated LPS.	[Hajjar, Adeline M.; Yi, Jaehun; Yam, Cathy S.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Ernst, Robert K.] Univ Maryland, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Miller, Samuel I.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hajjar, AM (corresponding author), Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.	hajjar@uw.edu		Hajjar, Adeline/0000-0002-4838-8070; Ernst, Robert/0000-0001-5016-8694	National Institutes of Health [U54AI057141, R21OD017233]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R21OD017233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health grants U54AI057141 (SIM) and R21OD017233 (AMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bihl F, 2003, J IMMUNOL, V170, P6141, DOI 10.4049/jimmunol.170.12.6141; Bottcher MF, 2004, J ALLERGY CLIN IMMUN, V114, P561, DOI 10.1016/j.jaci.2004.04.050; CAROFF M, 1988, CARBOHYD RES, V175, P273, DOI 10.1016/0008-6215(88)84149-1; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Douville RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012087; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; Ernst RK, 2007, J INFECT DIS, V196, P1088, DOI 10.1086/521367; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; FISCHER W, 1983, EUR J BIOCHEM, V133, P523, DOI 10.1111/j.1432-1033.1983.tb07495.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gast A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024370; Hajjar AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002963; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Kalis C, 2003, EUR J IMMUNOL, V33, P798, DOI 10.1002/eji.200323431; Kawahara K, 2002, INFECT IMMUN, V70, P4092, DOI 10.1128/IAI.70.8.4092-4098.2002; Kumpf O, 2010, CRIT CARE, V14, DOI 10.1186/cc9047; Maeshima N, 2015, J BIOL CHEM, V290, P13440, DOI 10.1074/jbc.M115.653881; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Ohto U, 2012, J BIOL CHEM, V287, P40611, DOI 10.1074/jbc.M112.404608; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Persing DH, 2002, TRENDS MICROBIOL, V10, pS32, DOI 10.1016/S0966-842X(02)02426-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rallabhandi P, 2008, J IMMUNOL, V180, P1139, DOI 10.4049/jimmunol.180.2.1139; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Roy MF, 2006, GENES IMMUN, V7, P372, DOI 10.1038/sj.gene.6364309; Schneider S, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0031-2; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Schwartz DA, 2005, CLIN INFECT DIS, V41, pS403, DOI 10.1086/431985; Sellers RM, 2015, J PERIODONTAL RES; Smirnova I, 2001, GENETICS, V158, P1657; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Tulic MK, 2007, J IMMUNOL, V179, P132, DOI 10.4049/jimmunol.179.1.132; von Aulock S, 2003, J INFECT DIS, V188, P938, DOI 10.1086/378095; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Weyrich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013980; Yam C.S., 2013, BIO-PROTOCOL, V3, pe834, DOI DOI 10.21769/BIOPROTOC.834; Yamakawa N, 2013, INT IMMUNOL, V25, P45, DOI 10.1093/intimm/dxs084; Zhou JH, 2016, INFLUENZA OTHER RESP, V10, P224, DOI 10.1111/irv.12378	47	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186308	10.1371/journal.pone.0186308	http://dx.doi.org/10.1371/journal.pone.0186308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020088	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400091
J	Lee, BH; Seo, S; Kim, MH; Kim, Y; Jo, S; Choi, MK; Lee, H; Choi, JB; Kim, MK				Lee, Byung Ho; Seo, Sangjae; Kim, Min Hyeok; Kim, Youngjin; Jo, Soojin; Choi, Moon-ki; Lee, Hoomin; Choi, Jae Boong; Kim, Moon Ki			Normal mode-guided transition pathway generation in proteins	PLOS ONE			English	Article							CONFORMATIONAL TRANSITIONS; MOLECULAR-DYNAMICS; NUCLEIC-ACIDS; NETWORK MODEL; MOTIONS; SIMULATIONS; PREDICTION; SCATTERING; DIFFUSION; MACHINES	The biological function of proteins is closely related to its structural motion. For instance, structurally misfolded proteins do not function properly. Although we are able to experimentally obtain structural information on proteins, it is still challenging to capture their dynamics, such as transition processes. Therefore, we need a simulation method to predict the transition pathways of a protein in order to understand and study large functional deformations. Here, we present a new simulation method called normal mode-guided elastic network interpolation (NGENI) that performs normal modes analysis iteratively to predict transition pathways of proteins. To be more specific, NGENI obtains displacement vectors that determine intermediate structures by interpolating the distance between two end-point conformations, similar to a morphing method called elastic network interpolation. However, the displacement vector is regarded as a linear combination of the normal mode vectors of each intermediate structure, in order to enhance the physical sense of the proposed pathways. As a result, we can generate more reasonable transition pathways geometrically and thermodynamically. By using not only all normal modes, but also in part using only the lowest normal modes, NGENI can still generate reasonable pathways for large deformations in proteins. This study shows that global protein transitions are dominated by collective motion, which means that a few lowest normal modes play an important role in this process. NGENI has considerable merit in terms of computational cost because it is possible to generate transition pathways by partial degrees of freedom, while conventional methods are not capable of this.	[Lee, Byung Ho; Kim, Youngjin; Jo, Soojin; Choi, Moon-ki; Lee, Hoomin; Choi, Jae Boong; Kim, Moon Ki] Sungkyunkwan Univ, Sch Mech Engn, Suwon, South Korea; [Seo, Sangjae] Nagoya Univ, Dept Mat Chem, Nagoya, Aichi, Japan; [Kim, Min Hyeok] Korea Inst Adv Study, Sch Computat Sci, Seoul, South Korea; [Choi, Jae Boong; Kim, Moon Ki] Sungkyunkwan Univ, SKKU Adv Inst Nanotechnol SAINT, Suwon, South Korea	Sungkyunkwan University (SKKU); Nagoya University; Korea Institute for Advanced Study (KIAS); Sungkyunkwan University (SKKU)	Kim, MK (corresponding author), Sungkyunkwan Univ, Sch Mech Engn, Suwon, South Korea.; Kim, MK (corresponding author), Sungkyunkwan Univ, SKKU Adv Inst Nanotechnol SAINT, Suwon, South Korea.	mkkim@me.skku.ac.kr		Jo, Soojin/0000-0002-5100-316X; Seo, Sangjae/0000-0002-3555-6223	Pioneer Research Center Program [2012-0009579]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2015R1D1A1A01057280]	Pioneer Research Center Program; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This research was supported by the Pioneer Research Center Program (2012-0009579 to Moon Ki Kim) and the Basic Science Research Program (2015R1D1A1A01057280 to Moon Ki Kim) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology. None of the authors has any conflicts of interest with respect to the material contained in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acbas G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4076; Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Athanasios CA, 2001, CONT MATH, V280, P193; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Blanchet CE, 2013, ANNU REV PHYS CHEM, V64, P37, DOI 10.1146/annurev-physchem-040412-110132; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bray JK, 2011, BIOPHYS J, V101, P2966, DOI 10.1016/j.bpj.2011.10.054; BROWN KG, 1972, P NATL ACAD SCI USA, V69, P1467, DOI 10.1073/pnas.69.6.1467; Chiu W, 2005, STRUCTURE, V13, P363, DOI 10.1016/j.str.2004.12.016; Das A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003521; Eitoku T, 2006, BIOPHYS J, V91, P3797, DOI 10.1529/biophysj.106.092882; Elber R, 2005, CURR OPIN STRUC BIOL, V15, P151, DOI 10.1016/j.sbi.2005.02.004; Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9; Gur M, 2013, BIOPHYS J, V105, P1643, DOI 10.1016/j.bpj.2013.07.058; He LL, 2011, ANAL CHEM, V83, P1510, DOI 10.1021/ac1032353; Kim MH, 2015, J STRUCT BIOL, V190, P338, DOI 10.1016/j.jsb.2015.04.007; Kim MK, 2005, BIOPHYS J, V89, P43, DOI 10.1529/biophysj.104.044347; Kim MK, 2002, BIOPHYS J, V83, P1620, DOI 10.1016/S0006-3495(02)73931-3; Kruger DM, 2012, NUCLEIC ACIDS RES, V40, pW310, DOI 10.1093/nar/gks478; Leckband D, 2010, ANNU REV CHEM BIOMOL, V1, P365, DOI 10.1146/annurev-chembioeng-073009-100931; Lee J, 2009, IEEE T MICROW THEORY, V12, P3219; LEVITT M, 1995, COMPUT PHYS COMMUN, V91, P215, DOI 10.1016/0010-4655(95)00049-L; LEVITT M, 1983, J MOL BIOL, V168, P595, DOI 10.1016/S0022-2836(83)80304-0; Magnusson U, 2002, J BIOL CHEM, V277, P14077, DOI 10.1074/jbc.M200514200; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Nada T, 2003, BIOPHYS J, V85, P1876, DOI 10.1016/S0006-3495(03)74615-3; Pfreundschuh M, 2014, NANO LETT, V14, P2957, DOI 10.1021/nl5012905; Lopez-Blanco JR, 2014, NUCLEIC ACIDS RES, V42, pW271, DOI 10.1093/nar/gku339; SARKAR HK, 1984, BIOCHEMISTRY-US, V23, P1882, DOI 10.1021/bi00303a046; Seo S, 2014, J MOL GRAPH MODEL, V47, P25, DOI 10.1016/j.jmgm.2013.10.009; Seo S, 2012, NUCLEIC ACIDS RES, V40, pW531, DOI 10.1093/nar/gks525; Shi YG, 2014, CELL, V159, P995, DOI 10.1016/j.cell.2014.10.051; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Tekpinar M, 2010, PROTEINS, V78, P2469, DOI 10.1002/prot.22755; TERAZIMA M, 1993, J CHEM PHYS, V98, P6257, DOI 10.1063/1.464819; Turton DA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4999; Uyar A, 2014, BIOPHYS J, V106, P2656, DOI 10.1016/j.bpj.2014.05.017; Yang L, 2007, BIOPHYS J, V93, P920, DOI 10.1529/biophysj.106.095927; Zheng WJ, 2007, PROTEINS, V69, P43, DOI 10.1002/prot.21465	45	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185658	10.1371/journal.pone.0185658	http://dx.doi.org/10.1371/journal.pone.0185658			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020017	Green Submitted, gold, Green Published			2022-12-26	WOS:000412754400039
J	Payton, L; Sow, M; Massabuau, JC; Ciret, P; Tran, D				Payton, Laura; Sow, Mohamedou; Massabuau, Jean-Charles; Ciret, Pierre; Tran, Damien			How annual course of photoperiod shapes seasonal behavior of diploid and triploid oysters, Crassostrea gigas	PLOS ONE			English	Article							PACIFIC OYSTER; BIOCHEMICAL-COMPOSITION; PINNA-NOBILIS; TEMPERATURE; RHYTHMS; GROWTH; GAMETOGENESIS; THUNBERG; BIVALVE; FRANCE	In this work, we study if ploidy (i.e. number of copies of chromosomes) in the oyster Crassostrea gigas may introduce differences in behavior and in its synchronization by the annual photoperiod. To answer to the question about the effect of the seasonal course of the photoperiod on the behavior of C. gigas according to its ploidy, we quantified valve activity by HFNI valvometry in situ for 1 year in both diploid and triploid oysters. Chronobiological analyses of daily, tidal and lunar rhythms were performed according the annual change of the photoperiod. In parallel, growth and gametogenesis status were measured and spawning events were detected by valvometry. The results showed that triploids had reduced gametogenesis, without spawning events, and approximately three times more growth than diploids. These differences in physiological efforts could explain the result that photoperiod (daylength and/or direction of daylength) differentially drives and modulates seasonal behavior of diploid and triploid oysters. Most differences were observed during long days (spring and summer), where triploids showed longer valve opening duration but lower opening amplitude, stronger daily rhythm and weaker tidal rhythm. During this period, diploids did major gametogenesis and spawning whereas triploids did maximal growth. Differences were also observed in terms of moonlight rhythmicity and neap-spring tidal cycle rhythmicity. We suggest that the seasonal change of photoperiod differentially synchronizes oyster behavior and biological rhythms according to physiological needs based on ploidy.	[Payton, Laura; Sow, Mohamedou; Massabuau, Jean-Charles; Ciret, Pierre; Tran, Damien] Univ Bordeaux, EPOC, UMR 5805, Arcachon, France; [Payton, Laura; Massabuau, Jean-Charles; Ciret, Pierre; Tran, Damien] CNRS, EPOC, UMR 5805, Arcachon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU)	Tran, D (corresponding author), Univ Bordeaux, EPOC, UMR 5805, Arcachon, France.; Tran, D (corresponding author), CNRS, EPOC, UMR 5805, Arcachon, France.	d.tran@epoc.u-bordeaux1.fr	Tran, Damien/AAU-8147-2020	Payton, Laura/0000-0001-5090-0929; Massabuau, Jean-Charles/0000-0003-1302-1719	French National Research Agency (ANR); ACCUTOX project [13-CESA-0019]; French ministerial PhD scholarship	French National Research Agency (ANR)(French National Research Agency (ANR)); ACCUTOX project; French ministerial PhD scholarship	This work was supported by the financial support of the French National Research Agency (ANR), ACCUTOX project 13-CESA-0019 (2013-2017) and a French ministerial PhD scholarship for L. Payton.	Ahmed H, 2016, IEEE T CONTR SYST T, V24, P1140, DOI 10.1109/TCST.2015.2472999; ALLEN SK, 1986, J EXP MAR BIOL ECOL, V102, P197, DOI 10.1016/0022-0981(86)90176-0; Andrade H, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00187; B?nning E., 1936, BER DEUT BOT GES, V54, P590; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Bernard I, 2016, LIMNOL OCEANOGR, V61, P635, DOI 10.1002/lno.10240; Berthelin C, 2000, COMP BIOCHEM PHYS B, V125, P359, DOI 10.1016/S0305-0491(99)00187-X; BINGHAM C, 1982, CHRONOBIOLOGIA, V9, P397; Birchler JA, 2007, BBA-GENE STRUCT EXPR, V1769, P422, DOI 10.1016/j.bbaexp.2006.12.002; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; BROWN JR, 1988, MAR ECOL PROG SER, V45, P225, DOI 10.3354/meps045225; Chavez-Villalba J, 2002, AQUACULTURE, V214, P115, DOI 10.1016/S0044-8486(01)00898-5; Cloern JE, 1996, REV GEOPHYS, V34, P127, DOI 10.1029/96RG00986; Tran D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32435; Dridi S, 2007, AQUACULTURE, V263, P238, DOI 10.1016/j.aquaculture.2006.10.028; Duchemin MB, 2007, AQUACULTURE, V264, P73, DOI 10.1016/j.aquaculture.2006.12.030; Enriquez-Diaz M, 2009, AQUACULT INT, V17, P491, DOI 10.1007/s10499-008-9219-1; Fabioux C, 2005, AQUACULTURE, V250, P458, DOI 10.1016/j.aquaculture.2005.02.038; FAO, 2016, CONTR FOOD SEC NUTR, P200; FAO, 1793, FAO FISH AQ SPEC FAC; FORWARD RB, 1987, B MAR SCI, V41, P165; Foster RG, 2009, SEASONS OF LIFE: THE BIOLOGICAL RHYTHMS THAT ENABLE LIVING THINGS TO THRIVE AND SURVIVE, P1; Galtsoff PS, 1938, BIOL BULL-US, V74, P461, DOI 10.2307/1537816; Garcia-March JR, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2812-3; Garnier-Gere PH, 2002, MOL ECOL, V11, P1499, DOI 10.1046/j.1365-294X.2002.01531.x; Gle C, 2008, ESTUAR COAST SHELF S, V76, P642, DOI 10.1016/j.ecss.2007.07.043; Gouthiere L, 2005, PATHOL BIOL, V53, P285, DOI 10.1016/j.patbio.2004.12.025; Gouthiere L, 2005, BIOL RHYTHM RES, V36, P177, DOI 10.1080/09291010400026298; Gouthiere L, 2004, 35 C SOC FRANC CHRON, P10; Haberkorn H, 2010, AQUAT TOXICOL, V97, P96, DOI 10.1016/j.aquatox.2009.12.006; Hawkins AJS, 2000, GENET RES, V76, P273, DOI 10.1017/S0016672300004766; Helm B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0016; Herbert RJH, 2016, BIODIVERS CONSERV, V25, P2835, DOI 10.1007/s10531-016-1209-4; Jou LJ, 2013, COMPUT ELECTRON AGR, V90, P106, DOI 10.1016/j.compag.2012.09.008; Jouaux A, 2010, J EXP MAR BIOL ECOL, V395, P162, DOI 10.1016/j.jembe.2010.08.030; Kaniewska P, 2015, ELIFE, V4, DOI 10.7554/eLife.09991; LEES AD, 1950, NATURE, V166, P874, DOI 10.1038/166874a0; MANN R, 1979, J MAR BIOL ASSOC UK, V59, P95, DOI 10.1017/S0025315400046208; Mao YZ, 2006, AQUACULTURE, V253, P322, DOI 10.1016/j.aquaculture.2005.05.033; Marteil L., 1976, BIOL HUITRE MOULE; Mat AM, 2012, CHRONOBIOL INT, V29, P857, DOI 10.3109/07420528.2012.699126; MCCLINTOCK JB, 1990, J EXP MAR BIOL ECOL, V139, P175, DOI 10.1016/0022-0981(90)90145-3; Meuti ME, 2013, INTEGR COMP BIOL, V53, P131, DOI 10.1093/icb/ict023; Naylor E, 2001, EARTH MOON PLANETS, V85-6, P291, DOI 10.1023/A:1017088504226; Nell JA, 2002, AQUACULTURE, V210, P69, DOI 10.1016/S0044-8486(01)00861-4; Nelson TC, 1928, ECOLOGY, V9, P145, DOI 10.2307/1929351; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Normand J, 2008, AQUACULTURE, V282, P124, DOI 10.1016/j.aquaculture.2008.06.026; Normand J, 2009, AQUAT BIOL, V7, P229, DOI 10.3354/ab00190; Numata H., 2014, ANN LUNAR TIDAL CLOC; OSADA M, 1989, COMP BIOCHEM PHYS C, V93, P171, DOI 10.1016/0742-8413(89)90029-7; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Perrigault M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169790; Garcia-March JR, 2008, MAR BIOL, V153, P689, DOI 10.1007/s00227-007-0842-6; Ren JS, 2003, NEW ZEAL J MAR FRESH, V37, P171, DOI 10.1080/00288330.2003.9517155; Riddle NC, 2006, THEOR APPL GENET, V114, P101, DOI 10.1007/s00122-006-0414-z; Saunders DS, 2005, J INSECT PHYSIOL, V51, P599, DOI 10.1016/j.jinsphys.2004.12.002; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; SHPIGEL M, 1992, J EXP MAR BIOL ECOL, V161, P15, DOI 10.1016/0022-0981(92)90186-E; Stevenson TJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1453; Sugama N, 2008, J PINEAL RES, V45, P133, DOI 10.1111/j.1600-079X.2008.00566.x; Suquet M, 2016, AQUACULTURE, V451, P11, DOI 10.1016/j.aquaculture.2015.08.032; Tessmar-Raible K, 2011, BIOESSAYS, V33, P165, DOI 10.1002/bies.201000096; Tran D, 2003, ENVIRON TOXICOL CHEM, V22, P914, DOI [10.1897/1551-5028(2003)022&lt;0914:EOPALO&gt;2.0.CO;2, 10.1002/etc.5620220432]; Tran D, 2015, AQUAT TOXICOL, V158, P41, DOI 10.1016/j.aquatox.2014.10.023; Tran D, 2011, CHRONOBIOL INT, V28, P307, DOI 10.3109/07420528.2011.565897; Visser ME, 2010, PHILOS T R SOC B, V365, P3113, DOI 10.1098/rstb.2010.0111; Zantke J, 2013, CELL REP, V5, P99, DOI 10.1016/j.celrep.2013.08.031	68	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185918	10.1371/journal.pone.0185918	http://dx.doi.org/10.1371/journal.pone.0185918			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020114	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400050
J	Pucelik, B; Paczynski, R; Dubin, G; Pereira, MM; Arnaut, LG; Dabrowski, JM				Pucelik, Barbara; Paczynski, Robert; Dubin, Grzegorz; Pereira, Mariette M.; Arnaut, Luis G.; Dabrowski, Janusz M.			Properties of halogenated and sulfonated porphyrins relevant for the selection of photosensitizers in anticancer and antimicrobial therapies	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; PHOTOPHYSICAL PROPERTIES; CATIONIC BACTERIOCHLORINS; SINGLET-OXYGEN; CENTRAL METAL; IN-VITRO; INACTIVATION; BLOCK; METALLOPORPHYRINS; PHOTOINACTIVATION	The impact of substituents on the photochemical and biological properties of tetraphenylporphyrin-based photosensitizers for photodynamic therapy of cancer (PDT) as well as photodynamic inactivation of microorganisms (PDI) was examined. Spectroscopic and physicochemical properties were related with therapeutic efficacy in PDT of cancer and PDI of microbial cells in vitro. Less polar halogenated, sulfonamide porphyrins were most readily taken up by cells compared to hydrophilic and anionic porphyrins. The uptake and PDT of a hydrophilic porphyrin was significantly enhanced with incorporation in polymeric micelles (Pluronic L121). Photodynamic inactivation studies were performed against Gram-positive (S. aureus, E. faecalis), Gram-negative bacteria (E. coli, P. aeruginosa, S. marcescens) and fungal yeast (C. albicans). We observed a 6 logs reduction of S. aureus after irradiation (10 J/cm(2)) in the presence of 20 mu M of hydrophilic porphyrin, but this was not improved with incorporation in Pluronic L121. A 2-3 logs reduction was obtained for E. coli using similar doses, and a decrease of 3-4 logs was achieved for C. albicans. Rational substitution of tetraphenylporphyrins improves their photodynamic properties and informs on strategies to obtain photosensitizers for efficient PDT and PDI. However, the design of the photosensitizers must be accompanied by the development of tailored drug formulations.	[Pucelik, Barbara; Dabrowski, Janusz M.] Jagiellonian Univ, Fac Chem, Gronostajowa 2, Krakow, Poland; [Paczynski, Robert; Dubin, Grzegorz] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Paczynski, Robert; Dubin, Grzegorz] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland; [Pereira, Mariette M.; Arnaut, Luis G.] Univ Coimbra, Dept Chem, Coimbra, Portugal	Jagiellonian University; Jagiellonian University; Jagiellonian University; Universidade de Coimbra	Dabrowski, JM (corresponding author), Jagiellonian Univ, Fac Chem, Gronostajowa 2, Krakow, Poland.	jdabrows@chemia.uj.edu.pl	Pereira, Mariette/N-2648-2013; Pucelik, Barbara/HII-5213-2022; Dabrowski, Janusz M./E-7250-2015; Dubin, Grzegorz/J-8168-2014; Arnaut, Luis/Q-4135-2016	Pereira, Mariette/0000-0003-4958-7677; Pucelik, Barbara/0000-0002-0235-6532; Dabrowski, Janusz M./0000-0002-8791-7035; Dubin, Grzegorz/0000-0002-5535-5760; Arnaut, Luis/0000-0002-3223-4819	National Science Center (NCN), Poland within the Sonata Bis grant [0085/IP3/2015/73]	National Science Center (NCN), Poland within the Sonata Bis grant	This work was funded by National Science Center (NCN), Poland within the Sonata Bis grant no 0085/IP3/2015/73 given to JMD.	Arnaut LG, 2014, CHEM-EUR J, V20, P5346, DOI 10.1002/chem.201304202; Azenha EG, 2002, CHEM PHYS, V280, P177, DOI 10.1016/S0301-0104(02)00485-8; Aziz MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150295; Batrakova EV, 2003, J PHARMACOL EXP THER, V304, P845, DOI 10.1124/jpet.102.043307; Cassidy CM, 2009, J PHOTOCH PHOTOBIO B, V95, P71, DOI 10.1016/j.jphotobiol.2009.01.005; Chin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097894; Dabrowski JM, 2016, COORDIN CHEM REV, V325, P67, DOI 10.1016/j.ccr.2016.06.007; Dabrowski JM, 2015, PHOTOCH PHOTOBIO SCI, V14, P1765, DOI 10.1039/c5pp00132c; Dabrowski JM, 2015, J COORD CHEM, V68, P3116, DOI 10.1080/00958972.2015.1073723; Dabrowski JM, 2017, ADV INORGANIC CHEM; De Boni L, 2015, CHEM PHYS LETT, V633, P146, DOI 10.1016/j.cplett.2015.05.040; Demidova TN, 2004, INT J IMMUNOPATH PH, V17, P245, DOI 10.1177/039463200401700304; Foley JW, 2006, J MED CHEM, V49, P5291, DOI 10.1021/JM060153i; Gibbs JH, 2015, J PHOTOCH PHOTOBIO B, V145, P35, DOI 10.1016/j.jphotobiol.2015.02.006; Goncalves PJ, 2006, J PHOTOCH PHOTOBIO A, V181, P378, DOI 10.1016/j.jphotochem.2005.12.023; Goncalves PJ, 2005, CHEM PHYS LETT, V407, P236, DOI 10.1016/j.cplett.2005.03.100; GONSALVES AMAR, 1991, J HETEROCYCLIC CHEM, V28, P635, DOI 10.1002/jhet.5570280317; Grinholc M, 2015, APPL MICROBIOL BIOT, V99, P4031, DOI 10.1007/s00253-015-6539-8; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hamblin MR, 2002, J ANTIMICROB CHEMOTH, V49, P941, DOI 10.1093/jac/dkf053; Hamblin MR, 2001, CANCER RES, V61, P7155; Huang LY, 2014, J PHOTOCH PHOTOBIO B, V141, P119, DOI 10.1016/j.jphotobiol.2014.09.016; Huang L, 2010, ANTIMICROB AGENTS CH, V54, P3834, DOI 10.1128/AAC.00125-10; Huang YY, 2012, CHEMMEDCHEM, V7, P2155, DOI 10.1002/cmdc.201200351; Johnstone RAW, 1996, HETEROCYCLES, V43, P1423; KESSEL D, 1987, PHOTOCHEM PHOTOBIOL, V45, P787, DOI 10.1111/j.1751-1097.1987.tb07883.x; Maisch T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111792; Mamone L, 2016, J PHOTOCH PHOTOBIO B, V161, P222, DOI 10.1016/j.jphotobiol.2016.05.026; McCoy CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108500; Merchat M, 1996, J PHOTOCH PHOTOBIO B, V32, P153, DOI 10.1016/1011-1344(95)07147-4; Monteiro CJP, 2008, TETRAHEDRON, V64, P5132, DOI 10.1016/j.tet.2008.03.055; Mroz P, 2009, CANCER LETT, V282, P63, DOI 10.1016/j.canlet.2009.02.054; Murov S. L., 1993, HDB PHOTOCHEMISTRY; Pereira MM, 2010, TETRAHEDRON, V66, P9545, DOI 10.1016/j.tet.2010.09.106; Pitto-Barry A, 2014, POLYM CHEM-UK, V5, P3291, DOI 10.1039/c4py00039k; Prates RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054387; Price M, 2009, PHOTOCHEM PHOTOBIOL, V85, P1177, DOI 10.1111/j.1751-1097.2009.00555.x; Pucelik B, 2016, EUR J MED CHEM, V124, P284, DOI 10.1016/j.ejmech.2016.08.035; Pucelik B, 2016, ACS APPL MATER INTER, V8, P22039, DOI 10.1021/acsami.6b07031; Rae M, 2006, J PHYS CHEM B, V110, P12809, DOI 10.1021/jp061010a; Regiel-Futyra A, 2017, COORDINATION CHEM RE; Rinco O, 2009, J PHOTOCH PHOTOBIO A, V208, P91, DOI 10.1016/j.jphotochem.2009.08.009; Ruzie C, 2008, J ORG CHEM, V73, P5806, DOI 10.1021/jo800736c; Schastak S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011674; Shen SS, 2015, VACCINE, V33, P4341, DOI 10.1016/j.vaccine.2015.04.051; Silva EFF, 2010, CHEM-EUR J, V16, P9273, DOI 10.1002/chem.201000111; Silva M, 2014, CHEM COMMUN, V50, P6571, DOI 10.1039/c4cc01100g; Soares HT, 2016, CHEMBIOCHEM, V17, P836, DOI 10.1002/cbic.201500573; Taraszkiewicz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129301; Tegos GP, 2006, ANTIMICROB AGENTS CH, V50, P1402, DOI 10.1128/AAC.50.4.1402-1410.2006; Tim M, 2015, J PHOTOCH PHOTOBIO B, V150, P2, DOI 10.1016/j.jphotobiol.2015.05.010; Topal SZ, 2014, DALTON T, V43, P6897, DOI 10.1039/c3dt53410c; Vilsinski BH, 2015, PHOTOCHEM PHOTOBIOL, V91, P518, DOI 10.1111/php.12421; Yao L, 2013, J CHEM, V2013, P10; Yuan Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176529; Zhang QZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174627; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	57	42	42	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185984	10.1371/journal.pone.0185984	http://dx.doi.org/10.1371/journal.pone.0185984			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016698	Green Published, Green Submitted, gold			2022-12-26	WOS:000412627400045
J	Westercamp, N; Mehta, SD; Jaoko, W; Okeyo, TA; Bailey, RC				Westercamp, Nelli; Mehta, Supriya D.; Jaoko, Walter; Okeyo, Timothy A.; Bailey, Robert C.			Penile coital injuries in men decline after circumcision: Results from a prospective study of recently circumcised and uncircumcised men in western Kenya	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; RANDOMIZED CONTROLLED-TRIAL; MEDICAL MALE CIRCUMCISION; ADULT MALE CIRCUMCISION; GENITAL ULCER DISEASE; HIV-INFECTION; RISK-FACTORS; FORESKIN; TRANSMISSION; METAANALYSIS	Background Penile coital injuries are one of the suggested mechanisms behind the increased risk of HIV among uncircumcised men. We evaluated the prevalence and correlates of self-reported penile coital injuries in a longitudinal community-based cohort of young (18-24 years old), newly circumcised and uncircumcised men in Western Kenya. Methods Self-reported penile coital injuries were assessed at baseline, 6, 12, 18 and 24 months of follow-up, and were defined as scratches, cuts or abrasions during sex, penile soreness during sex, and skin of the penis bleeding during sex. Associations between penile coital injuries, circumcision, sexual satisfaction, and other covariates were estimated with mixed effect models. Results Between November 2008 and April 2010 3,186 participants were enrolled (1,588 into circumcision group and 1,598 as age-matched controls). Among 2,106 (66%) participants sexually active at baseline, 53% reported any penile injury, including 44% scratches, cuts or abrasions; 32% penile pain/soreness; and 22% penile bleeding. In multivariable modeling, risk was lower for circumcised men than uncircumcised men for scratches, cuts and abrasions (aOR = 0.39; 95% CI 0.34-0.44); penile pain/soreness (aOR = 0.58; 95% CI 0.51-0.65), penile bleeding (aOR = 0.53; 95% CI 0.46-0.62), and any penile coital injuries (aOR = 0.47; 95% CI 0.42-0.53). Other significant risk factors included increasing age, history of STIs and genital sores, and multiple sex partners, while condom use was protective. Coital injuries were significantly associated with lower levels of sexual satisfaction in longitudinal analyses (scratches, cuts or abrasions: aOR = 0.87, 95% CI: 0.76-0.98; penile pain/soreness: aOR = 0.82, 95% CI: 0.72-0.93; and penile bleeding: aOR = 0.65, 95% CI: 0.55-0.76). Conclusions Self-reported penile coital injuries were common and decreased significantly following circumcision. Improving sexual experience through the removal of a potential source of sexual discomfort may resonate with many men targeted for circumcision services. The role of penile coital injuries in sexual satisfaction, HIV, HSV-2, and as a motivator for seeking circumcision services should be explored further.	[Westercamp, Nelli; Mehta, Supriya D.; Bailey, Robert C.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA; [Jaoko, Walter] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Okeyo, Timothy A.] Nyanza Reprod Hlth Soc, Kisumu, Kenya	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Nairobi	Westercamp, N (corresponding author), Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA.	kapooosha@gmail.com	Jaoko, Walter/AAN-5048-2020	Jaoko, Walter/0000-0002-7134-6581; Westercamp, Nelli/0000-0003-0136-9750	Bill and Melinda Gates Foundation [FHI360]; EngenderHealth; University of Illinois at Chicago; Nyanza Reproductive Health Society [47394]; Chicago Developmental Center for AIDS Research; NIH [P30 AI 082151]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EngenderHealth; University of Illinois at Chicago; Nyanza Reproductive Health Society; Chicago Developmental Center for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support for this study was provided by a grant to FHI360 from the Bill and Melinda Gates Foundation (www.gatesfoundation.org) to support the Male Circumcision Consortium, a partnership between FHI360, EngenderHealth, and University of Illinois at Chicago working closely with the Nyanza Reproductive Health Society (grant #47394, RCB). Robert C. Bailey (RCB) received support from the Chicago Developmental Center for AIDS Research, an NIH (www.nih.gov) funded program (P30 AI 082151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D, 2011, AM J REPROD IMMUNOL, V65, P220, DOI 10.1111/j.1600-0897.2010.00941.x; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 1999, J ACQ IMMUN DEF SYND, V22, P294; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Boily MC, 2008, SEX TRANSM INFECT, V84, pII28, DOI 10.1136/sti.2008.030346; Brito MO, 2017, J SEX MED, V14, P526, DOI 10.1016/j.jsxm.2017.01.020; CAMERON DW, 1989, LANCET, V2, P403; Cary, 2008, SAS SOFTW VERS 9 1; Desai K, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-19; Dinh MH, 2011, AM J REPROD IMMUNOL, V65, P279, DOI 10.1111/j.1600-0897.2010.00934.x; Fahrbach KM, 2010, MUCOSAL IMMUNOL, V3, P410, DOI 10.1038/mi.2010.18; FIGUEROA JP, 1994, J ACQ IMMUN DEF SYND, V7, P310; FINK AJ, 1986, NEW ENGL J MED, V315, P1167; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Ganor Y, 2010, MUCOSAL IMMUNOL, V3, P506, DOI 10.1038/mi.2010.32; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000187; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; Hu FB, 1998, AM J EPIDEMIOL, V147, P694; Kigozi G, 2009, AIDS, V23, P2209, DOI 10.1097/QAD.0b013e328330eda8; Krieger JN, 2008, J SEX MED, V5, P2610, DOI 10.1111/j.1743-6109.2008.00979.x; Langhaug LF, 2010, TROP MED INT HEALTH, V15, P362, DOI 10.1111/j.1365-3156.2009.02464.x; Layer EH, 2012, AIDS CARE; Mayer KH, 2011, AM J REPROD IMMUNOL, V65, P308, DOI 10.1111/j.1600-0897.2010.00942.x; Mehta SD, 2013, AIDS; Mehta SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038991; Mehta SD, 2012, AIDS, V26, P1141, DOI 10.1097/QAD.0b013e328352d116; Mehta SD, 2010, J UROLOGY, V184, P203, DOI 10.1016/j.juro.2010.03.015; Mehta SD, 2009, J INFECT DIS, V200, P370, DOI 10.1086/600074; Mensch BS, 2003, DEMOGRAPHY, V40, P247, DOI 10.1353/dem.2003.0017; Morris BJ, 2012, AIDS CARE, V24, P1565, DOI 10.1080/09540121.2012.661836; Nordstrom MPC, 2017, J SEX MED, V14, P601, DOI 10.1016/j.jsxm.2017.02.014; OFARRELL N, 1993, GENITOURIN MED, V69, P297; Phillips AE, 2010, INT J EPIDEMIOL, V39, P1541, DOI 10.1093/ije/dyq114; Porter WM, 2001, INT J STD AIDS, V12, P216, DOI 10.1258/0956462011922922; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; SIMONSEN JN, 1988, NEW ENGL J MED, V319, P274, DOI 10.1056/NEJM198808043190504; STONE KM, 1986, JAMA-J AM MED ASSOC, V255, P1763, DOI 10.1001/jama.255.13.1763; Szabo R, 2000, BRIT MED J, V320, P1592, DOI 10.1136/bmj.320.7249.1592; Vu LT, 2012, ASIA PACIFIC J PUBLI; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Westercamp N, 2012, KEN INT AIDS C WASH; Westercamp N, 2014, AIDS BEHAV, V18, P1764, DOI 10.1007/s10461-014-0846-4; World Health Organization, 2007, MAL CIRC GLOB TRENDS; Zhou ZC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002100	47	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185917	10.1371/journal.pone.0185917	http://dx.doi.org/10.1371/journal.pone.0185917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3JE	29016638	Green Published, Green Submitted, gold			2022-12-26	WOS:000412627400037
J	Seidl, R; Moser, C; Blumer, Y				Seidl, Roman; Moser, Corinne; Blumer, Yann			Navigating behavioral energy sufficiency. Results from a survey in Swiss cities on potential behavior change	PLOS ONE			English	Article							SUSTAINABLE LIFE-STYLES; ENVIRONMENTAL ATTITUDES; CLIMATE-CHANGE; MODEL; INTERVENTION; PSYCHOLOGY; EFFICIENCY; VALUES; GREEN	Many countries have some kind of energy-system transformation either planned or ongoing for various reasons, such as to curb carbon emissions or to compensate for the phasing out of nuclear energy. One important component of these transformations is the overall reduction in energy demand. It is generally acknowledged that the domestic sector represents a large share of total energy consumption in many countries. Increased energy efficiency is one factor that reduces energy demand, but behavioral approaches (known as "sufficiency") and their respective interventions also play important roles. In this paper, we address citizens' heterogeneity regarding both their current behaviors and their willingness to realize their sufficiency potentials-that is, to reduce their energy consumption through behavioral change. We collaborated with three Swiss cities for this study. A survey conducted in the three cities yielded thematic sets of energy-consumption behavior that various groups of participants rated differently. Using this data, we identified four groups of participants with different patterns of both current behaviors and sufficiency potentials. The paper discusses intervention types and addresses citizens' heterogeneity and behaviors from a city-based perspective.	[Seidl, Roman] Swiss Fed Inst Technol, D USYS Transdisciplinar Lab, Zurich, Switzerland; [Moser, Corinne] ZHAW Sch Engn, Inst Sustainable Dev, Winterthur, Switzerland; [Blumer, Yann] Ctr Innovat & Entrepreneurship, ZHAW Sch Management & Law, Winterthur, Switzerland	ETH Zurich	Seidl, R (corresponding author), Swiss Fed Inst Technol, D USYS Transdisciplinar Lab, Zurich, Switzerland.	roman.seidl@usys.ethz.ch	Blumer, Yann/I-3346-2018	Blumer, Yann/0000-0003-0224-4538; Moser, Corinne/0000-0001-8071-3681; Seidl, Roman/0000-0002-6658-8789	Swiss National Science Foundation (SNSF) [153769]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was funded by the Swiss National Science Foundation (SNSF), http.//p3.snf.ch/project-153769. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; Aldenderfer MS, 1999, CLUSTER ANAL; Anable J, 2005, TRANSPORT POLICY, V12, P65, DOI 10.1016/j.tranpol.2004.11.004; [Anonymous], 2015, PERMANENT RESIDENT P; [Anonymous], AD PAR AGR 2015; [Anonymous], 2016, INTEGRATION INDIKATO; [Anonymous], 2016, AVERAGE AGE PERMANEN; Bamberg S, 2013, J ENVIRON PSYCHOL, V34, P151, DOI 10.1016/j.jenvp.2013.01.002; Barr S, 2001, ENVIRON PLANN A, V33, P2025, DOI 10.1068/a33225; Barr S, 2007, ENVIRON BEHAV, V39, P435, DOI 10.1177/0013916505283421; Barr S, 2006, GEOFORUM, V37, P906, DOI 10.1016/j.geoforum.2006.05.002; Batel S, 2013, ENERG POLICY, V58, P1, DOI 10.1016/j.enpol.2013.03.018; Brehm J.W., 1966, THEORY PSYCHOL REACT; Breukers Sylvia, 2013, HDB SUSTAINABLE ENG, P773, DOI DOI 10.1007/978-1-4020-8939-8; Bull R, 2015, ENERGY RES SOC SCI, V8, P32, DOI 10.1016/j.erss.2015.04.006; Cheyne C, 2016, ENERGY RES SOC SCI, V18, P139, DOI 10.1016/j.erss.2016.04.012; Cialdini R. B., 2002, Cornell Hotel and Restaurant Administration Quarterly, V43, P40, DOI 10.1016/S0010-8804(02)80030-1; Daamen DDL, 2001, ENVIRON BEHAV, V33, P229, DOI 10.1177/00139160121972963; Diekmann A, 2003, RATION SOC, V15, P441, DOI 10.1177/1043463103154002; Dietz T, 2013, DAEDALUS-US, V142, P78, DOI 10.1162/DAED_a_00186; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; European Energy Award, 2017, EUR EN AW GOLD MUN 2; Eurostat, CONS EN 2017; Frick V, ENERGY EFFI IN PRESS; Gardner GT, 2008, ENVIRONMENT, V50, P12, DOI 10.3200/ENVT.50.5.12-25; Geller ES, 2015, APPL BEHAV SCI ENV S, P307; Goldman T, 2006, TECHNOL SOC, V28, P261, DOI 10.1016/j.techsoc.2005.10.007; Gollwitzer P. M., 1990, HDB MOTIVATION COGNI, V2, P53; Harris J, 2008, ENERG EFFIC, V1, P175, DOI 10.1007/s12053-008-9011-0; Heinrichs H, 2013, GAIA, V22, P228, DOI 10.14512/gaia.22.4.5; Hinchliffe S, 1996, GLOBAL ENVIRON CHANG, V6, P53, DOI 10.1016/0959-3780(95)00113-1; Holtz T, 2015, SUFFIZIENZ ENERGIEBE; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Klockner CA, 2015, PSYCHOLOGY OF PRO-ENVIRONMENTAL COMMUNICATION: BEYOND STANDARD INFORMATION STRATEGIES, P146; Lilliestam J, 2016, ENERGY RES SOC SCI, V17, P20, DOI 10.1016/j.erss.2016.03.011; Macias T, 2014, ENVIRON BEHAV; MILLIGAN GW, 1988, J CLASSIF, V5, P181, DOI 10.1007/BF01897163; Mont O, 2014, J CLEAN PROD, V63, P24, DOI 10.1016/j.jclepro.2013.09.007; Moomaw W, 2011, RENEWABLE ENERGY SOURCES AND CLIMATE CHANGE MITIGATION: SPECIAL REPORT OF THE INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE, P161; Moser C, 2015, P ECEEE SUMM STUD 20; Moser C, 2016, 2016 INT EN POL PROG; Moser C, 2015, FRONT ENERGY RES, DOI 10.3389/fenrg.2015.00040; Nassen J, 2009, ENERG EFFIC, V2, P221, DOI 10.1007/s12053-009-9046-x; Notter DA, 2013, ENVIRON SCI TECHNOL, V47, P4014, DOI 10.1021/es3037548; Ohnmacht T, 2017, ENERGY RES SOC SCI, V26, P40, DOI 10.1016/j.erss.2017.01.017; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Otto S, 2014, EUR PSYCHOL, V19, P96, DOI 10.1027/1016-9040/a000182; Parag Y, 2014, ENERGY RES SOC SCI, V3, P102, DOI 10.1016/j.erss.2014.07.011; Poortinga W, 2003, J ECON PSYCHOL, V24, P49, DOI 10.1016/S0167-4870(02)00154-X; Rose G, 2007, TRANSPORT RES A-POL, V41, P351, DOI 10.1016/j.tra.2006.10.001; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Schultz PW, 2011, CONSERV BIOL, V25, P1080, DOI 10.1111/j.1523-1739.2011.01766.x; Schwartz SH, 2004, J RES PERS, V38, P230, DOI 10.1016/S0092-6566(03)00069-2; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; Sutterlin B, 2011, ENERG POLICY, V39, P8137, DOI 10.1016/j.enpol.2011.10.008; Sutterlin B, 2012, SEGMENTATION CHARACT; Swiss Federal Council, 2013, BOTSCH ZUM ERST MASS; Swiss Federal Council, 2014, ORD HUM RES EXC CLIN; Swiss Federal Office of Energy, 2014, SCHWEIZ GES 2014; Swiss Federal Office of Energy, 2014, SCHWEIZ GES 2014; Tiefenbeck V, 2013, ENERG POLICY, V57, P160, DOI 10.1016/j.enpol.2013.01.021; Tobler C, 2012, J ENVIRON PSYCHOL, V32, P197, DOI 10.1016/j.jenvp.2012.02.001; Trancik JE, 2014, NATURE, V507, P300, DOI 10.1038/507300a; van Zomeren M, 2008, PSYCHOL BULL, V134, P504, DOI 10.1037/0033-2909.134.4.504; Verplanken B, 2016, J ENVIRON PSYCHOL, V45, P127, DOI 10.1016/j.jenvp.2015.11.008; WHITE LT, 1984, EVALUATION REV, V8, P167, DOI 10.1177/0193841X8400800202; Wolsink M, 2012, RENEW SUST ENERG REV, V16, P822, DOI 10.1016/j.rser.2011.09.006	68	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185963	10.1371/journal.pone.0185963	http://dx.doi.org/10.1371/journal.pone.0185963			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	29016642	Green Published, Green Submitted, gold			2022-12-26	WOS:000412601800031
J	Kumar, K; Espaillat, A; Cava, F				Kumar, Keshav; Espaillat, Akbar; Cava, Felipe			PG-Metrics: A chemometric-based approach for classifying bacterial peptidoglycan data sets and uncovering their subjacent chemical variability	PLOS ONE			English	Article							VIBRIO-CHOLERAE; CELL-WALL; ALGORITHMS; BIOSYNTHESIS; SINGLE	Bacteria cells are protected from osmotic and environmental stresses by an exoskeleton-like polymeric structure called peptidoglycan ( PG) or murein sacculus. This structure is fundamental for bacteria's viability and thus, the mechanisms underlying cell wall assembly and how it is modulated serve as targets for many of our most successful antibiotics. Therefore, it is now more important than ever to understand the genetics and structural chemistry of the bacterial cell walls in order to find new and effective methods of blocking it for the treatment of disease. In the last decades, liquid chromatography and mass spectrometry have been demonstrated to provide the required resolution and sensitivity to characterize the fine chemical structure of PG. However, the large volume of data sets that can be produced by these instruments today are difficult to handle without a proper data analysis work-flow. Here, we present PG-metrics, a chemometric based pipeline that allows fast and easy classification of bacteria according to their muropeptide chromatographic profiles and identification of the subjacent PG chemical variability between e.g. bacterial species, growth conditions and, mutant libraries. The pipeline is successfully validated here using PG samples from different bacterial species and mutants in cell wall proteins. The obtained results clearly demonstrated that PG-metrics pipeline is a valuable bioanalytical tool that can lead us to cell wall classification and biomarker discovery.	[Kumar, Keshav; Espaillat, Akbar; Cava, Felipe] Umea Univ, Umea Ctr Microbial Res, Dept Mol Biol, Lab Mol Infect Med Sweden, Umea, Sweden	Umea University	Cava, F (corresponding author), Umea Univ, Umea Ctr Microbial Res, Dept Mol Biol, Lab Mol Infect Med Sweden, Umea, Sweden.	felipe.cava@molbiol.umu.se			Knut and Alice Wallenberg Foundation (KAW); Laboratory of Molecular Infection Medicine Sweden (MIMS); Swedish Research Council; Kempe Foundation	Knut and Alice Wallenberg Foundation (KAW)(Knut & Alice Wallenberg Foundation); Laboratory of Molecular Infection Medicine Sweden (MIMS); Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundation	Research in the Cava lab is funded by The Knut and Alice Wallenberg Foundation (KAW), The Laboratory of Molecular Infection Medicine Sweden (MIMS), the Swedish Research Council and the Kempe Foundation. KK and AE thank Kempe foundation for the scholarship.	Andrade L, 2003, J VLSI SIG PROC SYST, V35, P229, DOI 10.1023/B:VLSI.0000003022.86639.1f; Atrih A, 1996, J BACTERIOL, V178, P6173, DOI 10.1128/jb.178.21.6173-6183.1996; Bloemberg TG, 2010, CHEMOMETR INTELL LAB, V104, P65, DOI 10.1016/j.chemolab.2010.04.008; Brereton GR, 2009, CHEMOMETRICS PATTERN; Bro R, 2014, ANAL METHODS-UK, V6, P2812, DOI 10.1039/c3ay41907j; Desmarais SM, 2015, J BIOL CHEM, V290, P31090, DOI 10.1074/jbc.M115.661660; Ebrahimi P, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0996-7; Eilers PHC, 2004, ANAL CHEM, V76, P404, DOI 10.1021/ac034800e; Espaillat A, 2016, J AM CHEM SOC, V138, P9193, DOI 10.1021/jacs.6b04430; Gredilla A, 2016, TRAC-TREND ANAL CHEM, V76, P30, DOI 10.1016/j.trac.2015.11.011; Hofmann T, 2001, MACH LEARN, V42, P177, DOI 10.1023/A:1007617005950; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Jones EA, 2012, J PROTEOMICS, V75, P4962, DOI 10.1016/j.jprot.2012.06.014; Kassidas A, 1998, AICHE J, V44, P864, DOI 10.1002/aic.690440412; Kaufman L, 2005, FINDING GROUPS IN DA; Knolhoff AM, 2016, ANAL CHEM, V88, P3617, DOI 10.1021/acs.analchem.5b04208; KOHONEN T, 1982, BIOL CYBERN, V44, P135, DOI 10.1007/BF00317973; Kuhner D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07494; Kumar K, 2013, ANAL METHODS-UK, V5, P3482, DOI 10.1039/c3ay40352a; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Liu S, 2016, J CHROMATOGR B, V1015, P82, DOI 10.1016/j.jchromb.2016.02.011; Massart DL, 1998, TXB DATA HANDLING SC; MENGINLECREULX D, 1985, J BACTERIOL, V163, P208, DOI 10.1128/JB.163.1.208-212.1985; Moll A, 2015, ENVIRON MICROBIOL, V17, P527, DOI 10.1111/1462-2920.12779; Moll A, 2014, J BACTERIOL, V196, P3937, DOI 10.1128/JB.02094-14; Monchamp P, 2007, SYSTEMS BIOINFORMATI, P101; Nielsen NPV, 1998, J CHROMATOGR A, V805, P17, DOI 10.1016/S0021-9673(98)00021-1; Pravdova V, 2002, ANAL CHIM ACTA, V456, P77, DOI 10.1016/S0003-2670(02)00008-9; Ramaker HJ, 2003, ANAL CHIM ACTA, V498, P133, DOI 10.1016/j.aca.2003.08.045; Roberts JJ, 2016, FOOD ANAL METHOD, V9, P3258, DOI 10.1007/s12161-016-0574-7; Savorani F, 2013, ROY SOC CH, V343, P14; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Schneider T, 2010, INT J MED MICROBIOL, V300, P161, DOI 10.1016/j.ijmm.2009.10.005; Siqueira LFS, 2016, ANALYST, V141, P4833, DOI 10.1039/c6an01247g; Skov T, 2006, J CHEMOMETR, V20, P484, DOI 10.1002/cem.1031; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Tomasi G, 2004, J CHEMOMETR, V18, P231, DOI 10.1002/cem.859; Tomasi G, 2011, J CHROMATOGR A, V1218, P7832, DOI 10.1016/j.chroma.2011.08.086; van Nederkassel AM, 2006, J CHROMATOGR A, V1118, P199, DOI 10.1016/j.chroma.2006.03.114; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Want EJ, 2013, NAT PROTOC, V8, P17, DOI 10.1038/nprot.2012.135; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Yang LP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157601; Yi LZ, 2016, ANAL CHIM ACTA, V914, P17, DOI 10.1016/j.aca.2016.02.001	44	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186197	10.1371/journal.pone.0186197	http://dx.doi.org/10.1371/journal.pone.0186197			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040278	Green Published, gold, Green Submitted			2022-12-26	WOS:000413167500024
J	Lee, EJ; Han, JC; Kee, C				Lee, Eun Jung; Han, Jong Chul; Kee, Changwon			Intereye comparison of ocular factors in normal tension glaucoma with asymmetric visual field loss in Korean population	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CENTRAL CORNEAL THICKNESS; OPTIC-NERVE HEAD; PARAPAPILLARY CHORIORETINAL ATROPHY; LAMINA-CRIBROSA DEFECTS; LONG-TERM PROGRESSION; INTRAOCULAR-PRESSURE; RISK-FACTORS; MYOPIC EYES; PERIPAPILLARY ATROPHY	Purpose To identify ocular parameters corresponding to asymmetric visual field (VF) loss in normal tension glaucoma (NTG) through intereye comparisons. Patients and methods Medical records of NTG patients with asymmetric and symmetric VF losses were retrospectively reviewed. The criterion for asymmetry in VF was 6 dB difference of mean deviation. Refractive error, intraocular pressure (IOP), central corneal thickness, ovality index, and peripapillary atrophy (PPA)/disc area ratio were obtained from each patient. Intereye comparison was performed for asymmetric group, symmetric group, and myopic and nonmyopic asymmetric subgroups. Results We included 155 patients; 110 patients in asymmetric group and 45 patients in symmetric group. In intereye comparison for total asymmetric group, refractive error (P = 0.006), initial IOP (P = 0.001), ovality index (P = 0.008), and PPA (P < 0.001) were significantly asymmetric. For myopic subgroup, refractive error (P = 0.004), ovality index (P = 0.001), and PPA (P = 0.003) were significant factors. For nonmyopic subgroup, initial IOP (P = 0.003) and PPA (P = 0.007) were significant factors. Symmetric group showed no significant difference between the eyes. Multivariate analysis demonstrated that refractive error (P = 0.002) and PPA (P = 0.028) were significant factors in myopic subgroup, and initial IOP (P = 0.022) and PPA (P = 0.002) were significant factors in nonmyopic subgroup. Conclusions In this intereye comparison, the more myopic eye in myopic NTG patient, and the more pressured eye in nonmyopic NTG patient demonstrated more severe VF loss. Myopic and nonmyopic patients may follow different pathophysiologic processes. Discriminative attentions should be paid to NTG patients by subtypes.	[Lee, Eun Jung; Han, Jong Chul; Kee, Changwon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Kee, C (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	ckee@skku.edu		Kee, Changwon/0000-0002-7419-0316				Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Alward WLM, 2001, OPHTHALMOLOGY, V108, P247; Anand A, 2010, INVEST OPHTH VIS SCI, V51, P6514, DOI 10.1167/iovs.10-5580; Anderson Douglas R, 2003, Curr Opin Ophthalmol, V14, P86; ARAIE M, 1994, OPHTHALMOLOGY, V101, P1440; Araie M, 2012, ACTA OPHTHALMOL, V90, pe337, DOI 10.1111/j.1755-3768.2012.02425.x; Bellezza AJ, 2000, INVEST OPHTH VIS SCI, V41, P2991; Bengtsson B, 2007, OPHTHALMOLOGY, V114, P205, DOI 10.1016/j.ophtha.2006.07.060; BUUS DR, 1989, OPHTHALMOLOGY, V96, P16; Caprioli J, 2008, OPHTHALMOLOGY, V115, P1123, DOI 10.1016/j.ophtha.2007.10.031; Carbonaro F, 2014, AM J OPHTHALMOL, V157, P441, DOI 10.1016/j.ajo.2013.10.017; CARTWRIGHT MJ, 1988, ARCH OPHTHALMOL-CHIC, V106, P898; Chauhan BC, 2005, BRIT J OPHTHALMOL, V89, P1008, DOI 10.1136/bjo.2004.062927; Chihara E, 1997, OPHTHALMOLOGICA, V211, P66, DOI 10.1159/000310760; Congdon NG, 2006, AM J OPHTHALMOL, V141, P868, DOI 10.1016/j.ajo.2005.12.007; CRICHTON A, 1989, OPHTHALMOLOGY, V96, P1312; Daugeliene L, 1999, GRAEF ARCH CLIN EXP, V237, P105, DOI 10.1007/s004170050203; Doshi A, 2007, OPHTHALMOLOGY, V114, P472, DOI 10.1016/j.ophtha.2006.07.036; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Ernest PJ, 2013, OPHTHALMOLOGY, V120, P512, DOI 10.1016/j.ophtha.2012.09.005; Faridi OS, 2014, OPHTHALMOLOGY, V121, P1524, DOI 10.1016/j.ophtha.2014.02.017; GAASTERLAND DE, 1994, OPHTHALMOLOGY, V101, P1445; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Greenfield DS, 2007, OPHTHALMOLOGY, V114, P460, DOI 10.1016/j.ophtha.2006.06.056; HAEFLIGER IO, 1990, ACTA OPHTHALMOL, V68, P564; Han JC, 2016, INVEST OPHTH VIS SCI, V57, P486, DOI 10.1167/iovs.15-17722; Helmy H, 2016, CLIN OPHTHALMOL, V10, P503, DOI 10.2147/OPTH.S93725; Herndon LW, 2004, ARCH OPHTHALMOL-CHIC, V122, P17, DOI 10.1001/archopht.122.1.17; Hutchings N, 2000, INVEST OPHTH VIS SCI, V41, P3429; Ishida K, 1998, J GLAUCOMA, V7, P372; Jonas JB, 2005, INVEST OPHTH VIS SCI, V46, P1269, DOI 10.1167/iovs.04-0265; Jonas JB, 2000, PROG RETIN EYE RES, V19, P1, DOI 10.1016/S1350-9462(99)00002-6; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P919; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2660, DOI 10.1167/iovs.03-1363; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2613, DOI 10.1167/iovs.03-1274; JONAS JB, 1993, AM J OPHTHALMOL, V115, P501, DOI 10.1016/S0002-9394(14)74453-8; JONAS JB, 1992, ARCH OPHTHALMOL-CHIC, V110, P214, DOI 10.1001/archopht.1992.01080140070030; Jonas JB, 2002, AM J OPHTHALMOL, V134, P547, DOI 10.1016/S0002-9394(02)01644-6; Jonas JB, 2016, INVEST OPHTH VIS SCI, V57, P396, DOI 10.1167/iovs.15-18263; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Jonas RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138701; Lee JY, 2015, INVEST OPHTH VIS SCI, V56, P1775, DOI 10.1167/iovs.14-16002; Lee JR, 2016, J GLAUCOMA, V25, P330, DOI 10.1097/IJG.0000000000000218; Lee KM, 2015, INVEST OPHTH VIS SCI, V56, P2958, DOI 10.1167/iovs.14-15953; Lee YA, 2008, J FORMOS MED ASSOC, V107, P952, DOI 10.1016/S0929-6646(09)60019-X; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; LEVENE RZ, 1980, SURV OPHTHALMOL, V24, P621, DOI 10.1016/0039-6257(80)90123-X; Morita T, 2012, ACTA OPHTHALMOL, V90, pE48, DOI 10.1111/j.1755-3768.2011.02242.x; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; Naito T, 2016, CLIN OPHTHALMOL, V10, P1397, DOI 10.2147/OPTH.S109732; Nakagami T, 2006, JPN J OPHTHALMOL, V50, P38, DOI 10.1007/s10384-005-0273-1; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; Park HYL, 2012, OPHTHALMOLOGY, V119, P1844, DOI 10.1016/j.ophtha.2012.03.006; Park HYL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003500; Park KH, 1996, OPHTHALMOLOGY, V103, P1899, DOI 10.1016/S0161-6420(96)30409-0; Park SC, 2009, ARCH OPHTHALMOL-CHIC, V127, P1275, DOI 10.1001/archophthalmol.2009.247; Perdicchi A, 2007, EUR J OPHTHALMOL, V17, P534, DOI 10.1177/112067210701700409; Qiu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133189; ROCKWOOD EJ, 1988, GRAEF ARCH CLIN EXP, V226, P510, DOI 10.1007/BF02169197; Sakata R, 2013, J GLAUCOMA, V22, P250, DOI 10.1097/IJG.0b013e31823298fb; Shields MB, 2008, CURR OPIN OPHTHALMOL, V19, P85, DOI 10.1097/ICU.0b013e3282f3919b; Sigal IA, 2004, INVEST OPHTH VIS SCI, V45, P4378, DOI 10.1167/iovs.04-0133; Sohn SW, 2010, AM J OPHTHALMOL, V149, P831, DOI 10.1016/j.ajo.2009.12.033; Stewart WC, 2000, AM J OPHTHALMOL, V130, P274, DOI 10.1016/S0002-9394(00)00487-6; Sullivan-Mee Michael, 2006, Optometry, V77, P134, DOI 10.1016/j.optm.2005.12.013; Sullivan-Mee M, 2006, OPTOMETRY VISION SCI, V83, P516, DOI 10.1097/01.opx.0000218433.49803.e7; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Teng CC, 2011, OPHTHALMOLOGY, V118, P2409, DOI 10.1016/j.ophtha.2011.06.014; Teng CC, 2010, OPHTHALMOLOGY, V117, P909, DOI 10.1016/j.ophtha.2009.10.016; Wang SY, 2014, J GLAUCOMA, V23, P606, DOI 10.1097/IJG.0000000000000088; Wells AP, 2008, INVEST OPHTH VIS SCI, V49, P3262, DOI 10.1167/iovs.07-1556; Xu L, 2007, AM J OPHTHALMOL, V144, P541, DOI 10.1016/j.ajo.2007.05.038; Yamada H, 2016, OPHTHALMOLOGY, V123, P542, DOI 10.1016/j.ophtha.2015.10.061; Yoo YJ, 2016, INVEST OPHTH VIS SCI, V57, P4187, DOI 10.1167/iovs.16-19059; You JY, 2013, JAMA OPHTHALMOL, V131, P314, DOI 10.1001/jamaophthalmol.2013.1926	76	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186236	10.1371/journal.pone.0186236	http://dx.doi.org/10.1371/journal.pone.0186236			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040292	Green Submitted, Green Published, gold			2022-12-26	WOS:000413167500028
J	Pilleron, S; Rajaobelina, K; Teguo, MT; Dartigues, JF; Helmer, C; Delcourt, C; Rigalleau, V; Feart, C				Pilleron, Sophie; Rajaobelina, Kalina; Teguo, Maturin Tabue; Dartigues, Jean-Francois; Helmer, Catherine; Delcourt, Cecile; Rigalleau, Vincent; Feart, Catherine			Accumulation of advanced glycation end products evaluated by skin autofluorescence and incident frailty in older adults from the Bordeaux Three-City cohort	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; SERUM-LEVELS; CARDIOVASCULAR-DISEASE; CARBOXYMETHYL-LYSINE; METABOLIC MEMORY; MORTALITY	Aim We analyzed the cross-sectional and prospective relationships between the accumulation of advanced glycation end products (AGE), assessed by skin autofluorescence (AF) and frailty and its components. Methods A total of 423 participants of the Bordeaux sample of the Three-City study 75 years of age or older in 2009-2010 were included in the cross-sectional analysis. Among them, 255 initially non-frail participants were re-examined 4 years later. Skin AF (arbitrary units (AU)) was measured using the AGE Reader. Frailty was defined using Fried's criteria. Associations were assessed with logistic regression models. Results Mean skin AF at baseline was 2.81 +/- 0.68 AU and 16.8% participants were frail. Adjusted for sociodemographic and health characteristics, skin AF was associated neither with prevalent frailty as a whole (Odds Ratio (OR) = 1.2; 95% Confidence Interval: 0.8-1.9) nor with any of its components. Among 255 non-frail participants, 32 became frail over 4 years. In multivariate analyses, skin AF was not associated with incident frailty as a whole (OR = 1.0; 0.5-2.0) but with a doubled risk of incident exhaustion (OR = 2.0; 1.2-3.6) and low energy expenditure (OR = 2.0; 1.1-3.7). No association was observed with other criteria. Conclusion In French older community-dwellers aged 75 years and over, the accumulation of AGEs evaluated by skin AF was not associated with prevalent or incident frailty but with the 4-year risk of exhaustion and low energy expenditure. Further studies with larger samples are needed to confirm our results.	[Pilleron, Sophie; Rajaobelina, Kalina; Teguo, Maturin Tabue; Dartigues, Jean-Francois; Helmer, Catherine; Delcourt, Cecile; Rigalleau, Vincent; Feart, Catherine] Univ Bordeaux, INSERM, Bordeaux Populat Hlth Res Ctr, Team LEHA,UMR 1219, Bordeaux, France; [Rigalleau, Vincent] CHU Bordeaux, Hop Haut Leveque, Serv Nutr Diabetol, Pessac, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Pilleron, S; Feart, C (corresponding author), Univ Bordeaux, INSERM, Bordeaux Populat Hlth Res Ctr, Team LEHA,UMR 1219, Bordeaux, France.	sophie_pilleron@hotmail.com; catherine.feart-couret@u-bordeaux.fr	Delcourt, Cecile/I-2627-2013; FEART, Catherine/A-3339-2016; HELMER, Catherine/AAG-5126-2021; DARTIGUES, Jean François/T-4513-2019; HELMER, Catherine/I-6581-2015; Sophie, PILLERON/O-8136-2018; Rigalleau, vincent/A-3766-2016	Delcourt, Cecile/0000-0002-2099-0481; HELMER, Catherine/0000-0002-5169-7421; Sophie, PILLERON/0000-0001-7146-4740; FEART, Catherine/0000-0002-7959-1610	Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; Conseils Regionaux of Aquitaine and Bourgogne; Fondation de France, Ministry of Research-INSERM Program Cohortes et collections de donnees biologiques; Fondation Plan Alzheimer [FCS2009-2012]; Caisse Nationale pour la Solidarite et l'Autonomie (CNSA); European Union's Seventh Framework Programme FRAILOMIC [305483]; Fondation pour la Recherche Medicale	Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); Conseils Regionaux of Aquitaine and Bourgogne(Region Bourgogne-Franche-ComteRegion Nouvelle-Aquitaine); Fondation de France, Ministry of Research-INSERM Program Cohortes et collections de donnees biologiques; Fondation Plan Alzheimer; Caisse Nationale pour la Solidarite et l'Autonomie (CNSA); European Union's Seventh Framework Programme FRAILOMIC; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	The Three-City Study is conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), Victor Segalen - Bordeaux2 University and the Sanofi-Synthelabo company. The Fondation pour la Recherche Medicale funded the preparation and beginning of the study. The 3C-Study is also sponsored by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Conseils Regionaux of Aquitaine and Bourgogne, Fondation de France, Ministry of Research-INSERM Program Cohortes et collections de donnees biologiques, the Fondation Plan Alzheimer (FCS2009-2012), and the Caisse Nationale pour la Solidarite et l'Autonomie (CNSA). This work was supported by the European Union's Seventh Framework Programme (FP7/2007-2013) FRAILOMIC Project (grant number 305483) to SP. Study sponsors played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Dalal M, 2009, J GERONTOL A-BIOL, V64, P132, DOI 10.1093/gerona/gln018; den Dekker MAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083084; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; Goon JA, 2009, J PHYS ACT HEALTH, V6, P43, DOI 10.1123/jpah.6.1.43; Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007; Kato M, 2016, GERIATR GERONTOL INT; Kilhovd BK, 2007, DIABETOLOGIA, V50, P1409, DOI 10.1007/s00125-007-0687-z; Koetsier M, 2010, DIABETES TECHNOL THE, V12, P399, DOI 10.1089/dia.2009.0113; Kop WJ, 1996, J PSYCHOSOM RES, V40, P397, DOI 10.1016/0022-3999(95)00613-3; KOP WJ, 1994, PSYCHOSOM MED, V56, P281, DOI 10.1097/00006842-199407000-00001; Koyama H, 2010, EUR J CLIN INVEST, V40, P623, DOI 10.1111/j.1365-2362.2010.02298.x; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Lutgers HL, 2010, EUR J CLIN INVEST, V40, P812, DOI 10.1111/j.1365-2362.2010.02329.x; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Meerwaldt R, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-29; Momma H, 2011, EUR J APPL PHYSIOL, V111, P1545, DOI 10.1007/s00421-010-1779-x; Mulder DJ, 2009, NETH HEART J, V17, P162, DOI 10.1007/BF03086239; Mulder DJ, 2008, ATHEROSCLEROSIS, V197, P217, DOI 10.1016/j.atherosclerosis.2007.03.027; Newman AB, 2001, J GERONTOL A-BIOL, V56, pM158, DOI 10.1093/gerona/56.3.M158; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rajaobelina K, 2015, J GERONTOL A-BIOL, V70, P841, DOI 10.1093/gerona/glu243; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; Semba RD, 2010, EUR J APPL PHYSIOL, V108, P191, DOI 10.1007/s00421-009-1192-5; Semba RD, 2009, J AM GERIATR SOC, V57, P1874, DOI 10.1111/j.1532-5415.2009.02438.x; Snow LM, 2007, J GERONTOL A-BIOL, V62, P1204, DOI 10.1093/gerona/62.11.1204; Stirban A, 2008, DIABETES TECHNOL THE, V10, P200, DOI 10.1089/dia.2007.0275; Sun K, 2012, J AGING RES, V2012, DOI DOI 10.1155/2012/586385; Tabue-Teguo M, 2017, J GERONTOL A; Whitson HE, 2014, J GERONTOL A-BIOL, V69, P710, DOI 10.1093/gerona/glt155; Yoshikawa T, 2009, MED SCI MONITOR, V15, pPH65	36	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186087	10.1371/journal.pone.0186087	http://dx.doi.org/10.1371/journal.pone.0186087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KA	29040310	gold, Green Published, Green Submitted			2022-12-26	WOS:000413167500018
J	Richetin, J; Preti, E; Costantini, G; De Panfilis, C				Richetin, Juliette; Preti, Emanuele; Costantini, Giulio; De Panfilis, Chiara			The centrality of affective instability and identity in Borderline Personality Disorder: Evidence from network analysis	PLOS ONE			English	Article							DIALECTICAL BEHAVIOR-THERAPY; TRANSFERENCE-FOCUSED PSYCHOTHERAPY; INVERSE COVARIANCE ESTIMATION; DEPRESSION; PERSPECTIVE; INVENTORY; FACETS; TRIAL; DSM	We argue that the series of traits characterizing Borderline Personality Disorder samples do not weigh equally. In this regard, we believe that network approaches employed recently in Personality and Psychopathology research to provide information about the differential relationships among symptoms would be useful to test our claim. To our knowledge, this approach has never been applied to personality disorders. We applied network analysis to the nine Borderline Personality Disorder traits to explore their relationships in two samples drawn from university students and clinical populations (N = 1317 and N = 96, respectively). We used the Fused Graphical Lasso, a technique that allows estimating networks from different populations separately while considering their similarities and differences. Moreover, we examined centrality indices to determine the relative importance of each symptom in each network. The general structure of the two networks was very similar in the two samples, although some differences were detected. Results indicate the centrality of mainly affective instability, identity, and effort to avoid abandonment aspects in Borderline Personality Disorder. Results are consistent with the new DSM Alternative Model for Personality Disorders. We discuss them in terms of implications for therapy.	[Richetin, Juliette; Preti, Emanuele; Costantini, Giulio] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Preti, Emanuele; De Panfilis, Chiara] Personal Disorders Lab, Parma, Italy; [De Panfilis, Chiara] Univ Parma, Dept Med & Surg, Parma, Italy	University of Milano-Bicocca; University of Parma	Richetin, J; Preti, E (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	juliette.richetin@unimib.it; emanuele.preti@unimib.it	De Panfilis, Chiara/AAC-5286-2022; Costantini, Giulio/F-3829-2018	De Panfilis, Chiara/0000-0003-1907-6702; Costantini, Giulio/0000-0001-6610-5452; RICHETIN, Juliette/0000-0002-9175-5892				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; [Anonymous], 2016, MENTALIZATION BASED, DOI DOI 10.1093/MED:PSYCH/9780199680375.001.0001; Arntz A, 2003, J PERS DISORD, V17, P45, DOI 10.1521/pedi.17.1.45.24053; Barnicot K, 2014, PSYCHOTHER PSYCHOSOM, V83, P192, DOI 10.1159/000357365; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bohus M, 2013, PSYCHOTHER PSYCHOSOM, V82, P221, DOI 10.1159/000348451; Borgatti SP, 2006, SOC NETWORKS, V28, P124, DOI 10.1016/j.socnet.2005.05.001; Borsboom D, 2017, WORLD PSYCHIATRY, V16, P5, DOI 10.1002/wps.20375; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Bos FM, 2017, PSYCHOTHER PSYCHOSOM, V86, P175, DOI 10.1159/000453583; Boschloo L, 2016, PSYCHOTHER PSYCHOSOM, V85, P183, DOI 10.1159/000442001; Bringmann LF, 2015, PSYCHOL MED, V45, P747, DOI 10.1017/S0033291714001809; Bringmann LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060188; Chiesa M, 2017, ATTACH HUM DEV, V19, P151, DOI 10.1080/14616734.2016.1261915; Clarkin JF, 2007, AM J PSYCHIAT, V164, P922, DOI 10.1176/appi.ajp.164.6.922; Clarkin JF, 2013, J NERV MENT DIS, V201, P88, DOI 10.1097/NMD.0b013e31827f61f6; Cooper LD, 2010, J ABNORM PSYCHOL, V119, P886, DOI 10.1037/a0021078; Costantini G, 2017, PERS INDIVID DIF; Costantini G., 2017, ESTIMATEGROUPNETWORK; Costantini G, 2015, EUR J PERSONALITY, V29, P548, DOI 10.1002/per.2014; Costantini G, 2015, J RES PERS, V54, P13, DOI 10.1016/j.jrp.2014.07.003; Cramer AOJ, 2012, EUR J PERSONALITY, V26, P414, DOI 10.1002/per.1866; Danaher P, 2014, J R STAT SOC B, V76, P373, DOI 10.1111/rssb.12033; De Panfilis C, 2015, PERSONAL DISORD, V6, P301, DOI 10.1037/per0000132; Doering S, 2010, BRIT J PSYCHIAT, V196, P389, DOI 10.1192/bjp.bp.109.070177; Epskamp S, 2016, TUTORIAL REGULARIZED, P1; Epskamp S., 2017, DISCOVERING PSYCHOL; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Farmer RF, 2002, COMPR PSYCHIAT, V43, P285, DOI 10.1053/comp.2002.33494; First M.B., 2015, STRUCTURED CLIN INTE; Fonagy P, 2006, J CLIN PSYCHOL, V62, P411, DOI 10.1002/jclp.20241; Fonagy P, 2008, J PERS DISORD, V22, P4, DOI 10.1521/pedi.2008.22.1.4; Fried E, 2015, FRONT, V6, P4; Fried EI, 2017, REPLICABILITY GEN PT; Fried EI, 2016, PSYCHOL ASSESSMENT, V28, P1354, DOI 10.1037/pas0000275; Fried EI, 2016, J AFFECT DISORDERS, V189, P314, DOI 10.1016/j.jad.2015.09.005; Fried EI, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00117; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Gunderson J. G., 1998, DSM 4 SOURCE BOOK, V4, P1123; Gunderson JG, 1996, AM J PSYCHIAT, V153, P752; Gunderson JG, 2007, AM J PSYCHIAT, V164, P1333, DOI 10.1176/appi.ajp.2007.07050727; Horz-Sagstetter S, 2017, J PERS ASSESS; Isvoranu AM, 2017, SCHIZOPHRENIA BULL, V43, P187, DOI 10.1093/schbul/sbw055; Jobst A, 2014, PSYCHOTHER PSYCHOSOM, V83, P252, DOI 10.1159/000358526; Kendler KS, 2016, WORLD PSYCHIATRY, V15, P5, DOI 10.1002/wps.20292; KERNBERG O, 1967, J AM PSYCHOANAL ASS, V15, P641, DOI 10.1177/000306516701500309; Kernberg O., 1984, SEVERE PERSONALITY D; Kernberg O. F., 2005, MAJOR THEORIES PERSO, V2nd, P114; Kim NS, 2002, J EXP PSYCHOL GEN, V131, P451, DOI 10.1037//0096-3445.131.4.451; Koenders MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141420; Lenzenweger MF, 2008, J PERS DISORD, V22, P313, DOI 10.1521/pedi.2008.22.4.313; Levy KN, 2006, J CONSULT CLIN PSYCH, V74, P1027, DOI 10.1037/0022-006X.74.6.1027; Levy KN, 2005, DEV PSYCHOPATHOL, V17, P959, DOI 10.1017/S0954579405050455; Linehan M. M., 1993, COGNITIVE BEHAV TREA; McNally RJ, 2015, CLIN PSYCHOL SCI, V3, P836, DOI 10.1177/2167702614553230; Meares RA., 2012, DISSOCIATION MODEL B; Preti E, 2015, PERSONAL DISORD, V6, P129, DOI 10.1037/per0000119; Priebe S, 2012, PSYCHOTHER PSYCHOSOM, V81, P356, DOI 10.1159/000338897; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Prunas A., 2006, MINERVA PSICHIATRICA, V47, P1; Robinaugh DJ, 2014, J ABNORM PSYCHOL, V123, P510, DOI 10.1037/abn0000002; Sherman R., 2017, OXFORD HDB PSYCHOL S; Wardenaar KJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-201; Wichers M, 2016, PSYCHOTHER PSYCHOSOM, V85, P114, DOI 10.1159/000441458; Wigman JTW, 2015, PSYCHOL MED, V45, P2375, DOI 10.1017/S0033291715000331; Yeomans FE, 2015, TRANSFERENCE FOCUSED; ZANARINI MC, 1990, AM J PSYCHIAT, V147, P161; Zanarini MC, 1998, HARVARD REV PSYCHIAT, V6, P201, DOI 10.3109/10673229809000330	68	44	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186695	10.1371/journal.pone.0186695	http://dx.doi.org/10.1371/journal.pone.0186695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KA	29040324	Green Submitted, gold, Green Published			2022-12-26	WOS:000413167500069
J	Inambao, M; Kilembe, W; Canary, LA; Czaicki, NL; Kakungu-Simpungwe, M; Chavuma, R; Wall, KM; Tichacek, A; Pulerwitz, J; Thior, I; Chomba, E; Allen, SA				Inambao, Mubiana; Kilembe, William; Canary, Lauren A.; Czaicki, Nancy L.; Kakungu-Simpungwe, Matilda; Chavuma, Roy; Wall, Kristin M.; Tichacek, Amanda; Pulerwitz, Julie; Thior, Ibou; Chomba, Elwyn; Allen, Susan A.			Transitioning couple's voluntary HIV counseling and testing (CVCT) from stand-alone weekend services into routine antenatal and VCT services in government clinics in Zambia's two largest cities	PLOS ONE			English	Article							MALE INVOLVEMENT; CARE; TRANSMISSION; BARRIERS; RWANDA	Introduction Most HIV infections in Africa are acquired by married/cohabiting adults and WHO recommends couple's voluntary HIV counseling and testing (CVCT) for prevention. The handover from NGO-sponsored weekend CVCT to government-sponsored services in routine weekday antenatal care (ANC) and individual voluntary testing and counseling (VCT) services in Zambia's two largest cities from 2009-2015 is described. Methods Government clinic counselors were trained to provide CVCT, and along with community health workers they promoted CVCT services in their clinic and surrounding areas. When client volume exceeded the capacity of on-duty staff in ANC and VCT, non-governmental organization (NGO) subsidies were offered for overtime pay. Results Implementation of routine CVCT services varied greatly by clinic and city. The 12 highest volume clinics were examined further, while 13 clinics had CVCT numbers that were too low to warrant further investigation. In Lusaka, the proportion of pregnant women whose partners were tested rose from 2.6% in 2009 to a peak of 26.2% in 2012 and 24.8% in 2015. Corresponding reports in Ndola were 2.0% in 2009, 17.0% in 2012 and 14.5% in 2015. Obstacles to CVCT included: limited space and staffing, competing priorities, record keeping not adapted for couples, and few resources for promotion and increasing male involvement. Conflicting training models for 'partner testing' with men and women separately vs. CVCT with joint post-test counseling led to confusion in reporting to district health authorities. Discussion A focused and sustained effort will be required to reach a meaningful number of couples with CVCT to prevent heterosexual and perinatal HIV transmission. Establishing targets and timelines, funding for dedicated and appropriately trained staff, adoption of standardized data recording instruments with couple-level indicators, and expansion of community and clinic-based promotions using proven models are recommended.	[Inambao, Mubiana; Kilembe, William; Canary, Lauren A.; Czaicki, Nancy L.; Wall, Kristin M.; Tichacek, Amanda; Allen, Susan A.] Emory Univ, Dept Pathol & Lab Med, Rwanda Zambia HIV Res Grp, Sch Med, Atlanta, GA 30322 USA; [Inambao, Mubiana; Kilembe, William; Canary, Lauren A.; Czaicki, Nancy L.; Wall, Kristin M.; Tichacek, Amanda; Allen, Susan A.] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Inambao, Mubiana] Zambia Emory HIV Res Project ZEHRP, Ndola, Zambia; [Kilembe, William] Zambia Emory HIV Res Project ZEHRP, Lusaka, Zambia; [Kakungu-Simpungwe, Matilda; Chavuma, Roy] MCDMCH, DHMT, Lusaka, Zambia; [Wall, Kristin M.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Pulerwitz, Julie; Thior, Ibou] PATH, Washington, DC USA; [Chomba, Elwyn] MCDMCH, Lusaka, Zambia	Emory University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Allen, SA (corresponding author), Emory Univ, Dept Pathol & Lab Med, Rwanda Zambia HIV Res Grp, Sch Med, Atlanta, GA 30322 USA.; Allen, SA (corresponding author), Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	sallen5@emory.edu		, Mubiana/0000-0002-1474-652X; Canary, Lauren/0000-0002-4297-2102	Canadian Government through Foreign Affairs, Trade and Development Canada (DFATD); AIDS International Training and Research Program Fogarty International Center [D43 TW001042]; American people through the United States Agency for International Development (USAID)	Canadian Government through Foreign Affairs, Trade and Development Canada (DFATD); AIDS International Training and Research Program Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This document was produced under Arise Enhancing HIV Prevention Programs for At Risk Populations, through financial support provided by the Canadian Government through Foreign Affairs, Trade and Development Canada (DFATD) with technical support from PATH (CID.1450-08863-SUB). Arise implements innovative HIV prevention initiatives for vulnerable communities, with a focus on determining costeffectiveness through rigorous evaluations; AIDS International Training and Research Program Fogarty International Center (D43 TW001042); the Emory Center for AIDS Research (P30 AI050409); the National Institutes of Mental Health (MH95503); Emory Rollins School of Public Health Global Field Experience (GEE) Fund; and the International AIDS Vaccine Initiative. This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; [Anonymous], 2010, GLOBAL REPORT UNAIDS; Audet CM, 2016, QUAL HEALTH RES, V26, P1721, DOI 10.1177/1049732315580302; Audet CM, 2016, AIDS BEHAV, V20, P2090, DOI 10.1007/s10461-016-1341-x; Bakari JP, 2000, ANN NY ACAD SCI, V918, P64; Boeras DI, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-18; Brent RJ, 2010, HEALTH ECON, V19, P154, DOI 10.1002/hec.1457; Brou H, 2007, PLOS MED, V4, P1912, DOI 10.1371/journal.pmed.0040342; Byamugisha R, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-43; Byamugisha R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-12; Chomba E, 2008, JAIDS-J ACQ IMM DEF, V47, P108, DOI 10.1097/QAI.0b013e31815b2d67; COLEBUNDERS R, 1993, LANCET, V342, P601, DOI 10.1016/0140-6736(93)91417-K; Conkling M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-10; Crankshaw TL, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18832; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Karamagi CAS, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-284; Kelley AL, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3424-z; Kelley AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019573; Lambdin BH, 2011, HEALTH AFFAIR, V30, P1488, DOI 10.1377/hlthaff.2009.0994; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Matovu JKB, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1720-y; McKenna SL, 1997, AIDS, V11, pS103; Mohlala BKF, 2011, AIDS, V25, P1535, DOI 10.1097/QAD.0b013e328348fb85; Morfaw F, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-5; Musheke M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3396-z; Musheke M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-97; Nannozi V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4043-z; Odong J, 2015, UGANDA COUPLES HIV T; Prevention CfDCa, COUPL HIV COUNS TEST; SAHARA, 2009, DEV HARM MIN STAND G; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; Wall K, 2012, AIDS, V26, P217, DOI 10.1097/QAD.0b013e32834dc593; Wall KM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001171; World Health Organization, 2012, GUID OR PREEXP PROPH; Zambia, 2008, ZAMB NAT PROT GUID I; Zambia, 2007, DEM HLTH SURV; Zambia Central Statistical Office, 2014, ZAMB DEM HLTH SURV	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0185142	10.1371/journal.pone.0185142	http://dx.doi.org/10.1371/journal.pone.0185142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ8YP	29036208	Green Published, Green Submitted, gold			2022-12-26	WOS:000413054800004
J	Stroo, I; Yang, J; Anas, AA; de Boer, JD; van Mierlo, G; Roem, D; Wouters, D; Engel, R; Roelofs, JJTH; van 't Veer, C; van der Poll, T; Zeerleder, S				Stroo, Ingrid; Yang, Jack; Anas, Adam A.; de Boer, J. Daan; van Mierlo, Gerard; Roem, Dorina; Wouters, Diana; Engel, Ruchira; Roelofs, Joris J. T. H.; van 't Veer, Cornelis; van der Poll, Tom; Zeerleder, Sacha			Human plasma-derived C1 esterase inhibitor concentrate has limited effect on house dust mite-induced allergic lung inflammation in mice	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE PNEUMONIA; PULMONARY COMPLEMENT ACTIVATION; C1-ESTERASE INHIBITOR; HEREDITARY ANGIOEDEMA; VASCULAR-PERMEABILITY; REPERFUSION INJURY; ASTHMA; C1-INHIBITOR; BLOOD; MODEL	C1 esterase inhibitor (C1-INH) can inhibit multiple pathways (complement, contact-kinin, coagulation, and fibrinolysis) that are all implicated in the pathophysiology of asthma. We explored the effect of human plasma-derived C1-INH on allergic lung inflammation in a house dust mite (HDM) induced asthma mouse model by daily administration of C1-INH (15 U) during the challenge phase. NaCl and HDM exposed mice had comparable plasma C1-INH levels, while bronchoalveolar lavage fluid (BALF) levels were increased in HDM exposed mice coinciding with slightly reduced activation of complement (C5a). C1-INH treatment reduced Th-2 response and enhanced HDM-specific IgG(1). Influx of eosinophils in BALF or lung, pulmonary damage, mucus production, procoagulant response or plasma leakage in BALF was similar in both groups. In conclusion, C1-INH dampens Th2 responses during HDM induced allergic lung inflammation.	[Stroo, Ingrid; van Mierlo, Gerard; Roem, Dorina; Wouters, Diana; Engel, Ruchira; Zeerleder, Sacha] Sanquin Res, Dept Immunopathol, Amsterdam, Netherlands; [Stroo, Ingrid; Yang, Jack; Anas, Adam A.; de Boer, J. Daan; van 't Veer, Cornelis; van der Poll, Tom] Univ Amsterdam, Ctr Expt & Mol Med, Acad Med Ctr, Amsterdam, Netherlands; [Roelofs, Joris J. T. H.] Univ Amsterdam, Dept Pathol, Acad Med Ctr, Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Div Infect Dis, Acad Med Ctr, Amsterdam, Netherlands; [Zeerleder, Sacha] Univ Amsterdam, Dept Hematol, Acad Med Ctr, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Stroo, I (corresponding author), Sanquin Res, Dept Immunopathol, Amsterdam, Netherlands.; Stroo, I (corresponding author), Univ Amsterdam, Ctr Expt & Mol Med, Acad Med Ctr, Amsterdam, Netherlands.	i.stroo@sanquin.nl		Yang, Jack/0000-0002-5548-7771; Roelofs, Joris/0000-0001-9595-6571; Engel, Ruchira/0000-0002-0630-5767	Viropharma [C1-11-01]; ZonMW (Translational Program) [40-41200-98-9206]; Netherlands Asthma Foundation [3.2.08.009]	Viropharma; ZonMW (Translational Program); Netherlands Asthma Foundation	This research was supported by a unrestricted grant from Viropharma (grant number C1-11-01) to IS, a grant from ZonMW (Translational Program, project 40-41200-98-9206) to JY, and a grant from the Netherlands Asthma Foundation (project 3.2.08.009) to JDdB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM WM, 1991, AM REV RESPIR DIS, V143, P787, DOI 10.1164/ajrccm/143.4_Pt_1.787; Abraham WM, 2006, EUR J PHARMACOL, V533, P215, DOI 10.1016/j.ejphar.2005.12.071; Caliezi C, 2000, PHARMACOL REV, V52, P91; Crowther M, 2014, ALLERGY ASTHMA PROC, V35, P444, DOI 10.2500/aap.2014.35.3799; de Beer FM, 2014, CELL BIOCHEM BIOPHYS, V70, P795, DOI 10.1007/s12013-014-9983-7; de Beer F, 2016, CELL BIOCHEM BIOPHYS, V74, P545, DOI 10.1007/s12013-016-0766-1; de Boer JD, 2013, AM J RESP CELL MOL, V48, P382, DOI 10.1165/rcmb.2012-0331OC; de Boer JD, 2012, BLOOD, V119, P3236, DOI 10.1182/blood-2011-11-391532; De Simoni MG, 2004, AM J PATHOL, V164, P1857, DOI 10.1016/S0002-9440(10)63744-3; DESMET BJGL, 1993, BLOOD, V81, P56, DOI 10.1182/blood.V81.1.56.bloodjournal81156; DiScipio RG, 2007, INT IMMUNOPHARMACOL, V7, P1909, DOI 10.1016/j.intimp.2007.07.006; Gandhi PK, 2012, PHARMACOTHERAPY, V32, P902, DOI 10.1002/j.1875-9114.2012.01126; Gobel K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11626; Hirai T, 2016, CLIN EXP ALLERGY, V46, P992, DOI 10.1111/cea.12722; Jay DC, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0473-1; Khan MA, 2014, RESP MED, V108, P543, DOI 10.1016/j.rmed.2014.01.005; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Krijnen PAJ, 2012, ATHEROSCLEROSIS, V220, P86, DOI 10.1016/j.atherosclerosis.2011.10.021; Krug N, 2001, AM J RESP CRIT CARE, V164, P1841, DOI 10.1164/ajrccm.164.10.2010096; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lee EDH, 2003, IMMUNOL LETT, V89, P155, DOI 10.1016/S0165-2478(03)00130-5; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; Lener M, 1998, EUR J BIOCHEM, V254, P117, DOI 10.1046/j.1432-1327.1998.2540117.x; Liu DX, 2005, BLOOD, V105, P2350, DOI 10.1182/blood-2004-05-1963; Liu DX, 2003, J IMMUNOL, V171, P2594, DOI 10.4049/jimmunol.171.5.2594; Lu FX, 2013, CARDIOVASC PATHOL, V22, P75, DOI 10.1016/j.carpath.2012.05.003; Lu FX, 2010, AM J PHYSIOL-GASTR L, V298, pG878, DOI 10.1152/ajpgi.00400.2009; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; Mejia P, 2012, SHOCK, V38, P220, DOI 10.1097/SHK.0b013e31825bf40e; Muller MCA, 2014, VOX SANG, V107, P71, DOI 10.1111/vox.12128; Post S, 2012, THORAX, V67, P488, DOI 10.1136/thoraxjnl-2011-200606; Post S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091206; Rate A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044941; Schurmann D, 2014, THROMB HAEMOSTASIS, V112, P960, DOI 10.1160/TH13-06-0469; Shagdarsuren E, 2008, CIRCULATION, V117, P70, DOI 10.1161/CIRCULATIONAHA.107.715649; SOLER M, 1990, Pulmonary Pharmacology, V3, P9, DOI 10.1016/0952-0600(90)90003-2; Thomson NC, 2013, RESP MED, V107, P1501, DOI 10.1016/j.rmed.2013.07.017; Thorgersen EB, 2010, INNATE IMMUN-LONDON, V16, P254, DOI 10.1177/1753425909340420; Vasquez-Pinto LMC, 2010, NEUROPEPTIDES, V44, P107, DOI 10.1016/j.npep.2009.11.001; Wang JY, 2013, ALLERGY ASTHMA IMMUN, V5, P68, DOI 10.4168/aair.2013.5.2.68; Zeerleder S, 2011, SEMIN THROMB HEMOST, V37, P362, DOI 10.1055/s-0031-1276585	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186652	10.1371/journal.pone.0186652	http://dx.doi.org/10.1371/journal.pone.0186652			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036225	Green Published, Green Submitted, gold			2022-12-26	WOS:000413054800055
J	Bader, BM; Steder, A; Klein, AB; Frolund, B; Schroeder, OHU; Jensen, AA				Bader, Benjamin M.; Steder, Anne; Klein, Anders Bue; Frolund, Bente; Schroeder, Olaf H. U.; Jensen, Anders A.			Functional characterization of GABAA receptor-mediated modulation of cortical neuron network activity in microelectrode array recordings	PLOS ONE			English	Article							DENTATE GYRUS; EXTRASYNAPTIC RECEPTORS; TONIC INHIBITION; MOLECULAR-BASIS; DELTA-SUBUNIT; IN-VITRO; EXPRESSION; SUBTYPES; RECOMBINANT; SELECTIVITY	The numerous gamma-aminobutyric acid type A receptor (GABA(A)R) subtypes are differentially expressed and mediate distinct functions at neuronal level. In this study we have investigated GABA(A)R-mediated modulation of the spontaneous activity patterns of primary neuronal networks from murine frontal cortex by characterizing the effects induced by a wide selection of pharmacological tools at a plethora of activity parameters in microelectrode array (MEA) recordings. The basic characteristics of the primary cortical neurons used in the recordings were studied in some detail, and the expression levels of various GABA(A)R subunits were investigated by western blotting and RT-qPCR. In the MEA recordings, the pan-GABA(A)R agonist muscimol and the GABABR agonist baclofen were observed to mediate phenotypically distinct changes in cortical network activity. Selective augmentation of a. GABA(A)R signaling by diazepam and of delta-containing GABAAR (delta-GABAAR) signaling by DS1 produced pronounced changes in the majority of the activity parameters, both drugs mediating similar patterns of activity changes as muscimol. The apparent importance of delta GABA(A)R signaling for network activity was largely corroborated by the effects induced by the functionally selective delta-GABA(A)R agonists THIP and Thio-THIP, whereas the delta-GABA(A)R selective potentiator DS2 only mediated modest effects on network activity, even when coapplied with low THIP concentrations. Interestingly, diazepam exhibited dramatically rightshifted concentration-response relationships at many of the activity parameters when coapplied with a trace concentration of DS1 compared to when applied alone. In contrast, the potencies and efficacies displayed by DS1 at the networks were not substantially altered by the concomitant presence of diazepam. In conclusion, the holistic nature of the information extractable from the MEA recordings offers interesting insights into the contributions of various GABA(A)R subtypes/subgroups to cortical network activity and the putative functional interplay between these receptors in these neurons.	[Bader, Benjamin M.; Steder, Anne; Schroeder, Olaf H. U.] NeuroProof GmbH, Friedrich Barnewitz Str 4, Rostock, Germany; [Klein, Anders Bue; Frolund, Bente; Jensen, Anders A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Parken 2, Copenhagen O, Denmark	University of Copenhagen	Jensen, AA (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Parken 2, Copenhagen O, Denmark.	aaj@sund.ku.dk	Frølund, Bente/GQQ-8918-2022; Jensen, Anders/AAJ-3335-2020	Jensen, Anders/0000-0002-7927-5052; Frolund, Bente/0000-0001-5476-6288; Klein, Anders Bue/0000-0002-0236-3089	Novo Nordisk Foundation; NeuroProof GmbH; Novo Nordisk Fonden [NNF11OC1014338] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NeuroProof GmbH; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported financially by the Novo Nordisk Foundation to AAJ. NeuroProof GmbH provided support in the form of salaries for authors BMB, AS, and OHUS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; This study was supported financially by the Novo Nordisk Foundation.	Ahring PK, 2016, PHARMACOL RES, V111, P563, DOI 10.1016/j.phrs.2016.05.014; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Baur R, 2007, J NEUROCHEM, V103, P2556, DOI 10.1111/j.1471-4159.2007.04982.x; Belelli D, 2005, J NEUROSCI, V25, P11513, DOI 10.1523/JNEUROSCI.2679-05.2005; Braat S, 2015, NEURON, V86, P1119, DOI 10.1016/j.neuron.2015.03.042; Brauner-Osborne H, 1999, BRIT J PHARMACOL, V128, P1370, DOI 10.1038/sj.bjp.0702914; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Casula MA, 2001, J NEUROCHEM, V77, P445, DOI 10.1046/j.1471-4159.2001.00289.x; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Chiappalone M, 2007, INT J NEURAL SYST, V17, P87, DOI 10.1142/S0129065707000968; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Comenencia-Ortiz E, 2014, PSYCHOPHARMACOLOGY, V231, P3453, DOI 10.1007/s00213-014-3617-z; Cotterill E, 2016, J BIOMOL SCREEN, V21, P510, DOI 10.1177/1087057116640520; Eaton MM, 2014, MOL PHARMACOL, V86, P647, DOI 10.1124/mol.114.094813; Ebert B, 1997, MOL PHARMACOL, V52, P1150, DOI 10.1124/mol.52.6.1150; Ebert B, 2006, DRUG DISCOV TODAY TH, V3, P547; Enna SJ, 2006, ADV PHARMACOL, V54, P1, DOI 10.1016/S1054-3589(06)54001-3; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; FRITSCHY JM, 1994, J NEUROSCI, V14, P5302; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Gramowski A, 2004, EUR J NEUROSCI, V19, P2815, DOI 10.1111/j.0953-816X.2004.03373.x; Gramowski A, 2006, ALTEX, V23, P410, DOI DOI 10.1289/EHP.0901661; Gramowski A, 2006, EUR J NEUROSCI, V24, P455, DOI 10.1111/j.1460-9568.2006.04892.x; Gramowski-Voss A, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur2015.00158, 10.3389/fneur.2015.00158]; Hammer H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120239; Harris RA, 1997, ALCOHOL CLIN EXP RES, V21, P444; Hashimoto T, 2009, BIOL PSYCHIAT, V65, P1015, DOI 10.1016/j.biopsych.2009.01.004; Herculano-Houzel S, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00035; Herd MB, 2008, J PHYSIOL-LONDON, V586, P989, DOI 10.1113/jphysiol.2007.146746; Hoestgaard-Jensen K, 2014, J NEUROSCI, V34, P16256, DOI 10.1523/JNEUROSCI.1495-14.2014; Hornung JP, 1996, J COMP NEUROL, V367, P413, DOI 10.1002/(SICI)1096-9861(19960408)367:3<413::AID-CNE7>3.0.CO;2-8; Jensen ML, 2013, BRIT J PHARMACOL, V168, P1118, DOI 10.1111/bph.12001; Johnstone AFM, 2010, NEUROTOXICOLOGY, V31, P331, DOI 10.1016/j.neuro.2010.04.001; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Klein AB, 2016, NEUROCHEM INT, V100, P138, DOI 10.1016/j.neuint.2016.09.002; Korpi ER, 2006, PHARMACOL THERAPEUT, V109, P12, DOI 10.1016/j.pharmthera.2005.05.009; Krogsgaard-Larsen P, 2004, BIOCHEM PHARMACOL, V68, P1573, DOI 10.1016/j.bcp.2004.06.040; KROGSGAARDLARSEN P, 1983, J MED CHEM, V26, P895, DOI 10.1021/jm00360a020; KROGSGAARDLARSEN P, 1977, NATURE, V268, P53, DOI 10.1038/268053a0; Lantz SR, 2014, NEUROTOXICOLOGY, V45, P38, DOI 10.1016/j.neuro.2014.09.003; Liu QL, 2004, J APPL PHYSIOL, V96, P1825, DOI 10.1152/japplphysiol.01264.2003; Marowsky A, 2012, J NEUROSCI, V32, P8611, DOI 10.1523/JNEUROSCI.4404-11.2012; McConnell ER, 2012, NEUROTOXICOLOGY, V33, P1048, DOI 10.1016/j.neuro.2012.05.001; Meera P, 2011, J NEUROPHYSIOL, V106, P2057, DOI 10.1152/jn.00450.2011; Milenkovic I, 2013, NEUROSCIENCE, V254, P80, DOI 10.1016/j.neuroscience.2013.09.019; Mody I, 2005, J PHYSIOL-LONDON, V562, P37, DOI 10.1113/jphysiol.2004.077362; Mohler H, 2012, NEUROPHARMACOLOGY, V62, P42, DOI 10.1016/j.neuropharm.2011.08.040; Mortensen M, 2010, J PHYSIOL-LONDON, V588, P1251, DOI 10.1113/jphysiol.2009.182444; Mortensen M, 2006, J PHYSIOL-LONDON, V577, P841, DOI 10.1113/jphysiol.2006.117952; Novellino A, 2011, Front Neuroeng, V4, P4, DOI 10.3389/fneng.2011.00004; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Parenti C, 2013, NEUROPHARMACOLOGY, V71, P70, DOI 10.1016/j.neuropharm.2013.03.008; Patel B, 2014, BRIT J PHARMACOL, V171, P985, DOI 10.1111/bph.12514; Pinard A, 2010, ADV PHARMACOL, V58, P231, DOI 10.1016/S1054-3589(10)58010-4; Rabe H, 2007, NEUROPHARMACOLOGY, V52, P796, DOI 10.1016/j.neuropharm.2006.09.013; Rudolph U, 2014, ANNU REV PHARMACOL, V54, P483, DOI 10.1146/annurev-pharmtox-011613-135947; Sahara S, 2012, J NEUROSCI, V32, P4755, DOI 10.1523/JNEUROSCI.6412-11.2012; Sanna E, 2002, EUR J PHARMACOL, V451, P103, DOI 10.1016/S0014-2999(02)02191-X; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schoch S, 1996, J BIOL CHEM, V271, P3317, DOI 10.1074/jbc.271.6.3317; Shu HJ, 2012, BRIT J PHARMACOL, V165, P2228, DOI 10.1111/j.1476-5381.2011.01690.x; Sieghart W, 2015, ADV PHARMACOL, V72, P53, DOI 10.1016/bs.apha.2014.10.002; Storustovu SI, 2006, J PHARMACOL EXP THER, V316, P1351, DOI 10.1124/jpet.105.092403; van Pelt J, 2005, PROG BRAIN RES, V147, P173, DOI 10.1016/S0079-6123(04)47013-7; Wafford KA, 2009, NEUROPHARMACOLOGY, V56, P182, DOI 10.1016/j.neuropharm.2008.08.004; WAFFORD KA, 1993, MOL PHARMACOL, V43, P240; Wagoner KR, 2010, J BIOL CHEM, V285, P14187, DOI 10.1074/jbc.M110.104257; Whiting PJ, 2003, CURR OPIN DRUG DISC, V6, P648; Wisden W, 2002, NEUROPHARMACOLOGY, V43, P530, DOI 10.1016/S0028-3908(02)00151-X; Wise A, 1999, NEUROPHARMACOLOGY, V38, P1647, DOI 10.1016/S0028-3908(99)00119-7; Wu X, 2013, J BIOL CHEM, V288, P25053, DOI 10.1074/jbc.M113.491464; Yamada J, 2007, CEREB CORTEX, V17, P1782, DOI 10.1093/cercor/bhl087	73	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186147	10.1371/journal.pone.0186147	http://dx.doi.org/10.1371/journal.pone.0186147			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028808	gold, Green Published, Green Submitted			2022-12-26	WOS:000412980300019
J	Asaoka, R; Murata, H; Yanagisawa, M; Fujino, Y; Matsuura, M; Inoue, T; Inoue, K; Yamagami, J				Asaoka, Ryo; Murata, Hiroshi; Yanagisawa, Mieko; Fujino, Yuri; Matsuura, Masato; Inoue, Tatsuya; Inoue, Kenji; Yamagami, Junkichi			The association between photoreceptor layer thickness measured by optical coherence tomography and visual sensitivity in glaucomatous eyes	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NERVE-FIBER LAYER; NORMAL-TENSION GLAUCOMA; INTRAOCULAR-PRESSURE; DIAGNOSTIC-ACCURACY; MACULAR THICKNESS; AXIAL LENGTH; PREVALENCE; POPULATION; DAMAGE	Purpose To assess the thickness of the photoreceptor layer in the macular region in glaucomatous eyes. Method Humphrey 10-2 visual field (VF) testing was carried out and mean threshold (mTH) was calculated in 118 eyes from 118 patients with open angle glaucoma. Macular optical coherence tomography (OCT) measurements (RS 3000, Nidek Co.ltd., Aichi, Japan) were also carried out in all eyes. Thickness measurements were recorded in the outer segment and retinal pigment epithelium (OS+RPE), the nerve fiber layer (NFL), the ganglion cell layer and inner plexiform layer (GCL+IPL), the inner nuclear layer and outer plexiform layer (INL+OPL) and the outer nuclear layer and inner segment (ONL+IS). The relationship between mTH and the thickness of these five different layers was investigated. Additionally, the influence of OS+RPE on mTH was investigated using partial correlation eliminating the effect of other variables of NFL, GCL+IPL, INL+OPL, ONL+IS, age, gender and axial length. Results The thickness of the OS+RPE layer was significantly decreased with the decrease of mTH (coefficient = 0.63 p < 0.001). Partial correlation analysis suggested OS+RPE thickness is significantly (coefficient = 0.31, p < 0.001) related to mTH, independent from NFL, GCL+IPL, INL+OPL, ONL+IS, age, gender and axial length. Conclusions The thickness of the RPE+OS layer appears to be related to visual sensitivity in glaucoma.	[Asaoka, Ryo; Murata, Hiroshi; Yanagisawa, Mieko; Fujino, Yuri; Matsuura, Masato; Inoue, Tatsuya] Univ Tokyo, Dept Ophthalmol, Tokyo, Japan; [Inoue, Kenji] Inouye Eye Hosp, Tokyo, Japan; [Yamagami, Junkichi] JR Tokyo Gen Hosp, Tokyo, Japan	University of Tokyo	Asaoka, R (corresponding author), Univ Tokyo, Dept Ophthalmol, Tokyo, Japan.	rasaoka-tky@umin.ac.jp			Japan Science and Technology Agency (JST)-CREST [JPMJCR1304]; Ministry of Education, Culture, Sports, Science and Technology of Japan [17K11418]	Japan Science and Technology Agency (JST)-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Japan Science and Technology Agency (JST)-CREST JPMJCR1304 and Grant 17K11418 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Araie M, 2014, INVEST OPHTH VIS SCI, V55, P7199, DOI 10.1167/iovs.14-14964; Asaoka R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098525; Bengtsson B, 2000, INVEST OPHTH VIS SCI, V41, P2201; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Bonomi L, 1998, OPHTHALMOLOGY, V105, P209, DOI 10.1016/S0161-6420(98)92665-3; Buhrmann RR, 2000, INVEST OPHTH VIS SCI, V41, P40; Cedrone C, 1997, Ophthalmic Epidemiol, V4, P59; Choi SS, 2008, INVEST OPHTH VIS SCI, V49, P2103, DOI 10.1167/iovs.07-0980; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Dandona L, 2000, OPHTHALMOLOGY, V107, P1702, DOI 10.1016/S0161-6420(00)00275-X; DIELEMANS I, 1994, OPHTHALMOLOGY, V101, P1851; Fan N, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/264803; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Foster PJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1235, DOI 10.1001/archopht.1996.01100140435011; Foster PJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P1105, DOI 10.1001/archopht.118.8.1105; Garas A, 2011, EYE, V25, P57, DOI 10.1038/eye.2010.139; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Honjo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141293; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; James S., 2002, APPL MULTIVARIATE ST; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Kim SK, 2015, ANN RHEUM DIS, V74, P937, DOI 10.1136/annrheumdis-2015-eular.4317; Kimura Y, 2013, AM J OPHTHALMOL, V156, P907, DOI 10.1016/j.ajo.2013.06.029; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Kotowski J, 2012, BRIT J OPHTHALMOL, V96, P1420, DOI 10.1136/bjophthalmol-2011-301021; Leibowitz H M, 1980, Surv Ophthalmol, V24, P335; LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821, DOI 10.1001/archopht.1994.01090180121046; Leung CKS, 2013, OPHTHALMOLOGY, V120, P2485, DOI 10.1016/j.ophtha.2013.07.021; Liu XT, 2015, AM J OPHTHALMOL, V160, P53, DOI 10.1016/j.ajo.2015.03.012; MASON RP, 1989, OPHTHALMOLOGY, V96, P1363; Miraftabi A, 2016, INVEST OPHTH VIS SCI, V57, P4815, DOI 10.1167/iovs.16-19648; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Mori S, 2010, J GLAUCOMA, V19, P528, DOI 10.1097/IJG.0b013e3181ca7acf; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; PANDA S, 1992, INVEST OPHTH VIS SCI, V33, P2532; Quigley HA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1819, DOI 10.1001/archopht.119.12.1819; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Raza AS, 2015, INVEST OPHTH VIS SCI, V56, P5548, DOI 10.1167/iovs.14-16366; RICHARD A. J., 2002, APPL MULTIVARIATE ST; Rotchford AP, 2002, ARCH OPHTHALMOL-CHIC, V120, P471, DOI 10.1001/archopht.120.4.471; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258; Shiba D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104126; SHIOSE Y, 1991, JPN J OPHTHALMOL, V35, P133; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; SOMMER A, 1991, NEW ENGL J MED, V325, P1412, DOI 10.1056/NEJM199111143252004; Takagi ST, 2012, J GLAUCOMA, V21, P318, DOI 10.1097/IJG.0b013e31820d7e9d; Takeyama A, 2014, JPN J OPHTHALMOL, V58, P86, DOI 10.1007/s10384-013-0292-2; Tan O, 2008, OPHTHALMOLOGY, V115, P949, DOI 10.1016/j.ophtha.2007.08.011; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; VAEGAN, 1995, EXP EYE RES, V60, P697, DOI 10.1016/S0014-4835(05)80011-9; Vajaranant TS, 2011, EYE, V25, P612, DOI 10.1038/eye.2011.17; Walji MF, 2013, INT J MED INFORM, V82, P128, DOI 10.1016/j.ijmedinf.2012.05.018; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wensor MD, 1998, OPHTHALMOLOGY, V105, P733, DOI 10.1016/S0161-6420(98)94031-3; Whittaker J., 1990, GRAPHICAL MODELS APP; Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309; Yoshida T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106117; Zeimer R, 1998, OPHTHALMOLOGY, V105, P224, DOI 10.1016/S0161-6420(98)92743-9	63	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0184064	10.1371/journal.pone.0184064	http://dx.doi.org/10.1371/journal.pone.0184064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023460	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100004
J	Chen, H; Shen, JL				Chen, Hao; Shen, Julia			A degradation-based sorting method for lithium-ion battery reuse	PLOS ONE			English	Article							DAMAGE EVALUATION; REGRESSION; DEFECTS; STATE	In a world where millions of people are dependent on batteries to provide them with convenient and portable energy, battery recycling is of the utmost importance. In this paper, we developed a new method to sort 18650 Lithium-ion batteries in large quantities and in real time for harvesting used cells with enough capacity for battery reuse. Internal resistance and capacity tests were conducted as a basis for comparison with a novel degradation-based method based on X-ray radiographic scanning and digital image contrast computation. The test results indicate that the sorting accuracy of the test cells is about 79% and the execution time of our algorithm is at a level of 200 milliseconds, making our method a potential real-time solution for reusing the remaining capacity in good used cells.	[Chen, Hao] Shanghai Univ Engn Sci, Sch Automot Engn, Shanghai, Peoples R China; [Chen, Hao] Univ Michigan, Dept Comp & Informat Sci, Dearborn, MI 48128 USA; [Shen, Julia] Detroit Country Day, Beverly Hills, CA 48025 USA	Shanghai University of Engineering Science; University of Michigan System; University of Michigan	Shen, JL (corresponding author), Detroit Country Day, Beverly Hills, CA 48025 USA.	she3201@dcds.edu	; CHen, Hao/N-6060-2015	Shen, Julia/0000-0001-5411-7413; CHen, Hao/0000-0002-9036-4937	National Science Foundation [IIP-1445355]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation, IIP-1445355. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APTE C, 1994, ACM T INFORM SYST, V12, P233, DOI 10.1145/183422.183423; Bailey RF, 1992, Patent Number, Patent No. [US 5158181 A, 5158181]; Castillo S, 2002, J POWER SOURCES, V112, P247, DOI 10.1016/S0378-7753(02)00361-0; Chen H, 2017, INT J DAMAGE MECH, V26, P192, DOI 10.1177/1056789517693411; Contestabile M, 2001, J POWER SOURCES, V92, P65, DOI 10.1016/S0378-7753(00)00523-1; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dang C, 2002, RES NONDESTRUCT EVAL, V14, P141, DOI 10.1007/s00164-002-0004-7; Hanisch C., 2015, HDB CLEAN ENERGY SYS, V5, P2865; Hedegor EK, 2003, Patent Number, Patent No. [US 6781344 B1, 6781344]; Kenderian S, 2001, RES NONDESTRUCT EVAL, V13, P189, DOI 10.1080/09349840108968186; Kim BH, 2006, J SOUND VIB, V292, P82, DOI 10.1016/j.jsv.2005.07.035; Lain MJ, 2001, J POWER SOURCES, V97-8, P736, DOI 10.1016/S0378-7753(01)00600-0; Lemaitre J, 1996, COURSE DAMAGE MECH; Li M, 2013, Patent Number, Patent No. [US 20130175206 A1, 0175206]; Liu BH, 2016, APPL ENERG, V183, P278, DOI 10.1016/j.apenergy.2016.08.101; Liu DT, 2014, NEURAL COMPUT APPL, V25, P557, DOI 10.1007/s00521-013-1520-x; Michelson A.A., 1995, STUDIES OPTICS; Nan JM, 2005, J POWER SOURCES, V152, P278, DOI 10.1016/j.jpowsour.2005.03.134; PELI E, 1990, J OPT SOC AM A, V7, P2032, DOI 10.1364/JOSAA.7.002032; Pillot C., 2015, P 5 ISR POW SOURC C, P1; Saha B, 2007, IEEE AUTOTESTCON, P646, DOI 10.1109/AUTEST.2007.4374280; Shen J, 2014, ENG COMPUT, V31, P647; Shen J, 2014, INT J DAMAGE MECH, V23, P537, DOI 10.1177/1056789513501913; Shen J, 2009, INT J DAMAGE MECH, V18, P739, DOI 10.1177/1056789509346693; Singal AG, 2013, AM J GASTROENTEROL, V108, P1723, DOI 10.1038/ajg.2013.332; Solutions UR, 2004, BATTERIES INT, V60, P42; Wang P, 2014, Patent Number, Patent No. [CN 103920658 A, 103920658]; Wang RC, 2009, HYDROMETALLURGY, V99, P194, DOI 10.1016/j.hydromet.2009.08.005; Wooh SC, 2001, RES NONDESTRUCT EVAL, V13, P215, DOI [10.1080/09349840108968188, 10.1007/s00164-001-0021-y]; Xu JS, 2016, SCI REP-UK, V6, DOI [10.1038/srep21829, 10.1038/srep27524]; Xu M, 2015, METHOD SYSTEM OBTAIN, Patent No. [US 13/686,052, US9217779 B2]	31	17	17	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185922	10.1371/journal.pone.0185922	http://dx.doi.org/10.1371/journal.pone.0185922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023485	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100039
J	Cross, ES; Hamilton, AFD; Cohen, NR; Grafton, ST				Cross, Emily S.; Hamilton, Antonia F. de C.; Cohen, Nichola Rice; Grafton, Scott T.			Learning to tie the knot: The acquisition of functional object representations by physical and observational experience	PLOS ONE			English	Article							ACTION OBSERVATION NETWORK; POSTERIOR PARIETAL CORTEX; NEURAL REPRESENTATIONS; MIRROR NEURONS; TOOL USE; CONCEPTUAL REPRESENTATIONS; CORTICAL MECHANISMS; GRASPABLE OBJECTS; PATTERN-ANALYSIS; MOTOR SKILL	Here we examined neural substrates for physically and observationally learning to construct novel objects, and characterized brain regions associated with each kind of learning using fMRI. Each participant was assigned a training partner, and for five consecutive days practiced tying one group of knots ("tied" condition) or watched their partner tie different knots ("watched" condition) while a third set of knots remained untrained. Functional MRI was obtained prior to and immediately following the week of training while participants performed a visual knot-matching task. After training, a portion of left superior parietal lobule demonstrated a training by scan session interaction. This means this parietal region responded selectively to knots that participants had physically learned to tie in the post-training scan session but not the pre-training scan session. A conjunction analysis on the post-training scan data showed right intraparietal sulcus and right dorsal premotor cortex to respond when viewing images of knots from the tied and watched conditions compared to knots that were untrained during the post-training scan session. This suggests that these brain areas track both physical and observational learning. Together, the data provide preliminary evidence of engagement of brain regions associated with hand-object interactions when viewing objects associated with physical experience, and with observational experience without concurrent physical practice.	[Cross, Emily S.] Bangor Univ, Wales Inst Cognit Neurosci, Sch Psychol, Bangor, Gwynedd, Wales; [Hamilton, Antonia F. de C.] UCL, Inst Cognit Neurosci, London, England; [Cohen, Nichola Rice] Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA USA; [Grafton, Scott T.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA	Bangor University; University of London; University College London; Brandeis University; University of California System; University of California Santa Barbara	Cross, ES (corresponding author), Bangor Univ, Wales Inst Cognit Neurosci, Sch Psychol, Bangor, Gwynedd, Wales.	e.cross@bangor.ac.uk	Cross, Emily S./B-4565-2009; Hamilton, Antonia/AAC-6648-2019; Hamilton, Antonia/ABC-4196-2021	Cross, Emily S./0000-0002-1671-5698; Hamilton, Antonia/0000-0001-8000-0219; 	NRSA predoctoral fellowship from the National Institute of Neurological Disorders and Stroke [F31-NS056720]; Economic and Social Research Council Future Research Leaders Award [ES/K001892/1]; Marie Curie Career Integration Grant [PCIG-GA-2012-322256]; European Research Council starting grant [ERC-2015-StG-677270]; ESRC [ES/K001892/1] Funding Source: UKRI; Economic and Social Research Council [ES/K001892/1] Funding Source: researchfish	NRSA predoctoral fellowship from the National Institute of Neurological Disorders and Stroke; Economic and Social Research Council Future Research Leaders Award; Marie Curie Career Integration Grant; European Research Council starting grant(European Research Council (ERC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by an NRSA predoctoral fellowship from the National Institute of Neurological Disorders and Stroke (F31-NS056720), an Economic and Social Research Council Future Research Leaders Award (ES/K001892/1), a Marie Curie Career Integration Grant (PCIG-GA-2012-322256), and a European Research Council starting grant (ERC-2015-StG-677270) to ESC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieux M, 2013, EXP BRAIN RES, V229, P125, DOI 10.1007/s00221-013-3598-x; Barrett TM, 2007, DEV PSYCHOL, V43, P352, DOI 10.1037/0012-1649.43.2.352; Bellebaum C, 2013, CORTEX, V49, P1110, DOI 10.1016/j.cortex.2012.03.023; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Binkofski F, 1999, EXP BRAIN RES, V128, P210, DOI 10.1007/s002210050838; Buxbaum LJ, 2001, NEUROCASE, V7, P445, DOI 10.1093/neucas/7.6.445; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Creem-Regehr SH, 2007, J INT NEUROPSYCH SOC, V13, P1009, DOI 10.1017/S1355617707071093; Creem-Regehr SH, 2005, COGNITIVE BRAIN RES, V22, P457, DOI 10.1016/j.cogbrainres.2004.10.006; Cross ES, 2012, NEUROPSYCHOLOGIA, V50, P3207, DOI 10.1016/j.neuropsychologia.2012.09.028; Cross ES, 2009, CEREB CORTEX, V19, P315, DOI 10.1093/cercor/bhn083; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; DERENZI E, 1982, BRAIN, V105, P301, DOI 10.1093/brain/105.2.301; DEUTSCH G, 1988, NEUROPSYCHOLOGIA, V26, P445, DOI 10.1016/0028-3932(88)90097-8; Diedrichsen J, 2005, NEUROIMAGE, V27, P624, DOI 10.1016/j.neuroimage.2005.04.039; Eickhoff SB, 2006, CEREB CORTEX, V16, P254, DOI 10.1093/cercor/bhi105; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Frey SH, 2006, J NEUROSCI, V26, P13194, DOI 10.1523/JNEUROSCI.3914-06.2006; Frey SH, 2007, CORTEX, V43, P368, DOI 10.1016/S0010-9452(08)70462-3; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gardner EP, 2007, J NEUROPHYSIOL, V98, P3708, DOI 10.1152/jn.00609.2007; Gardner EP, 2007, J NEUROPHYSIOL, V97, P387, DOI 10.1152/jn.00558.2006; Gardner EP, 2007, J NEUROPHYSIOL, V97, P1656, DOI 10.1152/jn.01031.2006; Gardner T, 2017, NEUROIMAGE, V156, P174, DOI 10.1016/j.neuroimage.2017.04.060; Gerson SA, 2010, NEOCONSTRUCTIVISM NE; Gerson SA, 2014, INFANT BEHAV DEV, V37, P94, DOI 10.1016/j.infbeh.2013.12.013; Ghio M, 2016, BEHAV BRAIN RES, V308, P143, DOI 10.1016/j.bbr.2016.04.013; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Grol MJ, 2007, J NEUROSCI, V27, P11877, DOI 10.1523/JNEUROSCI.3923-07.2007; Grol MJ, 2006, J NEUROSCI, V26, P117, DOI 10.1523/JNEUROSCI.2786-05.2006; Hodges NJ, 2007, J SPORT SCI, V25, P531, DOI 10.1080/02640410600946860; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Johnson SH, 2000, NEUROREPORT, V11, P729, DOI 10.1097/00001756-200003200-00015; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; Kellenbach ML, 2003, J COGNITIVE NEUROSCI, V15, P30, DOI 10.1162/089892903321107800; Kiefer M, 2007, J COGNITIVE NEUROSCI, V19, P525, DOI 10.1162/jocn.2007.19.3.525; Kiefer M, 2012, CORTEX, V48, P805, DOI 10.1016/j.cortex.2011.04.006; Kirsch LP, 2015, CEREB CORTEX, V25, P4799, DOI 10.1093/cercor/bhv167; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Kroliczak G, 2016, NEUROPSYCHOLOGIA, V93, P501, DOI 10.1016/j.neuropsychologia.2016.03.023; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Mahon BZ, 2007, NEURON, V55, P507, DOI 10.1016/j.neuron.2007.07.011; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; Meltzoff A. N, 2002, THE IMITATIVE MIND D, V6; Meltzoff AN, 2007, ACTA PSYCHOL, V124, P26, DOI 10.1016/j.actpsy.2006.09.005; Muthukumaraswamy SD, 2004, COGNITIVE BRAIN RES, V19, P195, DOI 10.1016/j.cogbrainres.2003.12.001; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oosterhof NN, 2014, BEHAV BRAIN SCI, V37, P213, DOI 10.1017/S0140525X13002434; PASSINGHAM RE, 1985, BEHAV BRAIN RES, V18, P175, DOI 10.1016/0166-4328(85)90073-7; Peissig JJ, 2007, CEREB CORTEX, V17, P1323, DOI 10.1093/cercor/bhl043; Penhune VB, 2012, BEHAV BRAIN RES, V226, P579, DOI 10.1016/j.bbr.2011.09.044; Ramsey R, 2010, NEUROIMAGE, V50, P1142, DOI 10.1016/j.neuroimage.2009.12.124; Richetin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129601; Rieger M, 2014, PSYCHOL RES-PSYCH FO, V78, P10, DOI 10.1007/s00426-013-0481-0; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1999, ARCH ITAL BIOL, V137, P85; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rohbanfard H, 2011, EXP BRAIN RES, V215, P183, DOI 10.1007/s00221-011-2882-x; Rothi L. J. G., 1997, APRAXIA NEUROPSYCHOL; Ruther NN, 2014, BEHAV BRAIN RES, V261, P328, DOI 10.1016/j.bbr.2013.12.033; Sakata H, 2005, NEUROPSYCHOLOGIA, V43, P151, DOI 10.1016/j.neuropsychologia.2004.11.003; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Steele CJ, 2010, J NEUROSCI, V30, P8332, DOI 10.1523/JNEUROSCI.5569-09.2010; Tracy J, 2003, CEREB CORTEX, V13, P904, DOI 10.1093/cercor/13.9.904; Tunik E, 2007, NEUROIMAGE, V36, pT77, DOI 10.1016/j.neuroimage.2007.03.026; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vingerhoets G, 2008, NEUROIMAGE, V40, P1380, DOI 10.1016/j.neuroimage.2007.12.058; Vinter A, 2002, MEM COGNITION, V30, P256, DOI 10.3758/BF03195286; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Watson CE, 2015, CORTEX, V65, P65, DOI 10.1016/j.cortex.2015.01.007; Weisberg J, 2006, CEREB CORTEX; Weisberg J, 2007, CEREB CORTEX, V17, P513, DOI 10.1093/cercor/bhj176; Wiestler T, 2013, ELIFE, V2, DOI 10.7554/eLife.00801; Wilcox RR, 2012, MODERN STAT SOCIAL B; Witt JK, 2008, J EXP PSYCHOL HUMAN, V34, P1479, DOI 10.1037/a0010781; Yee E, 2013, PSYCHOL SCI, V24, P909, DOI 10.1177/0956797612464658	87	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185044	10.1371/journal.pone.0185044	http://dx.doi.org/10.1371/journal.pone.0185044			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ6DU	29023463	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000412845100013
J	Cubuk, C; Markowsky, H; Herwig, A				Cubuk, Ceyda; Markowsky, Hanna; Herwig, Annika			Hypothalamic control systems show differential gene expression during spontaneous daily torpor and fasting-induced torpor in the Djungarian hamster (Phodopus sungorus)	PLOS ONE			English	Article							THYROID-HORMONE; BODY-WEIGHT; SUPRACHIASMATIC NUCLEUS; SIBERIAN HAMSTER; CIRCADIAN CLOCK; NEUROPEPTIDE-Y; PHOTOPERIOD; HYPOTHERMIA; HIBERNATION; ACTIVATION	Djungarian hamsters are able to use spontaneous daily torpor (SDT) during the winter season as well as fasting-induced torpor (FIT) at any time of the year to cope with energetically challenging environmental conditions. Torpor is a state of severely reduced metabolism with a pronounced decrease in body temperature, which enables animals to decrease their individual energy requirements. Despite sharing common characteristics, such as reduced body mass before first torpor expression and depressed metabolism and body temperature during the torpid state, FIT and SDT differ in several physiological properties including torpor bout duration, minimal body temperature, fuel utilization and circadian organization. It remains unclear, whether SDT and FIT reflect the same phenomenon or two different physiological states. The hypothalamus has been suggested to play a key role in regulating energy balance and torpor. To uncover differences in molecular control mechanisms of torpor expression, we set out to investigate hypothalamic gene expression profiles of genes related to orexigenic (Agrp/Npy), circadian clock (Bmal1/Per1) and thyroid hormone (Dio2/Mct8) systems of animals undergoing SDT and FIT during different torpor stages. Orexigenic genes were mainly regulated during FIT and remained largely unaffected by SDT. Expression patterns of clock genes showed disturbed circadian clock rhythmicity in animals undergoing FIT, but not in animals undergoing SDT. During both, SDT and FIT, decreased Dio2 expression was detected, indicating reduced hypothalamic T3 availability in both types of torpor. Taken together, our results provide evidence that SDT and FIT also differ in certain central control mechanisms and support the observation that animals undergoing SDT are in energetical balance, whereas animals undergoing FIT display a negative energy balance. This should be carefully taken into account when interpreting data in torpor research, especially from animal models of fasting-induced hypometabolism such as mice.	[Cubuk, Ceyda; Markowsky, Hanna] Univ Hamburg, Zool Inst, Hamburg, Germany; [Herwig, Annika] Univ Ulm, Inst Neurobiol, Ulm, Germany	University of Hamburg; Ulm University	Cubuk, C (corresponding author), Univ Hamburg, Zool Inst, Hamburg, Germany.	ceyda.cubuk@uni-hamburg.de			Deutsche Forschungsgemeinschaft [HE6383]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft;,www.dfg.de; HE6383 to Annika Herwig. All authors and work were funded by this grant.	Arendt T, 2003, J NEUROSCI, V23, P6972, DOI 10.1523/JNEUROSCI.23-18-06972.2003; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Bank JHH, 2017, J NEUROENDOCRINOL, V29, DOI 10.1111/jne.12487; Bank JHH, 2017, J COMP PHYSIOL B, V187, P857, DOI 10.1007/s00360-017-1086-5; Bank JHH, 2015, HORM BEHAV, V75, P120, DOI 10.1016/j.yhbeh.2015.09.006; Barrett P, 2007, ENDOCRINOLOGY, V148, P3608, DOI 10.1210/en.2007-0316; Bi S, 2003, AM J PHYSIOL-REG I, V285, pR1030, DOI 10.1152/ajpregu.00734.2002; Bianco AC, 2005, BIOSCIENCE REP, V25, P191, DOI 10.1007/s10540-005-2885-6; Brown JCL, 2010, BBA-BIOENERGETICS, V1797, P476, DOI 10.1016/j.bbabio.2010.01.009; Cakir I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008322; Carey HV, 2003, J COMP PHYSIOL B, V173, P269, DOI 10.1007/s00360-003-0330-3; Cubuk C, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00122; DARK J, 1994, AM J PHYSIOL, V267, pR496, DOI 10.1152/ajpregu.1994.267.2.R496; Diedrich V, 2015, J COMP PHYSIOL B, V185, P355, DOI 10.1007/s00360-014-0882-4; Diedrich Victoria, 2012, P231; Ellis C, 2008, AM J PHYSIOL-REG I, V294, pR1148, DOI 10.1152/ajpregu.00825.2007; Figala J, 1973, JAHRESPERIODIK BEIM; Fleck CC, 2005, AM J PHYSIOL-REG I, V289, pR586, DOI 10.1152/ajpregu.00100.2005; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; GEISER F, 1991, J COMP PHYSIOL B, V161, P590, DOI 10.1007/BF00260749; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; HELDMAIER G, 1992, J COMP PHYSIOL B, V162, P696, DOI 10.1007/BF00301619; Herwig A, 2006, CHRONOBIOL INT, V23, P269, DOI 10.1080/07420520500522424; Herwig A, 2007, EUR J NEUROSCI, V26, P2739, DOI 10.1111/j.1460-9568.2007.05927.x; Herwig A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062003; Herwig A, 2009, AM J PHYSIOL-REG I, V296, pR1307, DOI 10.1152/ajpregu.90755.2008; Herwig A, 2008, OBESITY FACTS, V1, P71, DOI 10.1159/000123428; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; ILLNEROVA H, 1984, NEUROENDOCRINOLOGY, V38, P226, DOI 10.1159/000123895; Jastroch M, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12437; KIRSCH R, 1991, J COMP PHYSIOL A, V168, P121, DOI 10.1007/BF00217110; Kohrle J, 1999, MOL CELL ENDOCRINOL, V151, P103, DOI 10.1016/S0303-7207(99)00040-4; Melvin RG, 2009, TRENDS ENDOCRIN MET, V20, P490, DOI 10.1016/j.tem.2009.09.005; Murphy M, 2012, ENDOCRINOLOGY, V153, P101, DOI 10.1210/en.2011-1249; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Paul MJ, 2005, BRAIN RES, V1055, P83, DOI 10.1016/j.brainres.2005.06.090; Paul MJ, 2004, J BIOL RHYTHM, V19, P226, DOI 10.1177/0748730404264337; Pelz KM, 2008, AM J PHYSIOL-REG I, V294, pR255, DOI 10.1152/ajpregu.00387.2007; Pelz KM, 2007, AM J PHYSIOL-REG I, V292, pR2299, DOI 10.1152/ajpregu.00790.2006; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; RUBY NF, 1992, AM J PHYSIOL, V263, pR353, DOI 10.1152/ajpregu.1992.263.2.R353; RUF T, 1991, J COMP PHYSIOL B, V160, P609, DOI 10.1007/BF00571257; RUF T, 1992, PHYSIOL ZOOL, V65, P994, DOI 10.1086/physzool.65.5.30158554; Ruf T, 2015, BIOL REV, V90, P891, DOI 10.1111/brv.12137; Scherbarth F, 2010, J COMP PHYSIOL B, V180, P935, DOI 10.1007/s00360-010-0498-2; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; STEINLECHNER S, 1982, INT J BIOMETEOROL, V26, P329, DOI 10.1007/BF02219503; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; THOMAS EM, 1993, AM J PHYSIOL, V265, pR951, DOI 10.1152/ajpregu.1993.265.4.R951; Visser TJ, 2000, ENDOTEXT; VITALE PM, 1985, J ENDOCRINOL, V106, P367, DOI 10.1677/joe.0.1060367; WEBB GP, 1982, COMP BIOCHEM PHYS A, V72, P211, DOI 10.1016/0300-9629(82)90035-4; Wirth EK, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00098	57	13	13	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186299	10.1371/journal.pone.0186299	http://dx.doi.org/10.1371/journal.pone.0186299			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023516	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100103
J	Hassan, AO; Amen, O; Sayedahmed, EE; Vemula, SV; Amoah, S; York, I; Gangappa, S; Sambhara, S; Mittal, SK				Hassan, Ahmed O.; Amen, Omar; Sayedahmed, Ekramy E.; Vemula, Sai V.; Amoah, Samuel; York, Ian; Gangappa, Shivaprakash; Sambhara, Suryaprakash; Mittal, Suresh K.			Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses	PLOS ONE			English	Article							T-CELL RESPONSES; A VIRUS; HUMAN INFECTION; MF59-ADJUVANTED INFLUENZA; AIRBORNE TRANSMISSION; CONJUGATE VACCINES; IMMUNE-RESPONSES; MAJOR TARGET; MICE; IMMUNOGENICITY	The emergence of H5, H7, and H9 avian influenza virus subtypes in humans reveals their pandemic potential. Although human-to-human transmission has been limited, the genetic reassortment of the avian and human/porcine influenza viruses or mutations in some of the genes resulting in virus replication in the upper respiratory tract of humans could generate novel pandemic influenza viruses. Current vaccines do not provide cross protection against antigenically distinct strains of the H5, H7, and H9 influenza viruses. Therefore, newer vaccine approaches are needed to overcome these potential threats. We developed an egg-independent, adenovirus vector-based, multi-epitope (ME) vaccine approach using the relatively conserved immunogenic domains of the H5N1 influenza virus [M2 ectodomain (M2e), hemagglutinin (HA) fusion domain (HFD), T-cell epitope of nucleoprotein (TNP). and HA alpha-helix domain (H alpha D)]. Our ME vaccine induced humoral and cell-mediated immune responses and caused a significant reduction in the viral loads in the lungs of vaccinated mice that were challenged with antigenically distinct H5, H7, or H9 avian influenza viruses. These results suggest that our ME vaccine approach provided broad protection against the avian influenza viruses. Further improvement of this vaccine will lead to a pre-pandemic vaccine that may lower morbidity, hinder transmission, and prevent mortality in a pandemic situation before a strain-matched vaccine becomes available.	[Hassan, Ahmed O.; Amen, Omar; Sayedahmed, Ekramy E.; Vemula, Sai V.; Mittal, Suresh K.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Hassan, Ahmed O.; Amen, Omar; Sayedahmed, Ekramy E.; Vemula, Sai V.; Mittal, Suresh K.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA; [Amen, Omar] Assiut Univ, Poultry Dis Dept, Fac Vet Med, Assiut, Egypt; [Amoah, Samuel; York, Ian; Gangappa, Shivaprakash; Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Egyptian Knowledge Bank (EKB); Assiut University; Centers for Disease Control & Prevention - USA	Mittal, SK (corresponding author), Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.; Mittal, SK (corresponding author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.; Sambhara, S (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	ssambhara@cdc.gov; mittal@purdue.edu	Sayedahmed, Ekramy/ABE-4350-2020; York, Ian/X-9351-2019; Hassan, Ahmed/AAG-3491-2019; Sambhara, Suryaprakash/AAC-4428-2021; Sayedahmed, Ekramy/GYD-4387-2022	Sayedahmed, Ekramy/0000-0002-4294-6422; York, Ian/0000-0002-3478-3344; 	Public Health Service grant from the National Institute of Allergy and Infectious Diseases [AI059374]; Hatch funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059374] Funding Source: NIH RePORTER	Public Health Service grant from the National Institute of Allergy and Infectious Diseases; Hatch funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Public Health Service grant AI059374 from the National Institute of Allergy and Infectious Diseases, and the Hatch funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Public Health Service grant AI059374 from the National Institute of Allergy and Infectious Diseases, and the Hatch funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Jane Kovach, Donna Schrader, GuangJun Zhang, and Sara Penka for their assistance in preparing the manuscript.	Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; ATASSI MZ, 1983, P NATL ACAD SCI-BIOL, V80, P840, DOI 10.1073/pnas.80.3.840; Atmar RL, 2006, CLIN INFECT DIS, V43, P1135, DOI 10.1086/508174; Atmar RL, 2011, VACCINE, V29, P8066, DOI 10.1016/j.vaccine.2011.08.044; Bangari DS, 2006, VACCINE, V24, P849, DOI 10.1016/j.vaccine.2005.08.101; Baz M, 2013, VIRUS RES, V178, P78, DOI 10.1016/j.virusres.2013.05.006; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Cao WP, 2016, VACCINE, V34, P744, DOI 10.1016/j.vaccine.2015.12.062; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; Crowe SR, 2003, J EXP MED, V198, P399, DOI 10.1084/jem.20022151; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; Deliyannis G, 2002, J VIROL, V76, P4212, DOI 10.1128/JVI.76.9.4212-4221.2002; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; FAO, 2017, H7N9 FAO; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fu TM, 2009, VACCINE, V27, P1440, DOI 10.1016/j.vaccine.2008.12.034; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Grant E, 2013, IMMUNOL CELL BIOL, V91, P184, DOI 10.1038/icb.2012.78; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Gurwith M, 2013, LANCET INFECT DIS, V13, P238, DOI 10.1016/S1473-3099(12)70345-6; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoelscher MA, 2007, CLIN PHARMACOL THER, V82, P665, DOI 10.1038/sj.clpt.6100418; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Hoelscher MA, 2008, J INFECT DIS, V197, P1185, DOI 10.1086/529522; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Ionescu RM, 2006, J PHARM SCI-US, V95, P70, DOI 10.1002/jps.20493; Kaminski DA, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00076; Katz JM, 2009, POULTRY SCI, V88, P872, DOI 10.3382/ps.2008-00465; Krammer F, 2012, J VIROL, V86, P10302, DOI 10.1128/JVI.01336-12; Lee JM, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/782041, 10.1155/2013/758731]; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; MITTAL SK, 1995, VIROLOGY, V213, P131, DOI 10.1006/viro.1995.1553; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Ng P, 1999, HUM GENE THER, V10, P2667, DOI 10.1089/10430349950016708; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Noblitt LW, 2004, CANCER GENE THER, V11, P757, DOI 10.1038/sj.cgt.7700761; Pandey A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033428; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; REED L. J., 1938, AMER JOUR HYG, V27, P493; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; Sharma A, 2010, GENE THER, V17, P634, DOI 10.1038/gt.2010.1; Stanekova Z, 2011, ACTA VIROL, V55, P61, DOI 10.4149/av_2011_01_61; Stanekova Z, 2012, INFLUENZA OTHER RESP, V6, P389, DOI 10.1111/j.1750-2659.2011.00328.x; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Stephenson I, 2003, VACCINE, V21, P1687, DOI 10.1016/S0264-410X(02)00632-1; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; Tao P, 2009, ANTIVIR RES, V81, P253, DOI 10.1016/j.antiviral.2008.12.009; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; TOWNSEND ARM, 1984, VIROLOGY, V133, P456, DOI 10.1016/0042-6822(84)90413-6; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Van Kampen KR, 2005, VACCINE, V23, P1029, DOI 10.1016/j.vaccine.2004.07.043; van Olphen AL, 2002, J VIROL, V76, P5882, DOI 10.1128/JVI.76.12.5882-5892.2002; Vemula SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062496; Vemula SV, 2010, EXPERT OPIN BIOL TH, V10, P1469, DOI 10.1517/14712598.2010.519332; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wesley RD, 2004, VACCINE, V22, P3427, DOI 10.1016/j.vaccine.2004.02.040; WHO, 2017, CUM NUMB CONF HUM CA; WHO, 2017, AV OTH ZOON INFL; Xu R, 2013, SCIENCE, V342, P1230, DOI 10.1126/science.1243761; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	73	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186244	10.1371/journal.pone.0186244	http://dx.doi.org/10.1371/journal.pone.0186244			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023601	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100090
J	Luhung, I; Wu, Y; Xu, SY; Yamamoto, N; Chang, VWC; Nazaroff, WW				Luhung, Irvan; Wu, Yan; Xu, Siyu; Yamamoto, Naomichi; Chang, Victor Wei-Chung; Nazaroff, William W.			DNA accumulation on ventilation system filters in university buildings in Singapore	PLOS ONE			English	Article							AIRBORNE FUNGI; BACTERIAL COMMUNITIES; RIBOSOMAL-RNA; INDOOR; EMISSIONS; TOOL; PCR	Introduction Biological particles deposit on air handling system filters as they process air. This study reports and interprets abundance and diversity information regarding biomass accumulation on ordinarily used filters acquired from several locations in a university environment. Methods DNA-based analysis was applied both to quantify (via DNA fluorometry and qPCR) and to characterize (via high-throughput sequencing) the microbial material on filters, which mainly processed recirculated indoor air. Results were interpreted in relation to building occupancy and ventilation system operational parameters. Results Based on accumulated biomass, average DNA concentrations per AHU filter surface area across nine indoor locations after twelve weeks of filter use were in the respective ranges 1.1 to 41 ng per cm(2) for total DNA, 0.02 to 3.3 ng per cm(2) for bacterial DNA and 0.2 to 2.0 ng DNA per cm(2) for fungal DNA. The most abundant genera detected on the AHU filter samples were Clostridium, Streptophyta, Bacillus, Acinetobacter and Ktedonobacter for bacteria and Aspergillus, Cladosporium, Nigrospora, Rigidoporus and Lentinus for fungi. Conditional indoor airborne DNA concentrations (median (range)) were estimated to be 13 (2.6-107) pg/m(3) for total DNA, 0.4 (0.05-8.4) pg/m(3) for bacterial DNA and 2.3 (1.0-5.1) pg/m(3) for fungal DNA. Conclusion Conditional airborne concentrations and the relative abundances of selected groups of genera correlate well with occupancy level. Bacterial DNA was found to be more responsive than fungal DNA to differences in occupancy level and indoor environmental conditions.	[Luhung, Irvan; Wu, Yan; Chang, Victor Wei-Chung] Berkeley Educ Alliance Res Singapore, Singapore, Singapore; [Luhung, Irvan; Wu, Yan; Chang, Victor Wei-Chung] Nanyang Technol Univ, Civil & Environm Engn, Singapore, Singapore; [Wu, Yan] Shandong Univ, Sch Environm Sci & Engn, Jinan, Shandong, Peoples R China; [Xu, Siyu; Yamamoto, Naomichi] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Nazaroff, William W.] Univ Calif Berkeley, Civil & Environm Engn, Berkeley, CA 94720 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Shandong University; Seoul National University (SNU); University of California System; University of California Berkeley	Chang, VWC (corresponding author), Berkeley Educ Alliance Res Singapore, Singapore, Singapore.; Chang, VWC (corresponding author), Nanyang Technol Univ, Civil & Environm Engn, Singapore, Singapore.	wcchang@ntu.edu.sg	Nazaroff, William W/C-4106-2008; Nazaroff, William/AAJ-7352-2021; Yamamoto, Naomichi/D-4099-2014; CHANG, Victor Wei-Chung/A-3796-2011	Nazaroff, William W/0000-0001-5645-3357; Nazaroff, William/0000-0001-5645-3357; Yamamoto, Naomichi/0000-0002-5969-5500; CHANG, Victor Wei-Chung/0000-0003-4683-1267	Republic of Singapore's National Research Foundation	Republic of Singapore's National Research Foundation	This research is funded by the Republic of Singapore's National Research Foundation through a grant to the Berkeley Education Alliance for Research in Singapore (BEARS) for the Singapore Berkeley Building Efficiency and Sustainability in the Tropics (SinBerBEST) program. BEARS has been established by the University of California, Berkeley, as a center for intellectual excellence in research and education in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bhangar S, 2014, INDOOR AIR, V24, P604, DOI 10.1111/ina.12111; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P2519, DOI 10.1128/AEM.03870-12; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Correa-Galeote D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01016; Crook Brian, 2010, Fungal Biology Reviews, V24, P106, DOI 10.1016/j.fbr.2010.05.001; Dannemiller KC, 2014, J BASIC MICROB, V54, P315, DOI 10.1002/jobm.201200507; Deng WJ, 2016, ATMOS ENVIRON, V128, P268, DOI 10.1016/j.atmosenv.2016.01.017; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Haaland D, 2017, INDOOR AIR, V27, P364, DOI 10.1111/ina.12319; Herrera ML, 2009, J CLIN MICROBIOL, V47, P1325, DOI 10.1128/JCM.02073-08; Hoisington A, 2016, INDOOR AIR, V26, P857, DOI 10.1111/ina.12273; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Hospodsky D, 2010, APPL ENVIRON MICROB, V76, P7004, DOI 10.1128/AEM.01240-10; Kembel SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087093; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Liu CM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-255; Liu ZJ, 2015, ENERG BUILDINGS, V103, P166, DOI 10.1016/j.enbuild.2015.06.056; Luhung I, 2016, IND C 2016 GENT BELG; Luhung I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141158; Marupakula S, 2016, ENVIRON MICROBIOL, V18, P1470, DOI 10.1111/1462-2920.13102; Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047; Nilsson RH, 2009, SOURCE CODE BIOL MED, V4, DOI 10.1186/1751-0473-4-1; Noris F, 2011, ATMOS ENVIRON, V45, P338, DOI 10.1016/j.atmosenv.2010.10.017; O'Connor GT, 2004, J ALLERGY CLIN IMMUN, V114, P599, DOI 10.1016/j.jaci.2004.05.064; Pigeot-Remy S, 2014, APPL CATAL B-ENVIRON, V144, P654, DOI 10.1016/j.apcatb.2013.07.036; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; Sautour M, 2009, SCI TOTAL ENVIRON, V407, P3766, DOI 10.1016/j.scitotenv.2009.02.024; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xu ZQ, 2011, AEROSOL SCI TECH, V45, P1337, DOI 10.1080/02786826.2011.593591; Yamamoto N, 2015, ENVIRON SCI TECHNOL, V49, P5098, DOI 10.1021/es506165z; Yamamoto N, 2011, J AEROSOL SCI, V42, P499, DOI 10.1016/j.jaerosci.2011.05.004	37	3	4	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186295	10.1371/journal.pone.0186295	http://dx.doi.org/10.1371/journal.pone.0186295			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023520	Green Published, gold			2022-12-26	WOS:000412845100101
J	Oziel, M; Korenstein, R; Rubinsky, B				Oziel, Moshe; Korenstein, Rafi; Rubinsky, Boris			Radar based technology for non-contact monitoring of accumulation of blood in the head: A numerical study	PLOS ONE			English	Article							GROUND-PENETRATING RADAR; INTRACEREBRAL HEMORRHAGE; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; HEMATOMA GROWTH; ACUTE STROKE; BRAIN; ANTENNA; CT; REFLECTOR	Background This theoretical study examines the use of radar to continuously monitor "accumulation of blood in the head" (ACBH) non-invasively and from a distance, after the location of a hematoma or hemorrhage in the brain was initially identified with conventional medical imaging. Current clinical practice is to monitor ABCH with multiple, subsequent, conventional medical imaging. The radar technology introduced in this study could provide a lower cost and safe alternative to multiple conventional medical imaging monitoring for ACBH. Materials and methods The goal of this study is to evaluate the feasibility of using radar to monitor changes in blood volume in the brain through a numerical simulation of ACBH monitoring from remote, with a directional spiral slot antennae, in 3-D models of the brain. The focus of this study is on evaluating the effect of frequencies on the antennae reading. To that end we performed the calculations for frequencies of 100 MHz, 500 MHz and 1 GHz. Results and discussion The analysis shows that the ACBH can be monitored with radar and the monitoring resolution improves with an increase in frequency, in the range studied. However, it also appears that when typical clinical dimensions of hematoma and hemorrhage are used, the variable ratio of blood volume radius and radar wavelength can bring the measurements into the Mie and Rayleigh regions of the radar cross section. In these regions there is an oscillatory change in signal with blood volume size. For some frequencies there is an increase in signal with an increase in volume while in others there is a decrease. Conclusions While radar can be used to monitor ACBH non-invasively and from a distance, the observed Mie region dependent oscillatory relation between blood volume size and wavelength requires further investigation. Classifiers, multifrequency algorithms or ultra-wide band radar are possible solutions that should be explored in the future.	[Oziel, Moshe; Korenstein, Rafi] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, Tel Aviv, Israel; [Rubinsky, Boris] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	Tel Aviv University; Sackler Faculty of Medicine; University of California System; University of California Berkeley	Korenstein, R (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, Tel Aviv, Israel.	korens@post.tau.ac.il		Oziel, Moshe/0000-0003-1242-1630				Aardal O., 2010, 201000958 FFI; Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Blumrosen Gaddi, 2010, 2010 International Conference on Body Sensor Networks (BSN), P187, DOI 10.1109/BSN.2010.28; Blumrosen G, 2012, IEEE T BIO-MED ENG, V59, P674, DOI 10.1109/TBME.2011.2177977; Bowick C., 2008, RF CIRCUIT DESIGN, V2nd; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Chethan P., 2017, NEUROCRIT CARE; DAVIS JL, 1989, GEOPHYS PROSPECT, V37, P531, DOI 10.1111/j.1365-2478.1989.tb02221.x; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Donahue J, 2015, J NEURORADIOLOGY, V42, P21, DOI 10.1016/j.neurad.2014.11.003; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gao YM, 2017, BMC MED IMAGING, V17, DOI 10.1186/s12880-017-0199-3; Gonzales CA, 2005, P ANN INT IEEE EMBS, P3518, DOI 10.1109/IEMBS.2005.1617238; Gonzalez CA, 2006, PHYSIOL MEAS, V27, P539, DOI 10.1088/0967-3334/27/6/007; Gonzalez CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063223; Haddad W, Patent #, Patent No. [6,233,479, 6]; Hasgall P.A., 2022, ITIS DATABASE THERMA, DOI [10.13099/VIP21000-04-0, DOI 10.13099/VIP21000-04-0]; Hill EP, 2017, J TRAUMA ACUTE CARE, V82, P896, DOI 10.1097/TA.0000000000001406; Huisman TAGM, 2005, EUR RADIOL, V15, P434, DOI 10.1007/s00330-004-2615-7; Huisman TAGM, 2010, CHILD NERV SYST, V26, P1275, DOI 10.1007/s00381-010-1203-1; JOHNSON CC, 1972, PR INST ELECTR ELECT, V60, P692, DOI 10.1109/PROC.1972.8728; Joi HM, 2009, GROUND PENETRATING R; KOBAYASHI S, 1983, SURG NEUROL, V20, P25, DOI 10.1016/0090-3019(83)90101-5; Lai WWL, 2017, CONSTR BUILD MATER, V151, P840, DOI 10.1016/j.conbuildmat.2017.06.148; Li Q, 2015, STROKE, V46, P2119, DOI 10.1161/STROKEAHA.115.009185; Lim- Hing K, 2017, FRONT NEUROL, P8; Mahafz R., 2000, RADAR SYSTEMS ANAL D; McEwan T, 1996, United States Patent, Patent No. [5,573,012, 5]; Mobashsher AT, 2016, IEEE T ANTENN PROPAG, V64, P3245, DOI 10.1109/TAP.2016.2560909; Mobashsher AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152351; Mobashsher AT, 2016, IEEE ANTENN WIREL PR, V15, P1618, DOI 10.1109/LAWP.2016.2519527; Mobashsher AT, 2014, IEEE T MICROW THEORY, V62, P1826, DOI 10.1109/TMTT.2014.2342669; Mobashsher AT, 2016, SCI REPORTS, P6; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Moskalenko YE, 1958, BIOPHYSICS-USSR, V3, P619; Nair SM, 1990, THESIS; NAKANO H, 1986, IEEE T ANTENN PROPAG, V34, P791, DOI 10.1109/TAP.1986.1143893; Nakano H, 2009, IEEE T ANTENN PROPAG, V57, P1309, DOI 10.1109/TAP.2009.2016697; Oziel M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21667; Parisi MT, 2017, SEMIN NUCL MED, V47, P258, DOI 10.1053/j.semnuclmed.2017.01.002; Paulson CN, 2005, P SPIE INT SOC OPT E; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Rani G.R., 2013, INT J ELECT COMMUNIC, V6, P119; Rojas R, 2008, PHYSIOL MEAS, V29, pS255, DOI 10.1088/0967-3334/29/6/S22; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Staderini EM, 2002, IEEE AERO EL SYS MAG, V17, P13, DOI 10.1109/62.978359; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Torrealba-Melendez R, 2014, INT CONF ELECTR COMM, P189, DOI 10.1109/CONIELECOMP.2014.6808589; Turkel E, 1998, APPL NUMER MATH, V27, P533, DOI 10.1016/S0168-9274(98)00026-9; Ucar H.., 2013, J NAVAL SCI ENG, V9, P72; Wintermark M, 2013, J AM COLL RADIOL, V10, P828, DOI [10.1016/j.jacr.2013.06.019, 10.3174/ajnr.A3690]; Wu TY, 2017, STROKE, V48, P873, DOI 10.1161/STROKEAHA.116.014416	52	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186381	10.1371/journal.pone.0186381	http://dx.doi.org/10.1371/journal.pone.0186381			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023544	gold, Green Published, Green Submitted			2022-12-26	WOS:000412845100120
J	Liu, D; Chiappe, LM; Serrano, F; Habib, M; Zhang, YG; Meng, QJ				Liu, Di; Chiappe, Luis M.; Serrano, Francisco; Habib, Michael; Zhang, Yuguang; Meng, Qinjing			Flight aerodynamics in enantiornithines: Information from a new Chinese Early Cretaceous bird	PLOS ONE			English	Article							EARLY EVOLUTION; WINGTIP SHAPE; PARAMETERS; RADAR	We describe an exquisitely preserved new avian fossil (BMNHC-PH-919) from the Lower Cretaceous Yixian Formation of eastern Inner Mongolia, China. Although morphologically similar to Cathayornithidae and other small-sized enantiornithines from China's Jehol Biota, many morphological features indicate that it represents a new species, here named Junornis houi. The new fossil displays most of its plumage including a pair of elongated, rachis-dominated tail feathers similarly present in a variety of other enantiornithines. BMNHC-PH-919 represents the first record of a Jehol enantiornithine from Inner Mongolia, thus extending the known distribution of these birds into the eastern portion of this region. Furthermore, its well-preserved skeleton and wing outline provide insight into the aerodynamic performance of enantiornithines, suggesting that these birds had evolved bounding flight-a flight mode common to passeriforms and other small living birds-as early as 125 million years ago.	[Liu, Di] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Di; Zhang, Yuguang; Meng, Qinjing] Beijing Museum Nat Hist, Beijing, Peoples R China; [Chiappe, Luis M.; Serrano, Francisco; Habib, Michael] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA 90007 USA; [Serrano, Francisco] Univ Malaga, Campus Univ Teatinos S-N, Malaga, Spain; [Habib, Michael] Univ Southern Calif, Los Angeles, CA USA	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Universidad de Malaga; University of Southern California	Liu, D (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Liu, D (corresponding author), Beijing Museum Nat Hist, Beijing, Peoples R China.; Chiappe, LM (corresponding author), Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA 90007 USA.	liudi0716@qq.com; lchiappe@nhm.org	Serrano, Francisco J./H-4568-2015; Serrano, Francisco J./AAD-2671-2019	Serrano, Francisco J./0000-0003-2527-617X; Serrano, Francisco J./0000-0003-2527-617X; Chiappe, Luis/0000-0001-9661-0601				Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Bruderer B, 2001, IBIS, V143, P178, DOI 10.1111/j.1474-919X.2001.tb04475.x; Bruderer B, 2010, IBIS, V152, P272, DOI 10.1111/j.1474-919X.2010.01014.x; Carvalho ID, 2015, BRAZ J GEOL, V45, P161, DOI 10.1590/23174889201500020001; Chang SC, 2009, PALAEOGEOGR PALAEOCL, V280, P94, DOI 10.1016/j.palaeo.2009.06.021; CHIAPPE LM, 1994, J VERTEBR PALEONTOL, V14, P230, DOI 10.1080/02724634.1994.10011554; Chiappe LM, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P125; Chiappe LM, 2016, BIRDS OF STONE: CHINESE AVIAN FOSSILS FROM THE AGE OF DINOSAURS, P3; Chiappe Luis M., 1995, Courier Forschungsinstitut Senckenberg, V181, P55; Chiappe Luis M., 2002, P240; Chiappe LM, 1992, J VERTEBR PALEONTOL, V12, P344, DOI 10.1080/02724634.1992.10011464; Feo TJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2864; Hou L., 1997, MESOZOIC BIRDS CHINA; Hou LH, 1994, VERTEBRAT PALASIATIC, V32, P259; Hu DY, 2011, J VERTEBR PALEONTOL, V31, P154, DOI 10.1080/02724634.2011.546305; Li JJ, 2008, ACTA GEOL SIN-ENGL, V82, P1115; Li L, 2006, ACTA GEOL SIN-ENGL, V80, P38, DOI 10.1111/j.1755-6724.2006.tb00792.x; Linnaeus C, 1758, SYSTEMS NATURAE; Lockwood R, 1998, J AVIAN BIOL, V29, P273, DOI 10.2307/3677110; Longrich N, 2006, PALEOBIOLOGY, V32, P417, DOI 10.1666/04014.1; Meseguer J, 2007, CUADERNOS AENA, V9; Navalon G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14864; Norberg UML, 2002, J MORPHOL, V252, P52, DOI 10.1002/jmor.10013; O'Connor JK, 2011, J SYST PALAEONTOL, V9, P135, DOI 10.1080/14772019.2010.526639; O'Connor JMK, 2011, ACTA PALAEONTOL POL, V56, P463, DOI 10.4202/app.2010.0047; O'Connor JK., 2011, LIVING DINOSAURS EVO, P39, DOI [10.1002/9781119990475.ch3, DOI 10.1002/9781119990475.CH3]; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Rayner J. M. V., 1993, CONT MATH, V141, P351, DOI DOI 10.1090/conm/141/1212584; Sanz JL, 1996, NATURE, V382, P442, DOI 10.1038/382442a0; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; Sereno Paul C., 2002, P184; SERENO PC, 1992, SCIENCE, V255, P845, DOI 10.1126/science.255.5046.845; Serrano FJ, 2017, PALEOBIOLOGY, V43, P144, DOI 10.1017/pab.2016.35; Serrano FJ, 2015, ZOOL J LINN SOC-LOND, V173, P929, DOI 10.1111/zoj.12215; Shyy W, 2008, CAMB AERO SER, P1; Swaddle JP, 2003, IBIS, V145, P457, DOI 10.1046/j.1474-919X.2003.00189.x; Tennekes H., 2009, SIMPLE SCI FLIGHT IN; Tobalske BW, 2009, EXP FLUIDS, V46, P963, DOI 10.1007/s00348-009-0614-9; Tobalske BW, 1999, J EXP BIOL, V202, P1725; Tobalske BW, 2001, AM ZOOL, V41, P177, DOI 10.1668/0003-1569(2001)041[0177:MVAIFI]2.0.CO;2; VISCOR G, 1987, COMP BIOCHEM PHYS A, V87, P231, DOI 10.1016/0300-9629(87)90118-6; Von Mises R., 1945, THEORY FLIGHT; WALKER CA, 1981, NATURE, V292, P51, DOI 10.1038/292051a0; Wang M, 2015, J SYST PALAEONTOL, V14, P29, DOI 10.1080/14772019.2014.994087; Wang Min, 2014, Vertebrata Palasiatica, V52, P31; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955; Zhang FC, 2001, CHINESE SCI BULL, V46, P945, DOI 10.1007/BF02900473; Zhang Y.G., 2010, GEOLOGICAL B CHINA, V29, P988; Zheng XT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2104; Zheng XT, 2013, NATURE, V495, P507, DOI 10.1038/nature11985; ZHOU ZH, 1992, CHINESE SCI BULL, V37, P1365; Zhou ZH, 2002, J VERTEBR PALEONTOL, V22, P49, DOI 10.1671/0272-4634(2002)022[0049:ANAPEB]2.0.CO;2; Zhou Zhong-He, 2006, Vertebrata Palasiatica, V44, P74	55	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0184637	10.1371/journal.pone.0184637	http://dx.doi.org/10.1371/journal.pone.0184637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020077	Green Published, gold, Green Submitted			2022-12-26	WOS:000412754400014
J	Thein, HH; Anyiwe, K; Jembere, N; Yu, B; De, P; Earle, CC				Thein, Hla-Hla; Anyiwe, Kika; Jembere, Nathaniel; Yu, Brian; De, Prithwish; Earle, Craig C.			Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort study	PLOS ONE			English	Article							BREAST-CANCER SURVIVAL; BARRETTS-ESOPHAGUS; GASTROESOPHAGEAL-REFLUX; RISK-FACTORS; UNITED-STATES; CASE-MIX; CARE; ONTARIO; IMPACT; CANADA	The incidence of esophageal adenocarcinoma (EAC) is increasing worldwide and has overtaken squamous histology in occurrence. We studied the impact of socioeconomic status (SES) on EAC stage at diagnosis, receipt of treatment, and survival. A population-based retrospective cohort study was conducted using Ontario Cancer Registry-linked administrative health data. Multinomial logistic regression was used to examine the association between SES (income quintile) and stage at EAC diagnosis and EAC treatment. Survival times following EAC diagnosis were estimated using Kaplan-Meier method. Cox proportional-hazards regression analysis was used to examine the association between SES and EAC survival. Between 2003-2012, 2,125 EAC cases were diagnosed. Median survival for the lowest-SES group was 10.9 months compared to 11.6 months for the highest-SES group; the 5-year survival was 9.8% vs. 15.0%. Compared to individuals in the highest-SES group, individuals in the lowest-SES category experienced no significant difference in EAC treatment (91.6% vs. 93.3%, P = 0.314) and deaths (78.9% vs. 75.6%, P = 0.727). After controlling for covariates, no significant associations were found between SES and cancer stage at diagnosis and EAC treatment. Additionally, after controlling for age, gender, urban/rural residence, birth country, health region, aggregated diagnosis groups, cancer stage, treatment, and year of diagnosis, no significant association was found between SES and EAC survival. Moreover, increased mortality risk was observed among those with older age (P = 0.001), advanced-stage of EAC at diagnosis (P < 0.001), and those receiving chemotherapy alone, radiotherapy alone, or surgery plus chemotherapy (P < 0.001). Adjusted proportional-hazards model findings suggest that there is no association between SES and EAC survival. While the unadjusted model suggests reduced survival among individuals in lower income quintiles, this is no longer significant after adjusting for any covariate. Additionally, there is an apparent association between SES and survival when considering only those individuals diagnosed with stage 0-III EAC. These analyses suggest that the observed direct relationship between SES and survival is explained by patient-level factors including receipt of treatment, something that is potentially modifiable.	[Thein, Hla-Hla; Anyiwe, Kika; Jembere, Nathaniel] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Thein, Hla-Hla; Earle, Craig C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Yu, Brian] Western Univ, Med Sci, London, ON, Canada; [De, Prithwish; Earle, Craig C.] Canc Care Ontario, Toronto, ON, Canada; [Earle, Craig C.] Ontario Inst Canc Res, Toronto, ON, Canada	University of Toronto; University of Toronto; Western University (University of Western Ontario); Cancer Care Ontario; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Thein, HH (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Thein, HH (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	rosie.thein@utoronto.ca		Thein, Hla-Hla/0000-0003-4950-187X; Yu, Brian/0000-0001-7790-7629	annual grant by the Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Ontario Institute for Cancer Research Health Services Research Program at the Dalla Lana School of Public Health, University of Toronto [IA-034]	annual grant by the Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Ontario Institute for Cancer Research Health Services Research Program at the Dalla Lana School of Public Health, University of Toronto	This study was supported through provision of data by the Institute for Clinical Evaluative Sciences and Cancer Care Ontario and through funding support to Institute for Clinical Evaluative Sciences from an annual grant by the Ministry of Health and Long-Term Care and the Ontario Institute for Cancer Research. The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by Institute for Clinical Evaluative Sciences, Cancer Care Ontario, Ontario Institute for Cancer Research or the Government of Ontario is intended or should be inferred. Hla-Hla Thein received a New Investigator Award IA-034 from the Ontario Institute for Cancer Research Health Services Research Program at the Dalla Lana School of Public Health, University of Toronto.	[Anonymous], 2015, J HOPK ACG SYST EXC; Anyiwe K, 2016, LIVER INT, V36, P902, DOI 10.1111/liv.12982; Ault Kimberly, 2012, MULTIPLE IMPUTATION; Austin PC, 2011, MED CARE, V49, P932, DOI 10.1097/MLR.0b013e318215d5e2; Bellis MA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2766-x; Bhat SK, 2015, GUT, V64, P20, DOI 10.1136/gutjnl-2013-305506; Booth CM, 2010, CANCER-AM CANCER SOC, V116, P4160, DOI 10.1002/cncr.25427; Byers TE, 2008, CANCER-AM CANCER SOC, V113, P582, DOI 10.1002/cncr.23567; Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2015, CAN CANC STAT 2015; Cancer Care Ontario, 2013, CANC FACT CHANG PATT; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044325; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; Coleman HG, 2012, GASTROENTEROLOGY, V142, P233, DOI 10.1053/j.gastro.2011.10.034; Corsi DJ, 2014, CANCER CAUSE CONTROL, V25, P45, DOI 10.1007/s10552-013-0307-9; de Jonge PJF, 2006, AM J GASTROENTEROL, V101, P1421, DOI 10.1111/j.1572-0241.2006.00626.x; de Jonge PJF, 2014, GUT, V63, P191, DOI 10.1136/gutjnl-2013-305490; El-Serag HB, 2002, GUT, V50, P368, DOI 10.1136/gut.50.3.368; Fleming ID, 2001, J SURG ONCOL, V77, P233, DOI 10.1002/jso.1101; Ford AC, 2005, AM J EPIDEMIOL, V162, P454, DOI 10.1093/aje/kwi218; Gorey KM, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0246-z; Gorey KM, 2011, AM J PUBLIC HEALTH, V101, P112, DOI 10.2105/AJPH.2009.173112; Gorey KM, 2010, BREAST J, V16, P416, DOI 10.1111/j.1524-4741.2010.00922.x; Gorey KM, 2010, HEALTH PLACE, V16, P156, DOI 10.1016/j.healthplace.2009.09.011; Gorey KM, 2009, CANCER-AM CANCER SOC, V115, P3563, DOI 10.1002/cncr.24401; Gorey KM, 2009, ANN EPIDEMIOL, V19, P121, DOI 10.1016/j.annepidem.2008.10.010; Hoyo C, 2012, INT J EPIDEMIOL, V41, P1706, DOI 10.1093/ije/dys176; Hur C, 2013, CANCER-AM CANCER SOC, V119, P1149, DOI 10.1002/cncr.27834; Jansson C, 2007, CLIN GASTROENTEROL H, V5, P1029, DOI 10.1016/j.cgh.2007.04.009; Jembere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040917; Kendall BJ, 2013, INT J CANCER, V132, P2192, DOI 10.1002/ijc.27887; Koeter M, 2015, CANCER EPIDEMIOL, V39, P863, DOI 10.1016/j.canep.2015.10.007; KOGEVINAS M, 1991, J EPIDEMIOL COMMUN H, V45, P216, DOI 10.1136/jech.45.3.216; Lepage C, 2008, AM J GASTROENTEROL, V103, P2694, DOI 10.1111/j.1572-0241.2008.02191.x; Lineback CM, 2017, ANN THORAC SURG, V103, P416, DOI 10.1016/j.athoracsur.2016.08.085; Mackillop WJ, 1997, J CLIN ONCOL, V15, P1680, DOI 10.1200/JCO.1997.15.4.1680; McDonald JT, 2014, J OTOLARYNGOL-HEAD N, V43, DOI 10.1186/1916-0216-43-2; Moshkowitz M, 2011, WORLD J GASTROENTERO, V17, P1332, DOI 10.3748/wjg.v17.i10.1332; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Pohl H, 2013, AM J GASTROENTEROL, V108, P200, DOI 10.1038/ajg.2012.387; Reid RJ, 2002, HEALTH SERV RES, V37, P1345, DOI 10.1111/1475-6773.01029; Reid RJ, 2001, MED CARE, V39, P86, DOI 10.1097/00005650-200101000-00010; Rubenstein JH, 2010, ALIMENT PHARM THER, V32, P1222, DOI 10.1111/j.1365-2036.2010.04471.x; Rubenstein JH, 2015, GASTROENTEROLOGY, V149, P302, DOI 10.1053/j.gastro.2015.04.053; Rubin DB, 2004, MULTIPLE IMPUTATION; SAS Institute Inc, 2015, SASSTAT 141 USERS GU; Siu S, 2014, THYROID, V24, P545, DOI 10.1089/thy.2013.0090; STARFIELD B, 1991, HEALTH SERV RES, V26, P53; Tinmouth J, 2011, J GASTROINTEST SURG, V15, P782, DOI 10.1007/s11605-011-1450-9; Wang NN, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0579-9; WEINER JP, 1991, MED CARE, V29, P452, DOI 10.1097/00005650-199105000-00006; Wu CW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003566	51	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186350	10.1371/journal.pone.0186350	http://dx.doi.org/10.1371/journal.pone.0186350			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020052	Green Published, gold, Green Submitted			2022-12-26	WOS:000412754400093
J	Bragulat, MR; Eustaquio, A; Cabanes, FJ				Bragulat, M. Rosa; Eustaquio, Alba; Cabanes, F. Javier			Study on the presence of ochratoxin a in cultures of ochratoxigenic and nonochratoxigenic strains of Aspergillus carbonarius	PLOS ONE			English	Article							TEMPERATURE; GROWTH; GRAPES; FUNGI	Ochratoxin A (OTA) is a potent nephrotoxin and carcinogen which is found in a wide variety of common foods and beverages and it is produced by several species of Aspergillus and Penicillium. Ochratoxin a (OT alpha), a major metabolite of OTA, has also been reported to occur in cultures of OTA-producing species. However there is some controversial about the participation of OT alpha in the biosynthesis of OTA, mainly because its biosynthesis pathway has not yet been completely characterized. Aspergillus carbonarius is the main responsible source of ochratoxin A (OTA) in food commodities such as wine, grapes or dried vine fruits from main viticultural regions worldwide. However, little is known about the presence of OT alpha in isolates of A. carbonarius. In this study we evaluated the effects of temperature and incubation time on OT alpha production by both OTA and non-OTA-producing strains of A. carbonarius. OTA and OT alpha were detected on the basis of HPLC fluorometric response compared with that of their standards and confirmed by HPLC-MS in selected samples. The non-OTA-producing strains did produce neither OTA nor OT alpha at any of the conditions tested. The OTA-producing strains studied were able to produce both OTA and OT alpha in most of the conditions tested. In general, higher amounts of OTA than OT alpha were produced, but a positive correlation in the production of these two metabolites was detected. The lack of production of both OTA and OT alpha in the non-OTA-producing strains could be caused by the presence of silent genes or by mutations in functional or regulatory genes involved in OTA production.	[Bragulat, M. Rosa; Cabanes, F. Javier] Univ Autonoma Barcelona, Dept Anim Hlth & Anat, Vet Mycol Grp, Bellaterra, Spain; [Eustaquio, Alba] Univ Autonoma Barcelona, Chem Anal Serv, Bellaterra, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Cabanes, FJ (corresponding author), Univ Autonoma Barcelona, Dept Anim Hlth & Anat, Vet Mycol Grp, Bellaterra, Spain.	javier.cabanes@uab.es	Cabanes, F. Javier/B-8255-2009; Bragulat, M. Rosa/L-1910-2014	Cabanes, F. Javier/0000-0002-2244-5778; Bragulat, M. Rosa/0000-0003-1853-1777	Ministerio de Economia y Competitividad of the Spanish Government [AGL2014-52516-R]	Ministerio de Economia y Competitividad of the Spanish Government(Spanish Government)	This research was supported by the Ministerio de Economia y Competitividad of the Spanish Government (AGL2014-52516-R). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca ML, 2014, FOOD MICROBIOL, V44, P243, DOI 10.1016/j.fm.2014.06.014; Astoreca AL, 2010, TOXINS, V2, P2593, DOI 10.3390/toxins2112593; Bragulat MR, 2001, INT J FOOD MICROBIOL, V71, P139, DOI 10.1016/S0168-1605(01)00581-5; Cabanes FJ, 2013, FOOD MICROBIOL, V36, P135, DOI 10.1016/j.fm.2013.05.004; Copetti MV, 2014, INT J FOOD MICROBIOL, V178, P13, DOI 10.1016/j.ijfoodmicro.2014.02.023; Crespo-Sernpere A, 2010, INT J FOOD MICROBIOL, V142, P170, DOI 10.1016/j.ijfoodmicro.2010.06.019; Esteban A, 2004, RES MICROBIOL, V155, P861, DOI 10.1016/j.resmic.2004.07.002; Farber P, 2001, Mycotoxin Res, V17 Suppl 2, P150, DOI 10.1007/BF03036425; Ferrara M, 2016, APPL ENVIRON MICROB, V78, P8208; Frisvad JC, 2004, STUD MYCOL, V59, P31; Gallo A, 2012, APPL ENVIRON MICROB, V78, P8208, DOI 10.1128/AEM.02508-12; Garcia-Cela E, 2014, INT J FOOD MICROBIOL, V173, P89, DOI 10.1016/j.ijfoodmicro.2013.12.012; Harris JP, 2001, PHYTOCHEMISTRY, V58, P709, DOI 10.1016/S0031-9422(01)00316-8; Cabanes FJ, 2008, ASPERGILLUS IN THE GENOMIC ERA, P57; Cabanes FJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09086; Cabanes FJ, 2010, TOXINS, V2, P1111, DOI 10.3390/toxins2051111; Mitchell D, 2004, J APPL MICROBIOL, V97, P439, DOI 10.1111/j.1365-2672.2004.02321.x; Noonim P, 2008, INT J FOOD MICROBIOL, V128, P197, DOI 10.1016/j.ijfoodmicro.2008.08.005; Pfohl-Leszkowicz A, 2007, MOL NUTR FOOD RES, V51, P61, DOI 10.1002/mnfr.200600137; VANDERME.KJ, 1965, NATURE, V205, P1112, DOI 10.1038/2051112a0; Varga J, 2010, TOXINS, V2, P1718, DOI 10.3390/toxins2071718; Vettorazzi A, 2014, FOOD CHEM TOXICOL, V72, P273, DOI 10.1016/j.fct.2014.07.020	22	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185986	10.1371/journal.pone.0185986	http://dx.doi.org/10.1371/journal.pone.0185986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016677	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400046
J	Rosenberg, M; Ranapurwala, SI; Townes, A; Bengtson, AM				Rosenberg, Molly; Ranapurwala, Shabbar I.; Townes, Ashley; Bengtson, Angela M.			Do black lives matter in public health research and training?	PLOS ONE			English	Article							LIFE EXPECTANCY GAP; STRUCTURAL RACISM; UNITED-STATES; GUN VIOLENCE; TRENDS; DEATH	Objective To examine whether investments made in public health research align with the health burdens experienced by white and black Americans. Methods In this cross-sectional study of all deaths in the United States in 2015, we compared the distribution of potential years of life lost (PYLL) across 39 causes of death by race and identified key differences. We examined the relationship between cause-of-death-specific PYLL and key indicators of public health investment (federal funding and number of publications) by race using linear spline models. We also compared the number of courses available at the top schools of public health relevant to the top causes of death contributor to PYLL for black and white Americans. Results Homicide was the number one contributor to PYLL among black Americans, while ischemic heart disease was the number one contributor to PYLL among white Americans. Firearm-related violence accounted for 88% of black PYLL attributed to homicide and 71% of white PYLL attributed to homicide. Despite the high burden of PYLL, homicide research was the focus of few federal grants or publications. In comparison, ischemic heart disease garnered 341 grants and 594 publications. The number of public health courses available relevant to homicide (n = 9) was similar to those relevant to ischemic heart disease (n = 10). Conclusions Black Americans are disproportionately affected by homicide, compared to white Americans. For both black and white Americans, the majority of PYLL due to homicide are firearm-related. Yet, homicide research is dramatically underrepresented in public health research investments in terms of grant funding and publications, despite available public health training opportunities. If left unchecked, the observed disproportionate distribution of investments in public health resources threatens to perpetuate a system that disadvantages black Americans.	[Rosenberg, Molly] Indiana Univ, Dept Epidemiol & Biostat, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA; [Ranapurwala, Shabbar I.; Bengtson, Angela M.] Univ North Carolina Chapel Hill, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Townes, Ashley] Indiana Univ, Sch Publ Hlth, Dept Appl Hlth Sci, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Indiana University System; Indiana University Bloomington	Rosenberg, M (corresponding author), Indiana Univ, Dept Epidemiol & Biostat, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA.	rosenmol@indiana.edu		Bengtson, Angela/0000-0003-1305-8132; Rosenberg, Molly/0000-0001-6679-6791				American Public Health Association, 2017, WHAT IS PUBL HLTH 20; [Anonymous], 2017, US NEWS WORLD REPORT; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Brownson RC, 2009, ANNU REV PUBL HEALTH, V30, P175, DOI 10.1146/annurev.publhealth.031308.100134; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P649; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P243; Centers for Disease Control and Prevention (CDC), 1999, MMWR-MORBID MORTAL W, V48, P369; Centers for Disease Control and Prevention National Center for Health Statistics, 2017, MORT MULT CAUS FIL 2; Crosby AE, 2013, MMWR-MORBID MORTAL W, V62, P179; Garcia JJL, 2015, AM J PUBLIC HEALTH, V105, pE27, DOI 10.2105/AJPH.2015.302706; Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012; Grosse SD, 2009, MED CARE, V47, pS94, DOI 10.1097/MLR.0b013e31819c9571; Hardeman RR, 2016, NEW ENGL J MED, V375, P2113, DOI 10.1056/NEJMp1609535; Harper S, 2007, JAMA-J AM MED ASSOC, V297, P1224, DOI 10.1001/jama.297.11.1224; Harper S, 2014, HEALTH AFFAIR, V33, P1375, DOI 10.1377/hlthaff.2013.1273; National Center for Helath Statistics, 2012, STATUS TURTLES QATAR; Parks SE, 2014, MMWR SURVEILL SUMM, V63, P1; Rubin R, 2016, JAMA-J AM MED ASSOC, V315, P1689, DOI 10.1001/jama.2016.1707; Stark DE, 2017, JAMA-J AM MED ASSOC, V317, P84, DOI 10.1001/jama.2016.16215; U.S. Census Bureau, 2015, QUICKF US 2015; United States Department of Health and Human Services Office of Disease Prevention and Health Promotion, 2017, HLTH PEOPL 2020; US Department of Health and Human Services, 2017, NIH RES PORT ONL REP; US Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics, 2009, ICD10 US DEP HLTH HU	23	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185957	10.1371/journal.pone.0185957	http://dx.doi.org/10.1371/journal.pone.0185957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3JE	29016639	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400043
J	Dinse, GE; Parks, CG; Weinberg, CR; Meier, HCS; Co, CA; Chan, EKL; Miller, FW				Dinse, Gregg E.; Parks, Christine G.; Weinberg, Clarice R.; Meier, Helen C. S.; Co, Carol A.; Chan, Edward K. L.; Miller, Frederick W.			Antinuclear antibodies and mortality in the National Health and Nutrition Examination Survey (1999-2004)	PLOS ONE			English	Article							GENERAL-POPULATION; AUTOANTIBODIES; CANCER; AUTOIMMUNITY; RISK; PREVALENCE; DISEASE; BREAST; SERUM	Objective Recent studies suggest antinuclear antibodies (ANA) may be related to mortality risk, but evidence is sparse and inconclusive. Thus, we investigated ANA associations with all-cause and cause-specific mortality in U.S. adults. Methods Our sample included 3357 adults (ages >= 20 years) from the 1999-2004 National Health and Nutrition Examination Survey with ANA measurements (1: 80 dilution) and mortality data through 2011 (median follow-up: 9.4 years). We estimated hazard ratios (HRs) and 95% confidence intervals (CIs) via weighted Cox regression to assess ANA associations with mortality from all causes, cardiovascular disease (CVD), and cancer. Models adjusted for age, sex, race/ethnicity, education, and obesity. Analyses examined mortality in the full sample and in subgroups based on self-reported histories of CVD and cancer, both overall and stratified by sex and age at enrollment. Results Overall, ANA were not strongly associated with death from all causes (HR: 1.13; CI: 0.79, 1.60), from CVD (HR: 1.60; CI: 0.80, 3.20), or from cancer (HR: 1.58; CI: 0.75, 3.33), though all three HR estimates exceeded 1. In the subgroup with a history of cancer, ANA were associated with elevated all-cause mortality in men (HR: 2.28; CI: 1.01, 5.14) and in participants who enrolled at age >= 75 years (HR: 1.99; CI: 1.04, 3.80). Conclusion These findings suggest that ANA are not strongly associated with mortality in the general population. Longitudinal studies with repeated assessments are needed to understand the temporal relationship between ANA, aging-associated diseases, and mortality.	[Dinse, Gregg E.; Co, Carol A.] Social & Sci Syst, Durham, NC USA; [Parks, Christine G.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Weinberg, Clarice R.] NIEHS, Biostat & Computat Biol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Meier, Helen C. S.] Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA; [Chan, Edward K. L.] Univ Florida, Hlth Sci Ctr, Gainesville, FL USA; [Miller, Frederick W.] NIEHS, Clin Res Branch, NIH, Bethesda, MD 20892 USA	Social & Scientific Systems; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Wisconsin System; University of Wisconsin Milwaukee; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Miller, FW (corresponding author), NIEHS, Clin Res Branch, NIH, Bethesda, MD 20892 USA.	millerf@mail.nih.gov	Chan, Edward K. L./B-5671-2009; Miller, Frederick/D-2431-2019	Chan, Edward K. L./0000-0003-3938-9503; Miller, Frederick/0000-0003-2831-9593; Weinberg, Clarice/0000-0002-7713-8556; Meier, Helen/0000-0003-4400-0216	NIH, National Institute of Environmental Health Sciences [ES101074, GS-23F-9806H]; Social & Scientific Systems; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101074] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Social & Scientific Systems; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (project ES101074) and contract GS-23F-9806H to Social & Scientific Systems. Two authors (GED, CAC) were employed by Social & Scientific Systems; this company provided support in the form of salaries for these authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Cardonick E, 2014, INT J WOMENS HEALTH, V6, P935, DOI 10.2147/IJWH.S52381; Castelo-Branco C, 2014, GYNECOL ENDOCRINOL, V30, P16, DOI 10.3109/09513590.2013.852531; Chan EKL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00412; COX DR, 1972, J R STAT SOC B, V34, P187; Cox DR., 1970, ANAL BINARY DATA; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Dodd AH, 2009, CURR MED RES OPIN, V25, P1605, DOI 10.1185/03007990902973300; Franks AL, 2012, ANTICANCER RES, V32, P1119; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Harrell FE, 2001, REGRESSION MODELING; Hayashi N, 2008, MOD RHEUMATOL, V18, P153, DOI 10.1007/s10165-008-0028-1; Heegaard NHH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030997; Hollingsworth Peter N., 1996, P74, DOI 10.1016/B978-044482383-0/50013-3; Hurme M, 2007, MECH AGEING DEV, V128, P407, DOI 10.1016/j.mad.2007.03.001; Ishikawa M, 2008, CLIN EXP NEPHROL, V12, P200, DOI 10.1007/s10157-008-0030-0; Lewandowski LB, 2016, CURR OPIN RHEUMATOL, V28, P460, DOI 10.1097/BOR.0000000000000307; Li QZ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3271; Liang KP, 2009, J RHEUMATOL, V36, P2462, DOI 10.3899/jrheum.090188; Litwin Christine M, 2016, J Immunoassay Immunochem, V37, P439, DOI 10.1080/15321819.2016.1174136; Liu L, 2016, INT J PUBLIC HEALTH, V61, P751, DOI 10.1007/s00038-016-0858-0; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Majka DS, 2014, RHEUM DIS CLIN N AM, V40, P659, DOI 10.1016/j.rdc.2014.07.006; Meier HC, 2016, CANC EPIDEMIOL BIOMA; Miller FW, 2011, ADV EXP MED BIOL, V711, P61; Nakano H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081678; O'Sullivan M, 2016, BEST PRACT RES CL RH, V30, P81, DOI 10.1016/j.berh.2016.03.003; Parks CG, 2014, CANCER EPIDEM BIOMAR, V23, P2492, DOI 10.1158/1055-9965.EPI-14-0429; Reinstatler L, 2012, DIABETES CARE, V35, P327, DOI 10.2337/dc11-1582; Rich-Edwards JW, 2014, EPIDEMIOL REV, V36, P57, DOI 10.1093/epirev/mxt006; Rubin RL, 2015, EXPERT OPIN DRUG SAF, V14, P361, DOI 10.1517/14740338.2015.995089; Satoh M, 2012, ARTHRITIS RHEUM-US, V64, P2319, DOI 10.1002/art.34380; Selmi C, 2016, AUTOIMMUN REV, V15, P162, DOI 10.1016/j.autrev.2015.10.007; Shah AA, 2015, ARTHRITIS RHEUMATOL, V67, P317, DOI 10.1002/art.38928; Singh RP, 2012, AUTOIMMUN REV, V11, P664, DOI 10.1016/j.autrev.2011.11.017; Solow EB, 2015, J AM COLL CARDIOL, V65, P2669, DOI 10.1016/j.jacc.2015.03.578; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Tan EM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3557; Teague H, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-015-0557-y; Wang Y, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-16; WASSERMAN J, 1975, CLIN EXP IMMUNOL, V19, P417; Watanabe A, 2004, ARTHRITIS RHEUM-US, V50, P892, DOI 10.1002/art.20096; XAVIER RM, 1995, MECH AGEING DEV, V78, P145, DOI 10.1016/0047-6374(94)01532-Q; YADIN O, 1989, CLIN EXP IMMUNOL, V75, P402; Yang Y, 2012, EXP GERONTOL, V47, P695, DOI 10.1016/j.exger.2012.06.009	46	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185977	10.1371/journal.pone.0185977	http://dx.doi.org/10.1371/journal.pone.0185977			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016697	Green Published, Green Submitted, gold			2022-12-26	WOS:000412601800034
J	Malmstrom, CM; Butterfield, HS; Planck, L; Long, CW; Eviner, VT				Malmstrom, Carolyn M.; Butterfield, H. Scott; Planck, Laura; Long, Christopher W.; Eviner, Valerie T.			Novel fine-scale aerial mapping approach quantifies grassland weed cover dynamics and response to management	PLOS ONE			English	Article							TAENIATHERUM-CAPUT-MEDUSAE; INVASIVE PLANTS; RANGELAND; DISPERSAL; DIVERSITY; PATTERNS; CHEATGRASS; AGREEMENT; PHENOLOGY; COMMUNITY	Invasive weeds threaten the biodiversity and forage productivity of grasslands worldwide. However, management of these weeds is constrained by the practical difficulty of detecting small-scale infestations across large landscapes and by limits in understanding of landscape- scale invasion dynamics, including mechanisms that enable patches to expand, contract, or remain stable. While high-end hyperspectral remote sensing systems can effectively map vegetation cover, these systems are currently too costly and limited in availability for most land managers. We demonstrate application of a more accessible and cost-effective remote sensing approach, based on simple aerial imagery, for quantifying weed cover dynamics over time. In California annual grasslands, the target communities of interest include invasive weedy grasses (Aegilops triuncialis and Elymus caput-medusae) and desirable forage grass species (primarily Avena spp. and Bromus spp.). Detecting invasion of annual grasses into an annual-dominated community is particularly challenging, but we were able to consistently characterize these two communities based on their phenological differences in peak growth and senescence using maximum likelihood supervised classification of imagery acquired twice per year (in mid-and end-of season). This approach permitted us to map weed-dominated cover at a 1-m scale (correctly detecting 93% of weed patches across the landscape) and to evaluate weed cover change over time. We found that weed cover was more pervasive and persistent in management units that had no significant grazing for several years than in those that were grazed, whereas forage cover was more abundant and stable in the grazed units. This application demonstrates the power of this method for assessing fine-scale vegetation transitions across heterogeneous landscapes. It thus provides means for small-scale early detection of invasive species and for testing fundamental questions about landscape dynamics.	[Malmstrom, Carolyn M.; Planck, Laura; Long, Christopher W.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Malmstrom, Carolyn M.] Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA; [Malmstrom, Carolyn M.] Michigan State Univ, Grad Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA; [Butterfield, H. Scott] Nature Conservancy, San Francisco, CA USA; [Eviner, Valerie T.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Planck, Laura] Quantum Spatial Inc, Portland, OR USA	Michigan State University; Michigan State University; Michigan State University; Nature Conservancy; University of California System; University of California Davis	Malmstrom, CM (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.; Malmstrom, CM (corresponding author), Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA.; Malmstrom, CM (corresponding author), Michigan State Univ, Grad Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA.	carolynm@msu.edu		Eviner, Valerie/0000-0001-5530-9417	United States Department of Agriculture National Institute of Food and Agriculture National Research Initiative Controlling Weedy and Invasive Plants Program Grant [2006-55320-17247]; Michigan State University AgBioResearch; United States Department of Food and Agriculture National Institute of Food and Agriculture, Agricultural Experiment Station Project [CA-D-PLS-7641-H]; CalFed Bay-Delta Authority Grant [2001-H2110-1-N31]	United States Department of Agriculture National Institute of Food and Agriculture National Research Initiative Controlling Weedy and Invasive Plants Program Grant; Michigan State University AgBioResearch; United States Department of Food and Agriculture National Institute of Food and Agriculture, Agricultural Experiment Station Project; CalFed Bay-Delta Authority Grant	This project was supported by the United States Department of Agriculture National Institute of Food and Agriculture National Research Initiative Controlling Weedy and Invasive Plants Program Grant #2006-55320-17247, https://www.nifa.usda.gov/(CMM, VTE); Michigan State University AgBioResearch, http://agbioresearch.msu.edu/ (CMM); and by the United States Department of Food and Agriculture National Institute of Food and Agriculture, Agricultural Experiment Station Project CA-D-PLS-7641-H, https://www.nifa.usda.gov (VTE). It built on work previously funded by the CalFed Bay-Delta Authority Grant 2001-H2110-1-N31, http://calwater.ca.gov/calfed/oversight/CBDA/(CMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Arianoutsou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079174; BARTOLOME JW, 1980, J RANGE MANAGE, V33, P4, DOI 10.2307/3898219; Belnap J, 2012, RANGELAND ECOL MANAG, V65, P569, DOI 10.2111/REM-D-11-00157.1; Bestelmeyer BT, 2011, J APPL ECOL, V48, P746, DOI 10.1111/j.1365-2664.2011.01982.x; BOVEY R W, 1987, Reviews of Weed Science, V3, P57; BOVEY RODNEY W., 1961, WEEDS, V9, P307, DOI 10.2307/4040420; Bradley BA, 2005, REMOTE SENS ENVIRON, V94, P204, DOI 10.1016/j.rse.2004.08.016; Bradley BA, 2014, BIOL INVASIONS, V16, P1411, DOI 10.1007/s10530-013-0578-9; Butterfield HS, 2009, INT J REMOTE SENS, V30, P3133, DOI 10.1080/01431160802558774; Butterfield HS, 2006, RANGELAND ECOL MANAG, V59, P541, DOI 10.2111/05-184R1.1; Chase JM, 2013, ECOL LETT, V16, P17, DOI 10.1111/ele.12112; Chuong J, 2016, RANGELAND ECOL MANAG, V69, P52, DOI 10.1016/j.rama.2015.10.009; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Collins SL, 2015, AM NAT, V185, pE30, DOI 10.1086/679315; Congalton R. G., 2009, MATER CHARACT, DOI DOI 10.1016/J.MATCHAR.2009.07.002; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Daubenmire R., 1968, Advances in Ecological Research, V5, P209, DOI 10.1016/S0065-2504(08)60226-3; Davies K.W., 2008, RANGELANDS, V30, P13; Davies KW, 2007, WEED SCI, V55, P178, DOI 10.1614/WS-06-161; Davies KW, 2011, OECOLOGIA, V167, P481, DOI 10.1007/s00442-011-1992-2; Davy JS, 2015, CALIF AGR, V69, P230, DOI 10.3733/ca.v069n04p230; Decarolis F, 2014, CENT ISS CONT ECON T, P1, DOI 10.1007/s11119-013-9304-y; Denison R.F., 1996, CALIF AGR, V50, P9; DiTomaso JM, 2000, WEED SCI, V48, P255, DOI 10.1614/0043-1745(2000)048[0255:IWIRSI]2.0.CO;2; DITOMASO JM, 2010, RANGELANDS, V32, P43, DOI DOI 10.2111/RANGELANDS-D-09-00007.1; DiTomaso JM, 2008, INVAS PLANT SCI MANA, V1, P241, DOI 10.1614/IPSM-07-031.1; Drenovsky RE, 2007, BIOL INVASIONS, V9, P107, DOI 10.1007/s10530-006-0007-4; Duncan C., 2005, INVASIVE PLANTS RANG; Duncan CA, 2004, WEED TECHNOL, V18, P1411, DOI 10.1614/0890-037X(2004)018[1411:ATEEAS]2.0.CO;2; Eviner VT, 2016, ECOSYSTEMS OF CALIFORNIA, P449; EVINER VT, 2010, RANGELANDS, V32, P21, DOI DOI 10.2111/RANGELANDS-D-09-00005.1; GAMON JA, 1993, REMOTE SENS ENVIRON, V44, P239, DOI 10.1016/0034-4257(93)90019-T; GEORGE MR, 1992, J RANGE MANAGE, V45, P436, DOI 10.2307/4002898; He KS, 2011, DIVERS DISTRIB, V17, P381, DOI 10.1111/j.1472-4642.2011.00761.x; Hengl T, 2006, COMPUT GEOSCI-UK, V32, P1283, DOI 10.1016/j.cageo.2005.11.008; Herold M, 2002, ENVIRON PLANN A, V34, P1443, DOI 10.1068/a3496; Homburger H, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0053-6; Huang C, 2009, INT J REMOTE SENS, V30, P897, DOI 10.1080/01431160802395243; Huang CY, 2009, SENSORS-BASEL, V9, P4869, DOI 10.3390/s90604869; James JJ, 2015, RANGELAND ECOL MANAG, V68, P215, DOI 10.1016/j.rama.2015.03.006; Jelinski DE, 1996, LANDSCAPE ECOL, V11, P129, DOI 10.1007/BF02447512; Julia R, 2007, J ENVIRON MANAGE, V85, P876, DOI 10.1016/j.jenvman.2006.10.024; Laliberte AS, 2011, REMOTE SENS-BASEL, V3, P2529, DOI 10.3390/rs3112529; Laliberte AS, 2004, REMOTE SENS ENVIRON, V93, P198, DOI 10.1016/j.rse.2004.07.011; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lelong CCD, 2008, SENSORS-BASEL, V8, P3557, DOI 10.3390/s8053557; Macon D. K., 2016, Rangelands, V38, P222; Malmstrom CM, 2009, RESTOR ECOL, V17, P526, DOI 10.1111/j.1526-100X.2008.00411.x; Malmstrom CM, 2004, 01N31 CALFED EC REST; Mariotte P, 2017, APPL VEG SCI, V20, P28, DOI 10.1111/avsc.12291; McGarigal K., 2012, FRAGSTATS V4 SPATIAL; Nafus AM, 2017, INVAS PLANT SCI MANA, V7, P210; Ndzeidze SK, 2011, DETECTING MEDUSAHEAD; Nelson P.R., 2005, ANAL MEANS GRAPHICAL; O'Neill RV, 1988, LANDSCAPE ECOL, V1, P153, DOI 10.1007/BF00162741; Parece T, 2014, REMOTE SENSING ANAL; Perovic D, 2015, J APPL ECOL, V52, P505, DOI 10.1111/1365-2664.12394; Peters A., 1996, Rangelands, V18, P8; Peterson EB, 2005, INT J REMOTE SENS, V26, P2491, DOI 10.1080/01431160500127815; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Plieninger T, 2012, ENVIRON MANAGE, V50, P427, DOI 10.1007/s00267-012-9900-z; Porensky LM, 2016, J APPL ECOL, V53, P1013, DOI 10.1111/1365-2664.12630; Powell KI, 2013, SCIENCE, V339, P316, DOI 10.1126/science.1226817; Sandel B, 2012, J VEG SCI, V23, P906, DOI 10.1111/j.1654-1103.2012.01406.x; Santos MJ, 2016, ECOL APPL, V26, P1733, DOI 10.1890/15-0615; Sawalhah MN, 2014, RANGELAND ECOL MANAG, V67, P710, DOI 10.2111/REM-D-14-00047.1; Seabloom EW, 2005, ECOL MONOGR, V75, P199, DOI 10.1890/03-0841; Sheley R, 2010, RANGELAND ECOL MANAG, V63, P605, DOI 10.2111/REM-D-09-00187.1; Sheley R., 2011, CONSERVATION BENEFIT, P291; Singh N, 2009, INT J REMOTE SENS, V30, P3441, DOI 10.1080/01431160802562222; Stromberg MR., 2007, CALIFORNIA GRASSLAND, P254; Tamouridou AA, 2017, INT J REMOTE SENS, V38, P2246, DOI 10.1080/01431161.2016.1252475; Teillet PM, 1997, REMOTE SENS ENVIRON, V61, P139, DOI 10.1016/S0034-4257(96)00248-9; Thomason MJS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169328; TORELL PAUL J., 1961, WEEDS, V9, P124, DOI 10.2307/4040395; Trimble Navigation Limited, 2009, TRIMBL MAPP GIS PROD; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172	81	4	5	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0181665	10.1371/journal.pone.0181665	http://dx.doi.org/10.1371/journal.pone.0181665			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016604	Green Published, Green Submitted, gold			2022-12-26	WOS:000412601800003
J	Swasthi, HM; Mukhopadhyay, S				Swasthi, Hema M.; Mukhopadhyay, Samrat			Electrostatic lipid-protein interactions sequester the curli amyloid fold on the lipopolysaccharide membrane surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; atomic force microscopy (AFM); biofilm; fibril; fluorescence; lipopolysaccharide (LPS); protein aggregation; protein misfolding	ESCHERICHIA-COLI K-12; FIBRIL FORMATION; DISEASES; AGGREGATION; MECHANISM; OLIGOMERS; POLYMERIZATION; NUCLEATOR; BETA; CSGB	Curli is a functional amyloid protein in the extracellular matrix of enteric Gram-negative bacteria. Curli is assembled at the cell surface and consists of CsgA, the major subunit of curli, and a membrane-associated nucleator protein, CsgB. Oligomeric intermediates that accumulate during the lag phase of amyloidogenesis are generally toxic, but the underlying mechanism by which bacterial cells overcome this toxicity during curli assembly at the surface remains elusive. Here, we elucidated the mechanism of curli amyloidogenesis and provide molecular insights into the strategy by which bacteria can potentially bypass the detrimental consequences of toxic amyloid intermediates. Using a diverse range of biochemical and biophysical tools involving circular dichroism, fluorescence, Raman spectroscopy, and atomic force microscopy imaging, we characterized the molecular basis of the interaction of CsgB with a membrane-mimetic anionic surfactant as well as with lipopolysaccharide (LPS) constituting the outer leaflet of Gram-negative bacteria. Aggregation studies revealed that the electrostatic interaction of the positively charged C-terminal region of the protein with a negatively charged head group of surfactant/LPS promotes a protein-protein interaction that results in facile amyloid formation without a detectable lag phase. We also show that CsgB, in the presence of surfactant/LPS, accelerates the fibrillation rate of CsgA by circumventing the lag phase during nucleation. Our findings suggest that the electrostatic interactions between lipid and protein molecules play a pivotal role in efficiently sequestering the amyloid fold of curli on the membrane surface without significant accumulation of toxic oligomeric intermediates.	[Swasthi, Hema M.; Mukhopadhyay, Samrat] Indian Inst Sci Educ & Res, Ctr Prot Sci Design & Engn, Sect 81, Mohali, Punjab, India; [Mukhopadhyay, Samrat] Indian Inst Sci Educ & Res, Dept Biol Sci, Sect 81, Mohali, Punjab, India; [Swasthi, Hema M.; Mukhopadhyay, Samrat] Indian Inst Sci Educ & Res, Dept Chem Sci, Sect 81, Mohali, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali; Indian Institute of Science Education & Research (IISER) - Mohali; Indian Institute of Science Education & Research (IISER) - Mohali	Mukhopadhyay, S (corresponding author), Indian Inst Sci Educ & Res, Ctr Prot Sci Design & Engn, Sect 81, Mohali, Punjab, India.; Mukhopadhyay, S (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Sect 81, Mohali, Punjab, India.; Mukhopadhyay, S (corresponding author), Indian Inst Sci Educ & Res, Dept Chem Sci, Sect 81, Mohali, Punjab, India.	mukhopadhyay@iisermohali.ac.in		Mukhopadhyay, Samrat/0000-0003-1242-9958	Indian Institute of Science Education and Research (IISER) Mohali; Ministry of Human Resource Development; Department of Science and Technology, Ministry of Science and Technology, Government of India	Indian Institute of Science Education and Research (IISER) Mohali; Ministry of Human Resource Development; Department of Science and Technology, Ministry of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by Indian Institute of Science Education and Research (IISER) Mohali, the Ministry of Human Resource Development, and the Department of Science and Technology, Ministry of Science and Technology, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Andreasen M, 2015, BBA-BIOMEMBRANES, V1848, P1897, DOI 10.1016/j.bbamem.2015.01.018; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Auer S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000222; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bhattacharya M, 2015, LANGMUIR, V31, P8911, DOI 10.1021/acs.langmuir.5b02074; Bhattacharya M, 2013, J PHYS CHEM LETT, V4, P480, DOI 10.1021/jz3019786; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chaudhary H, 2014, FEBS LETT, V588, P4457, DOI 10.1016/j.febslet.2014.10.016; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Collinson SK, 1999, J MOL BIOL, V290, P741, DOI 10.1006/jmbi.1999.2882; Dalal V, 2015, BIOCHEMISTRY-US, V54, P7505, DOI 10.1021/acs.biochem.5b01110; Domingues MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008385; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Elbaum-Garfinkle S, 2010, BIOPHYS J, V98, P2722, DOI 10.1016/j.bpj.2010.03.013; Evans ML, 2015, MOL CELL, V57, P445, DOI 10.1016/j.molcel.2014.12.025; Evans ML, 2014, BBA-MOL CELL RES, V1843, P1551, DOI 10.1016/j.bbamcr.2013.09.010; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; Gershenson A, 2014, NAT CHEM BIOL, V10, P884, DOI 10.1038/nchembio.1670; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hammar M, 1996, P NATL ACAD SCI USA, V93, P6562, DOI 10.1073/pnas.93.13.6562; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Hammer ND, 2012, J MOL BIOL, V422, P376, DOI 10.1016/j.jmb.2012.05.043; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kumar S, 2010, CURR SCI INDIA, V98, P639; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Li LY, 2014, TRENDS BIOCHEM SCI, V39, P130, DOI 10.1016/j.tibs.2014.01.002; Minter MR, 2016, J NEUROCHEM, V136, P457, DOI 10.1111/jnc.13411; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Narang D, 2016, J PHYS CHEM B, V120, P7815, DOI 10.1021/acs.jpcb.6b05619; Olsen A, 1998, INFECT IMMUN, V66, P944; Olsen A, 2002, J BIOL CHEM, V277, P34568, DOI 10.1074/jbc.M206353200; Otzen D, 2008, CELL MOL LIFE SCI, V65, P910, DOI 10.1007/s00018-007-7404-4; Otzen DE, 2010, CURR PROTEIN PEPT SC, V11, P355; Pain C, 2015, BIOCHIMIE, V111, P82, DOI 10.1016/j.biochi.2015.01.012; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Romling U, 1998, J BACTERIOL, V180, P722; Sciacca MFM, 2012, BIOPHYS J, V103, P702, DOI 10.1016/j.bpj.2012.06.045; Shewmaker F, 2009, J BIOL CHEM, V284, P25065, DOI 10.1074/jbc.M109.007054; Shu Q, 2012, P NATL ACAD SCI USA, V109, P6502, DOI 10.1073/pnas.1204161109; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Valastyan JS, 2014, DIS MODEL MECH, V7, P9, DOI 10.1242/dmm.013474; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Zhou YZ, 2012, METHODS MOL BIOL, V849, P303, DOI 10.1007/978-1-61779-551-0_21	52	18	19	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19861	19872		10.1074/jbc.M117.815522	http://dx.doi.org/10.1074/jbc.M117.815522			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29021250	Green Published, hybrid			2022-12-26	WOS:000416911300029
J	Rush, JS; Edgar, RJ; Deng, P; Chen, J; Zhu, HN; van Sorge, NM; Morris, AJ; Korotkov, KV; Korotkova, N				Rush, Jeffrey S.; Edgar, Rebecca J.; Deng, Pan; Chen, Jing; Zhu, Haining; van Sorge, Nina M.; Morris, Andrew J.; Korotkov, Konstantin V.; Korotkova, Natalia			The molecular mechanism of N-acetylglucosamine side-chain attachment to the Lancefield group A carbohydrate in Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate biosynthesis; cell wall; glycosyltransferase; polysaccharide; Streptococcus pyogenes (S; pyogenes); lipid intermediate	RHAMNOSE-GLUCOSE POLYSACCHARIDE; TANDEM MASS-SPECTROMETRY; GROUP-B STREPTOCOCCI; CELL-WALL; ANOMERIC CONFIGURATION; ENTEROCOCCUS-FAECALIS; ESCHERICHIA-COLI; BACILLUS-CEREUS; GENE-CLUSTER; WEB SERVER	In many Lactobacillales species (i.e. lactic acid bacteria), peptidoglycan is decorated by polyrhamnose polysaccharides that are critical for cell envelope integrity and cell shape and also represent key antigenic determinants. Despite the biological importance of these polysaccharides, their biosynthetic pathways have received limited attention. The important human pathogen, Streptococcus pyogenes, synthesizes a key antigenic surface polymer, the Lancefield group A carbohydrate (GAC). GAC is covalently attached to peptidoglycan and consists of a polyrhamnose polymer, with N-acetylglucosamine (GlcNAc) side chains, which is an essential virulence determinant. The molecular details of the mechanism of polyrhamnose modification with GlcNAc are currently unknown. In this report, using molecular genetics, analytical chemistry, and mass spectrometry analysis, we demonstrated that GAC biosynthesis requires two distinct undecaprenol-linked GlcNAc-lipid intermediates: GlcNAc-pyrophosphoryl-undecaprenol (GlcNAc-P-P-Und) produced by the GlcNAc-phosphate transferase GacO and GlcNAc-phosphate-undecaprenol (GlcNAc-P-Und) produced by the glycosyltransferase GacI. Further investigations revealed that the GAC polyrhamnose backbone is assembled on GlcNAc-P-P-Und. Our results also suggested that a GT-C glycosyltransferase, GacL, transfers GlcNAc from GlcNAc-P-Und to polyrhamnose. Moreover, GacJ, a small membrane-associated protein, formed a complex with GacI and significantly stimulated its catalytic activity. Of note, we observed that GacI homologs perform a similar function in Streptococcus agalactiae and Enterococcus faecalis. In conclusion, the elucidation of GAC biosynthesis in S. pyogenes reported here enhances our understanding of how other Gram-positive bacteria produce essential components of their cell wall.	[Rush, Jeffrey S.; Edgar, Rebecca J.; Chen, Jing; Zhu, Haining; Korotkov, Konstantin V.; Korotkova, Natalia] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Deng, Pan; Morris, Andrew J.] Univ Kentucky, Div Cardiovasc Med, Lexington, KY 40536 USA; [Deng, Pan; Morris, Andrew J.] Univ Kentucky, Gill Heart Inst, Lexington, KY 40536 USA; [van Sorge, Nina M.] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands	University of Kentucky; University of Kentucky; University of Kentucky; Utrecht University; Utrecht University Medical Center	Korotkova, N (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	nkorotkova@uky.edu	Deng, Pan/AAS-2346-2020; Zhu, Haining/A-6076-2008; van Sorge, Nina/E-3290-2017	Deng, Pan/0000-0003-2974-7389; Zhu, Haining/0000-0001-5498-6694; Korotkova, Natalia/0000-0002-8696-4892; van Sorge, Nina/0000-0002-2695-5863; Korotkov, Konstantin/0000-0002-2182-6843	National Institutes of Health from the NIAID [R21AI113253]; Center of Biomedical Research Excellence (COBRE) pilot grant; National Institutes of Health from the NIGMS [P30GM110787]; Vidi Grant from the Netherlands Organization for Scientific Research (NWO) [91713303];  [R01GM102129];  [1S10OD021753]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI113253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527, R01GM102129, P30GM110787] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021753] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center of Biomedical Research Excellence (COBRE) pilot grant; National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Vidi Grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants R21AI113253 from the NIAID (to N. K.), R01GM102129 (to J. S. R.), and 1S10OD021753 (to A. J. M.) and by the Center of Biomedical Research Excellence (COBRE) pilot grant (to K. V. K., N. K., and J. S. R.) supported by National Institutes of Health Grant P30GM110787 from the NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Vidi Grant 91713303 from the Netherlands Organization for Scientific Research (NWO).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Ardiccioni C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10175; Berg KH, 2012, J BACTERIOL, V194, P627, DOI 10.1128/JB.06273-11; BEVENUE A, 1951, ARCH BIOCHEM BIOPHYS, V34, P225, DOI 10.1016/S0003-9861(51)80032-8; Bui NK, 2012, ANAL BIOCHEM, V421, P657, DOI 10.1016/j.ab.2011.11.026; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chaffin DO, 2000, J BACTERIOL, V182, P4466, DOI 10.1128/JB.182.16.4466-4477.2000; Chu M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005946; COLIGAN JE, 1978, IMMUNOCHEMISTRY, V15, P755, DOI 10.1016/0161-5890(78)90105-0; Dale JL, 2015, ANTIMICROB AGENTS CH, V59, P4094, DOI 10.1128/AAC.00344-15; DANILOV LL, 1989, CHEM PHYS LIPIDS, V51, P191, DOI 10.1016/0009-3084(89)90006-6; DITTMER JC, 1964, J LIPID RES, V5, P126; Edgar RJ, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00126; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gomez-Casati DF, 2013, PROTEIN PEPTIDE LETT, V20, P856; Hancock LE, 2002, P NATL ACAD SCI USA, V99, P1574, DOI 10.1073/pnas.032448299; Hoff JS, 2011, INFECT IMMUN, V79, P2404, DOI 10.1128/IAI.01191-10; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Kabanova A, 2010, VACCINE, V29, P104, DOI 10.1016/j.vaccine.2010.09.018; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lancefield RC, 1933, J EXP MED, V57, P571, DOI 10.1084/jem.57.4.571; Linton D, 2005, MOL MICROBIOL, V55, P1695, DOI 10.1111/j.1365-2958.2005.04519.x; Lis M, 2003, INFECT IMMUN, V71, P1938, DOI 10.1128/IAI.71.4.1938-1943.2003; Lood R, 2014, ANTIMICROB AGENTS CH, V58, P3073, DOI 10.1128/AAC.00115-14; Mann E, 2016, CAN J CHEM, V94, P883, DOI 10.1139/cjc-2015-0594; MCCARTY M, 1956, J EXP MED, V104, P629, DOI 10.1084/jem.104.5.629; MCCARTY M, 1952, J EXP MED, V96, P569, DOI 10.1084/jem.96.6.569; MEIERDIETER U, 1992, J BIOL CHEM, V267, P746; MICHON F, 1991, INFECT IMMUN, V59, P1690, DOI 10.1128/IAI.59.5.1690-1696.1991; Mistou MY, 2016, FEMS MICROBIOL REV, V40, P464, DOI 10.1093/femsre/fuw006; MURAZUMI N, 1979, J BIOL CHEM, V254, P1791; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; PRITCHARD DG, 1984, ARCH BIOCHEM BIOPHYS, V235, P385, DOI 10.1016/0003-9861(84)90211-X; Raz A, 2008, P NATL ACAD SCI USA, V105, P18549, DOI 10.1073/pnas.0808301105; REUSCH VM, 1977, J BACTERIOL, V129, P1407, DOI 10.1128/JB.129.3.1407-1414.1977; Ruiz N, 1998, MOL MICROBIOL, V27, P337, DOI 10.1046/j.1365-2958.1998.00681.x; Ruiz Natividad, 2015, Lipid Insights, V8, P21, DOI 10.4137/LPI.S31783; Rush JS, 1997, GLYCOBIOLOGY, V7, P315, DOI 10.1093/glycob/7.2.315; Sabharwal H, 2006, J INFECT DIS, V193, P129, DOI 10.1086/498618; Santander J, 2013, MICROBIOL-SGM, V159, P1471, DOI 10.1099/mic.0.066639-0; Schaefer K, 2017, NAT CHEM BIOL, V13, P396, DOI 10.1038/nchembio.2302; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Shibata Y, 2002, INFECT IMMUN, V70, P2891, DOI 10.1128/IAI.70.6.2891-2898.2002; Skovierova H, 2010, J BIOL CHEM, V285, P41348, DOI 10.1074/jbc.M110.188110; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soldo B, 2002, MICROBIOL-SGM, V148, P2079, DOI 10.1099/00221287-148-7-2079; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Tsukioka Y, 1997, J BACTERIOL, V179, P4411, DOI 10.1128/jb.179.13.4411-4414.1997; van der Beek SL, 2015, MOL MICROBIOL, V98, P946, DOI 10.1111/mmi.13169; van Sorge NM, 2014, CELL HOST MICROBE, V15, P729, DOI 10.1016/j.chom.2014.05.009; Wolucka BA, 1996, J AM SOC MASS SPECTR, V7, P541, DOI 10.1016/1044-0305(96)00020-7; Wolucka BA, 1998, ANAL BIOCHEM, V255, P244, DOI 10.1006/abio.1997.2421; YAMAMORI S, 1978, J BIOL CHEM, V253, P6516; Yamashita Y, 1999, J BACTERIOL, V181, P6556, DOI 10.1128/JB.181.20.6556-6559.1999; Yamashita Y, 1998, J BACTERIOL, V180, P5803, DOI 10.1128/JB.180.21.5803-5807.1998	63	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19441	19457		10.1074/jbc.M117.815910	http://dx.doi.org/10.1074/jbc.M117.815910			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	29021255	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000416226700024
J	Lee, CJ; Lee, Y; Park, S; Kang, SM; Jang, Y; Lee, JH; Lee, SH				Lee, Chan Joo; Lee, Yunbeom; Park, Sungha; Kang, Seok-Min; Jang, Yangsoo; Lee, Ji Hyun; Lee, Sang-Hak			Rare and common variants of APOB and PCSK9 in Korean patients with extremely low low-density lipoprotein-cholesterol levels	PLOS ONE			English	Article							APOLIPOPROTEIN-B; GENETIC-VARIANTS; FAMILIAL HYPOBETALIPOPROTEINEMIA; MOLECULAR DIAGNOSIS; HEART-DISEASE; FATTY LIVER; LOW LDL; MUTATIONS; JAPANESE; DYSLIPIDEMIAS	Background Screening of variants, related to lipid metabolism in patients with extreme cholesterol levels, is a tool used to identify targets affecting cardiovascular outcomes. The aim of this study was to examine the prevalence and characteristics of rare and common variants of APOB and PCSK9 in Korean patients with extremely low low-density lipoprotein-cholesterol (LDLC) levels. Methods Among 13,545 participants enrolled in a cardiovascular genome cohort, 22 subjects, whose LDL-C levels without lipid-lowering agents were <= 1 percentile (48 mg/dL) of Korean population, were analyzed. Two target genes, APOB and PCSK9, were sequenced by targeted next-generation sequencing. Prediction of functional effects was conducted using SIFT, PolyPhen-2, and Mutation Taster, and matched against a public database of variants. Results Eight rare variants of the two candidate genes (five in APOB and three in PCSK9) were found in nine subjects. Two subjects had more than two different rare variants of either gene (one subject in APOB and another subject in APOB/PCSK9). Conversely, 12 common variants (nine in APOB and three in PCSK9) were discovered in 21 subjects. Among all variants, six in APOB and three in PCSK9 were novel. Several variants previously reported functional, including c. C277T (p. R93C) and c. G2009A (p. G670E) of PCSK9, were found in our population. Conclusions Rare variants of APOB or PCSK9 were identified in nine of the 22 study patients with extremely low LDL-C levels, whereas most of them had common variants of the two genes.The common novelty of variants suggested polymorphism of the two genes among them. Our results provide rare genetic information associated with this lipid phenotype in East Asian people.	[Lee, Chan Joo; Park, Sungha; Kang, Seok-Min; Jang, Yangsoo; Lee, Sang-Hak] Yonsei Univ, Coll Med, Severance Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea; [Lee, Chan Joo; Park, Sungha; Kang, Seok-Min; Jang, Yangsoo; Lee, Sang-Hak] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea; [Lee, Yunbeom] Kyung Hee Univ, Grad Sch, Dept Med, Seoul, South Korea; [Lee, Ji Hyun] Kyung Hee Univ, Coll Med, Dept Clin Pharmacol & Therapeut, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Kyung Hee University; Kyung Hee University	Lee, SH (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea.; Lee, SH (corresponding author), Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea.; Lee, JH (corresponding author), Kyung Hee Univ, Coll Med, Dept Clin Pharmacol & Therapeut, Seoul, South Korea.	hyunihyuni@khu.ac.kr; shl1106@yuhs.ac		Kang, Seok-Min/0000-0001-9856-9227; Jang, Yangsoo/0000-0002-2169-3112; Park, Sungha/0000-0001-5362-478X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2012R1A4A1029061, 2014R1A1A2056104]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [2015M3A9B6029138]; National Research Council of Science & Technology (NST) grant by the Korean government (MSIP) [CAP-12-2-KBSI]; Basic Science Research Program through the NRF - Ministry of Science, ICT and Future Planning [NRF-2015R1A2A2A03006577]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP; National Research Council of Science & Technology (NST) grant by the Korean government (MSIP); Basic Science Research Program through the NRF - Ministry of Science, ICT and Future Planning	This research was financially supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2012R1A4A1029061 and 2014R1A1A2056104) (SH Lee); the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (2015M3A9B6029138) (SH Lee); the National Research Council of Science & Technology (NST) grant by the Korean government (MSIP) (No. CAP-12-2-KBSI) (SH Lee); and the Basic Science Research Program through the NRF funded by the Ministry of Science, ICT and Future Planning (No: NRF-2015R1A2A2A03006577 (JH Lee).	Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Arsenault BJ, 2014, ATHEROSCLEROSIS, V236, P321, DOI 10.1016/j.atherosclerosis.2014.07.010; Baragetti A, 2017, EUR J PREV CARDIOL; Benn M, 2010, J AM COLL CARDIOL, V55, P2833, DOI 10.1016/j.jacc.2010.02.044; Chen SN, 2005, J AM COLL CARDIOL, V45, P1611, DOI 10.1016/j.jacc.2005.01.051; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Fouchier SW, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029454; Fu J, 2013, CAN J CARDIOL, V29, P934, DOI 10.1016/j.cjca.2013.01.008; Hooper AJ, 2005, CRIT REV CL LAB SCI, V42, P515, DOI 10.1080/10408360500295113; Hooper AJ, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0423-3; Huijgen R, 2012, HUM MUTAT, V33, P448, DOI 10.1002/humu.21660; Katsuda S, 2009, CLIN CHIM ACTA, V399, P64, DOI 10.1016/j.cca.2008.09.021; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Levenson AE, 2017, PEDIAT DIABETES; Mayne J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-70; Miyake Y, 2008, ATHEROSCLEROSIS, V196, P29, DOI 10.1016/j.atherosclerosis.2006.12.035; Ohta N, 2016, J CLIN LIPIDOL, V10, P547, DOI 10.1016/j.jacl.2015.12.024; Ramasamy I, 2016, CLIN CHIM ACTA, V454, P143, DOI 10.1016/j.cca.2015.10.033; Rimbert A, 2016, ATHEROSCLEROSIS, V250, P52, DOI 10.1016/j.atherosclerosis.2016.04.010; Seo MH, 2011, J CLIN ENDOCR METAB, V96, pE2050, DOI 10.1210/jc.2011-1857; Shioji K, 2004, J HUM GENET, V49, P109, DOI 10.1007/s10038-003-0114-3; Tarugi P, 2007, ATHEROSCLEROSIS, V195, pE19, DOI 10.1016/j.atherosclerosis.2007.05.003; Welty FK, 2014, CURR OPIN LIPIDOL, V25, P161, DOI 10.1097/MOL.0000000000000072; Yang MH, 2016, J CLIN LIPIDOL, V10, P289, DOI 10.1016/j.jacl.2015.11.017; Yilmaz BS, 2016, CLIN CHIM ACTA, V452, P185, DOI 10.1016/j.cca.2015.11.017	25	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186446	10.1371/journal.pone.0186446	http://dx.doi.org/10.1371/journal.pone.0186446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036232	Green Submitted, gold, Green Published			2022-12-26	WOS:000413054800035
J	Fan, WB; Fan, SS; Feng, J; Xiao, DS; Fan, SQ; Luo, JD				Fan, Weibing; Fan, Shuang-Shi; Feng, Juan; Xiao, Desheng; Fan, Songqing; Luo, Jiadi			Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma	PLOS ONE			English	Article							LOW-GRADE GLIOMA; EARLY-PREGNANCY FACTOR; ADJUVANT TEMOZOLOMIDE; PROTEOMIC ANALYSIS; CARDIAC-MUSCLE; HSP60; RADIOTHERAPY; MANAGEMENT; SURVIVAL; CANCER	Astrocytoma is the most common type of primary malignant brain tumor, with pretty lowly 5-year survival rate in patients. Although extended surgical removal of the tumor and postoperative chemotherapy/radiotherapy executed, still there is large recurrence rate, mainly because diffuse glioma tumor cells ubiquitously infiltrate into normal parenchyma. So it becomes a priority to hunt novel molecular and signaling pathway targets to suppress astrocyma progression. HSP10, an important member of Heat shock proteins (Hsps) family, classically works as molecular chaperone folding or degradating of target proteins. Evolutionarily, HSP10 is also reported to be involved in immunomodulation and tumor progression. Poly (ADP-ribose) polymerase (PARP), important in DNA repair, is one of the main cleavage targets of caspase. And cleaved PARP (c-PARP) can serve as a marker of cells undergoing apoptosis. So far, whether the expression of HSP10 or c-PARP is associated with clinicopathologic implication for astrocytoma has not been reported. Meanwhile, it is unclear about the relationship between HSP10 and cell apoptosis. The purpose of this research is to elucidate the association between the expression of HSP10 and c-PARP and clinicopathological characteristics of astrocytoma by immunohistochemistry. The results showed that positive percentage of high HSP10 expression in astrocytoma 42/103, 40.8%) was significantly higher than that in the non-tumor control brain tissues (8/43, 18.6%) (P = 0.01). While no apparent difference of high c-PARP expression existed between astrocytoma and non-tumor control brain tissues. Furthermore, elevated expression of HSP10 was negative related to low expression of c-PARP (r = -0.224, P = 0.023), indicating high expression of HSP10 in astrocytoma inhibited apoptosis process effectively. And overexpression of HSP10 was proved to be the independent poor prognostic factor for astrocytoma by multivariate analysis. Taken together, our results suggest that elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma.	[Fan, Weibing] Third Hosp Changsha, Dept Neurol, Changsha, Hunan, Peoples R China; [Fan, Shuang-Shi] Childrens Hosp Hunan Prov, Dept Surg, Changsha, Hunan, Peoples R China; [Feng, Juan; Fan, Songqing; Luo, Jiadi] Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China; [Xiao, Desheng] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Fan, SQ; Luo, JD (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China.	songqingfan@csu.edu.cn; jiadiluo@csu.edu.cn			National Natural Sciences Foundations of China [81272566, 81472773]; discipline personnel training fund of the third hospital of Changsha	National Natural Sciences Foundations of China(National Natural Science Foundation of China (NSFC)); discipline personnel training fund of the third hospital of Changsha	The work was supported by grants from the National Natural Sciences Foundations of China (NO:81272566; 81472773) to Songqing Fan and the discipline personnel training fund of the third hospital of Changsha to Weibing Fan. http://isisn.nsfc.gov.cn.; This work was supported by grants from the National Natural Sciences Foundations of China (NO: 81272566; 81472773) and the discipline personnel training fund of the third hospital of Changsha.	Aghi MK, 2015, J NEURO-ONCOL, V125, P503, DOI 10.1007/s11060-015-1867-1; Akyol S, 2006, GYNECOL ONCOL, V101, P481, DOI 10.1016/j.ygyno.2005.11.014; BOYAGES J, 1987, RADIOTHER ONCOL, V8, P209, DOI 10.1016/S0167-8140(87)80244-X; Cappello F, 2004, EUR J HISTOCHEM, V48, P261; Cappello F, 2003, GYNECOL ONCOL, V91, P661, DOI 10.1016/j.ygyno.2003.08.009; Cappello F, 2003, ANTICANCER RES, V23, P1325; Cappello F, 2006, CANCER-AM CANCER SOC, V107, P2417, DOI 10.1002/cncr.22265; Corrao S, 2010, LIFE SCI, V86, P145, DOI 10.1016/j.lfs.2009.11.004; Czarnecka AM, 2006, CELL STRESS CHAPERON, V11, P287, DOI 10.1379/CSC-200.1; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; David Sabrina, 2013, Front Biosci (Elite Ed), V5, P768; Fan WB, 2017, J NEURO-ONCOL, V131, P485, DOI 10.1007/s11060-016-2327-2; Ghobrial IM, 2005, BLOOD, V105, P3722, DOI 10.1182/blood-2004-10-3999; Hu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072104; Isabelle M, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-22; Jia Haibo, 2011, Int J Biochem Mol Biol, V2, P47; Jubin T, 2016, CELL PROLIFERAT, V49, P421, DOI 10.1111/cpr.12268; Kaul Z, 2006, ANN NY ACAD SCI, V1067, P469, DOI 10.1196/annals.1354.067; Li J, 2014, HUM PATHOL, V45, P2447, DOI 10.1016/j.humpath.2014.08.010; Lin KM, 2004, FASEB J, V18, P1004, DOI 10.1096/fj.03-0348fje; Luo JD, 2014, INT J CLIN EXP PATHO, V7, P6117; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Macario AJL, 2010, ANN NY ACAD SCI, V1197, P85, DOI 10.1111/j.1749-6632.2010.05187.x; Morton H, 2000, IMMUNOL CELL BIOL, V78, P603, DOI 10.1046/j.1440-1711.2000.00951.x; Osswald M, 2015, NATURE, V528, P93, DOI 10.1038/nature16071; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P1, DOI 10.1093/neuonc/nou223; Rappa F, 2016, CELL STRESS CHAPERON, V21, P927, DOI 10.1007/s12192-016-0721-5; Rappa F, 2014, ANTICANCER RES, V34, P4153; Ryken TC, 2015, J NEURO-ONCOL, V125, P551, DOI 10.1007/s11060-015-1948-1; Shan YX, 2003, J BIOL CHEM, V278, P45492, DOI 10.1074/jbc.M304498200; Shan YX, 2003, J MOL CELL CARDIOL, V35, P1135, DOI 10.1016/S0022-2828(03)00229-3; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tetu B, 2008, MODERN PATHOL, V21, P1002, DOI 10.1038/modpathol.2008.80; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Vis JC, 2005, ACTA NEUROPATHOL, V109, P321, DOI 10.1007/s00401-004-0957-5; Wang WY, 2016, ONCOTARGET, V7, P21728, DOI 10.18632/oncotarget.7824; Ye YB, 2013, PROTEOM CLIN APPL, V7, P403, DOI 10.1002/prca.201100103; Zheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089220; Ziu M, 2015, J NEURO-ONCOL, V125, P585, DOI 10.1007/s11060-015-1931-x	41	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0185563	10.1371/journal.pone.0185563	http://dx.doi.org/10.1371/journal.pone.0185563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028811	Green Published, Green Submitted, gold			2022-12-26	WOS:000412980300010
J	Anderegg, WRL; Wolf, A; Arango-Velez, A; Choat, B; Chmura, DJ; Jansen, S; Kolb, T; Li, S; Meinzer, F; Pita, P; de Dios, VR; Sperry, JS; Wolfe, BT; Pacala, S				Anderegg, William R. L.; Wolf, Adam; Arango-Velez, Adriana; Choat, Brendan; Chmura, Daniel J.; Jansen, Steven; Kolb, Thomas; Li, Shan; Meinzer, Frederick; Pita, Pilar; Resco de Dios, Victor; Sperry, John S.; Wolfe, Brett T.; Pacala, Stephen			Plant water potential improves prediction of empirical stomatal models	PLOS ONE			English	Article							BIOCHEMICAL-MODEL; HYDRAULIC FAILURE; WOODY-PLANTS; DROUGHT; RESPONSES; CONDUCTANCE; PHOTOSYNTHESIS; TRANSPIRATION; VULNERABILITY; HUMIDITY	Climate change is expected to lead to increases in drought frequency and severity, with deleterious effects on many ecosystems. Stomatal responses to changing environmental conditions form the backbone of all ecosystem models, but are based on empirical relationships and are not well-tested during drought conditions. Here, we use a dataset of 34 woody plant species spanning global forest biomes to examine the effect of leaf water potential on stomatal conductance and test the predictive accuracy of three major stomatal models and a recently proposed model. We find that current leaf-level empirical models have consistent biases of over-prediction of stomatal conductance during dry conditions, particularly at low soil water potentials. Furthermore, the recently proposed stomatal conductance model yields increases in predictive capability compared to current models, and with particular improvement during drought conditions. Our results reveal that including stomatal sensitivity to declining water potential and consequent impairment of plant water transport will improve predictions during drought conditions and show that many biomes contain a diversity of plant stomatal strategies that range from risky to conservative stomatal regulation during water stress. Such improvements in stomatal simulation are greatly needed to help unravel and predict the response of ecosystems to future climate extremes.	[Anderegg, William R. L.; Sperry, John S.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Wolf, Adam] Arable Labs, Princeton, NJ USA; [Arango-Velez, Adriana] Connecticut Agr Expt Stn, New Haven, CT 06504 USA; [Choat, Brendan] Western Sydney Univ, Hawkesbury Inst Environm, Penrith, NSW, Australia; [Chmura, Daniel J.] Polish Acad Sci, Inst Dendrol, Kornik, Poland; [Jansen, Steven; Li, Shan] Ulm Univ, Inst Systemat Bot & Ecol, Ulm, Germany; [Kolb, Thomas] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; [Meinzer, Frederick] US Forest Serv, Pacific Northwest Res Stn, Portland, OR 97208 USA; [Pita, Pilar] Tech Univ Madrid, Madrid, Spain; [Resco de Dios, Victor] Univ Lleida, Dept Crop & Forest Sci, Lleida, Spain; [Resco de Dios, Victor] Univ Lleida, Agrotecnio Ctr, Lleida, Spain; [Wolfe, Brett T.] Smithsonian Trop Res Inst, Balboa, Panama; [Pacala, Stephen] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Utah System of Higher Education; University of Utah; Connecticut Agricultural Experiment Station; Western Sydney University; Polish Academy of Sciences; Ulm University; Northern Arizona University; United States Department of Agriculture (USDA); United States Forest Service; Universidad Politecnica de Madrid; Universitat de Lleida; Universitat de Lleida; Smithsonian Institution; Smithsonian Tropical Research Institute; Princeton University	Anderegg, WRL (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	anderegg@utah.edu	Pita, Pilar/AAA-6513-2019; Choat, Brendan/C-8445-2009; Chmura, Daniel J/H-6245-2011; Jansen, Steven/A-9868-2012; Meinzer, Frederick/N-8373-2019; de Dios, Víctor Resco/AAH-3655-2019	Choat, Brendan/0000-0002-9105-640X; Chmura, Daniel J/0000-0002-8776-1472; Jansen, Steven/0000-0002-4476-5334; Meinzer, Frederick/0000-0003-2387-2031; de Dios, Víctor Resco/0000-0002-5721-1656; , Shan/0000-0002-9853-163X	NSF DEB [EF-1340270, 1714972]; Climate Mitigation Initiative at the Princeton Environmental Institute, Princeton University; China Scholarship Council (CSC); Ramon y Cajal fellowship [RYC-2012-10970]; Next Generation Ecosystem Experiments-Tropics - U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research; National Science Centre, Poland [NN309 713340]; Direct For Biological Sciences [1450650] Funding Source: National Science Foundation	NSF DEB(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Climate Mitigation Initiative at the Princeton Environmental Institute, Princeton University; China Scholarship Council (CSC)(China Scholarship Council); Ramon y Cajal fellowship(Spanish Government); Next Generation Ecosystem Experiments-Tropics - U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Science Centre, Poland(National Science Centre, Poland); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this research was provided by NSF DEB EF-1340270 and the Climate Mitigation Initiative at the Princeton Environmental Institute, Princeton University. SL acknowledges financial support from the China Scholarship Council (CSC). VRD acknowledges funding from Ramon y Cajal fellowship (RYC-2012-10970). BTW was supported by the Next Generation Ecosystem Experiments-Tropics, funded by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research. DJC acknowledges funding from the National Science Centre, Poland (NN309 713340). WRLA was supported in part by NSF DEB 1714972. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; WRLA was supported in part by NSF DEB 1714972. We appreciate the assistance from Marion Feifel in collecting data of leaf photosynthetic parameters of five European tree species.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Allison P. D., 1999, MULTIPLE REGRESSION; Anderegg LDL, 2013, TREE PHYSIOL, V33, P701, DOI 10.1093/treephys/tpt044; Anderegg WRL, 2015, SCIENCE, V349, P528, DOI 10.1126/science.aab1833; Anderegg WRL, 2015, NAT GEOSCI, V8, P367, DOI [10.1038/ngeo2400, 10.1038/NGEO2400]; Anderegg WRL, 2015, NEW PHYTOL, V205, P1008, DOI 10.1111/nph.12907; Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; Anderegg WR, 2016, P NATL ACAD SCI; Ball J.T., 1987, PROGR PHOTOSYNTHESIS, P221, DOI [10.1007/978-94-017-0519-6_48, DOI 10.1007/978-94-017-0519-6_48]; Bartlett MK, 2016, P NATL ACAD SCI USA, V113, P13098, DOI 10.1073/pnas.1604088113; Best MJ, 2011, GEOSCI MODEL DEV, V4, P677, DOI 10.5194/gmd-4-677-2011; Bonan GB, 2014, GEOSCI MODEL DEV, V7, P2193, DOI 10.5194/gmd-7-2193-2014; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brodribb TJ, 2017, PLANT CELL ENVIRON, V40, P872, DOI 10.1111/pce.12817; Brodribb TJ, 2014, P NATL ACAD SCI USA, V111, P14489, DOI 10.1073/pnas.1407930111; Brodribb TJ, 2004, NEW PHYTOL, V162, P663, DOI 10.1111/j.1469-8137.2004.01060.x; Brodribb TJ, 2003, PLANT CELL ENVIRON, V26, P443, DOI 10.1046/j.1365-3040.2003.00975.x; Buckley TN, 2016, PLANT CELL ENVIRON, V39, P482, DOI 10.1111/pce.12651; Buckley TN, 2013, PLANT CELL ENVIRON, V36, P1691, DOI 10.1111/pce.12140; Buckley TN, 2005, NEW PHYTOL, V168, P275, DOI 10.1111/j.1469-8137.2005.01543.x; Buckley TN, 2003, PLANT CELL ENVIRON, V26, P1767, DOI 10.1046/j.1365-3040.2003.01094.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Christoffersen BO, 2016, GEOSCI MODEL DEV, V9, P4227, DOI 10.5194/gmd-9-4227-2016; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Cowan I R, 1977, Symp Soc Exp Biol, V31, P471; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Dow GJ, 2014, NEW PHYTOL, V201, P1218, DOI 10.1111/nph.12608; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Frank D, 2015, GLOB CHANGE BIOL; Franks PJ, 1998, PLANT CELL ENVIRON, V21, P94, DOI 10.1046/j.1365-3040.1998.00248.x; Gleason SM, 2016, NEW PHYTOL, V209, P123, DOI 10.1111/nph.13646; Heald, 2010, TECHNICAL DESCRIPTIO; Heroult A, 2013, PLANT CELL ENVIRON, V36, P262, DOI 10.1111/j.1365-3040.2012.02570.x; Hickler T, 2006, GLOBAL ECOL BIOGEOGR, V15, P567, DOI 10.1111/j.1466-8238.2006.00254.x; Jansen S, 2015, NEW PHYTOL, V205, P961, DOI 10.1111/nph.13229; Klein T, 2014, FUNCT ECOL, V28, P1313, DOI 10.1111/1365-2435.12289; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; Lin YS, 2015, NAT CLIM CHANGE, V5, P459, DOI [10.1038/nclimate2550, 10.1038/NCLIMATE2550]; Mackay DS, 2015, WATER RESOUR RES; Maherali H, 2004, ECOLOGY, V85, P2184, DOI 10.1890/02-0538; Manzoni S, 2013, NEW PHYTOL, V198, P169, DOI 10.1111/nph.12126; Manzoni S, 2011, FUNCT ECOL, V25, P456, DOI 10.1111/j.1365-2435.2010.01822.x; Martinez-Vilalta J, 2014, NEW PHYTOL, V204, P105, DOI 10.1111/nph.12912; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; Medlyn BE, 2011, GLOBAL CHANGE BIOL, V17, P2134, DOI 10.1111/j.1365-2486.2010.02375.x; Meinzer FC, 2016, ECOL LETT, V19, P1343, DOI 10.1111/ele.12670; Meinzer FC, 2009, FUNCT ECOL, V23, P922, DOI 10.1111/j.1365-2435.2009.01577.x; Mitchell PJ, 2013, NEW PHYTOL, V197, P862, DOI [10.1111/nph.12064, 10.1111]; Mott KA, 2013, PLANT CELL ENVIRON, V36, P936, DOI 10.1111/pce.12026; Nardini A, 2013, NEW PHYTOL, V200, P322, DOI 10.1111/nph.12288; Peak D, 2011, PLANT CELL ENVIRON, V34, P162, DOI 10.1111/j.1365-3040.2010.02234.x; Powell TL, 2013, NEW PHYTOL, V200, P350, DOI 10.1111/nph.12390; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Schulze ED., 1982, PHYSIOLOGICAL PLANT, P181, DOI [10.1007/978-3-642, DOI 10.1007/978-3-642-68150-9_8]; Sellers PJ, 1996, J CLIMATE, V9, P676, DOI 10.1175/1520-0442(1996)009<0676:ARLSPF>2.0.CO;2; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Shope JC, 2008, PLANT CELL ENVIRON, V31, P1290, DOI 10.1111/j.1365-3040.2008.01844.x; Sperry JS, 2017, PLANT CELL ENVIRON, V40, P816, DOI 10.1111/pce.12852; Sperry JS, 2002, PLANT CELL ENVIRON, V25, P251, DOI 10.1046/j.0016-8025.2001.00799.x; Sperry JS, 2016, NEW PHYTOL; Sperry JS, 2015, NEW PHYTOL; Thomas DS, 1999, J EXP BOT, V50, P393, DOI 10.1093/jxb/50.332.393; Tuzet A, 2003, PLANT CELL ENVIRON, V26, P1097, DOI 10.1046/j.1365-3040.2003.01035.x; West AG, 2008, ECOL APPL, V18, P911, DOI 10.1890/06-2094.1; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Wolf A, 2016, P NATL ACAD SCI USA, V113, pE7222, DOI 10.1073/pnas.1615144113; Xu X, 2016, NEW PHYTOL; Zhou SX, 2013, AGR FOREST METEOROL, V182, P204, DOI 10.1016/j.agrformet.2013.05.009	72	45	46	11	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185481	10.1371/journal.pone.0185481	http://dx.doi.org/10.1371/journal.pone.0185481			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023453	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100019
J	Cornejo-Donoso, J; Einarsson, B; Birnir, B; Gaines, SD				Cornejo-Donoso, Jorge; Einarsson, Baldvin; Birnir, Bjorn; Gaines, Steven D.			Effects of fish movement assumptions on the design of a marine protected area to protect an overfished stock	PLOS ONE			English	Article							INDIVIDUAL-BASED MODEL; FISHERIES MANAGEMENT; POPULATION-MODELS; FEEDING-BEHAVIOR; RESPIRATION RATE; SWIMMING SPEED; RESERVE DESIGN; PELAGIC FISH; HIGH SEAS; SIMULATION	Marine Protected Areas (MPA) are important management tools shown to protect marine organisms, restore biomass, and increase fisheries yields. While MPAs have been successful in meeting these goals for many relatively sedentary species, highly mobile organisms may get few benefits from this type of spatial protection due to their frequent movement outside the protected area. The use of a large MPA can compensate for extensive movement, but testing this empirically is challenging, as it requires both large areas and sufficient time series to draw conclusions. To overcome this limitation, MPA models have been used to identify designs and predict potential outcomes, but these simulations are highly sensitive to the assumptions describing the organism's movements. Due to recent improvements in computational simulations, it is now possible to include very complex movement assumptions in MPA models (e.g. Individual Based Model). These have renewed interest in MPA simulations, which implicitly assume that increasing the detail in fish movement overcomes the sensitivity to the movement assumptions. Nevertheless, a systematic comparison of the designs and outcomes obtained under different movement assumptions has not been done. In this paper, we use an individual based model, interconnected to population and fishing fleet models, to explore the value of increasing the detail of the movement assumptions using four scenarios of increasing behavioral complexity: a) random, diffusive movement, b) aggregations, c) aggregations that respond to environmental forcing (e.g. sea surface temperature), and d) aggregations that respond to environmental forcing and are transported by currents. We then compare these models to determine how the assumptions affect MPA design, and therefore the effective protection of the stocks. Our results show that the optimal MPA size to maximize fisheries benefits increases as movement complexity increases from similar to 10% for the diffusive assumption to similar to 30% when full environment forcing was used. We also found that in cases of limited understanding of the movement dynamics of a species, simplified assumptions can be used to provide a guide for the minimum MPA size needed to effectively protect the stock. However, using oversimplified assumptions can produce suboptimal designs and lead to a density underestimation of ca. 30%; therefore, the main value of detailed movement dynamics is to provide more reliable MPA design and predicted outcomes. Large MPAs can be effective in recovering overfished stocks, protect pelagic fish and provide significant increases in fisheries yields. Our models provide a means to empirically test this spatial management tool, which theoretical evidence consistently suggests as an effective alternative to managing highly mobile pelagic stocks.	[Cornejo-Donoso, Jorge] Univ Calif Santa Barbara, Interdept Grad Program Marine Sci, Marine Sci Inst, Santa Barbara, CA 93106 USA; [Cornejo-Donoso, Jorge] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Einarsson, Baldvin; Birnir, Bjorn] Univ Calif Santa Barbara, Dept Math, South Hall, Santa Barbara, CA 93106 USA; [Birnir, Bjorn] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Gaines, Steven D.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Bren Hall, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Iceland; University of California System; University of California Santa Barbara	Cornejo-Donoso, J (corresponding author), Univ Calif Santa Barbara, Interdept Grad Program Marine Sci, Marine Sci Inst, Santa Barbara, CA 93106 USA.; Cornejo-Donoso, J (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.	cornejotux@gmail.com	Gaines, Steven/Y-3234-2019	Cornejo-Donoso, Jorge F./0000-0002-4244-2865; Birnir, Bjorn/0000-0003-0953-4001	Fulbright commission; Chilean National Science and Technology Commission; University of California, Santa Barbara; Chilean National Science and Technology Commission (CONICYT)	Fulbright commission; Chilean National Science and Technology Commission; University of California, Santa Barbara(University of California System); Chilean National Science and Technology Commission (CONICYT)	Jorge Cornejo-Donoso was funded by the Fulbright commission, the Chilean National Science and Technology Commission and the University of California, Santa Barbara through the Latinoamerican Fisheries Fellowship and other fellowships.; During the model development and manuscript writing, Jorge Cornejo-Donoso was funded by the Fulbright commission, the Chilean National Science and Technology Commission (CONICYT), and the University of California, Santa Barbara, through the Latinoamerican fisheries fellowship and several awards and fellowships. We also want to acknowledge the support from the Center for Scientific Computing at the California Nano Systems Institute (CNSI) University of California, Santa Barbara (UCSB; NSF CNS-0960316), which provided the high-performance computers used during the modelling, to E. Aceves-Bueno and April Ridlon for their help editing this manuscript and the two anonymous reviewers whose comments/suggestions helped improve and clarify this manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; AOKI I, 1982, B JPN SOC SCI FISH, V48, P1081; Babcock RC, 2012, ENVIRON CONSERV, V39, P282, DOI 10.1017/S0376892912000148; Barbaro A, 2009, ICES J MAR SCI, V66, P826, DOI 10.1093/icesjms/fsp067; Bastardie F, 2014, CAN J FISH AQUAT SCI, V71, P366, DOI 10.1139/cjfas-2013-0126; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Birnir B, 2007, J STAT PHYS, V128, P535, DOI 10.1007/s10955-007-9292-2; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Botsford LW, 2003, ECOL APPL, V13, pS25; Braun M, 2011, EVALUACION HIDROA AN; Castillo J., 2009, EVALUACION HIDROACUS; Castillo J, 2008, EVALUACION HIDROACUS; CeDePesca, 2010, ANCH PER NORT CHIL F; Codling EA, 2008, HYDROBIOLOGIA, V606, P55, DOI 10.1007/s10750-008-9345-9; Corrigan CM, 2008, PROG OCEANOGR; Czirok A, 2000, PHYSICA A, V281, P17, DOI 10.1016/S0378-4371(00)00013-3; De Leo GA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0276; FROESE R, 2000, FISHBASE 2000 CONCEP; Gaines SD, 2003, ECOL APPL, V13, pS32; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P1; Game ET, 2010, TRENDS ECOL EVOL, V25, P63, DOI 10.1016/j.tree.2009.09.002; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Gerber LR, 2003, ECOL APPL, V13, pS47; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Halpern BS, 2003, ECOL APPL, V13, pS117; Hastings A, 1999, SCIENCE, V284, P1537, DOI 10.1126/science.284.5419.1537; Hilborn R, 2006, CAN J FISH AQUAT SCI, V63, P642, DOI 10.1139/f05-243; Hubbard S, 2004, ECOL MODEL, V174, P359, DOI 10.1016/j.ecolmodel.2003.06.006; Huse G, 2004, ICES J MAR SCI, V61, P1201, DOI 10.1016/j.icesjms.2004.06.011; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; JAMES AG, 1989, J EXP MAR BIOL ECOL, V131, P81, DOI 10.1016/0022-0981(89)90001-4; Kellner JB, 2008, THEOR ECOL-NETH, V1, P117, DOI 10.1007/s12080-008-0012-6; Kerwath SE, 2008, AFR J MAR SCI, V30, P337, DOI 10.2989/AJMS.2008.30.2.10.560; Leal E, 2009, INVESTIGACIO EVALUAC; Leslie HM, 2005, CONSERV BIOL, V19, P1701, DOI 10.1111/j.1523-1739.2005.00268.x; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; McGilliard CR, 2008, CAN J FISH AQUAT SCI, V65, P2509, DOI 10.1139/F08-150; Meynecke JO, 2014, ICES J MAR SCI, V71, P484, DOI 10.1093/icesjms/fst181; Moustakas A, 2011, STOCH ENV RES RISK A, V25, P403, DOI 10.1007/s00477-010-0411-2; O'Leary BC, 2012, MAR POLICY, V36, P598, DOI 10.1016/j.marpol.2011.11.003; Rossetto M, 2015, CAN J FISH AQUAT SCI, V72, P1503, DOI 10.1139/cjfas-2013-0623; Royer F, 2005, OIKOS, V109, P473, DOI 10.1111/j.0030-1299.2005.13777.x; Santana-Garcon J, 2014, J EXP MAR BIOL ECOL, V460, P153, DOI 10.1016/j.jembe.2014.07.003; Serra R, 2009, INVESTIGACIO EVALUAC; Sumaila UR, 2007, MAR ECOL PROG SER, V345, P305, DOI 10.3354/meps07065; vanderLingen CD, 1995, MAR ECOL PROG SER, V129, P41, DOI 10.3354/meps129041; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Werner FE, 2001, SARSIA, V86, P411, DOI 10.1080/00364827.2001.10420483; White C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001826; Yemane D, 2009, ICES J MAR SCI, V66, P378, DOI 10.1093/icesjms/fsn171	50	7	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186309	10.1371/journal.pone.0186309	http://dx.doi.org/10.1371/journal.pone.0186309			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023580	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100104
J	Ebadat, S; Ahmadi, S; Ahmadi, M; Nematpour, F; Barkhordari, F; Mahdian, R; Davami, F; Mahboudi, F				Ebadat, Saeedeh; Ahmadi, Samira; Ahmadi, Maryam; Nematpour, Fatemeh; Barkhordari, Farzaneh; Mahdian, Reza; Davami, Fatemeh; Mahboudi, Fereidoun			Evaluating the efficiency of CHEF and CMV promoter with IRES and Furin/2A linker sequences for monoclonal antibody expression in CHO cells	PLOS ONE			English	Article							PROTEIN EXPRESSION; THERAPEUTIC LEVELS; MAMMALIAN-CELLS; 2A; STABILITY; LEVEL; METHYLATION; COEXPRESSION; GENERATION; STRATEGIES	In recent years, monoclonal antibodies (mAbs) have been developed as powerful therapeutic and diagnostic agents and Chinese hamster ovary (CHO) cells have emerged as the dominant host for the recombinant expression of these proteins. A critical step in recombinant expression is the utilization of strong promoters, such as the Chinese Hamster Elongation Factor-1 alpha (CHEF-1) promoter. To compare the strengths of CHEF with cytomegalovirus (CMV) promoter for mAb expression in CHO cells, four bicistronic vectors bearing either internal ribosome entry site (IRES) or Furin/2A (F2A) sequences were designed. The efficiency of these promoters was evaluated by measuring level of expressed antibody in stable cell pools. Our results indicated that CHEF promoter-based expression of mAbs was 2.5 fold higher than CMV-based expression in F2A-mediated vectors. However, this difference was less significant in IRES-mediated mAb expressing cells. Studying the stability of the F2A expression system in the course of 18 weeks, we observed that the cells having CHEF promoter maintained their antibody expression at higher level than those transfected with CMV promoter. Further analyses showed that both IRES-mediated vectors, expressed mAbs with correct size, whereas in antibodies expressed via F2A system heterogeneity of light chains were detected due to incomplete furin cleavage. Our findings indicated that the CHEF promoter is a viable alternative to CMV promoter-based expression in F2A-mediated vectors by providing both higher expression and level of stability.	[Ebadat, Saeedeh; Ahmadi, Samira; Ahmadi, Maryam; Nematpour, Fatemeh; Barkhordari, Farzaneh; Davami, Fatemeh; Mahboudi, Fereidoun] Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran; [Ahmadi, Maryam] Semnan Univ Med Sci, Med Biotechnol Dept, Semnan, Iran; [Mahdian, Reza] Pasteur Inst Iran, Mol Med Dept, Biotechnol Res Ctr, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Semnan University of Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Davami, F; Mahboudi, F (corresponding author), Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran.	F_davami@pasteur.ac.ir; mahboudi@pasteur.ac.ir	barkhordari, farzaneh/AAB-3783-2020; barkhordari, farzaneh/AAE-1137-2020; Mahdian, Reza/L-5072-2017	barkhordari, farzaneh/0000-0003-0500-1726; Mahdian, Reza/0000-0003-1458-4767	Pasteur Institute of Iran	Pasteur Institute of Iran	This paper was supported by a grant from the Pasteur Institute of Iran.	Ahmadi M, 2016, BIOTECHNOL PROGR, V32, P1570, DOI 10.1002/btpr.2362; Ahmadi S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179902; [Anonymous], PLOS ONE; Ayoubi TAY, 1996, MOL BIOL REP, V23, P87, DOI 10.1007/BF00424434; Bailey LA, 2012, BIOTECHNOL BIOENG, V109, P2093, DOI 10.1002/bit.24485; Barnes LM, 2003, BIOTECHNOL BIOENG, V81, P631, DOI 10.1002/bit.10517; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Chan HY V S, 2011, PLOS ONE, V6; Chan KKK, 2008, STEM CELLS DEV, V17, P825, DOI 10.1089/scd.2008.0233; Chartrain M, 2008, CURR PHARM BIOTECHNO, V9, P447, DOI 10.2174/138920108786786367; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Chng J, 2015, MABS-AUSTIN, V7, P403, DOI 10.1080/19420862.2015.1008351; Chon JH, 2011, NEW BIOTECHNOL, V28, P458, DOI 10.1016/j.nbt.2011.03.015; Chung NPY, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-33; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; Costa AR, 2010, EUR J PHARM BIOPHARM, V74, P127, DOI 10.1016/j.ejpb.2009.10.002; Deer JR, 2004, BIOTECHNOL PROGR, V20, P880, DOI 10.1021/bp034383r; Fadloun A, 2013, NAT STRUCT MOL BIOL, V20, P332, DOI 10.1038/nsmb.2495; Fang JM, 2007, MOL THER, V15, P1153, DOI 10.1038/sj.mt.6300142; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Frenzel A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00217; Furler S, 2001, GENE THER, V8, P864, DOI 10.1038/sj.gt.3301469; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Ha SH, 2010, PLANT BIOTECHNOL J, V8, P928, DOI 10.1111/j.1467-7652.2010.00543.x; Ho SCL, 2015, MOL BIOTECHNOL, V57, P138, DOI 10.1007/s12033-014-9809-2; Ho SCL, 2013, PHARM BIOPROCESS, V1, P71, DOI 10.4155/PBP.13.8; Ho SCL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063247; Ho SCL, 2013, J BIOTECHNOL, V165, P157, DOI 10.1016/j.jbiotec.2013.03.019; Jostock T, 2010, APPL MICROBIOL BIOT, V87, P1517, DOI 10.1007/s00253-010-2625-0; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; Kaufman WL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn508; Khan KH, 2013, ADV PHARM BULL, V3, P257, DOI 10.5681/apb.2013.042; Kim JW, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/109164; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kuzmich AI, 2013, RUSS J BIOORG CHEM+, V39, P406, DOI 10.1134/S1068162013040122; Li M, 2012, MOL THER, V20, P46, DOI 10.1038/mt.2011.197; Liu JM, 2014, PROTEIN J, V33, P174, DOI 10.1007/s10930-014-9550-5; Martinez-Salas E, 1999, CURR OPIN BIOTECH, V10, P458, DOI 10.1016/S0958-1669(99)00010-5; McBurney MW, 2002, EXP CELL RES, V274, P1, DOI 10.1006/excr.2001.5443; MOUNTFORD PS, 1995, TRENDS GENET, V11, P179, DOI 10.1016/S0168-9525(00)89040-X; Nematpour F, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0330-0; Orlova NA, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-56; Osterlehner A, 2011, BIOTECHNOL BIOENG, V108, P2670, DOI 10.1002/bit.23216; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Preininger A, 1999, CYTOTECHNOLOGY, V30, P1, DOI 10.1023/A:1008030407679; Rasmussen SK, 2012, ARCH BIOCHEM BIOPHYS, V526, P139, DOI 10.1016/j.abb.2012.07.001; Reisinger H, 2008, APPL MICROBIOL BIOT, V81, P701, DOI 10.1007/s00253-008-1701-1; Sambrook J., 2001, MOL CLONING LAB MANU; Strutzenberger K, 1999, J BIOTECHNOL, V69, P215, DOI 10.1016/S0168-1656(99)00044-9; Yang YS, 2010, J BIOTECHNOL, V147, P180, DOI 10.1016/j.jbiotec.2010.04.004; Zhu JW, 2012, BIOTECHNOL ADV, V30, P1158, DOI 10.1016/j.biotechadv.2011.08.022	51	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185967	10.1371/journal.pone.0185967	http://dx.doi.org/10.1371/journal.pone.0185967			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023479	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100045
J	Fagagnini, S; Heinrich, H; Rossel, JB; Biedermann, L; Frei, P; Zeitz, J; Spalinger, M; Battegay, E; Zimmerli, L; Vavricka, SR; Rogler, G; Scharl, M; Misselwitz, B				Fagagnini, Stefania; Heinrich, Henriette; Rossel, Jean-Benoit; Biedermann, Luc; Frei, Pascal; Zeitz, Jonas; Spalinger, Marianne; Battegay, Edouard; Zimmerli, Lukas; Vavricka, Stephan R.; Rogler, Gerhard; Scharl, Michael; Misselwitz, Benjamin			Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases	PLOS ONE			English	Article							CROHNS-DISEASE; ULCERATIVE-COLITIS; ILEAL RESECTION; ENERGY-INTAKE; PREVALENCE; CHOLELITHIASIS; UROLITHIASIS; BILE; NEPHROLITHIASIS; PATHOGENESIS	Background Gallstones and kidney stones are known complications of inflammatory bowel diseases (IBD). Risk factors have been insufficiently studied and explanatory studies date back up to 30 years. It remains unclear, whether improved treatment options also influenced risk factors for these complications. Objectives Identifying risk factors for gallstones and kidney stones in IBD patients. Methods Using data from the Swiss Inflammatory Bowel Disease Cohort Study we assessed associations of diseases characteristics with gallstones and kidney stones in univariate and multivariate logistic regression analyses. Results Out of 2323 IBD patients, 104 (7.8%) Crohn's disease (CD) and 38 (3.8%) ulcerative colitis (UC) patients were diagnosed with gallstones. Significant risk factors for gallstones were diagnosis of CD, age at diagnosis, disease activity and duration, NSAID intake, extra-intestinal manifestations and intestinal surgery. Kidney stones were described in 61 (4.6%) CD and 30 (3.0%) UC patients. Male gender, disease activity, intestinal surgery, NSAID usage and reduced physical activity were significant risk factors. Hospitalization was associated with gallstones and kidney stones. The presence of gallstones increased the risk for kidney stones (OR 4.87, p< 0.001). Conclusion The diagnosis of CD, intestinal surgery, prolonged NSAID use, disease activity and duration and bowel stenosis were significantly associated with cholecystonephrolithiasis in IBD.	[Fagagnini, Stefania; Heinrich, Henriette; Biedermann, Luc; Zeitz, Jonas; Spalinger, Marianne; Vavricka, Stephan R.; Rogler, Gerhard; Scharl, Michael; Misselwitz, Benjamin] Univ Hosp Zurich USZ, Div Gastroenterol & Hepatol, Zurich, Switzerland; [Fagagnini, Stefania; Heinrich, Henriette; Biedermann, Luc; Zeitz, Jonas; Spalinger, Marianne; Battegay, Edouard; Vavricka, Stephan R.; Rogler, Gerhard; Scharl, Michael; Misselwitz, Benjamin] Zurich Univ, Zurich, Switzerland; [Fagagnini, Stefania; Battegay, Edouard; Scharl, Michael] Univ Hosp Zurich, Div Internal Med, Zurich, Switzerland; [Rossel, Jean-Benoit] Inst Social & Prevent Med, Hlth Care Evaluat Unit, Lausanne, Switzerland; [Frei, Pascal] Gastroenterol Bethanien, Zurich, Switzerland; [Zimmerli, Lukas] Kantonsspital Olten, Dept Internal Med, Olten, Switzerland; [Vavricka, Stephan R.] Stadtspital Triemli, Div Gastroenterol & Hepatol, Zurich, Switzerland; [Vavricka, Stephan R.; Rogler, Gerhard; Scharl, Michael] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University Zurich Hospital; Kantonsspital Olten; Triemli Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Scharl, M (corresponding author), Univ Hosp Zurich USZ, Div Gastroenterol & Hepatol, Zurich, Switzerland.; Scharl, M (corresponding author), Zurich Univ, Zurich, Switzerland.; Scharl, M (corresponding author), Univ Hosp Zurich, Div Internal Med, Zurich, Switzerland.; Scharl, M (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.	michael.scharl@usz.ch	Misselwitz, Benjamin/L-7193-2016; Heinrich, Henriette/A-1918-2017	Misselwitz, Benjamin/0000-0002-8719-5175; Heinrich, Henriette/0000-0001-6355-0921; Rossel, Jean-Benoit/0000-0001-5803-3233; Scharl, Michael/0000-0002-6729-1469	Swiss National Science Foundation [32473B_156525, 314730-146204, 314730_166381, CRSII3 154488/1]; Swiss IBD Cohort [3347C0-108792]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss IBD Cohort	This work was supported by research grants from the Swiss National Science Foundation to BM [grant no. 32473B_156525], to MS [grant no. 314730-146204, grant no. 314730_166381 and grant no. CRSII3 154488/1] and the Swiss IBD Cohort [grant no. 3347C0-108792] to GR (www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADMIRAND WH, 1968, J CLIN INVEST, V47, P1043, DOI 10.1172/JCI105794; ANDERSSON H, 1987, SCAND J GASTROENTERO, V22, P253, DOI 10.3109/00365528708991889; Bargiggia S, 2003, J CLIN GASTROENTEROL, V36, P417, DOI 10.1097/00004836-200305000-00012; BENNETT RC, 1972, BMJ-BRIT MED J, V2, P494, DOI 10.1136/bmj.2.5812.494; Brink MA, 1999, GASTROENTEROLOGY, V116, P1420, DOI 10.1016/S0016-5085(99)70507-X; COE FL, 1992, NEW ENGL J MED, V327, P1141, DOI 10.1056/NEJM199210153271607; Corica D, 2016, J CROHNS COLITIS, V10, P226, DOI 10.1093/ecco-jcc/jjv138; Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002; Cury DB, 2013, INT J NEPHROL RENOV, V6, P139, DOI 10.2147/IJNRD.S45466; Damiao AOMC, 1997, DIGESTION, V58, P458, DOI 10.1159/000201483; DOWLING RH, 1972, GUT, V13, P415, DOI 10.1136/gut.13.6.415; EVERSON GT, 1991, GASTROENTEROL CLIN N, V20, P85; FARKKILA MA, 1988, SURGERY, V104, P18; Ferraro PM, 2015, J UROLOGY, V193, P864, DOI 10.1016/j.juro.2014.09.010; Fraquelli M, 2001, ARCH INTERN MED, V161, P2201, DOI 10.1001/archinte.161.18.2201; Ha JH, 2015, INTEST RES, V13, P122, DOI 10.5217/ir.2015.13.2.122; HOFMANN AF, 1972, GASTROENTEROLOGY, V62, P918; HUTCHINSON R, 1994, GUT, V35, P94, DOI 10.1136/gut.35.1.94; Jeong BC, 2005, UROL RES, V33, P453, DOI 10.1007/s00240-005-0507-1; JONES MR, 1976, CLIN RADIOL, V27, P561, DOI 10.1016/S0009-9260(76)80132-8; Kane S, 2006, AM J GASTROENTEROL, V101, pS640, DOI 10.1111/j.1572-0241.2006.00976.x; KNUDSEN L, 1978, SCAND J GASTROENTERO, V13, P433, DOI 10.3109/00365527809181917; Kratzer W, 2005, WORLD J GASTROENTERO, V11, P6170, DOI 10.3748/wjg.v11.i39.6170; Kumar R, 2004, J GASTROEN HEPATOL, V19, P1403, DOI 10.1111/j.1440-1746.2004.03510.x; Lapidus A, 1999, AM J GASTROENTEROL, V94, P1261, DOI 10.1111/j.1572-0241.1999.01076.x; LAPIDUS A, 1991, GUT, V32, P1488, DOI 10.1136/gut.32.12.1488; LORUSSO D, 1990, DIS COLON RECTUM, V33, P791, DOI 10.1007/BF02052328; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; MARATKA Z, 1964, GUT, V5, P214, DOI 10.1136/gut.5.3.214; McConnell N, 2002, BJU INT, V89, P835, DOI 10.1046/j.1464-410X.2002.02739.x; Mukewar S, 2013, J CROHNS COLITIS, V7, P70, DOI 10.1016/j.crohns.2012.05.006; Parente F, 2007, HEPATOLOGY, V45, P1267, DOI 10.1002/hep.21537; Parks JH, 2003, KIDNEY INT, V63, P255, DOI 10.1046/j.1523-1755.2003.00725.x; Pittet V, 2009, INT J EPIDEMIOL, V38, P922, DOI 10.1093/ije/dyn180; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Sorensen MD, 2014, J AM SOC NEPHROL, V25, P362, DOI 10.1681/ASN.2013050548; Taylor EN, 2011, J UROLOGY, V186, P1882, DOI 10.1016/j.juro.2011.06.067; WHORWELL PJ, 1984, DIGEST DIS SCI, V29, P930, DOI 10.1007/BF01312482; York NE, 2015, EXPERT OPIN DRUG SAF, V14, P1865, DOI 10.1517/14740338.2015.1100604; Zhang FM, 2015, J DIGEST DIS, V16, P634, DOI 10.1111/1751-2980.12286	40	29	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185193	10.1371/journal.pone.0185193	http://dx.doi.org/10.1371/journal.pone.0185193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023532	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100014
J	Guasti, L; Squizzato, A; Moretto, P; Vigetti, D; Ageno, W; Dentali, F; Maresca, AM; Campiotti, L; Grandi, AM; Passi, A				Guasti, Luigina; Squizzato, Alessandro; Moretto, Paola; Vigetti, Davide; Ageno, Walter; Dentali, Francesco; Maresca, Andrea M.; Campiotti, Leonardo; Grandi, Anna M.; Passi, Alberto			In vitro effects of Apixaban on 5 different cancer cell lines	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; FACTOR-VIIA; HYALURONAN; MIGRATION; PROLIFERATION; TRANSCRIPTION; MECHANISMS; INHIBITORS; EXPRESSION; MOTILITY	Background Cancer is associated with hypercoagulability. However, several data suggest that anticoagulant drugs may have an effect on tumor development and progression mediated by both coagulation dependent processes and non-coagulation dependent processes. Therefore, we investigated the in vitro effects of Apixaban on cell proliferation, mortality, cell migration, gene expression and matrix metalloproteinase in 5 different cancer cell lines. Methods The following cancer cell lines, and 2 normal fibroblast cultures (lung and dermal fibroblasts), were studied: OVCAR3 (ovarian cancer), MDA MB 231 (breast cancer), CaCO-2 (colon cancer), LNCaP (prostate cancer) and U937 (histiocytic lymphoma). Proliferation and cell mortality were assessed in control cells and Apixaban treated cultures (dose from 0.1 to 5 mu g/ml, 0 to 96-h). Necrosis/Apoptosis (fluorescence microscopy), cell migration (24-h after scratch test), matrix metalloproteinase (MMP) activity and mRNA expression (RT PCR) of p16, p21, p53 and HAS were also assessed. Results High-dose (5 aeg/ml) Apixaban incubation was associated with a significantly reduced proliferation in 3 cancer cell lines (OVCAR3, CaCO-2 and LNCaP) and with increased cancer cell mortality in all, except LNCaP, cancer lines. Apoptosis seems to account for the increased mortality. The migration capacity seems to be impaired after high-dose Apixaban incubation in OVCAR3 and CaCO-2 cells. Data on mRNA expression suggest a consistent increase in tumor suppression gene p16 in all cell lines. Conclusions Our data suggest that high-dose Apixaban may be able to interfere with cancer cell in vitro, reducing proliferation and increasing cancer cell mortality through apoptosis in several cancer cell lines.	[Guasti, Luigina; Squizzato, Alessandro; Moretto, Paola; Vigetti, Davide; Ageno, Walter; Dentali, Francesco; Maresca, Andrea M.; Campiotti, Leonardo; Grandi, Anna M.; Passi, Alberto] Univ Insubria, Dept Med & Surg, Varese, Italy	University of Insubria	Guasti, L; Squizzato, A (corresponding author), Univ Insubria, Dept Med & Surg, Varese, Italy.	luigina.guasti@uninsubria.it; alessandro.squizzato@uninsubria.it	Campiotti, Leonardo/AAH-9346-2021; Squizzato, Alessandro/AAC-3575-2019; Maresca, Andrea/AAC-5356-2022; Campiotti, Leonardo/R-3684-2017	Campiotti, Leonardo/0000-0001-6948-2966; Squizzato, Alessandro/0000-0001-5705-2897; Campiotti, Leonardo/0000-0001-6948-2966; maresca, andrea maria/0000-0001-7896-2021	Pfizer Italia, Via Valbondione, Rome, Italy; Medical Department, Italy, Pfizer	Pfizer Italia, Via Valbondione, Rome, Italy; Medical Department, Italy, Pfizer	The study was funded by Pfizer Italia, Via Valbondione 113, 00181 Rome, Italy (to LG). The active molecule Apixaban was supplied by Bristol-Myers Squibb, New Jersey, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Cataldo Miola and to the Medical Department, Italy, Pfizer, for their support in conducting this research project.	Abu Arab W, 2011, CAN J PHYSIOL PHARM, V89, P705, DOI [10.1139/y11-068, 10.1139/Y11-068]; Acquati F, 2011, P NATL ACAD SCI USA, V108, P1104, DOI 10.1073/pnas.1013746108; Agnelli G, 2015, J THROMB HAEMOST, V13, P2187, DOI 10.1111/jth.13153; Balzarotti M, 2006, ONCOL RES, V16, P245, DOI 10.3727/000000006783981053; Bobek V, 2012, ANTI-CANCER AGENT ME, V12, P580, DOI 10.2174/187152012800617687; Borensztajn K, 2010, THROMB RES, V125, pE323, DOI 10.1016/j.thromres.2010.02.018; Borsig L, 2010, THROMB RES, V125, pS66, DOI 10.1016/S0049-3848(10)70017-7; Carmazzi Y, 2012, CELL PROLIFERAT, V45, P545, DOI 10.1111/j.1365-2184.2012.00847.x; Congiu T, 2010, MICRON, V41, P532, DOI 10.1016/j.micron.2010.01.006; Cosgrove RH, 2002, SEMIN THROMB HEMOST, V28, P79, DOI 10.1055/s-2002-20566; Daneshmand M, 2003, CLIN CANCER RES, V9, P2457; Dentali F, 2011, THROMB HAEMOSTASIS, V106, P363, DOI 10.1160/TH10-10-0660; Falcone C, 2013, SCI WORLD J, DOI 10.1155/2013/584504; Frost CE, 2015, CLIN PHARMACOKINET, V54, P651, DOI 10.1007/s40262-014-0228-0; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gerotziafas GT, 2016, THROMB RES, V140, pS169, DOI 10.1016/S0049-3848(16)30120-7; Hejna M, 1999, JNCI-J NATL CANCER I, V91, P22, DOI 10.1093/jnci/91.1.22; Hembrough TA, 2003, CANCER RES, V63, P2997; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; Hoffman R, 2001, BLOOD REV, V15, P61, DOI 10.1054/blre.2001.0149; Itano N, 2008, CANCER SCI, V99, P1720, DOI 10.1111/j.1349-7006.2008.00885.x; Jiang X, 2004, J THROMB HAEMOST, V2, P93, DOI 10.1111/j.1538-7836.2004.00545.x; Jiang XF, 2008, THROMB HAEMOSTASIS, V100, P127, DOI 10.1160/TH07-12-0722; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; LaPak KM, 2014, MOL CANCER RES, V12, P167, DOI 10.1158/1541-7786.MCR-13-0350; Lean QY, 2014, INTEGR BIOL-UK, V6, P90, DOI 10.1039/c3ib40206a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matzdorff AC, COAGULATION CANC CAN, V148, P83; McKay BC, 2001, ONCOGENE, V20, P6805, DOI 10.1038/sj.onc.1204901; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; Nabeshima K, 2004, J PATHOL, V202, P341, DOI 10.1002/path.1518; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Rickles FR, 2001, THROMB RES, V102, pV215, DOI 10.1016/S0049-3848(01)00285-7; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rousseau A, 2015, THROMB RES, V136, P1273, DOI 10.1016/j.thromres.2015.08.009; Schunemann HJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010569; Staehler M, 2005, BJU INT, V95, P1153, DOI 10.1111/j.1464-410X.2005.05537.x; Striefler JK, 2016, PATHOL RES PRACT; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Testa S, 2016, THROMB RES, V137, P178, DOI 10.1016/j.thromres.2015.12.001; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Ventura JS, 2013, BIOMED PHARMACOTHER, V67, P192, DOI 10.1016/j.biopha.2012.11.009; Vigetti D, 2008, J BIOL CHEM, V283, P4448, DOI 10.1074/jbc.M709051200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; Vigetti D, 2014, ADV CANCER RES, V123, P95, DOI 10.1016/B978-0-12-800092-2.00004-6; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Vlodavsky I, 2007, THROMB RES, V120, pS112, DOI 10.1016/S0049-3848(07)70139-1; You JJ, 2012, UROL ONCOL-SEMIN ORI, V30, P502, DOI 10.1016/j.urolonc.2010.02.013; Zalpour A, 2011, ADV HEMATOL, V2011; ZHANG LR, 1995, CANCER RES, V55, P428; Zhang N, 2016, J CANCER RES CLIN, V142, P1807, DOI 10.1007/s00432-016-2131-6; Zhong GX, 2015, TUMOR BIOL, V36, P4689, DOI 10.1007/s13277-015-3117-8	57	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185035	10.1371/journal.pone.0185035	http://dx.doi.org/10.1371/journal.pone.0185035			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023465	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100012
J	Ursu, O; Gosline, SJC; Beeharry, N; Fink, L; Bhattacharjee, V; Huang, SSC; Zhou, Y; Yen, T; Fraenkel, E				Ursu, Oana; Gosline, Sara J. C.; Beeharry, Neil; Fink, Lauren; Bhattacharjee, Vikram; Huang, Shao-shan Carol; Zhou, Yan; Yen, Tim; Fraenkel, Ernest			Network modeling of kinase inhibitor polypharmacology reveals pathways targeted in chemical screens	PLOS ONE			English	Article							PANCREATIC-CANCER CELLS; HISTONE DEACETYLASE INHIBITOR; GEMCITABINE RESISTANCE; MESENCHYMAL TRANSITION; DRUG-COMBINATIONS; HUMAN GENOME; DNA-DAMAGE; CHECKPOINT; GENE; CHEMORESISTANCE	Small molecule screens are widely used to prioritize pharmaceutical development. However, determining the pathways targeted by these molecules is challenging, since the compounds are often promiscuous. We present a network strategy that takes into account the polypharmacology of small molecules in order to generate hypotheses for their broader mode of action. We report a screen for kinase inhibitors that increase the efficacy of gemcitabine, the first-line chemotherapy for pancreatic cancer. Eight kinase inhibitors emerge that are known to affect 201 kinases, of which only three kinases have been previously identified as modifiers of gemcitabine toxicity. In this work, we use the SAMNet algorithm to identify pathways linking these kinases and genetic modifiers of gemcitabine toxicity with transcriptional and epigenetic changes induced by gemcitabine that we measure using DNaseI-seq and RNA-seq. SAMNet uses a constrained optimization algorithm to connect genes from these complementary datasets through a small set of protein-protein and protein-DNA interactions. The resulting network recapitulates known pathways including DNA repair, cell proliferation and the epithelial-to-mesenchymal transition. We use the network to predict genes with important roles in the gemcitabine response, including six that have already been shown to modify gemcitabine efficacy in pancreatic cancer and ten novel candidates. Our work reveals the important role of polypharmacology in the activity of these chemosensitizing agents.	[Ursu, Oana] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Gosline, Sara J. C.; Fraenkel, Ernest] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Beeharry, Neil; Bhattacharjee, Vikram; Zhou, Yan; Yen, Tim] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Fink, Lauren] Fox Chase Canc Ctr, Canc Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Huang, Shao-shan Carol] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Huang, Shao-shan Carol] Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Huang, Shao-shan Carol] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Ursu, Oana] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Beeharry, Neil] LAM Therapeut, Guilford, CT USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Fox Chase Cancer Center; Fox Chase Cancer Center; Salk Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute; Stanford University	Fraenkel, E (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	fraenkel-admin@mit.edu		Fraenkel, Ernest/0000-0001-9249-8181; Ursu, Oana/0000-0001-8743-4730; Gosline, Sara/0000-0002-6534-4774	National Institutes of Health [R01-GM089903, U01-CA184898, CA06927, CA182651, CA191956, CA16970]; Commonwealth of Pennsylvania; MIT; NATIONAL CANCER INSTITUTE [U01CA184898, P30CA006927, R21CA182651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; MIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01-GM089903 (https.//projectreporter.nih.gov/project_info_description.cfm?projectnumber=5R01GM089903-05) and U01-CA184898 (https://projectreporter.nih.gov/project_info_details.cfm?aid-9070448&icde= 33514951&ddparam=&ddvalue=&ddsub&cr=l &csb=default&cs=ASC&pball=). O.U. acknowledges support from the Alexander J. Denner and the Alexander Laats funds within the MIT Undergraduate Research Opportunities Program. T. J. Y. was supported by National Institutes of Health Core Grants CA06927 (https://projectreporter.nih.gov/proiect_info_details.cfm?aid=9147875&icde=33514952&ddparam=&ddvalue=&ddsub=&cr=2&csb=default&cs=ASC&pball=), CA182651 (https://projectreporter. nih.gov/project_info_details.cfm?aid=8883439&icde=33514958&ddpararn=&ddvalue=&ddsub=&cr=3&csb=defaul&cs=ASC&pball=), CA191956 and CA16970, and an Appropriation from the Commonwealth of Pennsylvania, and generous gifts from Mrs. C Greenberg and the Bucks County Board of Associates.	Akada M, 2005, CLIN CANCER RES, V11, P3094, DOI 10.1158/1078-0432.CCR-04-1785; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Andersson R, 2009, SCAND J GASTROENTERO, V44, P782, DOI 10.1080/00365520902745039; [Anonymous], 2000, NON TRADITIONAL REF; Aranda B, 2011, NAT METHODS, V8, P528, DOI 10.1038/nmeth.1637; Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Beeharry N, 2014, CELL CYCLE, V13, P2172, DOI 10.4161/cc.29214; Bhattacharjee V, 2014, CELL CYCLE, V13, P3839, DOI 10.4161/15384101.2014.967070; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fabbro D, 2012, METHODS MOL BIOL, V795, P1, DOI 10.1007/978-1-61779-337-0_1; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fink LS, 2015, MOL CANCER THER, V14, P298, DOI 10.1158/1535-7163.MCT-14-0529; Giroux V, 2006, FASEB J, V20, P1982, DOI 10.1096/fj.06-6239com; Gosline SJC, 2016, CELL REP, V14, P310, DOI 10.1016/j.celrep.2015.12.031; Gosline SJC, 2012, INTEGR BIOL-UK, V4, P1415, DOI 10.1039/c2ib20072d; Griesmann H, 2013, NEOPLASIA, V15, P11, DOI 10.1593/neo.121312; Hamada S, 2014, CELL SIGNAL, V26, P179, DOI 10.1016/j.cellsig.2013.11.003; Hantschel O, 2015, ACS CHEM BIOL, V10, P234, DOI 10.1021/cb500886n; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Hou JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036252; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang M, 2012, ONCOGENE, V31, P2783, DOI 10.1038/onc.2011.450; Huang SSC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002887; Isham CR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004358; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim YW, 2011, NEURO-ONCOLOGY, V13, P367, DOI 10.1093/neuonc/nor012; Kindler HL, 2008, AM J CLIN ONCOL-CANC, V31, P553, DOI 10.1097/COC.0b013e318178e4cd; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mottamal M, 2015, MOLECULES, V20, P3898, DOI 10.3390/molecules20033898; Parsels LA, 2009, MOL CANCER THER, V8, P45, DOI 10.1158/1535-7163.MCT-08-0662; Pemovska T, 2015, NATURE, V519, P102, DOI 10.1038/nature14119; Qiao ZX, 2013, BIOCHEM BIOPH RES CO, V434, P95, DOI 10.1016/j.bbrc.2013.03.059; Rajeshkumar NV, 2011, CLIN CANCER RES, V17, P2799, DOI 10.1158/1078-0432.CCR-10-2580; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Roadmap Epigenomics Consortium, 2015, Nature, V518, P317, DOI 10.1038/nature14248; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimasaki T, 2007, SUIZO, V22, P14; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Valdez BC, 2013, EXP HEMATOL, V41, P719, DOI 10.1016/j.exphem.2013.04.009; Wang G, 2006, P NATL ACAD SCI USA, V103, P4640, DOI 10.1073/pnas.0509341103; Wang R, 2014, CURR CANCER DRUG TAR, V14, P407, DOI 10.2174/1568009614666140226114015; Wei WT, 2012, INT J BIOL SCI, V8, P1, DOI 10.7150/ijbs.8.1; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Yang L, 2012, J ZHEJIANG UNIV-SC B, V13, P855, DOI 10.1631/jzus.B1100382; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Yeh BW, 2016, TOXICOL APPL PHARM, V290, P98, DOI 10.1016/j.taap.2015.11.007; Zhang NX, 2009, EMBO REP, V10, P1029, DOI 10.1038/embor.2009.122; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	56	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185650	10.1371/journal.pone.0185650	http://dx.doi.org/10.1371/journal.pone.0185650			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023490	Green Submitted, gold, Green Published			2022-12-26	WOS:000412845100024
J	Haskell, CA; Beauchamp, DA; Bollens, SM				Haskell, Craig A.; Beauchamp, David A.; Bollens, Stephen M.			Linking functional response and bioenergetics to estimate juvenile salmon growth in a reservoir food web	PLOS ONE			English	Article							CHINOOK SALMON; LOWER COLUMBIA; ONCORHYNCHUS-TSHAWYTSCHA; SOCKEYE-SALMON; AMERICAN SHAD; ZOOPLANKTON; SIZE; TEMPERATURE; FISH; CONSUMPTION	Juvenile salmon (Oncorhynchus spp.) use of reservoir food webs is understudied. We examined the feeding behavior of subyearling Chinook salmon (O. tshawytscha) and its relation to growth by estimating the functional response of juvenile salmon to changes in the density of Daphnia, an important component of reservoir food webs. We then estimated salmon growth across a broad range of water temperatures and daily rations of two primary prey, Daphnia and juvenile American shad (Alosa sapidissima) using a bioenergetics model. Laboratory feeding experiments yielded a Type-II functional response curve: C = 29.858 P *(4.271 + P)(-1) indicating that salmon consumption (C) of Daphnia was not affected until Daphnia densities (P) were < 30 . L-1. Past field studies documented Daphnia densities in lower Columbia River reservoirs of < 3 . L-1 in July but as high as 40 . L-1 in August. Bioenergetics modeling indicated that subyearlings could not achieve positive growth above 22 degrees C regardless of prey type or consumption rate. When feeding on Daphnia, subyearlings could not achieve positive growth above 20 degrees C (water temperatures they commonly encounter in the lower Columbia River during summer). At 16-18 degrees C, subyearlings had to consume about 27,000 Daphnia . day(-1) to achieve positive growth. However, when feeding on juvenile American shad, subyearlings had to consume 20 shad . day(-1) at 16-18 degrees C, or at least 25 shad . day(-1) at 20 degrees C to achieve positive growth. Using empirical consumption rates and water temperatures from summer 2013, subyearlings exhibited negative growth during July (-0.23 to -0.29 g . d(-1)) and August (-0.05 to -0.07 g . d(-1)). By switching prey from Daphnia to juvenile shad which have a higher energy density, subyearlings can partially compensate for the effects of higher water temperatures they experience in the lower Columbia River during summer. However, achieving positive growth as piscivores requires subyearlings to feed at higher consumption rates than they exhibited empirically. While our results indicate compromised growth in reservoir habitats, the long-term repercussions to salmon populations in the Columbia River Basin are unknown.	[Haskell, Craig A.] US Geol Survey, Western Fisheries Res Ctr, Cook, WA 98605 USA; [Beauchamp, David A.] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA; [Bollens, Stephen M.] Washington State Univ, Sch Environm, Vancouver, WA USA; [Bollens, Stephen M.] Washington State Univ, Sch Biol Sci, Vancouver, WA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Washington State University; Washington State University	Haskell, CA (corresponding author), US Geol Survey, Western Fisheries Res Ctr, Cook, WA 98605 USA.	chaskell@usgs.gov		Haskell, Craig/0000-0002-3604-1758	National Science Foundation GK-12 Grant; U.S. Geological Survey through the YES (Youth and Education in Science)	National Science Foundation GK-12 Grant(National Science Foundation (NSF)); U.S. Geological Survey through the YES (Youth and Education in Science)	This work was supported by a National Science Foundation GK-12 Grant to Stephen Bollens and administered as a fellowship to Craig Haskell by Washington State University. The U.S. Geological Survey provided funds through the YES (Youth and Education in Science).	Adams JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144095; Alexander ME, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0946; BARTELL SM, 1986, CAN J FISH AQUAT SCI, V43, P160, DOI 10.1139/f86-018; Beauchamp DA, 2009, AM FISHERIES SOC S, P19; Bollens SM, 2012, AQUAT INVASIONS, V7, P101, DOI 10.3391/ai.2012.7.1.011; Brachvogel R, 2013, MAR BIOL, V160, P465, DOI 10.1007/s00227-012-2104-5; BRETT JR, 1969, J FISH RES BOARD CAN, V26, P2363, DOI 10.1139/f69-230; BRETT JR, 1971, J FISH RES BOARD CAN, V28, P409, DOI 10.1139/f71-053; BRODEUR RD, 1992, CAN J FISH AQUAT SCI, V49, P1670, DOI 10.1139/f92-186; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Burnham B K, 2002, MODEL SELECTION INFE; Chipps SR, 2008, T AM FISH SOC, V137, P298, DOI 10.1577/T05-236.1; Claiborne AM, 2014, MAR ECOL PROG SER, V515, P187, DOI 10.3354/meps10963; Connor WP, 2012, T AM FISH SOC, V141, P1207, DOI 10.1080/00028487.2012.685121; Coutant C. C., 2006, RETURN RIVER RESTORI, P249; CRADDOCK DR, 1976, T AM FISH SOC, V105, P72, DOI 10.1577/1548-8659(1976)105<72:OAUOZB>2.0.CO;2; CULVER DA, 1985, CAN J FISH AQUAT SCI, V42, P1380, DOI 10.1139/f85-173; Cummins KW, 1971, INT ASS THEOR APPL L, V18; DART (Data access in real time), 2016, DART DAT ACC REAL TI; DAUBLE DD, 1989, FISH B-NOAA, V87, P775; Dick JTA, 2013, BIOL INVASIONS, V15, P837, DOI 10.1007/s10530-012-0332-8; Duffy EJ, 2011, CAN J FISH AQUAT SCI, V68, P232, DOI 10.1139/F10-144; Duffy EJ, 2010, T AM FISH SOC, V139, P803, DOI 10.1577/T08-244.1; EGGERS DM, 1979, J FISH RES BOARD CAN, V36, P1018, DOI 10.1139/f79-141; Emerson JE, 2015, AQUAT INVASIONS, V10, P25, DOI 10.3391/ai.2015.10.1.03; Gadomski DM, 1998, ENVIRON BIOL FISH, V51, P353, DOI 10.1023/A:1007485015830; Galbreath GC, 2000, MANUAL FISHERIES SUR; Gilbreath LG, 2000, LIMNOLOGICAL INVESTI, P140; Gosselain V, 1998, FRESHWATER BIOL, V39, P9, DOI 10.1046/j.1365-2427.1998.00258.x; Guo Z, 2016, ECOL FRESHW FISH; Hanson P. C., 1997, WISCUT97001 U WISC S; Hartman KJ, 2007, BIOENERGETICS ANAL I, P515; Haskell CA, 2017, ECOL FRESHW FISH, P1; Haskell CA, 2006, RIVER RES APPL, V22, P739, DOI 10.1002/rra.927; Haskell CA, 2006, NORTHWEST SCI, V80, P47; Haskell CA, 2017, T AM FISH SOC, V146, P291, DOI 10.1080/00028487.2016.1264997; Haskell CA, 2013, T AM FISH SOC, V142, P606, DOI 10.1080/00028487.2012.728164; Huntington C, 1996, FISHERIES, V21, P6, DOI 10.1577/1548-8446(1996)021&lt;0006:ASOHNS&gt;2.0.CO;2; Huusko A, 2011, FUNCT ECOL, V25, P628, DOI 10.1111/j.1365-2435.2010.01808.x; Koski ML, 2002, CAN J FISH AQUAT SCI, V59, P707, DOI 10.1139/F02-045; LUECKE C, 1993, T AM FISH SOC, V122, P386, DOI 10.1577/1548-8659(1993)122<0386:NETEDO>2.3.CO;2; Madenjian CP, 2004, CAN J FISH AQUAT SCI, V61, P627, DOI [10.1139/f04-033, 10.1139/F04-033]; Mains EM, 1956, DISTRIBUTION SIZE TI; Mantua N, 2010, CLIMATIC CHANGE, V102, P187, DOI 10.1007/s10584-010-9845-2; Marine KR, 2004, N AM J FISH MANAGE, V24, P198, DOI 10.1577/M02-142; McConnaha WE, 2006, RETURN RIVER RESTORI, P1; Moss JH, 2007, J FISH BIOL, V70, P610, DOI 10.1111/j.1095-8649.2007.01340.x; Moss JH, 2009, DEEP-SEA RES PT II, V56, P2553, DOI 10.1016/j.dsr2.2009.03.005; MUIR W D, 1988, Regulated Rivers Research and Management, V2, P1, DOI 10.1002/rrr.3450020102; Naiman RJ, 2012, P NATL ACAD SCI USA, V109, P21201, DOI 10.1073/pnas.1213408109; NMFS (National Marine Fisheries Service), 1992, FED REGISTER, V57, P14653; PACE ML, 1992, CAN J FISH AQUAT SCI, V49, P1060, DOI 10.1139/f92-117; Plumb JM, 2015, T AM FISH SOC, V144, P323, DOI 10.1080/00028487.2014.986336; PTAGIS (Pit Tag Information System), 2016, COL BAS PIT TAG INF; Quinn T. P., 2004, BEHAV ECOLOGY PACIFI; REAL LA, 1979, ECOLOGY, V60, P481, DOI 10.2307/1936067; RONDORF DW, 1990, T AM FISH SOC, V119, P16, DOI 10.1577/1548-8659(1990)119&lt;0016:FEOSCS&gt;2.3.CO;2; Schindler DE, 2005, ECOLOGY, V86, P198, DOI 10.1890/03-0408; Sommer TR, 2001, CAN J FISH AQUAT SCI, V58, P325, DOI 10.1139/cjfas-58-2-325; STEWART DJ, 1991, CAN J FISH AQUAT SCI, V48, P909, DOI 10.1139/f91-107; Stockwell JD, 1999, T AM FISH SOC, V128, P169, DOI 10.1577/1548-8659(1999)128&lt;0169:KFADIT&gt;2.0.CO;2; Thompson JN, 2016, J FISH BIOL, V89, P1720, DOI 10.1111/jfb.13078; Tomaro LM, 2012, MAR ECOL PROG SER, V452, P237, DOI 10.3354/meps09620; Trudel M, 2005, N AM J FISH MANAGE, V25, P374, DOI 10.1577/M04-018.1; Woodson LE, 2013, MAR ECOL PROG SER, V487, P163, DOI 10.3354/meps10353	65	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185933	10.1371/journal.pone.0185933	http://dx.doi.org/10.1371/journal.pone.0185933			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020032	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400053
J	Dardmeh, F; Alipour, H; Gazerani, P; van der Horst, G; Brandsborg, E; Nielsen, HI				Dardmeh, Fereshteh; Alipour, Hiva; Gazerani, Parisa; van der Horst, Gerhard; Brandsborg, Erik; Nielsen, Hans Ingolf			Lactobacillus rhamnosus PB01 (DSM 14870) supplementation affects markers of sperm kinematic parameters in a diet-induced obesity mice model	PLOS ONE			English	Article							BODY-MASS INDEX; HIGH-FAT DIET; DECREASED ANDROGEN LEVELS; SEMEN QUALITY; OXIDATIVE STRESS; REPRODUCTIVE HORMONES; LINOLEIC-ACID; C57BL/6 MICE; IN-VITRO; MEN	Probiotics have been proposed as alternatives to pharmacological products in several medical conditions including the modulation of obesity, which is frequently associated with poor semen quality. However, effects of probiotics on male fertility have been less investigated. This study assessed the effect of Lactobacillus rhamnosus PB01 (DSM-14870) on sperm kinematic parameters in Normal-weight (NW) and diet-induced obese (DIO) models. NW and DIO C57BL/6NTac mice were divided into two subgroups with or without a single daily dose (1x10(9)CFU) of L. rhamnosus for four weeks. Sperm motility and kinematics together with blood lipid profiles and reproductive hormone levels were assessed using the sperm class analyzer system. Probiotic supplementation increased serum testosterone, LH and FSH levels in both NW and DIO groups resulting in significantly (P<0.05) higher velocity (VSL, VCL and VAP) and percentages of progressively motile sperm and significantly lower percentages of immotile sperm. Other kinematic parameters (Lin, STR, ALH and BCF) were also increased in both probiotic supplemented DIO and NW groups at the 10% level of significance. Probiotic supplemented DIO mice demonstrated significantly higher percentages of progressively motile sperm versus DIO controls. This study demonstrated the potential of L. rhamnosus PB01 as a regulatory agent with positive effects on weight loss and reproductive-hormones, significantly improving sperm motility and kinematic parameters in male DIO models.	[Dardmeh, Fereshteh; Alipour, Hiva; Gazerani, Parisa; Nielsen, Hans Ingolf] Aalborg Univ, Fac Med, Dept Hlth Sci & Technol, Biomed Grp, Aalborg, Denmark; [Dardmeh, Fereshteh; Gazerani, Parisa] Aalborg Univ, SMI, Dept Hlth Sci & Technol, Fac Med, Aalborg, Denmark; [van der Horst, Gerhard] Univ Western Cape, Dept Med Biosci, Bellville, South Africa; [Brandsborg, Erik] Bifodan AS, Hundested, Denmark	Aalborg University; Aalborg University; University of the Western Cape	Dardmeh, F (corresponding author), Aalborg Univ, Fac Med, Dept Hlth Sci & Technol, Biomed Grp, Aalborg, Denmark.; Dardmeh, F (corresponding author), Aalborg Univ, SMI, Dept Hlth Sci & Technol, Fac Med, Aalborg, Denmark.	Feda@hst.aau.dk	Gazerani, Parisa/D-1540-2009; Van+der+Horst, Gerhard/AAB-7489-2020; Alipour, Hiva/D-1106-2010	Gazerani, Parisa/0000-0003-0109-3600; Alipour, Hiva/0000-0002-8500-4208; Dardmeh, Fereshteh/0000-0002-2034-0147	"Department of Health Science and Technology", Aalborg University, Aalborg, Denmark; Ferring pharmaceuticals; Department of Health Science and Technology (Aalborg University, Denmark)	"Department of Health Science and Technology", Aalborg University, Aalborg, Denmark; Ferring pharmaceuticals(Ferring Pharmaceuticals); Department of Health Science and Technology (Aalborg University, Denmark)	This study was supported by internal funding from the "Department of Health Science and Technology", Aalborg University, Aalborg, Denmark. The sperm class analyzer (SCA) computer aided sperm analysis (CASA) system was provided by a fund from Ferring pharmaceuticals to Aalborg University Hospital (H.I.N). Bifodan A/S provided the probiotic supplements used in this study. EB is employed at the Research and Development department of Bifodan A/S. EB provided scientific input on the preparation and use of the probiotics but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This commercial affiliation does not alter our adherence to PLOS ONE policies on sharing data and materials. The funders ("Ferring pharmaceuticals" and "Bifodan A/S") provided support only in the form of the mentioned materials and instruments used in the study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors would like to thank the Department of Health Science and Technology (Aalborg University, Denmark) for their research grant supporting this study, Bifodan A/S for providing the Probiotic supplements, the Staff at the animal facility of Aalborg University Hospital and Dr. Afshin Samani for his excellent guidance in statistical analysis.	Aggerholm AS, 2008, FERTIL STERIL, V90, P619, DOI 10.1016/j.fertnstert.2007.07.1292; Amann RP, 2004, J ANDROL, V25, P317; Amann RP, 2014, THERIOGENOLOGY, V81, P5, DOI 10.1016/j.theriogenology.2013.09.004; Angelakis E, 2013, LANCET INFECT DIS, V13, P889, DOI 10.1016/S1473-3099(13)70179-8; Ariagno JI, 2016, ASIAN J ANDROL; Arora T, 2013, NUTRITION, V29, P591, DOI 10.1016/j.nut.2012.07.017; Bakos HW, 2011, FERTIL STERIL, V95, P1700, DOI 10.1016/j.fertnstert.2010.11.044; Bieniek JM, 2016, FERTIL STERIL, V106, P1070, DOI 10.1016/j.fertnstert.2016.06.041; BROOKS DE, 1983, AUST J BIOL SCI, V36, P205, DOI 10.1071/BI9830205; Chen XL, 2013, ANIMAL, V7, P287, DOI 10.1017/S1751731112001528; Dardmeh F, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/5080438; Duty SM, 2004, J ANDROL, V25, P293; Fan YN, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005533; Fejes I, 2006, ARCH ANDROLOGY, V52, P97, DOI 10.1080/01485010500315479; Fejes I, 2005, ANDROLOGIA, V37, P155, DOI 10.1111/j.1439-0272.2005.00671.x; Fernandez CDB, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-32; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Gatti JL, 2004, ANIM REPROD SCI, V82-3, P321, DOI 10.1016/j.anireprosci.2004.05.011; GIAGULLI VA, 1994, J CLIN ENDOCR METAB, V79, P997, DOI 10.1210/jc.79.4.997; Gong T, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140889; Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011; Henderson NA, 2005, BIOL REPROD, V72, P436, DOI 10.1095/biolreprod.104.033548; Hofny ERM, 2010, FERTIL STERIL, V94, P581, DOI 10.1016/j.fertnstert.2009.03.085; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Ibrahim HAM, 2012, BIOL TRACE ELEM RES, V147, P251, DOI 10.1007/s12011-011-9308-2; Jensen TK, 2004, FERTIL STERIL, V82, P863, DOI 10.1016/j.fertnstert.2004.03.056; Jungheim ES, 2012, OBSTET GYN CLIN N AM, V39, P479, DOI 10.1016/j.ogc.2012.09.002; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054617; Kim M, 2013, BIOMOL THER, V21, P476, DOI 10.4062/biomolther.2013.063; Kondo S, 2010, BIOSCI BIOTECH BIOCH, V74, P1656, DOI 10.1271/bbb.100267; Kort HI, 2006, J ANDROL, V27, P450, DOI 10.2164/jandrol.05124; Lee HY, 2006, BBA-MOL CELL BIOL L, V1761, P736, DOI 10.1016/j.bbalip.2006.05.007; Lee K, 2007, J APPL MICROBIOL, V103, P1140, DOI 10.1111/j.1365-2672.2007.03336.x; Levkovich T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053867; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ljiljak D, 2012, ADVANCES IN EMBRYO TRANSFER, P65; Magnusdottir EV, 2005, HUM REPROD, V20, P208, DOI 10.1093/humrep/deh569; Mah PM, 2010, MOL CELL ENDOCRINOL, V316, P180, DOI 10.1016/j.mce.2009.06.007; Maretti C, 2017, ANDROLOGY-US, V5, P439, DOI 10.1111/andr.12336; Martinez AIP, 2004, ANIM REPROD SCI, V82-3, P209, DOI 10.1016/j.anireprosci.2004.04.024; Mortimer ST, 2015, ASIAN J ANDROL, V17, P545, DOI 10.4103/1008-682X.154312; Nguyen RHN, 2007, HUM REPROD, V22, P2488, DOI 10.1093/humrep/dem139; Ooi LG, 2010, INT J MOL SCI, V11, P2499, DOI 10.3390/ijms11062499; ORGEBINCRIST MC, 1973, NATURE, V245, P328, DOI 10.1038/245328a0; Oyeyipo I. P., 2015, Asian Pacific Journal of Reproduction, V4, P236; Palmer Nicole O, 2012, Spermatogenesis, V2, P253; Palmer NO, 2012, AM J PHYSIOL-ENDOC M, V5005, P768; Pasquali R, 2006, FERTIL STERIL, V85, P1319, DOI 10.1016/j.fertnstert.2005.10.054; Pauli EM, 2008, FERTIL STERIL, V90, P346, DOI 10.1016/j.fertnstert.2007.06.046; Pavlovich CP, 2001, J UROLOGY, V165, P837, DOI 10.1016/S0022-5347(05)66540-8; Pinto-Fochi ME, 2016, REPRODUCTION, V152, P795, DOI 10.1530/REP-16-0072; Poutahidis T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084877; Purohit Ashok, 1999, Indian Journal of Experimental Biology, V37, P396; Qin DD, 2007, ASIAN J ANDROL, V9, P827, DOI 10.1111/j.1745-7262.2007.00268.x; Ramlau-Hansen CH, 2007, HUM REPROD, V22, P1634, DOI 10.1093/humrep/dem035; Sallmen M, 2006, EPIDEMIOLOGY, V17, P520, DOI 10.1097/01.ede.0000229953.76862.e5; Schettgen T, 2002, J CHROMATOGR B, V778, P121, DOI 10.1016/S0378-4347(01)00452-2; Sekhavat L, 2010, AGING MALE, V13, P155, DOI 10.3109/13685530903536643; Shalaby MA, 2004, PHARMACOL RES, V50, P137, DOI 10.1016/j.phrs.2003.10.013; Sousa R, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-5; Su HM, 2016, J ZHEJIANG UNIV-SC B, V17, P437, DOI 10.1631/jzus.B1600074; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Suresh S, 2010, INT J ANDROL, V33, P22, DOI 10.1111/j.1365-2605.2008.00949.x; Takemura N, 2010, EXP BIOL MED, V235, P849, DOI 10.1258/ebm.2010.009377; Toocheck C, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.132068; van der Horst G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-351; Vermeulen A, 1996, ANN MED, V28, P13, DOI 10.3109/07853899608999068; Walker William H, 2011, Spermatogenesis, V1, P116; Williams LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106159; Winters SJ, 2006, J ANDROL, V27, P560, DOI 10.2164/jandrol.05193	72	40	40	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185964	10.1371/journal.pone.0185964	http://dx.doi.org/10.1371/journal.pone.0185964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016685	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400044
J	Dong, LY; Liu, SF; Xu, P; Deng, W; Li, XD; Tharreau, D; Li, J; Zhou, JW; Wang, Q; Tao, DY; Yang, QZ				Dong, Liying; Liu, Shufang; Xu, Peng; Deng, Wei; Li, Xundong; Tharreau, Didier; Li, Jing; Zhou, Jiawu; Wang, Qun; Tao, Dayun; Yang, Qinzhong			Fine mapping of Pi57(t) conferring broad spectrum resistance against Magnaporthe oryzae in introgression line IL-E1454 derived from Oryza longistaminata	PLOS ONE			English	Article							RICE BLAST RESISTANCE; RECESSIVE GENE; RECOMBINATION FREQUENCY; IDENTIFICATION; CULTIVAR; GRISEA; INDICA; DNA	Wild species of the genus Oryza are excellent gene pools for improvement of agronomic traits of Asian cultivated rice. The blast resistance gene Pi57(t) in the introgression line IL-E1454 derived from Oryza longistaminata was previously mapped on rice chromosome 12. Inoculation with 322 Magnaporthe oryzae isolates collected from 6 countries indicated that Pi57(t) conferred broad spectrum resistance against M. oryzae. Two mapping populations consisting of 29070 and 10375 F-2 plants derived from the crosses of resistant donor IL-E1454 with susceptible parents RD23 and Lijiangxintuanheigu respectively, were used for fine mapping of Pi57(t) locus. Based on genotyping and phenotyping results of recombinants screened from the two crosses, Pi57(t) was finally mapped to a 51.7-kb region flanked by two molecular markers (STS57-320 and STS57-372) on the short arm and close to the centromere of chromosome 12. Six candidate resistance genes were predicted in the target region according to the reference sequence of Nipponbare. These results could facilitate both marker-assisted selection for disease-resistant breeding and gene cloning.	[Dong, Liying; Liu, Shufang; Li, Xundong; Wang, Qun; Yang, Qinzhong] Yunnan Acad Agr Sci, Agr Environm & Resources Inst, Kunming, Yunnan, Peoples R China; [Xu, Peng; Deng, Wei; Li, Jing; Zhou, Jiawu; Tao, Dayun] Yunnan Acad Agr Sci, Food Crops Inst, Kunming, Yunnan, Peoples R China; [Xu, Peng] Xishuangbanna Trop Bot Garden, Key Lab Trop Plant Resources & Sustainable Use, Kunming, Yunnan, Peoples R China; [Tharreau, Didier] UMR BGPI, Ctr Cooperat Int Rech Agron Dev, Montpellier, France	Yunnan Academy of Agricultural Sciences; Yunnan Academy of Agricultural Sciences; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; CIRAD	Yang, QZ (corresponding author), Yunnan Acad Agr Sci, Agr Environm & Resources Inst, Kunming, Yunnan, Peoples R China.; Tao, DY (corresponding author), Yunnan Acad Agr Sci, Food Crops Inst, Kunming, Yunnan, Peoples R China.	taody12@aliyun.com; qzhyang@163.com	Tharreau, Didier/AAI-8632-2020; Li, xundong/GOH-1297-2022; Zhou, Jiawu/AAJ-1963-2021; Tao, Dayun/AAI-8321-2020; Tharreau, Didier/ABH-1048-2021	Tharreau, Didier/0000-0003-3961-6120; Tao, Dayun/0000-0002-8884-1589	National Natural Science Foundation of China [31360462, 31560493]; Yunnan Provincial Science and Technology Department [20141A009]; Special Fund for Agro-Scientific Research in the Public Interest [201303129]; Scientific Observing and Experimental Station of Crops Pests in Kunming, Ministry of Agriculture, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Science and Technology Department; Special Fund for Agro-Scientific Research in the Public Interest; Scientific Observing and Experimental Station of Crops Pests in Kunming, Ministry of Agriculture, China	This research was supported by grants from National Natural Science Foundation of China (31360462, 31560493) to Qinzhong Yang, Yunnan Provincial Science and Technology Department (20141A009) to Qinzhong Yang, the Special Fund for Agro-Scientific Research in the Public Interest (201303129), Scientific Observing and Experimental Station of Crops Pests in Kunming, Ministry of Agriculture, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Khay S, Dr. Douangboupha B, Dr. Somrith A and Dr. Chung NH for the provision of blast isolates. This research was supported by grants from National Natural Science Foundation of China (31360462, 31560493), Yunnan Provincial Science and Technology Department (20141A009), the Special Fund for Agro-Scientific Research in the Public Interest (201303129), Scientific Observing and Experimental Station of Crops Pests in Kunming, Ministry of Agriculture, China.	Ballini E, 2008, MOL PLANT MICROBE IN, V21, P859, DOI 10.1094/MPMI-21-7-0859; Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deng YW, 2017, SCIENCE, V355, P962, DOI 10.1126/science.aai8898; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Farkhari M, 2011, PLANT BREEDING, V130, P533, DOI 10.1111/j.1439-0523.2011.01866.x; Fukuoka S, 2001, THEOR APPL GENET, V103, P185, DOI 10.1007/s001220100611; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; He XY, 2012, SCI CHINA LIFE SCI, V55, P141, DOI 10.1007/s11427-012-4282-2; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jia YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043066; Koide Y, 2013, MOL BREEDING, V32, P241, DOI 10.1007/s11032-013-9865-5; Kumar P, 2010, MOL BREEDING, V25, P217, DOI 10.1007/s11032-009-9320-9; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lei CL, 2013, CROP J, V1, P2, DOI 10.1016/j.cj.2013.07.007; Li W, 2008, MOL BREEDING, V22, P141, DOI 10.1007/s11032-008-9163-9; Liang ZJ, 2016, RICE, V9, P1, DOI 10.1186/s12284-016-0120-7; Liao JJ, 2016, ELIFE, V5, DOI [10.7554/eLife.19377, 10.7554/elife.19377]; Liu XQ, 2007, MOL GENET GENOMICS, V278, P403, DOI 10.1007/s00438-007-0258-5; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; OU SH, 1985, COMMONWEALTH MYCOLOG, P109; Raboin LM, 2012, PLANT PATHOL, V61, P1103, DOI 10.1111/j.1365-3059.2012.02602.x; Sallaud C, 2003, THEOR APPL GENET, V106, P794, DOI 10.1007/s00122-002-1088-9; Sester M, 2014, PLANT PATHOL, V63, P373, DOI 10.1111/ppa.12099; SILUE D, 1992, PHYTOPATHOLOGY, V82, P577, DOI 10.1094/Phyto-82-577; Su J, 2015, THEOR APPL GENET, V128, P2213, DOI 10.1007/s00122-015-2579-9; Wang R, 2016, MATH PROBLEMS ENG, V2016, P1, DOI DOI 10.1016/J.NEUR0SCIENCE.2016.08.051; Wu JZ, 2003, PLANT J, V36, P720, DOI 10.1046/j.1365-313X.2003.01903.x; Xu P, 2015, EUPHYTICA, V205, P95, DOI 10.1007/s10681-015-1402-7; Yang QZ, 2009, THEOR APPL GENET, V118, P1027, DOI 10.1007/s00122-008-0959-0; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zeigler R. S., 1994, RICE BLAST DIS, P16; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	37	13	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186201	10.1371/journal.pone.0186201	http://dx.doi.org/10.1371/journal.pone.0186201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016662	Green Published, gold, Green Submitted			2022-12-26	WOS:000412627400059
J	Eloot, S; Van Biesen, W; Roels, S; Delrue, W; Schepers, E; Dhondt, A; Vanholder, R; Glorieux, G				Eloot, Sunny; Van Biesen, Wim; Roels, Sanne; Delrue, Willem; Schepers, Eva; Dhondt, Annemieke; Vanholder, Raymond; Glorieux, Griet			Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; P-CRESOL; ASYMMETRICAL DIMETHYLARGININE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; SYNBIOTIC TREATMENT; RENAL-FAILURE; MORTALITY; SOLUTES; TRIAL	Background and aim Numerous outcome studies and interventional trials in hemodialysis (HD) patients are based on uremic toxin concentrations determined at one single or a limited number of time points. The reliability of these studies however entirely depends on how representative these cross-sectional concentrations are. We therefore investigated the variability of predialysis concentrations of uremic toxins over time. Methods Prospectively collected predialysis serum samples of the midweek session of week 0, 1, 2, 3, 4, 8, 12, and 16 were analyzed for a panel of uremic toxins in stable chronic HD patients (N = 18) while maintaining dialyzer type and dialysis mode during the study period. Results Concentrations of the analyzed uremic toxins varied substantially between individuals, but also within stable HD patients (intra-patient variability). For urea, creatinine, beta-2-micro-globulin, and some protein-bound uremic toxins, Intra-class Correlation Coefficient (ICC) was higher than 0.7. However, for phosphorus, uric acid, symmetric and asymmetric dimethylarginine, and the protein-bound toxins hippuric acid and indoxyl sulfate, ICC values were below 0.7, implying a concentration variability within the individual patient even exceeding 65% of the observed inter-patient variability. Conclusion Intra-patient variability may affect the interpretation of the association between a single concentration of certain uremic toxins and outcomes. When performing future outcome and interventional studies with uremic toxins other than described here, one should quantify their intra-patient variability and take into account that for solutes with a large intra-patient variability associations could be missed.	[Eloot, Sunny; Van Biesen, Wim; Delrue, Willem; Schepers, Eva; Dhondt, Annemieke; Vanholder, Raymond; Glorieux, Griet] Ghent Univ Hosp, Dept Nephrol, Ghent, Belgium; [Roels, Sanne] Univ Ghent, Dept Data Anal, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University	Eloot, S (corresponding author), Ghent Univ Hosp, Dept Nephrol, Ghent, Belgium.	sunny.eloot@ugent.be			Belgian Fund for Research Flanders (FWO Vlaanderen) [G0A4614N]	Belgian Fund for Research Flanders (FWO Vlaanderen)	This study was financially supported by the Belgian Fund for Research Flanders (FWO Vlaanderen, project number G0A4614N).	Bammens B, 2006, KIDNEY INT, V69, P1081, DOI 10.1038/sj.ki.5000115; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Crespo-Salgado J, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0195-9; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Deltombe O, 2017, ANAL METHODS-UK, V9, P1935, DOI 10.1039/c7ay00054e; Dou L, 2015, J AM SOC NEPHROL, V26, P876, DOI 10.1681/ASN.2013121283; Eloot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076838; Fagugli RM, 2002, AM J KIDNEY DIS, V40, P339, DOI 10.1053/ajkd.2002.34518; FLEISS JL, 1986, CONTROL CLIN TRIALS, V7, P267, DOI 10.1016/0197-2456(86)90034-6; Guida B, 2014, NUTR METAB CARDIOVAS, V24, P1043, DOI 10.1016/j.numecd.2014.04.007; Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1; Liabeuf S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067168; Liabeuf S, 2012, KIDNEY INT, V82, P1297, DOI 10.1038/ki.2012.301; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Locatelli F, 2009, J AM SOC NEPHROL, V20, P645, DOI 10.1681/ASN.2008060590; Lu TM, 2011, CLIN J AM SOC NEPHRO, V6, P1566, DOI 10.2215/CJN.08490910; Meert N, 2012, NEPHROL DIAL TRANSPL, V27, P2388, DOI 10.1093/ndt/gfr672; Meert N, 2010, ARTIF ORGANS, V34, P580, DOI 10.1111/j.1525-1594.2010.01005.x; Meert N, 2009, J NEPHROL, V22, P352; Nakabayashi I, 2011, NEPHROL DIAL TRANSPL, V26, P1094, DOI 10.1093/ndt/gfq624; Nakazato Y, 2015, CLIN EXP NEPHROL, V19, P1165, DOI 10.1007/s10157-015-1108-0; Nazzal L, 2017, NEPHROL DIAL TRANSPL; Poesen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140820; Raj DSC, 2000, NEPHROL DIAL TRANSPL, V15, P58, DOI 10.1093/ndt/15.1.58; Rossi M, 2016, CLIN J AM SOC NEPHRO, V11, P223, DOI 10.2215/CJN.05240515; Santoro A, 2008, AM J KIDNEY DIS, V52, P507, DOI 10.1053/j.ajkd.2008.05.011; Shafi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126048; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Vanholder R, 2001, INT J ARTIF ORGANS, V24, P695, DOI 10.1177/039139880102401004; Vanholder R, 1999, J AM SOC NEPHROL, V10, P1815; Yilmaz MI, 2008, J AM SOC NEPHROL, V19, P388, DOI 10.1681/ASN.2007040461; Zewinger S, 2017, EUR HEART J, V38, P1597, DOI 10.1093/eurheartj/ehx118; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949	34	21	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186010	10.1371/journal.pone.0186010	http://dx.doi.org/10.1371/journal.pone.0186010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016645	gold, Green Published, Green Submitted			2022-12-26	WOS:000412627400048
J	Schriever, VA; Han, PF; Weise, S; Hosel, F; Pellegrino, R; Hummel, T				Schriever, Valentin Alexander; Han, Pengfei; Weise, Stefanie; Hoesel, Franziska; Pellegrino, Robert; Hummel, Thomas			Time frequency analysis of olfactory induced EEG-power change	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; STIMULUS CONCENTRATION; TRIGEMINAL STIMULI; IDENTIFICATION; VOLUME	Objectives The objective of the present study was to investigate the usefulness of time-frequency analysis (TFA) of olfactory-induced EEG change with a low-cost, portable olfactometer in the clinical investigation of smell function. Materials & methods A total of 78 volunteers participated. The study was composed of three parts where olfactory stimuli were presented using a custom-built olfactometer. Part I was designed to optimize the stimulus as well as the recording conditions. In part II EEG-power changes after olfactory/trigeminal stimulation were compared between healthy participants and patients with olfactory impairment. In Part III the test-retest reliability of the method was evaluated in healthy subjects. Results Part I indicated that the most effective paradigm for stimulus presentation was cued stimulus, with an interstimulus interval of 18-20s at a stimulus duration of 1000ms with each stimulus quality presented 60 times in blocks of 20 stimuli each. In Part II we found that central processing of olfactory stimuli analyzed by TFA differed significantly between healthy controls and patients even when controlling for age. It was possible to reliably distinguish patients with olfactory impairment from healthy individuals at a high degree of accuracy (healthy controls vs anosmic patients: sensitivity 75%; specificity 89%). In addition we could show a good test-retest reliability of TFA of chemosensory induced EEG-power changes in Part III. Conclusions Central processing of olfactory stimuli analyzed by TFA reliably distinguishes patients with olfactory impairment from healthy individuals at a high degree of accuracy. Importantly this can be achieved with a simple olfactometer.	[Schriever, Valentin Alexander; Han, Pengfei; Weise, Stefanie; Hoesel, Franziska; Pellegrino, Robert; Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany; [Schriever, Valentin Alexander] Tech Univ Dresden, Abt Neuropadiat Med Fak Carl Gustav Carus, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Hummel, T (corresponding author), Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany.	Thomas.hummel@uniklinikum-dresden.de	Pellegrino, Robert/L-1719-2019	Han, Pengfei/0000-0001-8266-6655	Dr. Robert Pfleger Stiftung; German Research Foundation; TU Dresden	Dr. Robert Pfleger Stiftung; German Research Foundation(German Research Foundation (DFG)); TU Dresden(European Commission)	This study was supported by the Dr. Robert Pfleger Stiftung to VAS and TH, the German Research Foundation, and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Dr. Robert Pfleger Stiftung to VAS and TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the TU Dresden.	Boesveldt S, 2007, CLIN NEUROPHYSIOL, V118, P690, DOI 10.1016/j.clinph.2006.11.004; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; EVANS WJ, 1993, CHEM SENSES, V18, P751, DOI 10.1093/chemse/18.6.751; Frasnelli J, 2011, CHEM SENSES, V36, P405, DOI 10.1093/chemse/bjr001; Frasnelli J, 2003, J CLIN NEUROPHYSIOL, V20, P80, DOI 10.1097/00004691-200302000-00011; Geisler MW, 2000, INT J PSYCHOPHYSIOL, V37, P309, DOI 10.1016/S0167-8760(00)00111-2; Huart C, 2013, RHINOLOGY, V51, P210, DOI [10.4193/Rhin13.007, 10.4193/Rhino13.007]; Huart C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033221; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KOBAL G, 1978, EEG-EMG-Z ELEK ELEKT, V9, P135; LIVERMORE A, 1992, ELECTROEN CLIN NEURO, V83, P201, DOI 10.1016/0013-4694(92)90145-8; Lotsch J, 2006, BEHAV BRAIN RES, V170, P78, DOI 10.1016/j.bbr.2006.02.013; Lorig TS, 2000, INT J PSYCHOPHYSIOL, V36, P91, DOI 10.1016/S0167-8760(99)00104-X; Lundstrom JN, 2010, INT J PSYCHOPHYSIOL, V78, P179, DOI 10.1016/j.ijpsycho.2010.07.007; Morgan CD, 1999, PSYCHOPHYSIOLOGY, V36, P281, DOI 10.1017/S0048577299980265; Rombaux P, 2006, ARCH OTOLARYNGOL, V132, P1346, DOI 10.1001/archotol.132.12.1346; Stuck BA, 2006, CLIN NEUROPHYSIOL, V117, P1367, DOI 10.1016/j.clinph.2006.03.004; Welge-Lussen A, 2003, J CLIN NEUROPHYSIOL, V20, P135, DOI 10.1097/00004691-200304000-00008	19	19	22	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185596	10.1371/journal.pone.0185596	http://dx.doi.org/10.1371/journal.pone.0185596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016623	Green Published, Green Submitted, gold			2022-12-26	WOS:000412627400024
J	Kushanov, FN; Buriev, ZT; Shermatov, SE; Turaev, OS; Norov, TM; Pepper, AE; Saha, S; Ulloa, M; Yu, JZ; Jenkins, JN; Abdukarimov, A; Abdurakhmonov, IY				Kushanov, Fakhriddin N.; Buriev, Zabardast T.; Shermatov, Shukhrat E.; Turaev, Ozod S.; Norov, Tokhir M.; Pepper, Alan E.; Saha, Sukumar; Ulloa, Mauricio; Yu, John Z.; Jenkins, Johnie N.; Abdukarimov, Abdusattor; Abdurakhmonov, Ibrokhim Y.			QTL mapping for flowering-time and photoperiod insensitivity of cotton Gossypium darwinii Watt	PLOS ONE			English	Article							PROTEIN-KINASE CK2; QUANTITATIVE TRAIT LOCUS; HIRSUTUM L. GERMPLASM; FIBER QUALITY TRAITS; 1ST FRUITING BRANCH; UPLAND COTTON; LINKAGE DISEQUILIBRIUM; MOLECULAR DIVERSITY; BARBADENSE L.; GENETIC-MAP	Most wild and semi-wild species of the genus Gossypium are exhibit photoperiod-sensitive flowering. The wild germplasm cotton is a valuable source of genes for genetic improvement of modern cotton cultivars. A bi-parental cotton population segregating for photoperiodic flowering was developed by crossing a photoperiod insensitive irradiation mutant line with its pre-mutagenesis photoperiodic wild-type G. darwinii Watt genotype. Individuals from the F-2 and F-3 generations were grown with their parental lines and F-1 hybrid progeny in the long day and short night summer condition (natural day-length) of Uzbekistan to evaluate photoperiod sensitivity, i.e., flowering-time during the seasons 2008-2009. Through genotyping the individuals of this bi-parental population segregating for flowering-time, linkage maps were constructed using 212 simple-sequence repeat (SSR) and three cleaved amplified polymorphic sequence (CAPS) markers. Six QTLs directly associated with flowering-time and photoperiodic flowering were discovered in the F-2 population, whereas eight QTLs were identified in the F-3 population. Two QTLs controlling photoperiodic flowering and duration of flowering were common in both populations. In silico annotations of the flanking DNA sequences of mapped SSRs from sequenced cotton (G. hirsutum L.) genome database has identified several potential 'candidate' genes that are known to be associated with regulation of flowering characteristics of plants. The outcome of this research will expand our understanding of the genetic and molecular mechanisms of photoperiodic flowering. Identified markers should be useful for marker-assisted selection in cotton breeding to improve early flowering characteristics.	[Kushanov, Fakhriddin N.; Buriev, Zabardast T.; Shermatov, Shukhrat E.; Turaev, Ozod S.; Norov, Tokhir M.; Abdukarimov, Abdusattor; Abdurakhmonov, Ibrokhim Y.] Acad Sci Uzbek, Ctr Genom & Bioinformat, Lab Struct & Funct Genom, Tashkent, Uzbekistan; [Pepper, Alan E.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Saha, Sukumar; Jenkins, Johnie N.] USDA ARS, Crop Sci Res Lab, Starkville, MS USA; [Ulloa, Mauricio] USDA ARS, Plant Stress & Germplasm Dev Res, Lubbock, TX USA; [Yu, John Z.] USDA ARS, Southern Plains Agr Res Ctr, College Stn, TX USA	Academy of Sciences of Uzbekistan; Center of Genomics & Bioinformatics; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Abdurakhmonov, IY (corresponding author), Acad Sci Uzbek, Ctr Genom & Bioinformat, Lab Struct & Funct Genom, Tashkent, Uzbekistan.	genomics@uzsci.net	Norov, Tokhir/AAA-9428-2021; Buriev, Zabardast/AAE-2579-2021; Shermatov, Shukhrat/H-1186-2015; Kushanov, Fakhriddin/C-9483-2018; To'rayev, Ozod/ABE-4791-2021; Turaev, Ozod/AAA-5527-2022; Abdurakhmonov, Ibrokhim Y./F-5588-2015; Kushanov, Fakhriddin/N-9968-2019	Shermatov, Shukhrat/0000-0002-1864-8126; Kushanov, Fakhriddin/0000-0001-8446-8118; Turaev, Ozod/0000-0002-6379-312X; Abdurakhmonov, Ibrokhim Y./0000-0001-9563-0686; Buriev, Zabardast/0000-0001-7737-9168	Academy of Sciences of Uzbekistan; Science and Technology Agency [FA-F5-T030, FA-A6-T081, FA-A6-T085, YF5-FA-T-005]; FNK; Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA) Agricultural Research Service (ARS); U.S. Civilian Research and Development Foundation (CRDF) [P121/P121B, P120/P120A]; Uzbekistan Government, Ministry of Foreign Economic Relations, Trade and Investments of Uzbekistan	Academy of Sciences of Uzbekistan; Science and Technology Agency; FNK; Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA) Agricultural Research Service (ARS); U.S. Civilian Research and Development Foundation (CRDF); Uzbekistan Government, Ministry of Foreign Economic Relations, Trade and Investments of Uzbekistan	This work was supported by the Academy of Sciences of Uzbekistan, and Committee for Coordination Science and Technology Development of Uzbekistan Currently renamed as Science and Technology Agency) have provided basic science research grant No. FA-F5-T030 to IYA, and several applied research grants No.FA-A6-T081, FA-A6-T085 and YF5-FA-T-005 to IYA and FNK and the Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA) Agricultural Research Service (ARS) and U.S. Civilian Research and Development Foundation (CRDF) have provided international cooperative grants P121/P121B, and P120/P120A to IYA, AEP, SS, JZY, and JNJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Academy of Sciences of Uzbekistan, and Committee for Coordination Science and Technology Development of Uzbekistan for basic science (FA-F5-T030), and several applied (FA-A6-T081, FA-A6-T085 and YF5-FA-T-005) research grants. We greatly acknowledge the Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA) Agricultural Research Service (ARS) and U.S. Civilian Research and Development Foundation (CRDF) for international cooperative grants P121/P121B, and P120/P120A, which were devoted to study cotton flowering and genetic mapping of agronomic traits. We thank the Uzbekistan Government, Ministry of Foreign Economic Relations, Trade and Investments of Uzbekistan for capacity funding of the Center of Genomics and Bioinformatics, Uzbekistan. We greatly acknowledge the Uzbek and US partner laboratories for the assistance with molecular mapping experiments described in this work. Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the US Department of Agriculture. The US Department of Agriculture is equal an opportunity provider and employer.	Abdurakhmonov IY, 2007, EUPHYTICA, V156, P141, DOI 10.1007/s10681-007-9361-2; Abdurakhmonov IY, 2008, GENOMICS, V92, P478, DOI 10.1016/j.ygeno.2008.07.013; Abdurakhmonov IY, 2007, J HERED, V98, P258, DOI 10.1093/jhered/esm007; Abdurakhmonov IY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4062; Abdurakhmonov IY, 2012, GENETIC DIVERSITY IN PLANTS, P313; Abdurakhmonov IY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-119; Abdurakhmonov IY, 2009, GENETICA, V136, P401, DOI 10.1007/s10709-008-9337-8; Abdurakhmonov Ibrokhim Y, 2008, Int J Plant Genomics, V2008, P574927, DOI 10.1155/2008/574927; Abdurakhmonov IY, 2016, PLANT SCI, V7, P202, DOI DOI 10.3389/FPLS.2016.00202; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bolek Y, 2005, PLANT SCI, V168, P1581, DOI 10.1016/j.plantsci.2005.02.008; Casal JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P1, DOI 10.1562/0031-8655(2000)071&lt;0001:PCPPII&gt;2.0.CO;2; Chen HD, 2015, GENE, V574, P273, DOI 10.1016/j.gene.2015.08.022; Chen Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078254, 10.1371/journal.pone.0080879, 10.1371/journal.pone.0080419]; Corbesier L, 2005, PLANT CELL ENVIRON, V28, P54, DOI 10.1111/j.1365-3040.2005.01283.x; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Fang DD, 2013, EUPHYTICA, V191, P391, DOI 10.1007/s10681-013-0886-2; Fankhauser C, 1997, ANNU REV CELL DEV BI, V13, P203, DOI 10.1146/annurev.cellbio.13.1.203; Garner WW, 1923, J AGRIC RES, V23, P0871; Godoy AS, 1999, EUPHYTICA, V105, P155, DOI 10.1023/A:1003490016166; Guo YF, 2008, EUPHYTICA, V163, P113, DOI 10.1007/s10681-007-9613-1; Guo YF, 2009, EUPHYTICA, V166, P317, DOI 10.1007/s10681-008-9809-z; Gutierrrez OA, 2010, THEOR APPL GENET, V121, P1323, DOI 10.1007/s00122-010-1391-9; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Jia YH, 2014, J INTEGR AGR, V13, P1845, DOI 10.1016/S2095-3119(13)60668-1; Keller O, 2011, BIOINFORMATICS, V27, P757, DOI 10.1093/bioinformatics/btr010; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kushanov FN, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0448-4; Lai D, 2011, PLOS ONE, V6, P1; Li CQ, 2013, BREEDING SCI, V63, P154, DOI 10.1270/jsbbs.63.154; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; Mathews S, 1997, PLANT CELL ENVIRON, V20, P666, DOI 10.1046/j.1365-3040.1997.d01-117.x; Muhammad Iqbal, 2013, World Applied Sciences Journal, V21, P1062; Mulekar JJ, 2014, J EXP BOT, V65, P2883, DOI 10.1093/jxb/ert401; Mulekar JJ, 2012, PLANT J, V69, P343, DOI 10.1111/j.1365-313X.2011.04794.x; Nelson JC, 1997, MOL BREEDING, V3, P239, DOI 10.1023/A:1009604312050; Ogiso E, 2010, PLANT PHYSIOL, V152, P808, DOI 10.1104/pp.109.148908; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Olsten MEK, 2005, MOL CELL BIOCHEM, V274, P115, DOI 10.1007/s11010-005-3072-6; Portoles S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001201; Qin HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118073; Saeed M, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue3-fulltext-3; SAID JI, 2015, COMP METAANALYSIS QT, V290, P1003, DOI DOI 10.1007/S00438-014-0963-9; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Shen XL, 2011, CROP SCI, V51, P2005, DOI 10.2135/cropsci2010.11.0653; Shen XL, 2005, MOL BREEDING, V15, P169, DOI 10.1007/s11032-004-4731-0; SINGH M, 1993, THEOR APPL GENET, V86, P437, DOI 10.1007/BF00838558; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Ulloa M, 2006, J COTTON SCI, V10, P114; Van Ooijen JW, 2001, PLANT RES INT; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang CCN, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-15; Wang S., WINDOWS QTL CARTOGRA; Wang WS, 2016, PLANT CELL REP, V35, P1071, DOI 10.1007/s00299-016-1939-5; Weebadde CK, 2008, PLANT BREEDING, V127, P94, DOI 10.1111/j.1439-0523.2007.01430.x; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1990, BIOCHEM SYST ECOL, V18, P517, DOI 10.1016/0305-1978(90)90123-W; Wu JX, 2009, EUPHYTICA, V165, P231, DOI 10.1007/s10681-008-9748-8; Wu YX, 2007, PLANT SYST EVOL, V268, P199, DOI 10.1007/s00606-007-0565-7; Yu JZ, 2014, MOL GENET GENOMICS, V289, P1347, DOI 10.1007/s00438-014-0930-5; Yu JZ, 2012, G3-GENES GENOM GENET, V2, P43, DOI 10.1534/g3.111.001552; Yu X., 2010, ARABIDOPSIS BOOK, pe0135; Zhang ZS, 2009, MOL BREEDING, V24, P49, DOI 10.1007/s11032-009-9271-1; Zhu LL, 2014, CROP SCI, V54, P2492, DOI 10.2135/cropsci2014.03.0258	68	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186240	10.1371/journal.pone.0186240	http://dx.doi.org/10.1371/journal.pone.0186240			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016665	Green Submitted, Green Published, gold			2022-12-26	WOS:000412601800048
J	List, R; Postolka, B; Schutz, P; Hitz, M; Schwilch, P; Gerber, H; Ferguson, SJ; Taylor, WR				List, Renate; Postolka, Barbara; Schutz, Pascal; Hitz, Marco; Schwilch, Peter; Gerber, Hans; Ferguson, Stephen J.; Taylor, William R.			A moving fluoroscope to capture tibiofemoral kinematics during complete cycles of free level and downhill walking as well as stair descent	PLOS ONE			English	Article							TOTAL KNEE ARTHROPLASTY; IN-VIVO KINEMATICS; TREADMILL WALKING; GAIT ANALYSIS; 3-DIMENSIONAL KINEMATICS; REPLACEMENT KINEMATICS; JOINT KINEMATICS; IMAGES; SINGLE; FORCE	Videofluoroscopy has been shown to provide essential information in the evaluation of the functionality of total knee arthroplasties. However, due to the limitation in the field of view, most systems can only assess knee kinematics during highly restricted movements. To avoid the limitations of a static image intensifier, a moving fluoroscope has been presented as a standalone system that allows tracking of the knee during multiple complete cycles of level- and downhill-walking, as well as stair descent, in combination with the synchronous assessment of ground reaction forces and whole body skin marker measurements. Here, we assess the ability of the system to keep the knee in the field of view of the image intensifier. By measuring ten total knee arthroplasty subjects, we demonstrate that it is possible to maintain the knee to within 1.8 +/- 1.4 cm vertically and 4.0 +/- 2.6 cm horizontally of the centre of the intensifier throughout full cycles of activities of daily living. Since control of the system is based on real-time feedback of a wire sensor, the system is not dependent on repeatable gait patterns, but is rather able to capture pathological motion patterns with low inter-trial repeatability.	[List, Renate; Postolka, Barbara; Schutz, Pascal; Hitz, Marco; Schwilch, Peter; Gerber, Hans; Ferguson, Stephen J.; Taylor, William R.] ETH, Inst Biomech, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	List, R (corresponding author), ETH, Inst Biomech, Zurich, Switzerland.	rlist@ethz.ch	Taylor, William R./F-8692-2010; Postolka, Barbara/P-9290-2019; Schütz, Pascal/E-4745-2014; Ferguson, Stephen J./A-4118-2012; List, Renate/D-3884-2011	Taylor, William R./0000-0003-4060-4098; Postolka, Barbara/0000-0002-1996-1501; Schütz, Pascal/0000-0003-1711-7881; Ferguson, Stephen J./0000-0003-0650-5889; List, Renate/0000-0003-3292-1915	RMS foundation (Bettlach, Switzerland); Philips Medical Systems (Switzerland); Medacta International SA (Castel San Pietro, Switzerland); Commission for Technology and Innovation (Bern, Switzerland)	RMS foundation (Bettlach, Switzerland); Philips Medical Systems (Switzerland); Medacta International SA (Castel San Pietro, Switzerland); Commission for Technology and Innovation (Bern, Switzerland)	The development was financially supported by RMS foundation (Bettlach, Switzerland), Philips Medical Systems (Switzerland), Medacta International SA (Castel San Pietro, Switzerland) and the Commission for Technology and Innovation (Bern, Switzerland).	Akbarshahi M, 2010, J BIOMECH, V43, P1292, DOI 10.1016/j.jbiomech.2010.01.002; Alton F, 1998, CLIN BIOMECH, V13, P434, DOI 10.1016/S0268-0033(98)00012-6; Andriacchi TP, 1998, J BIOMECH ENG-T ASME, V120, P743, DOI 10.1115/1.2834888; ANDRIACCHI TP, 1982, J BONE JOINT SURG AM, V64, P1328, DOI 10.2106/00004623-198264090-00008; Banks S, 2006, J BIOMECHANICS S1, V39, pS446, DOI [10.1016/S0021-9290(06)84824-4, DOI 10.1016/S0021-9290(06)84824-4]; Banks SA, 2005, KNEE SURG SPORT TR A, V13, P551, DOI 10.1007/s00167-004-0565-x; Banks SA, 1996, IEEE T BIO-MED ENG, V43, P638, DOI 10.1109/10.495283; Burckhardt K, 2005, IEEE T MED IMAGING, V24, P676, DOI 10.1109/TMI.2005.846849; Cappozzo A, 2005, GAIT POSTURE, V21, P186, DOI 10.1016/j.gaitpost.2004.01.010; Catani F, 2009, J ORTHOP RES, V27, P1569, DOI 10.1002/jor.20941; De K, 2013, PROCEDIA ENGINEER, V64, P149, DOI 10.1016/j.proeng.2013.09.086; Dennis A D, 1999, Acta Chir Orthop Traumatol Cech, V66, P323; deQuervain IAK, 1997, J ARTHROPLASTY, V12, P168, DOI 10.1016/S0883-5403(97)90063-2; Fantozzi S, 2003, GAIT POSTURE, V17, P225, DOI 10.1016/S0966-6362(02)00096-6; Foresti M, 2008, 8 INT S COMP METH BI; Foresti M., 2009, THESIS; Foresti M, 2006, J BIOMECH, V39, pS109; Gander W., 1997, SOLVING PROBLEMS SCI, V3, P339; Guan S, 2016, IEEE T MED IMAGING, V35, P326, DOI 10.1109/TMI.2015.2473168; Hoff WA, 1998, CLIN BIOMECH, V13, P455, DOI 10.1016/S0268-0033(98)00009-6; Kramers de Quervain I.A., 2008, SCHWEIZERISCHE Z SPO, V56, P35; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; Leardini A, 2006, CLIN BIOMECH, V21, P870, DOI 10.1016/j.clinbiomech.2006.03.007; Lee SJ, 2008, J APPL PHYSIOL, V104, P747, DOI 10.1152/japplphysiol.01380.2006; Li GA, 2004, J BIOMECH ENG-T ASME, V126, P314, DOI 10.1115/1.1691448; List R, 2012, FOOT ANKLE INT, V33, P883, DOI 10.3113/FAI.2012.0883; Liu F, 2006, J BIOMECH, V39, pS213, DOI 10.1016/S0021-9290(06)83779-6; Mahfouz MR, 2003, IEEE T MED IMAGING, V22, P1561, DOI 10.1109/TMI.2003.820027; McIntosh AS, 2006, J BIOMECH, V39, P2491, DOI 10.1016/j.jbiomech.2005.07.025; Moro-oka T, 2007, KNEE SURG SPORT TR A, V15, P93, DOI 10.1007/s00167-006-0134-6; Schutz P, 2016, 14 S 3 D AN HUM MOV; Sharma A, 2008, J BIOMECH, V41, P642, DOI 10.1016/j.jbiomech.2007.09.027; Stacoff A, 2005, GAIT POSTURE, V21, P24, DOI 10.1016/j.gaitpost.2003.11.003; Stolze H, 1997, ELECTROMYOGR MOTOR C, V105, P490, DOI 10.1016/S0924-980X(97)00055-6; Stoquart G, 2008, NEUROPHYSIOL CLIN, V38, P105, DOI 10.1016/j.neucli.2008.02.002; STRATHY GM, 1983, J BIOMECH, V16, P517, DOI 10.1016/0021-9290(83)90066-0; Van de Velde SK, 2010, ACTA ORTHOP BELG, V76, P107; Warabi T, 2005, NEUROSCI RES, V53, P343, DOI 10.1016/j.neures.2005.08.005; Wass E, 2005, GAIT POSTURE, V21, P72, DOI 10.1016/j.gaitpost.2004.01.003; Watt JR, 2010, CLIN BIOMECH, V25, P444, DOI 10.1016/j.clinbiomech.2009.09.002; Weese J, 1997, IEEE T INF TECHNOL B, P1; Yamokoski JD, 2011, GAIT POSTURE, V34, P508, DOI 10.1016/j.gaitpost.2011.07.002; Zhao D, 2007, J ORTHOP RES, V25, P789, DOI 10.1002/jor.20379; Zhu ZL, 2012, COMPUT METHOD BIOMEC, V15, P1245, DOI 10.1080/10255842.2011.597387; Zihlmann MS, 2006, GAIT POSTURE, V24, P475, DOI 10.1016/j.gaitpost.2005.12.012; Zuffi S, 1999, IEEE T MED IMAGING, V18, P981, DOI 10.1109/42.811310	47	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185952	10.1371/journal.pone.0185952	http://dx.doi.org/10.1371/journal.pone.0185952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016647	gold, Green Published, Green Submitted			2022-12-26	WOS:000412601800029
J	Rice, JP; Seifert, M; Moser, KS; Rodwell, TC				Rice, Jason P.; Seifert, Marva; Moser, Kathleen S.; Rodwell, Timothy C.			Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RAPID DETECTION; UNITED-STATES; SMEAR MICROSCOPY; DRUG-RESISTANCE; IMPLEMENTATION; MUTATIONS; ACCURACY; STRAINS; SAMPLES	Performance of the Xpert MTB/RIF assay, designed to simultaneously detect Mycobacterium tuberculosis complex (MTBC) and rifampin (RIF) resistance, has been well documented in low-resource settings with high TB-incidence. However, few studies have assessed its accuracy in low TB incidence settings. We evaluated the performance of Xpert MTB/RIF using clinical sputum specimens routinely collected from suspect pulmonary TB patients over a 4-year time period in San Diego County, California. Xpert MTB/RIF results were compared to acid-fast bacilli (AFB) smear microscopy, mycobacterial culture, and phenotypic drug susceptibility testing (DST). Of 751 sputum specimens, 134 (17.8%) were MTBC culture-positive and 2 (1.5%) were multidrug-resistant (MDR). For the detection of MTBC, Xpert MTB/RIF sensitivity was 89.6% (97.7% and 74.5% in smear-positive and -negative sputa, respectively) and specificity was 97.2%; while AFB smear sensitivity and specificity were 64.9% and 77.8%, respectively. Xpert MTB/RIF detected 35 of 47 smear-negative culture-positive specimens, and excluded 124 of 137 smear-positive culture-negative specimens. Xpert MTB/RIF also correctly excluded 99.2% (121/122) of nontuberculous mycobacteria (NTM) specimens, including all 33 NTM false-positives by smear microscopy. For the detection of RIF resistance, Xpert MTB/RIF sensitivity and specificity were 100% and 98.3%, respectively. Our findings demonstrate that Xpert MTB/RIF is able to accurately detect MTBC and RIF resistance in routinely collected respiratory specimens in a low TB-incidence setting, with comparable performance to that achieved in high-incidence settings; and suggest that under these conditions the assay has particular utility in detecting smear-negative TB cases, excluding smear-positive patients without MTBC disease, and differentiating MTBC from NTM.	[Rice, Jason P.] Univ Calif San Diego, Div Prevent Med, San Diego, CA 92103 USA; [Seifert, Marva; Rodwell, Timothy C.] Univ Calif San Diego, Div Pulm Crit Care & Sleep Med, San Diego, CA 92103 USA; [Moser, Kathleen S.] Cty San Diego Hlth & Human Serv Agcy, TB Control & Refugee Hlth Program, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Rice, JP (corresponding author), Univ Calif San Diego, Div Prevent Med, San Diego, CA 92103 USA.	ricejp78@gmail.com		Seifert, Marva/0000-0002-7554-6396	National Institutes of Health [T32-HL098062]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL134632, T32HL098062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	MS is supported by the National Institutes of Health [T32-HL098062]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2011, J CLIN MICROBIOL, V49, P2688, DOI 10.1128/JCM.00659-11; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P7; [Anonymous], 2013, FDA PERM MARK 1 US T; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bowles EC, 2011, INT J TUBERC LUNG D, V15, P988, DOI 10.5588/ijtld.10.0574; Centers for Disease Control and Prevention (CDC), 2008, REP EXP CONS RAP MOL; Centers for Disease Control and Prevention (CDC), 2008, REP EXP CONS US NUCL; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Choi HW, 2013, INT J TUBERC LUNG D, V17, P1328, DOI 10.5588/ijtld.13.0095; County of San Diego Tuberculosis Control Program, 2014, TUB CONTR PROGR 2013; County of San Diego Tuberculosis Control Program, 2016, COMP NAT STAT COUNT; Deggim V, 2013, J CLIN MICROBIOL, V51, P2396, DOI 10.1128/JCM.00151-13; Dickinson Becton, 2015, BACTEC MGIT 960 SIRE; Dickinson Becton, 2009, BACTEC MGIT 960 PZA; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; GLI, 2014, MYC LAB MAN; Global Laboratory Initiative (GLI), 2015, GUID PROV TECHN SUPP; Guerra RL, 2007, CHEST, V132, P946, DOI 10.1378/chest.06-2959; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Iademarco MF, 2013, MMWR-MORBID MORTAL W, V62, P821; Ioannidis P, 2011, J CLIN MICROBIOL, V49, P3068, DOI 10.1128/JCM.00718-11; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Lin SYG, 2014, J CLIN MICROBIOL, V52, P475, DOI 10.1128/JCM.01821-13; Lin SYG, 2014, CLIN LAB MED, V34, P297, DOI 10.1016/j.cll.2014.02.005; LoBue PA, 2005, INT J TUBERC LUNG D, V9, P501; Malbruny B, 2011, INT J TUBERC LUNG D, V15, P553, DOI 10.5588/ijtld.10.0497; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; McAlister AJ, 2015, J CLIN MICROBIOL, V53, P1752, DOI 10.1128/JCM.03433-14; McShane PJ, 2015, CHEST, V148, P1517, DOI 10.1378/chest.15-0458; Miller MB, 2011, J CLIN MICROBIOL, V49, P3458, DOI 10.1128/JCM.05212-11; Mirsaeidi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091879; Moore DF, 2005, DIAGN MICR INFEC DIS, V52, P247, DOI 10.1016/j.diagmicrobio.2005.02.014; Organization WH, 2016, GLOBAL TUBERCULOSIS; Pai M, 2015, J INFECT DIS, V211, pS21, DOI 10.1093/infdis/jiu803; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rigouts L, 2013, J CLIN MICROBIOL, V51, P2641, DOI 10.1128/JCM.02741-12; Rodwell TC, 2014, J CLIN MICROBIOL, V52, P781, DOI 10.1128/JCM.02701-13; Sohn H, 2014, CLIN INFECT DIS, V58, P970, DOI 10.1093/cid/ciu022; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; US Food and Drug Administration (FDA), 2013, 510 K DEC SUMM DE NO; Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; WHO, 2011, AUT REAL TIM NUCL AC; Williamson DA, 2012, DIAGN MICR INFEC DIS, V74, P207, DOI 10.1016/j.diagmicrobio.2012.06.013; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2014, WHOHTMTB20141; World Health Organization (WHO), 2015, WHOHTMTB201511 WHOHTMTB201511; World Health Organization (WHO), 2014, FRAM TUB EL LOW INC; World Health Organization-WHO, 2015, STOP TB PARTN GLOB P; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; 2012, GLOB TUB REP 2013, P1	55	29	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186139	10.1371/journal.pone.0186139	http://dx.doi.org/10.1371/journal.pone.0186139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016684	Green Published, gold, Green Submitted			2022-12-26	WOS:000412601800041
J	Li, MW; Sletten, AC; Lee, J; Pyles, KD; Matkovich, SJ; Ory, DS; Schaffer, JE				Li, Melissa W.; Sletten, Arthur C.; Lee, Jiyeon; Pyles, Kelly D.; Matkovich, Scot J.; Ory, Daniel S.; Schaffer, Jean E.			Nuclear export factor 3 regulates localization of small nucleolar RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intracellular trafficking; molecular cell biology; nuclear transport; RNA transport; small nucleolar RNA (snoRNA)	MESSENGER-RNA; METABOLIC STRESS; NONCODING RNAS; FACTOR FAMILY; BIOGENESIS; SNORNA; CELLS; U3; INVOLVEMENT; MECHANISMS	Small nucleolar RNAs (snoRNAs) guide chemical modifications of ribosomal and small nuclear RNAs, functions that are carried out in the nucleus. Although most snoRNAs reside in the nucleolus, a growing body of evidence indicates that snoRNAs are also present in the cytoplasm and that snoRNAs move between the nucleus and cytoplasm by a mechanism that is regulated by lipotoxic and oxidative stress. Here, in a genome-wide shRNA-based screen, we identified nuclear export factor 3 (NXF3) as a transporter that alters the nucleocytoplasmic distribution of box C/D snoRNAs from the ribosomal protein L13a (Rpl13a) locus. Using RNA-sequencing analysis, we show that NXF3 associates not only with Rpl13a snoRNAs, but also with a broad range of box C/D and box H/ACA snoRNAs. Under homeostatic conditions, gain- or loss-of-function of NXF3, but not related family member NXF1, decreases or increases cytosolic Rpl13a snoRNAs, respectively. Furthermore, treatment with the adenylyl cyclase activator forskolin diminishes cytosolic localization of the Rpl13a snoRNAs through a mechanism that is dependent on NXF3 but not NXF1. Our results provide evidence of a new role for NXF3 in regulating the distribution of snoRNAs between the nuclear and cytoplasmic compartments.	[Li, Melissa W.; Sletten, Arthur C.; Lee, Jiyeon; Pyles, Kelly D.; Ory, Daniel S.; Schaffer, Jean E.] Washington Univ, Sch Med, Dept Med, Diabet Res Ctr, St Louis, MO 63110 USA; [Matkovich, Scot J.] Washington Univ, Sch Med, Dept Med, Cardiovasc Res Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Schaffer, JE (corresponding author), Washington Univ, Sch Med, 660 South Euclid Ave,Campus Box 8086, St Louis, MO 63110 USA.	jschaff@wustl.edu	Matkovich, Scot J/AFP-0908-2022; Matkovich, Scot J/B-9077-2009	Matkovich, Scot J/0000-0002-7398-6857; Matkovich, Scot J/0000-0002-7398-6857; Lee, Jiyeon/0000-0002-8952-7938; Pyles, Kelly/0000-0001-9478-3365	NCI [P30 CA91842]; ICTS/CTSA from the NCRR [UL1 TR000448]; National Institutes of Health; National Institutes of Health Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, R01DK064989] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICTS/CTSA from the NCRR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Genome Technology Access Center at the Department of Genetics, Washington University School of Medicine, for help with RNA-sequencing. The Center is partially supported by NCI Cancer Center Support Grant P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant UL1 TR000448 from the NCRR, National Institutes of Health, and National Institutes of Health Roadmap for Medical Research.	BASERGA SJ, 1992, GENE DEV, V6, P1120, DOI 10.1101/gad.6.6.1120; Boulon S, 2004, MOL CELL, V16, P777, DOI 10.1016/j.molcel.2004.11.013; Caputa G, 2016, CELL DEATH DIFFER, V23, P347, DOI 10.1038/cdd.2015.105; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Dupuis-Sandoval F, 2015, WIRES RNA, V6, P381, DOI 10.1002/wrna.1284; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Fasold M, 2011, NUCLEIC ACIDS RES, V39, pW112, DOI 10.1093/nar/gkr357; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Freedman DA, 2004, CELL CYCLE, V3, P811; GALLI C, 1995, J NEUROSCI, V15, P1172; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Holley CL, 2015, J BIOL CHEM, V290, P11741, DOI 10.1074/jbc.M115.637413; Hoque KM, 2010, J GEN PHYSIOL, V135, P43, DOI 10.1085/jgp.200910339; Izaurralde E, 2001, CELL MOL LIFE SCI, V58, P1105, DOI 10.1007/PL00000924; Jenkinson EM, 2016, NAT GENET, V48, P1185, DOI 10.1038/ng.3661; Jun L, 2001, CURR BIOL, V11, P1381, DOI 10.1016/S0960-9822(01)00419-5; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; Katahira J, 2008, NUCLEIC ACIDS RES, V36, P616, DOI 10.1093/nar/gkm556; Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585; Kiss T, 2004, J CELL SCI, V117, P5949, DOI 10.1242/jcs.01487; Kuersten S, 2004, MOL CELL, V14, P599, DOI 10.1016/j.molcel.2004.05.004; Lee JY, 2016, J CLIN INVEST, V126, P4616, DOI 10.1172/JCI88069; Lefebvre FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27680; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; MICHAUD N, 1992, J CELL BIOL, V116, P851, DOI 10.1083/jcb.116.4.851; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Namkoong S, 2009, CELL SIGNAL, V21, P906, DOI 10.1016/j.cellsig.2009.01.038; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Sasaki M, 2005, GENOMICS, V85, P641, DOI 10.1016/j.ygeno.2005.01.003; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Scruggs BS, 2012, MOL CELL BIOL, V32, P4092, DOI 10.1128/MCB.00022-12; Shanker Savita, 2015, J Biomol Tech, V26, P4, DOI 10.7171/jbt.15-2601-001; Sienna N, 1996, EXP CELL RES, V227, P98, DOI 10.1006/excr.1996.0254; Siprashvili Z, 2016, NAT GENET, V48, P53, DOI 10.1038/ng.3452; Tretyakova I, 2005, J BIOL CHEM, V280, P31981, DOI 10.1074/jbc.M502736200; Vitali P, 2005, J CELL BIOL, V169, P745, DOI 10.1083/jcb.200411129; Watkins NJ, 2007, MOL CELL BIOL, V27, P7018, DOI 10.1128/MCB.00516-07; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Yang J, 2001, MOL CELL, V8, P397, DOI 10.1016/S1097-2765(01)00303-3; Yang K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13599; Yin YM, 2013, BIOCHEM J, V452, P67, DOI 10.1042/BJ20121006; Youssef OA, 2015, P NATL ACAD SCI USA, V112, P5023, DOI 10.1073/pnas.1424044112	44	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20228	20239		10.1074/jbc.M117.818146	http://dx.doi.org/10.1074/jbc.M117.818146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29021253	Green Published, hybrid			2022-12-26	WOS:000417696400027
J	Betts, J; Nagel, C; Schatzschneider, U; Poole, R; La Ragione, RM				Betts, Jonathan; Nagel, Christopher; Schatzschneider, Ulrich; Poole, Robert; La Ragione, Robert M.			Antimicrobial activity of carbon monoxidereleasing molecule [Mn(CO)(3)(tpa-kappa(3) N)] Br versus multidrug-resistant isolates of Avian Pathogenic Escherichia coli and its synergy with colistin	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ACINETOBACTER-BAUMANNII; ANTIBACTERIAL; INFECTIONS; COMBINATION; CHICKENS; EFFICACY	Antimicrobial resistance is a growing global concern in human and veterinary medicine, with an ever-increasing void in the arsenal of clinicians. Novel classes of compounds including carbon monoxoide-releasing molecules (CORMs), for example the light-activated metal complex [Mn(CO)(3)(tpa-kappa N-3)] Br, could be used as alternatives/to supplement traditional antibacterials. Avian pathogenic Escherichia coli (APEC) represent a large reservoir of antibiotic resistance and can cause serious clinical disease in poultry, with potential as zoonotic pathogens, due to shared serotypes and virulence factors with human pathogenic E. coli. The in vitro activity of [Mn(CO)(3)(tpa-kappa N-3)] Br against multidrug-resistant APECs was assessed via broth microtitre dilution assays and synergy testing with colistin performed using checkerboard and time-kill assays. In vivo antibacterial activity of [Mn(CO)(3)(tpa-kappa N-3)] Br alone and in combination with colistin was determined using the Galleria mellonella wax moth larvae model. Animals were monitored for life/death, melanisation and bacterial numbers enumerated from larval haemolymph. In vitro testing produced relatively high [Mn(CO)(3)(tpa-kappa N-3)] Br minimum inhibitory concentrations (MICs) of 1024 mg/L. However, its activity was significantly increased with the addition of colistin, bringing MICs down to <= 32 mg/L. This synergy was confirmed in time-kill assays. In vivo assays showed that the combination of [Mn (CO)(3)(tpa-kappa N-3)] Br with colistin produced superior bacterial killing and significantly increased larval survival. In both in vitro and in vivo assays light activation was not required for antibacterial activity. This data supports further evaluation of [Mn(CO)(3)(tpa-kappa N-3)] Br as a potential agent for treatment of systemic infections in humans and animals, when used with permeabilising agents such as colistin.	[Betts, Jonathan; La Ragione, Robert M.] Univ Surrey, Sch Vet Med, Dept Pathol & Infect Dis, Guildford, Surrey, England; [Nagel, Christopher; Schatzschneider, Ulrich] Julius Maximilians Univ Wurzburg, Inst Anorgan Chem, Wurzburg, Germany; [Poole, Robert] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield, S Yorkshire, England	University of Surrey; University of Wurzburg; University of Sheffield	Betts, J (corresponding author), Univ Surrey, Sch Vet Med, Dept Pathol & Infect Dis, Guildford, Surrey, England.	jono.betts@surrey.ac.uk	Betts, Jonathan/U-2168-2017	Betts, Jonathan/0000-0002-0619-0648	Biotechnology and Biological Sciences Research Council [BB/M022579/1]; Biotechnology and Biological Sciences Council (BBSRC) [BB/M022579/1]; BBSRC [BB/M022579/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by Biotechnology and Biological Sciences Research Council - BB/M022579/1 to Robert Poole and Roberto M La Ragione (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to gratefully acknowledge Dr Tim Wallis at Ridgeway Biologicals for the supply of the Escherichia coli strains. We would like to gratefully acknowledge the Biotechnology and Biological Sciences Council (BBSRC) for funding this work (BB/M022579/1).	[Anonymous], 2017, BREAKP TABL INT MICS; Davidge KS, 2009, J BIOL CHEM, V284, P4516, DOI 10.1074/jbc.M808210200; Ewers C, 2003, BERL MUNCH TIERARZTL, V116, P381; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Gordon NC, 2010, ANTIMICROB AGENTS CH, V54, P5316, DOI 10.1128/AAC.00922-10; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; Hornsey M, 2011, ANTIMICROB AGENTS CH, V55, P3534, DOI 10.1128/AAC.00230-11; Howe RA, 2012, J ANTIMICROB CHEMOTH, V67, P2783, DOI 10.1093/jac/dks391; Kabir SML, 2010, INT J ENV RES PUB HE, V7, P89, DOI 10.3390/ijerph7010089; Karlowsky JA, 2006, INT J ANTIMICROB AG, V27, P174, DOI 10.1016/j.ijantimicag.2005.10.014; Kemmett K, 2014, AVIAN PATHOL, V43, P37, DOI 10.1080/03079457.2013.866213; La Ragione RM, 2013, AVIAN DIS, V57, P273, DOI 10.1637/10326-081512-Reg.1; La Ragione RM, 2002, RES VET SCI, V73, P27, DOI 10.1016/S0034-5288(02)00075-9; Lee JH, 2007, NAT REV DRUG DISCOV, V6, P938, DOI 10.1038/nrd2201-c1; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Livermore DM, 2011, INT J ANTIMICROB AG, V37, P415, DOI 10.1016/j.ijantimicag.2011.01.012; Mellata M, 2013, FOODBORNE PATHOG DIS, V10, P916, DOI 10.1089/fpd.2013.1533; Nagel C, 2014, DALTON T, V43, P9986, DOI 10.1039/c3dt51848e; O'Neill J., 2016, REV ANTIMICROBIAL RE; Pacholewicz E, 2015, INT J FOOD MICROBIOL, V215, P57, DOI 10.1016/j.ijfoodmicro.2015.08.010; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Simpson PV, 2015, ORGANOMETALLICS, V34, P3809, DOI 10.1021/acs.organomet.5b00458; Tinajero-Trejo M, 2016, ANTIOXID REDOX SIGN, V24, P765, DOI 10.1089/ars.2015.6484; Tsai CJY, 2016, VIRULENCE, V7, P214, DOI 10.1080/21505594.2015.1135289; Tsubery H, 2005, ANTIMICROB AGENTS CH, V49, P3122, DOI 10.1128/AAC.49.8.3122-3128.2005; Ward JS, 2017, MEDCHEMCOMM, V8, P346, DOI 10.1039/c6md00603e	26	30	30	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e186359	10.1371/journal.pone.0186359	http://dx.doi.org/10.1371/journal.pone.0186359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040287	Green Published, gold, Green Submitted			2022-12-26	WOS:000413167500038
J	Fukuzawa, R; Anaka, MR; Morison, IM; Reeve, AE				Fukuzawa, Ryuji; Anaka, Matthew R.; Morison, Ian M.; Reeve, Anthony E.			The developmental programme for genesis of the entire kidney is recapitulated in Wilms tumour	PLOS ONE			English	Article							NEPHROGENIC RESTS; NEUROTROPHIC FACTOR; PRECURSOR LESIONS; GDNF EXPRESSION; FETAL KIDNEY; RAT-KIDNEY; WT1 GENE; MORPHOGENESIS; LOCALIZATION; MUTATIONS	Wilms tumour (WT) is an embryonal tumour that recapitulates kidney development. The normal kidney is formed from two distinct embryological origins: the metanephric mesenchyme (MM) and the ureteric bud (UB). It is generally accepted that WT arises from precursor cells in the MM; however whether UB-equivalent structures participate in tumorigenesis is uncertain. To address the question of the involvement of UB, we assessed 55 Wilms tumours for the molecular features of MM and UB using gene expression profiling, immunohistochemsitry and immunofluorescence. Expression profiling primarily based on the Genitourinary Molecular Anatomy Project data identified molecular signatures of the UB and collecting duct as well as those of the proximal and distal tubules in the triphasic histology group. We performed immunolabeling for fetal kidneys and WTs. We focused on a central epithelial blastema pattern which is the characteristic of triphasic histology characterized by UB-like epithelial structures surrounded by MM and MM-derived epithelial structures, evoking the induction/ aggregation phase of the developing kidney. The UB-like epithelial structures and surrounding MM and epithelial structures resembling early glomerular epithelium, proximal and distal tubules showed similar expression patterns to those of the developing kidney. These observations indicate WTs can arise from a precursor cell capable of generating the entire kidney, such as the cells of the intermediate mesoderm from which both the MM and UB are derived. Moreover, this provides an explanation for the variable histological features of mesenchymal to epithelial differentiation seen in WT.	[Fukuzawa, Ryuji; Anaka, Matthew R.; Reeve, Anthony E.] Univ Otago, Dept Biochem, Canc Genet Lab, Dunedin, New Zealand; [Fukuzawa, Ryuji] Tokyo Metropolitan Childrens Med Ctr, Dept Pathol, Fuchu, Tokyo, Japan; [Fukuzawa, Ryuji; Morison, Ian M.] Univ Otago, Dept Pathol, Dunedin, New Zealand; [Fukuzawa, Ryuji] Int Univ Hlth & Welf, Sch Med, Dept Pathol, Narita, Japan; [Anaka, Matthew R.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Otago; Tokyo Metropolitan Children's Medical Center; University of Otago; International University of Health & Welfare; University of Toronto	Fukuzawa, R (corresponding author), Univ Otago, Dept Biochem, Canc Genet Lab, Dunedin, New Zealand.; Fukuzawa, R (corresponding author), Tokyo Metropolitan Childrens Med Ctr, Dept Pathol, Fuchu, Tokyo, Japan.; Fukuzawa, R (corresponding author), Univ Otago, Dept Pathol, Dunedin, New Zealand.; Fukuzawa, R (corresponding author), Int Univ Hlth & Welf, Sch Med, Dept Pathol, Narita, Japan.	fukuzawa@1998.jukuin.keio.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25460427]; Japan Society for the Promotion of Science; Ministry of Business, Innovation, and Employment of Zealand	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Business, Innovation, and Employment of Zealand	We acknowledge funding from Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 25460427, Prof. Ryuji Fukuzawa, Joint Research Project Grant from the Japan Society for the Promotion of Science, Prof. Ryuji Fukuzawa and from the Ministry of Business, Innovation, and Employment of Zealand, Prof Ian M Morison.	Barasch J, 1999, CELL, V99, P377, DOI 10.1016/S0092-8674(00)81524-X; BECKWITH J B, 1990, Pediatric Pathology, V10, P1; BECKWITH JB, 1993, MED PEDIATR ONCOL, V21, P158, DOI 10.1002/mpo.2950210303; Bedford JJ, 2003, J AM SOC NEPHROL, V14, P2581, DOI 10.1097/01.ASN.0000089566.28106.F6; Boutros M, 2005, KIDNEY INT, V67, P443, DOI 10.1111/j.1523-1755.2005.67100.x; Camassei FD, 2003, PEDIATR DEVEL PATHOL, V6, P511, DOI 10.1017/s10024-003-2013-1; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Charles AK, 1998, AM J PATHOL, V153, P991, DOI 10.1016/S0002-9440(10)65641-6; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Crisi GM, 2009, PEDIATR RES, V65, P79, DOI 10.1203/PDR.0b013e31818912b7; ECCLES MR, 1995, AM J PATHOL, V146, P40; Fukuzawa R, 2008, J PATHOL, V215, P377, DOI 10.1002/path.2366; Fukuzawa R, 2004, PEDIATR DEVEL PATHOL, V7, P125, DOI 10.1007/s10024-003-3023-8; Fukuzawa R, 2009, ONCOGENE, V28, P1063, DOI 10.1038/onc.2008.455; Fukuzawa R, 2007, J CLIN PATHOL, V60, P1013, DOI 10.1136/jcp.2006.043083; Fukuzawa R, 2010, J MED GENET, V47, P791, DOI 10.1136/jmg.2010.080663; Gadd S, 2012, NEOPLASIA, V14, P742, DOI 10.1593/neo.12714; Guertl B, 2003, HUM PATHOL, V34, P278, DOI 10.1053/hupa.2003.32; Guertl B, 2006, VIRCHOWS ARCH, V449, P171, DOI 10.1007/s00428-006-0225-2; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Horster MF, 1999, PHYSIOL REV, V79, P1157, DOI 10.1152/physrev.1999.79.4.1157; Hu QH, 2011, J CLIN INVEST, V121, P174, DOI 10.1172/JCI43772; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Kuure S, 2000, MECH DEVELOP, V92, P31, DOI 10.1016/S0925-4773(99)00323-8; Leroy X, 2003, AM J CLIN PATHOL, V120, P544, DOI 10.1309/A9YM1CBQDYFRC2EY; Li CM, 2002, AM J PATHOL, V160, P2181, DOI 10.1016/S0002-9440(10)61166-2; Linton JM, 2007, DEVELOPMENT, V134, P2501, DOI 10.1242/dev.005033; Little MH, 2012, COLD SPRING HARBOR P, V4; Lovvorn HN, 2007, NEOPLASIA, V9, P589, DOI 10.1593/neo.07358; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Menezes LFC, 2004, KIDNEY INT, V66, P1345, DOI 10.1111/j.1523-1755.2004.00844.x; MIERAU GW, 1987, ULTRASTRUCT PATHOL, V11, P313, DOI 10.3109/01913128709048329; MOLL R, 1991, LAB INVEST, V65, P74; Mugford JW, 2008, DEV BIOL, V319, P396, DOI 10.1016/j.ydbio.2008.03.044; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; MUNDEL P, 1991, J HISTOCHEM CYTOCHEM, V39, P1047, DOI 10.1177/39.8.1856454; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Patterson LT, 2004, DEV DYNAM, V229, P771, DOI 10.1002/dvdy.10474; Pode-Shakked N, 2013, EMBO MOL MED, V5, P18, DOI 10.1002/emmm.201201516; Price KL, 2007, PHYSIOL GENOMICS, V28, P193, DOI 10.1152/physiolgenomics.00147.2006; QIAO J, 1995, DEVELOPMENT, V121, P3207; Sainio K, 1997, DEVELOPMENT, V124, P4077; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Seguier-Lipszyc E, 2001, J UROLOGY, V165, P2269, DOI 10.1016/S0022-5347(05)66182-4; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Shukrun R, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.013; Stupar Z, 2007, HISTOPATHOLOGY, V51, P265, DOI 10.1111/j.1365-2559.2007.02741.x; Takano K, 2007, TOHOKU J EXP MED, V212, P81, DOI 10.1620/tjem.212.81; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Urbach A, 2014, GENE DEV, V28, P971, DOI 10.1101/gad.237149.113; Wetzel RK, 2001, AM J PHYSIOL-RENAL, V281, pF531, DOI 10.1152/ajprenal.2001.281.3.F531; WILIMAS JA, 1991, AM J PEDIAT HEMATOL, V13, P26; YEGER H, 1987, AM J CLIN PATHOL, V88, P278, DOI 10.1093/ajcp/88.3.278	56	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e186333	10.1371/journal.pone.0186333	http://dx.doi.org/10.1371/journal.pone.0186333			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040332	gold, Green Published, Green Submitted			2022-12-26	WOS:000413167500036
J	Chan, SL; Chua, APG; Aminkeng, F; Chee, CB; Jin, SN; Loh, M; Gan, SH; Wang, YT; Brunham, LR				Chan, Sze Ling; Chua, Angeline Poh Gek; Aminkeng, Folefac; Chee, Cynthia Bin Eng; Jin, Shengnan; Loh, Marie; Gan, Suay Hong; Wang, Yee Tang; Brunham, Liam R.			Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients	PLOS ONE			English	Article							DRUG-INDUCED HEPATOTOXICITY; N-ACETYLTRANSFERASE 2; CYTOCHROME-P450 2E1 GENOTYPE; S-TRANSFERASE M1; GENETIC POLYMORPHISMS; CYP2E1 POLYMORPHISMS; SUSCEPTIBILITY; RISK; VARIANTS; TUBERCULOSIS	Background and aims Isoniazid (INH) is part of the first-line-therapy for tuberculosis (TB) but can cause drug-induced liver injury (DILI). Several candidate single nucleotide polymorphisms (SNPs) have been previously identified but the clinical utility of these SNPs in the prediction of INH-DILI remains uncertain. The aim of this study was to assess the association between selected candidate SNPs and the risk of INH-DILI and to assess the clinical validity of associated variants in a Singaporean population. Methods This was a case-control study where 24 INH-DILI cases and 79 controls were recruited from the TB control unit in a tertiary hospital. Logistic regression was used to test for the association between candidate SNPs and INH-DILI. NAT2 acetylator status was inferred from genotypes and tested for association with INH-DILI. Finally, clinical validity measures were estimated for significant variants. Results Two SNPs in NAT2 (rs1041983 and rs1495741) and NAT2 slow acetylators (SA) were significantly associated with INH-DILI (OR (95% CI) = 13.86 (4.30-44.70), 0.10 (0.03-0.33) and 9.98 (3.32-33.80), respectively). Based on an INH-DILI prevalence of 10%, the sensitivity, specificity, positive and negative predictive values of NAT2 SA were 75%, 78%, 28% and 97%, respectively. The population attributable fraction (PAF) and number needed to test (NNT) for NAT2 SA were estimated to be 0.67 and 4.08, respectively. A model with clinical and NAT2 acetylator status provided significantly better prediction for INH-DILI than a clinical model alone (area under receiver operating characteristic curve = 0.863 vs. 0.766, respectively, p = 0.027). Conclusions We show the association between NAT2 SA and INH-DILI in a Singaporean population and demonstrated its clinical utility in the prediction of INH-DILI.	[Chan, Sze Ling; Aminkeng, Folefac; Loh, Marie; Brunham, Liam R.] Agcy Sci Technol & Res, Translat Lab Genet Med, Singapore, Singapore; [Chan, Sze Ling; Aminkeng, Folefac; Loh, Marie; Brunham, Liam R.] Natl Univ Singapore, Singapore, Singapore; [Chua, Angeline Poh Gek; Chee, Cynthia Bin Eng; Gan, Suay Hong; Wang, Yee Tang] Tan Tock Seng Hosp, Dept Resp Med, Singapore, Singapore; [Jin, Shengnan] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Peoples R China; [Brunham, Liam R.] Univ British Columbia, Dept Med, Ctr Heart Lung Innovat, Vancouver, BC, Canada	Agency for Science Technology & Research (A*STAR); National University of Singapore; Tan Tock Seng Hospital; Wenzhou Medical University; University of British Columbia	Brunham, LR (corresponding author), Agcy Sci Technol & Res, Translat Lab Genet Med, Singapore, Singapore.; Brunham, LR (corresponding author), Natl Univ Singapore, Singapore, Singapore.; Brunham, LR (corresponding author), Univ British Columbia, Dept Med, Ctr Heart Lung Innovat, Vancouver, BC, Canada.	liam.brunham@ubc.ca	Jin, Shengnan/I-6264-2012; Chan, Sze Ling/AAU-5913-2020; gan, siew hua/A-6266-2011	Jin, Shengnan/0000-0003-0467-6502; Chan, Sze Ling/0000-0003-4272-4595; gan, siew hua/0000-0001-6470-3651; Loh, Marie/0000-0003-3626-8466; Aminkeng, Folefac/0000-0001-8916-9758; Brunham, Liam/0000-0002-3686-3807	Biomedical Research Council of the Agency for Science, Technology and Research of Singapore (Strategic Positioning Funds) [SPF2014/001]; National University of Singapore; Canadian Institutes of Health Research New Investigator award; Michael Smith Foundation for Health Research Scholar Award	Biomedical Research Council of the Agency for Science, Technology and Research of Singapore (Strategic Positioning Funds)(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore); Canadian Institutes of Health Research New Investigator award(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research Scholar Award(Michael Smith Foundation for Health Research)	This study was supported by the Biomedical Research Council of the Agency for Science, Technology and Research of Singapore (Strategic Positioning Funds - SPF2014/001) to LRB and by the National University of Singapore. LRB is supported by a Canadian Institutes of Health Research New Investigator award and a Michael Smith Foundation for Health Research Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; An HR, 2012, CLIN EXP PHARMACOL P, V39, P535, DOI 10.1111/j.1440-1681.2012.05713.x; Azuma J, 2013, EUR J CLIN PHARMACOL, V69, P1091, DOI 10.1007/s00228-012-1429-9; Ben Mahmoud L, 2012, PATHOL BIOL, V60, P324, DOI 10.1016/j.patbio.2011.07.001; Bjornsson ES, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020224; Bose PD, 2011, J GASTROEN HEPATOL, V26, P312, DOI 10.1111/j.1440-1746.2010.06355.x; Chan SL, 2016, PHARMACOGENET GENOM, V26, P28, DOI 10.1097/FPC.0000000000000182; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chang JC, 2012, INT J TUBERC LUNG D, V16, P376, DOI 10.5588/ijtld.11.0404; Chen R, 2015, J CLIN PHARM THER, V40, P110, DOI 10.1111/jcpt.12211; Cho HJ, 2007, TUBERCULOSIS, V87, P551, DOI 10.1016/j.tube.2007.05.012; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Du HJ, 2013, MOL BIOL REP, V40, P3591, DOI 10.1007/s11033-012-2433-y; Gupta VH, 2013, J GASTROEN HEPATOL, V28, P1368, DOI 10.1111/jgh.12194; Hein DW, 2012, PHARMACOGENOMICS, V13, P31, DOI [10.2217/pgs.11.122, 10.2217/PGS.11.122]; Higuchi N, 2007, WORLD J GASTROENTERO, V13, P6003, DOI 10.3748/wjg.13.6003; Ho HT, 2013, PHARMACOGENET GENOM, V23, P200, DOI 10.1097/FPC.0b013e32835e95e1; Huang YS, 2007, J HEPATOL, V47, P128, DOI 10.1016/j.jhep.2007.02.009; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Jung JA, 2015, DRUG DES DEV THER, V9, DOI 10.2147/DDDT.S87131; Khalili H, 2011, CURR DRUG SAF, V6, P17, DOI 10.2174/157488611794479946; Kim SH, 2012, LIVER INT, V32, P809, DOI 10.1111/j.1478-3231.2011.02697.x; Kim SH, 2009, PHARMACOGENOMICS, V10, P1767, DOI 10.2217/PGS.09.100; Kim S, 2017, ANN LAB MED, V37, P180, DOI 10.3343/alm.2017.37.2.180; Lee SW, 2010, INT J TUBERC LUNG D, V14, P622; Leiro-Fernandez V, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00034; Lv X, ANN HEPATOL, V11, P700; Metushi IG, 2011, CLIN PHARMACOL THER, V89, P911, DOI 10.1038/clpt.2010.355; Mishra S, 2013, NATL MED J INDIA, V26, P260; Mushiroda Taisei, 2016, Hum Genome Var, V3, P16014, DOI 10.1038/hgv.2016.14; Nanashima K, 2012, TUBERCULOSIS, V92, P253, DOI 10.1016/j.tube.2011.12.004; National Institutes of Health, CAT LIK DRUG IND LIV; National Institutes of Health, SERV GRAD DRUG IND L; National Institutes of Health, IS; Ohno M, 2000, INT J TUBERC LUNG D, V4, P256; Possuelo LG, 2008, EUR J CLIN PHARMACOL, V64, P673, DOI 10.1007/s00228-008-0484-8; Preziosi P, 2007, CURR DRUG METAB, V8, P839, DOI 10.2174/138920007782798216; R Core Team, 2021, R LANGUAGE ENV STAT; Rana SV, 2014, J CLIN PHARM THER, V39, P91, DOI 10.1111/jcpt.12105; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Roy B, 2006, J GASTROEN HEPATOL, V21, P784, DOI 10.1111/j.1440-1746.2006.04197.x; Roy B, 2001, J GASTROEN HEPATOL, V16, P1033, DOI 10.1046/j.1440-1746.2001.02585.x; Santos NPC, 2013, INT J TUBERC LUNG D, V17, P499, DOI 10.5588/ijtld.12.0645; Sharma SK, 2014, INT J TUBERC LUNG D, V18, P588, DOI 10.5588/ijtld.13.0344; Shi J, 2015, PHARMACOGENOMICS, V16, P2083, DOI 10.2217/pgs.15.144; Shimizu Y, 2006, TUBERCULOSIS, V86, P374, DOI 10.1016/j.tube.2005.09.002; Singh M, 2014, INFECT GENET EVOL, V23, P42, DOI 10.1016/j.meegid.2014.01.027; Singla N, 2014, TUBERCULOSIS, V94, P293, DOI 10.1016/j.tube.2014.02.003; Sotsuka T, 2011, IN VIVO, V25, P803; Suarez-Kurtz G, 2016, PHARMACOGENET GENOM, V26, P363, DOI 10.1097/FPC.0000000000000225; Tang SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057526; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Wang FJ, 2016, J CLIN PHARM THER, V41, P334, DOI 10.1111/jcpt.12388; Wang Jian-qiang, 2015, ScientificWorldJournal, V2015, P806983, DOI 10.1155/2015/806983; Wang T, 2010, J INT MED RES, V38, P977, DOI 10.1177/147323001003800324; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Xiang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085905; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yuliwulandari R, 2016, J HUM GENET, V61, P533, DOI 10.1038/jhg.2016.10	62	20	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186200	10.1371/journal.pone.0186200	http://dx.doi.org/10.1371/journal.pone.0186200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036176	Green Submitted, gold, Green Published			2022-12-26	WOS:000413054800016
J	Soliani, FCDG; Cabbia, R; Batistela, MF; Almeida, AG; Kumpel, VD; Yamauchi, L; de Andrade, TGCS				de Brito Guzzo Soliani, Flaviane Cristina; Cabbia, Rafael; Batistela, Matheus Fitipaldi; Almeida, Amarylis Garcia; Kumpel, Vinicius Dias; Yamauchi Junior, Luiz; Carneiro Spera de Andrade, Telma Goncalves			Impact of social separation during pregnancy on the manifestation of defensive behaviors related to generalized anxiety and panic throughout offspring development	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; PRENATALLY STRESSED RATS; PITUITARY-ADRENAL AXIS; T-MAZE; MATERNAL STRESS; FEMALE RATS; VENTRAL HIPPOCAMPUS; EXPERIMENTAL-MODEL; ANIMAL-MODEL; EXPOSURE	The multiple insecurities, anatomical, physiological and psychological changes arising from the gestational period can generate an overload of stress in the mother and cause disturbances in the offspring, affecting it throughout its development. The existing analysis linking prenatal stress and offspring's anxiety have divergent results, being limited as to gestational week, type of stressor and age of progeny's assessment. Social separation has been described as a stressor that causes increase in anxiety. Thus, the present study evaluated the effects of social separation applied in one of the three gestational weeks of rat dams on the manifestation of the defensive behaviors related to generalized anxiety disorder and panic in the Elevated T Maze of the male progeny in three stages of development (1, 3 or 6 months of life). It was found, in the offspring of grouped (control) dams, increased behaviors associated with generalized anxiety disorder and a reduction of panic-like behaviors throughout development. For animals whose dams were socially separated during pregnancy, the most critical period of exposure was the 2nd gestational week, which affected the acquisition of aversive memory, demonstrated by the impairment on learning of avoidances of the offspring in all ages evaluated. Stressor exposure in this week also increased the avoidances, related to generalized anxiety of progeny in the 1st month and decreased escapes, related to panic in the 3rd month of life and, at the age of 6 months old, an inverse situation, with the reduction of the defensive behaviors associated to generalized anxiety disorder. The results show that, when assessing effects of prenatal stress on the manifestation of anxiety, not only the period of exposure is important, but also the age of offspring assessed.	[de Brito Guzzo Soliani, Flaviane Cristina; Cabbia, Rafael; Batistela, Matheus Fitipaldi; Almeida, Amarylis Garcia; Kumpel, Vinicius Dias; Yamauchi Junior, Luiz] UNESP Univ Estadual Paulista, Lab Physiol, Assis, SP, Brazil; [Carneiro Spera de Andrade, Telma Goncalves] UNESP Univ Estadual Paulista, Lab Physiol, Dept Biol Sci, Assis, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	de Andrade, TGCS (corresponding author), UNESP Univ Estadual Paulista, Lab Physiol, Dept Biol Sci, Assis, SP, Brazil.	raica@assis.unesp.br	Batistela, Matheus/V-9924-2018; Andrade, Telma/H-2649-2012	Andrade, Telma/0000-0002-7918-8776	Sao Paulo Research Foundation (FAPESP) [2012/19973-6, 2013/10808-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grant #2012/19973-6 and 2013/10808-5 from Sao Paulo Research Foundation (FAPESP).	Abe H, 2007, NEUROSCI RES, V59, P145, DOI 10.1016/j.neures.2007.06.1465; Andrade MMM, 2003, PHYSIOL BEHAV, V78, P125, DOI 10.1016/S0031-9384(02)00941-1; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Guzzo SFCD, 2015, PHYSIOL BEHAV, V142, P137, DOI 10.1016/j.physbeh.2015.02.014; Darwish M, 2001, PHYSIOL BEHAV, V72, P403, DOI 10.1016/S0031-9384(00)00424-8; de Souza MA, 2013, NEUROCHEM RES, V38, P1479, DOI 10.1007/s11064-013-1049-5; Del Giudice M, 2012, PSYCHONEUROENDOCRINO, V37, P1614, DOI 10.1016/j.psyneuen.2012.05.014; dos Santos L, 2010, J PSYCHOPHARMACOL, V24, P725, DOI 10.1177/0269881109106954; Engelbregt MJT, 2000, PEDIATR RES, V48, P803, DOI 10.1203/00006450-200012000-00017; Estanislau C, 2005, BEHAV BRAIN RES, V163, P70, DOI 10.1016/j.bbr.2005.04.003; Estanislau C, 2006, INT J DEV NEUROSCI, V24, P255, DOI 10.1016/j.ijdevneu.2006.03.001; Garcia-Caceres C, 2010, PSYCHONEUROENDOCRINO, V35, P1525, DOI 10.1016/j.psyneuen.2010.05.006; Graeff FG, 1998, NEUROSCI BIOBEHAV R, V23, P237, DOI 10.1016/S0149-7634(98)00024-4; GRAEFF FG, 1993, BRAZ J MED BIOL RES, V26, P67; Green MK, 2011, NEUROSCIENCE, V192, P438, DOI 10.1016/j.neuroscience.2011.06.041; Grigoryan G, 2013, BIOL PSYCHIAT, V73, P1095, DOI 10.1016/j.biopsych.2013.02.003; Hawkley LC, 2012, HORM BEHAV, V62, P314, DOI 10.1016/j.yhbeh.2012.05.011; Holloway T, 2013, J NEUROSCI, V33, P1088, DOI 10.1523/JNEUROSCI.2331-12.2013; Huizink AC, 2004, PSYCHOL BULL, V130, P115, DOI 10.1037/0033-2909.130.1.115; IMHOF JT, 1993, BEHAV BRAIN RES, V56, P177, DOI 10.1016/0166-4328(93)90036-P; Khashan AS, 2008, ARCH GEN PSYCHIAT, V65, P146, DOI 10.1001/archgenpsychiatry.2007.20; Laloux C, 2012, PSYCHONEUROENDOCRINO, V37, P1646, DOI 10.1016/j.psyneuen.2012.02.010; Louvart H, 2009, PSYCHONEUROENDOCRINO, V34, P786, DOI 10.1016/j.psyneuen.2008.12.002; MAISONNETTE S, 1993, PHYSIOL BEHAV, V54, P753, DOI 10.1016/0031-9384(93)90087-V; Marrocco J, 2012, J NEUROSCI, V32, P17143, DOI 10.1523/JNEUROSCI.1040-12.2012; Miyagawa K, 2011, NEUROSCI RES, V70, P111, DOI 10.1016/j.neures.2011.02.002; Nishio H, 2006, INT J DEV NEUROSCI, V24, P263, DOI 10.1016/j.ijdevneu.2006.02.003; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Pallares ME, 2007, PHYSIOL BEHAV, V92, P951, DOI 10.1016/j.physbeh.2007.06.021; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Poltronieri SC, 2003, BEHAV BRAIN RES, V147, P185, DOI 10.1016/S0166-4328(03)00151-7; Poltyrev T, 2005, PSYCHOPHARMACOLOGY, V181, P118, DOI 10.1007/s00213-005-2229-z; Rex A, 2004, PSYCHOPHARMACOLOGY, V177, P23, DOI 10.1007/s00213-004-1914-7; Richardson HN, 2006, ENDOCRINOLOGY, V147, P2506, DOI 10.1210/en.2005-1054; Sadler TR, 2011, BRAIN RES, V1385, P163, DOI 10.1016/j.brainres.2011.01.104; Tazumi T, 2005, BEHAV BRAIN RES, V162, P153, DOI 10.1016/j.bbr.2005.03.006; TREIT D, 1993, PHARMACOL BIOCHEM BE, V44, P463, DOI 10.1016/0091-3057(93)90492-C; Van den Bergh BRH, 2004, CHILD DEV, V75, P1085, DOI 10.1111/j.1467-8624.2004.00727.x; Van den Hove DLA, 2006, BRAIN RES, V1090, P29, DOI 10.1016/j.brainres.2006.03.057; Van den Hove DLA, 2014, EUR NEUROPSYCHOPHARM, V24, P595, DOI 10.1016/j.euroneuro.2013.09.006; Van den Hove DLA, 2013, EUR NEUROPSYCHOPHARM, V23, P1226, DOI 10.1016/j.euroneuro.2012.09.011; VIANA MB, 1994, PHARMACOL BIOCHEM BE, V49, P549, DOI 10.1016/0091-3057(94)90067-1; Weinstock M, 2005, BRAIN BEHAV IMMUN, V19, P296, DOI 10.1016/j.bbi.2004.09.006; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Wilson CA, 2013, BEHAV BRAIN RES, V238, P279, DOI 10.1016/j.bbr.2012.10.003; Wyrwoll CS, 2012, NEUROENDOCRINOLOGY, V95, P47, DOI 10.1159/000331345; Xu J, 2013, BRAIN RES, V1527, P57, DOI 10.1016/j.brainres.2013.06.025; Zagron G, 2006, BEHAV BRAIN RES, V175, P323, DOI 10.1016/j.bbr.2006.09.003; Zangrossi H, 1997, BRAIN RES BULL, V44, P1, DOI 10.1016/S0361-9230(96)00381-4; Zangrossi H, 2001, NEUROSCI BIOBEHAV R, V25, P637, DOI 10.1016/S0149-7634(01)00047-1; Zuena AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002170	51	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0185572	10.1371/journal.pone.0185572	http://dx.doi.org/10.1371/journal.pone.0185572			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036201	Green Submitted, Green Published, gold			2022-12-26	WOS:000413054800007
J	Perez-Zamorano, B; Rosas-Madrigal, S; Lozano, OAM; Mendez, MC; Valverde-Garduno, V				Perez-Zamorano, Bernardo; Rosas-Madrigal, Sandra; Migueles Lozano, Oscar Arturo; Castillo Mendez, Manuel; Valverde-Garduno, Veronica			Identification of cis-regulatory sequences reveals potential participation of lola and Deaf1 transcription factors in Anopheles gambiae innate immune response	PLOS ONE			English	Article							GENE-EXPRESSION; MALARIA MOSQUITO; OPEN CHROMATIN; BINDING-SITES; CHIP-SEQ; VECTOR; GENOME; PLASMODIUM; INFECTION; DROSOPHILA	The innate immune response of Anopheles gambiae involves the transcriptional upregulation of effector genes. Therefore, the cis-regulatory sequences and their cognate binding factors play essential roles in the mosquito's immune response. However, the genetic control of the mosquito's innate immune response is not yet fully understood. To gain further insight on the elements, the factors and the potential mechanisms involved, an open chromatin profiling was carried out on A. gambiae-derived immune-responsive cells. Here, we report the identification of cis-regulatory sites, immunity-related transcription factor binding sites, and cis-regulatory modules. A de novo motif discovery carried out on this set of cis-regulatory sequences identified immunity-related motifs and cis-regulatory modules. These modules contain motifs that are similar to binding sites for REL-, STAT-, lola- and Deaf1-type transcription factors. Sequence motifs similar to the binding sites for GAGA were found within a cis-regulatory module, together with immunity-related transcription factor binding sites. The presence of Deaf1- and lola-type binding sites, along with REL- and STAT-type binding sites, suggests that the immunity function of these two factors could have been conserved both in Drosophila and Anopheles gambiae.	[Perez-Zamorano, Bernardo; Rosas-Madrigal, Sandra; Migueles Lozano, Oscar Arturo; Castillo Mendez, Manuel; Valverde-Garduno, Veronica] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Dept Infecc & Inmunidad, Cuernavaca, Morelos, Mexico; [Perez-Zamorano, Bernardo; Rosas-Madrigal, Sandra; Castillo Mendez, Manuel; Valverde-Garduno, Veronica] Inst Nacl Salud Publ, Escuela Salud Publ Mexico, Cuernavaca, Morelos, Mexico; [Migueles Lozano, Oscar Arturo] Winter Genom, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica	Valverde-Garduno, V (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Dept Infecc & Inmunidad, Cuernavaca, Morelos, Mexico.; Valverde-Garduno, V (corresponding author), Inst Nacl Salud Publ, Escuela Salud Publ Mexico, Cuernavaca, Morelos, Mexico.	vvalverde@insp.mx		Rosas Madrigal, Sandra/0000-0002-9980-6658	Consejo Nacional de Ciencia y Tecnologia [84012, 257990]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding was provided by Consejo Nacional de Ciencia y Tecnologia, Grants 84012 and 257990. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959; BarillasMury C, 1996, EMBO J, V15, P4691, DOI 10.1002/j.1460-2075.1996.tb00846.x; Baton LA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-257; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bryant WB, 2014, J EXP BIOL, V217, P1238, DOI 10.1242/jeb.094573; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Ding J, 2014, METHODS; Ding J, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1288; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Eggleston P, 2000, INSECT MOL BIOL, V9, P481, DOI 10.1046/j.1365-2583.2000.00212.x; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Fuda NJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005108; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Herrero J., 2016, DATABASE J BIOL DATA; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kleino A, 2005, EMBO J, P24; Kriventseva EV, 2015, NUCLEIC ACIDS RES, V43, pD250, DOI 10.1093/nar/gku1220; Kumar V, 2013, NAT BIOTECHNOL, V31, P615, DOI 10.1038/nbt.2596; Kuttenkeuler D, 2010, J INNATE IMMUN, V2, P181, DOI 10.1159/000248649; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Li XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r34; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; McArthur M, 2001, J MOL BIOL, V313, P27, DOI 10.1006/jmbi.2001.4969; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; Meredith JM, 2006, INSECT MOL BIOL, V15, P393, DOI 10.1111/j.1365-2583.2006.00635.x; Mondal BC, 2014, ELIFE, V3, DOI 10.7554/eLife.03626; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reed DE, 2008, P NATL ACAD SCI USA, V105, P8351, DOI 10.1073/pnas.0802921105; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Sharakhova MV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r5; Smit A., 2015, REPEAT MASKER OPEN 4; Smith RC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002965; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Spence PJ, 2013, NATURE, V498, P228, DOI 10.1038/nature12231; Thomas S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r43; Zou Z, 2008, P NATL ACAD SCI USA, V105, P18454, DOI 10.1073/pnas.0804658105	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186435	10.1371/journal.pone.0186435	http://dx.doi.org/10.1371/journal.pone.0186435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028826	Green Submitted, Green Published, gold			2022-12-26	WOS:000412980300035
J	Jahan, M; Kracht, S; Ho, Y; Haque, Z; Bhattachatyya, BN; Wynn, PC; Wang, B				Jahan, Marefa; Kracht, Susie; Ho, Yen; Haque, Ziaul; Bhattachatyya, Birendra N.; Wynn, Peter C.; Wang, Bing			Dietary lactoferrin supplementation to gilts during gestation and lactation improves pig production and immunity	PLOS ONE			English	Article							BOVINE LACTOFERRIN; GROWTH-FACTOR; POSTNATAL PIGLETS; BIRTH-WEIGHT; SERUM IRON; PROTEIN; MILK; EXPRESSION; PERFORMANCE; MORPHOLOGY	Lactoferrin (LF), a sialylated iron-binding glycoprotein, performs multiple beneficial functions including modulating immunity and improves neurodevelopment, health and growth performance. Maternal LF intervention for gilts (first parity sows) on the performance of gilts and their offspring remains unknown. In the current study gilts were fed with a commercial pig feed supplemented with 1g LF /day (treatment group) or 1g milk casein/day (control group) from day 1 post mating throughout pregnancy and lactation for about 135 days. The milk production and body weight gain was monitored. The immunoglobulin concentrations in the serum of gilts and piglets were measured using ELISA. Our study showed that maternal LF supplementation to the gilt (1) significantly increased milk production at different time points (day 1, 3, 7 and 19) of lactation compared to the control (p<0.001); (2) significantly increased body weight gain of their piglets during the first 19 days of life compared to the control group (p<0.05); (3) tended to increase pregnancy rate, litter size and birth weight, number of piglets born alive, and decrease the number of dead and intrauterine growth restriction (IUGR) piglets; (4) significantly increased the concentration of serum IgA in gilt and serum sIgA in piglet (p<0.05). In summary, maternal Lf intervention in gilts can improve milk production, pig production and serum IgA and sIgA levels, and therefore plays a key role in shaping the performance of their progeny.	[Wang, Bing] Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; NSW Dept Primary Ind, Wagga Wagga, NSW, Australia	Charles Sturt University; NSW Department of Primary Industries	Wang, B (corresponding author), Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia.	biwang@csu.edu.au		Jahan, Marefa/0000-0002-6370-0050; Wang, Bing/0000-0003-2146-8529	Pork CRC Australia [2C-20]; Pork CRC Australia; Charles Sturt University	Pork CRC Australia(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Pork CRC Australia(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Charles Sturt University	This study was funded by an innovative project grant from Pork CRC Australia #2C-20 (to BW and PW), Pork CRC Australia Honours Research Scholarship (to SK) and Charles Sturt University Postgraduate Research Scholarship (to MJ).	Garcia-Montoya IA, 2012, BBA-GEN SUBJECTS, V1820, P226, DOI 10.1016/j.bbagen.2011.06.018; AISEN P, 1972, BIOCHIM BIOPHYS ACTA, V257, P314, DOI 10.1016/0005-2795(72)90283-8; Akiyama Y, 2013, J BIOCHEM, V154, P437, DOI 10.1093/jb/mvt073; ATINMO T, 1974, J ANIM SCI, V39, P703, DOI 10.2527/jas1974.394703x; Bakker-Zierikzee AM, 2006, PEDIAT ALLERG IMM-UK, V17, P134, DOI 10.1111/j.1399-3038.2005.00370.x; Barber RS, 1955, J AGR SCI, V46, P77; BENNETT RM, 1978, BRIT J HAEMATOL, V39, P509, DOI 10.1111/j.1365-2141.1978.tb03620.x; BOURNE FJ, 1973, IMMUNOLOGY, V24, P157; BUTLER JE, 1983, VET IMMUNOL IMMUNOP, V4, P43, DOI 10.1016/0165-2427(83)90056-9; CEBULSKA A, 2012, RES PIG BREEDING, V6, P13; Chen Y, 2015, MOL NEUROBIOL, V52, P256, DOI 10.1007/s12035-014-8856-9; Davis TA, 1997, AM J PHYSIOL-ENDOC M, V272, pE877, DOI 10.1152/ajpendo.1997.272.5.E877; Debbabi H, 1998, J DAIRY RES, V65, P283, DOI 10.1017/S0022029997002732; Drago M. E, 2006, ENF INF MICROBIOL, V26, P58; Fix JS, 2009, N CAROLINA SWINE EXT, V32, P1; Giansanti F, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9040061; Gonzalez-Chavez SA, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.020; HAGIWARA T, 1995, BIOSCI BIOTECH BIOCH, V59, P1875, DOI 10.1271/bbb.59.1875; Hurley WL, 2001, LIVEST PROD SCI, V70, P149, DOI 10.1016/S0301-6226(01)00208-1; Manzoni P, 2010, EARLY HUM DEV, V86, pS59, DOI 10.1016/j.earlhumdev.2010.01.009; Manzoni P, 2012, PEDIATRICS, V129, P116, DOI 10.1542/peds.2011-0279; Marshall KM, 2006, J ANIM SCI, V84, P2346, DOI 10.2527/jas.2005-764; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; MEAD PE, 1990, NUCLEIC ACIDS RES, V18, P7167, DOI 10.1093/nar/18.23.7167; Montagne P, 2001, ADV EXP MED BIOL, V501, P241; Naot D, 2005, CLIN MED RES, V3, P93, DOI 10.3121/cmr.3.2.93; Oakes SR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1411; Paesano R, 2006, BIOCHEM CELL BIOL, V84, P377, DOI 10.1139/O06-040; PIERCE A, 1991, EUR J BIOCHEM, V196, P177, DOI 10.1111/j.1432-1033.1991.tb15801.x; Pierce A, 2009, M S-MED SCI, V25, P361, DOI 10.1051/medsci/2009254361; POND WG, 1969, J NUTR, V99, P61, DOI 10.1093/jn/99.1.61; Prunier A, 2010, ANIMAL, V4, P886, DOI 10.1017/S175173111000008X; Riley LG, 2008, J DAIRY RES, V75, P319, DOI 10.1017/S0022029908003403; Schoknecht PA, 1997, PEDIATR RES, V42, P201, DOI 10.1203/00006450-199708000-00012; Shan T, 2007, J ANIM SCI, V85, P2140, DOI 10.2527/jas.2006-754; Sherman MP, 2004, BIOMETALS, V17, P285, DOI 10.1023/B:BIOM.0000027706.51112.62; Somm E, 2014, PEDIATR RES, V75, P51, DOI 10.1038/pr.2013.199; Tang XS, 2012, APPL BIOCHEM BIOTECH, V168, P887, DOI 10.1007/s12010-012-9827-0; Tang ZR, 2009, BRIT J NUTR, V101, P998, DOI 10.1017/S0007114508055633; Vaclavkova E., 2012, RES PIG BREEDING, V6; van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4; Wang Y, 2006, J ANIM SCI, V84, P2636, DOI 10.2527/jas.2005-544; Wang YZ, 2007, ANIM FEED SCI TECH, V135, P263, DOI 10.1016/j.anifeedsci.2006.07.013; Ward PP, 2005, CELL MOL LIFE SCI, V62, P2540, DOI 10.1007/s00018-005-5369-8; Ward PP, 2004, BIOMETALS, V17, P203, DOI 10.1023/B:BIOM.0000027693.60932.26; WILDE CJ, 1990, J AGR SCI, V114, P235, DOI 10.1017/S0021859600072592; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Yamauchi K, 2006, BIOCHEM CELL BIOL, V84, P291, DOI 10.1139/O06-054; Yang CW, 2014, J NUTR BIOCHEM, V25, P834, DOI 10.1016/j.jnutbio.2014.03.015; Yang TS, 2000, RES VET SCI, V69, P95, DOI 10.1053/rvsc.2000.0393	51	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185817	10.1371/journal.pone.0185817	http://dx.doi.org/10.1371/journal.pone.0185817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023467	gold, Green Published			2022-12-26	WOS:000412845100029
J	Mailander-Sanchez, D; Braunsdorf, C; Grumaz, C; Muller, C; Lorenz, S; Stevens, P; Wagener, J; Hebecker, B; Hube, B; Bracher, F; Sohn, K; Schaller, M				Mailaender-Sanchez, Daniela; Braunsdorf, Christina; Grumaz, Christian; Mueller, Christoph; Lorenz, Stefan; Stevens, Philip; Wagener, Jeanette; Hebecker, Betty; Hube, Bernhard; Bracher, Franz; Sohn, Kai; Schaller, Martin			Antifungal defense of probiotic Lactobacillus rhamnosus GG is mediated by blocking adhesion and nutrient depletion	PLOS ONE			English	Article							VULVO-VAGINAL CANDIDIASIS; IRRITABLE-BOWEL-SYNDROME; GENE-EXPRESSION; FATTY-ACID; ASSAY; SUPPLEMENTATION; INFECTIONS; PREVENTION; CYTOKINE; DIARRHEA	Candida albicans is an inhabitant of mucosal surfaces in healthy individuals but also the most common cause of fungal nosocomial blood stream infections, associated with high morbidity and mortality. As such life-threatening infections often disseminate from superficial mucosal infections we aimed to study the use of probiotic Lactobacillus rhamnosus GG (LGG) in prevention of mucosal C. albicans infections. Here, we demonstrate that LGG protects oral epithelial tissue from damage caused by C. albicans in our in vitro model of oral candidiasis. Furthermore, we provide insights into the mechanisms behind this protection and dissect direct and indirect effects of LGG on C. albicans pathogenicity. C. albicans viability was not affected by LGG. Instead, transcriptional profiling using RNA-Seq indicated dramatic metabolic reprogramming of C. albicans. Additionally, LGG had a significant impact on major virulence attributes, including adhesion, invasion, and hyphal extension, whose reduction, consequently, prevented epithelial damage. This was accompanied by glucose depletion and repression of ergosterol synthesis, caused by LGG, but also due to blocked adhesion sites. Therefore, LGG protects oral epithelia against C. albicans infection by preventing fungal adhesion, invasion and damage, driven, at least in parts, by metabolic reprogramming due to nutrient limitation caused by LGG.	[Mailaender-Sanchez, Daniela; Braunsdorf, Christina; Wagener, Jeanette; Schaller, Martin] Univ Hosp Tubingen, Dept Dermatol, Tubingen, Germany; [Grumaz, Christian; Lorenz, Stefan; Sohn, Kai] Fraunhofer IGB, Stuttgart, Germany; [Mueller, Christoph; Bracher, Franz] Ludwig Maximilians Univ Munchen, Dept Pharm, Ctr Drug Res, Munich, Germany; [Stevens, Philip] Univ Vienna, Med Univ Vienna, Ctr Integrat Bioinformat Vienna, Max F Perutz Labs, Vienna, Austria; [Stevens, Philip] Univ Stuttgart, IGVP, Stuttgart, Germany; [Hebecker, Betty; Hube, Bernhard] Leibniz Inst Nat Product Res & Infect Biol, Dept Microbial Pathogen Mech, Hans Knoell Inst Jena HKI, Jena, Germany; [Hebecker, Betty; Hube, Bernhard] Ctr Sepsis Control & Care, Jena, Germany; [Hube, Bernhard] Friedrich Schiller Univ, Jena, Germany; [Mailaender-Sanchez, Daniela] Univ Hosp Tubingen, Dept Internal Med 1, Tubingen, Germany; [Braunsdorf, Christina] Univ Zurich, Sect Immunol, Vetsuisse Fac, Zurich, Switzerland; [Stevens, Philip] Noscendo GmbH, Stuttgart, Germany; [Wagener, Jeanette; Hebecker, Betty] Univ Aberdeen, Aberdeen Fungal Grp, MRC Ctr Med Mycol, Aberdeen, Scotland	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Stuttgart; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Zurich; University of Aberdeen	Schaller, M (corresponding author), Univ Hosp Tubingen, Dept Dermatol, Tubingen, Germany.	Martin.Schaller@med.uni-tuebingen.de		Braunsdorf, Christina/0000-0003-4327-3394; Muller, Christoph/0000-0002-1163-2527; Wagener, Jeanette/0000-0002-7227-4348	German Research Council (DFG) Graduation College [685, FKZ: 0315409BBM BF]; Dr. Manfred Plempel-foundation; Dr. Siegried Stettendorf-Foundation; InfectERA Program (FunCom Path) [BMBF FKZ 031L0001A]; Integrated Research and Treatment Center for Sepsis Control and Care (CSCC) project CanBac (BMBF) [FKZ: 01E01002]; German Research Council (DFG) [GZ:HE7565/1-1]	German Research Council (DFG) Graduation College(German Research Foundation (DFG)); Dr. Manfred Plempel-foundation; Dr. Siegried Stettendorf-Foundation; InfectERA Program (FunCom Path); Integrated Research and Treatment Center for Sepsis Control and Care (CSCC) project CanBac (BMBF); German Research Council (DFG)(German Research Foundation (DFG))	This work was funded by the German Research Council (DFG) Graduation College 685, Dr. Jekyll and Mr. Hyde: A systems approach to the therapy of nosocomial infections caused by Candida albicans: a commensal organism switches to a deadly pathogen/PTJ (FKZ: 0315409BBM BF), the Dr. Manfred Plempel-foundation, the Dr. Siegried Stettendorf-Foundation, the InfectERA Program (FunCom Path; BMBF FKZ 031L0001A), the Integrated Research and Treatment Center for Sepsis Control and Care (CSCC) project CanBac (BMBF, FKZ: 01E01002), and the German Research Council (DFG) GZ:HE7565/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Birgit Fehrenbacher, Renate Nordin, Hannelore Bischof and Theresia Schneider for excellent technical assistance. We thank Prof. Marius Ueffing, for providing the Zeiss Apo tome used to study C. albicans invasiveness and hyphal growth, and Michelle Dierstein for excellent technical assistance in operating the Apotome. This work was funded by the German Research Council (DFG) Graduation College 685, Dr. Jekyll and Mr. Hyde: A systems approach to the therapy of nosocomial infections caused by Candida albicans: a commensal organism switches to a deadly pathogen/PTJ (FKZ: 0315409BBMBF), the Dr. Manfred Plempel-foundation, the Dr. Siegried Stettendorf-Foundation, the InfectERA Program (FunComPath; BMBF FKZ 031L0001A), the Integrated Research and Treatment Center for Sepsis Control and Care (CSCC) project CanBac (BMBF, FKZ: 01EO1002), and the German Research Council (DFG) GZ:HE7565/1-1.	Abbas Z, 2014, EUR J GASTROEN HEPAT, V26, P630, DOI 10.1097/MEG.0000000000000094; Burger-Kentischer A, 2011, ANTIMICROB AGENTS CH, V55, P4789, DOI 10.1128/AAC.01657-10; Burkholder KM, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-14; Calderone RA., 2002, CANDIDA CANDIDIASIS; Canani RB, 2007, BMJ-BRIT MED J, V335, P340, DOI 10.1136/bmj.39272.581736.55; Coman MM, 2014, J APPL MICROBIOL, V117, P518, DOI 10.1111/jam.12544; Donnarumma G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-137; Garber G, 2001, DRUGS, V61, P1, DOI 10.2165/00003495-200161001-00001; Grumaz C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-212; Guertler A, 2011, RADIAT PROT DOSIM, V143, P487, DOI 10.1093/rpd/ncq515; Han Y, 2012, PEDIAT ALLERG IMM-UK, V23, P667, DOI 10.1111/pai.12010; Hasslof P, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-18; Hatakka K, 2007, J DENT RES, V86, P125, DOI 10.1177/154405910708600204; Hu HJ, 2016, PEDIAT NEONATOL; Kakisu E, 2013, J DAIRY RES, V80, P64, DOI 10.1017/S0022029912000659; Kohler Gerwald A, 2012, Infect Dis Obstet Gynecol, V2012, P636474, DOI 10.1155/2012/636474; Kunze M, 2006, BBA-MOL CELL RES, V1763, P1441, DOI 10.1016/j.bbamcr.2006.09.009; KURIHARA T, 1992, J BIOCHEM-TOKYO, V111, P783, DOI 10.1093/oxfordjournals.jbchem.a123836; Lenoir-Wijnkoop I, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00013; Li D, 2014, MYCOSES, V57, P141, DOI 10.1111/myc.12116; Lin CS, 2014, BIOMEDICAL J; Lorenzo-Zuniga V, 2014, WORLD J GASTROENTERO, V20, P8709, DOI 10.3748/wjg.v20.i26.8709; Luoto R, 2014, J ALLERGY CLIN IMMUN, V133, P405, DOI 10.1016/j.jaci.2013.08.020; Mailander-Sanchez D., 2014, THESIS; Mailander-Sanchez D, 2012, MYCOSES, V55, P17, DOI 10.1111/j.1439-0507.2010.01967.x; Manzoni P, 2006, CLIN INFECT DIS, V42, P1735, DOI 10.1086/504324; Manzoni P, 2011, EARLY HUM DEV, V87, pS35, DOI 10.1016/j.earlhumdev.2011.01.036; Marranzino G, 2012, MICROBIOL IMMUNOL, V56, P771, DOI 10.1111/j.1348-0421.2012.00495.x; Martin SW, 2004, EUKARYOT CELL, V3, P675, DOI 10.1128/EC.3.3.675-684.2004; Martinez RCR, 2009, LETT APPL MICROBIOL, V48, P269, DOI 10.1111/j.1472-765X.2008.02477.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller C, 2013, STEROIDS, V78, P483, DOI 10.1016/j.steroids.2013.02.006; Noverr MC, 2004, INFECT IMMUN, V72, P6206, DOI 10.1128/IAI.72.11.6206-6210.2004; Oliveira VMC, 2016, J APPL MICROBIOL, V121, P1737, DOI 10.1111/jam.13289; Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Plaza-Diaz J, 2014, WORLD J GASTROENTERO, V20, P15632, DOI 10.3748/wjg.v20.i42.15632; Ribeiro FC, 2016, J APPL MICROBIOLOGY; Rizzo A, 2013, IMMUNOL LETT, V156, P102, DOI 10.1016/j.imlet.2013.08.013; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Schaller M, 2004, MICROBIOL-SGM, V150, P2807, DOI 10.1099/mic.0.27169-0; Schaller M, 2006, NAT PROTOC, V1, P2767, DOI 10.1038/nprot.2006.474; Sedlazeck FJ, 2013, BIOINFORMATICS, V29, P2790, DOI 10.1093/bioinformatics/btt468; Strus Magdalena, 2005, Infect Dis Obstet Gynecol, V13, P69, DOI 10.1080/10647440400028136; Tursi A, 2010, AM J GASTROENTEROL, V105, P2218, DOI 10.1038/ajg.2010.218; Vicariotto F, 2012, J CLIN GASTROENTEROL, V46, pS73, DOI 10.1097/MCG.0b013e3182684d71; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Zhou H, 2008, MICROBIOL-SGM, V154, P500, DOI 10.1099/mic.0.2007/014555-0	49	27	29	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0184438	10.1371/journal.pone.0184438	http://dx.doi.org/10.1371/journal.pone.0184438			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023454	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100006
J	Mancini, M; Megna, AS; Ragucci, M; De Luca, M; Marsilia, GM; Nardone, G; Coccoli, P; Prinster, A; Mannelli, L; Vergara, E; Monti, S; Liuzzi, R; Incoronato, M				Mancini, Marcello; Megna, Angelo Salomone; Ragucci, Monica; De Luca, Massimo; Marsilia, Giuseppina Marino; Nardone, Gerardo; Coccoli, Pietro; Prinster, Anna; Mannelli, Lorenzo; Vergara, Emilia; Monti, Serena; Liuzzi, Raffaele; Incoronato, Mariarosaria			Reproducibility of shear wave elastography (SWE) in patients with chronic liver disease	PLOS ONE			English	Article							CHRONIC VIRAL-HEPATITIS; TRANSIENT ELASTOGRAPHY; AMERICAN ASSOCIATION; STIFFNESS VALUES; FIBROSIS; BIOPSY; ULTRASOUND; MANAGEMENT; REGRESSION; DIAGNOSIS	The presence of significant fibrosis is an indicator for liver disease staging and prognosis. The aim of the study was to determine reproducibility of real-time shear wave elastography using a hepatic biopsy as the reference standard to identify patients with chronic liver disease. Forty patients with chronic liver disease and 12 normal subjects received shear wave elastography performed by skilled operators. Interoperator reproducibility was studied in 29 patients. Fibrosis was evaluated using the Metavir score. The median and range shear wave elastography values in chronic liver disease subjects were 6.15 kPa and 3.14-16.7 kPa and were 4.49 kPa and 2.92-7.32 kPa in normal subjects, respectively. With respect to fibrosis detected by liver biopsy, shear wave elastography did not change significantly between F0 and F1 (p = 0.334), F1 and F2 (p = 0.611), or F3 and F4 (0.327); a significant difference was observed between the F0-F2 and F3-F4 groups (p = 0.002). SWE also correlated with inflammatory activity (Rs = 0.443, p = 0.0023) and ALT levels (Rs = 0.287, p = 0.0804). Age, sex and body mass index did not affect shear wave elastography measurements. Using receiver operator characteristic curves, two threshold values for shear wave elastography were identified: 5.62 kPa for patients with fibrosis (>= F2; sensitivity 80%, specificity 69.4%, and accuracy 77%) and 7.04 kPa for patients with severe fibrosis (>= F3; sensitivity 88.9%, specificity 81%, and accuracy 89%). Overall interobserver agreement was excellent and was analysed using an interclass correlation coefficient (0.94; CI 0.87-0.97). This study shows that shear wave elastography executed by skilled operators can be performed on almost all chronic liver disease patients with high reproducibility. It is not influenced by age, sex or body mass index, identifies severely fibrotic patients and is also related to inflammatory activity.	[Mancini, Marcello; Ragucci, Monica; Prinster, Anna; Liuzzi, Raffaele] CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Megna, Angelo Salomone] Rummo Hosp, Div Infect Dis, Benevento, Italy; [De Luca, Massimo] AORN Cardarelli, Liver Unit, Naples, Italy; [Marsilia, Giuseppina Marino] Cardarelli Hosp, Pathol Unit, Naples, Italy; [Nardone, Gerardo; Coccoli, Pietro] Univ Naples Federico II, Dept Clin Med & Surg, Gastroenterol Unit, Naples, Italy; [Mannelli, Lorenzo] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA; [Vergara, Emilia; Monti, Serena; Incoronato, Mariarosaria] IRCCS SDN, Naples, Italy; [Vergara, Emilia] AOU Federico II, Dipartimento Assistenziale Integrato Diagnost Mor, Radioterapia, Med Legale, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Antonio Cardarelli Hospital; University of Naples Federico II; Memorial Sloan Kettering Cancer Center; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN)	Mancini, M (corresponding author), CNR, Inst Biostruct & Bioimaging, Naples, Italy.	marcello.mancini58@gmail.com	Monti, Serena/C-1062-2015; Incoronato, Mariarosaria/K-8727-2016; Liuzzi, Raffaele/AIC-0886-2022; Prinster, Anna/AAW-3129-2020; Mannelli, Lorenzo/A-7165-2012; Incoronato, Mariarosaria/AAA-7541-2021	Monti, Serena/0000-0002-8777-7837; Incoronato, Mariarosaria/0000-0001-7019-0581; Liuzzi, Raffaele/0000-0002-2350-6691; Mannelli, Lorenzo/0000-0002-9102-4176; Incoronato, Mariarosaria/0000-0001-7019-0581	Italian Minister of Health [RF-2010-2314264]	Italian Minister of Health	This work was supported by the Italian Minister of Health Project Code: RF-2010-2314264. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; [Anonymous], 2002, GASTROENTEROLOGY, V123, P2082; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Carrion JA, 2007, GASTROENTEROLOGY, V132, P1746, DOI 10.1053/j.gastro.2007.03.041; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Cholongitas E, 2006, AM J CLIN PATHOL, V125, P710, DOI 10.1309/W3XCNT4HKFBN2G0B; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Cooper C, 2012, CLIN INFECT DIS, V55, P418, DOI 10.1093/cid/cis375; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Frulio N, 2013, Diagn Interv Imaging, V94, P515, DOI 10.1016/j.diii.2013.02.005; Gennisson J-L, 2013, Diagn Interv Imaging, V94, P487, DOI 10.1016/j.diii.2013.01.022; Ishak K, 1995, J HEPATOL, V24, P289; Kircheis G, 2012, WORLD J GASTROENTERO, V18, P1077, DOI 10.3748/wjg.v18.i10.1077; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Nightingale K, 2002, ULTRASOUND MED BIOL, V28, P227, DOI 10.1016/S0301-5629(01)00499-9; Pinzani M, 2008, NAT CLIN PRACT GASTR, V5, P95, DOI 10.1038/ncpgasthep1025; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Rousselet MC, 2005, HEPATOLOGY, V41, P257, DOI 10.1002/hep.20535; Sande JA, 2017, WORLD J HEPATOL, V9, P38, DOI 10.4254/wjh.v9.i1.38; Seeff LB, 2010, CLIN GASTROENTEROL H, V8, P877, DOI 10.1016/j.cgh.2010.03.025; Sirli R, 2015, WORLD J GASTROENTERO, V21, P11542, DOI 10.3748/wjg.v21.i41.11542; Sorrell MF, 2009, HEPATOLOGY, V49, pS4, DOI 10.1002/hep.22946; Stotland BR, 1996, AM J GASTROENTEROL, V91, P1295; Suh CH, 2014, RADIOLOGY, V271, P895, DOI 10.1148/radiol.14131251; Tang A, 2015, AM J ROENTGENOL, V205, P22, DOI 10.2214/AJR.15.14552; Zatonski W, 2000, HLTH TRANSFORMATION; Zatonski WA, 2010, EUR ADDICT RES, V16, P193, DOI 10.1159/000317248	36	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185391	10.1371/journal.pone.0185391	http://dx.doi.org/10.1371/journal.pone.0185391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023554	gold, Green Submitted, Green Published			2022-12-26	WOS:000412845100018
J	Phumisantiphong, U; Siripanichgon, K; Reamtong, O; Diraphat, P				Phumisantiphong, Uraporn; Siripanichgon, Kanokrat; Reamtong, Onrapak; Diraphat, Pornphan			A novel bacteriocin from Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant enterococci	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; I-TASSER SERVER; SERINE-PROTEASE; GENETIC-CHARACTERIZATION; ANTIMICROBIAL PEPTIDES; FAECIUM; OPTIMIZATION; PURIFICATION; PATHOGENESIS; PROTEINS	The emergence of multidrug-resistant enterococci (MDRE) and particularly vancomycin-resistant enterococci (VRE) is considered a serious health problem worldwide, causing the need for new antimicrobials. The aim of this study was to discover and characterize bacteriocin against clinical isolates of MDRE and VRE. Over 10,000 bacterial isolates from water, environment and clinical samples were screened. E. faecalis strain 478 isolated from human feces produced the highest antibacterial activity against several MDRE and VRE strains. The optimum condition for bacteriocin production was cultivation in MRS broth at 37 degrees C, pH 5-6 for 16 hours. The bacteriocin-like substance produced from E. faecalis strain EF478 was stable at 60 degrees C for at least 1 hour and retained its antimicrobial activity after storage at -20 degrees C for 1 year, at 4 degrees C for 6 months, and at 25 degrees C for 2 months. A nano-HPLC electro-spray ionization multi-stage tandem mass spectrometry (nLC-ESI-MS/MS) analysis showed that the amino acid sequences of the bacteriocin-like substance was similar to serine protease of E. faecalis, gi|488296663 (NCBI database), which has never been reported as a bacteriocin. This study reported a novel bacteriocin with high antibacterial activity against VRE and MDRE.	[Phumisantiphong, Uraporn; Siripanichgon, Kanokrat; Diraphat, Pornphan] Mahidol Univ, Fac Publ Hlth, Dept Microbiol, Bangkok, Thailand; [Reamtong, Onrapak] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand	Mahidol University; Mahidol University	Diraphat, P (corresponding author), Mahidol Univ, Fac Publ Hlth, Dept Microbiol, Bangkok, Thailand.	pornphan.dir@mahidol.edu		Phumisantiphong, Uraporn/0000-0002-5795-6623	China Medical Board (CMB), Faculty of Public Health, Mahidol University, Bangkok, Thailand	China Medical Board (CMB), Faculty of Public Health, Mahidol University, Bangkok, Thailand	The study was partially supported for publication by the China Medical Board (CMB), Faculty of Public Health, Mahidol University, Bangkok, Thailand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo Higuita NI., 2014, ENTEROCOCCI COMMENSA; [Anonymous], 2014, ENTEROCOCCI COMMENSA; Aunpad R, 2007, CURR MICROBIOL, V55, P308, DOI 10.1007/s00284-006-0632-2; Aymerich T, 2000, J APPL MICROBIOL, V88, P686, DOI 10.1046/j.1365-2672.2000.01012.x; Baldassarri L, 2005, INT J ARTIF ORGANS, V28, P1101, DOI 10.1177/039139880502801107; Balla E, 2000, APPL ENVIRON MICROB, V66, P1298, DOI 10.1128/AEM.66.4.1298-1304.2000; Basbulbul Ozdemir G, 2011, INDIAN J MICROBIOL, V51, P182, DOI 10.1007/s12088-011-0143-0; Belguesmia Y, 2010, J ENVIRON PUBLIC HEA, V2010, DOI 10.1155/2010/986460; Birri DJ, 2010, APPL ENVIRON MICROB, V76, P483, DOI 10.1128/AEM.01597-09; Bonten MJM, 1996, LANCET, V348, P1615, DOI 10.1016/S0140-6736(96)02331-8; Booijink CCGM, 2007, FUTURE MICROBIOL, V2, P285, DOI 10.2217/17460913.2.3.285; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHATTERJEE S, 1992, J ANTIBIOT, V45, P839, DOI 10.7164/antibiotics.45.839; Cintas LM, 1997, APPL ENVIRON MICROB, V63, P4321, DOI 10.1128/AEM.63.11.4321-4330.1997; Cleveland J, 2001, INT J FOOD MICROBIOL, V71, P1, DOI 10.1016/S0168-1605(01)00560-8; Coates ARM, 2007, BRIT J PHARMACOL, V152, P1147, DOI 10.1038/sj.bjp.0707432; Contreras BGL, 1997, APPL ENVIRON MICROB, V63, P13, DOI 10.1128/AEM.63.1.13-20.1997; Corsetti A, 2004, J APPL MICROBIOL, V96, P521, DOI 10.1111/j.1365-2672.2004.02171.x; Cortes G, 2002, INFECT IMMUN, V70, P4772, DOI 10.1128/IAI.70.9.4772-4776.2002; DABA H, 1991, APPL ENVIRON MICROB, V57, P3450, DOI 10.1128/AEM.57.12.3450-3455.1991; Dawid S, 2009, J BACTERIOL, V191, P1509, DOI 10.1128/JB.01213-08; de Kwaadsteniet M, 2008, APPL ENVIRON MICROB, V74, P547, DOI 10.1128/AEM.01862-07; de Oliveira F, 2016, TOXICON, V111, P130, DOI 10.1016/j.toxicon.2016.01.055; De Vuyst L, 2003, INT J FOOD MICROBIOL, V84, P299, DOI 10.1016/S0168-1605(02)00425-7; del Campo R, 2001, ANTIMICROB AGENTS CH, V45, P905, DOI 10.1128/AAC.45.3.905-912.2001; Du Toit M, 2000, J APPL MICROBIOL, V88, P482; Dunny GM, 1997, ANNU REV MICROBIOL, V51, P527, DOI 10.1146/annurev.micro.51.1.527; Ennahar S, 1999, J BIOSCI BIOENG, V87, P705, DOI 10.1016/S1389-1723(99)80142-X; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Furtado DN, 2014, BRAZ J MICROBIOL, V45, P1541, DOI 10.1590/S1517-83822014000400052; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Giraffa G, 2003, INT J FOOD MICROBIOL, V88, P215, DOI 10.1016/S0168-1605(03)00183-1; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Hammami R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-22; Hu CCA, 2009, J EXP MED, V206, P2429, DOI 10.1084/jem.20090782; Ibrahim KS, 2011, J MICROBIOL BIOTECHN, V21, P20, DOI 10.4014/jmb.1009.09001; IMAEDA T, 1968, J BACTERIOL, V96, P557, DOI 10.1128/JB.96.2.557-559.1968; Inoue T, 2006, ANTIMICROB AGENTS CH, V50, P1202, DOI 10.1128/AAC.50.4.1202-1212.2006; Joseph Baby, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P942, DOI 10.1016/S2221-1691(13)60183-5; Keren T, 2004, APPL ENVIRON MICROB, V70, P2098, DOI 10.1128/AEM.70.4.2098-2104.2004; Kishor Chauhan, 2007, Bioresource Technology, V98, P98, DOI 10.1016/j.biortech.2005.11.017; KOLATTUKUDY PE, 1993, INFECT IMMUN, V61, P2357, DOI 10.1128/IAI.61.6.2357-2368.1993; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; LEWUS CB, 1991, APPL ENVIRON MICROB, V57, P1683, DOI 10.1128/AEM.57.6.1683-1688.1991; Li C, 2002, J BIOTECHNOL, V93, P27, DOI 10.1016/S0168-1656(01)00377-7; Low DE, 2001, CLIN INFECT DIS, V32, pS133, DOI 10.1086/320185; LU G, 1993, J IMMUNOL, V150, P2823; Lyon WR, 2004, INFECT IMMUN, V72, P1618, DOI 10.1128/IAI.72.3.1618-1625.2004; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Millan-Zambrano G, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140085; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; Naghmouchi K, 2013, ANTIMICROB AGENTS CH, V57, P2719, DOI 10.1128/AAC.02328-12; Navarro L, 2000, J APPL MICROBIOL, V88, P44, DOI 10.1046/j.1365-2672.2000.00865.x; Nel HA, 2001, J APPL MICROBIOL, V91, P1131, DOI 10.1046/j.1365-2672.2001.01486.x; Nes I.F., 2014, ENTEROCOCCI COMMENSA; Nespolo CR, 2010, BRAZ J MICROBIOL, V41, P1009, DOI [10.1590/S1517-83822010000400020, 10.1590/S1517-838220100004000020]; PALLARES R, 1993, ARCH INTERN MED, V153, P1581, DOI 10.1001/archinte.153.13.1581; Papadimitriou-Olivgeris M, 2014, INFECTION, V42, P1013, DOI 10.1007/s15010-014-0678-1; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Rajanbabu V, 2011, PEPTIDES, V32, P415, DOI 10.1016/j.peptides.2010.11.005; REESE ET, 1969, APPL MICROBIOL, V17, P242, DOI 10.1128/AEM.17.2.242-245.1969; Riaz S, 2010, BRAZ J MICROBIOL, V41, P643, DOI 10.1590/S1517-83822010000300015; Riley MA, 1998, ANNU REV GENET, V32, P255, DOI 10.1146/annurev.genet.32.1.255; Rodriguez E, 1998, J DAIRY RES, V65, P143, DOI 10.1017/S0022029997002549; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russell JB, 2002, J MOL MICROB BIOTECH, V4, P347; Salgado Cassandra D, 2008, Am J Infect Control, V36, DOI 10.1016/j.ajic.2008.10.010; SCHLEGEL R, 1974, J GEN MICROBIOL, V81, P275, DOI 10.1099/00221287-81-1-275; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Simova ED, 2009, J APPL MICROBIOL, V106, P692, DOI 10.1111/j.1365-2672.2008.04052.x; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; TAGG JR, 1971, APPL MICROBIOL, V21, P943, DOI 10.1128/AEM.21.5.943-943.1971; Todorov SD, 2005, J MICROBIOL, V43, P370; Tomita H, 1996, J BACTERIOL, V178, P3585, DOI 10.1128/jb.178.12.3585-3593.1996; Tripathi LP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-549; Udby L, 2002, J IMMUNOL METHODS, V263, P43, DOI 10.1016/S0022-1759(02)00033-9; Valli S., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P469, DOI 10.1016/S2221-1691(12)60078-1; van Heel AJ, 2013, NUCLEIC ACIDS RES, V41, pW448, DOI 10.1093/nar/gkt391; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Vijayendra SVN, 2010, INDIAN J MICROBIOL, V50, P243, DOI 10.1007/s12088-010-0030-0; Wang HT, 2012, BIOSCI BIOTECH BIOCH, V76, P34, DOI 10.1271/bbb.110348; Watorek W, 2003, ACTA BIOCHIM POL, V50, P743; Wayne P.A., 2014, M100S24 CLSI; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zendo T, 2006, APPL ENVIRON MICROB, V72, P3383, DOI 10.1128/AEM.72.5.3383-3389.2006; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	89	29	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186415	10.1371/journal.pone.0186415	http://dx.doi.org/10.1371/journal.pone.0186415			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023515	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100125
J	Xu, WX; Wang, J; Tang, HP; Chen, LH; Lian, WB; Zhan, JM; Gupta, SK; Ji, CN; Gu, SH; Xie, Y				Xu, Wan-Xiang; Wang, Jian; Tang, Hai-Ping; Chen, Ling-Han; Lian, Wen-Bo; Zhan, Jian-Min; Gupta, Satish K.; Ji, Chao-Neng; Gu, Shao-Hua; Xie, Yi			A simpler and more cost-effective peptide biosynthetic method using the truncated GST as carrier for epitope mapping	PLOS ONE			English	Article							B-CELL EPITOPES; PROTEIN; IDENTIFICATION; EXPRESSION; ANTIBODIES; E7; CONTRACEPTION; GLYCOPROTEIN; VACCINATION; RESOLUTION	There is a need to develop better methods for epitope mapping and/or identification of anti-body-recognizing motifs. Here, we describe improved biosynthetic peptide (BSP) method using a newly developed plasmid pXXGST-3 as vector, which has a viral E7 gene in the cloning sites of pXXGST-1. It is crucial to employ pXXGST-3 instead of pXXGST-1, since it makes use of the BSP method simpler and easier to perform, and more cost-effective for epitope mapping. These merits are embodied in two aspects: i) convenient recovery of double enzyme-digested product due to the existence of 315 bp inserted between BamH I and Sal I sites, and thus greatly reducing the production of self-ligation clones, and ii) no longer requiring control protein when screening recombinant (r-) clones expressing 8/18mer peptides by running polyacrylamide gel electrophoresis. The protocol involves the following core steps: (i) design of plus and minus strands of DNA fragments encoding overlapping 8/18mer peptides; (ii) chemical synthesis of the designed DNA fragments; (iii) development of r-clones using pXXGST-3 vector expressing each 8/18mer peptide fused with truncated GST188 protein; (iv) screening r-clones by running the cell pellets from each induced clone on SDS-PAGE gel followed by sequencing of inserted DNA fragments for each verified r-clone; and (v) Western blotting with either monoclonal antibodies or polyclonal antibodies. This improved GST188-BSP method provides a powerful alternative tool for epitope mapping.	[Xu, Wan-Xiang; Wang, Jian; Tang, Hai-Ping; Chen, Ling-Han; Lian, Wen-Bo; Zhan, Jian-Min] Fudan Univ, Shanghai Inst Planned Parenthood Res, Div Reprod Immunol, Key Lab Reprod Regulat NPFPC, Shanghai, Peoples R China; [Gupta, Satish K.] Natl Inst Immunol, Reprod Cell Biol Lab, Aruna Asaf Ali Marg, New Delhi, India; [Ji, Chao-Neng; Gu, Shao-Hua; Xie, Yi] Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China	Fudan University; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Fudan University	Xu, WX (corresponding author), Fudan Univ, Shanghai Inst Planned Parenthood Res, Div Reprod Immunol, Key Lab Reprod Regulat NPFPC, Shanghai, Peoples R China.; Gupta, SK (corresponding author), Natl Inst Immunol, Reprod Cell Biol Lab, Aruna Asaf Ali Marg, New Delhi, India.; Xie, Y (corresponding author), Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China.	xuwanxiang@sippr.org.cn; skgupta@nii.ac.in; yxie@fudan.edu.cn		Xu, Wanxiang/0000-0003-3518-3583	National Natural Science Foundation, China [81370768, 31470884, 31270968]; Science and Technology Commission of Shanghai Municipality, China [10510704100, 08JC1417700]; Ministry of Science and Technology, China [2012BAI311307]; National Institute of Immunology, New Delhi, India; Science and Engineering Research Board, Department of Science and Technology, Government of India [SB/S2/JCB-040/2015]	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Institute of Immunology, New Delhi, India; Science and Engineering Research Board, Department of Science and Technology, Government of India	This work was supported by the grant Nos. 81370768, 31470884 and 31270968 from the National Natural Science Foundation, China, grants No. 10510704100, and 08JC1417700 from the Science and Technology Commission of Shanghai Municipality, China, and grant No. 2012BAI311307 from Ministry of Science and Technology, China as well as National Institute of Immunology, New Delhi, India. SKG received a J. C. Bose Fellowship (SB/S2/JCB-040/2015) by the Science and Engineering Research Board, Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the grant Nos. 81370768, 31470884 and 31270968 from the National Natural Science Foundation, China, grants No. 10510704100, and 08JC1417700 from the Science and Technology Commission of Shanghai Municipality, China, and grant No. 2012BAI31B07 from Ministry of Science and Technology, China as well as National Institute of Immunology, New Delhi, India is gratefully acknowledged. SKG would also like to acknowledge J. C. Bose Fellowship (SB/S2/JCB-040/2015) by Science and Engineering Research Board, Department of Science and Technology, Government of India.	Afzalpurkar A, 1997, AM J REPROD IMMUNOL, V38, P26; BANKS L, 1987, J GEN VIROL, V68, P1351, DOI 10.1099/0022-1317-68-5-1351; BLEUL C, 1991, J CLIN MICROBIOL, V29, P1579, DOI 10.1128/JCM.29.8.1579-1588.1991; BURCH HB, 1993, J IMMUNOL METHODS, V158, P123, DOI 10.1016/0022-1759(93)90264-8; Christensen ND, 1996, VIROLOGY, V223, P174, DOI 10.1006/viro.1996.0466; Cui XL, 2005, MOL REPROD DEV, V70, P485, DOI 10.1002/mrd.20220; GEYSEN HM, 1987, J IMMUNOL METHODS, V102, P259, DOI 10.1016/0022-1759(87)90085-8; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; Harlow E, 2006, CSH PROTOC; He YP, 2011, J BIOTECHNOL, V151, P15, DOI 10.1016/j.jbiotec.2010.11.003; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Hua RH, 2005, DNA CELL BIOL, V24, P503, DOI 10.1089/dna.2005.24.503; Hua RH, 2004, BIOCHEM BIOPH RES CO, V319, P929, DOI 10.1016/j.bbrc.2004.05.066; KAIN KC, 1991, BIOTECHNIQUES, V10, P366; LAVER WG, 1990, CELL, V61, P553, DOI 10.1016/0092-8674(90)90464-P; LENSTRA JA, 1990, ARCH VIROL, V110, P1, DOI 10.1007/BF01310699; Li K, 2015, PROTEIN EXPRES PURIF, V114, P23, DOI 10.1016/j.pep.2015.06.005; Liu DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098855; Maier RH, 2010, J BIOMOL SCREEN, V15, P418, DOI 10.1177/1087057110363821; MEHRA V, 1986, P NATL ACAD SCI USA, V83, P7013, DOI 10.1073/pnas.83.18.7013; MILLAR SE, 1989, SCIENCE, V246, P935, DOI 10.1126/science.2479101; Paterson M, 1998, AM J REPROD IMMUNOL, V40, P198; Reineke U, 2001, CURR OPIN BIOTECH, V12, P59, DOI 10.1016/S0958-1669(00)00178-6; Rua RH, 2005, PROG BIOCHEM BIOPHYS, V32, P1030; Sambrook J., 2001, MOL CLONING LAB MANU; SELVEY LA, 1990, J IMMUNOL, V145, P3105; Skinner SM, 1999, BIOL REPROD, V61, P1373, DOI 10.1095/biolreprod61.6.1373; Slupetzky K, 2007, VACCINE, V25, P2001, DOI 10.1016/j.vaccine.2006.11.049; Song Li-Wen, 2005, Shengli Xuebao, V57, P682; TROPAK MB, 1994, J NEUROCHEM, V62, P854; Tumban E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023310; Wang DN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123944; Wang JL, 2007, VET MICROBIOL, V125, P224, DOI 10.1016/j.vetmic.2007.05.033; Xu WX, 2016, SCI REP-UK, V6, DOI 10.1038/srep34686; Xu WX, 2012, AM J REPROD IMMUNOL, V68, P465, DOI 10.1111/j.1600-0897.2012.01177.x; Xu WX, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/831010; Xu Wan-Xiang, 2004, Sheng Wu Gong Cheng Xue Bao, V20, P49; Xu WX, 2009, J REPROD IMMUNOL, V81, P9, DOI 10.1016/j.jri.2009.04.004; Xue F, 2016, AM J REPROD IMMUNOL, V75, P474, DOI 10.1111/aji.12485; Yu RS, 2015, VET MICROBIOL, V175, P132, DOI 10.1016/j.vetmic.2014.10.012	40	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186097	10.1371/journal.pone.0186097	http://dx.doi.org/10.1371/journal.pone.0186097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023483	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100061
J	Bogdanov, P; Dereli, N; Dang, XH; Bassett, DS; Wymbs, NF; Grafton, ST; Singh, AK				Bogdanov, Petko; Dereli, Nazli; Dang, Xuan-Hong; Bassett, Danielle S.; Wymbs, Nicholas F.; Grafton, Scott T.; Singh, Ambuj K.			Learning about learning: Mining human brain sub-network biomarkers from fMRI data	PLOS ONE			English	Article							HUMAN PARIETAL OPERCULUM; FUNCTIONAL CONNECTIVITY; COMMUNICATION; CORTEX; AREAS; TESTS	Modeling the brain as a functional network can reveal the relationship between distributed neurophysiological processes and functional interactions between brain structures. Existing literature on functional brain networks focuses mainly on a battery of network properties in "resting state" employing, for example, modularity, clustering, or path length among regions. In contrast, we seek to uncover functionally connected subnetworks that predict or correlate with cohort differences and are conserved within the subjects within a cohort. We focus on differences in both the rate of learning as well as overall performance in a sensorimotor task across subjects and develop a principled approach for the discovery of discriminative subgraphs of functional connectivity based on imaging acquired during practice. We discover two statistically significant subgraph regions: one involving multiple regions in the visual cortex and another involving the parietal operculum and planum temporale. High functional coherence in the former characterizes sessions in which subjects take longer to perform the task, while high coherence in the latter is associated with high learning rate ( performance improvement across trials). Our proposed methodology is general, in that it can be applied to other cognitive tasks, to study learning or to differentiate between healthy patients and patients with neurological disorders, by revealing the salient interactions among brain regions associated with the observed global state. The discovery of such significant discriminative subgraphs promises a better data-driven understanding of the dynamic brain processes associated with high-level cognitive functions.	[Bogdanov, Petko] SUNY Albany, Dept Comp Sci, 1400 Washington Ave, Albany, NY 12222 USA; [Dereli, Nazli] Ticketmaster, Los Angeles, CA USA; [Dang, Xuan-Hong; Singh, Ambuj K.] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; [Bassett, Danielle S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Bassett, Danielle S.] Univ Penn, Dept Elect Engn, Philadelphia, PA 19104 USA; [Wymbs, Nicholas F.] Johns Hopkins Med Inst, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA; [Grafton, Scott T.] Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA; [Grafton, Scott T.] Univ Calif Santa Barbara, UCSB Brain Imaging Ctr, Santa Barbara, CA 93106 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of California System; University of California Santa Barbara; University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Bogdanov, P (corresponding author), SUNY Albany, Dept Comp Sci, 1400 Washington Ave, Albany, NY 12222 USA.	pbogdanov@albany.edu		Bogdanov, Petko/0000-0001-6310-3224	National Science Foundation [IIS-1219254, BCS-1441502, CAREER PHY-1554488, BCS-1631550]; US National Institutes of Health [P01 NS044393]; Institute for Collaborative Biotechnologies from the U.S. Army Research Office [W911NF-09-0001]; John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation; Army Research Laboratory; Army Research Office [W911NF-10-2-0022, W911NF-14-1-0679]; National Institute of Health [2-R01-DC-009209-11, 1R01HD086888-01, R01-MH107235, R01-MH107703, R01MH109520, R21-M MH-106799]; Office of Naval Research	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Collaborative Biotechnologies from the U.S. Army Research Office; John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Army Research Office; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research)	AKS would like to acknowledge support from the National Science Foundation grant IIS-1219254. This data is based on support to STG by the US National Institutes of Health (grant: P01 NS044393) and the Institute for Collaborative Biotechnologies through contract W911NF-09-0001 from the U.S. Army Research Office. DSB would also like to acknowledge support from the John D. and Catherine T. MacArthur Foundation, the Alfred P. Sloan Foundation, the Army Research Laboratory and the Army Research Office through contract numbers W911NF-10-2-0022 and W911NF-14-1-0679, the National Institute of Health (2-R01-DC-009209-11, 1R01HD086888-01, R01-MH107235, R01-MH107703, R01MH109520, and R21-M MH-106799), the Office of Naval Research, and the National Science Foundation (BCS-1441502, CAREER PHY-1554488, and BCS-1631550). The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ND contributed to the manuscript while pursuing her MS degree at UCSB, thus, her current employer Ticketmaster did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript nor in providing financial support.; AKS would like to acknowledge support from the National Science Foundation grant IIS-1219254. This data is based on support to STG by the US National Institutes of Health (grant: P01 NS044393) and the Institute for Collaborative Biotechnologies through contract W911NF-09-0001 from the U.S. Army Research Office. DSB would also like to acknowledge support from the John D. and Catherine T. MacArthur Foundation, the Alfred P. Sloan Foundation, the Army Research Laboratory and the Army Research Office through contract numbers W911NF-10-2-0022 and W911NF-14-1-0679, the National Institute of Health (2-R01-DC-009209-11, 1R01HD086888-01, R01-MH107235, R01-MH107703, R01MH109520, and R21-M MH-106799), the Office of Naval Research, and the National Science Foundation (BCS-1441502, CAREER PHY-1554488, and BCS-1631550). The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Bassett D. S., 2011, P NATL ACAD SCI; Bassett DS, 2015, NAT NEUROSCI, V18, P744, DOI 10.1038/nn.3993; Bassett DS, 2014, CHAOS, V24, DOI 10.1063/1.4858457; Bassett DS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003171; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassett DS, 2016, NEUROSCIENT IN PRESS; BASSETTI C, 1993, NEUROLOGY, V43, P1942, DOI 10.1212/WNL.43.10.1942; Blakemore SJ, 1999, NEUROIMAGE, V10, P448, DOI 10.1006/nimg.1999.0478; Boas P.R.V., 2010, J STAT MECH-THEORY E, V2010; Bogdanov P., 2011, Proceedings of the 2011 IEEE 11th International Conference on Data Mining (ICDM 2011), P81, DOI 10.1109/ICDM.2011.101; Borgatti SP, 1999, SOC NETWORKS, V21, P375; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Buch ER, 2016, NEUROSCIENTIST; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Caspers J, 2014, HUM BRAIN MAPP, V35, P2754, DOI 10.1002/hbm.22364; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Dang XH, 2014, MACHINE LEARNING KNO, P290; Davison EN, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004029; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Duda R.O., 2000, PATTERN CLASSIFICATI; Dutkowski J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002180; Echtermeyer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015765; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Eickhoff SB, 2006, CEREB CORTEX, V16, P254, DOI 10.1093/cercor/bhi105; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Heitger MH, 2012, NEUROIMAGE, V61, P633, DOI 10.1016/j.neuroimage.2012.03.067; Huang, 2006, P IEEE INT C AC SPEE, V3, pIII; Hubbard EM, 2005, NEURON, V48, P509, DOI 10.1016/j.neuron.2005.10.012; Jancke L, 2001, CEREB CORTEX, V11, P114, DOI 10.1093/cercor/11.2.114; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jiang CT, 2013, KNOWL ENG REV, V28, P75, DOI 10.1017/S0269888912000331; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Kim J, 2015, NEUROIMAGE-CLIN, V9, P625, DOI 10.1016/j.nicl.2015.10.004; Kim JH, 2014, NEUROIMAGE, V101, P681, DOI 10.1016/j.neuroimage.2014.07.031; KRUBITZER L, 1995, J NEUROSCI, V15, P3821; Li RH, 2015, P INT C DAT ENG ICDE; Lu XS, 2012, LECT NOTES COMPUT SC, V7338, P195, DOI 10.1007/978-3-642-31235-9_13; Mantzaris AV, 2013, J COMPLEX NETW, V1, P83, DOI 10.1093/comnet/cnt001; Maule F, 2013, CEREB CORTEX, V25, P528; Mazzola L, 2012, NEUROIMAGE, V60, P409, DOI 10.1016/j.neuroimage.2011.12.072; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Mongiovi M, 2013, IEEE DATA MINING, P537, DOI 10.1109/ICDM.2013.106; Muhei-aldin O, 2014, J NEUROSCI METH, V227, P75, DOI 10.1016/j.jneumeth.2014.02.003; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Ranu S, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P509; Rosenbaum DA, 2010, HUMAN MOTOR CONTROL, 2ND EDITION, P1; Ruben J, 2001, CEREB CORTEX, V11, P463, DOI 10.1093/cercor/11.5.463; Schmidt R.A., 2005, MOTOR CONTROL LEARNI, V4; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stephan KE, 2009, NEUROIMAGE, V47, P1628, DOI 10.1016/j.neuroimage.2009.05.096; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Summerfield C, 2006, PLOS BIOL, V4, P855, DOI 10.1371/journal.pbio.0040128; Sun FT, 2007, CEREB CORTEX, V17, P1227, DOI 10.1093/cercor/bhl033; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Tibshirani RJ, 2011, ANN STAT, V39, P1335, DOI 10.1214/11-AOS878; Tomassini V, 2011, HUM BRAIN MAPP, V32, P494, DOI 10.1002/hbm.21037; Turk-Browne NB, 2013, SCIENCE, V342, P580, DOI 10.1126/science.1238409; Ugurbil K, 2013, NEUROIMAGE, V80, P80, DOI 10.1016/j.neuroimage.2013.05.012; van Diessen E, 2015, CLIN NEUROPHYSIOL, V126, P1468, DOI 10.1016/j.clinph.2014.11.018; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wymbs NF, 2012, NEURON, V74, P936, DOI 10.1016/j.neuron.2012.03.038; Yan XF, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P721, DOI 10.1109/ICDM.2002.1184038; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672; Zalesky A, 2012, NEUROIMAGE, V60, P1055, DOI 10.1016/j.neuroimage.2012.01.068; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhang ZT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157243	74	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0184344	10.1371/journal.pone.0184344	http://dx.doi.org/10.1371/journal.pone.0184344			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016686	gold, Green Published, Green Submitted			2022-12-26	WOS:000412627400006
J	Botwright, S; Holroyd, T; Nanda, S; Bloem, P; Griffiths, UK; Sidibe, A; Hutubessy, RCW				Botwright, Siobhan; Holroyd, Taylor; Nanda, Shreya; Bloem, Paul; Griffiths, Ulla K.; Sidibe, Anissa; Hutubessy, Raymond C. W.			Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; ROUTINE IMMUNIZATION; COUNTRIES	From 2012 to 2016, Gavi, the Vaccine Alliance, provided support for countries to conduct small-scale demonstration projects for the introduction of the human papillomavirus vaccine, with the aim of determining which human papillomavirus vaccine delivery strategies might be effective and sustainable upon national scale-up. This study reports on the operational costs and cost determinants of different vaccination delivery strategies within these projects across twelve countries using a standardized micro-costing tool. The World Health Organization Cervical Cancer Prevention and Control Costing Tool was used to collect costing data, which were then aggregated and analyzed to assess the costs and cost determinants of vaccination. Across the one-year demonstration projects, the average economic and financial costs per dose amounted to US$19.98 (standard deviation +/- 12.5) and US$8.74 (standard deviation +/- 5.8), respectively. The greatest activities representing the greatest share of financial costs were social mobilization at approximately 30% (range, 6-67%) and service delivery at about 25% (range, 3-46%). Districts implemented varying combinations of school-based, facility-based, or outreach delivery strategies and experienced wide variation in vaccine coverage, drop-out rates, and service delivery costs, including transportation costs and per diems. Size of target population, number of students per school, and average length of time to reach an outreach post influenced cost per dose. Although the operational costs from demonstration projects are much higher than those of other routine vaccine immunization programs, findings from our analysis suggest that HPV vaccination operational costs will decrease substantially for national introduction. Vaccination costs may be decreased further by annual vaccination, high initial investment in social mobilization, or introducing/strengthening school health programs. Our analysis shows that drivers of cost are dependent on country and district characteristics. We therefore recommend that countries carry out detailed planning at the national and district levels to define a sustainable strategy for national HPV vaccine roll-out, in order to achieve the optimal balance between coverage and cost.	[Botwright, Siobhan; Sidibe, Anissa] Gavi, Vaccine Implementat, Vaccine Alliance, Geneva, Switzerland; [Holroyd, Taylor; Nanda, Shreya; Hutubessy, Raymond C. W.] WHO, Initiat Vaccine Res, Geneva, Switzerland; [Bloem, Paul] WHO, Expanded Program Immunizat, Geneva, Switzerland; [Griffiths, Ulla K.] UNICEF, Hlth Sect, New York, NY USA; [Botwright, Siobhan] Stop TB Partnership, Strateg Initiat & Innovat Financing, Geneva, Switzerland; [Holroyd, Taylor] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Nanda, Shreya] Food Stand Agcy, London, England	World Health Organization; World Health Organization; UNICEF; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hutubessy, RCW (corresponding author), WHO, Initiat Vaccine Res, Geneva, Switzerland.	hutubessyr@who.int		Holroyd, Taylor/0000-0003-1907-2218	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Ahanhanzo CD, 2015, VACCINE, V33, pA66, DOI 10.1016/j.vaccine.2014.12.069; [Anonymous], 2016, HPV VACC LESS LEARNT; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Brenzel L, 2015, VACCINE, V33, pA93, DOI 10.1016/j.vaccine.2014.12.076; de Sanjose S, 2012, Vaccine, V30 Suppl 4, pD1, DOI 10.1016/S0264-410X(12)01435-1; Dorji T, 2015, VACCINE, V33, P3726, DOI 10.1016/j.vaccine.2015.05.078; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gavi The Vaccine Alliance, 2016, APPL FOR SUPP; Ginsberg GM, 2009, VACCINE, V27, P6060, DOI 10.1016/j.vaccine.2009.07.026; Hanson CM, 2015, VACCINES-BASEL, V3, P408, DOI 10.3390/vaccines3020408; Hutubessy R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-136; Jarrett C, 2015, VACCINE, V33, P4180, DOI 10.1016/j.vaccine.2015.04.040; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Kabakama S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3517-8; Le Gargasson JB, 2015, VACCINE, V33, pA40, DOI 10.1016/j.vaccine.2014.12.081; Levin A, 2014, PLOS ONE, V9, P8; Maceira D, 2015, VALUE HEALTH, V18, pA746, DOI 10.1016/j.jval.2015.09.2881; Mvundura M, 2015, VACCINE, V33, P2697, DOI 10.1016/j.vaccine.2015.03.084; Ngabo F, 2015, VACCINE, V33, P7357, DOI 10.1016/j.vaccine.2015.10.022; Quentin W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-137; Torres-Rueda S, 2016, SEX REPROD HEALTHC, V7, P46, DOI 10.1016/j.srhc.2015.11.006; Tsu V, 2016, NEW ENGL J MED, V374, P2509, DOI 10.1056/NEJMp1604113; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; WHO, 2015, VACCINE, V33, P76, DOI 10.1016/j.vaccine.2014.05.040; Wigle J, 2013, VACCINE, V31, P3811, DOI 10.1016/j.vaccine.2013.06.016; World Health Organization, 2016, WKLY EPIDEMIOL REC, V91, P561; World Health Organization, 2013, WHO UNICEF GUID DEV; World Health Organization, 2016, WHO CERV CANC PREV C	28	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0182663	10.1371/journal.pone.0182663	http://dx.doi.org/10.1371/journal.pone.0182663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016596	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400002
J	Thein, HH; Qiao, Y; Zaheen, A; Jembere, N; Sapisochin, G; Chan, KKW; Yoshida, EM; Earle, CC				Thein, Hla-Hla; Qiao, Yao; Zaheen, Ahmad; Jembere, Nathaniel; Sapisochin, Gonzalo; Chan, Kelvin K. W.; Yoshida, Eric M.; Earle, Craig C.			Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting	PLOS ONE			English	Article							QUALITY-OF-LIFE; EFFECTIVENESS ACCEPTABILITY CURVES; HEALTH-STATE UTILITIES; CHRONIC HEPATITIS-C; CASE-MIX GROUPS; TRANSARTERIAL CHEMOEMBOLIZATION; ECONOMIC-EVALUATION; PROPENSITY SCORE; CARE MANAGEMENT; STAGING SYSTEMS	Hepatocellular carcinoma (HCC) presentation is heterogeneous necessitating a variety of therapeutic interventions with varying efficacies and associated prognoses. Poor prognostic patients often undergo non-curative palliative interventions including transarterial chemoem-bolization (TACE), sorafenib, chemotherapy, or purely supportive care. The decision to pursue one of many palliative interventions for HCC is complex and an economic evaluation comparing these interventions has not been done. This study evaluates the cost-effectiveness of non-curative palliative treatment strategies such as TACE alone or TACE+sorafenib, sorafenib alone, and non-sorafenib chemotherapy compared with no treatment or best supportive care (BSC) among patients diagnosed with HCC between 2007 and 2010 in a Canadian setting. Using person-level data, we estimated effectiveness in life years and quality-adjusted life years (QALYs) along with total health care costs (2013 US dollars) from the health care payer's perspective (3% annual discount). A net benefit regression approach accounting for baseline covariates with propensity score adjustment was used to calculate incremental net benefit to generate incremental cost-effectiveness ratio (ICER) and uncertainty measures. Among 1,172 identified patients diagnosed with HCC, 4.5%, 7.9%, and 5.6%, received TACE alone or TACE+sorafenib, sorafenib, and non-sorafenib chemotherapy clone, respectively. Compared with no treatment or BSC (81.9%), ICER estimates for TACE alone or TACE+sorafenib was $6,665/QALY (additional QALY: 0.47, additional cost: $3,120; 95% CI: -$18,800-$34,500/QALY). The cost-effectiveness acceptability curve demonstrated that if the relevant threshold was $50,000/QALY, TACE alone or TACE+sorafenib, non-sorafenib chemotherapy, and sorafenib alone, would have a cost-effectiveness probability of 99.7%, 46.6%, and 5.5%, respectively. Covariates associated with the incremental net benefit of treatments are age, sex, comorbidity, and cancer stage. Findings suggest that TACE with or without sorafenib is currently the most cost-effective active non-curative palliative treatment approach to HCC. Further research into new combination treatment strategies that afford the best tumor response is needed.	[Thein, Hla-Hla; Qiao, Yao; Jembere, Nathaniel] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Thein, Hla-Hla; Earle, Craig C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Zaheen, Ahmad; Chan, Kelvin K. W.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Sapisochin, Gonzalo] Univ Toronto, Univ Hlth Network, Div Gen Surg, Multiorgan Transplant, Toronto, ON, Canada; [Chan, Kelvin K. W.] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada; [Chan, Kelvin K. W.; Earle, Craig C.] Canadian Ctr Appl Res Canc Control ARCC, Toronto, ON, Canada; [Yoshida, Eric M.] Univ British Columbia, Div Gastroenterol, Vancouver, BC, Canada; [Earle, Craig C.] Ontario Inst Canc Res, Toronto, ON, Canada; [Earle, Craig C.] Canc Care Ontario, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of British Columbia; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Cancer Care Ontario	Thein, HH (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Thein, HH (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	rosie.thein@utoronto.ca		Thein, Hla-Hla/0000-0003-4950-187X	Institute for Clinical Evaluative Sciences; Cancer Care Ontario; Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Ontario Institute for Cancer Research Health Services Research Program [IA-034]	Institute for Clinical Evaluative Sciences; Cancer Care Ontario; Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Ontario Institute for Cancer Research; Ontario Institute for Cancer Research Health Services Research Program	This study was supported through provision of data by the Institute for Clinical Evaluative Sciences and Cancer Care Ontario and through funding support to Institute for Clinical Evaluative Sciences from an annual grant by the Ministry of Health and Long-Term Care, and from the Ontario Institute for Cancer Research. The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by Institute for Clinical Evaluative Sciences, Cancer Care Ontario, Ontario Institute for Cancer Research or the Government of Ontario is intended or should be inferred. Hla-Hla Thein received a New Investigator Award IA-034 from the Ontario Institute for Cancer Research Health Services Research Program.	[Anonymous], 2010, TECHN APPR GUID 189; [Anonymous], 2006, LIF TABL CAN PROV TE; Ault Kimberly, 2012, MULTIPLE IMPUTATION; Barone C, 2013, ANN ONCOL S2, V24; Breunig IM, 2013, VALUE HEALTH, V16, P760, DOI 10.1016/j.jval.2013.03.1630; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Burak KW, 2015, CAN J GASTROENTEROL, V29, P178, DOI 10.1155/2015/824263; Camma C, 2008, ALIMENT PHARM THER, V28, P62, DOI 10.1111/j.1365-2036.2008.03692.x; Camma C, 2013, HEPATOLOGY, V57, P1046, DOI 10.1002/hep.26221; Canadian Cancer Statistics, 2013, CAN CANC STAT 2013; Carr BI, 2010, J GASTROEN HEPATOL, V25, P1739, DOI 10.1111/j.1440-1746.2010.06404.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choi GH, 2013, RADIOLOGY, V269, P602, DOI 10.1148/radiol.13130150; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Clarke EA, 1991, IARC SCI PUBL, P246; Cucchetti A, 2013, J HEPATOL, V59, P300, DOI 10.1016/j.jhep.2013.04.009; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Fenwick E, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-52; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fleming ID, 2001, J SURG ONCOL, V77, P233, DOI 10.1002/jso.1101; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fu QH, 2014, J CANCER RES CLIN, V140, P1429, DOI 10.1007/s00432-014-1684-5; Gomaa AI, 2015, WORLD J HEPATOL, V7, P673, DOI 10.4254/wjh.v7.i4.673; Hoch JS, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-68; Hoch JS, 2002, HEALTH ECON, V11, P415, DOI 10.1002/hec.678; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hsu PC, 2012, J GASTROEN HEPATOL, V27, P149, DOI 10.1111/j.1440-1746.2011.06813.x; Jacobs P, USING CANADIAN ADM D; Jembere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040917; Levy AR, 2008, VALUE HEALTH, V11, P527, DOI 10.1111/j.1524-4733.2007.00297.x; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Muszbek N, 2008, CURR MED RES OPIN, V24, P3559, DOI 10.1185/03007990802563706 ; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Organization for Economic Co-Operation and Development, 2015, PPPS EXCH RAT; Peng SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112530; PINK GH, 1994, CAN MED ASSOC J, V150, P1255; PINK GH, 1994, CAN MED ASSOC J, V150, P889; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Sherman KE, 2004, ARCH INTERN MED, V164, P2377, DOI 10.1001/archinte.164.21.2377; Shih YT, 2017, J CLIN ONCOL; Siebert U, 2001, HEPATOLOGY, V34; Siegel JE, 1997, PHARMACOECONOMICS, V11, P159, DOI 10.2165/00019053-199711020-00005; Statistics Canada, CANSIM TABL 326 0021; Thein HH, 2016, CURR ONCOL, V23, pE196, DOI 10.3747/co.23.2956; Thein HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138907; Thein HH, 2013, HEPATOLOGY, V58, P1375, DOI 10.1002/hep.26231; Vadot L, 2015, J CLIN PHARM THER, V40, P83, DOI 10.1111/jcpt.12230; VANHOUT BA, 1994, HEALTH ECON, V3, P309, DOI 10.1002/hec.4730030505; Woo G, 2012, CAN J GASTROENTEROL, V26, P445, DOI 10.1155/2012/736452; Wright M, 2006, HEALTH TECHNOL ASSES, V10, P1; Younossi ZM, 2001, AM J GASTROENTEROL, V96, P579; Zhang LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100305; Zhang PF, 2015, EUR J GASTROEN HEPAT, V27, P853, DOI 10.1097/MEG.0000000000000373	62	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185198	10.1371/journal.pone.0185198	http://dx.doi.org/10.1371/journal.pone.0185198			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3JE	29016627	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400015
J	Kim, B; Pai, H; Choi, WS; Kim, Y; Kweon, KT; Kim, HA; Ryu, SY; Wie, SH; Kim, J				Kim, Bongyoung; Pai, Hyunjoo; Choi, Won Suk; Kim, Yeonjae; Kweon, Ki Tae; Kim, Hyun Ah; Ryu, Seong Yeol; Wie, Seong-Heon; Kim, Jieun			Current status of indwelling urinary catheter utilization and catheter-associated urinary tract infection throughout hospital wards in Korea: A multicenter prospective observational study	PLOS ONE			English	Article								To evaluate the frequency and appropriateness of indwelling urinary catheters (IUC) use and the incidence of catheter-associated urinary tract infections (CA-UTI), and explore the risk factors for CA-UTI in hospitals as a whole, we conducted a study. This study was divided into two parts; a point-prevalence study on Dec 12th 2012 and a prospective cohort study from Dec 13th 2012 to Jan 9th 2013 were performed in six hospitals in Korea. All hospitalized patients with newly-placed IUCs were enrolled and monitored weekly for 28 days after IUC placement. In the point-prevalence study, the IUCs were present in median 14.9/100 hospitalized patients (1Q 14, 3Q 16) across the six hospitals. In the prospective cohort study, the median IUC-days per patient was 5 (1Q 3, 3Q 10) and the median CA-UTI prevalence per 1,000 catheter days was 1.9 (1Q 0.7, 3Q 3.8) with significant inter-hospital variation. The proportion of patients with inappropriate IUC maintenance increased with number of IUC-days (8.5% on day 7, 9.4% on day 14, 16.3% on day 21, and 23.1% on day 28). Urinary output monitoring (23/36, 63.9%) was the most common indication for inappropriate use after 1 week of ICU placement. In multivariate analysis, IUC-days was significantly associated with the development of CA-UTI (odds ratio 1.122, 95% confidence interval 1.074-1.173, P < 0.001). IUC-days and CA-UTI rates vary between hospitals. IUC-days is a risk factor for CA-UTI, and is correlated with inappropriate use.	[Kim, Bongyoung] Eulji Univ, Coll Med, Dept Internal Med, Daejeon, South Korea; [Pai, Hyunjoo; Kim, Jieun] Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Choi, Won Suk] Korea Univ, Coll Med, Dept Internal Med, Ansan, South Korea; [Kim, Yeonjae] Natl Med Ctr, Dept Infect Dis, Seoul, South Korea; [Kweon, Ki Tae] Patima Hosp, Dept Infect Dis, Daegu, South Korea; [Kim, Hyun Ah; Ryu, Seong Yeol] Gyemyeong Univ, Coll Med, Dept Internal Med, Daegu, South Korea; [Wie, Seong-Heon] St Vincent Hosp, Dept Internal Med, Suwon, South Korea	Eulji University; Hanyang University; Korea University; Korea University Medicine (KU Medicine); National Medical Center - Korea	Kim, J (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	quidam76@hanyang.ac.kr	Choi, Won Suk/V-2730-2017	Choi, Won Suk/0000-0001-5874-4764; Kim, Jieun/0000-0002-6214-3889	Hanyang University	Hanyang University	This work was supported by the research fund of Hanyang University (HY-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apisarnthanarak A, 2007, AM J INFECT CONTROL, V35, P594, DOI 10.1016/j.ajic.2006.11.007; BREITENBUCHER RB, 1984, ARCH INTERN MED, V144, P1585, DOI 10.1001/archinte.144.8.1585; 곽이경, 2015, [Korean Journal of Healthcare-Associated Infection Control and Prevention, 의료관련감염관리], V20, P49; Crouzet J, 2007, J HOSP INFECT, V67, P253, DOI 10.1016/j.jhin.2007.08.014; Elpern EH, 2009, AM J CRIT CARE, V18, P535, DOI 10.4037/ajcc2009938; Fakih MG, 2015, INFECT CONT HOSP EP, V29, P815; Gokula RM, 2007, AM J INFECT CONTROL, V35, P589, DOI 10.1016/j.ajic.2006.12.004; Gould CV, 2010, INFECT CONT HOSP EP, V31, P319, DOI 10.1086/651091; Jansen IAV, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-25; Janzen J, 2013, BMJ QUAL SAF, V22, P984, DOI 10.1136/bmjqs-2013-001908; Korean Society for Nosocomial Infection Control, 2012, KOR NOS INT SURV SYS; Lewis SS, 2013, INFECT CONT HOSP EP, V34, P744, DOI 10.1086/671000; Lo E, 2014, INFECT CONT HOSP EP, V35, P464, DOI [10.1086/675718, 10.1017/S0899823X00193845]; Meddings J, 2010, CLIN INFECT DIS, V51, P550, DOI 10.1086/655133; Saint S, 2000, AM J MED, V109, P476, DOI 10.1016/S0002-9343(00)00531-3; Saint S, 2000, AM J INFECT CONTROL, V28, P68, DOI 10.1016/S0196-6553(00)90015-4; Talaat M, 2010, AM J INFECT CONTROL, V38, P222, DOI 10.1016/j.ajic.2009.06.011; Tambyah PA, 2002, INFECT CONT HOSP EP, V23, P27, DOI 10.1086/501964; Tambyah PA, 2000, ARCH INTERN MED, V160, P678, DOI 10.1001/archinte.160.5.678; Temiz E, 2012, SCAND J INFECT DIS, V44, P344, DOI 10.3109/00365548.2011.639031	20	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185369	10.1371/journal.pone.0185369	http://dx.doi.org/10.1371/journal.pone.0185369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	28991927	Green Published, gold, Green Submitted			2022-12-26	WOS:000412601800015
J	Mertens, F; Tavora, R; Nakano, EY; Castilhos, ZC				Mertens, Frederic; Tavora, Renata; Nakano, Eduardo Yoshio; Castilhos, Zuleica Carmen			Information sources, awareness and preventive health behaviors in a population at risk of Arsenic exposure: The role of gender and social networks	PLOS ONE			English	Article							TRUST; COMMUNICATION; KNOWLEDGE; INNOVATIONS; DIFFUSION; ATTITUDES	The population of Paracatu is at risk of Arsenic (As) exposure associated with long-term exploration of the largest open pit gold mine in Brazil. As part of the interdisciplinary research "The Paracatu project: Arsenic environmental contamination and human health risks assessment in Paracatu-MG", carried out between 2011 and 2013, we used data disaggregated by gender to identify the sources of As-related information being accessed by inhabitants of Paracatu and to examine if access to these sources was correlated to awareness of As health effects and adoption of behaviors to reduce risk of As exposure. Semistructured, face-to-face interviews were carried out with 460 participants (294 women and 166 men) to collect data on respondent's socio-demographic characteristics, use of mass media and social communication networks as sources of information on As issues, the trustworthiness of these information sources, awareness of As health effects, and adoption of behaviors to reduce As exposure. For both men and women, interpersonal communication was used and trusted more frequently than mass media to obtain information on As. Discussion of As issues occurred preferentially among individuals of the same gender and was associated with awareness of As health risks. There are marked differences in variables correlated with the adoption of behaviors to reduce the risk of As exposure between men and women. Discussing As issues with women was associated with adoption of risk-reduction practices for both genders. In contrast, men who discuss As issues with other men were less likely to adopt As exposure prevention behaviors. Finally, adoption was associated with awareness of As health effects for women, but this was not the case for men. Policy implications for decision makers, practitioners and researchers are discussed, based on concrete examples of how gender-specific approaches can effectively guide the formulation and implementation of health promotion campaigns and programs.	[Mertens, Frederic; Tavora, Renata] Univ Brasilia, Ctr Desenvolvimento Sustentavel, Brasilia, DF, Brazil; [Mertens, Frederic; Tavora, Renata; Castilhos, Zuleica Carmen] Community Practice Ecosyst Approaches Hlth Latin, Brasilia, DF, Brazil; [Nakano, Eduardo Yoshio] Univ Brasilia, Dept Stat, Brasilia, DF, Brazil; [Castilhos, Zuleica Carmen] MCTI, Ctr Tecnol Mineral CETEM, Rio De Janeiro, RJ, Brazil	Universidade de Brasilia; Universidade de Brasilia	Mertens, F (corresponding author), Univ Brasilia, Ctr Desenvolvimento Sustentavel, Brasilia, DF, Brazil.; Mertens, F (corresponding author), Community Practice Ecosyst Approaches Hlth Latin, Brasilia, DF, Brazil.	mertens.br@gmail.com	Nakano, Eduardo Y/G-1660-2011; Mertens, Frédéric/AAZ-3379-2021	Nakano, Eduardo Y/0000-0002-9071-8512; Mertens, Frédéric/0000-0002-1449-8140	municipality of Paracatu, Minas Gerais, Brazil; International Development Research Centre of Canada; Latin America Caribbean	municipality of Paracatu, Minas Gerais, Brazil; International Development Research Centre of Canada(CGIAR); Latin America Caribbean	The authors received funding from the municipality of Paracatu, Minas Gerais, Brazil.; The present study is part of the research project "The Paracatu project: As environmental contamination and human health risks assessment in Paracatu-MG", coordinated by the Center for Mineral Technology, part of the Brazilian Science, Technology and Innovation Ministry, and carried out by several Brazilian institutions: Instituto Evandro Chagas, Universidade Federal Fluminense, Faculdade de Ciencias Medicas-Universidade de Campinas, FIOCRUZ-Escola Nacional de Saude Publica, Faculdade TECSOMA, Centro de Desenvolvimento Sustentavel-Universidade de Brasilia. The authors also thank the Community of Practice in Ecosystem Approaches to Health from Latin America & Caribbean and the International Development Research Centre of Canada for their support. Finally, the authors are grateful to Juliana Ferreira de Assis, Lucas Vieira da Silva, Marcela Dupont Britto, Marina Cazilda de Moura Alves, Sheila Lopes da Silva, undergraduate students from the University of Brasilia, for carrying out the interviews. We also thank Jordan Sky Oestreicher for English language editing of the manuscript.	Abernathy CO, 1999, ENVIRON HEALTH PERSP, V107, P593, DOI 10.2307/3434403; al-Taiar A, 2009, HEALTH POLICY PLANN, V24, P428, DOI 10.1093/heapol/czp034; Becker S, 1996, STUD FAMILY PLANN, V27, P291, DOI 10.2307/2138025; Boulay M, 1999, INT FAM PLAN PERSPEC, V25, P112, DOI 10.2307/2991959; Castilhos ZC, 2014, ONE CENTURY DISCOVER, P911; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Frewer LJ, 1996, RISK ANAL, V16, P473, DOI 10.1111/j.1539-6924.1996.tb01094.x; Go VF, 2006, DRUG ALCOHOL DEPEN, V84, P69, DOI 10.1016/j.drugalcdep.2005.12.006; Hadi A, 2003, HEALTH POLICY PLANN, V18, P93, DOI 10.1093/heapol/18.1.93; Hanchett S, 2002, HEALTH POLICY PLANN, V17, P393, DOI 10.1093/heapol/17.4.393; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Huston SA, 2009, WOMEN HEALTH ISS, V19, P144, DOI 10.1016/j.whi.2009.01.004; Jin SQ, 2015, NJAS-WAGEN J LIFE SC, V72-73, P23, DOI 10.1016/j.njas.2014.10.003; Lima C. A, 2014, ONE CENTURY DISCOVER, P652; Lindstrom M, 2007, SCAND J PUBLIC HEALT, V35, P460, DOI 10.1080/14034940701246090; Liu RD, 2014, FOOD CONTROL, V46, P291, DOI 10.1016/j.foodcont.2014.05.033; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mergler D, 2012, NEUROTOXICOLOGY, V33, P644, DOI 10.1016/j.neuro.2012.05.009; Mertens Frederic, 2005, EcoHealth, V2, P113, DOI 10.1007/s10393-004-0162-y; Mertens F, 2015, ECOL SOC, V20, DOI 10.5751/ES-07483-200318; Mertens F, 2012, SOC SCI MED, V75, P643, DOI 10.1016/j.socscimed.2011.10.016; Moller JC, 2001, BACIA SAO FRANCISCO, P199; Oexmann MJ, 2000, ETHNIC DIS, V11, P817; Ostlin P, 2006, HEALTH PROMOT INT, V21, P25, DOI 10.1093/heapro/dal048; Perkins JM, 2015, SOC SCI MED, V125, P60, DOI 10.1016/j.socscimed.2014.08.019; Triana DRR, 2016, ECOHEALTH, V13, P535, DOI 10.1007/s10393-016-1141-9; SAINT -CHARLES J., 2012, WHAT DIFFERENCE SEX, P69; Singhal A., 2003, COMBATING AIDS COMMU; Valente T W, 1996, J Health Commun, V1, P247, DOI 10.1080/108107396128040; Valente T W, 1995, Sci Commun, V16, P242, DOI 10.1177/1075547095016003002; Valente TW, 2007, HEALTH EDUC BEHAV, V34, P881, DOI 10.1177/1090198106297855; Valente TW, 2006, SEX TRANSM DIS, V33, pS23, DOI 10.1097/01.olq.0000221018.32533.6d; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Valente TW, 2003, AM J PUBLIC HEALTH, V93, P1837, DOI 10.2105/AJPH.93.11.1837; Valente TW, 1998, HUM COMMUN RES, V24, P366, DOI 10.1111/j.1468-2958.1998.tb00421.x; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Vlassoff C, 2002, SOC SCI MED, V54, P1713, DOI 10.1016/S0277-9536(01)00339-2; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Xiao N, 2014, DECIS SUPPORT SYST, V57, P417, DOI 10.1016/j.dss.2012.10.047; ZULU EM, 2003, DEMOGRAPHIC RES S, V0001	41	5	5	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186130	10.1371/journal.pone.0186130	http://dx.doi.org/10.1371/journal.pone.0186130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	29016663	Green Published, Green Submitted, gold			2022-12-26	WOS:000412601800040
J	Favaretto, A; Lazzarotto, A; Riccardi, A; Pravato, S; Margoni, M; Causin, F; Anglani, MG; Seppi, D; Poggiali, D; Gallo, P				Favaretto, Alice; Lazzarotto, Andrea; Riccardi, Alice; Pravato, Stefano; Margoni, Monica; Causin, Francesco; Anglani, Maria Giulia; Seppi, Dario; Poggiali, Davide; Gallo, Paolo			Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis	PLOS ONE			English	Article							SMALL VESSEL DISEASE; PERIVASCULAR SPACES; MAGNETIC-RESONANCE; ALZHEIMERS-DISEASE; NORMATIVE DATA; WHITE-MATTER; MRI; BRAIN; DILATATION; POPULATION	The clinical significance of Virchow Robin spaces (VRS) in inflammatory brain disorders, especially in multiple sclerosis (MS), is still undefined. We analysed enlarged VRS (eVRS) by means of phase sensitive inversion recovery (PSIR) MRI sequence and investigated their association with inflammation or brain atrophy, and to clinical or physical disability. Forty-three MS patients (21 clinically isolated syndrome suggestive of MS [ CIS], 15 RRMS, 7 progressive [ PMS]) and 10 healthy controls (HC) were studied. 3DT1, 3DFLAIR and 2DPSIR images were obtained with a 3T MRI scanner. eVRS number and volume were calculated by manual segmentation (ITK-SNAP). Freesurfer was used to assess brain parenchymal fraction (BPF). All patients underwent clinical (EDSS) and cognitive (Rao's BRB and DKEFS) evaluation. eVRS number and volume resulted significantly higher on 2D-PSIR compared to both 3D-T1 (p< 0.001) and 3D-FLAIR (p< 0.001) and were significantly increased in CIS compared to HC (p< 0.05), in PMS and RRMS compared to CIS (p< 0.001) and in male versus female patients (p< 0.05). eVRS volume increased significantly with disease duration (r = 0.6) but did not correlate with EDSS. eVRS significantly correlated with SPARTd (r = -0.47) and DKEFSfs (r = -0.46), especially when RRMS and PMS were merged in a single group (r = 0.89, p = 0.002 and r = 0.66, p = 0.009 respectively), while no correlation was found with BPF (r = 0.3), gadolinium-enhancing lesions (r = 0.2) and WMT2 lesion volume (r = 0.2). 2DPSIR allowed the detection of an impressive higher number of eVRS compared to 3DT1 and 3DFLAIR. eVRS associate with SPARTd and DKEFSfs failure in relapse-onset MS, suggesting they may contribute to cognitive decline in MS.	[Favaretto, Alice; Lazzarotto, Andrea; Riccardi, Alice; Pravato, Stefano; Margoni, Monica; Seppi, Dario; Poggiali, Davide; Gallo, Paolo] Univ Hosp Padova, Dept Neurosci, Multiple Sclerosis Ctr Veneto Reg, Med Sch, Padua, Italy; [Causin, Francesco; Anglani, Maria Giulia] Azienda Osped Padova, Neuroradiol Unit, Padua, Italy; [Seppi, Dario] Azienda Sanitaria Alto Adige, Unita Operat Neurol, Bolzano, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova	Gallo, P (corresponding author), Univ Hosp Padova, Dept Neurosci, Multiple Sclerosis Ctr Veneto Reg, Med Sch, Padua, Italy.	paolo.gallo@unipd.it	Margoni, Monica/ABE-3213-2020; Poggiali, Davide/AAR-2478-2020; Causin, Francesco/AAR-4624-2021	Poggiali, Davide/0000-0002-2894-0825; Causin, Francesco/0000-0001-6491-7027; Margoni, Monica/0000-0002-9232-8964				Achiron A, 2002, AM J NEURORADIOL, V23, P376; Adams Hieab H H, 2015, Alzheimers Dement (Amst), V1, P513, DOI 10.1016/j.dadm.2015.10.004; Barkhof F, 2004, J NEUROL NEUROSUR PS, V75, P1516, DOI 10.1136/jnnp.2004.044578; Chen W, 2011, AM J NEURORADIOL, V32, P1490, DOI 10.3174/ajnr.A2541; Conforti R, 2014, RADIOL MED, V119, P408, DOI 10.1007/s11547-013-0357-9; Doubal FN, 2010, STROKE, V41, P450, DOI 10.1161/STROKEAHA.109.564914; Etemadifar M, 2011, EUR J RADIOL, V80, pE104, DOI 10.1016/j.ejrad.2010.05.018; Favaretto A, 2016, MULT SCLER J, V22, P494, DOI 10.1177/1352458515594043; Favaretto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127805; Goretti B, 2014, NEUROL SCI, V35, P79, DOI 10.1007/s10072-013-1558-7; Groeschel S, 2006, NEURORADIOLOGY, V48, P745, DOI 10.1007/s00234-006-0112-1; HEIER LA, 1989, AM J NEURORADIOL, V10, P929; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Kilsdonk ID, 2015, MULT SCLER J, V21, P155, DOI 10.1177/1352458514540358; Klistorner A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149245; Kwee RM, 2007, RADIOGRAPHICS, V27, P1071, DOI 10.1148/rg.274065722; Lee MS, 2015, J MOV DISORD, V8, P106, DOI 10.14802/jmd.15013; MacLullich AMJ, 2004, J NEUROL NEUROSUR PS, V75, P1519, DOI 10.1136/jnnp.2003.030858; Mattioli F, 2014, NEUROL SCI, V35, P1895, DOI 10.1007/s10072-014-1857-7; Patankar TF, 2005, AM J NEURORADIOL, V26, P1512; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Popescu V, 2013, J NEUROL NEUROSUR PS, V84, P1082, DOI 10.1136/jnnp-2012-304094; Potter GM, 2015, INT J STROKE, V10, P376, DOI 10.1111/ijs.12054; Ramirez J, 2015, J ALZHEIMERS DIS, V43, P415, DOI 10.3233/JAD-132528; Sahin N, 2015, ACTA RADIOL, V56, P852, DOI 10.1177/0284185114544243; Tachibana Y, 2015, EUR RADIOL, V25, P1701, DOI 10.1007/s00330-014-3572-4; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; Wuerfel J, 2008, BRAIN, V131, P2332, DOI 10.1093/brain/awn171; Zhu YC, 2010, STROKE, V41, P2483, DOI 10.1161/STROKEAHA.110.591586	29	12	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185626	10.1371/journal.pone.0185626	http://dx.doi.org/10.1371/journal.pone.0185626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045421	gold, Green Submitted, Green Published			2022-12-26	WOS:000413168100022
J	Kondoh, T; Manzoor, R; Nao, N; Maruyama, J; Furuyama, W; Miyamoto, H; Shigeno, A; Kuroda, M; Matsuno, K; Fujikura, D; Kajihara, M; Yoshida, R; Igarashi, M; Takada, A				Kondoh, Tatsunari; Manzoor, Rashid; Nao, Naganori; Maruyama, Junki; Furuyama, Wakako; Miyamoto, Hiroko; Shigeno, Asako; Kuroda, Makoto; Matsuno, Keita; Fujikura, Daisuke; Kajihara, Masahiro; Yoshida, Reiko; Igarashi, Manabu; Takada, Ayato			Putative endogenous filovirus VP35-like protein potentially functions as an IFN antagonist but not a polymerase cofactor	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; VIRUS VP35 PROTEIN; EBOLA-VIRUS; INTERFERON-ANTAGONIST; ENVELOPE GLYCOPROTEIN; MULTIPLE-SCLEROSIS; FRUIT BATS; RETROVIRUS; TRANSCRIPTION; REPLICATION	It has been proposed that some non-retroviral RNA virus genes are integrated into vertebrate genomes. Endogenous filovirus-like elements (EFLs) have been discovered in some mammalian genomes. However, their potential roles in ebolavirus infection are unclear. A filovirus VP35-like element (mlEFL35) is found in the little brown bat (Myotis lucifugus) genome. Putative mlEFL35-derived protein (mlEFL35p) contains nearly full-length amino acid sequences corresponding to ebolavirus VP35. Ebola virus VP35 has been shown to bind double-stranded RNA, leading to inhibition of type I interferon (IFN) production, and is also known as a viral polymerase cofactor that is essential for viral RNA transcription/replication. In this study, we transiently expressed mlEFL35p in human kidney cells and investigated its biological functions. We first found that mlEFL35p was coimmunoprecipitated with itself and ebolavirus VP35s but not with the viral nucleoprotein. Then the biological functions of mlEFL35p were analyzed by comparing it to ebolavirus VP35s. We found that the expression of mlEFL35p significantly inhibited human IFN-beta promoter activity as well as VP35s. By contrast, expression of mlEFL35p did not support viral RNA transcription/replication and indeed slightly decrease the reporter gene expression in a minigenome assay. These results suggest that mlEFL35p potentially acts as an IFN antagonist but not a polymerase cofactor.	[Kondoh, Tatsunari; Manzoor, Rashid; Nao, Naganori; Maruyama, Junki; Furuyama, Wakako; Miyamoto, Hiroko; Shigeno, Asako; Kuroda, Makoto; Kajihara, Masahiro; Yoshida, Reiko; Igarashi, Manabu; Takada, Ayato] Hokkaido Univ, Div Global Epidemiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Matsuno, Keita] Hokkaido Univ, Dept Dis Control, Lab Microbiol, Fac Vet Med, Sapporo, Hokkaido, Japan; [Matsuno, Keita; Igarashi, Manabu; Takada, Ayato] Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Zoonosis Control, Sapporo, Hokkaido, Japan; [Fujikura, Daisuke] Hokkaido Univ, Div Infect & Immun, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Takada, Ayato] Univ Zambia, Sch Vet Med, Lusaka, Zambia	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; University of Zambia	Takada, A (corresponding author), Hokkaido Univ, Div Global Epidemiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan.; Takada, A (corresponding author), Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Zoonosis Control, Sapporo, Hokkaido, Japan.; Takada, A (corresponding author), Univ Zambia, Sch Vet Med, Lusaka, Zambia.	atakada@czc.hokudai.ac.jp	Maruyama, Junki/H-7993-2013; Maruyama, Junki/M-4735-2019; Kajihara, Masahiro/AAF-5724-2020; Manzoor, Rashid/ABB-8209-2020; Igarashi, Manabu/F-6871-2012	Maruyama, Junki/0000-0003-0088-4793; Maruyama, Junki/0000-0003-0088-4793; Matsuno, Keita/0000-0002-4205-6526; furuyama, wakako/0000-0001-7163-6960	Japan Society for the Promotion of Science (JSPS) [16J04404]; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) [15FM0108008H0001]; Science and Technology Research Partnership for Sustainable Development (SATREPS) [15JM0110005H0004]; JSPS; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [16H02627, 15H01249]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Research Partnership for Sustainable Development (SATREPS); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Society for the Promotion of Science (JSPS), Grant number 16J04404, https://www.jsps.go.jp/english/index.html (T.K. received this funding); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), Grant number 15FM0108008H0001, http://www.amed.go.jp/en/program/list/01/06/023.html (A.T. received this funding); Science and Technology Research Partnership for Sustainable Development (SATREPS), Grant number 15JM0110005H0004, http://www.jst.go.jp/global/english/index.html (A.T. received this funding); JSPS and the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant numbers 16H02627 and 15H01249, https://www.jsps.go.jp/english/index.html, http://www.mext.go.jp/en/ (A.T. received this funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony JM, 2007, J IMMUNOL, V179, P1210, DOI 10.4049/jimmunol.179.2.1210; Aswad A, 2012, TRENDS ECOL EVOL, V27, P627, DOI 10.1016/j.tree.2012.07.007; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Basler CF, 2009, J INTERF CYTOK RES, V29, P511, DOI 10.1089/jir.2009.0076; Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; Cardenas WB, 2006, J VIROL, V80, P5168, DOI 10.1128/JVI.02199-05; Chan SY, 2000, J VIROL, V74, P4933, DOI 10.1128/JVI.74.10.4933-4937.2000; Changula K, 2013, VIRUS RES, V176, P83, DOI 10.1016/j.virusres.2013.05.004; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0406509102; Ebihara Hideki, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020073; ELLIOTT LH, 1985, VIROLOGY, V147, P169, DOI 10.1016/0042-6822(85)90236-3; Fujino K, 2014, P NATL ACAD SCI USA, V111, P13175, DOI 10.1073/pnas.1407046111; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Guito JC, 2017, VIROLOGY, V501, P147, DOI 10.1016/j.virol.2016.11.015; Harcourt BH, 1998, VIROLOGY, V252, P179, DOI 10.1006/viro.1998.9446; Hartman AL, 2004, VIROLOGY, V328, P177, DOI 10.1016/j.virol.2004.07.006; Hartman AL, 2008, J VIROL, V82, P2699, DOI 10.1128/JVI.02344-07; He P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040435; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Kajihara M., 2015, CURRENT TROPICAL MED, V2, P30; Kash JC, 2006, J VIROL, V80, P3009, DOI 10.1128/JVI.80.6.3009-3020.2006; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kirchdoerfer RN, 2015, CELL REP, V12, P140, DOI 10.1016/j.celrep.2015.06.003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leung DW, 2015, CELL REP, V11, P376, DOI 10.1016/j.celrep.2015.03.034; Leung Daisy W, 2010, Virulence, V1, P526, DOI 10.4161/viru.1.6.12984; Leung DW, 2010, J MOL BIOL, V399, P347, DOI 10.1016/j.jmb.2010.04.022; Leung DW, 2009, P NATL ACAD SCI USA, V106, P411, DOI 10.1073/pnas.0807854106; Luthra P, 2013, CELL HOST MICROBE, V14, P74, DOI 10.1016/j.chom.2013.06.010; Machnik G, 2015, MOL BIOTECHNOL, V57, P801, DOI 10.1007/s12033-015-9873-2; Mameli G, 2007, J GEN VIROL, V88, P264, DOI 10.1099/vir.0.81890-0; Maruyama J, 2014, J VIROL, V88, P99, DOI 10.1128/JVI.02265-13; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Muhlberger E, 1999, J VIROL, V73, P2333; Myers KN, 2016, SCI REP-UK, V6, DOI 10.1038/srep35548; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ogawa H, 2015, J INFECT DIS, V212, pS101, DOI 10.1093/infdis/jiv063; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Prins KC, 2010, J VIROL, V84, P10581, DOI 10.1128/JVI.00925-10; Prins KC, 2009, J VIROL, V83, P3069, DOI 10.1128/JVI.01875-08; R_Core_Team, 2015, R LANG ENV STAT COMP; Rolland A, 2006, J IMMUNOL, V176, P7636, DOI 10.4049/jimmunol.176.12.7636; Sofuku K, 2015, CELL REP, V12, P1548, DOI 10.1016/j.celrep.2015.08.007; Spiropoulou CF, 2009, VIROLOGY, V392, P11, DOI 10.1016/j.virol.2009.06.032; St Reid P, 2005, VIROLOGY, V341, P179, DOI 10.1016/j.virol.2005.06.044; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Takada A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00034; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Taylor D.J., 2010, BMC EVOL BIOL, V10; Taylor DJ, 2014, PEERJ, V2, DOI 10.7717/peerj.556; Taylor DJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-336; Trunschke M, 2013, VIROLOGY, V441, P135, DOI 10.1016/j.virol.2013.03.013; Watanabe S, 2007, J INFECT DIS, V196, pS284, DOI 10.1086/520582; Yuan JF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-236	59	8	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186450	10.1371/journal.pone.0186450	http://dx.doi.org/10.1371/journal.pone.0186450			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040311	Green Published, gold, Green Submitted			2022-12-26	WOS:000413167500048
J	Yang, HJ; Bogomolnaya, L; McClelland, M; Andrews-Polymenis, H				Yang, Hee-Jeong; Bogomolnaya, Lydia; McClelland, Michael; Andrews-Polymenis, Helene			De novo pyrimidine synthesis is necessary for intestinal colonization of Salmonella Typhimurium in chicks	PLOS ONE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; SEROVAR TYPHIMURIUM; GENE-EXPRESSION; METABOLISM; VIRULENCE; MUTANTS; PERSISTENCE; OROTATE; GROWTH; CALVES	pyrE (STM3733) encodes orotate phosphoribosyltransferase (OPRTase; EC 2.4.2.10), the fifth enzyme of the de novo pyrimidine biosynthetic pathway. We identified Delta pyrE mutant as under selection in screening of a Salmonella mutant library in 4-day old chicks. Here, we confirm that Delta pyrE mutant colonizes 4-day old chicks poorly in competitive infection with isogenic wild type, and that the ability of this mutant to colonize chicks could be restored by providing a copy of pyrE in trans. We further show that our.pyrE mutant grows poorly in nutrient poor conditions in vitro, and that the ability of this mutant to grow is restored, both in vitro and in chicks, when precursors to the pyrimidine salvage pathway were provided. This finding suggests that the environment in the chick intestine during our infections lacks sufficient precursors of the pyrimidine salvage pathway to support Salmonella growth. Finally, we show that the colonization defect of a.pyrE mutant during infection occurs in to chicks, but not in CBA/J mice or ligated ileal loops in calves. Our data suggest that de novo pyrimidine synthesis is necessary for colonization of Salmonella Typhimurium in the chick, and that the salvage pathway is not used in this niche.	[Yang, Hee-Jeong; Bogomolnaya, Lydia; Andrews-Polymenis, Helene] Texas A&M Univ, Syst Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, College Stn, TX 77843 USA; [Bogomolnaya, Lydia] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [McClelland, Michael] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA USA; [McClelland, Michael] Univ Calif Irvine, Pathol & Lab Med, Irvine, CA USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Kazan Federal University; University of California System; University of California Irvine; University of California System; University of California Irvine	Andrews-Polymenis, H (corresponding author), Texas A&M Univ, Syst Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, College Stn, TX 77843 USA.	handrews@medicine.tamhsc.edu		McClelland, Michael/0000-0003-1788-9347; Andrews-Polymenis, Helene/0000-0002-1818-1335; Yang, Hee-Jeong/0000-0002-7351-8404	U.S. Department of Agriculture [CSREES 2009-03579]; National Institute of Allergy and Infectious Diseases [R01AI083646, R21AI083964, R56AI077645]; National Institute for Allergy and Infectious Diseases [R01AI075093, HHSN272200900040C]; National Institute for Allergy and Infectious Diseases (US-Isreal Binational Agricultural Research and Development Fund) [IS-4671-13CR]; Kazan Federal University	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute for Allergy and Infectious Diseases (US-Isreal Binational Agricultural Research and Development Fund); Kazan Federal University	This study was funded by a grant from the U.S. Department of Agriculture (CSREES 2009-03579, and the National Institute of Allergy and Infectious Diseases (R01AI083646, R21AI083964, R56AI077645) to HAP. In addition, this work was supported in part by a grant from the National Institute for Allergy and Infectious Diseases (R01AI075093 and HHSN272200900040C, and the US-Isreal Binational Agricultural Research and Development Fund grant # IS-4671-13CR) to MM. LB is supported in part by a subsidy to support the competitive growth of Kazan Federal University. The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK CF, 1972, J BACTERIOL, V110, P219, DOI 10.1128/JB.110.1.219-228.1972; Bogomolnaya LM, 2008, MOL MICROBIOL, V70, P1105, DOI 10.1111/j.1365-2958.2008.06461.x; Chaudhuri RR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003456; Elfenbein JR, 2013, INFECT IMMUN, V81, P4311, DOI 10.1128/IAI.00874-13; Evans ME, 2005, JPEN-PARENTER ENTER, V29, P315, DOI 10.1177/0148607105029005315; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; Frost AJ, 1997, VET PATHOL, V34, P369, DOI 10.1177/030098589703400501; Garavaglia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031252; Gonzalez-Segura L, 2007, BIOCHEMISTRY-US, V46, P14075, DOI 10.1021/bi701023z; HAGER SE, 1967, J BIOL CHEM, V242, P5674; Harvey PC, 2011, INFECT IMMUN, V79, P4105, DOI 10.1128/IAI.01390-10; JENSEN KF, 1989, J GEN MICROBIOL, V135, P805; JENSEN KF, 1982, EMBO J, V1, P69, DOI 10.1002/j.1460-2075.1982.tb01126.x; JONES ME, 1955, J AM CHEM SOC, V77, P819, DOI 10.1021/ja01608a101; Khatiwara A, 2012, APPL ENVIRON MICROB, V78, P3098, DOI 10.1128/AEM.06865-11; KLARSFELD AD, 1994, MOL MICROBIOL, V13, P585, DOI 10.1111/j.1365-2958.1994.tb00453.x; LIEBERMAN I, 1953, BIOCHIM BIOPHYS ACTA, V12, P223, DOI 10.1016/0006-3002(53)90141-3; LIEBERMAN I, 1954, J BIOL CHEM, V207, P911; Maniatis T, 1989, MOL CLONING; MARQUIS H, 1993, INFECT IMMUN, V61, P3756, DOI 10.1128/IAI.61.9.3756-3760.1993; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Nyhan WL, NUCLEOTIDE SYNTHESIS; ODONOVAN GA, 1970, BACTERIOL REV, V34, P278, DOI 10.1128/MMBR.34.3.278-343.1970; SANDERSON KE, 1972, BACTERIOL REV, V36, P558, DOI 10.1128/MMBR.36.4.558-586.1972; Santos RL, 2002, VET PATHOL, V39, P200, DOI 10.1354/vp.39-2-200; Sivula CP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-182; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; Yang HJ, 2016, INFECT IMMUN, V84, P1226, DOI 10.1128/IAI.01525-15; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002	32	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0183751	10.1371/journal.pone.0183751	http://dx.doi.org/10.1371/journal.pone.0183751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040285	Green Published, gold			2022-12-26	WOS:000413167500002
J	Marouen, S; du Cailar, G; Audo, R; Lukas, C; Vial, G; Tournadre, A; Barrat, E; Ribstein, J; Combe, B; Morel, J; Daien, CI				Marouen, Sarah; du Cailar, Guilhem; Audo, Rachel; Lukas, Cedric; Vial, Gaelle; Tournadre, Anne; Barrat, Emmanuel; Ribstein, Jean; Combe, Bernard; Morel, Jacques; Daien, Claire I.			Sodium excretion is higher in patients with rheumatoid arthritis than in matched controls	PLOS ONE			English	Article							DISEASE; CELLS; DIET	Objective It was shown that sodium can promote auto-immunity through the activation of the Th17 pathway. We aimed to compare sodium intake in patients with rheumatoid arthritis (RA) vs. matched controls. Methods This case-control study included 24 patients with RA at diagnosis and 24 controls matched by age, gender and body mass index. Sodium intake was evaluated by 24-hr urinary sodium excretion. Results Sodium excretion was greater for patients with early RA (2,849 +/- 1,350 vs. 2,182 +/- 751.7 mg/day, p = 0.039) than controls. This difference remained significant after adjustment for smoking and the use of anti-hypertensive and nonsteroidal anti-inflammatory drugs (p = 0.043). Patients with radiographic erosion at the time of diagnosis had a higher sodium excretion than those without (p = 0.028). Conclusion Patients with early RA showed increased sodium excretion which may have contributed to autoimmunity.	[Marouen, Sarah; Audo, Rachel; Lukas, Cedric; Combe, Bernard; Morel, Jacques; Daien, Claire I.] Lapeyronie Hosp, Rheumatol Dept, Montpellier, France; [Marouen, Sarah; du Cailar, Guilhem; Audo, Rachel; Lukas, Cedric; Ribstein, Jean; Combe, Bernard; Morel, Jacques; Daien, Claire I.] Montpellier Univ, Montpellier, France; [du Cailar, Guilhem; Ribstein, Jean] Lapeyronie Hosp, Internal Med & Hypertens, Montpellier, France; [Audo, Rachel; Combe, Bernard; Morel, Jacques; Daien, Claire I.] CNRS, UMR5535, Inst Mol Genet, Montpellier, France; [Vial, Gaelle; Tournadre, Anne] Gabriel Montpied Hosp, Rheumatol Dept, Clermont Ferrand, France; [Vial, Gaelle; Tournadre, Anne] Clermont Ferrand Univ, Clermont Ferrand, France; [Barrat, Emmanuel] Lab LESCUYER, Aytre, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; CHU Clermont Ferrand; CHU Clermont Ferrand	Daien, CI (corresponding author), Lapeyronie Hosp, Rheumatol Dept, Montpellier, France.; Daien, CI (corresponding author), Montpellier Univ, Montpellier, France.; Daien, CI (corresponding author), CNRS, UMR5535, Inst Mol Genet, Montpellier, France.	cidaien@gmail.com	AUDO, Rachel/AAD-6091-2020; Lukas, Cédric/AAB-2753-2019	AUDO, Rachel/0000-0002-0021-5349; Lukas, Cédric/0000-0002-1095-3492; Vial, Guillaume/0000-0002-7333-8526; Daien, Claire I/0000-0002-7287-9320	Passerelle grant; Passerelle grant (Pfizer)	Passerelle grant; Passerelle grant (Pfizer)	This work was supporter by Passerelle grant. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; This work was supported by the Passerelle grant (Pfizer). This does not alter our adherence to PLOS ONE policies on sharing data and materials. The funder had no role in the study design, performance, data analysis or decision to publish. We thank Elodie Derbord for food questionnaire analysis and Sumaiya Hoque for english revision. We also thank Pascale Vergne, Christophe Richez, Gael Mouterde, Charlotte Hua, Helene Che and le Projet Jeune Chercheur. This work was supported by Passerelle grant (Pfizer).	Adamopoulos IE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2936; Barrat E, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.18472; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Binger KJ, 2015, J CLIN INVEST, V125, P4223, DOI 10.1172/JCI80919; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Lerchl K, 2015, HYPERTENSION, V66, P850, DOI 10.1161/HYPERTENSIONAHA.115.05851; Pattison DJ, 2004, J RHEUMATOL, V31, P1310; Salgado E, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000924; Salminen E, 2002, PREV MED, V34, P529, DOI 10.1006/pmed.2002.1015; Sehnert B, 2015, ANN RHEUM DIS, V74, P73, DOI 10.1136/annrheumdis-2015-eular.5482; Sigaux J, 2017, JOINT BONE SPINE; Sugiyama D, 2010, ANN RHEUM DIS, V69, P70, DOI 10.1136/ard.2008.096487; Sundstrom B, 2015, RHEUMATOLOGY, V54, P487, DOI 10.1093/rheumatology/keu330; Toh ML, 2007, CURR OPIN RHEUMATOL, V19, P284, DOI 10.1097/BOR.0b013e32805e87e0; van der Linden MPM, 2011, ARTHRITIS RHEUM-US, V63, P37, DOI 10.1002/art.30100	16	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186157	10.1371/journal.pone.0186157	http://dx.doi.org/10.1371/journal.pone.0186157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028829	Green Submitted, Green Published, gold			2022-12-26	WOS:000412980300021
J	Askmyr, M; von Palffy, S; Hansen, N; Landberg, N; Hogberg, C; Rissler, M; Agerstam, H; Fioretos, T				Askmyr, Maria; von Palffy, Sofia; Hansen, Nils; Landberg, Niklas; Hogberg, Carl; Rissler, Marianne; Agerstam, Helena; Fioretos, Thoas			Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells	PLOS ONE			English	Article							STEM-CELLS; XENOGRAFT MODELS; CHRONIC-PHASE; LEUKEMIA; DISEASE; PRODUCE; NICHE	Several attempts have been made to model chronic myeloid leukemia (CML) in a xenograft setting but expansion of human myeloid cells in immunodeficient mice has proven difficult to achieve. Lack of cross-reacting cytokines in the microenvironment of the mice has been proposed as a potential reason. In this study we have used NOD/SCID IL2-receptor gamma deficient mice expressing human SCF, IL-3 and GM-CSF (NSGS mice), that should be superior in supporting human, and particularly, myeloid cell engraftment, to expand BCR-ABL1 expressing human cells in order to model CML. NSGS mice transplanted with BCR-ABL1 expressing cells became anemic and had to be sacrificed due to illness, however, this was not accompanied by an expansion of human myeloid cells but rather we observed a massive expansion of human T-cells and macrophages/histiocytes. Importantly, control human cells without BCR-ABL1 expression elicited a similar reaction, although with a slight delay of disease induction, suggesting that while BCR-ABL1 contributes to the inflammatory reaction, the presence of normal human hematopoietic cells is detrimental for NSGS mice.	[Askmyr, Maria; von Palffy, Sofia; Hansen, Nils; Landberg, Niklas; Hogberg, Carl; Rissler, Marianne; Agerstam, Helena; Fioretos, Thoas] Lund Univ, Dept Clin Genet, Lund, Sweden; [Fioretos, Thoas] Lund Univ, Dept Clin Genet, Lund, Sweden; [Fioretos, Thoas] Reg Skane, Reg Labs, Lund, Sweden	Lund University; Lund University	Askmyr, M; Fioretos, T (corresponding author), Lund Univ, Dept Clin Genet, Lund, Sweden.; Fioretos, T (corresponding author), Lund Univ, Dept Clin Genet, Lund, Sweden.; Fioretos, T (corresponding author), Reg Skane, Reg Labs, Lund, Sweden.	Maria.Askmyr@med.lu.se; Thoas.Fioretos@med.lu.se		Landberg, Niklas/0000-0001-6752-6507	Swedish Cancer Society [2014/430, CAN 2012/1253]; Swedish Research Council [2016/02020]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Cancer Society (project no. 2014/430) (TF); Swedish Research Council (project no 2016/02020) (TF); and Swedish Cancer Society CAN 2012/1253 (MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerstam H, 2016, BLOOD, V128, P2683, DOI 10.1182/blood-2015-11-679985; Agerstam H, 2015, P NATL ACAD SCI USA, V112, P10786, DOI 10.1073/pnas.1422749112; Agerstam H, 2010, BLOOD, V116, P2103, DOI 10.1182/blood-2009-05-217182; Askmyr M, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.89; Chalandon Y, 2005, LEUKEMIA, V19, P442, DOI 10.1038/sj.leu.2403650; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Eisterer W, 2005, LEUKEMIA, V19, P435, DOI 10.1038/sj.leu.2403649; Goyama S, 2015, BLOOD, V125, P2630, DOI 10.1182/blood-2014-11-570218; Groen RWJ, 2012, BLOOD, V120, pE9, DOI 10.1182/blood-2012-03-414920; Huettner CS, 2003, BLOOD, V102, P3363, DOI 10.1182/blood-2003-03-0768; Koschmieder S, 2005, BLOOD, V105, P324, DOI 10.1182/blood-2003-12-4369; Lewis ID, 1998, BLOOD, V91, P630, DOI 10.1182/blood.V91.2.630.630_630_640; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Lin S. C., 2016, ONCOTARGET; Medyouf H, 2014, CELL STEM CELL, V14, P824, DOI 10.1016/j.stem.2014.02.014; Miller PH, 2013, BLOOD, V121, pE1, DOI 10.1182/blood-2012-09-456566; Rhyasen GW, 2014, LEUKEMIA, V28, P1142, DOI 10.1038/leu.2013.372; Salari A, 2016, CANCER GENET-NY, V209, P258, DOI 10.1016/j.cancergen.2016.04.004; Sloma I, 2013, EXP HEMATOL, V41, P837, DOI 10.1016/j.exphem.2013.07.001; Sontakke P, 2016, LEUKEMIA, V30, P2064, DOI 10.1038/leu.2016.108; Theocharides APA, 2015, LEUKEMIA, V29, P177, DOI 10.1038/leu.2014.150; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Wunderlich M, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88181; Wunderlich M, 2014, BLOOD, V123, pE134, DOI 10.1182/blood-2014-02-556340; Wunderlich M, 2013, BLOOD, V121, pE90, DOI 10.1182/blood-2012-10-464677	25	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186035	10.1371/journal.pone.0186035	http://dx.doi.org/10.1371/journal.pone.0186035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023488	gold, Green Submitted, Green Published			2022-12-26	WOS:000412845100053
J	Sato, N; Kamimura, R; Kaneta, K; Yoshikawa, M; Tsuzuki, M				Sato, Norihiro; Kamimura, Ryohei; Kaneta, Kodai; Yoshikawa, Misato; Tsuzuki, Mikio			Species-specific roles of sulfolipid metabolism in acclimation of photosynthetic microbes to sulfur-starvation stress	PLOS ONE			English	Article							ELONGATUS PCC 7942; LONG-TERM TRENDS; SULFOQUINOVOSYL DIACYLGLYCEROL; CHLAMYDOMONAS-REINHARDTII; PHOTOSYSTEM-II; UNICELLULAR CYANOBACTERIA; RHODOBACTER-SPHAEROIDES; DEFICIENT MUTANT; PHOSPHATIDYLGLYCEROL; GROWTH	Photosynthetic organisms utilize sulfate for the synthesis of sulfur-compounds including proteins and a sulfolipid, sulfoquinovosyl diacylglycerol. Upon ambient deficiency in sulfate, cells of a green alga, Chlamydomonas reinhardtii, degrade the chloroplast membrane sulfolipid to ensure an intracellular-sulfur source for necessary protein synthesis. Here, the effects of sulfate-starvation on the sulfolipid stability were investigated in another green alga, Chlorella kessleri, and two cyanobacteria, Synechocystis sp. PCC 6803 and Synechococcus elongatus PCC 7942. The results showed that sulfolipid degradation was induced only in C. kessleri, raising the possibility that this degradation ability was obtained not by cyanobacteria, but by eukaryotic algae during the evolution of photosynthetic organisms. Meanwhile, Synechococcus disruptants concerning sqdB and sqdX genes, which are involved in successive reactions in the sulfolipid synthesis pathway, were respectively characterized in cellular response to sulfate-starvation. Phycobilisome degradation intrinsic to Synechococcus, but not to Synechocystis, and cell growth under sulfate-starved conditions were repressed in the sqdB and sqdX disruptants, respectively, relative to in the wild type. Their distinct phenotypes, despite the common loss of the sulfolipid, inferred specific roles of sqdB and sqdX. This study demonstrated that sulfolipid metabolism might have been developed to enable species- or cyanobacterial-strain dependent processes for acclimation to sulfate-starvation.	[Sato, Norihiro; Kamimura, Ryohei; Kaneta, Kodai; Yoshikawa, Misato; Tsuzuki, Mikio] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo, Japan; [Sato, Norihiro; Tsuzuki, Mikio] JST, Chiyoda Ku, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences; Japan Science & Technology Agency (JST)	Sato, N (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo, Japan.; Sato, N (corresponding author), JST, Chiyoda Ku, Tokyo, Japan.	nsato@toyaku.ac.jp		, Norihiro/0000-0001-8940-8923	Japan Science and Technology Agency CREST	Japan Science and Technology Agency CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by Japan Science and Technology Agency CREST, http.// www.jst.go.jp/kisoken/crest/, M.T.; and Tokyo University of Pharmacy and Life Sciences, https www.toyaku.ac.jp/, M.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2004, EUR J BIOCHEM, V271, P685, DOI 10.1111/j.1432-1033.2003.03970.x; Aoki Motohide, 2012, BMC Res Notes, V5, P98, DOI 10.1186/1756-0500-5-98; BENNING C, 1993, P NATL ACAD SCI USA, V90, P1561, DOI 10.1073/pnas.90.4.1561; Cape JN, 2003, ENVIRON INT, V29, P201, DOI 10.1016/S0160-4120(02)00180-0; Chapra SC, 2012, J GREAT LAKES RES, V38, P550, DOI 10.1016/j.jglr.2012.06.010; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Futter MN, 2014, AMBIO, V43, P77, DOI 10.1007/s13280-014-0563-2; Grossman AR, 1995, ANNU REV GENET, V29, P231, DOI 10.1146/annurev.ge.29.120195.001311; Guler S, 1996, J BIOL CHEM, V271, P7501; Hagio M, 2000, PLANT PHYSIOL, V124, P795, DOI 10.1104/pp.124.2.795; Kobayashi K, 2016, SUBCELL BIOCHEM, V86, P21, DOI 10.1007/978-3-319-25979-6_2; Kobayashi S, 2015, PLANT CELL PHYSIOL, V56, P1521, DOI 10.1093/pcp/pcv073; Minoda A, 2003, FEBS LETT, V553, P109, DOI 10.1016/S0014-5793(03)00981-5; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Norici A, 2005, PHOTOSYNTH RES, V86, P409, DOI 10.1007/s11120-005-3250-0; Richaud C, 2001, J BACTERIOL, V183, P2989, DOI 10.1128/JB.183.10.2989-2994.2001; Riekhof WR, 2003, PLANT PHYSIOL, V133, P864, DOI 10.1104/pp.103.029249; ROSSAK M, 1995, J BIOL CHEM, V270, P25792, DOI 10.1074/jbc.270.43.25792; SATO N, 1995, EUR J BIOCHEM, V230, P987, DOI 10.1111/j.1432-1033.1995.tb20646.x; SATO N, 1995, EUR J BIOCHEM, V234, P16, DOI 10.1111/j.1432-1033.1995.016_c.x; Sato N, 2004, J PLANT RES, V117, P495, DOI 10.1007/s10265-004-0183-1; Sato N, 2004, BBA-BIOENERGETICS, V1658, P235, DOI 10.1016/j.bbabio.2004.06.008; Sato N, 2003, BBA-MOL CELL BIOL L, V1633, P35, DOI 10.1016/S1388-1981(03)00070-2; Sato N, 2000, P NATL ACAD SCI USA, V97, P10655, DOI 10.1073/pnas.97.19.10655; Sato N, 2017, BIOCHEM BIOPH RES CO, V487, P734, DOI 10.1016/j.bbrc.2017.04.129; Sato N, 2016, BIOCHEM BIOPH RES CO, V477, P854, DOI 10.1016/j.bbrc.2016.06.148; Sato N, 2016, BIOCHEM BIOPH RES CO, V470, P123, DOI 10.1016/j.bbrc.2016.01.006; Schwarz R, 2005, MICROBIOL-SGM, V151, P2503, DOI 10.1099/mic.0.27883-0; Shiratake T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079630; Sugimoto K, 2007, FEBS LETT, V581, P4519, DOI 10.1016/j.febslet.2007.08.035; Sugimoto K, 2010, NEW PHYTOL, V185, P676, DOI 10.1111/j.1469-8137.2009.03115.x; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Weissenmayer B, 2000, MOL PLANT MICROBE IN, V13, P666, DOI 10.1094/MPMI.2000.13.6.666; Yu B, 2002, P NATL ACAD SCI USA, V99, P5732, DOI 10.1073/pnas.082696499	36	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186154	10.1371/journal.pone.0186154	http://dx.doi.org/10.1371/journal.pone.0186154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023570	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100070
J	Sosnik, J; Vieira, WA; Webster, KA; Siegfried, KR; McCusker, CD				Sosnik, Julian; Vieira, Warren A.; Webster, Kaitlyn A.; Siegfried, Kellee R.; McCusker, Catherine D.			A new and improved algorithm for the quantification of chromatin condensation from microscopic data shows decreased chromatin condensation in regenerating axolotl limb cells	PLOS ONE			English	Article							CARTILAGE; BLASTEMA	The nuclear landscape plays an important role in the regulation of tissue and positional specific genes in embryonic and developing cells. Changes in this landscape can be dynamic, and are associated with the differentiation of cells during embryogenesis, and the de-differentiation of cells during induced pluripotent stem cell (iPSC) formation and in many cancers. However, tools to quantitatively characterize these changes are limited, especially in the in vivo context, where numerous tissue types are present and cells are arranged in multiple layers. Previous tools have been optimized for the monolayer nature of cultured cells. Therefore, we present a new algorithm to quantify the condensation of chromatin in two in vivo systems. We first developed this algorithm to quantify changes in chromatin compaction and validated it in differentiating spermatids in zebrafish testes. Our algorithm successfully detected the typical increase in chromatin compaction as these cells differentiate. We then employed the algorithm to quantify the changes that occur in amphibian limb cells as they participate in a regenerative response. We observed that the chromatin in the limb cells de-compacts as they contribute to the regenerating organ. We present this new tool as an open sourced software that can be readily accessed and optimized to quantify chromatin compaction in complex multi-layered samples.	[Sosnik, Julian; Vieira, Warren A.; Webster, Kaitlyn A.; Siegfried, Kellee R.; McCusker, Catherine D.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Sosnik, Julian] Wentworth Inst Technol, Dept Interdisciplinary Engn, Boston, MA USA	University of Massachusetts System; University of Massachusetts Boston	McCusker, CD (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	catherine.mccusker@umb.edu	McCusker, Catherine/AAW-3258-2020; Sosnik, Julian/A-8310-2010	McCusker, Catherine/0000-0003-0127-433X; Sosnik, Julian/0000-0002-0528-9929; Siegfried, Kellee/0000-0002-7951-392X; Vieira, Warren Antonio/0000-0002-9417-7530; Webster, Kaitlyn/0000-0001-9902-0500	UMass Boston; NATIONAL CANCER INSTITUTE [U54CA156734] Funding Source: NIH RePORTER	UMass Boston; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by startup funds from UMass Boston to CDM.	[Anonymous], 1978, NEIGHBORHOOD CODING, V8, P127; [Anonymous], 2016, SPATIALLY RESOLVED Q, V11; [Anonymous], 1975, THRESHOLD SELECTION; [Anonymous], 2008, EZH1 EZH2 MAINTAIN R, V32, P503; [Anonymous], 1997, CRYSTAL STRUCTURE NU, V389, P251; [Anonymous], 2015, SPERMATOGENESIS COMM, V96, P1; [Anonymous], 2006, HISTONE TRIMETHYLATI, V20, P2041; [Anonymous], 2007, MEASURING STRUCTURAL, V41, P158; [Anonymous], 2009, HISTOLOGICAL STEREOL, V81, p177 ; [Anonymous], 2015, IMAGEJ ECOSYSTEM OPE, V82, P518; [Anonymous], 1980, THEORY EDGE DETECTIO, V207, P187; Chromatin Structure: A Repeating Unit of Histones and DNA, 1974, CHROM STRUCT REP UN, V184, P868; Dillon N, 2004, BIOL CELL, V96, P631, DOI 10.1016/j.biolcel.2004.06.003; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; HAY ED, 1959, DEV BIOL, V1, P555, DOI 10.1016/0012-1606(59)90018-1; Irianto J, 2014, MED ENG PHYS, V36, P412, DOI 10.1016/j.medengphy.2013.09.006; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Mascetti G, 2001, CYTOMETRY, V44, P113, DOI 10.1002/1097-0320(20010601)44:2<113::AID-CYTO1089>3.0.CO;2-A; McCusker C, 2015, REGENERATION, V2, P54, DOI 10.1002/reg2.32; McCusker CD, 2016, DEV BIOL, V416, P26, DOI 10.1016/j.ydbio.2016.05.032; McCusker CD, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0095-4; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Role of Histone H3 Lysine 27 Methylation in Polycomb- Group Silencing, 2002, ROL HIST H3 LYS 27 M, V298, P1039; TANK PW, 1987, J EXP ZOOL, V244, P409, DOI 10.1002/jez.1402440308; Translating the Histone Code, 2001, TRANSL HIST COD, V293, P1074	25	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185292	10.1371/journal.pone.0185292	http://dx.doi.org/10.1371/journal.pone.0185292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023511	gold, Green Submitted, Green Published			2022-12-26	WOS:000412845100017
J	Staveteig, S; Croft, TN; Kampa, KT; Head, SK				Staveteig, Sarah; Croft, Trevor N.; Kampa, Kathryn T.; Head, Sara K.			Reaching the ' first 90 ': Gaps in coverage of HIV testing among people living with HIV in 16 African countries	PLOS ONE			English	Article							BIAS	Background UNAIDS has recently proposed a set of three ambitious targets that, if achieved, are predicted to end the AIDS epidemic by 2030. The targets, known as 90-90-90, call for 90% of people living with HIV (PLHIV) to know their status, 90% of PLHIV to receive antiretroviral therapy, and 90% of those on antiretroviral therapy to achieve viral suppression by the year 2020. We examine the first of these targets, focusing on sub-Saharan Africa, the region of the world most affected by HIV, to measure the proportion of PLHIV estimated to know their HIV status, and to identify background and behavioral characteristics significantly associated with gaps in ever testing among PLHIV. Methods and findings We analyze cross-sectional population-based data from the Demographic and Health Surveys (DHS) and AIDS Indicator Surveys (AIS) fielded since 2010 in 16 sub-Saharan African countries where voluntary serological testing was recently conducted: Burkina Faso, Cameroon, Chad, Cote d'Ivoire, Ethiopia, Gabon, Lesotho, Malawi, Namibia, Rwanda, Sierra Leone, Tanzania, Togo, Uganda, Zambia, and Zimbabwe. Survey response rates averaged 95.0% (range 89.3-99.5%), while consent to serotesting averaged 94.9% (range 88.7-99.6%). This study, which includes more than 14,000 respondents living with HIV, finds that 69% of PLHIV in the average study country have ever been tested for HIV (range 34-95%). Based on timing of the last test and on ART coverage, we estimate that 54% of PLHIV in the average country are aware of their status (range 26-84%). Adjusted logistic regression finds that men (median adjusted odds ratio [AOR] = 0.38), adults with less than primary education (median AOR = 0.31), and adolescents (median AOR = 0.32) are consistently less likely to have ever been tested for HIV than women, adults with secondary and above education, and adults age 30-39, respectively. In most countries unadjusted logistic regression also finds significant gaps in testing among the poorest groups and those reporting never having had sex. Conclusion The fact that an average of 54% of PLHIV in these 16 countries are estimated to know their status reflects encouraging progress. However, not only is this average far short of the 90% target set by UNAIDS for 2020, but it also implies that in the average study country nearly one-half of PLHIV are unable to access lifesaving care and treatment because they are unaware that they are HIV-positive. Several gaps in HIV testing coverage exist, particularly among adolescents, the least educated, and men. While the need to target demographic groups at greatest risk of HIV continues, additional interventions focused on reaching men and on reaching socially vulnerable populations such as adolescents, the poorest, and the least educated are essential.	[Staveteig, Sarah] Avenir Hlth, Glastonbury, CT 06033 USA; [Staveteig, Sarah; Croft, Trevor N.] Demog & Hlth Surveys DHS Program, Rockville, MD 20850 USA; [Croft, Trevor N.] ICF, Int Hlth & Dev Div, Rockville, MD USA; [Kampa, Kathryn T.] ICF, Hlth Res Informat & Technol Div, Atlanta, GA USA		Staveteig, S (corresponding author), Avenir Hlth, Glastonbury, CT 06033 USA.; Staveteig, S (corresponding author), Demog & Hlth Surveys DHS Program, Rockville, MD 20850 USA.	sstaveteig@avenirhealth.org		Staveteig Ford, Sarah/0000-0003-4330-2917	United States Agency for International Development (USAID) through DHS [AIDOAA-C-13-00095]	United States Agency for International Development (USAID) through DHS(United States Agency for International Development (USAID))	This study was carried out with support provided by the United States Agency for International Development (USAID) through The DHS Program (#AIDOAA-C-13-00095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed are those of the authors and do not necessarily reflect the views of USAID or the United States Government.	[Anonymous], 2016, EV CHILD END AIDS 7; [Anonymous], 2015, GLOB HLTH SECT RESP; Chamie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084317; Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), 2017, AD HIV PRIOR E GLAS; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Fishel JD., 2014, VALIDITY DATA SELF R; Fishel JD, 2016, PERFORMANCE ENZYME I; Fonner VA, 2012, VOLUNTARY COUNSELING; Helleringer S, 2009, JAIDS-J ACQ IMM DEF, V51, P185, DOI 10.1097/QAI.0b013e31819c1726; ICF International, 2011, DEM HLTH SURV METH Q; ICF International, 2012, DEM HLTH SURV SAMPL; ICF International, 2016, DEM HLTH SURV DHS MO; Katz DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007602; Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276; Mishra V, 2008, SEX TRANSM INFECT, V84, pI63, DOI 10.1136/sti.2008.030411; Reniers G, 2009, AIDS, V23, P621, DOI 10.1097/QAD.0b013e3283269e13; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; South A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-802; Staveteig S., 2013, DEMOGRAPHIC PATTERNS; Takarinda KC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147828; UNAIDS, 2016, GLOB AIDS RESP PROGR; UNAIDS, 2015, MON HIV IMP US POP B; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2016, AIDSINFO DAT; UNAIDS, 2016, UNAIDS PREV GAP REP; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; WHO, 2016, GUID HIV SELF TEST P; WHO, 2013, HIV AD GUID HIV TEST; Wong VJ, 2017, ADOLESCENTS YOUNG PE; World Health Organization, 2015, POL BRIEF CONS GUID, P20; World Health Organization, 2012, GUID OR PREEXP PROPH; World Health Organization (WHO), 2016, WHO REC HIV SELF TES	32	68	68	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186316	10.1371/journal.pone.0186316	http://dx.doi.org/10.1371/journal.pone.0186316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023510	Green Submitted, gold, Green Published			2022-12-26	WOS:000412845100106
J	Burkhalter, H; Denhaerynck, K; Huynh-Do, U; Binet, I; Hadaya, K; De Geest, S				Burkhalter, Hanna; Denhaerynck, Kris; Huynh-Do, Uyen; Binet, Isabelle; Hadaya, Karine; De Geest, Sabina		Psychosocial Interest Grp; Swiss Transplant Cohort Study	Change of sleep quality from pre- to 3 years post-solid organ transplantation: The Swiss Transplant Cohort Study	PLOS ONE			English	Article							MEDICATION REGIMEN COMPLEXITY; OF-LIFE; KIDNEY-TRANSPLANTATION; RENAL-TRANSPLANTATION; GENERAL-POPULATION; DAYTIME SLEEPINESS; DEPRESSION SCALE; HOSPITAL ANXIETY; 1ST YEAR; RECIPIENTS	Background Poor sleep quality (SQ) is common after solid organ transplantation; however, very little is known about its natural history. We assessed the changes in SQ from pre- to 3 years post-transplant in adult heart, kidney, liver and lung recipients included in the prospective nationwide Swiss Transplant Cohort Study. We explored associations with selected variables in patients suffering persistent poor SQ compared to those with good or variable SQ. Methods Adult single organ transplant recipients enrolled in the Swiss Transplant Cohort Study with pre-transplant and at least 3 post-transplant SQ assessment data were included. SQ was self-reported pre-transplant (at listing), then at 6, 12, 24 and 36 months post-transplant. A single SQ item was used to identify poor (0-5) and good sleepers (6-10). Between organ groups, SQ was compared via logistic regression analysis with generalized estimating equations. Within the group reporting persistently poor SQ, we used logistic regression or Kaplan-Meier analysis as appropriate to check for differences in global quality of life and survival. Results In a sample of 1173 transplant patients (age: 52.1-13.2 years; 65% males; 66% kidney, 17% liver, 10% lung, 7% heart) transplanted between 2008 and 2012, pre-transplant poor SQ was highest in liver (50%) and heart (49%) recipients. Overall, poor SQ decreased significantly from pre-transplant (38%) to 24 months post-transplant (26%) and remained stable at 3 years (29%). Patients reporting persistently poor SQ had significantly more depressive symptomatology and lower global quality of life. Conclusion Because self-reported poor SQ is related to poorer global quality of life, these results emphasize the need for further studies to find suitable treatment options for poor SQ in transplant recipients.	[Burkhalter, Hanna; Denhaerynck, Kris; De Geest, Sabina] Univ Basel, Dept Publ Hlth, Inst Nursing Sci, Basel, Switzerland; [Burkhalter, Hanna] Hirslanden Grp, Ctr Sleep Med, Zurich, Switzerland; [Huynh-Do, Uyen] Univ Hosp Bern, Div Nephrol & Hypertens, Bern, Switzerland; [Binet, Isabelle] Cantonal Hosp St Gallen, Nephrol Transplantat Med, St Gallen, Switzerland; [Hadaya, Karine] Geneva Univ Hosp, Div Nephrol & Transplantat, Geneva, Switzerland; [De Geest, Sabina] Katholieke Univ Leuven, Dept Publ Hlth, Acad Ctr Nursing & Midwifery, Leuven, Belgium	University of Basel; University of Bern; University Hospital of Bern; Kantonsspital St. Gallen; University of Geneva; KU Leuven	De Geest, S (corresponding author), Univ Basel, Dept Publ Hlth, Inst Nursing Sci, Basel, Switzerland.; De Geest, S (corresponding author), Katholieke Univ Leuven, Dept Publ Hlth, Acad Ctr Nursing & Midwifery, Leuven, Belgium.	sabina.degeest@unibas.ch	Burkhalter, Hanna/L-2309-2019; Burkhalter, Hanna/O-2188-2019; Study, STCS Swiss Transplant Cohort/G-8344-2017	Burkhalter, Hanna/0000-0001-7011-0481; Burkhalter, Hanna/0000-0001-7011-0481; Study, STCS Swiss Transplant Cohort/0000-0002-6369-819X; De Geest, Sabina/0000-0001-6596-7237	Swiss National Research Foundation [3347CO-108795]; Astellas (CH Europe); Roche (CH); Novartis (CH)	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Astellas (CH Europe); Roche (CH); Novartis (CH)	The Swiss Transplant Cohort Study is funded by a grant from the Swiss National Research Foundation (Grant number 3347CO-108795). This work is further supported by unrestricted research grants of Astellas (CH & Europe), Roche (CH) and Novartis (CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham O, 2017, INT J PHARM PRACT; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bossola M, 2016, CLIN TRANSPLANT, V30, P1387, DOI 10.1111/ctr.12846; Brekke FB, 2017, TRANSPL INT, V30, P49, DOI 10.1111/tri.12866; Brekke FB, 2014, HEMODIAL INT, V18, P87, DOI 10.1111/hdi.12066; Bryant BM, 2016, ANN PHARMACOTHER, V50, P926, DOI 10.1177/1060028016657552; Burkhalter H, 2016, CHRONOBIOL INT, P1; Burkhalter H, 2014, CLIN TRANSPLANT, V28, P58, DOI 10.1111/ctr.12279; Burkhalter H, 2013, PROG TRANSPLANT, V23, P220, DOI 10.7182/pit2013788; Burkhalter H, 2011, PROG TRANSPLANT, V21, P27, DOI 10.7182/prtr.21.1.d15486415621357w; Colten HR, 2006, SLEEP DISORDERS SLEE; De Geest S, 2013, PROG TRANSPLANT, V23, P235, DOI 10.7182/pit2013250; Edell-Gustafsson Ulla M, 2003, Int J Nurs Pract, V9, P49, DOI 10.1046/j.1440-172X.2003.00402.x; Elder SJ, 2008, NEPHROL DIAL TRANSPL, V23, P998, DOI 10.1093/ndt/gfm630; Eppenberger L, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14169; Eryilmaz MM, 2005, TRANSPL P, V37, P2072, DOI 10.1016/j.transproceed.2005.03.084; Fatigati A, 2016, PROG TRANSPLANT, V26, P62, DOI 10.1177/1526924816632123; Feng Y, 2014, QUAL LIFE RES, V23, P977, DOI 10.1007/s11136-013-0537-z; Fiorentino Lavinia, 2011, Drug Discov Today Dis Models, V8, P167; Furihata R, 2012, SLEEP MED, V13, P831, DOI 10.1016/j.sleep.2012.03.011; Gabardi Steven, 2004, Prog Transplant, V14, P182; Garbarino S, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080831; Hinz A, 2006, PSYCHOTHER PSYCH MED, V56, P42, DOI 10.1055/s-2005-867061; Hinz A, 2011, J PSYCHOSOM RES, V71, P74, DOI 10.1016/j.jpsychores.2011.01.005; International Transplant Nusse Society, 2017, TRANSPL PAT ED BOOKL; Kachuee H, 2007, TRANSPL P, V39, P1095, DOI 10.1016/j.transproceed.2007.04.001; Kamila P, 2014, TRANSPLANTATION, V98, pE73, DOI 10.1097/TP.0000000000000403; Koller MT, 2013, EUR J EPIDEMIOL, V28, P347, DOI 10.1007/s10654-012-9754-y; Kugler C, 2013, TRANSPLANTATION, V96, P316, DOI 10.1097/TP.0b013e31829853eb; Lacruz ME, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-007919; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liaveri PG, 2017, J PSYCHOSOM RES, V93, P96, DOI 10.1016/j.jpsychores.2016.12.013; Liu HX, 2015, INT J CLIN EXP MED, V8, P16191; Martin SC, 2010, QUAL HEALTH RES, V20, P182, DOI 10.1177/1049732309356284; Monk TH, 2007, SLEEP, V30, P1402, DOI 10.1093/sleep/30.11.1402; Noohi S, 2007, TRANSPL P, V39, P1074, DOI 10.1016/j.transproceed.2007.04.002; Noohi S, 2007, TRANSPL P, V39, P1079, DOI 10.1016/j.transproceed.2007.03.009; Patel NP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-475; Reilly-Spong M, 2013, CLIN TRANSPLANT, V27, P901, DOI 10.1111/ctr.12255; Rodrigue JR, 2010, PROG TRANSPLANT, V20, P221, DOI 10.7182/prtr.20.3.x82q1832184j4733; Russcher M, 2015, NEPHRON, V129, P6, DOI 10.1159/000369308; Sabbatini M, 2008, J NEPHROL, V21, pS97; Schroeck JL, 2016, CLIN THER, V37, P2340, DOI 10.1016/j.clinthera.2016.09.010; Shi Y, 2014, CURR NEUROPHARMACOL, V12, P289, DOI 10.2174/1570159X11666131227001243; Silva DS, 2012, CLINICS, V67, P1365, DOI 10.6061/clinics/2012(12)04; Snyder CF, 2012, QUAL LIFE RES, V21, P1305, DOI 10.1007/s11136-011-0054-x; Tsuno N, 2005, J CLIN PSYCHIAT, V66, P1254, DOI 10.4088/JCP.v66n1008; van Ginneken BTJ, 2010, CLIN TRANSPLANT, V24, pE10, DOI 10.1111/j.1399-0012.2009.01083.x; Vodermaier A, 2011, SUPPORT CARE CANCER, V19, P1899, DOI 10.1007/s00520-011-1251-4; Xu JY, 2012, PROG TRANSPLANT, V22, P41, DOI 10.7182/pit2012815	50	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185036	10.1371/journal.pone.0185036	http://dx.doi.org/10.1371/journal.pone.0185036			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020112	Green Published, gold, Green Submitted			2022-12-26	WOS:000412754400019
J	Zhou, WJ; Wan, YJ; Guo, RH; Deng, MT; Deng, KP; Wang, Z; Zhang, YL; Wang, F				Zhou, Wenjun; Wan, Yongjie; Guo, Rihong; Deng, Mingtian; Deng, Kaiping; Wang, Zhen; Zhang, Yanli; Wang, Feng			Generation of beta-lactoglobulin knock-out goats using CRISPR/Cas9	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; OFF-TARGET SITES; COWS MILK; HOMOLOGOUS RECOMBINATION; TRANSGENIC GOATS; IGE BINDING; GENE; SPECIFICITY; MICE; DNA	Goat's milk, considered a substitute for cow's milk, has a high nutritional value. However, goat's milk contains various allergens, predominantly beta-lactoglobulin (BLG). In this study, we employed the CRISPR/Cas9 system to target the BLG locus in goat fibroblasts for sgRNA optimization and generate BLG knock-out goats through co-injection of Cas9 mRNA and small guide RNAs (sgRNAs) into goat embryos at the one-cell stage. We firstly tested sgRNA editing efficiencies in goat fibroblast cells, and approximately 8.00% - 9.09% of the cells were modified in single sgRNA-guided targeting experiment. Among the kids, the genome-targeting efficiencies of single sgRNA were 12.5% (10 ng/mu L sg1) and 0% (10 ng/mu L sg2) and efficiencies of dual sgRNAs were 25.0% (25 ng/mu L sg2+sg3 group) and 28.6% (50 ng/mu L sg2+sg3 group). Relative expression of BLG in BLG knock-out goat mammary glands significantly (p < 0.01) decreased as well as other milk protein coding genes, such as CSN1S1, CSN1S2, CSN2, CSN3 and LALBA (p < 0.05). As expected, BLG protein had been abolished in the milk of the BLG knock-out goat. In addition, most of the targeted kids were chimeric (3/4), and their various body tissues were edited simultaneously. Our study thus provides a basis for optimizing the quality of goat milk, which can be applied to biomedical and agricultural research.	[Zhou, Wenjun; Wan, Yongjie; Guo, Rihong; Deng, Mingtian; Deng, Kaiping; Wang, Zhen; Zhang, Yanli; Wang, Feng] Nanjing Agr Univ, Jiangsu Livestock Embryo Engn Lab, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, F (corresponding author), Nanjing Agr Univ, Jiangsu Livestock Embryo Engn Lab, Nanjing, Jiangsu, Peoples R China.	caeet@njau.edu.cn	, 郭日红/AAX-3843-2020	Deng, Mingtian/0000-0003-0470-2432; Zhou, Wenjun/0000-0002-7329-8149	China National Program for Transgenic Animal [2014ZX08008-004]; National Nature Science Foundation of China [31272443]	China National Program for Transgenic Animal; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is financially supported by the China National Program for Transgenic Animal (2014ZX08008-004) and the National Nature Science Foundation of China (No. 31272443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bibikova M, 2002, GENETICS, V161, P1169; Cammuso C, 2000, ANIM BIOTECHNOL, V11, P1, DOI 10.1080/10495390009525943; Chen XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07581; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Creamer L. K, 2002, ENCY DAIRY SCI, P1932; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Cui C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10482; Davis PJ, 1998, ALLERGY, V53, P102, DOI 10.1111/j.1398-9995.1998.tb04975.x; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Ehn BM, 2005, J AGR FOOD CHEM, V53, P3743, DOI 10.1021/jf048121w; Ehn BM, 2004, J AGR FOOD CHEM, V52, P1398, DOI 10.1021/jf0304371; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gall H, 1996, J ALLERGY CLIN IMMUN, V97, P1304, DOI 10.1016/S0091-6749(96)70199-9; Gao F., 2016, NAT BIOTECHNOL; Gong L, 2015, GENOME ENG USING CRI, P197; Guo RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29855; Haenlein GFW, 2004, SMALL RUMINANT RES, V51, P155, DOI 10.1016/j.smallrumres.2003.08.010; Hallen E., 2008, J ANIMAL BREEDING GE, V107, P458; Kim JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4157; KUMAR S, 1994, P NATL ACAD SCI USA, V91, P6138, DOI 10.1073/pnas.91.13.6138; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Liu JY, 2014, METHODS, V69, P22, DOI 10.1016/j.ymeth.2014.04.010; Lv QY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25029; Maga EA, 2006, J DAIRY SCI, V89, P518, DOI 10.3168/jds.S0022-0302(06)72114-2; Miura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12799; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Qi J, 2016, CELL RES; Rong ZL, 2014, PROTEIN CELL, V5, P258, DOI 10.1007/s13238-014-0032-5; Selo I, 1998, INT ARCH ALLERGY IMM, V117, P20, DOI 10.1159/000023986; Sharma S, 2001, J CHROMATOGR B, V756, P183, DOI 10.1016/S0378-4347(01)00107-4; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Tsiplakou E, 2015, J DAIRY RES, V82, P257, DOI 10.1017/S0022029915000333; Wal JM, 1998, ALLERGY, V53, P1013, DOI 10.1111/j.1398-9995.1998.tb03811.x; Wan YJ, 2016, CELL BIOL INT, V40, P74, DOI 10.1002/cbin.10540; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; WANG YX, 2015, SCI REP UK, V5; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153; Yuan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep22024	44	18	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186056	10.1371/journal.pone.0186056	http://dx.doi.org/10.1371/journal.pone.0186056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016691	Green Published, gold, Green Submitted			2022-12-26	WOS:000412627400052
J	Williamson, RL; Laulagnier, K; Miranda, AM; Fernandez, MA; Wolfe, MS; Sadoul, R; Di Paolo, G				Williamson, Rebecca L.; Laulagnier, Karine; Miranda, Andre M.; Fernandez, Marty A.; Wolfe, Michael S.; Sadoul, Remy; Di Paolo, Gilbert			Disruption of amyloid precursor protein ubiquitination selectively increases amyloid (A) 40 levels via presenilin 2-mediated cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid precursor protein (APP); amyloid- (A); endosome; intracellular processing; intracellular trafficking; lysosome; presenilin; ubiquitination	INTRACELLULAR A-BETA; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; SUBSTRATE-SPECIFICITY; MULTIVESICULAR BODIES; EFFICIENT INHIBITION; TERMINAL FRAGMENTS; APP; TRAFFICKING; A-BETA-42	Amyloid plaques, a neuropathological hallmark of Alzheimer's disease, are largely composed of amyloid (A) peptide, derived from cleavage of amyloid precursor protein (APP) by - and -secretases. The endosome is increasingly recognized as an important crossroad for APP and these secretases, with major implications for APP processing and amyloidogenesis. Among various post-translational modifications affecting APP accumulation, ubiquitination of cytodomain lysines may represent a key signal controlling APP endosomal sorting. Here, we show that substitution of APP C-terminal lysines with arginine disrupts APP ubiquitination and that an increase in the number of substituted lysines tends to increase APP metabolism. An APP mutant lacking all C-terminal lysines underwent the most pronounced increase in processing, leading to accumulation of both secreted and intracellular A40. Artificial APP ubiquitination with rapalog-mediated proximity inducers reduced A40 generation. A lack of APP C-terminal lysines caused APP redistribution from endosomal intraluminal vesicles (ILVs) to the endosomal limiting membrane, with a subsequent decrease in APP C-terminal fragment (CTF) content in secreted exosomes, but had minimal effects on APP lysosomal degradation. Both the increases in secreted and intracellular A40 were abolished by depletion of presenilin 2 (PSEN2), recently shown to be enriched on the endosomal limiting membrane compared with PSEN1. Our findings demonstrate that ubiquitin can act as a signal at five cytodomain-located lysines for endosomal sorting of APP. They further suggest that disruption of APP endosomal sorting reduces its sequestration in ILVs and results in PSEN2-mediated processing of a larger pool of APP-CTF on the endosomal membrane.	[Williamson, Rebecca L.; Miranda, Andre M.; Di Paolo, Gilbert] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Di Paolo, Gilbert] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Laulagnier, Karine; Sadoul, Remy] INSERM, Grenoble Inst Neurosci, F-38042 Grenoble, France; [Miranda, Andre M.] Univ Minho, Life & Hlth Sci Res Inst, Sch Med, P-4710057 Braga, Portugal; [Miranda, Andre M.] Life & Hlth Sci Res Inst, Res Grp 3Bs, Biodegradables & Biomimet Associate Lab, P-4710057 Braga, Portugal; [Fernandez, Marty A.; Wolfe, Michael S.] Harvard Univ, Ctr Neurol Dis, Boston, MA 02115 USA; [Wolfe, Michael S.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	Columbia University; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universidade do Minho; Harvard University; University of Kansas	Di Paolo, G (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, 630 West 168th St,P&S 12-510, New York, NY 10032 USA.	gd2175@cumc.columbia.edu		Fernandez, Marty/0000-0002-3211-2563; SADOUL, Remy/0000-0002-4763-0320; Miranda, Andre/0000-0002-0175-9938	National Institutes of Health [R01 NS056049, F30 AG047748, AG015379]; Fondation Plan Alzheimer; Inserm; Universite Grenoble Alpes; France Alzheimer Foundation; Fundacao para a Ciencia e Tecnologia [PD/BD/105915/2014]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG047748, P01AG015379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Plan Alzheimer; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Grenoble Alpes; France Alzheimer Foundation; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants R01 NS056049 (to G. D. P. and Ronald Liem), F30 AG047748 (to R. L. W.), and AG015379 (to M. S. W. and Dennis J. Selkoe). G. D. P. is a full time employee of Denali Therapeutics Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Fondation Plan Alzheimer.; Supported by Inserm, Universite Grenoble Alpes, France Alzheimer Foundation.; Supported by Fundacao para a Ciencia e Tecnologia Grant PD/BD/105915/2014.	Acx H, 2014, J BIOL CHEM, V289, P4346, DOI 10.1074/jbc.M113.530907; Azevedo Cristina, 2015, Advances in Biological Regulation, V60, P144, DOI 10.1016/j.jbior.2015.09.008; Bate C, 2010, J ALZHEIMERS DIS, V21, P985, DOI 10.3233/JAD-2010-100528; Bekes M, 2013, CELL REP, V5, P826, DOI 10.1016/j.celrep.2013.10.008; Bhalla A, 2012, NEUROBIOL DIS, V47, P126, DOI 10.1016/j.nbd.2012.03.030; Bohdanowicz M, 2012, MOL BIOL CELL, V23, P176, DOI 10.1091/mbc.E11-06-0489; Bohm C, 2015, MOL CELL NEUROSCI, V66, P3, DOI 10.1016/j.mcn.2015.02.016; Buggia-Prevot V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-1; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Bustamante HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083096; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Chivet M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00145; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; Das U, 2016, NAT NEUROSCI, V19, P55, DOI 10.1038/nn.4188; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; De Strooper B, 2015, ANNU REV PHARMACOL, V55, P419, DOI 10.1146/annurev-pharmtox-010814-124309; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Del Prete D, 2016, J BIOL CHEM, V291, P17209, DOI 10.1074/jbc.M116.733626; Edgar JR, 2015, J CELL SCI, V128, P2520, DOI 10.1242/jcs.170233; El Ayadi A, 2012, P NATL ACAD SCI USA, V109, P13416, DOI 10.1073/pnas.1206786109; Fernandez MA, 2014, J BIOL CHEM, V289, P31043, DOI 10.1074/jbc.M114.581165; Ford DL, 2007, BIOCHEMISTRY-US, V46, P8827, DOI 10.1021/bi700604q; Funmilayo E, 2016, J BIOL CHEM, V291, P15753, DOI 10.1074/jbc.M116.718023; Golde TE, 2013, BBA-BIOMEMBRANES, V1828, P2898, DOI 10.1016/j.bbamem.2013.06.005; Gouras Gunnar K, 2013, Int J Cell Biol, V2013, P141083, DOI 10.1155/2013/141083; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Kang EL, 2012, J BIOL CHEM, V287, P42867, DOI 10.1074/jbc.M112.407072; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Massey LK, 2004, J ALZHEIMERS DIS, V6, P79; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Meckler X, 2016, J BIOL CHEM, V291, P12821, DOI 10.1074/jbc.M115.708297; Morel E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3250; Muhammad A, 2008, P NATL ACAD SCI USA, V105, P7327, DOI 10.1073/pnas.0802545105; Murray MM, 2009, J AM CHEM SOC, V131, P6316, DOI 10.1021/ja8092604; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pauwels K, 2012, J BIOL CHEM, V287, P5650, DOI 10.1074/jbc.M111.264473; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Peric A, 2015, ACTA NEUROPATHOL, V129, P363, DOI 10.1007/s00401-014-1379-7; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rajendran L, 2008, SCIENCE, V320, P520, DOI 10.1126/science.1156609; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Rajendrana L, 2007, NEURODEGENER DIS, V4, P164, DOI 10.1159/000101841; Sannerud R, 2016, CELL, V166, P193, DOI 10.1016/j.cell.2016.05.020; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Small SA, 2015, NAT REV NEUROSCI, V16, P126, DOI 10.1038/nrn3896; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tanno H, 2013, J BIOCHEM, V153, P497, DOI 10.1093/jb/mvt028; Toh WH, 2016, BIOCHEM J, V473, P1977, DOI 10.1042/BCJ20160147; Tosto G, 2015, ANN CLIN TRANSL NEUR, V2, P810, DOI 10.1002/acn3.223; Tosto G, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0381-0; Ubelmann F, 2017, EMBO REP, V18, P102, DOI 10.15252/embr.201642738; Urwin H, 2009, BIOCHEM SOC T, V37, P208, DOI 10.1042/BST0370208; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vilette D, 2015, CELL MOL LIFE SCI, V72, P4409, DOI 10.1007/s00018-015-1945-8; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Watanabe T, 2012, J NEUROSCI, V32, P3352, DOI 10.1523/JNEUROSCI.5659-11.2012; Wegner CS, 2010, HISTOCHEM CELL BIOL, V133, P41, DOI 10.1007/s00418-009-0643-8; Wolfe MS, 2013, BBA-BIOMEMBRANES, V1828, P2886, DOI 10.1016/j.bbamem.2013.04.015; Wolfe MS, 2012, BIOL CHEM, V393, P899, DOI 10.1515/hsz-2012-0140; Xu F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13527; Yan YL, 2007, J MOL BIOL, V369, P909, DOI 10.1016/j.jmb.2007.04.014; Yonemura Y, 2016, BIOCHEM BIOPH RES CO, V478, P1751, DOI 10.1016/j.bbrc.2016.09.018; Yuyama K, 2015, FEBS LETT, V589, P84, DOI 10.1016/j.febslet.2014.11.027; Zou L, 2007, CELL RES, V17, P389, DOI 10.1038/cr.2007.5	82	15	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19873	19889		10.1074/jbc.M117.818138	http://dx.doi.org/10.1074/jbc.M117.818138			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29021256	Green Published, hybrid			2022-12-26	WOS:000416911300030
J	Korzeniewski, B				Korzeniewski, Bernard			Contribution of proton leak to oxygen consumption in skeletal muscle during intense exercise is very low despite large contribution at rest	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; LIVER-MITOCHONDRIA; RESPIRATION RATE; INNER MEMBRANE; H+ LEAK; ACTIVATION; EFFICIENCY; HUMANS	A computer model was used to simulate the dependence of protonmotive force (Delta p), proton leak and phenomenological (involving proton leak) ATP/O-2 ratio on work intensity in skeletal muscle. Delta p, NADH and proton leak decreased with work intensity. The contribution of proton leak to oxygen consumption ((V) over dot O-2) decreased from about 60% at rest to about 3 and 1% at moderate and heavy/severe exercise, respectively, while the ATP/O-2 ratio increased from 2.1 to 5.5 and 5.7. A two-fold increase in proton leak activity or its decrease to zero decreased/increased the ATP/O-2 ratio by only about 3 and 1% during moderate and heavy/severe exercise, respectively. The low contribution of proton leak to (V) over dotO(2) in intensively working skeletal muscle was mostly caused by a huge increase in ATP usage intensity during rest-to-work transition, while OXPHOS, and thus oxidative ATP supply and (V) over dotO(2) related to it, was mostly stimulated by high each-step activation (ESA) of OXPHOS complexes. The contribution of proton leak to (V) over dotO(2) and ATP/O-2 ratio in isolated mitochondria should not be directly extrapolated to working muscle, as mitochondria lack ESA, at least in the absence of Ca2+, and therefore (V) over dotO(2) cannot be elevated as much as in intact muscle.	[Korzeniewski, Bernard] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland	Jagiellonian University	Korzeniewski, B (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	bernard.korzeniewski@gmail.com		Korzeniewski, Bernard/0000-0001-6654-5263	KNOW program - Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University	KNOW program - Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University	This study was funded by the KNOW program, which supports the Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the KNOW program, which supports the Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAND MD, 1991, BIOCHEM J, V275, P81, DOI 10.1042/bj2750081; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; BROWN GC, 1990, EUR J BIOCHEM, V192, P355, DOI 10.1111/j.1432-1033.1990.tb19234.x; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; GARLID KD, 1989, BIOCHIM BIOPHYS ACTA, V976, P109, DOI 10.1016/S0005-2728(89)80219-1; Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983; HARPER ME, 1993, J BIOL CHEM, V268, P14850; Jarmuszkiewicz W, 2015, FREE RADICAL BIO MED, V83, P12, DOI 10.1016/j.freeradbiomed.2015.02.012; Korzeniewski B, 2003, BIOCHEM J, V375, P799, DOI 10.1042/BJ20030882; Korzeniewski B, 1998, BIOCHEM J, V330, P1189, DOI 10.1042/bj3301189; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; Korzeniewski B, 2004, BIOPHYS CHEM, V110, P147, DOI 10.1016/j.bpc.2004.01.011; Korzeniewski B, 2007, BIOPHYS CHEM, V129, P93, DOI 10.1016/j.bpc.2007.05.013; Korzeniewski B, 2017, PROG BIOPHYS MOL BIO, V125, P1, DOI 10.1016/j.pbiomolbio.2016.12.001; Korzeniewski B, 2015, J PHYSIOL-LONDON, V593, P5255, DOI 10.1113/JP271299; Korzeniewski B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117145; Korzeniewski B, 2014, J APPL PHYSIOL, V116, P83, DOI 10.1152/japplphysiol.00759.2013; KRISHNAMOORTHY G, 1984, BIOCHEMISTRY-US, V23, P1640, DOI 10.1021/bi00303a009; Lark DS, 2016, AM J PHYSIOL-CELL PH, V311, pC239, DOI 10.1152/ajpcell.00124.2016; Liguzinski P, 2006, AM J PHYSIOL-CELL PH, V291, pC1213, DOI 10.1152/ajpcell.00078.2006; Marcinek DJ, 2004, AM J PHYSIOL-CELL PH, V286, pC457, DOI 10.1152/ajpcell.00237.2003; Mogensen M, 2005, ACTA PHYSIOL SCAND, V185, P229, DOI 10.1111/j.1365-201X.2005.01488.x; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; PORTER RK, 1993, NATURE, V362, P628, DOI 10.1038/362628a0; Rolfe DFS, 1996, BBA-BIOENERGETICS, V1276, P45, DOI 10.1016/0005-2728(96)00029-1; Rolfe DFS, 1999, AM J PHYSIOL-CELL PH, V276, pC692, DOI 10.1152/ajpcell.1999.276.3.C692; Tonkonogi M, 2000, BIOCHEM J, V351, P805, DOI 10.1042/0264-6021:3510805	29	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185991	10.1371/journal.pone.0185991	http://dx.doi.org/10.1371/journal.pone.0185991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045413	Green Published, gold, Green Submitted			2022-12-26	WOS:000413168100033
J	Siutz, C; Nemeth, M; Wagner, KH; Quint, R; Ruf, T; Millesi, E				Siutz, Carina; Nemeth, Matthias; Wagner, Karl-Heinz; Quint, Ruth; Ruf, Thomas; Millesi, Eva			Effects of food store quality on hibernation performance in common hamsters	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; SQUIRRELS SPERMOPHILUS-LATERALIS; MARMOTS MARMOTA-FLAVIVENTRIS; IN-GROUND SQUIRRELS; BODY-TEMPERATURE; MAMMALIAN HIBERNATION; CRICETUS-CRICETUS; TORPOR PATTERNS; TAMIAS-STRIATUS; ADIPOSE-TISSUE	Hibernating animals can adjust torpor expression according to available energy reserves. Besides the quantity, the quality of energy reserves could play an important role for overwintering strategies. Common hamsters are food-storing hibernators and show high individual variation in hibernation performance, which might be related to the quality of food hoards in the hibernacula. In this study, we tested the effects of food stores high in fat content, particularly polyunsaturated fatty acids (PUFAs), on hibernation patterns under laboratory conditions. Control animals received standard rodent pellets only, while in the other group pellets were supplemented with sunflower seeds. We recorded body temperature during winter using subcutaneously implanted data loggers, documented total food consumption during winter, and analysed PUFA proportions in white adipose tissue (WAT) before and after the winter period. About half of the individuals in both groups hibernated and torpor expression did not differ between these animals. Among the high-fat group, however, individuals with high sunflower seeds intake strongly reduced the time spent in deep torpor. PUFA proportions in WAT decreased during winter in both groups and this decline was positively related to the time an individual spent in deep torpor. Sunflower seeds intake dampened the PUFA decline resulting in higher PUFA levels in animals of the high-fat group after winter. In conclusion, our results showed that common hamsters adjusted torpor expression and food intake in relation to the total energy of food reserves, underlining the importance of food hoard quality on hibernation performance.	[Siutz, Carina; Nemeth, Matthias; Millesi, Eva] Univ Vienna, Fac Life Sci, Dept Behav Biol, Vienna, Austria; [Wagner, Karl-Heinz; Quint, Ruth] Univ Vienna, Fac Life Sci, Dept Nutr Sci, Vienna, Austria; [Ruf, Thomas] Univ Vet Med, Res Inst Wildlife Ecol, Dept Integrat Biol & Evolut, Vienna, Austria	University of Vienna; University of Vienna; University of Veterinary Medicine Vienna	Siutz, C (corresponding author), Univ Vienna, Fac Life Sci, Dept Behav Biol, Vienna, Austria.	carina.siutz@univie.ac.at	; Wagner, Karl-Heinz/B-9098-2013	Millesi, Eva/0000-0003-0740-0413; Siutz, Carina/0000-0002-1614-2009; Wagner, Karl-Heinz/0000-0002-1683-7265; Ruf, Thomas/0000-0002-9235-7079	Austrian Science Fund (FWF) [24280-B20]; Austrian Science Fund (FWF) [P 24280] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded by the Austrian Science Fund (FWF, https://www.favtac.at, Project Number: 24280-B20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018641; Bieber C, 2014, FUNCT ECOL, V28, P167, DOI 10.1111/1365-2435.12173; Bieber C, 2012, OECOLOGIA, V169, P155, DOI 10.1007/s00442-011-2194-7; Carey HV, 2000, J COMP PHYSIOL B, V170, P551, DOI 10.1007/s003600000135; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; De Rosario-Martinez H., 2015, PHIA POST HOC INTERA; Falkenstein F, 2001, J COMP PHYSIOL B, V171, P189, DOI 10.1007/s003600000157; Florant GL, 1998, AM ZOOL, V38, P331; FLORANT GL, 1990, AM J PHYSIOL, V258, pR1123, DOI 10.1152/ajpregu.1990.258.5.R1123; FLORANT GL, 1993, AM J PHYSIOL, V264, pR747, DOI 10.1152/ajpregu.1993.264.4.R747; Florant GL, 2012, J COMP PHYSIOL B, V182, P451, DOI 10.1007/s00360-011-0630-y; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox J, 2011, AN R COMPANION TO AP; Franco M, 2013, COMP BIOCHEM PHYS A, V166, P338, DOI 10.1016/j.cbpa.2013.07.010; FRANK CL, 1992, PHYSIOL ZOOL, V65, P906, DOI 10.1086/physzool.65.5.30158549; Frank CL, 2002, J MAMMAL, V83, P1013, DOI 10.1644/1545-1542(2002)083&lt;1013:STVIDF&gt;2.0.CO;2; FRANK CL, 1995, J COMP PHYSIOL B, V164, P536; Frank CL, 2008, PHYSIOL BIOCHEM ZOOL, V81, P486, DOI 10.1086/589107; French AR, 2000, J MAMMAL, V81, P979, DOI 10.1644/1545-1542(2000)081<0979:IOSFAC>2.0.CO;2; GEISER F, 1990, BIOCHIM BIOPHYS ACTA, V1046, P159, DOI 10.1016/0005-2760(90)90183-X; GEISER F, 1995, PHYSIOL ZOOL, V68, P935, DOI 10.1086/physzool.68.6.30163788; GEISER F, 1987, AM J PHYSIOL, V252, pR897, DOI 10.1152/ajpregu.1987.252.5.R897; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser Fritz, 2012, P109; Giroud S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063111; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; HELDMAIER G, 1992, J COMP PHYSIOL B, V162, P696, DOI 10.1007/BF00301619; Hill VL, 2000, PHYSIOL BEHAV, V68, P431, DOI 10.1016/S0031-9384(99)00177-8; Hill VL, 1999, CAN J ZOOL, V77, P1494, DOI 10.1139/cjz-77-9-1494; Hoelzl F, 2016, J EXP BIOL, V219, P2469, DOI 10.1242/jeb.140871; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P180, DOI 10.1086/367949; Kobbe S, 2011, J COMP PHYSIOL B, V181, P165, DOI 10.1007/s00360-010-0507-5; Landry-Cuerrier M, 2008, ECOLOGY, V89, P3306, DOI 10.1890/08-0121.1; Lebl K, 2011, ECOGRAPHY, V34, P683, DOI 10.1111/j.1600-0587.2010.06691.x; Millesi E, 2001, J BIOL RHYTHM, V16, P264, DOI 10.1177/074873001129001971; Munro D, 2008, CAN J ZOOL, V86, P364, DOI 10.1139/Z08-008; Munro D, 2005, J ANIM ECOL, V74, P692, DOI 10.1111/j.1365-2656.2005.00968.x; Munro D, 2004, ZOOLOGY, V107, P29, DOI 10.1016/j.zool.2003.12.001; Pinheiro J, R PACKAGE VERSION; Prendergast BJ, 2002, AM J PHYSIOL-REG I, V282, pR1054, DOI 10.1152/ajpregu.00562.2001; Price ER, 2013, PHYSIOL BIOCHEM ZOOL, V86, P205, DOI 10.1086/668892; R. Core Team, 2015, R A LANGUAGE AND ENV; RACLOT T, 1993, J LIPID RES, V34, P1515; Raclot T, 2003, PROG LIPID RES, V42, P257, DOI 10.1016/S0163-7827(02)00066-8; Ruf T, 2008, AM J PHYSIOL-REG I, V294, pR1044, DOI 10.1152/ajpregu.00688.2007; Ruf T, 2015, BIOL REV, V90, P891, DOI 10.1111/brv.12137; Sheriff MJ, 2013, PHYSIOL BIOCHEM ZOOL, V86, P515, DOI 10.1086/673092; Siutz C, 2017, J COMP PHYSIOL B, V187, P881, DOI 10.1007/s00360-017-1093-6; Siutz C, 2016, J COMP PHYSIOL B, V186, P801, DOI 10.1007/s00360-016-0995-z; Siutz Carina, 2012, P155; Stawski C, 2010, NATURWISSENSCHAFTEN, V97, P29, DOI 10.1007/s00114-009-0606-x; Strijkstra AM, 2003, NEUROSCI LETT, V344, P29, DOI 10.1016/S0304-3940(03)00399-9; Turbill C, 2011, P ROY SOC B-BIOL SCI, V278, P3355, DOI 10.1098/rspb.2011.0190; US Department of Agriculture, 2015, USDA NATIONAL NUTRIE; Wagner KH, 2000, EUR FOOD RES TECHNOL, V210, P237, DOI 10.1007/s002179900080; Wassmer T, 1997, J COMP PHYSIOL B, V167, P270, DOI 10.1007/s003600050074; Wassmer T, 2004, J ZOOL, V262, P281, DOI 10.1017/S0952836903004643; Wathes DC, 2007, BIOL REPROD, V77, P190, DOI 10.1095/biolreprod.107.060558; WOLLNIK F, 1995, J COMP PHYSIOL B, V165, P171; Zervanos SM, 2014, INTEGR COMP BIOL, V54, P443, DOI 10.1093/icb/ict100	62	12	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185913	10.1371/journal.pone.0185913	http://dx.doi.org/10.1371/journal.pone.0185913			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045417	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100031
J	Chen, ZH; Du, JC; Xiang, M; Zhang, Y; Zhang, SY				Chen, Zhuohao; Du, Jinchen; Xiang, Min; Zhang, Yan; Zhang, Shuyue			Social exclusion leads to attentional bias to emotional social information: Evidence from eye movement	PLOS ONE			English	Article							LOW SELF-ESTEEM; SELECTIVE ATTENTION; REJECTION; ANXIETY; ACCEPTANCE; DISORDERS; OSTRACISM; RESPONSES; THREAT; INDIVIDUALS	Social exclusion has many effects on individuals, including the increased need to belong and elevated sensitivity to social information. Using a self-reporting method, and an eyetracking technique, this study explored people's need to belong and attentional bias towards the socio-emotional information (pictures of positive and negative facial expressions compared to those of emotionally-neutral expressions) after experiencing a brief episode of social exclusion. We found that: (1) socially-excluded individuals reported higher negative emotions, lower positive emotions, and stronger need to belong than those who were not socially excluded; (2) compared to a control condition, social exclusion caused a longer response time to probe dots after viewing positive or negative face images; (3) social exclusion resulted in a higher frequency ratio of first attentional fixation on both positive and negative emotional facial pictures (but not on the neutral pictures) than the control condition; (4) in the social exclusion condition, participants showed shorter first fixation latency and longer first fixation duration to positive pictures than neutral ones but this effect was not observed for negative pictures; (5) participants who experienced social exclusion also showed longer gazing duration on the positive pictures than those who did not; although group differences also existed for the negative pictures, the gaze duration bias from both groups showed no difference from chance. This study demonstrated the emotional response to social exclusion as well as characterising multiple eye-movement indicators of attentional bias after experiencing social exclusion.	[Chen, Zhuohao; Du, Jinchen; Zhang, Shuyue] Guangxi Univ, Sch Educ, Nanning, Guangxi Zhuang, Peoples R China; [Xiang, Min] Wenzhou Med Univ, Sch Stomatol, Wenzhou, Zhejiang, Peoples R China; [Zhang, Yan] Chinese Univ Hong Kong, Dept Educ Psychol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Yan] Shenzhen Univ, Coll Mass Commun, Shenzhen, Peoples R China	Guangxi University; Wenzhou Medical University; Chinese University of Hong Kong; Shenzhen University	Zhang, SY (corresponding author), Guangxi Univ, Sch Educ, Nanning, Guangxi Zhuang, Peoples R China.; Zhang, Y (corresponding author), Chinese Univ Hong Kong, Dept Educ Psychol, Hong Kong, Hong Kong, Peoples R China.; Zhang, Y (corresponding author), Shenzhen Univ, Coll Mass Commun, Shenzhen, Peoples R China.	zhangyansmile@gmail.com; gxushuyue@126.com			Guangxi Training Center for Teachers of Higher Educational Institutions [GXQG022014008]; School of Education, Guangxi University	Guangxi Training Center for Teachers of Higher Educational Institutions; School of Education, Guangxi University	This work was supported by Guangxi Training Center for Teachers of Higher Educational Institutions, grant number GXQG022014008, http://gxttc.gxnu.edu.cn/home/. This research was financially supported by the Guangxi Training Center for Teachers of Higher Educational Institutions.; We are grateful for the support provided by the School of Education, Guangxi University. We also thank all the participants and colleagues for their help.received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, BRIT MED J, DOI DOI 10.1136/BMJ.323.7306.191; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; BARNERBARRY C, 1986, ETHOL SOCIOBIOL, V7, P281, DOI 10.1016/0162-3095(86)90054-3; Baumeister RF, 2005, J PERS SOC PSYCHOL, V88, P589, DOI 10.1037/0022-3514.88.4.589; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; BAUMEISTER RF, 1990, J SOC CLIN PSYCHOL, V9, P165, DOI 10.1521/jscp.1990.9.2.165; Browning M, 2010, COGN AFFECT BEHAV NE, V10, P8, DOI 10.3758/CABN.10.1.8; Buckley KE, 2004, J EXP SOC PSYCHOL, V40, P14, DOI 10.1016/S0022-1031(03)00064-7; Carter-Sowell AR, 2008, SOC INFLUENCE, V3, P143, DOI 10.1080/15534510802204868; Castellanos EH, 2009, INT J OBESITY, V33, P1063, DOI 10.1038/ijo.2009.138; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Dandeneau SP, 2004, J SOC CLIN PSYCHOL, V23, P584, DOI 10.1521/jscp.23.4.584.40306; DeWall CN, 2009, J PERS SOC PSYCHOL, V96, P729, DOI 10.1037/a0014634; Duchowski A, 2007, EYE TRACKING METHODO, V373; Eisenberger NI, 2007, BIOL PSYCHIAT, V61, P1100, DOI 10.1016/j.biopsych.2006.08.007; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Gao XA, 2011, BEHAV RES THER, V49, P252, DOI 10.1016/j.brat.2011.01.009; Gardner W.L., 2005, SOCIAL OUTCAST OSTRA, P227; Gu YB, 2013, PERS INDIV DIFFER, V55, P671, DOI 10.1016/j.paid.2013.05.009; Halberstadt AG, 2001, SOC DEV, V10, P79, DOI 10.1111/1467-9507.00150; Heatherton TF, 2000, J PERS SOC PSYCHOL, V78, P725, DOI 10.1037/0022-3514.78.4.725; Jiang J, 2015, J EXP SOC PSYCHOL, V58, P48, DOI 10.1016/j.jesp.2015.01.001; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; Leary MR, 2003, PERS INDIV DIFFER, V35, P59, DOI 10.1016/S0191-8869(02)00141-1; LEARY MR, 1990, J SOC CLIN PSYCHOL, V9, P221, DOI 10.1521/jscp.1990.9.2.221; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; MACLEOD C, 1988, Q J EXP PSYCHOL-A, V40, P653, DOI 10.1080/14640748808402292; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Maner JK, 2007, J PERS SOC PSYCHOL, V92, P42, DOI 10.1037/0022-3514.92.1.42; Mendes WB, 2008, J PERS SOC PSYCHOL, V94, P278, DOI 10.1037/0022-3514.94.2.278; Mogg K, 1997, BEHAV RES THER, V35, P297, DOI 10.1016/S0005-7967(96)00109-X; Mogg K, 1998, BEHAV RES THER, V36, P227, DOI 10.1016/S0005-7967(97)00062-4; NAVON D, 1983, Q J EXP PSYCHOL-A, V35, P497, DOI 10.1080/14640748308402484; Nolan SA, 2003, J PERS SOC PSYCHOL, V85, P745, DOI 10.1037/0022-3514.85.4.745; Rieger E, 1998, INT J EAT DISORDER, V23, P199, DOI 10.1002/(SICI)1098-108X(199803)23:2<199::AID-EAT10>3.0.CO;2-W; Twenge JM, 2003, PERS SOC PSYCHOL B, V29, P261, DOI 10.1177/0146167202239051; van Beest I, 2006, J PERS SOC PSYCHOL, V91, P918, DOI 10.1037/0022-3514.91.5.918; [王妍 Wang Yan], 2005, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V13, P396; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Williams K. D., 1997, SOCIAL OSTRACISM AVE, P130; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 1997, PERS SOC PSYCHOL B, V23, P693, DOI 10.1177/0146167297237003; Woodworth R.S., 1954, EXP PSYCHOL	44	6	7	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e186313	10.1371/journal.pone.0186313	http://dx.doi.org/10.1371/journal.pone.0186313			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KA	29040279	Green Submitted, Green Published, gold			2022-12-26	WOS:000413167500033
J	Hake, AA; Shirasawa, K; Yadawad, A; Sukruth, M; Patil, M; Nayak, SN; Lingaraju, S; Patil, PV; Nadaf, HL; Gowda, MVC; Bhat, RS				Hake, Anil A.; Shirasawa, Kenta; Yadawad, Arati; Sukruth, M.; Patil, Malagouda; Nayak, Spurthi N.; Lingaraju, S.; Patil, P. V.; Nadaf, H. L.; Gowda, M. V. C.; Bhat, R. S.			Mapping of important taxonomic and productivity traits using genic and non-genic transposable element markers in peanut (Arachis hypogaea L.)	PLOS ONE			English	Article							HIGH OLEATE TRAIT; LOCI; EXPRESSION; SELECTION; GENOME; MUTANT; GENES	A mapping population of recombinant inbred lines (RILs) derived from TMV 2 and its mutant, TMV 2-NLM was employed for mapping important taxonomic and productivity traits using genic and non-genic transposable element markers in peanut. Single nucleotide polymorphism and copy number variation using RAD-Sequencing data indicated very limited polymorphism between TMV 2 and TMV 2-NLM. But phenotypically they differed significantly for many taxonomic and productivity traits. Also, the RIL population showed significant variation for a few additional agronomic traits. A genetic linkage map of 1,205.66 cM was constructed using 91 genic and non-genic Arachis hypogaea transposable element (AhTE) markers. Using single marker analysis and QTL analysis, the markers with high phenotypic variance explained (PVE) were identified for branching pattern (32.3%), number of primary and secondary branches (19.9% and 28.4%, respectively), protein content (26.4%), days to 50% flowering (22.0%), content of oleic acid (15.1%), test weight (13.6%) and pod width (12.0%). Three genic markers (AhTE0357, AhTE0391, AhTE0025) with Arachis hypogaea miniature inverted-repeat transposable element (AhMITE1) activity in the genes Araip. TG1BL (B02 chromosome), Aradu. 7N61X (A09 chromosome) and Aradu. 7065G (A07 chromosome), respectively showed strong linkage with these taxonomic, productivity and quality traits. Since TMV 2 and TMV 2-NLM differed subtly at DNA level, the background noise in detecting the marker-trait associations was minimum; therefore, the markers identified in this study for the taxonomic and productivity traits may be significant and useful in peanut molecular breeding.	[Hake, Anil A.; Yadawad, Arati; Sukruth, M.; Patil, Malagouda; Nayak, Spurthi N.; Nadaf, H. L.; Bhat, R. S.] Univ Agr Sci, Dept Biotechnol, Dharwad, Karnataka, India; [Shirasawa, Kenta] Kazusa DNA Res Inst, Dept Frontier Res, Chiba, Japan; [Lingaraju, S.; Patil, P. V.] Univ Agr Sci, Dept Plant Pathol, Dharwad, Karnataka, India; [Gowda, M. V. C.] Univ Agr Sci, Dept Genet & Plant Breeding, Dharwad, Karnataka, India	Kazusa DNA Research Institute	Bhat, RS (corresponding author), Univ Agr Sci, Dept Biotechnol, Dharwad, Karnataka, India.	bhatrs@uasd.in	Yadawad, Arati/AAX-5003-2021; Shirasawa, Kenta/L-9141-2019	Shirasawa, Kenta/0000-0001-7880-6221	DST-JSPS Bilateral Program	DST-JSPS Bilateral Program	Financial support received from the DST-JSPS Bilateral Program is gratefully acknowledged.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Bai ZT, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2589-2; Chen YS, 2008, THEOR APPL GENET, V117, P1241, DOI 10.1007/s00122-008-0858-4; Clevenger J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01446; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Fonceka D., 2009, BMC PLANT BIOL, V12, P26, DOI [10.1186/1471-2229-12-26, DOI 10.1186/1471-2229-12-26]; Gavidia I, 2002, EUR J BIOCHEM, V269, P2842, DOI 10.1046/j.1432-1033.2002.02931.x; Gowda M. V. C., 2002, International Arachis Newsletter, P32; Guo BZ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-12; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Huang L, 2015, THEOR APPL GENET, V128, P1103, DOI 10.1007/s00122-015-2493-1; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; IBPGR/ ICRISAT, 1992, DESCR GROUND ROM IT; Jung S, 2000, MOL GEN GENET, V263, P796, DOI 10.1007/s004380000244; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kyazma BV, 2006, SOFTWARE CALCULATION, P33; Landfort WR, 1965, CATALOGUE OF PEANUTS; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; MARTINIUK F, 1985, J BIOL CHEM, V260, P1238; Mei MH, 1999, CROP SCI, V39, P1711, DOI 10.2135/cropsci1999.3961711x; Mondal S, 2013, INDIAN J GENET PL BR, V73, P105, DOI 10.5958/j.0019-5200.73.1.016; Pattanashetti SK, 2005, GENETIC ANAL MUTATIO; PRASAD M V R, 1984, Indian Journal of Genetics and Plant Breeding, V44, P25; RAO RCN, 1995, AUST J PLANT PHYSIOL, V22, P545, DOI 10.1071/PP9950545; Shirasawa K, 2016, DNA RES, V23, P145, DOI 10.1093/dnares/dsw004; Shirasawa K, 2016, PLANT BIOTECHNOL J, V14, P51, DOI 10.1111/pbi.12348; Shirasawa K, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-80; Shirasawa K, 2012, THEOR APPL GENET, V124, P1429, DOI 10.1007/s00122-012-1798-6; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Stanley D, 2010, PLANT PHYSIOL, P110; Subbarao PV, 1990, 2 INT C FRENCH PHYT; Subrahmanyam P., 1995, INFORM B, V47, P1; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang S, 2007, WINDOWS QTL CARTOGRA, V2, P5; Wang Y, 2015, GENOME, V58, P375, DOI 10.1139/gen-2015-0008; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90	37	22	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186113	10.1371/journal.pone.0186113	http://dx.doi.org/10.1371/journal.pone.0186113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040293	gold, Green Published, Green Submitted			2022-12-26	WOS:000413167500021
J	Lee, TY; Chang, PC; Tseng, IJ; Chung, MH				Lee, Tzu-Yin; Chang, Pi-Chen; Tseng, Ing-Jy; Chung, Min-Huey			Nocturnal sleep mediates the relationship between morningness-eveningness preference and the sleep architecture of afternoon naps in university students	PLOS ONE			English	Article							YOUNG-ADULTS; PRESCHOOL-CHILDREN; NIGHTTIME SLEEP; OBESE-PATIENTS; SHIFT WORKERS; CHRONOTYPE; ASSOCIATION; SEX; QUESTIONNAIRE; ADOLESCENTS	The present study investigated the parameters of nocturnal sleep that mediate the relationship between morningness-eveningness preference and the sleep architecture of naps in university students. This study had a cross-sectional, descriptive correlational design. The sleep architecture of 52 students invited to take an afternoon nap in the laboratory was recorded. The morningness-eveningness questionnaire (MEQ) was used to evaluate morningness-eveningness preference. An actigraph was used to collect students' nighttime sleep data in the week preceding the study. Polysomnography was used to measure the sleep architecture of the participants' naps. After adjustments for potential factors, although the MEQ did not directly correlate with the percentage of sleep stages in naps, the effects of the MEQ on the percentage of Stage 1 sleep, slow-wave sleep, and rapid eye movement sleep; sleep duration; and sleep efficiency of naps were mediated by the total sleep time in the preceding week. This preliminary study suggests that nap quality was affected by morningness-eveningness preference through the mediation of total nocturnal sleep time. Therefore, future studies should be carefully designed to consider nighttime sleep patterns when analyzing the effects of chronotypes on daytime sleep.	[Lee, Tzu-Yin; Chang, Pi-Chen; Chung, Min-Huey] Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan; [Tseng, Ing-Jy] Taipei Med Univ, Coll Nursing, Sch Gerontol Hlth Management, Taipei, Taiwan; [Chung, Min-Huey] Taipei Med Univ, Shuang Ho Hosp, Dept Nursing, New Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital	Chung, MH (corresponding author), Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan.; Chung, MH (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Nursing, New Taipei, Taiwan.	minhuey300@tmu.edu.tw						Adan A, 2012, CHRONOBIOL INT, V29, P1153, DOI 10.3109/07420528.2012.719971; CARSKADON MA, 1989, SLEEP ALERTNESS CHRO, P53; Chelminski I, 1997, PERS INDIV DIFFER, V23, P647, DOI 10.1016/S0191-8869(97)00073-1; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; Desrochers PC, 2016, EXP BRAIN RES, V234, P763, DOI 10.1007/s00221-015-4506-3; DIJK DJ, 1990, SLEEP, V13, P430, DOI 10.1093/sleep/13.5.430; DINGES DF, 1986, ELECTROEN CLIN NEURO, V64, P224, DOI 10.1016/0013-4694(86)90170-7; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Giannotti F, 2002, J SLEEP RES, V11, P191, DOI 10.1046/j.1365-2869.2002.00302.x; Goldman SE, 2008, SLEEP, V31, P733, DOI 10.1093/sleep/31.5.733; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Heslop Pauline, 2002, Sleep Med, V3, P305, DOI 10.1016/S1389-9457(02)00016-3; HILLIKER NAJ, 1992, SLEEP, V15, P430, DOI 10.1093/sleep/15.5.430; Horne J. A., 1975, INT J CHRONOBIOL, V4, P97; Jafar NK, 2017, SLEEP MED, V30, P240, DOI 10.1016/j.sleep.2016.11.015; Komada Y, 2012, SLEEP MED, V13, P107, DOI 10.1016/j.sleep.2011.10.017; Lai HL, 2005, PUBLIC HEALTH NURS, V22, P240, DOI 10.1111/j.0737-1209.2005.220307.x; Lehnkering H, 2007, CHRONOBIOL INT, V24, P875, DOI 10.1080/07420520701648259; Li SX, 2011, SLEEP BIOL RHYTHMS, V9, P19, DOI 10.1111/j.1479-8425.2010.00480.x; Martin JS, 2016, J BIOL RHYTHM, V31, P205, DOI 10.1177/0748730415625510; Mongrain V, 2006, EUR J NEUROSCI, V23, P497, DOI 10.1111/j.1460-9568.2005.04561.x; Mongrain V, 2005, SLEEP, V28, P819, DOI 10.1093/sleep/28.7.819; Nam GE, 2017, SLEEP MED, V35, P62, DOI 10.1016/j.sleep.2017.04.009; Ong JC, 2007, J CLIN SLEEP MED, V3, P289; Osborne J.W., 2010, PRACTICAL ASSESS RES, V15, P1, DOI [10.7275/qbpc-gk17, DOI 10.7275/QBPC-GK17]; Park YM, 1998, PERCEPT MOTOR SKILL, V87, P199, DOI 10.2466/pms.1998.87.1.199; Purnell MT, 2002, J SLEEP RES, V11, P219, DOI 10.1046/j.1365-2869.2002.00309.x; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Resta O, 2003, J INTERN MED, V253, P536, DOI 10.1046/j.1365-2796.2003.01133.x; Rosenthal L, 2001, SLEEP MED, V2, P243, DOI 10.1016/S1389-9457(00)00047-2; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Smith SS, 2007, SLEEP BIOL RHYTHMS, V5, P117, DOI 10.1111/j.1479-8425.2007.00261.x; [宋国萍 Song Guoping], 2002, [中国心理卫生杂志, Chinese Mental Health Journal], V16, P515; Taillard J, 1999, J SLEEP RES, V8, P291, DOI 10.1046/j.1365-2869.1999.00176.x; van de Ven HA, 2016, ERGONOMICS, V59, P310, DOI 10.1080/00140139.2015.1058426; Vela-Bueno A, 2008, J AM COLL HEALTH, V57, P150, DOI 10.3200/JACH.57.2.150-158; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Vorona RD, 2005, ARCH INTERN MED, V165, P25, DOI 10.1001/archinte.165.1.25; Warner S, 2008, J ADOLESCENCE, V31, P595, DOI 10.1016/j.adolescence.2007.10.005; Ye LC, 2015, J AM COLL HEALTH, V63, P88, DOI 10.1080/07448481.2014.983926; Zbay Y, 2015, INTENS CARE MED, V41, P657	41	5	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0185616	10.1371/journal.pone.0185616	http://dx.doi.org/10.1371/journal.pone.0185616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KA	29040275	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500008
J	Riaz, F; Niazi, MA				Riaz, Faisal; Niazi, Muaz A.			Towards social autonomous vehicles: Efficient collision avoidance scheme using Richardson's arms race model	PLOS ONE			English	Article							SYSTEMS	This paper presents the concept of a social autonomous agent to conceptualize such Autonomous Vehicles (AVs), which interacts with other AVs using social manners similar to human behavior. The presented AVs also have the capability of predicting intentions, i.e. mentalizing and copying the actions of each other, i.e. mirroring. Exploratory Agent Based Modeling (EABM) level of the Cognitive Agent Based Computing (CABC) framework has been utilized to design the proposed social agent. Furthermore, to emulate the functionality of mentalizing and mirroring modules of proposed social agent, a tailored mathematical model of the Richardson's arms race model has also been presented. The performance of the proposed social agent has been validated at two levels-firstly it has been simulated using NetLogo, a standard agent-based modeling tool and also, at a practical level using a prototype AV. The simulation results have confirmed that the proposed social agent-based collision avoidance strategy is 78.52% more efficient than Random walk based collision avoidance strategy in congested flock-like topologies. Whereas practical results have confirmed that the proposed scheme can avoid rear end and lateral collisions with the efficiency of 99.876% as compared with the IEEE 802.11n-based existing state of the art mirroring neuron-based collision avoidance scheme.	[Riaz, Faisal] Iqra Univ, Dept Comp, Islamabad, Pakistan; [Niazi, Muaz A.] Dept Comp Sci COMSATS, Islamabad, Pakistan	Iqra University; COMSATS University Islamabad (CUI)	Niazi, MA (corresponding author), Dept Comp Sci COMSATS, Islamabad, Pakistan.	muaz.niazi@gmail.com	Niazi, Muaz/B-7567-2009	Niazi, Muaz/0000-0002-2259-6824				Anwar F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01299; Bicchi A, 2015, INFORM SOC, V31, P237, DOI 10.1080/01972243.2015.1020196; Chang CW, 2017, IEEE INT C INTELL TR; Chen C, 2016, J ADV TRANSPORTATION; Fawaz K, 2010, 2010 IEEE 17 INT C; Gopinath B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122732; Gracia L, 2013, IEEE T CONTR SYST T, V21, P2391, DOI 10.1109/TCST.2012.2231866; Hassanzadeh FF, 2009, RELIABLE BROADCAST S; Hu XS, 2017, IEEE T IND ELECTRON, V64, P8578, DOI 10.1109/TIE.2017.2703673; Kim SW, 2016, IEEE INTEL TRANSP SY, V8, P23, DOI 10.1109/MITS.2016.2573339; Li J, 2016, COMPUT HUM BEHAV, V55, P1222, DOI 10.1016/j.chb.2015.04.005; Li L, 2014, 2014 IEEE 17TH INTER; Li SE, 2017, IEEE T TRANSP ELECTR, V3, P259, DOI 10.1109/TTE.2016.2628823; Libero LE, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-50; Liu B, 2016, IEEE T INTELL TRANSP, V17, P644, DOI 10.1109/TITS.2015.2486140; Lu S, 2017, IEEE T IND ELECT; Lv C, 2015, ENERG CONVERS MANAGE, V92, P469, DOI 10.1016/j.enconman.2014.12.092; Macy ML, 2014, ACAD PEDIATR, V14, P279, DOI 10.1016/j.acap.2014.02.010; Milanes V, 2014, IEEE T INTELL TRANSP, V15, P296, DOI 10.1109/TITS.2013.2278494; Milanes V, 2012, EXPERT SYST APPL, V39, P3362, DOI 10.1016/j.eswa.2011.09.024; Muller Lars, 2016, P 2016 ACM INT JOINT; Niazi M. A., 2012, COGNITIVE AGENT BASE; Pintea CM, 2017, COMPLEX ADAPT SYST M, V5, DOI 10.1186/s40294-017-0048-9; Quadrelli E, 2016, BRIT J DEV PSYCHOL, V34, P6, DOI 10.1111/bjdp.12110; Riaz F, 2015, WIRELESS PERS COMMUN, P1; Riaz F, 2016, COMPLEX ADAPT SYST M, V4, DOI 10.1186/s40294-016-0025-8; Riener A, 2016, HUMAN COMPUTER CONFL, P294; Sato T, 2015, APPLYING FUZZY LOGIC; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; SCHRODT PA, 1978, J PEACE SCI, V3, P159; Schwindt O, 2015, US Patent, Patent No. [20,150,183,430, 20150183430]; Stilgoe J., 2017, SOCIAL LEARNING GOVE; Sun C, 2015, IEEE T CONTR SYST T, V23, P1075, DOI 10.1109/TCST.2014.2361294; Tapus A., 2007, P NEUR INF PROC SYST; Tramacere A, 2016, J ANTHROPOL SCI, V94, P113, DOI [10.4436/jass.94037, 10.4436/JASS.94037]; Vegni AM, 2015, IEEE COMMUN SURV TUT, V17, P2397, DOI 10.1109/COMST.2015.2453481; Xiong H, 2016, COMPLEX ADAPT SYST M, V4, DOI 10.1186/s40294-016-0033-8	38	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186103	10.1371/journal.pone.0186103	http://dx.doi.org/10.1371/journal.pone.0186103			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040294	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500020
J	Aiglstorfer, M; Costeur, L; Mennecart, B; Heizmann, EPJ				Aiglstorfer, Manuela; Costeur, Loic; Mennecart, Bastien; Heizmann, Elmar P. J.			Micromeryx? eiselei-A new moschid species from Steinheim am Albuch, Germany, and the first comprehensive description of moschid cranial material from the Miocene of Central Europe	PLOS ONE			English	Article							RUMINANT BONY LABYRINTH; MIDDLE MIOCENE; PETROSAL BONE; MAMMALIA; ARTIODACTYLA; IMPACT; SPAIN	Moschids are enigmatic pecoran ruminants whose phylogeny is still not fully understood. So far we know only little of the family's early evolutionary history and the origin of the modern genus, Moschus. Here we present a comprehensive description of cranial material, including the ear region and the dentition, of fossil moschid material from the Middle Miocene locality Steinheim am Albuch (13.5 Ma; Germany). This study provides the first exhaustive dataset for the cranial osteology of Micromeryx flourensianus, the most likely oldest true moschid. It furthermore reveals the presence of a second, so far undescribed moschid species, we here name Micromeryx? eiselei, in the abundant material from the locality. The two taxa can be clearly distinguished by characters of the skull, the ear region, the dentition, as well as by size. This evidences the sympatric occurrence of two moschid species in the locality Steinheim am Albuch.	[Aiglstorfer, Manuela; Heizmann, Elmar P. J.] Staatl Museum Nat Kunde Stuttgart, Rosenstein 1, Stuttgart, Germany; [Costeur, Loic; Mennecart, Bastien] Nat Hist Museum Basel, Basel, Switzerland; [Mennecart, Bastien] Nat Hist Museum Wien, Vienna, Austria		Aiglstorfer, M (corresponding author), Staatl Museum Nat Kunde Stuttgart, Rosenstein 1, Stuttgart, Germany.	manuela.aiglstorfer@smns-bw.de	Mennecart, B/AAO-8772-2020; Mennecart, Bastien/W-4477-2017; Aiglstorfer, Manuela/ABC-6683-2021	Mennecart, B/0000-0002-9669-2907; Mennecart, Bastien/0000-0002-9669-2907; Costeur, Loic/0000-0001-6213-8556; Aiglstorfer, Manuela/0000-0002-5231-3450	SYNTHESYS Project - European Community Research Infrastructure Action under the FP7 Integrating Activities Programme (Synthesys Projects) [FRTAF-1892, FRTAF-6335]; Swiss National Science Foundation [200021_159854/1]	SYNTHESYS Project - European Community Research Infrastructure Action under the FP7 Integrating Activities Programme (Synthesys Projects); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research received support from the SYNTHESYS Project http://www.syrithesys.info/ which is financed by European Community Research Infrastructure Action under the FP7 Integrating Activities Programme (Synthesys Projects: FRTAF-1892 and FRTAF-6335) and of the Swiss National Science Foundation (Project: 200021_159854/1).	Aiglstorfer M, 2017, MORPHOMUSEUM, V3, pe4; Aiglstorfer M, 2014, PALAEOBIO PALAEOENV, V94, P83, DOI 10.1007/s12549-013-0141-9; Aiglstorfer M, 2013, PALAEOBIO PALAEOENV, V93, P207, DOI 10.1007/s12549-013-0117-9; Barmann EV, 2011, MAMM BIOL, V76, P762, DOI 10.1016/j.mambio.2011.07.002; Barone R., 1999, ANATOMIE COMP MAMMIF, V1; Bibi Faysal, 2014, Zitteliana Reihe B, V32, P197; Bibi F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-166; Buchner E, 2013, Z DTSCH GES GEOWISS, V164, P433, DOI 10.1127/1860-1804/2013/0037; Costeur L, 2017, J ANAT, V230, P347, DOI 10.1111/joa.12549; Costeur Loic, 2014, Zitteliana Reihe B, V32, P99; Costeur Loic, 2011, Acta Geologica Slovaca, V3, P105; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Fernandez MH, 2005, BIOL REV, V80, P269, DOI 10.1017/S1464793104006670; Gentry A.W., 1994, Historical Biology, V7, P115; Gentry Alan W., 2000, P11; Gingerich P.D., 1989, U MICHIGAN PAPERS PA, V28, P1; Groves CP, 2011, HDB MAMMALS WORLD; Hassanin A, 2003, SYST BIOL, V52, P206, DOI 10.1080/10635150390192726; Hassanin A, 2012, C R BIOL, V335; Heizmann E.P.J., 2002, STEINHEIMER METEORKR; Hillenbrand Viktoria, 2009, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V111A, P519; Jager GF, 1835, FOSSILEN SAUGETIER W; Janis Christine M., 2014, Zitteliana Reihe B, V32, P15; Janis CM., 1987, AM MUS NOVIT, V2893, P1; Liu Z, 2016, AM J LIFE SCI, V4, P20; Marsh O.C., 1872, AM J SCI 1, V4, P122, DOI DOI 10.2475/AJS.S3-4.20.122; Mennecart B, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1211665; Mennecart B, 2016, J MORPHOL, V277, P1329, DOI 10.1002/jmor.20579; Mennecart B, 2016, J ANAT, V229, P422, DOI 10.1111/joa.12487; Metais Gregoire, 2007, P189; Morales J, 2012, MEM MUS NAT HIST NAT, V203, P225; Nickel R, 1968, BEWEGUNGSAPPARAT; Nixon K.C., 1999, WINCLADA VER 1 0000; O'Leary MA, 2010, B AM MUS NAT HIST, V335, P206; Orliac MJ, 2014, J MAMM EVOL, V21, P299, DOI 10.1007/s10914-014-9254-9; Rasser MW, 2014, HYDROBIOLOGIA, V739, P7, DOI 10.1007/s10750-013-1677-4; Rossner Gertrud Elisabeth, 1995, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V29, P1; Sanchez IM, 2008, J VERTEBR PALEONTOL, V28, P873, DOI 10.1671/0272-4634(2008)28[873:MASNRM]2.0.CO;2; Sanchez IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143034; Sanchez IM, 2010, PALAEONTOLOGY, V53, P1023, DOI 10.1111/j.1475-4983.2010.00992.x; Sanchez IM, 2009, J VERTEBR PALEONTOL, V29, P567, DOI 10.1671/039.029.0223; Schmidt-Kaler H., 1970, EXKURSIONSFUHRER GEO, P68; Seehuber U, 2015, DOCUMENTA NATURAE, V196, P49; Sen S, 1997, PALAEOGEOGR PALAEOCL, V133, P181, DOI 10.1016/S0031-0182(97)00079-5; Spoor F, 2007, P NATL ACAD SCI USA, V104, P10808, DOI 10.1073/pnas.0704250104; Stoffler D, 2002, METEORIT PLANET SCI, V37, P1893, DOI 10.1111/j.1945-5100.2002.tb01171.x; Su B, 1999, MOL PHYLOGENET EVOL, V12, P241, DOI 10.1006/mpev.1999.0616; Theodor Jessica M., 2007, P32; Tutken T, 2006, PALAEOGEOGR PALAEOCL, V241, P457, DOI 10.1016/j.palaeo.2006.04.007; Vislobokova IA, 2007, PALEONTOL J+, V41, P451, DOI 10.1134/S0031030107040119; Vislobokova IA, 2009, PALEONTOL J+, V43, P326, DOI 10.1134/S0031030109030125; Vislobokova IA, 1990, PALEONTOL J+, V24, P1; Wang SQ, 2015, PALEONTOL RES, V19, P143, DOI 10.2517/2014PR032; WEBB S D, 1980, Bulletin of the American Museum of Natural History, V167, P117	54	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0185679	10.1371/journal.pone.0185679	http://dx.doi.org/10.1371/journal.pone.0185679			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036194	gold, Green Published, Green Submitted			2022-12-26	WOS:000413054800009
J	Covaceuszach, S; Bozzi, M; Bigotti, MG; Sciandra, F; Konarev, PV; Brancaccio, A; Cassetta, A				Covaceuszach, Sonia; Bozzi, Manuela; Bigotti, Maria Giulia; Sciandra, Francesca; Konarev, Petr V.; Brancaccio, Andrea; Cassetta, Alberto			The effect of the pathological V72I, D109N and T190M missense mutations on the molecular structure of alpha-dystroglycan	PLOS ONE			English	Article							BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; MUSCULAR-DYSTROPHY; MUSCLE; PROTEINS; BEAMLINE; FLEXIBILITY; DEFICIENCY; RESOLUTION; LAMININ	Dystroglycan (DG) is a highly glycosylated protein complex that links the cytoskeleton with the extracellular matrix, mediating fundamental physiological functions such as mechanical stability of tissues, matrix organization and cell polarity. A crucial role in the glycosylation of the DG a subunit is played by its own N-terminal region that is required by the glycosyltransferase LARGE. Alteration in this O-glycosylation deeply impairs the high affinity binding to other extracellular matrix proteins such as laminins. Recently, three missense mutations in the gene encoding DG, mapped in the alpha-DG N-terminal region, were found to be responsible for hypoglycosylated states, causing congenital diseases of different severity referred as primary dystroglycanopaties. To gain insight on the molecular basis of these disorders, we investigated the crystallographic and solution structures of these pathological point mutants, namely V72I, D109N and T190M. Small Angle X-ray Scattering analysis reveals that these mutations affect the structures in solution, altering the distribution between compact and more elongated conformations. These results, supported by biochemical and biophysical assays, point to an altered structural flexibility of the mutant alpha-DG N-terminal region that may have repercussions on its interaction with LARGE and/or other DG-modifying enzymes, eventually reducing their catalytic efficiency.	[Covaceuszach, Sonia; Cassetta, Alberto] CNR, Ist Cristallog, Trieste Outstn, Trieste, Italy; [Bozzi, Manuela] Univ Cattolica Sacro Cuore, Ist Biochim, Rome, Italy; [Bozzi, Manuela] Univ Cattolica Sacro Cuore, Biochim Clin, Rome, Italy; [Bozzi, Manuela; Sciandra, Francesca; Brancaccio, Andrea] Univ Cattolica Sacro Cuore, CNR, Ist Chim Riconoscimento Mol, Rome, Italy; [Bigotti, Maria Giulia; Brancaccio, Andrea] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Konarev, Petr V.] Russian Acad Sci, Fed Sci Res Ctr Crystallog & Photon, AV Shubnikov Inst Crystallog, Moscow, Russia; [Konarev, Petr V.] Natl Res Ctr, Kurchatov Inst, Moscow, Russia	Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); University of Bristol; Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; National Research Centre - Kurchatov Institute	Covaceuszach, S (corresponding author), CNR, Ist Cristallog, Trieste Outstn, Trieste, Italy.; Brancaccio, A (corresponding author), Univ Cattolica Sacro Cuore, CNR, Ist Chim Riconoscimento Mol, Rome, Italy.; Brancaccio, A (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	sonia.covaceuszach@ts.ic.cnr.it; andrea.brancaccio@icrm.cnr.it	Konarev, Petr V/W-1380-2017; Cassetta, A./AAG-8712-2019; Sciandra, Francesca/AAY-4650-2020; Brancaccio, Andrea/C-5876-2009; Covaceuszach, Sonia/AAA-4116-2021	Cassetta, A./0000-0002-8600-4162; Sciandra, Francesca/0000-0002-2123-1516; Brancaccio, Andrea/0000-0003-4690-8826; Bigotti, Giulia/0000-0001-9595-3338; Konarev, Petr/0000-0002-5606-1596	AFMTELETHON [20009]; Wellcome Trust Career Re-entry fellowship	AFMTELETHON(Association Francaise contre les Myopathies); Wellcome Trust Career Re-entry fellowship(Wellcome Trust)	Funded by AFMTELETHON grant n. 20009 to AB; Wellcome Trust Career Re-entry fellowship to MGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2015, BIOL OPEN, V4, P1163, DOI 10.1242/bio.012468; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; BERNSTORFF S, 1995, REV SCI INSTRUM, V66, P1661, DOI 10.1063/1.1145875; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Bozic D, 2004, J BIOL CHEM, V279, P44812, DOI 10.1074/jbc.C400353200; Bozzi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124277; Bozzi M, 2013, BMC BIOCHEM, V14, DOI 10.1186/1471-2091-14-15; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; Briggs DC, 2016, NAT CHEM BIOL, V12, P810, DOI [10.1038/NCHEMBIO.2146, 10.1038/nchembio.2146]; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Concolino P, 2007, CLIN CHIM ACTA, V378, P164, DOI 10.1016/j.cca.2006.11.016; Covaceuszach S, 2017, FEBS OPEN BIO, V7, P1064, DOI 10.1002/2211-5463.12259; De Rosa MC, 2011, J MOL GRAPH MODEL, V29, P1015, DOI 10.1016/j.jmgm.2011.04.008; Dong MR, 2015, NEUROLOGY, V84, P273, DOI 10.1212/WNL.0000000000001162; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; ERVASTI JM, 1994, FEBS LETT, V350, P173, DOI 10.1016/0014-5793(94)00748-9; Gottlieb E, 2005, MOL GENET METAB, V86, P244, DOI 10.1016/j.ymgme.2005.07.003; Gupta V, 2011, HUM MOL GENET, V20, P1712, DOI 10.1093/hmg/ddr047; Hara Y, 2011, NEW ENGL J MED, V364, P939, DOI 10.1056/NEJMoa1006939; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jimenez-Mallebrera C, 2009, BRAIN PATHOL, V19, P596, DOI 10.1111/j.1750-3639.2008.00198.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M., 2016, TRANSLATIONAL RES MU, P21; Karshikoff A, 2015, FEBS J, V282, P3899, DOI 10.1111/febs.13343; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lausi A, 2015, EUR PHYS J PLUS, V130, DOI 10.1140/epjp/i2015-15043-3; Martin PT, 2008, NEUROMUSCULAR DISORD, V18, P942, DOI 10.1016/j.nmd.2008.08.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Palmieri V, 2017, BIOCH BIOPHYS ACTA; Parsons MJ, 2002, DEVELOPMENT, V129, P3505; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Phillips K, 2011, CURR PROTOC MOL BIOL, DOI DOI 10.28.1-10.28.28; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Saito F, 2005, FEBS LETT, V579, P2359, DOI 10.1016/j.febslet.2005.03.033; Sawle L, 2011, BIOPHYS J, V101, P217, DOI 10.1016/j.bpj.2011.05.059; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Sciandra F, 2013, CURR PROTEIN PEPT SC, V14, P626; Stadler AM, 2012, J R SOC INTERFACE, V9, P2845, DOI 10.1098/rsif.2012.0364; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taniguchi-Ikeda M, 2016, MOL ASPECTS MED, V51, P115, DOI 10.1016/j.mam.2016.07.003; THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Yoshida-Moriguchi T, 2015, GLYCOBIOLOGY, V25, P702, DOI 10.1093/glycob/cwv021	57	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186110	10.1371/journal.pone.0186110	http://dx.doi.org/10.1371/journal.pone.0186110			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036200	Green Published, gold			2022-12-26	WOS:000413054800013
J	Garba, A; Desmarets, LMB; Acar, DD; Devriendt, B; Nauwynck, HJ				Garba, Abubakar; Desmarets, Lowiese M. B.; Acar, Delphine D.; Devriendt, Bert; Nauwynck, Hans J.			Immortalized porcine mesenchymal cells derived from nasal mucosa, lungs, lymph nodes, spleen and bone marrow retain their stemness properties and trigger the expression of siglec-1 in co-cultured blood monocytic cells	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; SUPPRESS T-LYMPHOCYTE; STROMAL CELLS; ALVEOLAR MACROPHAGES; IN-VIVO; MODEL; DIFFERENTIATION; TRANSPLANTATION; PROLIFERATION; ANTIGEN	Mesenchymal stromal cells have been isolated from different sources. They are multipotent cells capable of differentiating into many different cell types, including osteocytes, chondrocytes and adipocytes. They possess a therapeutic potential in the management of immune disorders and the repair of damaged tissues. Previous work in our laboratory showed an increase of the percentages of CD172a(+), CD14(+), CD163(+), Siglec-1(+), CD4(+) and CD8(+) hematopoietic cells, when co-cultured with immortalized mesenchymal cells derived from bone marrow. The present work aimed to demonstrate the stemness properties of SV40-immortalized mesenchymal cells derived from nasal mucosa, lungs, spleen, lymph nodes and red bone marrow and their immunomodulatory effect on blood monocytes. Mesenchymal cells from nasal mucosa, lungs, spleen, lymph nodes and red bone marrow were isolated and successfully immortalized using simian virus 40 large T antigen (SV40LT) and later, co-cultured with blood monocytes, in order to examine their differentiation stage (expression of Siglec-1). Flow cytometric analysis revealed that the five mesenchymal cell lines were positive for mesenchymal cell markers CD105, CD44, CD90 and CD29, but lacked the expression of myeloid cell markers CD16 and CD11b. Growth analysis of the cells demonstrated that bone marrow derived-mesenchymal cells proliferated faster compared with those derived from the other tissues. All five mesenchymal cell lines co-cultured with blood monocytes for 1, 2 and 7 days triggered the expression of siglec-1 in the monocytes. In contrast, no siglec-1(+) cells were observed in monocyte cultures without mesenchymal cell lines. Mesenchymal cells isolated from nasal mucosa, lungs, spleen, lymph nodes and bone marrow were successfully immortalized and these cell lines retained their stemness properties and displayed immunomodulatory effects on blood monocytes.	[Garba, Abubakar; Desmarets, Lowiese M. B.; Acar, Delphine D.; Devriendt, Bert; Nauwynck, Hans J.] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium	Ghent University	Nauwynck, HJ (corresponding author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	hans.nauwynck@ugent.be	Devriendt, Bert/AAM-6666-2021	Devriendt, Bert/0000-0002-3222-8769; Nauwynck, Hans/0000-0001-5470-0713; Desmarets, Lowiese/0000-0001-5077-3333; Acar, Delphine/0000-0003-0967-1831	Scholarship Board of the Sokoto State Government of Nigeria; Ghent University Special Research Fund (BOF); F.W.O.-Vlaanderen	Scholarship Board of the Sokoto State Government of Nigeria; Ghent University Special Research Fund (BOF)(Ghent University); F.W.O.-Vlaanderen(FWO)	The funding for this work was obtained from the Scholarship Board of the Sokoto State Government of Nigeria and the Ghent University Special Research Fund (BOF). Bert Devriendt is supported by a postdoctoral grant from F.W.O.-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2005, BIOCHEM BIOPH RES CO, V326, P527, DOI 10.1016/j.bbrc.2004.11.059; Anker PSI, 2003, HAEMATOLOGICA, V88, P845; Anton K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035036; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Casado JG, 2012, VET IMMUNOL IMMUNOP, V147, P104, DOI 10.1016/j.vetimm.2012.03.015; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Darimont C, 2003, BIOCHIMIE, V85, P1231, DOI 10.1016/j.biochi.2003.10.015; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Delputte PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016827; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Duan XB, 1998, J VIROL, V72, P4520, DOI 10.1128/JVI.72.5.4520-4523.1998; English K, 2008, IMMUNOL LETT, V115, P50, DOI 10.1016/j.imlet.2007.10.002; Gerson SL, 1999, NAT MED, V5, P262, DOI 10.1038/6470; Gonzalez-Rey E, 2010, ANN RHEUM DIS, V69, P241, DOI 10.1136/ard.2008.101881; Hua JL, 2009, TISSUE CELL, V41, P448, DOI 10.1016/j.tice.2009.05.004; Hung CJ, 2010, CYTOTHERAPY, V12, P455, DOI 10.3109/14653240903555827; Jha KK, 1998, EXP CELL RES, V245, P1, DOI 10.1006/excr.1998.4272; Kang TJ, 2004, ACTA HAEMATOL-BASEL, V112, P230, DOI 10.1159/000081281; Khatri M, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0220-0; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Kirchhoff C, 2004, MOL CELL ENDOCRINOL, V216, P83, DOI 10.1016/j.mce.2003.10.073; Lee WYW, 2013, CYTOTHERAPY, V15, P1484, DOI 10.1016/j.jcyt.2013.06.010; Lin GT, 2009, STEM CELLS DEV, V18, P1399, DOI 10.1089/scd.2009.0010; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Singla DK, 2010, J CARDIOVASC TRANSL, V3, P73, DOI 10.1007/s12265-009-9151-4; Stewart SA, 2002, ONCOGENE, V21, P627, DOI 10.1038/sj.onc.1205062; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Sung JH, 2008, TRANSPL P, V40, P2649, DOI 10.1016/j.transproceed.2008.08.009; Amaral AT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085814; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Vanderheijden N, 2003, J VIROL, V77, P8207, DOI 10.1128/JVI.77.15.8207-8215.2003; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt145; Yang C, PLOS ONE, V10	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							0186343	10.1371/journal.pone.0186343	http://dx.doi.org/10.1371/journal.pone.0186343			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036224	gold, Green Submitted, Green Published			2022-12-26	WOS:000413054800021
J	Rollin, HB; Olutola, B; Channa, K; Odland, JO				Rollin, Halina B.; Olutola, Bukola; Channa, Kalavati; Odland, Jon O.			Reduction of in utero lead exposures in South African populations: Positive impact of unleaded petrol	PLOS ONE			English	Article							BLOOD LEAD; CORD BLOOD; BIRTH OUTCOMES; ESSENTIAL ELEMENTS; ESSENTIAL METALS; CHILDREN; PREGNANCY; LEVEL; WOMEN; INFANTS	Background Prenatal exposure to lead (Pb) has been shown to have negative and irreversible health impacts on foetal and early childhood development, affecting morbidity and mortality in adulthood. This study aimed to assess in utero Pb exposure, examine birth outcomes, and identify confounding factors in the large cohort of South African population, following the legislated removal of Pb from petrol. Methods Lead was measured in the maternal blood, urine and cord blood using Inductive Coupled Plasma Mass spectrometry (ICP-MS). The statistical analyses included Spearman's correlation, Wilcoxon rank sum (Mann Whitney), Kruskal-Wallis rank tests and multivariate linear regression. Results Overall, the geometric mean (GM) of Pb in maternal blood (PbB) was 1.32 mu g/dL (n = 640; 95% CI, 1.24-1.40). In the subset cohort, the GM of paired maternal PbB and cord blood (PbC) was 1.73 mu g/dL (n = 350; 95% CI, 1.60-1.86) and 1.26 ug/dL (n = 317; 95% CI, 1.18-1.35), respectively with a positive correlation between the log PbB and the log PbC (rho = 0.65, p = <0.001). Birth outcomes showed geographical differences in the gestational age (p<0.001), birth length (p = 0.028) and head circumference (p<0.001), Apgar score at 5 min (p<0.001) and parity (p<0.002). In female neonates, a positive association was found between PbC and head circumference (rho = 0.243; p<0.016).The maternal PbB levels were positively correlated with race, educational status, water sources, cooking fuels and use of pesticides at home. Conclusions This study has demonstrated not only the positive impact that the introduction of unleaded petrol and lead-free paint has had on in utero exposure to Pb in South Africa, but has also contributed new data on the topic, in a region where such data and scientific investigations in this field are lacking. Future research should evaluate if similar effects can be detected in young children and the adult population.	[Rollin, Halina B.; Olutola, Bukola; Odland, Jon O.] Univ Pretoria, Fac Hlth Sci, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa; [Rollin, Halina B.] MRC, Environm & Hlth Res Unit, Johannesburg, South Africa; [Channa, Kalavati] Lancet Labs, Dept Analyt Chem, Johannesburg, South Africa; [Channa, Kalavati] Univ Johannesburg, Sch Hlth Sci, Dept Biomed Technol, Johannesburg, South Africa; [Odland, Jon O.] Univ Tromso, Inst Community Med, Tromso, Norway	University of Pretoria; University of Johannesburg; UiT The Arctic University of Tromso	Rollin, HB (corresponding author), Univ Pretoria, Fac Hlth Sci, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa.; Rollin, HB (corresponding author), MRC, Environm & Hlth Res Unit, Johannesburg, South Africa.	Halina.Rollin@up.ac.za		Rollin, Halina/0000-0001-5247-6519	National Research Foundation (NRF), South Africa [64528]; Research Council of Norway; Arctic Monitoring and Assessment Programme (AMAP); Norwegian Royal Ministry for Foreign Affairs [RER-09/126]	National Research Foundation (NRF), South Africa(National Research Foundation - South Africa); Research Council of Norway(Research Council of Norway); Arctic Monitoring and Assessment Programme (AMAP); Norwegian Royal Ministry for Foreign Affairs	Support for this research was provided by the National Research Foundation (NRF), South Africa (Grant 64528 to HBR) and the Research Council of Norway, the Arctic Monitoring and Assessment Programme (AMAP) and the Norwegian Royal Ministry for Foreign Affairs (RER-09/126 to JOO). The funders were not involved in study design, sample collection or interpretation of data and in the decision to publish, or preparation of the manuscript.	Audrey S, 2002, SCI TOTAL ENVIRON, V290, P157, DOI 10.1016/S0048-9697(01)01071-3; Bellinger DC, 2005, BIRTH DEFECTS RES A, V73, P409, DOI 10.1002/bdra.20127; DEVEAUX P, 1986, S AFR MED J, V69, P421; Fukui Y, 1999, INT ARCH OCC ENV HEA, V72, P516, DOI 10.1007/s004200050409; Haman T, 2015, INT J ENV RES PUB HE, V12, P15022, DOI 10.3390/ijerph121214968; Harville EW, 2005, OCCUP ENVIRON MED, V62, P263, DOI 10.1136/oem.2003.012492; Hernandez-Avila M, 2002, ARCH ENVIRON HEALTH, V57, P482, DOI 10.1080/00039890209601441; Jedrychowski W, 2008, INT J HYG ENVIR HEAL, V211, P345, DOI 10.1016/j.ijheh.2007.07.023; Karimi PG, 1999, S AFR MED J, V89, P676; Lin CM, 2010, REPROD TOXICOL, V29, P443, DOI 10.1016/j.reprotox.2010.03.004; Lovei M., 1998, WORLD BANK TECHNICAL; Manton WI, 2003, ENVIRON RES, V92, P139, DOI 10.1016/S0013-9351(03)00020-3; Mathee A, 2006, ENVIRON RES, V100, P319, DOI 10.1016/j.envres.2005.08.001; Mathee A, 2003, SAMJ S AFR MED J, V93, P313; Mathee Angela, 2004, Reviews on Environmental Health, V19, P347; Naicker N, 2013, SAMJ S AFR MED J, V103, P935, DOI [10.7196/samj.7157, 10.7196/SAMJ.7157]; Naicker N, 2010, ENVIRON RES, V110, P355, DOI 10.1016/j.envres.2010.02.006; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Needleman H L, 1993, Adv Pediatr, V40, P125; Nieboer E, 2013, ENVIRON SCI-PROC IMP, V15, P1824, DOI 10.1039/c3em00270e; Nriagu J, 1997, SCI TOTAL ENVIRON, V197, P13, DOI 10.1016/S0048-9697(96)05408-3; Nriagu J, 1997, SCI TOTAL ENVIRON, V197, P1, DOI 10.1016/S0048-9697(96)05407-1; Obi Ejeatuluchukwu, 2014, Journal of UOEH, V36, P159, DOI 10.7888/juoeh.36.159; Odland JO, 1999, ACTA OBSTET GYN SCAN, V78, P852, DOI 10.1034/j.1600-0412.1999.781004.x; Osman K, 2000, CLIN BIOCHEM, V33, P131, DOI 10.1016/S0009-9120(00)00052-7; Peraza MA, 1998, ENVIRON HEALTH PERSP, V106, P203, DOI 10.2307/3433921; Raghunath R, 2000, SCI TOTAL ENVIRON, V250, P135, DOI 10.1016/S0048-9697(00)00372-7; Moreira MDR, 2008, CAD SAUDE PUBLICA, V24, P2151, DOI 10.1590/S0102-311X2008000900021; Rollin HB, 2007, ENVIRON RES, V103, P160, DOI 10.1016/j.envres.2006.08.011; Rollin HB, 2009, J ENVIRON MONITOR, V11, P618, DOI 10.1039/b816236k; Rudge CV, 2009, J ENVIRON MONITOR, V11, P1322, DOI 10.1039/b903805a; Sanin LH, 2001, PEDIATRICS, V107, P1016, DOI 10.1542/peds.107.5.1016; Schell LM, 2003, ENVIRON HEALTH PERSP, V111, P195, DOI 10.1289/ehp.5592; SILBERGELD EK, 1991, ENVIRON HEALTH PERSP, V91, P63, DOI 10.2307/3430984; Sirivarasai Jintana, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P180; Tang ML, 2016, CHEMOSPHERE, V148, P270, DOI 10.1016/j.chemosphere.2016.01.058; Thomas VM, 1999, ENVIRON SCI TECHNOL, V33, P3942, DOI 10.1021/es990231+; Torres-Sanchez LE, 1999, ENVIRON RES, V81, P297, DOI 10.1006/enrs.1999.3984; Tuakuila J, 2015, CHEMOSPHERE, V139, P326, DOI 10.1016/j.chemosphere.2015.06.039; U.S. EPA, 1986, EPA 600 8 83 028AF; Vimercati L, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5693-5; Wang J, 2017, ENVIRON POLLUT, V225, P193, DOI 10.1016/j.envpol.2017.03.031; World Health Organization, 2010, CHILDH LEAD POIS; Xie X, 2013, ENVIRON POLLUT, V175, P30, DOI 10.1016/j.envpol.2012.12.013; Yao Hong-yan, 2003, Zhonghua Fu Chan Ke Za Zhi, V38, P340; Zhang ZW, 2000, INT ARCH OCC ENV HEA, V73, P91, DOI 10.1007/s004200050013; Zhu MT, 2010, ENVIRON HEALTH PERSP, V118, P1471, DOI 10.1289/ehp.0901561	47	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186445	10.1371/journal.pone.0186445	http://dx.doi.org/10.1371/journal.pone.0186445			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036215	Green Published, Green Submitted, gold			2022-12-26	WOS:000413054800034
J	Wang, J; Du, JJ; Mu, XP; Wang, PF				Wang, Juan; Du, Junjie; Mu, Xiaopeng; Wang, Pengfei			Cloning and characterization of the Cerasus humilis sucrose phosphate synthase gene (ChSPS1)	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MESSENGER-RNA; METABOLISM; PLANTS; FRUIT; FAMILY; SPS; OVEREXPRESSION; ACCUMULATION; ISOFORMS	Sucrose is crucial to the growth and development of plants, and sucrose phosphate synthase (SPS) plays a key role in sucrose synthesis. To understand the genetic and molecular mechanisms of sucrose synthesis in Cerasus humilis, ChSPS1, a homologue of SPS, was cloned using RT-PCR. Sequence analysis showed that the open reading frame (ORF) sequence of ChSPS1 is 3174 bp in length, encoding a predicted protein of 1057 amino acids. The predicted protein showed a high degree of sequence identity with SPS homologues from other species. Real-time RT-PCR analysis showed that ChSPS1 mRNA was detected in all tissues and the transcription level was the highest in mature fruit. There is a significant positive correlation between expression of ChSPS1 and sucrose content. Prokaryotic expression of ChSPS1 indicated that ChSPS1 protein was expressed in E. coli and it had the SPS activity. Overexpression of ChSPS1 in tobacco led to upregulation of enzyme activity and increased sucrose contents in transgenic plants. Real-time RT-PCR analysis showed that the expression of ChSPS1 in transgenic tobacco was significantly higher than in wild type plants. These results suggested that ChSPS1 plays an important role in sucrose synthesis in Cerasus humilis.	[Wang, Juan; Du, Junjie; Mu, Xiaopeng; Wang, Pengfei] Shanxi Agr Univ, Dept Pomol, Coll Hort, Taigu, Peoples R China; [Wang, Juan] Shanxi Acad Agr Sci, Inst Pomol, Taiyuan, Shanxi, Peoples R China	Shanxi Agricultural University; Shanxi Agricultural University	Du, JJ (corresponding author), Shanxi Agr Univ, Dept Pomol, Coll Hort, Taigu, Peoples R China.	djj738@163.com			Shanxi Province Scientific Key Support Program [20130311020-7]; Platform Construction Project of Shanxi Province [2013091004-0101]; Research Fund for the Shanxi Province Major Science and Technology Program [20121101010]	Shanxi Province Scientific Key Support Program; Platform Construction Project of Shanxi Province; Research Fund for the Shanxi Province Major Science and Technology Program	This study was supported by the Shanxi Province Scientific Key Support Program (20130311020-7) and Platform Construction Project of Shanxi Province (2013091004-0101) received by JD. The design and conduct of study, the collection and analysis of the data were supported by these funds. It was also funded by the Research Fund for the Shanxi Province Major Science and Technology Program (20121101010) received by JD. The decision to preparation and publish of the manuscript were supported by this fund.	Aleman L, 2010, PLANTA, V231, P233, DOI 10.1007/s00425-009-1043-y; Chai YeMao, 2011, Acta Horticulturae Sinica, V38, P637; Chau CF, 2006, TRENDS FOOD SCI TECH, V17, P313, DOI 10.1016/j.tifs.2005.12.005; Choudhury SR, 2009, POSTHARVEST BIOL TEC, V54, P15, DOI 10.1016/j.postharvbio.2009.05.003; Dai ZW, 2013, J EXP BOT, V64, P1345, DOI 10.1093/jxb/ers396; doNascimento JRO, 1997, PLANTA, V203, P283, DOI 10.1007/s004250050193; Du JJ., 1993, CHINA FRUITS, P23; Du Junjie, 1992, J SHANXI AGR U, V12, P311; ElSayed AI, 2013, AGR RES, V2, P31, DOI 10.1007/s40003-013-0054-x; Farrar J, 2000, PLANT SCI, V154, P1, DOI 10.1016/S0168-9452(99)00260-5; Fung RWM, 2003, PLANT SCI, V164, P459, DOI 10.1016/S0168-9452(02)00430-2; Gebril S, 2015, PLANTA, V242, P1009, DOI 10.1007/s00425-015-2342-0; Hirose T, 2014, PLANT SCI, V225, P102, DOI 10.1016/j.plantsci.2014.05.018; HUBBARD NL, 1991, PHYSIOL PLANTARUM, V82, P191, DOI [10.1111/j.1399-3054.1991.tb00080.x, 10.1034/j.1399-3054.1991.820208.x]; Ishimaru K, 2008, PLANT PROD SCI, V11, P104, DOI 10.1626/pps.11.104; Jaiswal S, 2004, PROTEIN EXPRES PURIF, V33, P80, DOI 10.1016/j.pep.2003.09.009; Jiang X, 2015, GENE, V565, P122, DOI 10.1016/j.gene.2015.04.004; Komatsu A, 1999, PLANT SCI, V140, P169, DOI 10.1016/S0168-9452(98)00217-9; Komatsu A, 1996, MOL GEN GENET, V252, P346, DOI 10.1007/s004380050237; Langenkamper G, 1998, PLANT MOL BIOL, V36, P857, DOI 10.1023/A:1005964812161; Li WD, 2014, SCI HORTIC-AMSTERDAM, V175, P208, DOI 10.1016/j.scienta.2014.06.015; Liu BQ, 2009, J BIOTECHNOL, V141, P91, DOI 10.1016/j.jbiotec.2009.02.005; Lunn JE, 2003, CURR OPIN PLANT BIOL, V6, P208, DOI 10.1016/S1369-5266(03)00033-5; Lutfiyya LL, 2007, J PLANT PHYSIOL, V164, P923, DOI 10.1016/j.jplph.2006.04.014; McIntyre CL, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0286-5; Mu XP, 2016, J HORTIC SCI BIOTECH, V91, P71, DOI 10.1080/14620316.2015.1110994; Mu XP, 2015, J HORTIC SCI BIOTECH, V90, P525, DOI 10.1080/14620316.2015.11668709; Nguyen-Quoc B, 2001, J EXP BOT, V52, P881, DOI 10.1093/jexbot/52.358.881; Okamura M, 2011, PLANT SCI, V181, P159, DOI 10.1016/j.plantsci.2011.04.019; Reimholz R, 1997, PLANT CELL ENVIRON, V20, P291, DOI 10.1046/j.1365-3040.1997.d01-83.x; Seger M, 2015, PLANTA, V241, P69, DOI 10.1007/s00425-014-2165-4; Sharma S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-134; Stockinger EJ, 1996, J HERED, V87, P214, DOI 10.1093/oxfordjournals.jhered.a022987; Tian HM, 2010, BIOCHEM BIOPH RES CO, V393, P365, DOI 10.1016/j.bbrc.2010.01.124; Wang Peng-fei, 2011, Xibei Zhiwu Xuebao, V31, P1411; Wei ZG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120669; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; Yang ZY, 2013, J PLANT PHYSIOL, V170, P731, DOI 10.1016/j.jplph.2012.12.021; [姚改芳 YAO Gaifang], 2011, [南京农业大学学报, Journal of Nanjing Agricultural University], V34, P25; Yativ M, 2010, J PLANT PHYSIOL, V167, P589, DOI 10.1016/j.jplph.2009.11.009; Yoon SY, 2004, J PLANT BIOL, V47, P42; [于年文 YU Nianwen], 2011, [西南农业学报, Southwest China Journal of Agricultural Sciences], V24, P919; Zhang CH, 2013, ACTA PHYSIOL PLANT, V35, P589, DOI 10.1007/s11738-012-1100-1	43	4	8	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186650	10.1371/journal.pone.0186650	http://dx.doi.org/10.1371/journal.pone.0186650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036229	Green Submitted, Green Published, gold			2022-12-26	WOS:000413054800054
J	Whang, WJ; Piao, J; Yoo, YS; Joo, CK; Yoon, G				Whang, Woong-Joo; Piao, Junjie; Yoo, Young-Sik; Joo, Choun-Ki; Yoon, Geunyoung			The efficiency of aspheric intraocular lens according to biometric measurements	PLOS ONE			English	Article							CONTRAST SENSITIVITY; SPHERICAL-ABERRATION; CATARACT-SURGERY; PSEUDOPHAKIC EYES; VISUAL-ACUITY; METAANALYSIS; VISION; TECNIS; POWER	Purpose To analyze internal spherical aberration in pseudophakic eyes that underwent aspheric intraocular lens (IOL) implantation, and to investigate the relationships between biometric data and the effectiveness of aspheric IOL implantation. Methods This retrospective study included 40 eyes of 40 patients who underwent implantation of an IOL having a negative spherical aberration of -0.20 mu m (CT ASPHINA 509M; Carl Zeiss Meditec Inc., Germany). The IOLMaster (version 5.0; Carl Zeiss AG, Germany) was used for preoperative biometric measurements (axial length, anterior chamber depth, central corneal power) and the measurement of postoperative anterior chamber depth. The spherical aberrations were measured preoperatively and 3 months postoperatively using the iTrace (Tracey Technologies, Houston, TX, USA) at a pupil diameter of 5.0 mm. We investigated the relationships between preoperative biometric data and postoperative internal spherical aberration, and compared biometric measurements between 2 subgroups stratified according to internal spherical aberration (spherical aberration <= -0.06 mu m vs. spherical aberration > -0.06 mu m). Results The mean postoperative internal spherical aberration was -0.087 +/- 0.063 mu m. Preoperative axial length and residual total spherical aberration showed statistically significant correlations with internal spherical aberration (p = 0.041, 0.002). Preoperative axial length, postoperative anterior chamber depth, IOL power, and residual spherical aberration showed significant differences between the 2 subgroups stratified according to internal spherical aberration (p = 0.020, 0.029, 0.048, 0.041 respectively). Conclusion The corrective effect of an aspheric IOL is influenced by preoperative axial length and postoperative anterior chamber depth. Not only the amount of negative spherical aberration on the IOL surface but also the preoperative axial length should be considered to optimize spherical aberration after aspheric IOL implantation.	[Whang, Woong-Joo; Piao, Junjie; Yoo, Young-Sik; Joo, Choun-Ki] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Yoon, Geunyoung] Univ Rochester, Inst Opt, Flaum Eye Inst, Ctr Visual Sci, Rochester, NY 14627 USA	Catholic University of Korea; Seoul St. Mary's Hospital; University of Rochester	Joo, CK (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	ckjoo@catholic.ac.kr		PIAO, Junjie/0000-0003-3393-5518				Bartsch DU, 2008, EYE, V22, P1384, DOI 10.1038/sj.eye.6702901; Bellucci R, 2005, J CATARACT REFR SURG, V31, P712, DOI 10.1016/j.jcrs.2004.08.049; Bellucci R, 2007, J CATARACT REFR SURG, V33, P203, DOI 10.1016/j.jcrs.2006.10.068; Crnej A, ACTA OPHTHALMOL, V92, pe353; Denoyer A, 2007, J CATARACT REFR SURG, V33, P210, DOI 10.1016/j.jcrs.2006.10.035; Eom Y, 2015, CAN J OPHTHALMOL, V50, P26, DOI 10.1016/j.jcjo.2014.08.003; Eom Y, 2013, AM J OPHTHALMOL, V155, P492, DOI 10.1016/j.ajo.2012.09.024; Hofer H, 2001, J OPT SOC AM A, V18, P497, DOI 10.1364/JOSAA.18.000497; Holladay JT, 2002, J REFRACT SURG, V18, P683; Jun I, 2012, EYE, V26, P1243, DOI 10.1038/eye.2012.129; Kasper T, 2006, J CATARACT REFR SURG, V32, P2022, DOI 10.1016/j.jcrs.2006.07.029; Oshika T, 1999, INVEST OPHTH VIS SCI, V40, P1351; Piers PA, 2007, J REFRACT SURG, V23, P374; Savini G, 2016, J CATARACT REFR SURG, V42, P44, DOI 10.1016/j.jcrs.2015.07.044; Savini G, 2013, J CATARACT REFR SURG, V39, P1900, DOI 10.1016/j.jcrs.2013.04.047; Schuster AK, 2015, J CATARACT REFR SURG, V41, P1088, DOI 10.1016/j.jcrs.2015.04.005; Schuster AK, 2013, OPHTHALMOLOGY, V120, P2166, DOI 10.1016/j.ophtha.2013.04.011; Visser N, 2011, INVEST OPHTH VIS SCI, V52, P1302, DOI 10.1167/iovs.10-5841; Wang L, 2003, J CATARACT REFR SURG, V29, P970, DOI 10.1016/S0886-3350(02)01967-3	19	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0182606	10.1371/journal.pone.0182606	http://dx.doi.org/10.1371/journal.pone.0182606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036175	gold, Green Published, Green Submitted			2022-12-26	WOS:000413054800001
J	Bornheimer, R; Shea, KM; Sato, R; Weycker, D; Pelton, SI				Bornheimer, Rebecca; Shea, Kimberly M.; Sato, Reiko; Weycker, Derek; Pelton, Stephen I.			Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; INFLUENZA VACCINATION; HOSPITALIZED-PATIENTS; ECONOMIC BURDEN; ASSOCIATION; MORTALITY; HEALTH; AGE	Background Recent evidence demonstrates increased short-term risk of cardiac complications and respiratory failure among patients with heart failure (HF) and chronic obstructive pulmonary disease (COPD), respectively, concurrent with an episode of community-acquired pneumonia (CAP). We evaluated patients with pre-existing HF or COPD, beginning 30 days after CAP diagnosis, to determine if CAP had a prolonged impact on their underlying comorbidity. Methods A retrospective matched-cohort design using US healthcare claims was employed. In each month of accrual, patients with HF or COPD who developed CAP ("CAP patients") were matched (1: 1, without replacement, on demographic and clinical profiles) to patients with HF or COPD who did not develop CAP ("comparison patients"). All patients were aged >= 40 years, and were pneumonia free during prior 1-year period. Exacerbation beginning 30 days after the CAP diagnosis and for the subsequent 1-year period were compared between CAP and comparison patients. Findings 38,010 (4.6%) HF patients and 48,703 (5.9%) COPD patients experienced a new CAP episode requiring hospitalization or outpatient care only, and were matched to comparison patients. In the HF subset, CAP patients were 47.2% more likely to experience an exacerbation vs patients without CAP (17.8% vs. 12.1%; p<0.001); in the COPD subset, CAP patients were 42.3% more likely to experience an exacerbation (16.2% vs. 11.4%; p<0.001). Conclusions Our data provide evidence that CAP foreshadows a prolonged increase in risk of exacerbation of underlying HF or COPD in adults, and suggests a potential benefit to CAP prevention strategies.	[Bornheimer, Rebecca; Weycker, Derek] PAI, Brookline, MA USA; [Shea, Kimberly M.; Pelton, Stephen I.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Shea, Kimberly M.; Pelton, Stephen I.] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Sato, Reiko] Pfizer Inc, Collegeville, PA USA; [Pelton, Stephen I.] Boston Med Ctr, Boston, MA 02118 USA	Policy Analysis Inc; Boston University; Boston University; Pfizer; Boston Medical Center	Pelton, SI (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.; Pelton, SI (corresponding author), Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA.; Pelton, SI (corresponding author), Boston Med Ctr, Boston, MA 02118 USA.	spelton@bu.edu			Pfizer Inc.	Pfizer Inc.(Pfizer)	This work was supported by Pfizer Inc. to Policy Analysis Inc. (PAI). The funders had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. http://www.pfizer.com/	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bordon J, 2010, CHEST, V138, P279, DOI 10.1378/chest.09-2702; Broulette J, 2013, AM HEALTH DRUG BENEF, V6, P494; Brown AO, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004383; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; Corrales-Medina VF, 2015, AM HEART J, V170, P306, DOI 10.1016/j.ahj.2015.04.028; Corrales-Medina VF, 2013, LANCET, V381, P496, DOI 10.1016/S0140-6736(12)61266-5; Corrales-Medina VF, 2012, CIRCULATION, V125, P773, DOI 10.1161/CIRCULATIONAHA.111.040766; Corrales-Medina VF, 2009, MEDICINE, V88, P154, DOI 10.1097/MD.0b013e3181a692f0; Crisafulli E, 2013, CHEST, V143, P1009, DOI 10.1378/chest.12-1684; Eapen DJ, 2013, J AM COLL CARDIOL, V62, P329, DOI 10.1016/j.jacc.2013.03.072; Estabragh ZR, 2013, INT J CARDIOL, V167, P2397, DOI 10.1016/j.ijcard.2013.01.274; Eurich DT, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j413; Feldman C, 2015, CHEST, V148, P523, DOI 10.1378/chest.15-0484; Grijalva CG, 2015, JAMA-J AM MED ASSOC, V314, P1488, DOI 10.1001/jama.2015.12160; Howard Patricia A, 2013, Hosp Pharm, V48, P813, DOI 10.1310/hpj4810-813; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Kleinman NL, 2013, J OCCUP ENVIRON MED, V55, P1149, DOI 10.1097/JOM.0b013e3182a7e6af; Loomba RS, 2012, J CARDIOVASC PHARM T, V17, P277, DOI 10.1177/1074248411429965; Madjid M, 2004, TEX HEART I J, V31, P4; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; O'Meara ES, 2005, J AM GERIATR SOC, V53, P1108, DOI 10.1111/j.1532-5415.2005.53352.x; Polsky D, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-379; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Sato R, 2013, APPL HEALTH ECON HEA, V11, P251, DOI 10.1007/s40258-013-0026-0; Shea KM, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu024; Sibila O, 2014, EUR RESPIR J, V43, P36, DOI 10.1183/09031936.00117312; Udell JA, 2013, JAMA-J AM MED ASSOC, V310, P1711, DOI 10.1001/jama.2013.279206; Yu H, 2012, J AM GERIATR SOC, V60, P2137, DOI 10.1111/j.1532-5415.2012.04208.x	30	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0184877	10.1371/journal.pone.0184877	http://dx.doi.org/10.1371/journal.pone.0184877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028810	Green Published, gold, Green Submitted			2022-12-26	WOS:000412980300007
J	Reid, P; Wilson, P; Li, YR; Marcu, LG; Staudacher, AH; Brown, MP; Bezak, E				Reid, Paul; Wilson, Puthenparampil; Li, Yanrui; Marcu, Loredana G.; Staudacher, Alexander H.; Brown, Michael P.; Bezak, Eva			In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; CD44 EXPRESSION; POSITIVE HEAD; RADIOTHERAPY; CARCINOMA; MARKER; IDENTIFICATION; ASSOCIATION; RECURRENCE; BIOLOGY	Introduction Some head and neck squamous cell carcinomas (HNSCC) have a distinct aetiology, which depends on the presence of oncogenic human papilloma virus (HPV). Also, HNSCC contains cancer stem cells (CSCs) that have greater radioresistance and capacity to change replication dynamics in response to irradiation compared to non-clonogenic cells. Since there is limited data on CSCs in HNSCC as a function of HPV status, better understanding of their radiobiology may enable improved treatment outcome. Methods Baseline and post-irradiation changes in CSC proportions were investigated by flow cytometry in a HPV-negative (UM-SCC-1) and a HPV-positive (UM-SCC-47) HNSCC cell line, using fluorescent staining with CD44/ALDH markers. CSC proportions in both irradiated and unirradiated cultures were compared for the two cell lines at various times post-irradiation. To assess repopulation of CSCs, untreated cultures were depleted of CD44+/ALDH+ cells and re-cultured for 3 weeks before flow cytometry analysis. Results CSC proportions in untreated cell lines were 0.57% (UM-SCC-1) and 2.87% (UM-SCC-47). Untreated cell lines depleted of CD44+/ALDH+ repopulated this phenotype to a mean of 0.15% (UM-SCC-1) and 6.76% (UM-SCC-47). All UM-SCC-47 generations showed elevated CSC proportions after irradiation, with the most significant increase at 2 days post-irradiation. The highest elevation in UM-SCC-1 CSCs was observed at 1 day post-irradiation in the 2 nd generation and at 3 days after irradiation in the 3 rd generation. When measured after 10 days, only the 3 rd generation of UM-SCC-1 showed elevated CSCs. Conclusions CSC proportions in both cell lines were elevated after exposure and varied with time post irradiation. UM-SCC-47 displayed significant plasticity in repopulating the CSC phenotype in depleted cultures, which was not seen in UM-SCC-1.	[Reid, Paul; Marcu, Loredana G.; Bezak, Eva] Univ South Australia, Sch Hlth Sci, Adelaide, SA, Australia; [Reid, Paul; Li, Yanrui; Bezak, Eva] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA, Australia; [Wilson, Puthenparampil] Univ South Australia, Sch Engn, Adelaide, SA, Australia; [Wilson, Puthenparampil] Royal Adelaide Hosp, Dept Med Phys, Adelaide, SA, Australia; [Marcu, Loredana G.] Univ Oradea, Fac Sci, Oradea, Romania; [Staudacher, Alexander H.; Brown, Michael P.] SA Pathol, Ctr Canc Biol, Translat Oncol Lab, Adelaide, SA, Australia; [Staudacher, Alexander H.; Brown, Michael P.] Univ South Australia, Adelaide, SA, Australia; [Staudacher, Alexander H.; Brown, Michael P.] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Brown, Michael P.] Royal Adelaide Hosp, Canc Clin Trials Unit, Adelaide, SA, Australia; [Bezak, Eva] Univ Adelaide, Sch Phys Sci, Adelaide, SA, Australia	University of South Australia; University of South Australia; University of South Australia; Royal Adelaide Hospital; University of Oradea; Centre for Cancer Biology; SA Pathology; University of South Australia; University of Adelaide; Royal Adelaide Hospital; University of Adelaide	Reid, P (corresponding author), Univ South Australia, Sch Hlth Sci, Adelaide, SA, Australia.; Reid, P (corresponding author), Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA, Australia.	paul.reid@mymail.unisa.edu.au	Marcu, Loredana/B-9582-2011; Reid, Paul/AAV-4964-2021; Bezak, Eva/Q-6309-2017	Marcu, Loredana/0000-0002-6703-979X; Reid, Paul/0000-0002-2210-878X; Wilson, Puthenparampil/0000-0002-0448-7691; Staudacher, Alex/0000-0001-5034-9532; LI, YANRUI/0000-0002-0930-0590; Bezak, Eva/0000-0002-1315-1735	University of South Australia; Sansom Institute for Health Research internal funding	University of South Australia; Sansom Institute for Health Research internal funding	Funding was provided through the University of South Australia; Sansom Institute for Health Research 2015 internal funding.	Al-Assar O, 2011, CANCER BIOL THER, V11, P1028, DOI 10.4161/cbt.11.12.15699; Arenz A, 2014, STRAHLENTHER ONKOL, V190, P839, DOI 10.1007/s00066-014-0605-5; Baker M., 2008, NATURE REPORTS STEM; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Baumann M, 2010, CLIN CANCER RES, V16, P5091, DOI 10.1158/1078-0432.CCR-10-2244; Begg AC, 2012, SEMIN RADIAT ONCOL, V22, P108, DOI 10.1016/j.semradonc.2011.12.002; Bertrand G, 2014, STEM CELL REV REP, V10, P114, DOI 10.1007/s12015-013-9467-y; Boivin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014558; Brunner TB, 2012, SEMIN RADIAT ONCOL, V22, P151, DOI 10.1016/j.semradonc.2011.12.003; Campos MS, 2012, ORAL ONCOL, V48, P26, DOI 10.1016/j.oraloncology.2011.09.010; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; de Jong MC, 2010, CLIN CANCER RES, V16, P5329, DOI 10.1158/1078-0432.CCR-10-0799; Desiderio V, 2015, ONCOTARGET, V6, P71, DOI 10.18632/oncotarget.2698; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Ferlito A, 2001, ORL-J OTO-RHIN-LARYN, V63, P202, DOI 10.1159/000055740; Fitzgerald AL, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.44; Ghisolfi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043628; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gupta A, 2010, INDIAN J BIOCHEM BIO, V47, P96; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huq MS, 2001, PHYS MED BIOL, V46, P2985, DOI 10.1088/0031-9155/46/11/315; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim L, 2010, ONCOLOGY-NY, V24, P915; Kim MJ, 2011, J CELL SCI, V124, P3084, DOI 10.1242/jcs.080119; Krishnamurthy S, 2013, HEAD NECK-J SCI SPEC, V35, P1015, DOI 10.1002/hed.23076; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Lagadec C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-152; Lagadec C, 2012, STEM CELLS, V30, P833, DOI 10.1002/stem.1058; Lagadec C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2479; Lassen P, 2011, RADIOTHER ONCOL, V100, P49, DOI 10.1016/j.radonc.2011.02.010; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lindquist D, 2012, ANTICANCER RES, V32, P153; Linge A, 2016, RADIOTHER ONCOL, V121, P364, DOI 10.1016/j.radonc.2016.11.008; MUNGER K, 1992, CANCER SURV, V12, P197; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Pine SR, 2010, P NATL ACAD SCI USA, V107, P2195, DOI 10.1073/pnas.0909390107; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pramana J, 2007, INT J RADIAT ONCOL, V69, P1544, DOI 10.1016/j.ijrobp.2007.08.032; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Prince MEP, 2008, J CLIN ONCOL, V26, P2871, DOI 10.1200/JCO.2007.15.1613; Ritchie KE, 2013, CANCER LETT, V338, P41, DOI 10.1016/j.canlet.2012.07.025; SA Health, 2013, S AUSTR HEAD NECK CA, P146; Sanderson RJ, 2002, BMJ-BRIT MED J, V325, P822, DOI 10.1136/bmj.325.7368.822; Sayed SI, 2011, ORAL ONCOL, V47, P237, DOI 10.1016/j.oraloncology.2011.02.009; Stewart B, 2014, WORLD CANC REPORT 20; Vlashi E, 2016, INT J RAD ONCOLOGY B; Vlashi E, 2016, INT J RADIAT ONCOL, V94, P1198, DOI 10.1016/j.ijrobp.2016.01.005; Vlashi E, 2015, SEMIN CANCER BIOL, V31, P28, DOI 10.1016/j.semcancer.2014.07.001; Wang YY, 2014, ONCOTARGET, V5, P3743, DOI 10.18632/oncotarget.1992; WITHERS HR, 1988, ACTA ONCOL, V27, P131, DOI 10.3109/02841868809090333; Wu J, 2014, INT J ONCOL, V45, P2365, DOI 10.3892/ijo.2014.2677; Zhang MC, 2014, CANCER-AM CANCER SOC, V120, P992, DOI 10.1002/cncr.28538	59	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186186	10.1371/journal.pone.0186186	http://dx.doi.org/10.1371/journal.pone.0186186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028842	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000412980300022
J	Aik, WS; Lin, MH; Tan, DZ; Tripathy, A; Marzluff, WF; Dominski, Z; Chou, CY; Tong, L				Aik, Wei Shen; Lin, Min-Han; Tan, Dazhi; Tripathy, Ashutosh; Marzluff, William F.; Dominski, Zbigniew; Chou, Chi-Yuan; Tong, Liang			The N-terminal domains of FLASH and Lsm11 form a 2:1 heterotrimer for histone pre-mRNA 3'-end processing	PLOS ONE			English	Article							LOOP BINDING-PROTEIN; STEM-LOOP; U7 SNRNP; CELL-CYCLE; GENE-EXPRESSION; 3'-END; COMPLEX; BODIES; TRANSCRIPTION; ACTIVATION	Unlike canonical pre-mRNAs, animal replication-dependent histone pre-mRNAs lack introns and are processed at the 3'-end by a mechanism distinct from cleavage and polyadenylation. They have a 3' stem loop and histone downstream element (HDE) that are recognized by stem-loop binding protein (SLBP) and U7 snRNP, respectively. The N-terminal domain (NTD) of Lsm11, a component of U7 snRNP, interacts with FLASH NTD and these two proteins recruit the histone cleavage complex containing the CPSF-73 endonuclease for the cleavage reaction. Here, we determined crystal structures of FLASH NTD and found that it forms a coiled-coil dimer. Using solution light scattering, we characterized the stoichiometry of the FLASH NTD-Lsm11 NTD complex and found that it is a 2:1 heterotrimer, which is supported by observations from analytical ultracentrifugation and crosslinking.	[Aik, Wei Shen; Tan, Dazhi; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Lin, Min-Han; Chou, Chi-Yuan] Natl Yang Ming Univ, Dept Life Sci, Taipei, Taiwan; [Lin, Min-Han; Chou, Chi-Yuan] Natl Yang Ming Univ, Inst Genome Sci, Taipei, Taiwan; [Tripathy, Ashutosh; Marzluff, William F.; Dominski, Zbigniew] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Chapel Hill, NC USA; [Tan, Dazhi] Silicon Therapeut, Boston, MA USA	Columbia University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu		Aik, Wei Shen/0000-0003-4414-173X; Tong, Liang/0000-0002-0563-6468; Chou, Chi-Yuan/0000-0002-3400-171X; Lin, Min-Han/0000-0002-8639-0542	NIH [R35GM118093, S100D012018, GM29832]; Taiwan MOST [105-2320-B-010-012, 106-2320-B-010-013]; NIH-ORIP HEI [S10 RR029205]; Argonne National Laboratory [DE-ACO2-06CH11357]; NIH, NIGMS; HHMI; U.S. Department of Energy [DE-ACO2-05CH11231]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM029832, R35GM118093] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012018, S10OD021832] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan MOST; NIH-ORIP HEI; Argonne National Laboratory(United States Department of Energy (DOE)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHMI(Howard Hughes Medical Institute); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research is supported by NIH grants R35GM118093 and S100D012018 (to LT) and GM29832 (to WFM and ZD) and Taiwan MOST grant 105-2320-B-010-012 and 106-2320-B-010-013 (to CYC). This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines (NIH P41 GM103403), using the Pilatus 6M detector (NIH-ORIP HEI grant S10 RR029205).; We thank Aleksandra Skrajna for helpful discussions and comments on the manuscript; S. Banerjee, K. Perry, R. Rajashankar, J. Schuermann, N. Sukumar for access to NE-CAT 24 -ID-C and 24-ID-E beamlines at the Advanced Photon Source; and M. Allaire, N. Smith, and S. Ortega for access to Beamline 5.0.1 at the Advanced Light Source; and J. Seetharaman for assistance in X-ray data collection. This research is supported by NIH grants R35GM118093 and S100D012018 (to LT) and GM29832 (to WFM and ZD) and Taiwan MOST grant 105-2320-B-010-012 and 106-2320-B-010-013 (to CYC). This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines (NIH P41 GM103403), using the Pilatus 6M detector (NIH-ORIP HEI grant S10 RR029205). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated by Argonne National Laboratory under Contract No. DE-ACO2-06CH11357. The Berkeley Center for Structural Biology is supported in part by NIH, NIGMS, and HHMI. The Advanced Light Source is supported by the U.S. Department of Energy under Contract No. DE-ACO2-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alm-Kristiansen AH, 2008, ONCOGENE, V27, P4644, DOI 10.1038/onc.2008.105; Azzouz TN, 2005, NUCLEIC ACIDS RES, V33, P2106, DOI 10.1093/nar/gki516; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14808, DOI 10.1073/pnas.0604227103; Battle DJ, 2001, RNA, V7, P123, DOI 10.1017/S1355838201001820; Bongiorno-Borbone L, 2008, CELL CYCLE, V7, P2357, DOI 10.4161/cc.6344; Burch BD, 2011, RNA, V17, P1132, DOI 10.1261/rna.2566811; Cheng SC, 2010, BIOPHYS J, V98, P1327, DOI 10.1016/j.bpj.2009.12.4272; Chou CY, 2014, ACTA CRYSTALLOGR D, V70, P572, DOI 10.1107/S1399004713031040; Chou CY, 2006, J BIOL CHEM, V281, P13333, DOI 10.1074/jbc.M511077200; Chou YW, 2012, ARCH BIOCHEM BIOPHYS, V520, P74, DOI 10.1016/j.abb.2012.02.015; Dominski Z, 2005, CELL, V123, P37, DOI 10.1016/j.cell.2005.08.002; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Dominski Z, 2002, GENE DEV, V16, P58, DOI 10.1101/gad.932302; Dominski Z, 2013, BBA-GENE REGUL MECH, V1829, P532, DOI 10.1016/j.bbagrm.2013.01.010; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ghule PN, 2008, P NATL ACAD SCI USA, V105, P16964, DOI 10.1073/pnas.0809273105; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Ho BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144865; Hoefig KP, 2013, NAT STRUCT MOL BIOL, V20, P73, DOI 10.1038/nsmb.2450; Hsieh YH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-4; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiriyama M, 2009, MOL CELL BIOL, V29, P4729, DOI 10.1128/MCB.00289-09; Kolev NG, 2005, GENE DEV, V19, P2583, DOI 10.1101/gad.1371105; Koonin EV, 1999, NATURE, V401, P662, DOI 10.1038/44317; Krieghoff E, 2007, CELL CYCLE, V6, P771, DOI 10.4161/cc.6.7.4046; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lin MH, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-54; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Marzluff WF, 2005, CURR OPIN CELL BIOL, V17, P274, DOI 10.1016/j.ceb.2005.04.010; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOWRY KL, 1987, SCIENCE, V238, P1682, DOI 10.1126/science.2825355; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pillai RS, 2003, GENE DEV, V17, P2321, DOI 10.1101/gad.274403; Pillai RS, 2001, EMBO J, V20, P5470, DOI 10.1093/emboj/20.19.5470; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skrajna A, 2017, RNA, V23, P938, DOI 10.1261/rna.060806.117; Skrajna A, 2016, J MOL BIOL, V428, P1180, DOI 10.1016/j.jmb.2016.01.031; STRUB K, 1986, EMBO J, V5, P1675, DOI 10.1002/j.1460-2075.1986.tb04411.x; TAKAGAKI Y, 1989, GENE DEV, V3, P1711, DOI 10.1101/gad.3.11.1711; Tan DZ, 2013, SCIENCE, V339, P318, DOI 10.1126/science.1228705; Tatomer DC, 2016, J CELL BIOL, V213, P557, DOI 10.1083/jcb.201504043; Wagner EJ, 2007, MOL CELL, V28, P692, DOI 10.1016/j.molcel.2007.10.009; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; Wu CG, 2013, ACTA CRYSTALLOGR D, V69, P747, DOI 10.1107/S0907444913001315; Yang XC, 2014, J BIOL CHEM, V289, P33767, DOI 10.1074/jbc.M114.616466; Yang XC, 2013, MOL CELL BIOL, V33, P28, DOI 10.1128/MCB.00653-12; Yang XC, 2011, MOL CELL BIOL, V31, P1492, DOI 10.1128/MCB.00979-10; Yang XC, 2009, MOL CELL, V36, P267, DOI 10.1016/j.molcel.2009.08.016; Yang XC, 2009, MOL CELL BIOL, V29, P4045, DOI 10.1128/MCB.00296-09; Ye X, 2003, MOL CELL BIOL, V23, P8586, DOI 10.1128/MCB.23.23.8586-8600.2003; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700	62	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186034	10.1371/journal.pone.0186034	http://dx.doi.org/10.1371/journal.pone.0186034			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020104	Green Published, gold, Green Submitted			2022-12-26	WOS:000412754400060
J	Hailu, A; Lindtjorn, B; Deressa, W; Gari, T; Loha, E; Robberstad, B				Hailu, Alemayehu; Lindtjorn, Bernt; Deressa, Wakgari; Gari, Taye; Loha, Eskindir; Robberstad, Bjarne			Economic burden of malaria and predictors of cost variability to rural households in south-central Ethiopia	PLOS ONE			English	Article							CHILDHOOD FEBRILE ILLNESSES; COMBINATION THERAPIES; EPIDEMIC MALARIA; HEALTH-CARE; OF-ILLNESS; COUNTRIES; AREA; TRANSMISSION; COMMUNITIES; AFRICA	Background While recognizing the recent remarkable achievement in the global malaria reduction, the disease remains a challenge to the malaria endemic countries in Africa. Beyond the huge health consequence of malaria, policymakers need to be informed about the economic burden of the disease to the households. However, evidence on the economic burden of malaria in Ethiopia is scanty. The aims of this study were to estimate the economic burden of malaria episode and to identify predictors of cost variability to the rural households. Methods A prospective costing approach from a household perspective was employed. A total of 190 malaria patients were enrolled to the study from three health centers and nine health posts in Adami Tullu district in south-central Ethiopia, in 2015. Primary data were collected on expenditures due to malaria, forgone working days because of illness, socioeconomic and demographic situation, and households' assets. Quantile regression was applied to predict factors associated with the cost variation. Socioeconomic related inequality was measured using concentration index and concentration curve. Results The median cost of malaria per episode to the household was USD 5.06 (IQR: 2.98-8.10). The direct cost accounted for 39%, while the indirect counterpart accounted for 61%. The history of malaria in the last six months and the level of the facility visited in the health system predominantly influenced the direct cost. The indirect cost was mainly influenced by the availability of antimalarial drugs in the health facility. The concentration curve and the concentration index for direct cost indicate significant pro-rich inequality. Plasmodium falciparum is significantly more costly for households compared to Plasmodium vivax. Conclusion The economic burden of malaria to the rural households in Ethiopia was substantial-mainly to the poor-indicating that reducing malaria burden could contribute to the poverty reduction as well.	[Hailu, Alemayehu; Lindtjorn, Bernt; Robberstad, Bjarne] Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway; [Hailu, Alemayehu] Addis Ababa Univ, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Addis Ababa, Ethiopia; [Deressa, Wakgari] Addis Ababa Univ, Sch Publ Hlth, Dept Prevent Med, Addis Ababa, Ethiopia; [Gari, Taye; Loha, Eskindir] Hawassa Univ, Sch Publ & Environm Hlth, Hawassa, Ethiopia; [Robberstad, Bjarne] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth CISMAC, Bergen, Norway	University of Bergen; Addis Ababa University; Addis Ababa University; Hawassa University; University of Bergen	Hailu, A (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway.; Hailu, A (corresponding author), Addis Ababa Univ, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Addis Ababa, Ethiopia.	alemayehu4all@gmail.com	Shumbullo, Eskindir Loha/ABB-6422-2021; Hailu, Alemayehu/AAZ-5206-2020; Robberstad, Bjarne/AAG-9322-2020; Lindtjorn, Bernt/K-9465-2018; loha, eskindir/AAN-4925-2020	Shumbullo, Eskindir Loha/0000-0003-0003-2734; Hailu, Alemayehu/0000-0003-4872-8036; Robberstad, Bjarne/0000-0002-0708-2016; Lindtjorn, Bernt/0000-0002-6267-6984; 	Research Council of Norway [220554]	Research Council of Norway(Research Council of Norway)	This study has been funded by the Research Council of Norway (project number: 220554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhanom TDW, 2006, EPIDEMIOLOGY ECOLOGY, P556; Admassie A, 2014, RURAL POVERTY MARGIN, P269, DOI DOI 10.1007/978-94-007-7061-4_17; Akin J.S., 1987, FINANCING HLTH SERVI; [Anonymous], 2008, ANAL HLTH EQUITY USI; AsensoOkyere WK, 1997, SOC SCI MED, V45, P659, DOI 10.1016/S0277-9536(96)00383-8; Carasso BS, 2009, TROP MED INT HEALTH, V14, P1394, DOI 10.1111/j.1365-3156.2009.02383.x; Chuma JM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-76; Cibulskis RE, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0151-8; Cropper ML, 2004, J DEV ECON, V75, P303, DOI 10.1016/j.jdeveco.2003.02.006; Cropper ML, VALUE PREVENTING MAL, Vvi; Dalaba MA, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23848; Deressa W, 2003, B WORLD HEALTH ORGAN, V81, P261; Deressa W, 2007, TROP MED INT HEALTH, V12, P1148, DOI 10.1111/j.1365-3156.2007.01901.x; Deressa W, 2007, T ROY SOC TROP MED H, V101, P939, DOI 10.1016/j.trstmh.2007.04.018; Deressa W, 2007, ACTA TROP, V102, P1, DOI 10.1016/j.actatropica.2007.02.009; Deressa W, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1154-2; Ethiopia Federal Ministry of Health, 2004, GUID MAL EP PREV CON; Ethiopian Public Health Institute, 2016, 2015 ETH NAT MAL IND; Federal Ministry of Health of Ethiopia and World Health Organization, 2003, ASS PHARM SECT ETH; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Hansen KS., 2009, ACT CONSORTIUM GUIDA; ILO, 1996, ETH NAT LAB FORC SUR; James CD, 2006, APPL HEALTH ECON HEA, V5, P137, DOI 10.2165/00148365-200605030-00001; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; JAYAWARDENE R, 1993, SOC SCI MED, V37, P1169, DOI 10.1016/0277-9536(93)90256-4; Kebede A, 2010, INT J TECHNOL ASSESS, V26, P246, DOI 10.1017/S026646231000022X; Konradsen F, 1997, AM J TROP MED HYG, V56, P656, DOI 10.4269/ajtmh.1997.56.656; Larg A, 2011, PHARMACOECONOMICS, V29, P653, DOI 10.2165/11588380-000000000-00000; Lemma H, 2010, TROP MED INT HEALTH, V15, P241, DOI 10.1111/j.1365-3156.2009.02447.x; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Mullan Z, 2016, LANCET GLOB HEALTH, V4, pE344, DOI 10.1016/S2214-109X(16)30068-7; Mustafa M. H., 2007, Eastern Mediterranean Health Journal, V13, P1298; National Bank of Ethiopia, 2015, ETH MACR SOC IND; Newby G, 2016, LANCET, V387, P1775, DOI 10.1016/S0140-6736(16)00230-0; Okorosobo T, 2011, EUROPEAN J BUSINESS, V3; Onwujekwe O, 2010, TROP MED INT HEALTH, V15, P18, DOI 10.1111/j.1365-3156.2009.02418.x; Opiyo N, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009926.pub2; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Sagara I, 2012, AM J TROP MED HYG, V87, P50, DOI 10.4269/ajtmh.2012.11-0649; SHEPARD DS, 1991, TROP MED PARASITOL, V42, P199; SIAPS D Ethiopia PMI/AMDM Program, 2014, TECHN REP AV PRIC AF; Sicuri E, 2012, HEALTH POLICY PLANN, V27, P339, DOI 10.1093/heapol/czr046; StataCorp, 2015, STAT STAT SOFTW REL; Tarricone R, 2006, HEALTH POLICY, V77, P51, DOI 10.1016/j.healthpol.2005.07.016; Torrance, 2015, METHODS EC EVALUATIO, Vxiii; USAID D HSFR Project, 2012, HLTH CAR FIN REF ETH; Verguet S, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0697-0; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; WHO, 2016, WORLD MAL REP 2016; WHO, 2015, GLOB TECHN STRAT MAL; World Bank Group, 2015, ETH POV ASS 2014; World Health Organization, 2009, WHO GUID ID EC CONS; World Health Organization, 2010, WOLD HLTH ORG GUID T; Worrall E, 2004, AM J TROP MED HYG, V71, P136, DOI 10.4269/ajtmh.2004.71.136; Xia S, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0141-x	56	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185315	10.1371/journal.pone.0185315	http://dx.doi.org/10.1371/journal.pone.0185315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020063	Green Published, gold, Green Submitted			2022-12-26	WOS:000412754400026
J	Kane, M; Rayment, JH; Jensen, R; McDonald, R; Stanojevic, S; Ratjen, F				Kane, Mica; Rayment, Jonathan H.; Jensen, Renee; McDonald, Reginald; Stanojevic, Sanja; Ratjen, Felix			Correcting for tissue nitrogen excretion in multiple breath washout measurements	PLOS ONE			English	Article							LUNG CLEARANCE INDEX; ELIMINATION; CHILDREN	Nitrogen excreted from body tissues impacts the calculation of multiple breath nitrogen washout (MBWN2) outcomes. The aim of this study was to determine the effect of tissue N-2 on MBWN2 outcomes in both healthy subjects and patients with CF and to assess whether it is possible to correct for tissue N-2. The contribution of tissue N-2 to MBWN2 outcomes was estimated by comparing MBWN2-derived functional residual capacity (FRCN2) to FRC measured by body plethysmography (FRCpleth) and by comparing MBW outcome measures derived from MBWN2 and sulfur hexafluoride MBW (MBWSF6). Compared to plethysmography and MBWSF6, MBWN2 overestimated FRC and lung clearance index (LCI). Application of mathematical tissue N-2 corrections reduced FRCN2 values closer to FRCpleth in health and reduced LCIN2 in both health and CF, but did not explain all of the differences observed between N-2-dependent and -independent techniques. Use of earlier washout cut-offs could reduce the influence of tissue N-2. Applying tissue N-2 corrections to LCIN2 measurements did not significantly affect the interpretation of treatment effects reported in a previously published interventional trial. While tissue N-2 excretion likely has an impact on MBWN2 outcomes, better understanding of the nature of this phenomenon is required before routine correction can be implemented into current MBWN2 protocols.	[Kane, Mica; Rayment, Jonathan H.; Jensen, Renee; McDonald, Reginald; Stanojevic, Sanja; Ratjen, Felix] Hosp Sick Children, Dept Pediat, Div Resp Med, Toronto, ON, Canada; [Kane, Mica; Jensen, Renee; McDonald, Reginald; Stanojevic, Sanja; Ratjen, Felix] Hosp Sick Children, Res Inst, Translat Med, Toronto, ON, Canada; [Kane, Mica] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Rayment, Jonathan H.; Stanojevic, Sanja; Ratjen, Felix] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Jefferson University; University of Toronto	Ratjen, F (corresponding author), Hosp Sick Children, Dept Pediat, Div Resp Med, Toronto, ON, Canada.; Ratjen, F (corresponding author), Hosp Sick Children, Res Inst, Translat Med, Toronto, ON, Canada.; Ratjen, F (corresponding author), Univ Toronto, Toronto, ON, Canada.	felix.ratjen@sickkids.ca		Jensen, Renee/0000-0002-0877-9579; Rayment, Jonathan/0000-0003-4955-8876; Stanojevic, Sanja/0000-0001-7931-8051; Ratjen, Felix/0000-0003-4057-6592	Sellers Chair of Cystic Fibrosis at The Hospital For Sick Children; Irwin Family Fund	Sellers Chair of Cystic Fibrosis at The Hospital For Sick Children; Irwin Family Fund	FR is funded by the Sellers Chair of Cystic Fibrosis at The Hospital For Sick Children and the Irwin Family Fund. Neither source has a specific grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2016, RESP MED, V112, P59, DOI 10.1016/j.rmed.2016.01.020; Behnke AR, 1935, AM J PHYSIOL, V114, P137, DOI 10.1152/ajplegacy.1935.114.1.137; Benseler A, 2015, RESPIROLOGY, V20, P459, DOI 10.1111/resp.12470; Bodkin JJ, 2006, UNDERSEA HYPERBAR M, V33, P455; Coates AL, 1997, EUR RESPIR J, V10, P1415, DOI 10.1183/09031936.97.10061415; Cournand A, 1941, P SOC EXP BIOL MED, V48, P280; Curry TB, 2003, AVIAT SPACE ENVIR MD, V74, P1034; Darling RC, 1940, J CLIN INVEST, V19, P591, DOI 10.1172/JCI101161; Garcia G, 2012, REV MAL RESPIR, V29, P319, DOI 10.1016/j.rmr.2011.09.042; Hugon J, 2010, AVIAT SPACE ENVIR MD, V81, P1018, DOI 10.3357/ASEM.2811.2010; Jensen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056868; Kane M, 2016, THORAX, V71, P476, DOI 10.1136/thoraxjnl-2015-207894; LUNDIN G, 1953, Acta Physiol Scand Suppl, V111, P130; NELSON NM, 1964, J PEDIATR-US, V65, P299, DOI 10.1016/S0022-3476(64)80533-3; Nielsen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073335; Pendergast DR, 2012, UNDERSEA HYPERBAR M, V39, P595; Poncin W, 2017, J CYST FIBROS, V16, P258, DOI 10.1016/j.jcf.2016.11.004; ROBERTSON JS, 1950, J CLIN INVEST, V29, P577, DOI 10.1172/JCI102295; Robinson PD, 2013, EUR RESPIR J, V41, P507, DOI 10.1183/09031936.00069712; Sonneveld N, 2015, EUR RESPIR J, V46, P1055, DOI 10.1183/09031936.00211914; Stanojevic S, 2015, J CYST FIBROS, V14, P490, DOI 10.1016/j.jcf.2014.12.008; Sullivan L, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00679-2017; Summermatter S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132250; Verbanck S, 2012, RESPIRATION, V84, P177, DOI 10.1159/000341742; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Yammine S, 2015, J APPL PHYSIOL, V119, P1510, DOI 10.1152/japplphysiol.00333.2015	26	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185553	10.1371/journal.pone.0185553	http://dx.doi.org/10.1371/journal.pone.0185553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020072	Green Published, gold, Green Submitted			2022-12-26	WOS:000412754400035
J	Laugeray, A; Herzine, A; Perche, O; Richard, O; Montecot-Dubourg, C; Menuet, A; Mazaud-Guittot, S; Lesne, L; Jegou, B; Mortaud, S				Laugeray, Anthony; Herzine, Ameziane; Perche, Olivier; Richard, Olivier; Montecot-Dubourg, Celine; Menuet, Arnaud; Mazaud-Guittot, Severine; Lesne, Laurianne; Jegou, Bernard; Mortaud, Stephane			In utero and lactational exposure to low-doses of the pyrethroid insecticide cypermethrin leads to neurodevelopmental defects in male mice-An ethological and transcriptomic study	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; OXIDATIVE STRESS; DEVELOPMENTAL NEUROTOXICITY; SOCIAL RECOGNITION; PRENATAL EXPOSURE; BRAIN-REGIONS; BEHAVIOR; DOPAMINE; DAMAGE; NEURODEGENERATION	Accumulating evidence suggests that developmental exposure to environmental chemicals may modify the course of brain development, ultimately leading to neuropsychiatric /neuro-degenerative disorders later in life. In the present study, we assessed the impact of one of the most frequently used pesticides in both residential and agricultural applications-the synthetic pyrethroid cypermethrin (CYP)-on developmental neurotoxicity (DNT). Female mice were perinatally exposed to low doses of CYP (5 and 20 mg/kg body weight) from gestation to postnatal day 15. Behavioral analyses were performed during the offspring's early life and during adulthood. Postnatal analyses revealed that perinatal exposure to CYP disturbed motor development without modifying sensory and communicative skills. We found that later in life, CYP-exposed offspring expressed maladaptive behaviors in response to highly challenging tasks and abnormal sociability. Transcriptomic analyses performed in the offspring's brain at the end of the exposure, highlighted mitochondrial dysfunction as a relevant pathomechanism underlying CYP-induced DNT. Interestingly, several genes involved in proteostasis maintenance were also shown to be dysregulated suggesting that alterations in biogenesis, folding, trafficking and degradation of proteins may significantly contribute to CYP-related DNT. From a regulatory perspective, this study highlights that behavioral and transcriptomic analyses are complementary tools providing useful direction for better DNT characterization, and as such, should be used together more systematically.	[Laugeray, Anthony; Herzine, Ameziane; Perche, Olivier; Richard, Olivier; Montecot-Dubourg, Celine; Menuet, Arnaud; Mortaud, Stephane] CNRS, Immunol & Neurogenet Expt & Mol, UMR7355, Orleans, France; [Perche, Olivier] CHR, Dept Genet, Orleans, France; [Mazaud-Guittot, Severine; Lesne, Laurianne; Jegou, Bernard] Univ Rennes 1, INSERM, IRSET, U 1085, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre Hospitalier Regional d'Orleans; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Laugeray, A; Mortaud, S (corresponding author), CNRS, Immunol & Neurogenet Expt & Mol, UMR7355, Orleans, France.	alaugeray@yahoo.fr; smortaud@cnrs-orleans.fr	Mazaud-Guittot, Severine/I-4694-2015; Jégou, Bernard/I-4742-2015; Laugeray, Anthony/AAJ-2919-2020; Lesne, Laurianne/AAD-6180-2019	Mazaud-Guittot, Severine/0000-0003-0566-4124; Lesne, Laurianne/0000-0003-3165-9986; Perche, Olivier/0000-0002-6513-5534; JEGOU, Bernard/0000-0003-0623-3609; Mortaud, Stephane/0000-0003-0873-4781	French National Research Agency ANR [CESA-10-007 - NEUROPEST]; Region Centre (Doctoral fellowship to Ameziane Herzine)	French National Research Agency ANR(French National Research Agency (ANR)); Region Centre (Doctoral fellowship to Ameziane Herzine)	This work was supported by the French National Research Agency ANR (CESA-10-007 - NEUROPEST; allocated to SM), and Region Centre (Doctoral fellowship to Ameziane Herzine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2015, MOL NEUROBIOL, V51, P448, DOI 10.1007/s12035-014-8696-7; Baden KN, 2007, J BIOL CHEM, V282, P34839, DOI 10.1074/jbc.M703528200; Bal-Price A, 2016, NEUROTOXICOLOGY; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bertoglio LJ, 2005, BEHAV BRAIN RES, V162, P99, DOI 10.1016/j.bbr.2005.03.010; Bicks LK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01805; Bland ST, 2004, NEUROSCIENCE, V126, P705, DOI 10.1016/j.neuroscience.2004.04.025; Bonito-Oliva A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00290; CABIB S, 1994, J NEUROSCI, V14, P3333; Cabib S, 2012, NEUROSCI BIOBEHAV R, V36, P79, DOI 10.1016/j.neubiorev.2011.04.012; Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013; Dubovicky Michal, 2008, Interdiscip Toxicol, V1, P206, DOI 10.2478/v10102-010-0042-y; Ducottet C, 2003, PROG NEURO-PSYCHOPH, V27, P625, DOI 10.1016/S0278-5846(03)00051-4; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; Eriksson P, 1997, NEUROTOXICOLOGY, V18, P719; Farag AT, 2007, REPROD TOXICOL, V23, P560, DOI 10.1016/j.reprotox.2007.01.002; Ferrer I, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00163; Fonio E, 2012, NAT METHODS, V9, P1167, DOI 10.1038/nmeth.2252; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Grippo AJ, 2009, STRESS, V12, P1, DOI 10.1080/10253890802046281; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Herzine A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00191; Hohn A, 2013, J PROTEOMICS, V92, P132, DOI 10.1016/j.jprot.2013.01.004; Huang F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060885; HUSAIN R, 1992, B ENVIRON CONTAM TOX, V49, P402, DOI 10.1007/BF01239644; Kalueff AV, 2016, NAT REV NEUROSCI, V17, P45, DOI 10.1038/nrn.2015.8; Khazri A, 2015, ECOTOX ENVIRON SAFE, V115, P62, DOI 10.1016/j.ecoenv.2015.01.028; Kimata A, 2009, J OCCUP HEALTH, V51, P100, DOI 10.1539/joh.M7005; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Kutluyer F, 2016, PESTIC BIOCHEM PHYS, V128, P63, DOI 10.1016/j.pestbp.2015.10.001; Landrigan PJ, 2005, ENVIRON HEALTH PERSP, V113, P1230, DOI 10.1289/ehp.7571; Laugeray A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00390; Laviola G, 2002, BEHAV BRAIN RES, V130, P117, DOI 10.1016/S0166-4328(01)00420-X; Lee I, 2015, TOXICOLOGY, V335, P1, DOI 10.1016/j.tox.2015.06.010; Lemasson M, 2005, BEHAV PROCESS, V68, P13, DOI 10.1016/j.beproc.2004.09.001; Liu WS, 2007, GENETICS, V176, P937, DOI 10.1534/genetics.107.071688; Lloyd RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069003; Lohle M, 2009, J NEURAL TRANSM, V116, P1483, DOI 10.1007/s00702-009-0274-1; London L, 2012, NEUROTOXICOLOGY, V33, P887, DOI 10.1016/j.neuro.2012.01.004; MALAVIYA M, 1993, VET HUM TOXICOL, V35, P119; Martinez A, 2010, BRAIN PATHOL, V20, P281, DOI 10.1111/j.1750-3639.2009.00326.x; Matsuda I, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0196-4; Maurya SK, 2014, PESTIC BIOCHEM PHYS, V111, P51, DOI 10.1016/j.pestbp.2014.03.005; Molavi M, 2016, VET RES FORUM, V7, P125; Morgan MK, 2007, ENVIRON RES, V104, P266, DOI 10.1016/j.envres.2006.11.011; Morgan MK, 2012, INT J ENV RES PUB HE, V9, P2964, DOI 10.3390/ijerph9082964; Mossa ATH, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0740-2; Mun JY, 2005, TOXICOL MECH METHOD, V15, P399, DOI 10.1080/15376520500194742; Murgatroyd Chris, 2011, Front Psychiatry, V2, P16, DOI 10.3389/fpsyt.2011.00016; Narahashi T, 1996, PHARMACOL TOXICOL, V79, P1, DOI 10.1111/j.1600-0773.1996.tb00234.x; Nasuti C, 2007, TOXICOLOGY, V229, P194, DOI 10.1016/j.tox.2006.10.015; Nasuti C, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-7; Nasuti C, 2013, TOXICOLOGY, V303, P162, DOI 10.1016/j.tox.2012.09.016; Noack J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00152; OECD, 2007, OCED TEST NO 426 DEV; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Rehling P, 2001, CRIT REV BIOCHEM MOL, V36, P291, DOI 10.1080/20014091074200; Rodriguez JL, 2016, ENVIRON RES, V146, P388, DOI 10.1016/j.envres.2016.01.023; Rodriguez-Estrada J, 2016, FISH PHYSIOL BIOCHEM, V42, P859, DOI 10.1007/s10695-015-0180-4; Romero A, 2016, ARCH TOXICOLOGY; Russell WMS., 1959, MED J AUSTRALIA; Saillenfait AM, 2015, INT J HYG ENVIR HEAL, V218, P281, DOI 10.1016/j.ijheh.2015.01.002; Santoni G, 1999, TOXICOLOGY, V138, P175, DOI 10.1016/S0300-483X(99)00103-1; Santoni G, 1997, TOXICOLOGY, V120, P231, DOI 10.1016/S0300-483X(97)03662-7; Schaefers ATU, 2016, WORLD J BIOL PSYCHIA, V17, P587, DOI 10.3109/15622975.2013.797104; Shafer TJ, 2005, ENVIRON HEALTH PERSP, V113, P123, DOI 10.1289/ehp.7254; Sharma Poonam, 2014, J Hum Reprod Sci, V7, P99, DOI 10.4103/0974-1208.138867; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Singh AK, 2011, TOXICOL SCI, V122, P526, DOI 10.1093/toxsci/kfr115; Singh AK, 2012, NEUROBIOL AGING, V33, P404, DOI 10.1016/j.neurobiolaging.2010.02.018; Singh A, 2016, MOL NEUROBIOL, V53, P3670, DOI 10.1007/s12035-015-9307-y; Singh A, 2015, MOL NEUROBIOL, V52, P741, DOI 10.1007/s12035-014-8903-6; Singh P, 2011, TOXICOL MECH METHOD, V21, P193, DOI 10.3109/15376516.2010.538939; Sun H, 2007, CHEMOSPHERE, V66, P474, DOI 10.1016/j.chemosphere.2006.05.059; Tadaiesky MT, 2008, NEUROSCIENCE, V156, P830, DOI 10.1016/j.neuroscience.2008.08.035; Tiwari MN, 2010, FREE RADICAL RES, V44, P1416, DOI 10.3109/10715762.2010.512041; Vardavas AI, 2016, LIFE SCI, V145, P114, DOI 10.1016/j.lfs.2015.12.026; Viel JF, 2015, ENVIRON INT, V82, P69, DOI 10.1016/j.envint.2015.05.009; Wang H, 2011, ENVIRON TOXICOL, V26, P382, DOI 10.1002/tox.20566; Wei KQ, 2015, FISH SHELLFISH IMMUN, V43, P510, DOI 10.1016/j.fsi.2015.01.013; Yee BK, 2007, J NEURAL TRANSM, V114, P431, DOI 10.1007/s00702-006-0548-9; Zhang YT, 2016, ACCIDENT ANAL PREV, V96, P185, DOI 10.1016/j.aap.2016.08.003; Zimprich A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00125	85	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0184475	10.1371/journal.pone.0184475	http://dx.doi.org/10.1371/journal.pone.0184475			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020013	Green Published, gold, Green Submitted			2022-12-26	WOS:000412754400012
J	Li, G; Xu, LX; Zhao, YL; Li, LJ; Fu, JL; Zhang, Q; Li, NS; Xiao, XH; Li, CH; Mi, J; Gao, S; Li, M				Li, Ge; Xu, Linxin; Zhao, Yanglu; Li, Lujiao; Fu, Junling; Zhang, Qian; Li, Naishi; Xiao, Xinhua; Li, Changhong; Mi, Jie; Gao, Shan; Li, Ming			Leptin-adiponectin imbalance as a marker of metabolic syndrome among Chinese children and adolescents: The BCAMS study	PLOS ONE			English	Article							INSULIN-RESISTANCE; CARDIOVASCULAR RISK; OBESITY; RATIO; ASSOCIATIONS; PREVALENCE; PREDICTORS; ADIPOKINES; NUTRITION; HEALTH	Purpose Leptin and adiponectin have opposite effects on subclinical inflammation and insulin resistance, both involved in the development of metabolic syndrome (MS). We aimed to investigate whether leptin/adiponectin ratio (L/A), as a marker of these two adipokines imbalance, may improve diagnosis of MS in children and adolescents, and determined its cut-off value in the diagnosis of MS. Methods A total of 3,428 subjects aged 6-18 years were selected from Beijing Child and Adolescent Metabolic Syndrome study. Adipokine leptin and adiponectin were measured using enzyme-linked immunosorbent assay. Odds ratio of MS per 1 z-score of adipokine was examined using logistic regression. Diagnosis accuracy was assessed using c-statistics (AUC) and net reclassification index. Results The levels of leptin and L/A increased with number of positive MS components, while the levels of adiponectin declined in both boys and girls (all P < 0.001). AUCs for diagnosis of MS in girls were 0.793, 0.773, and 0.689 using L/A, leptin and adiponectin, respectively; and AUCs in boys were 0.822, 0.798, and 0.697 for L/A, leptin and adiponectin, respectively. Notably, L/A outperformed individual leptin or adiponectin in discriminating a diagnosis of MS (all P < 0.02 in AUC comparisons). In addition, the optimal cut-offs of L/A by ROC curve differed by genders and pubertal stages, which were 1.63, 1.28, 1.95 and 1.53 ng/ug for total, pre-, mid- and postpubertal boys, respectively and 2.19, 0.87,1.48 and 2.27 ng/ug for total, pre-, mid- and postpubertal girls, respectively, yielding high sensitivity and moderate specificity for a screening test. Conclusions In this pediatric population, leptin-adiponectin imbalance, as reflected by an increase in L/A level, was found to be a better diagnostic biomarker for MS than leptin or adiponectin alone. Future longitudinal studies are needed to further validate the gender-specific cutoff values.	[Li, Ge; Xu, Linxin; Li, Lujiao; Fu, Junling; Zhang, Qian; Li, Naishi; Xiao, Xinhua; Li, Ming] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Natl Hlth & Family Planning Commiss, Dept Endocrinol,Key Lab Endocrinol, Beijing, Peoples R China; [Xu, Linxin] Shanxi Med Univ, Affiliated Hosp 1, Dept Endocrinol, Taiyuan, Shanxi, Peoples R China; [Zhao, Yanglu] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Epidemiol Dept, Los Angeles, CA USA; [Li, Changhong] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Endocrinol, Philadelphia, PA 19104 USA; [Mi, Jie] Capital Inst Paediat, Dept Epidemiol, Beijing, Peoples R China; [Gao, Shan] Capital Med Univ, Beijing Chaoyang Hosp, Dept Endocrinol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Shanxi Medical University; University of California System; University of California Los Angeles; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Capital Medical University	Li, M (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Natl Hlth & Family Planning Commiss, Dept Endocrinol,Key Lab Endocrinol, Beijing, Peoples R China.	liming@pumch.cn	Li, Naishi/ABI-7607-2020; Li, Ming/I-1323-2018	Li, Naishi/0000-0002-2261-7349; Li, Ming/0000-0002-8427-605X; Gao, Shan/0000-0003-1066-0531	key program of Beijing Municipal Science & Technology Commission [D111100000611001, D111100000611002]; National Key Research program of China [2016YFC1304800]; Beijing Natural Science Foundation [7172169]; Beijing Science & Technology Star Program [2004A027]; Novo Nordisk Union Diabetes Research Talent Fund [2011A002]; National Key Program of Clinical Science [WBYZ 2011-873]	key program of Beijing Municipal Science & Technology Commission; National Key Research program of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Science & Technology Star Program; Novo Nordisk Union Diabetes Research Talent Fund; National Key Program of Clinical Science	This work was financially supported by key program of Beijing Municipal Science & Technology Commission (#D111100000611001, #D111100000611002), National Key Research program of China (#2016YFC1304800), Beijing Natural Science Foundation (#7172169), Beijing Science & Technology Star Program (#2004A027), Novo Nordisk Union Diabetes Research Talent Fund (#2011A002) and National Key Program of Clinical Science (#WBYZ 2011-873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Alikasifoglu Ayfer, 2009, J Clin Res Pediatr Endocrinol, V1, P233, DOI 10.4274/jcrpe.v1i5.233; [Anonymous], [No title captured]; Cambuli VM, 2008, J CLIN ENDOCR METAB, V93, P3051, DOI 10.1210/jc.2008-0476; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Erhardt E, 2014, INT J OBESITY, V38, pS32, DOI 10.1038/ijo.2014.133; Falahi E, 2015, DIABETES METAB SYND, V9, P366, DOI 10.1016/j.dsx.2013.06.014; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Group of China Obesity Task Force, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P97; Juonala M, 2011, ATHEROSCLEROSIS, V217, P234, DOI 10.1016/j.atherosclerosis.2011.03.016; Kang DR, 2017, YONSEI MED J, V58, P339, DOI 10.3349/ymj.2017.58.2.339; Korner A, 2007, PEDIATR RES, V61, P640, DOI 10.1203/01.pdr.0000262638.48304.ef; Kranz S, 2013, J OBES, V2013, DOI 10.1155/2013/376314; Li LJ, 2016, J CLIN ENDOCR METAB, V101, P1816, DOI 10.1210/jc.2015-3760; Li M, 2009, INT J OBESITY, V33, P424, DOI 10.1038/ijo.2009.44; Li M, 1997, CHIN J ENDOCRINOL ME, V5, P214; Li Ming, 2008, Zhonghua Yi Xue Za Zhi, V88, P3293; Li Q, 2012, METABOLISM, V61, P1803, DOI 10.1016/j.metabol.2012.06.001; Lopez-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053; Marshall WA, 1986, HUMAN GROWTH, P171, DOI DOI 10.1007/978-1-4899-0522-2_8; Mirza S, 2011, CLIN INVEST MED, V34, pE290; Mohlig M, 2006, EUR J ENDOCRINOL, V154, P295, DOI 10.1530/eje.1.02095; Mojiminiyi OA, 2007, INT J OBESITY, V31, P213, DOI 10.1038/sj.ijo.0803355; Moran O, 2003, Pediatr Diabetes, V4, P101, DOI 10.1034/j.1399-5448.2003.00017.x; Nappo A, 2017, NUTR METAB CARDIOVAS, V27, P543, DOI 10.1016/j.numecd.2017.04.003; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Papoutsakis C, 2012, METABOLISM, V61, P140, DOI 10.1016/j.metabol.2011.06.006; Parker-Duffen JL, 2014, BEST PRACT RES CL EN, V28, P81, DOI 10.1016/j.beem.2013.09.001; Patel SB, 2008, CURR HYPERTENS REP, V10, P131, DOI 10.1007/s11906-008-0025-y; Sainz N, 2015, METABOLISM, V64, P35, DOI 10.1016/j.metabol.2014.10.015; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Tailor AM, 2010, INT J PEDIATR OBES, V5, P202, DOI 10.3109/17477160903281079; Thorand B, 2010, DIABETIC MED, V27, P1004, DOI 10.1111/j.1464-5491.2010.03043.x; Wang J, 2008, OBESITY, V16, P172, DOI 10.1038/oby.2007.42; Wang QX, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-249; Xu L, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/389108; Yoon JH, 2011, CLIN CHIM ACTA, V412, P2199, DOI 10.1016/j.cca.2011.08.003; Yoshinaga M, 2008, CIRC J, V72, P1874, DOI 10.1253/circj.CJ-08-0180; Yun JE, 2011, ENDOCR J, V58, P807, DOI 10.1507/endocrj.K11E-084; Zhuo Q, 2009, DIABETES RES CLIN PR, V84, P27, DOI 10.1016/j.diabres.2008.12.019; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	44	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186222	10.1371/journal.pone.0186222	http://dx.doi.org/10.1371/journal.pone.0186222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020116	gold, Green Published, Green Submitted			2022-12-26	WOS:000412754400082
J	Silva, R; Afan, I; Gil, JA; Bustamante, J				Silva, Rafa; Afan, Isabel; Gil, Juan A.; Bustamante, Javier			Seasonal and circadian biases in bird tracking with solar GPS-tags	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; HABITAT SELECTION; SATELLITE TRACKING; COLLAR PERFORMANCE; GOLDEN EAGLES; TELEMETRY; MORTALITY; BEHAVIOR; DEER; TOPOGRAPHY	Global Positioning System (GPS) tags are nowadays widely used in wildlife tracking. This geolocation technique can suffer from fix loss biases due to poor satellite GPS geometry, that result in tracking data gaps leading to wrong research conclusions. In addition, new solar-powered GPS tags deployed on birds can suffer from a new "battery drain bias" currently ignored in movement ecology analyses. We use a GPS tracking dataset of bearded vultures (Gypaetus barbatus), tracked for several years with solar GPS tags, to evaluate the causes and triggers of fix and data retrieval loss biases. We compare two models of solar GPS tags using different data retrieval systems (Argos vs GSM-GPRS), and programmed with different duty cycles. Neither of the models was able to accomplish the duty cycle programed initially. Fix and data retrieval loss rates were always greater than expected, and showed non-random gaps in GPS locations. Number of fixes per month of tracking was a bad criterion to identify tags with smaller biases. Fix-loss rates were four times higher due to battery drain than due to poor GPS satellite geometry. Both tag models were biased due to the uneven solar energy available for the recharge of the tag throughout the annual cycle, resulting in greater fix-loss rates in winter compared to summer. In addition, we suggest that the bias found along the diurnal cycle is linked to a complex three-factor interaction of bird flight behavior, topography and fix interval. More fixes were lost when vultures were perching compared to flying, in rugged versus flat topography. But long fix-intervals caused greater loss of fixes in dynamic (flying) versus static situations (perching). To conclude, we emphasize the importance of evaluating fix-loss bias in current tracking projects, and deploying GPS tags that allow remote duty cycle updates so that the most appropriate fix and data retrieval intervals can be selected.	[Silva, Rafa; Bustamante, Javier] Estn Biol Donana EBD CSIC, Dept Wetland Ecol, Seville, Spain; [Afan, Isabel; Bustamante, Javier] Estn Biol Donana EBD CSIC, GIS & Remote Sensing Lab LAST EBD, Seville, Spain; [Gil, Juan A.] Fdn Conservac Quebrantahuesos, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Silva, R (corresponding author), Estn Biol Donana EBD CSIC, Dept Wetland Ecol, Seville, Spain.	rafasilva@ebd.csic.es	Afán, Isabel/F-4783-2015; Bustamante, Javier/C-2735-2008; Bustamante, Javier/AAA-7273-2019	Afán, Isabel/0000-0003-3874-0461; Bustamante, Javier/0000-0001-7515-0677; Bustamante, Javier/0000-0001-7515-0677	Fundacion para la Conservacion del Quebrantahuesos (FCQ); Gobierno de Aragon; Ministerio de Medio Ambiente; Fundacion Biodiversidad; Obra Social Caja Madrid; Telefonica; LIFE [12 NAT/ES/000322]; Ministerio de Educacion, Cultura y Deporte [FPU13-03484]	Fundacion para la Conservacion del Quebrantahuesos (FCQ); Gobierno de Aragon(Gobierno de Aragon); Ministerio de Medio Ambiente(Spanish Government); Fundacion Biodiversidad(European Commission); Obra Social Caja Madrid; Telefonica; LIFE; Ministerio de Educacion, Cultura y Deporte(Spanish Government)	Funding for tracking devices and field work was provided by Fundacion para la Conservacion del Quebrantahuesos (FCQ), Gobierno de Aragon, Ministerio de Medio Ambiente, Fundacion Biodiversidad, Obra Social Caja Madrid, Telefonica and LIFE 12 NAT/ES/000322. Rafa Silva was supported by a PhD contract from the Ministerio de Educacion, Cultura y Deporte (FPU13-03484). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; ASTER GDEM Validation Team, 2014, ASTER GLOBAL DIGITAL; Biggs JR, 2001, WEST N AM NATURALIST, V61, P213; Bjorneraas K, 2010, J WILDLIFE MANAGE, V74, P1361, DOI 10.2193/2009-405; Bogel Ralf, 1994, P325; Bouten W, 2013, J ORNITHOL, V154, P571, DOI 10.1007/s10336-012-0908-1; Bowman JL, 2000, WILDLIFE SOC B, V28, P141; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Cain JW, 2005, WILDLIFE SOC B, V33, P926, DOI 10.2193/0091-7648(2005)33[926:IOTAGF]2.0.CO;2; Clark PE, 2006, RANGELAND ECOL MANAG, V59, P334, DOI 10.2111/05-162R.1; Cramp S., 1980, HDB BIRDS EUROPE MID; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; D'Eon RG, 2003, J WILDLIFE MANAGE, V67, P858, DOI 10.2307/3802693; d'Oleire-Oltmanns W., 1989, P345; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Gau RJ, 2004, WILDLIFE SOC B, V32, P693, DOI 10.2193/0091-7648(2004)032[0693:UFPOTG]2.0.CO;2; Gil JA, 2010, JUVENILE DISPERSAL B; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Graves TA, 2006, J WILDLIFE MANAGE, V70, P844, DOI 10.2193/0022-541X(2006)70[844:UTCOMG]2.0.CO;2; Hernandez-Pliego J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145402; Kaplan E., 2005, UNDERSTANDING GPS PR; Katzner TE, 2012, J APPL ECOL, V49, P1178, DOI 10.1111/j.1365-2664.2012.02185.x; Kendall CJ, 2012, J RAPTOR RES, V46, P135, DOI 10.3356/JRR-10-87.1; Kenward RE., 2000, MANUAL WILDLIFE RADI; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; Kranstauber B, 2011, ENVIRON MODELL SOFTW, V26, P834, DOI 10.1016/j.envsoft.2010.12.005; Krasteva R., 2005, Problemy na Tekhnicheskata Kibernetika i Robotikata, V55, P30; Kruger S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114920; Lambertucci SA, 2014, BIOL CONSERV, V170, P145, DOI 10.1016/j.biocon.2013.12.041; Lopez-Lopez P, 2014, J RAPTOR RES, V48, P173, DOI 10.3356/JRR-13-00072.1; Margalida A, 2016, SCI REP-UK, V6, DOI 10.1038/srep35746; Margalida A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065857; Martin J, 2013, J ANIM ECOL, V82, P290, DOI 10.1111/j.1365-2656.2012.02038.x; Mattisson J, 2010, J WILDLIFE MANAGE, V74, P557, DOI 10.2193/2009-157; McIntyre CL, 2012, J RAPTOR RES, V46, P129, DOI 10.3356/JRR-10-96.1; Mills KJ, 2006, WILDLIFE SOC B, V34, P1463, DOI 10.2193/0091-7648(2006)34[1463:EOVSFO]2.0.CO;2; Nielson RM, 2009, ECOLOGY, V90, P2956, DOI 10.1890/08-1562.1; Ninyerola M, 2005, ATLAS CLIMATICO DIGI; Oleksy R, 2015, GLOB ECOL CONSERV, V3, P678, DOI 10.1016/j.gecco.2015.02.012; Parkinson B. W., 1996, GLOBAL POSITIONING S, V1, P409; Prichard AK, 2014, WILDLIFE SOC B, V38, P78, DOI 10.1002/wsb.357; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Scharf, 2015, MOVE VISUALIZING ANA; Schwartz Charles C., 1999, Ursus, V11, P261; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090	46	10	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185344	10.1371/journal.pone.0185344	http://dx.doi.org/10.1371/journal.pone.0185344			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020062	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400027
J	Angermann, S; Baumann, M; Steubl, D; Lorenz, G; Hauser, C; Suttmann, Y; Reichelt, AL; Satanovskij, R; Sonntag, F; Heemann, U; Grimmer, T; Schmaderer, C				Angermann, Susanne; Baumann, Marcus; Steubl, Dominik; Lorenz, Georg; Hauser, Christine; Suttmann, Yana; Reichelt, Anna-Lena; Satanovskij, Robin; Sonntag, Franziska; Heemann, Uwe; Grimmer, Timo; Schmaderer, Christoph			Cognitive impairment in hemodialysis patients: Implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-testfor feasible screening	PLOS ONE			English	Article							MINI-MENTAL STATE; DEMENTIA; ADULTS	Objective Reliable identification of cognitive impairment in hemodialysis patients is of utmost importance, as it is associated with poor outcomes including dialysis withdrawal and death. High prevalence of cognitive impairment has been demonstrated in several studies using brief screening instruments or neuropsychological test batteries. However, the relevance of cognitive impairment as well as the accuracy of screening procedures have never been studied in this patient population. Methods 151 chronic hemodialysis patients (mean age 65.78 +/- 14.88 years, 73,5% male) underwent cognitive testing under standardized conditions by the Montreal Cognitive Assessment (MoCA) and, in a second step, the Clinical Dementia Rating scale (CDR), an international standard to measure the severity of dementia. For calculating MoCA cut-off values on the basis of the CDR global score, receiver operator characteristics (ROC) analysis and c-statistic were applied. Results 49.0% of patients were categorized as 0.5 in the CDR global with memory being the predominantly affected domain (47.7% of patients scored >= 0.5). Youden's Index led to a threshold of 23.5 points for the MoCA test for optimal differentiation between cognitively normal (CDR global < 0.5) and impaired patients (CDR global >= 0.5) based on a sensitivity of approximately 99% and a specificity of approximately 74%. Conclusion Interference of cognitive impairment with patients' independence and daily life was shown using the CDR for the first time in hemodialysis patients. A MoCA score of 23.5 points turned out as optimal threshold to differentiate between patients with and without functional impairment in the CDR, thereby paving the way for implementation of the MoCA test as a quick and thus highly feasible screening instrument for periodic testing in clinical routine.	[Angermann, Susanne; Steubl, Dominik; Lorenz, Georg; Hauser, Christine; Suttmann, Yana; Reichelt, Anna-Lena; Satanovskij, Robin; Sonntag, Franziska; Heemann, Uwe; Schmaderer, Christoph] Tech Univ Munich, Klinikum Rechts Isar, Dept Nephrol, Munich, Bavaria, Germany; [Baumann, Marcus] Friedrich Alexander Univ Erlangen Nurnberg, Klinikum Ansbach, Dept Nephrol, Erlangen, Bavaria, Germany; [Grimmer, Timo] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychiat & Psychotherapy, Munich, Bavaria, Germany	Technical University of Munich; University of Erlangen Nuremberg; Technical University of Munich; University of Munich	Angermann, S; Schmaderer, C (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Nephrol, Munich, Bavaria, Germany.	Susanne.angermann@mri.tum.de; Christoph.Schmaderer@mri.tum.de	Lorenz, georg/AAK-4185-2021					American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Carrasco FR, 2009, TRANSPL P, V41, P2430, DOI 10.1016/j.transproceed.2009.06.166; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Kurella M, 2006, NEPHROL DIAL TRANSPL, V21, P2543, DOI 10.1093/ndt/gfl275; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pereira Arema A, 2007, Hemodial Int, V11, P309, DOI 10.1111/j.1542-4758.2007.00185.x; Rakowski DA, 2006, CLIN J AM SOC NEPHRO, V1, P1000, DOI 10.2215/CJN.00470705; Schmaderer C, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0374-8; Sugarman J, 1998, J AM GERIATR SOC, V46, P517, DOI 10.1111/j.1532-5415.1998.tb02477.x; Tamura MK, 2010, CLIN J AM SOC NEPHRO, V5, P1429, DOI 10.2215/CJN.01090210; Tamura MK, 2009, NEW ENGL J MED, V361, P1539, DOI 10.1056/NEJMoa0904655; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tholen S, 2014, DEMENT GERIATR COGN, V38, P31, DOI 10.1159/000357803; Tiffin-Richards FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106700; World Health Organization, INT CLASS DIS ICD	17	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0184589	10.1371/journal.pone.0184589	http://dx.doi.org/10.1371/journal.pone.0184589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3JE	29016605	Green Published, gold, Green Submitted			2022-12-26	WOS:000412627400009
J	Pearce, A; Haas, M; Viney, R; Pearson, SA; Haywood, P; Brown, C; Ward, R				Pearce, Alison; Haas, Marion; Viney, Rosalie; Pearson, Sallie-Anne; Haywood, Philip; Brown, Chris; Ward, Robyn			Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study	PLOS ONE			English	Article							QUALITY-OF-LIFE; ADJUVANT CHEMOTHERAPY; ADVERSE EVENTS; PATIENT PERCEPTIONS; BREAST-CANCER; SYMPTOMS; NAUSEA	Aim Chemotherapy side effects are often reported in clinical trials; however, there is little evidence about their incidence in routine clinical care. The objective of this study was to describe the frequency and severity of patient-reported chemotherapy side effects in routine care across treatment centres in Australia. Methods We conducted a prospective cohort study of individuals with breast, lung or colorectal cancer undergoing chemotherapy. Side effects were identified by patient self-report. The frequency, prevalence and incidence rates of side effects were calculated by cancer type and grade, and cumulative incidence curves for each side effect computed. Frequencies of side effects were compared between demographic subgroups using chi-squared statistics. Results Side effect data were available for 449 eligible individuals, who had a median follow-up of 5.64 months. 86% of participants reported at least one side effect during the study period and 27% reported a grade IV side effect, most commonly fatigue or dyspnoea. Fatigue was the most common side effect overall (85%), followed by diarrhoea (74%) and constipation (74%). Prevalence and incidence rates were similar across side effects and cancer types. Age was the only demographic factor associated with the incidence of side effects, with older people less likely to report side effects. Conclusion This research has produced the first Australian estimates of self-reported incidence of chemotherapy side effects in routine clinical care. Chemotherapy side effects in routine care are common, continue throughout chemotherapy and can be serious. This work confirms the importance of observational data in providing clinical practice-relevant information to decision-makers.	[Pearce, Alison; Haas, Marion; Viney, Rosalie; Haywood, Philip] Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW, Australia; [Pearson, Sallie-Anne] Univ New South Wales, Med Policy Res Unit, Sydney, NSW, Australia; [Brown, Chris] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia; [Ward, Robyn] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Ward, Robyn] Univ Queensland, Brisbane, Qld, Australia	University of Technology Sydney; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; University of Queensland	Pearce, A (corresponding author), Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW, Australia.	Alson.pearce@chere.uts.edu.au	Brown, Chris/H-2797-2019; Haas, Marion Ruth/H-2732-2017; Pearce, Alison/AAC-3702-2019; Ward, Robyn/I-2313-2013	Brown, Chris/0000-0003-2506-4871; Pearce, Alison/0000-0002-5690-9542; Haywood, Philip/0000-0001-5031-8648; Viney, Rosalie/0000-0002-0039-9635; Ward, Robyn/0000-0002-6877-8906	National Health and Medical Research Council [455366]; University of Technology Sydney Doctoral Scholarship; NHMRC Health Services Research Grant [455366]; Cancer Institute NSW Career Development Fellowship [12/CDF/2-25]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Technology Sydney Doctoral Scholarship; NHMRC Health Services Research Grant(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW Career Development Fellowship	The Elements of Cancer Care study was funded by the National Health and Medical Research Council (Health Services Research Grant ID 455366). AP was supported by a University of Technology Sydney Doctoral Scholarship, and a PhD top-up scholarship from NHMRC Health Services Research Grant (ID455366). SP is supported by a Cancer Institute NSW Career Development Fellowship (ID: 12/CDF/2-25). No funding organisation had any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Australian Bureau of Statistics, 2011, TABL 1 POST AR POA S; Azim HA, 2011, ANN ONCOL, V22, P1939, DOI 10.1093/annonc/mdq683; Basch E, 2006, LANCET ONCOL, V7, P903, DOI 10.1016/S1470-2045(06)70910-X; Basch E, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju244; Bent S, 2006, ANN INTERN MED, V144, P257, DOI 10.7326/0003-4819-144-4-200602210-00007; Bloechl-Daum B, 2006, J CLIN ONCOL, V24, P4472, DOI 10.1200/JCO.2006.05.6382; BONADONNA G, 1995, NEW ENGL J MED, V332, P901, DOI 10.1056/NEJM199504063321401; BONADONNA G, 1981, NEW ENGL J MED, V304, P10, DOI 10.1056/NEJM198101013040103; Cancer Institute NSW, EVIQ CANC TREATM ONL; Carelle N, 2002, CANCER-AM CANCER SOC, V95, P155, DOI 10.1002/cncr.10630; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; COATES A, 1983, EUR J CANCER CLIN ON, V19, P203, DOI 10.1016/0277-5379(83)90418-2; deBoerDennert M, 1997, BRIT J CANCER, V76, P1055, DOI 10.1038/bjc.1997.507; Di Maio M, 2015, J CLIN ONCOL, V33, P910, DOI 10.1200/JCO.2014.57.9334; Drummond MF, 1998, MED DECIS MAKING, V18, pS12, DOI 10.1177/0272989X98018002S03; Du X. L., 2002, J CLIN ONCOLOGY, V20; Eldadah BA, 2010, PM&R, V2, P406, DOI 10.1016/j.pmrj.2010.03.022; Fromme EK, 2004, J CLIN ONCOL, V22, P3485, DOI 10.1200/JCO.2004.03.025; Gallagher P, 2009, BEST PRACT RES CL GA, V23, P875, DOI 10.1016/j.bpg.2009.09.001; Garrison LP, 2007, VALUE HEALTH, V10, P326, DOI 10.1111/j.1524-4733.2007.00186.x; Henry DH, 2008, SUPPORT CARE CANCER, V16, P791, DOI 10.1007/s00520-007-0380-2; Ihbe-Heffinger A, 2004, ANN ONCOL, V15, P526, DOI 10.1093/annonc/mdh110; Institute NC, 2010, COMMON TERMINOLOGY C; Kahn KL, 2010, JAMA-J AM MED ASSOC, V303, P1037, DOI 10.1001/jama.2010.272; Kuo SH, 2008, BREAST, V17, P646, DOI 10.1016/j.breast.2008.05.006; Lopez-Jimenez J, 2006, HAEMATOLOGICA, V91, P84; OECD, 2005, HLTH TECHN DEC MAK; Pearce A, 2015, EXPERT REV PHARM OUT, V15, P215, DOI 10.1586/14737167.2015.990888; Pitrou I, 2009, ARCH INTERN MED, V169, P1756, DOI 10.1001/archinternmed.2009.306; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Sanoff HK, 2012, CANCER-AM CANCER SOC, V118, P4309, DOI 10.1002/cncr.27422; Scharf O, 2006, J CLIN ONCOL, V24, P3933, DOI 10.1200/JCO.2005.05.3959; Ward RL, 2015, ASIA-PAC J CLIN ONCO, V11, P178, DOI 10.1111/ajco.12354; Wisnivesky JP, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4013; WOOD WC, 1994, NEW ENGL J MED, V330, P1253, DOI 10.1056/NEJM199405053301801	35	203	203	9	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0184360	10.1371/journal.pone.0184360	http://dx.doi.org/10.1371/journal.pone.0184360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016607	Green Published, gold, Green Submitted			2022-12-26	WOS:000412627400007
J	Won, EJ; Choi, MJ; Shin, JH; Park, YJ; Byun, SA; Jung, JS; Kim, SH; Shin, MG; Suh, SP				Won, Eun Jeong; Choi, Min Ji; Shin, Jong Hee; Park, Yeon-Jun; Byun, Seung A.; Jung, Jee Seung; Kim, Soo Hyun; Shin, Myung Geun; Suh, Soon-Pal			Diversity of clinical isolates of Aspergillus terreus in antifungal susceptibilities, genotypes and virulence in Galleria mellonella model: Comparison between respiratory and ear isolates	PLOS ONE			English	Article							AMPHOTERICIN-B; MOLECULAR-IDENTIFICATION; DISSEMINATED INFECTION; OTOMYCOSIS; HOSPITALS; COMPLEX	We analyzed the antifungal susceptibility profiles, genotypes, and virulence of clinical Aspergillus terreus isolates from six university hospitals in South Korea. Thirty one isolates of A. terreus, comprising 15 respiratory and 16 ear isolates were assessed. Microsatellite genotyping was performed, and genetic similarity was assessed by calculating the Jaccard index. Virulence was evaluated by Galleria mellonella survival assay. All 31 isolates were susceptible to itraconazole, posaconazole, and voriconazole, while 23 (74.2%) and 6 (19.4%) showed amphotericin B (AMB) minimum inhibitory concentrations (MICs) of <= 1 mg/L and > 4 mg/L, respectively. Notably, respiratory isolates showed significantly higher geometric mean MICs than ear isolates to AMB (2.41 vs. 0.48 mg/L), itraconazole (0.40 vs. 0.19 mg/L), posaconazole (0.16 vs. 0.08 mg/L), and voriconazole (0.76 vs. 0.31 mg/L) (all, P < 0.05). Microsatellite genotyping separated the 31 isolates into 27 types, but the dendrogram demonstrated a closer genotypic relatedness among isolates from the same body site (ear or respiratory tract); in particular, the majority of ear isolates clustered together. Individual isolates varied markedly in their ability to kill infected G. mellonella after 72 h, but virulence did not show significant differences according to source (ear or respiratory tract), genotype, or antifungal susceptibility. The current study shows the marked diversity of clinical isolates of A. terreus in terms of antifungal susceptibilities, genotypes and virulence in the G. mellonella model, and ear isolates from Korean hospitals may have lower AMB or triazole MICs than respiratory isolates.	[Won, Eun Jeong; Choi, Min Ji; Shin, Jong Hee; Byun, Seung A.; Jung, Jee Seung; Kim, Soo Hyun; Shin, Myung Geun; Suh, Soon-Pal] Chonnam Natl Univ, Dept Lab Med, Med Sch, Gwangju, South Korea; [Park, Yeon-Jun] Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul, South Korea	Chonnam National University; Catholic University of Korea	Shin, JH (corresponding author), Chonnam Natl Univ, Dept Lab Med, Med Sch, Gwangju, South Korea.	shinjh@chonnam.ac.kr	Won, Eun Jeong/AGX-7670-2022		Research of Korea Centers for Disease Control and Prevention [2015E4400100]; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2016R1A2B4008181, NRF-2016R1C1B1009746]	Research of Korea Centers for Disease Control and Prevention; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by a fund (2015E4400100) by Research of Korea Centers for Disease Control and Prevention to Jong Hee Shin and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF-2016R1A2B4008181 to Jong Hee Shin; NRF-2016R1C1B1009746 to Eun Jeong Won).	Al-Wathiqi F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-126; Alastruey-Izquierdo A, 2012, ANN NY ACAD SCI, V1273, P18, DOI 10.1111/j.1749-6632.2012.06822.x; Anaissie E, 1989, Infect Dis Clin North Am, V3, P867; Baddley JW, 2009, J CLIN MICROBIOL, V47, P3271, DOI 10.1128/JCM.00854-09; Baddley JW, 2003, J CLIN MICROBIOL, V41, P5525, DOI 10.1128/JCM.41.12.5525-5529.2003; Balajee SA, 2009, J CLIN MICROBIOL, V47, P3138, DOI 10.1128/JCM.01070-09; Blum G, 2008, CLIN MICROBIOL INFEC, V14, P1146, DOI 10.1111/j.1469-0691.2008.02099.x; Blum G, 2013, ANTIMICROB AGENTS CH, V57, P1583, DOI 10.1128/AAC.01283-12; Clinical Laboratory Standards Institute, 2008, REF METH BROTH DIL A; de Valk HA, 2008, MYCOSES, V51, P463, DOI 10.1111/j.1439-0507.2008.01538.x; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Escribano P, 2012, CLIN MICROBIOL INFEC, V18, pE24, DOI 10.1111/j.1469-0691.2011.03714.x; Espinel-Ingroff A, 2016, REV IBEROAM MICOL, V33, P63, DOI 10.1016/j.riam.2016.04.001; Gomez-Lopez A, 2003, ANTIMICROB AGENTS CH, V47, P3085, DOI 10.1128/AAC.47.10.3085-3088.2003; Heo MS, 2015, ANN LAB MED, V35, P602, DOI 10.3343/alm.2015.35.6.602; Ho HC, 2014, J LARYNGOL OTOL, V128, P547, DOI 10.1017/S0022215114001273; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Kathuria S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118997; Kim MN, 2009, CLIN INFECT DIS, V48, pe57, DOI 10.1086/597108; Lackner M, 2016, CLIN MICROBIOL INFEC, V22, P270, DOI 10.1016/j.cmi.2015.10.021; LAHAM MN, 1982, AM REV RESPIR DIS, V125, P769; Lass-Florl C, 2005, BRIT J HAEMATOL, V131, P201, DOI 10.1111/j.1365-2141.2005.05763.x; Maurer E, 2015, VIRULENCE, V6, P603, DOI 10.1080/21505594.2015.1045183; Neal COS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-203; Paulussen C, 2017, MICROB BIOTECHNOL, V10, P296, DOI 10.1111/1751-7915.12367; Rougeron A, 2014, CLIN MICROBIOL INFEC, V20, P327, DOI 10.1111/1469-0691.12323; Speth C, 2013, MED MICROBIOL IMMUN, V202, P379, DOI 10.1007/s00430-013-0300-7; Tortorano AM, 2008, J CHEMOTHERAPY, V20, P756, DOI 10.1179/joc.2008.20.6.756; TRACY SL, 1983, AM J CLIN PATHOL, V80, P728, DOI 10.1093/ajcp/80.5.728; TRITZ DM, 1993, CLIN INFECT DIS, V16, P118, DOI 10.1093/clinids/16.1.118; Vennewald I, 2010, CLIN DERMATOL, V28, P202, DOI 10.1016/j.clindermatol.2009.12.003; Vesper SJ, 2007, J WATER HEALTH, V5, P427, DOI 10.2166/wh.2007.038; Walsh TJ, 2003, J INFECT DIS, V188, P305, DOI 10.1086/377210	33	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186086	10.1371/journal.pone.0186086	http://dx.doi.org/10.1371/journal.pone.0186086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016668	Green Submitted, gold, Green Published			2022-12-26	WOS:000412601800037
J	Hallmann, CA; Sorg, M; Jongejans, E; Siepel, H; Hofland, N; Schwan, H; Stenmans, W; Muller, A; Sumser, H; Horren, T; Goulson, D; de Kroon, H				Hallmann, Caspar A.; Sorg, Martin; Jongejans, Eelke; Siepel, Henk; Hofland, Nick; Schwan, Heinz; Stenmans, Werner; Mueller, Andreas; Sumser, Hubert; Hoerren, Thomas; Goulson, Dave; de Kroon, Hans			More than 75 percent decline over 27 years in total flying insect biomass in protected areas	PLOS ONE			English	Article							LONG-TERM CHANGES; SEMINATURAL GRASSLANDS; BRITISH BUTTERFLIES; ECOLOGICAL TRAPS; CLIMATE; BRITAIN; PLANTS; MOTHS; CONSERVATION; POLLINATORS	Global declines in insects have sparked wide interest among scientists, politicians, and the general public. Loss of insect diversity and abundance is expected to provoke cascading effects on food webs and to jeopardize ecosystem services. Our understanding of the extent and underlying causes of this decline is based on the abundance of single species or taxonomic groups only, rather than changes in insect biomass which is more relevant for ecological functioning. Here, we used a standardized protocol to measure total insect biomass using Malaise traps, deployed over 27 years in 63 nature protection areas in Germany (96 unique location-year combinations) to infer on the status and trend of local entomofauna. Our analysis estimates a seasonal decline of 76%, and mid-summer decline of 82% in flying insect biomass over the 27 years of study. We show that this decline is apparent regardless of habitat type, while changes in weather, land use, and habitat characteristics cannot explain this overall decline. This yet unrecognized loss of insect biomass must be taken into account in evaluating declines in abundance of species depending on insects as a food source, and ecosystem functioning in the European landscape.	[Hallmann, Caspar A.; Jongejans, Eelke; Siepel, Henk; Hofland, Nick; de Kroon, Hans] Radboud Univ Nijmegen, Inst Water & Wetland Res, Anim Ecol & Physiol & Expt Plant Ecol, POB 9100, NL-6500 GL Nijmegen, Netherlands; [Sorg, Martin; Schwan, Heinz; Stenmans, Werner; Mueller, Andreas; Sumser, Hubert; Hoerren, Thomas] Entomol Soc Krefeld eV, Entomol Collect Krefeld, Marktstr 159, D-47798 Krefeld, Germany; [Goulson, Dave] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	Radboud University Nijmegen; University of Sussex	Hallmann, CA (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Anim Ecol & Physiol & Expt Plant Ecol, POB 9100, NL-6500 GL Nijmegen, Netherlands.	c.hallmann@science.ru.nl	Siepel, Henk/Q-8145-2019; Siepel, Henk/C-2579-2011; Goulson, David/A-2462-2010; Jongejans, Eelke/B-4832-2008; de Kroon, Hans/B-3359-2009	Siepel, Henk/0000-0003-4503-4485; Siepel, Henk/0000-0003-4503-4485; Goulson, David/0000-0003-4421-2876; Jongejans, Eelke/0000-0003-1148-7419; de Kroon, Hans/0000-0001-6151-3561; Stenmans, Werner/0000-0001-8282-4668; Sorg, Martin/0000-0001-6406-2778; Horren, Thomas/0000-0003-4062-3707	Netherlands Organization for Scientific Research (NWO grants) [840.11.001, 841.11.007]; Triodos Foundation	Netherlands Organization for Scientific Research (NWO grants)(Netherlands Organization for Scientific Research (NWO)); Triodos Foundation	CH and EJ were supported by the Netherlands Organization for Scientific Research (NWO grants 840.11.001 and 841.11.007), and NH by the Triodos Foundation. The investigations of the Entomological Society Krefeld and its members are spread over numerous individual projects at different locations and in different years. Grants and permits that have made this work possible are listed below: Bezirksregierungen Dusseldorf & Koln, BfN - Bundesamt fur Naturschut, Land Nordrhein-Westfalen - Europaische Gemeinschaft ELER, Landesamt fur Agrarordnung Nordrhein-Westfalen, Landesamt fur Natur, Umwelt und Verbraucherschut Nordrhein-Westfalen, Landesamt fur Umwelt Brandenburg, Landesamt fur Umwelt Rheinland-Pfalz, LVR - Landschaftsverband Rheinland, Naturschutbund Deutschland, Nordrhein-Westfalen Stiftung, RBN Bergischer Naturschutverein, RVR - Regionalverband Ruhr, SGD Nord Rheinland-Pfalz, Universitaten Bonn, Duisburg-Essen & Koln, Untere Landschaftsbehorden: Kreis Duren, Kreis Heinsberg, Kreis Kleve, Kreis Viersen, Kreis Wesel & AGLW, Stadt Dusseldorf, Stadt Koln, Stadt Krefeld, Rheinisch Bergischer Kreis, Rhein Kreis Neuss & Rhein-Sieg-Kreis. Members of the Entomological Society Krefeld and cooperating botanists and entomologists that were involved in the empirical investigations are greatly acknowledged: U.W. Abts, F. Bahr, A. Baumler, D. & H. Beutler, P. Birnbrich, U. Bosch, J. Buchner, F. Cassese, K. Colin, A.W. Ebmer, R. Eckelboom, B. Franzen, M. Grigo, J. Gunneberg, J. Gusenleitner, K. Hamacher, F. Hartfeld, M. Hellenthal, J. Hembach, A. Hemmersbach, W. Hock, V. Huisman-Fiegen, J. Illmer, E. Jansen, U. Jackel, F. Koch, M. Kreuels, P. Leiderit, I. Loksa, F. B. Ludescher, F. J. Mehring, G. Milbert, N. Mohr, P. Randazzo, K. Reissmann, S. Risch, B. Robert, J. de Rond, U. Sandmann, S. Scharf, P. Scherz, J. Schiffer, C. Schmidt, O. & W. Schmitz, B. P. & W. Schnell, J. L. Schonfeld, E. Schraetz, M. Schwarz, R. Seliger, H. W. Siebeneicher, F. & H. Sonnenburg W. J. S. & P. Sorg, A. Ssymank, H. Sticht, M. Weithmann, W. Wichard and H. Wolf.; CH and EJ were supported by the Netherlands Organization for Scientific Research (NWO grants 840.11.001 and 841.11.007), and NH by the Triodos Foundation. The investigations of the Entomological Society Krefeld and its members are spread over numerous individual projects at different locations and in different years. Grants and permits that have made this work possible are listed below:; Bezirksregierungen Dusseldorf & Koln, BfN - Bundesamt fur Naturschut, Land Nordrhein-Westfalen - Europaische Gemeinschaft ELER, Landesamt fur Agrarordnung Nordrhein-Westfalen, Landesamt fur Natur, Umwelt und Verbraucherschut Nordrhein-Westfalen, Landesamt fur Umwelt Brandenburg, Landesamt fur Umwelt Rheinland-Pfalz, LVR - Landschaftsverband Rheinland, Naturschutbund Deutschland, Nordrhein-Westfalen Stiftung, RBN Bergischer Naturschutverein, RVR - Regionalverband Ruhr, SGD Nord Rheinland-Pfalz, Universitaten Bonn, Duisburg-Essen & Koln, Untere Landschaftsbehorden: Kreis Duren, Kreis Heinsberg, Kreis Kleve, Kreis Viersen, Kreis Wesel & AGLW, Stadt Dusseldorf, Stadt Koln, Stadt Krefeld, Rheinisch Bergischer Kreis, Rhein Kreis Neuss & Rhein-Sieg-Kreis. Members of the Entomological Society Krefeld and cooperating botanists and entomologists that were involved in the empirical investigations are greatly acknowledged: U.W. Abts, F. Bahr, A. Baumler, D. & H. Beutler, P. Birnbrich, U. Bosch, J. Buchner, F. Cassese, K. Colin, A.W. Ebmer, R. Eckelboom, B. Franzen, M. Grigo, J. Gunneberg, J. Gusenleitner, K. Hamacher, F. Hartfeld, M. Hellenthal, J. Hembach, A. Hemmersbach, W. Hock, V. Huisman-Fiegen, J. Illmer, E. Jansen, U. Jackel, F. Koch, M. Kreuels, P. Leiderit, I. Loksa, F. B. Ludescher, F. J. Mehring, G. Milbert, N. Mohr, P. Randazzo, K. Reissmann, S. Risch, B. Robert, J. de Rond, U. Sandmann, S. Scharf, P. Scherz, J. Schiffer, C. Schmidt, O. & W. Schmitz, B. P. & W. Schnell, J. L. Schonfeld, E. Schraetz, M. Schwarz, R. Seliger, H. W. Siebeneicher, F. & H. Sonnenburg W. J. S. & P. Sorg, A. Ssymank, H. Sticht, M. Weithmann, W. Wichard and H. Wolf.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bosch U, 1994, NATUR NIEDERRHEIN, V9, P40; Brandle M, 2001, BIODIVERS CONSERV, V10, P1497, DOI 10.1023/A:1011815325503; BROWN VK, 1985, OIKOS, V44, P17, DOI 10.2307/3544037; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Conrad KF, 2006, BIOL CONSERV, V132, P279, DOI 10.1016/j.biocon.2006.04.020; Conrad KF, 2002, BIOL CONSERV, V106, P329, DOI 10.1016/S0006-3207(01)00258-0; Cressie N, 1993, WILEY SERIES PROBABI, V15, P16; Dennis RLH, 2007, EUR J ENTOMOL, V104, P763, DOI 10.14411/eje.2007.097; Deutscher Wetterdienst, 2015, REC HIST DAIL NKDZ C; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; ELLENBERG H, 1974, Scripta Geobotanica, V9, P1; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1, DOI DOI 10.1002/FEDR.19931040323; Ewald JA, 2015, GLOBAL CHANGE BIOL, V21, P3931, DOI 10.1111/gcb.13026; Fliszkiewicz M, 2012, ENVIRON ENTOMOL, V41, P1621, DOI 10.1603/EN12004; Fox R, 2014, J APPL ECOL, V51, P949, DOI 10.1111/1365-2664.12256; Fox R, 2013, INSECT CONSERV DIVER, V6, P5, DOI 10.1111/j.1752-4598.2012.00186.x; Fuentes-Montemayor E, 2011, J APPL ECOL, V48, P532, DOI 10.1111/j.1365-2664.2010.01927.x; Furrer RD, 2016, BIOL REV, V91, P782, DOI 10.1111/brv.12195; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gilroy JJ, 2007, TRENDS ECOL EVOL, V22, P351, DOI 10.1016/j.tree.2007.03.014; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Gruebler MU, 2008, AGR ECOSYST ENVIRON, V123, P75, DOI 10.1016/j.agee.2007.05.001; Habel JC, 2015, CONSERV BIOL, P754; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Hellenthal Marlene, 2007, Volucella, V8, P219; Hennekens SM, 2001, J VEG SCI, V12, P589, DOI 10.2307/3237010; Ilyinykh A, 2011, BIOCONTROL, V56, P123, DOI 10.1007/s10526-010-9316-8; Jarvis A, 2008, HOLE FILLED SEAMLESS; Kuussaari M, 2007, J INSECT CONSERV, V11, P351, DOI 10.1007/s10841-006-9052-7; Long OM, 2017, J ANIM ECOL, V86, P108, DOI 10.1111/1365-2656.12594; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Luo W, 2008, INT J CLIMATOL, V28, P947, DOI 10.1002/joc.1583; Matthews R.W., 1983, Contributions of the American Entomological Institute, V20, P428; MATTSON WJ, 1975, SCIENCE, V190, P515, DOI 10.1126/science.190.4214.515; Morecroft MD, 2002, GLOBAL ECOL BIOGEOGR, V11, P7, DOI 10.1046/j.1466-822X.2002.00174.x; Morse D. H., 1971, A Rev Ecol Syst, V2, P177, DOI 10.1146/annurev.es.02.110171.001141; Nilsson SG, 2008, INSECT CONSERV DIVER, V1, P197, DOI 10.1111/j.1752-4598.2008.00027.x; Ockinger E, 2007, J APPL ECOL, V44, P50, DOI 10.1111/j.1365-2664.2006.01250.x; Ollerton J, 2014, SCIENCE, V346, P1360, DOI 10.1126/science.1257259; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Core Team, 2021, R LANGUAGE ENV STAT; Schmidt C, 1995, NATUR NIEDERRHEIN, V10, P62; Schwan H, 1993, NAT NIEDERRHEIN NF, V8, P1; Shortall CR, 2009, INSECT CONSERV DIVER, V2, P251, DOI 10.1111/j.1752-4598.2009.00062.x; Sorg M., 1990, Pflanzenschutz-Nachrichten Bayer, V43, P29; Sorg M., 2013, VER KREF, V1, P1; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; Thomas JA, 2016, SCIENCE, V353, P216, DOI 10.1126/science.aaf8838; TOWNES H, 1972, Entomological News, V83, P239; van Swaay C, 2013, EEA TECHNICAL REPORT, P11; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Woodcock BA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12459; World Wide Fund for Nature, 2016, LIV PLAN REP 2016 RI; Yang LH, 2014, CURR OPIN INSECT SCI, V2, P26, DOI 10.1016/j.cois.2014.06.004	65	1338	1430	663	1426	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185809	10.1371/journal.pone.0185809	http://dx.doi.org/10.1371/journal.pone.0185809			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045418	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100029
J	Deuel, NR; Conner, LM; Miller, KV; Chamberlain, MJ; Cherry, MJ; Tannenbaum, LV				Deuel, Nicholas R.; Conner, L. Mike; Miller, Karl V.; Chamberlain, Michael J.; Cherry, Michael J.; Tannenbaum, Larry V.			Habitat selection and diurnal refugia of gray foxes in southwestern Georgia, USA	PLOS ONE			English	Article							CLASSIFICATION-BASED ANALYSES; CAUSE-SPECIFIC MORTALITY; UROCYON-CINEREOARGENTEUS; RED FOXES; SPATIAL ECOLOGY; TEMPORAL SCALES; CANIS-LATRANS; USE PATTERNS; HOME-RANGE; SPACE-USE	Understanding habitat selection of gray foxes (Urocyon cinereoargenteus) is essential to evaluate their potential response to changes in land use and predator communities. Few studies have evaluated temporal habitat selection or explicitly identified habitats used by gray foxes for diurnal refugia. We used GPS collars to obtain location data for 34 gray foxes (20 males and 14 females) from February 2014 to December 2015 to evaluate temporal (seasonal and diel) habitat selection and selection of diurnal refugia in southwestern Georgia, USA. We analyzed habitat selection at 2 levels, selection of a core area within the home range and selection of locations within the home range. Habitat selection was non-random (P < 0.001) but consistent among seasons, between day and night, and between sexes (P > 0.05). Hardwoods, human use (i.e., areas associated with regular human activity such as buildings, lawns, parking areas, etc.), and roads were selected (P < 0.05), whereas pine dominated stands were used randomly (P > 0.05). Selection of habitats for diurnal refugia did not vary seasonally or by sex (P > 0.05), with foxes selecting (P < 0.05) areas near hardwood forests, roads, agriculture, human use, pastures/food plots, and shrub scrub habitats. Gray foxes were observed on the ground while resting, and we found no evidence of gray foxes diurnally resting in trees. Our results suggest that on our study area, gray foxes are an edge species that prefer forests with a hardwood component in areas near human use and roads.	[Deuel, Nicholas R.; Conner, L. Mike; Cherry, Michael J.] Joseph W Jones Ecol Res Ctr, 3988 Jones Ctr Dr, Newton, GA USA; [Deuel, Nicholas R.; Miller, Karl V.; Chamberlain, Michael J.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Tannenbaum, Larry V.] US Army, Publ Hlth Ctr, MCHB PH HRA, Bldg 1675, Aberdeen Proving Ground, MD USA; [Cherry, Michael J.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA	University System of Georgia; University of Georgia; Virginia Polytechnic Institute & State University	Conner, LM (corresponding author), Joseph W Jones Ecol Res Ctr, 3988 Jones Ctr Dr, Newton, GA USA.	mconner@jonesctr.org			Tenant/Garrison Contracting Division [W91ZLK, W91ZLK-13-P-0534]; Army Public Health Center; Joseph W. Jones Ecological Research Center; War-nell School of Forestry and Natural Resources	Tenant/Garrison Contracting Division; Army Public Health Center; Joseph W. Jones Ecological Research Center; War-nell School of Forestry and Natural Resources	This work was supported Tenant/Garrison Contracting Division-W91ZLK, contract number W91ZLK-13-P-0534. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jerry Wade and Darren McVey for assistance with animal capture, Gail Morris for assistance with day-to-day logistics and research advice, and Jean Brock for GIS assistance. The Army Public Health Center, the Joseph W. Jones Ecological Research Center and the War-nell School of Forestry and Natural Resources provide research support.	Benson JF, 2013, METHODS ECOL EVOL, V4, P244, DOI 10.1111/2041-210x.12006; Boring L. R., 2001, HOLISTIC SCI EVOLUTI, P233; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Chamberlain MJ, 2000, J WILDLIFE MANAGE, V64, P742, DOI 10.2307/3802744; Chamberlain MJ, 2005, AM MIDL NAT, V153, P171, DOI 10.1674/0003-0031(2005)153[0171:OISUAB]2.0.CO;2; Cherry MJ, 2016, WILDLIFE RES, V43, P662, DOI 10.1071/WR16052; Conner L. Mike, 2001, P275, DOI 10.1016/B978-012497781-5/50011-6; Conner LM, 2005, ECOLOGY, V86, P3125, DOI 10.1890/05-0760; Conner LM, 2003, ECOLOGY, V84, P526, DOI 10.1890/0012-9658(2003)084[0526:ACODBA]2.0.CO;2; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Cypher Brian L., 2013, Canid News, V16, P25; Dussault C, 2005, ECOLOGY, V86, P3119, DOI 10.1890/05-0203; Erickson Wallace P., 2001, P209, DOI 10.1016/B978-012497781-5/50009-8; Farias V, 2005, J ZOOL, V266, P249, DOI 10.1017/S0952836905006850; Farias V, 2012, SOUTHWEST NAT, V57, P176, DOI 10.1894/0038-4909-57.2.176; Fedriani JM, 2000, OECOLOGIA, V125, P258, DOI 10.1007/s004420000448; Follman EH, 1973, THESIS; Fritzell E.K., 1987, P408; FRITZELL E K, 1982, Mammalian Species, P1, DOI 10.2307/3503957; FULLER TK, 1978, J MAMMAL, V59, P446, DOI 10.2307/1379941; Gehrt SD, 2009, J MAMMAL, V90, P1045, DOI 10.1644/08-MAMM-A-277.1; George SL, 2006, BIOL CONSERV, V133, P107, DOI 10.1016/j.biocon.2006.05.024; Godbois IA, 2003, PROCEEDINGS OF THE FIFTY-SEVENTH ANNUAL CONFERENCE OF THE SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P228; Godbois IA, 2004, J WILDLIFE MANAGE, V68, P514, DOI 10.2193/0022-541X(2004)068[0514:SPOBRT]2.0.CO;2; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Goebel PC, 1997, 971 JON EC RES CTR; Grinnell J, 1937, BEARING MAMMALS CA; Gunderson H. L., 1961, Journal of Mammalogy, V42, P270; HAROLDSON KJ, 1984, J WILDLIFE MANAGE, V48, P222, DOI 10.2307/3808476; HARRISON DJ, 1989, J WILDLIFE MANAGE, V53, P181, DOI 10.2307/3801327; Harrison RL, 1997, J WILDLIFE MANAGE, V61, P112, DOI 10.2307/3802420; Henke SE, 1999, J WILDLIFE MANAGE, V63, P1066, DOI 10.2307/3802826; Hinton JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132203; HOCKMAN JG, 1983, AM MIDL NAT, V110, P276, DOI 10.2307/2425269; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Howze M. Brent, 2009, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V63, P17; JOHNSON AS, 1978, J WILDLIFE MANAGE, V42, P606, DOI 10.2307/3800824; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Johnson DH, 1948, VERTEBRATE ANIMALS P; JOHNSON WC, 1979, AM MIDL NAT, V101, P231, DOI 10.2307/2424918; Kamler JF, 2000, CAN J ZOOL, V78, P2106, DOI 10.1139/cjz-78-12-2106; Kie J.G., 2013, ANIM BIOTELEM, V1, P13, DOI [10.1186/2050-3385-1-13, DOI 10.1186/2050-3385-1-13]; Kirby RB, 2016, RESTOR ECOL IN PRESS; LANDERS JL, 1986, MISCELLANEOUS PUBLIC, V6; Levi T, 2012, ECOLOGY, V93, P921, DOI 10.1890/11-0165.1; Lombardi JV, 2017, URBAN ECOSYS; LORD REXFORD D., 1961, AMER MIDLAND NAT, V66, P87, DOI 10.2307/2422869; Morris G, 2016, FOREST ECOL MANAG, V366, P23, DOI 10.1016/j.foreco.2016.02.006; Newsome TM, 2015, J ANIM ECOL, V84, P49, DOI 10.1111/1365-2656.12258; ORIANS GH, 1991, AM NAT, V137, pS29, DOI 10.1086/285138; Pierce BM, 2004, J WILDLIFE MANAGE, V68, P533, DOI 10.2193/0022-541X(2004)068[0533:HSBMDF]2.0.CO;2; Progulske Donald R., 1997, Journal of Wildlife Research, V2, P15; Quinn T, 1997, NORTHWEST SCI, V71, P289; R Core Team, 2021, R LANGUAGE ENV STAT; Riley SPD, 2006, J WILDLIFE MANAGE, V70, P1425, DOI 10.2193/0022-541X(2006)70[1425:SEOBAG]2.0.CO;2; Riley SPD, 2003, CONSERV BIOL, V17, P566, DOI 10.1046/j.1523-1739.2003.01458.x; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Sacks BN, 1999, J WILDLIFE MANAGE, V63, P593, DOI 10.2307/3802648; Sawyer DT, 1994, PROCEEDINGS OF THE FORTY-EIGHTH ANNUAL CONFERENCE - SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P162; Sequin ES, 2003, CAN J ZOOL, V81, P2015, DOI 10.1139/Z03-204; SOVADA MA, 1995, J WILDLIFE MANAGE, V59, P1, DOI 10.2307/3809108; Sunquist M.E., 1989, Florida Field Naturalist, V17, P11; Temple DL, 2010, AM MIDL NAT, V163, P413, DOI 10.1674/0003-0031-163.2.413; WHITE PJ, 1994, CAN J ZOOL, V72, P1831, DOI 10.1139/z94-247; Wilson SE, 2007, AM MIDL NAT, V157, P175, DOI 10.1674/0003-0031(2007)157[175:HCORDR]2.0.CO;2; Wood J. E., 1958, Journal of Mammalogy, V39, P74, DOI 10.2307/1376612; WOOD JE, 1958, ECOLOGY, V39, P160, DOI 10.2307/1929984; Yeager LE, 1938, J MAMMAL, V19, P376; YEARSLEY EF, 1980, J WILDLIFE MANAGE, V44, P729, DOI 10.2307/3808030	69	10	10	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186402	10.1371/journal.pone.0186402	http://dx.doi.org/10.1371/journal.pone.0186402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040319	Green Submitted, Green Published, gold			2022-12-26	WOS:000413167500042
J	Uritani, D; Fukumoto, T; Myodo, T; Fujikawa, K; Usui, M; Tatara, D				Uritani, Daisuke; Fukumoto, Takahiko; Myodo, Tomoki; Fujikawa, Kazuhito; Usui, Miyuki; Tatara, Daisuke			The association between toe grip strength and osteoarthritis of the knee in Japanese women: A multicenter cross-sectional study	PLOS ONE			English	Article							CHRONIC POSTURAL PAIN; FOOT KINEMATICS; OLDER-ADULTS; FUNCTIONAL MOBILITY; GAIT STYLE; WALKING; REARFOOT; PEOPLE; MOTION; LIMITATIONS	We evaluated the relationship between altered foot function and knee osteoarthritis through a specific comparison of toe grip strength in older women with and without knee osteoarthritis. Participants were 120 women with knee osteoarthritis (OA group) and 108 healthy community-dwelling women with no history of knee pain and lower limb surgery (control group). The following factors and outcome variables were included in our analysis: measured toe grip strength, isometric knee extension strength, the timed Up-and-Go, and the WOMAC scale. Between-group differences were compared using unpaired t-tests for descriptive characteristics and outcome measures. Pearson's correlation coefficients between toe grip strength and age, body mass index, and other outcome measures were calculated. Multiple logistic regression analysis was used to evaluate the independence of toe grip strength and knee osteoarthritis. Compared to the control group, participants in the OA group were older, heavier, and had a higher body mass index. Toe grip strength and isometric knee extension strength were lower and the timed Up-and-Go longer for the OA group than the control group. Toe grip strength was correlated with age negatively and isometric knee extension strength positively in the OA group and to age and the timed Up-and-Go negatively, and isometric knee extension strength positively in the control group. Multiple logistic regression analysis revealed that body mass index, isometric knee extensor strength, and toe grip strength were independently associated with knee osteoarthritis. Our findings indicate a probable association between altered forefoot function and the incidence or progression of knee osteoarthritis. Increasing toe grip strength might provide a practical intervention for patients with knee osteoarthritis.	[Uritani, Daisuke; Fukumoto, Takahiko] Kio Univ, Dept Phys Therapy, Fac Hlth Sci, Nara, Japan; [Myodo, Tomoki] Nishinokyo Hosp, Dept Rehabil, Nara, Japan; [Fujikawa, Kazuhito] Yamato Kashihara Hosp, Dept Rehabil, Nara, Japan; [Usui, Miyuki] Oogaki Chuo Hosp, Dept Rehabil, Gifu, Japan; [Tatara, Daisuke] Fukuoka Shion Hosp, Dept Rehabil, Fukuoka, Japan; [Usui, Miyuki] Body Remake Motto, Gifu, Japan		Uritani, D (corresponding author), Kio Univ, Dept Phys Therapy, Fac Hlth Sci, Nara, Japan.	d.uritani@kio.ac.jp		Uritani, Daisuke/0000-0003-1009-1412	JSPS KAKENHI [25870971]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant number 25870971, http://www.jsps.go.jp/j-grantsinaid/index.html.	AHMED AM, 1983, J BIOMECH ENG-T ASME, V105, P216, DOI 10.1115/1.3138409; Amin S, 2004, ARTHRIT RHEUM-ARTHR, V51, P371, DOI 10.1002/art.20396; Arnold J, 2014, KNEE, V21, P1101, DOI 10.1016/j.knee.2014.08.004; Arnold JB, 2014, GAIT POSTURE, V39, P689, DOI 10.1016/j.gaitpost.2013.09.021; Bennell KL, 2011, ANN RHEUM DIS, V70, P1770, DOI 10.1136/ard.2010.147082; Bennell KL, 2010, ANN RHEUM DIS, V69, P1151, DOI 10.1136/ard.2009.118182; Burnfield JM, 2004, CLIN BIOMECH, V19, P78, DOI 10.1016/j.clinbiomech.2003.09.007; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; DANANBERG HJ, 1993, J AM PODIAT MED ASSN, V83, P615, DOI 10.7547/87507315-83-11-615; DANANBERG HJ, 1993, J AM PODIAT MED ASSN, V83, P433, DOI 10.7547/87507315-83-8-433; Dananberg HJ, 2007, MOVEMENT STABILITY L, P253; Gross KD, 2011, ARTHRIT CARE RES, V63, P937, DOI 10.1002/acr.20431; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Hashimoto Hideki, 2003, J Orthop Sci, V8, P288, DOI 10.1007/s10776-002-0629-0; Hessert Mary Josephine, 2005, BMC Geriatr, V5, P8; HICKS JH, 1954, J ANAT, V88, P25; HUGHES J, 1990, J BONE JOINT SURG BR, V72, P245, DOI 10.1302/0301-620X.72B2.2312564; Kamon M, 2005, TOKAI J SPORTS MED S, V17, P48; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Koblbauer IFH, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-249; LAFORTUNE MA, 1994, J ORTHOPAED RES, V12, P412, DOI 10.1002/jor.1100120314; Lee J, 2013, PM&R, V5, P609, DOI 10.1016/j.pmrj.2013.04.001; Levinger P, 2012, RHEUMATOLOGY, V51, P2191, DOI 10.1093/rheumatology/kes222; Levinger P, 2010, J FOOT ANKLE RES, V3, DOI 10.1186/1757-1146-3-29; Lundgren P, 2008, GAIT POSTURE, V28, P93, DOI 10.1016/j.gaitpost.2007.10.009; MANN RA, 1979, CLIN ORTHOP RELAT R, P24; Marschollek M, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-48; Misu S, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-143; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Nester CJ, 2000, FOOT ANKLE INT, V21, P578, DOI 10.1177/107110070002100709; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Reilly K, 2009, PHYSIOTHERAPY, V95, P164, DOI 10.1016/j.physio.2009.04.003; Reilly KA, 2006, FOOT ANKLE INT, V27, P206, DOI 10.1177/107110070602700310; Saito I, 2013, ARCH PHYS MED REHAB, V94, P2502, DOI 10.1016/j.apmr.2013.07.017; Souza TR, 2010, CLIN BIOMECH, V25, P745, DOI 10.1016/j.clinbiomech.2010.04.012; Uritani Daisuke, 2017, J Phys Ther Sci, V29, P361, DOI 10.1589/jpts.29.361; Uritani D, 2016, J AGING PHYS ACTIV, V24, P459, DOI 10.1123/japa.2015-0123; Uritani D, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/1757-1146-7-28; Uritani D, 2012, J PHYS THER SCI, V24, P639, DOI 10.1589/jpts.24.639; Wrisley DM, 2010, PHYS THER, V90, P761, DOI 10.2522/ptj.20090069	40	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186454	10.1371/journal.pone.0186454	http://dx.doi.org/10.1371/journal.pone.0186454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KA	29040330	gold, Green Submitted, Green Published			2022-12-26	WOS:000413167500049
J	Hermoso, M; Lefeuvre, B; Minoletti, F; de Rafelis, M				Hermoso, Michael; Lefeuvre, Benjamin; Minoletti, Fabrice; de Rafelis, Marc			Extreme strontium concentrations reveal specific biomineralization pathways in certain coccolithophores with implications for the Sr/Ca paleoproductivity proxy	PLOS ONE			English	Article							EMILIANIA-HUXLEYI; ISOTOPE FRACTIONATION; SR INCORPORATION; CALCITE; MAGNESIUM; CALCIFICATION; CARBONATE; RATIOS; PALEOCEANOGRAPHY; CALIBRATIONS	The formation of the coccolith biominerals by a group of marine algae (the Coccolithophores) offers fascinating research avenues both from the biological and geological sides. It is surprising how biomineralisation by a key phytoplanktonic group remains underconstrained, yet is influential on ocean alkalinity and responsible for the built up of our paleoclimatic archive over the last 200 Myrs. Here, we report two close relative coccolith taxa exhibiting substantial bioaccumulation of strontium: Scyphosphaera and Pontosphaera grown in the laboratory or retrieved from Pliocene sediments. This strontium enrichment relative to calcium is one order of magnitude greater than reported in other coccoliths of the orders Isochrysidales and Coccolithales, and extends well beyond established controls on Sr/Ca ratios by temperature and growth rate. We discuss this prominent vital effect in relation with possible specific uptake of strontium relative to calcium from the extracellular environment to the coccolith vesicle in coccolithophores excreting very large scale coccoliths. The report of Sr-rich biominerals challenges our current understanding of the cellular acquisition and intracellular trafficking of alkaline earth cations in phytoplanktonic calcifying eukaryotic algae. The presence of Sr-rich coccolith species in the geological record has to be quantitatively considered in future Sr/Ca-based palaeoceanographic reconstruction.	[Hermoso, Michael; Lefeuvre, Benjamin; Minoletti, Fabrice] UPMC Univ Paris 06, Sorbonne Univ, CNRS, Inst Sci Terre Paris,UMR 7193, Paris, France; [Hermoso, Michael] Univ Oxford, Dept Earth Sci, Oxford, England; [de Rafelis, Marc] Univ Toulouse III Paul Sabatier, CNRS, Geosci Environm Toulouse UMR GET 5563, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; University of Oxford; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Hermoso, M (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, CNRS, Inst Sci Terre Paris,UMR 7193, Paris, France.; Hermoso, M (corresponding author), Univ Oxford, Dept Earth Sci, Oxford, England.	Michael.Hermoso@upmc.fr	Lefeuvre, Benjamin/AAA-6618-2022; Hermoso, Michael/A-1029-2009	Hermoso, Michael/0000-0003-1427-1891; de Rafelis, Marc/0000-0002-1466-249X	Natural Environment Research Council [NE/H015523/1]; Sorbonne Universites; NERC [NE/H015523/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Sorbonne Universites(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	MH acknowledges funding from the Natural Environment Research Council through individual fellowship NE/H015523/1. MH and MF are grateful to the LABEx MATISSE led by Sorbonne Universites for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi G, 2015, BIOGEOSCIENCES, V12, P4665, DOI 10.5194/bg-12-4665-2015; Anning T, 1996, J MARINE SYST, V9, P45, DOI 10.1016/0924-7963(96)00015-2; Aubry MP, 2009, GEOL SOC AM SPEC PAP, V452, P279, DOI 10.1130/2009.2452(18); AUBRY MP, 1988, PALEOBIOLOGY, V14, P64, DOI 10.1017/S0094837300011805; Beltran C., 2006, THESIS; Blanco-Ameijeiras S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157697; Brownlee C, 2015, SEMIN CELL DEV BIOL, V46, P11, DOI 10.1016/j.semcdb.2015.10.027; Clemence ME, 2015, PALAEOGEOGR PALAEOCL, V427, P100, DOI 10.1016/j.palaeo.2015.03.024; DePaolo DJ, 2011, GEOCHIM COSMOCHIM AC, V75, P1039, DOI 10.1016/j.gca.2010.11.020; DEVISSER JP, 1989, PALAEOGEOGR PALAEOCL, V69, P45, DOI 10.1016/0031-0182(89)90155-7; Drescher B, 2012, J PHYCOL, V48, P1343, DOI 10.1111/j.1529-8817.2012.01227.x; Durak GM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10543; Elderfield H, 2006, EARTH PLANET SC LETT, V250, P633, DOI 10.1016/j.epsl.2006.07.041; Elderfield H., 2000, GEOCHEM GEOPHY GEOSY, V1, DOI DOI 10.1029/1999GC000031; Fink C, 2010, GEOBIOS-LYON, V43, P151, DOI 10.1016/j.geobios.2009.11.001; Gussone N, 2006, GEOLOGY, V34, P625, DOI 10.1130/G22733.1; Hermoso M, 2007, AM GEOPH UN FALL M; Hermoso M, 2014, CRYPTOGAMIE ALGOL, V35, P323, DOI 10.7872/crya.v35.iss4.2014.323; Hermoso M, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2009PA001764; Hermoso M, 2009, EARTH PLANET SC LETT, V277, P194, DOI 10.1016/j.epsl.2008.10.013; KELLER MD, 1987, J PHYCOL, V23, P633; KRINSLEY D, 1960, J PALEONTOL, V34, P744; Langer G, 2006, LIMNOL OCEANOGR, V51, P310, DOI 10.4319/lo.2006.51.1.0310; LANGEREIS CG, 1991, EARTH PLANET SC LETT, V104, P211, DOI 10.1016/0012-821X(91)90205-V; LaRoche J., 2010, GUIDE BEST PRACTICES, P81; Lea DW, 1999, GEOCHIM COSMOCHIM AC, V63, P2369, DOI 10.1016/S0016-7037(99)00197-0; Lea DWW, 2014, ELEMENTAL ISOTOPIC P, P373; Lourens LJ, 1996, PALEOCEANOGRAPHY, V11, P391, DOI 10.1029/96PA01125; Mackinder L, 2010, GEOMICROBIOL J, V27, P585, DOI 10.1080/01490451003703014; MANTON I, 1980, BRIT PHYCOL J, V15, P95, DOI 10.1080/00071618000650111; Muller MN, 2014, BIOGEOSCIENCES, V11, P1065, DOI 10.5194/bg-11-1065-2014; Payne VE, 2008, MINERAL MAG, V72, P269, DOI 10.1180/minmag.2008.072.1.269; Raddatz J, 2013, CHEM GEOL, V352, P143, DOI 10.1016/j.chemgeo.2013.06.013; RENARD M, 1986, MAR MICROPALEONTOL, V10, P117, DOI 10.1016/0377-8398(86)90027-7; Rickaby REM, 2007, EARTH PLANET SC LETT, V253, P83, DOI 10.1016/j.epsl.2006.10.016; Rickaby REM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001408; Rickaby REM, 2005, MET IONS BIOL SYST, V44, P241; Rosenthal Y, 1997, GEOCHIM COSMOCHIM AC, V61, P3633, DOI 10.1016/S0016-7037(97)00181-6; Saez AG, 2003, P NATL ACAD SCI USA, V100, P7163, DOI 10.1073/pnas.1132069100; Stevenson EI, 2014, GEOCHIM COSMOCHIM AC, V128, P225, DOI 10.1016/j.gca.2013.11.043; Stoll HM, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/1999GC000015; Stoll HM, 2002, GEOCHIM COSMOCHIM AC, V66, P927, DOI 10.1016/S0016-7037(01)00836-5; Stoll HM, 2002, PHILOS T R SOC A, V360, P719, DOI 10.1098/rsta.2001.0966; Sviben S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11228; Tang JW, 2008, GEOCHIM COSMOCHIM AC, V72, P3718, DOI 10.1016/j.gca.2008.05.031; Taylor A. R, 2016, ANNU REV MAR SCI, V9; Tesoriero AJ, 1996, GEOCHIM COSMOCHIM AC, V60, P1053, DOI 10.1016/0016-7037(95)00449-1; TUREKIAN KK, 1964, GEOCHIM COSMOCHIM AC, V28, P1479, DOI 10.1016/0016-7037(64)90163-2; Wolthers M, 2013, CRYSTENGCOMM, V15, P5506, DOI 10.1039/c3ce40249e; Young J. R., NANNOTAX3; Young J.R., 2003, J NANNOPLANKTON RES, V1, P1; YOUNG JR, 1992, NATURE, V356, P516, DOI 10.1038/356516a0	52	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0185655	10.1371/journal.pone.0185655	http://dx.doi.org/10.1371/journal.pone.0185655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036179	Green Published, gold, Green Submitted			2022-12-26	WOS:000413054800008
J	Loisel, J; MacDonald, GM; Thomson, MJ				Loisel, Julie; MacDonald, Glen M.; Thomson, Marcus J.			Little Ice Age climatic erraticism as an analogue for future enhanced hydroclimatic variability across the American Southwest	PLOS ONE			English	Article							EL-NINO; ATMOSPHERIC RIVERS; LAST MILLENNIUM; FIRE REGIMES; ENSO; DROUGHT; PROXY; CALIFORNIA; PRECIPITATION; WATER	The American Southwest has experienced a series of severe droughts interspersed with strong wet episodes over the past decades, prompting questions about future climate patterns and potential intensification of weather disruptions under warming conditions. Here we show that interannual hydroclimatic variability in this region has displayed a significant level of non-stationarity over the past millennium. Our tree ring-based analysis of past drought indicates that the Little Ice Age (LIA) experienced high interannual hydroclimatic variability, similar to projections for the 21st century. This is contrary to the Medieval Climate Anomaly (MCA), which had reduced variability and therefore may be misleading as an analog for 21st century warming, notwithstanding its warm (and arid) conditions. Given past non-stationarity, and particularly erratic LIA, a 'warm LIA' climate scenario for the coming century that combines high precipitation variability (similar to LIA conditions) with warm and dry conditions (similar to MCA conditions) represents a plausible situation that is supported by recent climate simulations. Our comparison of tree ring-based drought analysis and records from the tropical Pacific Ocean suggests that changing variability in El Nino Southern Oscillation (ENSO) explains much of the contrasting variances between the MCA and LIA conditions across the American Southwest. Greater ENSO variability for the 21st century could be induced by a decrease in meridional sea surface temperature gradient caused by increased greenhouse gas concentration, as shown by several recent climate modeling experiments. Overall, these results coupled with the paleo-record suggests that using the erratic LIA conditions as benchmarks for past hydroclimatic variability can be useful for developing future water-resource management and drought and flood hazard mitigation strategies in the Southwest.	[Loisel, Julie] Texas A&M Univ, Dept Geog, Eller O&M Bldg, College Stn, TX 77843 USA; [Loisel, Julie; MacDonald, Glen M.] Univ Calif Los Angeles, Inst Environm & Sustainabil, La Kretz Hall, Los Angeles, CA 90024 USA; [Loisel, Julie; MacDonald, Glen M.; Thomson, Marcus J.] Univ Calif Los Angeles, Dept Geog, Bunche Hall, Los Angeles, CA 90095 USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Loisel, J (corresponding author), Texas A&M Univ, Dept Geog, Eller O&M Bldg, College Stn, TX 77843 USA.; Loisel, J (corresponding author), Univ Calif Los Angeles, Inst Environm & Sustainabil, La Kretz Hall, Los Angeles, CA 90024 USA.; Loisel, J (corresponding author), Univ Calif Los Angeles, Dept Geog, Bunche Hall, Los Angeles, CA 90095 USA.	juloisel@hotmail.com		Thomson, Marcus/0000-0002-5693-0245	Department of Interior Southwest Climate Science Center core grant; Department of Interior Southwest Climate Science Center core grant [G11AC90008]	Department of Interior Southwest Climate Science Center core grant; Department of Interior Southwest Climate Science Center core grant	This research was supported by the Department of Interior Southwest Climate Science Center core grant to UCLA (GMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Department of Interior Southwest Climate Science Center core grant to UCLA (G11AC90008 to GMM).	Adams JB, 2003, NATURE, V426, P274, DOI 10.1038/nature02101; Bard E, 1997, EARTH PLANET SC LETT, V150, P453, DOI 10.1016/S0012-821X(97)00082-4; Bradley RS, 2016, HOLOCENE, V26, P990, DOI 10.1177/0959683615622552; Brown JN, 2015, DEEP-SEA RES PT II, V113, P47, DOI 10.1016/j.dsr2.2014.10.022; Brown JN, 2014, CLIM DYNAM, V42, P3061, DOI 10.1007/s00382-013-1931-5; Brown PM, 2005, ECOLOGY, V86, P3030, DOI 10.1890/05-0034; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Cai WJ, 2012, NATURE, V488, P365, DOI 10.1038/nature11358; Cane MA, 2005, EARTH PLANET SC LETT, V230, P227, DOI 10.1016/j.epsl.2004.12.003; Cayan DR, 1998, J CLIMATE, V11, P3148, DOI 10.1175/1520-0442(1998)011<3148:DVOPOW>2.0.CO;2; Cayan DR, 2016, WATER POLICY PLANNIN, V17; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; Coats S, 2013, J CLIMATE, V26, P7635, DOI 10.1175/JCLI-D-12-00603.1; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Conroy JL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039558; Cook BI, 2016, WIRES CLIM CHANGE, V7, P411, DOI 10.1002/wcc.394; Cook BI, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400082; Cook E. R., 2008, IGBP PAGES WORLD DAT; Cook ER, 1999, J CLIMATE, V12, P1145, DOI 10.1175/1520-0442(1999)012<1145:DRFTCU>2.0.CO;2; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Crowley TJ, 2013, EARTH SYST SCI DATA, V5, P187, DOI 10.5194/essd-5-187-2013; Crowley T.J., 2008, PAGES NEWS, V16, P22, DOI [DOI 10.1029/2002GL0166335, 10.22498/pages.16.2.22, DOI 10.22498/PAGES.16.2.22]; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; D'Arrigo R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022055; Daniau AL, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004249; Dettinger M, 2011, J AM WATER RESOUR AS, V47, P514, DOI 10.1111/j.1752-1688.2011.00546.x; Dettinger MD, 2011, WATER-SUI, V3, P445, DOI 10.3390/w3020445; Garfin G, 2013, NCA REGION INPUT REP, P1, DOI 10.5822/978-1-61091-484-0; Goosse H, 2006, CLIM DYNAM, V27, P165, DOI 10.1007/s00382-006-0128-6; Gouhier T.C., 2014, BIWAVELET CONDUCT UN; Graham NE, 2011, CLIM DYNAM, V37, P1217, DOI 10.1007/s00382-010-0914-z; Hamlet AF, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005099; Herweijer C, 2006, HOLOCENE, V16, P159, DOI 10.1191/0959683606hl917rp; Herweijer C, 2007, J CLIMATE, V20, P1353, DOI 10.1175/JCLI4042.1; Karnauskas KB, 2012, J CLIMATE, V25, P5943, DOI 10.1175/JCLI-D-11-00421.1; LEAN J, 1995, GEOPHYS RES LETT, V22, P3195, DOI 10.1029/95GL03093; Lewis SC, 2015, CLIM PAST, V11, P1347, DOI 10.5194/cp-11-1347-2015; Li JB, 2011, NAT CLIM CHANGE, V1, P114, DOI [10.1038/nclimate1086, 10.1038/NCLIMATE1086]; Lubbecke JF, 2014, J CLIMATE; MacDonald G. M., 2008, EOS T AGU, V89, P82, DOI DOI 10.1029/2008EO090003; MacDonald GM, 2007, QUATERN INT, V173, P87, DOI 10.1016/j.quaint.2007.03.012; MacDonald GM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33325; MacDonald GM, 2010, P NATL ACAD SCI USA, V107, P21256, DOI 10.1073/pnas.0909651107; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Marlon JR, 2013, QUATERNARY SCI REV, V65, P5, DOI 10.1016/j.quascirev.2012.11.029; Marlon JR, 2012, P NATL ACAD SCI USA, V109, pE535, DOI 10.1073/pnas.1112839109; McGregor HV, 2015, NAT GEOSCI, V8, P671, DOI 10.1038/NGEO2510; McGregor S, 2010, CLIM PAST, V6, P1, DOI 10.5194/cp-6-1-2010; McGregor S, 2011, J CLIMATE, V24, P2178, DOI 10.1175/2010JCLI3990.1; Meko DM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029988; Meko DM, 2001, J AM WATER RESOUR AS, V37, P1029, DOI 10.1111/j.1752-1688.2001.tb05530.x; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Myhre G., 2013, CLIMATE CHANGE; Newton A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027234; Otto-Bliesner BL, 2016, B AM METEOROL SOC, V97, P735, DOI 10.1175/BAMS-D-14-00233.1; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Polade SD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11285-y; Polade SD, 2014, SCI REP-UK, V4, DOI 10.1038/srep04364; Power MJ, 2008, CLIM DYNAM, V30, P887, DOI 10.1007/s00382-007-0334-x; Power MJ, 2012, HOLOCENE; Raje D, 2010, ADV WATER RESOUR, V33, P312, DOI 10.1016/j.advwatres.2009.12.008; Reilly John M., 2002, AGR POTENTIAL CONSEQ; Seager R, 2005, J CLIMATE, V18, P4065, DOI 10.1175/JCLI3522.1; Seager R, 2005, Q J ROY METEOR SOC, V131, P1501, DOI 10.1256/qj.04.96; Seager R, 2007, QUATERNARY SCI REV, V26, P2322, DOI 10.1016/j.quascirev.2007.04.020; Smerdon JE, 2015, CLIMATE DYNAMICS, V2684; Swetnam TW, 2010, ADV GLOB CHANGE RES, V41, P329, DOI 10.1007/978-90-481-8736-2_32; Swetnam TW, 2003, ECOL STU AN, V160, P158; Swetnam TW, 1998, J CLIMATE, V11, P3128, DOI 10.1175/1520-0442(1998)011<3128:MDAERT>2.0.CO;2; Taschetto AS, 2014, J CLIMATE, V27, P2861, DOI 10.1175/JCLI-D-13-00437.1; Taylor AH, 2008, INT J WILDLAND FIRE, V17, P60, DOI 10.1071/WF07033; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Timmermann A, 1999, J ATMOS SCI, V56, P2313, DOI 10.1175/1520-0469(1999)056<2313:DTNROE>2.0.CO;2; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Trouet V, 2009, SCIENCE, V324, P78, DOI 10.1126/science.1166349; Wang SY, 2014, GEOPHYS RES LETT, V41, P3220, DOI 10.1002/2014GL059748; Wang SY, 2013, J GEOPHYS RES-ATMOS, V118, P11059, DOI 10.1002/jgrd.50841; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Westerling A.L., 2003, EOS T AM GEOPHYS UN, V84, P554; Woodhouse CA, 2009, J CLIMATE, V22, P4336, DOI 10.1175/2009JCLI2705.1; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2; Woodhouse CA, 2010, P NATL ACAD SCI USA, V107, P21283, DOI 10.1073/pnas.0911197107; Yeh SW, 2007, J CLIMATE, V20, P203, DOI 10.1175/JCLI4001.1; Zvlstra ER, 2015, PLOS ONE, V10	86	8	8	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186282	10.1371/journal.pone.0186282	http://dx.doi.org/10.1371/journal.pone.0186282			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036207	Green Published, gold			2022-12-26	WOS:000413054800018
J	Williams, MR; Stedtfeld, RD; Engle, C; Salach, P; Fakher, U; Stedtfeld, T; Dreelin, E; Stevenson, RJ; Latimore, J; Hashsham, SA				Williams, Maggie R.; Stedtfeld, Robert D.; Engle, Cathrine; Salach, Paul; Fakher, Umama; Stedtfeld, Tiffany; Dreelin, Erin; Stevenson, R. Jan; Latimore, Jo; Hashsham, Syed A.			Isothermal amplification of environmental DNA (eDNA) for direct field-based monitoring and laboratory confirmation of Dreissena sp	PLOS ONE			English	Article							RAPID DETECTION; LAMP; QUANTIFICATION; POLYMORPHA; TEMPERATURE; PERSISTENCE; GENERATION; ABUNDANCE; GENES; PCR	Loop-mediated isothermal amplification (LAMP) of aquatic invasive species environmental DNA (AIS eDNA) was used for rapid, sensitive, and specific detection of Dreissena sp. relevant to the Great Lakes (USA) basin. The method was validated for two uses including i) direct amplification of eDNA using a hand filtration system and ii) confirmation of the results after DNA extraction using a conventional thermal cycler run at isothermal temperatures. Direct amplification eliminated the need for DNA extraction and purification and allowed detection of target invasive species in grab or concentrated surface water samples, containing both free DNA as well as larger cells and particulates, such as veligers, eggs, or seeds. The direct amplification method validation was conducted using Dreissena polymorpha and Dreissena bugensis and uses up to 1 L grab water samples for high target abundance (e. g., greater than 10 veligers (larval mussels) per L for Dreissena sp.) or 20 L samples concentrated through 35 mu m nylon screens for low target abundance, at less than 10 veligers per liter water. Surface water concentrate samples were collected over a period of three years, mostly from inland lakes in Michigan with the help of a network of volunteers. Field samples collected from 318 surface water locations included i) filtered concentrate for direct amplification validation and ii) 1 L grab water sample for eDNA extraction and confirmation. Though the extraction-based protocol was more sensitive (resulting in more positive detections than direct amplification), direct amplification could be used for rapid screening, allowing for quicker action times. For samples collected between May and August, results of eDNA direct amplification were consistent with known presence/absence of selected invasive species. A cross-platform smartphone application was also developed to disseminate the analyzed results to volunteers. Field tests of the direct amplification protocol using a portable device (Gene-Z) showed the method could be used in the field to obtain results within one hr (from sample to result). Overall, the direct amplification has the potential to simplify the eDNA-based monitoring of multiple aquatic invasive species. Additional studies are warranted to establish quantitative correlation between eDNA copy number, veliger, biomass or organismal abundance in the field.	[Williams, Maggie R.; Stedtfeld, Robert D.; Engle, Cathrine; Salach, Paul; Fakher, Umama; Stedtfeld, Tiffany; Hashsham, Syed A.] Michigan State Univ, Dept Civil & Environm Engn, E Lansing, MI 48824 USA; [Dreelin, Erin; Latimore, Jo] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Dreelin, Erin; Stevenson, R. Jan] Michigan State Univ, Ctr Water Sci, E Lansing, MI 48824 USA; [Stevenson, R. Jan] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; [Hashsham, Syed A.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University	Hashsham, SA (corresponding author), Michigan State Univ, Dept Civil & Environm Engn, E Lansing, MI 48824 USA.; Hashsham, SA (corresponding author), Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA.	hashsham@egr.msu.edu	Latimore, Jo/GRJ-9262-2022	Latimore, Jo/0000-0002-3362-9089	United States Environmental Protection Agency Great Lakes Restoration Initiative (US EPA GLRI) [GL-00E01127-0]	United States Environmental Protection Agency Great Lakes Restoration Initiative (US EPA GLRI)(United States Environmental Protection Agency)	This work was funded by the United States Environmental Protection Agency Great Lakes Restoration Initiative (US EPA GLRI), grant number GL-00E01127-0. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the United States Environmental Protection Agency Great Lakes Restoration Initiative (US EPA GLRI), grant number GL-00E01127-0. Special thanks to volunteers that assisted with sample collection, including those from the following groups: Michigan Clean Water Corps (MiCorps), Michigan Department of Environmental Quality (MDEQ), Huron River Watershed Council, Yellow Dog Watershed Preserve, Alger Conservation District, Dickinson Conservation District, Iron Conservation District, Little Traverse Bay Bands of Odawa Indians, Keweenaw Bay Indian Community, Great Lakes Indian Fish and Wildlife Commission, Marquette County Conservation District, Montmorency Conservation District, Michigan Lake and Stream Association, Upper Peninsula Resource Conservation and Development Council, and The Nature Conservancy.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Cai T, 2008, J CLIN VIROL, V41, P270, DOI 10.1016/j.jcv.2007.11.025; Collins RA, 2013, BIOL INVASIONS, V15, P1209, DOI 10.1007/s10530-012-0376-9; Darling JA, 2011, ENVIRON RES, V111, P978, DOI 10.1016/j.envres.2011.02.001; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Doi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122763; Ebbinghaus P, 2012, EXP PARASITOL, V131, P40, DOI 10.1016/j.exppara.2012.02.024; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fong PP, 1995, BIOL BULL, V189, P320, DOI 10.2307/1542149; Gadkar V, 2008, SOIL BIOL BIOCHEM, V40, P540, DOI 10.1016/j.soilbio.2007.08.018; Goldberg CS, 2015, BIOL CONSERV, V183, P1, DOI 10.1016/j.biocon.2014.11.040; GORHAM E, 1989, J GREAT LAKES RES, V15, P233, DOI 10.1016/S0380-1330(89)71479-9; Gregory TR, 2003, GENOME, V46, P841, DOI [10.1139/g03-069, 10.1139/G03-069]; Harvey JBJ, 2009, J EXP MAR BIOL ECOL, V369, P93, DOI 10.1016/j.jembe.2008.10.030; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Horvath TG, 2010, AQUAT INVASIONS, V5, P379, DOI 10.3391/ai.2010.5.4.07; Hunter ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121655; Huq Anwar, 2012, Curr Protoc Microbiol, VChapter 6, DOI 10.1002/9780471729259.mc06a05s26; Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Kanitkar YH, 2016, APPL ENVIRON MICROB, V82, P1799, DOI 10.1128/AEM.03660-15; Koloren Z, 2011, ANN TROP MED PARASIT, V105, P607, DOI 10.1179/2047773211Y.0000000011; Kostic T, 2015, APPL MICROBIOL BIOT, V99, P7711, DOI 10.1007/s00253-015-6774-z; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Misawa Yoshiki, 2007, Journal of Infection and Chemotherapy, V13, P134, DOI 10.1007/s10156-007-0508-9; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida M, 2008, REV MED VIROL, V18, P407, DOI 10.1002/rmv.593; Penarrubia L, 2016, SCI REP-UK, V6, DOI 10.1038/srep39067; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Samhan FA, 2017, WATER RES, V121, P162, DOI 10.1016/j.watres.2017.05.028; Soroka M, 2018, HYDROBIOLOGIA, V810, P255, DOI 10.1007/s10750-017-3088-4; Stedtfeld RD, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9994-1; Stedtfeld RD, 2014, ENVIRON SCI TECHNOL, V48, P13855, DOI 10.1021/es503472h; Stedtfeld RD, 2012, LAB CHIP, V12, P1454, DOI 10.1039/c2lc21226a; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Treguier A, 2014, J APPL ECOL, V51, P871, DOI 10.1111/1365-2664.12262; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; USGS USDOI, 2015, ZEBR QUAGG MUSSL DIS; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Wilcox TM, 2015, CONSERV GENET RESOUR, V7, P639, DOI 10.1007/s12686-015-0465-z; Wilcox Taylor M., 2013, PLoS ONE, V8, P1; Qiao YM, 2007, BIOTECHNOL LETT, V29, P1939, DOI 10.1007/s10529-007-9472-9; YOUSEF YA, 1980, WATER RES, V14, P841, DOI 10.1016/0043-1354(80)90265-1	52	19	22	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186462	10.1371/journal.pone.0186462	http://dx.doi.org/10.1371/journal.pone.0186462			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036210	Green Submitted, Green Published, gold			2022-12-26	WOS:000413054800037
J	Kobayashi, H; Otsubo, T; Teraoka, F; Ikeda, K; Seike, S; Takahashi, E; Okamoto, K; Yoshida, T; Tsuge, H; Yamanaka, H				Kobayashi, Hidetomo; Otsubo, Tadamune; Teraoka, Fumiteru; Ikeda, Kiyoshi; Seike, Soshi; Takahashi, Eizo; Okamoto, Keinosuke; Yoshida, Toru; Tsuge, Hideaki; Yamanaka, Hiroyasu			Involvement of the Arg(566) residue of Aeromonas sobria serine protease in substrate specificity	PLOS ONE			English	Article							GENUS AEROMONAS; HYDROPHILA; MUTAGENESIS; INFECTIONS; SUBTILASES; ACTIVATION; CLEAVAGE; ASP	Aeromonas sobria serine protease (ASP) is an extracellular serine protease secreted by the organism. Here, we identified the amino acid residue of ASP that contributes to substrate specificity by using both synthetic peptides and biological protein components. The results showed that the arginine residue at position 566 (Arg-566) of ASP, which is located in the extra occluding region of ASP close to an entrance of the catalytic cavity, is involved in the substrate specificity. A substitutional point mutation of the Arg-566 residue of ASP to Ala residue (ASP[R566A]) caused a decrease of the proteolytic efficiency for a certain substrate. In addition, ASP lost the ability to recognize the primary substrate by such a point mutation, and ASP[R566A] reacted to a wide range of synthetic substrates. It is likely that Arg-566 causes an interaction with the amino acid residue at position P3 of the substrate, which is the third amino acid residue upstream from the cleavage site. Another study using ORF2 protein, a chaperone protein of ASP, further suggested that Arg-566 could also play an important role in interaction with ORF2. We therefore conclude that the Arg-566 residue of ASP is likely responsible for the selection of substrates.	[Kobayashi, Hidetomo; Seike, Soshi; Yamanaka, Hiroyasu] Hiroshima Int Univ, Fac Pharmaceut Sci, Lab Mol Microbiol Sci, Hiroshima, Japan; [Otsubo, Tadamune; Teraoka, Fumiteru; Ikeda, Kiyoshi] Hiroshima Int Univ, Lab Synthet Organ Chem, Fac Pharmaceut Sci, Hiroshima, Japan; [Takahashi, Eizo; Okamoto, Keinosuke] Okayama Univ Infect Dis India, Collaborat Res Ctr, Natl Inst Cholera Enter Dis, JICA Bldg ID Hosp Campus, Kolkata, India; [Yoshida, Toru; Tsuge, Hideaki] Kyoto Sangyo Univ, Fac Life Sci, Dept Bioresource & Environm Sci, Kyoto, Japan	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Okayama University; Kyoto Sangyo University	Yamanaka, H (corresponding author), Hiroshima Int Univ, Fac Pharmaceut Sci, Lab Mol Microbiol Sci, Hiroshima, Japan.	h-yamana@ps.hirokoku-u.ac.jp	Yamanaka, Hiroyasu/AAG-7880-2021; Tsuge, Hideaki/ABF-6424-2021	Seike, Soshi/0000-0001-9029-0715; Kobayashi, Hidetomo/0000-0002-5918-4268; Otsubo, Tadamune/0000-0003-1949-9780; Tsuge, Hideaki/0000-0003-0166-9163	JSPS KAKENHI [JP19890254, JP16K18926]; Grants-in-Aid for Scientific Research [16K18926] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid from JSPS KAKENHI (Grant Numbers JP19890254 and JP16K18926) to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chi HF, 2014, BIOORGAN MED CHEM, V22, P1268, DOI 10.1016/j.bmc.2014.01.011; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fujii Y, 1998, MICROBIOL IMMUNOL, V42, P703, DOI 10.1111/j.1348-0421.1998.tb02343.x; Imamura T, 2006, J IMMUNOL, V177, P8723, DOI 10.4049/jimmunol.177.12.8723; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; JANDA JM, 1987, J INFECT DIS, V155, P589, DOI 10.1093/infdis/155.3.589; JONES BL, 1995, J ANTIMICROB CHEMOTH, V35, P453, DOI 10.1093/jac/35.4.453; Kobayashi H, 2006, FEMS MICROBIOL LETT, V256, P165, DOI 10.1111/j.1574-6968.2006.00134.x; Kobayashi H, 2015, J BIOL CHEM, V290, P11130, DOI 10.1074/jbc.M114.622852; Kobayashi H, 2009, J BIOL CHEM, V284, P27655, DOI 10.1074/jbc.M109.006114; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Newell-Caito JL, 2012, BIOCHEMISTRY-US, V51, P3451, DOI 10.1021/bi300070z; Nitta H, 2008, J IMMUNOL, V181, P3602, DOI 10.4049/jimmunol.181.5.3602; Nitta H, 2007, FEBS LETT, V581, P5935, DOI 10.1016/j.febslet.2007.11.076; Okamoto K, 2000, MICROBIOL IMMUNOL, V44, P787, DOI 10.1111/j.1348-0421.2000.tb02565.x; Parker JL, 2011, J INFECTION, V62, P109, DOI 10.1016/j.jinf.2010.12.003; Pemberton JM, 1997, FEMS MICROBIOL LETT, V152, P1, DOI 10.1016/S0378-1097(97)00186-9; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Takahashi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091149; Takahashi E, 2013, BIOL PHARM BULL, V36, P1174, DOI 10.1248/bpb.b13-00161; Tsai YH, 2007, J BONE JOINT SURG AM, V89A, P631, DOI 10.2106/JBJS.F.00580; Tsai YH, 2009, CLIN ORTHOP RELAT R, V467, P846, DOI 10.1007/s11999-008-0504-0; Yu HB, 2007, PROTEOMICS, V7, P436, DOI 10.1002/pmic.200600396; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	26	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186392	10.1371/journal.pone.0186392	http://dx.doi.org/10.1371/journal.pone.0186392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023605	gold, Green Published, Green Submitted			2022-12-26	WOS:000412845100122
J	Nam, SJ; Kwak, JY; Moon, HJ; Yoon, JH; Kim, EK; Koo, JS				Nam, Se Jin; Kwak, Jin Young; Moon, Hee Jung; Yoon, Jung Hyun; Kim, Eun-Kyung; Koo, Ja Seung			Large (>= 3cm) thyroid nodules with benign cytology: Can Thyroid Imaging Reporting and Data System (TIRADS) help predict false-negative cytology?	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; MALIGNANCY RISK STRATIFICATION; BETHESDA SYSTEM; 4 CM; FOLLICULAR VARIANT; GREATER-THAN; SINGLE INSTITUTION; CANCER-RISK; BIOPSY; ULTRASOUND	Background There is controversy about the accuracy of the fine-needle aspiration (FNA) cytology results in large sized thyroid nodules. Our aim was to evaluate the false-negative rate of FNA for large thyroid nodules and the usefulness of the Thyroid Imaging Reporting and Data System (TIRADS) in predicting false-negative cytology for large thyroid nodules with benign cytology. Methods 632 thyroid nodules larger than or equal to 3cm in size with subsequent benign cytology on US-guided FNA were included. US features of internal composition, echogenicity, margin, calcifications, and shape were evaluated, and nodules were classified according to TIRADS. TIRADS category 3 included nodules without any of the following suspicious features: solidity, hypoechogenicity or marked hypoechogenicity, microlobulated or irregular margins, microcalcifications, and taller-than-wide shape. Category 4a, 4b, 4c, and 5 were assigned to nodules showing one, two, three or four, or five suspicious US features, respectively. US features associated with malignancy for these lesions were analyzed and malignancy risk according to TIRADS was calculated. Results Of the 632 lesions, 23 lesions(3.6%) were malignant and 609(96.4%) were benign, suggesting a 3.6% false-negative rate for FNA cytology. Of the 23 malignant lesions, final pathology was mainly follicular carcinoma minimally invasive(65.2%, 15/23) and the follicular variant of papillary carcinoma(26.1%, 6/23). The malignancy risks of categories 3, 4a, 4b, and 4c nodules were 0.9%, 4.6%, 10.0%, and 11.8%, respectively. Conclusion Large thyroid nodules with benign cytology had a relatively high false-negative risk of 3.6% and TIRADS was helpful in predicting false-negative cytology for these lesions.	[Nam, Se Jin; Kwak, Jin Young; Moon, Hee Jung; Yoon, Jung Hyun; Kim, Eun-Kyung] Yonsei Univ, Res Inst Radiol Sci, Severance Hosp, Dept Radiol,Coll Med, Seoul, South Korea; [Koo, Ja Seung] Yonsei Univ, Severance Hosp, Dept Pathol, Coll Med, Seoul, South Korea; [Nam, Se Jin] Hallym Univ, Dongtan Sacred Heart Hosp, Dept Radiol, Coll Med, Hwaseong, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hallym University	Kim, EK (corresponding author), Yonsei Univ, Res Inst Radiol Sci, Severance Hosp, Dept Radiol,Coll Med, Seoul, South Korea.	ekkim@yuhs.ac	; Kim, Eun-Kyung/E-5211-2017	koo, ja seung/0000-0003-4546-4709; Kwak, Jin Young/0000-0002-6212-1495; Moon, Hee Jung/0000-0002-5643-5885; Yoon, Jung Hyun/0000-0002-2100-3513; Kim, Eun-Kyung/0000-0002-3368-5013				Albuja-Cruz MB, 2013, J SURG RES, V181, P6, DOI 10.1016/j.jss.2012.06.030; Carrillo JF, 2000, OTOLARYNG HEAD NECK, V122, P917, DOI 10.1016/S0194-5998(00)70025-8; Choi SH, 2014, EUR RADIOL, V24, P2819, DOI 10.1007/s00330-014-3325-4; Choi SH, 2010, THYROID, V20, P167, DOI 10.1089/thy.2008.0354; Choi YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063834; Cibas ES, 2009, AM J CLIN PATHOL, V132, P658, DOI 10.1309/AJCPPHLWMI3JV4LA; Frates MC, 2005, RADIOLOGY, V237, P794, DOI 10.1148/radiol.2373050220; Gharib H, 2016, ENDOCR PRACT, V22, P1, DOI 10.4158/EP161208.GL; Giles WH, 2015, ANN SURG ONCOL, V22, P152, DOI 10.1245/s10434-014-3952-7; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Horvath E, 2009, J CLIN ENDOCR METAB, V94, P1748, DOI 10.1210/jc.2008-1724; Jean-Gilles J, 2012, CANCER CYTOPATHOL, V120, P326, DOI 10.1002/cncy.21196; Kim YH, 2015, J ULTRAS MED, V34, P1801, DOI 10.7863/ultra.15.14.12028; Ko SY, 2016, ULTRASOUND Q, V32, P126, DOI 10.1097/RUQ.0000000000000189; Ko SY, 2014, ULTRASONOGRAPHY, V33, P49, DOI 10.14366/usg.13016; Kuru B, 2010, LANGENBECK ARCH SURG, V395, P127, DOI 10.1007/s00423-009-0470-3; Kwak JY, 2011, RADIOLOGY, V260, P892, DOI 10.1148/radiol.11110206; Kwak JY, 2010, RADIOLOGY, V254, P292, DOI 10.1148/radiol.2541090460; Lee L, 2015, THYROID; McCoy KL, 2007, SURGERY, V142, P837, DOI 10.1016/j.surg.2007.08.012; Mehanna R, 2013, LARYNGOSCOPE, V123, P1305, DOI 10.1002/lary.23861; Meko JB, 1995, SURGERY, V118, P1003; Min HS, 2014, APMIS, V122, P993, DOI 10.1111/apm.12244; Moon HJ, 2015, RADIOLOGY, V274, P287, DOI 10.1148/radiol.14140359; Moon HJ, 2014, ANN SURG ONCOL, V21, P1898, DOI 10.1245/s10434-014-3556-2; Na DG, 2012, THYROID, V22, P468, DOI 10.1089/thy.2011.0185; Nikiforov YE, 2016, JAMA ONCOL, V2, P1023, DOI 10.1001/jamaoncol.2016.0386; Pinchot SN, 2009, ARCH SURG-CHICAGO, V144, P649, DOI 10.1001/archsurg.2009.116; Porterfield JR, 2008, SURGERY, V144, P963, DOI 10.1016/j.surg.2008.09.006; Raj MD, 2012, ANZ J SURG, V82, P73, DOI 10.1111/j.1445-2197.2011.05667.x; Rosario PW, 2009, ARQ BRAS ENDOCRINOL, V53, P1143, DOI 10.1590/S0004-27302009000900011; Russ G, 2016, ULTRASONOGRAPHY, V35, P25, DOI 10.14366/usg.15027; Sclabas GM, 2003, AM J SURG, V186, P702, DOI 10.1016/j.amjsurg.2003.08.015; Shin JH, 2016, KOREAN J RADIOL, V17, P370, DOI 10.3348/kjr.2016.17.3.370; Shrestha M, 2012, THYROID, V22, P1251, DOI 10.1089/thy.2012.0265; Wharry LI, 2014, WORLD J SURG, V38, P614, DOI 10.1007/s00268-013-2261-9; Yoon JH, 2008, J ULTRAS MED, V27, P1431, DOI 10.7863/jum.2008.27.10.1431; Yoon JH, 2016, ULTRASONOGRAPHY, V35, P47, DOI 10.14366/usg.15037; Yoon JH, 2011, THYROID, V21, P993, DOI 10.1089/thy.2010.0458; Yoon RG, 2014, THYROID, V24, P1612, DOI 10.1089/thy.2014.0140	40	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186242	10.1371/journal.pone.0186242	http://dx.doi.org/10.1371/journal.pone.0186242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023564	Green Submitted, Green Published, gold			2022-12-26	WOS:000412845100089
J	Niu, ZR; Pang, RTK; Liu, WM; Li, Q; Cheng, RR; Yeung, WSB				Niu, Ziru; Pang, Ronald T. K.; Liu, Weimin; Li, Qian; Cheng, Ranran; Yeung, William S. B.			Polymer-based precipitation preserves biological activities of extracellular vesicles from an endometrial cell line	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; EXOSOME ISOLATION; BIOMARKERS; MICRORNA; PROTEIN; OVARIAN; MICROVESICLES; PATHWAY; EMBRYO	Extracellular vesicles (EVs) are membrane-bound vesicles released by cells and act as media for transfer of proteins, small RNAs and mRNAs to distant sites. They can be isolated by different methods. However, the biological activities of the purified EVs have seldom been studied. In this study, we compared the use of ultracentrifugation (UC), ultra-filtration (UF), polymer-based precipitation (PBP), and PBP with size-based purification (PBP+SP) for isolation of EVs from human endometrial cells and mouse uterine luminal fluid (ULF). Electron microscopy revealed that the diameters of the isolated EVs were similar among the tested methods. UF recovered the highest number of EVs followed by PBP, while UC and PBP+SP were significantly less efficient (P<0.05). Based on the number of EVs-to-protein ratios, PBP had the least protein contamination, significantly better than the other methods (P<0.05). All the isolated EVs expressed exosome-enriched proteins CD63, TSG101 and HSP70. Incubation of the trophoblast JEG-3 cells with an equal amount of the fluorescencelabelled EVs isolated by the studied methods showed that many of the PBP-EVs treated cells were fluorescence positive but only a few cells were labelled in the UC- and UF-EVs treated groups. Moreover, the PBP-EVs could transfer significantly more miRNA to the recipient cells than the other 3 methods (P<0.05). The PBP method could isolate EVs from mouse ULF; the diameter of the isolated EVs was 62 +/- 19 nm and expressed CD63, TSG101 and HSP70 proteins. In conclusion, PBP could best preserve the activities of the isolated EVs among the 4 methods studied and was able to isolate EVs from a small volume of sample. The simple setup and low equipment demands makes PBP the most suitable method for rapid EV assessment and isolation of EVs in clinical and basic research settings.	[Niu, Ziru; Pang, Ronald T. K.; Liu, Weimin; Li, Qian; Cheng, Ranran; Yeung, William S. B.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Obstet & Gynecol, Pokfulam, Hong Kong, Peoples R China; [Pang, Ronald T. K.; Liu, Weimin; Yeung, William S. B.] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China; [Yeung, William S. B.] Univ Hong Kong, Shenzhen Hosp, Shenzhen Key Lab Fertil Regulat, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Yeung, WSB (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Obstet & Gynecol, Pokfulam, Hong Kong, Peoples R China.; Yeung, WSB (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China.; Yeung, WSB (corresponding author), Univ Hong Kong, Shenzhen Hosp, Shenzhen Key Lab Fertil Regulat, Pokfulam, Hong Kong, Peoples R China.	wsbyeung@hku.hk	Cheng, Ranran/HGA-8919-2022; /B-8039-2013	Yeung, Shu Biu William/0000-0003-0670-0879; /0000-0001-5464-4125	General Research Fund of Hong Kong Research Grant Council [17107915]; General Program Fund of National Natural Science Foundation of China [31471398]; Sanming Project of Medicine in Shenzhen	General Research Fund of Hong Kong Research Grant Council; General Program Fund of National Natural Science Foundation of China; Sanming Project of Medicine in Shenzhen	This study is supported in part by grants to WSBY from the General Research Fund (17107915) of Hong Kong Research Grant Council, the General Program Fund (31471398) of National Natural Science Foundation of China, and the Sanming Project of Medicine in Shenzhen. The authors would also like to acknowledge the technical assistance of the University of Hong Kong Li Ka Shing Faculty of Medicine Faculty Core Facility.; This study is supported in part by grants to WSBY from the General Research Fund (17107915) of Hong Kong Research Grant Council, the General Program Fund (31471398) of National Natural Science Foundation of China, and the Sanming Project of Medicine in Shenzhen. (p.26, Acknowledgments). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ML, 2012, KIDNEY INT, V82, P1024, DOI 10.1038/ki.2012.256; Burns DA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086855, 10.1371/journal.pone.0090913]; Caradec J, 2014, CLIN BIOCHEM, V47, P1286, DOI 10.1016/j.clinbiochem.2014.06.011; Cheong AWY, 2014, HUM REPROD, V29, P750, DOI 10.1093/humrep/det462; Cheruvanky A, 2007, AM J PHYSIOL-RENAL, V292, pF1657, DOI 10.1152/ajprenal.00434.2006; Clayton A, 2001, J IMMUNOL METHODS, V247, P163, DOI 10.1016/S0022-1759(00)00321-5; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; Cuman C, 2014, REPRODUCTION, V147, pR75, DOI 10.1530/REP-13-0474; Cvjetkovic A, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23111; Denzer K, 2000, J CELL SCI, V113, P3365; Deregibus MC, 2016, INT J MOL MED, V38, P1359, DOI 10.3892/ijmm.2016.2759; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Erdbrugger U, 2016, CYTOM PART A, V89A, P123, DOI 10.1002/cyto.a.22795; Essandoh K, 2015, BBA-MOL BASIS DIS, V1852, P2362, DOI 10.1016/j.bbadis.2015.08.010; Figuera-Losada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124481; Gonzales P, 2008, NEPHROL DIAL TRANSPL, V23, P1799, DOI 10.1093/ndt/gfn058; Gould SJ, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20389; Grant R, 2011, J IMMUNOL METHODS, V371, P143, DOI 10.1016/j.jim.2011.06.024; Greening DW, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134890; Gudbergsson JM, 2016, CYTOTECHNOLOGY, V68, P579, DOI 10.1007/s10616-015-9913-6; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Ji H, 2008, ELECTROPHORESIS, V29, P2660, DOI 10.1002/elps.200800015; Lai RC, 2011, REGEN MED, V6, P481, DOI [10.2217/RME.11.35, 10.2217/rme.11.35]; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Li Y, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/893594; Liang B, 2013, J PROTEOMICS, V80, P171, DOI 10.1016/j.jprot.2012.12.029; Linares R, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.29509; Liu W., 2012, PLOS ONE, V7; Lobb RJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27031; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lopera-Vasquez R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148083; Lotvall J., 2014, J EXTRACELLULAR VESI, V3; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Machtinger R, 2015, EXTRACELLULAR VESICL; Masyuk AI, 2010, AM J PHYSIOL-GASTR L, V299, pG990, DOI 10.1152/ajpgi.00093.2010; Mateescu B, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1286095; Mathias Rommel A., 2009, V528, P227, DOI 10.1007/978-1-60327-310-7_16; Momen-Heravi F, 2013, BIOL CHEM, V394, P1253, DOI 10.1515/hsz-2013-0141; Muller L, 2014, J IMMUNOL METHODS, V411, P55, DOI 10.1016/j.jim.2014.06.007; Ng YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077575; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rekker K, 2014, CLIN BIOCHEM, V47, P135, DOI 10.1016/j.clinbiochem.2013.10.020; Rood IM, 2010, KIDNEY INT, V78, P810, DOI 10.1038/ki.2010.262; Savina A, 2002, J CELL SCI, V115, P2505; Shelke GV, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24783; Szatanek R, 2015, INT J MOL MED, V36, P11, DOI 10.3892/ijmm.2015.2194; Tanaka Y, 2013, CANCER-AM CANCER SOC, V119, P1159, DOI 10.1002/cncr.27895; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Taylor DD, 2015, METHODS, V87, P3, DOI 10.1016/j.ymeth.2015.02.019; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Traver S, 2014, HUM REPROD UPDATE, V20, P905, DOI 10.1093/humupd/dmu031; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Vilella F, 2015, DEVELOPMENT, V142, P3210, DOI 10.1242/dev.124289; Wang Z, 2012, PROTEOMICS, V12, P329, DOI 10.1002/pmic.201100477; Webber J, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19861; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Zhang MJ, 2009, MOL HUM REPROD, V15, P399, DOI 10.1093/molehr/gap031; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	65	56	58	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186534	10.1371/journal.pone.0186534	http://dx.doi.org/10.1371/journal.pone.0186534			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023592	gold, Green Published, Green Submitted			2022-12-26	WOS:000412845100136
J	Bohnert, R; Vivas, S; Jansen, G				Bohnert, Regina; Vivas, Sonia; Jansen, Gunther			Comprehensive benchmarking of SNV callers for highly admixed tumor data	PLOS ONE			English	Article							SOMATIC POINT MUTATIONS; INTRATUMOR HETEROGENEITY; GERMLINE MUTATIONS; SINGLE-NUCLEOTIDE; CANCER; EVOLUTION; DISCOVERY; FRAMEWORK; MEDICINE; IMPACT	Precision medicine attempts to individualize cancer therapy by matching tumor-specific genetic changes with effective targeted therapies. A crucial first step in this process is the reliable identification of cancer-relevant variants, which is considerably complicated by the impurity and heterogeneity of clinical tumor samples. We compared the impact of admixture of non-cancerous cells and low somatic allele frequencies on the sensitivity and precision of 19 state-of-the-art SNV callers. We studied both whole exome and targeted gene panel data and up to 13 distinct parameter configurations for each tool. We found vast differences among callers. Based on our comprehensive analyses we recommend joint tumor-normal calling with MuTect, EBCall or Strelka for whole exome somatic variant calling, and Haplotype-Caller or FreeBayes for whole exome germline calling. For targeted gene panel data on a single tumor sample, LoFreqStar performed best. We further found that tumor impurity and admixture had a negative impact on precision, and in particular, sensitivity in whole exome experiments. At admixture levels of 60% to 90% sometimes seen in pathological biopsies, sensitivity dropped significantly, even when variants were originally present in the tumor at 100% allele frequency. Sensitivity to low-frequency SNVs improved with targeted panel data, but whole exome data allowed more efficient identification of germline variants. Effective somatic variant calling requires high-quality pathological samples with minimal admixture, a consciously selected sequencing strategy, and the appropriate variant calling tool with settings optimized for the chosen type of data.	[Bohnert, Regina; Vivas, Sonia; Jansen, Gunther] Mol Hlth GmbH, Heidelberg, Germany		Jansen, G (corresponding author), Mol Hlth GmbH, Heidelberg, Germany.	gunther.jansen@molecularhealth.com			Molecular Health	Molecular Health	Molecular Health provided support in the form of salaries for authors RB, SV and GJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abrahams E, 2005, AM J PHARMACOGENOMIC, V5, P345, DOI 10.2165/00129785-200505060-00002; Alioto TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10001; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Arnedos M, 2015, NAT REV CLIN ONCOL, V12, P693, DOI 10.1038/nrclinonc.2015.123; Auffray C, 2009, GENOME MED, V1, DOI 10.1186/gm2; Bareke E, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S3; Basik M, 2013, NAT REV CLIN ONCOL, V10, P437, DOI 10.1038/nrclinonc.2013.101; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Burrell RA, 2014, MOL ONCOL, V8, P1095, DOI 10.1016/j.molonc.2014.06.005; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fernald GH, 2011, BIOINFORMATICS, V27, P1741, DOI 10.1093/bioinformatics/btr295; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Garrison E, 2012, ARXIV12073907QBIOL; Gatenby RA, 2009, CANCER RES, V69, P7499, DOI 10.1158/0008-5472.CAN-09-1354; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; Ginsburg GS, 2009, TRANSL RES, V154, P277, DOI 10.1016/j.trsl.2009.09.005; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Grant RC, 2015, GASTROENTEROLOGY, V148, P556, DOI 10.1053/j.gastro.2014.11.042; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen NF, 2013, BIOINFORMATICS, V29, P1498, DOI 10.1093/bioinformatics/btt183; Hofmann AL, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1417-7; Jacoby MA, 2015, TRENDS CANCER, V1, P231, DOI 10.1016/j.trecan.2015.10.006; Jones S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7161; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim S, 2013, BIOINFORMATICS, V29, P1076, DOI 10.1093/bioinformatics/btt074; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kroigard AB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151664; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu YC, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0300-5; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Morrissy AS, 2016, NATURE, V529, P351, DOI 10.1038/nature16478; Mroz EA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001786; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Overby CL, 2013, PERS MED, V10, P453, DOI 10.2217/pme.13.30; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Roberts ND, 2013, BIOINFORMATICS, V29, P2223, DOI 10.1093/bioinformatics/btt375; Roth A, 2012, BIOINFORMATICS, V28, P907, DOI 10.1093/bioinformatics/bts053; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Shiraishi Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt126; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang QG, 2013, GENOME MED, V5, DOI 10.1186/gm495; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Xu HL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-244; Yamamoto H, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt338; Zhao BY, 2014, P NATL ACAD SCI USA, V111, P10773, DOI 10.1073/pnas.1323934111; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	66	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186175	10.1371/journal.pone.0186175	http://dx.doi.org/10.1371/journal.pone.0186175			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020110	gold, Green Published, Green Submitted			2022-12-26	WOS:000412754400077
J	Mastrolorenzo, G; Palladino, DM; Pappalardo, L; Rossano, S				Mastrolorenzo, Giuseppe; Palladino, Danilo M.; Pappalardo, Lucia; Rossano, Sergio			Probabilistic-numerical assessment of pyroclastic current hazard at Campi Flegrei and Naples city: Multi-VEI scenarios as a tool for "full-scale" risk management	PLOS ONE			English	Article							NEAPOLITAN-YELLOW-TUFF; CAMPANIAN IGNIMBRITE ERUPTION; MULTISOURCE VOLCANIC AREA; PHLEGRAEAN FIELDS; DENSITY CURRENTS; MAGMATIC SYSTEM; GRAIN-SIZE; CALDERA; DEPOSITS; FLOW	The Campi Flegrei volcanic field (Italy) poses very high risk to the highly urbanized Neapolitan area. Eruptive history was dominated by explosive activity producing pyroclastic currents (hereon PCs; acronym for Pyroclastic Currents) ranging in scale from localized base surges to regional flows. Here we apply probabilistic numerical simulation approaches to produce PC hazard maps, based on a comprehensive spectrum of flow properties and vent locations. These maps are incorporated in a Geographic Information System (GIS) and provide all probable Volcanic Explosivity Index (VEI) scenarios from different source vents in the caldera, relevant for risk management planning. For each VEI scenario, we report the conditional probability for PCs (i.e., the probability for a given area to be affected by the passage of PCs in case of a PC-forming explosive event) and related dynamic pressure. Model results indicate that PCs from VEI<4 events would be confined within the Campi Flegrei caldera, PC propagation being impeded by the northern and eastern caldera walls. Conversely, PCs from VEI 4-5 events could invade a wide area beyond the northern caldera rim, as well as part of the Naples metropolitan area to the east. A major controlling factor of PC dispersal is represented by the location of the vent area. PCs from the potentially largest eruption scenarios (analogous to the similar to 15 ka, VEI 6 Neapolitan Yellow Tuff or even the similar to 39 ka, VEI 7 Campanian Ignimbrite extreme event) would affect a large part of the Campanian Plain to the north and the city of Naples to the east. Thus, in case of renewal of eruptive activity at Campi Flegrei, up to 3 million people will be potentially exposed to volcanic hazard, pointing out the urgency of an emergency plan. Considering the present level of uncertainty in forecasting the future eruption type, size and location (essentially based on statistical analysis of previous activity), we suggest that appropriate planning measures should face at least the VEI 5 reference scenario (at least 2 occurrences documented in the last 10 ka).	[Mastrolorenzo, Giuseppe; Pappalardo, Lucia] Ist Nazl Geofis & Vulcanol, Osservatorio Vesuviano, Sez Napoli, Naples, Italy; [Palladino, Danilo M.] Sapienza Univ Roma, Dipartimento Sci Terra, Rome, Italy; [Rossano, Sergio] Univ Federico II, Ric Dinam Interna Sistemi Vulcan & Rischi Idrogeo, Naples, Italy	Istituto Nazionale Geofisica e Vulcanologia (INGV); Sapienza University Rome; University of Naples Federico II	Pappalardo, L (corresponding author), Ist Nazl Geofis & Vulcanol, Osservatorio Vesuviano, Sez Napoli, Naples, Italy.	lucia.pappalardo@ingv.it						Acocella V, 2015, REV GEOPHYS, V53, P896, DOI 10.1002/2015RG000492; Alberico I, 2011, NAT HAZARD EARTH SYS, V11, P1057, DOI 10.5194/nhess-11-1057-2011; [Anonymous], 1986, B VOLCANOL; Arienzo I, 2010, CHEM GEOL, V270, P135, DOI 10.1016/j.chemgeo.2009.11.012; BARBERI F, 1991, J VOLCANOL GEOTH RES, V48, P33, DOI 10.1016/0377-0273(91)90031-T; Baxter PJ, 2005, B VOLCANOL, V67, P292, DOI 10.1007/s00445-004-0365-7; BEGET JE, 1989, J VOLCANOL GEOTH RES, V39, P349, DOI 10.1016/0377-0273(89)90098-X; BEGET JE, 1988, B VOLCANOL, V50, P148, DOI 10.1007/BF01079679; Bevilacqua A, 2015, J GEOPHYS RES-SOL EA, V120, P2309, DOI 10.1002/2014JB011775; Bobrowsky P., 1985, ENCY NATURAL HAZARDS; BRISSETTE FP, 1990, B VOLCANOL, V53, P60, DOI 10.1007/BF00680320; Bursik MI, 1996, B VOLCANOL, V58, P175, DOI 10.1007/s004450050134; Calderas Lipman P., 2000, ENCY VOLCANOES, P643; Cannatelli C, 2012, MINER PETROL, V104, P29, DOI 10.1007/s00710-011-0182-6; Cashman KV, 2014, J VOLCANOL GEOTH RES, V288, P28, DOI 10.1016/j.jvolgeores.2014.09.007; Chiodini G, 2016, NATURE COMMUNICATION; Chiodini G, 2015, GEOLOGY, V43, P767, DOI 10.1130/G36905.1; Chiodini G, 2012, GEOLOGY, V40, P943, DOI 10.1130/G33251.1; Cioni R, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000642; Costa A, 2009, B VOLCANOL, V71, P259, DOI 10.1007/s00445-008-0220-3; D'Antonio M, 1999, J VOLCANOL GEOTH RES, V91, P247, DOI 10.1016/S0377-0273(99)00038-4; D'Auria L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13100; De Natale G, 2006, GEOL SOC SPEC PUBL, V269, P25, DOI 10.1144/GSL.SP.2006.269.01.03; de Vita S, 1999, J VOLCANOL GEOTH RES, V91, P269, DOI 10.1016/S0377-0273(99)00039-6; De Vivo B, 2001, MINER PETROL, V73, P47, DOI 10.1007/s007100170010; De Vivo B, 2010, MINER PETROL, V99, P1, DOI 10.1007/s00710-009-0098-6; de' Gennaro M, 1999, J VOLCANOL GEOTH RES, V91, P303, DOI 10.1016/S0377-0273(99)00040-2; Dellino P, 2004, J VOLCANOL GEOTH RES, V133, P211, DOI 10.1016/S0377-0273(03)00399-8; Dellino P, 2004, J VOLCANOL GEOTH RES, V133, P193, DOI 10.1016/S0377-0273(03)00398-6; Dellino P, 2001, B VOLCANOL, V63, P443; Dellino P, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005365; DeVivo B, 2006, DEV VOLCANO, V9, P1; Di Vito MA, 1999, J VOLCANOL GEOTH RES, V91, P221, DOI 10.1016/S0377-0273(99)00037-2; Di Vito M, 1987, B VOLCANOL, V49, P608, DOI 10.1007/BF01079966; Druitt TH, 1998, GEOL SOC SPEC PUBL, V145, P145, DOI 10.1144/GSL.SP.1996.145.01.08; Dvorak JJ, 1991, GEOL SOC AM SP PAP, V163, P47, DOI [10.1130/SPE263, DOI 10.1130/SPE263]; Fedele L, 2011, B VOLCANOL, V73, P1323, DOI 10.1007/s00445-011-0478-8; FISHER RV, 1993, J VOLCANOL GEOTH RES, V56, P205, DOI 10.1016/0377-0273(93)90017-L; Gottsman J, 2008, DEV VOLCANOLOGY, V10; Hsu K. J., 1989, PHYS PRINCIPLES SEDI; Isaia R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040513; Lirer L, 2010, B VOLCANOL, V72, P411, DOI 10.1007/s00445-009-0334-2; MALIN MC, 1982, SCIENCE, V217, P637, DOI 10.1126/science.217.4560.637; Marzocchi W, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003155; Marzocchi W, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005908; MASTIN LG, 1995, B VOLCANOL, V57, P85, DOI 10.1007/BF00301399; Mastrolorenzo G, 2006, EARTH PLANET SC LETT, V250, P164, DOI 10.1016/j.epsl.2006.07.040; Mastrolorenzo G, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006871; Mastrolorenzo G, 2006, GEOL SOC SPEC PUBL, V269, P159, DOI 10.1144/GSL.SP.2006.269.01.10; Mastrolorenzo G, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB004954; MASTROLORENZO G, 1994, B VOLCANOL, V56, P561, DOI 10.1007/BF00302836; Mastrolorenzo G, 2001, J VOLCANOL GEOTH RES, V109, P41, DOI 10.1016/S0377-0273(00)00303-6; Mastrolorenzo G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011127; MCEWEN AS, 1989, J VOLCANOL GEOTH RES, V37, P205, DOI 10.1016/0377-0273(89)90080-2; Mei ETW, 2013, J VOLCANOL GEOTH RES, V261, P348, DOI 10.1016/j.jvolgeores.2013.03.010; Mele D, 2015, J VOLCANOL GEOTH RES, V299, P35, DOI 10.1016/j.jvolgeores.2015.04.002; Neri A, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000508; Neri A, 2008, J VOLCANOL GEOTH RES, V178, P397, DOI 10.1016/j.jvolgeores.2008.05.014; Neri A, 2015, J GEOPHYS RES-SOL EA, V120, P2330, DOI 10.1002/2014JB011776; Newhall C.G., 1988, US GEOL SURV B, V1855, P1, DOI DOI 10.3133/B1855; Ongaro TE, 2008, J VOLCANOL GEOTH RES, V178, P378, DOI 10.1016/j.jvolgeores.2008.06.036; Oppenheimer C, 2005, SUPER ERUPTIONS GLOB; Orsi G, 2004, B VOLCANOL, V66, P514, DOI 10.1007/s00445-003-0336-4; Orsi G, 1996, J VOLCANOL GEOTH RES, V74, P179, DOI 10.1016/S0377-0273(96)00063-7; ORSI G, 1992, J VOLCANOL GEOTH RES, V53, P275, DOI 10.1016/0377-0273(92)90086-S; Orsi G, 2009, EARTH PLANET SC LETT, V287, P265, DOI 10.1016/j.epsl.2009.08.013; Palladino DM, 2002, J VOLCANOL GEOTH RES, V116, P97, DOI 10.1016/S0377-0273(02)00213-5; Palladino DM, 1995, J VOLCANOL GEOTH RES, V69, P343, DOI 10.1016/0377-0273(95)00036-4; Pappalardo L, 1999, J VOLCANOL GEOTH RES, V91, P141, DOI 10.1016/S0377-0273(99)00033-5; Pappalardo L, 2002, J VOLCANOL GEOTH RES, V114, P479, DOI 10.1016/S0377-0273(01)00302-X; Pappalardo L, 2002, J PETROL, V43, P1415, DOI 10.1093/petrology/43.8.1415; Pappalardo L, 2008, CONTRIB MINERAL PETR, V156, P1, DOI 10.1007/s00410-007-0270-0; Pappalardo L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00712; Pappalardo L, 2010, EARTH PLANET SC LETT, V296, P133, DOI 10.1016/j.epsl.2010.05.010; Passaro S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22448; Perla R., 1980, AVALANCHE RELEASE, P397, DOI [DOI 10.1016/B978-0-12-179450-7.50012-7, 10.1016/B978-0-12-179450-7.50012-7]; Petrazzuoli SM, 2014, J VOLCANOL GEOTHERM, V133, p353 ; Robertson RM, 2012, ABS CITIES VOLCANOES, V7; Rolandi G, 2003, MINER PETROL, V79, P3, DOI 10.1007/s00710-003-0014-4; Rosi M, 1996, B VOLCANOL, V57, P541, DOI 10.1007/BF00304438; Rosi M, 1987, CNR QUAD RIC SCI, V114, P114; Rossano S, 1998, J VOLCANOL GEOTH RES, V82, P113, DOI 10.1016/S0377-0273(97)00060-7; Rossano S, 2004, J VOLCANOL GEOTH RES, V132, P1, DOI 10.1016/s0377-0273(03)00384-6; Rossano S, 1996, GEOPHYS RES LETT, V23, P3779, DOI 10.1029/96GL03570; SCARPATI C, 1993, B VOLCANOL, V55, P343, DOI 10.1007/BF00301145; Self S, 2006, PHILOS T R SOC A, V364, P2073, DOI 10.1098/rsta.2006.1814; Selva J., 2012, NAPLES J APPL VOLCAN, V1, P1, DOI [10.1186/2191-5040-1-1, DOI 10.1186/2191-5040-1-1]; Selva J, 2012, B VOLCANOL, V74, P497, DOI 10.1007/s00445-011-0528-2; Sheridan M. F., 1979, GEOL S AM S, V180, P125; SHERIDAN MF, 1983, J VOLCANOL GEOTH RES, V17, P187, DOI 10.1016/0377-0273(83)90067-7; Sigurdsson H., 1987, B VOLCANOL, V49, P467, DOI DOI 10.1007/BF01245474; Simakin AG, 2010, B VOLCANOL, V72, P85, DOI 10.1007/s00445-009-0306-6; SPARKS RSJ, 1976, SEDIMENTOLOGY, V23, P147, DOI 10.1111/j.1365-3091.1976.tb00045.x; Todesco M, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001314; Tonini R, 2015, NAT HAZARD EARTH SYS, V15, P409, DOI 10.5194/nhess-15-409-2015; Valentine GA, 1998, J VOLCANOL GEOTH RES, V87, P117, DOI 10.1016/S0377-0273(98)00094-8; VALENTINE GA, 1986, GEOLOGY, V14, P146, DOI 10.1130/0091-7613(1986)14<146:OOLDII>2.0.CO;2; Valentine GA, 1987, B VOLCANOL, V49, P616, DOI 10.1007/BF01079967; Voight B, 2000, J VOLCANOL GEOTH RES, V100, P69, DOI 10.1016/S0377-0273(00)00134-7; VOIGHT B, 1990, J VOLCANOL GEOTH RES, V44, P349, DOI 10.1016/0377-0273(90)90027-D; Voight B., 1988, EARTH MINER SCI, V57, p17 ; Voight B., 1996, MONITORING MITIGATIO, P719, DOI DOI 10.1007/978-3-642-80087-0_22; Wilson L., 1981, The 1980 eruptions of Mount St. Helens, Washington, P513; WOHLETZ K, 1995, J VOLCANOL GEOTH RES, V67, P263, DOI 10.1016/0377-0273(95)00002-C; Wohletz K.H., 1979, MODEL PYROCLASTIC SU, V180, P177, DOI DOI 10.1130/SPE180-P177; WOHLETZ KH, 1983, J VOLCANOL GEOTH RES, V17, P31, DOI 10.1016/0377-0273(83)90061-6; Woo JYL, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006913; Wu WN, 2015, AM MINERAL, V100, P2082, DOI 10.2138/am-2015-5274; YAMAMOTO T, 1993, B VOLCANOL, V55, P166, DOI 10.1007/BF00301514	109	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185756	10.1371/journal.pone.0185756	http://dx.doi.org/10.1371/journal.pone.0185756			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020018	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400044
J	Meyer, KA; Davis, TW; Watson, SB; Denef, VJ; Berry, MA; Dick, GJ				Meyer, Kevin Anthony; Davis, Timothy W.; Watson, Susan B.; Denef, Vincent J.; Berry, Michelle A.; Dick, Gregory J.			Genome sequences of lower Great Lakes Microcystis sp reveal strain-specific genes that are present and expressed in western Lake Erie blooms	PLOS ONE			English	Article							FORMING CYANOBACTERIUM MICROCYSTIS; HARMFUL ALGAL BLOOMS; RIBOSOMAL-RNA GENE; BLUE-GREEN-ALGAE; TOXIC CYANOBACTERIUM; PROCHLOROCOCCUS ECOTYPES; MARINE BACTERIOPLANKTON; NONTOXIC STRAINS; SINGLE-CELL; AERUGINOSA	Blooms of the potentially toxic cyanobacterium Microcystis are increasing worldwide. In the Laurentian Great Lakes they pose major socioeconomic, ecological, and human health threats, particularly in western Lake Erie. However, the interpretation of "omics" data is constrained by the highly variable genome of Microcystis and the small number of reference genome sequences from strains isolated from the Great Lakes. To address this, we sequenced two Microcystis isolates from Lake Erie (Microcystis aeruginosa LE3 and M. wesenbergii LE013-01) and one from upstream Lake St. Clair (M. cf aeruginosa LSC13-02), and compared these data to the genomes of seventeen Microcystis spp. from across the globe as well as one metagenome and seven metatranscriptomes from a 2014 Lake Erie Microcystis bloom. For the publically available strains analyzed, the core genome is similar to 1900 genes, representing similar to 11% of total genes in the pan-genome and similar to 45% of each strain's genome. The flexible genome content was related to Microcystis subclades defined by phylogenetic analysis of both housekeeping genes and total core genes. To our knowledge this is the first evidence that the flexible genome is linked to the core genome of the Microcystis species complex. The majority of strain-specific genes were present and expressed in bloom communities in Lake Erie. Roughly 8% of these genes from the lower Great Lakes are involved in genome plasticity (rapid gain, loss, or rearrangement of genes) and resistance to foreign genetic elements (such as CRISPR-Cas systems). Intriguingly, strain-specific genes from Microcystis cultured from around the world were also present and expressed in the Lake Erie blooms, suggesting that the Microcystis pangenome is truly global. The presence and expression of flexible genes, including strain-specific genes, suggests that strain-level genomic diversity may be important in maintaining Microcystis abundance during bloom events.	[Meyer, Kevin Anthony] Univ Michigan, CIGLR, Ann Arbor, MI USA; [Meyer, Kevin Anthony; Dick, Gregory J.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Davis, Timothy W.] NOAA, Great Lakes Environm Res Lab, Ann Arbor, MI USA; [Watson, Susan B.] Environm & Climate Change Canada, Burlington, ON, Canada; [Denef, Vincent J.; Berry, Michelle A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Oceanic Atmospheric Admin (NOAA) - USA; Environment & Climate Change Canada; University of Michigan System; University of Michigan	Dick, GJ (corresponding author), Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA.	gdick@umich.edu	Dick, Gregory/D-8901-2012	Dick, Gregory/0000-0001-7666-6288	Erb Family Foundation through University of Michigan Water Center [N017871]; Environmental Protection Agency Great Lakes Restoration Initiative [2015-062a]; National Oceanic and Atmospheric Administration; University of Michigan [NA120AR4320071]; University of Michigan Office for Research MCubed program; Erb Family Foundation through University of Michigan Water Center	Erb Family Foundation through University of Michigan Water Center; Environmental Protection Agency Great Lakes Restoration Initiative; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Michigan(University of Michigan System); University of Michigan Office for Research MCubed program; Erb Family Foundation through University of Michigan Water Center	This work was supported by a grant from the Erb Family Foundation made through the University of Michigan Water Center (Grant N017871) and by an Environmental Protection Agency Great Lakes Restoration Initiative Grant (2015-062a). Funding was awarded to the Cooperative Institute for Limnology and Ecosystems Research through the National Oceanic and Atmospheric Administration Cooperative Agreement with the University of Michigan (NA120AR4320071). This project was supported by grants from the University of Michigan Office for Research MCubed program and the Erb Family Foundation made through the University of Michigan Water Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank NOAA-GLERL, specifically Duane Gossiaux and the Captains and crew of NOAA-GLERL R/V R4105 and to CIGLR, specifically Tom Johengen and Dack Stuart, for their assistance with field collection of samples. Thanks also to Paul Den Uyl and Sunit Jain of the University of Michigan for assistance with fieldwork and bioinformatics, respectively. This project was supported by grants from the University of Michigan Office for Research MCubed program and the Erb Family Foundation made through the University of Michigan Water Center. This manuscript is CIGLR publication number 1118 and NOAA GLERL publication number 1868.	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2002, GENOME RES, V12, P1080; Avrani S, 2011, NATURE, V474, P604, DOI 10.1038/nature10172; Berry MA, 2017, ENVIRON MICROBIOL, V19, P1149, DOI 10.1111/1462-2920.13640; Briand E, 2009, ISME J, V3, P419, DOI 10.1038/ismej.2008.121; Bridgeman TB, 2013, J GREAT LAKES RES, V39, P83, DOI 10.1016/j.jglr.2012.11.004; Brittain SM, 2000, J GREAT LAKES RES, V26, P241, DOI 10.1016/S0380-1330(00)70690-3; Buffalo V., 2014, SCYTHE BAYESIAN ADAP; Bullerjahn GS, 2016, HARMFUL ALGAE, V54, P223, DOI 10.1016/j.hal.2016.01.003; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; Chaffin JD, 2011, J GREAT LAKES RES, V37, P92, DOI 10.1016/j.jglr.2010.11.016; Chen IMA, 2017, NUCLEIC ACIDS RES, V45, pD507, DOI 10.1093/nar/gkw929; Childs LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101710; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/106351501750435077; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; Crosbie ND, 2003, APPL ENVIRON MICROB, V69, P5716, DOI 10.1128/AEM.69.9.5716-5721.2003; Darling AE, 2014, PEERJ, V2, DOI 10.7717/peerj.243; Davis TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106093; Davis TW, 2010, AQUAT MICROB ECOL, V61, P149, DOI 10.3354/ame01445; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ejnohova S A L, 2007, LIMNOL OCEANOGR, V52, P609; Felsenstein J., 2005, PHYLOGENY INFERENCE; FERGUSON RL, 1984, APPL ENVIRON MICROB, V47, P49, DOI 10.1128/AEM.47.1.49-55.1984; Fiore MF, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00547-13; Fischer Steve, 2011, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0612s35; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gobler CJ, 2016, HARMFUL ALGAE, V54, P87, DOI 10.1016/j.hal.2016.01.010; Harke MJ, 2016, HARMFUL ALGAE, V54, P4, DOI 10.1016/j.hal.2015.12.007; Harke MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069834; Harke MJ, 2012, MICROB ECOL, V63, P188, DOI 10.1007/s00248-011-9894-8; Horst GP, 2014, WATER RES, V54, P188, DOI 10.1016/j.watres.2014.01.063; Humbert JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070747; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Janse I, 2004, APPL ENVIRON MICROB, V70, P3979, DOI 10.1128/AEM.70.7.3979-3987.2004; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Joshi N.A., SLIDING WINDOW ADAPT; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kuno S, 2014, MICROBIOL-SGM, V160, P903, DOI 10.1099/mic.0.073494-0; Kurmayer R, 2015, ISME J, V9, P909, DOI 10.1038/ismej.2014.189; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin S, 2011, GENE, V473, P139, DOI 10.1016/j.gene.2010.11.011; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Massana R, 2001, LIMNOL OCEANOGR, V46, P1181, DOI 10.4319/lo.2001.46.5.1181; Mella-Flores D, 2011, BIOGEOSCIENCES, V8, P2785, DOI 10.5194/bg-8-2785-2011; Meyer KA, 2013, THESIS, V15, P5353; Mlouka A, 2004, J BACTERIOL, V186, P2355, DOI 10.1128/JB.186.8.2355-2365.2004; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Okano K, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00135-15; Otsuka S, 1999, FEMS MICROBIOL LETT, V172, P15, DOI 10.1111/j.1574-6968.1999.tb13443.x; Otten TG, 2012, ENVIRON SCI TECHNOL, V46, P3480, DOI 10.1021/es2041288; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; Sandrini G, 2014, ISME J, V8, P589, DOI 10.1038/ismej.2013.179; Sant'Anna CL, 2011, NEUROTOX RES, V19, P389, DOI 10.1007/s12640-010-9177-z; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Scholz I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056470; Shalapyonok A, 2001, DEEP-SEA RES PT II, V48, P1231, DOI 10.1016/S0967-0645(00)00137-5; Simm S, 2015, FRONT MICROBIOL, P6; Sinclair JL, 2008, ADV EXP MED BIOL, V619, P45; Sohm JA, 2016, ISME J, V10, P333, DOI 10.1038/ismej.2015.115; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Steffen MM, 2017, ENV SCI TECHNOL; Steffen MM, 2015, APPL ENV MICROBIOL; Steffen MM, 2014, ISME J, P1; Steffen MM, 2014, J GREAT LAKES RES, V40, P215, DOI 10.1016/j.jglr.2013.12.012; Stumpf RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042444; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanabe Y, 2011, PLOS ONE, V6; Tanabe Y, 2007, MICROBIOL-SGM, V153, P3695, DOI 10.1099/mic.0.2007/010645-0; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tillett D, 2001, APPL ENVIRON MICROB, V67, P2810, DOI 10.1128/AEM.67.6.2810-2818.2001; van Gremberghe I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019561; Van Wichelen J, 2016, HARMFUL ALGAE, V55, P97, DOI 10.1016/j.hal.2016.02.009; Vinuesa P, 2015, METHODS MOL BIOL, V1231, P203, DOI 10.1007/978-1-4939-1720-4_14; Visser PM, 2016, HARMFUL ALGAE, V54, P145, DOI 10.1016/j.hal.2015.12.006; Watson SB, 2016, HARMFUL ALGAE, V56, P44, DOI 10.1016/j.hal.2016.04.010; Welker M, 2003, ARCH HYDROBIOL, V157, P227, DOI 10.1127/0003-9136/2003/0157-0227; Willenbrock H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r267; Yang C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00394; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zurawell RW, 2005, J TOXICOL ENV HEAL B, V8, P1, DOI 10.1080/10937400590889412	100	26	26	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0183859	10.1371/journal.pone.0183859	http://dx.doi.org/10.1371/journal.pone.0183859			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020009	gold, Green Published, Green Submitted			2022-12-26	WOS:000412754400008
J	Edmunds, PJ				Edmunds, Peter J.			Unusually high coral recruitment during the 2016 El Nino in Mo'orea, French Polynesia	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORALS; BLEACHING EVENT; CLIMATE-CHANGE; EASTERN PACIFIC; MALDIVIAN REEF; MORTALITY; RECOVERY; TEMPERATURE; REPRODUCTION	The negative implications of the thermal sensitivity of reef corals became clear with coral bleaching throughout the Caribbean in the 1980''s, and later globally, with the severe El Nino of 1998 and extensive seawater warming in 2005. These events have substantially contributed to declines in coral cover, and therefore the El Nino of 2016 raised concerns over the implications for coral reefs; on the Great Barrier Reef these concerns have been realized. A different outcome developed in Mo'orea, French Polynesia, where in situ seawater temperature from 15 March 2016 to 15 April 2016 was an average of 0.4 degrees C above the upper 95% CI of the decadal mean temperature, and the NOAA Degree Heating Weeks (DHW) metric supported a Level 1 bleaching alert (DHW >= 4.0). Starting 1 September 2016 and for the rest of the year (122 d), in situ seawater temperature was an average of 0.4 degrees C above the 95% CI of long-term values, although DHW remained at zero. Minor coral bleaching (0.2-2.6% of the coral) occurred on the outer reef (10-m and 17-m depth) in April 2016, by May 2016 it had intensified to affect 1.3-16.8% of the coral, but by August 2016, only 1.4-3.0% of the coral was bleached. Relative to the previous decade, recruitment of scleractinians to settlement tiles on the outer- (10 m) and back- (2 m) reef over 2016/17 was high, both from January 2016 to August 2016, and from August 2016 to January 2017, with increased relative abundances of pocilloporids on the outer reef, and acroporids in the back reef. The 2016 El Nino created a distinctive signature in seawater temperature for Mo'orea, but it did not cause widespread coral bleaching or mortality, rather, it was associated with high coral recruitment. While the 2016 El Nino has negatively affected other coral reefs in the Indo-Pacific, the coral communities of Mo'orea continue to show signs of resilience, thus cautioning against general statements regarding the effects of the 2015/16 El Nino on coral reefs in the region.	[Edmunds, Peter J.] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA	California State University System; California State University Northridge	Edmunds, PJ (corresponding author), Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA.	peter.edmunds@csun.edu		Edmunds, Peter/0000-0002-9039-9347	US National Science Foundation; Division Of Ocean Sciences [1619893] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was funded by the US National Science Foundation, https://www.nsf.gov.	Adam TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023717; Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Adjeroud M, 2002, MAR ECOL PROG SER, V237, P121, DOI 10.3354/meps237121; Adjeroud M, 2007, J EXP MAR BIOL ECOL, V341, P204, DOI 10.1016/j.jembe.2006.10.048; Ainsworth TD, 2016, SCIENCE, V352, P338, DOI 10.1126/science.aac7125; Alldredge AL, 2009, CORAL REEFS, V28, P895, DOI 10.1007/s00338-009-0534-4; Ampou EE, 2017, BIOGEOSCIENCES, V14, P817, DOI 10.5194/bg-14-817-2017; Andrefouet S, 2017, ENVIRON CONSERV, P1; [Anonymous], 2017, SCI REP, V7, P4058; Aronson RB, 2000, NATURE, V405, P36, DOI 10.1038/35011132; Aronson RB, 2002, MAR BIOL, V141, P435, DOI 10.1007/s00227-002-0842-5; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Bahr KD., 2015, PEERJ, V3, DOI DOI 10.1016/S0308-597X(03)00041-1; Bainbridge SJ, 2017, J OPER OCEANOGR, V10, P16, DOI 10.1080/1755876X.2017.1290863; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; BARBER RT, 1986, NATURE, V319, P279, DOI 10.1038/319279a0; Berumen ML, 2006, CORAL REEFS, V25, P647, DOI 10.1007/s00338-006-0145-2; BLACK KP, 1991, MAR ECOL PROG SER, V74, P1, DOI 10.3354/meps074001; Bouchon C., 1985, P 5 COR REEF C, V6, P279; Bramanti L, 2016, CORAL REEFS, V35, P543, DOI 10.1007/s00338-016-1413-4; Brown BE, 2015, MAR BIOL, V162, P479, DOI 10.1007/s00227-014-2596-2; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; Bruno JF, 2001, CORAL REEFS, V20, P127, DOI 10.1007/s003380100151; Burt J, 2008, MAR BIOL, V154, P27, DOI 10.1007/s00227-007-0892-9; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; DeCarlo TM, 2017, SCI REP-UK, V7, DOI 10.1038/srep44586; Donnelly JP, 2007, NATURE, V447, P465, DOI 10.1038/nature05834; Edmunds PJ, 2001, MAR BIOL, V139, P981; ENFIELD DB, 1991, J CLIMATE, V4, P1137, DOI 10.1175/1520-0442(1991)004<1137:LFCIEN>2.0.CO;2; Fan TY, 2017, MAR ECOL PROG SER, V569, P117, DOI 10.3354/meps12071; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Galzin Rene, 1993, Galaxea, V11, P73; Gleason MG, 1996, J EXP MAR BIOL ECOL, V207, P79, DOI 10.1016/S0022-0981(96)02647-0; Glynn PW, 2017, CORAL REEFS WORLD, V8, P251, DOI 10.1007/978-94-017-7499-4_8; GLYNN PW, 1988, ANNU REV ECOL SYST, V19, pU309; Glynn PW, 2000, MAR BIOL, V136, P785, DOI 10.1007/s002270000286; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Han XY, 2016, CORAL REEFS, V35, P999, DOI 10.1007/s00338-016-1423-2; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Hench JL, 2008, LIMNOL OCEANOGR, V53, P2681, DOI 10.4319/lo.2008.53.6.2681; Hochachka P.W., 2002, BIOCH ADAPTATIONS ME; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Kintisch E, 2016, SCIENCE, V352, P1501, DOI 10.1126/science.352.6293.1501; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Loch K, 2002, MAR ECOL-P S Z N I, V23, P219, DOI 10.1046/j.1439-0485.2002.02773.x; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Manzello DP, 2007, P NATL ACAD SCI USA, V104, P12035, DOI 10.1073/pnas.0701194104; Mapstone BD, 2007, MAR ECOL PROG SER, V332, P143, DOI 10.3354/meps332143; McClanahan TR, 2000, MAR POLLUT BULL, V40, P587, DOI 10.1016/S0025-326X(00)00064-3; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; McPhaden MJ, 2015, NAT CLIM CHANGE, V5, P791, DOI 10.1038/nclimate2775; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Monastersky R, 2016, NATURE, V529, P267, DOI 10.1038/529267a; Mumby PJ, 2001, MAR BIOL, V139, P183; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; Normile D., 2017, SCIENCE; Normile D, 2016, SCIENCE, V352, P15, DOI 10.1126/science.352.6281.15; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Oliver J. K., 2009, V205, P21; Penin L, 2013, MAR ECOL PROG SER, V473, P149, DOI 10.3354/meps10101; Pratchett MS, 2015, OCEANOGR MAR BIOL, V53, P215; Pratchett MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070443; Putnam HM, 2017, BIOL BULL, V215, P135, DOI DOI 10.2307/25470694; Rogers JS, 2015, J GEOPHYS RES-OCEANS, V120, P145, DOI 10.1002/2014JC010464; SALVAT B, 1992, CR ACAD SCI III-VIE, V314, P105; Schuhmacher H, 2005, FACIES, V51, P80, DOI 10.1007/s10347-005-0020-6; Sokal RR., 2011, BIOMETRY; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Tamelander J, 2002, AMBIO, V31, P551, DOI 10.1639/0044-7447(2002)031[0551:CRFAMM]2.0.CO;2; TRILLMICH F, 1985, OECOLOGIA, V67, P19, DOI 10.1007/BF00378445; Tsounis G, 2016, PEERJ, V4, DOI 10.7717/peerj.2544; Wang CZ, 2017, CORAL REEFS WORLD, V8, P85, DOI 10.1007/978-94-017-7499-4_4; Wood S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12571; Xie JY, 2016, MAR POLLUT B; Zar JH., 2010, BIOSTAT ANAL, V5th	83	24	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185167	10.1371/journal.pone.0185167	http://dx.doi.org/10.1371/journal.pone.0185167			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016624	Green Published, Green Submitted, gold			2022-12-26	WOS:000412627400014
J	Cui, CX; Li, YY; Gao, H; Zhang, HY; Han, JJ; Zhang, DJ; Li, Y; Zhou, J; Lu, CY; Su, XR				Cui, Chenxi; Li, Yanyan; Gao, Hang; Zhang, Hongyan; Han, Jiaojiao; Zhang, Dijun; Li, Ye; Zhou, Jun; Lu, Chenyang; Su, Xiurong			Modulation of the gut microbiota by the mixture of fish oil and krill oil in high-fat diet-induced obesity mice	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; MONONUCLEAR-CELLS; GEN. NOV.; ACIDS; INFLAMMATION; PREVENTS; IMPACT; ASSOCIATION; SENSITIVITY	Previous studies confirmed that dietary supplements of fish oil and krill oil can alleviate obesity in mice, but the underlying mechanism remains unclear. This study aims to discern whether oil treatment change the structure of the gut microbiota during the obesity alleviation. The ICR mice received high-fat diet (HFD) continuously for 12 weeks after two weeks of acclimatization with a standard chow diet, and the mice fed with a standard chow diet were used as the control. In the groups that received HFD with oil supplementation, the weight gains were attenuated and the liver index, total cholesterol, triglyceride and low-density lipoprotein cholesterol were reduced stepwise compared with the HFD group, and the overall structure of the gut microbiota, which was modulated in the HFD group, was shifted toward the structure found in the control group. Moreover, eighty-two altered operational taxonomic units responsive to oil treatment were identified and nineteen of them differing in one or more parameters associated with obesity. In conclusion, this study confirmed the effect of oil treatment on obesity alleviation, as well as on the microbiota structure alterations. We proposed that further researches are needed to elucidate the causal relationship between obesity alleviation and gut microbiota modulation.	[Cui, Chenxi; Zhang, Hongyan; Han, Jiaojiao; Zhang, Dijun; Li, Ye; Zhou, Jun; Lu, Chenyang; Su, Xiurong] Ningbo Univ, Sch Marine Sci, Ningbo, Zhejiang, Peoples R China; [Li, Yanyan] Cornell Univ, Dept Food Sci, New York, NY 10021 USA; [Gao, Hang] Jilin Univ, Bethune Hosp 1, Changchun, Jilin, Peoples R China	Ningbo University; Cornell University; Jilin University	Lu, CY; Su, XR (corresponding author), Ningbo Univ, Sch Marine Sci, Ningbo, Zhejiang, Peoples R China.	luchenyang@nbu.edu.cn; suxiurong_public@163.com	zhang, dijun/GQP-8906-2022	zhang, dijun/0000-0003-3417-9849	Key Specialty of Ningbo City; Ningbo University	Key Specialty of Ningbo City; Ningbo University	This work was supported by the the Key Specialty of Ningbo City (http://www.nbu.edu.cn) to XRS, the Talent project in Ningbo University (http://www.nbu.edu.cn) to XRS, the K.C.Wong Magna Fund in Ningbo University (ham//www.nbu.edu.cn) to CYL and XRS.	Albuquerque D, 2015, MOL GENET GENOMICS, V290, P1191, DOI 10.1007/s00438-015-1015-9; Antelo M, 2017, ECON HUM BIOL, V24, P61, DOI 10.1016/j.ehb.2016.11.002; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Bashir S, 2016, J NUTR BIOCHEM, V33, P82, DOI 10.1016/j.jnutbio.2016.02.011; Bendtsen KMB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046231; Burri Lena, 2011, Frontiers in Genetics, V2, P45, DOI 10.3389/fgene.2011.00045; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Carvalho BM, 2012, DIABETOLOGIA, V55, P2823, DOI 10.1007/s00125-012-2648-4; Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017; Connolly HM, 1997, NEW ENGL J MED, V337, P1775; Dangol M, 2017, J CONTROLLED RELEASE; Dasilva G, 2016, FOOD CHEM, V205, P196, DOI 10.1016/j.foodchem.2016.03.020; De Boer AA, 2016, J NUTR BIOCHEM, V34, P61, DOI 10.1016/j.jnutbio.2016.04.004; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eknoyan Garabed, 2007, Curr Diab Rep, V7, P449, DOI 10.1007/s11892-007-0076-5; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Fei N, 2013, ISME J, V7, P880, DOI 10.1038/ismej.2012.153; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FRIDAY KE, 1989, DIABETES CARE, V12, P276, DOI 10.2337/diacare.12.4.276; Haider J, 2017, FOOD HYDROCOLLOID, V63, P27, DOI 10.1016/j.foodhyd.2016.08.020; Hasan M, 2017, NEUROSCIENCE, V343, P322, DOI 10.1016/j.neuroscience.2016.12.002; Honda K, 2013, ELSE KRONER FRESEN S, V4, P43, DOI 10.1159/000346523; Ibrahim A, 2011, CLIN NUTR, V30, P678, DOI 10.1016/j.clnu.2011.05.002; Iizukaa Y, 2016, TOXICOL REP, V3, P4, DOI 10.1016/j.toxrep.2015.11.003; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Klaring K, 2013, INT J SYST EVOL MICR, V63, P4606, DOI 10.1099/ijs.0.051441-0; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Le Grandois J, 2009, J AGR FOOD CHEM, V57, P6014, DOI 10.1021/jf900903e; Lee MF, 2015, J FUNCT FOODS, V19, P913, DOI 10.1016/j.jff.2014.10.015; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li BZ, 2017, FOOD CHEM, V218, P199, DOI 10.1016/j.foodchem.2016.09.059; Bargut TCL, 2015, J NUTR BIOCHEM, V26, P960, DOI 10.1016/j.jnutbio.2015.04.002; Lopez-Cervantes J, 2006, BIOMED CHROMATOGR, V20, P981, DOI 10.1002/bmc.676; Lu CY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00905; Luo Qinfang, 2014, China patent, Patent No. [CN103976804A, 103976804A]; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maraninchi M, 2017, J CLIN LIPIDOL, V11, P495, DOI 10.1016/j.jacl.2017.02.012; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mehra MR, 2006, J HEART LUNG TRANSPL, V25, P834, DOI 10.1016/j.healun.2006.03.005; Micallef MA, 2009, ATHEROSCLEROSIS, V204, P476, DOI 10.1016/j.atherosclerosis.2008.09.020; Motoshima H, 2016, DIABETES RES CLIN PR, V120, pS83; Nascimento FAM, 2010, EXP TOXICOL PATHOL, V62, P17, DOI 10.1016/j.etp.2008.12.008; Norris GH, 2016, J NUTR BIOCHEM, V30, P93, DOI 10.1016/j.jnutbio.2015.12.003; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ruiz-Nunez B, 2013, J NUTR BIOCHEM, V24, P1183, DOI 10.1016/j.jnutbio.2013.02.009; Sakamoto M, 2007, INT J SYST EVOL MICR, V57, P342, DOI 10.1099/ijs.0.64709-0; Satil F, 2003, CHEM NAT COMPD+, V39, P322, DOI 10.1023/B:CONC.0000003408.63300.b5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Serini S, 2012, CURR ALZHEIMER RES, V9, P913, DOI 10.2174/156720512803251147; Shang QS, 2017, J FUNCT FOODS, V28, P138, DOI 10.1016/j.jff.2016.11.002; Silventoinen K, 2010, INT J OBESITY, V34, P29, DOI 10.1038/ijo.2009.177; SIPPONEN P, 1993, SCAND J GASTROENTERO, V28, P3, DOI 10.3109/00365529309098333; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Torres-Fuentes C, 2015, NUTR NEUROSCI, V18, P49, DOI 10.1179/1476830513Y.0000000099; Tuovinen E, 2013, ANAEROBE, V19, P70, DOI 10.1016/j.anaerobe.2012.11.002; Tur JA, 2012, BRIT J NUTR, V107, pS23, DOI 10.1017/S0007114512001456; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang B, 2017, INT J BIOL MACROMOL, V102, P104, DOI 10.1016/j.ijbiomac.2017.03.187; Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yamazaki RK, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-66; Yan YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035709; Yu HN, 2014, ARCH MED RES, V45, P195, DOI 10.1016/j.arcmed.2014.03.008; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhang CH, 2015, EBIOMEDICINE, V2, P968, DOI 10.1016/j.ebiom.2015.07.007; Zhang WL, 2014, OBES REV, V15, P957, DOI 10.1111/obr.12228; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10559; Zhao JL, 2017, GEN COMP ENDOCR, V252, P48, DOI 10.1016/j.ygcen.2017.07.013; Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089	73	48	50	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186216	10.1371/journal.pone.0186216	http://dx.doi.org/10.1371/journal.pone.0186216			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016689	gold, Green Published, Green Submitted			2022-12-26	WOS:000412601800046
J	Schuldenzucker, V; Schubert, R; Muratori, LM; Freisfeld, F; Rieke, L; Matheis, T; Schramke, S; Motlik, J; Kemper, N; Radespiel, U; Reilmann, R				Schuldenzucker, Verena; Schubert, Robin; Muratori, Lisa M.; Freisfeld, Frauke; Rieke, Lorena; Matheis, Tamara; Schramke, Sarah; Motlik, Jan; Kemper, Nicole; Radespiel, Ute; Reilmann, Ralf			Behavioral testing of minipigs transgenic for the Huntington gene-A three-year observational study	PLOS ONE			English	Article							DISEASE; MODELS; PREMANIFEST; HD	Background Large animal models of Huntington's disease (HD) may increase the reliability of translating preclinical findings to humans. Long live expectancy offers opportunities particularly for disease modifying approaches, but also challenges. The transgenic (tg) HD minipig model assessed in this study exhibits a high genetic homology with humans, similar body weight, and comparable brain structures. To test long-term safety, tolerability, and efficacy of novel therapeutic approaches in this model reliable assessments applicable longitudinally for several years are warranted for all phenotypical domains relevant in HD. Objective To investigate whether the tests proposed assessing motor, cognitive and behavioral domains can be applied repetitively over a 3-year period in minipigs with acceptable variability or learning effects and whether tgHD minipigs reveal changes in these domains compared to wildtype (wt) minipigs suggesting the development of an HD phenotype. Methods A cohort of 14 tgHD and 18 wt minipigs was followed for three years. Tests applied every six months included a tongue coordination and hurdle test for the motor domain, a color discrimination test for cognition, and a dominance test for assessing behavior. Statistical analyses were performed using repeated ANOVA for longitudinal group comparisons and Wilcoxon-tests for intra-visit differences between tgHD and wt minipigs. Results All tests applied demonstrated feasibility, acceptable variance and good consistency during the three-year period. No significant differences between tgHD and wt minipigs were detected suggesting lack of a phenotype before the age of four years. Conclusions The assessment battery presented offers measures in all domains relevant for HD and can be applied in long-term phenotyping studies with tgHD minipigs. The observation of this cohort should be continued to explore the timeline of phenotype development and provide information for future interventional studies.	[Schuldenzucker, Verena; Schubert, Robin; Muratori, Lisa M.; Freisfeld, Frauke; Rieke, Lorena; Matheis, Tamara; Schramke, Sarah; Reilmann, Ralf] George Huntington Inst, Technol Park, Munster, Germany; [Schuldenzucker, Verena; Radespiel, Ute] Univ Vet Med Hannover, Inst Zool, Hannover, Germany; [Muratori, Lisa M.] SUNY Stony Brook, Sch Hlth Technol & Management, Dept Phys Therapy, Stony Brook, NY 11794 USA; [Freisfeld, Frauke; Reilmann, Ralf] Univ Munster, Dept Clin Radiol, Albert Schweitzer Campus 1, Munster, Germany; [Rieke, Lorena; Matheis, Tamara; Kemper, Nicole] Univ Vet Med Hannover, Inst Anim Hyg Anim Welf & Farm Anim Behav, Hannover, Germany; [Motlik, Jan] AS CR, Inst Anim Physiol & Genet, Lab Cell Regenerat & Plast, Vvi, Libechov, Czech Republic; [Reilmann, Ralf] Univ Tubingen, Dept Neurodegenerat Dis, Tubingen, Germany; [Reilmann, Ralf] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany	University of Veterinary Medicine Hannover, Foundation; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Munster; University of Veterinary Medicine Hannover, Foundation; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Eberhard Karls University of Tubingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Reilmann, R (corresponding author), George Huntington Inst, Technol Park, Munster, Germany.; Reilmann, R (corresponding author), Univ Munster, Dept Clin Radiol, Albert Schweitzer Campus 1, Munster, Germany.; Reilmann, R (corresponding author), Univ Tubingen, Dept Neurodegenerat Dis, Tubingen, Germany.; Reilmann, R (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany.	ratf.reilmann@ghi-muenster..de		Reilmann, Ralf/0000-0002-5904-9517; Kemper, Nicole/0000-0003-0092-4302	CHDI Foundation; team of the Zentrale Tierexpermientelle Einrichtung (ZTE) of the University Hospital of Muenster, Muenster, Germany	CHDI Foundation; team of the Zentrale Tierexpermientelle Einrichtung (ZTE) of the University Hospital of Muenster, Muenster, Germany	The George-Huntington-Institute has received grant support from the CHDI Foundation (www.chdifoundation.org) to conduct the work reported in this study to RR. We are grateful for additional relevant support provided by private donations of families affected by HD that would like to remain anonymous. The authors are not aware of any competing interests of these donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no other financial interests related to this manuscript. We thank the team of the Zentrale Tierexpermientelle Einrichtung (ZTE) of the University Hospital of Muenster, Muenster, Germany, for continuous support. We thank the team of the Laboratory of Cell Regeneration and Plasticity, Institute of Animal Physiology and Genetics, Libechov, Czech Republic, for providing the animals and intense scientific exchange and guidance.	Bang A, 2010, ANIM BEHAV, V79, P631, DOI 10.1016/j.anbehav.2009.12.009; Craufurd D, 2001, NEUROPSY NEUROPSY BE, V14, P219; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; Dolezalova D, 2014, J COMP NEUROL, V522, P2784, DOI 10.1002/cne.23575; Dumas E., 2013, FRONT BIOSCI, P1; Fisher CA, 2014, J HUNTINGTONS DIS, V3, P319, DOI 10.3233/JHD-140127; Howland DS, 2014, MOVEMENT DISORD, V29, P1397, DOI 10.1002/mds.26008; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kieburtz K, 2017, RESULTS PHASE 2 DOUB, V88; Killoran A, 2014, MOVEMENT DISORD, V29, P1404, DOI 10.1002/mds.26014; Kim J, 2011, INT REV NEUROBIOL, V98, P419, DOI 10.1016/B978-0-12-381328-2.00016-X; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Lione LA, 1999, J NEUROSCI, V19, P10428; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Monika B, 2013, J HUNTINGTONS DIS, P47; Morton AJ, 2013, J HUNTINGTONS DIS, V2, P3, DOI 10.3233/JHD-130050; Paulsen JS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00078; Reilmann R, 2015, MOV DISORD, V30; Reilmann R., 2009, AKTUELLE NEUROL, V36, pP474, DOI DOI 10.1055/S-0029-1238568; Reilmann R, 2015, MOVEMENT DISORD, V30, P427, DOI 10.1002/mds.26174; Reilmann R, 2012, BASAL GANGLIA, V2, P241, DOI 10.1016/j.baga.2012.09.004; Reilmann R, 2010, MOVEMENT DISORD, V25, P2195, DOI 10.1002/mds.23243; Schramke S, 2015, CESK SLOV NEUROL S2, V78, P55; Schramke S, 2016, J NEUROSCI METH, V265, P34, DOI 10.1016/j.jneumeth.2015.11.013; Schubert R, 2016, J NEUROSCI METH, V265, P46, DOI 10.1016/j.jneumeth.2015.11.017; Stout JC, 2012, J NEUROL NEUROSUR PS, V83, P687, DOI 10.1136/jnnp-2011-301940; SZEKELY S, 1983, APPL ANIM ETHOL, V9, P279, DOI 10.1016/0304-3762(83)90008-1; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Valekova Ivona, 2015, Methods Mol Biol, V1212, P39, DOI 10.1007/7651_2014_94; Venuto CS, 2012, MOVEMENT DISORD, V27, P31, DOI 10.1002/mds.23953; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wild EJ, 2014, MOVEMENT DISORD, V29, P1434, DOI 10.1002/mds.26007; William Yang X., 2011, NEUROBIOLOGY HUNTING; Yang X. W., 2011, MOUSE MODELS VALIDAT	37	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185970	10.1371/journal.pone.0185970	http://dx.doi.org/10.1371/journal.pone.0185970			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016656	Green Published, gold, Green Submitted			2022-12-26	WOS:000412601800033
J	Matard-Mann, M; Bernard, T; Leroux, C; Barbeyron, T; Larocque, R; Prechoux, A; Jeudy, A; Jam, M; Collen, PN; Michel, G; Czjzek, M				Matard-Mann, Maria; Bernard, Thomas; Leroux, Cedric; Barbeyron, Tristan; Larocque, Robert; Prechoux, Aurelie; Jeudy, Alexandra; Jam, Murielle; Collen, Pi Nyvall; Michel, Gurvan; Czjzek, Mirjam			Structural insights into marine carbohydrate degradation by family GH16-carrageenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme kinetics; polysaccharide; processivity; site-directed mutagenesis; carbohydrate recognition; enzyme-substrate complex; kappa-carrageenan; sulfated polysaccharides	CELL-WALL POLYSACCHARIDE; KAPPA-CARRAGEENASE GENE; ACTIVE-SITE; HYDROLYSIS; PURIFICATION; RESIDUES; CELLOBIOHYDROLASE; NOMENCLATURE; RECOGNITION; FEATURES	Carrageenans are sulfated -1,3--1,4-galactans found in the cell wall of some red algae that are practically valuable for their gelation and biomimetic properties but also serve as a potential carbon source for marine bacteria. Carbohydrate degradation has been studied extensively for terrestrial plant/bacterial systems, but sulfation is not present in these cases, meaning the marine enzymes used to degrade carrageenans must possess unique features to recognize these modifications. To gain insights into these features, we have focused on -carrageenases from two distant bacterial phyla, which belong to glycoside hydrolase family 16 and cleave the -1,4 linkage of -carrageenan. We have solved the crystal structure of the catalytic module of ZgCgkA from Zobellia galactanivorans at 1.66 resolution and compared it with the only other structure available, that of PcCgkA from Pseudoalteromonas carrageenovora 9(T) (ATCC 43555(T)). We also describe the first substrate complex in the inactivated mutant form of PcCgkA at 1.7 resolution. The structural and biochemical comparison of these enzymes suggests key determinants that underlie the functional properties of this subfamily. In particular, we identified several arginine residues that interact with the polyanionic substrate, and confirmed the functional relevance of these amino acids using a targeted mutagenesis strategy. These results give new insight into the diversity of the -carrageenase subfamily. The phylogenetic analyses show the presence of several distinct clades of enzymes that relate to differences in modes of action or subtle differences within the same substrate specificity, matching the hybrid character of the -carrageenan polymer.	[Matard-Mann, Maria; Barbeyron, Tristan; Larocque, Robert; Prechoux, Aurelie; Jam, Murielle; Michel, Gurvan; Czjzek, Mirjam] UPMC Univ Paris 06, CNRS, UMR 8227, Sorbonne Univ,Integrat Biol Marine Models,Stn Bio, F-90074 Roscoff, Bretagne, France; [Bernard, Thomas] Univ Aix Marseille I & II, Architecture & Fonct Macromol Biol, Unite Mixed Rech 6098, CNRS, Case 932,163 Ave Luminy, F-13288 Marseille 9, France; [Leroux, Cedric; Jeudy, Alexandra] UPMC Univ Paris 06, Sorbonne Univ, CNRS, FR 2424,Stn Biol Roscoff, F-29682 Roscoff, Bretagne, France; [Matard-Mann, Maria; Collen, Pi Nyvall] Amadeite SAS, Pole Biotechnol Haut Bois, F-56580 Brehan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Czjzek, M (corresponding author), UPMC Univ Paris 06, CNRS, UMR 8227, Sorbonne Univ,Integrat Biol Marine Models,Stn Bio, F-90074 Roscoff, Bretagne, France.	czjzek@sb-roscoff.fr		MICHEL, Gurvan/0000-0002-3009-6205; LEROUX, Cedric/0000-0001-9225-1234	ANRT; Olmix group Ph.D. Grant [CIFRE-684/2014]; French National Research Agency [ANR-10-BTBR-04]; "Region Bretagne"	ANRT(French National Research Agency (ANR)); Olmix group Ph.D. Grant; French National Research Agency(French National Research Agency (ANR)); "Region Bretagne"(Region Bretagne)	This work was supported by ANRT and Olmix group Ph.D. Grant CIFRE-684/2014 (to M. M.-M.). This work was also supported by the French National Research Agency with regard to the investment expenditure program IDE-ALG (Grant Agreement ANR-10-BTBR-04) and supported by the "Region Bretagne." The authors declare that they have no conflicts of interest with the contents of this article.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; BARBEYRON T, 1994, GENE, V139, P105, DOI 10.1016/0378-1119(94)90531-2; Barbeyron T, 1998, MOL BIOL EVOL, V15, P528, DOI 10.1093/oxfordjournals.molbev.a025952; Barbeyron T, 2016, ENVIRON MICROBIOL, V18, P4610, DOI 10.1111/1462-2920.13584; Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200; Black GW, 1996, BIOCHEM J, V319, P515, DOI 10.1042/bj3190515; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falshaw R, 1996, CARBOHYD RES, V285, P81, DOI 10.1016/0008-6215(96)00031-6; Gilad R, 2003, J BACTERIOL, V185, P391, DOI 10.1128/JB.185.2.391-398.2003; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Grondin JM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00860-16; Guibet M, 2007, BIOCHEM J, V404, P105, DOI [10.1042//BJ20061359, 10.1042/BJ20061359]; Hall T., 2011, GERF B BIOSCI, V2, P60; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; KIDBY DK, 1973, ANAL BIOCHEM, V55, P321, DOI 10.1016/0003-2697(73)90323-0; KNUTSEN SH, 1994, BOT MAR, V37, P163, DOI 10.1515/botm.1994.37.2.163; KNUTSEN SH, 1987, BOT MAR, V30, P497, DOI 10.1515/botm.1987.30.6.497; Kobayashi T, 2012, BIOSCI BIOTECH BIOCH, V76, P506, DOI 10.1271/bbb.110809; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lemoine M, 2009, BIOCHEM J, V419, P545, DOI 10.1042/BJ20080619; Liu GL, 2011, PROCESS BIOCHEM, V46, P265, DOI 10.1016/j.procbio.2010.08.021; Liu ZM, 2013, APPL MICROBIOL BIOT, V97, P10057, DOI 10.1007/s00253-013-5215-0; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martin M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01487; Martin M, 2014, APPL MICROBIOL BIOT, V98, P2917, DOI 10.1007/s00253-014-5557-2; Michel G, 2003, J MOL BIOL, V334, P421, DOI 10.1016/j.jmb.2003.09.056; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; Michel G, 2013, WOODH PUB SER BIOMED, P429, DOI 10.1533/9781908818355.3.429; O'Dowd CD, 2002, NATURE, V417, P632, DOI 10.1038/nature00775; OSTLING S, 1946, ACTA PHYSIOL SCAND, V11, P289, DOI 10.1111/j.1748-1716.1946.tb00349.x; Planas N, 2000, BBA-PROTEIN STRUCT M, V1543, P361, DOI 10.1016/S0167-4838(00)00231-4; POTIN P, 1995, EUR J BIOCHEM, V228, P971, DOI 10.1111/j.1432-1033.1995.0971m.x; POTIN P, 1991, EUR J BIOCHEM, V201, P241, DOI 10.1111/j.1432-1033.1991.tb16280.x; Rebuffet E, 2010, BIOCHEMISTRY-US, V49, P7590, DOI 10.1021/bi1003475; RIORDAN JF, 1970, BIOCHEM BIOPH RES CO, V41, P122, DOI 10.1016/0006-291X(70)90477-8; RIORDAN JF, 1977, SCIENCE, V195, P884, DOI 10.1126/science.190679; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Senni K, 2011, MAR DRUGS, V9, P1664, DOI 10.3390/md9091664; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Usov A. I., 2011, POLYSACCHARIDES RED, P116; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Wang LN, 2015, J OCEAN U CHINA, V14, P759, DOI 10.1007/s11802-015-2713-y; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; WEIGL J, 1966, CAN J MICROBIOL, V12, P939, DOI 10.1139/m66-127; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu XY, 2015, J OCEAN U CHINA, V14, P1082, DOI 10.1007/s11802-015-2652-7; YAPHE W, 1955, APPL MICROBIOL, V3, P380, DOI 10.1128/AEM.3.6.380-383.1955; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	61	24	24	2	48	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19919	19934		10.1074/jbc.M117.808279	http://dx.doi.org/10.1074/jbc.M117.808279			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29030427	Green Published, hybrid			2022-12-26	WOS:000416911300033
J	Laboissiere, R; Barraud, PA; Cian, C				Laboissiere, Rafael; Barraud, Pierre-Alain; Cian, Corinne			Real and visually-induced body inclination differently affect the perception of object stability	PLOS ONE			English	Article							ORIENTATION; DIRECTION; REPRESENTATION; FRAME	The prediction of object stability on earth requires the establishment of a perceptual frame of reference based on the direction of gravity. Across three experiments, we measured the critical angle (CA) at which an object appeared equally likely to fall over or right itself. We investigated whether the internal representation of the gravity direction, biased by either simulated tilt rotating visual surround) or real body tilt situations, influences in a similar fashion the judgment of stability. In the simulated tilt condition, the estimated CA and the perceived gravity are both deviated in the same direction. In the real tilt condition, the orientation of the body affects the perception of gravity direction but has no effect on the estimated CA. Results suggest that people differently weigh gravity direction information provided by visual motion and by visual polarity cues for estimating the stability of objects.	[Laboissiere, Rafael; Cian, Corinne] Univ Grenoble Alpes, CNRS, LPNC, Grenoble, France; [Barraud, Pierre-Alain] Univ Grenoble Alpes, CNRS, TIMC IMAG, Grenoble, France; [Cian, Corinne] Inst Rech Biomed Armees, Bretigny Sur Orge, France	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Laboissiere, R (corresponding author), Univ Grenoble Alpes, CNRS, LPNC, Grenoble, France.	rafael.laboissiere@univ-grenoble-alpes.fr	Laboissière, Rafael/E-9814-2013	Laboissière, Rafael/0000-0002-2180-9250	Ministere de la Defense (France) [PDH-1-SMO-3-0810]	Ministere de la Defense (France)	This work was supported by grant # PDH-1-SMO-3-0810 from Ministere de la Defense (France), awarded to C. Cian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett-Cowan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019289; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Ceyte H, 2009, NEUROSCI LETT, V462, P85, DOI 10.1016/j.neulet.2009.06.048; Christensen R. H. B, 2016, LMER TEST TESTS LINE; Cian C, 2001, PERCEPTION, V30, P1427, DOI 10.1068/p3270; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Dichgans J, 1978, HDB SENSORY PHYSL, P755, DOI DOI 10.1007/978-3-642-46354-9_25; Gresty MA, 2008, AVIAT SPACE ENVIR MD, V79, P105, DOI 10.3357/ASEM.2143.2008; HELD R, 1975, VISION RES, V15, P357, DOI 10.1016/0042-6989(75)90083-8; Howard I. P., 1986, HDB PERCEPTION HUMAN, V1, P1801; Howard I. P., 1982, HUMAN VISUAL ORIENTA; HOWARD IP, 1994, PERCEPTION, V23, P753, DOI 10.1068/p230753; HOWARD IP, 1994, PERCEPTION, V23, P745, DOI 10.1068/p230745; Howard IP, 2001, PERCEPTION, V30, P583, DOI 10.1068/p3106; KERR B, 1985, J EXP PSYCHOL HUMAN, V11, P617, DOI 10.1037/0096-1523.11.5.617; Lopez C, 2009, J VISION, V9, DOI 10.1167/9.5.1; Meredith M., 2016, HDINTERVAL HIGHEST P; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; Mittelstaedt H, 1999, ANN NY ACAD SCI, V871, P334, DOI 10.1111/j.1749-6632.1999.tb09196.x; Rock I., 1990, LEGACY SOLOMON ASCH, P243; Samuel F, 2011, J EXP PSYCHOL HUMAN, V37, P529, DOI 10.1037/a0018732; Seno T, 2011, ATTEN PERCEPT PSYCHO, V73, P1467, DOI 10.3758/s13414-011-0129-3; Todorov V, 2009, J STAT SOFTW, V32, P1; Trousselard M, 2004, COGNITIVE BRAIN RES, V20, P355, DOI 10.1016/j.cogbrainres.2004.03.008; van Beuzekom AD, 2000, J NEUROPHYSIOL, V84, P11, DOI 10.1152/jn.2000.84.1.11; Wade MG, 1997, PHYS THER, V77, P619, DOI 10.1093/ptj/77.6.619; WADE NJ, 1972, J EXP PSYCHOL, V96, P203, DOI 10.1037/h0033473; WADE NJ, 1992, AUST J PSYCHOL, V44, P139, DOI 10.1080/00049539208259833	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186431	10.1371/journal.pone.0186431	http://dx.doi.org/10.1371/journal.pone.0186431			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ8YP	29036180	Green Published, Green Submitted, gold			2022-12-26	WOS:000413054800032
J	Rius-Ottenheim, N; Kromhout, D; Sijtsma, FPC; Geleijnse, JM; Giltay, EJ				Rius-Ottenheim, Nathaly; Kromhout, Daan; Sijtsma, Femke P. C.; Geleijnse, Johanna M.; Giltay, Erik J.			Dietary patterns and mental health after myocardial infarction	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; FOOD-FREQUENCY QUESTIONNAIRE; MAJOR DEPRESSIVE DISORDER; N-3 FATTY-ACIDS; DISPOSITIONAL OPTIMISM; VEGETABLE CONSUMPTION; CARDIOVASCULAR EVENTS; PHYSICAL-ACTIVITY; RISK; METAANALYSIS	Background Diet has been associated with better mental health in general populations, but less is known on this association in patients with a history of coronary heart disease. The objective of this study is to examine the cross-sectional associations between dietary patterns and mental health in elderly patients with a history of myocardial infarction. Methods Data were drawn from the final assessment of the Alpha Omega cohort that monitored patients with a history of myocardial infarction (age range 60-80 years). 2171 patients with complete data for diet and mental health were included in this study. Diet was assessed with the 203-item Food Frequency Questionnaire, and subsequently categorized into two scores: the Dutch Healthy Nutrient and Food Score (DHNaFS) and the Dutch Undesirable Nutrient and Food Score (DUNaFS). Depressive symptoms, assessed with the Geriatric Depression Scale (GDS-15), and dispositional optimism, assessed with the 4-item questionnaire (4Q), were cross-sectionally analyzed in relation to dietary patterns using linear regression analysis. Results Patients were on average 72.2 years old and 79.5% were male. The DHNaFS score was associated with less depressive symptoms and higher dispositional optimism (beta = -0.108; P<0.001; and beta = 0.074; P<0.001), whereas no associations were found with the DUNaFS score. Particularly, consumption of vegetables, fruits, whole grains, fish, and low fat-dairy were associated with less depressive symptoms and higher optimism. Similar associations were found when analyzing the association between average DHNaFS score over the preceding 41 months with depression beta = -0.085; P<0.001) and higher dispositional optimism (beta = 0.084; P<0.001). Conclusions A healthy dietary pattern, in particular a higher consumption of vegetables, fruit, whole grains, fish and low-fat dairy, was associated with less depressive symptoms and higher optimism. However, given the cross-sectional nature of our analyses, our findings may also be explained by more optimistic participants making healthier food choices. Therefore, future prospective or interventions studies are needed to establish the direction of causality of this association.	[Rius-Ottenheim, Nathaly; Giltay, Erik J.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Rius-Ottenheim, Nathaly] Spaarne Gasthuis Hosp, Dept Psychiat, Haarlem, Netherlands; [Kromhout, Daan; Sijtsma, Femke P. C.; Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Kromhout, Daan] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Spaarne Hospital; Wageningen University & Research; University of Groningen	Rius-Ottenheim, N (corresponding author), Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands.; Rius-Ottenheim, N (corresponding author), Spaarne Gasthuis Hosp, Dept Psychiat, Haarlem, Netherlands.	N.Rius_Ottenheim@lumc.nl	Geleijnse, Johanna Marianna M/B-5749-2012; Sijtsma, Femke/AFO-7055-2022; Giltay, Erik J./AAL-9948-2021	Geleijnse, Johanna Marianna M/0000-0001-7638-0589; 	Netherlands Heart Foundation [2000T401]; National Institutes of Health [R01 HL076200-03]; Unilever RAMP;D (the Netherlands); Unilever	Netherlands Heart Foundation(Netherlands Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Unilever RAMP;D (the Netherlands)(Netherlands Government); Unilever(Unilever)	The Alpha Omega Trial was supported by the Netherlands Heart Foundation (grant number 2000T401), the National Institutes of Health (grant number R01 HL076200-03), and Unilever R&D (the Netherlands). Unilever provided an unrestricted grant for the distribution of trial margarines to the patients.	Adjibade M., 2017, EUR J NUTR; Akbaraly TN, 2013, AM J CLIN NUTR, V97, P419, DOI 10.3945/ajcn.112.041582; [Anonymous], 2006, NEVO TABEL NEDERLAND; Baumeister H, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008012.pub3; Casacalenda N, 2002, AM J PSYCHIAT, V159, P1354, DOI 10.1176/appi.ajp.159.8.1354; de Craen AJM, 2003, INT J GERIATR PSYCH, V18, P63, DOI 10.1002/gps.773; FEUNEKES GIJ, 1993, AM J CLIN NUTR, V58, P489, DOI 10.1093/ajcn/58.4.489; Feunekes IJ, 1995, INT J FOOD SCI NUTR, V46, P117, DOI 10.3109/09637489509012539; Geleijnse JM, 2010, AM HEART J, V159, P539, DOI 10.1016/j.ahj.2009.12.033; Gilbert K, 2013, BRIT J NUTR, V109, P50, DOI 10.1017/S0007114512003807; Giltay EJ, 2006, ARCH INTERN MED, V166, P431, DOI 10.1001/.431; Giltay EJ, 2007, J PSYCHOSOM RES, V63, P483, DOI 10.1016/j.jpsychores.2007.07.014; Hackett ML, 2014, INT J STROKE, V9, P1017, DOI 10.1111/ijs.12357; Hastings CN, 2016, CURR TOP BEHAV NEURO; Hingle MD, 2014, J ACAD NUTR DIET, V114, P1036, DOI 10.1016/j.jand.2013.12.018; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Jacka FN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087657; Kelloniemi H, 2005, APPETITE, V45, P169, DOI 10.1016/j.appet.2005.05.001; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Lai JS, 2016, BRIT J NUTR, V115, P842, DOI 10.1017/S000711451500519X; Lai JS, 2014, AM J CLIN NUTR, V99, P181, DOI 10.3945/ajcn.113.069880; Le Port A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051593; Liu XQ, 2016, NUTRITION, V32, P296, DOI 10.1016/j.nut.2015.09.009; Lucas M, 2014, BRAIN BEHAV IMMUN, V36, P46, DOI 10.1016/j.bbi.2013.09.014; Martinez-Gonazlez MA, 2016, P NUTR SOC, V75, P139, DOI 10.1017/S0029665116000045; McMartin SE, 2013, PREV MED, V56, P225, DOI 10.1016/j.ypmed.2012.12.016; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Opie RS, 2015, PUBLIC HEALTH NUTR, V18, P2074, DOI 10.1017/S1368980014002614; Papakostas GI, 2015, MOL PSYCHIATR, V20, P1142, DOI 10.1038/mp.2015.92; Pietrzak RH, 2013, PSYCHOL MED, V43, P1401, DOI 10.1017/S0033291712002309; Rahe C, 2014, EUR J NUTR, V53, P997, DOI 10.1007/s00394-014-0652-9; Rondeau I, 2011, CAN J PHYSIOL PHARM, V89, P169, DOI 10.1139/Y11-007; Ruiz-Cabello P, 2017, J ACAD NUTR DIET, V117, P422, DOI 10.1016/j.jand.2016.09.023; Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055; Sanchez-Villegas A, 2015, BRIT J NUTR, V114, P1471, DOI 10.1017/S0007114515003074; Sanchez-Villegas A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-3; Sanhueza C, 2013, J HUM NUTR DIET, V26, P56, DOI 10.1111/j.1365-277X.2012.01283.x; Sarris J, 2015, ADV INTEGR MED, V2, P49, DOI 10.1016/j.aimed.2015.02.001; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schuit AJ, 1997, J CLIN EPIDEMIOL, V50, P541, DOI 10.1016/S0895-4356(97)00010-3; Serlachius A, 2015, PSYCHOL HEALTH, V30, P1221, DOI 10.1080/08870446.2015.1041394; Shatenstein B, 2016, EUR J NUTR, V55, P1671, DOI 10.1007/s00394-015-0986-y; Sijtsma FP, 2015, AM J CLIN NUTR; Tinker LF, 2007, J AM DIET ASSOC, V107, P1155, DOI 10.1016/j.jada.2007.04.010; Tsai AC, 2012, PUBLIC HEALTH NUTR, V15, P1087, DOI 10.1017/S1368980011002977; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Whitaker KM, 2014, NUTR RES, V34, P294, DOI 10.1016/j.nutres.2014.01.007; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zaborskis A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-94	51	6	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							0186368	10.1371/journal.pone.0186368	http://dx.doi.org/10.1371/journal.pone.0186368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036212	Green Published, gold, Green Submitted			2022-12-26	WOS:000413054800025
J	Zhang, Q; Xiao, XH; Li, M; Yu, M; Ping, F; Zheng, J; Wang, T; Wang, XJ				Zhang, Qian; Xiao, Xinhua; Li, Ming; Yu, Miao; Ping, Fan; Zheng, Jia; Wang, Tong; Wang, Xiaojing			Vildagliptin increases butyrate-producing bacteria in the gut of diabetic rats	PLOS ONE			English	Article							HIGH-FAT-DIET; INDUCED OBESITY; MICROBIOTA INTERACTIONS; INTESTINAL MICROBIOTA; INSULIN-RESISTANCE; INFLAMMATION; METFORMIN; RNA; IMPROVEMENT; MODULATION	Emerging evidence supports a key role for the gut microbiota in metabolic diseases, including type 2 diabetes (T2D) and obesity. The dipeptidyl peptidase-4 inhibitor vildagliptin is highly efficacious in treating T2D. However, whether vildagliptin can alter the gut microbiome is still unclear. This study aimed to identify whether vildagliptin modifies the gut microbiota structure during T2D treatment. Diabetic Sprague-Dawley (SD) rats were induced by a high-fat diet and streptozotocin injection (HFD/STZ). Diabetic rats were orally administered a low dose of vildagliptin (LV, 0.01 g/kg/d vildagliptin), high dose of vildagliptin (HV, 0.02 g/kg/d vildagliptin), or normal saline for 12 weeks. Fasting blood glucose, blood glucose after glucose loading, and serum insulin levels were significantly reduced in the LV and HV groups compared with those in the T2D group. The serum GLP-1 level increased more in the vildagliptin-treated group than in the T2D group. Pyrosequencing of the V3-V4 regions of 16S rRNA genes revealed that vildagliptin significantly altered the gut microbiota. The operational taxonomic units (OTUs) and community richness (Chao1) index were significantly reduced in the vildagliptin and diabetic groups compared with those in the control group. At the phylum level, a higher relative abundance of Bacteroidetes, lower abundance of Firmicutes, and reduced ratio of Fimicutes/Bacteroidetes were observed in the vildagliptin-treated group. Moreover, vildagliptin treatment increased butyrate-producing bacteria, including Baceroides and Erysipelotrichaeae, in the diabetic rats. Moreover, Lachnospira abundance was significantly negatively correlated with fasting blood glucose levels. In conclusion, vildagliptin treatment could benefit the communities of the gut microbiota.	[Zhang, Qian; Xiao, Xinhua; Li, Ming; Yu, Miao; Ping, Fan; Zheng, Jia; Wang, Tong; Wang, Xiaojing] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp,Key Lab Endocrinol, Dept Endocrinol,Translat Med Ctr,Minist Hlth, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Xiao, XH (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp,Key Lab Endocrinol, Dept Endocrinol,Translat Med Ctr,Minist Hlth, Beijing, Peoples R China.	xiaoxh2014@vip.163.com	Li, Ming/I-1323-2018	Li, Ming/0000-0002-8427-605X	National Key Research and Development Program of China [2016YFA0101002]; National Natural Science Foundation of China [81170736, 81570715]; National Natural Science Foundation for Young Scholars of China [81300649]; China Scholarship Council Foundation [201308110443]; PUMC Youth Fund [33320140022]; China Diabetes Young Scientific Talent Research Funding, Diabetes Research Fund from Clinical Research of Chinese Medical Association and Chinese Diabetes Society [12030500350]; Fundamental Research Funds for the Central Universities; Scientific Activities Foundation for Selected Returned Overseas Professional of Human Resources and Social Security Ministry	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); China Scholarship Council Foundation(China Scholarship Council); PUMC Youth Fund; China Diabetes Young Scientific Talent Research Funding, Diabetes Research Fund from Clinical Research of Chinese Medical Association and Chinese Diabetes Society; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Activities Foundation for Selected Returned Overseas Professional of Human Resources and Social Security Ministry	This work was supported by National Key Research and Development Program of China (2016YFA0101002), National Natural Science Foundation of China (81170736, 81570715), National Natural Science Foundation for Young Scholars of China (81300649), China Scholarship Council Foundation (201308110443), PUMC Youth Fund (33320140022), China Diabetes Young Scientific Talent Research Funding, Diabetes Research Fund from Clinical Research of Chinese Medical Association and Chinese Diabetes Society (12030500350), Fundamental Research Funds for the Central Universities, and the Scientific Activities Foundation for Selected Returned Overseas Professional of Human Resources and Social Security Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; l	Alles MS, 1996, BRIT J NUTR, V76, P211, DOI 10.1079/BJN19960026; Baothman OA, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0278-4; BEERENS H, 1977, AM J CLIN NUTR, V30, P1770, DOI 10.1093/ajcn/30.11.1770; Bosi E, 2007, DIABETES CARE, V30, P890, DOI 10.2337/dc06-1732; Candela M, 2016, BRIT J NUTR, V116, P80, DOI 10.1017/S0007114516001045; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang CJ, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8489, 10.1038/ncomms8216]; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Estaki M, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0189-7; Esteve E, 2011, CURR OPIN CLIN NUTR, V14, P483, DOI 10.1097/MCO.0b013e328348c06d; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA123, DOI 10.1289/ehp.120-a123a; Jung MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30887; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kubeck R, 2016, MOL METAB, V5, P1162, DOI 10.1016/j.molmet.2016.10.001; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee H, 2014, APPL ENVIRON MICROB, V80, P5935, DOI 10.1128/AEM.01357-14; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Loubinoux J, 2000, J CLIN MICROBIOL, V38, P931, DOI 10.1128/JCM.38.2.931-934.2000; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Maniar K, 2017, PHARMACOL RES, V117, P103, DOI 10.1016/j.phrs.2016.12.003; Mouzaki M, 2013, HEPATOLOGY, V58, P120, DOI 10.1002/hep.26319; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Rabot S, 2010, FASEB J, V24, P4948, DOI 10.1096/fj.10-164921; Ross SA, 2010, CAN FAM PHYSICIAN, V56, P639; Samah S, 2016, DIABETES RES CLIN PR, V118, P172, DOI 10.1016/j.diabres.2016.06.014; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Tai NW, 2015, REV ENDOCR METAB DIS, V16, P55, DOI 10.1007/s11154-015-9309-0; Tappenden KA, 1998, AM J CLIN NUTR, V68, P118, DOI 10.1093/ajcn/68.1.118; Tappenden KA, 1998, DIGEST DIS SCI, V43, P1526, DOI 10.1023/A:1018819032620; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weglarz L, 2003, CELL MOL BIOL LETT, V8, P991; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Xie GX, 2016, ONCOTARGET, V7, P19355, DOI 10.18632/oncotarget.8466; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zhang Q, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101767; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108; Zhang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep14405; Zhu Y, 2016, INT J FOOD SCI NUTR, V67, P686, DOI 10.1080/09637486.2016.1197185	55	53	63	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0184735	10.1371/journal.pone.0184735	http://dx.doi.org/10.1371/journal.pone.0184735			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036231	Green Published, Green Submitted, gold			2022-12-26	WOS:000413054800003
J	Luo, WG; Zhou, B; Luo, QZ; Fang, HL; Zuo, XX; Zou, YZ				Luo, Weiguang; Zhou, Bin; Luo, Qizhi; Fang, Huilong; Zuo, Xiaoxia; Zou, Yizhou			Polymorphism of keratin 1 associates with systemic lupus erythematosus and systemic sclerosis in a south Chinese population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; 2013 CLASSIFICATION CRITERIA; RHEUMATOLOGY/EUROPEAN LEAGUE; INTERMEDIATE-FILAMENTS; SUSCEPTIBILITY LOCI; AMERICAN-COLLEGE; GENE-EXPRESSION; DISEASE; INTERFERON; SKIN	Both systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) diseases are related to the genetic and environmental factors, causing damage to the skin. The mutations of keratin 1 gene (KRT1) were reported to associate with skin diseases. The single-nucleotide polymorphism (SNP, rs14024) and the indel polymorphism (cds-indel, rs267607656), consisting mostly of the common haplotypes and could be used for genotyping of KRT1. We used the PCR with sequence specific primers (PCR-SSP) to determine the genotype of KRT1 in 164 SLE, 99 SSc patients, and 418 healthy controls. The results showed that the mutant with G at SNP rs14024 was associated with the high risk to SLE (p = 6.48x10(-5)) and SSc (p = 8.75x10(-5)), while the deletion allele at rs267607656 was associated with the low risk to SSc (p = 4.89x10(-4)) comparing to the normal controls. Haplogenotype, Del-/MU+ was associated with high susceptibility to SLE (OR = 1.87, p = 0.001) and SSc (OR = 2.29, p = 2.34x10(-4)). In contrast, the Haplogenotype Del+/MU- was associated with resistance to SLE (OR = 0.35, p = 6.24x10(-5)) and SSc (OR = 0.34, p = 0.001). This study demonstrates that the variations in KRT1 and the specific polymorphism of KRT1 in this Chinese Han population are associated with autoimmune diseases SLE and SSc. Typing KRT1 might be helpful to identify SLE and SSc patients.	[Luo, Weiguang; Luo, Qizhi; Zou, Yizhou] Cent S Univ, Dept Immunol, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Zhou, Bin; Zuo, Xiaoxia] Cent S Univ, Dept Rheumatol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Fang, Huilong] Xiangnan Univ, Dept Pathogen Biol & Immunol, Chenzhou, Hunan, Peoples R China; [Zou, Yizhou] Cooperat Innovat Ctr Engn & New Prod Dev Biol Hun, Changsha, Hunan, Peoples R China	Central South University; Central South University; Xiangnan University	Zou, YZ (corresponding author), Cent S Univ, Dept Immunol, Xiangya Sch Med, Changsha, Hunan, Peoples R China.; Zuo, XX (corresponding author), Cent S Univ, Dept Rheumatol, Xiangya Hosp, Changsha, Hunan, Peoples R China.; Zou, YZ (corresponding author), Cooperat Innovat Ctr Engn & New Prod Dev Biol Hun, Changsha, Hunan, Peoples R China.	zuosusan@hotmail.com; yizhou_zou@sina.com	LUO, QI/GQH-7209-2022	Zou, Yizhou/0000-0002-9261-1161	National Natural Science Foundation of China [81273265, 81572562]; Hunan Science and Technology Project Foundation [2013FJ2005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Science and Technology Project Foundation	This work was supported in part by grant from the National Natural Science Foundation of China (Y. Zou, P.I., 81273265 and 81572562), and Hunan Science and Technology Project Foundation (Y. Zou, P.I., 2013FJ2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; Arin MJ, 2011, BRIT J DERMATOL, V164, P442, DOI 10.1111/j.1365-2133.2010.10096.x; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Chen LS, 2009, ADDICTION, V104, P1731, DOI 10.1111/j.1360-0443.2009.02697.x; Chen LY, 2017, CURR OPIN RHEUMATOL, V29, P423, DOI 10.1097/BOR.0000000000000411; Chen Y, 2015, CHEM ENG SCI, V132, P1, DOI 10.1016/j.ces.2015.04.006; CUNNINGHAME G, 2011, PLOS GENET, V0007; Demirkaya E, 2017, ARTHRITIS RHEUMATOL; Deng GM, 2015, NAT REV RHEUMATOL, V11, P663, DOI 10.1038/nrrheum.2015.106; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Guo X, 2017, J IMMUNOL RES; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Han M, 2013, HUM IMMUNOL, V74, P1453, DOI 10.1016/j.humimm.2013.05.003; Hasan AAK, 1998, P NATL ACAD SCI USA, V95, P3615, DOI 10.1073/pnas.95.7.3615; Ippagunta SK, 2016, P NATL ACAD SCI USA, V113, pE6162, DOI 10.1073/pnas.1606996113; KORGE BP, 1992, J INVEST DERMATOL, V99, P697, DOI 10.1111/1523-1747.ep12614149; Kyttaris VC, 2006, AUTOIMMUNITY, V39, P705, DOI 10.1080/08916930601061363; Lewis MJ, 2006, AUTOIMMUNITY, V39, P367, DOI 10.1080/08916930600739233; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Mahdi F, 2001, BLOOD, V97, P2342, DOI 10.1182/blood.V97.8.2342; Mayes MD, 2014, AM J HUM GENET, V94, P47, DOI 10.1016/j.ajhg.2013.12.002; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Oda H, 2014, AM J HUM GENET, V95, P121, DOI 10.1016/j.ajhg.2014.06.007; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Ramos PS, 2015, CURR OPIN RHEUMATOL, V27, P521, DOI 10.1097/BOR.0000000000000214; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rice LM, 2015, ARTHRITIS RHEUMATOL, V67, P3004, DOI 10.1002/art.39287; Roth W, 2012, J CELL SCI, V125, P5269, DOI 10.1242/jcs.116574; Saavedra P, 2015, BBA-MOL CELL RES, V1853, P2966, DOI 10.1016/j.bbamcr.2015.09.002; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; STEINERT PM, 1990, J BIOL CHEM, V265, P8766; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Tao H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000697; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; Van Eyck L, 2015, ARTHRITIS RHEUMATOL, V67, P1592, DOI 10.1002/art.39110; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Wallace L, 2012, J CELL SCI, V125, P1750, DOI 10.1242/jcs.097139; WOODCOCKMITCHELL J, 1982, J CELL BIOL, V95, P580, DOI 10.1083/jcb.95.2.580; Yang W., 2010, FRONT PHYS, V6, P1, DOI DOI 10.1007/S11467-010-0113-8; Yang WL, 2013, AM J HUM GENET, V92, P41, DOI 10.1016/j.ajhg.2012.11.018; Yang WL, 2009, HUM MOL GENET, V18, P2063, DOI 10.1093/hmg/ddp118	51	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186409	10.1371/journal.pone.0186409	http://dx.doi.org/10.1371/journal.pone.0186409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028840	Green Published, Green Submitted, gold			2022-12-26	WOS:000412980300033
J	Mesa, F; Lanza, E; Garcia, L; Marfil-Alvarez, R; Magan-Fernandez, A				Mesa, Francisco; Lanza, Esperanza; Garcia, Llenalia; Marfil-Alvarez, Rafael; Magan-Fernandez, Antonio			Polymorphism IL-1RN rs419598 reduces the susceptibility to generalized periodontitis in a population of European descent	PLOS ONE			English	Article							INTERLEUKIN-1 GENE POLYMORPHISMS; RECEPTOR ANTAGONIST; SUBGINGIVAL PLAQUE; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ASSOCIATION; METAANALYSIS; PATHOGENS; DISEASE; GINGIVITIS; GENOTYPE	Interleukin (IL) 1-ra is a potent endogenous competitive inhibitor of IL-alpha and beta and has an anti-inflammatory role. Study objectives were: 1) to assess the associations of IL-1RN genetic single nucleotide polymorphism (SNP) (rs419598) with generalized chronic periodontitis (GCP), generalized aggressive periodontitis (GAgP), and absence of periodontitis and 2) to assess its association with the load of five periodontopathogenic bacteria and periodontal clinical variables. A cross-sectional analytic study was conducted in 123 patients with GCP, 60 patients with GAgP, and 20 controls. Reverse hybridization PCR was used for genotyping analysis to detect SNPs in IL-1A (rs1800587), IL-1B (rs1143634), and IL-1RN (rs419598) genes and for determination of the load of five periodontopathogenic bacteria. The severity and extension of periodontitis were assessed. Multinomial logistic regression and mediated regression analyses were performed. Considering results for GCP and GAgP patients together, the presence of polymorphism in IL-1A and/or IL-1B gene was associated with a higher likelihood of periodontitis, (OR = 8.11; 95% CI [1.85-35.48]), but this likelihood was reduced when IL-1RN polymorphism was also present, (OR = 5.91; 95% CI [1.08-32.27]). IL-1RN polymorphism was significantly associated with lower counts of red complex bacteria, specifically Porphyromona gingivalis, Tannerella forsythia, and Prevotella intermedia, which were associated with improved clinical outcomes. The polymorphic expression of IL-1RN (rs419598) gene may be associated with a reduced susceptibility to GAgP and GCP in populations of European descent. This effect may be mediated by a decreased load of Porphyromona gingivalis, Tannerella forsythia, and Prevotella intermedia.	[Mesa, Francisco; Marfil-Alvarez, Rafael; Magan-Fernandez, Antonio] Univ Granada, Sch Dent, Periodontol Dept, Granada, Spain; [Garcia, Llenalia] Spin Off Univ Granada, SEPLIN Stat Solut, Granada, Spain	University of Granada; University of Granada	Mesa, F (corresponding author), Univ Granada, Sch Dent, Periodontol Dept, Granada, Spain.	fmesa@ugr.es	Magán-Fernández, Antonio/C-1047-2014; Mesa, Francisco/L-9712-2018	Magán-Fernández, Antonio/0000-0001-6430-2276; Mesa, Francisco/0000-0002-8293-2527				AINAMO J, 1975, INT DENT J, V25, P229; AREND WP, 1990, J CLIN INVEST, V85, P1694, DOI 10.1172/JCI114622; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Berdeli A, 2006, CLIN BIOCHEM, V39, P357, DOI 10.1016/j.clinbiochem.2005.12.002; Cullinan MP, 2001, J CLIN PERIODONTOL, V28, P1137, DOI 10.1034/j.1600-051X.2001.281208.x; Delima AJ, 2002, J INFECT DIS, V186, P511, DOI 10.1086/341778; Deng JS, 2013, HUM IMMUNOL, V74, P371, DOI 10.1016/j.humimm.2012.11.018; Ding C, 2012, ARCH ORAL BIOL, V57, P585, DOI 10.1016/j.archoralbio.2012.01.016; Dugard P, 2010, APPROACHING MULTIVAR; Eick S, 2002, J CLIN PERIODONTOL, V29, P638, DOI 10.1034/j.1600-051X.2002.290708.x; Gabay C, 2001, EUR J IMMUNOL, V31, P490, DOI 10.1002/1521-4141(200102)31:2<490::AID-IMMU490>3.0.CO;2-H; GRANOWITZ EV, 1991, LANCET, V338, P1423, DOI 10.1016/0140-6736(91)92725-H; Guzman S, 2003, J PERIODONTOL, V74, P1183, DOI 10.1902/jop.2003.74.8.1183; Haffajee AD, 2009, J CLIN PERIODONTOL, V36, P642, DOI 10.1111/j.1600-051X.2009.01434.x; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Harrel JFE, 2001, REGRESSION MODELILIN; Izawa A, 2014, INFECT IMMUN, V82, P1904, DOI 10.1128/IAI.01618-13; Karasneh JA, 2011, ARCH ORAL BIOL, V56, P269, DOI 10.1016/j.archoralbio.2010.10.001; Kim CK, 2006, J PERIODONTAL RES, V41, P498, DOI 10.1111/j.1600-0765.2006.00895.x; Komatsu Y, 2008, INT J IMMUNOGENET, V35, P165, DOI 10.1111/j.1744-313X.2008.00757.x; Kornman KS, 1997, J CLIN PERIODONTOL, V24, P72, DOI 10.1111/j.1600-051X.1997.tb01187.x; Kornman KS, 1999, J PERIODONTAL RES, V34, P353, DOI 10.1111/j.1600-0765.1999.tb02265.x; Laine ML, 2012, PERIODONTOL 2000, V58, P37, DOI 10.1111/j.1600-0757.2011.00415.x; Laine ML, 2001, J DENT RES, V80, P1695, DOI 10.1177/00220345010800080301; Lang NP, 1999, ANN PERIODONTOL, V4, P53, DOI DOI 10.1902/ANNALS.1999.4.1.53; Lanza E, 2016, ORAL DIS, V22, P430, DOI 10.1111/odi.12471; Mao M, 2013, GENE, V532, P114, DOI 10.1016/j.gene.2013.09.043; Marfil-Alvarez R, 2014, J DENT RES, V93, P993, DOI 10.1177/0022034514548223; Marsh PD, 2011, J CLIN PERIODONTOL, V38, P28, DOI 10.1111/j.1600-051X.2010.01673.x; MOMBELLI A, 1991, J PERIODONTAL RES, V26, P301, DOI 10.1111/j.1600-0765.1991.tb02067.x; NISHIHARA T, 1995, INFECT IMMUN, V63, P1893, DOI 10.1128/IAI.63.5.1893-1898.1995; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Palomo J, 2015, CYTOKINE, V76, P25, DOI 10.1016/j.cyto.2015.06.017; Teles R, 2013, PERIODONTOL 2000, V62, P95, DOI 10.1111/prd.12010; Tran SD, 1999, J CLIN MICROBIOL, V37, P3504, DOI 10.1128/JCM.37.11.3504-3508.1999; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wang WF, 2014, BIOMED REP, V2, P378, DOI 10.3892/br.2014.240; Yoshie H, 2007, PERIODONTOL 2000, V43, P102, DOI 10.1111/j.1600-0757.2006.00164.x; Yucesoy B, 2006, NEUROBIOL AGING, V27, P211, DOI 10.1016/j.neurobiolaging.2005.01.013; Zeng XT, 2015, J PERIODONTOL, V86, P812, DOI 10.1902/jop.2015.140698	42	10	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186366	10.1371/journal.pone.0186366	http://dx.doi.org/10.1371/journal.pone.0186366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023524	gold, Green Published, Green Submitted			2022-12-26	WOS:000412845100117
J	Sales, LP; Neves, OV; De Marco, P; Loyola, R				Sales, Lilian Patricia; Neves, Olivia Viana; De Marco, Paulo, Jr.; Loyola, Rafael			Model uncertainties do not affect observed patterns of species richness in the Amazon	PLOS ONE			English	Article							CLIMATE-CHANGE; BIODIVERSITY; AREAS; CONSERVATION; FRAGMENTATION; FRAMEWORK; HOTSPOTS; IMPACTS; RANGES; NICHES	Background Climate change is arguably a major threat to biodiversity conservation and there are several methods to assess its impacts on species potential distribution. Yet the extent to which different approaches on species distribution modeling affect species richness patterns at biogeographical scale is however unaddressed in literature. In this paper, we verified if the expected responses to climate change in biogeographical scale-patterns of species richness and species vulnerability to climate change-are affected by the inputs used to model and project species distribution. Methods We modeled the distribution of 288 vertebrate species (amphibians, birds and mammals), all endemic to the Amazon basin, using different combinations of the following inputs known to affect the outcome of species distribution models (SDMs): 1) biological data type, 2) modeling methods, 3) greenhouse gas emission scenarios and 4) climate forecasts. We calculated uncertainty with a hierarchical ANOVA in which those different inputs were considered factors. Results The greatest source of variation was the modeling method. Model performance interacted with data type and modeling method. Absolute values of variation on suitable climate area were not equal among predictions, but some biological patterns were still consistent. All models predicted losses on the area that is climatically suitable for species, especially for amphibians and primates. All models also indicated a current East-western gradient on endemic species richness, from the Andes foot downstream the Amazon river. Again, all models predicted future movements of species upwards the Andes mountains and overall species richness losses. Conclusions From a methodological perspective, our work highlights that SDMs are a useful tool for assessing impacts of climate change on biodiversity. Uncertainty exists but biological patterns are still evident at large spatial scales. As modeling methods are the greatest source of variation, choosing the appropriate statistics according to the study objective is also essential for estimating the impacts of climate change on species distribution. Yet from a conservation perspective, we show that Amazon endemic fauna is potentially vulnerable to climate change, due to expected reductions on suitable climate area. Climate-driven faunal movements are predicted towards the Andes mountains, which might work as climate refugia for migrating species.	[Sales, Lilian Patricia; Neves, Olivia Viana] Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil; [De Marco, Paulo, Jr.; Loyola, Rafael] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil; [De Marco, Paulo, Jr.; Loyola, Rafael] Inst Nacl Pesquisas Espaciais, Brazilian Res Network Climate Change Rede Clima, Sao Jose Dos Campos, SP, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Instituto Nacional de Pesquisas Espaciais (INPE)	Loyola, R (corresponding author), Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil.; Loyola, R (corresponding author), Inst Nacl Pesquisas Espaciais, Brazilian Res Network Climate Change Rede Clima, Sao Jose Dos Campos, SP, Brazil.	loyola@ufg.br	Loyola, Rafael/A-4425-2008; Sales, Lillian P./C-2300-2016; De Marco, Paulo/B-2209-2009; Loyola, Rafael/S-3978-2019	Loyola, Rafael/0000-0001-5323-2735; Sales, Lillian P./0000-0003-1159-6412; De Marco, Paulo/0000-0002-3628-6405; Loyola, Rafael/0000-0001-5323-2735	CAPES; CNPq [308694/2015-5, 308532/2014-7, 479959/2013-7, 407094/2013-0, 563621/2010-9, 550022/2014-7]; O Boticario Group Foundation for the Protection of Nature [PROG_0008_2013]; FINEP [01.13.0353.00]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); O Boticario Group Foundation for the Protection of Nature; FINEP(Financiadora de Inovacao e Pesquisa (Finep))	LPS and OVN are financed by CAPES. PDMJ research has been continously supported by CNPq productivity grants (grants # 308694/2015-5). PDMJ research has been continously supported by a CNPq productivity grant (grants #308694/2015-5). RL research has been constantly funded by CNPq (grants #308532/2014-7, 479959/2013-7, 407094/2013-0, 563621/2010-9), O Boticario Group Foundation for the Protection of Nature (grant #PROG_0008_2013). This paper is a contribution of the Brazilian Network on Global Climate Change Research funded by CNPq (grant #550022/2014-7) and FINEP (grant #01.13.0353.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson RP, 2013, ANN NY ACAD SCI, V1297, P8, DOI 10.1111/nyas.12264; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Brodie J, 2012, TRENDS ECOL EVOL, V27, P145, DOI 10.1016/j.tree.2011.09.008; Cayuela L, 2009, TROP CONSERV SCI, V2, P319, DOI 10.1177/194008290900200304; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cook J, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/4/048002; Cruz-McDonnell KK, 2016, GLOBAL CHANGE BIOL, V22, P237, DOI 10.1111/gcb.13092; de Oliveira G, 2014, ECOGRAPHY, V37, P637, DOI 10.1111/j.1600-0587.2013.00564.x; Diniz JAF, 2013, TRENDS ECOL EVOL, V28, P689, DOI 10.1016/j.tree.2013.09.003; Diniz JAF, 2012, OIKOS, V121, P201, DOI 10.1111/j.1600-0706.2011.19563.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Eros T, 2015, FRESHWATER BIOL, V60, P1487, DOI 10.1111/fwb.12596; Faleiro FV, 2013, BIOL CONSERV, V158, P248, DOI 10.1016/j.biocon.2012.09.020; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Forero-Medina G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028535; Franklin J, 2009, MAPPING SPECIES DIST; Gavin DG, 2014, NEW PHYTOL, V204, P37, DOI 10.1111/nph.12929; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Grinnell J, 1924, ECOLOGY, V5, P225, DOI 10.2307/1929447; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Khaliq I, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1097; Knutti R, 2008, J CLIMATE, V21, P2651, DOI 10.1175/2007JCLI2119.1; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Kuhn M, 2008, CARET PACKAGE MISC F; Lawler JJ, 2013, ECOL LETT, V16, P1014, DOI 10.1111/ele.12132; Lemes P, 2014, BIODIVERS CONSERV, V23, P357, DOI 10.1007/s10531-013-0605-2; Lemes P, 2011, NAT CONSERVACAO, V9, P240, DOI 10.4322/natcon.2011.032; Li YM, 2013, INTEGR ZOOL, V8, P145, DOI 10.1111/1749-4877.12001; Loyola RD, 2014, ECOGRAPHY, V37, P65, DOI 10.1111/j.1600-0587.2013.00396.x; Loyola RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046257; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Mayorga E., 2012, LBA ECO CD 06 AMAZON; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Rangel TFLVB, 2009, BIOENSEMBLES SOFTWAR; Rangel TF, 2012, NAT CONSERVACAO, V10, P119, DOI 10.4322/natcon.2012.030; Ribas CC, 2012, P ROY SOC B-BIOL SCI, V279, P681, DOI 10.1098/rspb.2011.1120; Ribeiro BR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165073; Rocchini D, 2011, PROG PHYS GEOG, V35, P211, DOI 10.1177/0309133311399491; Rull V, 2013, J BIOGEOGR, V40, P1413, DOI 10.1111/jbi.12141; Rylands Anthony B., 2009, P23, DOI 10.1007/978-0-387-78705-3_2; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Stoklosa J, 2015, METHODS ECOL EVOL, V6, P412, DOI 10.1111/2041-210X.12217; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Swenson JJ, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-1; Terribile LC, 2012, NAT CONSERVACAO, V10, P152, DOI 10.4322/natcon.2012.025; Tessarolo G, 2014, DIVERS DISTRIB, V20, P1258, DOI 10.1111/ddi.12236; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Vale MM, 2012, J BIOGEOGR, V39, P1744, DOI 10.1111/j.1365-2699.2012.02750.x; Vilela B, 2015, METHODS ECOL EVOL, V6, P1229, DOI 10.1111/2041-210X.12401; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Young BF, 2009, AUK, V126, P554, DOI 10.1525/auk.2009.08155; Zanin M, 2015, ORYX, V49, P96, DOI 10.1017/S0030605313001609	73	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0183785	10.1371/journal.pone.0183785	http://dx.doi.org/10.1371/journal.pone.0183785			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023503	gold, Green Submitted, Green Published			2022-12-26	WOS:000412845100003
J	Bardsley, N; Buchs, M; Schnepf, SV				Bardsley, Nicholas; Buchs, Milena; Schnepf, Sylke V.			Something from nothing: Estimating consumption rates using propensity scores, with application to emissions reduction policies	PLOS ONE			English	Article							ZERO EXPENDITURES; MODEL; UK	Consumption surveys often record zero purchases of a good because of a short observation window. Measures of distribution are then precluded and only mean consumption rates can be inferred. We show that Propensity Score Matching can be applied to recover the distribution of consumption rates. We demonstrate the method using the UK National Travel Survey, in which c.40% of motorist households purchase no fuel. Estimated consumption rates are plausible judging by households' annual mileages, and highly skewed. We apply the same approach to estimate CO2 emissions and outcomes of a carbon cap or tax. Reliance on means apparently distorts analysis of such policies because of skewness of the underlying distributions. The regressiveness of a simple tax or cap is overstated, and redistributive features of a revenue-neutral policy are understated.	[Bardsley, Nicholas] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England; [Bardsley, Nicholas] Univ Reading, Walker Inst Climate Syst Res, Reading, Berks, England; [Buchs, Milena] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Buchs, Milena] Univ Leeds, Sustainabil Res Inst, Leeds, W Yorkshire, England; [Schnepf, Sylke V.] European Commiss, Joint Res Ctr, Ispra, Italy	University of Reading; University of Reading; University of Leeds; University of Leeds; European Commission Joint Research Centre; EC JRC ISPRA Site	Bardsley, N (corresponding author), Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England.; Bardsley, N (corresponding author), Univ Reading, Walker Inst Climate Syst Res, Reading, Berks, England.	n.o.bardsley@reading.ac.uk	Buchs, Milena/AAU-2581-2021	Buchs, Milena/0000-0001-6304-3196	ESRC [RES-000-22-4083]; Economic and Social Research Council [ES/H044086/1] Funding Source: researchfish; ESRC [ES/H044086/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was funded by the ESRC, grant RES-000-22-4083 to MB.	AA, 2002, FUEL PRIC REP; Abadie A, 2008, ECONOMETRICA, V76, P1537, DOI 10.3982/ECTA6474; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Barker T. S., 1998, IMPACT ASSESS PROJ A, V16, P123; Blaylock J., 1991, EC RES SERVICE; Blow L., 1997, COMMENTARY I FISCAL, V65; BLUNDELL R, 1987, J ECONOMETRICS, V34, P179, DOI 10.1016/0304-4076(87)90072-8; Brand C, 2008, ENERG POLICY, V36, P224, DOI 10.1016/j.enpol.2007.08.016; Buchs M, 2013, ECOL ECON, V90, P114, DOI 10.1016/j.ecolecon.2013.03.007; Buchs M, 2011, CRIT SOC POLICY, V31, P285, DOI 10.1177/0261018310396036; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Cohmar Sustainable Development Council, 2008, STUD PERS CARB ALL C; DEATON A, 1984, J PUBLIC ECON, V23, P59, DOI 10.1016/0047-2727(84)90067-7; DECC, 2011, 2011 GUID DEFR DECCS; DFT, 2012, TABL NTS0707 AD PERS; Dresner S, 2006, FISC STUD, V27, P47, DOI 10.1111/j.1475-5890.2006.00027.x; Dresner S., 2004, 19 PSI; Figari F, 2012, SOC INDIC RES, V105, P387, DOI 10.1007/s11205-010-9775-4; Gibson J, 2012, AM J AGR ECON, V94, P257, DOI 10.1093/ajae/aar135; Goodwin P, 2004, TRANSPORT REV, V24, P275, DOI 10.1080/0144164042000181725; Gough I., 2011, 152 CASE LOND SCH EC; Griffiths W, 1998, ADV E, V13, P75; Hansen James, 2009, STORMS MY GRANDCHILD; Hasegawa H, 2008, OXFORD B ECON STAT, V70, P535, DOI 10.1111/j.1468-0084.2008.00507.x; Jann Ben, 2013, U BERN SOCIAL SCI WO; Jappelli T, 2014, AM ECON J-MACROECON, V6, P107, DOI 10.1257/mac.6.4.107; KAY JA, 1984, J PUBLIC ECON, V23, P169, DOI 10.1016/0047-2727(84)90071-9; Keen M.J., 1986, J APPL ECONOMET, V1, P277, DOI [https://doi.org/10.1002/jae.3950010305, DOI 10.1002/JAE.3950010305]; Labeaga JM, 1997, APPL ECON, V29, P795, DOI 10.1080/000368497326714; Leuven Edwin., 2003, PSMATCH2 STATA MODUL; Lietz C, 2006, RES LABOR ECON, V25, P1, DOI 10.1016/S0147-9121(06)25001-5; LITTLE RJA, 1986, INT STAT REV, V54, P139, DOI 10.2307/1403140; Matone M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1016; Nordstrom J, 2009, J HEALTH ECON, V28, P622, DOI 10.1016/j.jhealeco.2009.02.005; OECD, 2013, WHAT AR EQ SCAL; Olson K, 2012, PUBLIC OPIN QUART, V76, P611, DOI 10.1093/poq/nfs024; Olson K, 2012, J OFF STAT, V28, P29; Pudney S, 1989, MODELLING INDIVIDUAL; Pudney S., 1990, MEASUREMENT MODELLIN, P267; REMI, 2014, EC CLIM FISC POW DEM; Reynolds C.L., 2009, HIGH ED HDB THEORY R, V24, P47, DOI [10.1007/978-1-4020-5666-6, DOI 10.1007/978-1-4020-5666-6, 10.1007/978-1-4020-9628-0_2, DOI 10.1007/978-1-4020-9628-0_2]; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Salgado MF, 2014, REV INCOME WEALTH, V60, pS177, DOI 10.1111/roiw.12035; Sorrell S, 2010, CLIM POLICY, V10, P481, DOI 10.3763/cpol.2009.0008; Symons E., 2002, EUROPEAN ENV, V12, P203, DOI DOI 10.1002/EET.293; Villanti AC, 2011, EVALUATION REV, V35, P571, DOI 10.1177/0193841X11435399	48	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185538	10.1371/journal.pone.0185538	http://dx.doi.org/10.1371/journal.pone.0185538			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020029	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000412754400034
J	Zhang, CL; Yu, LD; Liu, SJ; Wang, YL				Zhang, Chunli; Yu, Lidong; Liu, Songjian; Wang, Yuli			Human amnion-derived mesenchymal stem cells promote osteogenic and angiogenic differentiation of human adipose-derived stem cells	PLOS ONE			English	Article							GUIDED BONE REGENERATION; ENDOTHELIAL-CELLS; OSTEOBLAST DIFFERENTIATION; SIGNALING PATHWAY; TISSUE; MARROW; REPAIR; RUNX2; PHOSPHATE; MINERALIZATION	Tissue engineering using suitable mesenchymal stem cells (MSCs) shows great potential to regenerate bone defects. Our previous studies have indicated that human amnion-derived mesenchymal stem cells (HAMSCs) could promote the osteogenic differentiation of human bone marrow mesenchymal stem cells (HBMSCs). Human adipose-derived stem cells (HASCs), obtained from adipose tissue in abundance, are capable of multi-lineage differentiation. In this study, the effects of HAMSCs on osteogenic and angiogenic differentiation of HASCs were systematically investigated. Proliferation levels were measured by flow cytometry. Osteoblastic differentiation and mineralization were investigated using chromogenic alkaline phosphatase activity (ALP) activity substrate assays, Alizarin red S staining, real-time polymerase chain reaction (real-time PCR) analysis of osteogenic marker expression, and Western blotting. We found that HAMSCs increased the proliferation and osteoblastic differentiation of HASCs. Moreover, enzyme-linked immunosorbent assay (ELISA) and human umbilical vein endothelial cells (HUVECs) tube formation suggested HAMSCs enhanced angiogenic potential of HASCs via secretion of increased vascular endothelial growth factor (VEGF). Thus, we conclude that HAMSC might be a valuable therapeutic approach to promote HASCs-involved bone regeneration.	[Zhang, Chunli] Nanjing Med Univ, Friendship Plast Surg Hosp, Dept Clin Res, Nanjing, Jiangsu, Peoples R China; [Yu, Lidong] Nanjing Med Univ, Dept Plast Surg, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China; [Liu, Songjian] Nanjing Med Univ, Dept Plast Surg, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Wang, Yuli] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, YL (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China.	78224340@qq.com		wang, yuli/0000-0002-5500-3351	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [2014-37]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD; 2014-37). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alard JE, 2009, FASEB J, V23, P2772, DOI 10.1096/fj.08-128785; Alviano F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-11; Ayatollahi M, 2016, IRAN J BASIC MED SCI, V19, P145; Bahlous Afef, 2006, Tunis Med, V84, P751; Balcerzak M, 2003, ACTA BIOCHIM POL, V50, P1019; Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303; Bodle JC, 2011, TISSUE ENG PART B-RE, V17, P195, DOI 10.1089/ten.teb.2010.0738; Bosnakovski D, 2005, CELL TISSUE RES, V319, P243, DOI 10.1007/s00441-004-1012-5; Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Cui FA, 2010, GROWTH FACTORS, V28, P306, DOI 10.3109/08977194.2010.484423; de Girolamo L, 2013, CURR PHARM DESIGN, V19, P2459, DOI 10.2174/1381612811319130015; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Herbert BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125387; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Hu N, 2015, INT J MOL SCI, V16, P10491, DOI 10.3390/ijms160510491; Jeong HM, 2011, BIOCHEM BIOPH RES CO, V409, P82, DOI 10.1016/j.bbrc.2011.04.113; Jiang F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/324014; Jin YQ, 2014, TISSUE ENG PT A, V20, P3303, DOI [10.1089/ten.tea.2013.0556, 10.1089/ten.TEA.2013.0556]; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Kim BG, 2006, PROTEOMICS, V6, P1166, DOI 10.1002/pmic.200500289; Kim SH, 2009, J PERIODONTOL, V80, P1815, DOI 10.1902/jop.2009.090249; Kim SW, 2012, CARDIOVASC RES, V93, P525, DOI 10.1093/cvr/cvr328; Kmiecik G, 2013, ADV MED SCI-POLAND, V58, P185, DOI 10.2478/ams-2013-0007; Kobayashi K, 2014, ACS APPL MATER INTER, V6, P22602, DOI 10.1021/am5067139; Konig J, 2012, STEM CELLS DEV, V21, P1309, DOI 10.1089/scd.2011.0223; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lee JS, 2011, BIOMATERIALS, V32, P760, DOI 10.1016/j.biomaterials.2010.09.042; Leyva-Leyva M, 2013, STEM CELLS DEV, V22, P1275, DOI 10.1089/scd.2012.0359; Li YN, 2014, J CELL MOL MED, V18, P1028, DOI 10.1111/jcmm.12249; Liu QH, 2009, TISSUE ENG PT A, V15, P3487, DOI 10.1089/ten.TEA.2009.0175; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llambes F, 2007, J PERIODONTOL, V78, P2036, DOI 10.1902/jop.2007.070017; Maeda H, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt74; Merfeld-Clauss S, 2010, TISSUE ENG PT A, V16, P2953, DOI [10.1089/ten.tea.2009.0635, 10.1089/ten.TEA.2009.0635]; Mizuno Hiroshi, 2009, Journal of Nippon Medical School, V76, P56; Mollazadeh S, 2017, PHYTOTHER RES, V31, P792, DOI 10.1002/ptr.5803; Murohara T, 2009, CURR PHARM DESIGN, V15, P2784, DOI 10.2174/138161209788923796; Mushahary D, 2014, COLLOID SURFACE B, V122, P719, DOI 10.1016/j.colsurfb.2014.08.005; Nathan S, 2003, TISSUE ENG, V9, P733, DOI 10.1089/107632703768247412; Park KH, 2009, J BIOSCI BIOENG, V108, P530, DOI 10.1016/j.jbiosc.2009.05.021; Park SH, 2007, J PERIODONTOL, V78, P47, DOI 10.1902/jop.2007.060125; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Qiao M, 2004, J BIOL CHEM, V279, P42709, DOI 10.1074/jbc.M404480200; Qin L, 2015, LIFE SCI, V131, P37, DOI 10.1016/j.lfs.2015.03.017; Rohringer S, 2014, ANGIOGENESIS, V17, P921, DOI 10.1007/s10456-014-9439-0; Ruetze M, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.9; Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Soncini M, 2007, J TISSUE ENG REGEN M, V1, P296, DOI 10.1002/term.40; Thangakumaran S, 2009, Indian J Dent Res, V20, P7; Tsuji Wakako, 2014, World J Stem Cells, V6, P312, DOI 10.4252/wjsc.v6.i3.312; Verseijden F, 2010, TISSUE ENG PT A, V16, P101, DOI [10.1089/ten.tea.2009.0106, 10.1089/ten.TEA.2009.0106]; Wang SY, 2009, BIOMATERIALS, V30, P2489, DOI 10.1016/j.biomaterials.2008.12.067; Wang Y., 2016, ELECT IMAG, V2016, P1, DOI DOI 10.1007/S00294-016-0593-3; Wang Y., 2016, STEM CELLS INT, V2016, P1, DOI DOI 10.1097/SLA.0000000000001928; Wang YL, 2015, J MOL HISTOL, V46, P13, DOI 10.1007/s10735-014-9600-5; Xia LG, 2016, SCI REP-UK, V6, DOI 10.1038/srep22005; Yang XC, 2009, TISSUE ENG PT A, V15, P945, DOI 10.1089/ten.tea.2007.0280; Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397; Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	63	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186253	10.1371/journal.pone.0186253	http://dx.doi.org/10.1371/journal.pone.0186253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020045	gold, Green Published, Green Submitted			2022-12-26	WOS:000412754400085
J	Ho, T; Oh, SR; Kim, H				Ho, ThienLuan; Oh, Seung-Rohk; Kim, HyunJin			A parallel approximate string matching under Levenshtein distance on graphics processing units using warp-shuffle operations	PLOS ONE			English	Article							MISMATCHES	Approximate string matching with k-differences has a number of practical applications, ranging from pattern recognition to computational biology. This paper proposes an efficient memory-access algorithm for parallel approximate string matching with k-differences on Graphics Processing Units (GPUs). In the proposed algorithm, all threads in the same GPUs warp share data using warp-shuffle operation instead of accessing the shared memory. Moreover, we implement the proposed algorithm by exploiting the memory structure of GPUs to optimize its performance. Experiment results for real DNA packages revealed that the performance of the proposed algorithm and its implementation archived up to 122.64 and 1.53 times compared to that of sequential algorithm on CPU and previous parallel approximate string matching algorithm on GPUs, respectively.	[Ho, ThienLuan; Oh, Seung-Rohk; Kim, HyunJin] Dankook Univ, Sch Elect & Elect Engn, Yongin, South Korea	Dankook University	Kim, H (corresponding author), Dankook Univ, Sch Elect & Elect Engn, Yongin, South Korea.	hyunjin2.kim@gmail.com		Kim, HyunJin/0000-0001-5017-3995	National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1B03030348]	National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education. (2017R1D1A1B03030348). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, GENOME DATABASE SACC; [Anonymous], 2017, NVIDIA CUDA C PROGR; [Anonymous], 2017, NVIDIA GFORCE GTX 66; Chen X, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1725-6; Fredriksson K, 2013, EUR J COMBIN, V34, P38, DOI 10.1016/j.ejc.2012.07.013; Guo L, 2013, 2013 IEEE 8 INT C, P257; Herbordt MC, 2006, ANN IEEE SYM FIELD P, P217; Ho T, 2016, IEICE T FUND ELECTR, VE99A, P1726, DOI 10.1587/transfun.E99.A.1726; Ho T, 2016, IEICE T COMMUN, VE99B, P1523, DOI 10.1587/transcom.2015EBP3411; Inoue K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037739; Intel, 2017, E31270 XEON CPU; Kim H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163535; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Lin CH, 2014, 2014 IEEE SYMPOSIUM ON COMPUTER APPLICATIONS AND COMMUNICATIONS (SCAC), P76, DOI 10.1109/SCAC.2014.23; Lin CH, 2013, IEEE T COMPUT, V62, P1906, DOI 10.1109/TC.2012.254; Liu Y, 2012, IEEE SYM PARA DISTR, P2414, DOI 10.1109/IPDPSW.2012.298; Man Duhu, 2013, 2013 IEEE 7th International Symposium on Embedded Multicore/Manycore System-on-Chip (MCSoC), P79, DOI 10.1109/MCSoC.2013.22; Mikami S, 2008, ITC CSCC INT TECHN C, P201; Navarro G, 2001, ACM COMPUT SURV, V33, P31, DOI 10.1145/375360.375365; Nunes LSN, 2016, INT SYMPOS COMPUT NE, P483, DOI [10.1109/CANDAR.2016.0090, 10.1109/CANDAR.2016.101]; Nunes LSN, 2015, INT SYMPOS COMPUT NE, P188, DOI 10.1109/CANDAR.2015.29; Prasad R., 2011, SCI RES ESSAYS, V6, P876, DOI DOI 10.5897/SRE10.895; Schulz MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041531; Shehab MA, 2017, INT CONF INFORM COMM, P12, DOI 10.1109/IACS.2017.7921938; Shirahata Koichi, 2010, Proceedings of the 2010 IEEE 2nd International Conference on Cloud Computing Technology and Science (CloudCom 2010), P733, DOI 10.1109/CloudCom.2010.55; Stothard P., 2017, BIOINFORMATICS; The Apache Software Foundation, 2017, AP SOFTW HOM PAG; Tran TT, 2016, PARALLEL COMPUT, V54, P128, DOI 10.1016/j.parco.2015.11.001; Van Court T, 2004, IEEE INT CONF ASAP, P354; Watanuki Yosuke, 2013, 2013 IEEE 6th International Workshop on Computational Intelligence and Applications (IWCIA), P137, DOI 10.1109/IWCIA.2013.6624801; Xu KF, 2013, PROCEDIA COMPUT SCI, V17, P523, DOI 10.1016/j.procs.2013.05.067; Zhong Cheng, 2004, Journal of Software, V15, P159; Zhou W, 2017, J AM CERAM SOC, V100, P1578, DOI 10.1111/jace.14691; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177; Zou Q, 2014, BRIEF BIOINFORM, V15, P637, DOI 10.1093/bib/bbs088	35	24	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186251	10.1371/journal.pone.0186251	http://dx.doi.org/10.1371/journal.pone.0186251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016700	Green Published, gold, Green Submitted			2022-12-26	WOS:000412627400063
J	Ivanov, SM; Cawley, A; Huber, RG; Bond, PJ; Warwicker, J				Ivanov, Stefan M.; Cawley, Andrew; Huber, Roland G.; Bond, Peter J.; Warwicker, Jim			Protein-protein interactions in paralogues: Electrostatics modulates specificity on a conserved steric scaffold	PLOS ONE			English	Article							TOXIN-ANTITOXIN COMPLEX; CRYSTAL-STRUCTURE; CONFORMATIONAL ENTROPY; RECOGNITION SITES; PREDICT PROTEIN; BINDING-SITE; ACTIVE-SITE; BH3 DOMAINS; INTERFACES; DETERMINANTS	An improved knowledge of protein-protein interactions is essential for better understanding of metabolic and signaling networks, and cellular function. Progress tends to be based on structure determination and predictions using known structures, along with computational methods based on evolutionary information or detailed atomistic descriptions. We hypothesized that for the case of interactions across a common interface, between proteins from a pair of paralogue families or within a family of paralogues, a relatively simple interface description could distinguish between binding and non-binding pairs. Using binding data for several systems, and large-scale comparative modeling based on known template complex structures, it is found that charge-charge interactions (for groups bearing net charge) are generally a better discriminant than buried non-polar surface. This is particularly the case for paralogue families that are less divergent, with more reliable comparative modeling. We suggest that electrostatic interactions are major determinants of specificity in such systems, an observation that could be used to predict binding partners.	[Ivanov, Stefan M.; Cawley, Andrew; Warwicker, Jim] Univ Manchester, Sch Chem, Manchester Inst Biotechnol, Manchester, Lancs, England; [Huber, Roland G.; Bond, Peter J.] ASTAR, Bioinformat Inst, Matrix, Singapore, Singapore; [Bond, Peter J.] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore	University of Manchester; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore	Warwicker, J (corresponding author), Univ Manchester, Sch Chem, Manchester Inst Biotechnol, Manchester, Lancs, England.	jim.warwicker@manchester.ac.uk	Huber, Roland G/AAG-6353-2019	Huber, Roland G/0000-0001-5093-5988; Bond, Peter/0000-0003-2900-098X; Warwicker, Jim/0000-0002-1302-0815	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D526561/1]; Singapore A*STAR Manchester (UK) programme; A*STAR Graduate Academy (A*GA) Singapore	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Singapore A*STAR Manchester (UK) programme; A*STAR Graduate Academy (A*GA) Singapore	AC was in receipt of a PhD studentship from the UK Biotechnology and Biological Sciences Research Council (BBSRC, grant number BB/D526561/1). SMI received a PhD studentship from the Singapore A*STAR Manchester (UK) programme.; We gratefully acknowledge discussions with Nicholas Fowler, and thank the A*STAR Graduate Academy (A*GA) Singapore for funding. We also thank the Reviewers for their constructive comments.	Ahidjo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021738; Aiello D, 2012, J MOL BIOL, V423, P257, DOI 10.1016/j.jmb.2012.06.039; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Beglov D, 2012, PROTEINS, V80, P591, DOI 10.1002/prot.23222; Bougouffa S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-448; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Cole C, 2002, PROTEIN SCI, V11, P2860, DOI 10.1110/ps.0222702; Cui ZY, 2014, J MOL CELL CARDIOL, V71, P32, DOI 10.1016/j.yjmcc.2013.10.008; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Dalton KM, 2010, BIOCHEMISTRY-US, V49, P2205, DOI 10.1021/bi902133s; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Delgado-Soler L, 2012, J CHEM INF MODEL, V52, P2107, DOI 10.1021/ci3001666; Fong JH, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r11; Fox SJ, 2014, PROTEINS, V82, P3335, DOI 10.1002/prot.24686; Fromer M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000627; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Guharoy M, 2005, P NATL ACAD SCI USA, V102, P15447, DOI 10.1073/pnas.0505425102; Hodson C, 2014, STRUCTURE, V22, P337, DOI 10.1016/j.str.2013.12.004; Im W, 2016, J MOL BIOL, V428, P2943, DOI 10.1016/j.jmb.2016.05.024; Ivanov SM, 2016, STRUCTURE, V24, P2024, DOI 10.1016/j.str.2016.09.006; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kar G, 2012, J PROTEOME RES, V11, P1196, DOI 10.1021/pr2009143; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Keskin O, 2016, CHEM REV, V116, P4884, DOI 10.1021/acs.chemrev.5b00683; Kim JS, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.118; KOEHL P, 1994, J MOL BIOL, V239, P249, DOI 10.1006/jmbi.1994.1366; Ku B, 2011, CELL RES, V21, P627, DOI 10.1038/cr.2010.149; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Min AB, 2012, PROTEIN SCI, V21, P1754, DOI 10.1002/pro.2161; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okamoto T, 2012, J VIROL, V86, P11501, DOI 10.1128/JVI.01115-12; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Petukh M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004276; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; Rajan S, 2015, PROTEINS, V83, P1262, DOI 10.1002/prot.24816; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Shirts MR, 2003, J CHEM PHYS, V119, P5740, DOI 10.1063/1.1587119; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Soni N, 2017, CURR OPIN STRUC BIOL, V44, P179, DOI 10.1016/j.sbi.2017.04.006; Steinbrecher T, 2006, J MED CHEM, V49, P1837, DOI 10.1021/jm0505720; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Tuncbag N, 2017, METHODS MOL BIOL, V1558, P255, DOI 10.1007/978-1-4939-6783-4_12; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Warwicker J, 1999, PROTEIN SCI, V8, P418; Webb B, 2014, METHODS MOL BIOL, V1091, P277, DOI 10.1007/978-1-62703-691-7_20; Winter C, 2012, J STRUCT BIOL, V179, P347, DOI 10.1016/j.jsb.2012.04.009; Xue LC, 2015, FEBS LETT, V589, P3516, DOI 10.1016/j.febslet.2015.10.003; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhang H, 2000, J BIOL CHEM, V275, P11092, DOI 10.1074/jbc.275.15.11092; Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005	68	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185928	10.1371/journal.pone.0185928	http://dx.doi.org/10.1371/journal.pone.0185928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016650	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400039
J	Kotowicz, B; Fuksiewicz, M; Jonska-Gmyrek, J; Berezowska, A; Radziszewski, J; Bidzinski, M; Kowalska, M				Kotowicz, Beata; Fuksiewicz, Malgorzata; Jonska-Gmyrek, Joanna; Berezowska, Alicja; Radziszewski, Jakub; Bidzinski, Mariusz; Kowalska, Maria			Clinical significance of pretreatment serum levels of VEGF and its receptors, IL-8, and their prognostic value in type I and II endometrial cancer patients	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL LUNG-CANCER; TUMOR ANGIOGENESIS; CA-125 LEVELS; INTERLEUKIN-8; EXPRESSION; PREDICTION; CARCINOMA; PROGRESSION; DISEASE	Objectives The study aimed to assess the usefulness of the determination of cytokines: IL-8, VEGF and its soluble receptors: VEGF-R1, VEGF-R2 in patients with endometrial cancer (EC). Material/Methods The study group consisted of 118 patients with EC subjected to surgical treatment. Before the treatment we determined the serum levels of cytokines IL-8, and VEGF as well as VEGFR1 and VEGFR2 receptors. For comparison, the concentration of CA 125 was also measured. VEGFR1 and CA 125 were determined in the COBAS e601 system using Roche Diagnostics kits, while IL-8, VEGF and VEGFR2 were measured by ELISA assay using R& D Systems kits. Results The concentrations of IL-8, VEGF, VEGFR1 and CA 125 allowed to distinguish patients for the control group. The highest diagnostic sensitivity has been shown for the concentrations of VEGF (AUC = 0.904) and IL-8 (AUC = 0.818). Among all studied parameters only CA125 concentrations increased with the clinical stage; being significantly higher in patients in FIGO III-IV, than FIGO I-IB. In patients at the FIGO stage I-IB, complementary determinations of CA 125 and VEGF resulted in the largest increase of diagnostic sensitivity. Patients with metastases to the para-aortic lymph nodes had significantly higher levels of VEGF compared to subjects without such lesions. The concentrations of IL-8 were an independent prognostic factor in the assessment of overall survival in patients with type I endometrial cancer, while the concentrations of VEGFR2 in those with type II. Conclusions In patients with endometrial cancer, the clinical usefulness of IL-8 and VEGFR2 measurements as the potential prognostic factors has been demonstrated. In type I, the concentrations of IL-8 determined before treatment can be helpful in predicting overall survival. In patients qualified to type II EC, the concentrations of VEGFR2 have the value of an independent prognostic factor for overall survival, this requires research on larger groups of patients. The increased levels of VEGF may be useful in the preoperative assessment of the status of para-aortic lymph nodes.	[Kotowicz, Beata; Fuksiewicz, Malgorzata; Berezowska, Alicja; Kowalska, Maria] Maria Sklodowska Curie Inst, Oncol Ctr, Dept Pathol & Lab Diagnost, Lab Tumor Markers, Warsaw, Poland; [Jonska-Gmyrek, Joanna] Maria Sklodowska Curie Inst, Oncol Ctr, Dept Urooncol, Warsaw, Poland; [Radziszewski, Jakub] Multidisciplinary Hosp, Dept Gen Vasc & Oncol Surg, Warsaw, Poland; [Bidzinski, Mariusz] Maria Sklodowska Curie Inst, Oncol Ctr, Dept Gynecol Oncol, Warsaw, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Kotowicz, B (corresponding author), Maria Sklodowska Curie Inst, Oncol Ctr, Dept Pathol & Lab Diagnost, Lab Tumor Markers, Warsaw, Poland.	hkotowicz@coi.pl	Radziszewski, Jakub/V-5663-2018; GMYREK, JOANNA JONSKA/S-9483-2019; Bidzinski, Mariusz/AAH-5019-2019	GMYREK, JOANNA JONSKA/0000-0001-8369-4594; Fuksiewicz, Malgorzata/0000-0001-9625-423X; Radziszewski, Jakub/0000-0002-4443-6653; kowalska, maria/0000-0003-0058-0976; Kotowicz, Beata/0000-0001-6790-3413; Mariusz, Bidzinski/0000-0003-4767-6369				Chen YL, 2011, AUST NZ J OBSTET GYN, V51, P397, DOI 10.1111/j.1479-828X.2011.01325.x; Chung HH, 2006, ACTA OBSTET GYN SCAN, V85, P1501, DOI 10.1080/00016340601022777; Ciortea R, 2014, ANTICANCER RES, V34, P379; Dobrzycka B, 2011, EUR CYTOKINE NETW, V22, P45, DOI 10.1684/ecn.2011.0276; Ewington L, 2012, CYTOKINE, V59, P417, DOI 10.1016/j.cyto.2012.04.036; Fujimoto J, 2002, ANN ONCOL, V13, P430, DOI 10.1093/annonc/mdf078; Fuksiewicz M, 2010, CLIN CHEM LAB MED, V48, P1481, DOI 10.1515/CCLM.2010.278; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kolbl AC, 2016, ONCOL LETT, V12, P2092, DOI 10.3892/ol.2016.4906; Kotowicz B, 2016, TUMOR BIOL, V37, P1271, DOI 10.1007/s13277-015-3914-0; Koukourakis MI, 2011, CYTOKINE, V53, P370, DOI 10.1016/j.cyto.2010.12.007; Larkins E, 2015, ONCOLOGIST, V20, P1320, DOI 10.1634/theoncologist.2015-0221; Lingli H, 2016, INT J GYNECOL CANCER, V26, P331; Ock CY, 2015, AM J CANCER RES, V5, P3376; Powell JL, 2005, J REPROD MED, V50, P585; Rutkowski P, 2002, INT J CANCER, V100, P463, DOI 10.1002/ijc.10496; Saarelainen SK, 2014, TUMOR BIOL, V35, P4651, DOI 10.1007/s13277-014-1609-6; Shaw E, 2016, RECENT RESULTS CANC, V208, P107, DOI 10.1007/978-3-319-42542-9_7; Shibuya M., 2011, CELL STRUCT FUNCT, V26, P25; Shibuya M, 2013, J BIOCHEM, V153, P13, DOI 10.1093/jb/mvs136; Sivridis E, 2002, J PATHOL, V196, P416, DOI 10.1002/path.1060; Skirnisdotir I, 2016, INT J ONCOL, V48, P998, DOI 10.3892/ijo.2016.3333; Sood AK, 1997, OBSTET GYNECOL, V90, P441, DOI 10.1016/S0029-7844(97)00286-X; Stefansson IM, 2006, CANCER RES, V66, P3303, DOI 10.1158/0008-5472.CAN-05-1163; Yokoyama Y, 2000, GYNECOL ONCOL, V77, P413, DOI 10.1006/gyno.2000.5802; Yuan A, 2000, AM J RESP CRIT CARE, V162, P1957, DOI 10.1164/ajrccm.162.5.2002108	27	17	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0184576	10.1371/journal.pone.0184576	http://dx.doi.org/10.1371/journal.pone.0184576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	28991928	Green Submitted, Green Published, gold			2022-12-26	WOS:000412601800008
J	van Hateren, A; Anderson, M; Bailey, A; Werner, JM; Skipp, P; Elliott, T				van Hateren, Andy; Anderson, Malcolm; Bailey, Alistair; Werner, Joern M.; Skipp, Paul; Elliott, Tim			Direct evidence for conformational dynamics in major histocompatibility complex class I molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antigen presentation; hydrogen-deuterium exchange; major histocompatibility complex (MHC); protein conformation; protein dynamic; protein folding; protein structure; structure-function; allotype; hydrogen-deuterium exchange mass spectrometry	MHC CLASS-I; PEPTIDE-LOADING COMPLEX; ANTIGEN PRESENTATION; MECHANISTIC BASIS; SELECTOR FUNCTION; ALPHA-2 DOMAIN; CUTTING EDGE; TAPASIN; TAP; HETERODIMER	Major histocompatibility complex class I molecules (MHC I) help protect jawed vertebrates by binding and presenting immunogenic peptides to cytotoxic T lymphocytes. Peptides are selected from a large diversity present in the endoplasmic reticulum. However, only a limited number of peptides complement the polymorphic MHC specificity determining pockets in a way that leads to high-affinity peptide binding and efficient antigen presentation. MHC I molecules possess an intrinsic ability to discriminate between peptides, which varies in efficiency between allotypes, but the mechanism of selection is unknown. Elucidation of the selection mechanism is likely to benefit future immune-modulatory therapies. Evidence suggests peptide selection involves transient adoption of alternative, presumably higher energy conformations than native peptide-MHC complexes. However, the instability of peptide-receptive MHC molecules has hindered characterization of such conformational plasticity. To investigate the dynamic nature of MHC, we refolded MHC proteins with peptides that can be hydrolyzed by UV light and thus released. We compared the resultant peptide-receptive MHC molecules with non-hydrolyzed peptide-loaded MHC complexes by monitoring the exchange of hydrogen for deuterium in solution. We found differences in hydrogen-deuterium exchange between peptide-loaded and peptide-receptive molecules that were negated by the addition of peptide to peptide-receptive MHC molecules. Peptide hydrolysis caused significant increases in hydrogen-deuterium exchange in sub-regions of the peptide-binding domain and smaller increases elsewhere, including in the 3 domain and the non-covalently associated (2)-microglobulin molecule, demonstrating long-range dynamic communication. Comparing two MHC allotypes revealed allotype-specific differences in hydrogen-deuterium exchange, consistent with the notion that MHC I plasticity underpins peptide selection.	[van Hateren, Andy; Bailey, Alistair; Elliott, Tim] Univ Southampton, Inst Life Sci, Fac Med, Bldg 85, Southampton SO17 1BJ, Hants, England; [van Hateren, Andy; Bailey, Alistair; Elliott, Tim] Univ Southampton, Ctr Canc Immunol, Fac Med, Bldg 85, Southampton SO17 1BJ, Hants, England; [Bailey, Alistair; Skipp, Paul] Univ Southampton, Ctr Prote Res, Biol Sci, Bldg 85, Southampton SO17 1BJ, Hants, England; [Bailey, Alistair; Skipp, Paul] Univ Southampton, Inst Life Sci, Bldg 85, Southampton SO17 1BJ, Hants, England; [Werner, Joern M.] Univ Southampton, Inst Life Sci, Ctr Biol Sci, Bldg 85, Southampton SO17 1BJ, Hants, England; [Werner, Joern M.] Univ Southampton, Fac Nat & Environm Sci, Bldg 85, Southampton SO17 1BJ, Hants, England; [Anderson, Malcolm] Waters Corp, Stamford Ave,Altrincham Rd, Wilmslow SK9 4AX, Cheshire, England	University of Southampton; University of Southampton; University of Southampton; University of Southampton; University of Southampton; University of Southampton; Waters UK	Elliott, T (corresponding author), Univ Southampton, Fac Med, Ctr Canc Immunol, Southampton Univ Hosp, Tremona Rd, Southampton SO16 6YD, Hants, England.	tje@soton.ac.uk	van Hateren, Andy/GZL-0129-2022	Werner, Jorn/0000-0002-4712-1833; Elliott, Tim/0000-0003-1097-0222; Bailey, Alistair/0000-0003-0023-8679; van Hateren, Andy/0000-0002-3915-0239	Cancer Research UK Program [C7056A]; Biotechnology and Biological Sciences Research Council (BBSRC) Project [BB/M012387/1, BB/L010402/1]; Biotechnology and Biological Sciences Research Council [BB/L010402/1, BB/M012387/1] Funding Source: researchfish; Cancer Research UK [16997] Funding Source: researchfish; BBSRC [BB/L010402/1, BB/M012387/1] Funding Source: UKRI	Cancer Research UK Program(Cancer Research UK); Biotechnology and Biological Sciences Research Council (BBSRC) Project(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Cancer Research UK Program Grant C7056A (to T. E.) and Biotechnology and Biological Sciences Research Council (BBSRC) Project Grants BB/M012387/1 (to P. S.) and BB/L010402/1 (to T. E. and J. M. W.). The authors declare that they have no conflicts of interest with the contents of this article.	ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; Bailey A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14928; Bailey A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089657; Bennett EM, 1999, J IMMUNOL, V162, P5049; Boname JM, 2005, EUR J IMMUNOL, V35, P171, DOI 10.1002/eji.200425459; Bouvier M, 1998, NAT STRUCT BIOL, V5, P377, DOI 10.1038/nsb0598-377; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Dalchau N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002144; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Fisette O, 2016, SCI REP-UK, V6, DOI 10.1038/srep19085; Fleischmann G, 2015, J IMMUNOL, V195, P4503, DOI 10.4049/jimmunol.1501515; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Garstka MA, 2015, P NATL ACAD SCI USA, V112, P1505, DOI 10.1073/pnas.1416543112; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; Hawse WF, 2013, J BIOL CHEM, V288, P24372, DOI 10.1074/jbc.M113.490664; Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952; Hodkinson JP, 2009, J AM SOC MASS SPECTR, V20, P278, DOI 10.1016/j.jasms.2008.10.005; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Jiang QA, 2010, TUMOR BIOL, V31, P451, DOI 10.1007/s13277-010-0054-4; KAUFMAN J, 1992, J IMMUNOL, V148, P1532; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; Koch M, 2007, IMMUNITY, V27, P885, DOI 10.1016/j.immuni.2007.11.007; Kurimoto E, 2013, MOL IMMUNOL, V55, P393, DOI 10.1016/j.molimm.2013.03.014; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Li SL, 1997, P NATL ACAD SCI USA, V94, P8708, DOI 10.1073/pnas.94.16.8708; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Rizvi SM, 2014, J IMMUNOL, V192, P4967, DOI 10.4049/jimmunol.1301670; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Seliger B, 2001, TISSUE ANTIGENS, V57, P39, DOI 10.1034/j.1399-0039.2001.057001039.x; Seliger B, 2010, CANCER IMMUNOL IMMUN, V59, P529, DOI 10.1007/s00262-009-0769-5; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; Sieker F, 2008, MOL IMMUNOL, V45, P3714, DOI 10.1016/j.molimm.2008.06.009; Sieker F, 2007, PROTEIN SCI, V16, P299, DOI 10.1110/ps.062568407; Simone LC, 2012, MOL IMMUNOL, V49, P628, DOI 10.1016/j.molimm.2011.11.002; Springer S, 1998, BIOCHEMISTRY-US, V37, P3001, DOI 10.1021/bi9717441; Suh WK, 1996, J EXP MED, V184, P337, DOI 10.1084/jem.184.2.337; Suh WK, 1999, J IMMUNOL, V162, P1530; Thomas C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00065; Thuring C, 2015, BRIT J CANCER, V113, P1640, DOI 10.1038/bjc.2015.387; van Hateren A, 2010, TISSUE ANTIGENS, V76, P259, DOI 10.1111/j.1399-0039.2010.01550.x; van Hateren Andy, 2017, F1000Res, V6, P158, DOI 10.12688/f1000research.10474.1; van Hateren A, 2015, MOL IMMUNOL, V68, P98, DOI 10.1016/j.molimm.2015.03.010; van Hateren A, 2013, J BIOL CHEM, V288, P32797, DOI 10.1074/jbc.M113.474031; Wallny HJ, 2006, P NATL ACAD SCI USA, V103, P1434, DOI 10.1073/pnas.0507386103; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Wearsch PA, 2011, P NATL ACAD SCI USA, V108, P4950, DOI 10.1073/pnas.1102524108; Wieczorek M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00292; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Yu YYL, 1999, J IMMUNOL, V163, P4427; Zacharias M, 2004, BIOPHYS J, V87, P2203, DOI 10.1529/biophysj.104.044743	57	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20255	20269		10.1074/jbc.M117.809624	http://dx.doi.org/10.1074/jbc.M117.809624			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29021251	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000417696400029
J	Dale, M; Fitzgerald, MP; Liu, ZB; Meisinger, T; Karpisek, A; Purcell, LN; Carson, JS; Harding, P; Lang, HL; Koutakis, P; Batra, R; Mietus, CJ; Casale, G; Pipinos, I; Baxter, BT; Xiong, WF				Dale, Matthew; Fitzgerald, Matthew P.; Liu, Zhibo; Meisinger, Trevor; Karpisek, Andrew; Purcell, Laura N.; Carson, Jeffrey S.; Harding, Paul; Lang, Haili; Koutakis, Panagiotis; Batra, Rishi; Mietus, Constance J.; Casale, George; Pipinos, Iraklis; Baxter, B. Timothy; Xiong, Wanfen			Premature aortic smooth muscle cell differentiation contributes to matrix dysregulation in Marfan Syndrome	PLOS ONE			English	Article							GENE-EXPRESSION; MOUSE MODEL; ANEURYSM PROGRESSION; IN-VIVO; MICE; MUTATIONS; ELASTIN; PATHOGENESIS; PROTEINS; LOSARTAN	Thoracic aortic aneurysm and dissection are life-threatening complications of Marfan syndrome (MFS). Studies of human and mouse aortic samples from late stage MFS demonstrate increased TGF-beta activation/signaling and diffuse matrix changes. However, the role of the aortic smooth muscle cell (SMC) phenotype in early aneurysm formation in MFS has yet to be fully elucidated. As our objective, we investigated whether an altered aortic SMC phenotype plays a role in aneurysm formation in MFS. We describe previously unrecognized concordant findings in the aortas of a murine model of MFS, mgR, during a critical and dynamic phase of early development. Using Western blot, gelatin zymography, and histological analysis, we demonstrated that at postnatal day (PD) 7, before aortic TGF-beta levels are increased, there is elastic fiber fragmentation/disorganization and increased levels of MMP-2 and MMP-9. Compared to wild type (WT) littermates, aortic SMCs in mgR mice express higher levels of contractile proteins suggesting a switch to a more mature contractile phenotype. In addition, tropoelastin levels are decreased in mgR mice, a finding consistent with a premature switch to a contractile phenotype. Proliferation assays indicate a decrease in the proliferation rate of mgR cultured SMCs compared to WT SMCs. KLF4, a regulator of smooth muscle cell phenotype, was decreased in aortic tissue of mgR mice. Finally, overexpression of KLF4 partially reversed this phenotypic change in the Marfan SMCs. This study indicates that an early phenotypic switch appears to be associated with initiation of important metabolic changes in SMCs that contribute to subsequent pathology in MFS.	[Dale, Matthew; Fitzgerald, Matthew P.; Liu, Zhibo; Meisinger, Trevor; Karpisek, Andrew; Purcell, Laura N.; Carson, Jeffrey S.; Harding, Paul; Lang, Haili; Koutakis, Panagiotis; Batra, Rishi; Mietus, Constance J.; Casale, George; Pipinos, Iraklis; Baxter, B. Timothy; Xiong, Wanfen] Univ Nebraska, Med Ctr, Dept Surg, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center	Xiong, WF (corresponding author), Univ Nebraska, Med Ctr, Dept Surg, Omaha, NE 68182 USA.	wxiong@unmc.edu		Pipinos, Iraklis/0000-0001-6873-6346; Koutakis, Panagiotis/0000-0002-8352-5667	National Marfan Foundation; NHLBI of the National Institutes of Health [R01HL062400, R01HL130623]	National Marfan Foundation; NHLBI of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Marfan Foundation (to W.X) and the NHLBI of the National Institutes of Health under award numbers: R01HL062400 (to B.T.B), R01HL130623 (to W.X). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Belknap JK, 1996, CIRC RES, V78, P388, DOI 10.1161/01.RES.78.3.388; Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37; Cook JR, 2015, ARTERIOSCL THROM VAS, V35, P911, DOI 10.1161/ATVBAHA.114.305150; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; HALME T, 1985, EXP MOL PATHOL, V43, P1, DOI 10.1016/0014-4800(85)90050-4; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Kato T, 2001, FEBS LETT, V508, P187, DOI 10.1016/S0014-5793(01)02897-6; Kucich U, 2002, AM J RESP CELL MOL, V26, P183, DOI 10.1165/ajrcmb.26.2.4666; Lacro RV, 2014, NEW ENGL J MED, V371, P2061, DOI 10.1056/NEJMoa1404731; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; LEMIRE JM, 1994, AM J PATHOL, V144, P1068; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; McGowan SE, 1997, AM J RESP CELL MOL, V17, P25, DOI 10.1165/ajrcmb.17.1.2686; MURDOCH JL, 1972, NEW ENGL J MED, V286, P804, DOI 10.1056/NEJM197204132861502; Nataatmadja M, 2003, CIRCULATION, V108, P329, DOI 10.1161/01.cir.0000087660.82721.15; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Pannu H, 2007, HUM MOL GENET, V16, P2453, DOI 10.1093/hmg/ddm201; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; RAMIREZ F, 1993, BIOESSAYS, V15, P589, DOI 10.1002/bies.950150904; ROSS R, 1971, J CELL BIOL, V50, P159, DOI 10.1083/jcb.50.1.159; Samaha FF, 1996, J BIOL CHEM, V271, P395, DOI 10.1074/jbc.271.1.395; Shanahan CM, 1998, ARTERIOSCL THROM VAS, V18, P333, DOI 10.1161/01.ATV.18.3.333; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Xiong W, 2008, J VASC SURG, V47, P166, DOI 10.1016/j.jvs.2007.09.016; Xiong WF, 2012, CIRC RES, V110, pE92, DOI 10.1161/CIRCRESAHA.112.268268; Xiong WF, 2009, J IMMUNOL, V183, P2741, DOI 10.4049/jimmunol.0803164; Zilberberg L, 2012, J CELL PHYSIOL, V227, P3828, DOI 10.1002/jcp.24094	36	29	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186603	10.1371/journal.pone.0186603	http://dx.doi.org/10.1371/journal.pone.0186603			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040313	gold, Green Submitted, Green Published			2022-12-26	WOS:000413167500061
J	Maqueda, M; Roca, E; Brotons, D; Soria, JM; Perera, A				Maqueda, Maria; Roca, Emma; Brotons, Daniel; Manuel Soria, Jose; Perera, Alexandre			Affected pathways and transcriptional regulators in gene expression response to an ultra-marathon trail: Global and independent activity approaches	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; BLOOD MONONUCLEAR-CELLS; ENDURANCE EXERCISE; STRENUOUS EXERCISE; R-PACKAGE; BIOLOGY; AVAILABILITY; MECHANISMS	Gene expression (GE) analyses on blood samples from marathon and half-marathon runners have reported significant impacts on the immune and inflammatory systems. An ultramarathon trail (UMT) represents a greater effort due to its more testing conditions. For the first time, we report the genome-wide GE profiling in a group of 16 runners participating in an 82 km UMT competition. We quantified their differential GE profile before and after the race using HuGene2.0st microarrays (Affymetrix Inc., California, US). The results obtained were decomposed by means of an independent component analysis (ICA) targeting independent expression modes. We observed significant differences in the expression levels of 5,084 protein coding genes resulting in an overrepresentation of 14% of the human biological pathways from the Kyoto Encyclopedia of Genes and Genomes database. These were mainly clustered on terms related with protein synthesis repression, altered immune system and infectious diseases related mechanisms. In a second analysis, 27 out of the 196 transcriptional regulators (TRs) included in the Open Regulatory Annotation database were overrepresented. Among these TRs, we identified transcription factors from the hypoxia-inducible factors (HIF) family EPAS1 (p< 0.01) and HIF1A (p<0.001), and others jointly described in the gluconeogenesis program such as HNF4 (p< 0.001), EGR1 (p<0.001), CEBPA (p< 0.001) and a highly specific TR, YY1 (p<0.01). The five independent components, obtained from ICA, further revealed a down-regulation of 10 genes distributed in the complex I, III and V from the electron transport chain. This mitochondrial activity reduction is compatible with HIF-1 system activation. The vascular endothelial growth factor (VEGF) pathway, known to be regulated by HIF, also emerged (p<0.05). Additionally, and related to the brain rewarding circuit, the endocannabinoid signalling pathway was overrepresented (p<0.05).	[Maqueda, Maria; Perera, Alexandre] Univ Politecn Cataluna, Dept ESAII, Ctr Biomed Engn Res, Barcelona, Catalonia, Spain; [Maqueda, Maria; Perera, Alexandre] CIBER BBN, Barcelona, Catalonia, Spain; [Roca, Emma] Summit 2014 SL, Barcelona, Catalonia, Spain; [Roca, Emma] Univ Politecn Cataluna, Ctr Biomed Engn Res, Dept Elect Engn, Barcelona, Catalonia, Spain; [Brotons, Daniel] Catalan Sports Council, Barcelona, Catalonia, Spain; [Manuel Soria, Jose] Hosp Santa Creu & Sant Pau, Inst Recerca, Unit Genom Complex Dis, Barcelona, Catalonia, Spain	Universitat Politecnica de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universitat Politecnica de Catalunya; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau	Maqueda, M (corresponding author), Univ Politecn Cataluna, Dept ESAII, Ctr Biomed Engn Res, Barcelona, Catalonia, Spain.; Maqueda, M (corresponding author), CIBER BBN, Barcelona, Catalonia, Spain.	maria.maqueda@upc.edu	Soria Fernández, José Manuel/AAD-6761-2019; Lluna, Alexandre Perera/R-8546-2018; Perera Lluna, Alexandre/CAG-2156-2022	Soria Fernández, José Manuel/0000-0002-6226-4293; Lluna, Alexandre Perera/0000-0001-6427-851X; Perera Lluna, Alexandre/0000-0001-6427-851X; Maqueda, Maria/0000-0001-9304-1714	Bioinformatics and Biomedical Signals Laboratory (B2SLab); consolidated research group of the Generalitat de Catalunya, Spain [2014SGR-1063]	Bioinformatics and Biomedical Signals Laboratory (B2SLab); consolidated research group of the Generalitat de Catalunya, Spain	The study was supported by the Bioinformatics and Biomedical Signals Laboratory (B2SLab), a consolidated research group of the Generalitat de Catalunya, Spain (2014SGR-1063). ER has a commercial affiliation with Summit 2014 S.L. This funder did not provide any support in the form of salaries for author ER and did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; The study was supported by the Bioinformatics and Biomedical Signals Laboratory (B2SLab), a consolidated research group of the Generalitat de Catalunya, Spain (2014SGR-1063). The authors would like to thank the runners who volunteered to participate in this research study.	Ameln H, 2005, FASEB J, V19, P1009, DOI 10.1096/fj.04-2304fje; Anderson PH, 2013, J STEROID BIOCHEM, V136, P190, DOI 10.1016/j.jsbmb.2012.08.008; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartlett JD, 2013, AM J PHYSIOL-REG I, V304, pR450, DOI 10.1152/ajpregu.00498.2012; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bolstad BM, 2004, INT REV NEUROBIOL, V60, P25; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Bresnick EH, 2012, NUCLEIC ACIDS RES, V40, P5819, DOI 10.1093/nar/gks281; Buttner P, 2007, J APPL PHYSIOL, V102, P26, DOI 10.1152/japplphysiol.00066.2006; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Cejka N, 2014, J SPORT SCI, V32, P354, DOI 10.1080/02640414.2013.825729; Connolly PH, 2004, J APPL PHYSIOL, V97, P1461, DOI 10.1152/japplphysiol.00316.2004; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Fehrenbach E, 2000, J APPL PHYSIOL, V89, P704, DOI 10.1152/jappl.2000.89.2.704; Fuss J, 2015, P NATL ACAD SCI USA, V112, P13105, DOI 10.1073/pnas.1514996112; Gentleman R, GENEFILTER GENEFILTE; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gjevestad GO, 2015, CURR CARDIOVASC RISK, V9, DOI 10.1007/s12170-015-0463-4; Goldstein I, 2015, TRENDS ENDOCRIN MET, V26, P699, DOI 10.1016/j.tem.2015.09.005; Gong DP, 2011, J INFECT DIS, V204, P592, DOI 10.1093/infdis/jir352; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Henderson J, 2005, HUM GENET, V118, P416, DOI 10.1007/s00439-005-0066-0; Henriquez-Olguin C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00282; Hoier B, 2014, MICROCIRCULATION, V21, P301, DOI 10.1111/micc.12117; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Hurdiel R, 2015, J SPORT SCI, V33, P670, DOI 10.1080/02640414.2014.960883; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jamart C, 2012, J APPL PHYSIOL, V112, P1529, DOI 10.1152/japplphysiol.00952.2011; Jenkins NT, 2011, J APPL PHYSIOL, V111, P929, DOI 10.1152/japplphysiol.00541.2011; Joro R, 2016, J SPORTS SCI, P1; Josse J, 2012, COMPUT STAT DATA AN, V56, P1869, DOI 10.1016/j.csda.2011.11.012; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Kimsa Magdalena C, 2014, Prague Med Rep, V115, P24; Knez WL, 2006, SPORTS MED, V36, P429, DOI 10.2165/00007256-200636050-00005; Kong W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S5-S7; Lago CU, 2011, ANTIOXID REDOX SIGN, V15, P1739, DOI 10.1089/ars.2010.3650; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee DC, 2014, J AM COLL CARDIOL, V64, P472, DOI 10.1016/j.jacc.2014.04.058; Lesurf R, 2016, NUCLEIC ACIDS RES, V44, pD126, DOI 10.1093/nar/gkv1203; Lindholm ME, 2016, EXP PHYSIOL, V101, P28, DOI 10.1113/EP085318; MacDonald JW, 2013, HUGENE20STTRANSCRIPT; Marchini JL, 2013, FASTICA FASTICA ALGO; McLean CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127089; Millet GP, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-77; Mrakic-Sposta S, 2015, PLOS ONE, P10; Nakamura S, 2010, BIOCHEM BIOPH RES CO, V391, P846, DOI 10.1016/j.bbrc.2009.11.150; Nickel T, 2012, EUR J APPL PHYSIOL, V112, P1699, DOI 10.1007/s00421-011-2140-8; Nieman DC, 2012, J SPORT HEALTH SCI, V1, P12, DOI 10.1016/j.jshs.2012.04.004; NIEMAN DC, 1995, THORAX, V50, P1229, DOI 10.1136/thx.50.12.1229; O'Keefe JH, 2012, MAYO CLIN PROC, V87, P587, DOI 10.1016/j.mayocp.2012.04.005; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Ostrowski K, 1998, J PHYSIOL-LONDON, V508, P949, DOI 10.1111/j.1469-7793.1998.949bp.x; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Pikosky MA, 2008, MED SCI SPORT EXER, V40, P505, DOI [10.1249/mss.0b013e31815f6643, 10.1249/MSS.0b013e31815f6643]; Raichlen DA, 2013, EUR J APPL PHYSIOL, V113, P869, DOI 10.1007/s00421-012-2495-5; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez-Miguelez P, 2014, AGE, V36, DOI 10.1007/s11357-014-9734-0; Salnikow K, 2008, CARCINOGENESIS, V29, P1493, DOI 10.1093/carcin/bgn088; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Shephard RJ, 2010, EXERC IMMUNOL REV, V16, P194; Smiles WJ, 2016, J EXP BIOL, V219, P214, DOI 10.1242/jeb.125104; Tantimonaco M, 2014, CELL MOL LIFE SCI, V71, P2681, DOI 10.1007/s00018-014-1575-6; Team R.C, R LANG ENV STAT COMP; Ulven SM, 2015, ARCH PHYSIOL BIOCHEM, V121, P41, DOI 10.3109/13813455.2014.1003566; Vance DD, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-6; Verschoor ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013565; Voisin S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-382; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Warnes G., GPLOTS VARIOUS R PRO; Wuthrich TU, 2015, MED SCI SPORT EXER, V47, P519, DOI 10.1249/MSS.0000000000000449; Xiang LB, 2014, MOL IMMUNOL, V60, P129, DOI 10.1016/j.molimm.2014.03.004; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	78	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0180322	10.1371/journal.pone.0180322	http://dx.doi.org/10.1371/journal.pone.0180322			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028836	gold, Green Published, Green Submitted			2022-12-26	WOS:000412980300001
J	Pedersen, NH; Tarp, J; Andersen, LB; Gejl, AK; Huang, T; Peijs, L; Bugge, A				Pedersen, Natascha Holbaek; Tarp, Jakob; Andersen, Lars Bo; Gejl, Anne Kaer; Huang, Tao; Peijs, Lone; Bugge, Anna			The association between serum brain-derived neurotrophic factor and a cluster of cardiovascular risk factors in adolescents: The CHAMPS-study DK	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; INSULIN SENSITIVITY; METABOLIC SYNDROME; HUMAN PLATELETS; CHILDREN; BDNF; PLASMA; DEPRESSION; DISEASE	Background and objective Cardiovascular disease and type 2 diabetes pose a global health burden. Therefore, clarifying the pathology of these risk factors is essential. Previous studies have found positive and negative associations between one or more cardiovascular risk factors and brain-derived neurotrophic factor (BDNF) probably due to diverse methodological approaches when analysing peripheral BDNF levels. Moreover, only a few studies have been performed in youth populations. Consequently, the main objective of this study was to examine the association between serum BDNF and a composite z-score consisting of six cardiovascular risk factors. A secondary aim was to examine the associations between serum BDNF and each of the six risk factors. Methods Four hundred and forty-seven apparently healthy adolescents between 11-17 years of age participated in this cross-sectional study. Cardiorespiratory fitness (CRF), anthropometrics, pubertal status, blood pressure (BP), serum BDNF, high-density lipoprotein cholesterol (HDL-C), triglyceride (TG), blood glucose and insulin were measured. Information about alcohol consumption and socio-economic status was collected via questionnaires. Associations were modelled using linear regression analysis. Results Serum BDNF was positively associated with the composite z-score in the total study sample (standardized beta coefficient (std.beta) = 0.10, P = 0.037). In males, serum BDNF was positively associated with the composite z-score (Std. beta = 0.14, P = 0.034) and HOMA-IR (Std. beta = 0.19, P = 0.004), and negatively associated with CRF (Std. beta = - 0.15, P = 0.026). In females, BDNF was positively associated with TG (Std. beta = 0.14, P = 0.030) and negatively associated with waist circumference (WC) (Std. beta = - 0.16, P = 0.012). Conclusion Serum BDNF was positively associated with a composite z-score of cardiovascular risk factors. This association seems to be mainly driven by the association between TG, HOMA-IR and serum BDNF, and particularly for males. Further longitudinal research is warranted to determine the temporal relationship between BDNF and cardiovascular risk factors.	[Pedersen, Natascha Holbaek; Tarp, Jakob; Gejl, Anne Kaer; Bugge, Anna] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Ctr Res Childhood Hlth, Odense, Denmark; [Andersen, Lars Bo] Western Norway Univ Appl Sci, Dept Teacher Educ & Sport, Campus Sogndal, Bergen, Norway; [Andersen, Lars Bo] Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway; [Huang, Tao] Shanghai Jiao Tong Univ, Dept Phys Educ, Shanghai, Peoples R China; [Peijs, Lone] Univ Copenhagen, Dept Infect Dis, Ctr Phys Act Res, Rigshosp, Copenhagen, Denmark	University of Southern Denmark; Western Norway University of Applied Sciences; Norwegian School of Sport Sciences; Shanghai Jiao Tong University; Rigshospitalet; University of Copenhagen	Pedersen, NH (corresponding author), Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Ctr Res Childhood Hlth, Odense, Denmark.	nhpedersen@health.sdu.dk	Peijs, Lone/P-7161-2018; Bugge, Anna/P-5100-2016	Peijs, Lone/0000-0002-7953-1976; Bugge, Anna/0000-0002-8345-1434; Pedersen, Natascha Holbaek/0000-0003-4260-3240; Tarp, Jakob/0000-0002-9186-7077; Kaer Gejl, Anne/0000-0001-6781-2263	TrygFonden [104982]; TrygFonden	TrygFonden; TrygFonden	CHAMPS Ill was supported by the TrygFonden (104982), www.trygfonden.dk. The funding source had no involvement in the article. During the study period, the Centre for Physical Activity Research (CFAS) was supported by a grant from TrygFonden, www.trygfonden.dk.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Andersen LB, 2008, J SPORT MED PHYS FIT, V48, P434; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Andersen LB, 2006, PREV MED, V42, P73, DOI 10.1016/j.ypmed.2005.10.009; Andersen LB, 2003, PREV MED, V37, P363, DOI 10.1016/S0091-7435(03)00145-2; Angiolillo DJ, 2010, CIRC J, V74, P597, DOI 10.1253/circj.CJ-09-0982; Begliuomini S, 2007, HUM REPROD, V22, P995, DOI 10.1093/humrep/del479; Boyuk B, 2014, J DIABETES RES, V2014; Bus BAA, 2015, MOL PSYCHIATR, V20, P602, DOI 10.1038/mp.2014.83; Bus BAA, 2011, PSYCHONEUROENDOCRINO, V36, P228, DOI 10.1016/j.psyneuen.2010.07.013; Caporali A, 2009, PHYSIOL REV, V89, P279, DOI 10.1152/physrev.00007.2008; Chaldakov GN, 2011, ARCH ITAL BIOL, V149, P257, DOI 10.4449/aib.v149i2.1366; DUKE PM, 1980, PEDIATRICS, V66, P918; Eisenmann JC, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-17; El-Gharbawy AH, 2006, J CLIN ENDOCR METAB, V91, P3548, DOI 10.1210/jc.2006-0658; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Fujinami A, 2008, CLIN BIOCHEM, V41, P812, DOI 10.1016/j.clinbiochem.2008.03.003; Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099; Gomez-Palacio-Schjetnan Andrea, 2013, Curr Top Behav Neurosci, V15, P117, DOI 10.1007/7854_2012_231; Hashimoto K, 2013, PROG NEUROBIOL, V100, P15, DOI 10.1016/j.pneurobio.2012.09.001; Hjorth MF, 2015, OBESITY, V23, P733, DOI 10.1002/oby.21034; Hristova MG, 2013, MED HYPOTHESES, V81, P627, DOI 10.1016/j.mehy.2013.07.018; Jiang H, 2011, BIOCHEM BIOPH RES CO, V415, P99, DOI 10.1016/j.bbrc.2011.10.020; Jung SH, 2011, EUR J APPL PHYSIOL, V111, P303, DOI 10.1007/s00421-010-1658-5; Karczewska-Kupczewska M, 2011, CLIN BIOCHEM, V44, P817, DOI 10.1016/j.clinbiochem.2011.05.008; Klakk H, 2014, SCAND J MED SCI SPOR, V24, pE275, DOI 10.1111/sms.12163; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Levinger I, 2008, MED SCI SPORT EXER, V40, P535, DOI [10.1249/MSS.0b013e31815dd057, 10.1249/mss.0b013e31815dd057]; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Mizui T, 2016, PHARMACOL RES, V105, P93, DOI 10.1016/j.phrs.2015.12.019; Noble EE, 2011, AM J PHYSIOL-REG I, V300, pR1053, DOI 10.1152/ajpregu.00776.2010; Ozek C, 2015, MOL METAB, V4, P867, DOI 10.1016/j.molmet.2015.08.002; Serra-Millas M, 2016, WORLD J PSYCHIATR, V6, P84, DOI 10.5498/wjp.v6.i1.84; Suwa M, 2006, METABOLISM, V55, P852, DOI 10.1016/j.metabol.2006.02.012; Tapia-Arancibia L, 2004, FRONT NEUROENDOCRIN, V25, P77, DOI 10.1016/j.yfrne.2004.04.001; Trajkovska V, 2007, BRAIN RES BULL, V73, P143, DOI 10.1016/j.brainresbull.2007.03.009; Tsuchimine S, 2014, NEUROPSYCHOBIOLOGY, V69, P83, DOI 10.1159/000358061; van Rooy MJ, 2015, THROMB RES, V135, P434, DOI 10.1016/j.thromres.2014.12.030; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wedderkopp N, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-128; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	41	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186384	10.1371/journal.pone.0186384	http://dx.doi.org/10.1371/journal.pone.0186384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028824	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000412980300032
J	Gardell, JL; Parker, DC				Gardell, Jennifer L.; Parker, David C.			Despite disorganized synapse structure, Th2 cells maintain directional delivery of CD40L to antigen-presenting B cells	PLOS ONE			English	Article							HELPER T-CELLS; IMMUNOLOGICAL SYNAPSE; LIGAND; DYNAMICS; EFFECTOR; SURFACE; DIFFERENTIATION; ACTIVATION; EXPRESSION; SELECTION	Upon recognition of peptide displayed on MHC molecules, Th1 and Th2 cells form distinct immunological synapse structures. Th1 cells have a bull's eye synapse structure with TCR/ MHC-peptide interactions occurring central to a ring of adhesion molecules, while Th2 cells have a multifocal synapse with small clusters of TCR/ MHC interactions throughout the area of T cell/antigen-presenting cell interaction. In this study, we investigated whether this structural difference in the immunological synapse affects delivery of T cell help. The immunological synapse is thought to ensure antigen-specific delivery of cytolytic granules and killing of target cells by NK cells and cytolytic T cells. In helper T cells, it has been proposed that the immunological synapse may direct delivery of other effector molecules including cytokines. CD40 ligand (CD40L) is a membrane-bound cytokine essential for antigen-specific T cell help for B cells in the antibody response. We incubated Th1 and Th2 cells overnight with a mixture of antigen-presenting and bystander B cells, and the delivery of CD40L to B cells and subsequent B cell responses were compared. Despite distinct immunological synapse structures, Th1 and Th2 cell do not differ in their ability to deliver CD40L and T cell help in an antigen-specific fashion, or in their susceptibility to inhibition of help by a blocking anti-CD40L antibody.	[Gardell, Jennifer L.; Parker, David C.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Gardell, Jennifer L.] Ben Towne Ctr Childhood Canc Res, Seattle Childrens Res Inst, Seattle, WA 98101 USA	Oregon Health & Science University; Seattle Children's Hospital	Gardell, JL (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.; Gardell, JL (corresponding author), Ben Towne Ctr Childhood Canc Res, Seattle Childrens Res Inst, Seattle, WA 98101 USA.	jennifer.gardell@seattlechildrens.org	Parker, David C/A-5428-2008	Parker, David/0000-0003-4456-2788	National Institutes of Health National Institute of Allergy and Infectious Diseases [R01 A1050823, R01 A1092080]; National Institute of Health Training Grants [T32 A1078903, T32 A1007472]	National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Health Training Grants	This work was supported by the National Institutes of Health grants R01 A1050823 (D.C.P.) and R01 A1092080 (D.C.P.) from the National Institute of Allergy and Infectious Diseases, <https://www.niaid.nih.gov/>. J.L.G. was supported by National Institute of Health Training Grants T32 A1078903, Inflammation and T Lymphocyte I mmunoregulation, and T32 A1007472, Interactions at the Microbe-Host Interface. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Brown ACN, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001152; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Clark LB, 1996, ADV IMMUNOL, V63, P43; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Donnarumma T, 2016, CELL REP, V17, P1571, DOI 10.1016/j.celrep.2016.10.013; Dustin ML, 2007, CURR PROTOC IMMUNOL; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Gardell JL, 2017, EUR J IMMUNOL, V47, P41, DOI 10.1002/eji.201646504; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Gutierrez-Vazquez C, 2013, IMMUNOL REV, V251, P125, DOI 10.1111/imr.12013; HAN SH, 1995, J IMMUNOL, V155, P556; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Huse M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00235; Koguchi Y, 2007, BLOOD, V110, P2520, DOI 10.1182/blood-2007-03-081299; Koguchi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031296; Koguchi Y, 2011, J IMMUNOL, V187, P626, DOI 10.4049/jimmunol.1004083; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; KUPFER A, 1989, J EXP MED, V170, P1697, DOI 10.1084/jem.170.5.1697; Lee BO, 2002, J EXP MED, V196, P693, DOI 10.1084/jem.20020845; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.iy.11.040193.001555; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; ROY M, 1995, EUR J IMMUNOL, V25, P596, DOI 10.1002/eji.1830250243; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Thauland TJ, 2008, J IMMUNOL, V181, P393, DOI 10.4049/jimmunol.181.1.393; Vardhana S., 2008, J VIS EXP; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wetzel SA, 2002, J IMMUNOL, V169, P6092, DOI 10.4049/jimmunol.169.11.6092; WHALEN BJ, 1988, J IMMUNOL, V141, P2230; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; YELLIN MJ, 1994, J IMMUNOL, V152, P598	36	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186573	10.1371/journal.pone.0186573	http://dx.doi.org/10.1371/journal.pone.0186573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023539	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100140
J	Morlando, M; Pelullo, CP; Di Giuseppe, G				Morlando, Marianna; Pelullo, Concetta Paola; Di Giuseppe, Gabriella			Prostate cancer screening: Knowledge, attitudes and practices in a sample of men in Italy. A survey	PLOS ONE			English	Article							AWARENESS; MORTALITY; PATTERNS	Background The aim of this study was to evaluate the knowledge, attitudes and behaviors towards prostate cancer and its prevention. Methods A cross-sectional survey was conducted on a random sample of 625 fathers of students attending eight public schools. The self-administered questionnaire included questions on: socio-demographic characteristics, personal and familiar medical history of prostate cancer, knowledge about prostate cancer and the prostate-specific antigen (PSA) test, perception of risk towards prostate cancer, perception of the benefits of having a PSA-test, willingness to receive the PSA-test and sources of and needs of information regarding prostate cancer and the PSA-test. Results 72.7% of respondents had heard about the PSA-test and 51.1% of those had heard about it through their physicians. This knowledge was higher: in men with older age, in those that had a higher level of education, in those who had a relative with prostrate problems or prostate cancer and in those with prostate problems. Perceived personal risk of contracting prostate cancer was associated with a higher level of education, in those who had received information about prostate cancer from a physician and in those with prostate problems. Only 29.6% of men had undergone a PSA-test and 59.4% were willing to do so in the future. The significant predictors of the willingness to receive a PSA-test were the belief that the PSA-test was useful, the perception of not very good personal health status, and need of additional information about the PSA-test. Conclusion Respondents have a moderate knowledge about prostate cancer and a good propensity to undergo the PSA-test. Therefore, it would be necessary to increase information on the risks of prostate cancer and the benefits of prostate cancer prevention.	[Morlando, Marianna; Pelullo, Concetta Paola; Di Giuseppe, Gabriella] Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy	Universita della Campania Vanvitelli	Di Giuseppe, G (corresponding author), Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy.	gabriella.digiuseppe@unicampania.it		DI GIUSEPPE, Gabriella/0000-0003-4466-6683				AIRTUM Working Group, 2016, IT CANC FIG; Bartsch G, 2008, BJU INT, V101, P809, DOI 10.1111/j.1464-410X.2008.07502.x; Bowen DJ, 2011, PROSTATE CANCER P D, V14, P155, DOI 10.1038/pcan.2010.55; Carrasco-Garrido P, 2014, EUR J PUBLIC HEALTH, V24, P264, DOI 10.1093/eurpub/ckt089; Carter HB, 2013, STRLY DETECTION PROS; Concato J, 2006, ARCH INTERN MED, V166, P38, DOI 10.1001/archinte.166.1.38; Cullati S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-118; Guerra CE, 2007, J GEN INTERN MED, V22, P901, DOI 10.1007/s11606-007-0142-3; Hevey D, 2009, PATIENT EDUC COUNS, V74, P244, DOI 10.1016/j.pec.2008.08.013; Hoffman RM, 2011, NEW ENGL J MED, V365, P2013, DOI 10.1056/NEJMcp1103642; Hoffman RM, 2009, ARCH INTERN MED, V169, P1611, DOI 10.1001/archinternmed.2009.262; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kabore FA, 2014, J CANCER EDUC, V29, P69, DOI 10.1007/s13187-013-0545-2; Konety BR, 2009, UROLOGY, V73, P603, DOI 10.1016/j.urology.2008.08.518; Krist AH, 2007, ANN FAM MED, V5, P112, DOI 10.1370/afm.623; Mofolo N, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0824-y; Morrison BF, 2016, J CANCER EPIDEMIOL, V2016, DOI 10.1155/2016/2606805; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Nakandi H, 2013, AFR J UROL, V19, P165, DOI 10.1016/j.afju.2013.08.001; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; van Vugt HA, 2010, EUR J CANCER, V46, P669, DOI 10.1016/j.ejca.2009.11.022; Wong MCS, 2016, EUR UROL, V70, P862, DOI 10.1016/j.eururo.2016.05.043	22	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186332	10.1371/journal.pone.0186332	http://dx.doi.org/10.1371/journal.pone.0186332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023514	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100108
J	Soldner, CA; Sticht, H; Horn, AHC				Soeldner, Christian A.; Sticht, Heinrich; Horn, Anselm H. C.			Role of the N-terminus for the stability of an amyloid-beta fibril with three-fold symmetry	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ALZHEIMERS-DISEASE; STRUCTURAL BASIS; PEPTIDES; PROTEIN; POLYMORPHISM; OLIGOMERS; AMBER; HETEROGENEITY; AGGREGATION	A key player in Alzheimer's disease is the peptide amyloid-beta (A beta), whose aggregation into small soluble oligomers, protofilaments, and fibrils finally leads to plaque deposits in human brains. The aggregation behavior of A beta is strongly modulated by the nature and composition of the peptide's environment and by its primary sequence properties. The N-terminal residues of A beta play an important role, because they are known to change the peptide's aggregation propensity. Since these residues are for the first time completely resolved at the molecular level in a three-fold symmetric fibril structure derived from a patient, we chose that system as template for a systematic investigation of the influence of the N-terminus upon structural stability. Using atomistic molecular dynamics simulations, we examined several fibrillar systems comprising three, six, twelve and an infinite number of layers, both with and without the first eight residues. First, we found that three layers are not sufficient to stabilize the respective A beta topology. Second, we observed a clear stabilizing effect of the N-terminal residues upon the overall fibril fold: truncated A beta systems were less stable than their full-length counterparts. The N-terminal residues Arg5, Asp7, and Ser8 were found to form important interfilament contacts stabilizing the overall fibril structure of three-fold symmetry. Finally, similar structural rearrangements of the truncated A beta species in different simulations prompted us to suggest a potential mechanism involved in the formation of amyloid fibrils with three-fold symmetry.	[Soeldner, Christian A.; Sticht, Heinrich; Horn, Anselm H. C.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Emil Fischer Ctr, Inst Biochem, Bioinformat, Erlangen, Germany	University of Erlangen Nuremberg	Horn, AHC (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Emil Fischer Ctr, Inst Biochem, Bioinformat, Erlangen, Germany.	Anselm.Horn@fau.de		Sticht, Heinrich/0000-0001-5644-045X; Horn, Anselm/0000-0003-3539-8103	Alzheimer Forschung Initiative (AFI) e.V. [16043]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	Alzheimer Forschung Initiative (AFI) e.V.; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	AH thanks the Alzheimer Forschung Initiative (AFI) e.V. for a Pilot Grant (16043) to AH, http://www.alzheimer-forschung.de/. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing to AH, http.//www.dfg.de/, http://www.fau.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JD, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.58; Alred EJ, 2015, PROTEIN SCI, V24, P923, DOI 10.1002/pro.2668; Annamalai K, 2016, ANGEW CHEM INT EDIT, V55, P4822, DOI 10.1002/anie.201511524; Berhanu WM, 2015, J PHYS CHEM B, V119, P13063, DOI 10.1021/acs.jpcb.5b07987; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Buchete NV, 2007, BIOPHYS J, V92, P3032, DOI 10.1529/biophysj.106.100404; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Case D.A., 2014, AMBER, V14, P29; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Fandrich M, 2009, PRION, V3, P89; Gaggelli E, 2008, J PHYS CHEM B, V112, P100, DOI 10.1021/jp075168m; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; Hatami A, 2017, J BIOL CHEM, V292, P3172, DOI 10.1074/jbc.M116.755264; Haupt C, 2012, ANGEW CHEM INT EDIT, V51, P1576, DOI 10.1002/anie.201105638; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Horn AHC, 2010, J PHYS CHEM B, V114, P2219, DOI 10.1021/jp100023q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu ZW, 2017, J BIOL CHEM, V292, P2611, DOI 10.1074/jbc.M116.757179; Ishimura H, 2017, CHEM PHYS LETT, V672, P13, DOI 10.1016/j.cplett.2017.01.041; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kahler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070521; Kassler K, 2010, J MOL MODEL, V16, P1011, DOI 10.1007/s00894-009-0611-1; Klement K, 2007, J MOL BIOL, V373, P1321, DOI 10.1016/j.jmb.2007.08.068; Klinger AL, 2014, BIOCHEMISTRY-US, V53, P7724, DOI 10.1021/bi5010409; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2011, J BIOL CHEM, V286, P34244, DOI 10.1074/jbc.M111.241141; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; Maler JM, 2007, PROTEOMICS, V7, P3815, DOI 10.1002/pmic.200700311; McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790; Miller Y, 2011, J AM CHEM SOC, V133, P2742, DOI 10.1021/ja1100273; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Muller-Schiffmann A, 2016, BRAIN, V139, P509, DOI 10.1093/brain/awv355; Muller-Schiffmann A, 2011, ACS CHEM NEUROSCI, V2, P242, DOI 10.1021/cn200011h; Noy D, 2008, J AM CHEM SOC, V130, P1376, DOI 10.1021/ja076282l; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Pauwels K, 2012, J BIOL CHEM, V287, P5650, DOI 10.1074/jbc.M111.264473; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Sasmal S, 2016, J PHYS CHEM B, V120, P12088, DOI 10.1021/acs.jpcb.6b09655; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; SELKOE DJ, 1991, SCI AM, V265, P40, DOI 10.1038/scientificamerican1191-68; Socher E, 2014, ACS CHEM NEUROSCI, V5, P161, DOI 10.1021/cn400208r; Stewart KL, 2017, BIOPHYSICAL REV; Taylor CA, 2017, MMWR-MORBID MORTAL W, V66, pS21, DOI 10.15585/mmwr.mm6620a1; Tekirian TL, 1998, J NEUROPATH EXP NEUR, V57, P76, DOI 10.1097/00005072-199801000-00009; Tripos, 1991, SYBYL7 3; Wetzel R, 2007, BIOCHEMISTRY-US, V46, P1, DOI 10.1021/bi0620959; Williams T., 2013, GNUPLOT 4 6; Wu C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000693; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Xu L, 2016, CHEM COMMUN, V52, P1733, DOI 10.1039/c5cc08107f; Zhao J, 2011, BIOMACROMOLECULES, V12, P1781, DOI 10.1021/bm2001507; Zheng J, 2008, J PHYS CHEM B, V112, P6856, DOI 10.1021/jp711335b; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700; Zheng J, 2010, J PHYS CHEM B, V114, P463, DOI 10.1021/jp907608s	65	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186347	10.1371/journal.pone.0186347	http://dx.doi.org/10.1371/journal.pone.0186347			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023579	gold, Green Submitted, Green Published			2022-12-26	WOS:000412845100112
J	Takada, T; Sato, R; Kikuta, S				Takada, Tomoyuki; Sato, Ryoichi; Kikuta, Shingo			A mannitol/sorbitol receptor stimulates dietary intake in Tribolium castaneum	PLOS ONE			English	Article							COLEOPTERA-TENEBRIONIDAE; GUSTATORY RECEPTOR; REFERENCE GENES; SUGAR-ALCOHOLS; BOMBYX-MORI; DROSOPHILA; SILKWORM; BEETLE; LEPIDOPTERA; METABOLISM	In insects, perception of chemical stimuli is involved in the acceptance or rejection of food. Gustatory receptors (Grs) that regulate external signals in chemosensory organs have been found in many insects. Tribolium castaneum, a major pest of stored products, possesses over 200 Gr genes. An expanded repertoire of Gr genes appears to be required for diet recognition in species that are generalist feeders; however, it remains unclear whether T. castaneum recognizes a suite of chemicals common to many products or whether its feeding is activated by specific chemicals, and whether its Grs are involved in feeding behavior. It is difficult to determine the food preferences of T. castaneum based on dietary intake due to a lack of appropriate methodology. This study established a novel dietary intake estimation method using gypsum, designated the TribUTE (Tribolium Urges To Eat) assay. For this assay, T. castaneum adults were fed a gypsum block without added organic compounds. Sweet preference was determined by adding sweeteners and measuring the amount of gypsum in the excreta. Mannitol was the strongest activator of T. castaneum dietary intake. In a Xenopus oocyte expression, TcGr20 was found to be responsible for mannitol and sorbitol responses, but not for responses to other tested non-volatile compounds. The EC50 values of TcGr20 for mannitol and sorbitol were 72.6 mM and 90.6 mM, respectively, suggesting that TcGr20 is a feasible receptor for the recognition of mannitol at lower concentrations. We used RNAi and the TribUTE assay to examine whether TcGr20 expression was involved in mannitol recognition. The amounts of excreta in TcGr20 dsRNA-injected adults decreased significantly, despite the presence of mannitol, compared to control adults. Taken together, our results indicate that T. castaneum adults recognized mannitol/sorbitol using the TcGr20 receptor, thereby facilitating the dietary intake of these compounds.	[Takada, Tomoyuki; Sato, Ryoichi; Kikuta, Shingo] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Tokyo, Japan	Tokyo University of Agriculture & Technology	Kikuta, S (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Tokyo, Japan.	Sincinq@gmail.com	Sato, Ryoichi/G-1074-2013; Kikuta, Shingo/J-5219-2013	Kikuta, Shingo/0000-0002-3925-576X	Japan Society for the Promotion of Science KAKENHI [17K15398]; Japan Science Society [29-424]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science Society	This research was partially supported by Japan Society for the Promotion of Science KAKENHI (Grant Number 17K15398 for SK), and by the Sasakawa Scientific Research Grant from The Japan Science Society (Grant Number 29-424 for SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001319; Ahmad F, 2012, ENTOMOL EXP APPL, V145, P272, DOI 10.1111/eea.12012; Alabi T, 2014, INSECT MOL BIOL, V23, P1, DOI 10.1111/imb.12056; Bernays EA, 1997, ECOLOGY, V78, P1157, DOI 10.1890/0012-9658(1997)078[1157:IHDRFB]2.0.CO;2; Briscoe AD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003620; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Devi M. B., 2015, Biological Forum, V7, P12; DEVITT BD, 1985, CAN ENTOMOL, V117, P343, DOI 10.4039/Ent117343-3; Dippel S, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0304-z; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; Ghaffar MBAB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022137; Glendinning JI, 2000, J EXP BIOL, V203, P1299; Grembecka M, 2015, EUR FOOD RES TECHNOL, V241, P1, DOI 10.1007/s00217-015-2437-7; Hameed M., 1985, SARHAD J AGR, V1, P97; ISHIKAWA S, 1969, ENTOMOL EXP APPL, V12, P544, DOI 10.1007/BF00297085; Isono K, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00020; ITO T, 1960, J INSECT PHYSIOL, V5, P95, DOI 10.1016/0022-1910(60)90035-4; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jiang XJ, 2015, INSECT BIOCHEM MOLEC, V60, P39, DOI 10.1016/j.ibmb.2015.03.002; Joseph RM, 2015, TRENDS GENET, V31, P683, DOI 10.1016/j.tig.2015.09.005; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; Kikuta S, 2016, INSECT BIOCHEM MOLEC, V74, P12, DOI 10.1016/j.ibmb.2016.04.010; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; KRISHNA SS, 1963, EXPERIENTIA, V19, P23, DOI 10.1007/BF02135336; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LECATO GL, 1975, J ECON ENTOMOL, V68, P763, DOI 10.1093/jee/68.6.763; LEWIS DH, 1967, NEW PHYTOL, V66, P143, DOI 10.1111/j.1469-8137.1967.tb05997.x; Ling F, 2014, J NEUROSCI, V34, P7148, DOI 10.1523/JNEUROSCI.0649-14.2014; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lushchak OV, 2014, J GERONTOL A-BIOL, V69, P3, DOI 10.1093/gerona/glt077; Matsumura Y, 2014, INT J HYDROGEN ENERG, V39, P7270, DOI 10.1016/j.ijhydene.2014.02.164; Meena M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01019; Miller SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047431; MILLS JT, 1983, PHYTOPATHOLOGY, V73, P330, DOI 10.1094/Phyto-73-330; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Niu Y., 2016, FOOD SCI HUM WELL, V5, P24, DOI DOI 10.1016/j.fshw.2015.11.002; Park JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029022; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sang W, 2015, ENVIRON ENTOMOL, V44, P418, DOI 10.1093/ee/nvv010; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; STARRATT AN, 1971, J INSECT PHYSIOL, V17, P407, DOI 10.1016/0022-1910(71)90020-5; WASHUTTL J, 1973, J FOOD SCI, V38, P1262, DOI 10.1111/j.1365-2621.1973.tb07257.x; WITTEVEEN CFB, 1995, FEMS MICROBIOL LETT, V134, P57, DOI 10.1111/j.1574-6968.1995.tb07914.x; WRIGHT VF, 1983, ENVIRON ENTOMOL, V12, P558, DOI 10.1093/ee/12.2.558; Xie YS, 1996, CAN ENTOMOL, V128, P865, DOI 10.4039/Ent128865-5; Xu W, 2016, SCI REP-UK, V6, DOI 10.1038/srep23666	46	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186420	10.1371/journal.pone.0186420	http://dx.doi.org/10.1371/journal.pone.0186420			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023543	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100126
J	Walker, M; Wanke, M				Walker, Mirella; Waenke, Michaela			Caring or daring? Exploring the impact of facial masculinity/femininity and gender category information on first impressions	PLOS ONE			English	Article							PERSON CATEGORIZATION; FACE GENDER; STEREOTYPE; JUDGMENTS; SEX; RECOGNITION; FEATURES; MODEL; CLASSIFICATION; ORIENTATION	In two studies we disentangled and systematically investigated the impact of subtle facial cues to masculinity/femininity and gender category information on first impressions. Participants judged the same unambiguously male and female target persons-either with masculine or feminine facial features slightly enhanced-regarding stereotypically masculine (i.e., competence) and feminine (i.e., warmth) personality traits. Results of both studies showed a strong effect of facial masculinity/femininity: Masculine-looking persons were seen as colder and more competent than feminine-looking persons. This effect of facial masculinity/femininity was not only found for typical (i.e., masculine-looking men and feminine-looking women) and atypical (i.e., masculine-looking women and feminine-looking men) category members; it was even found to be more pronounced for atypical than for typical category members. This finding reveals that comparing atypical members to the group prototype results in pronounced effects of facial masculinity/femininity. These contrast effects for atypical members predominate assimilation effects for typical members. Intriguingly, very subtle facial cues to masculinity/femininity strongly guide first impressions and may have more impact than the gender category.	[Walker, Mirella] Univ Basel, Basel, Switzerland; [Waenke, Michaela] Univ Mannheim, Mannheim, Germany	University of Basel; University of Mannheim	Walker, M (corresponding author), Univ Basel, Basel, Switzerland.	mirella.walker@unibas.ch	Walker, Mirella/Q-4374-2019	Walker, Mirella/0000-0002-1827-0733	Swiss National Science Foundation [100014-135213]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was partially supported by the Swiss National Science Foundation under grant no. 100014-135213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Armann R, 2012, VISION RES, V63, P69, DOI 10.1016/j.visres.2012.05.005; Ballew CC, 2007, P NATL ACAD SCI USA, V104, P17948, DOI 10.1073/pnas.0705435104; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates Douglas, 2014, LME4 LINEAR MIXED EF; BEM SL, 1974, J CONSULT CLIN PSYCH, V42, P155, DOI 10.1037/h0036215; Biernat M, 2003, AM PSYCHOL, V58, P1019, DOI 10.1037/0003-066X.58.12.1019; Blair IV, 2004, J PERS SOC PSYCHOL, V87, P763, DOI 10.1037/0022-3514.87.6.763; Blair IV, 2002, J PERS SOC PSYCHOL, V83, P5, DOI 10.1037/0022-3514.83.1.5; Blair IV, 2004, PSYCHOL SCI, V15, P674, DOI 10.1111/j.0956-7976.2004.00739.x; Blanz V, 1999, COMP GRAPH, P187, DOI 10.1145/311535.311556; Bless H, 2001, J EXP SOC PSYCHOL, V37, P386, DOI 10.1006/jesp.2000.1459; Bless H, 2010, ADV EXP SOC PSYCHOL, V42, P319, DOI 10.1016/S0065-2601(10)42006-7; Brebner JL, 2009, EUR J SOC PSYCHOL, V39, P1109, DOI 10.1002/ejsp.600; Cellerino A, 2004, BRAIN RES BULL, V63, P443, DOI 10.1016/j.brainresbull.2004.03.010; Chen M, 1997, J EXP SOC PSYCHOL, V33, P541, DOI 10.1006/jesp.1997.1329; Cheng YD, 2001, COGNITIVE SCI, V25, P819, DOI 10.1207/s15516709cog2505_8; Cloutier J, 2007, EUR J SOC PSYCHOL, V37, P1298, DOI 10.1002/ejsp.433; Deaux K., 1998, HDB SOCIAL PSYCHOL, V1, P788; FISKE ST, 1990, ADV EXP SOC PSYCHOL, V23, P1, DOI 10.1016/S0065-2601(08)60317-2; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Freeman JB, 2009, PSYCHOL SCI, V20, P1183, DOI 10.1111/j.1467-9280.2009.02422.x; Funk F, 2016, COGN EMOT; Gmuer M., 1991, 1 U KONST LEHRST MAN; Hoss RA, 2005, PERCEPTION, V34, P1459, DOI 10.1068/p5154; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Kunda Z, 1996, PSYCHOL REV, V103, P284, DOI 10.1037/0033-295X.103.2.284; Kuznetsova A., 2015, R PACKAGE VERSION, V2, P734; Little AC, 2013, PERS INDIV DIFFER, V54, P207; Little AC, 2014, BRIT J PSYCHOL, V105, P364, DOI 10.1111/bjop.12043; Locke V, 2005, SOC COGNITION, V23, P417, DOI 10.1521/soco.2005.23.5.417; MARTIN CL, 1987, J PERS SOC PSYCHOL, V52, P489, DOI 10.1037/0022-3514.52.3.489; Martin D, 2007, EUR J SOC PSYCHOL, V37, P806, DOI 10.1002/ejsp.445; O'Toole AJ, 1998, MEM COGNITION, V26, P146, DOI 10.3758/BF03211378; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Paysan P, 2009, AVSS: 2009 6TH IEEE INTERNATIONAL CONFERENCE ON ADVANCED VIDEO AND SIGNAL BASED SURVEILLANCE, P296, DOI 10.1109/AVSS.2009.58; Phillips PJ, 1998, IMAGE VISION COMPUT, V16, P295, DOI 10.1016/S0262-8856(97)00070-X; Pound N, 2007, PERS INDIV DIFFER, V43, P1572, DOI 10.1016/j.paid.2007.04.014; Questback GmbH, 2015, EFS SURVEY VERSION 1; Rudert SC, 2017, J EXP SOC PSYCHOL, V68, P101, DOI 10.1016/j.jesp.2016.06.005; Rule NO, 2008, J EXP SOC PSYCHOL, V44, P1100, DOI 10.1016/j.jesp.2007.12.001; Samochowiec J, 2010, SOC PSYCHOL PERS SCI, V1, P206, DOI 10.1177/1948550610372145; Schneider-Duker M., 1988, DIAGNOSTICA, V34, P256; SCHWARZ N, 1992, CONSTRUCTION OF SOCIAL JUDGMENTS, P217; Schwarz N, 2007, ASSIMILATION AND CONTRAST IN SOCIAL PSYCHOLOGY, P119; Shevlin M, 2003, PERS INDIV DIFFER, V35, P1373, DOI 10.1016/S0191-8869(02)00356-2; Spence JT, 2000, PSYCHOL WOMEN QUART, V24, P44, DOI 10.1111/j.1471-6402.2000.tb01021.x; Vetter T., 2011, OXFORD HDB FACE PERC, P387; Walker M, 2016, J PERS SOC PSYCHOL, V110, P609, DOI 10.1037/pspp0000064; Walker M, 2011, SOC PSYCHOL PERS SCI, V2, P609, DOI 10.1177/1948550611402519; Walker M, 2009, J VISION, V9, DOI 10.1167/9.11.12; Wanke M, 2003, Z SOZIALPSYCHOL, V34, P187, DOI 10.1024//0044-3514.34.3.187; Westfall J., 2015, PANGEA POWER ANAL GE, DOI [DOI 10.1002/CNM, 10.1002/cnm]; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Zebrowitz L.A., 2011, OXFORD HDB FACE PERC, P31, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0003	55	14	14	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0181306	10.1371/journal.pone.0181306	http://dx.doi.org/10.1371/journal.pone.0181306			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ6DU	29023451	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000412845100001
J	Wolniczak, I; Caceres-DelAguila, JA; Maguina, JL; Bernabe-Ortiz, A				Wolniczak, Isabella; Caceres-DelAguila, Jose A.; Maguina, Jorge L.; Bernabe-Ortiz, Antonio			Fruits and vegetables consumption and depressive symptoms: A population-based study in Peru	PLOS ONE			English	Article							NUTRITION; HEALTH; ADULTS; RISK; ASSOCIATION; PREVENTION; DISEASE; ANXIETY; OBESITY; STRESS	Objectives Among different factors, diet patterns seem to be related to depression. The aim of this study was to evaluate the association between the consumption of fruits and/or vegetables and depressive symptoms. Methodology/Principal findings A secondary data analysis was conducted using information from a population-based survey from 25 regions from Peru. The outcome was the presence of depressive symptoms according to the Patient Health Questionnaire (cutoff >= 15 to define major depressive syndrome); whereas the exposure was the self-reported consumption of fruits and/or vegetables (in tertiles and using WHO recommendation >= 5 servings/day). The association of interest was evaluated using Poisson regression models controlling for the complex-sample survey design and potential confounders. Data from 25,901 participants were analyzed, mean age 44.2 (SD: 17.7) and 13,944 (54.0%) women. Only 910 (3.8%; 95%CI: 3.5%-4.2%) individuals reported consuming >= 5 servings of fruits and/or vegetables/day; whereas 819 (2.8%; 95%CI: 2.5%-3.1%) had depressive symptoms. Those in the lowest tertile of fruits and/or vegetables consumption had greater prevalence of depressive symptoms (PR = 1.88; 95%CI: 1.39-2.55) than those in the highest tertile. This association was stronger with fruits (PR = 1.92; 95%CI: 1.46-2.53) than vegetables (PR = 1.42; 95%CI: 1.05-1.93) alone. Conclusions An inverse relationship between consumption of fruits and/or vegetables and depressive symptoms is reported. Less than 5% of subjects reported consuming the amount of fruits and vegetables recommended by the WHO. There is a need to implement strategies to promote better diet patterns with potential impact on mental health.	[Wolniczak, Isabella; Caceres-DelAguila, Jose A.; Maguina, Jorge L.; Bernabe-Ortiz, Antonio] Univ Peruana Ciencias Aplicadas UPC, Fac Hlth Sci, Sch Med, Lima, Peru; [Bernabe-Ortiz, Antonio] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Bernabe-Ortiz, Antonio] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England	Universidad Peruana de Ciencias Aplicadas (UPC); Universidad Peruana Cayetano Heredia; University of London; London School of Hygiene & Tropical Medicine	Bernabe-Ortiz, A (corresponding author), Univ Peruana Ciencias Aplicadas UPC, Fac Hlth Sci, Sch Med, Lima, Peru.; Bernabe-Ortiz, A (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.; Bernabe-Ortiz, A (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.	Antonio.Bernabe@upch.pe	Maguiña, Jorge L./AGQ-6299-2022	Maguiña, Jorge L./0000-0002-4136-7795; Caceres Del Aguila, Jose Alonso/0000-0001-7897-5033; Bernabe-Ortiz, Antonio/0000-0002-6834-1376	Research Training Fellowship in Public Health and Tropical Medicine - Wellcome Trust [103994/Z/14/Z]	Research Training Fellowship in Public Health and Tropical Medicine - Wellcome Trust	AB-O is supported by a Research Training Fellowship in Public Health and Tropical Medicine (103994/Z/14/Z) funded by Wellcome Trust (www.wellcome.ac.uk). The funder had no role in study design, data collection, data analysis, decision to publish or preparation of the manuscript.	Arribas-Harten C, 2015, REV CHIL NUTR, V42, P241; Avila-Funes JA, 2006, REV PANAM SALUD PUBL, V19, P321, DOI 10.1590/S1020-49892006000500005; Baader M Tomas, 2012, Rev. chil. neuro-psiquiatr., V50, P10; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bazzano LA, 2002, AM J CLIN NUTR, V76, P93; Bhupathiraju SN, 2013, AM J CLIN NUTR, V98, P1514, DOI 10.3945/ajcn.113.066381; Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y; Calderón María, 2012, Rev. perú. med. exp. salud publica, V29, P578; Ferrari AJ, 2013, PSYCHOL MED, V43, P471, DOI 10.1017/S0033291712001511; Fiestas Fabián, 2014, Rev. perú. med. exp. salud publica, V31, P39; Forsyth AK, 2012, AUST J PRIM HEALTH, V18, P172, DOI 10.1071/PY11023; Graubard B I, 1996, Stat Methods Med Res, V5, P263, DOI 10.1177/096228029600500304; Grosso G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096905; Hall JN, 2009, AM J PREV MED, V36, P402, DOI 10.1016/j.amepre.2009.01.029; Instituto Nacional de Estadistica e Informatica, 2014, ENC NAC HOG 2014; Instituto Nacional de Estadistica e Informatica, 2015, MICR BAS DAT ENC DEM; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Kain J, 2014, CURR OBES REP, V3, P150, DOI 10.1007/s13679-014-0097-8; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Knai C, 2006, PREV MED, V42, P85, DOI 10.1016/j.ypmed.2005.11.012; Kohn R, 2005, REV PANAM SALUD PUBL, V18, P4, DOI DOI 10.1590/S1020-49892005000900002; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lai JS, 2014, AM J CLIN NUTR, V99, P181, DOI 10.3945/ajcn.113.069880; Le Port A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051593; Liu CH, 2007, PHYSIOL BEHAV, V92, P748, DOI 10.1016/j.physbeh.2007.05.068; Meyer BJ, 2013, NUTRITION, V29, P1042, DOI 10.1016/j.nut.2013.02.006; Muntaner C, 2004, EPIDEMIOL REV, V26, P53, DOI 10.1093/epirev/mxh001; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Palazidou E, 2012, BRIT MED BULL, V101, P127, DOI 10.1093/bmb/lds004; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Ruiz-Grosso P, 2015, J IMMIGR MINOR HEALT, V17, P1635, DOI 10.1007/s10903-014-0121-9; Sanchez-Villegas A, 2009, ARCH GEN PSYCHIAT, V66, P1090, DOI 10.1001/archgenpsychiatry.2009.129; Sarlio-Lahteenkorva S, 2004, APPETITE, V42, P151, DOI 10.1016/j.appet.2003.08.014; Tsai AC, 2012, PUBLIC HEALTH NUTR, V15, P1087, DOI 10.1017/S1368980011002977; Uauy R, 2001, J NUTR, V131, p893S, DOI 10.1093/jn/131.3.893S; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; West BT, 2008, STATA J, V8, P520, DOI 10.1177/1536867X0800800404; Woo J, 2006, INT J GERIATR PSYCH, V21, P1036, DOI 10.1002/gps.1603; World Health Organization, 2008, EHO STEPWISE CHRON D; World Health Organization, 2012, DEPRESSION GLOBAL PU; World Health Organization and Food and Agriculture Organization of the United Nations, 2005, FRUIT VEG HLTH REP J; Yao W, 2016, SCI REP-UK, V6, DOI 10.1038/srep30659; Zhang JC, 2017, J NUTR BIOCHEM, V39, P134, DOI 10.1016/j.jnutbio.2016.10.004	43	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186379	10.1371/journal.pone.0186379	http://dx.doi.org/10.1371/journal.pone.0186379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023513	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000412845100119
J	Akpaka, PE; Kissoon, S; Jayaratne, P; Wilson, C; Golding, GR; Nicholson, AM; Lewis, DB; Hermelijn, SM; Wilson-Pearson, A; Smith, A				Akpaka, Patrick Eberechi; Kissoon, Shivnarine; Jayaratne, Padman; Wilson, Clyde; Golding, George R.; Nicholson, Alison M.; Lewis, Delores B.; Hermelijn, Sandra M.; Wilson-Pearson, Alexis; Smith, Ashley			Genetic characteristics and molecular epidemiology of vancomycin-resistant Enterococci isolates from Caribbean countries	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; SEQUENCE TYPING SCHEME; FAECIUM; HOSPITALS; PCR; ESP	Emergence of vancomycin-resistant Enterococci (VRE) that first appeared on the stage about three decades ago is now a major concern worldwide as it has globally reached every continent. Our aim was to simply undertake a multinational study to delineate the resistance and virulence genes of clinical isolates of VRE isolates from the Caribbean. We employed both conventional (standard microbiological methods including use of E-test strips, chromogenic agar) and molecular methods (polymerase chain reactions-PCR, pulsed-field gel electrophoresis-PFGE and multilocus sequence typing-MLST) to analyze and characterize 245 Enterococci species and 77 VRE isolates from twelve hospitals from eight countries in the Caribbean. The PCR confirmed and demonstrated the resistance and virulence genes (vanA and esp) among all confirmed VRE isolates. The PFGE delineated clonally related isolates from patients from the same country and other countries in the region. The main sequence types of the VRE isolates from the region included STs 412, 750, 203, 736 and 18, all from the common ancestor for clonal complex 17 (CC17). Despite this common ancestor and association of outbreaks of this lineage clones, there has been no reports of outbreaks of infection by VRE in several hospitals in the Caribbean.	[Akpaka, Patrick Eberechi; Kissoon, Shivnarine] Univ West Indies, Paraclin Sci, St Augustine, Trinidad Tobago; [Jayaratne, Padman] McMaster Univ, Dept Pathol Sci, Hamilton, ON, Canada; [Wilson, Clyde] King Edward VII Mem Hosp, Dept Pathol & Microbiol, Hamilton, Bermuda; [Golding, George R.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Nicholson, Alison M.] Univ West Indies, Dept Microbiol, Mona Kingston, Jamaica; [Lewis, Delores B.] Univ West Indies, Fac Med Sci, Cave Hill, Barbados; [Hermelijn, Sandra M.] Acad Hosp Paramaribo, Med Microbiol Lab, Paramaribo, Suriname; [Wilson-Pearson, Alexis] Georgetown Public Hosp Corp, Microbiol Lab, Georgetown, Guyana; [Smith, Ashley] King Edward VII Mem Hosp, Dept Pharm, Hamilton, Bermuda	University West Indies Mona Jamaica; University West Indies Saint Augustine; McMaster University; Public Health Agency of Canada; University West Indies Mona Jamaica; University West Indies Mona Jamaica; University West Indies Cave Hill Campus; Anton de Kom Universiteit van Suriname; Academisch Ziekenhuis Paramaribo	Akpaka, PE (corresponding author), Univ West Indies, Paraclin Sci, St Augustine, Trinidad Tobago.	peakpaka@yahoo.co.uk	Smith, Ashley/GZB-0298-2022	Akpaka, Patrick Eberechi/0000-0001-9895-3077				Agudelo Higuita NI., 2014, ENTEROCOCCI COMMENSA; Akpaka Patrick E, 2016, Adv Med, V2016, P8762691, DOI 10.1155/2016/8762691; Akpaka PE, PLOS ONE, V12; Ang S. W., 1996, Annals Academy of Medicine Singapore, V25, P270; Billstrom H, 2008, INT J ANTIMICROB AG, V32, P374, DOI 10.1016/j.ijantimicag.2008.04.026; Chuang YC, 2010, J CLIN MICROBIOL, V48, P2897, DOI 10.1128/JCM.00136-10; Clinical and Laboratory Standards Institute, 2014, PERFORMANCE STANDARD; Cuzon G, 2008, J CLIN MICROBIOL, V46, P2442, DOI 10.1128/JCM.00492-08; Deshpande LM, 2007, DIAGN MICR INFEC DIS, V58, P163, DOI 10.1016/j.diagmicrobio.2006.12.022; EUCAST, 2010, BREAKP TABL INT MICS; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Freitas AR, 2010, ANTIMICROB AGENTS CH, V54, P2660, DOI 10.1128/AAC.00134-10; FRIEDEN TR, 1993, LANCET, V342, P76, DOI 10.1016/0140-6736(93)91285-T; Healy M, 2005, J CLIN MICROBIOL, V43, P199, DOI 10.1128/JCM.43.1.199-207.2005; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Jayaratne P, 1999, J CLIN MICROBIOL, V37, P2090, DOI 10.1128/JCM.37.6.2090-2092.1999; Jayaratne P., 2014, DETECTION VANCOMYCIN; Khan MA, 2010, CLIN MICROBIOL INFEC, V16, P624, DOI 10.1111/j.1469-0691.2009.02898.x; Leavis HL, 2003, EMERG INFECT DIS, V9, P1108; Miller WR, 2014, EXPERT REV ANTI-INFE, V12, P1221, DOI 10.1586/14787210.2014.956092; MURRAY BE, 1990, J CLIN MICROBIOL, V28, P2059, DOI 10.1128/JCM.28.9.2059-2063.1990; Ochoa SA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-291; Palama IE, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/203676; Panesso D, 2010, J CLIN MICROBIOL, V48, P1562, DOI 10.1128/JCM.02526-09; da Silva LPP, 2012, DIAGN MICR INFEC DIS, V74, P267, DOI 10.1016/j.diagmicrobio.2012.07.012; Rice LB, 2003, J INFECT DIS, V187, P508, DOI 10.1086/367711; Ruiz-Garbajosa P, 2006, J CLIN MICROBIOL, V44, P2220, DOI 10.1128/JCM.02596-05; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Turabelidze D, 2000, J CLIN MICROBIOL, V38, P4242, DOI 10.1128/JCM.38.11.4242-4245.2000; UTTLEY AHC, 1988, LANCET, V1, P57; Vankerckhoven V, 2004, J CLIN MICROBIOL, V42, P4473, DOI 10.1128/JCM.42.10.4473-4479.2004; Werner G, 2008, Euro Surveill, V13; Willems RJL, 2001, LANCET, V357, P853, DOI 10.1016/S0140-6736(00)04205-7; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204; Woodford N, 1998, ANTIMICROB AGENTS CH, V42, P502, DOI 10.1128/AAC.42.3.502	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185920	10.1371/journal.pone.0185920	http://dx.doi.org/10.1371/journal.pone.0185920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020115	Green Submitted, gold, Green Published			2022-12-26	WOS:000412754400051
J	Ashwin, C; Wheelwright, S; Baron-Cohen, S				Ashwin, Chris; Wheelwright, Sally; Baron-Cohen, Simon			Differences in change blindness to real-life scenes in adults with autism spectrum conditions	PLOS ONE			English	Article							SELECTIVE ATTENTION; STIMULUS OVERSELECTIVITY; TUNNEL VISION; VISUAL-ACUITY; CHILDREN; DISORDER; PEOPLE; INDIVIDUALS; PERCEPTION; DEFICITS	People often fail to detect large changes to visual scenes following a brief interruption, an effect known as 'change blindness'. People with autism spectrum conditions (ASC) have superior attention to detail and better discrimination of targets, and often notice small details that are missed by others. Together these predict people with autism should show enhanced perception of changes in simple change detection paradigms, including reduced change blindness. However, change blindness studies to date have reported mixed results in ASC, which have sometimes included no differences to controls or even enhanced change blindness. Attenuated change blindness has only been reported to date in ASC in children and adolescents, with no study reporting reduced change blindness in adults with ASC. The present study used a change blindness flicker task to investigate the detection of changes in images of everyday life in adults with ASC (n = 22) and controls (n = 22) using a simple change detection task design and full range of original scenes as stimuli. Results showed the adults with ASC had reduced change blindness compared to adult controls for changes to items of marginal interest in scenes, with no group difference for changes to items of central interest. There were no group differences in overall response latencies to correctly detect changes nor in the overall number of missed detections in the experiment. However, the ASC group showed greater missed changes for marginal interest changes of location, showing some evidence of greater change blindness as well. These findings show both reduced change blindness to marginal interest changes in ASC, based on response latencies, as well as greater change blindness to changes of location of marginal interest items, based on detection rates. The findings of reduced change blindness are consistent with clinical reports that people with ASC often notice small changes to less salient items within their environment, and are in-line with theories of enhanced local processing and greater attention to detail in ASC. The findings of lower detection rates for one of the marginal interest conditions may be related to problems in shifting attention or an overly focused attention spotlight.	[Ashwin, Chris; Wheelwright, Sally; Baron-Cohen, Simon] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Douglas House, Cambridge, England; [Ashwin, Chris] Univ Bath, Dept Psychol, Bath, Avon, England; [Wheelwright, Sally] Univ Southampton, Dept Canc Sci, Southampton, Hants, England; [Baron-Cohen, Simon] Cambridgeshire & Peterborough NHS Fdn Trust, CLASS Clin, Cambridge, England	University of Cambridge; University of Bath; University of Southampton	Ashwin, C (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Douglas House, Cambridge, England.; Ashwin, C (corresponding author), Univ Bath, Dept Psychol, Bath, Avon, England.	c.ashwin@bath.ac.uk		Wheelwright, Sally/0000-0003-0657-2483; Baron-Cohen, Simon/0000-0001-9217-2544; Ashwin, Chris/0000-0003-4606-7318	Medical Research Council (MRC) UK; Wellcome Trust; Autism Research Trust; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust; MRC [G0600977] Funding Source: UKRI; Medical Research Council [G0600977] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10097] Funding Source: researchfish	Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Autism Research Trust; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors were supported by the Medical Research Council (MRC) UK, the Wellcome Trust, and the Autism Research Trust. The research was also supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DSM4TR DIAGNOSTIC ST; Ashwin E, 2009, BIOL PSYCHIAT, V65, P17, DOI 10.1016/j.biopsych.2008.06.012; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2006, ARCH DIS CHILD, V91, P2; Baron-Cohen S., 2003, ESSENTIAL DIFFERENCE; Baron-Cohen S., 2013, UNDERSTANDING OTHER; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; Belmonte M. K., 2000, AUTISM, V4, P269, DOI DOI 10.1177/1362361300004003004; Belmonte MK, 2003, COGNITIVE BRAIN RES, V17, P651, DOI 10.1016/S0926-6410(03)00189-7; BURACK JA, 1994, J ABNORM PSYCHOL, V103, P535, DOI 10.1037/0021-843X.103.3.535; Burack JA, 2009, J AUTISM DEV DISORD, V39, P471, DOI 10.1007/s10803-008-0647-6; Clery H, 2013, NEUROIMAGE-CLIN, V2, P303, DOI 10.1016/j.nicl.2013.01.010; COURCHESNE E, 1994, BEHAV NEUROSCI, V108, P848, DOI 10.1037/0735-7044.108.5.848; FEIN D, 1979, J CHILD PSYCHOL PSYC, V20, P325, DOI 10.1111/j.1469-7610.1979.tb00518.x; Fletcher-Watson S, 2006, BRIT J PSYCHOL, V97, P537, DOI 10.1348/000712606X114057; Fletcher-Watson S, 2008, J AUTISM DEV DISORD, V38, P1785, DOI 10.1007/s10803-008-0548-8; Fletcher-Watson S, 2012, BRIT J DEV PSYCHOL, V30, P446, DOI 10.1111/j.2044-835X.2011.02054.x; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Frith U., 2003, AUTISM EXPLAINING EN; Hagmann CE, 2016, J AUTISM DEV DISORD, V46, P1762, DOI 10.1007/s10803-016-2705-9; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Jolliffe T, 1997, J CHILD PSYCHOL PSYC, V38, P527, DOI 10.1111/j.1469-7610.1997.tb01539.x; Kanner L, 1943, NERV CHILD, V2, P217; Kikuchi Y, 2009, CHILD DEV, V80, P1421, DOI 10.1111/j.1467-8624.2009.01342.x; Latham K, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-4; Loth E, 2008, AUTISM RES, V1, P179, DOI 10.1002/aur.19; LOVAAS OI, 1971, BEHAV RES THER, V9, P305, DOI 10.1016/0005-7967(71)90042-8; LOVAAS OI, 1971, J ABNORM PSYCHOL, V77, P211, DOI 10.1037/h0031015; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; New JJ, 2010, NEUROPSYCHOLOGIA, V48, P51, DOI 10.1016/j.neuropsychologia.2009.08.008; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; O'Regan JK, 2000, VIS COGN, V7, P191, DOI 10.1080/135062800394766; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1081, DOI 10.1111/j.1469-7610.1991.tb00351.x; Ozonoff S., 1995, LEARNING COGNITION A, P199; Pascualvaca DM, 1998, J AUTISM DEV DISORD, V28, P467, DOI 10.1023/A:1026091809650; Plaisted K, 2006, J AUTISM DEV DISORD, V36, P107, DOI 10.1007/s10803-005-0047-0; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P765, DOI 10.1111/1469-7610.00375; Remington A, 2009, PSYCHOL SCI, V20, P1388, DOI 10.1111/j.1467-9280.2009.02454.x; Remington AM, 2012, J ABNORM PSYCHOL, V121, P544, DOI 10.1037/a0027670; Rensink RA, 2000, VIS COGN, V7, P127, DOI 10.1080/135062800394720; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Rensink RA, 2000, VIS COGN, V7, P345, DOI 10.1080/135062800394847; RINCOVER A, 1987, AM J MENT RETARD, V91, P422; Robertson C, 2013, J VIS, V13, P836; Robertson CE, 2016, CURR BIOL, V26, P80, DOI 10.1016/j.cub.2015.11.019; Robertson CE, 2013, J NEUROSCI, V 33, P16983, DOI 10.1523/JNEUROSCI.0448-13.2013; Robertson CE, 2013, J NEUROSCI, V33, P6776, DOI 10.1523/JNEUROSCI.5120-12.2013; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; Smith H, 2009, J CHILD PSYCHOL PSYC, V50, P300, DOI 10.1111/j.1469-7610.2008.01957.x; Sperber D., 1995, RELEVANCE COMMUNICAT, V2nd ed.; Swettenham J, 2014, NEUROPSYCHOLOGY, V28, P563, DOI 10.1037/neu0000042; Tavassoli T, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-29; Tavassoli T, 2011, VISION RES, V51, P1778, DOI 10.1016/j.visres.2011.06.004; Vattikuti S, 2010, BIOL PSYCHIAT, V67, P672, DOI 10.1016/j.biopsych.2009.09.008; Volkmar F.R., 2005, HDB AUTISM PERVASIVE; Wechsler D., 2011, WASI 2 WECHSLER ABBR; World Health Organization, 2008, ICD 10 INT STAT CLAS	60	1	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185120	10.1371/journal.pone.0185120	http://dx.doi.org/10.1371/journal.pone.0185120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020056	Green Published, gold			2022-12-26	WOS:000412754400022
J	Belcher, DA; Banerjee, U; Baehr, CM; Richardson, KE; Cabrales, P; Berthiaume, F; Palmer, AF				Belcher, Donald Andrew; Banerjee, Uddyalok; Baehr, Christopher Michael; Richardson, Kristopher Emil; Cabrales, Pedro; Berthiaume, Francois; Palmer, Andre Francis			Mixtures of tense and relaxed state polymerized human hemoglobin regulate oxygen affinity and tissue construct oxygenation	PLOS ONE			English	Article							HOLLOW-FIBER BIOREACTOR; BLOOD SUBSTITUTES; NITRIC-OXIDE; ENCAPSULATED HEMOGLOBIN; BIOPHYSICAL PROPERTIES; BOVINE HEMOGLOBINS; GASEOUS LIGANDS; CARRIER; BINDING; LIVER	Pure tense (T) and relaxed (R) quaternary state polymerized human hemoglobins (PolyhHbs) were synthesized and their biophysical properties characterized, along with mixtures of T-and R-state PolyhHbs. It was observed that the oxygen affinity of PolyhHb mixtures varied linearly with T-state mole fraction. Computational analysis of PolyhHb facilitated oxygenation of a single fiber in a hepatic hollow fiber (HF) bioreactor was performed to evaluate the oxygenation potential of T-and R-state PolyhHb mixtures. PolyhHb mixtures with T-state mole fractions greater than 50% resulted in hypoxic and hyperoxic zones occupying less than 5% of the total extra capillary space (ECS). Under these conditions, the ratio of the pericentral volume to the perivenous volume in the ECS doubled as the T-state mole fraction increased from 50 to 100%. These results show the effect of varying the T/R-state PolyhHb mole fraction on oxygenation of tissue-engineered constructs and their potential to oxygenate tissues.	[Belcher, Donald Andrew; Banerjee, Uddyalok; Richardson, Kristopher Emil; Palmer, Andre Francis] Ohio State Univ, Coll Engn, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Baehr, Christopher Michael] Ohio State Univ, Dept Biomed Engn, Coll Engn, Columbus, OH 43210 USA; [Cabrales, Pedro] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Berthiaume, Francois] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California San Diego; Rutgers State University New Brunswick	Palmer, AF (corresponding author), Ohio State Univ, Coll Engn, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA.	palmer.351@osu.edu	Banerjee, Uddyalok/J-4284-2019; Berthiaume, Francois/ABD-2139-2020; Belcher, Donald/ABC-7359-2020; Cabrales, Pedro/A-1930-2014	Banerjee, Uddyalok/0000-0002-8697-5129; Cabrales, Pedro/0000-0002-8794-2839	National Institutes of Health [R56HL123015, R01HL126945, R01EB021926]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126945, R56HL123015, R01HL138116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB021926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health grant R56HL123015, R01HL126945, and R01EB021926 to AFP (https://www.nih.gov/)	AABB, 2013, CIRC INF US HUM BLOO, P1; Ali AA, 2001, ANESTH ANALG, P863; Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569; Arifin DR, 2003, BIOTECHNOL PROGR, V19, P1798, DOI 10.1021/bp034120x; Baek JH, 2012, TOXICOL SCI, V127, P567, DOI 10.1093/toxsci/kfs109; Boykins RA, 2005, PROTEINS, V59, P840, DOI 10.1002/prot.20453; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buehler PW, 2010, BIOMATERIALS, V31, P3723, DOI 10.1016/j.biomaterials.2010.01.072; Buehler PW, 2005, ANTIOXID REDOX SIGN, V7, P1755, DOI 10.1089/ars.2005.7.1755; Buehler PW, 2005, ANAL CHEM, V77, P3466, DOI 10.1021/ac050064y; Carmichael FJL, 2000, CRIT CARE MED, V28, P2283, DOI 10.1097/00003246-200007000-00017; Carpentier B, 2009, GUT, V58, P1690, DOI 10.1136/gut.2008.175380; Chen G, 2009, BIOTECHNOL BIOENG, V102, P1603, DOI 10.1002/bit.22200; Day TK, 2003, J VET EMERG CRIT CAR, V13, P77, DOI 10.1046/j.1435-6935.2003.00084.x; deFigueiredo LFP, 1997, J TRAUMA, V42, P847; DULING BR, 1972, CIRC RES, V31, P481, DOI 10.1161/01.RES.31.4.481; Eaton WA, 1999, NAT STRUCT BIOL, V6, P351, DOI 10.1038/7586; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Harder DR, 1996, CIRC RES, V79, P54, DOI 10.1161/01.RES.79.1.54; Hawk P.B., 1965, HAWKS PHYSL CHEM; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; JACKSON WF, 1989, AM J PHYSIOL, V257, pH1565, DOI 10.1152/ajpheart.1989.257.5.H1565; Jia YP, 2004, BIOCHEM J, V384, P367, DOI 10.1042/BJ20040612; Kietzmann T, 2017, REDOX BIOL, V11, P622, DOI 10.1016/j.redox.2017.01.012; Lindros KO, 1997, GEN PHARMACOL, V28, P191, DOI 10.1016/S0306-3623(96)00183-8; Marcucci C, 2004, BRIT MED BULL, V70, P15, DOI 10.1093/bmb/ldh023; MATHEWS AJ, 1994, METHOD ENZYMOL, V232, P363; Moore EE, 2003, J AM COLL SURGEONS, V196, P1, DOI 10.1016/S1072-7515(02)01704-0; Mozzarelli A, 2011, CHEMISTRY AND BIOCHEMISTRY OF OXYGEN THERAPEUTICS: FROM TRANSFUSION TO ARTIFICIAL BLOOD, P1, DOI 10.1002/9781119975427; Napolitano LM, 2009, CRIT CARE CLIN, V25, P279, DOI 10.1016/j.ccc.2009.01.003; Olsen KW, 2011, CHEMISTRY AND BIOCHEMISTRY OF OXYGEN THERAPEUTICS: FROM TRANSFUSION TO ARTIFICIAL BLOOD, P327; Olson JS, 2003, HEMOGLOBIN DISORDERS; Palmer AF, 2011, J TRAUMA, V71, P798, DOI 10.1097/TA.0b013e3182028ab0; Palmer AF, 2009, BIOTECHNOL PROGR, V25, P1803, DOI 10.1002/btpr.265; Palmer AF, 2009, BIOTECHNOL PROGR, V25, P189, DOI 10.1002/btpr.119; Rameez S, 2012, BIOTECHNOL PROGR, V28, P636, DOI 10.1002/btpr.1532; Rameez S, 2012, MACROMOLECULES, V45, P2385, DOI 10.1021/ma202739f; Rameez S, 2011, LANGMUIR, V27, P8829, DOI 10.1021/la201246m; Sakai H, 2000, AM J PHYSIOL-HEART C, V279, pH908, DOI 10.1152/ajpheart.2000.279.3.H908; Sakai H, 2010, ADV EXP MED BIOL, V662, P433, DOI 10.1007/978-1-4419-1241-1_62; Sawicki CA, PROPERTIES T STATE H; Simoni J, 2009, ARTIF ORGANS, V33, P92, DOI 10.1111/j.1525-1594.2008.00691.x; Stamati K, 2011, J TISSUE ENG, V2, DOI 10.1177/2041731411432365; Sullivan JP, 2006, BIOTECHNOL BIOENG, V93, P306, DOI 10.1002/bit.20673; Tsai AG, 2006, BLOOD, V108, P3603, DOI 10.1182/blood-2006-02-005272; Vajpayee N., 2011, HENRYS CLIN DIAGNOSI, P509; Whitaker BI, 2011, 2009 NATL BLOOD COLL; Xu HX, 1999, PHYS REV LETT, V83, P4357, DOI 10.1103/PhysRevLett.83.4357; Zhang N, 2011, TISSUE ENG PT A, V17, P927, DOI [10.1089/ten.TEA.2010.0353, 10.1089/ten.tea.2010.0353]; Zhou Y., 2011, THESIS; Zhou YP, 2011, BIOTECHNOL PROGR, V27, P1172, DOI 10.1002/btpr.624	51	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185988	10.1371/journal.pone.0185988	http://dx.doi.org/10.1371/journal.pone.0185988			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020036	Green Submitted, gold, Green Published			2022-12-26	WOS:000412754400055
J	Kim, H; Cheang, UK; Kim, MJ				Kim, Hoyeon; Cheang, U. Kei; Kim, Min Jun			Autonomous dynamic obstacle avoidance for bacteria-powered microrobots (BPMs) with modified vector field histogram	PLOS ONE			English	Article							MAGNETIC MICROROBOTS	In order to broaden the use of microrobots in practical fields, autonomous control algorithms such as obstacle avoidance must be further developed. However, most previous studies of microrobots used manual motion control to navigate past tight spaces and obstacles while very few studies demonstrated the use of autonomous motion. In this paper, we demonstrated a dynamic obstacle avoidance algorithm for bacteria-powered microrobots (BPMs) using electric field in fluidic environments. A BPM consists of an artificial body, which is made of SU-8, and a high dense layer of harnessed bacteria. BPMs can be controlled using externally applied electric fields due to the electrokinetic property of bacteria. For developing dynamic obstacle avoidance for BPMs, a kinematic model of BPMs was utilized to prevent collision and a finite element model was used to characteristic the deformation of an electric field near the obstacle walls. In order to avoid fast moving obstacles, we modified our previously static obstacle avoidance approach using a modified vector field histogram (VFH) method. To validate the advanced algorithm in experiments, magnetically controlled moving obstacles were used to intercept the BPMs as the BPMs move from the initial position to final position. The algorithm was able to successfully guide the BPMs to reach their respective goal positions while avoiding the dynamic obstacles.	[Kim, Hoyeon; Kim, Min Jun] Southern Methodist Univ, Dept Mech Engn, Dallas, TX 75275 USA; [Cheang, U. Kei] South Univ Sci & Technol, Dept Mech Engn & Energy Engn, Shenzhen, Guangdong, Peoples R China	Southern Methodist University; Southern University of Science & Technology	Kim, MJ (corresponding author), Southern Methodist Univ, Dept Mech Engn, Dallas, TX 75275 USA.	mjkin@lyle.smu.edu	Cheang, U Kei/GWC-1944-2022	Cheang, U Kei/0000-0002-2324-6391; KIM, MINJUN/0000-0002-0819-1644	National Science Foundation (NSF) (DMR) [1306794]; National Science Foundation (NSF) (CMMI) [1712096]; Army Research Office [W911NF-11-1-0490]; Korea Evaluation Institute of Industrial Technology (KEIT) - Ministry of Trade, Industry, and Energy (MOTIE) [10052980]	National Science Foundation (NSF) (DMR)(National Science Foundation (NSF)); National Science Foundation (NSF) (CMMI)(National Science Foundation (NSF)); Army Research Office; Korea Evaluation Institute of Industrial Technology (KEIT) - Ministry of Trade, Industry, and Energy (MOTIE)	This work was funded by National Science Foundation (NSF) (DMR#1306794 and CMMI#1712096), Army Research Office (W911NF-11-1-0490), and Korea Evaluation Institute of Industrial Technology (KEIT) funded by the Ministry of Trade, Industry, and Energy (MOTIE#10052980).	Abbott JJ, 2007, IEEE ROBOT AUTOM MAG, V14, P92, DOI 10.1109/MRA.2007.380641; Behkam B, 2007, LECT NOTES ARTIF INT, V4850, P154; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BORENSTEIN J, 1991, IEEE T ROBOTIC AUTOM, V7, P278, DOI 10.1109/70.88137; Charreyron S, 2015, INT ROB SYST IROS 20; Copeland MF, 2009, SOFT MATTER, V5, P1174, DOI 10.1039/b812146j; Dauge M, 2007, SENSOR ACTUAT A-PHYS, V138, P239, DOI 10.1016/j.sna.2007.04.057; Di Leonardo R, 2010, P NATL ACAD SCI USA, V107, P9541, DOI 10.1073/pnas.0910426107; Diller E, 2013, INT J ROBOT RES, V32, P614, DOI 10.1177/0278364913483183; Fox D, 1997, IEEE ROBOT AUTOM MAG, V4, P23, DOI 10.1109/100.580977; Hassan U, 2013, 2013 TRANSD EUR 17 I; Honda T, 1996, IEEE T MAGN, V32, P5085, DOI 10.1109/20.539498; Jeong S, 2016, MED ENG PHYS; Julius AA, 2009, ROB AUT ICRA 2009 IE; Kim D, 2011, ROB AUT ICRA 2011 IE; Kim H, 2015, INT ROB SYST IROS 20; Kim H-S, 2014, BIOMED RES INT, V2014, P7, DOI DOI 10.3947/IC.2014.46.2.94; Kim H, 2016, IEEE T ROBOT, V32, P125, DOI 10.1109/TRO.2015.2504370; Kim H, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4918978; Li H, 2016, SMART MATER STRUCT, V25, DOI 10.1088/0964-1726/25/2/027001; Linder V, 2005, SMALL, V1, P730, DOI 10.1002/smll.200400159; Martel S, 2006, 2006 BIOM NAN C; MURRAY PR, 1994, ENTEROBACTERIACEAE, P227; Parmar J, 2016, SCI TECHNOL ADV MAT; Pieters R, 2015, ROB AUT ICRA 2015 IE; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Sakar MS, 2010, ROB AUT ICRA 2010 IE; Steager E, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2752721; Steager EB, 2013, INT J ROBOT RES, V32, P346, DOI 10.1177/0278364912472381; Steager EB, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/3/035001; Wong D, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824840; Yesin KB, 2006, INT J ROBOT RES, V25, P527, DOI 10.1177/0278364906065389; Zhang L, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3079655	33	3	3	7	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185744	10.1371/journal.pone.0185744	http://dx.doi.org/10.1371/journal.pone.0185744			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020016	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400043
J	Kromann, S; Kudirkiene, E; Li, LL; Thoefner, I; Daldorph, E; Christensen, JP; Meng, HC; Olsen, RH				Kromann, Sofie; Kudirkiene, Egle; Li, Lili; Thoefner, Ida; Daldorph, Elisabeth; Christensen, Jens Peter; Meng, Hecheng; Olsen, Rikke Heidemann			Treatment with high-dose antidepressants severely exacerbates the pathological outcome of experimental Escherichia coli infections in poultry	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; PHENOTHIAZINE-DERIVATIVES; ANTIBIOTIC USE; DNA-SEQUENCE; RESISTANCE; SERTRALINE; TETRACYCLINE; FLUOXETINE; PLASMID; THIORIDAZINE	There is an urgent need for novel antibiotics as the current antibiotics are losing their value due to increased resistance among clinically important bacteria. Sertraline, an on-marked anti-depressive drug, has been shown to modify bacterial activity in vitro, including increasing the susceptibility of Escherichia coli to antibiotics. The aim of the present study was to investigate if the antimicrobial activity of sertraline could be documented under clinical settings, hereunder if sertraline could potentiate the effect of tetracycline in treatment of an experimentally induced ascending infection in poultry. A total of 40 chickens were divided in four groups of 10 chickens each. All chickens were challenged with 4x10(3) colony forming units (CFU) of a tetracycline resistant E. coli strain using a surgical infection model, and subsequently treated with either high-dose sertraline, tetracycline, a combination hereof or received no treatment. Seven days post challenge all birds were submitted to necropsy and scored pathologically for lesions. The average lesion scores were significantly higher (P<0.05) in the groups that were treated with high-dose sertraline or high-dose sertraline combined with tetracycline. In conclusion high-dose treatments (four times the maximum therapeutic dose for treating human depression) with sertraline as an adjuvant for treatment of antibiotic resistant E. coli infections exacerbate the pathological outcome of infection in chickens.	[Kromann, Sofie; Kudirkiene, Egle; Thoefner, Ida; Daldorph, Elisabeth; Christensen, Jens Peter; Olsen, Rikke Heidemann] Univ Copenhagen, Dept Vet & Anim Sci, Frederiksberg, Denmark; [Li, Lili] Jinan Univ, Res Inst Food Safety & Nutr, Guangzhou, Guangdong, Peoples R China; [Meng, Hecheng] South China Univ Technol, Sch Food Sci & Engn, Guangzhou, Guangdong, Peoples R China	University of Copenhagen; Jinan University; South China University of Technology	Olsen, RH (corresponding author), Univ Copenhagen, Dept Vet & Anim Sci, Frederiksberg, Denmark.	cava@sund.ku.dk	Thøfner, Ida C. N./A-1387-2017; Kudirkiene, Egle/ABG-5736-2021	Thøfner, Ida C. N./0000-0003-2461-7024; Kromann, Sofie/0000-0001-5683-3974; Christensen, Jens Peter/0000-0002-6430-9010; Li, Lili/0000-0002-8027-0769	Danish Council of Independent Research [4184-00512]	Danish Council of Independent Research(Det Frie Forskningsrad (DFF))	This project has received funding from the Danish Council of Independent Research, grant agreement no. 4184-00512 to RHO.	Amantaa A, 2012, ANTIINFECTIVE AGENTS, V10; AMARAL L, 1991, ANTIMICROB AGENTS CH, V35, P1923, DOI 10.1128/AAC.35.9.1923; Amaral L, 2006, CURR DRUG TARGETS, V7, P887, DOI 10.2174/138945006777709539; Amita H, 2008, NEUROSCI RES, V61, pS112; Ayaz M, 2015, J BIOL RES-THESSALON, V22, DOI 10.1186/s40709-015-0028-1; Baharav E, 2012, NEUROIMMUNOMODULAT, V19, P309, DOI 10.1159/000339109; Chambers Lindsey, 2015, PLoS One, V10, pe0133764, DOI 10.1371/journal.pone.0133764; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Depoorter P, 2012, INT J FOOD MICROBIOL, V159, P30, DOI 10.1016/j.ijfoodmicro.2012.07.026; Deshpande D, 2016, ANTIMICROB AGENTS CH, V60, P4652, DOI 10.1128/AAC.02985-15; Duerschmied D, 2013, BLOOD, V121, P1008, DOI 10.1182/blood-2012-06-437392; Edgar VA, 1998, CELL SIGNAL, V10, P721, DOI 10.1016/S0898-6568(98)00016-3; EUCAST, 2015, ANT WILD TYP DISTR M; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Feltenstein MW, 2005, PSYCHOPHARMACOLOGY, V181, P153, DOI 10.1007/s00213-005-2227-1; Frick LR, 2008, BIOCHEM PHARMACOL, V75, P1817, DOI 10.1016/j.bcp.2008.01.015; Gobin V, 2014, INT IMMUNOPHARMACOL, V20, P148, DOI 10.1016/j.intimp.2014.02.030; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Graham JP, 2007, PUBLIC HEALTH REP, V122, P79, DOI 10.1177/003335490712200111; Hendricks O, 2005, BASIC CLIN PHARMACOL, V96, P33, DOI 10.1111/j.1742-7843.2005.pto960105.x; HOWELL J, 1970, CANADIAN VET J, V11, P99; Johnson TJ, 2005, ANTIMICROB AGENTS CH, V49, P4681, DOI 10.1128/AAC.49.11.4681-4688.2005; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Li LL, 2017, J ANTIBIOT, V70, P944, DOI 10.1038/ja.2017.78; Li LL, 2017, AVIAN PATHOL, V46, P300, DOI 10.1080/03079457.2016.1267857; Lillehoj HS, 1991, AVIAN CELLULAR IMMUN, P151; Liu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109158; MOLNAR J, 1977, ZBL BAKT-INT J MED M, V239, P521; MOLNAR J, 1980, ACTA MICROBIOL HUNG, V27, P309; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Olsen RH, 2016, VET MICROBIOL, V188, P59, DOI 10.1016/j.vetmic.2016.04.011; Ordway D, 2003, ANTIMICROB AGENTS CH, V47, P917, DOI 10.1128/AAC.47.3.917-922.2003; Paveenkittiporn W, 2017, DIAGN MICR INFEC DIS, V87, P157, DOI 10.1016/j.diagmicrobio.2016.11.005; Peretti S, 2000, ACTA PSYCHIAT SCAND, V101, P17, DOI 10.1111/j.1600-0447.2000.tb10944.x; Pillai SK, 2005, ANTIBIOTICS LAB MED, V5, P365; Pors SE, 2014, VET MICROBIOL, V170, P368, DOI 10.1016/j.vetmic.2014.02.043; Prestinaci F, 2015, PATHOG GLOB HEALTH, V109, P309, DOI 10.1179/2047773215Y.0000000030; Purslow C, 2013, EXPERT REV ANTI-INFE, V11, P763; Rogers MAM, 2013, J PSYCHOSOC NURS MEN, V51, P5, DOI 10.3928/02793695-20130903-01; Rogers MAM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-121; Frick LR, 2011, EUR J PHARMACOL, V659, P265, DOI 10.1016/j.ejphar.2011.03.037; Ronco T, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3415-6; Rossez Y, 2014, J BIOL CHEM, V289, P34349, DOI 10.1074/jbc.M114.587717; Roumestan C, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-35; Schnappinger D, 1996, ARCH MICROBIOL, V165, P359, DOI 10.1007/s002030050339; SETO F, 1981, POULTRY SCI, V60, P1981, DOI 10.3382/ps.0601981; Singer RS, 2006, AVIAN DIS, V50, P161, DOI 10.1637/7569-033106R.1; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; Skyberg JA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-24; Stevens Alan, 1996, P99; Stoute ST, 2009, J VET DIAGN INVEST, V21, P554, DOI 10.1177/104063870902100424; Taler M, 2007, EUR NEUROPSYCHOPHARM, V17, P774, DOI 10.1016/j.euroneuro.2007.03.010; Taler M, 2011, NEUROIMMUNOMODULAT, V18, P117, DOI 10.1159/000321634; Taragano F, 1999, Ann Clin Psychiatry, V11, P67; Tenover F C, 1995, J Intraven Nurs, V18, P297; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandevelde NM, 2016, DRUG DISCOV TODAY, V21, P1114, DOI 10.1016/j.drudis.2016.04.001; Viveiros M, 2005, ANTIMICROB AGENTS CH, V49, P3578, DOI 10.1128/AAC.49.8.3578-3582.2005; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3	61	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185914	10.1371/journal.pone.0185914	http://dx.doi.org/10.1371/journal.pone.0185914			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020098	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400049
J	Leitman, EM; Palmer, CD; Buus, S; Chen, F; Riddell, L; Sims, S; Klenerman, P; Saez-Cirion, A; Walker, BD; Hess, PR; Altfeld, M; Matthews, PC; Goulder, PJR				Leitman, Ellen M.; Palmer, Christine D.; Buus, Soren; Chen, Fabian; Riddell, Lynn; Sims, Stuart; Klenerman, Paul; Saez-Cirion, Asier; Walker, Bruce D.; Hess, Paul R.; Altfeld, Marcus; Matthews, Philippa C.; Goulder, Philip J. R.			Saporin-conjugated tetramers identify efficacious anti-HIV CD8+T-cell specificities	PLOS ONE			English	Article							T-CELL RESPONSES; CLASS-I TETRAMERS; PEPTIDE TETRAMERS; ESCAPE VARIANTS; MHC TETRAMERS; CTL RESPONSES; INFECTION; DELETION; VIREMIA; HLA	Antigen-specific T-cells are highly variable, spanning potent antiviral efficacy and damaging auto-reactivity. In virus infections, identifying the most efficacious responses is critical to vaccine design. However, current methods depend on indirect measures or on ex vivo expanded CTL clones. We here describe a novel application of cytotoxic saporin-conjugated tetramers to kill antigen-specific T-cells without significant off-target effects. The relative efficacy of distinct antiviral CD8+ T-cell specificity can be directly assessed via antigen-specific CD8+ T-cell depletion. The utility of these reagents is demonstrated here in identifying the CD8+ T-cell specificity most effective in preventing HIV progression in HIV-infected HLA-B*27-positive immune controllers.	[Leitman, Ellen M.; Goulder, Philip J. R.] Univ Oxford, Dept Paediat, Oxford, England; [Leitman, Ellen M.; Walker, Bruce D.; Altfeld, Marcus] Harvard Med Sch, Boston, MA USA; [Palmer, Christine D.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Buus, Soren] Univ Copenhagen, Fac Hlth Sci, Lab Expt Immunol, Copenhagen, Denmark; [Chen, Fabian] Royal Berkshire Hosp, Dept Sexual Hlth, Reading, Berks, England; [Riddell, Lynn] Northamptonshire Healthcare NHS Trust, Integrated Sexual Hlth Serv, Northampton, England; [Sims, Stuart] Univ Zurich, Inst Virol, Zurich, Switzerland; [Klenerman, Paul] Univ Oxford, John Radcliffe Hosp, NIHR Biomed Res Ctr, Oxford, England; [Klenerman, Paul] Univ Oxford, Nuffield Dept Med, Oxford, England; [Saez-Cirion, Asier] Inst Pasteur, Unite HIV Inflammat & Persistance, Paris, France; [Walker, Bruce D.; Goulder, Philip J. R.] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Hess, Paul R.] North Carolina State Univ, Coll Vet Med, Immunol Program, Raleigh, NC USA; [Altfeld, Marcus] Heinrich Pette Inst, Virus Immunol Unit, Hamburg, Germany; [Matthews, Philippa C.] John Radcliffe Hosp, Oxford Univ Hosp NHS Fdn Trust, Dept Infect Dis & Microbiol, Oxford, England	University of Oxford; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Copenhagen; Royal Berkshire Hospital; University of Zurich; University of Oxford; University of Oxford; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Kwazulu Natal; University of North Carolina; North Carolina State University; Heinrich Pette Institute; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Goulder, PJR (corresponding author), Univ Oxford, Dept Paediat, Oxford, England.; Goulder, PJR (corresponding author), Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa.	Philip.goulder@paediatrics.ox.ac.uk	Altfeld, Marcus/AAE-7306-2019; Saez-Cirion, Asier/A-8640-2008; Matthews, Philippa/P-7810-2019; Palmer, Christine/GXH-4415-2022	Altfeld, Marcus/0000-0001-5972-2997; Saez-Cirion, Asier/0000-0003-2406-7536; Matthews, Philippa/0000-0002-4036-4269; sims, stuart/0000-0002-6327-0927; klenerman, paul/0000-0003-4307-9161; Palmer, Christine Denise/0000-0003-3213-0398	National Institutes of Health [RO1AI46995]; Wellcome Trust [WT104748MA]; NIHR; Clarendon Fund; National Institute for Health Research [NF-SI-0515-10005, CL-2011-13-005] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR(National Institute for Health Research (NIHR)); Clarendon Fund; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants from the National Institutes of Health (RO1AI46995 to P.G.), the Wellcome Trust (WT104748MA to P.G.), NIHR research capability funding (to P.C.M.) and the Clarendon Fund (to E.L.).; This work was funded by grants from the National Institutes of Health (RO1AI46995 to P. G.), the Wellcome Trust (WT104748MA to P.G.), NIHR research capability funding (to PCM) and the Clarendon Fund (to E.L.).	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Altfeld M, 2001, J IMMUNOL, V167, P2743, DOI 10.4049/jimmunol.167.5.2743; Altfeld MA, 2000, J VIROL, V74, P8541, DOI 10.1128/JVI.74.18.8541-8549.2000; Altman J.D., 2003, CURR PROTOC IMMUNOL; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Cano P, 2007, HUM IMMUNOL, V68, P392, DOI 10.1016/j.humimm.2007.01.014; Carlson JM, 2012, J VIROL, V86, P13202, DOI 10.1128/JVI.01998-12; Chen H, 2009, J VIROL, V83, P3138, DOI 10.1128/JVI.02073-08; CLARK BR, 1994, J BIOL CHEM, V269, P94; Drake DR, 2005, J IMMUNOL, V175, P1507, DOI 10.4049/jimmunol.175.3.1507; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Hess PR, 2007, BLOOD, V109, P3300, DOI 10.1182/blood-2006-06-028001; Hess SM, 2013, TRANSPL IMMUNOL, V29, P138, DOI 10.1016/j.trim.2013.10.005; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jones N, 2003, J IMMUNOL METHODS, V274, P139, DOI 10.1016/S0022-1759(02)00510-0; Kappel BJ, 2006, BLOOD, V107, P2045, DOI 10.1182/blood-2005-07-2828; Keenan RD, 2001, BRIT J HAEMATOL, V115, P428, DOI 10.1046/j.1365-2141.2001.03106.x; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Ladell K, 2013, IMMUNITY, V38, P425, DOI 10.1016/j.immuni.2012.11.021; Leisner C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001678; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Payne RP, 2010, J VIROL, V84, P10543, DOI 10.1128/JVI.00793-10; Penaloza-MacMaster P, 2009, IMMUNOLOGY, V128, P164, DOI 10.1111/j.1365-2567.2009.03080.x; Saez-Cirion A, 2010, NAT PROTOC, V5, P1033, DOI 10.1038/nprot.2010.73; Schutz C, 2010, IMMUNOTHERAPY-UK, V2, P539, DOI 10.2217/IMT.10.26; Sims S, 2015, EUR J IMMUNOL, V45, P113, DOI 10.1002/eji.201445016; Sims S, 2010, EXPERT REV VACCINES, V9, P765, DOI 10.1586/ERV.10.66; Streeck H, 2014, J VIROL, V88, P12793, DOI 10.1128/JVI.02016-14; van Bockel DJ, 2011, J IMMUNOL, V186, P359, DOI 10.4049/jimmunol.1001807; Vincent BG, 2010, J IMMUNOL, V184, P4196, DOI 10.4049/jimmunol.0903931; Whelan JA, 1999, J IMMUNOL, V163, P4342; WONG JT, 1987, J IMMUNOL, V139, P1369; Yuan RR, 2004, BLOOD, V104, P2397, DOI 10.1182/blood-2004-01-0324	35	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0184496	10.1371/journal.pone.0184496	http://dx.doi.org/10.1371/journal.pone.0184496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020090	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000412754400013
J	Zhao, CY; Nabity, PD				Zhao, Chaoyang; Nabity, Paul D.			Phylloxerids share ancestral carotenoid biosynthesis genes of fungal origin with aphids and adelgids	PLOS ONE			English	Article							GALL-FORMATION; BACTERIA; GENOME; EVOLUTION; SEQUENCE; INSIGHTS; PEST	Gene transfer among reproductively isolated organisms can lead to novel phenotypes and increased fitness. Among the Sternorrhyncha, a suborder of plant sap-feeding hemipteran insects, both aphids and adelgids acquired carotenoid biosynthesis genes from a fungal donor that result in ecologically relevant pigmentation. Phylloxerids form another family that are closely related to aphids and adelgids and share similar pigmentation, but are largely uncharacterized for their presence and number of pigment genes that have duplicated among aphids. Here, we examined the transcriptomes of nine phylloxerid species, and performed PCR to amplify carotenoid genes from their genomic DNA. We identified carotenoid cyclase/synthase and desaturase genes in each species and demonstrated that they share the common fungal origin as those of aphids and adelgids based on their exon-intron gene structures and phylogenetic relationships. The phylogenetic analyses also indicated that carotenoid genes evolved following the differentiation of aphids, adelgids, and phylloxerids at the levels of family, genus, and species. Unlike aphids that duplicated these genes in their genomes, phylloxerids maintained only single copies, and some species may lack expression of certain genes. These results suggest that the phylloxerid lifestyle undergoes reduced selection pressure to expand carotenoid synthesis genes, and provides insight into these gene functions in insects.	[Zhao, Chaoyang; Nabity, Paul D.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Nabity, PD (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	pauln@ucr.edu		Nabity, Paul/0000-0001-5430-5748	Washington State University; University of California, Riverside	Washington State University; University of California, Riverside(University of California System)	Funds from Washington State University and University of California, Riverside were used to support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna R, 2012, P NATL ACAD SCI USA, V109, P4197, DOI 10.1073/pnas.1121190109; Altincicek B, 2012, BIOL LETTERS, V8, P253, DOI 10.1098/rsbl.2011.0704; Benoit JB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10165; Blackman R.L., 2000, APHIDS WORLDS CROPS, V2nd; Blum MS, COMP INSECT PHYSL BI, P193; Byron A, 2017, P NATL ACAD SCI, V114; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cobbs C, 2013, MOL PHYLOGENET EVOL, V68, P221, DOI 10.1016/j.ympev.2013.03.012; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Edge R, 1997, J PHOTOCH PHOTOBIO B, V41, P189, DOI 10.1016/S1011-1344(97)00092-4; Gaupels F, 2012, PHLOEM MOL CELL BIOL, P227, DOI DOI 10.1002/9781118382806.CH11; Hirschberg J, 1997, PURE APPL CHEM, V69, P2151, DOI 10.1351/pac199769102151; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Husnik F, 2013, CELL, V153, P1567, DOI 10.1016/j.cell.2013.05.040; Kanost MR, 2016, INSECT BIOCHEM MOLEC, V76, P118, DOI 10.1016/j.ibmb.2016.07.005; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeling CI, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r27; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Luan JB, 2015, GENOME BIOL EVOL, V7, P2635, DOI 10.1093/gbe/evv170; McKenna DD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1088-8; Mifsud David, 2010, BioRisk, V4, P511; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Nabity PD, 2016, AM J BOT, V103, P979, DOI 10.3732/ajb.1600111; Nabity PD, 2013, P NATL ACAD SCI USA, V110, P16663, DOI 10.1073/pnas.1220219110; Novakova E, 2012, MOL BIOL EVOL, V29, P313, DOI 10.1093/molbev/msr206; Pauchet Y, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1021; Shelomi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26388; Sloan DB, 2014, MOL BIOL EVOL, V31, P857, DOI 10.1093/molbev/msu004; Sloan DB, 2012, BIOL LETTERS, V8, P986, DOI 10.1098/rsbl.2012.0664; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terrapon N, 2014, NATURE COMMUNICATION, P5; van Bell AJE, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01840; Vershinin A, 1999, BIOFACTORS, V10, P99, DOI 10.1002/biof.5520100203; von Wintersdorff CJH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00173; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wybouw N, 2016, GENOME BIOL EVOL, V8, P1785, DOI 10.1093/gbe/evw119; Zhao C, 2014, INSECT MOL BIOL, V23, P821, DOI 10.1111/imb.12127; Zhao CY, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1000-5; Zhao CY, 2015, CURR BIOL, V25, P613, DOI 10.1016/j.cub.2014.12.057; Zhu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-248	40	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185484	10.1371/journal.pone.0185484	http://dx.doi.org/10.1371/journal.pone.0185484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020073	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400033
J	Leapman, MS; Westphalen, AC; Ameli, N; Lawrence, HJ; Febbo, PG; Cooperberg, MR; Carroll, PR				Leapman, Michael S.; Westphalen, Antonio C.; Ameli, Niloufar; Lawrence, H. Jeffrey; Febbo, Phillip G.; Cooperberg, Matthew R.; Carroll, Peter R.			Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa)	PLOS ONE			English	Article							ULTRASOUND-GUIDED BIOPSY; RADICAL PROSTATECTOMY; ACTIVE SURVEILLANCE; OUTCOMES; AGGRESSIVENESS; RECURRENCE	Background We aimed to directly compare results from multi-parametric prostate MRI (mpMRI) and a biopsy-based 17-gene RT-PCR assay providing a Genomic Prostate Score (GPS) among individuals who were candidates for active surveillance with low and intermediate risk prostate cancer (PCa). Patients and methods We evaluated the association between GPS results (scale 0-100) and endorectal mpMRI findings in men with clinically localized PCa. MR studies were reviewed to a five-tier scale of increasing suspicion of malignancy. Mean apparent diffusion coefficient (ADC) was calculated from a single dominant lesion. Mean rank of the GPS (0-100) among MRI strata was compared with the Kruskal-Wallis test and Dunn's multiple comparison test. Spearman's correlation was performed to examine the association between mean ADC and scaled GPS. Results Of 186 patients who received GPS testing, 100 were identified who received mpMRI. Mean GPS results differed between mpMRI categories (p = 0.001); however a broad range was observed in all mpMRI categories. Among men with biopsy Gleason pattern 3+3, mean GPS results were not significantly different among MRI groups (p = 0.179), but GPS differences were seen among MRI categories for patients with pattern 3+4 (p = 0.010). Mean ADC was weakly associated with GPS (sigma = -0.151). Stromal response (p = 0.015) and cellular organization (p = 0.045) gene group scores differed significantly by MRI findings, but no differences were seen among androgen signaling or proliferation genes. Conclusions Although a statistically significant association was observed between GPS results and MRI scores, a wide range of GPS values were observed across imaging categories suggesting that mpMRI and genomic profiling may offer non-overlapping clinical insights.	[Leapman, Michael S.; Cooperberg, Matthew R.] Yale Univ, Sch Med, Dept Urol, New Haven, CT 06520 USA; [Leapman, Michael S.; Ameli, Niloufar; Carroll, Peter R.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Westphalen, Antonio C.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Lawrence, H. Jeffrey; Febbo, Phillip G.] Genom Hlth Inc, Redwood City, CA USA; [Cooperberg, Matthew R.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Genomic Health; University of California System; University of California San Francisco	Leapman, MS (corresponding author), Yale Univ, Sch Med, Dept Urol, New Haven, CT 06520 USA.; Leapman, MS (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.	michael.leapman@yale.edu	Cooperberg, Matthew R/G-6249-2017	Cooperberg, Matthew R/0000-0003-4339-6685	Genomic Health Inc.	Genomic Health Inc.	The authors H. Jeffrey Lawrence, MD (HJL) and Phillip Febbo, MD (PF) are full-time employees of Genomic Health Inc, Redwood City, CA. PF and HJL reviewed the manuscript prior to submission. Genomic Health Inc. did not play a role in the study design, data collection, analysis, decision to publish, and only provided financial support in the form of the authors' salaries. The specific roles of these authors are articulated in the `author contributions' section.	Abd-Alazeez M, 2014, UROL ONCOL-SEMIN ORI, V32, P741, DOI 10.1016/j.urolonc.2014.01.008; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Bishoff JT, 2014, J UROLOGY, V192, P409, DOI 10.1016/j.juro.2014.02.003; Brand TC, 2016, UROLOGY, V89, P69, DOI 10.1016/j.urology.2015.12.008; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; Cullen J, 2014, EUR UROL; Cullen J, 2015, EUR UROL, V68, P123, DOI 10.1016/j.eururo.2014.11.030; Dianat SS, 2015, UROLOGY, V85, P147, DOI 10.1016/j.urology.2014.06.085; Donati OF, 2014, RADIOLOGY, V271, P143, DOI 10.1148/radiol.13130973; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Filson CP, 2016, CANCER-AM CANCER SOC, V122, P884, DOI 10.1002/cncr.29874; Flavell RR, 2014, ABDOM IMAGING, V39, P1027, DOI 10.1007/s00261-014-0136-7; Gondo T, 2014, EUR RADIOL, V24, P3161, DOI 10.1007/s00330-014-3367-7; Gupta RT, 2014, UROL ONCOL-SEMIN ORI, V32, P1292, DOI 10.1016/j.urolonc.2014.04.017; Inoue LYT, 2014, STAT MED, V33, P930, DOI 10.1002/sim.6003; Klein EA, 2014, EUR UROL, V66, P550, DOI 10.1016/j.eururo.2014.05.004; Klotz L, 2015, J CLIN ONCOL, V33, P272, DOI 10.1200/JCO.2014.55.1192; Knezevic D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-690; Morlacco A, 2017, EUR UROL, V71, P701, DOI 10.1016/j.eururo.2016.08.015; Park JJ, 2014, AM J ROENTGENOL, V202, pW459, DOI 10.2214/AJR.13.11381; Pickles MD, 2006, J MAGN RESON IMAGING, V23, P130, DOI 10.1002/jmri.20477; Pokorny MR, 2014, EUR UROL, V66, P22, DOI 10.1016/j.eururo.2014.03.002; Renard-Penna R, 2015, J UROL; Salami SS, 2014, CANCER-AM CANCER SOC, V120, P2876, DOI 10.1002/cncr.28790; Shariat SF, 2008, CLIN CANCER RES, V14, P4400, DOI 10.1158/1078-0432.CCR-07-4713; Siddiqui MM, 2015, JAMA-J AM MED ASSOC, V313, P390, DOI 10.1001/jama.2014.17942; Somford DM, 2013, J UROLOGY, V190, P1728, DOI 10.1016/j.juro.2013.05.021; Stoyanova R., 2016, ONCOTARGET; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003	30	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185535	10.1371/journal.pone.0185535	http://dx.doi.org/10.1371/journal.pone.0185535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016610	gold, Green Published, Green Submitted			2022-12-26	WOS:000412627400022
J	Mosconi, L; Berti, V; Guyara-Quinn, C; McHugh, P; Petrongolo, G; Osorio, RS; Connaughty, C; Pupi, A; Vallabhajosula, S; Isaacson, RS; de Leon, MJ; Swerdlow, RH; Brinton, RD				Mosconi, Lisa; Berti, Valentina; Guyara-Quinn, Crystal; McHugh, Pauline; Petrongolo, Gabriella; Osorio, Ricardo S.; Connaughty, Christopher; Pupi, Alberto; Vallabhajosula, Shankar; Isaacson, Richard S.; de Leon, Mony J.; Swerdlow, Russell H.; Brinton, Roberta Diaz			Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery	PLOS ONE			English	Article							CYTOCHROME-OXIDASE; COGNITIVE DECLINE; NORMAL INDIVIDUALS; APOLIPOPROTEIN-E; FAMILY-HISTORY; DISEASE; PET; TRANSITION; MODEL; AGE	After advanced age, female sex is the major risk factor for Alzheimer's disease (AD). The biological mechanisms underlying the increased AD risk in women remain largely undetermined. Preclinical studies identified the perimenopause to menopause transition, a neuroendocrine transition state unique to the female, as a sex-specific risk factor for AD. In animals, estrogenic regulation of cerebral glucose metabolism (CMRglc) falters during perimenopause. This is evident in glucose hypometabolism and decline in mitochondrial efficiency which is sustained thereafter. This study bridges basic to clinical science to characterize brain bioenergetics in a cohort of forty-three, 40-60 year-old clinically and cognitively normal women at different endocrine transition stages including premenopause (controls, CNT, n = 15), perimenopause (PERI, n = 14) and postmenopause (MENO, n = 14). All participants received clinical, laboratory and neuropsychological examinations, F-18-fluoro-deoxyglucose (FDG)Positron Emission Tomography (PET) FDG-PET scans to estimate CMRglc, and platelet mitochondrial cytochrome oxidase (COX) activity measures. Statistical parametric mapping and multiple regression models were used to examine clinical, CMRglc and COX data across groups. As expected, the MENO group was older than PERI and controls. Groups were otherwise comparable for clinical measures and distribution of APOE4 genotype. Both MENO and PERI groups exhibited reduced CMRglc in AD-vulnerable regions which was correlated with decline in mitochondrial COX activity compared to CNT (p's<0.001). A gradient in biomarker abnormalities was most pronounced in MENO, intermediate in PERI, and lowest in CNT (p<0.001). Biomarkers correlated with immediate and delayed memory scores (Pearson's 0.26 <= r <= 0.32, p <= 0.05). These findings validate earlier preclinical findings and indicate emergence of bioenergetic deficits in perimenopausal and postmenopausal women, suggesting that the optimal window of opportunity for therapeutic intervention in women is early in the endocrine aging process.	[Mosconi, Lisa; Isaacson, Richard S.] Weill Cornell Med Coll, Dept Neurol, New York, NY 10065 USA; [Mosconi, Lisa; Guyara-Quinn, Crystal; McHugh, Pauline; Petrongolo, Gabriella; Osorio, Ricardo S.; Connaughty, Christopher; de Leon, Mony J.] NYU, Sch Med, Dept Psychiat, New York, NY 10003 USA; [Berti, Valentina; Pupi, Alberto] Univ Florence, Nucl Med Unit, Dept Clin Pathophysiol, Florence, Italy; [Vallabhajosula, Shankar] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Swerdlow, Russell H.] Univ Kansas, Sch Med, Dept Neurol, Kansas City, KS USA; [Brinton, Roberta Diaz] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA; [Brinton, Roberta Diaz] Univ Arizona, Coll Med, Dept Neurol, Tucson, AZ USA	Cornell University; New York University; University of Florence; Cornell University; University of Kansas; University of Kansas Medical Center; University of Arizona; University of Arizona	Mosconi, L (corresponding author), Weill Cornell Med Coll, Dept Neurol, New York, NY 10065 USA.; Mosconi, L (corresponding author), NYU, Sch Med, Dept Psychiat, New York, NY 10003 USA.	lim2035@med.cornell.edu	Berti, Valentina/AAB-7426-2019; de Leon, Mony/AAP-7890-2021	de Leon, Mony/0000-0003-2245-4380; Osorio, Ricardo/0000-0002-2735-9609	National Institute of Health/National Institute on Aging (NIH/NIA) [AG035137, P01AG026572, AG13616, P30 AG035982]; Dept. of Neurology at Weill Cornell Medical College; NATIONAL INSTITUTE ON AGING [R01AG022374, P30AG035982, P30AG008051, P01AG026572] Funding Source: NIH RePORTER	National Institute of Health/National Institute on Aging (NIH/NIA); Dept. of Neurology at Weill Cornell Medical College; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institute of Health/National Institute on Aging (NIH/NIA) grants AG035137 to LM, P01AG026572 to RDB, AG13616 to MJdL, and P30 AG035982 to RHS; funding from the Dept. of Neurology at Weill Cornell Medical College; and philanthropic support to the Alzheimer's Prevention Clinic, Weill Cornell Memory Disorders Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Benzinger TLS, 2013, P NATL ACAD SCI USA, V110, pE4502, DOI 10.1073/pnas.1317918110; Berti V, 2014, PET CLIN, V9, P129, DOI 10.1016/j.cpet.2013.10.006; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bove R, 2014, NEUROLOGY, V82, P222, DOI 10.1212/WNL.0000000000000033; Brinton RD, 2015, NAT REV ENDOCRINOL, V11, P393, DOI 10.1038/nrendo.2015.82; Brinton RD, 2009, TRENDS PHARMACOL SCI, V30, P212, DOI 10.1016/j.tips.2008.12.006; Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; De Santi S, 2008, NEUROPSYCHOLOGY, V22, P469, DOI 10.1037/0894-4105.22.4.469; Ding F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079977; Espeland MA, 2015, NEUROLOGY, V85, P1131, DOI 10.1212/WNL.0000000000001816; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; GABUZDA D, 1994, J BIOL CHEM, V269, P13623; Greendale GA, 2011, OBSTET GYN CLIN N AM, V38, P519, DOI 10.1016/j.ogc.2011.05.007; Harlow SD, 2012, MENOPAUSE, V19, P387, DOI 10.1097/gme.0b013e31824d8f40; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Hodis HN, 2015, MENOPAUSE, V22, P391, DOI [10.1097/GME.0000000000000343, 10.1097/gme.0000000000000343]; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Joshi A, 2009, NEUROIMAGE, V46, P154, DOI 10.1016/j.neuroimage.2009.01.057; KAMPEN DL, 1994, OBSTET GYNECOL, V83, P979, DOI 10.1097/00006250-199406000-00017; Kanazawa M, 2017, J NUCL MED, V58, P1111, DOI 10.2967/jnumed.116.189159; KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Maki PM, 2000, NEUROBIOL AGING, V21, P373, DOI 10.1016/S0197-4580(00)00123-8; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014; Mosconi L, 2011, Q J NUCL MED MOL IM, V55, P250; Mosconi L, 2009, NEUROLOGY, V72, P513, DOI 10.1212/01.wnl.0000333247.51383.43; Mosconi L, 2008, NEUROBIOL AGING, V29, P676, DOI 10.1016/j.neurobiolaging.2006.12.008; Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385; Mosconi L, 2007, P NATL ACAD SCI USA, V104, P19067, DOI 10.1073/pnas.0705036104; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Mosconi L, 2014, NEUROLOGY, V82, P752, DOI 10.1212/WNL.0000000000000181; Mosconi L, 2011, J ALZHEIMERS DIS, V27, P483, DOI 10.3233/JAD-2011-110866; Mosconi L, 2010, P NATL ACAD SCI USA, V107, P5949, DOI 10.1073/pnas.0914141107; PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302; Rasgon NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089095; Rasgon NL, 2011, NEUROBIOL AGING, V32, P1942, DOI 10.1016/j.neurobiolaging.2009.12.005; Reiman EM, 2001, P NATL ACAD SCI USA, V98, P3334, DOI 10.1073/pnas.061509598; Rentz DM, 2016, MENOPAUSE; Rettberg JR, 2016, NEUROBIOL AGING, V40, P155, DOI 10.1016/j.neurobiolaging.2016.01.011; Santoro N, 2011, OBSTET GYN CLIN N AM, V38, pXVII, DOI 10.1016/j.ogc.2011.07.002; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Silverman DHS, 2011, PSYCHONEUROENDOCRINO, V36, P502, DOI 10.1016/j.psyneuen.2010.08.002; Sperling RA, 2013, NAT REV NEUROL, V9, P54, DOI 10.1038/nrneurol.2012.241; Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918; Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339; Ungar L, 2014, BRAIN IMAGING BEHAV, V8, P262, DOI 10.1007/s11682-013-9272-x; Valla J, 2010, J ALZHEIMERS DIS, V22, P307, DOI 10.3233/JAD-2010-100129; Vina J, 2010, J ALZHEIMERS DIS, V20, pS527, DOI 10.3233/JAD-2010-100501; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Yao J, 2012, ADV PHARMACOL, V64, P327, DOI 10.1016/B978-0-12-394816-8.00010-6; Yao J, 2012, NEUROBIOL AGING, V33, P1507, DOI 10.1016/j.neurobiolaging.2011.03.001; Yao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021788; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yin F, 2015, NEUROBIOL AGING, V36, P2282, DOI 10.1016/j.neurobiolaging.2015.03.013	59	74	74	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185926	10.1371/journal.pone.0185926	http://dx.doi.org/10.1371/journal.pone.0185926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016679	Green Published, Green Submitted, gold			2022-12-26	WOS:000412627400038
J	Sen, S; Sanyal, S; Srivastava, DK; Dasgupta, D; Roy, S; Das, C				Sen, Sabyasachi; Sanyal, Sulagna; Srivastava, Dushyant Kumar; Dasgupta, Dipak; Roy, Siddhartha; Das, Chandrima			Transcription factor 19 interacts with histone 3 lysine 4 trimethylation and controls gluconeogenesis via the nucleosome-remodeling-deacetylase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene transcription; gluconeogenesis; glucose metabolism; histone modification; nucleosome remodeling deacetylase (NuRD); PHD finger; transcription factor; transcription repressor; histone H3 lysine 4 trimethylation; histone deacetylation	LARGE GENE LISTS; PHD FINGER; HEPATIC GLUCONEOGENESIS; DIABETES-MELLITUS; DRUG-METABOLISM; CELL-LINES; GLUCOSE; PROTEIN; METHYLATION; INSULIN	Transcription factor 19 (TCF19) has been reported as a type 1 diabetes-associated locus involved in maintenance of pancreatic cells through a fine-tuned regulation of cell proliferation and apoptosis. TCF19 also exhibits genomic association with type 2 diabetes, although the precise molecular mechanism remains unknown. It harbors both a plant homeodomain and a forkhead-associated domain implicated in epigenetic recognition and gene regulation, a phenomenon that has remained unexplored. Here, we show that TCF19 selectively interacts with histone 3 lysine 4 trimethylation through its plant homeodomain finger. Knocking down TCF19 under high-glucose conditions affected many metabolic processes, including gluconeogenesis. We found that TCF19 overexpression represses de novo glucose production in HepG2 cells. The transcriptional repression of key genes, induced by TCF19, coincided with NuRD (nucleosome-remodeling-deacetylase) complex recruitment to the promoters of these genes. TCF19 interacted with CHD4 (chromodomain helicase DNA-binding protein 4), which is a part of the NuRD complex, in a glucose concentration-independent manner. In summary, our results show that TCF19 interacts with an active transcription mark and recruits a co-repressor complex to regulate gluconeogenic gene expression in HepG2 cells. Our study offers critical insights into the molecular mechanisms of transcriptional regulation of gluconeogenesis and into the roles of chromatin readers in metabolic homeostasis.	[Sen, Sabyasachi; Sanyal, Sulagna; Dasgupta, Dipak; Das, Chandrima] Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1-AF Bidhannagar, Kolkata 700064, India; [Srivastava, Dushyant Kumar; Roy, Siddhartha] CSIR Indian Inst Chem Biol, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India	Saha Institute of Nuclear Physics; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Das, C (corresponding author), Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1-AF Bidhannagar, Kolkata 700064, India.	chandrima.das@saha.ac.in	Das, Chandrima/AAI-7398-2021	Das, Chandrima/0000-0002-8117-2810	Department of Atomic Energy (DAE), Government of India [12-RD-SIN-5.04-0103]	Department of Atomic Energy (DAE), Government of India(Department of Atomic Energy (DAE))	This work was supported by a research grant entitled Biomolecular Assembly, Recognition and Dynamics (BARD) (Grant 12-R&D-SIN-5.04-0103) from the Department of Atomic Energy (DAE), Government of India (to C. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Adhikary S, 2016, J BIOL CHEM, V291, P2664, DOI 10.1074/jbc.M115.679985; Alqarni SSM, 2014, J BIOL CHEM, V289, P21844, DOI 10.1074/jbc.M114.558940; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boden G, 2001, AM J PHYSIOL-ENDOC M, V280, pE23, DOI 10.1152/ajpendo.2001.280.1.E23; Chakrabarti S, 1998, BIOCHEM PHARMACOL, V56, P1471, DOI 10.1016/S0006-2952(98)00249-4; Chalkiadaki A, 2011, EMBO REP, V12, P985, DOI 10.1038/embor.2011.179; Cheung YH, 2011, HUM GENET, V129, P161, DOI 10.1007/s00439-010-0908-2; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Donohoe DR, 2012, J CELL PHYSIOL, V227, P3169, DOI 10.1002/jcp.24054; Dreveny I, 2014, NUCLEIC ACIDS RES, V42, P822, DOI 10.1093/nar/gkt931; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Gray ST, 2005, DIABETES-METAB RES, V21, P416, DOI 10.1002/dmrr.559; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Harder MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120890; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Howe FS, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600095; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jufvas A, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-15; Kanebratt KP, 2008, DRUG METAB DISPOS, V36, P1444, DOI 10.1124/dmd.107.020016; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Kirchner H, 2013, TRENDS CELL BIOL, V23, P203, DOI 10.1016/j.tcb.2012.11.008; Krautkramer KA, 2013, AM J PHYSIOL-ENDOC M, V305, pE600, DOI 10.1152/ajpendo.00147.2013; KU DH, 1991, CELL GROWTH DIFFER, V2, P179; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lerner RG, 2009, EMBO REP, V10, P1175, DOI 10.1038/embor.2009.177; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Marion MJ, 2010, METHODS MOL BIOL, V640, P261, DOI 10.1007/978-1-60761-688-7_13; Mews P, 2014, MOL CELL BIOL, V34, P3968, DOI 10.1128/MCB.00763-14; Nair AK, 2014, DIABETOLOGIA, V57, P2334, DOI 10.1007/s00125-014-3351-4; Nibourg GAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038778; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Pan DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066294; Ravnskjaer K, 2013, J CLIN INVEST, V123, P4318, DOI 10.1172/JCI69035; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Saha SK, 2014, NATURE, V513, P110, DOI 10.1038/nature13441; Samanez CH, 2012, ARCH PHYSIOL BIOCHEM, V118, P102, DOI 10.3109/13813455.2012.683442; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Singh BK, 2013, J BIOL CHEM, V288, P30365, DOI 10.1074/jbc.M113.504845; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trape AP, 2012, MOL CANCER THER, V11, P464, DOI 10.1158/1535-7163.MCT-11-0033; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Vidal-Puig A, 2001, NATURE, V413, P125, DOI 10.1038/35093198; Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503; Winkler R, 2012, DIABETES, V61, P513, DOI 10.2337/db11-0313; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Zhan XM, 2011, P NATL ACAD SCI USA, V108, P12758, DOI 10.1073/pnas.1018510108; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057	61	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20362	20378		10.1074/jbc.M117.786863	http://dx.doi.org/10.1074/jbc.M117.786863			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29042441	Green Published, hybrid			2022-12-26	WOS:000418267000002
J	Mendez, V; McGinley, RH; Taylor, PW				Mendez, Vivian; McGinley, Rowan H.; Taylor, Phillip W.			Mating-induced sexual inhibition in the jumping spider Servaea incana (Araneae: Salticidae): A fast-acting and long-lasting effect	PLOS ONE			English	Article							PHIDIPPUS-JOHNSONI ARANEAE; MAEVIA-INCLEMENS ARANEAE; LEUCAUGE-MARIANA ARANEAE; AGELENA-LIMBATA ARANEAE; MALE-MALE COMPETITION; MATE CHOICE; FEMALE RECEPTIVITY; COURTSHIP BEHAVIOR; SPERM COMPETITION; NEPHILA-CLAVIPES	Mating- induced sexual inhibition has been studied extensively as an important facet of many insect mating systems but remains little understood in spiders. Once mated, females of many spider species become unreceptive and aggressive toward males, but the speed of onset and persistence of this effect are not known. Addressing this gap, the present study considers (1) mating tendency of virgins, latency to remating, and lifetime mating frequency and (2) how quickly sexual inhibition is expressed after the first mating in female Servaea incana jumping spiders. Encounters between males and females took place in two contexts that simulated locations where mating occurs in nature: in the light away from nests (` in the open') and in low light within the shelter of silken retreats ('at a retreat'). Virgin females exhibited high receptivity levels in both contexts but sexual inhibition was induced immediately after their first copulation. The most common tendency was for just one mating in a lifetime, and few females mated more than twice. Context also had an effect on female mating tendency, as virgin females in the open rejected more males before accepting their first mate than did virgin females in retreats. Considering only those females that did remate, females in the open tended to reject fewer males before remating. Given low levels of female remating, virgin females appear to be at a premium for male reproductive fitness in S. incana jumping spiders and this is a likely explanation for protandry found in nature.	[Mendez, Vivian; McGinley, Rowan H.; Taylor, Phillip W.] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia	Macquarie University	Mendez, V (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia.	vmendez17@gmail.com	Taylor, Phillip W/E-4620-2011; McGinley, Rowan/I-4915-2015	Taylor, Phillip W/0000-0002-7574-7737; McGinley, Rowan/0000-0003-3593-4754	Macquarie University Research Excellence Scholarship; Australian Postgraduate Award Scholarship	Macquarie University Research Excellence Scholarship; Australian Postgraduate Award Scholarship	VM was supported by a Macquarie University Research Excellence Scholarship and RM was supported by an Australian Postgraduate Award Scholarship.	Aisenberg A, 2005, ETHOLOGY, V111, P545, DOI 10.1111/j.1439-0310.2005.01077.x; Aisenberg A, 2009, ETHOLOGY, V115, P1127, DOI 10.1111/j.1439-0310.2009.01701.x; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Austad S.N., 1984, P223; Bednarski JV, 2012, ANIM BEHAV, V84, P1221, DOI 10.1016/j.anbehav.2012.08.032; Bel-Venner MC, 2008, P ROY SOC B-BIOL SCI, V275, P77, DOI 10.1098/rspb.2007.1278; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Brockerhoff AM, 2005, MAR ECOL PROG SER, V290, P179, DOI 10.3354/meps290179; Carducci JP, 2000, ANIM BEHAV, V59, P39, DOI 10.1006/anbe.1999.1282; Cerveira AM, 2013, J ARACHNOL, V41, P374, DOI 10.1636/Hi12-42.1; Chapman T, 1998, P ROY SOC B-BIOL SCI, V265, P1879, DOI 10.1098/rspb.1998.0516; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; CHEN PS, 1984, ANNU REV ENTOMOL, V29, P233, DOI 10.1146/annurev.en.29.010184.001313; CHRISTENSON TE, 1985, J COMP PSYCHOL, V99, P160, DOI 10.1037/0735-7036.99.2.160; CLARK DL, 1994, J ARACHNOL, V22, P94; Clark DL, 2001, P ROY SOC B-BIOL SCI, V268, P2461, DOI 10.1098/rspb.2001.1819; CRANE JOCELYN, 1949, ZOOLOGICA [NEW YORK], V34, P159; Cross FR, 2008, NEW ZEAL J ZOOL, V35, P151, DOI 10.1080/03014220809510112; DICKINSON JL, 1989, ANIM BEHAV, V38, P154, DOI 10.1016/S0003-3472(89)80074-0; DODSON GN, 1993, ANIM BEHAV, V46, P951, DOI 10.1006/anbe.1993.1276; DUELLI P, 1978, J COMP PHYSIOL, V124, P15, DOI 10.1007/BF00656387; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Elgar MA, 1996, J INSECT BEHAV, V9, P729, DOI 10.1007/BF02213553; Elias DO, 2005, ANIM BEHAV, V69, P931, DOI 10.1016/j.anbehav.2004.06.024; FRANKINO WA, 1994, ANIM BEHAV, V48, P1479, DOI 10.1006/anbe.1994.1389; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Girard MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025390; Gregoric M, 2016, SCI REP, P6; Hoefler CD, 2006, ANIM BEHAV, V71, P109, DOI 10.1016/j.anbehav.2005.03.033; Hoefler CD, 2007, ANIM BEHAV, V73, P943, DOI 10.1016/j.anbehav.2006.10.017; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; JACKSON R R, 1976, Psyche (Cambridge), V83, P243; JACKSON RR, 1981, EVOLUTION, V35, P601, DOI 10.1111/j.1558-5646.1981.tb04922.x; JACKSON RR, 1989, NEW ZEAL J ZOOL, V16, P169, DOI 10.1080/03014223.1989.10422566; JACKSON RR, 1989, NEW ZEAL J ZOOL, V16, P151, DOI 10.1080/03014223.1989.10422565; JACKSON RR, 1982, ZOOL J LINN SOC-LOND, V76, P293, DOI 10.1111/j.1096-3642.1982.tb02185.x; JACKSON RR, 1986, J NAT HIST, V20, P1193, DOI 10.1080/00222938600770791; JACKSON RR, 1989, NEW ZEAL J ZOOL, V16, P1; JACKSON RR, 1987, NEW ZEAL J ZOOL, V14, P1; JACKSON RR, 1980, J ARACHNOL, V8, P217; JACKSON RR, 1977, ANIM BEHAV, V25, P953, DOI 10.1016/0003-3472(77)90046-X; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Jiao XG, 2011, BEHAV ECOL SOCIOBIOL, V65, P2117, DOI 10.1007/s00265-011-1220-4; Johnson JC, 2001, ANIM BEHAV, V61, P905, DOI 10.1006/anbe.2000.1679; Kiszewski AE, 2002, J MED ENTOMOL, V39, P847, DOI 10.1603/0022-2585-39.6.847; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kralj-Fiser S, 2012, BEHAV ECOL SOCIOBIOL, V66, P145, DOI 10.1007/s00265-011-1262-7; LAND MF, 1969, J EXP BIOL, V51, P443; LAND MF, 1971, J EXP BIOL, V54, P119; Li DQ, 2003, BEHAVIOUR, V140, P739, DOI 10.1163/156853903322370652; Lim MLM, 2007, SCIENCE, V315, P481, DOI 10.1126/science.1134254; Maklakov AA, 2004, ANIM BEHAV, V68, P1041, DOI 10.1016/j.anbehav.2004.02.010; Maklakov AA, 2003, ANIM BEHAV, V66, P623, DOI 10.1006/anbe.2003.2245; MASUMOTO T, 1991, J ETHOL, V9, P1, DOI 10.1007/BF02350291; MASUMOTO T, 1993, J ARACHNOL, V21, P55; McGinley RH, 2016, BEHAV ECOL SOCIOBIOL, V70, P821, DOI 10.1007/s00265-016-2103-5; McGinley RH, 2015, AUST J ZOOL, V63, P300, DOI 10.1071/ZO15032; McGinley RH, 2015, ANIM BEHAV, V101, P89, DOI 10.1016/j.anbehav.2014.12.014; McGinley RH, 2013, BIOL J LINN SOC, V110, P644, DOI 10.1111/bij.12155; Mendez V, 2017, ETHOL ECOL EVOL, V29, P1; Mendez V, 2014, J ARACHNOL, V42, P284, DOI 10.1636/0161-8202-42.3.284; Michalik Peter, 2005, Front Zool, V2, P12, DOI 10.1186/1742-9994-2-12; Michalik P, 2013, ZOOMORPHOLOGY, V132, P11, DOI 10.1007/s00435-012-0166-z; Miyatake T, 1999, J INSECT PHYSIOL, V45, P1021, DOI 10.1016/S0022-1910(99)00083-9; Molina Y, 2008, ANIM BEHAV, V76, P1327, DOI 10.1016/j.anbehav.2008.04.021; Norton S, 2005, J ARACHNOL, V33, P16, DOI 10.1636/S02-72; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Perampaladas K, 2005, BEHAV ECOL, V26, P127; Persons MH, 2005, ANIM BEHAV, V69, P83, DOI 10.1016/j.anbehav.2003.12.030; Pitnick Scott, 2010, P379; PRENTER J, 1994, BEHAV ECOL SOCIOBIOL, V35, P39, DOI 10.1007/s002650050068; Radhakrishnan P, 2008, J INSECT PHYSIOL, V54, P421, DOI 10.1016/j.jinsphys.2007.10.014; Radhakrishnan P, 2007, J INSECT PHYSIOL, V53, P741, DOI 10.1016/j.jinsphys.2006.10.009; Richardson BJ, 2012, ZOOTAXA, P1; RICHMAN DB, 1982, J ARACHNOL, V10, P47; Ringo J, 1996, ANNU REV ENTOMOL, V41, P473, DOI 10.1146/annurev.en.41.010196.002353; Schafer MA, 2002, BEHAV ECOL SOCIOBIOL, V51, P368, DOI 10.1007/s00265-001-0448-9; Schafer MA, 2005, BEHAV ECOL, V16, P461, DOI 10.1093/beheco/ari013; SHERMAN PW, 1989, NATURE, V338, P418, DOI 10.1038/338418a0; Shine R, 2000, BIOL J LINN SOC, V70, P377, DOI 10.1111/j.1095-8312.2000.tb01229.x; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, SPERM COMPETITION SE; SINGER F, 1995, BEHAV ECOL SOCIOBIOL, V36, P313, DOI 10.1007/BF00167792; Sivalinghem S, 2010, BEHAV ECOL, V21, P1308, DOI 10.1093/beheco/arq150; Smith DT, 2009, GENET RES, V91, P237, DOI 10.1017/S0016672309000226; Su KFY, 2006, ANIM BEHAV, V71, P531, DOI 10.1016/j.anbehav.2005.04.024; Tarsitano M, 2006, ANIM BEHAV, V72, P1437, DOI 10.1016/j.anbehav.2006.05.007; TARSITANO MS, 1992, BEHAVIOUR, V123, P106, DOI 10.1163/156853992X00147; Taylor PW, 1999, NEW ZEAL J ZOOL, V26, P127, DOI 10.1080/03014223.1999.9518184; Taylor PW, 2001, BEHAV ECOL SOCIOBIOL, V50, P403, DOI 10.1007/s002650100390; Thornhill R., 1983, pi; Uhl G, 2010, GENETICA, V138, P75, DOI 10.1007/s10709-009-9388-5; van Helsdingen PJ, 1965, ZOOLOGISCHE MEDEDELI, V41, P15; Vincent SE, 2006, BIOL J LINN SOC, V87, P95, DOI 10.1111/j.1095-8312.2006.00553.x; WATSON PJ, 1986, SCIENCE, V233, P219, DOI 10.1126/science.3726530; WILLIAMS DS, 1980, NATURE, V288, P578, DOI 10.1038/288578a0; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7; Yamane T, 2008, J INSECT PHYSIOL, V54, P1522, DOI 10.1016/j.jinsphys.2008.09.001; Yamane T, 2010, J INSECT PHYSIOL, V56, P1565, DOI 10.1016/j.jinsphys.2010.05.014; Zurek DB, 2012, VISION RES, V66, P26, DOI 10.1016/j.visres.2012.06.011; Zurek DB, 2010, J EXP BIOL, V213, P2372, DOI 10.1242/jeb.042382	103	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0184940	10.1371/journal.pone.0184940	http://dx.doi.org/10.1371/journal.pone.0184940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KG	29045411	Green Published, Green Submitted, gold			2022-12-26	WOS:000413168100008
J	Sun, ZM; Li, GD; Tong, TJ; Chen, J				Sun, Zhaomeng; Li, Guodong; Tong, Tanjun; Chen, Jun			Micheliolide suppresses LPS-induced neuroinflammatory responses	PLOS ONE			English	Article							NF-KAPPA-B; GUAIANOLIDE SESQUITERPENE LACTONES; INFLAMMATORY RESPONSE; PRIMARY MICROGLIA; NRF2-ARE PATHWAY; HEME OXYGENASE-1; PROGENITOR CELLS; ACTIVATION; NEURODEGENERATION; MODEL	Microglia-involved neuroinflammation is thought to promote brain damage in various neurodegenerative disorders. Thus, inhibition of microglial over-activation may have a therapeutic benefit for the treatment of neurodegenerative disorders. Micheliolide (MCL) is a sesquiterpene lactone which inhibits various inflammatory response. However, whether MCL can inhibit neuroinflammation caused by LPS-activated BV2 microglia has not yet been explored. In this study, we demonstrated that treatment of BV2 cells with MCL significantly repressed LPS-stimulated nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression, as well as tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and nitric oxide (NO) induction. MCL also attenuated mRNA levels of multiple pro-inflammatory cytokines and mediators such as iNOS, COX-2, TNF-alpha, IL-6 and IL-1 beta. Mechanistic studies revealed that MCL suppressed LPS-stimulated the activation of I kappa B alpha/NF-kappa B pathway and Akt pathway. Moreover, MCL inhibited LPS-induced the activition of c-Jun N-terminal kinase (JNK), p38 MAPK kinase, and extracellular signal-regulated kinases 1/2 (ERK1/2). Meanwhile, MCL markedly promoted antioxidant protein heme oxygenase-1 (HO-1) expression by enhancing NF-E2-related factor 2 (Nrf2) activity. Together, our results imply that MCL may serve as a neuroprotective agent in neuroinflammation-related neurodegenerative disorders.	[Sun, Zhaomeng; Li, Guodong; Tong, Tanjun; Chen, Jun] Peking Univ, Res Ctr Aging, Beijing, Peoples R China; [Sun, Zhaomeng; Li, Guodong; Tong, Tanjun; Chen, Jun] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing, Peoples R China	Peking University; Peking University	Tong, TJ; Chen, J (corresponding author), Peking Univ, Res Ctr Aging, Beijing, Peoples R China.; Tong, TJ; Chen, J (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing, Peoples R China.	ttj@bjmu.edu.cn; cjbiochem@bjmu.edu.cn			Ministry of Science and Technology of the People's Republic of China (MOST) [2013CB530801, 2014CB910503]; National Natural Science Foundation of China (NSFC) [81370455]	Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of the People's Republic of China (MOST) Grants 2013CB530801 and 2014CB910503, and National Natural Science Foundation of China (NSFC) Grant 81370455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; An YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116202; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Ding YH, 2013, BIOORG MED CHEM LETT, V23, P6087, DOI 10.1016/j.bmcl.2013.09.028; Hammond RA, 1999, AM J VET RES, V60, P426; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Ji Q, 2016, ONCOTARGET, V7, P65012, DOI 10.18632/oncotarget.11342; Jia YS, 2015, ONCOTARGETS THER, V8, P3371, DOI 10.2147/OTT.S91805; Jia YS, 2015, ONCOTARGETS THER, V8, P2319, DOI 10.2147/OTT.S88661; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Kang CH, 2012, FOOD CHEM TOXICOL, V50, P4270, DOI 10.1016/j.fct.2012.08.041; Kim JH, 2008, FREE RADICAL BIO MED, V45, P885, DOI 10.1016/j.freeradbiomed.2008.06.019; Lee EJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0355-z; Lee IS, 2011, NEUROCHEM INT, V58, P153, DOI 10.1016/j.neuint.2010.11.008; Lee JW, 2014, MOL CELL BIOCHEM, V390, P143, DOI 10.1007/s11010-014-1965-y; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Long-Smith CM, 2009, PROG NEUROBIOL, V89, P277, DOI 10.1016/j.pneurobio.2009.08.001; Lue LF, 2010, MOL NEUROBIOL, V41, P115, DOI 10.1007/s12035-010-8106-8; Ma WW, 2013, MOLECULES, V18, P5980, DOI 10.3390/molecules18055980; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Olajide OA, 2014, MOL NUTR FOOD RES, V58, P1843, DOI 10.1002/mnfr.201400163; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Qin XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23240; Rahman Arshad, 2011, Proc Am Thorac Soc, V8, P497, DOI 10.1513/pats.201101-009MW; Suh GY, 2006, AM J RESP CELL MOL, V35, P220, DOI 10.1165/rcmb.2005-0154OC; Surh YJ, 2009, ARCH PHARM RES, V32, P1163, DOI 10.1007/s12272-009-1807-8; Viennois E, 2014, LAB INVEST, V94, P950, DOI 10.1038/labinvest.2014.89; Vijayan V, 2010, WORLD J GASTROENTERO, V16, P3112, DOI 10.3748/wjg.v16.i25.3112; Weng LH, 2017, INT IMMUNOPHARMACOL, V44, P1, DOI 10.1016/j.intimp.2016.12.018; Wu WQ, 2015, MOL NUTR FOOD RES, V59, P1663, DOI 10.1002/mnfr.201500109; Xu H, 2015, MOL MED REP, V11, P489, DOI 10.3892/mmr.2014.2767; Zhai JD, 2012, J ORG CHEM, V77, P7103, DOI 10.1021/jo300888s; Zhang Q, 2012, J MED CHEM, V55, P8757, DOI 10.1021/jm301064b	38	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186592	10.1371/journal.pone.0186592	http://dx.doi.org/10.1371/journal.pone.0186592			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040306	gold, Green Published, Green Submitted			2022-12-26	WOS:000413167500059
J	Hinsley, A; Sutherland, WJ; Johnston, A				Hinsley, Amy; Sutherland, William J.; Johnston, Alison			Men ask more questions than women at a scientific conference	PLOS ONE			English	Article							GENDER-DIFFERENCES; TEACHER EXPECTATIONS; SCIENCE; PARTICIPATION; OUTCOMES; IMPACT	Gender inequity in science and academia, especially in senior positions, is a recognised problem. The reasons are poorly understood, but include the persistence of historical gender ratios, discrimination and other factors, including gender-based behavioural differences. We studied participation in a professional context by observing question-asking behaviour at a large international conference with a clear equality code of conduct that prohibited any form of discrimination. Accounting for audience gender ratio, male attendees asked 1.8 questions for each question asked by a female attendee. Amongst only younger researchers, male attendees also asked 1.8 questions per female question, suggesting the pattern cannot be attributed to the temporary problem of demographic inertia. We link our findings to the 'chilly' climate for women in STEM, including wider experiences of discrimination likely encountered by women throughout their education and careers. We call for a broader and coordinated approach to understanding and addressing the barriers to women and other under-represented groups. We encourage the scientific community to recognise the context in which these gender differences occur, and evaluate and develop methods to support full participation from all attendees.	[Hinsley, Amy] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Hinsley, Amy] Univ Oxford, Dept Zool, Oxford, England; [Sutherland, William J.; Johnston, Alison] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Johnston, Alison] British Trust Ornithol, Nunnery, Thetford, England; [Johnston, Alison] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA	University of Kent; University of Oxford; University of Cambridge; British Trust for Ornithology; Cornell University	Hinsley, A (corresponding author), Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.; Hinsley, A (corresponding author), Univ Oxford, Dept Zool, Oxford, England.	amy.hinsley@zoo.ox.ac.uk	Johnston, Alison/N-4820-2016; Hinsley, Amy/J-3199-2019	Johnston, Alison/0000-0001-8221-013X; Hinsley, Amy/0000-0002-5590-7617	Natural Environmental Research Council [NE/J500458/1]; Arcadia; NERC; Natural Environment Research Council [1117644] Funding Source: researchfish	Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Arcadia; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors received no specific funding for this work, but AH's time and attendance at the conference where data collection took place was supported by the Natural Environmental Research Council (NE/J500458/1) (http://www.nerc.ac.uk). WJS was funded by Arcadia.; The organisers of the 2015 International and European Congress for Conservation Biology kindly allowed this study to proceed. Data were collected by the authors and a team of volunteers: Andrew Bladon, Dania Dadam, Lauren Gardiner, Elizabeth Green, Gemma Harding, Dario Massimino, Gail Austen, Tristan Pett, Rachel Sykes, Janna Steadman, Lydia Tiller, Emma Shepherd-Walwyn, Jessica Walsh, Rob Ward. Gorm Shackelford provided useful comments. WJS is funded by Arcadia. AH is funded by NERC.	[Anonymous], 2021, LANG ENV STAT COMP; Aukrust VG, 2008, GENDER EDUC, V20, P237, DOI 10.1080/09540250802000413; Beede DN., 2011, WOMEN STEM GENDER GA, DOI DOI 10.2139/SSRN.1964782; Bornmann L, 2007, J INFORMETR, V1, P226, DOI 10.1016/j.joi.2007.03.001; Budden AE, 2008, TRENDS ECOL EVOL, V23, P4, DOI 10.1016/j.tree.2007.07.008; Casadevall A, 2014, MBIO, V5, DOI [10.1128/mBio.00846-13, 10.1128/mBio.01730-14, 10.1128/mBio.01342-14, 10.1128/mBio.00064-14]; Caspi A, 2008, COMPUT EDUC, V50, P718, DOI 10.1016/j.compedu.2006.08.003; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Cheryan S, 2009, J PERS SOC PSYCHOL, V97, P1045, DOI 10.1037/a0016239; Clancy KBH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102172; Cox DR., 1989, ANAL BINARY DATA; DALY JA, 1994, COMMUN EDUC, V43, P27, DOI 10.1080/03634529409378959; Davenport JR, 2014, 223 M AM ASTR SOC; Ding WW, 2006, SCIENCE, V313, P665, DOI 10.1126/science.1124832; European Union, 2015, SHE FIG 2015 GEND RE; Fox CW, 2016, FUNCT ECOL, V30, P140, DOI 10.1111/1365-2435.12529; Fox CW, 2016, FUNCT ECOL, V30, P126, DOI 10.1111/1365-2435.12587; Genoways HH, 2001, J MAMMAL, V82, P582, DOI 10.1644/1545-1542(2001)082<0582:EOASME>2.0.CO;2; Goktepe-Hulten D, 2010, J TECHNOL TRANSFER, V35, P401, DOI 10.1007/s10961-009-9126-2; GOOD TL, 1981, EDUC LEADERSHIP, V38, P415; GOOD TL, 1987, J TEACH EDUC, V38, P32, DOI 10.1177/002248718703800406; Grunspan DZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148405; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hall Roberta M., 1984, OUT CLASSROOM CHILLY; Hall RobertaM., 1982, CLASSROOM CLIMATE CH; Halpern D. F., 2007, SCI SEX GOOD SENSE W; Hardin JW, 2003, GEN ESTIMATING EQUAT, V32, P33; Isbell LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049682; Johnston A., 2015, METHODS 5 ANN S GEND; KELLY A, 1988, RES EDUC, P1; King M. M., 2016, ARXIV160700376; Knobloch-Westerwick S, 2013, SCI COMMUN, V35, P603, DOI 10.1177/1075547012472684; KYVIK S, 1994, SCIENTOMETRICS, V29, P161, DOI 10.1007/BF02018388; Lane J, 2010, NATURE, V464, P488, DOI 10.1038/464488a; Lynn R, 2011, PERS INDIV DIFFER, V51, P321, DOI 10.1016/j.paid.2011.02.028; Martin G, 2015, ARXIV150206326; Mauleon E, 2006, SCIENTOMETRICS, V66, P199, DOI 10.1007/s11192-006-0014-3; McMullin JA, 2004, J AGING STUD, V18, P75, DOI 10.1016/j.jaging.2003.09.006; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Niederle M, 2007, Q J ECON, V122, P1067, DOI 10.1162/qjec.122.3.1067; Pan W., 2001, BIOMETRICS, V57; Pritchard J, 2014, ASTRON GEOPHYS, V55, P8; Sandberg S., 2013, LEAN WOMEN WORK WILL; Sapienza P, 2009, P NATL ACAD SCI USA, V106, P15268, DOI 10.1073/pnas.0907352106; Sardelis S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160015; SCB, 2015, ICCB ECCB COD COND M; Shaw AK, 2012, P ROY SOC B-BIOL SCI, V279, P3736, DOI 10.1098/rspb.2012.0822; Smiljanic J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148528; Steele CM, 2002, ADV EXP SOC PSYCHOL, V34, P379, DOI 10.1016/S0065-2601(02)80009-0; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; van der Lee R, 2015, P NATL ACAD SCI USA, V112, P12349, DOI 10.1073/pnas.1510159112; VANDERMEIJ H, 1994, LEARN INDIVID DIFFER, V6, P137, DOI 10.1016/1041-6080(94)90007-8; Waller, 2004, LEAPS DARK MAKING SC; Wei X, P 10 ACM INT C WEB S, P33; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0	55	54	54	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0185534	10.1371/journal.pone.0185534	http://dx.doi.org/10.1371/journal.pone.0185534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ8YP	29036191	Green Published, Green Submitted, gold			2022-12-26	WOS:000413054800006
J	Rose, S; Bennuri, SC; Murray, KF; Buie, T; Winter, H; Frye, RE				Rose, Shannon; Bennuri, Sirish C.; Murray, Katherine F.; Buie, Timothy; Winter, Harland; Frye, Richard Eugene			Mitochondrial dysfunction in the gastrointestinal mucosa of children with autism: A blinded case-control study	PLOS ONE			English	Article							ADOLESCENT RATS RELEVANCE; CHAIN FATTY-ACIDS; PROPIONIC-ACID; SPECTRUM DISORDERS; OXIDATIVE STRESS; PHYSIOLOGICAL ABNORMALITIES; SOCIAL-BEHAVIOR; MICROBIOTA; THERAPY; MICROFLORA	Gastrointestinal (GI) symptoms are prevalent in autism spectrum disorder (ASD) but the pathophysiology is poorly understood. Imbalances in the enteric microbiome have been associated with ASD and can cause GI dysfunction potentially through disruption of mitochondrial function as microbiome metabolites modulate mitochondrial function and mitochondrial dysfunction is highly associated with GI symptoms. In this study, we compared mitochondrial function in rectal and cecum biopsies under the assumption that certain microbiome metabolites, such as butyrate and propionic acid, are more abundant in the cecum as compared to the rectum. Rectal and cecum mucosal biopsies were collected during elective diagnostic colonoscopy. Using a single-blind case-control design, complex I and IV and citrate synthase activities and complex I-V protein quantity from 10 children with ASD, 10 children with Crohn's disease and 10 neurotypical children with nonspecific GI complaints were measured. The protein for all complexes, except complex II, in the cecum as compared to the rectum was significantly higher in ASD samples as compared to other groups. For both rectal and cecum biopsies, ASD samples demonstrated higher complex I activity, but not complex IV or citrate synthase activity, compared to other groups. Mitochondrial function in the gut mucosa from children with ASD was found to be significantly different than other groups who manifested similar GI symptomatology suggesting a unique pathophysiology for GI symptoms in children with ASD. Abnormalities localized to the cecum suggest a role for imbalances in the microbiome, potentially in the production of butyrate, in children with ASD.	[Rose, Shannon; Bennuri, Sirish C.; Frye, Richard Eugene] Arkansas Childrens Res Inst, Autism Res Program, Little Rock, AR 72202 USA; [Murray, Katherine F.; Winter, Harland] MassGen Hosp Children, Dept Pediat Gastroenterol & Nutr, Boston, MA USA; [Buie, Timothy] Boston Childrens Hosp, Dept Gastroenterol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital	Frye, RE (corresponding author), Arkansas Childrens Res Inst, Autism Res Program, Little Rock, AR 72202 USA.	REFrye@uams.edu	Frye, Richard/AAB-5543-2020	Frye, Richard/0000-0003-4442-2937; Rose, Shannon/0000-0003-0595-4367	Arkansas Biosciences Institute (Little Rock, AR); Autism Research Institute	Arkansas Biosciences Institute (Little Rock, AR); Autism Research Institute	This research was supported by the Arkansas Biosciences Institute (Little Rock, AR) to REF, Autism Research Institute to HW, and philanthropic support from Martin Schlaff (HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JB, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-111; Alvarez B, 2008, J CELL PHYSIOL, V214, P474, DOI 10.1002/jcp.21215; Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Angelidou A, 2011, J AUTISM DEV DISORD, V41, P1579, DOI 10.1007/s10803-010-1171-z; APA, 1994, DIAGN STAT MAN MENT; Bhardwaj J, 2012, J PEDIATR GASTR NUTR, V55, P194, DOI 10.1097/MPG.0b013e3182514805; Bresnahan M, 2015, JAMA PSYCHIAT, V72, P466, DOI 10.1001/jamapsychiatry.2014.3034; Brunet S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003338; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; Buie T, 2010, PEDIATRICS, V125, pS19, DOI 10.1542/peds.2009-1878D; Chaidez V, 2014, J AUTISM DEV DISORD, V44, P1117, DOI 10.1007/s10803-013-1973-x; Cybulsky AV, 2009, AM J PHYSIOL-RENAL, V297, pF971, DOI 10.1152/ajprenal.00294.2009; De Angelis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076993; Delhey LM, 2017, J CLIN MED, V6, DOI 10.3390/jcm6020018; Dharmasena MN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163511; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Douglas-Escobar M, 2013, JAMA PEDIATR, V167, P374, DOI 10.1001/jamapediatrics.2013.497; Farup PG, 2016, BMC GASTROENTEROL, P16; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Finegold SM, 2008, MED HYPOTHESES, V70, P508, DOI 10.1016/j.mehy.2007.07.019; Finegold SM, 2012, ANAEROBE, V18, P260, DOI 10.1016/j.anaerobe.2011.12.018; Foley KA, 2015, BEHAV BRAIN RES, V278, P244, DOI 10.1016/j.bbr.2014.09.032; Frye R, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.189; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.51; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; FRYE RE, 2015, MICROB ECOL HEALTH D, V26; Frye RE, 2012, N AM J MED SCI, V5, P141; Frye RE, 2015, MICROBIAL ECOLOGY HL; Frye RE, 2016, CLIN MED INSIGHTS-PE, V10, P43, DOI 10.4137/CMPed.S38337; Frye Richard E, 2013, Front Public Health, V1, P31, DOI 10.3389/fpubh.2013.00031; Frye RE, 2014, BIOMARK MED, V8, P321, DOI 10.2217/bmm.13.158; Frye RE, 2012, J PEDIATR NEUROL, V10, P35, DOI 10.3233/JPN-2012-0530; Frye RE, 2011, J PEDIATR NEUROL, V9, P427, DOI 10.3233/JPN-2011-0507; Frye RE, 2011, PEDIATR RES, V69, p41R, DOI 10.1203/PDR.0b013e318212f16b; Gorrindo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068444; Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hornig M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003140; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001; Kang DW, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0225-7; Kesli Recep, 2014, J Immunoassay Immunochem, V35, P101, DOI 10.1080/15321819.2013.792834; Kim JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104927; Kratsman N, 2016, NEUROPHARMACOLOGY, V102, P136, DOI 10.1016/j.neuropharm.2015.11.003; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; MacFabe D., 2008, AM J BIOCH BIOTECHNO, V4, P146, DOI 10.3844/ajbbsp.2008.146.166; Macfabe Derrick, 2013, Glob Adv Health Med, V2, P52, DOI 10.7453/gahmj.2013.089; MacFabe DF, 2007, BEHAV BRAIN RES, V176, P149, DOI 10.1016/j.bbr.2006.07.025; MacFabe Derrick F., 2012, Microbial Ecology in Health and Disease, V23, P19260, DOI 10.3402/mehd.v23i0.19260; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; MACFABE DF, 2015, MICROB ECOL HEALTH D, V26; Metzler-Zebeli BU, 2012, J NUTR, V142, P668, DOI 10.3945/jn.111.153007; Nankova BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103740; Nissenkorn A, 1999, ARCH DIS CHILD, V81, P209, DOI 10.1136/adc.81.3.209; Palmieri L, 2010, MOL PSYCHIATR, V15, P38, DOI 10.1038/mp.2008.63; Park J, 2015, MUCOSAL IMMUNOL, V8, P80, DOI 10.1038/mi.2014.44; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Richler J, 2006, J AUTISM DEV DISORD, V36, P299, DOI 10.1007/s10803-005-0070-1; Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979; Rose S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.15; Rose S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.61; Rose S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085436; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Saba H, 2008, RENAL FAILURE, V30, P125, DOI 10.1080/08860220701813327; Sajdel-Sulkowska EM, 2011, CEREBELLUM, V10, P43, DOI 10.1007/s12311-010-0223-4; Sajdel-Sulkowska EM, 2009, CEREBELLUM, V8, P366, DOI 10.1007/s12311-009-0105-9; Slattery J, 2016, CURR PHARM DESIGN, V22, P6107, DOI 10.2174/1381612822666160905123953; Slattery J, 2016, CLIN MED INSIGHTS-PE, V10, P91, DOI [10.4137/cmped.s38338, 10.4137/CMPed.S38338]; Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Sukhodolsky DG, 2013, PEDIATRICS, V132, pE1341, DOI 10.1542/peds.2013-1193; Takuma K, 2014, PHARMACOL BIOCHEM BE, V126, P43, DOI 10.1016/j.pbb.2014.08.013; Taurines R, 2012, ADHD-ATTEND DEFICIT, V4, P115, DOI 10.1007/s12402-012-0086-2; Thomas RH, 2010, J NEUROCHEM, V113, P515, DOI 10.1111/j.1471-4159.2010.06614.x; Valeur J, 2010, CLIN EXP GASTROENTER, V3, P65; Williams BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024585; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Yang S, 2016, FASEB J, V30	79	35	37	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186377	10.1371/journal.pone.0186377	http://dx.doi.org/10.1371/journal.pone.0186377			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ7ZQ	29028817	gold, Green Submitted, Green Published			2022-12-26	WOS:000412980300031
J	Abhishek, A; Valdes, AM; Jenkins, W; Zhang, WY; Doherty, M				Abhishek, Abhishek; Valdes, Ana M.; Jenkins, Wendy; Zhang, Weiya; Doherty, Michael			Triggers of acute attacks of gout, does age of gout onset matter? A primary care based cross-sectional study	PLOS ONE			English	Article							CHINESE MALE-POPULATION; PURINE-RICH FOODS; SERUM URIC-ACID; FATTY-ACIDS; INFLAMMASOME; ARTHRITIS; RISK; CLASSIFICATION; POLYMORPHISM; ASSOCIATION	Objectives To determine the proportion of people with gout who self-report triggers of acute attacks; identify the commonly reported triggers, and examine the disease and demographic features associated with self-reporting any trigger(s) of acute attacks of gout. Methods Individuals with gout were asked to fill a questionnaire enquiring about triggers that precipitated their acute gout attacks. Binary logistic regression was used to compute odds ratio (OR) and 95% confidence intervals (CI) to examine the association between having >= 1 self-reported trigger of acute gout and disease and demographic risk factors and to adjust for covariates. All statistical analyses were performed using STATA. Results 550 participants returned completed questionnaires. 206 (37.5%) reported at least one trigger of acute attacks, and less than 5% reported >2 triggers. Only 28.73% participants reported that their most recent gout attack was triggered by dietary or lifestyle risk factors. The most frequently self-reported triggers were alcohol intake (14.18%), red-meat or seafood consumption (6%), dehydration (4.91%), injury or excess activity (4.91%), and excessively warm or cold weather (4.36% and 5.45%). Patients who had onset of gout before the age of 50 years were significantly more likely to identify a trigger for precipitating their acute gout attacks (aOR (95% CI) 1.73 (1.12-2.68) after adjusting for covariates. Conclusion Most people with gout do not identify any triggers for acute attacks, and identifiable triggers are more common in those with young onset gout. Less than 20% people self-reported acute gout attacks from conventionally accepted triggers of gout e.g. alcohol, red-meat intake, while c.5% reported novel triggers such as dehydration, injury or physical activity, and weather extremes.	[Abhishek, Abhishek; Valdes, Ana M.; Jenkins, Wendy; Zhang, Weiya; Doherty, Michael] Univ Nottingham, Acad Rheumatol, Nottingham City Hosp, Clin Sci Bldg, Nottingham, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Abhishek, A (corresponding author), Univ Nottingham, Acad Rheumatol, Nottingham City Hosp, Clin Sci Bldg, Nottingham, England.	Abhishek.abhishek@nottingham.ac.uk	Zhang, Weiya/X-9481-2019	Zhang, Weiya/0000-0003-1142-1460; Valdes, Ana M./0000-0003-1141-4471; Doherty, Michael/0000-0002-5763-8326	Arthritis Research UK [18827, 19703]; Nottingham University Hospitals NHS Trust Charity; Versus Arthritis [19703] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Nottingham University Hospitals NHS Trust Charity; Versus Arthritis(Versus Arthritis)	These studies were supported by Arthritis Research UK (study ref numbers 18827 and 19703 to MD) and Nottingham University Hospitals NHS Trust Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to Arthritis Research UK (18827 and 19703) and Nottingham University Hospitals NHS Trust charity who funded these community-based studies. We are also very grateful to all the people who gave their time to respond to the questionnaire and provide the data for this study.	Abhishek A, 2016, ARTHRIT CARE RES, V68, P1573, DOI 10.1002/acr.22855; Chen Y, 2015, CELL PHYSIOL BIOCHEM, V35, P1394, DOI 10.1159/000373960; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; Choi HK, 2015, ARTHRITIS RHEUMATOL, V67, P555, DOI 10.1002/art.38917; Crisan TO, 2017, P NATL ACAD SCI USA, V114, P5485, DOI 10.1073/pnas.1620910114; Crisan TO, 2016, ANN RHEUM DIS, V75, P755, DOI 10.1136/annrheumdis-2014-206564; Dalbeth N, 2016, LANCET, V388, P2039, DOI 10.1016/S0140-6736(16)00346-9; Deng JP, 2015, INT J CLIN EXP PATHO, V8, P13747; DeSantis DA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/751374; Elliot AJ, 2009, ANN RHEUM DIS, V68, P1728, DOI 10.1136/ard.2008.096693; Flynn TJ, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0661-8; GREEN HJ, 1988, MED SCI SPORT EXER, V20, P55, DOI 10.1249/00005768-198802000-00008; HANDLER JS, 1960, J CLIN INVEST, V39, P1526, DOI 10.1172/JCI104172; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Jimenez-Linan LM, 2016, ARTHRITIS CARE RES; Joosten LAB, 2010, ARTHRITIS RHEUM-US, V62, P3237, DOI 10.1002/art.27667; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Karmacharya P, 2016, CLIN RHEUMATOL, V35, P523, DOI 10.1007/s10067-015-3042-7; Lippai D, 2013, J LEUKOCYTE BIOL, V94, P171, DOI 10.1189/jlb.1212659; Liu S, 2013, SCAND J RHEUMATOL, V42, P150, DOI 10.3109/03009742.2012.726372; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; McKinney C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0802-3; Neogi T, 2015, ANN RHEUM DIS, V74, P1789, DOI 10.1136/annrheumdis-2015-208237; Neogi T, 2014, AM J MED, V127, P311, DOI 10.1016/j.amjmed.2013.12.019; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Qing YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064845; Rasheed H, 2016, PLOS ONE, V11; Rees F, 2013, ANN RHEUM DIS, V72, P826, DOI 10.1136/annrheumdis-2012-201676; Roddy E, 2014, RHEUM DIS CLIN N AM, V40, P155, DOI 10.1016/j.rdc.2014.01.001; Valdes AM, 2016, RHEUMATOLOGY, V55, P1642, DOI 10.1093/rheumatology/kew235; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Yoshihara A, 2007, J ORAL REHABIL, V34, P733, DOI 10.1111/j.1365-2842.2007.01732.x; Zhang Yuqing, 2006, Am J Med, V119, DOI 10.1016/j.amjmed.2006.01.020; Zhang YQ, 2012, ARTHRITIS RHEUM-US, V64, P4004, DOI 10.1002/art.34677; Zhang YQ, 2012, ANN RHEUM DIS, V71, P1448, DOI 10.1136/annrheumdis-2011-201215	35	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186096	10.1371/journal.pone.0186096	http://dx.doi.org/10.1371/journal.pone.0186096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023487	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100060
J	Yamashita, T; Sakamoto, T; Yoshihara, N; Terasaki, H; Tanaka, M; Kii, Y; Nakao, K				Yamashita, Takehiro; Sakamoto, Taiji; Yoshihara, Naoya; Terasaki, Hiroto; Tanaka, Minoru; Kii, Yuya; Nakao, Kumiko			Correlations between local peripapillary choroidal thickness and axial length, optic disc tilt, and papillo-macular position in young healthy eyes	PLOS ONE			English	Article							CENTRAL SEROUS CHORIORETINOPATHY; NERVE-FIBER LAYER; COHERENCE TOMOGRAPHY; GLAUCOMA-PATIENTS; BEIJING EYE; HIGH MYOPIA	Optical coherence tomography (OCT) has made it possible for clinicians to measure the peripapillary choroidal thickness (ppCT) noninvasively in various ocular diseases. However, the ocular factors associated with the ppCT have not been conclusively determined. The purpose of this study was to determine the relationship between the local ppCT and the axial length, optic disc tilt, and the angle of the papillo-macular position (PMP) in healthy eyes. This was a prospective, observational cross-sectional study of 119 right eyes of 119 healthy Japanese volunteers. The ppCT was manually measured at eight sectors around the optic disc using the B-scan images of the Topcon 3D OCT RNFL 3.4 mm circle scan. The trajectory of the retinal pigment epithelium in the B-scan image was fitted to a sine curve using ImageJ, and the amplitude of the sine curve was used to determine the degree of the optic disc tilt. The PMP angle was determined in the color fundus photographs. The relationships between the ppCT and the axial length, the optic disc tilt, and PMP angle were determined by Spearman and multiple correlation analyses. The mean age was 25.8 +/- 3.9 years and the mean axial length was 25.5 +/- 1.4 mm. The ppCT was significantly and negatively associated with the axial length (R = -0.43 to -0.24, P<0.01) and positively associated with the PMP angle (R = 0.28 to 0.37, P<0.01) in all eight circumpapillary sectors. The temporal and infratemporal ppCTs were significantly and negatively associated with the optic disc tilt (R = -0.31, -0.20, P<0.05). The results of multiple regression analyses were similar to that of Spearman correlation analysis. In conclusion, the axial length and PMP angle can affect the ppCT in all circumferential sectors, however the tilt of the optic disc is correlated with only some of the sectors. This should be remembered in interpreting the ppCT.	[Yamashita, Takehiro; Sakamoto, Taiji; Yoshihara, Naoya; Terasaki, Hiroto; Tanaka, Minoru; Kii, Yuya; Nakao, Kumiko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima, Japan	Kagoshima University	Sakamoto, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima, Japan.	tsakamot@m3.kufm.kagoshima-u.ac.jp		Sakamoto, Taiji/0000-0003-0287-3801	JSPS KAKENHI [17K11426]; Suda memorial glaucoma research grant; Grants-in-Aid for Scientific Research [17K11426] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suda memorial glaucoma research grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI grant (17K11426) and Suda memorial glaucoma research grant. This study was registered with the University Hospital Medical Network-clinical trials registry (No. UMIN000015239). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2016, INVEST OPHTH VIS SCI, V57, P137, DOI 10.1167/iovs.15-17510; Ehrlich JR, 2011, EXP EYE RES, V92, P189, DOI 10.1016/j.exer.2011.01.002; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Gupta P, 2015, INVEST OPHTH VIS SCI, V56, P1475, DOI 10.1167/iovs.14-15742; Hirooka K, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-29; Ho J, 2011, OPHTHALMOLOGY, V118, P2001, DOI 10.1016/j.ophtha.2011.02.049; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huang WB, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-23; Ikuno Y, 2011, INVEST OPHTH VIS SCI, V52, P5536, DOI 10.1167/iovs.10-6811; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V50, P3876, DOI 10.1167/iovs.08-3325; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Jiang R, 2015, INVEST OPHTH VIS SCI, V56, P4045, DOI 10.1167/iovs.15-16521; Jonas RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141771; Li L, 2013, AM J OPHTHALMOL, V156, P1277, DOI 10.1016/j.ajo.2013.07.011; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Maul EA, 2011, OPHTHALMOLOGY, V118, P1571, DOI 10.1016/j.ophtha.2011.01.016; Oh Jaeryung, 2013, Korean J Ophthalmol, V27, P172, DOI 10.3341/kjo.2013.27.3.172; Park HYL, 2014, J GLAUCOMA, V23, P225, DOI 10.1097/IJG.0000000000000045; Roberts KF, 2012, ARCH OPHTHALMOL-CHIC, V130, P980, DOI 10.1001/archophthalmol.2012.371; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Spaide RF, 2014, PATHOLOGIC MYOPIA, P102; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Tanabe H, 2012, RETINA-J RET VIT DIS, V32, P134, DOI 10.1097/IAE.0b013e318217ff87; Terasaki H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156842; Vujosevic S, 2012, RETINA-J RET VIT DIS, V32, P1781, DOI 10.1097/IAE.0b013e31825db73d; Wang W, 2014, INVEST OPHTH VIS SCI, V55, P6007, DOI 10.1167/iovs.14-14996; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Xu J, 2013, OPHTHALMOLOGY, V120, P2023, DOI 10.1016/j.ophtha.2013.03.009; Yamashita T, 2017, J GLAUCOMA, V26, P34, DOI 10.1097/IJG.0000000000000550; Yamashita T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122191; Yamashita T, 2014, ACTA OPHTHALMOL, V92, pE481, DOI 10.1111/aos.12382; Yoshihara N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103586; Yun C, 2015, RETINA-J RET VIT DIS, V35, P1860, DOI 10.1097/IAE.0000000000000539; Zhou MW, 2013, INVEST OPHTH VIS SCI, V54, P1971, DOI 10.1167/iovs.12-11090	36	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186453	10.1371/journal.pone.0186453	http://dx.doi.org/10.1371/journal.pone.0186453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023585	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100130
J	Evans, LJ; Davies, AB; Goossens, B; Asner, GP				Evans, Luke J.; Davies, Andrew B.; Goossens, Benoit; Asner, Gregory P.			Riparian vegetation structure and the hunting behavior of adult estuarine crocodiles	PLOS ONE			English	Article							MACAQUES MACACA-FASCICULARIS; ANIMAL ECOLOGY; SCIENCE	Riparian ecosystems are amongst the most biodiverse tropical habitats. They are important, and essential, ecological corridors, linking remnant forest fragments. In this study, we hypothesised that crocodile's actively select nocturnal resting locations based on increased macaque predation potential. We examined the importance of riparian vegetation structure in the maintenance of crocodile hunting behaviours. Using airborne Light Detection and Ranging (LiDAR) and GPS telemetry on animal movement, we identified the repeated use of nocturnal resting sites by adult estuarine crocodiles (Crocodylus porosus) throughout the fragmented Lower Kinabatangan Wildlife Sanctuary in Sabah, Malaysia. Crocodile resting locations were found to resemble, in terms of habitat characteristics, the sleeping sites of long-tailed macaque; positioned in an attempt to avoid predation by terrestrial predators. We found individual crocodiles were actively selecting overhanging vegetation and that the protrusion of trees from the tree line was key to site selection by crocodiles, as well as influencing both the presence and group size of sleeping macaques. Although these findings are correlational, they have broad management implications, with the suggestion that riparian corridor maintenance and quality can have implications beyond that of terrestrial fauna. We further place our findings in the context of the wider ecosystem and the maintenance of trophic interactions, and discuss how future habitat management has the potential to mitigate human-wildlife conflict.	[Evans, Luke J.; Goossens, Benoit] Danau Girang Field Ctr, Kota Kinabalu, Sabah, Malaysia; [Evans, Luke J.; Goossens, Benoit] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Evans, Luke J.; Goossens, Benoit] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Evans, Luke J.; Davies, Andrew B.; Asner, Gregory P.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 20005 USA; [Goossens, Benoit] Cardiff Univ, Sustainable Places Res Inst, Cardiff, S Glam, Wales	Cardiff University; Carnegie Institution for Science; Cardiff University	Evans, LJ (corresponding author), Danau Girang Field Ctr, Kota Kinabalu, Sabah, Malaysia.; Evans, LJ (corresponding author), Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia.; Evans, LJ (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales.; Evans, LJ (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 20005 USA.	lukeevans603@yahoo.co.uk	Asner, Gregory/G-9268-2013	Asner, Gregory/0000-0001-7893-6421; Davies, Andrew/0000-0002-0003-1435; Evans, Luke James/0000-0002-6618-4733	UN Development Programme; Avatar Alliance Foundation; Roundtable on Sustainable Palm Oil; World Wildlife Fund; Morgan Family Foundation; Chester Zoo; Colom bus Zoo; Danau Girang Field Centre; IUCN-SSC Crocodile Specialist Group; Rainforest Trust; Margaret A. Cargill Foundation; David and Lucile Packard Foundation; Gordon and Betty Moore Foundation; Grantham Foundation for the Protection of the Environment; W. M. Keck Foundation; John D. and Catherine T. MacArthur Foundation; Andrew Mellon Foundation	UN Development Programme; Avatar Alliance Foundation; Roundtable on Sustainable Palm Oil; World Wildlife Fund; Morgan Family Foundation; Chester Zoo; Colom bus Zoo; Danau Girang Field Centre; IUCN-SSC Crocodile Specialist Group; Rainforest Trust; Margaret A. Cargill Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Grantham Foundation for the Protection of the Environment; W. M. Keck Foundation(W.M. Keck Foundation); John D. and Catherine T. MacArthur Foundation; Andrew Mellon Foundation	This study was supported by the UN Development Programme, Avatar Alliance Foundation, Roundtable on Sustainable Palm Oil, World Wildlife Fund, Morgan Family Foundation, Chester Zoo, Colom bus Zoo, Danau Girang Field Centre, IUCN-SSC Crocodile Specialist Group and the Rainforest Trust. The Carnegie Airborne Observatory has been made possible by grants and donations to G.P. Asner from the Avatar Alliance Foundation, Margaret A. Cargill Foundation, David and Lucile Packard Foundation, Gordon and Betty Moore Foundation, Grantham Foundation for the Protection of the Environment, W. M. Keck Foundation, John D. and Catherine T. MacArthur Foundation, Andrew Mellon Foundation, Mary Anne Nyburg Baker and G. Leonard Baker Jr, and William R. Hearst III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram NK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095388; Asner GP, 2015, J ZOOL, V297, P225, DOI 10.1111/jzo.12269; Asner GP, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2794018; Asner GP, 2012, REMOTE SENS ENVIRON, V124, P454, DOI 10.1016/j.rse.2012.06.012; Britton Adam R. C., 2012, Herpetological Review, V43, P541; Brotcorne F, 2014, AM J PRIMATOL, V76, P1140, DOI 10.1002/ajp.22299; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Caldicott DGE, 2005, WILD ENVIRON MED, V16, P143, DOI 10.1580/1080-6032(2005)16[143:CAIAAA]2.0.CO;2; Campbell HA, 2010, J ANIM ECOL, V79, P955, DOI 10.1111/j.1365-2656.2010.01709.x; CANT JGH, 1988, AM J PHYS ANTHROPOL, V76, P29, DOI 10.1002/ajpa.1330760104; Chiang P. J., 2007, THESIS, P1; Davies AB, 2014, TRENDS ECOL EVOL, V29, P681, DOI 10.1016/j.tree.2014.10.005; Di Bitetti MS, 2000, AM J PRIMATOL, V50, P257, DOI 10.1002/(SICI)1098-2345(200004)50:4&lt;257::AID-AJP3&gt;3.0.CO;2-J; Dinets Vladimir, 2014, Herpetology Notes, V7, P3; Dinets Vladimir, 2010, Herpetological Bulletin, P15; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Evans L. T., 2016, THESIS; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; GALDIKAS BMF, 1984, AM J PRIMATOL, V6, P49, DOI 10.1002/ajp.1350060106; Hambali K, 2014, ACTA BIOL MALAYSIANA, V3, P58, DOI [10.7593/abm/3.2.58, DOI 10.7593/ABM/3.2.58]; Kay Winston R., 2004, Herpetological Review, V35, P354; Lane KE, 2010, DEV PRIMATOL-PROG PR, P235, DOI 10.1007/978-1-4419-1560-3_13; Lindburg D. G, 1980, MACAQUES STUDIES ECO; MAGNUSSON WE, 1987, J HERPETOL, V21, P85, DOI 10.2307/1564468; Jose-Dominguez JM, 2015, INT J PRIMATOL, V36, P948, DOI 10.1007/s10764-015-9865-x; Martin S, 2008, HYDROBIOLOGIA, V595, P587, DOI 10.1007/s10750-007-9030-4; Mazzotti FJ, 2009, ECOL INDIC, V9, pS137, DOI 10.1016/j.ecolind.2008.06.008; Mech SG, 2001, CONSERV BIOL, V15, P467, DOI 10.1046/j.1523-1739.2001.015002467.x; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; Otani Y., 2012, J TROP BIOL CONS, V9, P214; Read MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000949; Ross J. P., 2012, CROCODILES STATUS SU; Runge CA, 2014, FRONT ECOL ENVIRON, V12, P395, DOI 10.1890/130237; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sabah Wildlife Department, 2010, CROC MAN PLAN, P1; SCHEEL D, 1991, ANIM BEHAV, V41, P697, DOI 10.1016/S0003-3472(05)80907-8; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Smith R, 2013, TIN MAPS, P1; SPILLER DA, 1994, ECOLOGY, V75, P182, DOI 10.2307/1939393; Tosun D. D., 2013, Journal of FisheriesSciences.com, V7, P43; van der Ploeg J, 2011, J INTEGR ENVIRON SCI, V8, P287, DOI 10.1080/1943815X.2011.610804; VANSCHAIK CP, 1985, FOLIA PRIMATOL, V44, P138, DOI 10.1159/000156208; Watanabe YY, 2013, AQUAT BIOL, V18, P1, DOI 10.3354/ab00489; Webb G., 1989, CROCODILES AUSTR; WWF, 2003, MAN RIV WIS, P1	46	6	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0184804	10.1371/journal.pone.0184804	http://dx.doi.org/10.1371/journal.pone.0184804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020111	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000412754400018
J	Nguyen, VL; Truong, CT; Nguyen, BCQ; Vo, TNV; Dao, TT; Nguyen, VD; Trinh, DTT; Huynh, HK; Bui, CB				Van-Linh Nguyen; Cong-Tri Truong; Binh Cao Quan Nguyen; Thanh-Niem Van Vo; Trong-Thuc Dao; Van-Dan Nguyen; Dieu-Thuong Thi Trinh; Hieu Kim Huynh; Bui, Chi-Bao			Anti-inflammatory and wound healing activities of calophyllolide isolated from Calophyllum inophyllum Linn	PLOS ONE			English	Article							GROWTH-FACTOR; INFLAMMATION	Due to the high-cost and limitations of current wound healing treatments, the search for alternative approaches or drugs, particularly from medicinal plants, is of key importance. In this study, we report anti-inflammatory and wound healing activities of the major calophyllolide (CP) compound isolated from Calophyllum inophyllum Linn. The results showed that CP had no effect on HaCaT cell viability over a range of concentrations. CP reduced fibrosis formation and effectively promoted wound closure in mouse model without causing body weight loss. The underlying molecular mechanisms of wound repair by CP was investigated. CP markedly reduced MPO activity, and increased M2 macrophage skewing, as shown by up-regulation of M2-related gene expression, which is beneficial to the wound healing process. CP treatment prevented a prolonged inflammatory process by down-regulation of the pro-inflammatory cytokines D IL-1 beta, IL-6, TNF-alpha, but up-regulation of the anti-inflammatory cytokine, IL-10. This study is the first to indicate a plausible role for CP in accelerating the process of wound healing through anti-inflammatory activity mechanisms, namely, by regulation of inflammatory cytokines, reduction in MPO, and switching of macrophages to an M2 phenotype. These findings may enable the utilization of CP as a potent therapeutic for cutaneous wound healing.	[Van-Linh Nguyen] Can Tho Univ, Biotechnol Res & Dev Inst, Can Tho City, Vietnam; [Van-Linh Nguyen; Thanh-Niem Van Vo; Trong-Thuc Dao; Van-Dan Nguyen; Hieu Kim Huynh; Bui, Chi-Bao] Univ Med & Pharm Ho Chi Minh City, Ctr Mol Biomed, Lab Cutaneous Res, Ho Chi Minh City, Vietnam; [Cong-Tri Truong] Univ Med & Pharm Ho Chi Minh City, Fac Pharm, Nanoprod Lab, Ho Chi Minh City, Vietnam; [Binh Cao Quan Nguyen] CuuLong Delta Rice Res Inst, Genet & Plant Breeding Dept, Can Tho City, Vietnam; [Binh Cao Quan Nguyen] PAK Res Ctr, Okinawa, Okinawa, Japan; [Van-Dan Nguyen; Dieu-Thuong Thi Trinh] Univ Med & Pharm Ho Chi Minh City, Fac Tradit Med, Ho Chi Minh City, Vietnam	Can Tho University; Hochiminh City University of Medicine & Pharmacy; Hochiminh City University of Medicine & Pharmacy; Hochiminh City University of Medicine & Pharmacy	Bui, CB (corresponding author), Univ Med & Pharm Ho Chi Minh City, Ctr Mol Biomed, Lab Cutaneous Res, Ho Chi Minh City, Vietnam.	bcbao@ump.edu.vn	Bui, Bao/GYE-1294-2022; Bui, Bao Chi/ABH-2694-2020	Bui, Bao/0000-0002-7937-1634; Bui, Bao Chi/0000-0002-7937-1634; Nguyen, Van-Dan/0000-0001-6975-8897	Soc Trang Department of Science and Development, Viet Nam [21/H/SKHCN-QLKHCN]	Soc Trang Department of Science and Development, Viet Nam	This research was supported by a grant from Soc Trang Department of Science and Development, Viet Nam (21/H/SKHCN-QLKHCN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoli A., 2017, MICROBIOL INFECT DIS, V51, P15; Abu-Seida Ashraf M, 2015, Vet Med Int, V2015, P672643, DOI 10.1155/2015/672643; ARORA RB, 1962, J PHARM PHARMACOL, V14, P534, DOI 10.1111/j.2042-7158.1962.tb11133.x; Asadi SY, 2013, INT J SURG, V11, P332, DOI 10.1016/j.ijsu.2013.02.014; BHALLA TN, 1980, INDIAN J MED RES, V72, P762; Bielefeld KA, 2013, CELL MOL LIFE SCI, V70, P2059, DOI 10.1007/s00018-012-1152-9; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Canesso MCC, 2014, J IMMUNOL, V193, P5171, DOI 10.4049/jimmunol.1400625; Chereddy KK, 2013, J CONTROL RELEASE, V171, P208, DOI 10.1016/j.jconrel.2013.07.015; Chong BF, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0839-3; Demidova-Rice TN, 2012, ADV SKIN WOUND CARE, V25, P304, DOI 10.1097/01.ASW.0000416006.55218.d0; Ebaid H, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-31; FEDARKO NS, 1995, J BONE MINER RES, V10, P1705; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Han D, 2007, J MICROBIOL BIOTECHN, V17, P1661; Hasmann A, 2013, ANN CLIN BIOCHEM, V50, P245, DOI 10.1258/acb.2011.010249; Ito C, 2006, J PHARM PHARMACOL, V58, P975, DOI 10.1211/jpp.58.7.0013; Jinnin M, 2005, J CELL PHYSIOL, V202, P510, DOI 10.1002/jcp.20154; Johnstone Carolyn C, 2005, Nurs Stand, V19, P59; Kolomytkin OV, 2002, AM J PHYSIOL-CELL PH, V282, pC1254, DOI 10.1152/ajpcell.01166.2000; Leguillier T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138602; Liu WH, 2015, MOLECULES, V20, P12314, DOI 10.3390/molecules200712314; Loi DT, 2004, CALOPHYLLUM INOPHYLL, P106; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murthy S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/972028; Papakonstantinou E, 2003, CYTOKINE, V24, P25, DOI 10.1016/S1043-4666(03)00253-9; Paquet P, 1996, INT ARCH ALLERGY IMM, V109, P308, DOI 10.1159/000237257; Pazyar N, 2014, SKIN PHARMACOL PHYS, V27, P303, DOI 10.1159/000357477; Praveena C, 2013, NAT PROD CHEM RES, V1; Qian LW, 2016, WOUND REPAIR REGEN, V24, P26, DOI 10.1111/wrr.12381; Rohl J, 2015, WOUND PRACT RES, V23, P8; Shen YC, 2003, CHEM PHARM BULL, V51, P802, DOI 10.1248/cpb.51.802; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Strodtbeck F, 2001, NEWBORN INFANT NURS, V1, P43, DOI [10.1053/nbin.2001.23176, DOI 10.1053/NBIN.2001.23176]; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tsai SC, 2012, ONCOL REP, V28, P1096, DOI 10.3892/or.2012.1873; Wang XJ, 2006, J INVEST DERM SYMP P, V11, P112, DOI 10.1038/sj.jidsymp.5650004; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yimdjo MC, 2004, PHYTOCHEMISTRY, V65, P2789, DOI 10.1016/j.phytochem.2004.08.024; Young A., 2011, SURGERY, V29, P475, DOI DOI 10.1016/J.MPSUR.2011.06.011; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e	41	49	49	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185674	10.1371/journal.pone.0185674	http://dx.doi.org/10.1371/journal.pone.0185674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020015	gold, Green Submitted, Green Published			2022-12-26	WOS:000412754400041
J	Wang, YW; Smith, JA; Wilmers, CC				Wang, Yiwei; Smith, Justine A.; Wilmers, Christopher C.			Residential development alters behavior, movement, and energetics in an apex predator, the puma	PLOS ONE			English	Article							TIME; URBANIZATION; RESPONSES; ECOLOGY; HABITAT; BUDGETS	Human development strongly influences large carnivore survival and persistence globally. Behavior changes are often the first measureable responses to human disturbances, and can have ramifications on animal populations and ecological communities. We investigated how a large carnivore responds to anthropogenic disturbances by measuring activity, movement behavior, and energetics in pumas along a housing density gradient. We used log-linear analyses to examine how habitat, time of day, and proximity to housing influenced the activity patterns of both male and female pumas in the Santa Cruz Mountains. We used spatial GPS location data in combination with Overall Dynamic Body Acceleration measurements recorded by onboard accelerometers to quantify how development density affected the average distances traveled and energy expended by pumas. Pumas responded to development differently depending on the time of day; at night, they were generally more active and moved further when they were in developed areas, but these relationships were not consistent during the day. Higher nighttime activity in developed areas increased daily caloric expenditure by 10.1% for females and 11.6% for males, resulting in increases of 3.4 and 4.0 deer prey required annually by females and males respectively. Our results support that pumas have higher energetic costs and resource requirements in human-dominated habitats due to human-induced behavioral change. Increased energetic costs for pumas are likely to have ramifications on prey species and exacerbate human-wildlife conflict, especially as exurban growth continues. Future conservation work should consider the consequences of behavioral shifts on animal energetics, individual fitness, and population viability.	[Wang, Yiwei] San Francisco Bay Bird Observ, 524 Valley Way, Milpitas, CA USA; [Wang, Yiwei; Smith, Justine A.; Wilmers, Christopher C.] Univ Calif Santa Cruz, Environm Studies Dept, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA; [Smith, Justine A.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Mulford Hall, Berkeley, CA 94720 USA	University of California System; University of California Santa Cruz; University of California System; University of California Berkeley	Smith, JA (corresponding author), Univ Calif Santa Cruz, Environm Studies Dept, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA.; Smith, JA (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Mulford Hall, Berkeley, CA 94720 USA.	jsmith5@berkeley.edu	Smith, Justine A/AAY-2879-2021	Smith, Justine A/0000-0001-8753-4061	National Science Foundation [0963022, 1255913]; Gordon and Betty Moore Foundation; Nature Conservancy; Felidae Conservation Fund; University of California, Santa Cruz; Midpeninsula Regional Open Space District	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Nature Conservancy; Felidae Conservation Fund; University of California, Santa Cruz(University of California System); Midpeninsula Regional Open Space District	Funded by 1. National Science Foundation (0963022), www.nsf.gov, Dr. Christopher C Wilmers. 2. National Science Foundation (1255913), www.nsf.gov,Dr. Christopher C Wilmers. 3. Gordon and Betty Moore Foundation, www.moore.org, Dr. Christopher C Wilmers. 4. The Nature Conservancy, www.nature.org, Dr. Christopher C Wilmers. 5. Felidae Conservation Fund, www.felidaefund.org, Dr. Christopher C Wilmers. 6. University of California, Santa Cruz, www.ucsc.edu, Dr. Yiwei Wang. 7. Midpeninsula Regional Open Space District, www.openspace.org, Dr. Christopher C Wilmers. No funders played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman B.B., 1986, P333; Batary P, 2004, CONSERV BIOL, V18, P389, DOI 10.1111/j.1523-1739.2004.00184.x; BEIER P, 1995, J MAMMAL, V76, P1056, DOI 10.2307/1382599; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caro T, 2007, TRENDS ECOL EVOL, V22, P394, DOI 10.1016/j.tree.2007.06.003; Caro T, 2011, TRENDS ECOL EVOL, V26, P111, DOI 10.1016/j.tree.2010.12.008; Caswell, 2000, MATRIX POPULATION MO; Christiansen F, 2013, BEHAV ECOL, V24, P1415, DOI 10.1093/beheco/art086; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; DASMANN R. F., 1956, JOUR MAMMAL, V37, P143, DOI 10.2307/1376672; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Elbroch LM, 2012, MAMM BIOL, V77, P377, DOI 10.1016/j.mambio.2012.02.010; Halsey LG, 2016, J EXP BIOL, V219, P1424, DOI 10.1242/jeb.133256; HORNOCKER M, 2009, COUGAR ECOLOGY CONSE; Kuijper DPJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1625; Laundre JW, 2008, WILDLIFE BIOL, V14, P221, DOI 10.2981/0909-6396(2008)14[221:TAOTFP]2.0.CO;2; Laundre JW, 2005, J WILDLIFE MANAGE, V69, P723, DOI 10.2193/0022-541X(2005)069[0723:PEAR]2.0.CO;2; Lusseau D, 2003, CONSERV BIOL, V17, P1785, DOI 10.1111/j.1523-1739.2003.00054.x; Magle SB, 2011, BEHAVIOUR, V148, P31, DOI 10.1163/000579510X545810; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ordiz A, 2014, BIOL CONSERV, V173, P1, DOI 10.1016/j.biocon.2014.03.006; Ordiz A, 2012, BIOL CONSERV, V152, P21, DOI 10.1016/j.biocon.2012.04.006; PARKER GA, 1976, AM NAT, V110, P1055, DOI 10.1086/283126; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; RUGG DJ, 1990, BIOMETRICS, V46, P1123, DOI 10.2307/2532453; Rutishauser M, 2011, EURASIP J WIREL COMM, DOI 10.1155/2011/968046; Sarkar D., 2019, NLME LINEAR NONLINEA; Smith JA, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0433; Smith JA, 2016, J WILDLIFE MANAGE, V80, P1040, DOI 10.1002/jwmg.21098; Smith JA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2711; Tadesse SA, 2012, BEHAV ECOL, V23, P1257, DOI 10.1093/beheco/ars110; TAYLOR CR, 1982, J EXP BIOL, V97, P1; Theobald DM, 2007, LANDSCAPE URBAN PLAN, V83, P340, DOI 10.1016/j.landurbplan.2007.06.002; Theobald DM, 2005, ECOL SOC, V10; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; US Geological Survey Gap Analysis Program (GAP), 2011, NAT LAND COV VERS 2; Wang YW, 2015, BIOL CONSERV, V190, P23, DOI 10.1016/j.biocon.2015.05.007; Wang YW, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0030-0; Williams TM, 2014, SCIENCE, V346, P81, DOI 10.1126/science.1254885; Wilmers CC, 2017, ECOSHPERE, V8, P1; Wilmers CC, 2015, ECOLOGY, V96, P1741, DOI 10.1890/14-1401.1; Wilmers CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060590; Wirsing AJ, 2012, MAR FRESHWATER RES, V63, P1069, DOI 10.1071/MF12074; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Zuur Alain F., 2009, P1	49	35	35	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0184687	10.1371/journal.pone.0184687	http://dx.doi.org/10.1371/journal.pone.0184687			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020087	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400015
J	Chen, JQ; Cai, WJ; Lin, Y; Chen, YM; Zheng, QF; Pan, JJ; Chen, CB				Chen, Junqiang; Cai, Wenjie; Lin, Yu; Chen, Yuanmei; Zheng, Qingfeng; Pan, Jianji; Chen, Chuanben			Patterns and rates of abdominal lymphatic metastasis following esophageal carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; POSTOPERATIVE RADIOTHERAPY; CURATIVE RESECTION; GASTRIC-CANCER; SURVIVAL; RECURRENCE; THERAPY	Aim To determine the rate of abdominal lymph node metastasis after radical surgery for esophageal cancer and define the radiotherapy target area. Methods Of the 1593 patients who underwent R0 radical esophagectomy for thoracic esophageal squamous cell carcinoma (TE-SCC), 148 developed abdominal lymph node (LN) metastases within three years of surgery. During that time interval, patients were examined by various imaging methods (enhanced computer tomography, magnetic resonance imaging, and positron emission tomography-CT) at set time points. The emerging recurrence pattern, preferred sites for abdominal metastasis, and correlation with added clinical factors were carefully recorded, to permit for delineation of a target area for radiotherapy. Results We found postoperative metastatic abdominal LNs in 9.3% of the patients treated for esophageal cancer. Lesions in the upper, middle, and lower esophageal segments metastasized to abdominal LNs at 2.3%, 7.8%, and 26.6% (P < 0.0001), respectively. Of all cases, 4.8% had fewer than two affected LNs, while 20.1% had more than three metastatic LNs (P < 0.0001). The metastasis rates of negative and positive celiac LNs were 4.6% and 22.7%, respectively. Abdominal LN metastasis rates for the following LNs: 16a2 and 16a1 of paraaortic, celiac artery, posterior surface of the pancreatic head and common hepatic artery were 64.9%, 41.2%, 37.8%, 32.4%, and 20.9%, respectively. The overall rate of metastasis to these groups of LNs was 91.9%. Conclusion This study determined that stations 16a1 and 16a2 of the para-aortic, truncus coeliacus, posterior surface of the pancreatic head, and arteria hepatica communis lymph nodes were the preferred sites for abdominal LN metastasis, thus defining target areas for postoperative radiotherapy.	[Chen, Junqiang; Lin, Yu; Pan, Jianji; Chen, Chuanben] Fujian Canc Hosp, Dept Radiat Oncol, Fuzhou, Fujian, Peoples R China; [Chen, Junqiang; Lin, Yu; Chen, Yuanmei; Zheng, Qingfeng; Pan, Jianji; Chen, Chuanben] Fujian Med Univ, Canc Hosp, Fuzhou, Fujian, Peoples R China; [Cai, Wenjie] Fujian Med Univ, Dept Radiat Oncol, Hosp Quanzhou Affiliated 1, Quanzhou, Fujian, Peoples R China; [Chen, Yuanmei; Zheng, Qingfeng] Fujian Canc Hosp, Dept Surg, Fuzhou, Fujian, Peoples R China	Fujian Medical University; Fujian Medical University	Chen, JQ (corresponding author), Fujian Canc Hosp, Dept Radiat Oncol, Fuzhou, Fujian, Peoples R China.; Chen, JQ (corresponding author), Fujian Med Univ, Canc Hosp, Fuzhou, Fujian, Peoples R China.	cjq122316@sina.com		Pan, Jianji/0000-0002-3211-7874	Natural Science Foundation of Fujian Province [2015J01377]; Science and Technology Foundation of Fujian Province [2011Y0014]; Key Clinical Specialty Discipline Construction Program of Fujian, P.R.C	Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Science and Technology Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Key Clinical Specialty Discipline Construction Program of Fujian, P.R.C	This study is supported by grants from the Natural Science Foundation of Fujian Province (2015J01377), the Key Project of Science and Technology Foundation of Fujian Province (2011Y0014) to Junqiang Chen, and the Key Clinical Specialty Discipline Construction Program of Fujian, P.R.C.	Bedard ELR, 2001, CANCER-AM CANCER SOC, V91, P2423, DOI 10.1002/1097-0142(20010615)91:12<2423::AID-CNCR1277>3.0.CO;2-1; Cai WJ, 2010, RADIOTHER ONCOL, V96, P104, DOI 10.1016/j.radonc.2010.04.029; Chen JQ, 2013, INT J RADIAT ONCOL, V86, P671, DOI 10.1016/j.ijrobp.2013.03.026; Chen JQ, 2010, ANN THORAC SURG, V90, P435, DOI 10.1016/j.athoracsur.2010.04.002; Chen JQ, 2009, EUR J CARDIO-THORAC, V36, P480, DOI 10.1016/j.ejcts.2009.03.056; Doki Y, 2005, WORLD J SURG, V29, P700, DOI 10.1007/s00268-005-7596-4; Edge SB, 2009, AJCC CANC STAGING MA, V7; Ge H, 2005, CHINESE CLIN ONCOLOG, V10, P526; Heye T, 2006, EUR RADIOL, V16, P2401, DOI 10.1007/s00330-006-0318-y; Kato H, 2004, BRIT J SURG, V91, P1004, DOI 10.1002/bjs.4595; Kim HJ, 2005, RADIOLOGY, V236, P879, DOI 10.1148/radiol.2363041101; Kim SK, 2006, EUR J NUCL MED MOL I, V33, P148, DOI 10.1007/s00259-005-1887-8; Liu M, 2014, RADIOTHER ONCOL, V113, P175, DOI 10.1016/j.radonc.2014.11.022; [刘文健 Liu Wenjian], 2010, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V37, P1358; Nakagawa S, 2004, J AM COLL SURGEONS, V198, P205, DOI 10.1016/j.jamcollsurg.2003.10.005; Qiao XY, 2008, INT J RADIAT ONCOL, V70, P396, DOI 10.1016/j.ijrobp.2007.06.031; TENIERE P, 1991, SURG GYNECOL OBSTET, V173, P123; Xiao Z, 2002, CHINESE CLIN ONCOLOG, V6, P608; Xiao ZF, 2005, INT J RADIAT ONCOL, V62, P82, DOI 10.1016/j.ijrobp.2004.08.046; [章文成 Zhang Wencheng], 2012, [中华放射肿瘤学杂志, Chinese Journal of Radiation Oncology], V21, P38	20	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185424	10.1371/journal.pone.0185424	http://dx.doi.org/10.1371/journal.pone.0185424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016614	Green Published, Green Submitted, gold			2022-12-26	WOS:000412627400018
J	Ohn, JH; Hwang, JY; Moon, MK; Ahn, HY; Kim, HH; Do Koo, Y; Kim, KI; Chang, HJ; Lee, HS; Jang, HC; Parka, YJ				Ohn, Jung Hun; Hwang, Ji Yeon; Moon, Min Kyong; Ahn, Hwa Young; Kim, Hwan Hee; Do Koo, Young; Kim, Kwang-Ii; Chang, Hyuk Jae; Lee, Hye Seung; Jang, Hak Chul; Park, Young Joo			Small heterodimer partner (SHP) deficiency protects myocardia from lipid accumulation in high fat diet-fed mice	PLOS ONE			English	Article							ORPHAN-NUCLEAR-RECEPTOR; CARDIAC-HYPERTROPHY; ACID OXIDATION; HEART-FAILURE; EXPRESSION PROFILES; GENE-EXPRESSION; METABOLISM; LIVER; CARDIOMYOPATHY; RESISTANCE	The small heterodimer partner (SHP) regulates fatty acid oxidation and lipogenesis in the liver by regulating peroxisome proliferator-activated receptor (PPAR) gamma expression. SHP is also abundantly expressed in the myocardium. We investigated the effect of SHP expression on myocardia assessing not only heart structure and function but also lipid metabolism and related gene expression in a SHP deletion animal model. Transcriptional profiling with a microarray revealed that genes participating in cell growth, cytokine signalling, phospholipid metabolism, and extracellular matrix are up-regulated in the myocardia of SHP knockout (KO) mice compared to those of wild-type (WT) mice (nominal p value < 0.05). Consistent with these gene expression changes, the left ventricular masses of SHP KO mice were significantly higher than WT mice (76.8 +/- 20.5 mg vs. 52.8 +/- 6.8 mg, P = 0.0093). After 12 weeks of high fat diet (HFD), SHP KO mice gained less weight and exhibited less elevation in serum-free fatty acid and less ectopic lipid accumulation in the myocardium than WT mice. According to microarray analysis, genes regulated by PPAR gamma 1 and PPAR alpha were down-regulated in myocardia of SHP KO mice compared to their expression in WT mice after HFD, suggesting that the reduction in lipid accumulation in the myocardium resulted from a decrease in lipogenesis regulated by PPAR gamma. We confirmed the reduced expression of PPAR gamma 1 and PPARa target genes such as CD36, medium-chain acyl-CoA dehydrogenase, long-chain acyl-CoA dehydrogenase, and very long-chain acyl-CoA dehydrogenase by SHP KO after HFD.	[Ohn, Jung Hun; Hwang, Ji Yeon; Kim, Kwang-Ii; Jang, Hak Chul] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seoul, South Korea; [Hwang, Ji Yeon] Seoul Natl Univ, Bundang Hosp, Preclin Res Ctr, Biomed Res Inst, Seoul, South Korea; [Moon, Min Kyong; Do Koo, Young; Kim, Kwang-Ii; Jang, Hak Chul; Park, Young Joo] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Moon, Min Kyong] Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Ahn, Hwa Young] Chung Ang Univ Hosp, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Hwan Hee; Do Koo, Young] Seoul Natl Univ Hosp, Clin Res Inst, Seoul, South Korea; [Chang, Hyuk Jae] Yonsei Univ, Coll Med, Div Cardiol, Yonsei Cardiovasc Ctr, Seoul, South Korea; [Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System; Seoul National University (SNU)	Moon, MK (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.; Moon, MK (corresponding author), Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	mkmoon@snu.ac.kr	Moon, Min Kyong/AAE-7663-2020; LEE, WON-YOUNG/C-7249-2018; Lee, Hye Seung/G-6419-2011; Kim, Kwang-il/D-8024-2012; Kim, Kwang-il/AAP-7315-2021	Moon, Min Kyong/0000-0002-5460-2846; LEE, WON-YOUNG/0000-0002-1082-7592; Lee, Hye Seung/0000-0002-1667-7986; Kim, Kwang-il/0000-0002-6658-047X; Kim, Kwang-il/0000-0002-6658-047X; Chang, Hyuk-Jae/0000-0002-6139-7545	Korean Diabetes Association	Korean Diabetes Association	This work was supported by a grant (Y.J. P., 2010) from the Korean Diabetes Association. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa E, 2007, DIABETES, V56, P1410, DOI 10.2337/db06-0655; Battiprolu PK, 2012, J CLIN INVEST, V122, P1109, DOI 10.1172/JCI60329; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Calligaris SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060931; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Fang CX, 2008, AM J PHYSIOL-HEART C, V295, pH1206, DOI 10.1152/ajpheart.00319.2008; Finck BN, 2007, CARDIOVASC RES, V73, P269, DOI 10.1016/j.cardiores.2006.08.023; Hartman HB, 2009, J LIPID RES, V50, P193, DOI 10.1194/jlr.M800323-JLR200; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jeong JY, 2012, DIABETES METAB J, V36, P328, DOI 10.4093/dmj.2012.36.5.328; Kong SW, 2005, PHYSIOL GENOMICS, V21, P34, DOI 10.1152/physiolgenomics.00226.2004; Lee IK, 2014, DIABETES METAB J, V38, P181, DOI 10.4093/dmj.2014.38.3.181; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nam YS, 2014, CIRC RES, V115, P493, DOI 10.1161/CIRCRESAHA.115.304388; Nishizawa H, 2002, J BIOL CHEM, V277, P1586, DOI 10.1074/jbc.M104301200; Osorio JC, 2002, CIRCULATION, V106, P606, DOI 10.1161/01.CIR.0000023531.22727.C1; Park YJ, 2011, J LIPID RES, V52, P2234, DOI 10.1194/jlr.M016048; Rodriguez-Calvo R, 2017, BBA-MOL CELL BIOL L, V1862, P541, DOI 10.1016/j.bbalip.2017.02.006; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang L, 2003, J BIOL CHEM, V278, P44475, DOI 10.1074/jbc.M305258200; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Wang Z, 2015, METABOLISM, V64, P917, DOI 10.1016/j.metabol.2015.04.010; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006	29	0	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186021	10.1371/journal.pone.0186021	http://dx.doi.org/10.1371/journal.pone.0186021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016649	Green Published, Green Submitted, gold			2022-12-26	WOS:000412627400049
J	Sarlah, A; Vilfan, A				Sarlah, Andreja; Vilfan, Andrej			Minimum requirements for motility of a processive motor protein	PLOS ONE			English	Article							AAA PLUS RING; MICROTUBULE-BINDING DOMAIN; CYTOPLASMIC DYNEIN; CRYSTAL-STRUCTURE; COILED-COIL; MYOSIN-V; KINESIN; MECHANISM; WALK; MOVEMENT	Motor proteins generally have a two-way coupling between the ATP hydrolysis site, the lever movement and the binding affinity for their track, which allows them to perform efficient stepping. Here we explore the minimal requirements for directed motility based on simpler schemes in which the binding/unbinding from the track is decoupled from the ATPase cycle. We show that a directed power stroke alone is not sufficient for motility, but combined with an asymmetry in force-induced unbinding rates it can generate stepping. The energetic efficiency of such stepping is limited to approximately 20%. We conclude that the allosteric coupling between the ATP hydrolysis and the track binding is not strictly necessary for motility, but it greatly improves its efficiency.	[Sarlah, Andreja] Univ Ljubljana, Fac Math & Phys, Ljubljana, Slovenia; [Vilfan, Andrej] J Stefan Inst, Ljubljana, Slovenia	University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Sarlah, A (corresponding author), Univ Ljubljana, Fac Math & Phys, Ljubljana, Slovenia.; Vilfan, A (corresponding author), J Stefan Inst, Ljubljana, Slovenia.	andreja.sarlah@fmf.uni-lj.si; andrej.vilfan@ijs.si	Vilfan, Andrej/B-1042-2008; Šarlah, Andreja/J-6884-2013	Vilfan, Andrej/0000-0001-8985-6072; Šarlah, Andreja/0000-0003-4913-4811	Slovenian Research Agency [J1-5437, J1-7441, P1-0099]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency, Grants J1-5437 (AV, AS), J1-7441 (AS) and P1-0099 (AV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bierbaum V, 2011, BIOPHYS J, V100, P1747, DOI 10.1016/j.bpj.2011.02.012; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Chowdhury D, 2013, PHYS REP, V529, P1, DOI 10.1016/j.physrep.2013.03.005; Cleary FB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5587; Derenyi I, 1996, P NATL ACAD SCI USA, V93, P6775, DOI 10.1073/pnas.93.13.6775; DeWitt MA, 2012, SCIENCE, V335, P221, DOI 10.1126/science.1215804; Duke T, 1996, BIOPHYS J, V71, P1235, DOI 10.1016/S0006-3495(96)79323-2; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; HAMMOND GS, 1955, J AM CHEM SOC, V77, P334, DOI 10.1021/ja01607a027; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P877, DOI 10.1038/nrm2807; Hoffmann PM, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/3/032601; HOLZBAUR ELF, 1989, BIOCHEMISTRY-US, V28, P7010, DOI 10.1021/bi00443a034; Howard J., 2001, MECH MOTOR PROTEINS; Imamula K, 2007, P NATL ACAD SCI USA, V104, P16134, DOI 10.1073/pnas.0702370104; Kikkawa M, 2013, J CELL BIOL, V202, P15, DOI 10.1083/jcb.201304099; Kolomeisky AB, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/46/463101; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Liepelt S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.258102; Lippert LG, 2017, P NATL ACAD SCI USA, V114, pE4564, DOI 10.1073/pnas.1620149114; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; Nicholas MP, 2015, P NATL ACAD SCI USA, V112, P6371, DOI 10.1073/pnas.1417422112; Nicholas MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7206; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Samii L, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021106; Sarlah A, 2014, BIOPHYS J, V107, P662, DOI 10.1016/j.bpj.2014.06.022; Schmidt H, 2015, BIOESSAYS, V37, P532, DOI 10.1002/bies.201400215; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Subramanian R, 2007, J GEN PHYSIOL, V130, P445, DOI 10.1085/jgp.200709866; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Thomas N, 2001, P ROY SOC B-BIOL SCI, V268, P2113, DOI 10.1098/rspb.2001.1764; Thoresen T, 2008, BIOCHEMISTRY-US, V47, P9514, DOI 10.1021/bi800747e; Tsygankov D, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3050098; von Delius M, 2010, NAT CHEM, V2, P96, DOI [10.1038/NCHEM.481, 10.1038/nchem.481]	42	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185948	10.1371/journal.pone.0185948	http://dx.doi.org/10.1371/journal.pone.0185948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016643	gold, Green Published, Green Submitted			2022-12-26	WOS:000412627400041
J	Dalla Rosa, I; Zhang, HL; Khiati, S; Wu, XL; Pommier, Y				Dalla Rosa, Ilaria; Zhang, Hongliang; Khiati, Salim; Wu, Xiaolin; Pommier, Yves			Transcription profiling suggests that mitochondrial topoisomerase IB acts as a topological barrier and regulator of mitochondrial DNA transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA topoisomerase; long noncoding RNA (long ncRNA; lncRNA); mitochondria; mitochondrial DNA (mtDNA); transcription; Top1mt	MAMMALIAN MITOCHONDRIA; NUCLEOID ORGANIZATION; POLY(A) POLYMERASE; NONCODING RNAS; II-BETA; MTDNA; GENOME; POLYADENYLATION; BINDING; PROTEIN	Mitochondrial DNA (mtDNA) is essential for cell viability because it encodes subunits of the respiratory chain complexes. Mitochondrial topoisomerase IB (TOP1MT) facilitates mtDNA replication by removing DNA topological tensions produced during mtDNA transcription, but it appears to be dispensable. To test whether cells lacking TOP1MT have aberrant mtDNA transcription, we performed mitochondrial transcriptome profiling. To that end, we designed and implemented a customized tiling array, which enabled genome-wide, strand-specific, and simultaneous detection of all mitochondrial transcripts. Our technique revealed that Top1mt KO mouse cells process the mitochondrial transcripts normally but that protein-coding mitochondrial transcripts are elevated. Moreover, we found discrete long noncoding RNAs produced by H-strand transcription and encompassing the noncoding regulatory region of mtDNA in human and murine cells and tissues. Of note, these noncoding RNAs were strongly up-regulated in the absence of TOP1MT. In contrast, 7S DNA, produced by mtDNA replication, was reduced in the Top1mt KO cells. We propose that the long noncoding RNA species in the D-loop region are generated by the extension of H-strand transcripts beyond their canonical stop site and that TOP1MT acts as a topological barrier and regulator for mtDNA transcription and D-loop formation.	[Dalla Rosa, Ilaria; Zhang, Hongliang; Khiati, Salim; Pommier, Yves] NCI, Mol Pharmacol Lab, Dev Therapeut Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Wu, Xiaolin] NCI, Lab Mol Technol, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pommier, Y (corresponding author), NCI, Mol Pharmacol Lab, Dev Therapeut Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	pommier@nih.gov		Dalla Rosa, Ilaria/0000-0003-4801-2396	National Institutes of Health Intramural Research Program from the Center for Cancer Research, NCI [Z01 BC006161]; NATIONAL CANCER INSTITUTE [ZIABC006161, Z01BC006161] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program from the Center for Cancer Research, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Intramural Research Program Grant Z01 BC006161 from the Center for Cancer Research, NCI. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akman G, 2016, P NATL ACAD SCI USA, V113, pE4276, DOI 10.1073/pnas.1600537113; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bobrowicz AJ, 2008, BIOCHEM SOC T, V36, P517, DOI 10.1042/BST0360517; Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005; Dalla Rosa I, 2014, J BIOL CHEM, V289, P18595, DOI 10.1074/jbc.M114.555367; Dietrich A, 2015, BIOCHIMIE, V117, P48, DOI 10.1016/j.biochi.2015.06.027; DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116; Douarre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041094; Freyer C, 2010, NUCLEIC ACIDS RES, V38, P6577, DOI 10.1093/nar/gkq527; GROSS NJ, 1969, J BIOL CHEM, V244, P1552; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khiati S, 2015, P NATL ACAD SCI USA, V112, P11282, DOI 10.1073/pnas.1511016112; Khiati S, 2014, CLIN CANCER RES, V20, P4873, DOI 10.1158/1078-0432.CCR-13-3373; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112; Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884; Low RL, 2003, EUR J BIOCHEM, V270, P4173, DOI 10.1046/j.1432-1033.2003.03814.x; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Miao ZH, 2007, CANCER RES, V67, P8752, DOI 10.1158/0008-5472.CAN-06-4554; MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rackham O, 2011, RNA, V17, P2085, DOI 10.1261/rna.029405.111; Rosa ID, 2009, NUCLEIC ACIDS RES, V37, P6414, DOI 10.1093/nar/gkp708; Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008; SBISA E, 1990, CURR GENET, V17, P247, DOI 10.1007/BF00312616; Schuster G, 2009, PROG MOL BIOL TRANSL, V85, P393, DOI 10.1016/S0079-6603(08)00810-6; Selwood SP, 2001, FEBS LETT, V494, P186, DOI 10.1016/S0014-5793(01)02345-6; Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005; Sobek S, 2013, NUCLEIC ACIDS RES, V41, P9848, DOI 10.1093/nar/gkt768; Solier S, 2013, CANCER RES, V73, P4830, DOI 10.1158/0008-5472.CAN-12-3504; Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923; Wang JC, 2009, ANNU REV BIOCHEM, V78, P31, DOI 10.1146/annurev.biochem.78.030107.090101; Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499; Wilson WC, 2014, HUM MOL GENET, V23, P6345, DOI 10.1093/hmg/ddu352; Zhang HL, 2004, NUCLEIC ACIDS RES, V32, P2087, DOI 10.1093/nar/gkh525; Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998; Zhang HL, 2008, BIOCHEMISTRY-US, V47, P11196, DOI 10.1021/bi800774b; Zhang HL, 2014, NUCLEIC ACIDS RES, V42, P7259, DOI 10.1093/nar/gku384	44	16	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20162	20172		10.1074/jbc.M117.815241	http://dx.doi.org/10.1074/jbc.M117.815241			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29021209	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000417696400021
J	Teng, T; Liang, LG; Chen, K; Xi, BW; Xie, J; Xu, P				Teng, Tao; Liang, Liguo; Chen, Kai; Xi, Bingwen; Xie, Jun; Xu, Pao			Isolation, identification and phenotypic and molecular characterization of pathogenic Vibrio vulnificus isolated from Litopenaeus vannamei	PLOS ONE			English	Article							SHRIMP	The morphology and the drug sensitivity of the strain GYX2014-1 isolated from the hepatic pancreatic tissue of moribund Litopenaeus vannamei were evaluated by conventional culture characteristics, physical and chemical characteristics, and molecular biology methods. Detection of extracellulase and hemolysin activity shows that the isolated GYX2014-1 has protease, lipase, gelatinase activity, but none of amylase, or lecithinase activity. The 16S rRNA gene (GenBank accession number: KT781675) was analyzed, and a phylogenetic tree analysis showed that the isolated pathogen was most closely related to V. vulnificus (GenBank accession number: NR 118570)-a match of more than 99%. The phenotypic traits and molecular biology of isolated bacteria, determined their identity as Vibrio vulnificus (V. vulnificus). In addition, artificially infected L. vannamei with Vibrio vulnificus appeared with the same disease symptoms as those of naturally infected shrimp. Drug sensitivity tests showed that V. vulnificus is highly sensitive to fosfomycin, cefradine and sinomin, and was resistant to penicillin, amikacin and kanamycin. This experiment is the first to separate V. vulnificus from L. vannamei, and the findings of this study can be used as a reference for disease control and health management.	[Teng, Tao; Xi, Bingwen; Xie, Jun; Xu, Pao] Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Jiangsu, Peoples R China; [Teng, Tao; Liang, Liguo; Chen, Kai; Xi, Bingwen; Xie, Jun; Xu, Pao] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Minist Agr, Key Lab Freshwater Fisheries & Germplasm Resource, Wuxi, Jiangsu, Peoples R China	Nanjing Agricultural University; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs	Xie, J (corresponding author), Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Jiangsu, Peoples R China.; Liang, LG; Xie, J (corresponding author), Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Minist Agr, Key Lab Freshwater Fisheries & Germplasm Resource, Wuxi, Jiangsu, Peoples R China.	lianglg@zju.edu.cn; xiej@ffrc.cn	liang, liguo/CAF-2773-2022	Xi, Bing-Wen/0000-0002-0402-7281; Liang, Liguo/0000-0002-4943-5166	China Agriculture Research System special project-the National Staple Freshwater Fish Industrial Technology System [CARS-46-10]; Aquaculture project in Jiangsu Province [D2015-13]	China Agriculture Research System special project-the National Staple Freshwater Fish Industrial Technology System; Aquaculture project in Jiangsu Province	This study was supported by the China Agriculture Research System special project-the National Staple Freshwater Fish Industrial Technology System (CARS-46-10) and Aquaculture project in Jiangsu Province (D2015-13).	Bi Ke-ran, 2011, Marine Sciences (Beijing), V35, P20; Bing Xu-Wen, 2009, Oceanologia et Limnologia Sinica, V40, P692; Bisharat N, 2005, EMERG INFECT DIS, V11, P30, DOI 10.3201/eid1101.040440; Cao HP, 2016, PROGR VET MED, V37, P128; Chen FR, 2014, Z NATURFORSCH C, V55, P94; Chen X, 2013, J MED RES, V42, P195; Chen XiaoMing, 2015, Chinese Journal of Animal Nutrition, V27, P2115; Chiang Shyh-Ren, 2003, Journal of Microbiology Immunology and Infection, V36, P81; Chung PH, 2006, EMERG INFECT DIS, V12, P1302, DOI 10.3201/eid1708.051495; [邓曦 Deng Xi], 2014, [食品工业科技, Science & Technology of Food Industry], V35, P197; Dong X.Z., 2001, COMMON BACTERIAL SYS; Duan YJ, 2015, SCI FISH FARMING, V1, P63; Garrity G.M., 2004, BERGEYS MANUAL SYSTE; Gopal S, 2005, INT J FOOD MICROBIOL, V102, P151, DOI 10.1016/j.ijfoodmicro.2004.12.011; Hoover DG, 2010, J FOOD SAFETY, V7, P35; Huang Jun, 2012, Nanfang Nongye Xuebao, V43, P107; KOENIG KL, 1991, WESTERN J MED, V155, P400; Kumaran M, 2017, AQUACULTURE, V468, P262, DOI 10.1016/j.aquaculture.2016.10.019; Lavilla-Pitogo CR, 1998, AQUACULTURE, V164, P337, DOI 10.1016/S0044-8486(98)00198-7; Li G. L., 2001, MAR SCI, V25, P1; Li K, 2016, AQUACULTURE, V457, P91, DOI 10.1016/j.aquaculture.2016.02.008; Li Mei, 2015, Journal of Shanghai Ocean University, V24, P579; Liu Heng, 1998, Oceanologia et Limnologia Sinica, V29, P113; Lu ZQ, 2009, J HUAZHONG U SCI-MED, V29, P193, DOI 10.1007/s11596-009-0211-4; Qing WU, 2015, CHIN J FOOD HYGI, V27, P363; Ramamurthy T, 2014, ENCY FOOD SAFETY, V27, P546; Shen Zhi-qiang, 2001, Chinese Journal of Veterinary Science & Technology, V31, P22; Teng Tao, 2015, Israeli Journal of Aquaculture Bamidgeh, V67, P1; Tian Ding, 2011, Fisheries Science ( Dalian), V30, P27; Wang L., 1994, OCEANOLOGIA LIMNOLOG, V25, P486; WRIGHT AC, 1981, INFECT IMMUN, V34, P503, DOI 10.1128/IAI.34.2.503-507.1981; Xu Bin-fu, 2005, Chinese Journal of Zoonoses, V21, P995; Yan MC, 2010, J HYDROECOL, V3, P136; Ye YF, 1997, NATL CLIN LAB PROCED; [尤荣开 YOU Rongkai], 2007, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V17, P1312; Zhai XiuMei, 2007, Journal of Shanghai Fisheries University, V16, P162; Zhang Jing, 2013, Chinese Journal of Zoonoses, V29, P54; Zhang XiaoJun, 2009, Oceanologia et Limnologia Sinica / Hai Yang Yu Hu Chao, V40, P654; Zhang ZH, 2016, J SCI FOOD AGR, V97; Zhu NingYu, 2015, Acta Agriculturae Zhejiangensis, V27, P756	40	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186135	10.1371/journal.pone.0186135	http://dx.doi.org/10.1371/journal.pone.0186135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045415	Green Published, gold, Green Submitted			2022-12-26	WOS:000413168100039
J	Peuhu, E; Salomaa, SI; De Franceschi, N; Potter, CS; Sundberg, JP; Pouwels, J				Peuhu, Emilia; Salomaa, Siiri I.; De Franceschi, Nicola; Potter, Christopher S.; Sundberg, John P.; Pouwels, Jeroen			Integrin beta 1 inhibition alleviates the chronic hyperproliferative dermatitis phenotype of SHARPIN-deficient mice	PLOS ONE			English	Article							NF-KAPPA-B; CHRONIC PROLIFERATIVE DERMATITIS; CHAIN ASSEMBLY COMPLEX; TERMINAL DIFFERENTIATION; EPIDERMAL PROLIFERATION; T-CELLS; SKIN; IMMUNE; DISEASE; BETA-1-INTEGRIN	SHARPIN (Shank-Associated RH Domain-Interacting Protein) is a component of the linear ubiquitin chain assembly complex (LUBAC), which enhances TNF-induced NF-kappa B activity. SHARPIN-deficient (Sharpin(cpdm/cpdm)) mice display multi-organ inflammation and chronic proliferative dermatitis (cpdm) due to TNF-induced keratinocyte apoptosis. In cells, SHARPIN also inhibits integrins independently of LUBAC, but it has remained enigmatic whether elevated integrin activity levels in the dermis of Sharpin(cpdm/cpdm) mice is due to increased integrin activity or is secondary to inflammation. In addition, the functional contribution of increased integrin activation to the Sharpin(cpdm/cpdm) phenotype has not been investigated. Here, we find increased integrin activity in keratinocytes from Tnfr1(-/-) Sharpin(cpdm/cpdm) double knockout mice, which do not display chronic inflammation or proliferative dermatitis, thus suggesting that SHARPIN indeed acts as an integrin inhibitor in vivo. In addition, we present evidence for a functional contribution of integrin activity to the Sharpin(cpdm/cpdm) skin phenotype. Treatment with an integrin beta 1 function blocking antibody reduced epidermal hyperproliferation and epidermal thickness in Sharpin(cpdm/cpdm) mice. Our data indicate that, while TNF-induced cell death triggers the chronic inflammation and proliferative dermatitis, absence of SHARPIN-dependent integrin inhibition exacerbates the epidermal hyperproliferation in Sharpin(cpdm/cpdm) mice.	[Peuhu, Emilia; Salomaa, Siiri I.; De Franceschi, Nicola; Pouwels, Jeroen] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Salomaa, Siiri I.] Univ Turku, Turku Drug Res Doctoral Programme, Turku, Finland; [Potter, Christopher S.; Sundberg, John P.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Pouwels, Jeroen] Univ Helsinki, TEHO Adapt Clin Trial Design, Helsinki, Finland	University of Turku; University of Turku; Jackson Laboratory; University of Helsinki	Peuhu, E; Pouwels, J (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.; Pouwels, J (corresponding author), Univ Helsinki, TEHO Adapt Clin Trial Design, Helsinki, Finland.	emilia.peuhu@utu.fi; jerpou@utu.fi	; De Franceschi, Nicola/S-8194-2016	Salomaa, Siiri/0000-0002-6583-0158; Peuhu, Emilia/0000-0003-4945-3046; De Franceschi, Nicola/0000-0002-7221-613X; Pouwels, Jeroen/0000-0002-5388-6103	Academy of Finland; University of Turku Graduate School (Drug Research Doctoral Programme); Instrumentarium Foundation; FinPharmaNet Doctoral Program; Orion Research Foundation; Finsk-Norska Medicinska Stiftelsen; Magnus Ehrnrooth Foundation; National Institutes of Health [T32 DK07449-28, R01-AR049288]; Finnish Cancer Institute; Intrumentarium Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049288] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); University of Turku Graduate School (Drug Research Doctoral Programme); Instrumentarium Foundation; FinPharmaNet Doctoral Program; Orion Research Foundation; Finsk-Norska Medicinska Stiftelsen; Magnus Ehrnrooth Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Finnish Cancer Institute; Intrumentarium Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We gratefully acknowledge these funding sources: E.P. - Academy of Finland Postdoc Grant; S.S. - University of Turku Graduate School (Drug Research Doctoral Programme), Instrumentarium Foundation; N.d.F. - FinPharmaNet Doctoral Program, Intrumentarium Foundation, Orion Research Foundation, Finsk-Norska Medicinska Stiftelsen and the Magnus Ehrnrooth Foundation; C.S.P. and J.P.S. - National Institutes of Health (T32 DK07449-28 and R01-AR049288); J.P. - Finnish Cancer Institute, Instrumentarium Foundation and Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599; Byron A, 2009, J CELL SCI, V122, P4009, DOI 10.1242/jcs.056770; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; Conrad C, 2007, NAT MED, V13, P836, DOI 10.1038/nm1605; De Franceschi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143423; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; GIJBELS MJJ, 1995, J INVEST DERMATOL, V105, P769, DOI 10.1111/1523-1747.ep12325599; Gijbels MJJ, 1996, AM J PATHOL, V148, P941; HOGENESCH H, 1993, AM J PATHOL, V143, P972; Hostager BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011380; HOTCHIN NA, 1995, J CELL BIOL, V128, P1209, DOI 10.1083/jcb.128.6.1209; HOTCHIN NA, 1993, J CELL SCI, V106, P1131; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kim C, 2014, EMBO MOL MED, V6, P970, DOI 10.15252/emmm.201303541; Kumari Snehlata, 2014, Elife, V3, DOI 10.7554/eLife.03422; Ley K, 2016, NAT REV DRUG DISCOV, V15, P173, DOI 10.1038/nrd.2015.10; Liang Y., 2011, PATHOLOG RES INT, V2011; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Park Y, 2016, NAT IMMUNOL, V17, P286, DOI 10.1038/ni.3352; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pouwels J, 2013, CELL REP, V5, P619, DOI 10.1016/j.celrep.2013.10.011; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Rebholz B, 2007, IMMUNITY, V27, P296, DOI 10.1016/j.immuni.2007.05.024; Rickard JA, 2014, ELIFE, V3, DOI 10.7554/eLife.03464; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Silva K, 2012, LAB MOUSE, P779; Tamiya H, 2014, J IMMUNOL, V192, P3793, DOI 10.4049/jimmunol.1302308; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Wang Z, 2012, J CELL MOL MED, V16, P2271, DOI 10.1111/j.1582-4934.2012.01574.x; Zak DE, 2011, P NATL ACAD SCI USA, V108, P11536, DOI 10.1073/pnas.1107577108; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904; Zinngrebe J, 2016, J EXP MED, V213, P2671, DOI 10.1084/jem.20160041	37	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186628	10.1371/journal.pone.0186628	http://dx.doi.org/10.1371/journal.pone.0186628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040328	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500064
J	Abrahamczyk, S; Lozada-Gobilard, S; Ackermann, M; Fischer, E; Krieger, V; Redling, A; Weigend, M				Abrahamczyk, Stefan; Lozada-Gobilard, Sissi; Ackermann, Markus; Fischer, Eberhard; Krieger, Vera; Redling, Almut; Weigend, Maximilian			A question of data quality-Testing pollination syndromes in Balsaminaceae	PLOS ONE			English	Article							FLORAL TRAITS; SPECIALIZATION; SYSTEMS; MORPHOLOGY; NETWORK; FLOWERS	Pollination syndromes and their predictive power regarding actual plant-animal interactions have been controversially discussed in the past. We investigate pollination syndromes in Balsaminaceae, utilizing quantitative respectively categorical data sets of flower morphometry, signal and reward traits for 86 species to test for the effect of different types of data on the test patterns retrieved. Cluster Analyses of the floral traits are used in combination with independent pollinator observations. Based on quantitative data we retrieve seven clusters, six of them corresponding to plausible pollination syndromes and one additional, well-supported cluster comprising highly divergent floral architectures. This latter cluster represents a non-syndrome of flowers not segregated by the specific data set here used. Conversely, using categorical data we obtained only a rudimentary resolution of pollination syndromes, in line with several earlier studies. The results underscore that the use of functional, exactly quanitified trait data has the power to retrieve pollination syndromes circumscribed by the specific data used. Data quality can, however, not be replaced by sheer data volume. With this caveat, it is possible to identify pollination syndromes from large datasets and to reliably extrapolate them for taxa for which direct observations are unavailable.	[Abrahamczyk, Stefan; Lozada-Gobilard, Sissi; Krieger, Vera; Redling, Almut; Weigend, Maximilian] Univ Bonn, Nees Inst Biodivers Plants, Meckenheimer Allee 170, Bonn, Germany; [Lozada-Gobilard, Sissi] Univ Potsdam, Inst Biochem & Biol, Maulbeerallee 1, Potsdam, Germany; [Ackermann, Markus; Fischer, Eberhard] Univ Koblenz Landau, Inst Integrated Nat Sci Biol, Univ Str 1, Koblenz, Germany	University of Bonn; University of Potsdam; University of Koblenz & Landau	Abrahamczyk, S (corresponding author), Univ Bonn, Nees Inst Biodivers Plants, Meckenheimer Allee 170, Bonn, Germany.	sabraham@uni-bonn.de	Ackermann, Markus/L-2425-2015; Lozada-Gobilard, Sissi/AAU-9166-2020; Weigend, Maximilian/F-7989-2014	Lozada-Gobilard, Sissi/0000-0002-1177-4015; Ackermann, Markus/0000-0002-3899-4392; Weigend, Maximilian/0000-0003-0813-6650; Krieger, Vera/0000-0002-3112-1425				Aigner PA, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P23; Akiyama S., 1991, THE HIMALAYAN PLANTS, V2, P67; [Anonymous], 1793, ENTDECKTE GEHEIMNIS, DOI [10.5962/bhl.title.50179, DOI 10.5962/BHL.TITLE.50179]; [Anonymous], 1766, VORLAUFIGE NACHRICHT; Armbruster WS, 2011, AM NAT, V178, P135, DOI 10.1086/660279; Auguie B, 2017, GRIDEXTRA MISCELLANE; BAKER GH, 1963, SCIENCE, V139, P877, DOI 10.1126/science.139.3558.877; Dafni A, 2005, PRACTICAL POLLINATIO, P503; Danieli-Silva A, 2012, OIKOS, V121, P35, DOI 10.1111/j.1600-0706.2011.19089.x; Darwin C., 1877, VARIOUS CONTRIVANCES; Delpino F, 1868, ATTI SOC ITAL SCI NA, VI; Delpino F, 1868, ATTI SOC ITAL SCI NA, VII; Erpenbach A, 2006, THESIS; Faegri K., 1979, PRINCIPLES POLLINATI; Faegri K., 1966, PRINCIPLES POLLINATI; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Grant V., 1965, FLOWER POLLINATION P; Grey-Wilson C., 1980, IMPATIENS AFRICA; Hawkins A.F.A., 2003, P94; Hingston AB, 2000, AUSTRAL ECOL, V25, P600, DOI 10.1111/j.1442-9993.2000.tb00065.x; Janecek S, 2015, BIOL J LINN SOC, V115, P127, DOI 10.1111/bij.12475; Janssens SB, 2009, MOL PHYLOGENET EVOL, V52, P806, DOI 10.1016/j.ympev.2009.04.013; Johnson KA, 2013, ANN BOT-LONDON, V112, P141, DOI 10.1093/aob/mct105; Johnson SD, 2017, FLORA, V232, P200, DOI 10.1016/j.flora.2017.02.005; Kato M, 1989, TROPICS, VI, P59; Knuth P, 1906, HDB BLUTENBIOLOGIE, VI-III; Kulloli SK, 2009, ECOL ENV CONS, V15, P235; Lazaro A, 2008, OECOLOGIA, V157, P249, DOI 10.1007/s00442-008-1066-2; Li JK, 2009, ANN BOT-LONDON, V104, P845, DOI 10.1093/aob/mcp173; Marten-Rodriguez S, 2009, J ECOL, V97, P348, DOI 10.1111/j.1365-2745.2008.01465.x; MULLER H, 1869, AM NAT, V5, P271; Muller H., 1883, FERTILIZATION FLOWER; Murua M, 2015, PLANT BIOLOGY, V17, P551, DOI 10.1111/plb.12225; Nienhuis Caroline Marijke, 2009, Journal of Pollination Ecology, V1, P1; Oksanen J., 2013, PACKAGE VEGAN R PACK, V254, P20; Ollerton J., 2015, Journal of Pollination Ecology, V16, P119; Ollerton J, 1996, J ECOL, V84, P767, DOI 10.2307/2261338; Ollerton J, 2000, SCANDINAVIAN ASS POL, V39, P149; Ollerton J, 2009, ANN BOT-LONDON, V103, P1471, DOI 10.1093/aob/mcp031; Perez F, 2006, AM J BOT, V93, P1029, DOI 10.3732/ajb.93.7.1029; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Potgieter CJ, 2005, ANN MO BOT GARD, V92, P254; Reynolds RJ, 2009, ECOLOGY, V90, P2077, DOI 10.1890/08-1141.1; Rosas-Guerrero V, 2014, ECOL LETT, V17, P388, DOI 10.1111/ele.12224; Saini M. S., 2007, Zoos Print Journal, V22, P2648; Smith SD, 2008, EVOLUTION, V62, P793, DOI 10.1111/j.1558-5646.2008.00327.x; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; Suzuki R., 2015, PACKAGE PVCLUST R TO, P14; Titze A, 2000, NORD J BOT, V20, P33, DOI 10.1111/j.1756-1051.2000.tb00729.x; Vervoort A, 2011, INT J PLANT SCI, V172, P366, DOI 10.1086/658152; Vlasankova A, 2017, NEW PHYTOL, V215, P1574, DOI 10.1111/nph.14677; Vogel S., 1954, BOT STUDIEN; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Wilson TC, 2017, INT J PLANT SCI, V178, P170, DOI 10.1086/690023; Yuan YM, 2004, TAXON, V53, P391, DOI 10.2307/4135617	56	14	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186125	10.1371/journal.pone.0186125	http://dx.doi.org/10.1371/journal.pone.0186125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036172	gold, Green Published, Green Submitted			2022-12-26	WOS:000413054800014
J	Pardi, E; Borsari, S; Saponaro, F; Bogazzi, F; Urbani, C; Mariotti, S; Pigliaru, F; Satta, C; Pani, F; Materazzi, G; Miccoli, P; Grantaliano, L; Marcocci, C; Cetani, F				Pardi, Elena; Borsari, Simona; Saponaro, Federica; Bogazzi, Fausto; Urbani, Claudio; Mariotti, Stefano; Pigliaru, Francesca; Satta, Chiara; Pani, Fabiana; Materazzi, Gabriele; Miccoli, Paolo; Grantaliano, Lorena; Marcocci, Claudio; Cetani, Filomena			Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features	PLOS ONE			English	Article							ENDOCRINE-NEOPLASIA TYPE-1; FAMILIAL ISOLATED HYPERPARATHYROIDISM; ISOLATED PITUITARY-ADENOMAS; LARGE GERMLINE DELETION; MEN1 GENE; AIP GENE; FUNCTIONAL-CHARACTERIZATION; ITALIAN PATIENTS; HIGHER RISK; TUMORS	The aim of this study was to carry out genetic screening of the MEN1, CDKN1B and AIP genes, both by direct sequencing of the coding region and multiplex ligation-dependent probe amplification (MLPA) assay in the largest monocentric series of Italian patients with Multiple Endocrine Neoplasia type 1 syndrome (MEN1) and Familial Isolated Hyperparathyroidism (FIHP). The study also aimed to describe and compare the clinical features of MEN1 mutation-negative and mutation-positive patients during long-term follow-up and to correlate the specific types and locations of MEN1 gene mutations with onset and aggressiveness of the main MEN1 manifestations. A total of 69 index cases followed at the Endocrinology Unit in Pisa over a period of 19 years, including 54 MEN1 and 15 FIHP kindreds were enrolled. Seven index cases with MEN1 but MEN1 mutation-negative, followed at the University Hospital of Cagliari, were also investigated. FIHP were also tested for CDC73 and CaSR gene alterations. MEN1 germline mutations were identified in 90% of the index cases of familial MEN1 (F-MEN1) and in 23% of sporadic cases (S-MEN1). MEN1 and CDC73 mutations accounted for 13% and 7% of the FIHP cohort, respectively. A CDKN1B mutation was identified in one F-MEN1. Two AIP variants of unknown significance were detected in two MEN1-negative S-MEN1. A MEN1 positive test best predicted the onset of all three major MEN1-related manifestations or parathyroid and gastro-entero-pancreatic tumors during follow-up. A comparison between the clinical characteristics of F and SMEN1 showed a higher prevalence of a single parathyroid disease and pituitary tumors in sporadic compared to familial MEN1 patients. No significant correlation was found between the type and location of MEN1 mutations and the clinical phenotype. Since all MEN1 mutation- positive sporadic patients had a phenotype resembling that of familial MEN1 (multiglandular parathyroid hyperplasia, a prevalence of gastro-entero-pancreatic tumors and/ or the classic triad) we might hypothesize that a subset of the sporadic MEN1 mutation-negative patients could represent an incidental coexistence of sporadic primary hyperparathyroidism and pituitary tumors or a MEN1 phenocopy, in our cohort, as in most cases described in the literature.	[Pardi, Elena; Borsari, Simona; Saponaro, Federica; Bogazzi, Fausto; Urbani, Claudio; Grantaliano, Lorena; Marcocci, Claudio] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Mariotti, Stefano; Pigliaru, Francesca; Satta, Chiara; Pani, Fabiana] Univ Cagliari, Dept Med Sci & Publ Hlth, Endocrinol Unit, Cagliari, Italy; [Materazzi, Gabriele; Miccoli, Paolo] Univ Pisa, Dept Surg Med & Mol Pathol & Crit Area, Pisa, Italy; [Grantaliano, Lorena] Hosp Villa Albani, Dept Med Sci, Anzio, RM, Italy; [Marcocci, Claudio; Cetani, Filomena] Univ Hosp Pisa, Endocrine Unit 2, Pisa, Italy	University of Pisa; University of Cagliari; University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Cetani, F (corresponding author), Univ Hosp Pisa, Endocrine Unit 2, Pisa, Italy.	cetani@endoc.med.unipi.it	Pardi, Elena/GQQ-0531-2022; Saponaro, federica/AAI-1372-2019; Mariotti, Stefano/AAN-1948-2020; Urbani, Claudio/K-8388-2016	Saponaro, federica/0000-0002-0277-1648; Mariotti, Stefano/0000-0002-1208-7057; Pani, Fabiana/0000-0003-2566-7971; PIGLIARU, FRANCESCA/0000-0002-3899-0391; Cetani, Filomena/0000-0003-2558-9547; Urbani, Claudio/0000-0002-2207-4727				Agarwal SK, 2009, J CLIN ENDOCR METAB, V94, P1826, DOI 10.1210/jc.2008-2083; ALLO M, 1982, SURGERY, V92, P486; Baciu I, 2013, ACTA ENDOCRINOL-BUCH, V9, P97, DOI 10.4183/aeb.2013.97; Balogh K, 2007, CLIN ENDOCRINOL, V67, P727, DOI 10.1111/j.1365-2265.2007.02953.x; Bartsch DK, 2014, J CLIN ENDOCR METAB, V99, pE2387, DOI 10.1210/jc.2013-4432; Belar O, 2012, CLIN ENDOCRINOL, V76, P719, DOI 10.1111/j.1365-2265.2011.04269.x; Bergman L, 2000, BRIT J CANCER, V83, P1009, DOI 10.1054/bjoc.2000.1380; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Cardinal JW, 2005, J MED GENET, V42, P69, DOI 10.1136/jmg.2003.017319; Cavaco BM, 2002, CLIN ENDOCRINOL, V56, P465, DOI 10.1046/j.1365-2265.2002.01505.x; Cazabat L, 2012, J CLIN ENDOCR METAB, V97, pE663, DOI 10.1210/jc.2011-2291; Cebrian A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e72; Cetani F, 2006, CLIN ENDOCRINOL, V64, P146, DOI 10.1111/j.1365-2265.2006.02438.x; Cetani F, 2004, J CLIN ENDOCR METAB, V89, P5583, DOI 10.1210/jc.2004-0294; Cetani F, 2002, CLIN ENDOCRINOL, V56, P457, DOI 10.1046/j.1365-2265.2002.01502.x; Cetani F, 2013, ENDOCR CONNECT, V2, P186, DOI 10.1530/EC-13-0046; CHOLOD EJ, 1970, AM J MED, V48, P700, DOI 10.1016/S0002-9343(70)80004-3; CHRISTENSSON T, 1976, ANN INTERN MED, V85, P614, DOI 10.7326/0003-4819-85-5-614; Concolino P, 2016, CANCER GENET-NY, V209, P36, DOI 10.1016/j.cancergen.2015.12.002; Cosme Angel, 2008, Gastroenterol Hepatol, V31, P637, DOI 10.1016/S0210-5705(08)75811-4; Daly AF, 2007, J CLIN ENDOCR METAB, V92, P1891, DOI 10.1210/jc.2006-2513; Daly AF, 2015, ENDOCRIN METAB CLIN, V44, P19, DOI 10.1016/j.ecl.2014.10.002; Davi MV, 2011, NEUROENDOCRINOLOGY, V94, P58, DOI 10.1159/000326164; de Laat JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0708-1; de Laat JM, 2015, J CLIN ENDOCR METAB, V100, P3288, DOI 10.1210/JC.2015-2015; DeLellis R, 2004, PATHOLOGY GENETICS T; Dinesen PT, 2015, ENDOCRINOL DIAB META, DOI 10.1530/EDM-14-0105; DOURY P, 1983, SEM HOP PARIS, V59, P3427; Ellard S, 2005, CLIN ENDOCRINOL, V62, P169, DOI 10.1111/j.1365-2265.2005.02190.x; Elston MS, 2015, CASE REP ENDOCRINOL, V2015, DOI 10.1155/2015/510985; FEIG DS, 1987, CANCER, V60, P429, DOI 10.1002/1097-0142(19870801)60:3<429::AID-CNCR2820600325>3.0.CO;2-3; Ferolla P, 2005, J CLIN ENDOCR METAB, V90, P2603, DOI 10.1210/jc.2004-1155; Formosa R, 2017, HORM CANC; Fromaget M, 2003, J MOL BIOL, V333, P87, DOI 10.1016/j.jmb.2003.08.001; Fukuuchi A, 2006, JPN J CLIN ONCOL, V36, P739, DOI 10.1093/jjco/hyl089; Georgitsi M, 2007, BRIT J CANCER, V96, P352, DOI 10.1038/sj.bjc.6603573; Georgitsi M, 2007, P NATL ACAD SCI USA, V104, P4101, DOI 10.1073/pnas.0700004104; Ghemigian A, 2013, HORM-INT J ENDOCRINO, V12, P454, DOI 10.1007/BF03401311; Giacche M, 2012, J ENDOCRINOL INVEST, V35, P124, DOI 10.1007/BF03345419; Giusti F, 2017, MULTIPLE ENDOCRINE N, P1; Goldman L, 1936, ANN SURG, V104, P971, DOI 10.1097/00000658-193612000-00002; GOLDSMITH RE, 1976, ANN INTERN MED, V84, P36, DOI 10.7326/0003-4819-84-1-36; GRABER AL, 1968, J AMER MED ASSOC, V204, P542, DOI 10.1001/jama.204.6.542; GREVSTEN S, 1974, UPSALA J MED SCI, V79, P109, DOI 10.3109/03009737409178978; Guan B, 2016, AM J HUM GENET, V99, P1034, DOI 10.1016/j.ajhg.2016.08.018; Guaraldi F, 2011, CTS-CLIN TRANSL SCI, V4, P55, DOI 10.1111/j.1752-8062.2010.00254.x; Isakov O, 2013, GENET RES, V95, P114, DOI 10.1017/S0016672313000141; JACKSON CE, 1967, AM J MED, V43, P727, DOI 10.1016/0002-9343(67)90114-3; Karges W, 2000, J ENDOCRINOL, V166, P1, DOI 10.1677/joe.0.1660001; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kikuchi M, 2004, CANCER LETT, V208, P81, DOI 10.1016/j.canlet.2003.10.011; Kishi M, 1999, CANCER LETT, V142, P105, DOI 10.1016/S0304-3835(99)00156-1; Kishi M, 1998, JPN J CANCER RES, V89, P1; Kong J, 2014, CLIN ENDOCRINOL, V81, P222, DOI 10.1111/cen.12461; Korbonits M, 2012, CLIN ENDOCRINOL, V77, P351, DOI 10.1111/j.1365-2265.2012.04445.x; Korpi-Hyovalti E, 2014, J CLIN ENDOCR METAB, V99, P3044, DOI 10.1210/jc.2014-1481; Kouvaraki MA, 2002, ARCH SURG-CHICAGO, V137, P641, DOI 10.1001/archsurg.137.6.641; Lairmore TC, 2004, ANN SURG, V239, P637, DOI 10.1097/01.sla.0000124383.98416.8d; LAW WM, 1983, NEW ENGL J MED, V309, P650, DOI 10.1056/NEJM198309153091107; Lee M, 2013, J ENDOCRINOL INVEST, V36, P781, DOI 10.3275/9021; Lemos MC, 2008, HUM MUTAT, V29, P22, DOI 10.1002/humu.20605; Lemos MC, 2009, J ENDOCRINOL, V203, P133, DOI 10.1677/JOE-09-0124; Machens A, 2007, CLIN ENDOCRINOL, V67, P613, DOI 10.1111/j.1365-2265.2007.02934.x; Manoharan J, 2016, ENDOCRINOL DIABETES, V2016, P1; MARSDEN P, 1971, BRIT MED J, V3, P87, DOI 10.1136/bmj.3.5766.87; Medford F E, 1970, W V Med J, V66, P1; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Morelli A, 2000, EUR J ENDOCRINOL, V142, P131, DOI 10.1530/eje.0.1420131; Namihira H, 1999, ENDOCR J, V46, P811, DOI 10.1507/endocrj.46.811; Odou MF, 2006, ANN ENDOCRINOL-PARIS, V67, P581, DOI 10.1016/S0003-4266(06)73010-4; Oriola J, 2013, EUR J ENDOCRINOL, V168, P9, DOI 10.1530/EJE-12-0457; Ospina NS, 2015, HORM CANCER-US, V6, P247, DOI 10.1007/s12672-015-0228-z; Owens M, 2008, CLIN ENDOCRINOL, V68, P350, DOI 10.1111/j.1365-2265.2007.03045.x; Pardi E, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0116; Pardi E, 2013, J CLIN ENDOCR METAB, V98, P2800, DOI 10.1210/jc.2012-4029; Pellegata NS, 2006, P NATL ACAD SCI USA, V103, P15558, DOI 10.1073/pnas.0603877103; Pontikides N, 2014, J BONE MINER METAB, V32, P351, DOI 10.1007/s00774-013-0551-9; Raef H, 2011, CLIN ENDOCRINOL, V75, P791, DOI 10.1111/j.1365-2265.2011.04134.x; Romei C, 2012, J ONCOL, V2012, DOI 10.1155/2012/705036; Rusconi D, 2011, CANCER GENET-NY, V204, P309, DOI 10.1016/j.cancergen.2011.03.006; Sambugaro S, 2015, ENDOCRINE, V49, P58, DOI 10.1007/s12020-015-0540-y; SCHOLZ DA, 1978, MAYO CLIN PROC, V53, P792; Takeuchi Takako, 2015, Clin Pediatr Endocrinol, V24, P185, DOI 10.1297/cpe.24.185; Thakker RV, 2012, J CLIN ENDOCR METAB, V97, P2990, DOI 10.1210/jc.2012-1230; Tham E, 2007, J CLIN ENDOCR METAB, V92, P3389, DOI 10.1210/jc.2007-0476; Thevenon J, 2013, HUM MOL GENET, V22, P1940, DOI 10.1093/hmg/ddt039; TODAKA M, 1992, INTERNAL MED, V31, P712, DOI 10.2169/internalmedicine.31.712; Travis WD, 2015, PATHOLOGY GENETICS T; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; WASSIF WS, 1993, J CLIN ENDOCR METAB, V77, P1485, DOI 10.1210/jc.77.6.1485; Zatelli MC, 2014, FAM CANCER, V13, P273, DOI 10.1007/s10689-014-9702-y; Zatelli MC, 2013, PITUITARY, V16, P238, DOI 10.1007/s11102-012-0409-5	92	20	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186485	10.1371/journal.pone.0186485	http://dx.doi.org/10.1371/journal.pone.0186485			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036195	Green Published, gold, Green Submitted			2022-12-26	WOS:000413054800038
J	Restin, T; Kajdi, ME; Schlapfer, M; Z'graggen, BR; Booy, C; Dumrese, C; Beck-Schimmer, B				Restin, Tanja; Kajdi, Marie-Elisabeth; Schlapfer, Martin; Z'graggen, Birgit Roth; Booy, Christa; Dumrese, Claudia; Beck-Schimmer, Beatrice			Sevoflurane protects rat brain endothelial barrier structure and function after hypoxia-reoxygenation injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; GROWTH-FACTOR; ADHERENS JUNCTIONS; EDEMA FORMATION; TIGHT JUNCTIONS; CELL-LINES; PERMEABILITY; VEGF; EXPRESSION; HYPERPERMEABILITY	Background After cerebral injury blood-brain barrier disruption significantly impairs brain homeostasis. Volatile anesthetics have been shown to be protective in ischemia-reperfusion injury scenarios. Their impact on brain endothelial cells after hypoxia-reoxygenation (H/R) has not yet been studied in detail. Methods Rat brain endothelial cells (RBE4) were exposed to severe hypoxia and reoxygenated in air in the presence or absence of sevoflurane. Changes in dextran permeability and architecture of the cellular junctional proteins ZO-1 and beta-catenin were measured. To determine necrosis and apoptosis rate DNA content, LDH release and caspase activity were quantified. The role of vascular endothelial growth factor (VEGF) as an inflammatory mediator increasing vascular permeability was assessed. At the same time, it was evaluated if sevoflurane effects are mediated through VEGF. Results were analyzed by unpaired t-tests or one way-analysis of variance followed by Bonferroni's correction. Results H/R led to a 172% increase in permeability (p< 0.001), cell swelling and qualitatively but not quantitatively modified expression of ZO-1, beta-catenin and F-actin. In the presence of sevoflurane during reoxygenation, barrier function improved by 96% (p = 0.042) in parallel to a decrease of the cell size and less re-arranged junction proteins and F-actin. Sevoflurane-induced improvement of the barrier function could not be explained on the level of necrosis or apoptosis as they remained unchanged independent of the presence or absence of the volatile anesthetic. Increased expression of VEGF after H/R was attenuated by sevoflurane by 34% (p = 0.004). Barrier protection provided by sevoflurane was similar to the application of a blocking VEGF-antibody. Furthermore, the protective effect of sevoflurane was abolished in the presence of recombinant VEGF. Conclusions In H/R-induced rat brain endothelial cell injury sevoflurane maintains endothelial barrier function through downregulation of VEGF, which is a key player not only in mediating injury, but also with regard to the protective effect of sevoflurane.	[Restin, Tanja; Schlapfer, Martin; Beck-Schimmer, Beatrice] Univ Hosp Zurich, Inst Anesthesiol, Zurich, Switzerland; [Restin, Tanja; Kajdi, Marie-Elisabeth; Schlapfer, Martin; Z'graggen, Birgit Roth; Booy, Christa; Beck-Schimmer, Beatrice] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Dumrese, Claudia] Univ Zurich, Flow Cytometry Facil, Zurich, Switzerland; [Beck-Schimmer, Beatrice] Univ Illinois, Dept Anesthesiol, Chicago, IL 60607 USA	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Beck-Schimmer, B (corresponding author), Univ Hosp Zurich, Inst Anesthesiol, Zurich, Switzerland.; Beck-Schimmer, B (corresponding author), Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.; Beck-Schimmer, B (corresponding author), Univ Illinois, Dept Anesthesiol, Chicago, IL 60607 USA.	beatrice.beckschimmer@uzh.ch	Schlaepfer, Martin/B-9243-2017; Restin, Tanja/Z-1454-2019; Restin, Tanja/AAF-5086-2020; Restin, Tanja/AAR-9091-2021; Schlaepfer, Martin/AAA-3587-2021	Schlaepfer, Martin/0000-0003-4288-7124; Restin, Tanja/0000-0002-8816-6069; Schlaepfer, Martin/0000-0003-4288-7124	Zurich Centre of Integrative Human Physiology (ZIHP) of the University of Zurich, Zurich, Switzerland; MD-PhD Program of the Swiss National Science Foundation (SNSF), Bern, Switzerland [323530_158128]	Zurich Centre of Integrative Human Physiology (ZIHP) of the University of Zurich, Zurich, Switzerland; MD-PhD Program of the Swiss National Science Foundation (SNSF), Bern, Switzerland	This work was supported by a grant from the Zurich Centre of Integrative Human Physiology (ZIHP) of the University of Zurich, Zurich, Switzerland (BBS). TR's position is funded through the MD-PhD Program of the Swiss National Science Foundation (SNSF), Bern, Switzerland (323530_158128).	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Adamczyk S, 2010, BRIT J ANAESTH, V104, P191, DOI 10.1093/bja/aep365; Al Ahmad A, 2009, J CELL PHYSIOL, V218, P612, DOI 10.1002/jcp.21638; Bae MJ, 2015, CURR NEUROVASC RES, V12, P375, DOI 10.2174/1567202612666150731105831; Basiji DA, 2007, CLIN LAB MED, V27, P653, DOI 10.1016/j.cll.2007.05.008; Beck-Schimmer B, 2008, ANN SURG, V248, P909, DOI 10.1097/SLA.0b013e31818f3dda; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; Daneman R, 2012, ANN NEUROL, V72, P648, DOI 10.1002/ana.23648; Davis B, 2010, INT J DEV NEUROSCI, V28, P423, DOI 10.1016/j.ijdevneu.2010.06.010; De Hert SG, 2004, ANESTHESIOLOGY, V101, P299, DOI 10.1097/00000542-200408000-00009; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Hayes S, 2006, NAT CELL BIOL, V8, P1052, DOI 10.1038/ncb1006-1052; Hippenstiel S, 1998, AM J PHYSIOL-LUNG C, V274, pL678, DOI 10.1152/ajplung.1998.274.5.L678; Ilan N, 2003, LAB INVEST, V83, P1105, DOI 10.1097/01.LAB.0000083531.84403.8B; Kimura R, 2005, STROKE, V36, P1259, DOI 10.1161/01.STR.0000165925.20413.14; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Lee HT, 2004, ANESTHESIOLOGY, V101, P1313; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Rist RJ, 1997, BRAIN RES, V768, P10, DOI 10.1016/S0006-8993(97)00586-6; Roux F, 2005, CELL MOL NEUROBIOL, V25, P41, DOI 10.1007/s10571-004-1376-9; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; Sims D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r20; Thal SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050752; Tietz S, 2015, J CELL BIOL, V209, P493, DOI 10.1083/jcb.201412147; Tornavaca O, 2015, J CELL BIOL, V208, P821, DOI 10.1083/jcb.201404140; Tzur A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016053; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; Voigtsberger S, 2009, ANESTHESIOLOGY, V111, P1238, DOI 10.1097/ALN.0b013e3181bdf857; Wang W, 2001, AM J PHYSIOL-HEART C, V280, pH434, DOI 10.1152/ajpheart.2001.280.1.H434; Yeh WL, 2008, MOL PHARMACOL, V73, P170, DOI 10.1124/mol.107.038851; Yue T, 2008, EUR RESPIR J, V31, P118, DOI 10.1183/09031936.00046307	41	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0184973	10.1371/journal.pone.0184973	http://dx.doi.org/10.1371/journal.pone.0184973			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023577	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000412845100011
J	Vendan, SE; Manivannan, S; Sunny, AM; Murugesan, R				Vendan, S. Ezhil; Manivannan, S.; Sunny, Anila M.; Murugesan, R.			Phytochemical residue profiles in rice grains fumigated with essential oils for the control of rice weevil	PLOS ONE			English	Article							PHOSPHINE; TOXICITY; INSECTICIDE; PRODUCTS; BORER	In the present study, we investigated the fumigant potential of five edible essential oils (EOs) against Sitophilus oryzae and their phytochemical residues in treated grains. Among the tested EOs, peppermint oil proved significantly effective (P <= 0.05) on S. oryzae at 400 mu l/L air concentration, inducing 83 and 100% mortalities in with-food and without-food conditions respectively over 72 h exposure. In addition, it was also observed that the binary mixtures of peppermint + lemon oil (1: 1 ratio) produced an equivalent effect to that of peppermint oil alone treatments. The phytochemical residue analysis by GC-MS revealed the presence of six compounds upon 72 h exposure to EOs. Further, the analysis of physicochemical properties of the compounds indicated a positive correlation between polar surface area (PSA) and its residual nature. The residue levels of eugenol were significantly elevated corresponding to its high PSA value (29) in clove and cinnamon oils. On the other hand, the compounds with zero PSA value imparted very less or no (D-Limonene, caryophyllene, pinene and terpinolene) residues in treated grains. With respect to the most active peppermint oil, L-menthone, menthyl acetate and eucalyptol residues were at 67, 41 and 23% levels respectively. The outcome of the present study indicate the peppermint oil as a potent fumigant against S. oryzae, and although the residues of phytochemicals in treated grains is higher; they belong to the generally recognised as safe (GRAS) status leaving no harmful effect.	[Vendan, S. Ezhil; Manivannan, S.; Sunny, Anila M.; Murugesan, R.] Cent Food Technol Res Inst, CSIR, Food Protectants & Infestat Control Dept, Mysore, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Vendan, SE (corresponding author), Cent Food Technol Res Inst, CSIR, Food Protectants & Infestat Control Dept, Mysore, Karnataka, India.	geneezil@yahoo.co.in	Vendan, S. Ezhil/I-6759-2019; MANIVANNAN, SELLADURAI/M-7272-2016; NITT, Physics/AGR-3228-2022	Vendan, S. Ezhil/0000-0001-8538-7109; NITT, Physics/0000-0002-3011-002X	Council of Scientific and Industrial Research, New Delhi, India [MLP 196]; Council of Scientific and Industrial Research (CSIR), New Delhi, Government of India [MLP-196]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (CSIR), New Delhi, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This study was funded by Council of Scientific and Industrial Research, New Delhi, India MLP 196 (In-House) to EV.; We thank Prof. Ram Rajasekharan, Director, CSIR-Central Food Technological Research Institute, Mysore for the support and facilities provided for this study. This research is financially supported by Council of Scientific and Industrial Research (CSIR), New Delhi, Government of India, under the MLP-196 project. We also thank Mr. Bhavani Eswaran, CIFS, CSIR-CFTRI for his assistance in GC-MS analysis. The authors sincerely thank the anonymous reviewers for their valuable comments/suggestions on the earlier version of the manuscript and Dr. P. Prabashankar, Senior Principal Scientist, CSIR-CFTRI, Mysore and Prof. James Premdoss Clement, Jawaharlal Nehru Centre for Advanced Scientific Research, India for editing the previous version of the manuscript.	Adams TB, 1996, FOOD CHEM TOXICOL, V34, P763, DOI 10.1016/S0278-6915(96)00051-8; [Anonymous], 1925, J ECON ENTOMOL; Belitz H. -D., 2009, FOOD CHEM, P340; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Cartalade D, 2006, J AGR FOOD CHEM, V54, P3086, DOI 10.1021/jf0514928; Dudareva N, 2004, PLANT PHYSIOL, V135, P1893, DOI 10.1104/pp.104.049981; FINNEY D J, 1971, P333; HARWOOD SH, 1990, J ECON ENTOMOL, V83, P1761, DOI 10.1093/jee/83.5.1761; Hyldgaard M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00012; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Isman MB, 2014, TRENDS PLANT SCI, V19, P140, DOI 10.1016/j.tplants.2013.11.005; Kamatou GPP, 2013, PHYTOCHEMISTRY, V96, P15, DOI 10.1016/j.phytochem.2013.08.005; Khani M., 2012, Journal of Medicinal Plants, V11, P97; Krishnarajah S. R., 1985, Tropical Science, V25, P249; Krishnaswamy NR, 1996, RESONANCE, V1, P40; Lee B-H, 2003, P AUSTR POSTH TECHN, P230; Lee SE, 2001, PEST MANAG SCI, V57, P548, DOI 10.1002/ps.322; Liska A., 2010, 10 INT WORK C STOR P, P716, DOI DOI 10.5073/JKA.2010.425.093; Manivannan S, 2016, RSC ADV, V6, P90024, DOI 10.1039/c6ra05670a; Manivannan S, 2015, J FOOD SCI TECH MYS, V52, P6810, DOI 10.1007/s13197-015-1799-y; Manivannan S, 2016, J STORED PROD RES, V69, P175, DOI 10.1016/j.jspr.2016.08.005; Nattudurai G., 2012, Journal of King Saud University Science, V24, P153, DOI 10.1016/j.jksus.2010.11.002; Nguyen TTX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116679; Opender Koul, 2008, Biopesticides International, V4, P63; Palm K, 1996, J PHARM SCI, V85, P32, DOI 10.1021/js950285r; Pecar D, 2014, CHEM ENG COMMUN, V201, P1548, DOI 10.1080/00986445.2013.819353; Prakash B, 2016, CURR SCI INDIA, V110, P1890; Rajendran S, 2008, J STORED PROD RES, V44, P126, DOI 10.1016/j.jspr.2007.08.003; Rajendran S, 2007, STEWART POSTHARVEST, V6, P1; Rajendran S., 2007, P INT C CONTR ATM FU, P345; Reddy PV, 2007, PEST MANAG SCI, V63, P96, DOI 10.1002/ps.1298; S.C.o. Food, 2002, OPINION SCI COMMITTE, P1; Shaaya E, 1997, J STORED PROD RES, V33, P7, DOI 10.1016/S0022-474X(96)00032-X; Tajkarimi MM, 2010, FOOD CONTROL, V21, P1199, DOI 10.1016/j.foodcont.2010.02.003; USEPA (U.S. Environmental Protection Agency), 1996, EX CERT PEST SUBST F, V61, P8876; USFDA (U.S. Food and Drug Administration), GRAS SUBST SCOGS DAT; USFDA (U.S. Food and Drug Administration), 1998, ESS OILS OL SOLV FRE, V6, P485	37	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186020	10.1371/journal.pone.0186020	http://dx.doi.org/10.1371/journal.pone.0186020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023481	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100052
J	Thickman, JD; Gobler, CJ				Thickman, Jake D.; Gobler, Christopher J.			The ability of algal organic matter and surface runoff to promote the abundance of pathogenic and non-pathogenic strains of Vibrio parahaemolyticus in Long Island Sound, USA	PLOS ONE			English	Article							WATER-QUALITY ASSESSMENT; ESCHERICHIA-COLI; ESTUARINE WATERS; NORTH-CAROLINA; COCHLODINIUM-POLYKRIKOIDES; MOLLUSCAN SHELLFISH; INDICATOR ORGANISMS; FECAL INDICATORS; COASTAL WATERS; PCR ASSAY	Food safety is a major concern in the shellfish industry, as severe illness can result from consuming shellfish that have accumulated waterborne pathogens. Shellfish harvesting areas are typically monitored for indicator bacteria such as fecal coliforms that serve as proxies for enteric pathogens although these indicators have shown little relation to some naturally occurring pathogenic bacteria such as Vibrio parahaemolyticus. To examine the dynamics and ecology of pathogenic and non-pathogenic strains of V. parahaemolyticus and address the relevance of indicator bacteria in predicting V. parahaemolyticus concentrations, field surveys and experiments were carried out in western Long Island Sound, NY, USA, a region that has experienced recent outbreaks of shellfish contaminated with V. parahaemolyticus. Pathogenic and non-pathogenic strains were quantified via PCR detection of marker genes and most probable number techniques. Field survey data showed little correspondence between fecal coliforms and V. parahaemolyticus, but significant correlations between V. parahaemolyticus and an alternative indicator, enterococci, and between V. parahaemolyticus and short-term (48 h) rainfall were observed. Experiments demonstrated that enrichment of seawater with phytoplankton-derived dissolved organic matter significantly increased the concentration of total V. parahaemolyticus and the presence pathogenic V. parahaemolyticus, but higher temperatures did not. Collectively, these study results suggest that fecal coliforms may fail to account for the full suite of important shellfish pathogens but that enterococci could provide a potential alternative or supplement to shellfish sanitation monitoring. Given the ability of algal-derived dissolved organic matter to promote the growth of pathogenic V. parahaemolyticus, restricting nutrient inputs into coastal water bodies that promote algal blooms may indirectly decrease the proliferation of V. parahaemolyticus and protect public health.	[Thickman, Jake D.; Gobler, Christopher J.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY 11968 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gobler, CJ (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY 11968 USA.	Christopher.gobler@stonybrook.edu			Laurie Landeau Foundation; Jim Simons Foundation; Rauch Foundation; Chicago Community Trust	Laurie Landeau Foundation; Jim Simons Foundation; Rauch Foundation; Chicago Community Trust	This work was supported by the Laurie Landeau Foundation, the Jim Simons Foundation, the Rauch Foundation, and the Chicago Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Laurie Landeau Foundation, the Jim Simons Foundation, the Rauch Foundation, and the Chicago Community Trust. We are indebted to Jennifer Goleski for logistic assistance, Dr. Theresa Hattenrath-Lehmann for analytical assistance, and useful edits and feedback from Drs. Gordon Taylor and Bassem Allam.	Anderson TH, 2001, ESTUARIES, V24, P228, DOI 10.2307/1352947; AZAM F, 1994, MICROBIAL ECOL, V28, P167, DOI 10.1007/BF00166806; BAINES SB, 1991, LIMNOL OCEANOGR, V36, P1078, DOI 10.4319/lo.1991.36.6.1078; Blackwell KD, 2008, J MICROBIOL, V46, P146, DOI 10.1007/s12275-007-0216-2; Burkhardt W, 2000, WATER RES, V34, P2207, DOI 10.1016/S0043-1354(99)00399-1; CABELLI VJ, 1983, J WATER POLLUT CON F, V55, P1306; Campos CJA, 2013, ESTUAR COAST, V36, P834, DOI 10.1007/s12237-013-9599-y; Cao YP, 2015, WATER RES, V70, P337, DOI 10.1016/j.watres.2014.12.008; Catherine A, 2012, WATER RES, V46, P1771, DOI 10.1016/j.watres.2011.12.056; Cook DW, 2002, J FOOD PROTECT, V65, P1873, DOI 10.4315/0362-028X-65.12.1873; Deepanjali A, 2005, APPL ENVIRON MICROB, V71, P3575, DOI 10.1128/AEM.71.7.3575-3580.2005; DePaola A, 2003, APPL ENVIRON MICROB, V69, P1521, DOI 10.1128/AEM.69.3.1521-1526.2003; DePaola A, 2010, APPL ENVIRON MICROB, V76, P2754, DOI 10.1128/AEM.02590-09; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Drake SL, 2007, COMPR REV FOOD SCI F, V6, P120, DOI 10.1111/j.1541-4337.2007.00022.x; Eckner KF, 1998, APPL ENVIRON MICROB, V64, P3079; Field KG, 2007, WATER RES, V41, P3517, DOI 10.1016/j.watres.2007.06.056; Fong TT, 2005, MICROBIOL MOL BIOL R, V69, P357, DOI 10.1128/MMBR.69.2.357-371.2005; Froelich BA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0209; Garrido A, 2012, FOOD CONTROL, V24, P128, DOI 10.1016/j.foodcont.2011.09.015; Garthright WE, 2003, FOOD MICROBIOL, V20, P439, DOI 10.1016/S0740-0020(02)00144-2; Gobler CJ, 2008, HARMFUL ALGAE, V7, P293, DOI 10.1016/j.hal.2007.12.006; Gobler CJ, 2012, HARMFUL ALGAE, V17, P64, DOI 10.1016/j.hal.2012.03.001; Harwood VJ, 2005, APPL ENVIRON MICROB, V71, P3163, DOI 10.1128/AEM.71.6.3163-3170.2005; Hattenrath TK, 2010, HARMFUL ALGAE, V9, P402, DOI 10.1016/j.hal.2010.02.003; Hattenrath-Lehmann TK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124148; Hattenrath-Lehmann TK, 2013, HARMFUL ALGAE, V26, P33, DOI 10.1016/j.hal.2013.03.005; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Hiyoshi H, 2010, INFECT IMMUN, V78, P1772, DOI 10.1128/IAI.01051-09; Honda T., 1993, REV MED MICROBIOL, V4, P106, DOI DOI 10.1097/00013542-199304000-00006; Jin G, 2004, WATER ENVIRON RES, V76, P245, DOI 10.2175/106143004X141807; Johnson CN, 2012, APPL ENVIRON MICROB, V78, P7249, DOI 10.1128/AEM.01296-12; Jones JL, 2014, APPL ENVIRON MICROB, V80, P7667, DOI 10.1128/AEM.02820-14; Kashefipour SM, 2006, WATER RES, V40, P1413, DOI 10.1016/j.watres.2005.12.046; Kaysner CA., 2004, BACTERIOLOGICAL ANAL; KOH EGL, 1994, APPL ENVIRON MICROB, V60, P3897, DOI 10.1128/AEM.60.10.3897-3900.1994; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Mallin MA, 2000, ECOL APPL, V10, P1047, DOI 10.2307/2641016; Mallin MA, 2001, HYDROBIOLOGIA, V460, P185, DOI 10.1023/A:1013169401211; METCALF TG, 1979, APPL ENVIRON MICROB, V38, P275, DOI 10.1128/AEM.38.2.275-282.1979; Nagata T., 2008, MICROBIAL ECOLOGY OC, P207, DOI DOI 10.1002/9780470281840.CH7; Noble RT, 2010, APPL ENVIRON MICROB, V76, P7437, DOI 10.1128/AEM.00651-10; Noble RT, 2003, WATER RES, V37, P1637, DOI 10.1016/S0043-1354(02)00496-7; Nordstrom JL, 2007, APPL ENVIRON MICROB, V73, P5840, DOI 10.1128/AEM.00460-07; O'Shea ML, 2000, ESTUARIES, V23, P877, DOI 10.2307/1353004; Oliveira J, 2011, FOOD CONTROL, V22, P805, DOI 10.1016/j.foodcont.2010.11.032; Paerl HW, 1998, MAR ECOL PROG SER, V166, P17, DOI 10.3354/meps166017; Parveen S, 2008, INT J FOOD MICROBIOL, V128, P354, DOI 10.1016/j.ijfoodmicro.2008.09.019; Pfeffer CS, 2003, APPL ENVIRON MICROB, V69, P3526, DOI 10.1128/AEM.69.6.3526-3531.2003; RIPPEY SR, 1994, CLIN MICROBIOL REV, V7, P419, DOI 10.1128/CMR.7.4.419-425.1994; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; Taylor GT, 2006, MAR ECOL PROG SER, V312, P67, DOI 10.3354/meps312067; Vezzulli L, 2013, MICROB ECOL, V65, P817, DOI 10.1007/s00248-012-0163-2; WANG RZ, 2015, FRONT MICROBIOL, V0006; Whistler CA, 2015, J CLIN MICROBIOL, V53, P1864, DOI 10.1128/JCM.00034-15; WITTMAN RJ, 1995, ANNU REV PUBL HEALTH, V16, P123; WOLFE DA, 1991, ESTUARIES, V14, P224, DOI 10.2307/1351658; Xu F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00272; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594; Zimmerman AM, 2007, APPL ENVIRON MICROB, V73, P7589, DOI 10.1128/AEM.01700-07	60	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185994	10.1371/journal.pone.0185994	http://dx.doi.org/10.1371/journal.pone.0185994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020074	gold, Green Published, Green Submitted			2022-12-26	WOS:000412754400056
J	Woodward, SH; Jamison, AL; Gala, S; Holmes, TH				Woodward, Steven H.; Jamison, Andrea L.; Gala, Sasha; Holmes, Tyson H.			Canine companionship is associated with modification of attentional bias in posttraumatic stress disorder	PLOS ONE			English	Article							QUALITY-OF-LIFE; FACIAL EXPRESSIONS; INTRANASAL OXYTOCIN; EMOTIONAL INFORMATION; AMYGDALA REACTIVITY; VISUAL-ATTENTION; SOCIAL SUPPORT; FEARFUL FACES; MALE VETERANS; SERVICE DOGS	Attentional bias towards aversive stimuli has been demonstrated in the anxiety disorders and in posttraumatic stress disorder, and attentional bias modification has been proposed as a candidate treatment. This study rigorously assessed attentional bias towards aversive and pleasant visual imagery associated with the presence or absence of a familiar service canine in 23 veterans with chronic military-related posttraumatic stress disorder. Participants were repeatedly tested with and without their service canines present on two tasks designed to elicit spontaneous visual attention to facial and scenic image pairs, respectively. Each stimulus contrasted an emotive image with a neutral image. Via eye-tracking, the difference in visual attention directed to each image was analyzed as a function of the valence contrast and presence/absence of the canine. Across both tasks, the presence of a familiar service canine attenuated the normative attentional bias towards aversive image content. In the facial task, presence of the service canine specifically reduced attention toward angry faces. In that task, as well, accumulated days with the service canine similarly modulated attention toward facial emotion. The results suggest that the presence of a familiar service canine is associated with attenuation of attentional bias to aversive stimuli in chronic military-service-related posttraumatic stress disorder. Questions remain regarding the generalization of such effects to other populations, their dependence on the familiarity, breed, and training of the canine, and on social context.	[Woodward, Steven H.; Jamison, Andrea L.; Gala, Sasha] VA Palo Alto Hlth Care Syst, Disseminat & Training Div, Natl Ctr PTSD, Palo Alto, CA USA; [Holmes, Tyson H.] Stanford Univ, Sch Med, HIMC, Inst Immun Transplantat & Infect, Stanford, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Woodward, SH (corresponding author), VA Palo Alto Hlth Care Syst, Disseminat & Training Div, Natl Ctr PTSD, Palo Alto, CA USA.	Steve.woodward@va.gov		Jamison, Andrea/0000-0002-8662-0045	Defense Health Program [W81XWH-15-2-0005, 13046055]; Military Operational Medical Research Program; U.S. Army Medical Research and Materiel Command; National Center for PTSD, Dissemination and Training Division, VA Palo Alto Health Care System	Defense Health Program; Military Operational Medical Research Program; U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Center for PTSD, Dissemination and Training Division, VA Palo Alto Health Care System	This research was supported by Contract W81XWH-15-2-0005 (Log #13046055), "Can a Canine Companion Modify Cardiac Autonomic Reactivity and Tone in PTSD?" to Steven H. Woodward, PhD, from the Defense Health Program, Military Operational Medical Research Program, and U.S. Army Medical Research and Materiel Command, and by the National Center for PTSD, Dissemination and Training Division, VA Palo Alto Health Care System.	Allen K, 1996, JAMA-J AM MED ASSOC, V275, P1001, DOI 10.1001/jama.275.13.1001; Anderson D. C., 2007, NEW DIRECTIONS HUMAN; Armstrong T, 2013, DEPRESS ANXIETY, V30, P497, DOI 10.1002/da.22115; Armstrong T, 2012, CLIN PSYCHOL REV, V32, P704, DOI 10.1016/j.cpr.2012.09.004; Badura-Brack AS, 2015, AM J PSYCHIAT, V172, P1233, DOI 10.1176/appi.ajp.2015.14121578; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Beetz A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00352; Block S. R., 2016, EXP NEUROL; Carlisle GK, 2015, J AUTISM DEV DISORD, V45, P1137, DOI 10.1007/s10803-014-2267-7; Cavanagh SR, 2011, EMOTION, V11, P241, DOI 10.1037/a0022572; Clark-Elford R, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu012; Ferreira GCDS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01460; Domes G, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0794-9; Domes G, 2013, PSYCHONEUROENDOCRINO, V38, P1198, DOI 10.1016/j.psyneuen.2012.10.002; Felmingham KL, 2011, J ANXIETY DISORD, V25, P668, DOI 10.1016/j.janxdis.2011.02.010; First M.B., 2015, STRUCTURED CLIN INTE; Frijling JL, 2015, J NEUROENDOCRINOL, V27, P743, DOI 10.1111/jne.12300; Frijling JL, 2016, NEUROPSYCHOPHARMACOL, V41, P1286, DOI 10.1038/npp.2015.278; Frijling JL, 2016, SOC COGN AFFECT NEUR, V11, P327, DOI 10.1093/scan/nsv116; Garrett AS, 2012, DEPRESS ANXIETY, V29, P449, DOI 10.1002/da.21892; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Harvey SB, 2012, AM J EPIDEMIOL, V176, P1177, DOI 10.1093/aje/kws248; Harvey SB, 2011, ANN EPIDEMIOL, V21, P666, DOI 10.1016/j.annepidem.2011.05.004; Javanbakht A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00154; Johnstone T, 2005, NEUROIMAGE, V25, P1112, DOI 10.1016/j.neuroimage.2004.12.016; Keane T.M., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Kim YR, 2014, PSYCHIAT INVEST, V11, P160, DOI 10.4306/pi.2014.11.2.160; Kimble M, 2014, J ANXIETY DISORD, V28, P241, DOI 10.1016/j.janxdis.2013.12.006; Kimble MO, 2010, J ANXIETY DISORD, V24, P293, DOI 10.1016/j.janxdis.2009.12.006; King AP, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00154; Koch S. B., 2016, NEUROPSYCHOPHARMACOL; Koch SBJ, 2016, NEUROPSYCHOPHARMACOL, V41, P1495, DOI 10.1038/npp.2015.299; Kuckertz JM, 2014, BEHAV RES THER, V63, P25, DOI 10.1016/j.brat.2014.09.002; Lang P. J., 1999, INT AFFECTIVE PICTUR; Lang P.J., 2008, A8 U FLOR; Lee JH, 2012, COGNITION EMOTION, V26, P1124, DOI 10.1080/02699931.2011.638906; Lunney CA, 2007, J TRAUMA STRESS, V20, P955, DOI 10.1002/jts.20269; Macatee RJ, 2017, BEHAV RES THER, V90, P96, DOI 10.1016/j.brat.2016.12.013; Marmar CR, 2006, ANN NY ACAD SCI, V1071, P1, DOI 10.1196/annals.1364.001; Miller MW, 2004, J ABNORM PSYCHOL, V113, P451, DOI 10.1037/0021-843x.113.3.451; Mogoase C, 2014, J CLIN PSYCHOL, V70, P1133, DOI 10.1002/jclp.22081; Nagasawa M, 2015, SCIENCE, V348, P333, DOI 10.1126/science.1261022; Nawijn L, 2016, SOC COGN AFFECT NEUR; Olff M, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.26513; Olff M, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.18597; Perkins J, 2008, AUSTRALAS J AGEING, V27, P177, DOI 10.1111/j.1741-6612.2008.00317.x; Pinheiro J., NLME LINEAR NONLINEA; Pollak SD, 2003, J ABNORM PSYCHOL, V112, P323, DOI 10.1037/0021-843X.112.3.323; Pollak SD, 2001, PSYCHOPHYSIOLOGY, V38, P267, DOI 10.1111/1469-8986.3820267; R Core Team, 2013, R LANG ENV STAT COMP; Riggs DS, 1998, J TRAUMA STRESS, V11, P87, DOI 10.1023/A:1024409200155; Rosen C, 2013, J TRAUMA STRESS, V26, P640, DOI 10.1002/jts.21841; ROSENHECK R, 1994, AM J PSYCHIAT, V151, P421; Rubenstein David A, 2012, US Army Med Dep J, P1; Sauder CL, 2013, PSYCHOPHYSIOLOGY, V50, P1147, DOI 10.1111/psyp.12129; Schnurr PP, 2006, J CONSULT CLIN PSYCH, V74, P707, DOI 10.1037/0022-006X.74.4.707; Schnurr PR, 2011, WOMEN HEALTH ISS, V21, pS169, DOI 10.1016/j.whi.2011.04.013; Schoorl M, 2014, J TRAUMA STRESS, V27, P240, DOI 10.1002/jts.21896; Schoorl M, 2014, J ANXIETY DISORD, V28, P203, DOI 10.1016/j.janxdis.2013.10.001; Schoorl M, 2013, PSYCHOTHER PSYCHOSOM, V82, P99, DOI 10.1159/000341920; Seefeldt WL, 2014, J BEHAV THER EXP PSY, V45, P105, DOI 10.1016/j.jbtep.2013.09.004; Shackman JE, 2014, DEV PSYCHOPATHOL, V26, P1021, DOI 10.1017/S0954579414000546; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Simmons AN, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-6; Thomas CL, 2013, J ANXIETY DISORD, V27, P447, DOI 10.1016/j.janxdis.2013.05.005; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; van der Zwaag W, 2012, BRAIN TOPOGR, V25, P125, DOI 10.1007/s10548-012-0219-0; Weathers F.W., 2013, CLIN ADM PTSD SCAL D; Weathers FW, 2013, THEPTSDCHECKLISTFORD; Weisman O, 2012, BIOL PSYCHIAT, V72, P982, DOI 10.1016/j.biopsych.2012.06.011; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Whalen PJ, 1998, J NEUROSCI, V18, P411; Yarborough BJH, 2017, PSYCHIAT SERV, V68, P730, DOI 10.1176/appi.ps.201500383	75	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0179912	10.1371/journal.pone.0179912	http://dx.doi.org/10.1371/journal.pone.0179912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020064	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400003
J	Yap, SH; Abdullah, NK; McStea, M; Takayama, K; Chong, ML; Crisci, E; Larsson, M; Azwa, I; Kamarulzaman, A; Leong, KH; Woo, YL; Rajasuriar, R				Yap, Siew Hwei; Abdullah, Noor Kamila; McStea, Megan; Takayama, Kozo; Chong, Meng Li; Crisci, Elisa; Larsson, Marie; Azwa, Iskandar; Kamarulzaman, Adeeba; Leong, Kok Hoong; Woo, Yin Ling; Rajasuriar, Reena			HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; T-CELL-ACTIVATION; SIMPLEX-VIRUS TYPE-2; MICROBIAL TRANSLOCATION; ANTIRETROVIRAL THERAPY; CYTOMEGALOVIRUS; CATABOLISM; MORTALITY; INDIVIDUALS; RECOVERY	Background Co-infections with human herpesvirus (HHV) have been associated with residual chronic inflammation in antiretroviral (ART)-treated human immunodeficiency virus (HIV)-infected individuals. However, the role of HHV in modulating the tryptophan-kynurenine pathway and clinical outcomes in HIV-infected individuals is poorly understood. Thus, we investigated the seroprevalence of four common HHVs among treated HIV-infected participants and their impact on kynurenine/tryptophan (K/T) ratio and long-term CD4 T-cell recovery in HIV/HHV co-infected participants. Method In this cross-sectional study, HIV-infected participants receiving suppressive ART for a minimum of 12 months were recruited from the University Malaya Medical Centre (UMMC), Malaysia. Stored plasma was analyzed for CMV, VZV, HSV-1 and HSV-2 IgG antibody levels, immune activation markers (interleukin-6, interferon-gamma, neopterin and sCD14), kynurenine and tryptophan concentrations. The influence of the number of HHV co-infection and K/T ratio on CD4 T-cell recovery was assessed using multivariate Poisson regression. Results A total of 232 HIV-infected participants were recruited and all participants were seropositive for at least one HHV; 96.1% with CMV, 86.6% with VZV, 70.7% with HSV-1 and 53.9% with HSV-2. K/T ratio had a significant positive correlation with CMV (rho = 0.205, p = 0.002), VZV (rho = 0.173, p = 0.009) and a tendency with HSV-2 (rho = 0.120, p = 0.070), with CMV antibody titer demonstrating the strongest modulating effect on K/T ratio among the four HHVs assessed in SOM analysis. In multivariate analysis, higher K/T ratio (p = 0.03) and increasing number of HHV co-infections (p<0.001) were independently associated with poorer CD4 T-cell recovery following 12 months of ART initiation. Conclusion Multiple HHV co-infections are common among ART-treated HIV-infected participants in the developing country setting and associated with persistent immune activation and poorer CD4 T-cell recovery.	[Yap, Siew Hwei; Abdullah, Noor Kamila; McStea, Megan; Chong, Meng Li; Azwa, Iskandar; Kamarulzaman, Adeeba; Woo, Yin Ling; Rajasuriar, Reena] Univ Malaya, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [Takayama, Kozo] Hoshi Univ, Dept Pharmaceut, Tokyo, Japan; [Crisci, Elisa; Larsson, Marie] Univ Linkoping, Dept Clin & Expt Med, Linkoping, Sweden; [Azwa, Iskandar; Kamarulzaman, Adeeba] Univ Malaya, Dept Med, Kuala Lumpur, Malaysia; [Leong, Kok Hoong; Rajasuriar, Reena] Univ Malaya, Dept Pharm, Kuala Lumpur, Malaysia; [Woo, Yin Ling] Univ Malaya, Dept Obstet & Gynecol, Kuala Lumpur, Malaysia; [Rajasuriar, Reena] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia	Universiti Malaya; Hoshi University; Linkoping University; Universiti Malaya; Universiti Malaya; Universiti Malaya; University of Melbourne	Rajasuriar, R (corresponding author), Univ Malaya, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia.; Rajasuriar, R (corresponding author), Univ Malaya, Dept Pharm, Kuala Lumpur, Malaysia.; Rajasuriar, R (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.	reena@um.edu.my	McStea, Megan/M-7721-2019; Crisci, Elisa/AAF-9263-2020; Rajasuriar, Reena/B-9569-2010; Leong, Kok Hoong/J-1956-2015; Azwa, Iskandar/N-9186-2017; Woo, Yin Ling/B-5198-2010; Woo, Yin Ling/GPX-0086-2022	McStea, Megan/0000-0002-1241-7845; Crisci, Elisa/0000-0002-4235-8508; Rajasuriar, Reena/0000-0003-3756-0629; Leong, Kok Hoong/0000-0002-7317-6117; Azwa, Iskandar/0000-0003-1977-6709; Woo, Yin Ling/0000-0003-1742-1066; Woo, Yin Ling/0000-0003-1742-1066; Larsson, Marie/0000-0002-4524-0177	High Impact Research/Ministry of Higher Education, Malaysia (HIR/MOHE) [H-20001-E000001]; UMRG [RP029-14HTM]; University of Malaya [PG164-2015B]; Swedish Research Council; Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova [A152731]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052731, R01AI052731] Funding Source: NIH RePORTER	High Impact Research/Ministry of Higher Education, Malaysia (HIR/MOHE); UMRG; University of Malaya(Universiti Malaya); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova(Vinnova); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by High Impact Research/Ministry of Higher Education Research Grant, Malaysia (HIR/MOHE; H-20001-E000001) to AK and RR; UMRG RP029-14HTM and the Postgraduate Research Grant (PG164-2015B), University of Malaya to RR, SHY, AK and YLW; The Swedish Research Council, The Swedish International Development Cooperation Agency, SIDA SARC, VINNMER for Vinnova (A152731) to ML.	Baran H, 2012, INT J TRYPTOPHAN RES, V5, P49, DOI 10.4137/IJTR.S10627; Barrett L, 2014, AIDS, V28, P2045, DOI 10.1097/QAD.0000000000000405; Bipath P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1087-5; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Bosch RJ, 2006, JAIDS-J ACQ IMM DEF, V43, P433, DOI 10.1097/01.qai.0000243097.27029.b7; Brunt SJ, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/947432; Byakwaga H, 2014, J INFECT DIS, V210, P383, DOI 10.1093/infdis/jiu115; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Chen Jinhu, 2014, Int J Endocrinol, V2014, P203930, DOI 10.1155/2014/203930; Conde-Glez C, 2013, VACCINE, V31, P5067, DOI 10.1016/j.vaccine.2013.08.077; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; Crisci E, 2016, J VIROL, V90, P4939, DOI 10.1128/JVI.00224-16; Dagenais-Lussier X, 2016, J VIROL, V90, P7967, DOI 10.1128/JVI.00994-16; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Fletcher JM, 2005, J IMMUNOL, V175, P8218, DOI 10.4049/jimmunol.175.12.8218; Freeman ML, 2016, CURR HIV-AIDS REP, V13, P10, DOI 10.1007/s11904-016-0297-9; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Gianella S, 2015, J INFECT DIS, V212, P845, DOI 10.1093/infdis/jiv148; Gianella S, 2014, J VIROL, V88, P7818, DOI 10.1128/JVI.00831-14; Hechter RC, 2012, ATHEROSCLEROSIS, V223, P433, DOI 10.1016/j.atherosclerosis.2012.03.002; Huang Y, 2013, BIOANALYSIS; Hunt PW, 2016, J INFECT DIS, V214, pS44, DOI 10.1093/infdis/jiw275; Hunt PW, 2011, AIDS, V25, P2123, DOI 10.1097/QAD.0b013e32834c4ac1; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Jenabian M-A, 2013, PLOS ONE, V8; Jenabian MA, 2015, J INFECT DIS, V212, P355, DOI 10.1093/infdis/jiv037; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, HIV AS PAC UNAIDS RE; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kohonen T., 2001, SELF ORG MAPS; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Le Moing V, 2007, HIV MED, V8, P156, DOI 10.1111/j.1468-1293.2007.00446.x; Lee SA, 2016, AIDS, V30, P1807, DOI 10.1097/QAD.0000000000001124; Leng SX, 2015, CURR HIV-AIDS REP, V12, P25, DOI 10.1007/s11904-014-0247-3; Letendre S, 2012, 19 C RETR OPP INF; Lichtner M, 2014, J INFECT DIS; Masia M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105442; Masia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064327; McNally JM, 2001, J VIROL, V75, P5965, DOI 10.1128/JVI.75.13.5965-5976.2001; Mehraj V, 2015, INT J TRYPTOPHAN RES, V8, P41, DOI 10.4137/IJTR.S26862; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Parrinello CM, 2012, J INFECT DIS, V205, P1788, DOI 10.1093/infdis/jis276; Rajasuriar R, 2017, AIDS LOND ENGL; Rajasuriar R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0391-6; Rajasuriar R, 2010, J INFECT DIS, V202, P1254, DOI 10.1086/656369; Redd AD, 2015, SEX TRANSM INFECT, V91, P485, DOI 10.1136/sextrans-2014-051867; Romanowski B, 2009, SEX TRANSM DIS, V36, P165, DOI 10.1097/OLQ.0b013e31818d3fb6; Schaftenaar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099243; Sheth PM, 2008, J INFECT DIS, V197, P1394, DOI 10.1086/587697; Singh R, 2003, CLIN EXP IMMUNOL, V133, P97, DOI 10.1046/j.1365-2249.2003.02183.x; Smith MZ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-100; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; van de Berg PJ, 2010, J INFECT DIS, V202, P690, DOI 10.1086/655472; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wittkop L, 2013, J INFECT DIS, V207, P622, DOI 10.1093/infdis/jis732; Yang S. Y., 2016, J STROKE CEREBROVASC; Yen YF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151684	58	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186000	10.1371/journal.pone.0186000	http://dx.doi.org/10.1371/journal.pone.0186000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016635	gold, Green Published, Green Submitted			2022-12-26	WOS:000412601800035
J	Lee, SH; Joo, K; Jung, EJ; Hong, H; Seo, J; Kim, J				Lee, Si-Hyung; Joo, Kwangsic; Jung, Eun Ji; Hong, Hyowon; Seo, Jimyung; Kim, Joon			Export of membrane proteins from the Golgi complex to the primary cilium requires the kinesin motor, KIFC1	FASEB JOURNAL			English	Article						ciliogenesis; ASAP1; TTBK2; dynein	RAB11 EFFECTOR FIP3; INTRACELLULAR-TRANSPORT; CYTOPLASMIC DYNEIN; SUPERFAMILY MOTOR; CILIARY MEMBRANE; MITOTIC SPINDLE; CANCER-CELLS; TRAFFICKING; RECEPTOR; HSET	Microtubule-based motors contribute to the efficiency and selectivity of Golgi exit and post-Golgi transport of membrane proteins that are targeted to distinct compartments. Cytoplasmic dynein moves post-Golgi vesicles that carry rhodopsin toward the base of the connecting cilium in photoreceptor cells; however, the identity of the motors that are involved in the vesicular trafficking of ciliary membrane proteins in nonphotoreceptor cells remains unclear. Here, we demonstrate that the minus end-directed kinesin KIFC1 (kinesin family member C1) is required for both ciliary membrane protein transport and serum starvation-induced ciliogenesis in retinal pigmented epithelial 1 cells. Although KIFC1 is known as a mitotic motor that is sequestered in the nucleus during interphase, KIFC1 immunoreactivity appeared in the Golgi region after serum starvation. Knockdown of KIFC1 inhibited the export of ciliary receptors from the Golgi complex. KIFC1 overexpression affected the Golgi localization of GMAP210 (Golgi microtubule-associated protein 210) and IFT20 (intraflagellar transport 20), which are involved in membrane protein transport to cilia. Moreover, KIFC1 physically interacted with ASAP1 (ADP-ribosylation factor GTPase-activating protein with SH3 domain, ankyrin repeat and PH domain 1), which regulates the budding of rhodopsin transport carriers from the Golgi complex, and KIFC1 depletion caused Golgi accumulation of ASAP1. A decrease in the centrosomal levels of IFT20 and TTBK2 (tau-tubulin kinase 2) was associated with ciliogenesis defects in KIFC1-depleted cells. Our results suggest that KIFC1 plays roles in the Golgi exit of ciliary receptors and in the recruitment of ciliogenesis regulators.	[Lee, Si-Hyung; Joo, Kwangsic; Jung, Eun Ji; Hong, Hyowon; Seo, Jimyung; Kim, Joon] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Lee, Si-Hyung] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Joo, Kwangsic] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Yonsei University Health System; Seoul National University (SNU)	Kim, J (corresponding author), Korea Adv Inst Sci & Technol, Biomed Res Ctr 5109, 291 Daehak Ro, Daejeon 34141, South Korea.	joonkim@kaist.ac.kr	Kim, Joon/C-1833-2011	Hong, Hyowon/0000-0002-3272-7859; Seo, Jimyung/0000-0003-3416-9990	National Research Foundation - Korean Ministry of Science and ICT [1711049553]; Health Industry Development Institute - Korean Ministry of Health Welfare [1465023644]	National Research Foundation - Korean Ministry of Science and ICT; Health Industry Development Institute - Korean Ministry of Health Welfare	The authors thank Dr. Erich Nigg (University of Basel, Basel, Switzerland) for the Cep164 Ab and Dr. Gregory Pazour (University of Massachusetts Medical School, Worcester, MA, USA) for the IFT20-Flag plasmid. Supported by an National Research Foundation grant funded by the Korean Ministry of Science and ICT (1711049553), and a Health Technology R&D Project through the Health Industry Development Institute funded by the Korean Ministry of Health & Welfare (1465023644).	Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Braun M, 2013, CYTOSKELETON, V70, P515, DOI 10.1002/cm.21133; Cai S, 2009, MOL BIOL CELL, V20, P1348, DOI 10.1091/mbc.E08-09-0971; Chavali PL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11005; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Delevoye C, 2014, CELL REP, V6, P445, DOI 10.1016/j.celrep.2014.01.002; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Follit JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000315; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Hanlon DW, 1997, NEURON, V18, P439, DOI 10.1016/S0896-6273(00)81244-1; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; Inoue H, 2008, MOL BIOL CELL, V19, P4224, DOI 10.1091/mbc.E08-03-0290; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Jackson PK, 2012, CELL, V151, P697, DOI 10.1016/j.cell.2012.10.027; Jaulin F, 2007, DEV CELL, V13, P511, DOI 10.1016/j.devcel.2007.08.001; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kim N, 2013, CELL STRUCT FUNCT, V38, P21, DOI 10.1247/csf.12014; Kleylein-Sohn J, 2012, J CELL SCI, V125, P5391, DOI 10.1242/jcs.107474; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lecland N, 2014, NAT CELL BIOL, V16, P770, DOI 10.1038/ncb2996; Lim YS, 2011, BIOL CELL, V103, P209, DOI 10.1042/BC20100150; Liu SJ, 2012, CELL MOL LIFE SCI, V69, P4093, DOI 10.1007/s00018-012-1021-6; Ma DD, 2017, ONCOTARGET, V8, P36082, DOI [10.18632/oncotarget.16429, 10.18632/oncotarget.8553]; Malicki JJ, 2017, TRENDS CELL BIOL, V27, P126, DOI 10.1016/j.tcb.2016.08.002; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nath S, 2007, MOL BIOL CELL, V18, P1839, DOI 10.1091/mbc.E06-06-0524; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Ogden A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42289; Pannu V, 2015, ONCOTARGET, V6, P6076, DOI 10.18632/oncotarget.3475; Rios RM, 2004, CELL, V118, P323; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Rohatgi R, 2010, CURR OPIN CELL BIOL, V22, P541, DOI 10.1016/j.ceb.2010.03.010; Saito N, 1997, NEURON, V18, P425, DOI 10.1016/S0896-6273(00)81243-X; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; She ZY, 2017, ONCOTARGET, V8, P36469, DOI 10.18632/oncotarget.16863; Singh SA, 2014, EMBO J, V33, P385, DOI 10.1002/embj.201385876; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Wang J, 2015, J CELL SCI, V128, P1375, DOI 10.1242/jcs.162925; Wang J, 2012, EMBO J, V31, P4057, DOI 10.1038/emboj.2012.253; Watanabe T, 2015, J CELL BIOL, V210, P737, DOI 10.1083/jcb.201412075; Xu Y, 2002, J CELL BIOL, V158, P293, DOI 10.1083/jcb.200202058; Yang WX, 2003, BIOL REPROD, V69, P1719, DOI 10.1095/biolreprod.102.014878; Yu KM, 2009, CELL TISSUE RES, V337, P113, DOI 10.1007/s00441-009-0800-3; Zimmerman W, 2000, TRAFFIC, V1, P927, DOI 10.1034/j.1600-0854.2000.011202.x	59	16	18	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					957	968		10.1096/fj.201700563R	http://dx.doi.org/10.1096/fj.201700563R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29042452	Bronze			2022-12-26	WOS:000425146900036
J	McWhirter, SR; Duffy, DL; Lee, KJ; Wimberley, G; McClenahan, P; Ling, N; Ardigo, M; Schaider, H; Soyer, HP; Sturm, RA				McWhirter, Seamus R.; Duffy, David L.; Lee, Katie J.; Wimberley, Glen; McClenahan, Philip; Ling, Natalie; Ardigo, Marco; Schaider, Helmut; Soyer, H. Peter; Sturm, Richard A.			Classifying dermoscopic patterns of naevi in a case-control study of melanoma	PLOS ONE			English	Article							PIGMENTED SKIN-LESIONS; MELANOCYTIC NEVI; EPILUMINESCENCE MICROSCOPY; ATYPICAL NEVI; RISK; CLASSIFICATION; METAANALYSIS; DIAGNOSIS; FEATURES; COHORT	Changes in dermoscopic patterns of naevi may be associated with melanoma; however, there is no consensus on which dermoscopic classification system is optimal. To determine whether different classification systems give comparable results and can be combined for analysis, we applied two systems to a case-control study of melanoma with 1037 participants: 573 classified using a "1/3 major feature" system, 464 classified based on rules of appearance, and 263 classified with both criteria. There was strong correlation for non-specific (Spearman R = 0.96) and reticular (Spearman R = 0.82) naevi, with a slight bias for globular naevi with the rules of appearance system. Inter-observer reliability was high for the rules of appearance system, particularly for reticular naevi (Pearson > 0.97). We show that different classification systems for naevi can be combined for data analysis, and describe a method for determining what adjustments may need to be applied to combine data sets.	[McWhirter, Seamus R.; Duffy, David L.; Lee, Katie J.; Wimberley, Glen; McClenahan, Philip; Ling, Natalie; Schaider, Helmut; Soyer, H. Peter; Sturm, Richard A.] Univ Queensland, Diamantina Inst, Translat Res Inst, Dermatol Res Ctr, Brisbane, Qld, Australia; [Duffy, David L.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Ardigo, Marco] IRCCS, IFO, San Gallicano Dermatol Inst, Rome, Italy; [Soyer, H. Peter] Princess Alexandra Hosp, Dept Dermatol, Brisbane, Qld, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG)	Sturm, RA (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, Dermatol Res Ctr, Brisbane, Qld, Australia.	r.sturm@uq.edu.au	Soyer, H. Peter/W-3791-2017; Sturm, Richard A/C-9943-2009; Ardigo, Marco/E-5741-2018; Soyer, H. Peter/E-6000-2010; Duffy, David L/B-7392-2013	Soyer, H. Peter/0000-0002-4770-561X; Sturm, Richard A/0000-0003-1301-0294; Ardigo, Marco/0000-0002-5772-4937; Soyer, H. Peter/0000-0002-4770-561X; Duffy, David L/0000-0001-7227-632X; Lee, Katie/0000-0002-9000-3226; McWhirter, Seamus/0000-0001-6682-3024; Schaider, Helmut/0000-0003-3195-2517	Australian National Health and Medical Research council: NHMRC project grants [APP1062935, APP1083612]; Centre of Research Excellence [APP1099021]	Australian National Health and Medical Research council: NHMRC project grants; Centre of Research Excellence	This study was supported by the Australian National Health and Medical Research council: NHMRC project grants APP1062935 (HPS, DLD, RAS, HS), APP1083612 (HPS, DLD, RAS, HS), and the Centre of Research Excellence for the Study of Naevi APP1099021 (HPS, DLD, RAS, HS). RAS is a Senior Research Fellows of the Australian NHMRC, http://www.nhmrc.gov.au/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argenziano G, 2007, BRIT J DERMATOL, V157, P217, DOI 10.1111/j.1365-2133.2007.07972.x; Argenziano G, 2003, J AM ACAD DERMATOL, V48, P679, DOI 10.1067/mjd.2003.281; Daley GM, 2017, EXP DERMATOL, V26, P730, DOI 10.1111/exd.13114; Ferrara G, 2002, CANCER, V95, P1094, DOI 10.1002/cncr.10768; Fonseca M, 2015, BRIT J DERMATOL, V173, P1486, DOI 10.1111/bjd.14035; Gamo R, 2013, DERMATOL SURG, V39, P864, DOI 10.1111/dsu.12143; Gandini S, 2005, EUR J CANCER, V41, P28, DOI 10.1016/j.ejca.2004.10.015; GOLDMAN L, 1951, J INVEST DERMATOL, V16, P407, DOI 10.1038/jid.1951.48; Hofmann-Wellenhof R, 2001, ARCH DERMATOL, V137, P1575; Lipoff JB, 2008, BRIT J DERMATOL, V158, P821, DOI 10.1111/j.1365-2133.2007.08404.x; Olsen CM, 2012, INT J EPIDEMIOL, V41, P929, DOI 10.1093/ije/dys107; PEHAMBERGER H, 1987, J AM ACAD DERMATOL, V17, P571, DOI 10.1016/S0190-9622(87)70239-4; Praetorius C, 2014, PIGM CELL MELANOMA R, V27, P339, DOI 10.1111/pcmr.12232; Scope A, 2011, J INVEST DERMATOL, V131, P1615, DOI 10.1038/jid.2011.107; STANGANELLI I, 1995, J AM ACAD DERMATOL, V33, P584, DOI 10.1016/0190-9622(95)91275-4; Sturm RA, 2014, J INVEST DERMATOL, V134, P141, DOI 10.1038/jid.2013.272; Tannous ZS, 2005, J AM ACAD DERMATOL, V52, P197, DOI 10.1016/j.jaad.2004.07.020; Vestergaard ME, 2008, BRIT J DERMATOL, V159, P669, DOI 10.1111/j.1365-2133.2008.08713.x	18	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186647	10.1371/journal.pone.0186647	http://dx.doi.org/10.1371/journal.pone.0186647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040338	Green Submitted, Green Published, gold			2022-12-26	WOS:000413167500066
J	Meleis, AM; Mahtabfar, A; Danish, S; Foty, RA				Meleis, Ahmed M.; Mahtabfar, Aria; Danish, Shabbar; Foty, Ramsey A.			Dexamethasone-mediated inhibition of Glioblastoma neurosphere dispersal in an ex vivo organotypic neural assay	PLOS ONE			English	Article							HUMAN ASTROCYTOMA MIGRATION; EXTRACELLULAR-MATRIX; BIOPSY SPECIMENS; CELL-MIGRATION; SURVIVAL; GLIOMA	Glioblastoma is highly aggressive. Early dispersal of the primary tumor renders localized therapy ineffective. Recurrence always occurs and leads to patient death. Prior studies have shown that dispersal of Glioblastoma can be significantly reduced by Dexamethasone (Dex), a drug currently used to control brain tumor related edema. However, due to high doses and significant side effects, treatment is tapered and discontinued as soon as edema has resolved. Prior analyses of the dispersal inhibitory effects of Dex were performed on tissue culture plastic, or polystyrene filters seeded with normal human astrocytes, conditions which inherently differ from the parenchymal architecture of neuronal tissue. The aim of this study was to utilize an ex-vivo model to examine Dex-mediated inhibition of tumor cell migration from low-passage, human Glioblastoma neurospheres on multiple substrates including mouse retina, and slices of mouse, pig, and human brain. We also determined the lowest possible Dex dose that can inhibit dispersal. Analysis by Two-Factor ANOVA shows that for GBM-2 and GBM-3, Dex treatment significantly reduces dispersal on all tissue types. However, the magnitude of the effect appears to be tissue-type specific. Moreover, there does not appear to be a difference in Dex-mediated inhibition of dispersal between mouse retina, mouse brain and human brain. To estimate the lowest possible dose at which Dex can inhibit dispersal, LogEC50 values were compared by Extra Sum-of-Squares F-test. We show that it is possible to achieve 50% reduction in dispersal with Dex doses ranging from 3.8x10(-8)M to 8.0x10(-9)M for GBM-2, and 4.3x10(-8)M to 1.8x10(-9)M for GBM-3, on mouse retina and brain slices, respectively. These doses are 3-30-fold lower than those used to control edema. This study extends our previous in vitro data and identifies the mouse retina as a potential substrate for in vivo studies of GBM dispersal.	[Meleis, Ahmed M.; Mahtabfar, Aria; Foty, Ramsey A.] Rutgers Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08854 USA; [Meleis, Ahmed M.] Rutgers New Jersey Med Sch, Dept Neurol Surg, Newark, NJ USA; [Danish, Shabbar] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Foty, RA (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08854 USA.	fotyra@rwjms.rutgers.edu			Carolyn L. Kukein Student Research Fellowship from the Alpha Omega Alpha Honor Medical Society; Summer Research Fellowship from the Rutgers-Robert Wood Johnson Medical School	Carolyn L. Kukein Student Research Fellowship from the Alpha Omega Alpha Honor Medical Society; Summer Research Fellowship from the Rutgers-Robert Wood Johnson Medical School	This study was supported, in part, by a Carolyn L. Kukein Student Research Fellowship from the Alpha Omega Alpha Honor Medical Society (http://alphaomegaalpha.org/student_research.html), as well as a Summer Research Fellowship from the Rutgers-Robert Wood Johnson Medical School (http://rwjms.umdnj.edu/ education/current_students/research_commexp/research_listing.html) to AM.	BERENS ME, 1994, CLIN EXP METASTAS, V12, P405, DOI 10.1007/BF01755884; Brandes AA, 2008, CRIT REV ONCOL HEMAT, V67, P139, DOI 10.1016/j.critrevonc.2008.02.005; Burgoyne AM, 2009, NEURO-ONCOLOGY, V11, P767, DOI 10.1215/15228517-2009-019; Clarke J, 2010, ARCH NEUROL-CHICAGO, V67, P279, DOI 10.1001/archneurol.2010.5; Claybon A, 2011, JOVE-J VIS EXP, DOI 10.3791/2563; Ferguson LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067265; Foty R, 2011, JOVE-J VIS EXP, DOI 10.3791/2720; GIESE A, 1994, CANCER RES, V54, P3897; HUBEL DAVID H., 1963, SCI AMER, V209, P54; Kostaras X, 2014, CURR ONCOL, V21, pE493, DOI 10.3747/co.21.1769; Mahesparan R, 1999, ACTA NEUROPATHOL, V97, P231, DOI 10.1007/s004010050979; Mehta M, 2015, MOL CANCER THER, V14, P1171, DOI 10.1158/1535-7163.MCT-14-0708; Metcalfe P., 2011, PREDICTION PHARMACOK; NIEMAN LK, 1987, NEW ENGL J MED, V316, P187, DOI 10.1056/NEJM198701223160404; PAULUS W, 1994, INT J CANCER, V58, P841, DOI 10.1002/ijc.2910580616; Perry Arie, 2016, Handb Clin Neurol, V134, P71, DOI 10.1016/B978-0-12-802997-8.00005-0; Pitter KL, 2016, BRAIN, V139, P1458, DOI 10.1093/brain/aww046; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Sabari J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024810; Shannon S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135951; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Winters BS, 2005, INT J CANCER, V114, P371, DOI 10.1002/ijc.20722; Zhou R., 2010, F1000 BIOL REP, V2	23	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186483	10.1371/journal.pone.0186483	http://dx.doi.org/10.1371/journal.pone.0186483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040322	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500053
J	Valiani, V; Sourdet, S; Schoeller, DA; Mackey, DC; Bauer, DC; Glynn, NW; Yamada, Y; Harris, TB; Manini, TM				Valiani, Vincenzo; Sourdet, Sandrine; Schoeller, Dale A.; Mackey, Dawn C.; Bauer, Douglas C.; Glynn, Nancy W.; Yamada, Yosuke; Harris, Tamara B.; Manini, Todd M.		Health Aging & Body Composition	Surveying predictors of late-life longitudinal change in daily activity energy expenditure	PLOS ONE			English	Article							DOUBLY-LABELED WATER; BASE-FREE MEASURE; QUALITY-OF-LIFE; FAT-FREE MASS; PHYSICAL-ACTIVITY; OLDER-ADULTS; FOLLOW-UP; EXERCISE ADHERENCE; BODY-COMPOSITION; ELDERLY SUBJECTS	Background Total daily energy expenditure (TEE) is composed of resting metabolic rate (RMR), postprandial thermogenesis and activity energy expenditure (AEE). Higher AEE is strongly associated with lower mortality and physical limitations among older adults, but factors that predict changes in AEE in septu and octogenarians are not clearly understood. Objective To identify factors associated with late-life longitudinal change in AEE. Design Energy expenditure was re-assessed in 83 participants (average age at baseline, 74.4 +/- 3.2 years)-an average of 7.5 +/- 0.54 years since the baseline measure. RMR was measured using indirect calorimetry and the thermic effect of meals was estimated at 10% of TEE. AEE was calculated as: TEE(0.9)-RMR. Participants were categorized into two groups according to the estimated day-to-day precision of the doubly-labeled water technique. Those who were within 10% or increased relative to their initial AEE measurement were categorized as having preserved AEE. Participants who declined greater than 10% of their initial measurement were categorized as having reduced AEE. A variety of socio-demographic, functional and mental factors, body composition, community and personal behaviors, blood measurements and health conditions were evaluated between groups at baseline and changes during follow-up. Results Daily AEE declined 106.61 +/- 293.25 kcal, which equated to a 14.63 +/- 40.57 kcal/d decrease per year. Fifty-nine percent (n = 49) preserved their AEE and 41% (n = 34) declined. Those who demonstrated a decline in AEE were older, had lower walking speed at baseline and showed a higher lean mass loss during follow up. Otherwise, groups were similar for sociodemographic characteristics, body composition, mental and physical function, health conditions and community and personal behaviors at baseline and change in these factors during follow-up. Conclusions This study demonstrates that AEE declines through the 8 th decade of life and is associated with age, lower walking speed at baseline and lean mass loss. Additionally, there are a significant number of individuals who appear to be resilient to these declines despite having health events that are expected to have a negative impact on their physical activity.	[Valiani, Vincenzo; Manini, Todd M.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA; [Valiani, Vincenzo] Univ Ban Aldo Moro, Clin Med Cesare Frugoni, Dipartimento Interdisciplinare Med, Bari, Italy; [Sourdet, Sandrine] Hop La Grave Casselardit, Gerontopole, Toulouse, France; [Schoeller, Dale A.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA; [Mackey, Dawn C.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Bauer, Douglas C.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Glynn, Nancy W.] Univ Pittsburgh, Dept Epidemiol, Ctr Aging & Populat Hlth, Pittsburgh, PA 15261 USA; [Yamada, Yosuke] Natl Inst Biomed Innovat Hlth & Nutr, Dept Nutr Sci, Tokyo, Japan; [Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, IRP, NIH, Bethesda, MD 20892 USA	State University System of Florida; University of Florida; CHU de Toulouse; University of Wisconsin System; University of Wisconsin Madison; Simon Fraser University; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Valiani, V (corresponding author), Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA.; Valiani, V (corresponding author), Univ Ban Aldo Moro, Clin Med Cesare Frugoni, Dipartimento Interdisciplinare Med, Bari, Italy.	v.valiani@ufl.edu	Yamada, Yosuke/AAX-7073-2020	Yamada, Yosuke/0000-0002-4284-6317; Manini, Todd/0000-0002-5970-4462; Glynn, Nancy/0000-0003-2265-0162; Valiani, Vincenzo/0000-0003-1841-3519	Intramural Research Program of the National Institutes of Health (NIH); National Institute on Aging (NIA) [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; NIA grant [R01-AG028050]; National Institute of Nursing Research NINR grant [R01-NR012459]; National Institute on Aging (NIA) grant [R01AG042525, R01HL121023]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028050, R01AG042525, P30AG028740] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA grant; National Institute of Nursing Research NINR grant; National Institute on Aging (NIA) grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported entirely by the Intramural Research Program of the National Institutes of Health (NIH), National Institute on Aging (NIA) Contracts N01-AG-6-2101; N01-AG-6-2103; N01-AG-6-2106; NIA grant R01-AG028050, and National Institute of Nursing Research NINR grant R01-NR012459. TMM was supported by the National Institute on Aging (NIA) grant R01AG042525, R01HL121023. The funder provided support in the form of salaries for authors [TMM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Ashe MC, 2009, GERONTOLOGY, V55, P64, DOI 10.1159/000141518; Bann D, 2014, AM J EPIDEMIOL, V179, P1197, DOI 10.1093/aje/kwu033; Bijnen FCH, 1998, J GERONTOL A-BIOL, V53, pM235, DOI 10.1093/gerona/53A.3.M235; BLACK AE, 1986, HUM NUTR-CLIN NUTR, V40C, P381; Black AE, 1996, EUR J CLIN NUTR, V50, P72; Blanc S, 2004, AM J CLIN NUTR, V79, P303; Blanc S, 2002, J APPL PHYSIOL, V92, P1036, DOI 10.1152/japplphysiol.00743.2001; BLOESCH D, 1988, J AM COLL NUTR, V7, P471; BOND L, 1979, PSYCHOMETRIKA, V44, P351, DOI 10.1007/BF02294701; Bouchard DR, 2007, J GERONTOL A-BIOL, V62, P1382, DOI 10.1093/gerona/62.12.1382; Brovold T, 2013, J AM GERIATR SOC, V61, P1580, DOI 10.1111/jgs.12400; Clark DO., 1999, J CLIN GEROPSYCHOL, V5, P51, DOI [DOI 10.1023/A:1022942913555, 10.1023/A:1022942913555]; Cohen-Mansfield J, 2010, J AGING PHYS ACTIV, V18, P141, DOI 10.1123/japa.18.2.141; Cooper JA, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-73; Coward WA, 1990, REPORT IDECG EXPERT, P48; CRONBACH LJ, 1970, PSYCHOL BULL, V74, P68, DOI 10.1037/h0029382; Dogra S, 2011, J AGING PHYS ACTIV, V19, P322, DOI 10.1123/japa.19.4.322; EMERY CF, 1992, PSYCHOL AGING, V7, P466; Eronen J, 2014, PREV MED, V67, P106, DOI 10.1016/j.ypmed.2014.07.020; Fillit H, 2008, AM J GERIATR PHARMAC, V6, P100, DOI 10.1016/j.amjopharm.2008.06.004; Gibney E, 1997, METABOLISM, V46, P1412, DOI 10.1016/S0026-0495(97)90140-2; GORAN MI, 1992, AM J PHYSIOL, V263, pE950, DOI 10.1152/ajpendo.1992.263.5.E950; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hamer M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-10; Harrington DM, 2013, APPETITE, V67, P1, DOI 10.1016/j.appet.2013.03.005; Harris AM, 2007, AM J PHYSIOL-ENDOC M, V292, pE1207, DOI 10.1152/ajpendo.00509.2006; Holfeld B, 2014, J APPL GERONTOL, V33, P791, DOI 10.1177/0733464812455097; Johannsen DL, 2008, J APPL PHYSIOL, V105, P495, DOI 10.1152/japplphysiol.90450.2008; Kant AK, 2002, J AM COLL NUTR, V21, P315, DOI 10.1080/07315724.2002.10719229; KESSLER RC, 1977, QUAL QUANT, V11, P43; Kimura M, 2012, AGE, V34, P203, DOI 10.1007/s11357-011-9225-5; Koster A, 2010, OBESITY, V18, P2354, DOI 10.1038/oby.2010.86; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; Manini TM, 2010, AGEING RES REV, V9, P1, DOI 10.1016/j.arr.2009.08.002; Manini TM, 2009, AM J EPIDEMIOL, V169, P1507, DOI 10.1093/aje/kwp069; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Markus G., 1980, MODELS ANAL PANEL DA; McAuley E, 2011, AM J PREV MED, V41, P284, DOI 10.1016/j.amepre.2011.04.014; Middleton LE, 2011, ARCH INTERN MED, V171, P1251, DOI 10.1001/archinternmed.2011.277; Motl RW, 2010, PHYS MED REH CLIN N, V21, P299, DOI 10.1016/j.pmr.2009.12.006; Nakamura E, 2008, J GERONTOL A-BIOL, V63, P936, DOI 10.1093/gerona/63.9.936; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161, DOI 10.1093/oxfordjournals.aje.a112608; Pereira CLN, 2014, DISABIL REHABIL, V36, P117, DOI 10.3109/09638288.2013.782355; Poehlman ET, 1999, J NUTR, V129, p260S, DOI 10.1093/jn/129.1.260S; Porter KN, 2011, MATURITAS, V70, P290, DOI 10.1016/j.maturitas.2011.07.024; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; Resnick B, 2011, RESILIENCE IN AGING: CONCEPTS, RESEARCH, AND OUTCOMES, P1, DOI 10.1007/978-1-4419-0232-0; ROBERTS SB, 1995, AM J CLIN NUTR, V62, P1053, DOI 10.1093/ajcn/62.5.1053S; Rothenberg EM, 2000, BRIT J NUTR, V84, P319; Rothenberg EM, 2003, ACTA DIABETOL, V40, pS134, DOI 10.1007/s00592-003-0046-6; SCHOELLER DA, 1986, AM J PHYSIOL, V250, pR823, DOI 10.1152/ajpregu.1986.250.5.R823; SCHOELLER DA, 1982, J APPL PHYSIOL, V53, P955, DOI 10.1152/jappl.1982.53.4.955; Schoeller DA, 1996, J NUTR, V126, pS348; Seidell JC, 2000, EUR J CLIN NUTR, V54, pS33, DOI 10.1038/sj.ejcn.1601023; Shea MK, 2011, J AM GERIATR SOC, V59, P1165, DOI 10.1111/j.1532-5415.2011.03476.x; Shephard RJ, 2013, J AM GERIATR SOC, V61, P1887, DOI 10.1111/jgs.12505; Simonsick EM, 2001, J GERONTOL A-BIOL, V56, pM644, DOI 10.1093/gerona/56.10.M644; Speakman JR, 2010, AM J CLIN NUTR, V92, P826, DOI 10.3945/ajcn.2009.28540; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Toth MJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE469, DOI 10.1152/ajpendo.1997.272.3.E469; Toth MJ, 1997, NEUROLOGY, V48, P88, DOI 10.1212/WNL.48.1.88; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P457, DOI 10.1007/BF02289517; Varma VR, 2016, AM J PREV MED, V50, P106, DOI 10.1016/j.amepre.2015.06.015; Visser M, 1999, J APPL PHYSIOL, V87, P1513, DOI 10.1152/jappl.1999.87.4.1513; Walsh JME, 2001, J GEN INTERN MED, V16, P721, DOI 10.1111/j.1525-1497.2001.00506.x; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Westerterp KR, 2001, J GERONTOL A-BIOL, V56, P7, DOI 10.1093/gerona/56.suppl_2.7; Williams P, 1995, PSYCHOL AGING, V10, P617, DOI 10.1037/0882-7974.10.4.617	68	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e186289	10.1371/journal.pone.0186289	http://dx.doi.org/10.1371/journal.pone.0186289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KA	29040301	Green Published, gold, Green Submitted			2022-12-26	WOS:000413167500032
J	Angamo, MT; Curtain, CM; Chalmers, L; Yilma, D; Bereznicki, L				Angamo, Mulugeta Tarekegn; Curtain, Colin Michael; Chalmers, Leanne; Yilma, Daniel; Bereznicki, Luke			Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study	PLOS ONE			English	Article							RISK-FACTORS; RENAL-FUNCTION; ADMISSIONS; PREVALENCE; DISEASE; EVENTS; FREQUENCY; COMMUNITY; FEATURES; BURDEN	Background Adverse drug reactions (ADRs) are important causes of morbidity and mortality in the healthcare system; however, there are no studies reporting on the magnitude and risk factors associated with ADR-related hospitalisation in Ethiopia. Objectives To characterise the reaction types and the drugs implicated in admission to Jimma University Specialized Hospital, Southwest Ethiopia, and to identify risk factors associated with ADR-related hospitalisation. Methods A prospective cross-sectional study was conducted from May 2015 to August 2016 among consenting patients aged >= 18 years consecutively admitted to medical wards taking at least one medication prior to admission. ADR-related hospitalisations were determined through expert review of medical records, laboratory tests, patient interviews and physical observation. ADR causality was assessed by the Naranjo algorithm followed by consensus review with internal medicine specialist. ADR preventability was assessed using Schumock and Thornton's criteria. Only definite and probable ADRs that provoked hospitalisation were considered. Binary logistic regression was used to identify independent predictors of ADR-related hospitalisation. Results Of 1,001 patients, 103 (10.3%) had ADR-related admissions. Common ADRs responsible for hospitalisation were hepatotoxicity (35, 29.4%) and acute kidney injury (27, 22.7%). The drug classes most frequently implicated were antitubercular agents (45, 25.0%) followed by antivirals (22, 12.2%) and diuretics (19, 10.6%). Independent predictors of ADR-related hospitalisation were body mass index (BMI) <18.5 kg/m(2) (adjusted odd ratio [AOR] = 1.69; 95% confidence interval [CI] = 1.10-2.62; p = 0.047), pre-existing renal disease (AOR = 2.84; 95% CI = 1.38-5.85, p = 0.004), pre-existing liver disease (AOR = 2.61; 95% CI = 1.38-4.96; p = 0.003), number of comorbidities >= 4 (AOR = 2.09; 95% CI = 1.27-3.44; p = 0.004), number of drugs >= 6 (AOR = 2.02; 95% CI = 1.26-3.25; p = 0.004) and history of previous ADRs (AOR = 24.27; 95% CI = 11.29-52.17; p<0.001). Most ADRs (106, 89.1%) were preventable. Conclusions ADRs were a common cause of hospitalisation. The majority of ADRs were preventable, highlighting the need for monitoring and review of patients with lower BMI, ADR history, renal and liver diseases, multiple comorbidities and medications. ADR predictors should be integrated into clinical pathways and pharmacovigilance systems.	[Angamo, Mulugeta Tarekegn; Curtain, Colin Michael; Chalmers, Leanne; Bereznicki, Luke] Univ Tasmania, Div Pharm, Sch Med, Hobart, Tas, Australia; [Yilma, Daniel] Jimma Univ, Dept Internal Med, Sch Med, Fac Med Sci, Jimma, Ethiopia	University of Tasmania; Jimma University	Angamo, MT (corresponding author), Univ Tasmania, Div Pharm, Sch Med, Hobart, Tas, Australia.	Mulugeta.Angamo@utas.edu.au	Yilma, Daniel/AAJ-2072-2021; Angamo, Mulugeta/O-9568-2014	Yilma, Daniel/0000-0001-6058-2696; Angamo, Mulugeta/0000-0002-8604-6258; Chalmers, Leanne/0000-0002-2477-2190				Alexopoulou A, 2008, EUR J INTERN MED, V19, P505, DOI 10.1016/j.ejim.2007.06.030; Alvarez Paulino A, 2013, Int J Risk Saf Med, V25, P185, DOI 10.3233/JRS-130596; Aminkeng F, 2014, PHARMACOGENOMICS J, V14, P160, DOI 10.1038/tpj.2013.13; Angamo MT, 2016, DRUG SAFETY, V39, P847, DOI 10.1007/s40264-016-0444-7; [Anonymous], 2010, TREATM TUB GUID NAT; Aziz Z, 2007, PHARMACOEPIDEM DR S, V16, P223, DOI 10.1002/pds.1313; Belachew T, 2015, ETHIOP J HEALTH SCI, V25, P1; Bushardt RL, 2008, CLIN INTERV AGING, V3, P383, DOI 10.2147/CIA.S2468; Caamano F, 2005, ARCH GERONTOL GERIAT, V40, P45, DOI 10.1016/j.archger.2004.05.005; Chen YC, 2012, INTERN MED J, V42, P651, DOI 10.1111/j.1445-5994.2011.02684.x; Classification Committee of the World Organization of Family Doctors, 1998, ICPC 2 INT CLASS PRI; Corsonello A, 2012, DRUG SAFETY, V35, P47, DOI 10.1007/BF03319102; Dargie B, 2016, BMC NUTR, V2, P7, DOI DOI 10.1186/S40795-016-0046-X; Gebretekle GB, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0101-z; Gedle D., 2015, BMC NUTR, V1, P5, DOI [10.1186/2055-0928-1-5, DOI 10.1186/2055-0928-1-5]; Getahun W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-390; Gurwitz JH, 2000, AM J MED, V109, P87, DOI 10.1016/S0002-9343(00)00451-4; Hassen AA, 2013, PLOS ONE, V8; Henry NL, 2012, PAN AFR MED J, V12, P1; HOIGNE R, 1984, SCHWEIZ MED WSCHR, V114, P1854; Hopf Y, 2008, PHARM WORLD SCI, V30, P854, DOI 10.1007/s11096-008-9240-5; Isah AO, 2012, THER ADV DRUG SAF, V3, P25, DOI 10.1177/2042098611425695; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mamo Y, 2007, CLIN MED, V7, P228, DOI 10.7861/clinmedicine.7-3-228; Manley HJ, 2003, AM J KIDNEY DIS, V41, P386, DOI 10.1053/ajkd.2003.50048; Mannesse CK, 2000, AGE AGEING, V29, P35, DOI 10.1093/ageing/29.1.35; McDonnell PJ, 2002, ANN PHARMACOTHER, V36, P1331, DOI 10.1345/aph.1A333; Mehta U, 2008, BRIT J CLIN PHARMACO, V65, P396, DOI 10.1111/j.1365-2125.2007.03034.x; Misganaw A, 2014, J HEALTH POPUL NUTR, V32, P1; Mouton JP, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003437; Nair NP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165757; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Netsanet WW, 2013, UNIVERSAL HLTH COVER, V10; Ogoina D, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/940580; Olivier P, 2009, DRUG AGING, V26, P475, DOI 10.2165/00002512-200926060-00004; Onder G, 2002, J AM GERIATR SOC, V50, P1962, DOI 10.1046/j.1532-5415.2002.50607.x; Oumer Sada, 2017, African Journal of Pharmacy and Pharmacology, V11, P191, DOI 10.5897/AJPP2017.4736; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Patel Hitesh, 2007, BMC Clin Pharmacol, V7, P9, DOI 10.1186/1472-6904-7-9; Patel K J, 2007, BMC Clin Pharmacol, V7, P8, DOI 10.1186/1472-6904-7-8; Pedros C, 2014, EUR J CLIN PHARMACOL, V70, P361, DOI 10.1007/s00228-013-1630-5; Rehan HS, 2002, NATL MED J INDIA, V15, P24; Reuben A, 2004, HEPATOLOGY, V39, P574, DOI 10.1002/hep.20081; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Ruiter R, 2012, DRUG AGING, V29, P225, DOI 10.2165/11599430-000000000-00000; Munoz-Torrero JFS, 2010, EUR J CLIN PHARMACOL, V66, P1257, DOI 10.1007/s00228-010-0866-6; Schumock G T, 1992, Hosp Pharm, V27, P538; Sekhar MS, 2011, SAUDI PHARM J, V19, P273, DOI 10.1016/j.jsps.2011.04.004; Sharif-Askari FS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095991; Subbaraman R, 2007, CLIN INFECT DIS, V45, P1093, DOI 10.1086/521150; Tegegne GT, 2015, GLOBAL J MED RES, V15, P20; Tipping B, 2006, SAMJ S AFR MED J, V96, P1255; van der Hooft CS, 2008, PHARMACOEPIDEM DR S, V17, P365, DOI 10.1002/pds.1565; van Olmen J, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/349312; Varallo FR, 2011, LAT AM J PHARM, V30, P347; Verbeeck RK, 2008, EUR J CLIN PHARMACOL, V64, P1147, DOI 10.1007/s00228-008-0553-z; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; Wawruch M, 2009, ARCH GERONTOL GERIAT, V48, P186, DOI 10.1016/j.archger.2008.01.004; World Health Organisation, TUB PROGR ETH; World Health Organization, 2014, NONC DIS NCD COUNTR; World Health Organization, 2002, SAF MED GUID DET REP; Yimer G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027810; Zeeh J, 2002, GERONTOLOGY, V48, P121, DOI 10.1159/000052829; Zhang M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a2752; Zopf Y, 2008, EUR J CLIN PHARMACOL, V64, P999, DOI 10.1007/s00228-008-0494-6; Zopf Y, 2008, DRUG SAFETY, V31, P789, DOI 10.2165/00002018-200831090-00007; [No title captured]	69	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e018663	10.1371/journal.pone.0186631	http://dx.doi.org/10.1371/journal.pone.0186631			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036230	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000413054800052
J	Mendlovic, F; Cruz-Rivera, M; Diaz-Gandarilla, JA; Flores-Torres, MA; Avila, G; Perfiliev, M; Salazar, AM; Arriaga-Pizano, L; Ostrosky-Wegman, P; Flisser, A				Mendlovic, Fela; Cruz-Rivera, Mayra; Alfredo Diaz-Gandarilla, Jose; Antonio Flores-Torres, Marco; Avila, Guillermina; Perfiliev, Maria; Maria Salazar, Ana; Arriaga-Pizano, Lourdes; Ostrosky-Wegman, Patricia; Flisser, Ana			Orally administered Taenia solium Calreticulin prevents experimental intestinal inflammation and is associated with a type 2 immune response	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INDUCED MOUSE MODELS; DNA-DAMAGE; BOWEL-DISEASE; CELLS; MICE; IMMUNIZATION; SYSTEM; GENOTOXICITY; INDUCTION	Intestinal helminth antigens are inducers of type 2 responses and can elicit regulatory immune responses, resulting in dampened inflammation. Several platyhelminth proteins with anti-inflammatory activity have been reported. We have identified, cloned and expressed the Taenia solium calreticulin (rTsCRT) and shown that it predominantly induces a type 2 response characterized by IgG1, IL-4 and IL-5 production in mice. Here, we report the rTsCRT anti-inflammatory activity in a well-known experimental colitis murine model. Mice were orally immunized with purified rTsCRT and colitis was induced with trinitrobenzene sulfonic acid (TNBS). Clinical signs of disease, macroscopic and microscopic tissue inflammation, cytokine production and micronuclei formation, as a marker of genotoxicity, were measured in order to assess the effect of rTsCRT immunization on experimentally induced colitis. rTsCRT administration prior to TNBS instillation significantly reduced the inflammatory parameters, including the acute phase cytokines TNF-alpha, IL-1 beta and IL-6. Dampened inflammation was associated with increased local expression of IL-13 and systemic IL-10 and TGF-beta production. Genotoxic damage produced by the inflammatory response was also precluded. Our results show that oral treatment with rTsCRT prevents excessive TNBS-induced inflammation in mice and suggest that rTsCRT has immunomodulatory properties associated with the expression of type 2 and regulatory cytokines commonly observed in other helminths.	[Mendlovic, Fela; Cruz-Rivera, Mayra; Alfredo Diaz-Gandarilla, Jose; Antonio Flores-Torres, Marco; Avila, Guillermina; Perfiliev, Maria; Flisser, Ana] Univ Nacl Autonoma Mexico, Dept Microbiol & Parasitol, Fac Med, Mexico City, DF, Mexico; [Mendlovic, Fela] Univ Anahuac Mexico Norte, Fac Ciencias Salud, Huixquilucan, Estado De Mexic, Mexico; [Alfredo Diaz-Gandarilla, Jose] Univ Juarez Autonoma Tabasco, Div Acad Multidisciplinaria Comalcalco, Comalcalco, Tabasco, Mexico; [Maria Salazar, Ana; Ostrosky-Wegman, Patricia] Univ Nacl Autonoma Mexico, Dept Med Genom & Toxicol Ambiental, Inst Invest Biomed, Mexico City, DF, Mexico; [Arriaga-Pizano, Lourdes] Hosp Especialidades CMN Siglo XXI, IMSS, Unidad Invest Med Inmunoquim, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Anahuac; Universidad Juarez Autonoma de Tabasco; Universidad Nacional Autonoma de Mexico; Instituto Mexicano del Seguro Social	Mendlovic, F (corresponding author), Univ Nacl Autonoma Mexico, Dept Microbiol & Parasitol, Fac Med, Mexico City, DF, Mexico.; Mendlovic, F (corresponding author), Univ Anahuac Mexico Norte, Fac Ciencias Salud, Huixquilucan, Estado De Mexic, Mexico.	fmendlo@yahoo.com	Díaz-Gandarilla, José Alfredo/AAH-2245-2020; Arriaga-Pizano, Lourdes/AAI-9628-2021	Díaz-Gandarilla, José Alfredo/0000-0001-9109-3246; Arriaga-Pizano, Lourdes/0000-0003-4433-2106; Flisser, Ana/0000-0002-1744-8480; Mendlovic, Fela/0000-0002-3542-6795; Avila, Guillermina/0000-0003-1607-3741; Cruz-Rivera, Mayra/0000-0001-8853-9489	Programa de Apoyo a Proyectos de Investigacion e lnnovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico [IN214813]; Direccion General de Asuntos del Personal (DGAPA), Universidad Nacional Autonoma de Mexico	Programa de Apoyo a Proyectos de Investigacion e lnnovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico; Direccion General de Asuntos del Personal (DGAPA), Universidad Nacional Autonoma de Mexico	FM and AF received funding from Programa de Apoyo a Proyectos de Investigacion e lnnovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico. Project No. IN214813. JADG received a post-doctoral fellowship from Direccion General de Asuntos del Personal (DGAPA), Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalid-Peralta L, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/981468; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Avila G, 2008, ANN NY ACAD SCI, V1149, P170, DOI 10.1196/annals.1428.079; Balmus G, 2015, NAT PROTOC, V10, P205, DOI 10.1038/nprot.2015.010; Davies CM, 2008, OSTEOARTHR CARTILAGE, V16, P624, DOI 10.1016/j.joca.2007.09.012; DOHERTY TM, 1993, J IMMUNOL, V151, P7151; Driss V, 2016, MUCOSAL IMMUNOL, V9, P322, DOI 10.1038/mi.2015.62; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Elliott DE, 2003, AM J PHYSIOL-GASTR L, V284, pG385, DOI 10.1152/ajpgi.00049.2002; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fonseca-Coronado S, 2011, EXP PARASITOL, V127, P313, DOI 10.1016/j.exppara.2010.07.017; Gao S, 2015, J MOL CELLULAR CARDI; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Gersemann M, 2012, J INTERN MED, V271, P421, DOI 10.1111/j.1365-2796.2012.02515.x; Helmby H, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0074-3; Heylen M, 2014, PHARMACOL THERAPEUT, V143, P153, DOI 10.1016/j.pharmthera.2014.02.011; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kucharzik T, 1996, CLIN EXP IMMUNOL, V104, P483, DOI 10.1046/j.1365-2249.1996.39750.x; Kunugita N, 2008, J TOXICOL SCI, V33, P31, DOI 10.2131/jts.33.31; Kusunoki Y, 2010, MUTAT RES-FUND MOL M, V689, P59, DOI 10.1016/j.mrfmmm.2010.05.002; Ledesma-Soto Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/563425; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Leon-Cabrera S, 2012, EXP PARASITOL, V132, P334, DOI 10.1016/j.exppara.2012.08.006; Lissner D, 2015, INFLAMM BOWEL DIS, V21, P1297, DOI 10.1097/MIB.0000000000000384; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maizels RM, 2016, J ALLERGY CLIN IMMUN, V138, P666, DOI 10.1016/j.jaci.2016.07.007; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marchi P, 2014, ENVIRON TOXICOL PHAR, V37, P819, DOI 10.1016/j.etap.2014.02.006; Salazar AM, 2013, ENVIRON MOL MUTAGEN, V54, P347, DOI 10.1002/em.21782; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Melon A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/384523; Mendlovic F, 2004, J PARASITOL, V90, P891, DOI 10.1645/GE-3325RN; Mendlovic F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121321; Mizoguchi A, 2010, CURR OPIN PHARMACOL, V10, P578, DOI 10.1016/j.coph.2010.05.007; Nagaraj SH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000301; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nono JK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001516; Pawaria S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1524; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Rostami A, 2016, CELL J, V18, P46; Rzepecka J, 2009, MOL IMMUNOL, V46, P1109, DOI 10.1016/j.molimm.2008.10.032; Scheiffele Frank, 2002, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1519s49; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Strober W, 2008, INFLAMM BOWEL DIS, V14, pS129, DOI 10.1002/ibd.20667; Terrazas CA, 2010, INT J PARASITOL, V40, P1051, DOI 10.1016/j.ijpara.2010.02.016; Verma A, 2011, MED MICROBIOL IMMUN, V200, P255, DOI 10.1007/s00430-011-0198-x; Wang Y, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0110-3; Westbrook AM, 2012, MUTAGENESIS, V27, P77, DOI 10.1093/mutage/ger063; Westbrook AM, 2009, CANCER RES, V69, P4827, DOI 10.1158/0008-5472.CAN-08-4416; Winter JA, 2005, PARASITE IMMUNOL, V27, P139, DOI 10.1111/j.1365-3024.2005.00756.x; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044	57	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186510	10.1371/journal.pone.0186510	http://dx.doi.org/10.1371/journal.pone.0186510			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036211	Green Submitted, gold, Green Published			2022-12-26	WOS:000413054800045
J	Saw, HP; Yao, NW; Chiu, CD; Chen, JY				Saw, Hean-Pat; Yao, Nai-Wei; Chiu, Cheng-Di; Chen, Jia-Yuh			The value of real-time continuous glucose monitoring in premature infants of diabetic mothers	PLOS ONE			English	Article							NEONATAL HYPOGLYCEMIA; VASCULAR CATHETERS; RISK-FACTOR; HYPERGLYCEMIA; DEATH; SENSOR	To determine the feasibility of using a real-time continuous glucose monitoring system (RTGMS) in intensive care units, our study focus on preterm infants with diabetic mothers owing to their high risk of blood sugar abnormalities. Thirty preterm babies (M = 15 and F = 15; <= 36 week gestation age) were studied from within 72 hours of delivery. These babies were admitted to the newborn intensive care and were further categorized into groups based on whether their mothers with or without diabetic mellitus. Blood sugar levels were monitored by both RTGMS and the traditional intermittent arterial line (A-Line) glucose method. Continuous glucose monitoring were well tolerated in 30 infants. There were good consistency between RTGMS and A-Line glucose concentration measurements. Of the preterm infants, 33.33% experienced abnormal glucose levels (hypoglycemia or hyperglycemia) between the checkpoint intervals of the intermittent A-Line blood sugar measurements. RTGM showed advantages with regards to reduced pain, greater comfort, the provision of real-time information, high sensitivity (94.59%) and specificity (97.87%) in discovering abnormalities of blood sugar, which are especially valuable for premature infants of diabetic mothers. RTGMS is comparable to A-line measurement for identifying fluctuations in blood glucose in premature infants. RTGMS detects more episodes of abnormal glucose concentration than intermittent A-line blood glucose measurement. High risk infants, especially premature infants with diabetic mothers, should receive more intensive blood sugar level checks by using continuous RTGMS.	[Saw, Hean-Pat; Chen, Jia-Yuh] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Saw, Hean-Pat] Cheng Ching Gen Hosp, Chung Kang Branch, Taichung, Taiwan; [Yao, Nai-Wei; Chiu, Cheng-Di] China Med Univ, Sch Med, Taichung, Taiwan; [Yao, Nai-Wei; Chiu, Cheng-Di] China Med Univ Hosp, Stroke Ctr, Taichung, Taiwan; [Chiu, Cheng-Di] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Chiu, Cheng-Di] China Med Univ Hosp, Dept Neurosurg, Taichung, Taiwan; [Chen, Jia-Yuh] Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan	Chung Shan Medical University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital	Chen, JY (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Chiu, CD (corresponding author), China Med Univ, Sch Med, Taichung, Taiwan.; Chiu, CD (corresponding author), China Med Univ Hosp, Stroke Ctr, Taichung, Taiwan.; Chiu, CD (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.; Chiu, CD (corresponding author), China Med Univ Hosp, Dept Neurosurg, Taichung, Taiwan.; Chen, JY (corresponding author), Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan.	cdchiu4046@gmail.com; jiayuh@csmu.edu.tw		Chiu, Cheng-Di/0000-0003-0369-0935				Abrahamsen Tore G., 1992, Tidsskrift for den Norske Laegeforening, V112, P3548; Alexandrou G, 2010, PEDIATRICS, V125, pE584, DOI 10.1542/peds.2009-0449; BARKER DP, 1995, ARCH DIS CHILD-FETAL, V72, pF47, DOI 10.1136/fn.72.1.F47; Beardsall K, 2005, ARCH DIS CHILD-FETAL, V90, pF307, DOI 10.1136/adc.2004.051979; Blanco CL, 2006, J PERINATOL, V26, P737, DOI 10.1038/sj.jp.7211594; Bridges BC, 2010, CRIT CARE, V14, DOI 10.1186/cc9280; Caplin NJ, 2003, DIABETIC MED, V20, P238, DOI 10.1046/j.1464-5491.2003.00837.x; Chen C, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010182; Cordero L, 2013, SAGE OPEN MED, V1, DOI 10.1177/2050312113516613; Cowett Richard M, 2002, Neonatal Netw, V21, P9; Duvanel CB, 1999, J PEDIATR-US, V134, P492, DOI 10.1016/S0022-3476(99)70209-X; Ertl T, 2006, BIOL NEONATE, V89, P56, DOI 10.1159/000088199; FURFARO S, 1991, AM J DIS CHILD, V145, P1037, DOI 10.1001/archpedi.1991.02160090089031; Harris DL, 2010, J PEDIATR-US, V157, P198, DOI 10.1016/j.jpeds.2010.02.003; Hay WW, 2009, J PEDIATR-US, V155, P612, DOI 10.1016/j.jpeds.2009.06.044; Hays SP, 2006, PEDIATRICS, V118, P1811, DOI 10.1542/peds.2006-0628; Hogan MJ, 1999, RADIOL CLIN N AM, V37, P1109, DOI 10.1016/S0033-8389(05)70252-9; Juneja D, 2011, EUR J INTERN MED, V22, P241, DOI 10.1016/j.ejim.2011.01.004; KALHAN SC, 1977, NEW ENGL J MED, V296, P375, DOI 10.1056/NEJM197702172960706; Kao LS, 2006, J PERINATOL, V26, P730, DOI 10.1038/sj.jp.7211593; KOMROWER GM, 1954, ARCH DIS CHILD, V29, P28, DOI 10.1136/adc.29.143.28; LUCAS A, 1988, BRIT MED J, V297, P1304, DOI 10.1136/bmj.297.6659.1304; Malone JI, 2008, PEDIATR DIABETES, V9, P531, DOI 10.1111/j.1399-5448.2008.00431.x; Mastrototaro J, 2009, DIABETES TECHNOL THE, V11, pS37, DOI 10.1089/dia.2008.0134; Nicholl Richard, 2003, Arch Dis Child, V88, P238, DOI 10.1136/adc.88.3.238; Ramasethu J, 2008, CLIN PERINATOL, V35, P199, DOI 10.1016/j.clp.2007.11.007; Reach G, 2008, CURR DIABETES REV, V4, P175, DOI 10.2174/157339908785294488; Rubio-Cabezas O, 2013, HORM RES PAEDIAT, V80, P137, DOI 10.1159/000354219; Schwartz RP, 1997, J PEDIATR-US, V131, P171; Stanescu A, 2014, J Med Life, V7 Spec No. 3, P51; Stensvold HJ, 2015, JAMA PEDIATR, V169, P1003, DOI 10.1001/jamapediatrics.2015.1667; van der Lugt NM, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-52; Zhu ZG, 2012, SENSORS-BASEL, V12, P5996, DOI 10.3390/s120505996	33	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186486	10.1371/journal.pone.0186486	http://dx.doi.org/10.1371/journal.pone.0186486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036213	Green Published, gold, Green Submitted			2022-12-26	WOS:000413054800039
J	Kapwata, T; Morris, N; Campbell, A; Mthiyane, T; Mpangase, P; Nelson, KN; Allana, S; Brust, JCM; Moodley, P; Mlisana, K; Gandhi, NR; Shah, NS				Kapwata, Thandi; Morris, Natashia; Campbell, Angela; Mthiyane, Thuli; Mpangase, Primrose; Nelson, Kristin N.; Allana, Salim; Brust, James C. M.; Moodley, Pravi; Mlisana, Koleka; Gandhi, Neel R.; Shah, N. Sarita			Spatial distribution of extensively drugresistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; HEALTH-CARE; MDR-TB; DISTANCE; OUTCOMES; HOME	Background KwaZulu-Natal province, South Africa, has among the highest burden of XDR TB worldwide with the majority of cases occurring due to transmission. Poor access to health facilities can be a barrier to timely diagnosis and treatment of TB, which can contribute to ongoing transmission. We sought to determine the geographic distribution of XDR TB patients and proximity to health facilities in KwaZulu-Natal. Methods We recruited adults and children with XDR TB diagnosed in KwaZulu-Natal. We calculated distance and time from participants' home to the closest hospital or clinic, as well as to the actual facility that diagnosed XDR TB, using tools within ArcGIS Network analyst. Speed of travel was assigned to road classes based on Department of Transport regulations. Results were compared to guidelines for the provision of social facilities in South Africa: 5km to a clinic and 30km to a hospital. Results During 2011-2014, 1027 new XDR TB cases were diagnosed throughout all 11 districts of KwaZulu-Natal, of whom 404 (39%) were enrolled and had geospatial data collected. Participants would have had to travel a mean distance of 2.9 km (CI 95%: 1.8-4.1) to the nearest clinic and 17.6 km (CI 95%: 11.4-23.8) to the nearest hospital. Actual distances that participants travelled to the health facility that diagnosed XDR TB ranged from < 10 km (n = 143, 36%) to > 50 km (n = 109, 27%), with a mean of 69 km. The majority (77%) of participants travelled farther than the recommended distance to a clinic (5 km) and 39% travelled farther than the recommended distance to a hospital (30 km). Nearly half (46%) of participants were diagnosed at a health facility in eThekwini district, of whom, 36% resided outside the Durban metropolitan area. Conclusions XDR TB cases are widely distributed throughout KwaZulu-Natal province with a denser focus in eThekwini district. Patients travelled long distances to the health facility where they were diagnosed with XDR TB, suggesting a potential role for migration or transportation in the XDR TB epidemic.	[Kapwata, Thandi] South African Med Res Council, Environm & Hlth Res Unit, Johannesburg, South Africa; [Morris, Natashia] South African Med Res Council, Biostat Unit, Durban, Kwazulu Natal, South Africa; [Campbell, Angela; Nelson, Kristin N.; Allana, Salim; Gandhi, Neel R.; Shah, N. Sarita] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Campbell, Angela; Nelson, Kristin N.; Allana, Salim; Gandhi, Neel R.; Shah, N. Sarita] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Mthiyane, Thuli; Mpangase, Primrose; Moodley, Pravi; Mlisana, Koleka] Univ KwaZulu Natal, Dept Med Microbiol, Durban, Kwazulu Natal, South Africa; [Mthiyane, Thuli; Mpangase, Primrose; Moodley, Pravi; Mlisana, Koleka] Univ KwaZulu Natal, Dept Virol, Durban, Kwazulu Natal, South Africa; [Brust, James C. M.] Albert Einstein Coll Med, Div Gen Internal Med, Bronx, NY 10467 USA; [Brust, James C. M.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Gandhi, Neel R.] Emory Sch Med, Div Infect Dis, Atlanta, GA 30307 USA; [Shah, N. Sarita] US Ctr Dis Control & Prevent, Ctr Global Hlth, Global TB Branch, Atlanta, GA USA	South African Medical Research Council; South African Medical Research Council; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; University of Kwazulu Natal; University of Kwazulu Natal; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Emory University; Centers for Disease Control & Prevention - USA	Gandhi, NR (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.; Gandhi, NR (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA.; Gandhi, NR (corresponding author), Emory Sch Med, Div Infect Dis, Atlanta, GA 30307 USA.	neel.r.gandhi@emory.edu	Nelson, Kristin Bratton/K-2135-2019	Campbell, Angela/0000-0003-3990-3656	US National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [R01A1089349]; NIH/NIAID [R01A1087465, K23A1083088, K24A1114444]; Emory CFAR [P30A1050409]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, UL1TR002378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089349, U19AI111211, K24AI114444, P30AI050409] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emory CFAR; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was primarily funded by a grant from the US National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH): R01A1089349 (PI Gandhi). It was also supported in part by NIH/NIAID grants: R01A1087465 (PI Gandhi), K23A1083088 (PI Brust), K24A1114444 (PI Gandhi), Emory CFAR P30A1050409 (PI Curran), Einstein CFAR P30A1051519 (PI Goldstein), by Einstein/Montefiore ICTR UL1 TR001073 (P1 Shamoon) and by Atlanta CTSI UL1 TR000454 (P1 Stephens). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis Z, 2015, ASIAN PAC J TROP MED, V8, P127, DOI 10.1016/S1995-7645(14)60302-3; Al-Taiar A, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-38; Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; Buor D, 2003, INT J HEALTH PLAN M, V18, P293, DOI 10.1002/hpm.729; Churchyard G J, 2014, SAMJ, S. Afr. med. j., V104, P234; Courtwright A, 2010, PUBLIC HEALTH REP, V125, P34, DOI 10.1177/00333549101250S407; Daftary A, 2012, AIDS CARE, V24, P1480, DOI 10.1080/09540121.2012.672719; Demissie M, 2002, BIOMEDCENTRAL PUBLIC, V2, P1; DHIS, 2013, S AFR NAT DEP HLTH D; Esri [Environmental Systems Research Institute], 2010, ARCGIS 10 0; Feikin DR, 2009, TROP MED INT HEALTH, V14, P54, DOI 10.1111/j.1365-3156.2008.02193.x; Green C, 2012, COUNCIL SCI IND RES; Harris B, 2011, J PUBLIC HEALTH POL, V32, pS102, DOI 10.1057/jphp.2011.35; Lim JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132076; Loveday M, 2012, INT J TUBERC LUNG D, V16, P209, DOI 10.5588/ijtld.11.0401; McLafferty SL, 2003, ANNU REV PUBL HEALTH, V24, P25, DOI 10.1146/annurev.publhealth.24.012902.141012; Moller V, 2007, S AFR REV SOCIOL, V38, P103, DOI 10.1080/21528586.2007.10419170; Muller I, 1998, INT J EPIDEMIOL, V27, P878, DOI 10.1093/ije/27.5.878; Nteta TP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013909; ODonnell MR, 2013, EMERGING INFECT DIS, V19; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; SANRAL, 2012, S AFR ROAD CLASS ACC; Shah NS, 2017, NEW ENGL J MED, V376, P243, DOI 10.1056/NEJMoa1604544; Shah NS, 2007, WORLDWIDE EMERGENCE; Skiena S., 1990, IMPLEMENTING DISCRET, P225; Stats SA, S AFR NAT DEP HLTH D; Tanser F, 2006, SOC SCI MED, V63, P691, DOI 10.1016/j.socscimed.2006.01.015; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; World Health Organization, 2015, GLOB TUB REP 2015	30	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0181797	10.1371/journal.pone.0181797	http://dx.doi.org/10.1371/journal.pone.0181797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ7ZQ	29028800	Green Submitted, Green Published, gold			2022-12-26	WOS:000412980300003
J	Romanelli, F; Corbo, A; Salehi, M; Yadav, MC; Salman, S; Petrosian, D; Rashidbaigi, OJ; Chait, J; Kuruvilla, J; Plummer, M; Radichev, I; Margulies, KB; Gerdes, AM; Pinkerton, AB; Millan, JAL; Savinov, AY; Savinova, OV				Romanelli, Filippo; Corbo, AnthonyMarco; Salehi, Maryam; Yadav, Manisha C.; Salman, Soha; Petrosian, David; Rashidbaigi, Omid J.; Chait, Jesse; Kuruvilla, Jes; Plummer, Maria; Radichev, Ilian; Margulies, Kenneth B.; Gerdes, A. Martin; Pinkerton, Anthony B.; Millan, Jose A. Luis; Savinov, Alexei Y.; Savinova, Olga V.			Overexpression of tissue-nonspecific alkaline phosphatase (TNAP) in endothelial cells accelerates coronary artery disease in a mouse model of familial hypercholesterolemia	PLOS ONE			English	Article							INHIBITS VASCULAR CALCIFICATION; HEART-DISEASE; OSTEOBLAST DIFFERENTIATION; ENU MUTAGENESIS; RISK PREDICTION; CALCIUM SCORE; IN-VIVO; MUSCLE; ATHEROSCLEROSIS; MICE	Objective Overexpression of tissue-nonspecific alkaline phosphatase (TNAP) in endothelium leads to arterial calcification in mice. The purpose of this study was to examine the effect of elevated endothelial TNAP on coronary atherosclerosis. In addition, we aimed to examine endogenous TNAP activity in human myocardium. Approach and results A vascular pattern of TNAP activity was observed in human non-failing, ischemic, and idiopathic dilated hearts (5 per group); no differences were noted between groups in this study. Endothelial overexpression of TNAP was achieved in mice harboring a homozygous recessive mutation in the low density lipoprotein receptor (whc allele) utilizing a Tie2-cre recombinase (WHC-eTNAP mice). WHC-eTNAP developed significant coronary artery calcification at baseline compared WHC controls (4312 vs 0 mu m(2) alizarin red area, p< 0.001). Eight weeks after induction of atherosclerosis, lipid deposition in the coronary arteries of WHC-eTNAP was increased compared to WHC controls (121633 vs 9330 mu m(2) oil red O area, p<0.05). Coronary lesions in WHC-eTNAP mice exhibited intimal thickening, calcifications, foam cells, and necrotic cores. This was accompanied by the reduction in body weight and left ventricular ejection fraction (19.5 vs. 23.6g, p<0.01; 35% vs. 47%, p<0.05). In a placebo-controlled experiment under atherogenic conditions, pharmacological inhibition of TNAP in WHC-eTNAP mice by a specific inhibitor SBI-425 (30mg*kg(-1)*d(-1), for 5 weeks) reduced coronary calcium (78838 vs. 144622 mu m(2)) and lipids (30754 vs. 77317 mu m(2)); improved body weight (22.4 vs. 18.8g) and ejection fraction (59 vs. 47%). The effects of SBI-425 were significant in the direct comparisons with placebo but disappeared after TNAP-negative placebo-treated group was included in the models as healthy controls. Conclusions Endogenous TNAP activity is present in human cardiac tissues. TNAP overexpression in vascular endothelium in mice leads to an unusual course of coronary atherosclerosis, in which calcification precedes lipid deposition. The prevalence and significance of this mechanism in human atherosclerosis requires further investigations.	[Romanelli, Filippo; Corbo, AnthonyMarco; Salman, Soha; Petrosian, David; Rashidbaigi, Omid J.; Chait, Jesse; Gerdes, A. Martin; Savinova, Olga V.] New York Inst Technol, Coll Osteopath Med, Dept Biomed Sci, Old Westbury, NY 11568 USA; [Salehi, Maryam; Kuruvilla, Jes; Radichev, Ilian; Savinov, Alexei Y.] Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD USA; [Yadav, Manisha C.; Millan, Jose A. Luis] Sanford Burnham Prebys Med Discovery Inst, Human Genet Program, La Jolla, CA USA; [Plummer, Maria] New York Inst Technol, Coll Osteopath Med, Dept Clin Specialties, Old Westbury, NY 11568 USA; [Margulies, Kenneth B.] Univ Penn, Translat Res Ctr, Perelman Sch Med, Heart Failure & Transplant Program, Philadelphia, PA 19104 USA; [Pinkerton, Anthony B.] Sanford Burnham Prebys Med Discovery Inst, Prebys Ctr Drug Discovery, La Jolla, CA USA	New York Institute Technology; Sanford Health; Sanford Burnham Prebys Medical Discovery Institute; New York Institute Technology; University of Pennsylvania; Pennsylvania Medicine; Sanford Burnham Prebys Medical Discovery Institute	Savinova, OV (corresponding author), New York Inst Technol, Coll Osteopath Med, Dept Biomed Sci, Old Westbury, NY 11568 USA.	osavinov@nyit.edu	plummer, maria/AHA-7650-2022	plummer, maria/0000-0001-9862-6244; Romanelli, Filippo/0000-0001-7103-4142; Chait, Jesse/0000-0002-4755-2596; Pinkerton, Anthony/0000-0003-4571-152X	NIH [DE12889, UC4 DK104194, P20 GM103548, P20 GM103620]; Juvenile Diabetes Research Foundation [47-2013-522]; Sanford Research Program funds; NYIT-COM; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012889] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Sanford Research Program funds; NYIT-COM; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by in part by grants NIH DE12889 (JLM), Juvenile Diabetes Research Foundation 47-2013-522 (AYS), the subcontract from NIH UC4 DK104194 grant (AYS), Sanford Research Program funds and NYIT-COM start-up funds (OVS). Sanford Research Imaging and Molecular Genetics Cores were supported by the NIH grants P20 GM103548 and P20 GM103620. FR and AMC were supported by the Academic Scholar Program, NYIT-COM. SS and DP received summer research support from NYIT-COM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghagolzadeh P, 2016, ATHEROSCLEROSIS, V251, P404, DOI 10.1016/j.atherosclerosis.2016.05.044; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Callegari A, 2013, ARTERIOSCL THROM VAS, V33, P2491, DOI 10.1161/ATVBAHA.113.301755; Clark AT, 2004, GENETICA, V122, P51, DOI 10.1007/s10709-004-1436-6; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Flammer AJ, 2012, EUR HEART J, V33, P2963, DOI 10.1093/eurheartj/ehs234; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; Gossl M, 2008, J AM COLL CARDIOL, V52, P1314, DOI 10.1016/j.jacc.2008.07.019; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; GRIM M, 1990, J HISTOCHEM CYTOCHEM, V38, P1907, DOI 10.1177/38.12.1701462; Humphries SE, 2006, J MOL MED, V84, P203, DOI 10.1007/s00109-005-0019-z; Jain A, 2011, CIRC-CARDIOVASC IMAG, V4, P8, DOI 10.1161/CIRCIMAGING.110.959403; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; Kumar D, 2005, CORONARY ARTERY DIS, V16, P41, DOI 10.1097/00019501-200502000-00008; Moe SM, 2003, KIDNEY INT, V63, P1003, DOI 10.1046/j.1523-1755.2003.00820.x; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Mozas Pilar, 2004, Hum Mutat, V24, P187, DOI 10.1002/humu.9264; Narisawa S, 2013, J BONE MINER RES, V28, P1587, DOI 10.1002/jbmr.1901; Ndrepepa G, 2017, EUROPEAN J CLIN INVE; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Panh L, 2017, ATHEROSCLEROSIS, V260, P81, DOI 10.1016/j.atherosclerosis.2017.03.030; Pazar B, 2011, J IMMUNOL, V186, P2495, DOI 10.4049/jimmunol.1001284; Pecin I, 2013, ANN HUM GENET, V77, P22, DOI 10.1111/j.1469-1809.2012.00735.x; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Price PA, 2001, ARTERIOSCL THROM VAS, V21, P1610, DOI 10.1161/hq1001.097102; ROMANUL FCA, 1962, J CELL BIOL, V15, P73, DOI 10.1083/jcb.15.1.73; RUFO M B, 1972, Journal of Histochemistry and Cytochemistry, V20, P336; Samokhin AO, 2010, ARTERIOSCL THROM VAS, V30, P1166, DOI 10.1161/ATVBAHA.110.203976; Savinov AY, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002499; Savinova OV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025054; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Sheen CR, 2015, J BONE MINER RES, V30, P824, DOI 10.1002/jbmr.2420; Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738; Song R, 2017, J BIOL CHEM, V292, P8657, DOI 10.1074/jbc.M117.783308; STEIN AA, 1962, JAMA-J AM MED ASSOC, V182, P534, DOI 10.1001/jama.1962.03050440026008; Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237; Svenson KL, 2008, J LIPID RES, V49, P2452, DOI 10.1194/jlr.M800303-JLR200; Taylor AJ, 2005, J AM COLL CARDIOL, V46, P807, DOI 10.1016/j.jacc.2005.05.049; Vergnes L, 2003, J BIOL CHEM, V278, P42774, DOI 10.1074/jbc.M306022200; Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916; Wanner C, 2016, LANCET, V388, P276, DOI 10.1016/S0140-6736(16)30508-6; Yadav MC, 2014, J BONE MINER RES, V29, P2369, DOI 10.1002/jbmr.2281; Yang SW, 2017, INT J CARDIOL, V227, P833, DOI 10.1016/j.ijcard.2016.10.036; Zamora A, 2017, J CLIN LIPIDOL, V11, P1013, DOI 10.1016/j.jacl.2017.05.012; Ziegler SG, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal1669	50	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186426	10.1371/journal.pone.0186426	http://dx.doi.org/10.1371/journal.pone.0186426			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023576	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100127
J	Braveman, P; Heck, K; Egerter, S; Dominguez, TP; Rinki, C; Marchi, KS; Curtis, M				Braveman, Paula; Heck, Katherine; Egerter, Susan; Dominguez, Tyan Parker; Rinki, Christine; Marchi, Kristen S.; Curtis, Michael			Worry about racial discrimination: A missing piece of the puzzle of Black-White disparities in preterm birth?	PLOS ONE			English	Article							SELF-REPORTED EXPERIENCES; AFRICAN-AMERICAN; MATERNAL STRESS; LIFE-COURSE; PSYCHOSOCIAL FACTORS; HEALTH; PREGNANCY; RISK; WEIGHT; PATHWAYS	Objectives The causes of the large and persistent Black-White disparity in preterm birth (PTB) are unknown. It is biologically plausible that chronic stress across a woman's life course could be a contributor. Prior research suggests that chronic worry about experiencing racial discrimination could affect PTB through neuroendocrine, vascular, or immune mechanisms involved in both responses to stress and the initiation of labor. This study aimed to examine the role of chronic worry about racial discrimination in Black-White disparities in PTB. Methods The data source was cross-sectional California statewide-representative surveys of 2,201 Black and 8,122 White, non-Latino, U.S.-born postpartum women with singleton live births during 2011-2014. Chronic worry about racial discrimination (chronic worry) was defined as responses of "very often" or "somewhat often" (vs. "not very often" or "never") to the question: "Overall during your life until now, how often have you worried that you might be treated or viewed unfairly because of your race or ethnic group?" Prevalence ratios (PRs) with 95% Confidence Intervals (CI) were calculated from sequential logistic regression models, before and after adjustment for multiple social/demographic, behavioral, and medical factors, to estimate the magnitude of: (a) PTB risks associated with chronic worry among Black women and among White women; and (b) Black-White disparities in PTB, before and after adjustment for chronic worry. Results Among Black and White women respectively, 36.9 (95% CI 32.9-40.9)% and 5.5 (95% CI 4.5-6.5) % reported chronic worry about racial discrimination; rates were highest among Black women of higher income and education levels. Chronic worry was significantly associated with PTB among Black women before (PR 1.73, 95% CI 1.12-2.67) and after (PR 2.00, 95% CI 1.33-3.01) adjustment for covariates. The unadjusted Black-White disparity in PTB (PR 1.59, 95% CI 1.21-2.09) appeared attenuated and became non-significant after adjustment for chronic worry (PR 1.30, 95% CI 0.93-1.81); it appeared further attenuated after adding the covariates (PR 1.17, 95% CI 0.85-1.63). Conclusions Chronic worry about racial discrimination may play an important role in Black-White disparities in PTB and may help explain the puzzling and repeatedly observed greater PTB disparities among more socioeconomically-advantaged women. Although the single measure of experiences of racial discrimination used in this study precluded examination of the role of other experiences of racial discrimination, such as overt incidents, it is likely that our findings reflect an association between one or more experiences of racial discrimination and PTB. Further research should examine a range of experiences of racial discrimination, including not only chronic worry but other psychological and emotional states and both subtle and overt incidents as well. These dramatic results from a large statewide-representative study add to a growing-but not widely known-literature linking racism-related stress with physical health in general, and shed light on the links between racism-related stress and PTB specifically. Without being causally definitive, this study's findings should stimulate further research and heighten awareness of the potential role of unmeasured social variables, such as diverse experiences of racial discrimination, in racial disparities in health.	[Braveman, Paula; Heck, Katherine; Egerter, Susan; Marchi, Kristen S.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Braveman, Paula; Heck, Katherine; Egerter, Susan; Marchi, Kristen S.] Univ Calif San Francisco, Ctr Social Dispar Hlth, San Francisco, CA 94143 USA; [Dominguez, Tyan Parker] Univ Southern Calif, Sch Social Work, Los Angeles, CA USA; [Rinki, Christine; Curtis, Michael] Calif Dept Publ Hlth, Maternal Child & Adolescent Hlth Div, Sacramento, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California; California Department of Public Health	Braveman, P (corresponding author), Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.; Braveman, P (corresponding author), Univ Calif San Francisco, Ctr Social Dispar Hlth, San Francisco, CA 94143 USA.	paula.braveman@ucsf.edu						Blondel B, 2002, J Gynecol Obstet Biol Reprod (Paris), V31, P725; Blumberg SJ, 1999, AM J PUBLIC HEALTH, V89, P1231, DOI 10.2105/AJPH.89.8.1231; Borrell LN, 2006, SOC SCI MED, V63, P1415, DOI 10.1016/j.socscimed.2006.04.008; Braveman PA, 2015, AM J PUBLIC HEALTH, V105, P694, DOI 10.2105/AJPH.2014.302008; Cole ER, 2003, J SOC ISSUES, V59, P785, DOI 10.1046/j.0022-4537.2003.00090.x; Colen CG, 2006, AM J PUBLIC HEALTH, V96, P2032, DOI 10.2105/AJPH.2005.076547; Collins JW, 2000, EPIDEMIOLOGY, V11, P337, DOI 10.1097/00001648-200005000-00019; Collins JW, 1997, EPIDEMIOLOGY, V8, P315, DOI 10.1097/00001648-199705000-00015; Dole N, 2004, AM J PUBLIC HEALTH, V94, P1358, DOI 10.2105/AJPH.94.8.1358; Dole N, 2003, AM J EPIDEMIOL, V157, P14, DOI 10.1093/aje/kwf176; Dominguez TP, 2008, HEALTH PSYCHOL, V27, P194, DOI 10.1037/0278-6133.27.2.194; Dominguez TP, 2009, SOC SCI MED, V69, P258, DOI 10.1016/j.socscimed.2009.03.022; Dunkel-Schetter C, 1998, PRENAT NEONAT MED, V3, P39; Foster HW, 2000, J NATL MED ASSOC, V92, P213; Fuller-Rowell TE, 2015, PSYCHOSOM MED, V77, P33, DOI 10.1097/PSY.0000000000000128; Giurgescu C, 2012, JOGNN-J OBST GYN NEO, V41, pE51, DOI 10.1111/j.1552-6909.2012.01409.x; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Heino A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149252; Hilmert CJ, 2014, HEALTH PSYCHOL, V33, P43, DOI 10.1037/a0031160; Hobel CJ, 1999, AM J OBSTET GYNECOL, V180, pS257, DOI 10.1016/S0002-9378(99)70712-X; Hoffman MC, 2016, OBSTET GYNECOL, V127, P545, DOI 10.1097/AOG.0000000000001287; Hudson DL, 2012, J MENS HEALTH, V9, P127, DOI 10.1016/j.jomh.2012.03.006; Jackson FM, 2012, WOMEN HEALTH ISS, V22, pE329, DOI 10.1016/j.whi.2012.01.003; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Knight AK, 2016, GENES-BASEL, V7, DOI 10.3390/genes7040015; Korte JE, 1999, THESIS, P60; Kramer MS, 2013, PAEDIATR PERINAT EP, V27, P237, DOI 10.1111/ppe.12042; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Krieger N, 2014, INT J HEALTH SERV, V44, P643, DOI 10.2190/HS.44.4.b; Landrine H, 2006, J BEHAV MED, V29, P79, DOI 10.1007/s10865-005-9029-0; Lewis TT, 2015, ANNU REV CLIN PSYCHO, V11, P407, DOI 10.1146/annurev-clinpsy-032814-112728; Lilliecreutz C, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-015-0775-x; Lu MC, 2004, AM J OBSTET GYNECOL, V191, P691, DOI 10.1016/j.ajog.2004.04.018; Lu MC, 2010, ETHNIC DIS, V20, P62; Margerison-Zilko CE, 2017, MATERN CHILD HLTH J, V21, P648, DOI 10.1007/s10995-016-2151-5; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; McDonald SW, 2014, ARCH WOMEN MENT HLTH, V17, P559, DOI 10.1007/s00737-014-0436-5; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; MCGRADY GA, 1992, AM J EPIDEMIOL, V136, P266, DOI 10.1093/oxfordjournals.aje.a116492; McNeilly M D, 1996, Ethn Dis, V6, P154; Misra D, 2010, PAEDIATR PERINAT EP, V24, P546, DOI 10.1111/j.1365-3016.2010.01148.x; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Murrell N L, 1996, J Natl Black Nurses Assoc, V8, P45; Mustillo S, 2004, AM J PUBLIC HEALTH, V94, P2125, DOI 10.2105/AJPH.94.12.2125; Myers HF, 2003, HDB RACIAL ETHNIC MI, DOI 10.4135/9781412976008.n19; Nuru-Jeter A, 2009, MATERN CHILD HLTH J, V13, P29, DOI 10.1007/s10995-008-0357-x; O'Campo P, 2016, SSM-POPUL HLTH, V2, P850, DOI 10.1016/j.ssmph.2016.10.014; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Rankin KM, 2011, ETHNIC DIS, V21, P370; Rosenberg L, 2002, EPIDEMIOLOGY, V13, P646, DOI 10.1097/00001648-200211000-00008; Rubens CE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009871; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; Shuey KM, 2008, RES AGING, V30, P200, DOI 10.1177/0164027507311151; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Tsai HJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005899; Vidal AC, 2014, GENET EPIGENETICS, V6, P37, DOI 10.4137/GEG.S18067; Wadhwa PD, 2011, CLIN PERINATOL, V38, P351, DOI 10.1016/j.clp.2011.06.007; Williams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305; Williams DR, 2013, AM BEHAV SCI, V57, P1152, DOI 10.1177/0002764213487340; Witt WP, 2014, AM J PUBLIC HEALTH, V104, pS73, DOI 10.2105/AJPH.2013.301688; Yaktine AL, 2009, WEIGHT GAIN PREGNANC; Yao YL, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0121-6	62	63	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186151	10.1371/journal.pone.0186151	http://dx.doi.org/10.1371/journal.pone.0186151			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020025	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400073
J	Marmiroli, P; Riva, B; Pozzi, E; Ballarini, E; Lim, D; Chiorazzi, A; Meregalli, C; Distasi, C; Renn, CL; Semperboni, S; Morosi, L; Ruffinatti, FA; Zucchetti, M; Dorsey, SG; Cavaletti, G; Genazzani, A; Carozzi, VA				Marmiroli, Paola; Riva, Beatrice; Pozzi, Eleonora; Ballarini, Elisa; Lim, Dmitry; Chiorazzi, Alessia; Meregalli, Cristina; Distasi, Carla; Renn, Cynthia L.; Semperboni, Sara; Morosi, Lavinia; Ruffinatti, Federico A.; Zucchetti, Massimo; Dorsey, Susan G.; Cavaletti, Guido; Genazzani, Armando; Carozzi, Valentina A.			Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights	PLOS ONE			English	Article							COLON-CANCER PATIENTS; COLORECTAL-CANCER; 1ST-LINE TREATMENT; INDUCED NEUROPATHY; CHEMOTHERAPY; MICE; FLUOROURACIL; POLYMORPHISM; LEUCOVORIN; CISPLATIN	Peripheral neurotoxicity is one of the most distressing side effects of oxaliplatin therapy for cancer. Indeed, most patients that received oxaliplatin experience acute and/or chronic severe sensory peripheral neuropathy. However, despite similar co-morbidities, cancer stage, demographics and treatment schedule, patients develop oxaliplatin-induced peripheral neurotoxicity with remarkably different severity. This suggests individual genetic variability, which might be used to glean the mechanistic insights into oxaliplatin neurotoxicity. We characterized the susceptibility of different mice strains to oxaliplatin neurotoxicity investigating the phenotypic features of neuropathy and gene expression profiles in dorsal root ganglia of six genetically different mice strains (Balb-c, C57BL6, DBA/2J, AJ, FVB and CD1) exposed to the same oxaliplatin schedule. Differential gene expression in dorsal root ganglia from each mice strain were assayed using a genome-wide expression analysis and selected genes were validated by RT-PCR analysis. The demonstration of consistent differences in the phenotypic response to oxaliplatin across different strains is interesting to allow the selection of the appropriate strain based on the pre-defined read-out parameters. Further investigation of the correlation between gene expression changes and oxaliplatin-induced neurotoxicity phenotype in each strain will be useful to deeper investigate the molecular mechanisms of oxaliplatin neurotoxicity.	[Marmiroli, Paola; Pozzi, Eleonora; Ballarini, Elisa; Chiorazzi, Alessia; Meregalli, Cristina; Semperboni, Sara; Cavaletti, Guido; Carozzi, Valentina A.] Univ Milano Bicocca, Sch Med & Surg, Expt Neurol Unit, Monza, Italy; [Riva, Beatrice; Lim, Dmitry; Distasi, Carla; Ruffinatti, Federico A.; Genazzani, Armando] Univ Piemonte Orientale, Dept Pharmaceut Sci, Novara, Italy; [Renn, Cynthia L.; Dorsey, Susan G.] Univ Maryland, Sch Nursing, Dept Pain & Translat Symptom Sci, Baltimore, MD 21201 USA; [Morosi, Lavinia; Zucchetti, Massimo] IRCCS, Dept Oncol, Ist Ric Farmacol Mario Negri, Milan, Italy	University of Milano-Bicocca; University of Eastern Piedmont Amedeo Avogadro; University System of Maryland; University of Maryland Baltimore; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Marmiroli, P (corresponding author), Univ Milano Bicocca, Sch Med & Surg, Expt Neurol Unit, Monza, Italy.	paola.marmiroli@unimib.it	Morosi, Lavinia/AAA-7593-2019; RUFFINATTI, FEDERICO ALESSANDRO/ABA-8065-2020; carozzi, valentina/AAM-1355-2020; Cavaletti, Guido/AAA-7063-2022; Genazzani, Armando/AAI-8280-2020; marmiroli, paola/AAB-6077-2022; Zucchetti, Massimo/AAA-6479-2020; Distasi, Carla/AAE-1839-2021	Morosi, Lavinia/0000-0003-1301-720X; RUFFINATTI, FEDERICO ALESSANDRO/0000-0002-3084-0380; Cavaletti, Guido/0000-0003-4128-2406; Zucchetti, Massimo/0000-0002-5427-052X; Pozzi, Eleonora/0000-0001-6438-286X; Distasi, Carla/0000-0001-8815-3252; Riva, Beatrice/0000-0002-4524-7600; Genazzani, Armando/0000-0003-1923-7430; SEMPERBONI, SARA/0000-0002-4257-8682; carozzi, valentina alda/0000-0003-0963-7107; Meregalli, Cristina/0000-0002-4281-4577; Chiorazzi, Alessia/0000-0002-3469-1829; marmiroli, paola/0000-0002-7590-7649	Fondazione Cariplo [2013-0842]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [Trideo (Transforming Ideas in Oncological Research) Grant] [15942]; NATIONAL INSTITUTE OF NURSING RESEARCH [P30NR014129] Funding Source: NIH RePORTER	Fondazione Cariplo(Fondazione Cariplo); Associazione Italiana per la Ricerca sul Cancro (AIRC) [Trideo (Transforming Ideas in Oncological Research) Grant]; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by Fondazione Cariplo [Grant ID 2013-0842], www.fondazionecariplo.it (PM); and Associazione Italiana per la Ricerca sul Cancro (AIRC) [Trideo (Transforming Ideas in Oncological Research) Grant ID 15942], www.airc.it (VAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AL-Atiyyat N, 2017, INT J PALLIAT NURS, V23, P13, DOI 10.12968/ijpn.2017.23.1.13; Argyriou AA, 2008, CANCER TREAT REV, V34, P368, DOI 10.1016/j.ctrv.2008.01.003; Argyriou AA, 2017, NAT REV NEUROL, V13, P492, DOI 10.1038/nrneurol.2017.88; Argyriou AA, 2012, CRIT REV ONCOL HEMAT, V82, P51, DOI 10.1016/j.critrevonc.2011.04.012; Argyriou AA, 2009, ONCOLOGY-BASEL, V77, P254, DOI 10.1159/000236049; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Canta A, 2011, CANCER CHEMOTH PHARM, V68, P1001, DOI 10.1007/s00280-011-1574-3; Canta A, 2016, NEUROBIOL AGING, V45, P136, DOI 10.1016/j.neurobiolaging.2016.05.014; Carozzi V, 2011, J PERIPHER NERV SYST, V16, pS7; Carozzi VA, 2010, EXP NEUROL, V226, P301, DOI 10.1016/j.expneurol.2010.09.004; CAROZZI VA, 2014, NEUROSCI LETT; Carozzi VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072995; Carozzi VA, 2015, EXP NEUROL, V264, P92, DOI [10.1016/j.expneurol.2014.11.002, 10.1016/j.expneuroL.2014.11.002]; CAVALETTI G, 1992, ACTA NEUROPATHOL, V84, P364; Cavaletti G, 2001, EUR J CANCER, P37; Cavaletti G, 2015, CURR OPIN NEUROL, V28, P500, DOI 10.1097/WCO.0000000000000234; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Cho ES, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1396-2; Custodio A, 2014, ANN ONCOL, V25, P398, DOI 10.1093/annonc/mdt546; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Kanai K, 2003, MUSCLE NERVE, V27, P113, DOI 10.1002/mus.10287; Lauria G, 2005, J PERIPHER NERV SYST, V10, P202, DOI 10.1111/j.1085-9489.2005.0010210.x; Lauria G, 2012, J PERIPHER NERV SYST, V17, pS30; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Li QF, 2010, J KOREAN MED SCI, V25, P846, DOI 10.3346/jkms.2010.25.6.846; Majithia N, 2016, ONCOLOGY-NY, V30, P1020; Marmiroli P, 2015, CURR MED CHEM; Park JH, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0141010, 10.1371/journal.pone.0112045]; Peng Z, 2013, CANCER CHEMOTH PHARM, V72, P305, DOI 10.1007/s00280-013-2194-x; Podratz JL, 2016, J NEUROL SCI, V362, P131, DOI 10.1016/j.jns.2015.12.038; Pulvers JN, 2017, ASIA PAC J CLIN ONCO; Renn CL, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-29; Rothenberg ML, 2003, J CLIN ONCOL, V21, P2059, DOI 10.1200/JCO.2003.11.126; Schellingerhout D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045776; Sereno M, 2017, BMC CANCER, V17, DOI 10.1186/s12885-016-3031-5; Smith SB, 2004, LIFE SCI, V74, P2593, DOI 10.1016/j.lfs.2004.01.002; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Souglakos J, 2002, J CLIN ONCOL, V20, P2651, DOI 10.1200/JCO.2002.08.015; Staff NP, 2017, ANN NEUROL, V81, P772, DOI 10.1002/ana.24951; Terrazzino S, 2015, J PERIPHER NERV SYST, V20, P15, DOI 10.1111/jns.12110; Won HH, 2012, CANCER-AM CANCER SOC, V118, P2828, DOI 10.1002/cncr.26614; Wozniak KM, 2011, CANCER RES, V71, P3952, DOI 10.1158/0008-5472.CAN-10-4184	42	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186250	10.1371/journal.pone.0186250	http://dx.doi.org/10.1371/journal.pone.0186250			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020118	gold, Green Published, Green Submitted			2022-12-26	WOS:000412754400084
J	Vandereyken, M; Jacques, S; Van Overmeire, E; Amand, M; Rocks, N; Delierneux, C; Singh, P; Singh, M; Ghuysen, C; Wathieu, C; Zurashvili, T; Sounni, NE; Moutschen, M; Gilles, C; Oury, C; Cataldo, D; Van Ginderachter, JA; Rahmouni, S				Vandereyken, Maud; Jacques, Sophie; Van Overmeire, Eva; Amand, Mathieu; Rocks, Natacha; Delierneux, Celine; Singh, Pratibha; Singh, Maneesh; Ghuysen, Camille; Wathieu, Caroline; Zurashvili, Tinatin; Sounni, Nor Eddine; Moutschen, Michel; Gilles, Christine; Oury, Cecile; Cataldo, Didier; Van Ginderachter, Jo A.; Rahmouni, Souad			Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner	PLOS ONE			English	Article							DUAL-SPECIFICITY PHOSPHATASE; VHR; ANGIOGENESIS; CANCER; EXPRESSION; CELLS; MICROENVIRONMENTS; SURVIVAL; ERK	Vaccinia-H1 Related (VHR) dual-specificity phosphatase, or DUSP3, plays an important role in cell cycle regulation and its expression is altered in several human cancers. In mouse model, DUSP3 deletion prevents neo-angiogenesis and b-FGF-induced microvessel outgrowth. Considering the importance of angiogenesis in metastasis formation, our study aimed to investigate the role of DUSP3 in tumour cell dissemination. Using a Lewis Lung carcinoma (LLC) experimental metastasis model, we observed that DUSP3(-/-) mice developed larger lung metastases than littermate controls. DUSP3(-/-) bone marrow transfer to lethally irradiated DUSP3(+/+) mice was sufficient to transfer the phenotype to DUSP3(+/+) mice, indicating that hematopoietic cells compartment was involved in the increased tumour cell dissemination to lung tissues. Interestingly, we found a higher percentage of tumour-promoting Ly6C(int) macrophages in DUSP3(-/-) LLC-bearing lung homogenates that was at least partially due to a better recruitment of these cells. This was confirmed by 1) the presence of higher number of the Ly6B(hi) macrophages in DUSP3(-/-) lung homogenates and by 2) the better migration of DUSP3(-/-) bone marrow sorted monocytes, peritoneal macrophages and bone marrow derived macrophages (BMDMs), compared to DUSP3(+/+) monocytes, macrophages and BMDMs, in response to LLC-conditioned medium. Our study demonstrates that DUSP3 phosphatase plays a key role in metastatic growth through a mechanism involving the recruitment of macrophages towards LLC-bearing lungs.	[Vandereyken, Maud; Jacques, Sophie; Amand, Mathieu; Singh, Pratibha; Singh, Maneesh; Ghuysen, Camille; Wathieu, Caroline; Zurashvili, Tinatin; Moutschen, Michel; Rahmouni, Souad] Univ Liege, GIGA I3, Immunol & Infect Dis Unit, Liege, Belgium; [Van Overmeire, Eva; Van Ginderachter, Jo A.] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium; [Van Overmeire, Eva; Van Ginderachter, Jo A.] VIB Inflammat Res Ctr, Lab Myeloid Cell Immunol, Ghent, Belgium; [Rocks, Natacha; Sounni, Nor Eddine; Gilles, Christine; Cataldo, Didier] Univ Liege, GIGA Canc, Lab Tumour & Dev Biol, Liege, Belgium; [Delierneux, Celine; Oury, Cecile] Univ Liege, GIGA Cardiovasc Sci Unit, Lab Thrombosis & Haemostasis, Liege, Belgium	University of Liege; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); University of Liege; University of Liege	Rahmouni, S (corresponding author), Univ Liege, GIGA I3, Immunol & Infect Dis Unit, Liege, Belgium.	srahmouni@ulg.ac.be	Cataldo, Didier/GPG-3453-2022; Sounni, Nor Eddine/AAY-8766-2021; Van Ginderachter, Jo A/H-5473-2013; Singh, Pratibha/AAD-5680-2020; Singh, Pratibha/AAI-6066-2020	Sounni, Nor Eddine/0000-0001-9962-9236; Van Ginderachter, Jo A/0000-0002-4442-7474; Singh, Pratibha/0000-0002-6919-8479; Zurashvili, Tinatin/0000-0002-4488-2581; Oury, Cecile/0000-0002-7561-0132; Vandereyken, Maud/0000-0002-6169-7396; Delierneux, Celine/0000-0003-2638-0104	Fonds Leon Fredericq and Centre anticancereux pres de l'ULg; Fond National de la Recherche Scientifique (FRS-FNRS); Fond Wetenschappelijk Onderzoek (FWO)	Fonds Leon Fredericq and Centre anticancereux pres de l'ULg; Fond National de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fond Wetenschappelijk Onderzoek (FWO)(FWO)	This work was supported by the Fonds Leon Fredericq and Centre anticancereux pres de l'ULg and by the Fond National de la Recherche Scientifique (FRS-FNRS) (to SR) and the Fond Wetenschappelijk Onderzoek (FWO to JAV). MV and MA are FNRS-Televie PhD fellows.	Alonso A, 2001, J BIOL CHEM, V276, P4766, DOI 10.1074/jbc.M006497200; Amand M, 2016, METHODS MOL BIOL, V1447, P331, DOI 10.1007/978-1-4939-3746-2_18; Amand M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-108; Arnoldussen YJ, 2008, CANCER RES, V68, P9255, DOI 10.1158/0008-5472.CAN-08-1224; Chen Y. R., 2017, ONCOGENE; Criscuoli ML, 2008, VASCULAR, V105, P1508; Dirkx AEM, 2006, J LEUKOCYTE BIOL, V80, P1183, DOI 10.1189/jlb.0905495; Donnem T, 2013, CANCER MED-US, V2, P427, DOI 10.1002/cam4.105; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Galdiero MR, 2013, IMMUNOBIOLOGY, V218, P1402, DOI 10.1016/j.imbio.2013.06.003; Hao L, 2007, INT J CANCER, V121, P39, DOI 10.1002/ijc.22597; Henkens R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-147; Hoyt R, 2007, J IMMUNOL, V179, P3402, DOI 10.4049/jimmunol.179.6.3402; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kuczynski EA, 2016, JNCI-J NATL CANCER I, V108, P1; Laoui D, 2014, CANCER RES, V74, P24, DOI 10.1158/0008-5472.CAN-13-1196; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Nakamura K, 2002, J BIOCHEM, V132, P463, DOI 10.1093/oxfordjournals.jbchem.a003244; Pereira SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082095; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Saigusa S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0620-x; Satoh H, 2010, CARCINOGENESIS, V31, P1833, DOI 10.1093/carcin/bgq105; Singh P, 2015, J IMMUNOL, V194, P4951, DOI 10.4049/jimmunol.1402431; Sounni NE, 2014, CELL METAB, V20, P280, DOI 10.1016/j.cmet.2014.05.022; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Todd JL, 2002, ONCOGENE; Wagner KW, 2013, J CLIN INVEST, V123, P5231, DOI 10.1172/JCI68642; Wang JY, 2011, J BIOL CHEM, V286, P10177, DOI 10.1074/jbc.M110.163295; Wong PP, 2015, CANCER CELL, V27, P123, DOI 10.1016/j.ccell.2014.10.015; Wu S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-413; Yoshimura T, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00332; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zhong H, 2014, INT J CANCER, V134, P2633, DOI 10.1002/ijc.28590; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521	42	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185786	10.1371/journal.pone.0185786	http://dx.doi.org/10.1371/journal.pone.0185786			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020102	Green Submitted, gold, Green Published			2022-12-26	WOS:000412754400045
J	Vogel, J; Auinger, A; Riedl, R; Kindermann, H; Helfert, M; Ocenasek, H				Vogel, Juergen; Auinger, Andreas; Riedl, Rene; Kindermann, Harald; Helfert, Markus; Ocenasek, Helmuth			Digitally enhanced recovery: Investigating the use of digital self-tracking for monitoring leisure time physical activity of cardiovascular disease (CVD) patients undergoing cardiac rehabilitation	PLOS ONE			English	Article							SECONDARY PREVENTION; PRACTICE GUIDELINES; AMERICAN-COLLEGE; WEARABLE SYSTEMS; HEART; EXERCISE; HEALTH; INTENSITY; MORTALITY; CORONARY	Research has shown that physical activity is essential in the prevention and treatment of chronic diseases like cardiovascular disease (CVD). Smart wearables (e.g., smart-watches) are increasingly used to foster and monitor human behaviour, including physical activity. However, despite this increased usage, little evidence is available on the effects of smart wearables in behaviour change. The little research which is available typically focuses on the behaviour of healthy individuals rather than patients. In this study, we investigate the effects of using smart wearables by patients undergoing cardiac rehabilitation. A field experiment involving 29 patients was designed and participants were either assigned to the study group (N = 13 patients who finished the study and used a self-tracking device) or the control group (N = 16 patients who finished the study and did not use a device). For both groups data about physiological performance during cardiac stress test was collected at the beginning (baseline), in the middle (in week 6, at the end of the rehabilitation in the organized rehabilitation setting), and at the end of the study (after 12 weeks, at the end of the rehabilitation, including the organized rehabilitation plus another 6 weeks of self-organized rehabilitation). Comparing the physiological performance of both groups, the data showed significant differences. The participants in the study group not only maintained the same performance level as during the midterm examination in week 6, they improved performance even further during the six weeks that followed. The results presented in this paper provide evidence for positive effects of digital self-tracking by patients undergoing cardiac rehabilitation on performance of the cardiovascular system. In this way, our study provides novel insight about the effects of the use of smart wearables by CVD patients. Our findings have implications for the design of self-management approaches in a patient rehabilitation setting. In essence, the use of smart wearables can prolong the success of the rehabilitation outside of the organized rehabilitation setting.	[Vogel, Juergen; Auinger, Andreas; Riedl, Rene; Kindermann, Harald] Univ Appl Sci Upper Austria, Sch Management, Steyr, Austria; [Vogel, Juergen; Ocenasek, Helmuth] CARDIOMED Outpatient Cardiac Rehabil Ctr, Linz, Austria; [Riedl, Rene] Johannes Kepler Univ Linz, Dept Business Informat Informat Engn, Linz, Austria; [Helfert, Markus] Dublin City Univ, Sch Comp, Fac Engn & Comp, Dublin, Ireland	Johannes Kepler University Linz; Dublin City University	Vogel, J (corresponding author), Univ Appl Sci Upper Austria, Sch Management, Steyr, Austria.; Vogel, J (corresponding author), CARDIOMED Outpatient Cardiac Rehabil Ctr, Linz, Austria.	juergen.vogel@liwest.at	Schäfer, Lea-Sophie/AFJ-7313-2022	Helfert, Markus/0000-0001-6546-6408; Kindermann, Harald/0000-0003-3308-2981; Auinger, Andreas/0000-0002-2672-0896				Ades PA, 2001, NEW ENGL J MED, V345, P892, DOI 10.1056/NEJMra001529; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Appelboom G, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-28; Benton DC, 2014, INT NURS REV, V61, P445, DOI 10.1111/inr.12150; Benzer W, 2008, AUSTRIAN J CARDIOLOG, V15, P289; Bidargaddi NP, 2008, METHOD INFORM MED, V47, P208, DOI 10.3414/ME9112; Blanchard CM, 2010, J CARDIOPULM REHABIL, V30, P240, DOI 10.1097/HCR.0b013e3181d0c4ae; Bonato Paolo, 2005, J Neuroeng Rehabil, V2, P2, DOI 10.1186/1743-0003-2-2; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Byrom B, 2016, CONTEMP CLIN TRIALS, V47, P172, DOI 10.1016/j.cct.2016.01.006; Case MA, 2015, JAMA-J AM MED ASSOC, V313, P625, DOI 10.1001/jama.2014.17841; Chan M, ARTIFICIAL INTELLIGE; Chan M, 2012, ARTIF INTELL MED, V56, P137, DOI 10.1016/j.artmed.2012.09.003; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Chiauzzi E, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0319-2; Colantonio S, 2015, BIOSYST ENG, V138, P33, DOI 10.1016/j.biosystemseng.2015.06.008; Colley RC, 2011, HLTH REP, V22, P7; de Bruin ED, 2008, CLIN REHABIL, V22, P878, DOI 10.1177/0269215508090675; Duncan GE, 2001, PREV MED, V33, P18, DOI 10.1006/pmed.2001.0847; El-Gayar Omar, 2013, J Diabetes Sci Technol, V7, P247; Evenson KR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0183-7; Finegold JA, 2013, INT J CARDIOL, V168, P934, DOI 10.1016/j.ijcard.2012.10.046; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Germano G, 2012, EUR HEART J, V33, P137; Gianuzzi P, 2001, EUR HEART J, V22, P125; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Gurrin Cathal, 2014, Foundations and Trends in Information Retrieval, V8, P5, DOI 10.1561/1500000033; Hamer M, 2009, EUR J CARDIOV PREV R, V16, P156, DOI 10.1097/HJR.0b013e32831f1b77; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Jolly K, 2006, INT J CARDIOL, V111, P343, DOI 10.1016/j.ijcard.2005.11.002; Kakria P, 2015, INT J TELEMED APPL, V2015, DOI 10.1155/2015/373474; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; King A. J., 2013, PLOS ONE, V8, P1, DOI DOI 10.1371/J0URNAL.P0NE.0062613; Kjonniksen L, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-69; Lee IM, 2003, CIRCULATION, V107, P1110, DOI 10.1161/01.CIR.0000052626.63602.58; Lewis ZH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1947-3; Lukowicz P, 2004, METHOD INFORM MED, V43, P232; Lukowicz P, 2008, ARTIF INTELL MED, V42, P95, DOI 10.1016/j.artmed.2007.12.002; Lupton D, 2013, CRIT PUBLIC HEALTH, V23, P393, DOI 10.1080/09581596.2013.794931; Lyons EJ, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3469; Maddison R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1236; Marcus BH, 2000, HEALTH PSYCHOL, V19, P32, DOI 10.1037/0278-6133.19.Suppl1.32; Martin BJ, 2013, MAYO CLIN PROC, V88, P455, DOI 10.1016/j.mayocp.2013.02.013; Meyer Jochen, 2015, MultiMedia Modeling. 21st International Conference, MMM 2015. Proceedings: LNCS 8936, P323, DOI 10.1007/978-3-319-14442-9_39; Miller TD, 1997, ANN BEHAV MED, V19, P220, DOI 10.1007/BF02892287; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Napolitano MA, 2010, CONTEMP CLIN TRIALS, V31, P514, DOI 10.1016/j.cct.2010.08.004; Niebauer J, 2014, WIEN KLIN WOCHENSCHR, V126, P148, DOI 10.1007/s00508-014-0527-3; Niebauer J, 2013, EUR J PREV CARDIOL, V20, P468, DOI 10.1177/2047487312446137; O'Brien T, 2015, GERIATR NURS, V36, pS21, DOI 10.1016/j.gerinurse.2015.02.019; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Pantzar M, 2015, CONSUMP MARK CULT, V18, P92, DOI 10.1080/10253866.2014.899213; Piwek L, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001953; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Rabbi M, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.4160; Saeb S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144795; Safavi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114306; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Sneha S, 2009, DECIS SUPPORT SYST, V46, P606, DOI 10.1016/j.dss.2008.11.014; Sung M., 2005, J NEUROENG REHABIL, V2, P17, DOI DOI 10.1186/1743-0003-2-17; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2013, APPL PHYSIOL NUTR ME, V38, P100, DOI 10.1139/apnm-2012-0235; Urrea Bruno, 2015, Curr Treat Options Cardiovasc Med, V17, P59, DOI 10.1007/s11936-015-0417-7; Virtanen P., 2014, POLAR LOOP ACTIVITY, P1; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wiederhold BK, 2012, CYBERPSYCH BEH SOC N, V15, P235, DOI 10.1089/cyber.2012.1545; Wonisch M, 2008, J KARDIOL, V15, P3; Worringham C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014669	75	15	16	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186261	10.1371/journal.pone.0186261	http://dx.doi.org/10.1371/journal.pone.0186261			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020079	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000412754400086
J	Yum, KS; Chang, JY; Jeong, WJ; Lee, S; Jeong, JH; Yeo, MJ; Hong, JH; Park, HK; Chung, I; Kim, BJ; Bang, JS; Bae, HJ; Han, MK				Yum, Kyu Sun; Chang, Jun Young; Jeong, Won Joo; Lee, Sangkil; Jeong, Jin-Heon; Yeo, Min-Ju; Hong, Jeong-Ho; Park, Hong-Kyun; Chung, Inyoung; Kim, Beom Joon; Bang, Jae Seung; Bae, Hee-Joon; Han, Moon-Ku			Effect of statin on progression of symptomatic basilar artery stenosis and subsequent ischemic stroke	PLOS ONE			English	Article							INTRACRANIAL ATHEROSCLEROSIS; THERAPY	Background and objective Symptomatic basilar artery stenosis (BAS) is associated with high risk of ischemic stroke recurrence. We aimed to investigate whether statin therapy might prevent the progression of symptomatic BAS and stroke recurrence. Methods We retrospectively analyzed the data of patients with acute ischemia with symptomatic BAS, which was assessed using magnetic resonance angiogram (MRA) imaging on admission day, and 1 year later (or the day of the clinical event). The clinical endpoints were recurrent ischemic stroke and its composites, transient ischemic attack, coronary disease, and vascular death. Results Of the 153 patients with symptomatic BAS, 114 (74.5%) were treated with a statin after experiencing a stroke. Statin therapy significantly prevented the progression of symptomatic BAS (7.0% vs 28.2%) and induced regression (22.8% vs 15.4%) compared to non-statin users (p = 0.002). There were 31 ischemic stroke incidences and 38 composite vascular events. Statin users showed significantly lower stroke recurrence (14.9% vs 35.9%, p = 0.05) and composite vascular events (17.5% vs 46.2%; odds ratio [OR], 0.29; 95% confidence interval [CI], 0.13-0.64) than those not using statins did. Recurrent stroke in the basilar territory and composite vascular events were more common in patients with progression of BAS than they were in other patients (OR, 5.16; 95% CI, 1.63-16.25 vs OR, 4.2; 95% CI, 1.56-11.34). Conclusion Our study suggests that statin therapy may prevent the progression of symptomatic BAS and decrease the risk of subsequent ischemic stroke. Large randomized trials are needed to confirm this result.	[Yum, Kyu Sun; Lee, Sangkil; Park, Hong-Kyun; Chung, Inyoung; Kim, Beom Joon; Bae, Hee-Joon; Han, Moon-Ku] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Neurol, Seongnam, South Korea; [Chang, Jun Young] Gyeongsang Natl Univ, Changwon Hosp, Dept Neurol, Chang Won, South Korea; [Jeong, Won Joo] Seoul Natl Univ, Bundang Hosp, Dept Crit Care, Seongnam, South Korea; [Jeong, Jin-Heon] Dong A Univ Hosp, Dept Intens Care Med & Neurol, Busan, South Korea; [Yeo, Min-Ju] Chungbuk Natl Univ Hosp, Dept Neurol, Chungju, South Korea; [Hong, Jeong-Ho] Keimyung Univ, Dongsan Med Ctr, Dept Neurol, Daegu, South Korea; [Bang, Jae Seung] Seoul Natl Univ, Bundang Hosp, Dept Neurosurg, Seongnam, South Korea	Seoul National University (SNU); Gyeongsang National University; Seoul National University (SNU); Dong A University; Chungbuk National University; Chungbuk National University Hospital; Keimyung University; Seoul National University (SNU)	Han, MK (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Neurol, Seongnam, South Korea.	mkhan@snu.ac.kr	Hong, Jeong-Ho/T-8099-2018; JEONG, JIN-HEON/O-3734-2017; Hong, Jeong-Ho/AAE-1002-2022; Kim, Beom Joon/C-2904-2011	Hong, Jeong-Ho/0000-0002-8235-9855; JEONG, JIN-HEON/0000-0002-5878-9206; Hong, Jeong-Ho/0000-0002-8235-9855; Kim, Beom Joon/0000-0002-2719-3012; Park, Hong-Kyun/0000-0002-8120-2469; Chung, Inyoung/0000-0002-3586-4162; Chang, Jun Young/0000-0003-4880-9258				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Akins PT, 1998, STROKE, V29, P433, DOI 10.1161/01.STR.29.2.433; Amarenco P, 2006, NEW ENGL J MED, V355, P549; [Anonymous], 1998, PROGR PAT SYMPT VERT, V29, P1389; Arenillas JF, 2001, STROKE, V32, P2898, DOI 10.1161/hs1201.099652; Arenillas JF, 2011, STROKE, V42, pS20, DOI 10.1161/STROKEAHA.110.597278; Caplan L, 2000, STROKE, V31, P2011, DOI 10.1161/01.STR.31.8.2011; Caplan LR, 2004, ANN NEUROL, V56, P389, DOI 10.1002/ana.20204; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; FELDMANN E, 1990, NEUROLOGY, V40, P1541, DOI 10.1212/wnl.40.10.1540; Feldmann E, 2007, NEUROLOGY, V68, P2099, DOI 10.1212/01.wnl.0000261488.05906.c1; Kang J, 2014, J STROKE, V16, P36, DOI 10.5853/jos.2014.16.1.36; Kang S, 2004, ATHEROSCLEROSIS, V177, P433, DOI 10.1016/j.atherosclerosis.2004.08.005; Kasner SE, 2006, CIRCULATION, V113, P555, DOI 10.1161/CIRCULATIONAHA.105.578229; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kim YJ, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-171; NISHIMARU K, 1984, STROKE, V15, P56, DOI 10.1161/01.STR.15.1.56; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Noyes AM, 2014, ATHEROSCLEROSIS, V234, P75, DOI 10.1016/j.atherosclerosis.2014.02.007; Qiao Y, 2016, STROKE, V47, P434, DOI 10.1161/STROKEAHA.115.009955; Savitz SI, 2005, NEW ENGL J MED, V352, P2618, DOI 10.1056/NEJMra041544; Tan TY, 2009, J NEUROL, V256, P187, DOI 10.1007/s00415-009-0960-9; Turan TN, 2014, CEREBROVASC DIS, V37, P203, DOI 10.1159/000358120; Wong KS, 2002, STROKE, V33, P532, DOI 10.1161/hs0202.102602; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Woolfenden A R, 2000, J Stroke Cerebrovasc Dis, V9, P57, DOI 10.1053/jscd.2000.0090057; Zhou PY, 2014, CLIN NEUROL NEUROSUR, V120, P6, DOI 10.1016/j.clineuro.2014.02.001	28	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0183798	10.1371/journal.pone.0183798	http://dx.doi.org/10.1371/journal.pone.0183798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020008	gold, Green Submitted, Green Published			2022-12-26	WOS:000412754400007
J	Quintero-Ronderos, P; Mercier, E; Fukuda, M; Gonzalez, R; Suarez, CF; Patarroyo, MA; Vaiman, D; Gris, JC; Laissue, P				Quintero-Ronderos, Paula; Mercier, Eric; Fukuda, Michiko; Gonzalez, Ronald; Fernando Suarez, Carlos; Alfonso Patarroyo, Manuel; Vaiman, Daniel; Gris, Jean-Christophe; Laissue, Paul			Novel genes and mutations in patients affected by recurrent pregnancy loss	PLOS ONE			English	Article							HUMAN EMBRYO IMPLANTATION; FACTOR-V; ADHESION MOLECULES; THROMBOMODULIN; MISCARRIAGE; POLYMORPHISMS; IMPACT; DOMAIN; ENDOTHELIUM; MECHANISMS	Recurrent pregnancy loss is a frequently occurring human infertility-related disease affecting similar to 1% of women. It has been estimated that the cause remains unexplained in >50% cases which strongly suggests that genetic factors may contribute towards the phenotype. Concerning its molecular aetiology numerous studies have had limited success in identifying the disease's genetic causes. This might have been due to the fact that hundreds of genes are involved in each physiological step necessary for guaranteeing reproductive success in mammals. In such scenario, next generation sequencing provides a potentially interesting tool for research into recurrent pregnancy loss causative mutations. The present study involved whole-exome sequencing and an innovative bioinformatics analysis, for the first time, in 49 unrelated women affected by recurrent pregnancy loss. We identified 27 coding variants (22 genes) potentially related to the phenotype (41% of patients). The affected genes, which were enriched by potentially deleterious sequence variants, belonged to distinct molecular cascades playing key roles in implantation/pregnancy biology. Using a quantum chemical approach method we established that mutations in MMP-10 and FGA proteins led to substantial energetic modifications suggesting an impact on their functions and/or stability. The next generation sequencing and bioinformatics approaches presented here represent an efficient way to find mutations, having potentially moderate/strong functional effects, associated with recurrent pregnancy loss aetiology. We consider that some of these variants (and genes) represent probable future biomarkers for recurrent pregnancy loss.	[Quintero-Ronderos, Paula; Laissue, Paul] Univ Rosario, Sch Med & Hlth Sci, GENIUROS Res Grp, Ctr Res Genet & Genom CIGGUR, Bogota, Colombia; [Mercier, Eric; Gris, Jean-Christophe] Univ Montpellier, Univ Hosp, Fac Pharm & Biol Sci, Dept Haematol, Montpellier, France; [Mercier, Eric; Gris, Jean-Christophe] Univ Montpellier, Res Team EA 2992, Montpellier, France; [Fukuda, Michiko] Natl Inst Adv Ind Sci & Technol, Lab Drug Discovery, Tsukuba, Ibaraki, Japan; [Gonzalez, Ronald; Fernando Suarez, Carlos; Alfonso Patarroyo, Manuel] Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia; [Fernando Suarez, Carlos] Univ Ciencias Aplicadas & Ambientales UDCA, Bogota, Colombia; [Fernando Suarez, Carlos; Alfonso Patarroyo, Manuel] Univ Rosario, Sch Med & Hlth Sci, Basic Sci Dept, Bogota, Colombia; [Vaiman, Daniel] Univ Paris 05, CNRS, Inst Cochin, UMR 8104, Paris, France; [Vaiman, Daniel] INSERM, U1016, Paris, France	Universidad del Rosario; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; National Institute of Advanced Industrial Science & Technology (AIST); Universidad del Rosario; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Laissue, P (corresponding author), Univ Rosario, Sch Med & Hlth Sci, GENIUROS Res Grp, Ctr Res Genet & Genom CIGGUR, Bogota, Colombia.	paul.laissue@urosario.edu.co	Vaiman, Daniel/O-6030-2015; Martínez, Carlos Fernando Suárez/ABH-7784-2020; GRIS, Jean-Christophe/AAA-2923-2019; Patarroyo, Manuel A/I-8046-2016; Fukuda, Michiko/M-2748-2018; Laissue, Paul/C-6787-2012	Vaiman, Daniel/0000-0002-1915-0717; Martínez, Carlos Fernando Suárez/0000-0001-8423-408X; GRIS, Jean-Christophe/0000-0002-9899-9910; Patarroyo, Manuel A/0000-0002-4751-2500; Fukuda, Michiko/0000-0001-8549-1555; QUINTERO-RONDEROS, PAULA/0000-0003-2925-7734; Laissue, Paul/0000-0003-4180-4796; Mercier, Eric/0000-0001-7917-1918	Universidad del Rosario [CS/ABN062/GENIUR0S 017]	Universidad del Rosario	The work of Laissue's lab is supported by the Universidad del Rosario (grant: CS/ABN062/GENIUR0S 017).	Acharya SS, 2008, HAEMOPHILIA, V14, P1151, DOI 10.1111/j.1365-2516.2008.01831.x; Anifandis G, 2014, INT J MOL SCI, V15, P12972, DOI 10.3390/ijms150712972; Asselta R, 2006, J THROMB HAEMOST, V4, P26, DOI 10.1111/j.1538-7836.2005.01590.x; Bos MHA, 2012, J BIOL CHEM, V287, P26342, DOI 10.1074/jbc.M112.377168; Casini A, 2015, J THROMB HAEMOST, V13, P909, DOI 10.1111/jth.12916; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Daher S, 2012, AM J REPROD IMMUNOL, V67, P341, DOI 10.1111/j.1600-0897.2012.01123.x; Diejomaoh MFE, 2015, MED PRIN PRACT, V24, P38, DOI 10.1159/000365973; Erdogan E, 2008, J THROMB HAEMOST, V6, P118; Fukuda MN, 2008, J OBSTET GYNAECOL RE, V34, P129, DOI 10.1111/j.1447-0756.2008.00776.x; Fukuda Michiko N., 2012, Shengli Xuebao, V64, P247; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Fonseca DJ, 2015, FERTIL STERIL, V104, P154, DOI 10.1016/j.fertnstert.2015.04.016; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; Kolte AM, 2011, MOL HUM REPROD, V17, P379, DOI 10.1093/molehr/gar003; Koot YEM, 2012, BBA-MOL BASIS DIS, V1822, P1943, DOI 10.1016/j.bbadis.2012.05.017; Kujovich JL, 2011, GENET MED, V13, P1, DOI 10.1097/GIM.0b013e3181faa0f2; L'Hote D, 2007, GENETICS, V176, P1907, DOI 10.1534/genetics.107.072157; L'Hote D, 2010, BIOESSAYS, V32, P132, DOI 10.1002/bies.200900027; Laissue P, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160109; Larsen EC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-154; Li TC, 2002, HUM REPROD UPDATE, V8, P463, DOI 10.1093/humupd/8.5.463; Li YH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-34; Lissalde-Lavigne G, 2005, J THROMB HAEMOST, V3, P2178, DOI 10.1111/j.1538-7836.2005.01581.x; Martin FA, 2013, AM J PHYSIOL-HEART C, V304, pH1585, DOI 10.1152/ajpheart.00096.2013; MARUYAMA I, 1985, J CELL BIOL, V101, P363, DOI 10.1083/jcb.101.2.363; Mercier E, 2007, NEW ENGL J MED, V357, P1984, DOI 10.1056/NEJMc071528; Peng W, 2005, J THROMB HAEMOST, V3, P351, DOI 10.1111/j.1538-7836.2004.01083.x; Puscheck EE, 2007, CURR OPIN OBSTET GYN, V19, P222, DOI 10.1097/GCO.0b013e32813e3ff0; Renaud SJ, 2014, J BIOL CHEM, V289, P5025, DOI 10.1074/jbc.M113.523746; Seng KC, 2008, EUR J HUM GENET, V16, P554, DOI 10.1038/ejhg.2008.12; Simcox LE, 2015, INT J MOL SCI, V16, P28418, DOI 10.3390/ijms161226104; Sood R, 2008, BLOOD, V112, P585, DOI 10.1182/blood-2007-09-111302; Steen M, 2002, J BIOL CHEM, V277, P38424, DOI 10.1074/jbc.M204972200; Stortoni P, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-1; Su MT, 2011, HUM REPROD UPDATE, V17, P803, DOI 10.1093/humupd/dmr027; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Vaiman D, 2015, BIOMED J, V38, P11, DOI 10.4103/2319-4170.133777; Vatin M, 2014, AM J PATHOL, V184, P362, DOI 10.1016/j.ajpath.2013.10.024; Vatin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043356; Vu D, 2007, J THROMB HAEMOST, V5, P125, DOI 10.1111/j.1538-7836.2007.02465.x; Walters-Sen LC, 2015, MOL GENET GENOM MED, V3, P99, DOI 10.1002/mgg3.116; Wang L, 2010, REPROD SCI, V17, P578, DOI 10.1177/1933719110364248; White MD, 2015, CURR TOP DEV BIOL, V112, P1, DOI 10.1016/bs.ctdb.2014.11.022; Zhao YL, 2010, FERTIL STERIL, V94, P2264, DOI 10.1016/j.fertnstert.2010.01.068	45	36	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186149	10.1371/journal.pone.0186149	http://dx.doi.org/10.1371/journal.pone.0186149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016666	Green Published, Green Submitted, gold			2022-12-26	WOS:000412627400056
J	Fernandez-Aguilar, X; Cabezon, O; Frey, J; Velarde, R; Serrano, E; Colom-Cadena, A; Gelormini, G; Marco, I; Mentaberre, G; Lavin, S; Lopez-Olvera, JR				Fernandez-Aguilar, Xavier; Cabezon, Oscar; Frey, Joachim; Velarde, Roser; Serrano, Emmanuel; Colom-Cadena, Andreu; Gelormini, Giuseppina; Marco, Ignasi; Mentaberre, Gregorio; Lavin, Santiago; Lopez-Olvera, Jorge Ramon			Long-term dynamics of Mycoplasma conjunctivae at the wildlife-livestock interface in the Pyrenees	PLOS ONE			English	Article							RUPICAPRA-R.-RUPICAPRA; BORDER DISEASE VIRUS; INFECTIOUS KERATOCONJUNCTIVITIS; ALPINE CHAMOIS; IDENTIFYING RESERVOIRS; BIGHORN SHEEP; TRANSMISSION; POPULATION; CAPRINAE; IBEX	Functional roles of domestic and wild host populations in infectious keratoconjunctivitis (IKC) epidemiology have been extensively discussed claiming a domestic reservoir for the more susceptible wild hosts, however, based on limited data. With the aim to better assess IKC epidemiology in complex host-pathogen alpine systems, the long-term infectious dynamics and molecular epidemiology of Mycoplasma conjunctivae was investigated in all host populations from six study areas in the Pyrenees and one in the Cantabrian Mountains (Northern Spain). Detection of M. conjunctivae was performed by qPCR on 3600 eye swabs collected during seven years from hunted wild ungulates and sympatric domestic sheep (n = 1800 animals), and cluster analyses of the strains were performed including previous reported local strains. Mycoplasma conjunctivae was consistently detected in three Pyrenean chamois (Rupicapra p. pyrenaica) populations, as well as in sheep flocks (17.0% of sheep) and occasionally in mouflon (Ovis aries musimon) from the Pyrenees (22.2% in one year/area); statistically associated with ocular clinical signs only in chamois. Chamois populations showed different infection dynamics with low but steady prevalence (4.9%) and significant yearly fluctuations (0.0%- 40.0%). Persistence of specific M. conjunctivae strain clusters in wild host populations is demonstrated for six and nine years. Cross-species transmission between chamois and sheep and chamois and mouflon were also sporadically evidenced. Overall, independent M. conjunctivae sylvatic and domestic cycles occurred at the wildlife-livestock interface in the alpine ecosystems from the Pyrenees with sheep and chamois as the key host species for each cycle, and mouflon as a spill-over host. Host population characteristics and M. conjunctivae strains resulted in different epidemiological scenarios in chamois, ranging from the fading out of the mycoplasma to the epidemic and endemic long-term persistence. These findings highlight the capacity of M. conjunctivae to establish diverse interactions and persist in host populations, also with different transmission conditions.	[Fernandez-Aguilar, Xavier; Cabezon, Oscar; Velarde, Roser; Serrano, Emmanuel; Colom-Cadena, Andreu; Marco, Ignasi; Mentaberre, Gregorio; Lavin, Santiago; Lopez-Olvera, Jorge Ramon] Univ Autonoma Barcelona, Dept Med & Cirurgia, Serv Ecopatol Fauna Salvatge SEFaS, Bellaterra, Spain; [Fernandez-Aguilar, Xavier; Cabezon, Oscar; Colom-Cadena, Andreu] UAB, IRTA, Ctr Recerca Sanitat Anim CReSA, Campus, Bellaterra, Spain; [Frey, Joachim; Gelormini, Giuseppina] Univ Bern, Vetsuisse Fac, Inst Vet Bacteriol, Bern, Switzerland; [Serrano, Emmanuel] UA, Dept Biol & Cesam, Aveiro, Portugal	Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA; University of Bern; Universidade de Aveiro	Fernandez-Aguilar, X; Lopez-Olvera, JR (corresponding author), Univ Autonoma Barcelona, Dept Med & Cirurgia, Serv Ecopatol Fauna Salvatge SEFaS, Bellaterra, Spain.; Fernandez-Aguilar, X (corresponding author), UAB, IRTA, Ctr Recerca Sanitat Anim CReSA, Campus, Bellaterra, Spain.	xfdezagullar@gmail.com; joroli.lopez.olvera@uab.cat	SERRANO-FERRON, Emmanuel/J-4489-2013; Marco, Ignasi/E-8633-2015; Lavín, Santiago/L-5975-2014; Fernandez Aguilar, Xavier/P-9919-2017; Mentaberre, Gregorio/AAB-5912-2020; Velarde, Roser/M-1614-2014; Cabezón, Oscar/AAV-7876-2020; Mentaberre, Gregorio A/H-4629-2015; Cabezon, Oscar/L-3812-2014	SERRANO-FERRON, Emmanuel/0000-0002-9799-9804; Marco, Ignasi/0000-0001-7479-3419; Lavín, Santiago/0000-0001-5655-588X; Fernandez Aguilar, Xavier/0000-0002-4939-6048; Mentaberre, Gregorio/0000-0001-9542-7514; Velarde, Roser/0000-0003-3332-6405; Mentaberre, Gregorio A/0000-0001-9542-7514; Cabezon, Oscar/0000-0001-7543-8371	FI-DGR program from the Government of Catalonia; postdoctoral programme of the Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BPD/96637/2013]; University of Aveiro (Department of Biology); FCT/MEC [UID/AMB/50017]; FEDER, within the PT2020 Partnership Agreement	FI-DGR program from the Government of Catalonia; postdoctoral programme of the Fundacao para a Ciencia e a Tecnologia, Portugal; University of Aveiro (Department of Biology); FCT/MEC; FEDER, within the PT2020 Partnership Agreement	This study was funded by the research projects CGL2009-11631 and CGL2012-40043-C02-02 of the Spanish MICINN (to JRL). X. Fernandez-Aguilar and A. Colom-Cadena were supported by the FI-DGR program from the Government of Catalonia. E. Serrano was supported by the postdoctoral programme (SFRH/BPD/96637/2013) of the Fundacao para a Ciencia e a Tecnologia, Portugal, the University of Aveiro (Department of Biology) and FCT/MEC through financial support to CESAM RU (UID/AMB/50017) and, where applicable, co-financed by the FEDER, within the PT2020 Partnership Agreement.; We are grateful to the rangers and directors of the National Game Reserves for their support in collecting the samples from wild ungulates and to the livestock owners that agreed to the sheep sampling. We also would like to thank the invaluable support of several colleagues from SEFaS research group and students from the Universitat Autonoma de Barcelona that occasionally assist in the sample collection, as well as the technical assistance of Amandine Ruffieux, from the Institute of Veterinary Bacteriology, University of Bern.	Arnal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061887; Baker SE, 2001, VET REC, V104, P1998; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Belloy L, 2003, APPL ENVIRON MICROB, V69, P1913, DOI 10.1128/AEM.69.4.1913-1919.2003; Belloy L, 2003, MICROBIOL-SGM, V149, P185, DOI 10.1099/mic.0.25864-0; Boots M, 2004, SCIENCE, V303, P842, DOI 10.1126/science.1088542; Cassirer EF, 2007, J WILDLIFE MANAGE, V71, P1080, DOI 10.2193/2006-002; Citti C, 2013, TRENDS MICROBIOL, V21, P196, DOI 10.1016/j.tim.2013.01.003; Corlatti L, 2015, ZOOLOGY, V118, P213, DOI 10.1016/j.zool.2015.01.003; Crawley J. M., 2013, R BOOK; DAGNALL GJR, 1994, EPIDEMIOL INFECT, V112, P561, DOI 10.1017/S0950268800051268; Darmon G, 2012, ECOGRAPHY, V35, P44, DOI 10.1111/j.1600-0587.2011.06664.x; Degiorgis MP, 2000, SCHWEIZ ARCH TIERH, V142, P520; Fenton A, 2005, EMERG INFECT DIS, V11, P1815, DOI 10.3201/eid1112.050306; Fernandez-Aguilar X, 2016, VET REC, V178, P586, DOI 10.1136/vr.103577; Fernandez-Aguilar X, 2017, VET REC; Fernandez-Aguilar X, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00690-17; Fernandez-Aguilar X, 2014, EMERG INFECT DIS, V20, P1062, DOI 10.3201/eid2006.130961; Fernandez-Aguilar X, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-253; Fernandez-Sirera L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051031; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Gauthier D, 1991, ETUDE EPIDEMIOLOGIQU; Gelormini G, 2016, 12 C EUR WILDL DIS A, P18; Giacometti M, 1998, VET MICROBIOL, V61, P279, DOI 10.1016/S0378-1135(98)00186-2; Giacometti M, 2002, J WILDLIFE DIS, V38, P297, DOI 10.7589/0090-3558-38.2.297; Giacometti M, 2002, REV SCI TECH OIE, V21, P335, DOI 10.20506/rst.21.2.1338; Grattarola C, 1999, VET REC, V145, P588, DOI 10.1136/vr.145.20.588; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Holzwarth N, 2011, J VET DIAGN INVEST, V23, P333, DOI 10.1177/104063871102300223; J-P Crampe, 1992, TAUX SURVIE CARACTER; Janovsky M, 2001, VET MICROBIOL, V83, P11, DOI 10.1016/S0378-1135(01)00407-2; Jansen BD, 2006, J WILDLIFE DIS, V42, P407, DOI 10.7589/0090-3558-42.2.407; Kamath PL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11448; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lauvergne J-J, 1977, ANN GENETIQUE SELECT, V9, P151; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Loison A, 1996, J WILDLIFE MANAGE, V60, P517, DOI 10.2307/3802069; Loison A, 1999, J MAMMAL, V80, P620, DOI 10.2307/1383306; Luzzago C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168232; Manlove KR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2331; Marco I, 1991, VET EN PRAX, V6, P57; Marco I, 2009, J WILDLIFE DIS, V45, P1; Marco I, 2009, EMERG INFECT DIS, V15, P448, DOI 10.3201/eid1503.081155; Mavrot F, 2012, J WILDLIFE DIS, V48, P619, DOI 10.7589/0090-3558-48.3.619; Mayer D, 1997, J WILDLIFE DIS, V33, P413, DOI 10.7589/0090-3558-33.3.413; NICOLET J, 1975, ZBL VET MED B, V22, P302; Panella P, 2010, HYSTRIX, V21, P183, DOI 10.4404/Hystrix-21.2-4558; Pepin D, 2008, ANIM BEHAV, V75, P361, DOI 10.1016/j.anbehav.2006.09.030; QGIS Development Team, 2016, QGIS GEOG INF SYST; R Development Core Team, 2015, LANG ENV STAT COMP; Richomme C, 2006, EPIDEMIOL INFECT, V134, P21, DOI 10.1017/S0950268805004693; Ryser-Degiorgis Marie-Pierre, 2002, Hystrix, V13, P1; Ryser-Degiorgis MP, 2009, VET MICROBIOL, V134, P368, DOI 10.1016/j.vetmic.2008.08.005; Sanchez-Belda A, 1985, S INT CHER INF CAM, P73; Serrano E, 2011, EPIDEMIOL INFECT, V139, P1626, DOI 10.1017/S0950268811000951; Serrano E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01307; Sokal R. R., 1973, PRINCIPLES PRACTICE; Swinton J, 2009, ECOLOGY WILDLIFE DIS, P83; Sydenstricker KV, 2005, J WILDLIFE DIS, V41, P326, DOI 10.7589/0090-3558-41.2.326; TERLAAK EA, 1988, VET QUART, V10, P217, DOI 10.1080/01652176.1988.9694175; TERLAAK EA, 1988, VET QUART, V10, P73, DOI 10.1080/01652176.1988.9694153; TROTTER SL, 1977, INFECT IMMUN, V18, P816, DOI 10.1128/IAI.18.3.816-822.1977; Tschopp R, 2005, VET REC, V157, P13, DOI 10.1136/vr.157.1.13; Viana M, 2014, TRENDS ECOL EVOL, V29, P270, DOI 10.1016/j.tree.2014.03.002; Vilei EM, 2007, J MICROBIOL METH, V70, P384, DOI 10.1016/j.mimet.2007.05.007; Williams PD, 2014, J EVOLUTION BIOL, V27, P1271, DOI 10.1111/jeb.12379; WILSMORE AJ, 1990, VET REC, V127, P229; Wood S.N., 2006, TEXTS STAT SCI, Vxvii, P392, DOI DOI 10.1111/J.1541-0420.2007.00905_3.X; Zimmermann L, 2008, WILDLIFE BIOL, V14, P118, DOI 10.2981/0909-6396(2008)14[118:SOMCSF]2.0.CO;2; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	70	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186069	10.1371/journal.pone.0186069	http://dx.doi.org/10.1371/journal.pone.0186069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016676	Green Published, gold, Green Submitted			2022-12-26	WOS:000412601800036
J	Miiro, G; DeCelles, J; Rutakumwa, R; Nakiyingi-Miiro, J; Muzira, P; Ssembajjwe, W; Musoke, S; Gibson, LJ; Hershow, RB; Francis, S; Torondel, B; Ross, DA; Weiss, HA				Miiro, George; DeCelles, Jeff; Rutakumwa, Rwamahe; Nakiyingi-Miiro, Jessica; Muzira, Philip; Ssembajjwe, Wilber; Musoke, Saidat; Gibson, Lorna J.; Hershow, Rebecca B.; Francis, Suzanna; Torondel, Belen; Ross, David A.; Weiss, Helen A.		MENISCUS Project	Soccer-based promotion of voluntary medical male circumcision: A mixed-methods feasibility study with secondary students in Uganda	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SOUTH-AFRICA; ACCEPTABILITY; INTERVENTION; PREVENTION	The Ugandan government is committed to scaling-up proven HIV prevention strategies including safe male circumcision, and innovative strategies are needed to increase circumcision uptake. The aim of this study was to assess the acceptability and feasibility of implementing a soccer-based intervention ("Make The Cut") among schoolboys in a peri-urban district of Uganda. The intervention was led by trained, recently circumcised "coaches" who facilitated a 60-minute session delivered in schools, including an interactive penalty shoot-out game using metaphors for HIV prevention, sharing of the coaches' circumcision story, group discussion and ongoing engagement from the coach to facilitate linkage to male circumcision. The study took place in four secondary schools in Entebbe sub-district, Uganda. Acceptability of safe male circumcision was assessed through a cross-sectional quantitative survey. The feasibility of implementing the intervention was assessed by piloting the intervention in one school, modifying it, and implementing the modified version in a second school. Perceptions of the intervention were assessed with in-depth interviews with participants. Of the 210 boys in the cross-sectional survey, 59% reported being circumcised. Findings showed high levels of knowledge and generally favourable perceptions of circumcision. The initial implementation of Make The Cut resulted in 6/58 uncircumcised boys (10.3%) becoming circumcised. Changes made included increasing engagement with parents and improved liaison with schools regarding the timing of the intervention. Following this, uptake improved to 18/69 (26.1%) in the second school. In-depth interviews highlighted the important role of family and peer support and the coach in facilitating the decision to circumcise. This study showed that the modified Make The Cut intervention may be effective to increase uptake of safe male circumcision in this population. However, the intervention is time-intensive, and further work is needed to assess the cost-effectiveness of the intervention conducted at scale.	[Miiro, George; Ssembajjwe, Wilber; Musoke, Saidat] Uganda Virus Res Inst, Entebbe, Uganda; [DeCelles, Jeff; Muzira, Philip] Grassroot Soccer, Cape Town, South Africa; [DeCelles, Jeff; Hershow, Rebecca B.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Rutakumwa, Rwamahe; Nakiyingi-Miiro, Jessica] MRC, Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda; [Gibson, Lorna J.; Francis, Suzanna; Weiss, Helen A.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Med Res Council, Trop Epidemiol Grp, London, England; [Torondel, Belen] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Ross, David A.] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland	Uganda Virus Research Institute; University of North Carolina; University of North Carolina Chapel Hill; Uganda Virus Research Institute; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Weiss, HA (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Med Res Council, Trop Epidemiol Grp, London, England.	helen.weiss@lshtm.ac.uk	weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; Francis, Suzanna Carter/0000-0002-3724-4813	UK Medical Research Council [MC_PC_14098]; World Health Organisation [WCCPRD3992640 2016/599225]; UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID Concordat [MR/K012126/1]; European Union; MRC [MC_PC_14098, G1002369] Funding Source: UKRI; Medical Research Council [G1002369, MC_PC_14098, MR/K012126/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); World Health Organisation(World Health Organization); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a research grant MC_PC_14098 from the UK Medical Research Council and the World Health Organisation (WCCPRD3992640 2016/599225). HAW was supported in part by a grant jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) (MR/K012126/1) under the MRC/DFID Concordat agreement and is also part of the EDCTP2 programme supported by the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, PURSUIT PIVOT REACHI; Barnabas RV, 2016, LANCET HIV, V3, pE212, DOI 10.1016/S2352-3018(16)00020-5; DeCelles J, 2016, JAIDS-J ACQ IMM DEF, V72, pS304, DOI 10.1097/QAI.0000000000001172; George G, 2014, AJAR-AFR J AIDS RES, V13, P179, DOI 10.2989/16085906.2014.943253; Hatzold K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085051; Kaufman ZA, 2014, 20 INT AIDS C MELB A; Kaufman ZA, 2016, J ACQ IMMUN DEF SYND, V72, P292; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158693; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Montague C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096468; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Thirumurthy H, 2016, JAIDS-J ACQ IMM DEF, V72, pS309, DOI 10.1097/QAI.0000000000001045; Thirumurthy H, 2014, JAMA-J AM MED ASSOC, V312, P703, DOI 10.1001/jama.2014.9087; UNAIDS, 2014, UG HIV AIDS COUNTR P; UNAIDS, 2014, UG HIV EP PROF; UNAIDS, 2016, GLOB AIDS UPD; UNAIDS, 2011, JOINT STRAT ACT FRAM; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; Weiss SM, 2015, LANCET HIV, V2, pE181, DOI 10.1016/S2352-3018(15)00042-9; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; World Health Organization, 2016, VOL MED MAL CIRC HIV; Wouabe ED, 2013, SCOPING REPORT INTER	23	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185929	10.1371/journal.pone.0185929	http://dx.doi.org/10.1371/journal.pone.0185929			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016651	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000412601800026
J	Montalto, GJ; Sawe, FK; Miruka, A; Maswai, J; Kiptoo, I; Aoko, A; Oreyo, C; Obiero, E; Korir, S; Bii, SK; Song, KX; Kunz, AN				Montalto, Gregg Joseph; Sawe, Fredrick K.; Miruka, Argwings; Maswai, Jonah; Kiptoo, Ignatius; Aoko, Appolonia; Oreyo, Chrispine; Obiero, Eunice; Korir, Sheila; Bii, Stephen K.; Song, Katherine X.; Kunz, Anjali N.			Diagnosis disclosure to adolescents living with HIV in rural Kenya improves antiretroviral therapy adherence and immunologic outcomes: A retrospective cohort study	PLOS ONE			English	Article							INFECTED CHILDREN; BARRIERS; FACILITATORS; PREVALENCE; TIME	Background & aims Emphasis on adolescent HIV has increased worldwide as antiretroviral treatment has greatly extended life expectancies of HIV-positive children. Few evidence-based guidelines exist on the optimal time to disclose to an adolescent living with HIV (ALHIV); little is known about the medical effects of disclosure. This study looked to determine whether disclosure is associated with improved medical outcomes in ALHIV. Prior work has tended to be qualitative, cross-sectional, and with an emphasis on psychosocial outcomes. This paper addresses the adolescent cohort retrospectively (longitudinally), building upon what is already known about disclosure. Methods Retrospective, longitudinal clinical record reviews of ALHIV seen at Kericho District Hospital between April 2004 and November 2012 were performed. Patient demographics and clinical outcomes were systematically extracted. The student's t-test was used to calculate changes in mean CD4 count, antiretroviral therapy (ART), and cotrimoxazole adherence pre-vs. post-disclosure. Linear regression modelling assessed for trends in those clinical outcomes associated with age of disclosure. Results Ninety-six ALHIV (54 female, 42 male) were included; most (73%) entered care through the outpatient department. Nearly half were cared for by parents, and 20% experienced a change in their primary caregiver. The mean time in the study was 2.47 years; mean number of visits 10.97 per patient over the mean time in the study. Mean disclosure age was 12.34 years. An increase in mean ART adherence percentage was found with disclosure (0.802 vs. 0.917; p = 0.0015). Younger disclosure age was associated with significantly higher mean CD4 counts over the course of the study (p = 0.001), and a nonsignificant trend toward a higher mean ART adherence percentage (p = 0.055). Conclusion ART adherence and improved immunologic status are both associated with disclosure of HIV infection to adolescent patients. Disclosure of an HIV diagnosis to an adolescent is an important means to improve HIV care.	[Montalto, Gregg Joseph] Naval Med Ctr San Diego, Div Adolescent Med, Dept Pediat, San Diego, CA 92134 USA; [Sawe, Fredrick K.; Miruka, Argwings; Maswai, Jonah; Kiptoo, Ignatius; Aoko, Appolonia; Oreyo, Chrispine] Kenya Govt Med Res Ctr, Walter Reed Project, Kericho, Kenya; [Obiero, Eunice; Korir, Sheila; Bii, Stephen K.] Kericho Dist Hosp, Minist Med Serv, Kericho, Kenya; [Song, Katherine X.] US Mil HIV Res Program, Rockville, MD USA; [Kunz, Anjali N.] Madigan Army Med Ctr, Dept Pediat, Joint Base Lewis Mcchord, WA USA	United States Department of Defense; United States Navy; Naval Medical Center San Diego; Kenya Medical Research Institute; Walter Reed Army Institute of Research (WRAIR); Madigan Army Medical Center	Montalto, GJ (corresponding author), Naval Med Ctr San Diego, Div Adolescent Med, Dept Pediat, San Diego, CA 92134 USA.	gregg.j.montalo.mil@mail.mil			Global Emerging Infections Surveillance and Response System (DoD - GEIS); Walter Reed Army Institute of Research (WRAIR)	Global Emerging Infections Surveillance and Response System (DoD - GEIS); Walter Reed Army Institute of Research (WRAIR)	A small grant was provided by the Global Emerging Infections Surveillance and Response System (DoD - GEIS). This grant paid for the travel of GJM to the research site in Kericho, to hire non-study (i.e. independent) personnel for data collection from the medical records at Kericho District Hospital, and for office supplies. Funding was also provided by the Walter Reed Army Institute of Research (WRAIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, KEN FAST TRACK PLAN; [Anonymous], 2014, KEN AIDS RESP PROGR; Arrive E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033690; Biadgilign S, 2009, SAHARA J-J SOC ASP H, V6, P148, DOI 10.1080/17290376.2009.9724943; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Brown BJ, 2011, AIDS CARE, V23, P1053, DOI 10.1080/09540121.2011.554523; Cluver Lucie D, 2015, AIDS, V29 Suppl 1, pS57, DOI 10.1097/QAD.0000000000000695; Domek GJ, 2010, J TROP PEDIATRICS, V56, P440, DOI 10.1093/tropej/fmq013; Ferrand R, 2010, B WORLD HEALTH ORGAN, V88, P428, DOI 10.2471/BLT.09.066126; Ferris M, 2007, AIDS CARE, V19, P1088, DOI 10.1080/09540120701367124; Fetzer BC, 2011, AIDS PATIENT CARE ST, V25, P611, DOI 10.1089/apc.2011.0083; Haberer JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018505; John-Stewart GC, 2013, AIDS CARE, V25, P1067, DOI 10.1080/09540121.2012.749333; Kidia KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087322; Mavedzenge SMN, 2011, J ADOLESCENT HEALTH, V49, P568, DOI 10.1016/j.jadohealth.2011.02.007; Mburu G, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18866; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Pinzon-Iregui MC, 2013, J TROP PEDIATRICS, V59, P84, DOI 10.1093/tropej/fms052; Santamaria EK, 2011, AIDS PATIENT CARE ST, V25, P257, DOI 10.1089/apc.2010.0161; Sirengo M, 2010, KENYA SERVICE PROVIS, P171; Spiegel Hans M L, 2011, Adolesc Med State Art Rev, V22, P277; Taddeo D, 2008, PAED CHILD HEALT-CAN, V13, P19, DOI 10.1093/pch/13.1.19; Vaz LME, 2010, AIDS PATIENT CARE ST, V24, P247, DOI 10.1089/apc.2009.0217; Vreeman RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086616; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; Vreeman RC, 2010, AIDS PATIENT CARE ST, V24, P639, DOI 10.1089/apc.2010.0079; WHO, 2013, HIV AD GUID HIV TEST; World Health Organization, 2011, GUID HIV DISCL COUNS; World Population Prospects, 2013, WORLD POP PROSP 2012, VII	30	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0183180	10.1371/journal.pone.0183180	http://dx.doi.org/10.1371/journal.pone.0183180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	28991913	Green Submitted, gold, Green Published			2022-12-26	WOS:000412601800004
J	Pera, T; Deshpande, DA; Ippolito, M; Wang, B; Gavrila, A; Michael, JV; Nayak, AP; Tompkins, E; Farrell, E; Kroeze, WK; Roth, BL; Panettieri, RA; Benovic, JL; An, SS; Dulin, NO; Penn, RB				Pera, Tonio; Deshpande, Deepak A.; Ippolito, Michael; Wang, Bin; Gavrila, Adelina; Michael, James V.; Nayak, Ajay P.; Tompkins, Eric; Farrell, Eleni; Kroeze, Wesley K.; Roth, Bryan L.; Panettieri, Reynold A., Jr.; Benovic, Jeffrey L.; An, Steven S.; Dulin, Nickolai O.; Penn, Raymond B.			Biased signaling of the proton-sensing receptor OGR1 by benzodiazepines	FASEB JOURNAL			English	Article						airway smooth muscle; asthma; biased agonism; GPR68; qualitative signaling	AIRWAY SMOOTH-MUSCLE; PARATHYROID-HORMONE RECEPTOR; PROTEIN-KINASE-A; EXTRACELLULAR PH; BETA-ARRESTINS; HYPERRESPONSIVENESS; EXPRESSION; AGONISTS; ASTHMA; CELLS	GPCRs have diverse signaling capabilities, based on their ability to assume various conformations. Moreover, it is now appreciated that certain ligands can promote distinct receptor conformations and thereby bias signaling toward a specific pathway to differentially affect cell function. The recently deorphanized G protein-coupled receptor OGR1 [ovarian cancer G protein-coupled receptor 1 (GPR68)] exhibits diverse signaling events when stimulated by reductions in extracellular pH. We recently demonstrated airway smooth muscle cells transduce multiple signaling events, reflecting a diverse capacity to couple to multiple G proteins. Moreover, we recently discovered that the benzodiazepine lorazepam, more commonly recognized as anagonist of the gamma-aminobutyric acid A(GABA(A)) receptor, canfunctionas an allosteric modulator of OGR1 and, similarly, can promote multiple signaling events. In this study, we demonstrated that different benzodiazepines exhibit a range of biases for OGR1, with sulazepam selectively activating the canonical Gs of the G protein signaling pathway, in heterologous expression systems, as well as in several primary cell types. These findings highlight the potential power of biased ligand pharmacology for manipulating receptor signaling qualitatively, to preferentially activate pathways that are therapeutically beneficial.	[Pera, Tonio; Deshpande, Deepak A.; Ippolito, Michael; Wang, Bin; Gavrila, Adelina; Michael, James V.; Nayak, Ajay P.; Tompkins, Eric; Farrell, Eleni; Penn, Raymond B.] Thomas Jefferson Univ, Jane & Leonard Korman Lung Ctr, Div Pulm & Crit Care Med, Dept Med,Ctr Translat Med, Room 543 JAH,1020 Locust St, Philadelphia, PA 19107 USA; [Kroeze, Wesley K.; Roth, Bryan L.] Thomas Jefferson Univ, Dept Biochem, Philadelphia, PA 19107 USA; [Kroeze, Wesley K.; Roth, Bryan L.] Univ N Carolina, Chapel Hill Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Roth, Bryan L.] Univ N Carolina, Chapel Hill Sch Med, NIMH, Psychoact Drug Screening Program,Sch Med, Chapel Hill, NC USA; [Panettieri, Reynold A., Jr.] Univ N Carolina, Chapel Hill Sch Med, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC USA; [Benovic, Jeffrey L.] Rutgers State Univ, Child Hlth Inst New Jersey, Rutgers Inst Translat Med & Sci, New Brunswick, NJ USA; [An, Steven S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD USA; [Dulin, Nickolai O.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	Jefferson University; Jefferson University; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Rutgers State University New Brunswick; Rutgers State University Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Chicago	Penn, RB (corresponding author), Thomas Jefferson Univ, Jane & Leonard Korman Lung Ctr, Div Pulm & Crit Care Med, Dept Med,Ctr Translat Med, Room 543 JAH,1020 Locust St, Philadelphia, PA 19107 USA.	raymond.penn@jefferson.edu	panettieri, reynold/AAG-9485-2019; Roth, Bryan/ABE-7032-2020; An, Steven/AAM-3848-2020; Roth, Bryan L/F-3928-2010	Roth, Bryan/0000-0002-0561-6520; An, Steven/0000-0003-4723-1888; Michael, James/0000-0001-8796-5259	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute [P01 HL114471, HL087560]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114471, K99HL087560, R00HL087560, R01HL137030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI135082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK116195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH104974] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (Grant P01 HL114471 to R.B.P., R.A.P., J.L.B., and S.S.A.; and Grant HL087560 to D.A.D.) The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	An SS, 2006, AM J RESP CELL MOL, V35, P55, DOI 10.1165/rcmb.2005-0453OC; Carr R, 2014, J BIOL CHEM, V289, P35668, DOI 10.1074/jbc.M114.618819; Deshpande DA, 2003, FASEB J, V17, P452, DOI 10.1096/fj.02-0450fje; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Disthabanchong S, 2002, KIDNEY INT, V62, P1171, DOI 10.1111/j.1523-1755.2002.kid568.x; Dogra S, 2016, METHOD CELL BIOL, V132, P233, DOI 10.1016/bs.mcb.2015.11.001; Dong SY, 2010, NAT PROTOC, V5, P561, DOI 10.1038/nprot.2009.239; Erlenbach I, 2001, J NEUROCHEM, V77, P1327, DOI 10.1046/j.1471-4159.2001.00344.x; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Forkuo GS, 2016, AM J RESP CELL MOL, V55, P234, DOI 10.1165/rcmb.2015-0373OC; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Huang XP, 2015, NATURE, V527, P477, DOI 10.1038/nature15699; Ichimonji I, 2010, AM J PHYSIOL-LUNG C, V299, pL567, DOI 10.1152/ajplung.00415.2009; Isom DG, 2013, MOL CELL, V51, P531, DOI 10.1016/j.molcel.2013.07.012; Kong KC, 2008, BIOCHEMISTRY-US, V47, P9279, DOI 10.1021/bi801056w; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; Misior AM, 2008, MOL PHARMACOL, V73, P566, DOI 10.1124/mol.107.040519; Mizuta K, 2011, AM J RESP CELL MOL, V45, P1232, DOI 10.1165/rcmb.2011-0088OC; Morgan SJ, 2014, J BIOL CHEM, V289, P23065, DOI 10.1074/jbc.M114.557652; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ogata N, 2011, J BIOL CHEM, V286, P13733, DOI 10.1074/jbc.M110.200196; Patel CB, 2010, MOL PHARMACOL, V78, P983, DOI 10.1124/mol.110.067066; Pauwels RA, 1997, AM J RESP CRIT CARE, V156, pS78, DOI 10.1164/ajrccm.156.4.12-tac-1; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Pereverzev A, 2008, BONE, V42, P150, DOI 10.1016/j.bone.2007.08.044; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Saxena H, 2012, BRIT J PHARMACOL, V166, P981, DOI 10.1111/j.1476-5381.2011.01807.x; Soergel DG, 2014, PAIN, V155, P1829, DOI 10.1016/j.pain.2014.06.011; Tang DD, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0296-1; Tomura H, 2005, J BIOL CHEM, V280, P34458, DOI 10.1074/jbc.M505287200; Walker JKL, 2011, BRIT J PHARMACOL, V163, P18, DOI 10.1111/j.1476-5381.2010.01178.x; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Yan HD, 2011, FASEB J, V25, P389, DOI 10.1096/fj.10-164798; Yang MH, 2006, J BIOL CHEM, V281, P23598, DOI 10.1074/jbc.M602191200; Yang YM, 2017, MOL BIOL CELL, V28, P1792, DOI 10.1091/mbc.E17-02-0096	39	29	29	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					862	874		10.1096/fj.201700555R	http://dx.doi.org/10.1096/fj.201700555R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29042451	Bronze, Green Published			2022-12-26	WOS:000425146900028
J	Zapata, RC; Singh, A; Chelikani, PK				Zapata, Rizaldy C.; Singh, Arashdeep; Chelikani, Prasanth K.			Peptide YY mediates the satiety effects of diets enriched with whey protein fractions in male rats	FASEB JOURNAL			English	Article						lactalbumin; lactoferrin; Y2 receptor blockade; energy balance; conditioned taste preference	FOOD-INTAKE; GENE-EXPRESSION; ENERGY-BALANCE; GUT HORMONES; ALPHA-LACTALBUMIN; WEIGHT REGAIN; VISCERAL FAT; BODY-WEIGHT; LACTOFERRIN; RECEPTOR	Dairy proteins-whey protein, in particular-are satiating and often recommended for weight control; however, little is known about the mechanisms by which whey protein and its components promote satiety and weight loss. We used diet-induced obese rats to determine whether the hypophagic effects of diets that are enriched with whey and its fractions, lactalbumin and lactoferrin, are mediated by the gut hormone, peptide YY (PYY). We demonstrate that high protein diets that contain whey, lactalbumin, and lactoferrin decreased food intake and body weight with a concurrent increase in PYY mRNA abundance in the colon and/or plasma PYY concentrations. Of importance, blockade of PYY neuropeptide Y receptor subtype 2 (Y2) receptors with a peripherally restricted antagonist attenuated the hypophagic effects of diets that are enriched with whey protein fractions. Diets that are enriched with whey fractions were less preferred; however, in a modified conditioned taste preference test, PYY Y2 receptor blockade induced hyperphagia of a lactoferrin diet, but caused a reduction in preference for Y2 antagonist-paired flavor, which suggested that PYY signaling is important for lactoferrin-induced satiety, but not essential for preference for lactoferrin-enriched diets. Taken together, these data provide evidence that the satiety of diets that are enriched with whey protein components is mediated, in part, via enhanced PYY secretion and action in obese male rats.	[Zapata, Rizaldy C.; Singh, Arashdeep; Chelikani, Prasanth K.] Univ Calgary, Fac Vet Med, Dept Prod Anim Hlth, HS 1871,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada; [Chelikani, Prasanth K.] Univ Calgary, Snyder Inst Chron Dis, Gastrointestinal Res Grp, Calgary, AB, Canada	University of Calgary; University of Calgary	Chelikani, PK (corresponding author), Univ Calgary, Fac Vet Med, Dept Prod Anim Hlth, HS 1871,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	pchelika@ucalgary.ca	Chelikani, Prasanth/N-3462-2019; Chelikani, Prasanth/AAY-2145-2021; Singh, Arashdeep/L-4795-2019	Chelikani, Prasanth/0000-0002-7300-2918; Singh, Arashdeep/0000-0002-2477-1438; Zapata, Rizaldy/0000-0003-4745-8513	Gerald L. (Jerry) Weber Cosmopolitan International Club of Calgary Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada [355993]; Alberta Livestock and Meat Agency [2015P001R]; Koopmans Memorial Research Fund; Canada Foundation for Innovation [18617]; Alberta Advanced Education and Technology [URSI-09-008-SEG]	Gerald L. (Jerry) Weber Cosmopolitan International Club of Calgary Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Livestock and Meat Agency; Koopmans Memorial Research Fund; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Advanced Education and Technology	The authors thank Dr. Roger Reidelberger (Creighton University, Omaha, NE, USA) for providing the syntax for analyses of meal patterns and Dr. Adel Pezeshki (Oklahoma State University, Stillwater, OK, USA) for help in conducting Experiment 2. Supported by Gerald L. (Jerry) Weber Cosmopolitan International Club of Calgary Graduate Scholarship (to R.C.Z.), and funded by operating grants from the Natural Sciences and Engineering Research Council of Canada (Grant 355993), Alberta Livestock and Meat Agency (Grant 2015P001R), and Koopmans Memorial Research Fund, with infrastructure support from the Canada Foundation for Innovation (Grant 18617) and Alberta Advanced Education and Technology (Grant URSI-09-008-SEG; to P.K.C.).	Abbott CR, 2005, BRAIN RES, V1043, P139, DOI 10.1016/j.brainres.2005.02.065; Abbott CR, 2005, BRAIN RES, V1044, P127, DOI 10.1016/j.brainres.2005.03.011; Adams SH, 2006, J NUTR, V136, P195, DOI 10.1093/jn/136.1.195; Akhavan T, 2014, J NUTR BIOCHEM, V25, P36, DOI 10.1016/j.jnutbio.2013.08.012; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Batterham RL, 2006, CELL METAB, V4, P223, DOI 10.1016/j.cmet.2006.08.001; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Bendtsen LQ, 2013, ADV NUTR, V4, P418, DOI 10.3945/an.113.003723; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Boey D, 2006, DIABETOLOGIA, V49, P1360, DOI 10.1007/s00125-006-0237-0; Boey D, 2008, NEUROPEPTIDES, V42, P19, DOI 10.1016/j.npep.2007.11.003; Brothers SP, 2010, MOL PHARMACOL, V77, P46, DOI 10.1124/mol.109.058677; Burdyga G, 2008, J NEUROSCI, V28, P11583, DOI 10.1523/JNEUROSCI.2493-08.2008; Chelikani PK, 2005, ENDOCRINOLOGY, V146, P879, DOI 10.1210/en.2004-1138; Chelikani PK, 2006, PEPTIDES, V27, P3193, DOI 10.1016/j.peptides.2006.08.001; Chungchunlam SMS, 2015, EUR J CLIN NUTR, V69, P179, DOI 10.1038/ejcn.2014.266; Dailey MJ, 2010, OBESITY, V18, P904, DOI 10.1038/oby.2010.14; DIBATTISTA D, 1988, PHYSIOL BEHAV, V44, P189, DOI 10.1016/0031-9384(88)90136-9; Diepvens K, 2008, INT J OBESITY, V32, P510, DOI 10.1038/sj.ijo.0803758; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; Guo Y, 2006, OBESITY, V14, P1562, DOI 10.1038/oby.2006.180; Hamad EM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-57; Hassan AM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40968; Hertel A, 2010, PHYSIOL BEHAV, V99, P482, DOI 10.1016/j.physbeh.2009.12.016; Hursel R, 2010, BRIT J NUTR, V103, P775, DOI 10.1017/S0007114509992352; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Keire DA, 2002, PEPTIDES, V23, P305, DOI 10.1016/S0196-9781(01)00602-7; Koda S, 2005, ENDOCRINOLOGY, V146, P2369, DOI 10.1210/en.2004-1266; Krissansen GW, 2007, J AM COLL NUTR, V26, p713S, DOI 10.1080/07315724.2007.10719652; La Sala MS, 2013, FASEB J, V27, P5022, DOI 10.1096/fj.13-228064; Leidy HJ, 2015, AM J CLIN NUTR, V101, p1320S, DOI 10.3945/ajcn.114.084038; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Luhovyy BL, 2007, J AM COLL NUTR, V26, p704S, DOI 10.1080/07315724.2007.10719651; Ma J, 2009, DIABETES CARE, V32, P1600, DOI 10.2337/dc09-0723; McManus B, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0049-7; Morishita S, 2013, J OLEO SCI, V62, P97, DOI 10.5650/jos.62.97; Nieuwenhuizen AG, 2009, BRIT J NUTR, V101, P1859, DOI 10.1017/S0007114508131774; Ono T, 2010, BRIT J NUTR, V104, P1688, DOI 10.1017/S0007114510002734; Pal S, 2014, EUR J CLIN NUTR, V68, P980, DOI 10.1038/ejcn.2014.84; Parker LA, 2014, EUR J PHARMACOL, V722, P122, DOI 10.1016/j.ejphar.2013.09.070; Perez C, 1998, PHARMACOL BIOCHEM BE, V59, P451, DOI 10.1016/S0091-3057(97)00439-5; Pezeshki A, 2015, J NUTR, V145, P2236, DOI 10.3945/jn.115.213843; Pilvi TK, 2009, BRIT J NUTR, V102, P337, DOI 10.1017/S0007114508199445; Reidelberger R, 2013, AM J PHYSIOL-ENDOC M, V304, pE944, DOI 10.1152/ajpendo.00075.2013; Reidelberger R, 2011, PEPTIDES, V32, P770, DOI 10.1016/j.peptides.2011.01.005; Shi J, 2012, J FUNCT FOODS, V4, P66, DOI 10.1016/j.jff.2011.08.001; Singh A, 2017, OBESITY, V25, P1050, DOI 10.1002/oby.21840; Singh A, 2016, J NUTR BIOCHEM, V37, P47, DOI 10.1016/j.jnutbio.2016.07.011; Steinert RE, 2017, PHYSIOL REV, V97, P411, DOI 10.1152/physrev.00031.2014; Sukkar SG, 2013, MEDITERR J NUTR META, V6, P259, DOI 10.1007/s12349-013-0121-7; Sun J, 2016, J FUNCT FOODS, V22, P189, DOI 10.1016/j.jff.2016.01.022; Svendsen B, 2015, ENDOCRINOLOGY, V156, P847, DOI 10.1210/en.2014-1710; Tauriainen E, 2011, J NUTRIGENET NUTRIGE, V4, P49, DOI 10.1159/000327132; Tranberg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071439; Ullrich SS, 2015, AM J PHYSIOL-REG I, V308, pR300, DOI 10.1152/ajpregu.00504.2014; van der Klaauw AA, 2013, OBESITY, V21, P1602, DOI 10.1002/oby.20154; Veldhorst MAB, 2009, CLIN NUTR, V28, P147, DOI 10.1016/j.clnu.2008.12.003; Wang SY, 2015, HORM RES PAEDIAT, V83, P19, DOI 10.1159/000362168; Westerterp-Plantenga MS, 2009, ANNU REV NUTR, V29, P21, DOI 10.1146/annurev-nutr-080508-141056; Wortley KE, 2007, GASTROENTEROLOGY, V133, P1534, DOI 10.1053/j.gastro.2007.08.024; Xiao RJ, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-1; Zapata RC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09781-2; Zhang L, 2010, AM J PHYSIOL-REG I, V299, pR1618, DOI 10.1152/ajpregu.00345.2010; Zhou J, 2011, OBESITY, V19, P1568, DOI 10.1038/oby.2011.14; Zorrilla EP, 2005, AM J PHYSIOL-REG I, V288, pR1450, DOI 10.1152/ajpregu.00175.2004	66	11	11	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					850	861		10.1096/fj.201700519RR	http://dx.doi.org/10.1096/fj.201700519RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29042449	Bronze			2022-12-26	WOS:000425146900027
J	Yamasaki, K; Daiho, T; Danko, S; Yasuda, S; Suzuki, H				Yamasaki, Kazuo; Daiho, Takashi; Danko, Stefania; Yasuda, Satoshi; Suzuki, Hiroshi			Nanodisc-based kinetic assays reveal distinct effects of phospholipid headgroups on the phosphoenzyme transition of sarcoplasmic reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium ATPase; kinetics; lipid-protein interaction; membrane enzyme; phospholipid; sarcoplasmic reticulum (SR)	ADP-INSENSITIVE PHOSPHOENZYME; CALCIUM-PUMP; CA-ATPASE; CRYSTAL-STRUCTURES; TRANSMEMBRANE HELIX; CYTOPLASMIC DOMAINS; HYDROLYSIS; PROTEIN; H+; COUNTERTRANSPORT	Sarco(endo)plasmic reticulum Ca2+-ATPase catalyzes ATP-driven Ca2+ transport from the cytoplasm to the lumen and is critical for a range of cell functions, including muscle relaxation. Here, we investigated the effects of the headgroups of the 1-palmitoyl-2-oleoyl glycerophospholipids phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), and phosphatidylglycerol (PG) on sarcoplasmic reticulum (SR) Ca2+-ATPase embedded into a nanodisc, a lipid-bilayer construct harboring the specific lipid. We found that Ca2+-ATPase activity in a PC bilayer is comparable with that of SR vesicles and is suppressed in the other phospholipids, especially in PS. Ca2+ affinity at the high-affinity transport sites in PC was similar to that of SR vesicles, but 2-3-fold reduced in PE and PS. Ca2+ on- and off-rates in the non-phosphorylated ATPase were markedly reduced in PS. Rate-limiting phosphoenzyme (EP) conformational transition in 0.1 m KCl was as rapid in PC as in SR vesicles, but slowed in other phospholipids, especially in PS. Using kinetic plots of the logarithm of rate versus the square of mean activity coefficient of solutes in 0.1-1 m KCl, we noted that PC is optimal for the EP transition, but PG and especially PS had markedly unfavorable electrostatic effects, and PE exhibited a strong non-electrostatic restriction. Thus, the major SR membrane lipid PC is optimal for all steps and, unlike the other headgroups, contributes favorable electrostatics and non-electrostatic elements during the EP transition. Our analyses further revealed that the surface charge of the lipid bilayer directly modulates the transition rate.	[Yamasaki, Kazuo; Daiho, Takashi; Danko, Stefania; Yasuda, Satoshi; Suzuki, Hiroshi] Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Yamasaki, K (corresponding author), Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	kyamasak@asahikawa-med.ac.jp			JSPS KAKENHI Grant [JP15K06988, JP15H04346]; Grants-in-Aid for Scientific Research [15H04346, 17K07297] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant JP15K06988 (to K. Y.) and JSPS KAKENHI Grant JP15H04346 (to H. S.). The authors declare that they have no conflicts of interest with the contents of this article.	BARRABIN H, 1984, BIOCHEMISTRY-US, V23, P1542, DOI 10.1021/bi00302a031; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bick RJ, 1998, J MEMBRANE BIOL, V164, P169, DOI 10.1007/s002329900402; CAFFREY M, 1981, BIOCHEMISTRY-US, V20, P1949, DOI 10.1021/bi00510a034; Clausen JD, 2013, EMBO J, V32, P3231, DOI 10.1038/emboj.2013.250; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2017, SCI REP-UK, V7, DOI 10.1038/srep41172; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Dowhan W, 2008, N COMP BIOC, P1, DOI 10.1016/B978-044453219-0.50003-9; Drachmann ND, 2014, FEBS J, V281, P4249, DOI 10.1111/febs.12957; Fuller N, 2003, BIOPHYS J, V85, P1667, DOI 10.1016/S0006-3495(03)74596-2; Gustavsson M, 2011, BIOCHEMISTRY-US, V50, P10367, DOI 10.1021/bi200759y; Habeck M, 2017, P NATL ACAD SCI USA, V114, P2904, DOI 10.1073/pnas.1620799114; HARA H, 1986, J BIOL CHEM, V261, P6584; Her C, 2016, BIOPHYS J, V111, P989, DOI 10.1016/j.bpj.2016.06.041; Hunter GW, 1999, BIOCHEMISTRY-US, V38, P1356, DOI 10.1021/bi9822224; Justesen BH, 2013, J BIOL CHEM, V288, P26419, DOI 10.1074/jbc.M112.446948; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martin-Molina A, 2012, BIOPHYS J, V102, P2095, DOI 10.1016/j.bpj.2012.03.009; Meissner G, 1974, Methods Enzymol, V32, P475; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; NAKAMURA S, 1994, J BIOL CHEM, V269, P16015; Norimatsu Y, 2017, NATURE, V545, P193, DOI 10.1038/nature22357; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Scarlata S, 1997, BIOPHYS CHEM, V67, P269, DOI 10.1016/S0301-4622(97)00053-7; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; STARLING AP, 1995, BIOCHEM J, V310, P875, DOI 10.1042/bj3100875; Starling AP, 1996, BIOCHEM J, V320, P309, DOI 10.1042/bj3200309; TANFORD C, 1978, SCIENCE, V200, P1012, DOI 10.1126/science.653353; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; WEBER K, 1969, J BIOL CHEM, V244, P4406; Winther AML, 2010, J BIOL CHEM, V285, P28883, DOI 10.1074/jbc.M110.136242; YAMAGUCHI M, 1985, J BIOL CHEM, V260, P4896; YAMAGUCHI M, 1984, J BIOL CHEM, V259, P9526; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2013, J BIOL CHEM, V288, P20646, DOI 10.1074/jbc.M113.482711; YU X, 1993, BIOPHYS J, V64, P1232, DOI 10.1016/S0006-3495(93)81489-9; YU X, 1994, J BIOL CHEM, V269, P16656	50	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20218	20227		10.1074/jbc.M117.816702	http://dx.doi.org/10.1074/jbc.M117.816702			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29032359	Green Published, hybrid			2022-12-26	WOS:000417696400026
J	Suarez-Bregua, P; Saxena, A; Bronner, ME; Rotllant, J				Suarez-Bregua, Paula; Saxena, Ankur; Bronner, Marianne E.; Rotllant, Josep			Targeted Pth4-expressing cell ablation impairs skeletal mineralization in zebrafish	PLOS ONE			English	Article							PARATHYROID-HORMONE; OSTEOBLAST DIFFERENTIATION; PHOSPHATE HOMEOSTASIS; GENE-EXPRESSION; BONE-FORMATION; PATHWAYS; MODEL; FGF23; PHEX; METABOLISM	Skeletal development and mineralization are essential processes driven by the coordinated action of neural signals, circulating molecules and local factors. Our previous studies revealed that the novel neuropeptide Pth4, synthesized by hypothalamic cells, was involved in bone metabolism via phosphate regulation in adult zebrafish. Here, we investigate the role of pth4 during skeletal development using single-cell resolution, two-photon laser ablation of Pth4:eGFP-expressing cells and confocal imaging in vivo. Using a stable transgenic Pth4:eGFP zebrafish line, we identify Pth4: eGFP-expressing cells as post-mitotic neurons. After targeted ablation of eGFP-expressing cells in the hypothalamus, the experimental larvae exhibited impaired mineralization of the craniofacial bones whereas cartilage development was normal. In addition to a decrease in pth4 transcript levels, we noted altered expression of phex and entpd5, genes associated with phosphate homeostasis and mineralization, as well as a delay in the expression of osteoblast differentiation markers such as sp7 and sparc. Taken together, these results suggest that Pth4-expressing hypothalamic neurons participate in the regulation of bone metabolism, possibly through regulating phosphate balance during zebrafish development.	[Suarez-Bregua, Paula; Rotllant, Josep] Inst Marine Res IIM CSIC, Aquat Mol Pathobiol Grp, Vigo, Spain; [Saxena, Ankur; Bronner, Marianne E.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Saxena, Ankur] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); California Institute of Technology; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Rotllant, J (corresponding author), Inst Marine Res IIM CSIC, Aquat Mol Pathobiol Grp, Vigo, Spain.	rotllant@iim.csic.es	Suarez-Bregua, Paula/A-5124-2019; Rotllant, Josep/K-1146-2014	Saxena, Ankur/0000-0001-8646-2887; Rotllant, Josep/0000-0001-5331-807X	Spanish Economy and Competitiveness Ministry project [ALG2011-23581, AGL2014-52473R]; National Institutes of Health (NIH) [R01DE024157]; Campus do Mar PhD grant; Xunta de Galicia [AGL2014-52473R, PRE/2012/532]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE024157] Funding Source: NIH RePORTER	Spanish Economy and Competitiveness Ministry project; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Campus do Mar PhD grant; Xunta de Galicia(Xunta de GaliciaEuropean Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by the Spanish Economy and Competitiveness Ministry project ALG2011-23581 and AGL2014-52473R to JR. AS was supported by a National Institutes of Health (NIH) grant R01DE024157 and PSB was supported by a Campus do Mar PhD grant, Xunta de Galicia (PRE/2012/532) and AGL2014-52473R project contract.; We thank Prof. K.M. Kwan for the Bactin2: H2A-mCherry line. This work was funded by the Spanish Economy and Competitiveness Ministry project ALG2011-23581 and AGL2014-52473R to JR. AS was supported by a National Institutes of Health (NIH) grant R01DE024157 and PSB was supported by a Campus do Mar PhD grant, Xunta de Galicia (PRE/2012/532) and AGL2014-52473R project contract.	Bajayo A, 2012, P NATL ACAD SCI USA, V109, P15455, DOI 10.1073/pnas.1206061109; Blair HC, 2008, BIOL REV, V83, P401, DOI 10.1111/j.1469-185X.2008.00048.x; Bonjour JP, 2011, J AM COLL NUTR, V30, p438S, DOI 10.1080/07315724.2011.10719988; Driessler F, 2010, J MOL ENDOCRINOL, V45, P175, DOI 10.1677/JME-10-0015; Elefteriou F, 2008, ARCH BIOCHEM BIOPHYS, V473, P231, DOI 10.1016/j.abb.2008.03.016; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Huitema LFA, 2012, P NATL ACAD SCI USA, V109, P21372, DOI 10.1073/pnas.1214231110; Ichikawa S, 2012, J BONE MINER RES, V27, P453, DOI 10.1002/jbmr.544; Jackman WR, 2004, DEV BIOL, V274, P139, DOI 10.1016/j.ydbio.2004.07.003; Javed A, 2010, ORAL MAXIL SURG CLIN, V22, P283, DOI 10.1016/j.coms.2010.05.001; Kiela PR, 2009, LAB INVEST, V89, P7, DOI 10.1038/labinvest.2008.114; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potts JT, 2005, J ENDOCRINOL, V187, P311, DOI 10.1677/joe.1.06057; Quiros-Gonzalez I, 2014, ARCH BIOCHEM BIOPHYS, V561, P130, DOI 10.1016/j.abb.2014.06.005; Razzaque MS, 2011, IUBMB LIFE, V63, P240, DOI 10.1002/iub.437; Redruello B, 2005, J BONE MINER RES, V20, P682, DOI 10.1359/JBMR.041201; Rowe PSN, 2012, CRIT REV EUKAR GENE, V22, P61, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.50; Rowe PSN, 2004, CRIT REV ORAL BIOL M, V15, P264, DOI 10.1177/154411130401500503; Ruchon AF, 1998, J HISTOCHEM CYTOCHEM, V46, P459; Sabbagh Y, 2009, J AM SOC NEPHROL, V20, P2348, DOI 10.1681/ASN.2009050559; Sapir-Koren R, 2011, IBMS BONEKEY, V8, P286, DOI [10.1138/20110516, DOI 10.1138/20110516]; Saxena A, 2013, ELIFE, V2, DOI 10.7554/eLife.00336; Schmidt R, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-3; Suarez-Bregua P, 2017, FASEB J, V31, P569, DOI 10.1096/fj.201600815R; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Westerfield M., 2007, GUIDE LAB USE ZEBRAF; Yadav MC, 2011, J BONE MINER RES, V26, P286, DOI 10.1002/jbmr.195; Yan YL, 2012, J ENDOCRINOL, V214, P421, DOI 10.1530/JOE-12-0110	39	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186444	10.1371/journal.pone.0186444	http://dx.doi.org/10.1371/journal.pone.0186444			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040309	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000413167500047
J	Carioca, AAF; Gorgulho, B; Teixeira, JA; Fisberg, RM; Marchioni, DM				Ferreira Carioca, Antonio Augusto; Gorgulho, Bartira; Teixeira, Juliana Araujo; Fisberg, Regina Mara; Marchioni, Dirce Maria			Dietary patterns in internal migrants in a continental country: A population-based study	PLOS ONE			English	Article							SELF-REPORTED HYPERTENSION; CORONARY-HEART-DISEASE; NATIONAL-HEALTH SURVEY; TO-URBAN MIGRANTS; RISK-FACTORS; METABOLIC SYNDROME; DIABETES-MELLITUS; AVAILABILITY; OBESITY; BRAZIL	Objective The objective of this study was to assess the differences and similarities in dietary patterns among migrants and natives. Methods A population-based, cross-sectional study was conducted in the city of Sao Paulo. The study population included internal migrants, defined as individuals born outside Sao Paulo city who had lived in the city for ten years or longer. The final population (n = 999) was divided into three groups: natives of Sao Paulo (n = 354), migrants from the Southeast (n = 349) and migrants from the Northeast (n = 296). Factor and principal component analysis was employed to derive dietary patterns. The standardized scores were compared among groups using linear regression. Results Differences in income per capita, years of education, self-reported race, smoking habits, alcohol consumption, nutritional status and prevalence of hypertension were found for place of birth. Three dietary patterns were identified: prudent (salad dressings, vegetables, natural flavorings, fruits, whole-grain bread, white cheeses and juices), traditional (rice, beans, bread/toast/crackers, butter/margarine, whole milk, coffee/teas, sugar), and modern (sodas, pastries/sandwiches/pizzas, yellow cheeses, pastas, sauces, alcoholic beverages, sweets, processed meats). Compared to natives, migrants from the Southeast had an inversely proportional adherence to the modern pattern whereas migrants from the Northeast had an inverse association with the prudent and modern patterns and a positive association with the traditional pattern. Conclusions Sao Paulo natives and internal migrants from other regions of Brazil exhibited different dietary patterns. The results presented here add perspectives to be considered in the study of non-communicable diseases and its different incidences among migrants and natives.	[Ferreira Carioca, Antonio Augusto; Gorgulho, Bartira; Teixeira, Juliana Araujo; Fisberg, Regina Mara; Marchioni, Dirce Maria] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil	Universidade de Sao Paulo	Marchioni, DM (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil.	marchioni@usp.br	Carioca, Antonio Augusto/AAV-7358-2021; Gorgulho, Bartira M/I-1283-2016; Teixeira, Juliana Antunes/HCG-9705-2022; Fisberg, Regina M/C-4069-2012; Marchioni, Dirce M/C-6053-2012; Fisberg, Regina Mara/Q-6494-2019; Marchioni, Dirce/ABH-7023-2020	Carioca, Antonio Augusto/0000-0002-1194-562X; Gorgulho, Bartira M/0000-0002-1714-3548; Teixeira, Juliana Antunes/0000-0002-2742-4765; Fisberg, Regina M/0000-0002-4490-9035; Marchioni, Dirce M/0000-0002-6810-5779; Fisberg, Regina Mara/0000-0002-4490-9035; Marchioni, Dirce/0000-0002-6810-5779	Sao Paulo Research Foundation (FAPESP) [2009/15831-0, 2014/16347-2, 2014/19355-6, 2014/12647-1]; National Council for Scientific and Technological Development (CNPq) [503128/2010-4]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported, in part, by the Sao Paulo Research Foundation (FAPESP) (grant 2009/15831-0; 2014/16347-2; 2014/19355-6; 2014/12647-1) to Antonio Augusto Ferreira Carioca, Bartira Gorgulho, Dirce Maria Marchioni, and Juliana Araujo Teixeira as well as the National Council for Scientific and Technological Development (CNPq process no. 503128/2010-4) to Regina Mara Fisberg.	Bagno S, 2013, TRAJETORIA SEVERINO, V2; Bowen L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014822; Brasil. Instituto Brasileiro de Geografia e Estatistica, 2014, PESQ NAC SAUD 2013 P; Brasil. Ministerio da Saude (MS), 2017, GUIA PRAT HANS; Campanella G, 2014, INT J EPIDEMIOL; Carrillo-Larco RM, 2016, INT J OBESITY, V40, P181, DOI 10.1038/ijo.2015.140; Carvalho Aline Martins de, 2014, Rev. bras. epidemiol., V17, P735, DOI 10.1590/1809-4503201400030013; Castro MA, 2016, BRIT J NUTR, V115, P1586, DOI 10.1017/S0007114516000556; Claro RM, 2007, REV SAUDE PUBL, V41, P557, DOI 10.1590/S0034-89102007000400009; Claro RM, 2015, EPIDEMIOL SERV SAUDE, V24, P257, DOI 10.5123/S1679-49742015000200008; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cunha J., 2005, SAO PAULO PERSPECT, V19, P3, DOI DOI 10.1590/S0102-88392005000400001; Cunha JMPd, 2013, REV BRASILEIRA ESTUD, V17, P97; de Castro MA, 2015, CAD SAUDE PUBLICA, V31, P298, DOI 10.1590/0102-311X00070814; Selem SSD, 2014, J ACAD NUTR DIET, V114, P1216, DOI 10.1016/j.jand.2014.01.007; Selem SSD, 2013, ARQ BRAS CARDIOL, V100, P52, DOI 10.1590/S0066-782X2012005000119; Duran AC, 2013, HEALTH PLACE, V23, P39, DOI 10.1016/j.healthplace.2013.05.001; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Elliott HR, 2015, INT J EPIDEMIOL, V44, P1449, DOI [10.1093/ije/dyv010, 10.1093/ije/dyu258]; Eussen SJPM, 2013, BRIT J NUTR, V110, P363, DOI 10.1017/S0007114512004990; Ferreira-Batista Natalia, 2012, Nova econ., V22, P515, DOI 10.1590/S0103-63512012000300004; Fisberg R.M., 2002, MANUAL RECEITAS MEDI; Fontanelli MD, 2017, REV SAUDE PUBL, V51, DOI [10.1590/s1518-8787.2017051006378, 10.1590/S1518-8787.2017051006378]; Franco M, 2008, AM J PREV MED, V35, P561, DOI 10.1016/j.amepre.2008.07.003; Freire RD, 2005, DIABETES CARE, V28, P1779, DOI 10.2337/diacare.28.7.1779; Diez Garcia Rosa Wanda, 2003, Rev. Nutr., V16, P483, DOI 10.1590/S1415-52732003000400011; Gimeno SGA, 2002, DIABETOLOGIA, V45, P1635, DOI 10.1007/s00125-002-0963-x; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th; Hara H, 1996, DIABETIC MED, V13, pS133; Haubrock J, 2011, J NUTR, V141, P914, DOI 10.3945/jn.109.120394; Heckert J, 2015, PUBLIC HEALTH NUTR, V18, P1262, DOI 10.1017/S1368980014001372; Himmelgreen DA, 2014, PHYSIOL BEHAV, V134, P76, DOI 10.1016/j.physbeh.2013.12.012; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Jacques PF, 2001, AM J CLIN NUTR, V73, P1, DOI 10.1093/ajcn/73.1.1; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Jaime PC, 2015, EPIDEMIOL SERV SAUDE, V24, P267, DOI 10.5123/S1679-49742015000200009; Kamphuis CBM, 2015, AM J CLIN NUTR, V101, P768, DOI 10.3945/ajcn.114.096776; Kinra S, 2011, AM J EPIDEMIOL, V174, P154, DOI 10.1093/aje/kwr053; LEBRAO ML, 2003, SABE SAUDE BEM ESTAR; Ledikwe JH, 2005, J NUTR, V135, P273, DOI 10.1093/jn/135.2.273; Lesser IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088495; Levy RB, 2012, REV SAUDE PUBL, V46, P6, DOI 10.1590/S0034-89102011005000088; MARMOT MG, 1984, LANCET, V1, P1003; Marmot MG, 1984, OPCS STUDIES MED POP, V27, P229; Martinez ME, 1998, AM J EPIDEMIOL, V148, P17, DOI 10.1093/oxfordjournals.aje.a009552; MCKEIGUE PM, 1985, LANCET, V2, P1086; Mendez M. A., 2004, FAO Food and Nutrition Paper, P55; Mendonça Cristina Pinheiro, 2004, Cad. Saúde Pública, V20, P698, DOI 10.1590/S0102-311X2004000300006; Miller V, 2016, LANCET GLOB HEALTH, V4, pE695, DOI 10.1016/S2214-109X(16)30186-3; Nutrition Data System for Research, NUTR DAT SYST RES; Oliveira KFd, 2005, SAO PAULO PERSPECT, V19, P134, DOI DOI 10.1590/S0102-88392005000400009; Pena MSB, 2015, J EPIDEMIOL COMMUN H, V69, P715, DOI 10.1136/jech-2015-205657; Pinheiro A.B.V., 2008, TABELA AVALIACAO CON; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Raper N, 2004, J FOOD COMPOS ANAL, V17, P545, DOI 10.1016/j.jfca.2004.02.013; Varadharajan KS, 2013, ASIA PAC J CLIN NUTR, V22, P416, DOI 10.6133/apjcn.2013.22.3.14; VINEIS P, 1992, TUMORI, V78, P235, DOI 10.1177/030089169207800403; Walsh MC, 2014, BRIT J NUTR, V111, P424, DOI 10.1017/S0007114513002602; World Health Organization, 2000, WHO TECHN REP SER, V894	59	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0185882	10.1371/journal.pone.0185882	http://dx.doi.org/10.1371/journal.pone.0185882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036177	gold, Green Published, Green Submitted			2022-12-26	WOS:000413054800012
J	Hsu, CY; Ho, HL; Lin, SC; Ho, TDH; Ho, DMT				Hsu, Chih-Yi; Ho, Hsiang-Ling; Lin, Shih-Chieh; Ho, Tiffany Dai-Hwa; Ho, Donald Ming-Tak			The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma	PLOS ONE			English	Article							O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; LUNG-CANCER; T ALLELE; RS16906252; GENE; TEMOZOLOMIDE; SURVIVAL; CELLS; RISK; SNP	Promoter methylation is the most significant mechanism to regulate O-6-methylguanineDNA- methyltransferase (MGMT) expression. Single-nucleotide polymorphisms (SNPs) in the MGMT promoter region may also play a role. The aim of this study was to evaluate the clinical significance of SNPs in the MGMT promoter region of glioblastoma. Genomic DNAs from 118 glioblastomas were collected for polymerase chain reaction (PCR) amplification. Sanger sequencing was used to sequence the MGMT promoter region to detect SNPs. The results were correlated with MGMT status and patient survival. Rs1625649 was the only polymorphic SNP located at the MGMT promoter region in 37.5% of glioblastomas. Homozygous rs1625649 (AA genotype) was correlated with a higher MGMT methylation level and a lower protein expression, but the result was not statistically significant. In patients with MGMT methylated glioblastoma, cases with homozygous rs1625649 (AA genotype) were significantly associated with a lack of MGMT protein expression and a better progressionfree survival (PFS) than the cases with wild type rs1625649 (CC genotype) or heterozygous rs1625649 (CA genotype). The survival impact was significant in multivariate analyses. In conclusion, the MGMT promoter homozygous rs1625649 (AA genotype) was found to correlate with a better PFS in patients with MGMT methylated glioblastoma.	[Hsu, Chih-Yi; Ho, Hsiang-Ling; Lin, Shih-Chieh; Ho, Donald Ming-Tak] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Hsu, Chih-Yi; Ho, Hsiang-Ling; Lin, Shih-Chieh; Ho, Donald Ming-Tak] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Ho, Tiffany Dai-Hwa] Duke Univ, Dept Comp Sci, Durham, NC 27706 USA; [Ho, Tiffany Dai-Hwa] Duke Univ, Dept Stat, Durham, NC 27706 USA; [Ho, Donald Ming-Tak] Cheng Hsin Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Duke University; Duke University; Cheng Hsin General Hospital	Ho, DMT (corresponding author), Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan.; Ho, DMT (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Ho, DMT (corresponding author), Cheng Hsin Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan.	mtho11728@gmail.com			Taipei Veterans General Hospital [V104C-187, V105C-185, V105C-187]; Ministry of Science and Technology, Executive Yuan, R.O.C. [MOST 104-2320-B-075-003, MOST 104-2320-B-075-004]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology, Executive Yuan, R.O.C.	The authors CYH and DMH received funding from "Taipei Veterans General Hospital, Grant Number: V104C-187, V105C-185, V105C-187 (https://www.vghtpe.gov.tw/Index.action)"; and from The Ministry of Science and Technology, Executive Yuan, R.O.C., Grant Number: MOST 104-2320-B-075-003, MOST 104-2320-B-075-004 (https://www.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blough MD, 2007, CANCER RES, V67, P580, DOI 10.1158/0008-5472.CAN-06-2782; Candiloro ILM, 2009, CANCER PREV RES, V2, P862, DOI 10.1158/1940-6207.CAPR-09-0056; Crone TM, 1996, MUTAT RES-DNA REPAIR, V363, P15, DOI 10.1016/0921-8777(95)00058-5; Du L, 2013, TUMOR BIOL, V34, P3227, DOI 10.1007/s13277-013-0893-x; Fogli A, 2016, CARCINOGENESIS, V37, P169, DOI 10.1093/carcin/bgv251; Hsu CY, 2017, APPL IMMUNOHISTO M M, V25, P497, DOI 10.1097/PAI.0000000000000331; Hsu CY, 2015, J NEURO-ONCOL, V122, P179, DOI 10.1007/s11060-014-1701-1; Hsu CY, 2015, J NEURO-ONCOL, V121, P459, DOI 10.1007/s11060-014-1663-3; Hsu CY, 2013, AM J SURG PATHOL, V37, P264, DOI 10.1097/PAS.0b013e318267b061; Hu ZB, 2007, HUM MUTAT, V28, P431, DOI 10.1002/humu.20462; Iatsyshyna A. P., 2013, Biopolymers and Cell, V29, P367, DOI 10.7124/bc.00082B; IMAI Y, 1995, CARCINOGENESIS, V16, P2441; Kitange GJ, 2012, CLIN CANCER RES, V18, P4070, DOI 10.1158/1078-0432.CCR-12-0560; Kreth S, 2013, ACTA NEUROPATHOL, V125, P671, DOI 10.1007/s00401-013-1081-1; Kristensen LS, 2011, LUNG CANCER, V71, P130, DOI 10.1016/j.lungcan.2010.05.008; Krzesniak M, 2004, ANN HUM GENET, V68, P300, DOI 10.1046/j.1529-8817.2004.00079.x; Kushwaha D, 2014, ONCOTARGET, V5, P4026, DOI 10.18632/oncotarget.1974; Leng SG, 2011, CLIN CANCER RES, V17, P2014, DOI 10.1158/1078-0432.CCR-10-3026; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Margison GP, 2005, CARCINOGENESIS, V26, P1473, DOI 10.1093/carcin/bgi087; McDonald KL, 2013, EUR J CANCER, V49, P360, DOI 10.1016/j.ejca.2012.08.012; Park JH, 2010, J CANCER RES CLIN, V136, P1135, DOI 10.1007/s00432-010-0760-8; PEGG AE, 1995, PROG NUCLEIC ACID RE, V51, P167, DOI 10.1016/S0079-6603(08)60879-X; Ramalho-Carvalho J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058206; Rapkins RW, 2015, NEURO-ONCOLOGY, V17, P1589, DOI 10.1093/neuonc/nov064; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Xu MX, 2014, CARCINOGENESIS, V35, P564, DOI 10.1093/carcin/bgt355; Zawlik I, 2009, NEUROEPIDEMIOLOGY, V32, P21, DOI 10.1159/000170088; Zhao W, 2005, J BIOCHEM, V137, P431, DOI 10.1093/jb/mvi048	30	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186430	10.1371/journal.pone.0186430	http://dx.doi.org/10.1371/journal.pone.0186430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036186	Green Submitted, Green Published, gold			2022-12-26	WOS:000413054800031
J	Scott, RH; Bajos, N; Slaymaker, E; Wellings, K; Mercer, CH				Scott, Rachel H.; Bajos, Nathalie; Slaymaker, Emma; Wellings, Kaye; Mercer, Catherine H.			Understanding differences in conception and abortion rates among under-20 year olds in Britain and France: Examining the contribution of social disadvantage	PLOS ONE			English	Article							PEOPLES SEXUAL-BEHAVIOR; TEENAGE PREGNANCY; NATIONAL-SURVEY; LIFE-STYLES; DEBUT; RISK; ATTITUDES; EDUCATION	Objectives Socioeconomic status has been shown to be associated with sexual activity, contraceptiveuse, pregnancy and abortion among young people. Less is known about whether the strength of the association differs for each outcome, between men and women, or crossnationally. We investigate this using contemporaneous national probability survey data from Britain and France. Methods Data were analysed for 17-29 year-olds in Britain's third National Survey of Sexual Attitudes and Lifestyles (Natsal-3, n = 5959) undertaken 2010-2012, and the 2010 French Fertility, Contraception and Sexual Dysfunction survey (FECOND, n = 3027). For each country, we estimated the gender- specific prevalence of sex before-16, contraceptive-use, conception before-20, and abortion in the event of conception, and used logistic regression to examine associations between two measures of socioeconomic status-educational-level and parental socioeconomic-group-and each outcome. We tested for interactions between socioeconomic characteristics and country, and socioeconomic characteristics and gender, for each outcome. Results For each outcome, Britain and France differed with regard to prevalence but associations with socioeconomic characteristics were similar. Respondents of higher educational level, and, less consistently, with parents from higher socioeconomic-groups, were less likely to report sex before-16 (Britain, men: adjusted OR (aOR) 0.5, women: aOR 0.5; France, men: aOR 0.5, women: aOR 0.5), no contraception at first sex (Britain, men: aOR 0.4, women: aOR 0.6; France, men: aOR 0.4, women: aOR 0.4), pregnancy before-20 (Britain: aOR 0.3; France: aOR 0.1), and in Britain, a birth rather than an abortion in the event of conception (Britain: aOR 3.1). We found no strong evidence of variation in the magnitude of the associations with socioeconomic characteristics by country or gender. Conclusions Population level differences in conception and abortion rates between the two countries may partly be driven by the larger proportion of the population that is disadvantaged in Britain. This research highlights the role intra-country comparisons can play in understanding young people's sexual and reproductive behaviours.	[Scott, Rachel H.; Slaymaker, Emma] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England; [Bajos, Nathalie] INSERM, Dept Gender Hlth & Sexual, Paris, France; [Wellings, Kaye] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London, England; [Mercer, Catherine H.] UCL, Inst Global Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Scott, RH (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, London, England.	rachel.scott@lshtm.ac.uk	Bajos, Nathalie/M-4170-2018	Bajos, Nathalie/0000-0001-8073-9056; Mercer, Catherine/0000-0002-4220-5034	Medical Research Council [G0701757]; Wellcome Trust [084840]; French National Institute for Health and Medical Research (INSERM); French National Institute for Demographic Research (INED); Economic and Social Research Council; MRC [G0701757] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); French National Institute for Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French National Institute for Demographic Research (INED); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Natsal-3 was supported by grants from the Medical Research Council [G0701757]; and the Wellcome Trust [084840]; with contributions from the Economic and Social Research Council and Department of Health. The FECUND survey was funded by the French National Institute for Health and Medical Research (INSERM) and the French National Institute for Demographic Research (INED). RS was funded by the Economic and Social Research Council. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	[Anonymous], [No title captured]; Arai L, 2003, SOCIOL REV, V51, P199, DOI 10.1111/1467-954X.00415; Bajos N, 2000, SOC SCI MED, V50, P1533, DOI 10.1016/S0277-9536(99)00463-3; Bajos N, 2003, REPROD HLTH BEHAV YO, V1; Bajos N, TEENAGE SEXUAL REPRO; Bonell CP, 2003, J EPIDEMIOL COMMUN H, V57, P871, DOI 10.1136/jech.57.11.871; Bozon M, 1998, SEX BEHAV HIV AIDS E; Bozon M., 2013, SOCIOLOGIE SEXUALITE; Bozon M, 2012, SEX FR PRACT GEND HE; Conrad D, 2012, J PUBLIC HEALTH-UK, V34, P609, DOI 10.1093/pubmed/fds031; Copas AJ, 2002, SEX TRANSM INFECT, V78, P26, DOI 10.1136/sti.78.1.26; Erens B, 2014, SEX TRANSM INFECT, V90, P84, DOI 10.1136/sextrans-2013-051359; Hall KS, 2013, J ADOLESCENT HEALTH, V53, P241, DOI 10.1016/j.jadohealth.2013.02.009; Hofferth SL, 2001, FAM PLANN PERSPECT, V33, P259, DOI 10.2307/3030193; Jewell D, 2000, FAM PRACT, V17, P522, DOI 10.1093/fampra/17.6.522; Jones RK, 2007, STUD FAMILY PLANN, V38, P187, DOI 10.1111/j.1728-4465.2007.00130.x; Kiernan KE, 1997, BRIT J SOCIOL, V48, P406, DOI 10.2307/591138; Kneale D, 2013, J EPIDEMIOL COMMUN H, V67, P48, DOI 10.1136/jech-2011-200867; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lee E, 2004, INLUENCES YOUNG WOME; Lee E., 2004, MATTER CHOICE EXPLAI; Legleye S, 2013, PUBLIC OPIN QUART, V77, P666, DOI 10.1093/poq/nft031; LeVan C, 1998, GROSSESSE ADOLESCENC; Marston C, 2006, LANCET, V368, P1581, DOI 10.1016/S0140-6736(06)69662-1; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Moreau C, 2005, ACTIVITE SEXUELLE IS, P329; OECD, 2011, DIV WE STAND WHY IN; Organisation for Economic Co-operation and Development / International Transport Forum (OECD/ITF), 2015, IMPACT MEGASHIPS, P1; Parkes A, 2010, J ADOLESCENCE, V33, P741, DOI 10.1016/j.adolescence.2009.10.006; Rossier C, 2007, STUD FAMILY PLANN, V38, P163, DOI 10.1111/j.1728-4465.2007.00128.x; Santelli J, 2009, NEW VISION ADOLESCEN; Scott R. S., 2016, THESIS; Sedgh G, 2015, J ADOLESCENT HEALTH, V56, P223, DOI 10.1016/j.jadohealth.2014.09.007; Shafii T, 2007, AM J PUBLIC HEALTH, V97, P1090, DOI 10.2105/AJPH.2005.068437; Sihvo S, 2003, J EPIDEMIOL COMMUN H, V57, P601, DOI 10.1136/jech.57.8.601; Singh BS, 2001, FAM PLANN PERSPECT, V33, P289; Singh S, 2001, FAM PLANN PERSPECT, V33, P251, DOI 10.2307/3030192; Spriggs AL, 2008, PERSPECT SEX REPRO H, V40, P152, DOI 10.1363/4015208; UNICEF Office of Research, 2013, CHILD WELL BEING RIC; Van de Velde C, 2008, DEVENIR ADULTE SOCIO, P288; van Le C., 2006, ADOLESCENCE, V55, P225; Wellings F, 2001, LANCET, V358, P1843, DOI 10.1016/S0140-6736(01)06885-4; Wight D, 2006, J ADOLESCENCE, V29, P473, DOI 10.1016/j.adolescence.2005.08.007; Wilkinson R., 2009, SPIRIT LEVEL	44	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							0186412	10.1371/journal.pone.0186412	http://dx.doi.org/10.1371/journal.pone.0186412			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ8YP	29036209	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000413054800029
J	Hugg, TT; Hjort, J; Antikainen, H; Rusanen, J; Tuokila, M; Korkonen, S; Weckstrom, J; Jaakkola, MS; Jaakkola, JJK				Hugg, Timo T.; Hjort, Jan; Antikainen, Harri; Rusanen, Jarmo; Tuokila, Mirkka; Korkonen, Sanna; Weckstrom, Jan; Jaakkola, Maritta S.; Jaakkola, Jouni J. K.			Urbanity as a determinant of exposure to grass pollen in Helsinki Metropolitan area, Finland	PLOS ONE			English	Article							ALLERGIC RHINITIS; AEROALLERGENS; ASTHMA; SENSITIZATION; ENVIRONMENT; SYMPTOMS; BURDEN; IMPACT	Little is known about the levels of exposure to grass pollen in urban environments. We assessed the spatio-temporal variation of grass pollen concentrations and the role of urbanity as a determinant of grass pollen exposure in the Helsinki Metropolitan area. We monitored grass pollen concentrations in 2013 at 16 sites during the peak pollen season by using rotorod-type samplers at the breathing height. The sites were in the cities of Helsinki and Espoo, Finland, and formed city-specific lines that represented urban-rural gradient. The monitoring sites were both visually and based on land use data ranked as high to low (graded 1 to 8) pollen area. The lowest grass pollen concentrations were observed in the most urban sites compared to the least urban sites (mean 3.6 vs. 6.8 grains/m(3) in Helsinki; P < 0.0001, and 5.2 vs. 87.5 grains/m(3) in Espoo; P < 0.0001). Significant differences were observed between concentrations measured in morning periods compared to afternoon periods (4.9 vs. 5.4 in Helsinki, P = 0.0186, and 21.8 vs. 67.1 in Espoo, P = 0.0004). The mean pollen concentration increased with decreasing urbanity both in Helsinki (0.59 grains/m(3) per urbanity rank, 95% CI 0.25-0.93) and Espoo (8.42, 6.23-10.61). Pollen concentrations were highest in the afternoons and they were related to the ambient temperature. Urbanity was a strong and significant determinant of pollen exposure in two Finnish cities. Pollen exposure can periodically reach such high levels even in the most urban environments that can cause allergic reactions among individuals with allergies.	[Hugg, Timo T.; Tuokila, Mirkka; Jaakkola, Maritta S.; Jaakkola, Jouni J. K.] Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Hugg, Timo T.; Jaakkola, Maritta S.; Jaakkola, Jouni J. K.] Univ Oulu, Med Res Ctr Oulu, Oulu Univ Hosp, Oulu, Finland; [Hugg, Timo T.; Jaakkola, Maritta S.; Jaakkola, Jouni J. K.] Univ Oulu, Oulu, Finland; [Hjort, Jan; Antikainen, Harri; Rusanen, Jarmo] Univ Oulu, Geog Res Unit, Oulu, Finland; [Korkonen, Sanna; Weckstrom, Jan] Univ Helsinki, Dept Environm Sci, Helsinki, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Helsinki	Jaakkola, JJK (corresponding author), Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland.; Jaakkola, JJK (corresponding author), Univ Oulu, Med Res Ctr Oulu, Oulu Univ Hosp, Oulu, Finland.; Jaakkola, JJK (corresponding author), Univ Oulu, Oulu, Finland.	jouni.jaakkola@oulu.fi	Jaakkola, Jouni J.K./G-4314-2012; Hugg, Timo/P-5531-2018; Weckstrom, Jan/N-7665-2013	Hjort, Jan/0000-0002-4521-2088; Jaakkola, Maritta S./0000-0003-1373-7784; Korkonen, Sanna/0000-0003-3598-8496; Weckstrom, Jan/0000-0001-5604-617X; Hugg, Timo/0000-0003-2558-1780; Jaakkola, Jouni/0000-0003-4168-4683	Academy of Finland [266314, 267995]; University of Oulu; Research Council for Health	Academy of Finland(Academy of Finland); University of Oulu; Research Council for Health	This work was supported by the Research Council for Health, the Academy of Finland [grant numbers 266314 to JJ and 267995 to JH (APTA Consortium)] and the University of Oulu Strategic Funding to JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aina R, 2010, ALLERGY, V65, P1313, DOI 10.1111/j.1398-9995.2010.02364.x; Albertine JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111712; Alcazar P, 1999, J INVEST ALLERG CLIN, V9, P89; Annesi-Maesano I, 2012, INT ARCH ALLERGY IMM, V158, P397, DOI 10.1159/000332964; [Anonymous], 2013, AR; [Anonymous], 2012, SEUTUCD12; Armentia A, 2001, CLIN EXP ALLERGY, V31, P1250, DOI 10.1046/j.1365-2222.2001.01142.x; Arroba D., 2000, AEROBIOLOGIA, V16, P233, DOI DOI 10.1023/A:1007674620285; Beggs PJ, 2004, CLIN EXP ALLERGY, V34, P1507, DOI 10.1111/j.1365-2222.2004.02061.x; Bergmann KC, 2013, ALLERGO J, V22, P471; Blomme K, 2013, INT ARCH ALLERGY IMM, V160, P200, DOI 10.1159/000339853; Bosch-Cano F, 2011, ENVIRON RES, V111, P619, DOI 10.1016/j.envres.2011.04.001; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brookhaven National Laboratory, 1970, EXPT DATA DISPERSION; Carinanos P, 2002, J ENVIRON MONITOR, V4, P734, DOI 10.1039/b205595c; Constable G., 1985, GRASSLANDS TUNDRA PL; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; Douglas Ian, 1983, URBAN ENV; EMBERLIN J, 1991, GRANA, V30, P190, DOI 10.1080/00173139109427798; Brito FF, 2010, J INVEST ALLERG CLIN, V20, P295; Frenz D., 1996, AEROBIOLOGIA, V12, P51; Galan C, 2014, AEROBIOLOGIA, V30, P385, DOI 10.1007/s10453-014-9335-5; Gilmour M, 2006, ENVIRON HEALTH PERSP, V114, P627, DOI 10.1289/ehp.8380; Gonzalo-Garijo MA, 2006, J INVEST ALLERG CLIN, V16, P37; Haahtela T, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-3; Hamid N, 2015, GRANA, V54, P53, DOI 10.1080/00173134.2014.967289; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Hjort J, 2016, ENVIRON HEALTH PERSP, V124, P619, DOI 10.1289/ehp.1509761; Hugg T, 2007, AEROBIOLOGIA, V23, P119, DOI 10.1007/s10453-007-9057-z; Jurvelin J, 2001, J AIR WASTE MANAGE, V51, P17, DOI 10.1080/10473289.2001.10464251; KAPYLA M, 1981, Grana, V20, P55; Kasprzyk I, 2006, AEROBIOLOGIA, V22, P185, DOI 10.1007/s10453-006-9031-1; Khwarahm N, 2014, INT J BIOMETEOROL, V58, P529, DOI 10.1007/s00484-013-0739-7; Majd Ahmad, 2004, Aerobiologia, V20, P111, DOI 10.1023/B:AERO.0000032950.12169.38; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Rodriguez AFM, 2010, ANN AGR ENV MED, V17, P87; Ozdoganoglu T, 2012, THER ADV RESPIR DIS, V6, P11, DOI 10.1177/1753465811431975; Peel RG, 2014, INT J BIOMETEOROL, V58, P1317, DOI 10.1007/s00484-013-0728-x; Priftis KN, 2007, PEDIATR ALLERGY IMMU, V18, P209, DOI 10.1111/j.1399-3038.2006.00514.x; Ranta H, 2005, FINNISH POLLEN B SUM; RANTIOLEHTIMAKI A, 1991, ALLERGY, V46, P68, DOI 10.1111/j.1398-9995.1991.tb00545.x; RANTIOLEHTIMAKI A, 1992, ALLERGY, V47, P388, DOI 10.1111/j.1398-9995.1992.tb02077.x; Raynor GS., 1972, IBP AEROBIOLOGY PROG, P82; Simoleit A, 2016, AEROBIOLOGIA, V32, P199, DOI 10.1007/s10453-015-9390-6; Skjoth CA, 2013, BIOGEOSCIENCES, V10, P541, DOI 10.5194/bg-10-541-2013; SLICES, 2012, SLICES LAND US; Sterling DA, 1998, ANN ALLERG ASTHMA IM, V80, P279, DOI 10.1016/S1081-1206(10)62971-7; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Taylor PE, 2007, INT ARCH ALLERGY IMM, V144, P162, DOI 10.1159/000103230; Werchan B, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-5876-8; White JF, 2003, ANN ALLERG ASTHMA IM, V91, P425, DOI 10.1016/S1081-1206(10)61509-8; Ziello C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034076; Ziska LH, 2004, OECOLOGIA, V139, P454, DOI 10.1007/s00442-004-1526-2	53	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186348	10.1371/journal.pone.0186348	http://dx.doi.org/10.1371/journal.pone.0186348			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023565	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100113
J	Mumm, CAS; Knornschild, M				Mumm, Christina A. S.; Knoernschild, Mirjam			Territorial choruses of giant otter groups (Pteronura brasiliensis) encode information on group identity	PLOS ONE			English	Article							SCENT-MARKING; CALLS; DISCRIMINATION; COMMUNICATION; EVOLUTION; MOVEMENT; SONG	Group living animals often engage in corporate territorial defence. Territorial group vocalizations can provide information about group identity, size and composition. Neighbouring groups may use this information to avoid unfavourable direct conflicts. Giant otters are highly social and territorial animals with an elaborate vocal repertoire. They produce long-range screams when they are alert or excited, i.e. in an alarm, isolation or begging context. Long-range screams are not only produced by one individual at a time ('single screams') but also by multiple group members simultaneously, resulting in a highly conspicuous 'group chorus'. Wild giant otters regularly produce group choruses during interactions with predators, when they detect intruders in their territory or before group reunions after separation. Since single screams and especially group choruses probably contribute to the groups' corporate territorial defence, we hypothesized that group identity is encoded in single screams and group choruses. We analysed vocalizations from five wild and three captive giant otter groups and found statistical evidence for a group signature in group choruses. Results for single screams were less conclusive, which might have been caused by the comparatively lower sample size. We suggest that giant otters may gain information on group identity by listening to group choruses. Group identity likely constitutes important social information for giant otters since territory boundaries of neighbouring groups can overlap and direct intergroup conflicts are severe. Therefore, group chorusing may contribute to the mutual avoidance of members from different groups.	[Mumm, Christina A. S.; Knoernschild, Mirjam] Free Univ Berlin, Inst Biol, Anim Behav Lab, Berlin, Germany; [Knoernschild, Mirjam] Smithsonian Trop Res Inst, Ancon, Panama; [Knoernschild, Mirjam] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Berlin, Germany	Free University of Berlin; Smithsonian Institution; Smithsonian Tropical Research Institute; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Mumm, CAS; Knornschild, M (corresponding author), Free Univ Berlin, Inst Biol, Anim Behav Lab, Berlin, Germany.; Knornschild, M (corresponding author), Smithsonian Trop Res Inst, Ancon, Panama.; Knornschild, M (corresponding author), Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, Berlin, Germany.	CAS_Mumm@gmx.de; mirjam.knoernschild@fu-berlin.de		Knornschild, Mirjam/0000-0003-0448-9600	Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg; Deutsche Forschungsgemeinschaft [DFG KN935 3-1]; Freie Universitat Berlin, Germany; Estacion Biologica Cocha Cashu; Casa Machiguengka; Posada Amazonas; Explorer's Inn; SZF Peru; AIDER Peru; Mejia Lodge and family Mejia	Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Freie Universitat Berlin, Germany; Estacion Biologica Cocha Cashu; Casa Machiguengka; Posada Amazonas; Explorer's Inn; SZF Peru; AIDER Peru; Mejia Lodge and family Mejia	This study was funded by a Dissertation Fellowship from the Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg to Christina A.S. Mumm and a Heisenberg Fellowship from the Deutsche Forschungsgemeinschaft to Mirjam Knornschild (DFG KN935 3-1). The authors also acknowledge support by the Open Access Publication Funds of the Freie Universitat Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the following persons and institutions for their support: E. K. V. Kalko (deceased), M. Tschapka, L. Davenport, J. Groenendijk, N. Duplaix, R. Williams, M. C. Urrutia, S. Wieluch, A. M. L. Chunga Lee, J. M. Camargo Alvarez, P. Toledo Monsonis, Estacion Biologica Cocha Cashu, Casa Machiguengka, Posada Amazonas, Explorer's Inn and L. Paypay, Mejia Lodge and family Mejia, SZF Peru and AIDER Peru. We thank the SERNANP and DGFFS authorities, Zoo Dortmund, Zoo Duisburg and Tierpark Hagenbeck for research permission.	Ahonen H, 2014, ANIM BEHAV, V97, P229, DOI 10.1016/j.anbehav.2014.09.010; Alcock J., 2006, ANIMAL BEHAV EVOLUTI; Baker MC, 2004, ETHOLOGY, V110, P21, DOI 10.1046/j.1439-0310.2003.00941.x; Baker MC, 2009, ETHOLOGY, V115, P227, DOI 10.1111/j.1439-0310.2008.01606.x; Bousquet CAH, 2011, P ROY SOC B-BIOL SCI, V278, P1482, DOI 10.1098/rspb.2010.1739; Bradbury Jack W., 1998, pi; Campello S, 2014, I ARAGUIA; Carter SK, 1997, MAMMAL REV, V27, P1, DOI 10.1111/j.1365-2907.1997.tb00370.x; Crockford C, 2004, ETHOLOGY, V110, P221, DOI 10.1111/j.1439-0310.2004.00968.x; Davenport LC, 2008, BEHAV ECOLOGY GIANT; Ding T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066751; DUPLAIX N, 1980, TERRE VIE-REV ECOL A, V34, P495; EAST ML, 1991, ANIM BEHAV, V42, P651, DOI 10.1016/S0003-3472(05)80247-7; Evangelista E., 2011, IUCN OTTER SPEC GR B, V28, P5; Evangelista E., 2004, IUCN OTTER SPEC GROU, V21, P47; Gazzola A, 2002, ITAL J ZOOL, V69, P157, DOI 10.1080/11250000209356454; Gese EM, 1998, CAN J ZOOL, V76, P1037, DOI 10.1139/cjz-76-6-1037; Groenendijk J., 2015, PTERONURA BRASILIENS, DOI [10.2305/IUCN.UK.2015-2.RLTS.T18711A21938411.en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T18711A21938411.EN]; Groenendijk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106202; HARRINGTON F H, 1989, Bioacoustics, V2, P117; Harrington Fred H., 2003, P66; Jahns G, 2008, COMPUT ELECTRON AGR, V62, P54, DOI 10.1016/j.compag.2007.09.005; Jain A., 2013, INT J RES ELECT COMM, V4, P26; Kondo N, 2009, JPN PSYCHOL RES, V51, P197, DOI 10.1111/j.1468-5884.2009.00399.x; Kruuk H., 2006, SOCIOBIOL; Leuchtenberger C, 2016, BIOACOUSTICS, V25, P279, DOI 10.1080/09524622.2016.1157704; Leuchtenberger C, 2016, ACTA ETHOL, V19, P143, DOI 10.1007/s10211-016-0233-4; Leuchtenberger C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126073; Leuchtenberger C, 2014, J ACOUST SOC AM, V136, P2861, DOI 10.1121/1.4896518; Leuchtenberger C, 2013, J MAMMAL, V94, P320, DOI 10.1644/12-MAMM-A-210.1; Leuchtenberger C, 2009, ETHOLOGY, V115, P210, DOI 10.1111/j.1439-0310.2008.01607.x; Logan B., 2000, P 1 INT S MUS INF RE; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Machado MRB, 2004, THESIS; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; Mech D., 2003, WOLVES BEHAV ECOLOGY; MITANI JC, 1985, BEHAVIOUR, V92, P59, DOI 10.1163/156853985X00389; Mourao G, 2001, MAMMALIA, V65, P225; Mumm CAS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112562; Mumm CAS, 2014, ANIM BEHAV, V88, P243, DOI 10.1016/j.anbehav.2013.12.005; Cuong NV, 2012, PROC INT C TOOLS ART, P253, DOI 10.1109/ICTAI.2012.42; Nowak S, 2007, J ETHOL, V25, P231, DOI 10.1007/s10164-006-0015-y; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; PETERS RP, 1975, AM SCI, V63, P628; Price T, 2014, BEHAV ECOL SOCIOBIOL, V68, P815, DOI 10.1007/s00265-014-1694-y; Radford AN, 2005, ANIM BEHAV, V70, P1227, DOI 10.1016/j.anbehav.2005.04.002; Radford AN, 2004, ETHOLOGY, V110, P11, DOI 10.1046/j.1439-0310.2003.00943.x; Radford AN, 2003, ANIM BEHAV, V66, P1035, DOI 10.1006/anbe.2003.2292; Ramsauer S., 2005, COGN BRAIN BEHAV, V9, P539; Ribas Carolina, 2004, IUCN Otter Specialist Group Bulletin, V21, P89; Ribas C, 2016, BEHAV ECOL SOCIOBIOL, V70, P61, DOI 10.1007/s00265-015-2025-7; Robbins RL, 2000, BEHAVIOUR, V137, P1271, DOI 10.1163/156853900501926; Rosas FCW, 2003, IUC OTTER SPEC GR B, V20, p7 ; Sato N., 2007, INF MEDIA TECHNOL, V2, P835, DOI [10.5715/jnlp.14.4_83, DOI 10.5715/JNLP.14.4_83]; SCHALLER G B, 1972, P480; Schassburger R.M., 1993, Advances in Ethology, V30, P1; SEKULIC R, 1982, BEHAVIOUR, V81, P38, DOI 10.1163/156853982X00517; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Sykes-Gatz S., 2005, INT GIANT OTTER STUD; Tyack PL, 2008, J COMP PSYCHOL, V122, P319, DOI 10.1037/a0013087; Weber Rosas Fernando Cesar, 2008, IUCN Otter Specialist Group Bulletin, V25, P100; Rosas FCW, 2009, SOCIOBIOLOGY, V54, P919; Zaccaroni M, 2012, ETHOL ECOL EVOL, V24, P322, DOI 10.1080/03949370.2012.664569	64	10	10	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185733	10.1371/journal.pone.0185733	http://dx.doi.org/10.1371/journal.pone.0185733			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023545	Green Published, gold			2022-12-26	WOS:000412845100027
J	van Houwelingen, J; Roerdink, M; Huibers, AV; Evers, LLW; Beek, PJ				van Houwelingen, Josje; Roerdink, Melvyn; Huibers, Alja V.; Evers, Lotte L. W.; Beek, Peter J.			Pacing the phasing of leg and arm movements in breaststroke swimming to minimize intra-cyclic velocity fluctuations	PLOS ONE			English	Article							COORDINATION; STROKE; SWIMMERS; REHABILITATION; EXERCISE; TIME; FLAT; BEAT	In swimming propelling efficiency is partly determined by intra-cyclic velocity fluctuations. The higher these fluctuations are at a given average swimming velocity, the less efficient is the propulsion. This study explored whether the leg-arm coordination (i.e. phase relation phi) within the breaststroke cycle can be influenced with acoustic pacing, and whether the so induced changes are accompanied by changes in intra-cyclic velocity fluctuations. Twentysix participants were asked to couple their propulsive leg and arm movements to a double-tone metronome beat and to keep their average swimming velocity constant over trials. The metronome imposed five different phase relations phi(i) ( 90, 135, 180, 225 and 270 degrees) of leg-arm coordination. Swimmers adjusted their technique under the influence of the metronome, but failed to comply to the velocity requirement for phi = 90 and 135 degrees. For imposed phi = 180, 225 and 270 degrees, the intra-cyclic velocity fluctuations increased with increasing phi, while average swimming velocity did not differ. This suggests that acoustic pacing may be used to adjust phi and thereby performance of breaststroke swimming given the dependence of propelling efficiency on phi.	[van Houwelingen, Josje] Eindhoven Univ Technol, Dept Appl Phys, Postbus 513, NL-5600 MB Eindhoven, Netherlands; [van Houwelingen, Josje] JM Burgers Ctr Fluid Dynam, Postbus 513, NL-5600 MB Eindhoven, Netherlands; [Roerdink, Melvyn; Huibers, Alja V.; Evers, Lotte L. W.; Beek, Peter J.] Vrije Univ Amsterdam, Amsterdam Movement Sci, Dept Human Movement Sci, van der Boechorststr 9, NL-1081 BT Amsterdam, Netherlands	Eindhoven University of Technology; Vrije Universiteit Amsterdam	van Houwelingen, J (corresponding author), Eindhoven Univ Technol, Dept Appl Phys, Postbus 513, NL-5600 MB Eindhoven, Netherlands.; van Houwelingen, J (corresponding author), JM Burgers Ctr Fluid Dynam, Postbus 513, NL-5600 MB Eindhoven, Netherlands.	j.v.houwelingen@tue.nl		Roerdink, Melvyn/0000-0002-8534-1124; Beek, Peter/0000-0002-0917-8548	Stichting voor de Technische Weteschappen [12868]; STW ('Stichting Technische Wetenschappen') research program Sport [12868]	Stichting voor de Technische Weteschappen; STW ('Stichting Technische Wetenschappen') research program Sport	The funder (Stichting voor de Technische Weteschappen, grant number 12868), had no role in study design, data collection and analysis, decision to publish or preperation of the manuscript.; This project was supported by the STW ('Stichting Technische Wetenschappen') research program Sport (project #12868). Thanks go to Innosportlab de Tongelreep for providing the facilities for the experiments.	Alberty M, 2008, J SPORT SCI, V26, P1191, DOI 10.1080/02640410801974984; Alberty MR, 2011, J STRENGTH COND RES, V25, P392, DOI 10.1519/JSC.0b013e3181b94a51; Balasubramaniam R, 2004, EXP BRAIN RES, V159, P129, DOI 10.1007/s00221-004-2066-z; Barbosa TM, 2006, INT J SPORTS MED, V27, P894, DOI 10.1055/s-2006-923776; Barbosa TM, 2010, J SCI MED SPORT, V13, P262, DOI 10.1016/j.jsams.2009.01.003; Barbosa TM, 2005, EUR J APPL PHYSIOL, V93, P519, DOI 10.1007/s00421-004-1251-x; Barbosa TM, 2011, INTECH; Bood RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070758; Borg G., 1998, BORGS PERCEIVED EXER; Chollet D, 2004, INT J SPORTS MED, V25, P486, DOI 10.1055/s-2004-820943; Colman V, 1998, J SPORT SCI, V16, P653, DOI 10.1080/026404198366461; Costill DL, 1987, J SWIM RES, V3, P5; Fink PW, 2000, EXP BRAIN RES, V134, P9, DOI 10.1007/s002210000439; Holmer I., 1979, SWIMMING, P118; KELSO JAS, 1990, ATTENTION PERFORM, P139; Komar J, 2014, J APPL BIOMECH, V30, P189, DOI 10.1123/jab.2013-0073; Kudo K, 2006, J EXP PSYCHOL HUMAN, V32, P599, DOI 10.1037/0096-1523.32.3.599; Leblanc H, 2007, INT J SPORTS MED, V28, P140, DOI 10.1055/s-2006-924205; Leblanc H, 2009, J SCI MED SPORT, V12, P352, DOI 10.1016/j.jsams.2008.01.001; Maglischo CW, 1987, J SWIMMING RES, V3, P11; MANLEY PK, 1992, BIOMECHANICS AND MEDICINE IN SWIMMING, P151; Nigg BM, 1983, BIOMECHANICS MED SWI, VV, P72; Roerdink M, 2013, ANN BIOMED ENG, V41, P1726, DOI 10.1007/s10439-012-0680-7; Roerdink M, 2011, GAIT POSTURE, V33, P690, DOI 10.1016/j.gaitpost.2011.03.001; Schollhorn WI, 2010, MEDICINA-LITHUANIA, V46, P365, DOI 10.3390/medicina46060052; Seifert L, 2014, J SCI MED SPORT, V17, P439, DOI 10.1016/j.jsams.2013.07.003; Seifert L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107839; Takagi Hideki, 2004, Sports Biomech, V3, P15, DOI 10.1080/14763140408522827; Thompson KG, 2002, J SPORT SCI, V20, P537, DOI 10.1080/026404102760000044; TOUSSAINT HM, 1992, SPORTS MED, V13, P8, DOI 10.2165/00007256-199213010-00002; Vilas-Boas JP, 1996, J SPORTS SCI LONDON, V18, P421	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186160	10.1371/journal.pone.0186160	http://dx.doi.org/10.1371/journal.pone.0186160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023496	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100071
J	Rivera-Gutierrez, HF; Martens, T; Pinxten, R; Eens, M				Fabio Rivera-Gutierrez, Hector; Martens, Tine; Pinxten, Rianne; Eens, Marcel			Learning speed is affected by personality and reproductive investment in a songbird	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; GREAT TITS; EXPLORATORY-BEHAVIOR; NEST DEFENSE; PARUS-MAJOR; HABITUATION; INFORMATION; POPULATIONS; AGGRESSION; ANIMALS	Individuals from different taxa, including songbirds, differ consistently in behaviour and personality when facing different situations. Although our understanding of animal behaviour has increased, knowledge about between-individual differences in cognitive abilities is still limited. By using an experimental approach and a free-living songbird (Parus major) as a model, we attempted to understand between-individual differences in habituation to playbacks (as a proxy of learning speed), by investigating the role of personality, age and reproductive investment (clutch size). Pre-breeding males were tested for exploration (a proxy of personality) in standardized conditions. In addition, the same individuals were exposed to three playbacks in the field during incubation. Birds significantly moved less, stayed further away and overlapped less the playback with successive playback stimulation. While a decrease in the locomotor behaviour can be explained by personality, differences in habituation of overlapping were predicted by both reproductive investment and personality. Fast explorers habituated less. Moreover, males paired to females with larger clutches did not vary the intensity of overlapping. Since habituation requires information for recognition of non-threatening signals, personality may bias information gathering. While fast explorers may collect less information from the environment, slow explorers (reactive birds) seem to pay attention to environmental clues and collect detailed information. We provided evidence that the rate of habituation of behavioural responses, a proxy of cognitive abilities, may be affected by different factors and in a complex way.	[Fabio Rivera-Gutierrez, Hector] Univ Antioquia UdeA, Fac Ciencias Exactas & Nat, Grp Ecol & Evoluc Vertebrados, Inst Biol, Medellin, Colombia; [Fabio Rivera-Gutierrez, Hector; Martens, Tine; Pinxten, Rianne; Eens, Marcel] Univ Antwerp, Behav Ecol & Ecophysiol Grp, Campus Drie Eiken,Univ Pl 1, Antwerp, Belgium; [Pinxten, Rianne] Univ Antwerp, Fac Social Sci, Res Unit Didact, Venusstr 35, Antwerp, Belgium	Universidad de Antioquia; University of Antwerp; University of Antwerp	Rivera-Gutierrez, HF (corresponding author), Univ Antioquia UdeA, Fac Ciencias Exactas & Nat, Grp Ecol & Evoluc Vertebrados, Inst Biol, Medellin, Colombia.; Rivera-Gutierrez, HF (corresponding author), Univ Antwerp, Behav Ecol & Ecophysiol Grp, Campus Drie Eiken,Univ Pl 1, Antwerp, Belgium.	fabio.rivera@udea.edu.co	Rivera-Gutierrez, Hector/AAE-7879-2020; Eens, Marcel/AAC-8466-2020	Rivera-Gutierrez, Hector/0000-0001-6025-3470; 	University of Antwerp; FWO-Flanders; Universidad de Antioquia	University of Antwerp; FWO-Flanders(FWO); Universidad de Antioquia	Financial support was provided by University of Antwerp and FWO-Flanders to ME. Universidad de Antioquia provides financial support to HR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrhein V, 2008, BEHAV ECOL SOCIOBIOL, V62, P1633, DOI 10.1007/s00265-008-0592-6; Bell AM, 2007, P ROY SOC B-BIOL SCI, V274, P755, DOI 10.1098/rspb.2006.0199; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; Carere C, 2005, BEHAVIOUR, V142, P1149, DOI 10.1163/156853905774539436; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; David M, 2015, BEHAV ECOL SOCIOBIOL, V69, P1085, DOI 10.1007/s00265-015-1921-1; Deecke VB, 2002, NATURE, V420, P171, DOI 10.1038/nature01030; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Dong S, 2009, NEUROBIOL LEARN MEM, V92, P183, DOI 10.1016/j.nlm.2008.09.009; Rivera-Gutierrez HF, 2015, BEHAVIOUR, V152, P1277, DOI 10.1163/1568539X-00003278; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Griffin AS, 2015, TRENDS ECOL EVOL, V30, P207, DOI 10.1016/j.tree.2015.01.012; Guillette LM, 2011, P ROY SOC B-BIOL SCI, V278, P767, DOI 10.1098/rspb.2010.1669; Guillette LM, 2009, BEHAV PROCESS, V82, P265, DOI 10.1016/j.beproc.2009.07.005; Hollander FA, 2008, ETHOLOGY, V114, P405, DOI 10.1111/j.1439-0310.2008.01488.x; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kortet R, 2007, BIOL J LINN SOC, V91, P475, DOI 10.1111/j.1095-8312.2007.00812.x; KREBS JR, 1981, ANIM BEHAV, V29, P918, DOI 10.1016/S0003-3472(81)80029-2; KREBS JR, 1976, BEHAV ECOL SOCIOBIOL, V1, P215, DOI 10.1007/BF00299198; LAMBRECHTS MM, 1992, NATO ADV SCI I A-LIF, V228, P135; Marchetti C, 2000, ANIM BEHAV, V60, P131, DOI 10.1006/anbe.2000.1443; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Peake TM, 2002, P ROY SOC B-BIOL SCI, V269, P1925, DOI 10.1098/rspb.2002.2112; Peeke H. V. S., 1984, HABITUATION SENSITIZ, P393; Poesel A, 2005, ANIM BEHAV, V70, P1419, DOI 10.1016/j.anbehav.2005.04.004; Radford AN, 2000, P ROY SOC B-BIOL SCI, V267, P535, DOI 10.1098/rspb.2000.1033; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Redmond LJ, 2009, WILSON J ORNITHOL, V121, P1, DOI 10.1676/07-166.1; Rivera-Gutierrez HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016003; Rivera-Gutierrez HF, 2012, ANIM BEHAV, V83, P1279, DOI 10.1016/j.anbehav.2012.03.001; Rivera-Gutierrez HF, 2011, BIOL LETTERS, V7, P339, DOI 10.1098/rsbl.2010.0962; Searcy WA, 2009, ANIM BEHAV, V78, P1281, DOI 10.1016/j.anbehav.2009.08.011; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sneddon LU, 2003, J FISH BIOL, V62, P971, DOI 10.1046/j.1095-8649.2003.00084.x; Stoddard Philip Kraft, 1996, P356; Thompson RF, 2009, NEUROBIOL LEARN MEM, V92, P127, DOI 10.1016/j.nlm.2008.07.011; Thys B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08001-1; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; van Overveld T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054199; VANBALEN JH, 1967, ARDEA, V55, P1; Verbeek MEM, 1996, BEHAVIOUR, V133, P945, DOI 10.1163/156853996X00314; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344	47	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185410	10.1371/journal.pone.0185410	http://dx.doi.org/10.1371/journal.pone.0185410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020028	gold, Green Submitted, Green Published			2022-12-26	WOS:000412754400030
J	Guan, QJ; Liao, X; He, ML; Li, XF; Wang, ZY; Ma, HY; Yu, S; Liu, SK				Guan, Qingjie; Liao, Xu; He, Mingliang; Li, Xiufeng; Wang, Zhenyu; Ma, Haiyan; Yu, Song; Liu, Shenkui			Tolerance analysis of chloroplast OsCu/Zn-SOD overexpressing rice under NaCl and NaHCO3 stress	PLOS ONE			English	Article							COPPER/ZINC SUPEROXIDE-DISMUTASE; ENHANCED TOLERANCE; REACTIVE OXYGEN; SALT STRESS; EXPRESSION; PLANT; GENE; IDENTIFICATION; TRANSFORMATION; H2O2	The 636-bp-long cDNA sequence of OsCu/Zn-SOD (AK059841) was cloned from Oryza sativa var. Longjing 11 via reverse transcription polymerase chain reaction (RT-PCR). The encoded protein comprised of 211 amino acids is highly homologous to Cu/Zn-SOD proteins from tuscacera rice and millet. Quantitative RT-PCR revealed that in rice, the level of OsCu/ Zn-SOD gene expression was lowest in roots and was highest in petals and during the S5 leaf stage. Moreover, the expression level of OsCu/Zn-SOD gene expression decreased during the L5 leaf stage to maturity. The level of OsCu/Zn-SOD gene expression, however, was increased under saline-sodic stress and NaHCO3 stress. Germination tests under 125, 150, and 175 mM NaCl revealed that OsCu/Zn-SOD-overexpressing lines performed better than the non-transgenic (NT) Longjing11 lines in terms of germination rate and height. Subjecting seedlings to NaHCO3 and water stress revealed that OsCu/Zn-SOD-overexpressing lines performed better than NT in terms of SOD activity, fresh weight, root length, and height. Under simulated NaHCO3 stress, OsCu/Zn-SOD-overexpressing lines performed better than NT in terms of survival rate (25.19% > 6.67%) and yield traits (average grain weight 20.6 > 18.15 g). This study showed that OsCu/Zn-SOD gene overexpression increases the detoxification capacity of reactive oxygen species in O. sativa and reduces salt-induced oxidative damage. We also revealed the regulatory mechanism of OsCu/Zn-SOD enzyme in saline-sodic stress resistance in O. sativa. Moreover, we provided an experimental foundation for studying the mechanism of OsCu/Zn-SOD enzymes in the chloroplast.	[Guan, Qingjie; Liao, Xu; He, Mingliang; Ma, Haiyan; Yu, Song; Liu, Shenkui] Northeast Forestry Univ, ASNESC, Minist Educ, Key Lab Saline Alkali Vegetat Ecol Restorat SAVER, Harbin, Heilongjiang, Peoples R China; [Li, Xiufeng; Wang, Zhenyu] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Lab Soybean Mol Biol & Mol Breeding, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS	Liu, SK (corresponding author), Northeast Forestry Univ, ASNESC, Minist Educ, Key Lab Saline Alkali Vegetat Ecol Restorat SAVER, Harbin, Heilongjiang, Peoples R China.	shenkuiliu@nefu.edu.cn	Liu, Shenkui/AAC-5405-2019; ma, haiyan/GWQ-7425-2022	Liu, Shenkui/0000-0001-5294-4765; 	Fundamental Research Funds for the Central Universities [2572016EAJ6]; National Key Research and Development Program of China [2016YFC0501203]; Heilongjiang Postdoctoral Scientific Research Developmental Fund [LBH408 Q15004]; Program for Chang jiang Scholars and Innovative Research Team in University [IRT13053]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Key Research and Development Program of China; Heilongjiang Postdoctoral Scientific Research Developmental Fund; Program for Chang jiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Fundamental Research Funds for the Central Universities (Grant no. 2572016EAJ6); The National Key Research and Development Program of China (2016YFC0501203); The Heilongjiang Postdoctoral Scientific Research Developmental Fund (LBH408 Q15004) and the Program for Chang jiang Scholars and Innovative Research Team in University (IRT13053).	Alinsug MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030846; ALLEN RD, 1995, PLANT PHYSIOL, V107, P1049, DOI 10.1104/pp.107.4.1049; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Badawi GH, 2004, PLANT SCI, V166, P919, DOI 10.1016/j.plantsci.2003.12.007; Bubliy O. A., 2005, CORRELATED RESPONSES; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Ding YR, 2012, BIOPOLYMERS, V97, P864, DOI 10.1002/bip.22093; Filiz E, 2015, TURK J BIOL, V39, P49, DOI 10.3906/biy-1403-9; Foyer CH, 2003, PHYSIOL PLANTARUM, V119, P355, DOI 10.1034/j.1399-3054.2003.00223.x; Gopavajhula VR, 2013, GENET MOL BIOL, V36, P225, DOI [10.1590/S1415-47572013005000023, 10.1590/s1415-47572013005000023]; Hasanuzzaman M., 2014, BIOMED RES INT; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hussain S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-10; Izawa T, 1996, TRENDS PLANT SCI, V1, P95, DOI 10.1016/S1360-1385(96)80041-0; Jing XS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00023; Lee SH, 2007, J PLANT PHYSIOL, V164, P1626, DOI 10.1016/j.jplph.2007.01.003; Lv BS, 2013, AGRON J, V105, P1889, DOI 10.2134/agronj2013.0017er; Martin CS, 1996, J STUD ALCOHOL, V57, P549, DOI 10.15288/jsa.1996.57.549; McKersie BD, 2000, PLANT PHYSIOL, V122, P1427, DOI 10.1104/pp.122.4.1427; Melchiorre M, 2009, PLANT GROWTH REGUL, V57, P57, DOI 10.1007/s10725-008-9322-3; Merlino A, 2010, J STRUCT BIOL, V172, P343, DOI 10.1016/j.jsb.2010.08.008; Nath K, 2014, GENES GENOM, V36, P45, DOI 10.1007/s13258-013-0138-9; Ohtsubo K, 2007, J AGR FOOD CHEM, V55, P1501, DOI 10.1021/jf062737z; [Pan Xiaoyun 潘晓云], 2002, [生态学报, Acta Ecologica Sinica], V22, P1902; Pedersen HL, 2009, ACTA CRYSTALLOGR F, V65, P84, DOI 10.1107/S1744309109001110; Prashanth SR, 2008, TRANSGENIC RES, V17, P281, DOI 10.1007/s11248-007-9099-6; Rubio MC, 2002, PHYSIOL PLANTARUM, V115, P531, DOI 10.1034/j.1399-3054.2002.1150407.x; Sambrook J., 2002, MOL CLONING LAB MANU, P461; Sambrook J, 1989, MOL CLONING LAB MANU, P1566; Sheng L Q., 2006, SCI TECHNOLOGY W CHI, P14; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Tseng MJ, 2007, PLANT PHYSIOL BIOCH, V45, P822, DOI 10.1016/j.plaphy.2007.07.011; Upadhyaya NM, 2000, AUST J PLANT PHYSIOL, V27, P201; [王慧中 Wang Huizhong], 2002, [科技通报, Bulletin of Science and Technology], V18, P441; Wang YH, 2004, PLANT SCI, V167, P671, DOI 10.1016/j.plantsci.2004.03.032; Wang YC, 2010, MOL BIOL REP, V37, P1119, DOI 10.1007/s11033-009-9884-9; WISE RR, 1987, PLANT PHYSIOL, V83, P278, DOI 10.1104/pp.83.2.278; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Wu JH, 2016, PLANT GROWTH REGUL, V79, P55, DOI 10.1007/s10725-015-0110-6; Yang JH, 2013, GENE, V518, P388, DOI 10.1016/j.gene.2012.12.101; Yang Y, 2012, BIORESOURCE TECHNOL, V116, P190, DOI 10.1016/j.biortech.2012.03.126; Zhang HaiNa, 2008, Acta Agronomica Sinica, V34, P1403, DOI 10.3724/SP.J.1006.2008.01403; Zhang YM, 2009, PLANT CELL ENVIRON, V32, P509, DOI 10.1111/j.1365-3040.2009.01945.x; Zhao KF, 2002, B BIOL FR BELG, V37, P7; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	46	43	51	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186052	10.1371/journal.pone.0186052	http://dx.doi.org/10.1371/journal.pone.0186052			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020034	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400061
J	Matson, JS; Livny, J; DiRita, VJ				Matson, Jyl S.; Livny, Jonathan; DiRita, Victor J.			A putative Vibrio cholerae two-component system controls a conserved periplasmic protein in response to the antimicrobial peptide polymyxin B	PLOS ONE			English	Article							BIOFILM FORMATION; RESISTANCE; VIRULENCE; IDENTIFICATION; EXPRESSION; REGULATOR; VECTORS; GENE	The epidemic pathogen Vibrio cholerae senses and responds to different external stresses it encounters in the aquatic environment and in the human host. One stress that V. cholerae encounters in the host is exposure to antimicrobial peptides on mucosal surfaces. We used massively parallel cDNA sequencing (RNA-Seq) to quantitatively identify the transcriptome of V. cholerae grown in the presence and absence of sub-lethal concentrations of the antimicrobial peptide polymyxin B. We evaluated the transcriptome of both wild type V. cholerae and a mutant carrying a deletion of vc1639, a putative sensor kinase of an uncharacterized two-component system, under these conditions. In addition to many previously uncharacterized pathways responding with elevated transcript levels to polymyxin B exposure, we confirmed the predicted elevated transcript levels of a previously described LPS modification system in response to polymyxin B exposure. Additionally, we identified the V. cholerae homologue of visP (ygiW) as a regulatory target of VC1639. VisP is a conserved periplasmic protein implicated in lipid A modification in Salmonellae. This study provides the first systematic analysis of the transcriptional response of Vibrio cholerae to polymyxin B, raising important questions for further study regarding mechanisms used by V. cholerae to sense and respond to envelope stress.	[Matson, Jyl S.] Univ Toledo, Sch Med, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA; [Livny, Jonathan] Broad Inst MIT & Harvard, Infect Dis & Microbiome Program, Cambridge, MA USA; [DiRita, Victor J.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	University System of Ohio; University of Toledo; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Michigan State University	Matson, JS (corresponding author), Univ Toledo, Sch Med, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	Jyl.Matson@utoledo.edu			NIAID [R01 AI045125]; University of Toledo Startup funds	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Toledo Startup funds	This work was supported in part by NIAID R01 AI045125 (VJD) and University of Toledo Startup funds (JSM).	Acosta N, 2015, J BACTERIOL, V197, P262, DOI 10.1128/JB.01957-14; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bilecen K, 2015, INFECT IMMUN, V83, P1199, DOI 10.1128/IAI.02700-14; Bilecen K, 2009, ENVIRON MICROBIOL, V11, P2015, DOI 10.1111/j.1462-2920.2009.01923.x; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Chattejee SN, 2003, BBA-MOL BASIS DIS, V1639, P65, DOI 10.1016/j.bbadis.2003.08.004; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Ginalski K, 2004, FEBS LETT, V567, P297, DOI 10.1016/j.febslet.2004.04.086; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hankins JV, 2012, P NATL ACAD SCI USA, V109, P8722, DOI 10.1073/pnas.1201313109; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Herrera CM, 2014, MBIO, V5, DOI 10.1128/mBio.02283-14; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINN T, 1990, J BACTERIOL, V172, P1077, DOI 10.1128/jb.172.2.1077-1084.1990; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; Matson JS, 2010, J BACTERIOL, V192, P2044, DOI 10.1128/JB.00023-10; Merighi M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-42; Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Moreira CG, 2013, P NATL ACAD SCI USA, V110, P1470, DOI 10.1073/pnas.1215416110; Padilla E, 2010, ANTIMICROB AGENTS CH, V54, P177, DOI 10.1128/AAC.00715-09; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilonieta MC, 2009, J BACTERIOL, V191, P7243, DOI 10.1128/JB.00688-09; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Srinivasan VB, 2013, ANTIMICROB AGENTS CH, V57, P4449, DOI 10.1128/AAC.02284-12; Taveirne ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073586; 1995, 2 COMPONENT SIGNAL T	34	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186199	10.1371/journal.pone.0186199	http://dx.doi.org/10.1371/journal.pone.0186199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020117	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400080
J	Royal, AA; Tinker, A; Harmer, SC				Royal, Alice A.; Tinker, Andrew; Harmer, Stephen C.			Phosphatidylinositol-4,5-bisphosphate is required for KCNQ1/KCNE1 channel function but not anterograde trafficking	PLOS ONE			English	Article							LONG-QT SYNDROME; GATED POTASSIUM CHANNELS; I-KS; INWARD RECTIFIER; PHOSPHOINOSITIDE 3-KINASE; K+ CURRENT; PIP2; HERG; 4,5-BISPHOSPHATE; SENSITIVITY	The slow delayed-rectifier potassium current (I-Ks) is crucial for human cardiac action potential repolarization. The formation of I-Ks requires co-assembly of the KCNQ1 a-subunit and KCNE1 beta-subunit, and mutations in either of these subunits can lead to hereditary long QT syndrome types 1 and 5, respectively. It is widely recognised that the KCNQ1/KCNE1 (Q1/E1) channel requires phosphatidylinositol-4,5-bisphosphate (PIP2) binding for function. We previously identified a cluster of basic residues in the proximal C-terminus of KCNQ1 that form a PIP2/phosphoinositide binding site. Upon charge neutralisation of these residues we found that the channel became more retained in the endoplasmic reticulum, which raised the possibility that channel-phosphoinositide interactions could play a role in channel trafficking. To explore this further we used a chemically induced dimerization (CID) system to selectively deplete PIP2 and/or phosphatidylinositol-4-phosphate (PI(4)P) at the plasma membrane (PM) or Golgi, and we subsequently monitored the effects on both channel trafficking and function. The depletion of PIP2 and/or PI(4)P at either the PM or Golgi did not alter channel cell-surface expression levels. However, channel function was extremely sensitive to the depletion of PIP2 at the PM, which is in contrast to the response of other cardiac potassium channels tested (Kir2.1 and Kv11.1). Surprisingly, when using the CID system IKs was dramatically reduced even before dimerization was induced, highlighting limitations regarding the utility of this system when studying processes highly sensitive to PIP2 depletion. In conclusion, we identify that the Q1/E1 channel does not require PIP2 or PI(4) P for anterograde trafficking, but is heavily reliant on PIP2 for channel function once at the PM.	[Royal, Alice A.; Tinker, Andrew; Harmer, Stephen C.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, Heart Ctr, London, England	University of London; Queen Mary University London	Tinker, A (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, Heart Ctr, London, England.	a.tinker@qmul.ac.uk	Harmer, Stephen/D-5512-2015	Harmer, Stephen/0000-0003-3909-6698	British Heart Foundation (BHF); BHF grant [FS/12/21/29482, RG/15/15/31742]; BHF Intermediate Basic Science Research Fellowship [FS/12/59/29756]; British Heart Foundation [FS/12/59/29756, FS/12/21/29482, FS/16/30/32162, RG/15/15/31742] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); BHF grant; BHF Intermediate Basic Science Research Fellowship; British Heart Foundation(British Heart Foundation)	This work was funded by the British Heart Foundation (BHF). BHF grant numbers: [FS/12/21/29482 and RG/15/15/31742]. S.C.H is supported by a BHF Intermediate Basic Science Research Fellowship [FS/12/59/29756]. The work was facilitated by The National Institute for Health Research Barts Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai T, 2002, CIRCULATION, V105, P2592, DOI 10.1161/01.CIR.0000019906.35135.A3; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bian JS, 2004, AM J PHYSIOL-HEART C, V287, pH2154, DOI 10.1152/ajpheart.00120.2004; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown DA, 2007, J PHYSIOL-LONDON, V582, P917, DOI 10.1113/jphysiol.2007.132498; Dahimene S, 2006, CIRC RES, V99, P1076, DOI 10.1161/01.RES.0000250262.12219.95; DeRose R, 2013, PFLUG ARCH EUR J PHY, V465, P409, DOI 10.1007/s00424-012-1208-6; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dickson EJ, 2014, P NATL ACAD SCI USA, V111, pE2281, DOI 10.1073/pnas.1407133111; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Fegan A, 2010, CHEM REV, V110, P3315, DOI 10.1021/cr8002888; Giblin JP, 1999, J BIOL CHEM, V274, P22652, DOI 10.1074/jbc.274.32.22652; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Harmer SC, 2016, BIOL CHEM, V397, P679, DOI 10.1515/hsz-2015-0306; Harmer SC, 2014, BIOCHEM J, V462, P133, DOI 10.1042/BJ20140425; Harmer SC, 2012, BIOCHEM J, V443, P635, DOI 10.1042/BJ20111912; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Huang LQ, 2001, CARDIOVASC RES, V51, P670, DOI 10.1016/S0008-6363(01)00350-9; Idevall-Hagren O, 2015, BBA-MOL CELL BIOL L, V1851, P736, DOI 10.1016/j.bbalip.2014.12.008; Kruse M, 2013, CHANNELS, V7, P530, DOI 10.4161/chan.25816; Kruse M, 2012, J GEN PHYSIOL, V140, P189, DOI 10.1085/jgp.201210806; Kubo T, 2015, J PHARMACOL SCI, V127, P127, DOI 10.1016/j.jphs.2014.11.013; Li Y, 2011, P NATL ACAD SCI USA, V108, P9095, DOI 10.1073/pnas.1100872108; Liang J, 1999, ACTA CRYSTALLOGR D, V55, P736, DOI 10.1107/S0907444998014747; Liu YS, 2005, CHEM BIOL, V12, P99, DOI 10.1016/j.chembiol.2004.11.009; Loussouarn G, 2003, EMBO J, V22, P5412, DOI 10.1093/emboj/cdg526; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Matavel A, 2009, J MOL CELL CARDIOL, V46, P704, DOI 10.1016/j.yjmcc.2009.02.006; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; Quinn KV, 2008, J PHYSIOL-LONDON, V586, P2855, DOI 10.1113/jphysiol.2008.153791; Quinn KV, 2003, CIRC RES, V93, P646, DOI 10.1161/01.RES.0000095247.81449.8E; Rjasanow A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00127; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Schwartz PJ, 2001, CIRCULATION, V103, P89; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Sun J, 2017, CELL, V169, P1042, DOI 10.1016/j.cell.2017.05.019; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Takida S, 2004, FEBS LETT, V567, P209, DOI 10.1016/j.febslet.2004.04.062; Telezhkin V, 2013, PFLUG ARCH EUR J PHY, V465, P945, DOI 10.1007/s00424-012-1199-3; Telezhkin V, 2012, J BIOL CHEM, V287, P10001, DOI 10.1074/jbc.M111.322552; Terrenoire C, 2005, CIRC RES, V96, pE25, DOI 10.1161/01.RES.0000160555.58046.9a; Thomas AM, 2011, J BIOL CHEM, V286, P2088, DOI 10.1074/jbc.M110.153551; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Volders PGA, 2003, CIRCULATION, V107, P2753, DOI 10.1161/01.CIR.0000068344.54010.B3; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069; Wilson AJ, 2005, CARDIOVASC RES, V67, P476, DOI 10.1016/j.cardiores.2005.04.036; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Zaritsky JJ, 2001, J PHYSIOL-LONDON, V533, P697, DOI 10.1111/j.1469-7793.2001.t01-1-00697.x; Zaydman MA, 2013, P NATL ACAD SCI USA, V110, P13180, DOI 10.1073/pnas.1305167110; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P11384, DOI 10.1073/pnas.1202194109	61	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186293	10.1371/journal.pone.0186293	http://dx.doi.org/10.1371/journal.pone.0186293			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020060	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400089
J	Agusti, A; Compte, A; Fener, R; Garcia-Aymerich, J; Noell, G; Cosio, BG; Rodriguez-Roisin, R; Cell, B; Anto, JM				Agusti, Alvar; Compte, Albert; Fener, Rosa; Garcia-Aymerich, Judith; Noell, Guillaume; Cosio, Borja G.; Rodriguez-Roisin, Robert; Cell, Bartolome; Maria Anto, Josep			The EASI model: A first integrative computational approximation to the natural history of COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION DECLINE; AIR-FLOW OBSTRUCTION; MEDICINE; SPIROMETRY; MANAGEMENT; PERCEPTION; MECHANISMS; SYMPTOMS; DYSPNEA	The natural history of chronic obstructive pulmonary disease (COPD) is still not well understood. Traditionally believed to be a self-inflicted disease by smoking, now we know that not all smokers develop COPD, that other inhaled pollutants different from cigarette smoke can also cause it, and that abnormal lung development can also lead to COPD in adulthood. Likewise, the inflammatory response that characterizes COPD varies significantly between patients, and not all of them perceive symptoms (mostly breathlessness) similarly. To investigate the variability and determinants of different "individual natural histories" of COPD, we developed a theoretical, multi-stage, computational model of COPD (EASI) that integrates dynamically and represents graphically the relationships between exposure (E) to inhaled particles and gases (smoking), the biological activity (inflammatory response) of the disease (A), the severity (S) of airflow limitation (FEV1) and the impact (I) of the disease (breathlessness) in different clinical scenarios. EASI shows that the relationships between E, A, S and I vary markedly within individuals (through life) and between individuals (at the same age). It also helps to delineate some potentially relevant, but often overlooked concepts, such as disease progression, susceptibility to COPD and issues related to symptom perception. In conclusion, EASI is an initial conceptual model to interpret the longitudinal and cross-sectional relationships between E, A, S and I in different clinical scenarios. Currently, it does not have any direct clinical application, thus it requires experimental validation and further mathematical development. However, it has the potential to open novel research and teaching alternatives.	[Agusti, Alvar; Rodriguez-Roisin, Robert] Univ Barcelona, Resp Inst, Hosp Clin, Barcelona, Spain; [Agusti, Alvar; Compte, Albert; Fener, Rosa; Noell, Guillaume; Rodriguez-Roisin, Robert] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain; [Agusti, Alvar; Fener, Rosa; Noell, Guillaume; Cosio, Borja G.; Rodriguez-Roisin, Robert] CIBER Enfermedades Respiratorias CIBERES, Barcelona, Spain; [Garcia-Aymerich, Judith; Maria Anto, Josep] ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Garcia-Aymerich, Judith; Maria Anto, Josep] Hosp Mar, IMIM, Med Res Inst, Barcelona, Spain; [Garcia-Aymerich, Judith; Maria Anto, Josep] Univ Pompeu Fabra, Barcelona, Spain; [Garcia-Aymerich, Judith; Maria Anto, Josep] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Cosio, Borja G.] Hosp Univ Son Espases IdISBa, Palma De Mallorca, Spain; [Cell, Bartolome] Harvard Med Sch, Boston, MA USA	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; ISGlobal; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Harvard University; Harvard Medical School	Agusti, A (corresponding author), Univ Barcelona, Resp Inst, Hosp Clin, Barcelona, Spain.; Agusti, A (corresponding author), Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain.; Agusti, A (corresponding author), CIBER Enfermedades Respiratorias CIBERES, Barcelona, Spain.	AAGUSTI@clinic.cat	J, Garcia-Aymerich/G-6867-2014; G.Cosio, Borja/P-4963-2017; Anto, J M/H-2676-2014; Agusti Garcia-Navarro, Alvar/F-4474-2015; Compte, Albert/A-2491-2009	J, Garcia-Aymerich/0000-0002-7097-4586; G.Cosio, Borja/0000-0002-6388-8209; Anto, J M/0000-0002-4736-8529; Faner, Rosa/0000-0002-8159-0115; Agusti Garcia-Navarro, Alvar/0000-0003-3271-3788; Compte, Albert/0000-0001-6594-6946	Institute de Salud Carlos III FEDER [PI15/00799, CP16/00039]; SEPAR [PI065/2013]; IDIBAPS Cellex; IDIBAPS-Cellex; Institute de Salud Carlos III FEDER (COPD research program of CIBERES)	Institute de Salud Carlos III FEDER; SEPAR; IDIBAPS Cellex; IDIBAPS-Cellex; Institute de Salud Carlos III FEDER (COPD research program of CIBERES)	This work was supported, in part, by Institute de Salud Carlos III FEDER (PI15/00799 to AA, CP16/00039 and the COPD research program of CIBERES), SEPAR (PI065/2013) and IDIBAPS Cellex.; Supported, in part, by Instituto de Salud Carlos III FEDER (PI15/00799, CP16/00039 and the COPD research program of CIBERES), SEPAR (PI065/2013) and IDIBAPS-Cellex. None of the authors has any conflict of interest with the content of this article.	Agusti A, 2011, EUR RESPIR J, V38, P749, DOI 10.1183/09031936.00062211; Agusti A, 2014, THORAX, V69, P857, DOI 10.1136/thoraxjnl-2014-205507; Agusti A, 2011, AM J RESP CRIT CARE, V183, P1129, DOI 10.1164/rccm.201009-1414PP; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Barreiro E, 2004, EUR RESPIR J, V24, P219, DOI 10.1183/09031936.04.00074703; Bush A, 2016, ANN AM THORAC SOC, V13, pS438, DOI 10.1513/AnnalsATS.201602-112AW; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Diez D, 2014, AM J RESP CRIT CARE, V190, P981, DOI 10.1164/rccm.201403-0421PP; Dransfield MT, 2016, AM J RESP CRITICAL C; Dratva J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145127; Ferrer M, 1997, ANN INTERN MED, V127, P1072, DOI 10.7326/0003-4819-127-12-199712150-00003; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Garcia-Aymerich J, 2007, AM J RESP CRIT CARE, V175, P458, DOI 10.1164/rccm.200607-896OC; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Jameson JL, 2015, NEW ENGL J MED, V372, P2229, DOI 10.1056/NEJMsb1503104; Jones PW, 2006, EUR RESPIR J, V27, P822, DOI 10.1183/09031936.06.00145104; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Laforest L, 2009, ANN ALLERG ASTHMA IM, V102, P378, DOI 10.1016/S1081-1206(10)60508-X; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Martinez FD, 2016, NEW ENGL J MED, V375, P871, DOI 10.1056/NEJMra1603287; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Rodriguez-Roisin R, 2017, AM J RESP CRIT CARE, V195, P17, DOI 10.1164/rccm.201607-1376PP; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Scioscia G, 2017, THORAX, V72, P117, DOI 10.1136/thoraxjnl-2016-208332; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vestbo J, 2010, AM J RESP CRIT CARE, V182, P863, DOI 10.1164/rccm.201004-0602ED; Vogelmeier C, 2017, GLOBAL STRATEGY DIAG; Woodruff PG, 2016, NEW ENGL J MED, V374, P1811, DOI 10.1056/NEJMoa1505971; Woodruff PG, 2015, LANCET, V385, P1789, DOI 10.1016/S0140-6736(15)60693-6; Zafari Z, 2016, CAN MED ASSOC J, V188, P1004, DOI 10.1503/cmaj.151483	34	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185502	10.1371/journal.pone.0185502	http://dx.doi.org/10.1371/journal.pone.0185502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016620	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400021
J	Cepeda, RE; Pardo, RV; Macaya, CC; Sarrazin, AF				Cepeda, Rodrigo E.; Pardo, Renato V.; Macaya, Constanza C.; Sarrazin, Andres F.			Contribution of cell proliferation to axial elongation in the red flour beetle Tribolium castaneumlee	PLOS ONE			English	Article							SEGMENTATION CLOCK; VERTEBRATE SEGMENTATION; ANCESTRAL ROLE; GROWTH ZONE; DROSOPHILA; DYNAMICS; GENES; EMBRYOGENESIS; EXPRESSION; GERMBAND	Most arthropods generate their posterior bodies by adding segments periodically, as the embryo grows, from a posteriorly located region called the segment addition zone. This mode of segmentation is shared with vertebrates and relies on oscillatory mechanisms, where the temporal periodicity of a clock is translated into repetitive spatial patterns. This ordered anterior-to-posterior pattern is achieved at the same time as the tissue elongates, opening the question of the functional coordination between the mechanisms of segmental patterning and posterior growth. The study of these processes in different arthropods has played an important role in unravelling some of the molecular mechanisms of segment formation. However, the behavior of cells during elongation and how cellular processes affect this segmental patterning has been poorly studied. Cell proliferation together with cell rearrangements are presumed to be the major forces driving axis elongation in the red flour beetle Tribolium castaneum. However, there still no strong evidence about the role and distribution of cell proliferation within the embryo. In this study, we propose to address these questions by using whole embryo cultures and pharmacological manipulation. We show that considerable cell proliferation occurs during germband elongation, measured by incorporation of the nucleoside analog of thymidine 5-Ethynyl-2'-deoxyuridine, EdU. Moreover, proliferating cells appeared to be spread along the elongating embryo with a posterior bias at early segmentation. In addition, when we blocked cell division, treated germbands were always shorter than controls and in some cases not able to fully elongate, even when control embryos already started to retract and leg buds are evident. Finally, we found that the absence of cell proliferation has no apparent effect on segmental patterning, as evidenced by Tc-engrailed (Tc-en) gene expression.	[Cepeda, Rodrigo E.; Pardo, Renato V.; Macaya, Constanza C.; Sarrazin, Andres F.] Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso	Sarrazin, AF (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile.	andres.sarrazin@pucv.cl		Sarrazin, Andres/0000-0002-4307-1744; Macaya Ramos, Constanza/0000-0003-3075-0948	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1130824]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by a Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1130824) grant to AFS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auman T, 2017, DEVELOPMENT, V144, P1896, DOI 10.1242/dev.142091; Beermann A, 2011, DEVELOPMENT, V138, P2793, DOI 10.1242/dev.063644; Benazeraf B, 2013, ANNU REV CELL DEV BI, V29; Benton MA, 2016, CURR BIOL, V26, P1609, DOI 10.1016/j.cub.2016.04.055; Benton Matthew A, 2014, Bioarchitecture, V4, P16, DOI 10.4161/bioa.27815; Benton MA, 2013, DEVELOPMENT, V140, P3210, DOI 10.1242/dev.096271; Bolognesi R, 2008, CURR BIOL, V18, P1624, DOI 10.1016/j.cub.2008.09.057; Bolognesi R, 2009, DEV GENES EVOL, V219, P369, DOI 10.1007/s00427-009-0299-3; Bonner J, 2008, DEV BIOL, V313, P398, DOI 10.1016/j.ydbio.2007.10.041; Brena C, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-112; Brown S. J., 2009, COLD SPRING HARB PRO; BROWN SJ, 1994, DEV GENET, V15, P7, DOI 10.1002/dvg.1020150103; Brusca R. C., 2016, INVERTEBRATES; Chipman AD, 2010, BIOESSAYS, V32, P60, DOI 10.1002/bies.200900130; Copf T, 2004, P NATL ACAD SCI USA, V101, P17711, DOI 10.1073/pnas.0407327102; da Silva SM, 2007, DEVELOPMENT, V134, P3049, DOI 10.1242/dev.004911; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; El-Sherif E, 2012, DEVELOPMENT, V139, P4341, DOI 10.1242/dev.085126; Fasulo B, 2012, MOL BIOL CELL, V23, P1047, DOI 10.1091/mbc.E11-10-0832; Gilles AF, 2015, DEVELOPMENT, V142, P2832, DOI 10.1242/dev.125054; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Macaya CC, 2016, DEV GENES EVOL, V226, P53, DOI 10.1007/s00427-015-0524-1; Nakamoto A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7635; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Oberhofer G, 2014, DEVELOPMENT, V141, P4740, DOI 10.1242/dev.112797; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pare AC, 2014, NATURE, V515, P523, DOI 10.1038/nature13953; Peel AD, 2005, NAT REV GENET, V6, P905, DOI 10.1038/nrg1724; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sarrazin AF, 2012, SCIENCE, V336, P338, DOI 10.1126/science.1218256; Schmidt-Ott U, 2016, CURR OPIN GENET DEV, V39, P116, DOI 10.1016/j.gde.2016.06.004; Schulz C, 1998, DEV GENES EVOL, V208, P283, DOI 10.1007/s004270050183; Stelzer E. H. K., 2014, DEVELOPMENT, P1; SUGINO A, 1980, P NATL ACAD SCI-BIOL, V77, P7049, DOI 10.1073/pnas.77.12.7049; Williams TA, 2017, ARTHROPOD STRUCT DEV, V46, P380, DOI 10.1016/j.asd.2016.10.003; Zhang LX, 2008, DEVELOPMENT, V135, P2065, DOI 10.1242/dev.022673	37	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186159	10.1371/journal.pone.0186159	http://dx.doi.org/10.1371/journal.pone.0186159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016664	Green Published, gold, Green Submitted			2022-12-26	WOS:000412601800042
J	Eriksson, M; Keeling, LJ; Rehn, T				Eriksson, Matilda; Keeling, Linda J.; Rehn, Therese			Cats and owners interact more with each other after a longer duration of separation	PLOS ONE			English	Article							EPISODIC-LIKE MEMORY; PERSONALITY-CHARACTERISTICS; DOMESTIC CATS; BEHAVIOR; ATTACHMENT; GREETINGS; PATTERNS; ANXIETY; PEOPLE; TAIL	Little is known about the cat's (Felis silvestris catus) need for human contact, although it is generally believed that cats are more independent pets than e. g. dogs. In this study, we investigated the effect of time left alone at home on cat behaviour (e. g. social and distressrelated) before, during and after separation from their owner. Fourteen privately owned cats (single-housed) were each subjected to two treatments: the cat was left alone in their home environment for 30 min (T-0.5) and for 4 h (T-4). There were no differences between treatments in the behaviour of the cat (or owner) before owner departure, nor during the first 5 min of separation. During separation, cats were lying down resting proportionally less (T = 22.5, P = 0.02) in T-0.5 (0.27 +/- 0.1 (mean +/- SE)) compared to in T-4 (0.58 +/- 0.08), probably due to a similar duration of higher activity early in the separation phase in both treatments. Comparisons of the time interval (min 20 +/- 25) in both treatments indicated no differences across treatments, which supports such an explanation. Towards the end of the separation phase (the last two 5-min intervals of separation in both treatments), no differences were observed in the cats' behaviour, indicating that cats were unaffected by separation length. At reunion however, cats purred more (T = 10.5, P = 0.03) and stretched their body more (T = 17, P = 0.04) after a longer duration of separation (T4: 0.05 +/- 0.02; 0.03 +/- 0.01; T-0.5: 0.01 +/- 0.007; 0.008 +/- 0.003). Also, owners initiated more verbal contact (T = 33.5, P = 0.04) after 4 h (0.18 +/- 0.05) compared to after 30 min (0.12 +/- 0.03). There was no evidence of any correlations between the level of purring or body stretching by the cat and verbal contact by the owner implying that the behavioural expressions seen in the cats are independent of the owner's behaviour. Hence, it seemed as cats coped well with being left alone, but they were affected by the time they were left alone, since they expressed differences in behaviour when the owner returned home. The increased level of social contact initiated by the cats after a longer duration of separation indicates a rebound of contact-seeking behaviour, implying that the owner is an important part of the cat's social environment.	[Eriksson, Matilda; Keeling, Linda J.; Rehn, Therese] Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Uppsala, Sweden	Swedish University of Agricultural Sciences	Rehn, T (corresponding author), Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Uppsala, Sweden.	Therese.Rehn@slu.se	Keeling, Linda J/K-6542-2012; Rehn, Therese/C-5980-2014	Keeling, Linda J/0000-0003-2629-0117; Rehn, Therese/0000-0002-5687-1521	Swedish Research Council Formas [221-2013-329]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	The study was funded by the Swedish Research Council Formas (http://www.formas.se/en/), grant number: 221-2013-329 to LJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORT.MD, 1970, CHILD DEV, V41, P49, DOI 10.2307/1127388; Aureli F., 2000, NATURAL CONFLICT RES, P409; Bernstein PL, 2005, ANIMAL WEL, V3, P47; Bradshaw J., 2000, DOMESTIC CAT BIOL IT, P67; Bradshaw JWS, 2016, J VET BEHAV, V11, P113, DOI 10.1016/j.jveb.2015.09.004; BROWN KA, 1978, DEV PSYCHOBIOL, V11, P559, DOI 10.1002/dev.420110605; Brown S. L., 2014, DOMESTIC CAT BIOL IT; Cafazzo S, 2009, BEHAV PROCESS, V80, P60, DOI 10.1016/j.beproc.2008.09.008; Clayton NS, 2001, PHILOS T R SOC B, V356, P1483, DOI 10.1098/rstb.2001.0947; Curtis TM, 2003, AM J VET RES, V64, P1151, DOI 10.2460/ajvr.2003.64.1151; EAST ML, 1993, BEHAV ECOL SOCIOBIOL, V33, P355; Edwards C, 2007, J VET BEHAV, V2, P119, DOI 10.1016/j.jveb.2007.06.004; Finka LR, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-73; Fugazza C, 2016, CURR BIOL, V26, P3209, DOI 10.1016/j.cub.2016.09.057; Gosling SD, 2010, ANTHROZOOS, V23, P213, DOI 10.2752/175303710X12750451258850; HINDE RA, 1972, J CHILD PSYCHOL PSYC, V13, P227, DOI 10.1111/j.1469-7610.1972.tb01149.x; Horn JA, 2011, J WILDLIFE MANAGE, V75, P1177, DOI 10.1002/jwmg.145; Houpt KA, 2007, APPL ANIM BEHAV SCI, V106, P221, DOI 10.1016/j.applanim.2007.01.005; Kerby G., 1988, P67; KIDD AH, 1980, PSYCHOL REP, V46, P939, DOI 10.2466/pr0.1980.46.3.939; KILEYWORTHINGTON M, 1976, BEHAVIOUR, V56, P69, DOI 10.1163/156853976X00307; Kis A, 2012, INTERACT STUD, V13, P373, DOI 10.1075/is.13.3.03kis; KUMMER H, 1978, SOC SCI INFORM, V17, P687, DOI 10.1177/053901847801700418; Mangold, 2010, INTERACT QUICK START; MARTINEZ RL, 1980, PSYCHOL REP, V47, P318, DOI 10.2466/pr0.1980.47.1.318; McComb K, 2009, CURR BIOL, V19, pR507, DOI 10.1016/j.cub.2009.05.033; MCCRAVE EA, 1991, VET CLIN N AM-SMALL, V21, P247, DOI 10.1016/S0195-5616(91)50030-9; MCCUNE S, 1995, APPL ANIM BEHAV SCI, V45, P109, DOI 10.1016/0168-1591(95)00603-P; Merola I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150040; Mertens C., 1991, Anthrozoos, V4, P214, DOI 10.2752/089279391787057062; Mertens C., 1989, Anthrozoos, V2, P83, DOI 10.2752/089279389787058109; Moelk M, 1944, AM J PSYCHOL, V57, P184, DOI 10.2307/1416947; Potter A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135109; Reevy GM, 2015, J APPL ANIM WELF SCI, V18, P239, DOI 10.1080/10888705.2014.988333; Rehn T, 2016, APPL ANIM BEHAV SCI, V183, P1, DOI 10.1016/j.applanim.2016.07.003; Rehn T, 2014, PHYSIOL BEHAV, V124, P45, DOI 10.1016/j.physbeh.2013.10.009; Rehn T, 2011, APPL ANIM BEHAV SCI, V129, P129, DOI 10.1016/j.applanim.2010.11.015; Schaller G. B., 1972, SERENGETI LION; Schwartz S, 2002, J AM VET MED ASSOC, V220, P1028, DOI 10.2460/javma.2002.220.1028; Shreve KRV, 2017, BEHAV PROCESS, V141, P322, DOI 10.1016/j.beproc.2017.03.016; Smith JE, 2011, ANIM BEHAV, V81, P401, DOI 10.1016/j.anbehav.2010.11.007; TURNER DC, 1986, ANIM BEHAV, V34, P1890, DOI 10.1016/S0003-3472(86)80275-5; TURNER DC, 1991, SCHWEIZ ARCH TIERH, V133, P63; Turner DC, 2014, DOMESTIC CAT: THE BIOLOGY OF ITS BEHAVIOUR, 3RD EDITION, P63; van den Bos R, 1998, J ETHOL, V16, P1, DOI 10.1007/BF02896348; Wedl M, 2011, BEHAV PROCESS, V86, P58, DOI 10.1016/j.beproc.2010.09.001; Wells DL, 2000, APPL ANIM BEHAV SCI, V69, P55, DOI 10.1016/S0168-1591(00)00118-0	47	17	17	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185599	10.1371/journal.pone.0185599	http://dx.doi.org/10.1371/journal.pone.0185599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KG	29045424	Green Submitted, Green Published, gold			2022-12-26	WOS:000413168100020
J	Jager, MD; Michaela, S; Beneke, J; Muller, JA; Schrem, H; Kaltenborn, A; Ramackers, W; Ringe, BP; Gwiasda, J; Trankenschuh, W; Klempnauer, J; Scheumann, GFW				Jaeger, Mark D.; Serttas, Michaela; Beneke, Jan; Muller, Joerg A.; Schrem, Harald; Kaltenborn, Alexander; Ramackers, Wolf; Ringe, Bastian P.; Gwiasda, Jill; Traenkenschuh, Wolfgang; Klempnauer, Juergen; Scheumann, Georg F. W.			Risk-factors for nodular hyperplasia of parathyroid glands in sHPT patients	PLOS ONE			English	Article							SECONDARY HYPERPARATHYROIDISM; HEMODIALYSIS-PATIENTS; ETHANOL INJECTION; ULTRASOUND; ULTRASONOGRAPHY; HISTOPATHOLOGY; MANAGEMENT; PATTERNS; THERAPY; VOLUME	Introduction Nodular hyperplasia of parathyroid glands (PG) is the most probable cause of medical treatment failure in secondary hyperparathyroidism (sHPT). This prospective cohort study is located at the interface of medical and surgical consideration of sHPT treatment options and identifies risk-factors for nodular hyperplasia of PG. Material and methods One-hundred-eight resected PG of 27 patients with a broad spectrum of sHPT severity were classified according to the degree of hyperplasia by histopathology. Twenty routinely gathered parameters from medical history, ultrasound findings of PG and laboratory results were analyzed for their influence on nodular hyperplasia of PG by risk-adjusted multivariable binary regression. A prognostic model for non-invasive assessment of PG was developed and used to weight the individual impact of identified risk-factors on the probability of nodular hyperplasia of single PG. Results Independent risk-factors for nodular hyperplasia of single PG were duration of dialysis in years, PG volume in mm 3 determined by ultrasound and serum level of parathyroid hormone in pg/mL. Multivariable analyses computed a model with an Area Under the Receiver Operative Curve of 0.857 (95%-CI: 0.773-0.941) when predicting nodular hyperplasia of PG. Theoretical assessment of risk-factor interaction revealed that the duration of dialysis had the strongest influence on the probability of nodular hyperplasia of single PG. Conclusions The three identified risk-factors (duration of dialysis, PG volume determined by ultrasound and serum level of parathyroid hormone) can be easily gathered in daily routine and could be used to non-invasively assess the probability of nodular hyperplasia of PG. This assessment would benefit from periodically collected data sets of PG changes during the course of sHPT, so that the choice of medical or surgical sHPT treatment could be adjusted more to the naturally changing type of histological PG lesion on an individually adopted basis in the future.	[Jaeger, Mark D.] Stadt Klinikum Wolfenbuttel gGmbH, Klin Allgemein Viszeral & Minimal Invas Chirurg, Wolfenbuttel, Germany; [Serttas, Michaela; Schrem, Harald; Kaltenborn, Alexander; Ramackers, Wolf; Ringe, Bastian P.; Klempnauer, Juergen; Scheumann, Georg F. W.] Hannover Med Sch, Klin Allgemein Viszeral & Transplantat Chirurg, Hannover, Germany; [Beneke, Jan; Schrem, Harald; Kaltenborn, Alexander; Gwiasda, Jill] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat, Core Facil Qual Management Transplantat, Hannover, Germany; [Muller, Joerg A.] Hannover Med Sch, Klin Nukl Med, Hannover, Germany; [Kaltenborn, Alexander] Bundeswehrkrankenhaus Westerstede, Klin Unfallchirurg & Orthopadie, Westerstede, Germany; [Traenkenschuh, Wolfgang] Hannover Med Sch, Inst Pathol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Jager, MD (corresponding author), Stadt Klinikum Wolfenbuttel gGmbH, Klin Allgemein Viszeral & Minimal Invas Chirurg, Wolfenbuttel, Germany.	mark.jaeger@khwf.de			German Federal Ministry of Education and Research [01E00802]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was supported by a research grant from the German Federal Ministry of Education and Research (reference number: 01E00802).	Basile C, 2006, NEPHROL DIAL TRANSPL, V21, P968, DOI 10.1093/ndt/gfi311; Brunaud L, 2016, SURGERY, V159, P183, DOI 10.1016/j.surg.2015.06.058; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Fukagawa M, 2003, NEPHROL DIAL TRANSPL, V18, P31, DOI 10.1093/ndt/gfg1008; GIANGRANDE A, 1992, NEPHROL DIAL TRANSPL, V7, P412; Goto S, 2008, CLIN KIDNEY J, V1, pIII2, DOI 10.1093/ndtplus/sfn079; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hirai T, 2010, THER APHER DIAL, V14, P577, DOI 10.1111/j.1744-9987.2010.00843.x; Ichii M, 2010, NEPHRON CLIN PRACT, V115, pC195, DOI 10.1159/000313035; Kaltenborn A, 2015, J SURG ONCOL; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Komaba H, 2010, CLIN J AM SOC NEPHRO, V5, P2305, DOI 10.2215/CJN.02110310; Kovacevic B, 2012, LANGENBECK ARCH SURG, V397, P413, DOI 10.1007/s00423-011-0901-9; Lorenz K, 2015, LANGENBECK ARCH SURG, V400, P907, DOI 10.1007/s00423-015-1344-5; Martin LNC, 1998, HISTOPATHOLOGY, V33, P46; Matsuoka S, 2008, THER APHER DIAL, V12, P391, DOI 10.1111/j.1744-9987.2008.00615.x; Meola M, 2011, Ultraschall Med, V32 Suppl 1, pS74, DOI 10.1055/s-0029-1245236; Meola M, 2013, J NEPHROL, V26, P848, DOI 10.5301/jn.5000219; Okada M, 2011, THER APHER DIAL, V15, P33, DOI 10.1111/j.1744-9987.2011.00924.x; Onoda N, 2003, NEPHROL DIAL TRANSPL, V18, P34, DOI 10.1093/ndt/gfg1009; Parfitt AM, 1997, KIDNEY INT, V52, P3, DOI 10.1038/ki.1997.297; Schlosser K, 2004, Scand J Surg, V93, P288; Tanaka M, 2008, CLIN KIDNEY J, V1, pIII49, DOI 10.1093/ndtplus/sfn087; Tominaga Y, 1997, SEMIN SURG ONCOL, V13, P78, DOI 10.1002/(SICI)1098-2388(199703/04)13:2<78::AID-SSU3>3.0.CO;2-Z; Tominaga Y, 2007, THER APHER DIAL, V11, P266, DOI 10.1111/j.1744-9987.2007.00489.x; Vulpio C, 2013, RADIOL MED, V118, P707, DOI 10.1007/s11547-012-0882-x; Vulpio C, 2016, SEMIN DIAL; Vulpio C, 2008, AM J NEPHROL, V28, P589, DOI 10.1159/000116875; Vulpio C, 2013, EUR J ENDOCRINOL, V168, P811, DOI 10.1530/EJE-12-0947	29	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186093	10.1371/journal.pone.0186093	http://dx.doi.org/10.1371/journal.pone.0186093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040300	Green Submitted, Green Published, gold			2022-12-26	WOS:000413167500019
J	Kshirsagar, AV; Manickam, RN; Mu, Y; Flythe, JE; Chin, AI; Bang, H				Kshirsagar, Abhijit V.; Manickam, Raj N.; Mu, Yi; Flythe, Jennifer E.; Chin, Andrew I.; Bang, Heejung			Area-level poverty, race/ethnicity & dialysis star ratings	PLOS ONE			English	Article							INCIDENT HEMODIALYSIS-PATIENTS; VASCULAR ACCESS; UNITED-STATES; DISPARITIES; ASSOCIATION; SEGREGATION; POPULATION; MORTALITY; VETERANS; OUTCOMES	The Centers for Medicare and Medicaid Services recently released a five star rating system as part of 'Dialysis Facility Compare' to help patients identify and choose high performing clinics in the US. Eight dialysis-related measures determine ratings. Little is known about the association between surrounding community sociodemographic characteristics and star ratings. Using data from the U.S. Census and over 6000 dialysis clinics across the country, we examined the association between dialysis clinic star ratings and characteristics of the local population: 1) proportion of population below the federal poverty level (FPL); 2) proportion of black individuals; and 3) proportion of Hispanic individuals, by correlation and regression analyses. Secondary analyses with Quality Incentive Program (QIP) scores and population characteristics were also performed. We observed a negligible correlation between star ratings and the proportion of local individuals below FPL; Spearman coefficient, R = -0.09 (p<0.0001), and a stronger correlation between star ratings and the proportion of black individuals; R = -0.21 (p<0.0001). Ordered logistic regression analyses yielded adjusted odds ratio of 0.91 (95% confidence interval [0.80-1.30], p =0.12) and 0.55 ([0.48-0.63], p<0.0001) for high vs. low level of proportion below FPL and proportion of black individuals, respectively. In contrast, a near-zero correlation was observed between star ratings and the proportion of Hispanic individuals. Correlations varied substantially by country region, clinic profit status and clinic size. Analyses using clinic QIP scores provided similar results. Sociodemographic characteristics of the surrounding community, factors typically outside of providers' direct control, have varying levels of association with clinic dialysis star ratings.	[Kshirsagar, Abhijit V.; Flythe, Jennifer E.] Univ N Carolina, Div Nephrol & Hypertens, UNC Kidney Ctr, Chapel Hill, NC 27599 USA; [Manickam, Raj N.; Mu, Yi; Bang, Heejung] Univ Calif Davis, Grad Grp Epidemiol, Davis, CA 95616 USA; [Chin, Andrew I.] Univ Calif Sacramento, Davis Sch Med, Div Nephrol, Sacramento, CA USA; [Chin, Andrew I.] VA Northern Calif Hlth Care Syst, Sacramento VA Med Ctr, Div Nephrol, Mather Field, CA USA; [Bang, Heejung] Univ Calif Davis, Dept Publ Hlth Sci, Div Biostat, Davis, CA 95616 USA; [Bang, Heejung] Univ Calif Sacramento, Ctr Healthcare Policy & Res, Sch Med, Sacramento, CA USA	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Davis; California State University System; California State University Sacramento; University of California System; University of California Davis; California State University System; California State University Sacramento	Kshirsagar, AV (corresponding author), Univ N Carolina, Div Nephrol & Hypertens, UNC Kidney Ctr, Chapel Hill, NC 27599 USA.	sagar@med.unc.edu		Flythe, Jennifer/0000-0003-4596-8536	National Institutes of Health through grants [UL1 TR001860]; Dialysis Clinic, Inc.; National Institute of Diabetes and Digestive and Kidney Diseases grant [K23DK109401]; Amgen for Investigator Initiated Research; Renal Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK109401] Funding Source: NIH RePORTER	National Institutes of Health through grants; Dialysis Clinic, Inc.; National Institute of Diabetes and Digestive and Kidney Diseases grant; Amgen for Investigator Initiated Research; Renal Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	HB was partly supported by the National Institutes of Health through grants UL1 TR001860. HB and YM were additionally supported by Dialysis Clinic, Inc. JEF is supported by National Institute of Diabetes and Digestive and Kidney Diseases grant K23DK109401. AVK has received funding from Amgen for Investigator Initiated Research. JEF has received speaking honoraria from Dialysis Clinic, Inc., Renal Ventures, American Renal Associates, American Society of Nephrology, Baxter and numerous universities and research funding for studies unrelated to the present study from the Renal Research Institute, a subsidiary of Fresenius Medical Care, North America. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The interpretation and reporting of the data are the responsibility of the authors and in no way should be seen as an official policy or interpretation of the US government.	Agency for Healthcare Quality and Research, NAT QUAL STRAT; Astor BC, 2005, J AM SOC NEPHROL, V16, P1449, DOI 10.1681/ASN.2004090748; Bernheim SM, 2016, HEALTH AFFAIR, V35, P1461, DOI 10.1377/hlthaff.2015.0394; Bower KM, 2014, PREV MED, V58, P33, DOI 10.1016/j.ypmed.2013.10.010; Centers for Medicare and Medicaid Services (CMS), 2012, FED REGISTER, V77, P40952; Centers for Medicare & Medicaid Services ( CMS) HHS, 2010, FED REGISTER, V75, P49030; Chand DH, 2008, NEPHRON CLIN PRACT, V108, pC91, DOI 10.1159/000113525; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Cook NL, 2015, CIRCULATION, V132, P1519, DOI 10.1161/CIRCULATIONAHA.115.018953; Daumit GL, 1999, ANN INTERN MED, V130, P173, DOI 10.7326/0003-4819-130-3-199902020-00002; Erickson KF, 2017, CLIN J AM SOC NEPHRO, V12, P536, DOI 10.2215/CJN.06340616; Garrity BH, 2016, HEMODIAL INT, V20, P78, DOI 10.1111/hdi.12325; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; Hall YN, 2014, HEALTH SERV RES, V49, P971, DOI 10.1111/1475-6773.12144; Hilmers A, 2012, AM J PUBLIC HEALTH, V102, P1644, DOI 10.2105/AJPH.2012.300865; Iceland J, 2013, DEMOGRAPHY, V50, P97, DOI 10.1007/s13524-012-0136-6; Kovesdy CP, 2015, CIRCULATION, V132, P1538, DOI 10.1161/CIRCULATIONAHA.114.015124; Krumholz HM, 2014, ANN INTERN MED, V161, P833, DOI 10.7326/M14-2308; Manickam RN, 2017, AM J MED, V130, pE153, DOI 10.1016/j.amjmed.2016.08.047; Martsolf GR, 2016, J HLTH CARE ORG PROV, V53, P1, DOI DOI 10.1177/0046958016667596; Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040; Nee R, 2015, AM J NEPHROL, V42, P328, DOI 10.1159/000441804; Norton JM, 2016, J AM SOC NEPHROL, V27, P2576, DOI 10.1681/ASN.2016010027; Saha S, 2008, J GEN INTERN MED, V23, P654, DOI 10.1007/s11606-008-0521-4; Walker RE, 2010, HEALTH PLACE, V16, P876, DOI 10.1016/j.healthplace.2010.04.013; World Health Organization (WHO), SOCIAL DETERMINANTS	26	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186651	10.1371/journal.pone.0186651	http://dx.doi.org/10.1371/journal.pone.0186651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KA	29040342	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500067
J	Zeng, G; Liu, B; Ferguson, DK; Rohwer, JG; Yang, Y				Zeng, Gang; Liu, Bing; Ferguson, David K.; Rohwer, Jens G.; Yang, Yong			Floral structure and ontogeny of Syndiclis (Lauraceae)	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; GENUS; CHLOROPLAST; PHYLLOTAXIS; SINOPORA	Generic delimitation in the Beilschmiedia group of the Lauraceae remains ambiguous because flowering specimens of a few genera with confined distribution are poorly represented in herbaria, and a few floral characters important for taxonomy are still poorly known. Syndiclis is sporadically distributed in southwestern China, and is represented in the herbaria by only a few flowering specimens. We conducted field investigations to collect floral materials of four species and observed structures and ontogeny of the tiny flowers using both light microscopy (LM) and scanning electron microscopy (SEM). The results show that the genus Syndiclis possesses flowers with huge variation in both merosity and organ number. Flowers of the genus are dimerous, trimerous, or tetramerous, or have mixed merosity with monomerous and dimerous, or dimerous and trimerous, or trimerous and tetramerous whorls. The number of staminodes ranges from two to eight, depending on floral merosity, and on how many stamens of the third androecial whorl are reduced to staminodes. The staminodes of the fourth androecial whorl are comparable to the staminodes in Potameia, but the staminodes of the third androecial whorl of Syndiclis are relatively larger than the staminodes in Potameia. They are erect or curved inwards, covering the ovary. The anthers are usually two-locular, but rarely one-locular or three-locular. Each stamen of the third androecial whorl bears two conspicuous and enlarged glands at the base. The lability of floral merosity and organ number of Syndiclis may have been caused by changes of pollination system and loss of special selective pressures that are present in most Lauraceous plants with fixed floral organ number. This study furthers our understanding of variation and evolution of a few important characters of the Beilschmiedia group and provides essential data for a revised generic classification of the group.	[Zeng, Gang; Liu, Bing; Yang, Yong] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Zeng, Gang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ferguson, David K.] Univ Vienna, Dept Paleontol, Vienna, Austria; [Rohwer, Jens G.] Biozentrum Klein Flottbek, Hamburg, Germany	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Vienna	Yang, Y (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	ephedra@ibcas.ac.cn	Yang, Yong/S-1202-2019		National Natural Science Foundation of China [31470301, 31270238, 30970177]; Scientific Research Project of Shenzhen Urban Administration [201519]; Major Technical Research Project of the Innovation of Science and Technology Commission of Shenzhen [JSGG20140515164852417]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Project of Shenzhen Urban Administration; Major Technical Research Project of the Innovation of Science and Technology Commission of Shenzhen	This work was supported by the National Natural Science Foundation of China [31470301, 31270238, 30970177] to Yong Yang, the Scientific Research Project of Shenzhen Urban Administration [201519], and a Major Technical Research Project of the Innovation of Science and Technology Commission of Shenzhen [JSGG20140515164852417]. None of the authors is employed or contracted by the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buzgo M, 2007, INT J PLANT SCI, V168, P261, DOI 10.1086/510297; Chanderbali AS, 2001, ANN MO BOT GARD, V88, P104, DOI 10.2307/2666133; Endress PK, 2007, CURR OPIN PLANT BIOL, V10, P52, DOI 10.1016/j.pbi.2006.11.007; Endress PK, 2004, AUST SYST BOT, V17, P343, DOI 10.1071/SB04004; Endress PK, 2001, J EXP ZOOL, V291, P105, DOI 10.1002/jez.1063; Hooker J.D., 1886, FLORA BRIT INDIA, V5; HYLAND B P M, 1989, Australian Systematic Botany, V2, P135, DOI 10.1071/SB9890135; Kaspaligil B., 1951, U CALIF PUBL BOT, V25, P115; KOPP LUCILLE E., 1966, MEM NEW YORK BOTGARD, V14, P1; KOSTERMANS A J G H, 1974, Reinwardtia, V9, P119; Kostermans A. JG. H., 1957, Reinwardtia, V4, P193; Kubitzki K., 1982, FLORA NEOTROPICA MON, V31, P1; Kubitzki K, 1993, FAMILIES GENERA VASC, P334, DOI DOI 10.1016/j.palaeo.2014.02.004; Lee SK, 1982, FLORA REIPUBLICAE PO, V31, P123; Li HW, 1982, FLORA REIPUBLICAE PO, V31, P152; Li J, 2004, PLANT SYST EVOL, V246, P19, DOI 10.1007/s00606-003-0113-z; Li J, 2008, NOVON, V18, P199, DOI 10.3417/2006126; Li L, 2011, AM J BOT, V98, P1520, DOI 10.3732/ajb.1100006; Liu B. S., 2013, THESIS; Liu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067636; Philipson W.R, 1993, FAMILIES GENERA VASC, P426, DOI DOI 10.1007/978-3-662-02899-5_50; Rohwer JG, 2009, PLANT BIOLOGY, V11, P490, DOI 10.1111/j.1438-8677.2008.00184.x; Rohwer J. G., 1993, FAMILIES GENERA VASC, V2, P366, DOI DOI 10.1007/978-3-662-02899-5_46; Rohwer JG, 2014, PHYTOTAXA, V158, P111, DOI 10.11646/phytotaxa.158.2.1; Rohwer JG, 2009, TAXON, V58, P1153, DOI 10.1002/tax.584009; ROHWER JG, 1991, ANN MO BOT GARD, V78, P388, DOI 10.2307/2399568; Singh G., 2004, PLANT SYSTEMATICS IN; SINGH V, 1985, Phytomorphology, V35, P61; Staedler YM, 2009, INT J PLANT SCI, V170, P522, DOI 10.1086/597272; Trofimov D, 2016, TAXON, V65, P980, DOI 10.12705/655.3; van der Werff Henk, 2003, Adansonia (Paris), V25, P77; van der Werff H, 2010, NOVON, V20, P493, DOI 10.3417/2010030; vanderWerff H, 1996, ANN MO BOT GARD, V83, P409, DOI 10.2307/2399870; Yang Y, 2012, SYST BOT, V37, P861, DOI 10.1600/036364412X656518	34	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186358	10.1371/journal.pone.0186358	http://dx.doi.org/10.1371/journal.pone.0186358			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028818	gold, Green Published, Green Submitted			2022-12-26	WOS:000412980300029
J	Jiang, HC; Wan, SM; Ma, XL; Zhong, N; Zhao, DB				Jiang, Hanchao; Wan, Shiming; Ma, Xiaolin; Zhong, Ning; Zhao, Debo			End-member modeling of the grain-size record of Sikouzi fine sediments in Ningxia (China) and implications for temperature control of Neogene evolution of East Asian winter monsoon	PLOS ONE			English	Article							LOESS PLATEAU; LACUSTRINE SEDIMENTS; TIBETAN PLATEAU; NORTHERN CHINA; CLIMATE-CHANGE; YELLOW-RIVER; PROVENANCE; MA; DEPOSITS; ATLANTIC	The Late Cenozoic East Asian winter monsoon (EAWM) enhancement has been attributed to several factors, such as uplift of the Tibetan Plateau, retreat of the Paratethys Sea, and global cooling related to polar ice volume increment. However, the fundamental forcing factors remain enigmatic due to the absence of long and continuous climate records and sensitive indicators. Here we reanalyzed the published grain-size record of Sikouzi fine sediments in the western Chinese Loess Plateau through end-member (EM) modeling. The results indicate that EM 2 with grain-size peaks between 10-100 mu m decreased in content from 20.1 to 17 Ma and stepwise increased from 17 to 0.07 Ma during the following six stages (17-15 Ma, 15-12 Ma, 12-8 Ma, 8-6 Ma, 6-4 Ma and 4-0 Ma). Such varying trends can be successively correlated in seven stages with the integrated benthic delta O-18 record, implying that global warming weakened the EAWM from 20.1 to 17 Ma and global cooling has stepwise strengthened the EAWM since 17 Ma. Therefore, we conclude that global temperature change played a major role on the evolution of EAWM during the Neogene period. By contrast, Late Cenozoic palaeogeographic reorganization caused by uplift of the Tibetan Plateau and retreat of the Paratethys Sea contributed less to the evolutionary evolution of EAWM. Spectral analysis of the EM 2 data first provided direct evidence of orbitally influenced deposition in the study area and thus the EAWM variations during the Neogene period. The 100-kyr period became weak since similar to 10 Ma, possibly due to the decrease in sensitivity of a more stable, continental-scale ice sheet in Antarctica to local insolation forcing, deserving further investigation.	[Jiang, Hanchao; Zhong, Ning] China Earthquake Adm, Inst Geol, State Key Lab Earthquake Dynam, Beijing, Peoples R China; [Wan, Shiming; Zhao, Debo] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Geol & Environm, Qingdao, Peoples R China; [Ma, Xiaolin] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian, Shaanxi, Peoples R China	China Earthquake Administration; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; Institute of Earth Environment, CAS	Jiang, HC (corresponding author), China Earthquake Adm, Inst Geol, State Key Lab Earthquake Dynam, Beijing, Peoples R China.	hcjiang@ies.ac.cn	Wan, Shiming/B-4735-2011; Jiang, Hanchao/ABG-2653-2020	Wan, Shiming/0000-0001-9335-2248; Jiang, Hanchao/0000-0003-3391-4477; Ma, Xiaolin/0000-0002-5073-418X	National Natural Science Foundation of China [41602358, 41572346]; special project of fundamental scientific research of the Institute of Geology, China Earthquake Administration [IGCEA1713, IGCEA1508]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special project of fundamental scientific research of the Institute of Geology, China Earthquake Administration	This work was supported by the National Natural Science Foundation of China (grants 41602358, 41572346) and the special project of the fundamental scientific research of the Institute of Geology, China Earthquake Administration (IGCEA1713, IGCEA1508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAUFORT L, 1994, PALEOCEANOGRAPHY, V9, P821, DOI 10.1029/94PA02115; Chen FH, 2013, J GEOPHYS RES-ATMOS, V118, P2149, DOI 10.1002/jgrd.50140; Derbyshire E, 1998, J ARID ENVIRON, V39, P497, DOI 10.1006/jare.1997.0369; Ding ZL, 1999, PALAEOGEOGR PALAEOCL, V152, P49, DOI 10.1016/S0031-0182(99)00034-6; DING ZL, 1993, CATENA, V20, P73, DOI 10.1016/0341-8162(93)90030-S; Ding ZL, 1998, GEOPHYS RES LETT, V25, P1225, DOI 10.1029/98GL00836; Ding ZL, 2000, QUATERNARY SCI REV, V19, P547, DOI 10.1016/S0277-3791(99)00017-7; DOWSETT HJ, 1992, SCIENCE, V258, P1133, DOI 10.1126/science.258.5085.1133; Eldrett JS, 2007, NATURE, V446, P176, DOI 10.1038/nature05591; Galeotti S, 2016, SCIENCE, V352, P76, DOI 10.1126/science.aab0669; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Hermoyian CS, 2001, PALEOCEANOGRAPHY, V16, P95, DOI 10.1029/2000PA000501; Ji JF, 1999, CLAY MINER, V34, P525, DOI 10.1180/000985599546398; Jiang H, 2009, J ARID ENVIRON, V73, P765, DOI 10.1016/j.jaridenv.2009.03.011; Jiang HC, 2008, PALAEOGEOGR PALAEOCL, V265, P148, DOI 10.1016/j.palaeo.2008.05.006; Jiang HC, 2008, PALAEOGEOGR PALAEOCL, V265, P30, DOI 10.1016/j.palaeo.2008.04.016; Jiang HC, 2007, PALAEOGEOGR PALAEOCL, V243, P223, DOI 10.1016/j.palaeo.2006.07.016; Jiang HC, 2016, PALAEOGEOGR PALAEOCL, V446, P32, DOI 10.1016/j.palaeo.2016.01.017; Jiang HC, 2014, GEOMORPHOLOGY, V204, P518, DOI 10.1016/j.geomorph.2013.08.032; Jiang HC, 2010, PALAEOGEOGR PALAEOCL, V298, P201, DOI 10.1016/j.palaeo.2010.09.025; Jiang HC, 2010, GEOL SOC AM BULL, V122, P843, DOI 10.1130/B26583.1; KSt John, 2008, PALEOCEANOGRPAHY, V23; LaRiviere JP, 2012, NATURE, V486, P97, DOI 10.1038/nature11200; [李云 Li Yun], 2014, [地质论评, Geological Review], V60, P380; Liang LJ, 2017, QUATERN INT, V430, P41, DOI 10.1016/j.quaint.2015.07.037; Licht A, 2016, GEOL SOC AM BULL, V128, P944, DOI 10.1130/B31375.1; Ma WT, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047680; Miao YF, 2016, GONDWANA RES, V29, P320, DOI 10.1016/j.gr.2014.12.007; Muhs DR, 2013, QUATERNARY RES, V80, P468, DOI 10.1016/j.yqres.2013.06.006; Nie JS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600762; Nie JS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9511; Passega R., 1964, J SEDIMENT RES, V34, P830, DOI [DOI 10.1306/74D711A4-2B21-11D7-8648000102C1865D, 10.1306/74D711A4-2B21-11D7-8648000102C1865D]; Passega R., 1957, AAPG BULL, V41, DOI [DOI 10.1306/0BDA594E-16BD-11D7-8645000102C1865D, 10.1306/0BDA594E-16BD-11D7-8645000102C1865D]; Paterson GA, 2015, GEOCHEM GEOPHY GEOSY, V16, P4494, DOI 10.1002/2015GC006070; Qiang XK, 2011, SCI CHINA EARTH SCI, V54, P136, DOI 10.1007/s11430-010-4126-5; Schulz M, 2002, COMPUT GEOSCI-UK, V28, P421, DOI 10.1016/S0098-3004(01)00044-9; Shang Y, 2016, EARTH PLANET SC LETT, V439, P88, DOI 10.1016/j.epsl.2016.01.031; Stevens T, 2013, QUATERNARY SCI REV, V78, P355, DOI 10.1016/j.quascirev.2012.11.032; Sun DH, 2008, PALAEOGEOGR PALAEOCL, V264, P39, DOI 10.1016/j.palaeo.2008.03.011; Sun JM, 2002, EARTH PLANET SC LETT, V203, P845, DOI 10.1016/S0012-821X(02)00921-4; Sun JM, 2002, QUATERNARY RES, V58, P341, DOI 10.1006/qres.2002.2381; Sun YB, 2015, GEOCHEM GEOPHY GEOSY, V16, P2097, DOI 10.1002/2015GC005750; Sun YB, 2010, EARTH PLANET SC LETT, V297, P525, DOI 10.1016/j.epsl.2010.07.004; Thiede J, 1998, QUATERNARY SCI REV, V17, P185, DOI 10.1016/S0277-3791(97)00076-0; Tian J, 2014, EARTH PLANET SC LETT, V406, P72, DOI 10.1016/j.epsl.2014.09.013; Tian J, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002045; Weltje GJ, 1997, MATH GEOL, V29, P503, DOI 10.1007/BF02775085; WHALLEY WB, 1982, NATURE, V300, P433, DOI 10.1038/300433a0; Yu SY, 2016, MATH GEOSCI, V48, P723, DOI 10.1007/s11004-015-9611-0; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zhai QM, 2006, PALAEOGEOGR PALAEOCL, V241, P95, DOI 10.1016/j.palaeo.2006.06.011; Zhang YB, 2014, GLOBAL PLANET CHANGE, V120, P1, DOI 10.1016/j.gloplacha.2014.05.009; Zhong N, 2017, J ASIAN EARTH SCI, V146, P251, DOI 10.1016/j.jseaes.2017.05.035	55	16	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186153	10.1371/journal.pone.0186153	http://dx.doi.org/10.1371/journal.pone.0186153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023505	gold, Green Published, Green Submitted			2022-12-26	WOS:000412845100069
J	Korse, NS; Kruit, MC; Peul, WC; Vleggeert-Lankamp, CLA				Korse, Nina S.; Kruit, Mark C.; Peul, Wilco C.; Vleggeert-Lankamp, Carmen L. A.			Lumbar spinal canal MRI diameter is smaller in herniated disc cauda equina syndrome patients	PLOS ONE			English	Article							BACK SYMPTOMS; STENOSIS; SURGERY; METAANALYSIS; DYSFUNCTION; MICTURITION; DEFECATION; FEATURES; VALUES; PAIN	Introduction Correlation between magnetic resonance imaging (MRI) and clinical features in cauda equina syndrome (CES) is unknown; nor is known whether there are differences in MRI spinal canal size between lumbar herniated disc patients with CES versus lumbar herniated discs patients without CES, operated for sciatica. The aims of this study are 1) evaluating the association of MRI features with clinical presentation and outcome of CES and 2) comparing lumbar spinal canal diameters of lumbar herniated disc patients with CES versus lumbar herniated disc patients without CES, operated because of sciatica. Methods MRIs of CES patients were assessed for the following features: level of disc lesion, type (uni- or bilateral) and severity of caudal compression. Pre- and postoperative clinical features (micturition dysfunction, defecation dysfunction, altered sensation of the saddle area) were retrieved from the medical files. In addition, anteroposterior (AP) lumbar spinal canal diameters of CES patients were measured at MRI. AP diameters of lumbar herniated disc patients without CES, operated for sciatica, were measured for comparison. Results 48 CES patients were included. At MRI, bilateral compression was seen in 82%; complete caudal compression in 29%. MRI features were not associated with clinical presentation nor outcome. AP diameter was measured for 26 CES patients and for 31 lumbar herniated disc patients without CES, operated for sciatica. Comparison displayed a significant smaller AP diameter of the lumbar spinal canal in CES patients (largest p = 0.002). Compared to average diameters in literature, diameters of CES patients were significantly more often below average than that of the sciatica patients (largest p = 0.021). Conclusion This is the first study demonstrating differences in lumbar spinal canal size between lumbar herniated disc patients with CES and lumbar herniated disc patients without CES, operated for sciatica. This finding might imply that lumbar herniated disc patients with a relative small lumbar spinal canal might need to be approached differently in managing complaints of herniated disc. Since the number of studied patients is relatively small, further research should be conducted before clinical consequences are considered.	[Korse, Nina S.; Vleggeert-Lankamp, Carmen L. A.] Leiden Univ, Dept Neurosurg, Med Ctr, Leiden, Netherlands; [Kruit, Mark C.] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Peul, Wilco C.] Haaglanden Med Ctr, Dept Neurosurg, The Hague, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haaglanden Medical Center	Korse, NS (corresponding author), Leiden Univ, Dept Neurosurg, Med Ctr, Leiden, Netherlands.	n.s.korse@lumc.nl	Kruit, Mark C/K-2431-2012; Vleggeert-Lankamp, Carmen/AGX-9660-2022	Kruit, Mark C/0000-0002-4319-834X; Vleggeert-Lankamp, Carmen/0000-0001-9597-7225	National Health organisation; Braun; Paradigm Spine	National Health organisation; Braun; Paradigm Spine	I have read the journal's policy. Outside the submitted work, Dr Vleggeert-Lankamp and Dr Peul report the following interests: National Health organisation sponsors a trial on treatment of cervical radiculopathy, and has been paying a trial on the treatment of spinal stenosis. Braun sponsors a study after the surgical treatment of cervical discectomies. Medtronic sponsors a study after the surgical treatment of spondylolytic listhesis. Paradigm Spine sponsors a study after the surgical treatment of spinal stenosis. These are all Investigator Initiated trials. The payment is not made to private accounts but to the research department only. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Ahn UM, 2000, SPINE, V25, P1515, DOI 10.1097/00007632-200006150-00010; AMUNDSEN T, 1995, SPINE, V20, P1178, DOI 10.1097/00007632-199505150-00013; Beculic Hakija, 2016, Med Glas (Zenica), V13, P136, DOI 10.17392/861-16; Busse J W, 2001, CJEM, V3, P285; Chang HS, 2000, SURG NEUROL, V53, P100, DOI 10.1016/S0090-3019(99)00180-9; Chatha DS, 2011, BULL HOSP JT DIS, V69, P303; Cheung JPY, 2014, SPINE, V39, P1067, DOI 10.1097/BRS.0000000000000335; Delong WB, 2008, J NEUROSURG-SPINE, V8, P305, DOI 10.3171/SPI/2008/8/4/305; DINNING TAR, 1993, AUST NZ J SURG, V63, P927, DOI 10.1111/j.1445-2197.1993.tb01721.x; el Barzouhi A, 2016, J NEUROSURG-SPINE, V24, P978, DOI 10.3171/2015.10.SPINE15858; Fraser S, 2009, ARCH PHYS MED REHAB, V90, P1964, DOI 10.1016/j.apmr.2009.03.021; Geisser ME, 2007, CLIN J PAIN, V23, P780, DOI 10.1097/AJP.0b013e31815349bf; GEPSTEIN R, 1991, SURG RADIOL ANAT, V13, P289, DOI 10.1007/BF01627760; GLEAVE J R W, 1990, British Journal of Neurosurgery, V4, P205, DOI 10.3109/02688699008992725; Gleave JRW, 2002, BRIT J NEUROSURG, V16, P325, DOI 10.1080/0268869021000032887; GOUZIEN P, 1990, SURG RADIOL ANAT, V12, P143, DOI 10.1007/BF01623341; Haig AJ, 2002, SPINE, V27, P1918, DOI 10.1097/00007632-200209010-00019; Haig AJ, 2007, J BONE JOINT SURG AM, V89A, P358, DOI 10.2106/JBJS.E.00704; Janjua M Z, 1989, J Pak Med Assoc, V39, P264; JENNETT WB, 1956, J NEUROL NEUROSUR PS, V19, P109, DOI 10.1136/jnnp.19.2.109; JOHANSON JF, 1989, J CLIN GASTROENTEROL, V11, P525, DOI 10.1097/00004836-198910000-00008; Jonsson B, 1997, SPINE, V22, P2932, DOI 10.1097/00007632-199712150-00016; Kitab SA, 2014, SPINE J, V14, P808, DOI 10.1016/j.spinee.2013.09.012; Kobayashi S, 2006, AM J NEURORADIOL, V27, P346; Korse NS, 2017, EUR SPINE J, V26, P894, DOI 10.1007/s00586-017-4943-8; Korse NS, 2013, EUR SPINE J, V22, P1019, DOI 10.1007/s00586-012-2601-8; Kuittinen P, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-348; LEWIS TT, 1991, CURR OPIN NEUROL NEU, V4, P612; Nascone JW, 1999, U PA ORTHOP J, V12, P73; Pawar I., 2014, J ORTHOPEDICS ALLIED, V2, P3; Podnar S, 2006, EUR J NEUROL, V13, P1112, DOI 10.1111/j.1468-1331.2006.01423.x; SHEPHARD RH, 1959, BRIT MED J, V2, P1434, DOI 10.1136/bmj.2.5164.1434; Tandon PN., 1967, INDIAN J ORTHOP, V1, P112; Todd NV, 2005, BRIT J NEUROSURG, V19, P301, DOI 10.1080/02688690500305324; TWOMEY L, 1988, PARAPLEGIA, V26, P238, DOI 10.1038/sc.1988.37; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; Wildermuth S, 1998, RADIOLOGY, V207, P391, DOI 10.1148/radiology.207.2.9577486	37	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186148	10.1371/journal.pone.0186148	http://dx.doi.org/10.1371/journal.pone.0186148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023556	gold, Green Published, Green Submitted			2022-12-26	WOS:000412845100068
J	Loya, TJ; O'Rourke, TW; Reines, D				Loya, Travis J.; O'Rourke, Thomas W.; Reines, Daniel			The hnRNP-like Nab3 termination factor can employ heterologous prion-like domains in place of its own essential low complexity domain	PLOS ONE			English	Article							RNA-BINDING PROTEINS; CELL-FREE FORMATION; TRANSCRIPTION TERMINATION; SACCHAROMYCES-CEREVISIAE; POLYMERASE-II; YEAST NAB3; AGGREGATION; SELECTION; FEATURES; STRAINS	Many RNA-binding proteins possess domains with a biased amino acid content. A common property of these low complexity domains (LCDs) is that they assemble into an ordered amyloid form, juxtaposing RNA recognition motifs in a subcellular compartment in which RNA metabolism is focused. Yeast Nab3 is one such protein that contains RNA-binding domains and a low complexity, glutamine/ proline-rich, prion-like domain that can self-assemble. Nab3 also contains a region of structural homology to human hnRNP-C that resembles a leucine zipper which can oligomerize. Here we show that the LCD and the human hnRNP-C homology domains of Nab3 were experimentally separable, as cells were viable with either segment, but not when both were missing. In exploiting the lethality of deleting these regions of Nab3, we were able to test if heterologous prion-like domains known to assemble into amyloid, could substitute for the native sequence. Those from the hnRNP-like protein Hrp1, the canonical prion Sup35, or the epsin-related protein Ent2, could rescue viability and enable the new Nab3 chimeric protein to support transcription termination. Other low complexity domains from RNA-binding, termination-related proteins or a yeast prion, could not. As well, an unbiased genetic selection revealed a new protein sequence that could rescue the loss of Nab3's essential domain via multimerization. This new sequence and Sup35's prion domain could also rescue the lethal loss of Hrp1's prion-like domain when substituted for it. This suggests there are different cross-functional classes of amyloid-forming LCDs and that appending merely any assembly-competent LCD to Nab3 does not restore function or rescue viability. The analysis has revealed the functional complexity of LCDs and provides a means by which the differing classes of LCD can be dissected and understood.	[Loya, Travis J.; O'Rourke, Thomas W.; Reines, Daniel] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Reines, D (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	dreines@emory.edu	excellency, Your/R-2357-2019	excellency, Your/0000-0003-0832-6243	Emory University School of Medicine Flow Cytometry Core; National Institute of General Medical Sciences of the National Institutes of Health [R01GM120271]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R01GM120271] Funding Source: NIH RePORTER	Emory University School of Medicine Flow Cytometry Core; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research project was supported in part by the Emory University School of Medicine Flow Cytometry Core. Research reported in this publication was supported by the the National Institute of General Medical Sciences of the National Institutes of Health under awards R01GM120271 to D.R. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Anna Kania and Juan Rodriguez for their contributions to this work during their rotation research. We also thank Dr. Natalya Degtyareva for helpful discussions and tetrad analysis and Dr. Graeme Conn for a critical reading of the manuscript. This research project was supported in part by the Emory University School of Medicine Flow Cytometry Core. Contributions of strains or antibodies from the labs of Drs. Pamela Silver, Maurice Swanson, and Michael Henry are acknowledged. Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under awards R01GM120271. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alberti S, 2010, METHOD ENZYMOL, V470, P709, DOI 10.1016/S0076-6879(10)70030-6; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arndt KM, 2015, ANNU REV BIOCHEM, V84, P381, DOI 10.1146/annurev-biochem-060614-034457; Boke E, 2016, CELL, V166, P637, DOI 10.1016/j.cell.2016.06.051; Bresson S, 2017, MOL CELL, V65, P787, DOI 10.1016/j.molcel.2017.01.005; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen X, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006863; Courchaine E, 2015, J CELL BIOL, V210, P527, DOI 10.1083/jcb.201507052; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; Darby MM, 2012, MOL CELL BIOL, V32, P1762, DOI 10.1128/MCB.00050-12; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Henry MF, 2003, MOL BIOL CELL, V14, P3929, DOI 10.1091/mbc.E03-01-0854; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kuehner JN, 2008, MOL CELL, V31, P201, DOI 10.1016/j.molcel.2008.05.018; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Loya TJ, 2013, J BIOL CHEM, V288, P34158, DOI 10.1074/jbc.M113.516765; Loya TJ, 2013, J BIOL CHEM, V288, P2111, DOI 10.1074/jbc.M112.430678; Loya TJ, 2012, NUCLEIC ACIDS RES, V40, P7476, DOI 10.1093/nar/gks377; MORRISON A, 1991, P NATL ACAD SCI USA, V88, P9473, DOI 10.1073/pnas.88.21.9473; O'Rourke TW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150865; O'Rourke TW, 2015, PRION, V9, P34, DOI 10.1080/19336896.2014.997618; REINES D, 1985, J BIOL CHEM, V260, P4248; Remy I, 1999, P NATL ACAD SCI USA, V96, P5394, DOI 10.1073/pnas.96.10.5394; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SIKORSKI RS, 1989, GENETICS, V122, P19; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Van Nues R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00025-5; Walker LC, 2016, ANNU REV GENET, V50, P329, DOI 10.1146/annurev-genet-120215-034943; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173	37	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186187	10.1371/journal.pone.0186187	http://dx.doi.org/10.1371/journal.pone.0186187			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023495	gold, Green Published			2022-12-26	WOS:000412845100076
J	Mensah, SA; Cheng, MJ; Homayoni, H; Plouffe, BD; Coury, AJ; Ebong, EE				Mensah, Solomon A.; Cheng, Ming J.; Homayoni, Homa; Plouffe, Brian D.; Coury, Arthur J.; Ebong, Eno E.			Regeneration of glycocalyx by heparan sulfate and sphingosine 1-phosphate restores inter-endothelial communication	PLOS ONE			English	Article							GAP-JUNCTION PROTEIN; INTERCELLULAR COMMUNICATION; VASCULAR-PERMEABILITY; ZONULA OCCLUDENS-1; SHEAR-STRESS; FLOW; SYNDECAN-1; CELLS; ATHEROSCLEROSIS; PROTEOGLYCANS	Vasculoprotective endothelium glycocalyx (GCX) shedding plays a critical role in vascular disease. Previous work demonstrated that GCX degradation disrupts endothelial cell (EC) gap junction connexin (Cx) proteins, likely blocking interendothelial molecular transport that maintains EC and vascular tissue homeostasis to resist disease. Here, we focused on GCX regeneration and tested the hypothesis that vasculoprotective EC function can be stimulated via replacement of GCX when it is shed. We used EC with [i] intact heparan sulfate (HS), the most abundant GCX component; [ii] degraded HS; or [iii] HS that was restored after enzyme degradation, by cellular self-recovery or artificially. Artificial HS restoration was achieved via treatment with exogenous HS, with or without the GCX regenerator and protector sphingosine 1-phosphate (S1P). In these cells we immunocytochemically examined expression of Cx isotype 43 (Cx43) at EC borders and characterized Cx-containing gap junction activity by measuring interendothelial spread of gap junction permeable Lucifer Yellow dye. With intact HS, 60% of EC borders expressed Cx43 and dye spread to 2.88 +/- 0.09 neighboring cells. HS degradation decreased Cx43 expression to 30% and reduced dye spread to 1.87 +/- 0.06 cells. Cellular self-recovery of HS restored baseline levels of Cx43 and dye transfer. Artificial HS recovery with exogenous HS partially restored Cx43 expression to 46% and yielded dye spread to only 1.03 +/- 0.07 cells. Treatment with both HS and S1P, recovered HS and restored Cx43 to 56% with significant dye transfer to 3.96 +/- 0.23 cells. This is the first evidence of GCX regeneration in a manner that effectively restores vasculoprotective EC communication.	[Mensah, Solomon A.; Ebong, Eno E.] Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA; [Cheng, Ming J.; Homayoni, Homa; Plouffe, Brian D.; Coury, Arthur J.; Ebong, Eno E.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Ebong, Eno E.] Albert Einstein Coll Med, Dept Neurosci, New York, NY 10461 USA; [Plouffe, Brian D.] Regis Coll, Dept STEM, Weston, MA USA	Northeastern University; Northeastern University; Yeshiva University; Regis University	Ebong, EE (corresponding author), Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA.; Ebong, EE (corresponding author), Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.; Ebong, EE (corresponding author), Albert Einstein Coll Med, Dept Neurosci, New York, NY 10461 USA.	e.ebong@northeastern.edu	Plouffe, Brian/GON-3496-2022; Plouffe, Brian/O-2520-2015	Plouffe, Brian/0000-0002-1576-5714; Mensah, Solomon/0000-0002-3444-4932	National Institutes of Health [K01 HL125499]; National Science Foundation [DGE-096843, DGE-145070]; Northeastern University; Northeastern Departments of Pharmaceutical Sciences and Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL125499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Northeastern University; Northeastern Departments of Pharmaceutical Sciences and Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Institutes of Health (K01 HL125499 awarded to Eno Ebong), the National Science Foundation (DGE-096843 awarded to Srinivas Sridhar, director of the Nanomedicine Science and Technology Center; DGE-145070 awarded to Solomon Mensah), and Northeastern University (startup funds; Tier 1 Provost Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support was provided by the Northeastern Departments of Pharmaceutical Sciences and Biology, where the confocal microscopes used for this work are housed. Confocal microscopy equipment was provided by the Northeastern Departments of Pharmaceutical Sciences and Biology on a fee-for-service basis. Curtis Sayers of Studio Sayers (Waban, MA) provided technical illustration services (Fig 5), and we are appreciative of his contribution to this report. We are also pleased to acknowledge James A. Hamilton (Boston University School of Medicine) and John M. Tarbell (City College of New York) for the invaluable assistance in reviewing, proof-reading and/or editing this manuscript.	Abbasi Taimur, 2013, Handb Exp Pharmacol, P201, DOI 10.1007/978-3-7091-1511-4_10; Ampey BC, 2014, ADV EXP MED BIOL, V814, P117, DOI 10.1007/978-1-4939-1031-1_11; BAI XM, 1994, J HISTOCHEM CYTOCHEM, V42, P1043, DOI 10.1177/42.8.8027524; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Broekhuizen LN, 2009, CURR OPIN LIPIDOL, V20, P57, DOI 10.1097/MOL.0b013e328321b587; Cancel LM, 2016, ATHEROSCLEROSIS, V252, P136, DOI 10.1016/j.atherosclerosis.2016.07.930; Chen C. H., 2015, AM J PHYSL CELL PHYS, V19; Cheng MJ, 2016, INT J NANOMED, V11, P3305, DOI 10.2147/IJN.S106299; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Constantinescu AA, 2011, THROMB HAEMOSTASIS, V105, P790, DOI 10.1160/TH10-08-0560; Cui S., 2017, APPL PHYSIOL NUTR ME, P1; Daniels B. A., 2014, GOOGLE PATENTS; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Du ZJ, 2017, INT J NANOMED, V12, P2179, DOI 10.2147/IJN.S127904; Ebong EE, 2006, AM J PHYSIOL-HEART C, V290, pH2015, DOI 10.1152/ajpheart.00204.2005; Ebong EE, 2014, INTEGR BIOL-UK, V6, P338, DOI 10.1039/c3ib40199e; Ebong EE, 2013, PFLUG ARCH EUR J PHY, V465, P1293, DOI 10.1007/s00424-013-1245-9; Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Giantsos-Adams KM, 2013, CELL MOL BIOENG, V6, P160, DOI 10.1007/s12195-013-0273-z; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Grondahl F, 2011, CARBOHYD RES, V346, P50, DOI 10.1016/j.carres.2010.10.025; Haefliger JA, 2004, CARDIOVASC RES, V62, P345, DOI 10.1016/j.cardiores.2003.11.015; Harada N, 1998, BIOSCI BIOTECH BIOCH, V62, P1647, DOI 10.1271/bbb.62.1647; Jiang GJ, 2017, ONCOL LETT, V13, P857, DOI 10.3892/ol.2016.5471; Joshi Chintamani N, 2015, ARCH PSYSL, V2, P1; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200; LEWIS JC, 1982, LAB INVEST, V46, P123; MAEDA M, 1991, PHYTOCHEMISTRY, V30, P3611, DOI 10.1016/0031-9422(91)80076-D; MARCUM JA, 1985, BIOCHEM BIOPH RES CO, V126, P365, DOI 10.1016/0006-291X(85)90615-1; Masola V, 2014, INT ANGIOL, V33, P243; Matsuuchi L, 2013, BBA-BIOMEMBRANES, V1828, P94, DOI 10.1016/j.bbamem.2012.05.014; Mitchell MJ, 2014, AM J PHYSIOL-CELL PH, V306, pC89, DOI 10.1152/ajpcell.00285.2013; Morel S, 2014, THROMB HAEMOSTASIS, V112, P390, DOI 10.1160/TH13-09-0773; Nakase T., 2016, NEUROPATHOLOGY; Paka L, 1999, J BIOL CHEM, V274, P4816, DOI 10.1074/jbc.274.8.4816; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Ross JS, 2001, ANN NY ACAD SCI, V947, P271; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Salmon AHJ, 2012, J AM SOC NEPHROL, V23, P1339, DOI 10.1681/ASN.2012010017; Shu CL, 2017, ANATOL J CARDIOL, V18, P3, DOI 10.14744/AnatolJCardiol.2017.7602; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Svenja Illien-Junger, 2013, PLOS ONE, V8; Tarbell JM, 2016, J INTERNAL MED; Tarbell JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.140pt8; Thi MM, 2004, P NATL ACAD SCI USA, V101, P16483, DOI 10.1073/pnas.0407474101; van den Berg BM, 2006, AM J PHYSIOL-HEART C, V290, pH915, DOI 10.1152/ajpheart.00051.2005; Veenstra RD, 2012, CARDIOVASC RES, V93, P8, DOI 10.1093/cvr/cvr295; Vijayagopal P, 1998, J SURG ONCOL, V68, P250, DOI 10.1002/(SICI)1096-9098(199808)68:4<250::AID-JSO9>3.0.CO;2-3; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Wang ZH, 2005, BIOCHEMISTRY-US, V44, P12355, DOI 10.1021/bi050620i; Wu D, 2013, P NATL ACAD SCI USA, V110, P12096, DOI 10.1073/pnas.1310003110; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yanagishita M, 1992, CELL SURFACE HEPARAN; Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007; Zeng Y, 2015, EXP CELL RES, V339, P90, DOI 10.1016/j.yexcr.2015.08.013; Zeng Y, 2014, AM J PHYSIOL-HEART C, V306, pH363, DOI 10.1152/ajpheart.00687.2013; Zeng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086249; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043168; Zhang L, 2016, MICROCIRCULATION, V23, P301, DOI 10.1111/micc.12278	64	40	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186116	10.1371/journal.pone.0186116	http://dx.doi.org/10.1371/journal.pone.0186116			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023478	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100065
J	Thomas, NA; Churches, O; White, I; Mohr, C; Schrag, Y; Obucina, S; Nicholls, MER				Thomas, Nicole A.; Churches, Owen; White, Ian; Mohr, Christine; Schrag, Yann; Obucina, Sabrina; Nicholls, Michael E. R.			An investigation of left/right driving rules on deviations while walking	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; RIGHTWARD COLLISIONS; SPATIAL ATTENTION; FAR SPACE; PSEUDONEGLECT; NEGLECT; GAIT; TASK; PARAMETERS; BEHAVIOR	When traversing through an aperture, such as a doorway, people characteristically deviate towards the right. This rightward deviation can be explained by a rightward attentional bias which leads to rightward bisections in far space. It is also possible, however, that left or right driving practices affect the deviation. To explore this possibility, Australian (left-side drivers) and Swiss (right-side drivers) participants (n = 36 & 34) walked through the middle of an aperture. To control for the sway of the body, participants started with either their left or right foot. Sway had a significant effect on participants' position in the doorway and the amount of sway was greater for Australians-perhaps due to national differences in gait. There was a significant rightward deviation for the Swiss, but not for the Australians. It is suggested that driving practices have a small additive effect on rightward attentional biases whereby the bias is increased for people who drive on the right and reduced in people who drive on the left.	[Thomas, Nicole A.; Churches, Owen; White, Ian; Nicholls, Michael E. R.] Flinders Univ S Australia, Sch Psychol, Adelaide, SA, Australia; [Mohr, Christine; Schrag, Yann; Obucina, Sabrina] Univ Lausanne, Inst Psychol, Lausanne, Switzerland	Flinders University South Australia; University of Lausanne	Nicholls, MER (corresponding author), Flinders Univ S Australia, Sch Psychol, Adelaide, SA, Australia.	mike.nicholls@flinders.edu.au		Mohr, Christine/0000-0002-3720-7115; Nicholls, Mike/0000-0002-7072-3744; Churches, Owen/0000-0002-2571-4849; Thomas, Nicole/0000-0002-1112-9024	Australian Research Council [DP 160100757]	Australian Research Council(Australian Research Council)	This research was supported with a grant from the Australian Research Council (DP 160100757; http://www.arc.gov.au/) to MN and NT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Obaidi S, 2003, J REHABIL RES DEV, V40, P361, DOI 10.1682/JRRD.2003.07.0361; Berti A, 2002, NEUROPSYCHOLOGY, V16, P390, DOI 10.1037//0894-4105.16.3.390; Bonato M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00195; BOWERS D, 1980, NEUROPSYCHOLOGIA, V18, P491, DOI 10.1016/0028-3932(80)90151-7; Cai Q, 2013, P NATL ACAD SCI USA, V110, pE322, DOI 10.1073/pnas.1212956110; Cho SH, 2004, CLIN BIOMECH, V19, P145, DOI 10.1016/j.clinbiomech.2003.10.003; Cinelli ME, 2009, Q J EXP PSYCHOL, V62, P483, DOI 10.1080/17470210802168583; Cromie S, 2007, LATERALITY, V12, P500, DOI 10.1080/13576500701575140; Ebersbach G, 2000, MOVEMENT DISORD, V15, P1145, DOI 10.1002/1531-8257(200011)15:6<1145::AID-MDS1013>3.0.CO;2-C; Fujikake H, 2011, EXP BRAIN RES, V210, P195, DOI 10.1007/s00221-011-2621-3; Hatin B, 2012, CORTEX, V48, P997, DOI 10.1016/j.cortex.2011.05.015; Iyer S., 2012, INT J ENG SCI TECHNO, V4, P4571; Jang S. - L., 2009, CYBERPSYCHOLOGY BEHA, V12, P81, DOI [10.1089/cpb.2008.9999.abs, DOI 10.1089/CPB.2008.9999.ABS]; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; Mattingley JB, 2004, NEUROPSYCHOLOGIA, V42, P387, DOI 10.1016/j.neuropsychologia.2003.07.007; MATTINGLEY JB, 1992, BRAIN, V115, P1849, DOI 10.1093/brain/115.6.1849; Mohr C, 2004, BEHAV BRAIN RES, V151, P321, DOI 10.1016/j.bbr.2003.09.006; Mohr C, 2007, LATERALITY, V12, P172, DOI 10.1080/13576500601051580; Nicholls ME, 2016, J EXPT PSYCHOL APPL; Nicholls MER, 2008, BRAIN COGNITION, V68, P166, DOI 10.1016/j.bandc.2008.04.003; Nicholls MER, 2007, NEUROPSYCHOLOGIA, V45, P1122, DOI 10.1016/j.neuropsychologia.2006.07.015; Nicholls MER, 2013, CORTEX, V49, P2914, DOI 10.1016/j.cortex.2013.02.002; Nicholls MER, 2011, BRAIN COGNITION, V76, P349, DOI 10.1016/j.bandc.2011.04.006; Nicholls MER, 2010, ATTEN PERCEPT PSYCHO, V72, P1576, DOI 10.3758/APP.72.6.1576; Robertson JS, 2014, ATTEN PERCEPT PSYCHO, V77, P830; Ryu T, 2006, INT J IND ERGONOM, V36, P1023, DOI 10.1016/j.ergon.2006.09.013; SELTZER C, 1990, J COMP PSYCHOL, V104, P159, DOI 10.1037/0735-7036.104.2.159; Simon-Dack SL, 2013, NEUROREPORT, V24, P827, DOI 10.1097/WNR.0b013e328364125b; Slagter HA, 2010, NEUROPSYCHOLOGIA, V48, P1265, DOI 10.1016/j.neuropsychologia.2009.12.027; Thomas NA, 2009, J INT NEUROPSYCH SOC, V15, P225, DOI 10.1017/S1355617709090328; Turnbull OH, 1998, BRAIN COGNITION, V37, P31; WEINTRAUB S, 1988, J NEUROL NEUROSUR PS, V51, P1481, DOI 10.1136/jnnp.51.12.1481; WEINTRAUB S, 1987, ARCH NEUROL-CHICAGO, V44, P621, DOI 10.1001/archneur.1987.00520180043014; Weiss PH, 2000, BRAIN, V123, P2531, DOI 10.1093/brain/123.12.2531	35	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186171	10.1371/journal.pone.0186171	http://dx.doi.org/10.1371/journal.pone.0186171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020027	Green Published, Green Accepted, gold			2022-12-26	WOS:000412754400076
J	Kala, P; Kanovsky, J; Novakova, T; Miklik, R; Bocek, O; Poloczek, M; Jerabek, P; Prymkova, L; Ondrus, T; Jarkovsky, J; Blaha, M; Mintz, GS				Kala, Petr; Kanovsky, Jan; Novakova, Tereza; Miklik, Roman; Bocek, Otakar; Poloczek, Martin; Jerabek, Petr; Prymkova, Lenka; Ondrus, Tomas; Jarkovsky, Jiri; Blaha, Milan; Mintz, Gary S.			Radial artery neointimal hyperplasia after transradial PCI-Serial optical coherence tomography volumetric study	PLOS ONE			English	Article							CORONARY-ANGIOGRAPHY; ACCESS SITE; INTERVENTION; ULTRASOUND; BENEFIT; INJURY	Aims Transradial catheterization (TRC) is a dominant access site for coronary catheterization and percutaneous coronary interventions (PCI) in many centers. Previous studies reported higher intimal thickness of the radial artery (RA) wall in patients with a previous history of TRC. In this investigation the aim was to assess the intimal changes of RA using the optical coherence tomography (OCT) intravascular imaging in a serial manner. Methods and results 100 patients with the diagnosis of non-ST-elevation myocardial infarction (nSTEMI) treated by PCI were enrolled (6 patients were excluded from this analysis because of occluded RA at follow-up [2 patients] and insufficient quality of OCT images [4 patients]). An 54mm long OCT run of the RA was performed immediately after the index PCI and repeated 9 months later. Volumetric analyses of the intimal layer and lumen changes were conducted. Median intimal volume at baseline versus 9 months was 33.9mm(3) (19.0; 69.4) versus 39.0mm(3) (21.7; 72.6) (p<0.001); and median arterial lumen volume was 356.3mm(3) (227.8; 645.3) versus 304.7mm(3) (186.1; 582.7) (p<0.001). There was no significant difference in the effect of any clinical factor on the RA volume changes. Conclusions OCT volumetric analyses at baseline and 9 months showed a significant increase in the radial artery intimal layer volume and a decrease in lumen volume after transradial PCI. No significant factors affecting this process were identified.	[Kala, Petr; Kanovsky, Jan; Novakova, Tereza; Miklik, Roman; Bocek, Otakar; Poloczek, Martin; Jerabek, Petr; Prymkova, Lenka; Ondrus, Tomas] Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic; [Kala, Petr; Kanovsky, Jan; Novakova, Tereza; Miklik, Roman; Bocek, Otakar; Poloczek, Martin; Jerabek, Petr; Prymkova, Lenka; Ondrus, Tomas] Masaryk Univ Brno, Med Fac, Brno, Czech Republic; [Jarkovsky, Jiri; Blaha, Milan] Masaryk Univ Brno, Inst Biostat & Anal, Brno, Czech Republic; [Mintz, Gary S.] Cardiovasc Res Fdn, New York, NY USA	University Hospital Brno; Masaryk University Brno; Institute of Biostatistics & Analyses; Masaryk University Brno; Cardiovascular Research Foundation (CRF)	Kanovsky, J (corresponding author), Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic.; Kanovsky, J (corresponding author), Masaryk Univ Brno, Med Fac, Brno, Czech Republic.	kanovsky.jan@fnbrno.cz	Ondrus, Tomas/AAV-2604-2021; Kanovsky, Jan/ABC-1404-2021	Ondrus, Tomas/0000-0002-6621-0364; Kanovsky, Jan/0000-0003-1352-6274	Internal Grant Agency of the Ministry of Health of the Czech Republic [NT/13830-4]	Internal Grant Agency of the Ministry of Health of the Czech Republic	This study was supported by the grant of the Internal Grant Agency of the Ministry of Health of the Czech Republic NT/13830-4.	Bertrand OF, 2010, JACC-CARDIOVASC INTE, V3, P1022, DOI 10.1016/j.jcin.2010.07.013; Bezerra HG, 2009, JACC-CARDIOVASC INTE, V2, P1035, DOI 10.1016/j.jcin.2009.06.019; Burris NS, 2008, ANN THORAC SURG, V85, P1271, DOI 10.1016/j.athoracsur.2007.12.044; CAMPEAU L, 1989, CATHETER CARDIO DIAG, V16, P3, DOI 10.1002/ccd.1810160103; Caputo RP, 2011, CATHETER CARDIO INTE, V78, P823, DOI 10.1002/ccd.23052; Chase AJ, 2008, HEART, V94, P1019, DOI 10.1136/hrt.2007.136390; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; KIEMENEIJ F, 1993, CATHETER CARDIO DIAG, V30, P173, DOI 10.1002/ccd.1810300220; Mamas MA, 2014, EUROINTERVENTION, V10, P824, DOI 10.4244/EIJV10I7A142; Mattea V, 2017, IJC HEART VASC, V14, P46, DOI 10.1016/j.ijcha.2016.12.003; Nakata T, 2015, INT HEART J, V56, P489, DOI 10.1536/ihj.15-094; Novakova T, 2016, BIOMED PAP, V160, P393, DOI 10.5507/bp.2016.035; Wakeyama T, 2003, J AM COLL CARDIOL, V41, P1109, DOI 10.1016/S0735-1097(03)00089-5; Yonetsu T, 2010, EUR HEART J, V31, P1608, DOI 10.1093/eurheartj/ehq102	14	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185404	10.1371/journal.pone.0185404	http://dx.doi.org/10.1371/journal.pone.0185404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016632	Green Published, gold, Green Submitted			2022-12-26	WOS:000412627400017
J	Takada, YK; Yu, J; Fujita, M; Saegusa, J; Wu, CY; Takada, Y				Takada, Yoko K.; Yu, Jessica; Fujita, Masaaki; Saegusa, Jun; Wu, Chun-Yi; Takada, Yoshikazu			Direct binding to integrins and loss of disulfide linkage in interleukin-1 (IL-1) are involved in the agonistic action of IL-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; integrin; interleukin-1 (IL-1); mutagenesis; NF-B (NF-KB); IL-1; disulfide linkage; agonistic action	TERNARY COMPLEX-FORMATION; RECEPTOR IGF1R; DEFECTIVE MUTANT; ALPHA-V-BETA-3; ANTAGONIST; ALPHA-6-BETA-4; TUMORIGENESIS; FIBRONECTIN; ACTIVATION; CELLS	There is a strong link between integrins and interleukin-1 (IL-1), but the specifics of the role of integrins in IL-1 signaling are unclear. We describe that IL-1 specifically bound to integrins v3 and 51. The E128K mutation in the IL1R-binding site enhanced integrin binding. We studied whether direct integrin binding is involved in IL-1 signaling. We compared sequences of IL-1 and IL-1 receptor antagonist (IL1RN), which is an IL-1 homologue but has no agonistic activity. Several surface-exposed Lys residues are present in IL-1, but not in IL1RN. A disulfide linkage is present in IL1RN, but is not in IL-1 because of natural C117F mutation. Substitution of the Lys residues to Glu markedly reduced integrin binding of E128K IL-1, suggesting that the Lys residues mediate integrin binding. The Lys mutations reduced, but did not completely abrogate, agonistic action of IL-1. We studied whether the disulfide linkage plays a role in agonistic action of IL-1. Reintroduction of the disulfide linkage by the F117C mutation did not affect agonistic activity of WT IL-1, but effectively reduced the remaining agonistic activity of the Lys mutants. Also, deletion of the disulfide linkage in IL1RN by the C116F mutation did not make it agonistic. We propose that the direct binding to IL-1 to integrins is primarily important for agonistic IL-1 signaling, and that the disulfide linkage indirectly affects signaling by blocking conformational changes induced by weak integrin binding to the Lys mutants. The integrin-IL-1 interaction is a potential target for drug discovery.	[Takada, Yoko K.; Yu, Jessica; Fujita, Masaaki; Saegusa, Jun; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Takada, Yoko K.; Yu, Jessica; Fujita, Masaaki; Wu, Chun-Yi; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Yu, Jessica] Acad Sinica, Inst Biol Chem, 128 Acad Rd,Sec 2, Taipei 11529, Taiwan; [Yu, Jessica] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, 250 Wu Hsing St, Taipei 11031, Taiwan	University of California System; University of California Davis; University of California System; University of California Davis; Academia Sinica - Taiwan; Taipei Medical University	Takada, Y (corresponding author), Suite 3300,4645 Second Ave, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu			National Institutes of Health [R33CA196445, T32 HL007013]; Kanae Foundation for the Promotion of Medical Science; Taiwan Protein Project [MOST105-0210-01-12-01, MOST106-0210-01-15-04]; NATIONAL CANCER INSTITUTE [R33CA196445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kanae Foundation for the Promotion of Medical Science; Taiwan Protein Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R33CA196445, funding from The Kanae Foundation for the Promotion of Medical Science (to M.F.), and National Institutes of Health Grant T32 HL007013 (to J.Y.). This research was supported by Taiwan Protein Project Grants MOST105-0210-01-12-01 and MOST106-0210-01-15-04. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; CURTIS BM, 1989, P NATL ACAD SCI USA, V86, P3045, DOI 10.1073/pnas.86.9.3045; Dangerfield JP, 2005, J LEUKOCYTE BIOL, V77, P159, DOI 10.1189/jlb.0704421; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Fujita M, 2013, J BIOL CHEM, V288, P19593, DOI 10.1074/jbc.M113.470872; Fujita M, 2013, J BIOL CHEM, V288, P3059, DOI 10.1074/jbc.M112.412536; Fujita M, 2012, J IMMUNOL, V189, P5809, DOI 10.4049/jimmunol.1200889; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; GRUTTER MG, 1994, PROTEIN ENG, V7, P663, DOI 10.1093/protein/7.5.663; Hailey KL, 2013, J MOL BIOL, V425, P2382, DOI 10.1016/j.jmb.2013.03.016; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Kawaguchi M, 2001, BIOCHEM BIOPH RES CO, V288, P711, DOI 10.1006/bbrc.2001.5809; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Oakley FD, 2009, J BIOL CHEM, V284, P33255, DOI 10.1074/jbc.M109.042127; Peng Q, 2005, J IMMUNOL, V174, P2258, DOI 10.4049/jimmunol.174.4.2258; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang AZ, 1997, ARTHRITIS RHEUM, V40, P1298, DOI 10.1002/art.1780400715; Yamaji S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010273	27	10	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20067	20075		10.1074/jbc.M117.818302	http://dx.doi.org/10.1074/jbc.M117.818302			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29030430	hybrid, Green Published			2022-12-26	WOS:000417696400014
J	Tian, YY; Shen, X; Wang, R; Klages-Mundt, NL; Lynn, EJ; Martin, SK; Ye, Y; Gao, M; Chen, JJ; Schlacher, K; Li, L				Tian, Yanyan; Shen, Xi; Wang, Rui; Klages-Mundt, Naeh L.; Lynn, Erica J.; Martin, Sara K.; Ye, Yin; Gao, Min; Chen, Junjie; Schlacher, Katharina; Li, Lei			Constitutive role of the Fanconi anemia D2 gene in the replication stress response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA repair; DNA replication; gene knock-out; genomic instability; Fanconi anemia; nucleases; replication stress	CROSS-LINK REPAIR; DNA-END-RESECTION; MONOUBIQUITINATED FANCD2; CORE-COMPLEX; HOMOLOGOUS RECOMBINATION; UBIQUITIN LIGASE; GENOME STABILITY; BINDING-PROTEIN; FORK RECOVERY; BREAK REPAIR	In response to DNA cross-linking damage, the Fanconi anemia (FA) core complex activates the FA pathway by monoubiquitinating Fanconi anemia complementation group D2 (FANCD2) for the initiation of the nucleolytic processing of the DNA cross-links and stabilization of stalled replication forks. Given that all the classic FA proteins coordinately monoubiquitinate FANCD2, it is unclear why losses of individual classic FA genes yield varying cellular sensitivities to cross-linking damage. To address this question, we generated cellular knock-out models of FA core complex components and FANCD2 and found that FANCD2-null mutants display higher levels of spontaneous chromosomal damage and hypersensitivity to replication-blocking lesions than Fanconi anemia complementation group L (FANCL)-null mutants, suggesting that FANCD2 provides a basal level of DNA protection countering endogenous lesions in the absence of monoubiquitination. FANCD2's ubiquitination-independent function is likely involved in optimized recruitment of nucleolytic activities for the processing and protection of stressed replication forks. Our results reveal that FANCD2 has a ubiquitination-independent role in countering endogenous levels of replication stress, a function that is critical for the maintenance of genomic stability.	[Tian, Yanyan; Shen, Xi; Wang, Rui; Klages-Mundt, Naeh L.; Lynn, Erica J.; Martin, Sara K.; Ye, Yin; Gao, Min; Chen, Junjie; Li, Lei] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Schlacher, Katharina] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Klages-Mundt, Naeh L.; Martin, Sara K.; Chen, Junjie; Li, Lei] Univ Texas MD Anderson Canc Ctr, Program Genet & Epigenet, Hlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Schlacher, Katharina] Univ Texas MD Anderson Canc Ctr, Program Canc Biol, Hlth Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Li, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 1052, 6565 MD Anderson Blvd, Houston, TX 77030 USA.	leili@mdanderson.org		SCHLACHER, KATHARINA/0000-0001-7226-6391; Martin, Sara/0000-0002-7661-272X; Klages-Mundt, Naeh/0000-0001-8240-6589; /0000-0002-5592-9349	National Institutes of Health [CA179441, CA190635, CA193124-Project 3, CA157448]; Cancer Prevention and Research Institute of Texas Grant [RP150538]; Olive Stringer endowed professorship; Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE [R01CA157448, P01CA193124, P30CA016672, R01CA190635, R21CA179441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas Grant; Olive Stringer endowed professorship; Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA179441 and CA190635 and CA193124-Project 3 (to L. L.) and CA157448 (to J. C.), Cancer Prevention and Research Institute of Texas Grant RP150538 (to J. C. and L. L.), the Olive Stringer endowed professorship (to L. L.), and a recruitment award from the Cancer Prevention and Research Institute of Texas (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali AM, 2012, BLOOD, V119, P3285, DOI 10.1182/blood-2011-10-385963; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Bhagwat N, 2009, MOL CELL BIOL, V29, P6427, DOI 10.1128/MCB.00086-09; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chaudhury I, 2013, NUCLEIC ACIDS RES, V41, P6444, DOI 10.1093/nar/gkt348; Collis SJ, 2006, DNA REPAIR, V5, P1398, DOI 10.1016/j.dnarep.2006.06.010; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Feeney L, 2017, MOL CELL, V66, P610, DOI 10.1016/j.molcel.2017.04.021; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; GERMAN J, 1987, BLOOD, V69, P1637; Hira A, 2015, AM J HUM GENET, V96, P1001, DOI 10.1016/j.ajhg.2015.04.022; HOPPESEYLER F, 1993, J VIROL, V67, P3111, DOI 10.1128/JVI.67.6.3111-3117.1993; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Huang YL, 2014, CELL REP, V7, P1849, DOI 10.1016/j.celrep.2014.04.029; Inano S, 2017, MOL CELL, V66, P622, DOI 10.1016/j.molcel.2017.04.022; Kais Z, 2016, CELL REP, V15, P2488, DOI 10.1016/j.celrep.2016.05.031; Kalb R, 2007, AM J HUM GENET, V80, P895, DOI 10.1086/517616; Karanja KK, 2014, CELL CYCLE, V13, P1540, DOI 10.4161/cc.28476; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Lachaud C, 2016, SCIENCE, V351, P846, DOI 10.1126/science.aad5634; Leung JWC, 2012, P NATL ACAD SCI USA, V109, P4491, DOI 10.1073/pnas.1118720109; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Liang CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12124; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Lossaint G, 2013, MOL CELL, V51, P678, DOI 10.1016/j.molcel.2013.07.023; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; POLL EHA, 1985, HUM GENET, V71, P206, DOI 10.1007/BF00284574; Rajendra E, 2014, MOL CELL, V54, P858, DOI 10.1016/j.molcel.2014.05.001; Rickman KA, 2015, CELL REP, V12, P35, DOI 10.1016/j.celrep.2015.06.014; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Schwab RA, 2015, MOL CELL, V60, P351, DOI 10.1016/j.molcel.2015.09.012; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Thongthip S, 2016, GENE DEV, V30, P645, DOI 10.1101/gad.276261.115; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Unno J, 2014, CELL REP, V7, P1039, DOI 10.1016/j.celrep.2014.04.005; Vandenberg CJ, 2003, MOL CELL, V12, P247, DOI 10.1016/S1097-2765(03)00281-8; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Wang AT, 2015, MOL CELL, V59, P478, DOI 10.1016/j.molcel.2015.07.009; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Yan ZJ, 2012, MOL CELL, V47, P61, DOI 10.1016/j.molcel.2012.05.026; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Yeo JE, 2014, HUM MOL GENET, V23, P3695, DOI 10.1093/hmg/ddu078; Zhang XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000645	56	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20184	20195		10.1074/jbc.M117.814780	http://dx.doi.org/10.1074/jbc.M117.814780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29021208	hybrid, Green Published			2022-12-26	WOS:000417696400023
J	Burchill, MA; Roby, JA; Crochet, N; Wind-Rotolo, M; Stone, AE; Edwards, MG; Dran, RJ; Kriss, MS; Gale, M; Rosen, HR				Burchill, Matthew A.; Roby, Justin A.; Crochet, Nanette; Wind-Rotolo, Megan; Stone, Amy E.; Edwards, Michael G.; Dran, Rachael J.; Kriss, Michael S.; Gale, Michael, Jr.; Rosen, Hugo R.			Rapid reversal of innate immune dysregulation in blood of patients and livers of humanized mice with HCV following DAA therapy	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; INTERFERON-FREE THERAPY; INFECTED PATIENTS; ASSOCIATION; ACTIVATION; MANAGEMENT; AMERICAN; FIBROSIS; PROTEIN	Chronic hepatitis C virus (HCV)infection results in sustained immune activation in both the periphery and hepatic tissue. HCV infection induces innate immune signaling that is responsible for recognition of dsRNA, leading to activation of transcription factors and production of Type I and III IFNs, as well as pro-inflammatory cytokines and chemokines. Continued activation of host-immune mediated inflammation is thought to contribute to pathologic changes that result in progressive hepatic fibrosis. The current standard treatment for chronic HCV infection is directly-acting antivirals (DAAs), which have provided the unique opportunity to determine whether successful, rapid treatment-induced eradication of viral RNA normalizes the dysregulated antiviral innate immune response in patients chronically infected with HCV.	[Burchill, Matthew A.; Dran, Rachael J.; Kriss, Michael S.; Rosen, Hugo R.] UCD, Dept Med, Hepatitis C Ctr, Div Gastroenterol & Hepatol, Aurora, CO 80204 USA; [Roby, Justin A.; Crochet, Nanette; Stone, Amy E.; Gale, Michael, Jr.] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA; [Roby, Justin A.; Crochet, Nanette; Stone, Amy E.; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Wind-Rotolo, Megan] Bristol Myers Squibb Exploratory Clin & Translat, Lawrenceville, NJ USA; [Edwards, Michael G.] Bioinfo Solut LLC, Parker, CO USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rosen, HR (corresponding author), UCD, Dept Med, Hepatitis C Ctr, Div Gastroenterol & Hepatol, Aurora, CO 80204 USA.	Hugo.Rosen@UCDENVER.edu	Stone, Amy/T-7852-2019; Kriss, Michael/AAA-9959-2021	Roby, Justin/0000-0003-2434-4273; STONE, AMY E/0000-0002-9140-6510	Gilead North American Research Scholars Award; Bioinfo Solutions LLC; Bristol-Myers Squibb; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118916, R01AI120622] Funding Source: NIH RePORTER	Gilead North American Research Scholars Award; Bioinfo Solutions LLC; Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Gilead North American Research Scholars Award: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; and by Bioinfo Solutions LLC: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MGE was involved in the data analysis as a contractor. This work was also supported by Bristol-Myers Squibb: The funders provided support in the form of salaries for authors (MWR) and provided study materials in collaboration with our group. Thus, the funders reviewed the manuscript but did not have any additional roles in the study design, data collection and analysis or decision to publish.	Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bachofner JA, 2017, LIVER INT, V37, P369, DOI 10.1111/liv.13256; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Burchill MA, 2015, J VIRAL HEPATITIS, V22, P983, DOI 10.1111/jvh.12465; Burton JR, 2008, J HEPATOL, V49, P329, DOI 10.1016/j.jhep.2008.05.020; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P231, DOI 10.1053/j.gastro.2005.11.010; Ellis ECS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078550; Everson G, 2015, LIVER INT, V35, P108, DOI 10.1111/liv.12471; Fried MW, 2002, HEPATOLOGY, V36, pS237, DOI 10.1053/jhep.2002.36810; Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; Horner SM, 2014, J MOL BIOL, V426, P1198, DOI 10.1016/j.jmb.2013.10.032; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Kurelac I, 2012, J INTERF CYTOK RES, V32, P386, DOI 10.1089/jir.2012.0006; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; McMahan RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159217; Meissner EG, 2014, J CLIN INVEST, V124, P3352, DOI 10.1172/JCI75938; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Rosen HR, 2013, J CLIN INVEST, V123, P4121, DOI 10.1172/JCI67714; Schaefer M, 2012, J HEPATOL, V57, P1379, DOI 10.1016/j.jhep.2012.07.037; Schaefer M, 2012, ANN INTERN MED, V157, P94, DOI 10.7326/0003-4819-157-2-201207170-00006; Serti E, 2015, GASTROENTEROLOGY, V149, P190, DOI 10.1053/j.gastro.2015.03.004; Spaan M, 2016, J INFECT DIS, V213, P216, DOI 10.1093/infdis/jiv391; Taylor MW, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-66; Tsuchida T., 2017, NAT REV GASTROENTERO; Wilkins C, 2013, HEPATOLOGY, V57, P461, DOI 10.1002/hep.26066	30	19	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186213	10.1371/journal.pone.0186213	http://dx.doi.org/10.1371/journal.pone.0186213			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040318	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500026
J	Clarke, F; Jordan, CK; Gutierrez-Martinez, E; Bibby, JA; Sanchez-Blanco, C; Cornish, GH; Dai, XZ; Rawlings, DJ; Zamoyska, R; Guermonprez, P; Cope, AP; Purvis, HA				Clarke, Fiona; Jordan, Christine K.; Gutierrez-Martinez, Enrique; Bibby, Jack A.; Sanchez-Blanco, Cristina; Cornish, Georgina H.; Dai, Xuezhi; Rawlings, David J.; Zamoyska, Rose; Guermonprez, Pierre; Cope, Andrew P.; Purvis, Harriet A.			Protein tyrosine phosphatase PTPN22 is dispensable for dendritic cell antigen processing and promotion of T-cell activation by dendritic cells	PLOS ONE			English	Article							AUTOIMMUNE-DISEASE; MANNOSE RECEPTOR; VARIANT; MACROPINOCYTOSIS; COMPLEX; PHOSPHORYLATION; DEGRADATION; ENDOCYTOSIS; INTERFERON; IMMUNITY	The PTPN22(R620W) single nucleotide polymorphism increases the risk of developing multiple autoimmune diseases including type 1 diabetes, rheumatoid arthritis and lupus. PTPN22 is highly expressed in antigen presenting cells (APCs) where the expression of the murine disease associated variant orthologue (Ptpn22(R619W)) is reported to dysregulate pattern recognition receptor signalling in dendritic cells (DCs) and promote T-cell proliferation. Because T-cell activation is dependent on DC antigen uptake, degradation and presentation, we analysed the efficiency of these functions in splenic and GM-CSF bone marrow derived DC from wild type (WT), Ptpn22(-/-) or Ptpn22(R619W) mutant mice. Results indicated no differential ability of DCs to uptake antigen via macropinocytosis or receptor-mediated endocytosis. Antigen degradation and presentation was also equal as was WT T-cell conjugate formation and subsequent T-cell proliferation. Despite the likely presence of multiple phosphatase-regulated pathways in the antigen uptake, processing and presentation pathways that we investigated, we observed that Ptpn22 and the R619W autoimmune associated variant were dispensable. These important findings indicate that under non-inflammatory conditions there is no requirement for Ptpn22 in DC dependent antigen uptake and T-cell activation. Our findings reveal that perturbations in antigen uptake and processing, a fundamental pathway determining adaptive immune responses, are unlikely to provide a mechanism for the risk associated with the Ptpn22 autoimmune associated polymorphism.	[Clarke, Fiona; Jordan, Christine K.; Bibby, Jack A.; Sanchez-Blanco, Cristina; Cornish, Georgina H.; Cope, Andrew P.; Purvis, Harriet A.] Kings Coll London, Acad Dept Rheumatol, Fac Life Sci & Med, Ctr Inflammat Biol & Canc Immunol, London, England; [Gutierrez-Martinez, Enrique; Guermonprez, Pierre] Kings Coll London, Fac Life Sci & Med, Dept Immunobiol, Ctr Inflammat Biol & Canc Immunol, London, England; [Dai, Xuezhi; Rawlings, David J.] Univ Washington, Sch Med, Seattle Childrens Res Inst, Seattle, WA USA; [Dai, Xuezhi; Rawlings, David J.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Dai, Xuezhi; Rawlings, David J.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA USA; [Zamoyska, Rose] Univ Edinburgh, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland	University of London; King's College London; University of London; King's College London; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Edinburgh	Purvis, HA (corresponding author), Kings Coll London, Acad Dept Rheumatol, Fac Life Sci & Med, Ctr Inflammat Biol & Canc Immunol, London, England.	harriet.purvis@kcl.ac.uk	Guermonprez, Pierre/ABE-7718-2020; Gutiérrez-Martínez, Enric/J-5965-2017; Rawlings, David/CAI-4751-2022	Guermonprez, Pierre/0000-0001-5621-2262; Gutiérrez-Martínez, Enric/0000-0003-1316-3936; Bibby, Jack/0000-0002-0875-446X; Cornish, Georgina/0000-0002-1984-6677; Zamoyska, Rose/0000-0001-9816-2638; Cope, Andrew/0000-0001-6735-5496	Arthritis Research UK [20218, 20525]; Wellcome Trust [096669AIA]; National Institutes of Health [DP3-DK097672, DP3-DK111802]; Children's Guild Association Endowed Chair in Pediatric Immunology; Benaroya Family Gift Fund; National Institute for Health Research (NIHR) BioResource Clinical Research facility and Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust; King's College London [guysbrc-2012-17]; BBSRC [BB/M029735/1] Funding Source: UKRI; MRC [MR/K01241X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M029735/1] Funding Source: researchfish; Medical Research Council [MR/K01241X/1] Funding Source: researchfish; Rosetrees Trust [M652] Funding Source: researchfish; Versus Arthritis [20218, 20525] Funding Source: researchfish; National Centre for the Replacement [NC/K001868/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK111802] Funding Source: NIH RePORTER	Arthritis Research UK(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Guild Association Endowed Chair in Pediatric Immunology; Benaroya Family Gift Fund; National Institute for Health Research (NIHR) BioResource Clinical Research facility and Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust; King's College London; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Versus Arthritis(Versus Arthritis); National Centre for the Replacement; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by Arthritis Research UK (http://www.arthritsresearchuk.org) grants 20218 (awarded to H.A.P and A.P.C), 20525 (awarded to G.H.C, P.G, R.Z and A.P.C), Wellcome Trust (https://wellcome.ac.uk) Investigator Award 096669AIA (awarded to R.Z) and National Institutes of Health (https:/www.nih.gov): DP3-DK097672 and DP3-DK111802 (to D.J.R). Additional support was provided by the Children's Guild Association Endowed Chair in Pediatric Immunology and the Benaroya Family Gift Fund (to D.J.R.). This work was also supported by infrastructure funded by the National Institute for Health Research (NIHR) BioResource Clinical Research facility and Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust and King's College London (reference: guysbrc-2012-17). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brownlie RJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003365; Burn GL, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2195; Burn GL, 2011, FEBS LETT, V585, P3689, DOI 10.1016/j.febslet.2011.04.032; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cox D, 2001, J EXP MED, V193, P61, DOI 10.1084/jem.193.1.61; Dai XZ, 2013, J CLIN INVEST, V123, P2024, DOI 10.1172/JCI66963; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Fiorillo E, 2010, J BIOL CHEM, V285, P26506, DOI 10.1074/jbc.M110.111104; Freeman SA, 2014, IMMUNOL REV, V262, P193, DOI 10.1111/imr.12212; Gomez CP, 2012, J IMMUNOL, P189; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Holmes DA, 2015, J EXP MED, V212, P1081, DOI 10.1084/jem.20142130; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Lecuit M, 2007, CELL MICROBIOL, V9, P2629; Li MH, 2017, J AUTOIMMUN, V79, P74, DOI 10.1016/j.jaut.2017.01.009; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Maine CJ, 2014, J IMMUNOL, V192, P1415, DOI 10.4049/jimmunol.1302418; Norbury CC, 1997, EUR J IMMUNOL, V27, P280, DOI 10.1002/eji.1830270141; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Purvis HA, 2017, EUR J; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Salmond RJ, 2014, NAT IMMUNOL, V15, P875, DOI 10.1038/ni.2958; Savina A, 2010, METHODS MOL BIOL, V595, P383, DOI 10.1007/978-1-60761-421-0_25; Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Suzuki T, 2000, J IMMUNOL, P165; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Viret C, 2000, J IMMUNOL, P164; Wang YY, 2015, ARTHRITIS RHEUMATOL, V67, P2403, DOI 10.1002/art.39211; Wang YY, 2013, IMMUNITY, V39, P111, DOI 10.1016/j.immuni.2013.06.013; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhu JW, 2007, J BIOL CHEM, V282, P16086, DOI 10.1074/jbc.M701997200	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186625	10.1371/journal.pone.0186625	http://dx.doi.org/10.1371/journal.pone.0186625			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040339	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500063
J	Walsh, JC; Angstmann, CN; Duggin, IG; Curmi, PMG				Walsh, James C.; Angstmann, Christopher N.; Duggin, Iain G.; Curmi, Paul M. G.			Non-linear Min protein interactions generate harmonics that signal mid-cell division in Escherichia coli	PLOS ONE			English	Article							TOPOLOGICAL SPECIFICITY FACTOR; PATTERN-FORMATION; FTSZ RING; MEMBRANE; LOCALIZATION; OSCILLATIONS; CYTOKINESIS; DYNAMICS; REVEALS; DOMAINS	The Min protein system creates a dynamic spatial pattern in Escherichia coli cells where the proteins MinD and MinE oscillate from pole to pole. MinD positions MinC, an inhibitor of FtsZ ring formation, contributing to the mid-cell localization of cell division. In this paper, Fourier analysis is used to decompose experimental and model MinD spatial distributions into time-dependent harmonic components. In both experiment and model, the second harmonic component is responsible for producing a mid-cell minimum in MinD concentration. The features of this harmonic are robust in both experiment and model. Fourier analysis reveals a close correspondence between the time-dependent behaviour of the harmonic components in the experimental data and model. Given this, each molecular species in the model was analysed individually. This analysis revealed that membrane-bound MinD dimer shows the mid-cell minimum with the highest contrast when averaged over time, carrying the strongest signal for positioning the cell division ring. This concurs with previous data showing that the MinD dimer binds to MinC inhibiting FtsZ ring formation. These results show that non-linear interactions of Min proteins are essential for producing the mid-cell positioning signal via the generation of second-order harmonic components in the time-dependent spatial protein distribution.	[Walsh, James C.; Curmi, Paul M. G.] Univ New South Wales, Sch Phys, Sydney, NSW, Australia; [Walsh, James C.; Duggin, Iain G.] Univ Technol Sydney, Ithree Inst, Sydney, NSW, Australia; [Angstmann, Christopher N.] Univ New South Wales, Sch Math & Stat, Sydney, NSW, Australia; [Walsh, James C.] Univ New South Wales, Sch Med Sci, Single Mol Sci, Sydney, NSW, Australia	University of New South Wales Sydney; University of Technology Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Curmi, PMG (corresponding author), Univ New South Wales, Sch Phys, Sydney, NSW, Australia.	p.curmi@unsw.edu.au	Duggin, Iain/B-3904-2011; Curmi, Paul/G-7185-2011; Angstmann, Christopher/G-1990-2015	Duggin, Iain/0000-0003-4868-7350; Walsh, James/0000-0003-0447-2323; Curmi, Paul/0000-0001-5762-7638; Angstmann, Christopher/0000-0002-6688-9346	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	JCW is a recipient of an Australian Postgraduate Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey MW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004504; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; Crampin EJ, 1999, B MATH BIOL, V61, P1093, DOI 10.1006/bulm.1999.0131; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Fischer-Friedrich E, 2010, P NATL ACAD SCI USA, V107, P6134, DOI 10.1073/pnas.0911708107; Ghasriani Houman, 2011, Commun Integr Biol, V4, P101, DOI 10.4161/cib.4.1.14162; Ghosal D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6341; Hu ZL, 2000, J BACTERIOL, V182, P3965, DOI 10.1128/JB.182.14.3965-3971.2000; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Juarez JR, 2010, J BACTERIOL, V192, P4134, DOI 10.1128/JB.00364-10; Kang GB, 2010, MOL MICROBIOL, V76, P1222, DOI 10.1111/j.1365-2958.2010.07160.x; King GF, 2000, NAT STRUCT BIOL, V7, P1013, DOI 10.1038/80917; Kruse K, 2002, BIOPHYS J, V82, P618, DOI 10.1016/S0006-3495(02)75426-X; Loose M, 2011, ANNU REV BIOPHYS, V40, P315, DOI 10.1146/annurev-biophys-042910-155332; Meacci G, 2005, PHYS BIOL, V2, P89, DOI 10.1088/1478-3975/2/2/002; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Oliferenko S, 2009, GENE DEV, V23, P660, DOI 10.1101/gad.1772009; Park KT, 2012, MOL MICROBIOL, V85, P271, DOI 10.1111/j.1365-2958.2012.08110.x; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Rodrigues CDA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002561; Schiesser WE, 1991, NUMERICAL METHOD LIN, Vxiii; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Taghbalout A, 2006, J BACTERIOL, V188, P2993, DOI 10.1128/JB.188.8.2993-3001.2006; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Walsh JC, 2016, AIMS BIOPHYS, V3, P119, DOI 10.3934/biophy.2016.1.119; Walsh JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128148; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x	29	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0185947	10.1371/journal.pone.0185947	http://dx.doi.org/10.1371/journal.pone.0185947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040283	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500015
J	Aly, M; Elrobh, M; Alzayer, M; Aljuhani, S; Balkhy, H				Aly, Mahmoud; Elrobh, Mohamed; Alzayer, Maha; Aljuhani, Sameera; Balkhy, Hanan			Occurrence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) across the Gulf Corporation Council countries: Four years update	PLOS ONE			English	Article							DROMEDARY CAMELS; SAUDI-ARABIA; BATS; INFECTION; ORIGIN; TRACT	The emergence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections has become a global issue of dire concerns. MERS-CoV infections have been identified in many countries all over the world whereas high level occurrences have been documented in the Middle East and Korea. MERS-CoV is mainly spreading across the geographical region of the Middle East, especially in the Arabian Peninsula, while some imported sporadic cases were reported from the Europe, North America, Africa, and lately Asia. The prevalence of MERS-CoV infections across the Gulf Corporation Council (GCC) countries still remains unclear. Therefore, the objective of the current study was to report the prevalence of MERS-CoV in the GCC countries and to also elucidate on its demographics in the Arabian Peninsula. To date, the World Health Organization (WHO) has reported 1,797 laboratory-confirmed cases of MERS-CoV infection since June 2012, involving 687 deaths in 27 different countries worldwide. Within a time span of 4 years from June 2012 to July 2016, we collect samples form MERS-CoV infected individuals from National Guard Hospital, Riyadh, and Ministry of health Saudi Arabia and other GCC countries. Our data comprise a total of 1550 cases (67.1% male and 32.9% female). The age-specific prevalence and distribution of MERS-CoV was as follow: <20 yrs (36 cases: 3.28%), 20-39 yrs (331 cases: 30.15%), 40-59 yrs (314 cases: 28.60%), and the highest-risk elderly group aged >= 60 yrs (417 cases: 37.98%). The case distribution among GCC countries was as follows: Saudi Arabia (1441 cases: 93%), Kuwait (4 cases: 0.3%), Bahrain (1 case: 0.1%), Oman (8 cases: 0.5%), Qatar (16 cases: 1.0%), and United Arab Emirates (80 cases: 5.2%). Thus, MERS-CoV was found to be more prevalent in Saudi Arabia especially in Riyadh, where 756 cases (52.4%) were the worst hit area of the country identified, followed by the western region Makkah where 298 cases (20.6%) were recorded. This prevalence update indicates that the Arabian Peninsula, particularly Saudi Arabia, is the hardest hit region regarding the emerging MERS-CoV infections worldwide. GCC countries including Saudi Arabia now have the infrastructure in place that allows physicians and scientific community to identify and immediately respond to the potential risks posed by new outbreaks of MERS-CoV infections in the region. Given the continuum of emergence and the large magnitude of the disease in our region, more studies will be required to bolster capabilities for timely detection and effective control and prevention of MERS-CoV in our region.	[Aly, Mahmoud; Alzayer, Maha; Aljuhani, Sameera; Balkhy, Hanan] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Aly, Mahmoud; Aljuhani, Sameera; Balkhy, Hanan] King Saud bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Elrobh, Mohamed] King Saud Univ Riyadh, Coll Sci, Dept Biochem, Riyadh, Saudi Arabia; [Aljuhani, Sameera; Balkhy, Hanan] King Abdul Aziz Med City, Riyadh, Saudi Arabia	King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Saud Bin Abdulaziz University for Health Sciences; King Saud University	Aly, M (corresponding author), King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.; Aly, M (corresponding author), King Saud bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia.	alyma@ngha.med.sa	Aly, Mahmoud/AAY-6528-2020; Aly, Mahmoud/AAE-6579-2022; Elrobh, Mohamed S/H-5696-2012	, Mohamed/0000-0003-1967-8850; Aly, Mahmoud/0000-0002-0256-6169	King Abdullah International Medical Research Center KAIMRC (IRB) [RC15/128]	King Abdullah International Medical Research Center KAIMRC (IRB)	This study has been supported by funds from King Abdullah International Medical Research Center KAIMRC (IRB #RC15/128); The authors thank the KAIMRC members and Infectious Disease research unit for their help and support. This study was approved by the IRB and supported by funds from King Abdullah International Medical Research Center KAIMRC (Grant #RC15/128).	Al Shehri AM, 2015, MED TEACH, V37, pS88, DOI 10.3109/0142159X.2015.1006610; Al-Hameed F, 2015, J INTENSIVE CARE MED; Alagaili Abdulaziz N, 2014, mBio, V5, pe00884, DOI 10.1128/mBio.00884-14; Badawi A, 2016, INT J INFECT DIS, V49, P129, DOI 10.1016/j.ijid.2016.06.015; Chan RWY, 2014, LANCET RESP MED, V2, P813, DOI 10.1016/S2213-2600(14)70158-4; Chu DKW, 2014, EMERG INFECT DIS, V20, P1049, DOI 10.3201/eid2006.140299; Hawkes Nigel, 2013, BMJ, V347, pf6141, DOI 10.1136/bmj.f6141; Khalafalla AI, 2015, EMERG INFECT DIS, V21, P1153, DOI 10.3201/eid2107.150070; Kupferschmidt K, 2013, SCIENCE, V341, P948, DOI 10.1126/science.341.6149.948; Lau SKP, 2013, J VIROL, V87, P8638, DOI 10.1128/JVI.01055-13; Memish ZA, 2015, RECENT PAT ANTIINFEC; Memish ZA, 2014, EMERG INFECT DIS, V20, P1012, DOI 10.3201/eid2006.140402; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Mohd HA, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0544-0; Muller MA, 2014, EMERG INFECT DIS, V20, P2093, DOI 10.3201/eid2012.141026; Pebody R, 2012, EUROSURVEILLANCE, V17, P2; Reeves Tarian, 2015, BMC Res Notes, V8, P801, DOI 10.1186/s13104-015-1789-1; Reusken CB, 2014, EURO SURVEILL, V19; Shapiro Michael, 2016, Disaster Mil Med, V2, P9, DOI 10.1186/s40696-016-0019-2; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; van Doremalen N, 2015, ANTIVIR RES, V122, P28, DOI 10.1016/j.antiviral.2015.07.005; Yusof MF, 2015, VIRUS GENES, V50, P509, DOI 10.1007/s11262-015-1174-0; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8; Zumla A, 2014, LANCET, V383, P1869, DOI 10.1016/S0140-6736(14)60852-7	25	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0183850	10.1371/journal.pone.0183850	http://dx.doi.org/10.1371/journal.pone.0183850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028812	Green Published, Green Submitted, gold			2022-12-26	WOS:000412980300004
J	Ma, L; Chu, WL; Chai, JK; Shen, CA; Li, DW; Wang, XT				Ma, Li; Chu, Wanli; Chai, Jiake; Shen, Chuanan; Li, Dawei; Wang, Xiaoteng			ER stress and subsequent activated calpain play a pivotal role in skeletal muscle wasting after severe burn injury	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; 4-PHENYLBUTYRIC ACID; PROTEIN RESPONSE; INHIBITION; AUTOPHAGY; BONE; RATS; PROTEOLYSIS; CATABOLISM; ATROGIN-1	Severe burns are typically followed by hypermetabolism characterized by significant muscle wasting, which causes considerable morbidity and mortality. The aim of the present study was to explore the underlying mechanisms of skeletal muscle damage/wasting post-burn. Rats were randomized to the sham, sham+ 4-phenylbutyrate (4-PBA, a pharmacological chaperone promoting endoplasmic reticulum (ER) folding/trafficking, commonly considered as an inhibitor of ER), burn (30% total body surface area), and burn+ 4-PBA groups; and sacrificed at 1, 4, 7, 14 days after the burn injury. Tibial anterior muscle was harvested for transmission electron microscopy, calcium imaging, gene expression and protein analysis of ER stress /ubiquitin-proteasome system /autophagy, and calpain activity measurement. The results showed that ER stress markers were increased in the burn group compared with the sham group, especially at post-burn days 4 and 7, which might consequently elevate cytoplasmic calcium concentration, promote calpain production as well as activation, and cause skeletal muscle damage/wasting of TA muscle after severe burn injury. Interestingly, treatment with 4-PBA prevented burn-induced ER swelling and altered protein expression of ER stress markers and calcium release, attenuating calpain activation and skeletal muscle damage/ wasting after severe burn injury. Atrogin-1 and LC3-II/LC3-I ratio were also increased in the burn group compared with the sham group, while MuRF-1 remained unchanged; 4-PBA decreased atrogin-1 in the burn group. Taken together, these findings suggested that severe burn injury induces ER stress, which in turns causes calpain activation. ER stress and subsequent activated calpain play a critical role in skeletal muscle damage/wasting in burned rats.	[Ma, Li; Chu, Wanli; Chai, Jiake; Shen, Chuanan; Li, Dawei; Wang, Xiaoteng] Chinese Peoples Liberat Army, Gen Hosp, Hosp 1, Dept Burn & Plast Surg,Burns Inst, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Chai, JK (corresponding author), Chinese Peoples Liberat Army, Gen Hosp, Hosp 1, Dept Burn & Plast Surg,Burns Inst, Beijing, Peoples R China.	cjk304@126.com	Shen, Chuanan/M-2370-2019		National Natural Science Foundation of China [81501662, 81071544]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from the National Natural Science Foundation of China, the project number was 81501662 and 81071544 (to JC).	Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; Bartoli M, 2005, INT J BIOCHEM CELL B, V37, P2115, DOI 10.1016/j.biocel.2004.12.012; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Chai JK, 2003, CRIT CARE MED, V31, P1802, DOI 10.1097/01.CCM.0000069728.49939.E4; Chai JK, 2002, BURNS, V28, P527, DOI 10.1016/S0305-4179(02)00049-9; Choi SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep31925; Diao L, 2014, SHOCK, V41, P138, DOI 10.1097/SHK.0000000000000075; Diaz EC, 2015, BURNS, V41, P649, DOI 10.1016/j.burns.2014.10.010; Fareed MU, 2006, AM J PHYSIOL-REG I, V290, pR1589, DOI 10.1152/ajpregu.00668.2005; Feng DY, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12395; Gauglitz GG, 2010, SHOCK, V33, P299, DOI 10.1097/SHK.0b013e3181b2f439; Gissel H, 2005, ANN NY ACAD SCI, V1066, P166, DOI 10.1196/annals.1363.013; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hart DW, 2000, ANN SURG, V232, P455, DOI 10.1097/00000658-200010000-00001; Hart DW, 2000, SURGERY, V128, P312, DOI 10.1067/msy.2000.108059; Huang J, 1998, P NATL ACAD SCI USA, V95, P12100, DOI 10.1073/pnas.95.21.12100; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jeschke MG, 2016, J BURN CARE RES, V37, P86, DOI 10.1097/BCR.0000000000000265; Jewo P I, 2015, Ann Burns Fire Disasters, V28, P105; KLEIN GL, 1995, BONE, V17, P455, DOI 10.1016/8756-3282(95)00279-1; Klein GL, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.2; Klein GL, 2014, J BONE MINER METAB, V32, P136, DOI 10.1007/s00774-013-0483-4; Klionsky DJ, 2008, AUTOPHAGY, V4, P740, DOI 10.4161/auto.6398; Kolb PS, 2015, INT J BIOCHEM CELL B, V61, P45, DOI 10.1016/j.biocel.2015.01.015; Kym D, 2015, ANN SURG TREAT RES, V88, P281, DOI 10.4174/astr.2015.88.5.281; Lee CS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14659; Liu H, 2016, NATURAL OCCURRING CO, V2016; Liu LM, 2016, CRIT CARE MED, V44, pE689, DOI 10.1097/CCM.0000000000001662; Ma L, 2015, SHOCK, V43, P85, DOI 10.1097/SHK.0000000000000244; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Merritt EK, 2012, J BURN CARE RES OFFI, V33, pe783; Nelson WB, 2012, CRIT CARE MED, V40, P1857, DOI 10.1097/CCM.0b013e318246bb5d; Pereira C, 2005, INT J BIOCHEM CELL B, V37, P1948, DOI 10.1016/j.biocel.2005.05.009; Porter C, 2016, BURNS, V42, P112, DOI 10.1016/j.burns.2015.10.026; Quintana HT, 2015, INFLAMM RES, V64, P53, DOI 10.1007/s00011-014-0783-8; Rashid HO, 2015, AUTOPHAGY, V11, P1956, DOI 10.1080/15548627.2015.1091141; Rohrer-Mirtschink S, 2015, Ann Burns Fire Disasters, V28, P71; Saeman MR, 2016, J SURG RES, V202, P372, DOI 10.1016/j.jss.2016.02.037; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Smith IJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE762, DOI 10.1152/ajpendo.90226.2008; Smith IJ, 2010, INT J BIOCHEM CELL B, V42, P701, DOI 10.1016/j.biocel.2010.01.006; Song JQ, 2015, SHOCK, V44, P479, DOI 10.1097/SHK.0000000000000444; Song JQ, 2014, J SURG RES, V187, P128, DOI 10.1016/j.jss.2013.09.042; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; Wang ZG, 2016, ONCOTARGET, V7, P78455, DOI 10.18632/oncotarget.12925	49	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186128	10.1371/journal.pone.0186128	http://dx.doi.org/10.1371/journal.pone.0186128			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028830	gold, Green Published, Green Submitted			2022-12-26	WOS:000412980300018
J	Fortmann, C; Goen, T; Kruger, M; Ure, BM; Petersen, C; Kubler, JF				Fortmann, Caroline; Goeen, Thomas; Krueger, Marcus; Ure, Benno M.; Petersen, Claus; Kuebler, Joachim F.			Trace metal release after minimally-invasive repair of pectus excavatum	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; NUSS PROCEDURE; ION RELEASE; CORROSION; ALLERGY; EXPERIENCE; PROSTHESES; IMPROVES; WEAR	Background Several studies have shown a high incidence of metal allergy after minimally-invasive repair of pectus excavatum (MIRPE). We postulated that MIRPE is associated with a significant release of trace metal ions, possibly causing the allergic symptoms. Methods We evaluated the concentration with chromium, cobalt and nickel in blood, urine and tissue in patients prior to MIRPE and in patients who underwent an explantation of the stainless-steel bar(s) after three years. Results Our study group consisted of 20 patients (mean age 19 years) who had bar explantation and our control group included 20 patients (mean age 16 years) prior to MIRPE. At the time of bar removal we detected significantly elevated concentrations of chromium and nickel in the tissue compared to patients prior to the procedure (p < 0,001). We also found a significant increase in the levels of chromium in urine and nickel in blood in patients three years post MIRPE (p < 0,001). Four patients temporarily developed symptoms of metal allergy, all had elevated metal values in blood and urine at explantation. Conclusions Minimally-invasive repair of pectus excavatum can lead to a significant trace metal exposure.	[Fortmann, Caroline; Ure, Benno M.; Petersen, Claus; Kuebler, Joachim F.] Hannover Med Sch, Dept Pediat Surg, Hannover, Germany; [Goeen, Thomas] Friedrich Alexander Univ Erlangen Nurnberg, Inst & Outpatient Clin Occupat Social & Environm, Erlangen, Germany; [Krueger, Marcus] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany; [Krueger, Marcus] Hosp Martha Maria, Dept Thorac Surg, Halle, Germany	Hannover Medical School; University of Erlangen Nuremberg; Hannover Medical School	Fortmann, C (corresponding author), Hannover Med Sch, Dept Pediat Surg, Hannover, Germany.	Fortmann.Caroline@mh-hannover.de	Krüger, Marcus/C-4809-2019	Goen, Thomas/0000-0002-8226-9227; Fortmann, Caroline/0000-0002-2289-5330				Aneja S, 2011, CONTACT DERMATITIS, V65, P317, DOI 10.1111/j.1600-0536.2011.01966.x; Antunes RA, 2012, ACTA BIOMATER, V8, P937, DOI 10.1016/j.actbio.2011.09.012; Cundy TP, 2012, J PEDIATR SURG, V47, P1506, DOI 10.1016/j.jpedsurg.2012.02.005; de Smet K, 2008, J BONE JOINT SURG AM, V90A, P202, DOI 10.2106/JBJS.H.00672; Engh CA, 2014, J BONE JOINT SURG AM, V96A, P448, DOI 10.2106/JBJS.M.00164; Goen T, 2012, INT ARCH OCC ENV HEA, V85, P571, DOI 10.1007/s00420-011-0699-3; Goen T, 2012, INT J HYG ENVIR HEAL, V215, P229, DOI 10.1016/j.ijheh.2011.08.012; Hart AJ, 2014, J BONE JOINT SURG AM, V96A, P1091, DOI 10.2106/JBJS.M.00957; Hartmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070359; Hug KT, 2013, CLIN ORTHOP RELAT R, V471, P430, DOI 10.1007/s11999-012-2547-5; Kelly RE, 2010, ANN SURG, V252, P1072, DOI 10.1097/SLA.0b013e3181effdce; Kelly RE, 2008, PEDIATRICS, V122, P1218, DOI 10.1542/peds.2007-2723; Krasopoulos G, 2006, EUR J CARDIO-THORAC, V29, P1, DOI 10.1016/j.ejcts.2005.09.018; Masse A, 2003, J BIOMED MATER RES B, V67B, P750, DOI 10.1002/jbm.b.10070; Meier B., 2010, NY TIMES; Meier B., 2011, NY TIMES; Merritt K, 1996, CLIN ORTHOP RELAT R, pS233; Nuss D, 1998, J PEDIATR SURG, V33, P545, DOI 10.1016/S0022-3468(98)90314-1; Nuss D, 2016, ANN CARDIOTHORAC SUR, V5, P422, DOI 10.21037/acs.2016.08.05; Obermeyer RJ, 2016, J PEDIATR SURG, V51, P154, DOI 10.1016/j.jpedsurg.2015.10.036; Pelt CE, 2011, J ARTHROPLASTY, V26, P1494, DOI 10.1016/j.arth.2011.03.037; Pilegaard HK, 2015, J THORAC DIS, V7, pS172, DOI 10.3978/j.issn.2072-1439.2015.04.07; Polyzois I, 2012, J APPL TOXICOL, V32, P255, DOI 10.1002/jat.2729; Rushing GD, 2007, J PEDIATR SURG, V42, P93, DOI 10.1016/j.jpedsurg.2006.09.056; Sesia SB, 2013, J PEDIAT SURG CASE R, V1, P152, DOI 10.1016/j.epsc.2013.05.004; Shah B, 2014, J PEDIATR SURG, V49, P451, DOI 10.1016/j.jpedsurg.2013.07.014; Shimotakahara A, 2007, PEDIATR SURG INT, V23, P447, DOI 10.1007/s00383-006-1851-0; Vendittoli PA, 2010, J BONE JOINT SURG BR, V92B, P12, DOI 10.1302/0301-620X.92B1.22226; Yoo YR, 2008, J BIOMED MATER RES B, V86B, P310, DOI 10.1002/jbm.b.31018	29	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186323	10.1371/journal.pone.0186323	http://dx.doi.org/10.1371/journal.pone.0186323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023602	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100107
J	Jones, HE; White, KO; Norman, WV; Guilbert, E; Lichtenberg, ES; Paul, M				Jones, Heidi E.; White, Katharine O'Connell; Norman, Wendy V.; Guilbert, Edith; Lichtenberg, E. Steve; Paul, Maureen			First trimester medication abortion practice in the United States and Canada	PLOS ONE			English	Article							FEDERATION MEMBERS; MIFEPRISTONE; MISOPROSTOL; INFECTION; SERVICES; RATES	We conducted a cross-sectional survey of abortion facilities from professional networks in the United States (US, n = 703) and Canada (n = 94) to estimate the prevalence of medication abortion practices in these settings and to look at regional differences. Administrators responded to questions on gestational limits, while up to five clinicians per facility reported on 2012 medication abortion practice. At the time of fielding, mifepristone was not approved in Canada. 383 (54.5%) US and 78 (83.0%) Canadian facilities participated. In the US, 95.3% offered first trimester medication abortion compared to 25.6% in Canada. While 100% of providers were physicians in Canada, just under half (49.4%) were advanced practice clinicians in the US, which was more common in Eastern and Western states. All Canadian providers used misoprostol; 85.3% with methotrexate. 91.4% of US providers used 200 mg of mifepristone and 800 mcg of misoprostol, with 96.7% reporting home misoprostol administration. More than three-quarters of providers in both countries required an in-person follow-up visit, generally with ultrasound. 87.7% of US providers routinely prescribed antibiotics compared to 26.2% in Canada. Nonsteroidal anti-inflammatory drugs were the most commonly reported analgesic, with regional variation in opioid narcotic prescription. In conclusion, medication abortion practice follows evidence-based guidelines in the US and Canada. Efforts to update practice based on the latest evidence for reducing in-person visits and increasing provision by advanced practice clinicians could strengthen these services and reduce barriers to access. Research is needed on optimal antibiotic and analgesic use.	[Jones, Heidi E.] CUNY, Sch Publ Hlth, Dept Epidemiol & Biostat, New York, NY 10021 USA; [White, Katharine O'Connell] Baystate Med Ctr, Dept Obstet & Gynecol, Springfield, MA USA; [White, Katharine O'Connell] Boston Univ, Boston Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA; [Norman, Wendy V.] Univ British Columbia, Vancouver, BC, Canada; [Guilbert, Edith] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Lichtenberg, E. Steve] Family Planning Med Associates Med Grp, Chicago, IL USA; [Paul, Maureen] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA	City University of New York (CUNY) System; Baystate Medical Center; Boston Medical Center; Boston University; University of British Columbia; Institut national de sante publique du Quebec (INSPQ); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Jones, HE (corresponding author), CUNY, Sch Publ Hlth, Dept Epidemiol & Biostat, New York, NY 10021 USA.	Heidi.Jones@sph.cuny.edu	Jones, Heidi E/ABF-8381-2020; Dangal, Ganesh/O-1989-2017; Norman, Wendy V./D-6796-2015	Jones, Heidi E/0000-0002-4285-3752; Dangal, Ganesh/0000-0002-5834-5525; Norman, Wendy V./0000-0003-4340-7882	Society of Family Planning Research Fund [SFPRF6-3]; NIH Clinical and Translational Science Center of the National Center for Advancing Translational Sciences [2UL1-TR000457-06]; Canadian Institutes for Health Research and Public Health Agency of Canada Chair in Applied Public Health Research [CPP137903]; Scholar of the Michael Smith Foundation for Health Research	Society of Family Planning Research Fund; NIH Clinical and Translational Science Center of the National Center for Advancing Translational Sciences; Canadian Institutes for Health Research and Public Health Agency of Canada Chair in Applied Public Health Research; Scholar of the Michael Smith Foundation for Health Research	This work was supported by the Society of Family Planning Research Fund (https://www.societyfp.org/Research-and-grants.aspx) grant number SFPRF6-3. The views and opinions expressed are those of the authors and do not necessarily represent the views and opinions of the Society of Family Planning Research Fund. Supplemental funding from the NIH Clinical and Translational Science Center of the National Center for Advancing Translational Sciences (2UL1-TR000457-06) was used for French translations of the questionnaires. Dr. Norman is supported by a Canadian Institutes for Health Research and Public Health Agency of Canada Chair in Applied Public Health Research (CPP137903), and as a Scholar of the Michael Smith Foundation for Health Research.	Canadian Institute for Health Information, 2014, NUMB IND AB REP CAN; Chen MJ, 2015, OBSTET GYNECOL, V126, P12, DOI 10.1097/AOG.0000000000000897; Creinin MD, 2014, CONTRACEPTION, V89, P148, DOI 10.1016/j.contraception.2014.01.016; Davis JD, 2006, J OBSTET GYNAECOL CA, V28, P1015; Dressler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067070; Dunn S, 2015, CONTRACEPTION, V92, P220, DOI 10.1016/j.contraception.2015.05.013; Fjerstad M, 2011, CONTRACEPTION, V83, P330, DOI 10.1016/j.contraception.2010.08.022; Fjerstad M, 2009, NEW ENGL J MED, V361, P145, DOI 10.1056/NEJMoa0809146; Guilbert ER, 2016, CAN FAM PHYSICIAN, V62, pE201; Guttmacher Institute, STAT POL BRIEF; Gynuity Health Projects, 2016, MAP MIF APPR; Jones R. K., 2011, PERSPECT SEX REPRO H, V46, P3, DOI DOI 10.1363/46E0414; Jones RK, 2011, OBSTET GYNECOL, V117, P1358, DOI 10.1097/AOG.0b013e31821c405e; Lichtenberg ES, 2001, CONTRACEPTION, V64, P345, DOI 10.1016/S0010-7824(01)00279-7; Livshits A, 2009, FERTIL STERIL, V91, P1877, DOI 10.1016/j.fertnstert.2008.01.084; National Abortion Federation, 2016, 2016 CLIN POL GUID N; National Abortion Federation, 2015, 2013 CLIN POL GUID N; Norman WV, 2016, CAN FAM PHYSICIAN, V62, pE209; Norman WV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067023; Norman WV, 2012, CONTRACEPTION, V85, P185, DOI 10.1016/j.contraception.2011.06.009; O'Connell K, 2009, CONTRACEPTION, V79, P385, DOI 10.1016/j.contraception.2008.11.005; O'Connell K, 2008, CONTRACEPTION, V78, P492, DOI 10.1016/j.contraception.2008.07.011; Pazol K, 2015, MMWR SURVEILL SUMM, V64, P1, DOI 10.15585/ss6410a1; Raymond EG, 2015, CONTRACEPTION, V92, P190, DOI 10.1016/j.contraception.2015.06.020; Raymond EG, 2014, CONTRACEPTION, V90, P476, DOI 10.1016/j.contraception.2014.07.012; Raymond EG, 2013, CONTRACEPTION, V87, P26, DOI 10.1016/j.contraception.2012.06.011; Strauss Lilo T., 2004, Morbidity and Mortality Weekly Report, V53, P1; Weitz TA, 2014, AM J PUBLIC HEALTH, V104, pE3, DOI 10.2105/AJPH.2014.302212; Wiegerinck MMJ, 2008, CONTRACEPTION, V78, P486, DOI 10.1016/j.contraception.2008.07.015; Winikoff B, 2012, OBSTET GYNECOL, V120, P1070, DOI [10.1097/AOG.0b013e31826c315f, http://10.1097/AOG.0b013e31826c315f]; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.	31	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186487	10.1371/journal.pone.0186487	http://dx.doi.org/10.1371/journal.pone.0186487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023594	Green Published, gold			2022-12-26	WOS:000412845100134
J	Riascos, AP; Mateos, JAL				Riascos, A. P.; Mateos, Jose A. L.			Emergence of encounter networks due to human mobility	PLOS ONE			English	Article							LEVY FLIGHTS; PATTERNS	There is a burst of work on human mobility and encounter networks. However, the connection between these two important fields just begun recently. It is clear that both are closely related: Mobility generates encounters, and these encounters might give rise to contagion phenomena or even friendship. We model a set of random walkers that visit locations in space following a strategy akin to Levy flights. We measure the encounters in space and time and establish a link between walkers after they coincide several times. This generates a temporal network that is characterized by global quantities. We compare this dynamics with real data for two cities: New York City and Tokyo. We use data from the location-based social network Foursquare and obtain the emergent temporal encounter network, for these two cities, that we compare with our model. We found long-range (Levy-like) distributions for traveled distances and time intervals that characterize the emergent social network due to human mobility. Studying this connection is important for several fields like epidemics, social influence, voting, contagion models, behavioral adoption and diffusion of ideas.	[Riascos, A. P.] Univ Mariana, Dept Civil Engn, San Juan De Pasto, Colombia; [Mateos, Jose A. L.] Univ Nacl Autonoma Mexico, Inst Fis, Ciudad De Mexico, Mexico	Universidad Nacional Autonoma de Mexico	Riascos, AP (corresponding author), Univ Mariana, Dept Civil Engn, San Juan De Pasto, Colombia.	aaappprrr@gmail.com	Riascos, Alejandro Pérez/AAZ-1334-2020	Perez Riascos, Alejandro/0000-0002-9243-3246	Secretaria de Ciencia, Tecnologia e Innovacion (SECITI); Centro Latinoamericano de Fisica (CLAF); Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico	Secretaria de Ciencia, Tecnologia e Innovacion (SECITI); Centro Latinoamericano de Fisica (CLAF); Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	A.P.R. acknowledges support from the Secretaria de Ciencia, Tecnologia e Innovacion (SECITI), the Centro Latinoamericano de Fisica (CLAF), and the Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A.P.R. acknowledges support from the Secretaria de Ciencia, Tecnologia e Innovacion (SECITI), the Centro Latinoamericano de Fisica (CLAF), and the Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Baronchelli A, 2013, CHAOS SOLITON FRACT, V56, P101, DOI 10.1016/j.chaos.2013.07.013; Barrat A, 2013, EUR PHYS J-SPEC TOP, V222, P1295, DOI 10.1140/epjst/e2013-01927-7; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Batty M., 2013, NEW SCI CITIES; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Borge-Holthoefer J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501158; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brown CT, 2007, HUM ECOL, V35, P129, DOI 10.1007/s10745-006-9083-4; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Colak S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10793; Crandall DJ, 2010, P NATL ACAD SCI USA, V107, P22436, DOI 10.1073/pnas.1006155107; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Danon L, 2012, J R SOC INTERFACE, V9, P2826, DOI 10.1098/rsif.2012.0357; De Domenico M, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0038-0; De Domenico M, 2013, PERVASIVE MOB COMPUT, V9, P798, DOI 10.1016/j.pmcj.2013.07.008; Deville P, 2016, P NATL ACAD SCI USA, V113, P7047, DOI 10.1073/pnas.1525443113; Estrada E, 2017, J COMPLEX NETWORKS; Estrada E, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.042805; Fournet J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107878; Gallotti R, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500445; Gauvin L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03099; Genois M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9860; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Google Sites, FOURSQ DAT DINGQ YAN; Grabowicz PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092196; HOLME P, 2015, EUR PHYS J B, V88; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Hossmann T., 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. Workshops, P876, DOI 10.1109/INFCOMW.2011.5928936; Hu Q, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032704; Hughes BD., 1996, RANDOM WALKS RANDOM, V1; Kuhn SL, 2016, EVOL ANTHROPOL, V25, P86, DOI 10.1002/evan.21480; Lenormand M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0473; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Lin Y, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062140; Louail T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7007; Louail T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05276; Louf R, 2014, SCI REP-UK, V4, DOI 10.1038/srep05561; Mastrandrea R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136497; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Noulas A, 2015, WWW'15 COMPANION: PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P431, DOI 10.1145/2740908.2745402; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Pan W, 2015, J THEOR BIOL, V382, P309, DOI 10.1016/j.jtbi.2015.07.009; Pan W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2961; Pappalardo L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9166; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Raichlen David A, 2014, Proc Natl Acad Sci U S A, V111, P728, DOI 10.1073/pnas.1318616111; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Rhee I, 2011, IEEE ACM T NETWORK, V19, P630, DOI 10.1109/TNET.2011.2120618; Riascos AP, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.052814; Riascos AP, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/07/P07015; Riascos AP, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032809; Riascos AP, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.056110; Saramaki J, 2015, EUR PHYS J B, V88, DOI [10.1140/epjb/e2015-60106-6, 10.1140/epjb/e2015-60660-9]; Schlapfer M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0789; Schneider CM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0246; Serok N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132576; Sim A, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0315; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Sun LJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05099; Sun LJ, 2013, P NATL ACAD SCI USA, V110, P13774, DOI 10.1073/pnas.1306440110; Toole JL, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1128; Viswanathan G. M., 2011, PHYS FORAGING; Wang D., 2011, P 17 ACM SIGKDD INT, P1100, DOI DOI 10.1145/2020408.2020581; Weng TF, 2015, SCI REP-UK, V5, DOI 10.1038/srep17309; Yan XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02678; Yang DQ, 2015, IEEE T SYST MAN CY-S, V45, P129, DOI 10.1109/TSMC.2014.2327053; Yang LT, 2012, AD HOC NETW, V10, P524, DOI 10.1016/j.adhoc.2011.09.008; Yang SS, 2010, IEEE NETWORK, V24, P6, DOI 10.1109/MNET.2010.5578912; Zaburdaev V, 2015, REV MOD PHYS, V87, P483, DOI 10.1103/RevModPhys.87.483; Zhao K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09136	78	33	33	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0184532	10.1371/journal.pone.0184532	http://dx.doi.org/10.1371/journal.pone.0184532			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023458	gold, Green Published, Green Submitted			2022-12-26	WOS:000412845100008
J	Vinholt, PJ; Nybo, M; Nielsen, CB; Hvas, AM				Vinholt, Pernille Just; Nybo, Mads; Nielsen, Camilla Brodsgaard; Hvas, Anne-Mette			Light transmission aggregometry using pre-coated microtiter plates and a Victor X5 plate reader	PLOS ONE			English	Article							MICROPLATE READER; AGGREGATION; ASSAY	Background Light transmission aggregometry (LTA) can be performed with microtiter plates (96-well LTA). When conducting LTA, an agonist is added to platelet-rich plasma and the sample is shaken for minutes after which absorbance readings are done. Platelet aggregation is detected as decrease in absorbance. However, the classical method is cumbersome and therefore microtiter plates can be used for concomitant testing of multiple samples. Furthermore, it would be convenient to prepare the plate in advance of platelet aggregation testing. Aim: The aim of the present study was to establish a simplified 96-well LTA protocol, where plates were pre-coated with agonists and stored at -80 C until use. Results We developed and validated a protocol for 96-well LTA using a Victor X5 plate reader and pre-coated microtiter plates. The minimum requirement of platelet-rich plasma was 45 mu L per sample and the sample platelet count should not be below 100 x109/L. Optimal absorbance reading was 595 nm wavelengths. Platelet aggregation results were higher at 37 degrees C than at room temperature. Platelet adherence to wells after stimulation was observed; it was not avoided by pre-coating of the wells with gelatin. A range of up to 7 concentrations for each agonist (collagen, arachidonic acid, adenosine diphosphate, thrombin receptor-activating peptide and protease-activated receptor-4) was tested concomitantly. A transient rise in platelet aggregation was observed after 2 minutes of shaking in some samples with low agonist concentration, and platelet aggregation was optimal after 10 minutes of shaking for samples with high agonist concentration. Plates could be stored at -80 degrees C for 15 days without significant change in the platelet aggregation results. Conclusion The 96-well LTA is suitable for platelet aggregation testing and a range of agonist concentrations can be concomitantly tested.	[Vinholt, Pernille Just; Nybo, Mads; Nielsen, Camilla Brodsgaard] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Odense, Denmark; [Hvas, Anne-Mette] Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark	University of Southern Denmark; Odense University Hospital; Aarhus University	Vinholt, PJ (corresponding author), Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Odense, Denmark.	pernille.vinholt@rsyd.dk	Nybo, Mads/J-6040-2019	Nybo, Mads/0000-0002-3029-2855; Just Vinholt, Pernille/0000-0002-2035-0169	CSL Behring; Leo Pharma; Octapharma	CSL Behring; Leo Pharma(LEO Pharma); Octapharma	AMH has received speaker fees from CSL Behring and Leo Pharma and research support from CSL Behring, Octapharma and Leo Pharma. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	BEDNAR B, 1995, THROMB RES, V77, P453, DOI 10.1016/0049-3848(95)93881-Y; Cattaneo M, 2013, J THROMB HAEMOST, V11, P1183, DOI 10.1111/jth.12231; Chan MV, 2012, PLATELETS, V23, P404, DOI 10.3109/09537104.2011.603066; Chan MV, 2011, PLATELETS, V22, P485, DOI 10.3109/09537104.2011.592958; de Groot Philip G, 2012, Handb Exp Pharmacol, P87, DOI 10.1007/978-3-642-29423-5_4; FRATANTONI JC, 1990, AM J CLIN PATHOL, V94, P613, DOI 10.1093/ajcp/94.5.613; Golebiewska EM, 2015, BLOOD REV, V29, P153, DOI 10.1016/j.blre.2014.10.003; Harrison P, 2011, BRIT J HAEMATOL, V155, P30, DOI 10.1111/j.1365-2141.2011.08793.x; Hoylaerts MF, 1996, BLOOD COAGUL FIBRIN, V7, P187, DOI 10.1097/00001721-199603000-00019; Lordkipanidze M, 2014, BLOOD, V123, pE11, DOI 10.1182/blood-2013-08-520387; Moran N, 2006, ANAL BIOCHEM, V357, P77, DOI 10.1016/j.ab.2006.06.037; MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x; Salmon DM, 1996, THROMB RES, V84, P213, DOI 10.1016/0049-3848(96)00179-X; Walkowiak B, 1997, THROMB RES, V87, P95, DOI 10.1016/S0049-3848(97)00108-4	14	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185675	10.1371/journal.pone.0185675	http://dx.doi.org/10.1371/journal.pone.0185675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023589	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100026
J	Virgili, G; Michelessi, M; Miele, A; Oddone, F; Crescioli, G; Fameli, V; Lucenteforte, E				Virgili, Gianni; Michelessi, Manuele; Miele, Alba; Oddone, Francesco; Crescioli, Giada; Fameli, Valeria; Lucenteforte, Ersilia			STARD 2015 was reproducible in a large set of studies on glaucoma	PLOS ONE			English	Article							DIAGNOSTIC-ACCURACY; QUALITY; GUIDELINES; EQUATOR	Aim To investigate the reproducibility of the updated Standards for the Reporting of Diagnostic Accuracy Studies tool (STARD 2015) in a set of 106 studies included in a Cochrane diagnostic test accuracy (DTA) systematic review of imaging tests for diagnosing manifest glaucoma. Methods One senior rater with DTA methodological and clinical expertise used STARD 2015 on all studies, and each of three raters with different training profiles assessed about a third of the studies. Results Raw agreement was very good or almost perfect between the senior rater and an ophthalmology resident with DTA methods training, acceptable with a clinical rater with little DTA methods training, and only moderate with a pharmacology researcher with general, but not DTA, systematic review training and no clinical expertise. The relationship between adherence with STARD 2015 and methodological quality with QUADAS 2 was only partial and difficult to investigate, suggesting that raters used substantial context knowledge in risk of bias assessment. Conclusions STARD 2015 proved to be reproducible in this specific research field, provided that both clinical and DTA methodological expertise are achieved through training of its users.	[Virgili, Gianni; Miele, Alba] Univ Florence, Dept Translat Surg & Med, Florence, Italy; [Michelessi, Manuele; Oddone, Francesco] IRCS Fdn GB Bietti, Rome, Italy; [Crescioli, Giada; Lucenteforte, Ersilia] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth NEURO, Florence, Italy; [Fameli, Valeria] Univ Rome Sapienza, Dept Sens, Ophthalmol Unit, Organs, Rome, Italy	University of Florence; University of Florence; Sapienza University Rome	Lucenteforte, E (corresponding author), Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth NEURO, Florence, Italy.	ersilia.lucenteforte@unifi.it	Oddone, Francesco/K-8876-2016; Crescioli, Giada/L-6736-2019; Lucenteforte, Ersilia/AAB-9055-2019; Virgili, Gianni/P-6607-2014	Oddone, Francesco/0000-0002-2504-0004; Lucenteforte, Ersilia/0000-0001-5608-5902; Crescioli, Giada/0000-0002-1071-6120; Virgili, Gianni/0000-0002-9960-2989	Italian Ministry of Health and by Fondazione Roma	Italian Ministry of Health and by Fondazione Roma	The contribution of the IRCCS Fondazione Bietti in this paper was supported by the Italian Ministry of Health and by Fondazione Roma. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2008, LANCET, V371, P1149, DOI 10.1016/S0140-6736(08)60505-X; Altman DG, 2016, J ROY SOC MED, V109, P67, DOI 10.1177/0141076815625599; [Anonymous], BASED MED, V19, P47; Banister K, 2016, OPHTHALMOLOGY, V123, P930, DOI 10.1016/j.ophtha.2016.01.041; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Crabb DP, 2016, EYE, V30, P304, DOI 10.1038/eye.2015.244; Fidalgo BMR, 2015, OPHTHAL PHYSL OPT, V35, P315, DOI 10.1111/opo.12208; Gopalakrishna G, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0252-x; Johnson ZK, 2007, OPHTHALMOLOGY, V114, P1607, DOI 10.1016/j.ophtha.2006.11.036; King A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3518; Medeiros FA, 2007, INVEST OPHTH VIS SCI, V48, P214, DOI 10.1167/iovs.06-0618; Michelessi M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008803.pub2; Ochodo EA, 2013, CLIN CHEM, V59, P917, DOI 10.1373/clinchem.2013.206516; Paranjothy B, 2007, J GLAUCOMA, V16, P670, DOI 10.1097/IJG.0b013e3180457c6d; Saunders LJ, 2014, INVEST OPHTH VIS SCI, V55, P102, DOI 10.1167/iovs.13-13006; Shunmugam M, 2006, INVEST OPHTH VIS SCI, V47, P2317, DOI 10.1167/iovs.05-1250; Smidt Nynke, 2006, BMC Med Res Methodol, V6, P12, DOI 10.1186/1471-2288-6-12; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	20	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186209	10.1371/journal.pone.0186209	http://dx.doi.org/10.1371/journal.pone.0186209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023557	Green Published, gold			2022-12-26	WOS:000412845100081
J	Callejon, S; Sendra, R; Ferrer, S; Pardo, I				Callejon, Sara; Sendra, Ramon; Ferrer, Sergi; Pardo, Isabel			Recombinant laccase from Pediococcus acidilactici CECT 5930 with ability to degrade tyramine	PLOS ONE			English	Article							BIOGENIC-AMINES; BACILLUS-LICHENIFORMIS; FERMENTED FOODS; OXIDASE; BACTERIA; MEDIATORS; OXIDATION; SUBTILIS; SYSTEMS; CHEESE	Biogenic amines degradation by bacterial laccases is little known, so we have cloned and heterologously expressed, in E. coli, a new laccase from Pediococcus acidilactici CECT 5930 (Lpa5930), a lactic acid bacterium commonly found in foods able to degrade tyramine. The recombinant enzyme has been characterized by physical and biochemical assays. Here we report the optimization of expression and purification procedures of this laccase. DNA encoding sequence of laccase from P. acidilactici was amplified by PCR and cloned into the expression plasmid pET28a for induction by isopropyl-beta-D-thiogalactoipyranoside. Protein expression was performed in E. coli BL21(DE3) harboring pGro7 plasmid expressing a chaperone folding assistant induced by arabinose. Purification was performed by column metal-chelating chromatography on Ni-NTA-agarose. The laccase enzyme obtained has an apparent molecular mass of similar to 60 kDa, an optimum temperature activity toward 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) of 28 degrees C, and was quickly inactivated at temperatures higher than 70 degrees C. The apparent K-m value for ABTS was 1.7 mM and the V-max obtained was 24 U/mg. In addition to ABTS, recombinant Lpa5930 laccase degraded the biogenic amine tyramine at pH 9.5 and pH 4.0 with or without ABTS as a mediator. Tyramine degradation by laccases could solve the problems generated in food due to the presence of this toxic compound.	[Callejon, Sara; Ferrer, Sergi; Pardo, Isabel] Univ Valencia, ENOLAB Estruct Recerca Interdisciplinar BioTecMed, C Dr Moliner 50, Burjassot, Spain; [Callejon, Sara; Ferrer, Sergi; Pardo, Isabel] Univ Valencia, Dept Microbiol & Ecol, C Dr Moliner 50, Burjassot, Spain; [Sendra, Ramon] Univ Valencia, Dept Bioquim & Biol Mol, C Dr Moliner 50, Burjassot, Spain	University of Valencia; University of Valencia; University of Valencia	Pardo, I (corresponding author), Univ Valencia, ENOLAB Estruct Recerca Interdisciplinar BioTecMed, C Dr Moliner 50, Burjassot, Spain.; Pardo, I (corresponding author), Univ Valencia, Dept Microbiol & Ecol, C Dr Moliner 50, Burjassot, Spain.	Isabel.Pardo@uv.es	Pardo, Isabel/K-9641-2014; Ferrer, Sergi/J-3414-2012; Sendra, Ramón/K-3549-2014	Pardo, Isabel/0000-0002-6871-0012; Ferrer, Sergi/0000-0001-8887-9002; Sendra, Ramón/0000-0002-5519-4362	European Regional Development Fund [AGL2015-71227-R]; Spanish Ministerio de Economia y Competitividad	European Regional Development Fund(European Commission); Spanish Ministerio de Economia y Competitividad(Spanish Government)	The present work has been partially financed by Project AGL2015-71227-R from European Regional Development Fund and the Spanish Ministerio de Economia y Competitividad (http://www.rnineco.gob.es/portal/site/mineco/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre G, 2000, TRENDS BIOTECHNOL, V18, P41, DOI 10.1016/S0167-7799(99)01406-7; Arias ME, 2003, APPL ENVIRON MICROB, V69, P1953, DOI 10.1128/AEM.69.4.1953-1958.2003; Bains J, 2003, BIOTECHNOL LETT, V25, P1155, DOI 10.1023/A:1024569722413; Balgir PP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/583850; Barbosa J, 2015, INT J FOOD SCI TECH, V50, P1151, DOI 10.1111/ijfs.12768; Boguta AM, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0097-0; Callejon S, 2016, APPL MICROBIOL BIOT, V100, P3113, DOI 10.1007/s00253-015-7158-0; Callejon S, 2014, APPL MICROBIOL BIOT, V98, P185, DOI 10.1007/s00253-013-4829-6; Camarero S, 2005, APPL ENVIRON MICROB, V71, P1775, DOI 10.1128/AEM.71.4.1775-1784.2005; Chandra R, 2015, ENVIRON SCI-PROC IMP, V17, P326, DOI [10.1039/c4em00627e, 10.1039/C4EM00627E]; Claus H, 2003, ARCH MICROBIOL, V179, P145, DOI 10.1007/s00203-002-0510-7; Dadakova E, 2009, FOOD CHEM, V116, P365, DOI 10.1016/j.foodchem.2009.02.018; Durao P, 2008, J BIOL INORG CHEM, V13, P183, DOI 10.1007/s00775-007-0312-0; Endo K, 2003, J BIOCHEM, V133, P671, DOI 10.1093/jb/mvg086; Galli I, 2004, J BIOL INORG CHEM, V9, P90, DOI 10.1007/s00775-003-0501-4; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; GIVAUDAN A, 1993, FEMS MICROBIOL LETT, V108, P205, DOI 10.1111/j.1574-6968.1993.tb06100.x; Gunne M., 2014, THESIS; Gunne M, 2013, J BIOTECHNOL, V168, P252, DOI 10.1016/j.jbiotec.2013.06.011; Gunne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052360; HALASZ A, 1994, TRENDS FOOD SCI TECH, V5, P42, DOI 10.1016/0924-2244(94)90070-1; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Innocente N, 2002, J FOOD PROTECT, V65, P1498, DOI 10.4315/0362-028X-65.9.1498; Johannes C, 2000, APPL ENVIRON MICROB, V66, P524, DOI 10.1128/AEM.66.2.524-528.2000; Kiiskinen LL, 2002, APPL MICROBIOL BIOT, V59, P198, DOI 10.1007/s00253-002-1012-x; KLAENHAMMER TR, 1993, FEMS MICROBIOL REV, V12, P39, DOI 10.1111/j.1574-6976.1993.tb00012.x; Komprda T, 2008, FOOD MICROBIOL, V25, P219, DOI 10.1016/j.fm.2007.11.006; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Kunamneni Adinarayana, 2008, Recent Pat Biotechnol, V2, P10, DOI 10.2174/187220808783330965; Machczynski MC, 2004, PROTEIN SCI, V13, P2388, DOI 10.1110/ps.04759104; Maijala R, 2003, ENCY DAIRY SCI, P156; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Mazzucco E, 2010, J AGR FOOD CHEM, V58, P127, DOI 10.1021/jf9030053; Miyazaki K, 2005, EXTREMOPHILES, V9, P415, DOI 10.1007/s00792-005-0458-z; Mohammadian M, 2010, J IND MICROBIOL BIOT, V37, P863, DOI 10.1007/s10295-010-0734-5; Molina-Guijarro JM, INT MICROBIOL; Molina-Guijarro JM, 2009, INT MICROBIOL, V12, P13, DOI 10.2436/20.1501.01.77; Morozova OV, 2007, APPL BIOCHEM MICRO+, V43, P523, DOI 10.1134/S0003683807050055; Nieto-Lozano JC, 2006, MEAT SCI, V72, P57, DOI 10.1016/j.meatsci.2005.06.004; Osma Johann F, 2010, Enzyme Res, V2010, P918761, DOI 10.4061/2010/918761; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; PEDERSON CS, 1949, BACTERIOL REV, V13, P225, DOI 10.1128/MMBR.13.4.225-232.1949; RACCACH M, 1987, CRC CR REV MICROBIOL, V14, P291, DOI 10.3109/10408418709104442; Reiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065633; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Riva S, 2006, TRENDS BIOTECHNOL, V24, P219, DOI 10.1016/j.tibtech.2006.03.006; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Ruijssenaars HJ, 2004, APPL MICROBIOL BIOT, V65, P177, DOI 10.1007/s00253-004-1571-0; Salony, 2008, BBA-PROTEINS PROTEOM, V1784, P259, DOI 10.1016/j.bbapap.2007.11.006; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sondhi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096951; STRATTON JE, 1991, J FOOD PROTECT, V54, P460, DOI 10.4315/0362-028X-54.6.460; TANASUPAWAT S, 1983, J GEN APPL MICROBIOL, V29, P487, DOI 10.2323/jgam.29.487; Thomas JG, 1997, APPL BIOCHEM BIOTECH, V66, P197, DOI 10.1007/BF02785589; Ventorino V, 2015, SCI REP-UK, V5, DOI 10.1038/srep08161; Xu F, 2007, CATALYTIC APPL LACCA, P43	58	16	20	7	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186019	10.1371/journal.pone.0186019	http://dx.doi.org/10.1371/journal.pone.0186019			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020076	gold, Green Published, Green Submitted			2022-12-26	WOS:000412754400059
J	Yurkovich, JT; Zielinski, DC; Yang, L; Paglia, G; Rolfsson, O; Sigurjonsson, OE; Broddrick, JT; Bordbar, A; Wichuk, K; Brynjolfsson, S; Palsson, S; Gudmundsson, S; Palsson, BO				Yurkovich, James T.; Zielinski, Daniel C.; Yang, Laurence; Paglia, Giuseppe; Rolfsson, Ottar; Sigurjonsson, Olafur E.; Broddrick, Jared T.; Bordbar, Aarash; Wichuk, Kristine; Brynjolfsson, Sigurdur; Palsson, Sirus; Gudmundsson, Sveinn; Palsson, Bernhard O.			Quantitative time-course metabolomics in human red blood cells reveal the temperature dependence of human metabolic networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						computational biology; erythrocyte; metabolism; metabolomics; systems biology	OMICS TECHNOLOGIES; STORAGE; QUALITY; COEFFICIENT; RESPONSES; HEMOLYSIS; DATABASE; SCALE	The temperature dependence of biological processes has been studied at the levels of individual biochemical reactions and organism physiology (e.g. basal metabolic rates) but has not been examined at the metabolic network level. Here, we used a systems biology approach to characterize the temperature dependence of the human red blood cell (RBC) metabolic network between 4 and 37 degrees C through absolutely quantified exo- and endometabolomics data. We used an Arrhenius-type model (Q(10)) to describe how the rate of a biochemical process changes with every 10 degrees C change in temperature. Multivariate statistical analysis of the metabolomics data revealed that the same metabolic network-level trends previously reported for RBCs at 4 degrees C were conserved but accelerated with increasing temperature. We calculated a median Q(10) coefficient of 2.89 +/- 1.03, within the expected range of 2-3 for biological processes, for 48 individual metabolite concentrations. We then integrated these metabolomics measurements into a cell-scale metabolic model to study pathway usage, calculating a median Q(10) coefficient of 2.73 +/- 0.75 for 35 reaction fluxes. The relative fluxes through glycolysis and nucleotide metabolism pathways were consistent across the studied temperature range despite the non-uniform distributions of Q(10) coefficients of individual metabolites and reaction fluxes. Together, these results indicate that the rate of change of network-level responses to temperature differences in RBC metabolism is consistent between 4 and 37 degrees C. More broadly, we provide a baseline characterization of a biochemical network given no transcriptional or translational regulation that can be used to explore the temperature dependence of metabolism.	[Yurkovich, James T.; Zielinski, Daniel C.; Yang, Laurence; Broddrick, Jared T.; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Palsson, Bernhard O.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Yurkovich, James T.; Palsson, Bernhard O.] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Broddrick, Jared T.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Paglia, Giuseppe] EURAC Res, Inst Biomed, Viale Druso Drususallee 1, I-39100 Bolzano, Bozen, Italy; [Rolfsson, Ottar; Wichuk, Kristine; Brynjolfsson, Sigurdur; Palsson, Sirus; Palsson, Bernhard O.] Univ Iceland, Ctr Syst Biol, Sturlugata 8, IS-101 Reykjavik, Iceland; [Sigurjonsson, Olafur E.; Gudmundsson, Sveinn] Landspitali Univ Hosp, Blood Bank, Snorrabraut 60, IS-105 Reykjavik, Iceland; [Sigurjonsson, Olafur E.] Reykjavik Univ, Sch Sci & Engn, Menntavegur 1, IS-101 Reykjavik, Iceland; [Bordbar, Aarash; Palsson, Sirus] Sinopia Biosci, San Diego, CA 92101 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; European Academy of Bozen-Bolzano; University of Iceland; Landspitali National University Hospital; Reykjavik University	Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.; Palsson, BO (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.; Palsson, BO (corresponding author), Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA.; Palsson, BO (corresponding author), Univ Iceland, Ctr Syst Biol, Sturlugata 8, IS-101 Reykjavik, Iceland.	palsson@ucsd.edu	/AAG-5264-2021; Sigurjonsson, Olafur/T-8190-2019; Brynjolfsson, Sigurdur/AAT-4654-2020; Paglia, Giuseppe/H-2012-2018; Brynjolfsson, Sigurdur/H-4588-2012	/0000-0001-6460-6771; Sigurjonsson, Olafur/0000-0002-4968-842X; Paglia, Giuseppe/0000-0003-4724-6801; Rolfsson, Ottar/0000-0003-4258-6057; Yang, Laurence/0000-0001-6663-7643; Brynjolfsson, Sigurdur/0000-0001-9435-2258; Broddrick, Jared/0000-0003-4871-4822	European Research Council [ERC-232816]; United States Department of Energy [DE-SC0008701]; NHLBI, National Institutes of Health [R43HL123074]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL123074] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); United States Department of Energy(United States Department of Energy (DOE)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by European Research Council Grant ERC-232816; United States Department of Energy Grant DE-SC0008701 and NHLBI, National Institutes of Health Grant R43HL123074. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Fageeh MB, 2006, BIOCHEM J, V397, P247, DOI 10.1042/BJ20060166; Belehradek J, 1930, BIOL REV BIOL P CAMB, V5, P30; Bordbar A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46249; Bordbar A, 2016, TRANSFUSION, V56, P852, DOI 10.1111/trf.13460; Bordbar A, 2015, CELL SYST, V1, P283, DOI 10.1016/j.cels.2015.10.003; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-110; BORGMANN AI, 1976, J COMP PHYSIOL, V107, P185, DOI 10.1007/BF00691225; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Burnside WR, 2014, OIKOS, V123, P1449, DOI 10.1111/oik.01199; Chaui-Berlinck JG, 2002, P ROY SOC B-BIOL SCI, V269, P15, DOI 10.1098/rspb.2001.1845; Clarke A, 2004, FUNCT ECOL, V18, P243, DOI 10.1111/j.0269-8463.2004.00841.x; Cohen E, 1896, STUDIES CHEM DYNAMIC, P130; CRIDDLE RS, 1994, PLANT CELL ENVIRON, V17, P233, DOI 10.1111/j.1365-3040.1994.tb00289.x; D'Alessandro A, 2017, TRANSFUS APHER SCI, V56, P248, DOI 10.1016/j.transci.2017.03.006; D'Alessandro A, 2015, TRANSFUSION, V55, P1155, DOI 10.1111/trf.12975; D'Alessandro A, 2015, TRANSFUSION, V55, P205, DOI 10.1111/trf.12804; Elias M, 2014, TRENDS BIOCHEM SCI, V39, P1, DOI 10.1016/j.tibs.2013.11.001; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hardy R. N, 1979, STUDIES BIOL; HEGARTY TW, 1973, NATURE, V243, P305, DOI 10.1038/243305a0; Hochachka P.W., 1991, Biochemistry and Molecular Biology of Fishes, V1, P313; HOGMAN CF, 1981, VOX SANG, V41, P274; KAVANAU JL, 1950, J GEN PHYSIOL, V34, P193, DOI 10.1085/jgp.34.2.193; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; LAIDLER KJ, 1984, J CHEM EDUC, V61, P494, DOI 10.1021/ed061p494; Larhlimi A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-57; Lee JS, 2017, J CLIN INVEST, V127, P100, DOI 10.1172/JCI91309; Leifeld J, 2005, BIOGEOCHEMISTRY, V75, P433, DOI 10.1007/s10533-005-2237-4; Paglia G, 2016, BLOOD, V128, pE43, DOI 10.1182/blood-2016-06-721688; Paglia G, 2014, TRANSFUSION, V54, P2911, DOI 10.1111/trf.12710; Rapido F, 2017, J CLIN INVEST, V127, P375, DOI 10.1172/JCI90837; Roback JD, 2014, TRANSFUS MED REV, V28, P41, DOI 10.1016/j.tmrv.2014.01.003; Schulte PM, 2015, J EXP BIOL, V218, P1856, DOI 10.1242/jeb.118851; Sierra CA, 2012, BIOGEOCHEMISTRY, V108, P1, DOI 10.1007/s10533-011-9596-9; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; SOMERO GN, 1968, BIOCHEM J, V110, P395, DOI 10.1042/bj1100395; Southwood AL, 2003, J EXP BIOL, V206, P4521, DOI 10.1242/jeb.00689; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yurkovich J. T., 2017, P 1 IEEE C CONTR TEC; Yurkovich JT, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005424	40	30	30	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19556	19564		10.1074/jbc.M117.804914	http://dx.doi.org/10.1074/jbc.M117.804914			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29030425	hybrid, Green Published			2022-12-26	WOS:000416911300002
J	Wylie, T; Garg, R; Ridley, AJ; Conte, MR				Wylie, Thomas; Garg, Ritu; Ridley, Anne J.; Conte, Maria R.			Analysis of the interaction of Plexin-B1 and Plexin-B2 with Rnd family proteins	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; CONTROLS INVASIVE GROWTH; RECEPTOR PLEXIN-B1; RHO FAMILY; R-RAS; BINDING; DOMAIN; MET; TRANSMEMBRANE; NEURONS	The Rnd family of proteins, Rnd1, Rnd2 and Rnd3, are atypical Rho family GTPases, which bind to but do not hydrolyse GTP. They interact with plexins, which are receptors for semaphorins, and are hypothesised to regulate plexin signalling. We recently showed that each Rnd protein has a distinct profile of interaction with three plexins, Plexin-B1, Plexin-B2 and Plexin-B3, in mammalian cells, although it is unclear which region(s) of these plexins contribute to this specificity. Here we characterise the binary interactions of the Rnd proteins with the Rho-binding domain (RBD) of Plexin-B1 and Plexin-B2 using biophysical approaches. Isothermal titration calorimetry (ITC) experiments for each of the Rnd proteins with Plexin-B1-RBD and Plexin-B2-RBD showed similar association constants for all six interactions, although Rnd1 displayed a small preference for Plexin-B1-RBD and Rnd3 for Plexin-B2-RBD. Furthermore, mutagenic analysis of Rnd3 suggested similarities in its interaction with both Plexin-B1-RBD and Plexin-B2-RBD. These results suggest that Rnd proteins do not have a clear-cut specificity for different Plexin-B-RBDs, possibly implying the contribution of additional regions of Plexin-B proteins in conferring functional substrate selection.	[Wylie, Thomas; Garg, Ritu; Ridley, Anne J.; Conte, Maria R.] Kings Coll London, Randall Div Cell & Mol Biophys, Guys Campus, London, England	University of London; King's College London	Conte, MR (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, Guys Campus, London, England.	sasi.conte@kcl.ac.uk	Conte, Maria/W-3088-2019; Conte, Maria R/C-4102-2008; Jones, Gareth E/H-2282-2012	Conte, Maria/0000-0001-8558-2051; Conte, Maria R/0000-0001-8558-2051; Ridley, Anne/0000-0001-8186-5708; Jones, Gareth E/0000-0001-5879-3048; Wylie, Tom/0000-0003-1077-730X	BBSRC; Cancer Research UK [C6620/A15961]; Wellcome Trust; Biotechnology and Biological Sciences Research Council [1111460] Funding Source: researchfish; Cancer Research UK [15961] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	This project was supported by a BBSRC PhD studentship (TW) and Cancer Research UK grant C6620/A15961 (AJR). We are grateful to the Wellcome Trust for funding the King's College London Centre for Biomolecular Spectroscopy (MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artigiani S, 2004, EMBO REP, V5, P710, DOI 10.1038/sj.embor.7400189; Azzarelli R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4405; Conrotto P, 2004, ONCOGENE, V23, P5131, DOI 10.1038/sj.onc.1207650; Fansa EK, 2013, BIOCHEM BIOPH RES CO, V434, P785, DOI 10.1016/j.bbrc.2013.04.012; Foster R, 1996, MOL CELL BIOL, V16, P2689; Garavini H, 2002, BIOCHEMISTRY-US, V41, P6303, DOI 10.1021/bi025651h; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Hands-Taylor KLD, 2010, NUCLEIC ACIDS RES, V38, P4052, DOI 10.1093/nar/gkq141; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Holbrook JA, 2001, J MOL BIOL, V310, P379, DOI 10.1006/jmbi.2001.4768; Hota PK, 2012, CELL MOL LIFE SCI; Hota PK, 2009, PROTEIN SCI, V18, P1060, DOI 10.1002/pro.116; King PD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003669; Korostylev A, 2008, DEVELOPMENT, V135, P3333, DOI 10.1242/dev.019760; Le AP, 2015, ONCOTARGET, V6, P7293, DOI 10.18632/oncotarget.3421; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; Martino L, 2012, NUCLEIC ACIDS RES, V40, P1381, DOI 10.1093/nar/gkr890; Masuda K, 2004, GENES CELLS, V9, P821, DOI 10.1111/j.1365-2443.2004.00766.x; McColl B, 2016, J CELL SCI, V129, P4046, DOI 10.1242/jcs.192211; Merret R, 2013, RNA, V19, P36, DOI 10.1261/rna.035469.112; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Okada T, 2015, NAT CELL BIOL, V17, P81, DOI 10.1038/ncb3082; Perala N, 2012, DIFFERENTIATION, V83, P77, DOI 10.1016/j.diff.2011.08.001; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Smith Susan J M, 2002, Methods Mol Biol, V189, P13; Swiercz JM, 2008, J BIOL CHEM, V283, P1893, DOI 10.1074/jbc.M706822200; TAKAGI S, 1987, DEV BIOL, V122, P90, DOI 10.1016/0012-1606(87)90335-6; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Wang H, 2011, J BIOL CHEM, V286, P26093, DOI 10.1074/jbc.M110.197053; Wang YX, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002636; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008	37	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0185899	10.1371/journal.pone.0185899	http://dx.doi.org/10.1371/journal.pone.0185899			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040270	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500014
J	Nguyen, TQ; Chenon, M; Vilela, F; Velours, C; Aumont-Nicaise, M; Andreani, J; Varela, PF; Llinas, P; Menetrey, J				The Quyen Nguyen; Chenon, Melanie; Vilela, Fernando; Velours, Christophe; Aumont-Nicaise, Magali; Andreani, Jessica; Varela, Paloma F.; Llinas, Paola; Menetrey, Julie			Structural plasticity of the N-terminal capping helix of the TPR domain of kinesin light chain	PLOS ONE			English	Article							PROTEIN; CARGO; TRANSPORT	Kinesin1 plays a major role in neuronal transport by recruiting many different cargos through its kinesin light chain (KLC). Various structurally unrelated cargos interact with the conserved tetratricopeptide repeat (TPR) domain of KLC. The N-terminal capping helix of the TPR domain exhibits an atypical sequence and structural features that may contribute to the versatility of the TPR domain to bind different cargos. We determined crystal structures of the TPR domain of both KLC1 and KLC2 encompassing the N-terminal capping helix and show that this helix exhibits two distinct and defined orientations relative to the rest of the TPR domain. Such a difference in orientation gives rise, at the N-terminal part of the groove, to the formation of one hydrophobic pocket, as well as to electrostatic variations at the groove surface. We present a comprehensive structural analysis of available KLC1/2-TPR domain structures that highlights that ligand binding into the groove can be specific of one or the other N-terminal capping helix orientations. Further, structural analysis reveals that the N-terminal capping helix is always involved in crystal packing contacts, especially in a TPR1: TPR1' contact which highlights its propensity to be a protein-protein interaction site. Together, these results underline that the structural plasticity of the N-terminal capping helix might represent a structural determinant for TPR domain structural versatility in cargo binding.	[The Quyen Nguyen; Chenon, Melanie; Vilela, Fernando; Velours, Christophe; Varela, Paloma F.; Llinas, Paola; Menetrey, Julie] Univ Paris Sud, CNRS, LEBS, 1 Ave Terrasse, Gif Sur Yvette, France; [The Quyen Nguyen; Chenon, Melanie; Vilela, Fernando; Velours, Christophe; Aumont-Nicaise, Magali; Andreani, Jessica; Varela, Paloma F.; Llinas, Paola; Menetrey, Julie] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Llinas, P; Menetrey, J (corresponding author), Univ Paris Sud, CNRS, LEBS, 1 Ave Terrasse, Gif Sur Yvette, France.; Llinas, P; Menetrey, J (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France.	paola.llinas@i2bc.paris-saclay.fr; julie.menetrey@i2bc.paris-saclay.fr	Ménétrey, Julie/AAM-6408-2021; Varela, Paloma/AFT-0478-2022	Varela, Paloma/0000-0001-5078-7102; Vilela, Fernando/0000-0002-1593-5648; Andreani, Jessica/0000-0003-4435-9093; MENETREY, Julie/0000-0003-0091-8842	French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05]; ARC [SF120121205592, DOC20160603834]	French Infrastructure for Integrated Structural Biology (FRISBI); ARC(Australian Research Council)	This work was supported by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05, and by grants SF120121205592 and DOC20160603834 from ARC to J.M and T.Q.N, respectively.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Bricogne G., 2016, BUSTER VERSION 2 10; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dodding MP, 2011, EMBO J, V30, P4523, DOI 10.1038/emboj.2011.326; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hirokawa N, 2015, EXP CELL RES, V334, P16, DOI 10.1016/j.yexcr.2015.02.016; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Jeppesen GM, 2012, BIOCHEM SOC T, V40, P438, DOI 10.1042/BST20110768; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Marold JD, 2015, STRUCTURE, V23, P2055, DOI 10.1016/j.str.2015.07.022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Morihara T, 2014, P NATL ACAD SCI USA, V111, P2638, DOI 10.1073/pnas.1307345111; Nguyen Q, 2005, J BIOL CHEM, V280, P30185, DOI 10.1074/jbc.M505499200; Pernigo S, 2013, SCIENCE, V340, P356, DOI 10.1126/science.1234264; Rath O, 2012, KINESINS AND CANC, P1; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Yip YY, 2016, P NATL ACAD SCI USA, V113, P2418, DOI 10.1073/pnas.1520817113; Zhu HZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033943	32	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							0186354	10.1371/journal.pone.0186354	http://dx.doi.org/10.1371/journal.pone.0186354			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036226	Green Published, Green Submitted, gold			2022-12-26	WOS:000413054800022
J	Russo, R; Giordano, D; Paredi, G; Marchesani, F; Milazzo, L; Altomonte, G; Del Canale, P; Abbruzzetti, S; Ascenzi, P; Di Prisco, G; Viappiani, C; Fago, A; Bruno, S; Smulevich, G; Verde, C				Russo, Roberta; Giordano, Daniela; Paredi, Gianluca; Marchesani, Francesco; Milazzo, Lisa; Altomonte, Giovanna; Del Canale, Pietro; Abbruzzetti, Stefania; Ascenzi, Paolo; Di Prisco, Guido; Viappiani, Cristiano; Fago, Angela; Bruno, Stefano; Smulevich, Giulietta; Verde, Cinzia			The Greenland shark Somniosus microcephalus -Hemoglobins and ligand-binding properties	PLOS ONE			English	Article							RESONANCE RAMAN-SPECTRA; AMINO-ACID-SEQUENCE; OXYGEN-BINDING; HETERODONTUS-PORTUSJACKSONI; STRETCHING FREQUENCIES; MOLECULAR ADAPTATIONS; QUATERNARY STRUCTURE; NOTOTHENIOID FISH; HYPOXIA TOLERANCE; ALLOSTERIC MODEL	A large amount of data is currently available on the adaptive mechanisms of polar bony fish hemoglobins, but structural information on those of cartilaginous species is scarce. This study presents the first characterisation of the hemoglobin system of one of the longest-living vertebrate species (392 +/- 120 years), the Arctic shark Somniosus microcephalus. Three major hemoglobins are found in its red blood cells and are made of two copies of the same a globin combined with two copies of three very similar beta subunits. The three hemoglobins show very similar oxygenation and carbonylation properties, which are unaffected by urea, a very important compound in marine elasmobranch physiology. They display identical electronic absorption and resonance Raman spectra, indicating that their heme-pocket structures are identical or highly similar. The quaternary transition equilibrium between the relaxed (R) and the tense (T) states is more dependent on physiological allosteric effectors than in human hemoglobin, as also demonstrated in polar teleost hemoglobins. Similar to other cartilaginous fishes, we found no evidence for functional differentiation among the three isoforms. The very similar ligand-binding properties suggest that regulatory control of O-2 transport may be at the cellular level and that it may involve changes in the cellular concentrations of allosteric effectors and/or variations of other systemic factors. The hemoglobins of this polar shark have evolved adaptive decreases in O2 affinity in comparison to temperate sharks.	[Russo, Roberta; Giordano, Daniela; Altomonte, Giovanna; Di Prisco, Guido; Verde, Cinzia] CNR, Inst Biosci & BioResources, Via Pietro Castellino 111, Naples, Italy; [Giordano, Daniela; Verde, Cinzia] Stn Zool Anton Dohrn, Naples, Italy; [Paredi, Gianluca; Marchesani, Francesco; Bruno, Stefano] Univ Parma, Dipartimento Sci Alimenti & Farmaco, Parco Area Sci 23-A, Parma, Italy; [Milazzo, Lisa; Smulevich, Giulietta] Univ Firenze, Dipartimento Chim Ugo Schiff, Via Lastruccia 3-13, Sesto Fiorentino, FI, Italy; [Altomonte, Giovanna; Verde, Cinzia] Univ Roma 3, Dipartimento Biol, Viale Marconi 448, Rome, Italy; [Del Canale, Pietro; Abbruzzetti, Stefania; Viappiani, Cristiano] Univ Parma, Dipartimento Sci Matemat Fis & Informat, Parco Area Sci 7A, Parma, Italy; [Abbruzzetti, Stefania; Viappiani, Cristiano] CNR, NEST Ist Nanosci, Piazza San Silvestro 12, Pisa, Italy; [Ascenzi, Paolo] Univ RomaTre, Lab Interdipartimentale Microscopia Elettron, Via Vasca Navale 79, Rome, Italy; [Fago, Angela] Aarhus Univ, Dept Biosci, Zoophysiol, Aarhus, Denmark	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Stazione Zoologica Anton Dohrn di Napoli; University of Parma; University of Florence; Roma Tre University; University of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Roma Tre University; Aarhus University	Verde, C (corresponding author), CNR, Inst Biosci & BioResources, Via Pietro Castellino 111, Naples, Italy.; Verde, C (corresponding author), Stn Zool Anton Dohrn, Naples, Italy.; Verde, C (corresponding author), Univ Roma 3, Dipartimento Biol, Viale Marconi 448, Rome, Italy.	c.verde@ibp.cnr.it	Viappiani, Cristiano/AAC-7579-2019; Paredi, Gianluca/N-9977-2019; abbruzzetti, stefania/AAE-5518-2020; Bruno, Stefano/A-4582-2011; Fago, Angela/J-5946-2013	Viappiani, Cristiano/0000-0001-7470-4770; abbruzzetti, stefania/0000-0001-7685-8554; Bruno, Stefano/0000-0002-7890-2472; VERDE, Cinzia/0000-0001-6185-282X; Marchesani, Francesco/0000-0003-4384-9015; Fago, Angela/0000-0001-7315-2628	Italian National Programme for Antarctic Research (PNRA) [2013/AZ1.20]; Danish Council for Independent Research, Natural Sciences [10-084-565]; SCAR programme "Antarctic Thresholds-Ecosystem Resilience and Adaptation" (AnT-ERA)	Italian National Programme for Antarctic Research (PNRA); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); SCAR programme "Antarctic Thresholds-Ecosystem Resilience and Adaptation" (AnT-ERA)	The authors acknowledge grant support from the Italian National Programme for Antarctic Research (PNRA) (Project 2013/AZ1.20) and from the Danish Council for Independent Research, Natural Sciences (grant 10-084-565 to AF); The specimens were collected during the TUNU-V expedition, as part of the TEAM-Fish Programme, UiT-The Arctic University of Tromso, Norway. This study is in the framework of the project "TUNU Euro-Arctic Marine Fishes (TEAM-Fish): Impact of climate change on biodiversity, adaptation, contaminant bioaccumulation. Comparison with the Antarctic", funded by the Italian National Programme for Antarctic Research (PNRA); and of the SCAR programme "Antarctic Thresholds-Ecosystem Resilience and Adaptation" (AnT-ERA). The authors are grateful to colleagues and crew onboard the RV Helmer Hanssen for their kind collaboration. We thank Elin E. Petersen (Aarhus) for skilled technical assistance in the lab. We are grateful to four anonimous Reviewers, whose comments and suggestions helped us to improve the manuscript.	Abbruzzetti S, 2005, J AM CHEM SOC, V127, P9865, DOI 10.1021/ja051702x; Abbruzzetti S, 2007, J PHYS CHEM B, V111, P12582, DOI 10.1021/jp074954o; Abbruzzetti S, 2006, PHOTOCH PHOTOBIO SCI, V5, P1109, DOI 10.1039/b610236k; Adar F., 1978, PORPHYRINS, P167; ANDERSEN ME, 1973, J BIOL CHEM, V248, P331; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; ASCHAUER H, 1985, BIOL CHEM H-S, V366, P589, DOI 10.1515/bchm3.1985.366.1.589; BALDWIN J, 1990, J EXP MAR BIOL ECOL, V144, P145, DOI 10.1016/0022-0981(90)90025-8; Berenbrink M, 2005, SCIENCE, V307, P1752, DOI 10.1126/science.1107793; BIGELOW H. B., 1948, MEM SEARS FOUND MARINE RES [NEW HAVEN], V1, P59; BRAUNITZER G, 1961, H-S Z PHYSIOL CHEM, V325, P283, DOI 10.1515/bchm2.1961.325.1.283; Brill R, 2008, J EXP MAR BIOL ECOL, V354, P132, DOI 10.1016/j.jembe.2007.10.011; BRITTAIN T, 1982, COMP BIOCHEM PHYS B, V72, P689, DOI 10.1016/0305-0491(82)90528-4; BRUNNER H, 1974, NATURWISSENSCHAFTEN, V61, P129, DOI 10.1007/BF00606289; Butler P.J., 1988, P1; Cheng CHC, 2007, PHILOS T R SOC B, V362, P2215, DOI 10.1098/rstb.2006.1946; Cheviron ZA, 2014, MOL BIOL EVOL, V31, P2948, DOI 10.1093/molbev/msu234; Chong KT, 1999, ACTA CRYSTALLOGR D, V55, P1291, DOI 10.1107/S0907444999005934; Colbert E.H., 1955, EVOLUTION VERTEBRATE; Coppola D, 2015, HYDROBIOLOGIA, V761, P315, DOI 10.1007/s10750-015-2439-2; Coppola D, 2012, MOL BIOSYST, V8, P3295, DOI 10.1039/c2mb25210d; Coppola D, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-66; Damsgaard C, 2013, AM J PHYSIOL-REG I, V305, pR961, DOI 10.1152/ajpregu.00284.2013; DAVINO R, 1988, COMP BIOCHEM PHYS B, V90, P579, DOI 10.1016/0305-0491(88)90298-2; Dettai A, 2008, METHOD ENZYMOL, V436, P539, DOI 10.1016/S0076-6879(08)36030-3; di Prisco G, 2007, GENE, V398, P143, DOI 10.1016/j.gene.2007.02.047; DICKINSON FM, 1981, BIOCHEM J, V197, P437, DOI 10.1042/bj1970437; DIPRISCO G, 1991, TRENDS BIOCHEM SCI, V16, P471, DOI 10.1016/0968-0004(91)90182-U; Eastman JT, 1997, CYBIUM, V12, P276; Fago A, 1997, COMP BIOCHEM PHYS B, V118, P319, DOI 10.1016/S0305-0491(97)00160-0; FEIS A, 1994, BIOCHEMISTRY-US, V33, P4577, DOI 10.1021/bi00181a019; FISHER WK, 1977, AUST J BIOL SCI, V30, P487, DOI 10.1071/BI9770487; FYHN UEH, 1975, COMP BIOCHEM PHYSIOL, V50, P119, DOI 10.1016/0305-0491(75)90311-9; Gabba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049770; GILLEN RG, 1973, ARCH BIOCHEM BIOPHYS, V154, P348, DOI 10.1016/0003-9861(73)90067-2; Giordano D, 2010, J FISH BIOL, V76, P301, DOI 10.1111/j.1095-8649.2009.02528.x; Giordano D, 2015, HYDROBIOLOGIA, V761, P293, DOI 10.1007/s10750-015-2306-1; Giordano D, 2013, ADV MICROB PHYSIOL, V63, P329, DOI 10.1016/B978-0-12-407693-8.00008-X; Goldbeck RA, 1996, BIOCHEMISTRY-US, V35, P8628, DOI 10.1021/bi952248k; Gouterman M., 1978, PORPHYRINS, P1, DOI DOI 10.1016/B978-0-12-220103-5.50008-8; Henry ER, 1997, BIOCHEMISTRY-US, V36, P6511, DOI 10.1021/bi9619177; HIROTA S, 1994, J AM CHEM SOC, V116, P10564, DOI 10.1021/ja00102a025; HORI H, 1980, J AM CHEM SOC, V102, P3608, DOI 10.1021/ja00530a049; Janecka JE, 2015, J EXP BIOL, V218, P2402, DOI 10.1242/jeb.125369; Jensen B, 2016, COMP BIOCHEM PHYS A, V195, P10, DOI 10.1016/j.cbpa.2016.01.018; Jensen Frank B., 1998, Fish Physiology, V17, P1, DOI 10.1016/S1546-5098(08)60257-5; JONES CM, 1992, BIOCHEMISTRY-US, V31, P6692, DOI 10.1021/bi00144a008; KITAGAWA T, 1979, FEBS LETT, V104, P376, DOI 10.1016/0014-5793(79)80856-X; Kitagawa T, 1988, BIOL APPL RAMAN SPEC, V3, P97; KOMIYAMA NH, 1991, NATURE, V352, P349, DOI 10.1038/352349a0; LADNER RC, 1977, J MOL BIOL, V114, P385, DOI 10.1016/0022-2836(77)90256-X; LARSSON A, 1976, J FISH BIOL, V9, P425, DOI 10.1111/j.1095-8649.1976.tb04691.x; MacNeil MA, 2012, J FISH BIOL, V80, P991, DOI 10.1111/j.1095-8649.2012.03257.x; Manwell C, 1970, MOL BIOL ORIGIN SPEC; MATSUKAWA S, 1985, J AM CHEM SOC, V107, P1108, DOI 10.1021/ja00291a004; Mecklenburg Catherine W., 2011, Marine Biodiversity, V41, P109, DOI 10.1007/s12526-010-0070-z; NAGAI K, 1980, J MOL BIOL, V136, P271, DOI 10.1016/0022-2836(80)90374-5; NAGAI K, 1980, P NATL ACAD SCI-BIOL, V77, P2033, DOI 10.1073/pnas.77.4.2033; Nagatomo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135080; Naoi Y, 2001, J MOL BIOL, V307, P259, DOI 10.1006/jmbi.2000.4446; NASH AR, 1976, AUST J BIOL SCI, V29, P73, DOI 10.1071/BI9760073; Natarajan C, 2016, SCIENCE, V354, P336, DOI 10.1126/science.aaf9070; Nielsen J, 2016, SCIENCE, V353, P702, DOI 10.1126/science.aaf1703; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; PENNELLY RR, 1975, COMP BIOCHEM PHYS B, V52, P83, DOI 10.1016/0305-0491(75)90119-4; PERUTZ MF, 1982, NATURE, V299, P421, DOI 10.1038/299421a0; PERUTZ MF, 1983, MOL BIOL EVOL, V1, P1; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; PERUTZ MF, 1974, BIOCHEMISTRY-US, V13, P2163, DOI 10.1021/bi00707a026; Portner HO, 2006, DEEP-SEA RES PT II, V53, P1071, DOI 10.1016/j.dsr2.2006.02.015; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portoro I, 2008, BBA-PROTEINS PROTEOM, V1784, P1402, DOI 10.1016/j.bbapap.2008.03.005; Rajani C, 1998, J AM CHEM SOC, V120, P7278, DOI 10.1021/ja981280+; Riggs A., 1970, P209; Ronda L, 2008, METHOD ENZYMOL, V437, P311, DOI 10.1016/S0076-6879(07)37016-X; SCHOLNICK DA, 1991, J EXP ZOOL, V259, P32, DOI 10.1002/jez.1402590106; SHIH DTB, 1993, J MOL BIOL, V230, P1291; Skomal GB, 2004, MAR BIOL, V145, P489, DOI 10.1007/s00227-004-1332-8; Speers-Roesch B, 2012, J EXP BIOL, V215, P93, DOI 10.1242/jeb.059642; Speers-Roesch B, 2012, J EXP BIOL, V215, P103, DOI 10.1242/jeb.059667; Spiro TG, 1988, BIOL APPL RAMAN SPEC, V3, P1; Spiro TG, 1988, BIOL APPL RAMAN SPEC, V3, P97; STEIN P, 1980, J AM CHEM SOC, V102, P7795, DOI 10.1021/ja00546a035; Stokesbury MJW, 2005, MAR BIOL, V148, P159, DOI 10.1007/s00227-005-0061-y; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; TETENS V, 1984, COMP BIOCHEM PHYS A, V79, P165, DOI 10.1016/0300-9629(84)90726-6; TSUBAKI M, 1982, BIOCHEMISTRY-US, V21, P1132, DOI 10.1021/bi00535a004; Tufts DM, 2015, MOL BIOL EVOL, V32, P287, DOI 10.1093/molbev/msu311; Verde C, 2005, BIOCHEM J, V389, P297, DOI 10.1042/BJ20050305; Verde C, 2002, J BIOL CHEM, V277, P36312, DOI 10.1074/jbc.M202474200; Verde C, 2006, J BIOL CHEM, V281, P22073, DOI 10.1074/jbc.M513080200; Viappiani C, 2014, P NATL ACAD SCI USA, V111, P12758, DOI 10.1073/pnas.1413566111; Weber RE, 2011, ACTA PHYSIOL, V202, P549, DOI 10.1111/j.1748-1716.2010.02204.x; WEBER RE, 1983, J EXP BIOL, V103, P109; WEBER RE, 1983, LIFE SCI, V32, P2157, DOI 10.1016/0024-3205(83)90105-4; WEBER RE, 1992, J APPL PHYSIOL, V72, P1611, DOI 10.1152/jappl.1992.72.4.1611; WELLS RMG, 1985, COMP BIOCHEM PHYS A, V81, P643, DOI 10.1016/0300-9629(85)91041-2; WYMAN J, 1948, ADV PROTEIN CHEM, V4, P407, DOI 10.1016/S0065-3233(08)60011-X	98	3	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186181	10.1371/journal.pone.0186181	http://dx.doi.org/10.1371/journal.pone.0186181			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023598	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100075
J	Cardenosa, D; Fields, A; Abercrombie, D; Feldheim, K; Shea, SKH; Chapman, DD				Cardenosa, Diego; Fields, Andrew; Abercrombie, Debra; Feldheim, Kevin; Shea, Stanley K. H.; Chapman, Demian D.			A multiplex PCR mini-barcode assay to identify processed shark products in the global trade	PLOS ONE			English	Article							GENETIC IDENTIFICATION; CONSERVATION; CATCHES	Protecting sharks from overexploitation has become global priority after widespread population declines have occurred. Tracking catches and trade on a species-specific basis has proven challenging, in part due to difficulties in identifying processed shark products such as fins, meat, and liver oil. This has hindered efforts to implement regulations aimed at promoting sustainable use of commercially important species and protection of imperiled species. Genetic approaches to identify shark products exist but are typically based on sequencing or amplifying large DNA regions and may fail to work on heavily processed products in which DNA is degraded. Here, we describe a novel multiplex PCR mini-barcode assay based on two short fragments of the cytochrome oxidase I (COI) gene. This assay can identify to species all sharks currently listed on the Convention of International Trade of Endangered Species (CITES) and most shark species present in the international trade. It achieves species diagnosis based on a single PCR and one to two downstream DNA sequencing reactions. The assay is capable of identifying highly processed shark products including fins, cooked shark fin soup, and skin-care products containing liver oil. This is a straightforward and reliable identification method for data collection and enforcement of regulations implemented for certain species at all governance levels.	[Cardenosa, Diego; Fields, Andrew] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Abercrombie, Debra] Abercrombie & Fish, Miller Pl, New York, NY USA; [Feldheim, Kevin] Field Museum, Pritzker Lab Mol Systemat & Evolut, Chicago, IL USA; [Shea, Stanley K. H.] BLOOM Assoc, Hong Kong, Hong Kong, Peoples R China; [Chapman, Demian D.] Florida Int Univ, Dept Biol Sci, North Miami, FL USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Field Museum of Natural History (Chicago); State University System of Florida; Florida International University	Cardenosa, D (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	diego.cardeosa@stonybrook.edu		Cardenosa, Diego/0000-0001-9414-7385; Abercrombie, Debra/0000-0002-2572-1862				Abercrombie D, 2013, NMFSSEFSC643, V643, P1; Abercrombie DL, 2005, CONSERV GENET, V6, P775, DOI 10.1007/s10592-005-9036-2; Caballero S, 2012, MOL ECOL RESOUR, V12, P233, DOI 10.1111/j.1755-0998.2011.03089.x; Cardenosa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110193; Chapman DD, 2003, CONSERV GENET, V4, P415, DOI 10.1023/A:1024771215616; Clarke S., 2015, STATE GLOBAL MARKET; Clarke SC, 2003, THESIS; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Clarke SC, 2013, CONSERV BIOL, V27, P197, DOI 10.1111/j.1523-1739.2012.01943.x; Fields AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114844; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hyde JR, 2005, MAR ECOL PROG SER, V286, P269, DOI 10.3354/meps286269; ICCAT, 2011, RES REC OTH DEC; National Marine Fisheries Service (NMFS), 1999, FIN FISH MAN PLAN AT; Naylor GJP, 2012, B AM MUS NAT HIST, P1; Shivji M, 2002, CONSERV BIOL, V16, P1036, DOI 10.1046/j.1523-1739.2002.01188.x; Simpfendorfer CA, 2017, CURR BIOL, V27, pR97, DOI 10.1016/j.cub.2016.12.017; Techera E.J., 2014, SHARKS CONSERVATION; Vincent ACJ, 2014, FISH FISH, V15, P563, DOI 10.1111/faf.12035; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	21	32	33	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185368	10.1371/journal.pone.0185368	http://dx.doi.org/10.1371/journal.pone.0185368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020095	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400028
J	Joyce, TW; Durban, JW; Claridge, DE; Dunn, CA; Fearnbach, H; Parsons, KM; Andrews, RD; Ballance, LT				Joyce, Trevor W.; Durban, John W.; Claridge, Diane E.; Dunn, Charlotte A.; Fearnbach, Holly; Parsons, Kim M.; Andrews, Russel D.; Ballance, Lisa T.			Physiological, morphological, and ecological tradeoffs influence vertical habitat use of deep-diving toothed-whales in the Bahamas	PLOS ONE			English	Article							SPERM-WHALES; BODY-SIZE; PHYSETER-MACROCEPHALUS; OPTIMAL ALLOCATION; FORAGING BEHAVIOR; SKELETAL-MUSCLE; SEX DETERMINATION; METABOLIC-RATES; WEDDELL SEALS; KILLER WHALES	Dive capacity among toothed whales (suborder: Odontoceti) has been shown to generally increase with body mass in a relationship closely linked to the allometric scaling of metabolic rates. However, two odontocete species tagged in this study, the Blainville's beaked whale Mesoplodon densirostris and the Cuvier's beaked whale Ziphius cavirostris, confounded expectations of a simple allometric relationship, with exceptionally long (mean: 46.1 min & 65.4 min) and deep dives (mean: 1129 m & 1179 m), and comparatively small body masses (med.: 842.9 kg & 1556.7 kg). These two species also exhibited exceptionally long recovery periods between successive deep dives, or inter-deep-dive intervals (M. densirostris: med. 62 min; Z. cavirostris: med. 68 min). We examined competing hypotheses to explain observed patterns of vertical habitat use based on body mass, oxygen binding protein concentrations, and inter-deep-dive intervals in an assemblage of five sympatric toothed whales species in the Bahamas. Hypotheses were evaluated using dive data from satellite tags attached to the two beaked whales (M. densirostris, n = 12; Z. cavirostris, n = 7), as well as melon-headed whales Peponocephala electra (n = 13), short-finned pilot whales Globicephala macrorhynchus (n = 15), and sperm whales Physeter macrocephalus (n = 27). Body mass and myoglobin concentration together explained only 36% of the variance in maximum dive durations. The inclusion of inter-deep-dive intervals, substantially improved model fits (R-2 = 0.92). This finding supported a hypothesis that beaked whales extend foraging dives by exceeding aerobic dive limits, with the extension of inter-deep-dive intervals corresponding to metabolism of accumulated lactic acid. This inference points to intriguing tradeoffs between body size, access to prey in different depth strata, and time allocation within dive cycles. These tradeoffs and resulting differences in habitat use have important implications for spatial distribution patterns, and relative vulnerabilities to anthropogenic impacts.	[Joyce, Trevor W.; Ballance, Lisa T.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Joyce, Trevor W.; Durban, John W.; Ballance, Lisa T.] NOAA, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA; [Claridge, Diane E.; Dunn, Charlotte A.] Bahamas Marine Mammal Res Org, Marsh Harbor, Abaco, Bahamas; [Claridge, Diane E.; Dunn, Charlotte A.] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Fearnbach, Holly] SR3 SeaLife Response Rehabil & Res, Mukilteo, WA USA; [Parsons, Kim M.] NOAA, Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Andrews, Russel D.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Andrews, Russel D.] Marine Ecol & Telemetry Res, Seabeck, WA USA; [Joyce, Trevor W.] Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Newport, OR 97365 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Oceanic Atmospheric Admin (NOAA) - USA; University of St Andrews; National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Fairbanks; Oregon State University	Joyce, TW (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.; Joyce, TW (corresponding author), NOAA, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA.; Joyce, TW (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Newport, OR 97365 USA.	trevorwjoyce@gmail.com	Ballance, Lisa/AAF-5472-2020	Andrews, Russel/0000-0002-4545-137X; Dunn, Charlotte/0000-0002-4274-7239	United States (U.S.) Navy Office of Naval Research [N000140710120]; Naval Facilities Engineering Command [N002441110021, N002441210007, N6660413P2671]; Strategic Environmental Research and Development Program [RC-2114]; NOAA Fisheries Acoustic Program; U.S. National Science Foundation Graduate Research Fellowship Program	United States (U.S.) Navy Office of Naval Research; Naval Facilities Engineering Command; Strategic Environmental Research and Development Program; NOAA Fisheries Acoustic Program; U.S. National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	The research reported here was financially supported by the United States (U.S.) Navy Office of Naval Research (grant N000140710120; www.onr.navy.mil), the Naval Facilities Engineering Command (grants N002441110021, N002441210007 and contract N6660413P2671; www.navfac.navy.mil), the Strategic Environmental Research and Development Program (award RC-2114; www.serdp.org), and the NOAA Fisheries Acoustic Program (http://www.nmfs.noaa.gov/pr/acoustics/). Graduate student funding support for the first author was provided by the U.S. National Science Foundation Graduate Research Fellowship Program (www.nsfgrfp.org). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Anderson D, 2004, MODEL SELECTION MULT, V2nd; Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; ANGEL MV, 1990, PHILOS T R SOC A, V331, P15, DOI 10.1098/rsta.1990.0053; [Anonymous], 2008, CANADIAN ACOUSTICS; Aoki K, 2012, MAR ECOL PROG SER, V444, P289, DOI 10.3354/meps09371; Arranz P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028353; BAILEY TG, 1986, MAR BIOL, V91, P131, DOI 10.1007/BF00397578; Baird RW, 2001, CAN J ZOOL, V79, P988, DOI 10.1139/cjz-79-6-988; BARHAM EG, 1966, SCIENCE, V151, P1399, DOI 10.1126/science.151.3716.1399; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; BUTLER PJ, 1982, ADV COMP PHYSIOL BIO, V8, P179; Carbone C, 1996, ANIM BEHAV, V51, P1247, DOI 10.1006/anbe.1996.0129; CASTELLINI MA, 1981, J COMP PHYSIOL, V143, P191; CASTELLINI MA, 1992, J EXP BIOL, V165, P181; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; Childress JJ, 1973, DEEP SEA RES OCEANOG, P1093; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1053, DOI 10.1098/rstb.1996.0093; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Costa DP, 2001, COMP BIOCHEM PHYS A, V129, P771, DOI 10.1016/S1095-6433(01)00346-4; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; DREWS GA, 1961, J HISTOCHEM CYTOCHEM, V9, P206, DOI 10.1177/9.2.206; Evans K, 2004, ICES J MAR SCI, V61, P1313, DOI 10.1016/j.icesjms.2004.07.026; Gage J. D., 1991, DEEP SEA BIOL NATURA; Georges JY, 2000, POLAR BIOL, V23, P59, DOI 10.1007/s003000050008; Gillespie D, 2009, J ACOUST SOC AM, V125, P3428, DOI 10.1121/1.3110832; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Halsey LG, 2006, AM NAT, V167, P276, DOI 10.1086/499439; HAYSSEN V, 1985, COMP BIOCHEM PHYS A, V81, P741, DOI 10.1016/0300-9629(85)90904-1; Hazen EL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500469; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Hooker SK, 1999, P ROY SOC B-BIOL SCI, V266, P671, DOI 10.1098/rspb.1999.0688; Hooker SK, 2001, MAMMAL REV, V31, P81, DOI 10.1046/j.1365-2907.2001.00080.x; HOUSTON AI, 1992, BEHAV ECOL, V3, P255, DOI 10.1093/beheco/3.3.255; Jerlov N.G., 1968, OPTICAL OCEANOGRAPHY; Jimenez AG, 2011, J EXP BIOL, V214, P3688, DOI 10.1242/jeb.060301; Johnson D, 2013, CRAWL FIT CONTINUOUS; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; JOHNSON MW, 1948, J MAR RES, V7, P443; Johnston IA, 2004, J EXP BIOL, V207, P4343, DOI 10.1242/jeb.01292; Joyce TW, 2016, MAR MAMMAL SCI, V32, P1044, DOI 10.1111/mms.12323; Kielhorn CE, 2013, J MORPHOL, V274, P663, DOI 10.1002/jmor.20124; KLEIBER M, 1975, J THEOR BIOL, V53, P199, DOI 10.1016/0022-5193(75)90110-1; KOOYMAN GL, 1983, J COMP PHYSIOL, V151, P171, DOI 10.1007/BF00689915; KOOYMAN GL, 1980, J COMP PHYSIOL, V138, P335, DOI 10.1007/BF00691568; Laidre KL, 2002, CAN J ZOOL, V80, P624, DOI 10.1139/Z02-041; Lang TG., 1966, WHALES DOLPHINS PORP, P410; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; LINDSTEDT SL, 1985, AM NAT, V125, P873, DOI 10.1086/284385; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; MARSHALL N. B., 1965, DEEP SEA RES OCEANOGR ABSTR, V12, P299, DOI 10.1016/0011-7471(65)90004-5; Martin AR, 1999, CAN J ZOOL, V77, P1783, DOI 10.1139/cjz-77-11-1783; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; MAYO CA, 1990, CAN J ZOOL, V68, P2214, DOI 10.1139/z90-308; McCarthy E, 2011, MAR MAMMAL SCI, V27, pE206, DOI 10.1111/j.1748-7692.2010.00457.x; McClain CR, 2006, J BIOGEOGR, V33, P1578, DOI 10.1111/j.1365-2699.2006.01545.x; McClintock BT, 2015, METHODS ECOL EVOL, V6, P266, DOI 10.1111/2041-210X.12311; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Miller PJO, 2004, J EXP BIOL, V207, P1953, DOI 10.1242/jeb.00993; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Mirceta S, 2013, SCIENCE, V340, DOI 10.1126/science.1234192; Moretti D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085064; Mori Y, 2002, J EVOLUTION BIOL, V15, P269, DOI 10.1046/j.1420-9101.2002.00382.x; Mori Y, 1999, BEHAV ECOL, V10, P155, DOI 10.1093/beheco/10.2.155; Morin PA, 2005, MOL ECOL, V14, P3275, DOI 10.1111/j.1365-294X.2005.02651.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NEMETH PM, 1984, J HISTOCHEM CYTOCHEM, V32, P1211, DOI 10.1177/32.11.6491255; New LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068725; Noren SR, 2000, COMP BIOCHEM PHYS A, V126, P181, DOI 10.1016/S1095-6433(00)00182-3; OHMAN MD, 1983, SCIENCE, V220, P1404, DOI 10.1126/science.220.4604.1404; Pabst DA, 2016, INTEGR COMP BIOL, V56, P1337, DOI 10.1093/icb/icw126; PETER JB, 1972, BIOCHEMISTRY-US, V11, P2627, DOI 10.1021/bi00764a013; Ponganis PJ, 2011, J EXP BIOL, V214, P3325, DOI 10.1242/jeb.031252; Ponganis PJ, PHYSIOL; Reisinger RR, 2015, J EXP MAR BIOL ECOL, V473, P90, DOI 10.1016/j.jembe.2015.08.008; Rosel PE, 2003, CONSERV GENET, V4, P647, DOI 10.1023/A:1025666212967; Rosen DAS, 2015, J EXP MAR BIOL ECOL, V469, P93, DOI 10.1016/j.jembe.2015.04.017; Sato K, 2007, P R SOC B, V274, P471, DOI 10.1098/rspb.2006.0005; Schorr GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092633; Schreer JF, 1997, CAN J ZOOL, V75, P339, DOI 10.1139/z97-044; Scott Michael D., 2001, Journal of Cetacean Research and Management, V3, P87; Sharp JG, 1953, WHALEMEAT PRODUCTION; Sierra E, 2015, SCI REP-UK, V5, DOI 10.1038/srep15909; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Smith SC, 2000, MAR MAMMAL SCI, V16, P315, DOI 10.1111/j.1748-7692.2000.tb00927.x; SNYDER GK, 1983, RESP PHYSIOL, V54, P269, DOI 10.1016/0034-5687(83)90072-5; Soto NA, 2008, J ANIM ECOL, V77, P936, DOI 10.1111/j.1365-2656.2008.01393.x; Sparling CE, 2007, BIOL LETTERS, V3, P94, DOI 10.1098/rsbl.2006.0566; STICKNEY DG, 1989, MAR BIOL, V103, P13, DOI 10.1007/BF00391060; Teloni V, 2008, J EXP MAR BIOL ECOL, V354, P119, DOI 10.1016/j.jembe.2007.10.010; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Velten BP, 2013, J EXP BIOL, V216, P1862, DOI 10.1242/jeb.081323; Villemereuil P.D., 2014, MODERN PHYLOGENETIC, P287, DOI [10.1007/978-3-662-43550-2_11, DOI 10.1007/978-3-662-43550-2_11]; Waring GT, 2001, MAR MAMMAL SCI, V17, P703, DOI 10.1111/j.1748-7692.2001.tb01294.x; WATKINS WA, 1993, MAR MAMMAL SCI, V9, P55, DOI 10.1111/j.1748-7692.1993.tb00426.x; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; WELLS RE, 1962, J CLIN INVEST, V41, P1591, DOI 10.1172/JCI104617; WESTGATE AJ, 1995, CAN J FISH AQUAT SCI, V52, P1064, DOI 10.1139/f95-104; Zuur Alain F., 2009, P1	99	22	23	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185113	10.1371/journal.pone.0185113	http://dx.doi.org/10.1371/journal.pone.0185113			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020021	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400021
J	Hughey, CC; James, FD; Bracy, DP; Donahue, EP; Young, JD; Viollet, B; Foretz, M; Wasserman, DH				Hughey, Curtis C.; James, Freyja D.; Bracy, Deanna P.; Donahue, E. Patrick; Young, Jamey D.; Viollet, Benoit; Foretz, Marc; Wasserman, David H.			Loss of hepatic AMP-activated protein kinase impedes the rate of glycogenolysis but not gluconeogenic fluxes in exercising mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						energy metabolism; fibroblast growth factor (FGF); intermediary metabolism; isotopic tracer; liver metabolism; metabolic flux analysis	SKELETAL-MUSCLE GLYCOGEN; IN-VIVO; METABOLIC-REGULATION; GLUCOSE-HOMEOSTASIS; ENERGY-METABOLISM; MUSCULAR WORK; FATTY LIVER; SHORT-TERM; INSULIN; METFORMIN	Pathologies including diabetes and conditions such as exercise place an unusual demand on liver energy metabolism, and this demand induces a state of energy discharge. Hepatic AMP-activated protein kinase (AMPK) has been proposed to inhibit anabolic processes such as gluconeogenesis in response to cellular energy stress. However, both AMPK activation and glucose release from the liver are increased during exercise. Here, we sought to test the role of hepatic AMPK in the regulation of in vivo glucose-producing and citric acid cycle-related fluxes during an acute bout of muscular work. We used H-2/C-13 metabolic flux analysis to quantify intermediary metabolism fluxes in both sedentary and treadmill-running mice. Additionally, liver-specific AMPK 1 and 2 subunit KO and WT mice were utilized. Exercise caused an increase in endogenous glucose production, glycogenolysis, and gluconeogenesis from phosphoenolpyruvate. Citric acid cycle fluxes, pyruvate cycling, anaplerosis, and cataplerosis were also elevated during this exercise. Sedentary nutrient fluxes in the postabsorptive state were comparable for the WT and KO mice. However, the increment in the endogenous rate of glucose appearance during exercise was blunted in the KO mice because of a diminished glycogenolytic flux. This lower rate of glycogenolysis was associated with lower hepatic glycogen content before the onset of exercise and prompted a reduction in arterial glucose during exercise. These results indicate that liver AMPK12 is required for maintaining glucose homeostasis during an acute bout of exercise.	[Hughey, Curtis C.; James, Freyja D.; Bracy, Deanna P.; Donahue, E. Patrick; Young, Jamey D.; Wasserman, David H.] Vanderbilt Univ, Dept Mol Physiol & Biophys, 823 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA; [James, Freyja D.; Bracy, Deanna P.; Wasserman, David H.] Vanderbilt Univ, Mouse Metab Phenotyping Ctr, Nashville, TN 37232 USA; [Young, Jamey D.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37232 USA; [Viollet, Benoit; Foretz, Marc] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Viollet, Benoit; Foretz, Marc] CNRS, UMR 8104, F-75014 Paris, France; [Viollet, Benoit; Foretz, Marc] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University; Vanderbilt University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Wasserman, DH (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 823 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	david.wasserman@vanderbilt.edu	Viollet, Benoit/N-2397-2019; Young, Jamey/A-5857-2012; Viollet, Benoit/O-6927-2017; FORETZ, Marc/O-7334-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032	NIDDK, National Institutes of Health [DK050277, DK054902, DK106348]; Diabetes Canada Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, P30DK058404, U24DK059637, P30DK020593, U2CDK059637, R01DK106348, R01DK050277, R01DK054902, R56DK054902, R37DK050277] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Diabetes Canada Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grants DK050277 (to D. H. W.), DK054902 (to D. H. W.), and DK106348 (to J. D. Y.) and a Diabetes Canada Postdoctoral Fellowship (to C. C. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Antoniewicz MR, 2011, ANAL CHEM, V83, P3211, DOI 10.1021/ac200012p; ATKINSON DE, 1969, ANNU REV MICROBIOL, V23, P47, DOI 10.1146/annurev.mi.23.100169.000403; Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Burgess SC, 2005, AM J PHYSIOL-ENDOC M, V289, pE53, DOI 10.1152/ajpendo.00601.2004; Camacho RC, 2006, AM J PHYSIOL-ENDOC M, V290, pE405, DOI 10.1152/ajpendo.00385.2005; Camacho RC, 2005, EXERC SPORT SCI REV, V33, P17; Carlson CL, 1999, J APPL PHYSIOL, V86, P669, DOI 10.1152/jappl.1999.86.2.669; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hasenour CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170382; Hasenour CM, 2015, AM J PHYSIOL-ENDOC M, V309, pE191, DOI 10.1152/ajpendo.00003.2015; Hasenour CM, 2014, J BIOL CHEM, V289, P5950, DOI 10.1074/jbc.M113.528232; Hasenour CM, 2013, MOL CELL ENDOCRINOL, V366, P152, DOI 10.1016/j.mce.2012.06.018; Hedegaard J, 2004, PROTEOMICS, V4, P2448, DOI 10.1002/pmic.200300761; HEMS R, 1966, BIOCHEM J, V101, P284, DOI 10.1042/bj1010284; Jiao P, 2013, MOL CELL ENDOCRINOL, V375, P157, DOI 10.1016/j.mce.2013.05.021; Kang L, 2012, J APPL PHYSIOL, V113, P1173, DOI 10.1152/japplphysiol.01344.2011; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; KREBS H, 1964, PROC R SOC SER B-BIO, V159, P545, DOI 10.1098/rspb.1964.0019; Lee-Young RS, 2010, AM J PHYSIOL-REG I, V298, pR1399, DOI 10.1152/ajpregu.00004.2010; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luptak I, 2007, J CLIN INVEST, V117, P1432, DOI 10.1172/JCI30658; Markan KR, 2016, SEMIN CELL DEV BIOL, V53, P85, DOI 10.1016/j.semcdb.2015.09.021; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; MORGAN CR, 1965, DIABETES, V14, P669, DOI 10.2337/diab.14.10.669; Nilsson EC, 2006, J BIOL CHEM, V281, P7244, DOI 10.1074/jbc.M510461200; Otero YF, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.250; Perry RJ, 2016, J BIOL CHEM, V291, P12161, DOI 10.1074/jbc.M116.720631; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Previs SF, 2015, AM J PHYSIOL-ENDOC M, V309, pE727, DOI 10.1152/ajpendo.00216.2015; Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; ROACH PJ, 1976, J BIOL CHEM, V251, P1920; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; Salminen A, 2017, J MOL MED, V95, P123, DOI 10.1007/s00109-016-1477-1; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scheffler T. L., 2016, PHYSL REP; SCRUTTON MC, 1974, J BIOL CHEM, V249, P7057; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shearer J, 2004, EXERC SPORT SCI REV, V32, P120, DOI 10.1097/00003677-200407000-00008; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tanimura Y., 2016, PHYSL REP; VERHOEVEN AJM, 1995, EUR J BIOCHEM, V228, P236; Vernia S, 2009, J BIOL CHEM, V284, P8247, DOI 10.1074/jbc.M808492200; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Wang HM, 2008, BIOCHEM PHARMACOL, V75, P457, DOI 10.1016/j.bcp.2007.08.028; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Wasserman DH, 2009, AM J PHYSIOL-ENDOC M, V296, pE11, DOI 10.1152/ajpendo.90563.2008; WASSERMAN DH, 1989, AM J PHYSIOL, V256, pE500, DOI 10.1152/ajpendo.1989.256.4.E500; WASSERMAN DH, 1989, AM J PHYSIOL, V257, pE108, DOI 10.1152/ajpendo.1989.257.1.E108; WASSERMAN DH, 1992, AM J PHYSIOL, V263, pE345, DOI 10.1152/ajpendo.1992.263.2.E345; WASSERMAN DH, 1991, AM J PHYSIOL, V260, pE811, DOI 10.1152/ajpendo.1991.260.6.E811; Williams AS, 2017, DIABETES, V66, P325, DOI 10.2337/db16-0484; WOLFE RR, 1986, J CLIN INVEST, V77, P900, DOI 10.1172/JCI112388; WOODS HF, 1973, BIOCHEM J, V132, P55, DOI 10.1042/bj1320055; WOODS HG, 1970, BIOCHEM J, V119, P501, DOI 10.1042/bj1190501; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhu SL, 2014, ACTA BIOCH BIOPH SIN, V46, P1041, DOI 10.1093/abbs/gmu097	82	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20125	20140		10.1074/jbc.M117.811547	http://dx.doi.org/10.1074/jbc.M117.811547			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29038293	Green Published, hybrid			2022-12-26	WOS:000417696400019
J	Nilsson, I; Grove, K; Dovala, D; Uehara, T; Lapointe, G; Six, DA				Nilsson, Inga; Grove, Kerri; Dovala, Dustin; Uehara, Tsuyoshi; Lapointe, Guillaume; Six, David A.			Molecular characterization and verification of azido-3,8-dideoxy-d-manno-oct-2-ulosonic acid incorporation into bacterial lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gel electrophoresis; gram-negative bacteria; lipopolysaccharide (LPS); mass spectrometry (MS); metabolic tracer; microscopy; outer membrane; Kdo; labeling	ESCHERICHIA-COLI; OUTER-MEMBRANE; BIOSYNTHESIS; CONSERVATION; PURIFICATION; RESISTANCE; ENDOTOXIN; EXCISION; DIVISION; PROGRESS	3-Deoxy-d-manno-oct-2-ulosonic acid (Kdo) is an essential component of LPS in the outer leaflet of the Gram-negative bacterial outer membrane. Although labeling of Escherichia coli with the chemical reporter 8-azido-3,8-dideoxy-d-manno-oct-2-ulosonic acid (Kdo-N-3) has been reported, its incorporation into LPS has not been directly shown. We have now verified Kdo-N-3 incorporation into E. coli LPS at the molecular level. Using microscopy and PAGE analysis, we show that Kdo-N-3 is localized to the outer membrane and specifically incorporates into rough and deep-rough LPS. In an E. coli strain lacking endogenous Kdo biosynthesis, supplementation with exogenous Kdo restored full-length core-LPS, which suggests that the Kdo biosynthetic pathways might not be essential in vivo in the presence of sufficient exogenous Kdo. In contrast, exogenous Kdo-N-3 only restored a small fraction of core LPS with the majority incorporated into truncated LPS. The truncated LPS were identified as Kdo-N-3-lipid IVA and (Kdo-N-3)(2)-lipid IVA by MS analysis. The low level of Kdo-N-3 incorporation could be partly explained by a 6-fold reduction in the specificity constant of the CMP-Kdo synthetase KdsB with Kdo-N-3 compared with Kdo. These results indicate that the azido moiety in Kdo-N-3 interferes with its utilization and may limit its utility as a tracer of LPS biosynthesis and transport in E. coli. We propose that our findings will be helpful for researchers using Kdo and its chemical derivatives for investigating LPS biosynthesis, transport, and assembly in Gram-negative bacteria.	[Nilsson, Inga; Dovala, Dustin; Uehara, Tsuyoshi; Six, David A.] Novartis Inst BioMed Res, Dept Infect Dis, Emeryville, CA 94608 USA; [Grove, Kerri; Lapointe, Guillaume] Novartis Inst BioMed Res, Dept Global Discovery Chem, Emeryville, CA 94608 USA	Novartis; Novartis	Six, DA (corresponding author), Novartis Inst BioMed Res, Dept Infect Dis, Emeryville, CA 94608 USA.	david.six@novartis.com	Six, David A/D-6523-2011	Six, David A/0000-0002-9013-1711; Uehara, Tsuyoshi/0000-0001-6994-4286; Lapointe, Guillaume/0000-0002-0451-0505				BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; Carroll L, 2013, ORG BIOMOL CHEM, V11, P5772, DOI 10.1039/c3ob40897c; COOK WR, 1986, J BACTERIOL, V168, P1430, DOI 10.1128/jb.168.3.1430-1438.1986; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis MR, 2012, JOVE-J VIS EXP, DOI 10.3791/3916; Dumont A, 2012, ANGEW CHEM INT EDIT, V51, P3143, DOI 10.1002/anie.201108127; Dumont M, 2016, PLANT J, V85, P437, DOI 10.1111/tpj.13104; Fugier E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127700; Gu YH, 2015, STRUCTURE, V23, P496, DOI 10.1016/j.str.2015.01.001; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g; Kanipes MI, 2001, J BIOL CHEM, V276, P1156, DOI 10.1074/jbc.M009019200; Khan AU, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1012-8; Kocaoglu O, 2016, NAT CHEM BIOL, V12, P472, DOI [10.1038/NCHEMBIO.2109, 10.1038/nchembio.2109]; Lewenza S, 2006, J BACTERIOL, V188, P3516, DOI 10.1128/JB.188.10.3516-3524.2006; Li L, 2016, MOLECULES, V21, DOI 10.3390/molecules21101393; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Lin CH, 1997, BIOCHEMISTRY-US, V36, P780, DOI 10.1021/bi962055c; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; Mikula H, 2014, CARBOHYD CHEM, V2, P207; Moison E, 2017, ACS CHEM BIOL, V12, P928, DOI 10.1021/acschembio.7b00159; Moon K, 2013, MOL MICROBIOL, V89, P52, DOI 10.1111/mmi.12257; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Ning XH, 2008, ANGEW CHEM INT EDIT, V47, P2253, DOI 10.1002/anie.200705456; Okuda S, 2016, NAT REV MICROBIOL, V14, P337, DOI 10.1038/nrmicro.2016.25; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rajapaksha RMCP, 2004, APPL ENVIRON MICROB, V70, P2966, DOI 10.1128/AEM.70.5.2966-2973.2004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siegrist MS, 2015, FEMS MICROBIOL REV, V39, P184, DOI 10.1093/femsre/fuu012; Six DA, 2008, BIOCHEMISTRY-US, V47, P8623, DOI 10.1021/bi800873n; Smyth KM, 2013, CARBOHYD RES, V380, P70, DOI 10.1016/j.carres.2013.07.006; Strohalm M, 2008, RAPID COMMUN MASS SP, V22, P905, DOI 10.1002/rcm.3444; Ventola C Lee, 2015, P T, V40, P344; Wang W, 2017, BIOCHEMISTRY-US, V56, P3889, DOI 10.1021/acs.biochem.7b00539; Wang Z, 2015, MAR DRUGS, V13, P3325, DOI 10.3390/md13063325; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Yilmaz C, 2017, BIOCHEM PHARMACOL, V133, P43, DOI 10.1016/j.bcp.2016.10.005; Zhao JS, 2010, MOL MICROBIOL, V78, P820, DOI 10.1111/j.1365-2958.2010.07305.x; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	46	17	17	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19840	19848		10.1074/jbc.M117.814962	http://dx.doi.org/10.1074/jbc.M117.814962			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29018092	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000416911300027
J	Barlow-Anacker, A; Bochkov, Y; Gern, J; Seroogy, CM				Barlow-Anacker, Amanda; Bochkov, Yury; Gern, James; Seroogy, Christine M.			Neonatal immune response to rhinovirus A16 has diminished dendritic cell function and increased B cell activation	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; RECEPTOR STIMULATION; PERIPHERAL-BLOOD; YOUNG-CHILDREN; CORD BLOOD; EARLY-LIFE; IN-VIVO; ASTHMA; DISTINCT; INFANTS	Background Rhinovirus infections during infancy account for the majority of respiratory illness health care utilization and are an associated risk factor for subsequent development of allergic asthma. Neonatal type I interferon production is diminished compared to adults after stimulation with TLR agonists. However, broad profiling of immune cell responses to infectious rhinovirus has not been undertaken and we hypothesized that additional immune differences can be identified in neonates. In this study, we undertook a comparative analysis of neonatal and adult blood immune cell responses after in vitro incubation with infectious RVA16 for 6 and 24 hours. Methods Intracellular proinflammatory and type I interferon cytokines along with expression of surface co-stimulatory and maturation markers were measured using multi-parameter flow cytometry. Results Both circulating myeloid dendritic cell (mDC) and plasmacytoid dendritic cell (pDC) frequency were lower in cord blood. Qualitative and quantitative plasmacytoid dendritic cell IFN-alpha + TNF-alpha responses to rhinovirus were significantly lower in cord pDCs. In cord blood samples, the majority of responsive pDCs were single-positive TNF-alpha producing cells, whereas in adult samples rhinovirus increased double-positive TNF-alpha + IFN-alpha+ pDCs. Rhinovirus upregulated activation and maturation markers on monocytes, mDCs, pDCs, and B cells, but CD40+ CD86+ monocytes, mDCs, and pDCs cells were significantly higher in adult samples compared to cord samples. Surprisingly, rhinovirus increased CD40+ CD86+ B cells to a significantly greater extent in cord samples compared to adults. Conclusions These findings define a number of cell-specific differences in neonatal responses to rhinovirus. This differential age-related immune response to RV may have implications for the immune correlates of protection to viral respiratory illness burden and determination of potential biomarkers for asthma risk.	[Barlow-Anacker, Amanda; Bochkov, Yury; Gern, James; Seroogy, Christine M.] Univ Wisconsin, Sch Med & Publ Hlth, Div Allergy Immunol & Rheumatol, Dept Pediat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Seroogy, CM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Div Allergy Immunol & Rheumatol, Dept Pediat, Madison, WI 53706 USA.	cmseroogy@wisc.edu			National Institutes of Health [U19 AI104317, UL1TR000427]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI104317] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant numbers U19 AI104317 and UL1TR000427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arico E, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-67; Blimkie D, 2011, J IMMUNOL METHODS, V366, P89, DOI 10.1016/j.jim.2011.01.009; Bosco A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2405-z; Bourke E, 2003, BLOOD, V102, P956, DOI 10.1182/blood-2002-11-3355; Chu HY, 2016, J PEDIAT INF DIS SOC, V5, P29, DOI 10.1093/jpids/piu099; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; de Winter JJH, 2015, IMMUN INFLAMM DIS, V3, P398, DOI 10.1002/iid3.77; De Wit D, 2004, BLOOD, V103, P1030, DOI 10.1182/blood-2003-04-1216; Drohan L, 2004, HUM IMMUNOL, V65, P1356, DOI 10.1016/j.humimm.2004.09.011; Edlmayr J, 2011, EUR RESPIR J, V37, P44, DOI 10.1183/09031936.00149109; Elliott SR, 1999, HUM IMMUNOL, V60, P1039, DOI 10.1016/S0198-8859(99)00090-7; Forbes RL, 2012, J INFECT DIS, V206, P646, DOI 10.1093/infdis/jis377; Franz A, 2010, J CLIN VIROL, V48, P239, DOI 10.1016/j.jcv.2010.05.007; Gardeux V, 2015, J BIOMED INFORM, V55, P94, DOI 10.1016/j.jbi.2015.03.003; Hagendorens MM, 2003, CLIN EXP ALLERGY, V33, P633, DOI 10.1046/j.1365-2222.2003.01649.x; Heinonen S, 2016, AM J RESP CRIT CARE, V193, P772, DOI 10.1164/rccm.201504-0749OC; ISAACS D, 1981, LANCET, V2, P950; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jackson DJ, 2012, AM J RESP CRIT CARE, V185, P281, DOI 10.1164/rccm.201104-0660OC; Jansen K, 2008, J IMMUNOL METHODS, V336, P183, DOI 10.1016/j.jim.2008.04.013; Kinnear E., 2017, MUCOSAL IMMUNOL; Kirchberger S, 2007, INT ARCH ALLERGY IMM, V142, P1, DOI 10.1159/000095993; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Lee WM, 2015, METHODS MOL BIOL, V1221, P49, DOI 10.1007/978-1-4939-1571-2_5; LEE WM, 1995, VIRUS GENES, V9, P177, DOI 10.1007/BF01702661; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Marr N, 2014, J IMMUNOL, V192, P948, DOI 10.4049/jimmunol.1302007; Meyer-Bahlburg A, 2012, FRONT BIOSCI-LANDMRK, V17, P1499, DOI 10.2741/4000; Muehling LM, 2016, J IMMUNOL, V197, P3214, DOI 10.4049/jimmunol.1600663; Niespodziana K, 2015, EBIOMEDICINE, V2, P64, DOI 10.1016/j.ebiom.2014.11.012; Papadopoulos NG, 2002, THORAX, V57, P328, DOI 10.1136/thorax.57.4.328; Parry DE, 2000, J ALLERGY CLIN IMMUN, V105, P692, DOI 10.1067/mai.2000.104785; Pettengill MA, 2016, INNATE IMMUN-LONDON, V22, P433, DOI 10.1177/1753425916651985; Pettengill MA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00121; Pitkaranta A, 1999, J CLIN VIROL, V14, P199, DOI 10.1016/S1386-6532(99)00056-6; Prabhu SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162242; Rajan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114322; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Schrauf C, 2009, J IMMUNOL, V183, P4440, DOI 10.4049/jimmunol.0804147; SHERRY B, 1985, J VIROL, V53, P137, DOI 10.1128/JVI.53.1.137-143.1985; Shooshtari P, 2010, CYTOM PART A, V77A, P873, DOI 10.1002/cyto.a.20943; Silver E, 2009, PEDIAT ALLERG IMM-UK, V20, P471, DOI 10.1111/j.1399-3038.2008.00818.x; Smolen KK, 2014, J ALLERGY CLIN IMMUN, V133, P818, DOI 10.1016/j.jaci.2013.09.038; Subbarao P, 2015, THORAX, V70, P998, DOI 10.1136/thoraxjnl-2015-207246; Toivonen L, 2016, PEDIATR INFECT DIS J, V35, pE362, DOI 10.1097/INF.0000000000001304; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Unger BL, 2014, J VIROL, V88, P3705, DOI 10.1128/JVI.03039-13; Upham JW, 2009, J ALLERGY CLIN IMMUN, V124, P707, DOI 10.1016/j.jaci.2009.07.009; Willems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391; Xi Y, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.27; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; Zens KD, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85832; Zhang XM, 2014, J INFECT DIS, V210, P424, DOI 10.1093/infdis/jiu103	54	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0180664	10.1371/journal.pone.0180664	http://dx.doi.org/10.1371/journal.pone.0180664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045416	Green Published, gold, Green Submitted			2022-12-26	WOS:000413168100002
J	Catenazzi, A; Swei, A; Finkle, J; Foreyt, E; Wyman, L; Vredenburg, VT				Catenazzi, Alessandro; Swei, Andrea; Finkle, Jacob; Foreyt, Emily; Wyman, Lauren; Vredenburg, Vance T.			Epizootic to enzootic transition of a fungal disease in tropical Andean frogs: Are surviving species still susceptible?	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; MANU NATIONAL-PARK; BATRACHOCHYTRIUM-DENDROBATIDIS; EASTERN SLOPES; CHYTRIDIOMYCOSIS; MORTALITY; DECLINES; ITRACONAZOLE; INFECTION; PATHOGEN	The fungal pathogen Batrachochytrium dendrobatidis (Bd), which causes the disease chytridiomycosis, has been linked to catastrophic amphibian declines throughout the world. Amphibians differ in their vulnerability to chytridiomycosis; some species experience epizootics followed by collapse while others exhibit stable host/pathogen dynamics where most amphibian hosts survive in the presence of Bd (e.g., in the enzootic state). Little is known about the factors that drive the transition between the two disease states within a community, or whether populations of species that survived the initial epizootic are stable, yet this information is essential for conservation and theory. Our study focuses on a diverse Peruvian amphibian community that experienced a Bd-caused collapse. We explore host/Bd dynamics of eight surviving species a decade after the mass extinction by using population level disease metrics and Bd-susceptibility trials. We found that three of the eight species continue to be susceptible to Bd, and that their populations are declining. Only one species is growing in numbers and it was non-susceptible in our trials. Our study suggests that some species remain vulnerable to Bd and exhibit ongoing population declines in enzootic systems where Bd-host dynamics are assumed to be stable.	[Catenazzi, Alessandro] Southern Illinois Univ, Dept Zool, Carbondale, IL 62901 USA; [Swei, Andrea; Finkle, Jacob; Vredenburg, Vance T.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Foreyt, Emily] Gonzaga Univ, Dept Biol, Spokane, WA 99258 USA; [Wyman, Lauren] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Catenazzi, Alessandro] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	Southern Illinois University System; Southern Illinois University; California State University System; San Francisco State University; Gonzaga University; Princeton University; State University System of Florida; Florida International University	Catenazzi, A (corresponding author), Southern Illinois Univ, Dept Zool, Carbondale, IL 62901 USA.; Catenazzi, A (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.	acatenazzi@gmail.com	Swei, Andrea/AAD-9649-2021; Catenazzi, Alessandro/C-8615-2009	Catenazzi, Alessandro/0000-0002-3650-4783; Vredenburg, Vance/0000-0002-9682-1190	Asociacion para la Conservacion de la Cuenca Amazonica; Rufford Small Grants Foundation; Chicago Board of Trade Endangered Species Fund; Fondation Mathey-Dupraz; Amphibian Specialist Group; Princeton Environmental Institute; National Science Foundation [DEB-11202283, NSF 1633948]	Asociacion para la Conservacion de la Cuenca Amazonica; Rufford Small Grants Foundation; Chicago Board of Trade Endangered Species Fund; Fondation Mathey-Dupraz; Amphibian Specialist Group; Princeton Environmental Institute; National Science Foundation(National Science Foundation (NSF))	This work was funded by grants from the Asociacion para la Conservacion de la Cuenca Amazonica (www.acca.org.pe), the Rufford Small Grants Foundation (www.rufford.org), the Chicago Board of Trade Endangered Species Fund (https://www.CZS.org.Chicago-Zoological-Society/Conservation-Leadership/Field-Work/CBOT- Endangered-Species-Fund.aspx), the Fondation Mathey-Dupraz and the Amphibian Specialist Group (A. Catenazzi), the Princeton Environmental Institute (L. Wyman), and the National Science Foundation (V. T. Vredenburg; DEB-11202283, Belmont Forum project NSF 1633948; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Burkart D, 2017, ANIMAL CONSERVATION; Carey C, 2000, ENVIRON HEALTH PERSP, V108, P143, DOI 10.2307/3454639; Cashins SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056747; Catenazzi A, 2015, ANNU REV ENV RESOUR, V40, P91, DOI 10.1146/annurev-environ-102014-021358; Catenazzi A, 2014, HERPETOL MONOGR, V28, P1, DOI 10.1655/HERPMONOGRAPHS-D-13-00003; Catenazzi A, 2014, CONSERV BIOL, V28, P509, DOI 10.1111/cobi.12194; Catenazzi A, 2013, BIOTA NEOTROP, V13, P269, DOI 10.1590/S1676-06032013000400024; Catenazzi A, 2011, CONSERV BIOL, V25, P382, DOI 10.1111/j.1523-1739.2010.01604.x; Catenazzi A, 2010, DIS AQUAT ORGAN, V92, P187, DOI 10.3354/dao02250; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Garner TWJ, 2009, DIS AQUAT ORGAN, V83, P257, DOI 10.3354/dao02008; Geiger CC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05798-9; Grogan LF, 2016, J ANIM ECOL, V85, P806, DOI 10.1111/1365-2656.12500; Hudson MA, 2016, BIOL CONSERV, V195, P37, DOI 10.1016/j.biocon.2015.12.041; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059499; NICHOLSON BJ, 1985, IEEE T RELIAB, V34, P227, DOI 10.1109/TR.1985.5222126; Puschendorf R, 2011, CONSERV BIOL, V25, P956, DOI 10.1111/j.1523-1739.2011.01728.x; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Raffel TR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2039; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Scheele BC, 2017, CONSERV BIOL, V31, P592, DOI 10.1111/cobi.12830; Scheele BC, 2017, BIOL CONSERV, V206, P37, DOI 10.1016/j.biocon.2016.12.010; Scheele BC, 2016, J ANIM ECOL, V85, P1453, DOI 10.1111/1365-2656.12569; Scheele BC, 2015, BIOL CONSERV, V182, P36, DOI 10.1016/j.biocon.2014.11.032; Scheele B, 2014, BIOL CONSERV, V170, P86, DOI 10.1016/j.biocon.2013.12.034; Seimon TA, 2007, GLOBAL CHANGE BIOL, V13, P288, DOI 10.1111/j.1365-2486.2006.01278.x; Simmons J.E., 2002, HERPETOLOGICAL COLLE; Stice MJ, 2010, J WILDLIFE DIS, V46, P70, DOI 10.7589/0090-3558-46.1.70; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Therneau T, 2012, R PACKAGE VERSION, V2, P2; Therneau T.M., 2000, MODELING SURVIVAL DA; Tobler U., 2012, PLOS ONE, V7; Venegas Pablo J., 2008, Salamandra, V44, P163; Voyles J, 2009, ORYX, V43, P527, DOI 10.1017/S0030605309990469; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Warne RW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145864; Woodhams DC, 2012, DIS AQUAT ORGAN, V98, P11, DOI 10.3354/dao02429	54	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186478	10.1371/journal.pone.0186478	http://dx.doi.org/10.1371/journal.pone.0186478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040327	Green Submitted, Green Published, gold			2022-12-26	WOS:000413167500051
J	Goldman, SM; Corona, BT				Goldman, Stephen M.; Corona, Benjamin T.			Co-delivery of micronized urinary bladder matrix damps regenerative capacity of minced muscle grafts in the treatment of volumetric muscle loss injuries	PLOS ONE			English	Article							SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; FUNCTIONAL RECOVERY; BIOLOGIC SCAFFOLD; SATELLITE CELLS; TISSUE; FIBROSIS; REPAIR; MODEL; TRANSPLANTATION	Minced muscle grafts (MG) promote de novo muscle fiber regeneration and neuromuscular strength recovery in small and large animal models of volumetric muscle loss. The most noteworthy limitation of this approach is its reliance on a finite supply of donor tissue. To address this shortcoming, this study sought to evaluate micronized acellular urinary bladder matrix (UBM) as a scaffolding to promote in vivo expansion of this MG therapy in a rat model. Rats received volumetric muscle loss injuries to the tibialis anterior muscle of their left hind limb which were either left untreated or repaired with minced muscle graft at dosages of 50% and 100% of the defect mass, urinary bladder matrix in isolation, or a with an expansion product consisting of a combination of the two putative therapies in which the minced graft is delivered at a dosage of 50% of the defect mass. Rats survived to 2 and 8 weeks post injury before functional (in vivo neuromuscular strength), histological, morphological, and biochemical analyses were performed. Rats treated with the expansion product exhibited improved neuromuscular function relative to untreated VML after an 8 week time period following injury. This improvement in functional capacity, however, was accompanied with a concomitant reduction in graft mediated regeneration, as evidenced cell lineage tracing enable by a transgenic GFP expressing donor, and a mixed histological outcome indicating coincident fibrous matrix deposition with interspersed islands of nascent muscle fibers. Furthermore, quantitative immunofluorescence and transcriptional analysis following the 2 week time point suggests an exacerbated immune response to the UBM as a possible nidus for the observed suboptimal regenerative outcome. Moving forward, efforts related to the development of a MG expansion product should carefully consider the effects of the host immune response to candidate biomaterials in order to avoid undesirable dysregulation of pro-regenerative cross talk between the immune system and myogenic processes.	[Goldman, Stephen M.; Corona, Benjamin T.] US Army, Inst Surg Res, Ft Sam Houston, TX 78234 USA		Corona, BT (corresponding author), US Army, Inst Surg Res, Ft Sam Houston, TX 78234 USA.	corona.benjamin.t@gmail.com	Goldman, Stephen/AAT-7318-2020	Goldman, Stephen/0000-0002-2244-1443	United States Army Medical Research and Materiel Command, Clinical and Rehabilitative Medical Research Program [C_003_2015_USAISR]; Clinical and Rehabilitative Medicine Research Program, United States Army Medical Research and Materiel Command	United States Army Medical Research and Materiel Command, Clinical and Rehabilitative Medical Research Program; Clinical and Rehabilitative Medicine Research Program, United States Army Medical Research and Materiel Command	Funding was provided by the United States Army Medical Research and Materiel Command, Clinical and Rehabilitative Medical Research Program (Award# C_003_2015_USAISR to BTC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by the Clinical and Rehabilitative Medicine Research Program, United States Army Medical Research and Materiel Command. We thank Mr. Javier Chapa, Ms. Monica Farley, Ms. Monica Jalomo and Ms. Shayna Levine for their technical assistance.	Aurora A, 2015, BIOMATERIALS, V67, P393, DOI 10.1016/j.biomaterials.2015.07.040; Bedke J, 2007, AM J TRANSPLANT, V7, P527, DOI 10.1111/j.1600-6143.2006.01654.x; CALDWELL CJ, 1990, NEUROPATH APPL NEURO, V16, P225, DOI 10.1111/j.1365-2990.1990.tb01159.x; CARLSON BM, 1970, AM J ANAT, V128, P21, DOI 10.1002/aja.1001280103; CARLSON BM, 1972, EXP NEUROL, V36, P239, DOI 10.1016/0014-4886(72)90020-9; Carlson BM, 1972, REGENERATION MINCED; Chen XYK, 2013, J PLAST RECONSTR AES, V66, P1750, DOI 10.1016/j.bjps.2013.07.037; Corona BT, 2013, AM J PHYSIOL-CELL PH, V305, pC761, DOI 10.1152/ajpcell.00189.2013; Corona BT, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13249; Corona BT, 2016, BIOMATERIALS, V104, P238, DOI 10.1016/j.biomaterials.2016.07.020; Corona BT, 2015, J REHABIL RES DEV, V52, P785, DOI 10.1682/JRRD.2014.07.0165; Corona BT, 2013, BIOMATERIALS, V34, P3324, DOI 10.1016/j.biomaterials.2013.01.061; Corona BT, 2012, TISSUE ENG PT A, V18, P1213, DOI [10.1089/ten.tea.2011.0614, 10.1089/ten.TEA.2011.0614]; Doi K, 2002, CLIN PLAST SURG, V29, P483; Dziki JL, 2016, TISSUE ENG PT A, V22, P1129, DOI 10.1089/ten.tea.2016.0340; Fishman JM, 2013, P NATL ACAD SCI USA, V110, P14360, DOI 10.1073/pnas.1213228110; Gambichler T, 2011, REGUL PEPTIDES, V170, P4, DOI 10.1016/j.regpep.2011.05.003; Garg K, 2015, J ORTHOP RES, V33, P40, DOI 10.1002/jor.22730; Garg K, 2014, CELL TISSUE RES, V358, P857, DOI 10.1007/s00441-014-2006-6; GHINS E, 1984, J MUSCLE RES CELL M, V5, P711, DOI 10.1007/BF00713929; GHINS E, 1985, ARCH INT PHYSIOL BIO, V93, P143, DOI 10.3109/13813458509079600; Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007; Horuk R, 2001, J BIOL CHEM, V276, P4199, DOI 10.1074/jbc.M007457200; Hutchins AP, 2013, BRIEF FUNCT GENOMICS, V12, P489, DOI 10.1093/bfgp/elt028; Kasukonis B, 2016, TISSUE ENG PT A, V22, P1151, DOI 10.1089/ten.tea.2016.0134; Lemos DR, 2015, NAT MED, V21, P786, DOI 10.1038/nm.3869; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lin CH, 2007, PLAST RECONSTR SURG, V119, P2118, DOI 10.1097/01.prs.0000260595.85557.41; Lund DK, 2013, FEBS J, V280, P4089, DOI 10.1111/febs.12171; Ma JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175853; Ma JJ, 2015, J BIOMED MATER RES B, V103, P355, DOI 10.1002/jbm.b.33166; Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24; Merritt EK, 2010, TISSUE ENG PT A, V16, P1395, DOI [10.1089/ten.tea.2009.0226, 10.1089/ten.TEA.2009.0226]; Mohs A, 2017, J HEPATOL, V66, P743, DOI 10.1016/j.jhep.2016.12.011; MONEIM MS, 1986, J HAND SURG-AM, V11A, P135, DOI 10.1016/S0363-5023(86)80121-6; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Petrek M, 1997, EUR RESPIR J, V10, P1207, DOI 10.1183/09031936.97.10061207; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sadtler K, 2016, SCIENCE, V352, P366, DOI 10.1126/science.aad9272; Serrano AL, 2011, CURR TOP DEV BIOL, V96, P167, DOI 10.1016/B978-0-12-385940-2.00007-3; Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085; Tidball JG, 2011, COMPR PHYSIOL, V1, P2029, DOI 10.1002/cphy.c100092; Turner NJ, 2012, J SURG RES, V176, P490, DOI 10.1016/j.jss.2011.11.1029; Valentin JE, 2010, BIOMATERIALS, V31, P7475, DOI 10.1016/j.biomaterials.2010.06.039; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Ward CL, 2016, J ORTHOP TRAUMA, V30, pE396, DOI 10.1097/BOT.0000000000000673; Ward CL, 2015, BIORESEARCH OPEN ACC, V4, P198, DOI 10.1089/biores.2015.0009	48	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186593	10.1371/journal.pone.0186593	http://dx.doi.org/10.1371/journal.pone.0186593			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040321	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500060
J	Yang, HS; Kim, JG; Cha, JB; Yun, YI; Park, JH; Woo, JE				Yang, Hyun Seung; Kim, June-Gone; Cha, Jae Bong; Yun, Young In; Park, Jong Hoon; Woo, Jong Eun			Quantitative analysis of neural tissues around the optic disc after panretinal photocoagulation in patients with diabetic retinopathy	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NERVE-FIBER LAYER; LAMINA-CRIBROSA THICKNESS; INTRAOCULAR-PRESSURE REDUCTION; NORMAL-TENSION GLAUCOMA; COHERENCE TOMOGRAPHY; VESSEL DENSITY; MACULAR EDEMA; DEPTH; EYE	In this retrospective cross-sectional study, we quantitatively analyzed the tomographic features in the neural tissues around the optic disc in patients with diabetic retinopathy with and without panretinal photocoagulation. We analyzed 206 eyes, comprising 33 normal eyes in subjects without diabetes (group I), 30 eyes without diabetic retinopathy (group II), 66 eyes with non-proliferative diabetic retinopathy (group III), 45 eyes with panretinal photocoagulation (group IV), and 32 eyes with normal tension glaucoma (group V). Sequential images acquired using swept-source optical coherence tomography in three-dimensional mode were used to measure peripapillary retinal nerve fiber layer thickness, neuro-retinal rim thickness, anterior lamina cribrosa depth, prelaminar thickness, and thickness of the lamina cribrosa. The peripapillary retinal nerve fiber layer thickness and lamina cribrosa thickness were significantly thinner in group IV than in group III (p = 0.019 and p < 0.001). However, there was no significant difference in rim thickness, anterior lamina cribrosa depth, or prelaminar thickness between groups III and IV (p = 0.307, p = 0.877, and p = 0.212). Multivariate analysis revealed that time since panretinal photocoagulation and thickness of the lamina cribrosa had a significant effect on peripapillary retinal nerve fiber layer thickness (p < 0.001 and p = 0.014). In group IV, there was a negative correlation between time elapsed since panretinal photocoagulation and peripapillary retinal nerve fiber layer thickness, rim thickness, and thickness of the lamina cribrosa (r = -0.765, r = -0.490, and r = -0.419), but no correlation with prelaminar thickness or anterior lamina cribrosa depth (r = 0.104 and r = -0.171). Panretinal photocoagulation may be related to thinning of the peripapillary retinal nerve fiber layer, rim thickness, and lamina cribrosa, but not prelaminar thickness or anterior lamina cribrosa depth. These features are different from the peripapillary features of eyes with typical normal tension glaucoma.	[Yang, Hyun Seung; Park, Jong Hoon] Seoul Shinsegae Eye Ctr, Dept Ophthalmol, Eui Jung Bu, Gyeonggi Do, South Korea; [Kim, June-Gone] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Cha, Jae Bong; Woo, Jong Eun] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Ophthalmol, Ulsan, South Korea; [Yun, Young In] Seoul Natl Univ, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Ulsan University Hospital; Seoul National University (SNU)	Kim, JG (corresponding author), Univ Ulsan, Asan Med Ctr, Coll Med, Dept Ophthalmol, Seoul, South Korea.	junekim@amc.seoul.kr	Yang, Hyun Seung/AAC-4319-2020; Yang, Hyun Seung/GRS-1440-2022	Yang, Hyun Seung/0000-0002-0470-676X; 				Albon J, 2000, BRIT J OPHTHALMOL, V84, P311, DOI 10.1136/bjo.84.3.311; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Barber AJ, 2003, PROG NEURO-PSYCHOPH, V27, P283, DOI 10.1016/S0278-5846(03)00023-X; Burgoyne CF, 2008, J GLAUCOMA, V17, P318, DOI 10.1097/IJG.0b013e31815a343b; Caprioli J, 2010, AM J OPHTHALMOL, V149, P704, DOI 10.1016/j.ajo.2010.01.018; Chauhan BC, 2008, CAN J OPHTHALMOL, V43, P356, DOI 10.3129/i08-060; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Dielemans I, 1996, OPHTHALMOLOGY, V103, P1271, DOI 10.1016/S0161-6420(96)30511-3; Downs JC, 2011, EXP EYE RES, V93, P133, DOI 10.1016/j.exer.2010.08.004; Hollo G, 2017, J GLAUCOMA, V26, pE7, DOI 10.1097/IJG.0000000000000527; Hollo G, 2016, EUR J OPHTHALMOL, V26, pE42, DOI 10.5301/ejo.5000717; Hsu Sheng-Yao, 2002, Kaohsiung Journal of Medical Sciences, V18, P397; Hwang DJ, 2014, INVEST OPHTH VIS SCI, V55, P4213, DOI 10.1167/iovs.13-13776; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; JOHNS KJ, 1989, OPHTHALMOLOGY, V96, P211; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; KAHN HA, 1977, AM J EPIDEMIOL, V106, P33, DOI 10.1093/oxfordjournals.aje.a112429; Kim Ho Young, 2009, Korean J Ophthalmol, V23, P23, DOI 10.3341/kjo.2009.23.1.23; Kim Jee Hyun, 2014, Korean J Ophthalmol, V28, P473, DOI 10.3341/kjo.2014.28.6.473; Kim JT, 2013, INVEST OPHTH VIS SCI, V54, P3378, DOI 10.1167/iovs.12-11503; Kim J, 2012, RETINA-J RET VIT DIS, V32, P2052, DOI 10.1097/IAE.0b013e3182562000; Kim S, 2013, OPHTHALMOLOGY, V120, P1798, DOI 10.1016/j.ophtha.2013.02.015; KLEIN BEK, 1994, OPHTHALMOLOGY, V101, P1173; Kwun Y, 2015, AM J OPHTHALMOL, V159, P512, DOI 10.1016/j.ajo.2014.11.034; Lee DS, 2015, INVEST OPHTH VIS SCI, V56, P2833, DOI 10.1167/iovs.14-15869; Lee EJ, 2015, OPHTHALMOLOGY, V122, P721, DOI 10.1016/j.ophtha.2014.10.007; Lee EJ, 2011, AM J OPHTHALMOL, V152, P87, DOI 10.1016/j.ajo.2011.01.024; Lee KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114935; Lee SB, 2013, RETINA-J RET VIT DIS, V33, P188, DOI 10.1097/IAE.0b013e318261a710; Lim MC, 2009, ARCH OPHTHALMOL-CHIC, V127, P857, DOI 10.1001/archophthalmol.2009.135; Mitchell P, 1997, OPHTHALMOLOGY, V104, P712, DOI 10.1016/S0161-6420(97)30247-4; Oshitari T, 2009, EYE, V23, P884, DOI 10.1038/eye.2008.119; Park HYL, 2014, INVEST OPHTH VIS SCI, V55, P233, DOI 10.1167/iovs.12-10329; Park HYL, 2013, OPHTHALMOLOGY, V120, P745, DOI 10.1016/j.ophtha.2012.09.051; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Park Yi-Ryeung, 2014, Korean J Ophthalmol, V28, P220, DOI 10.3341/kjo.2014.28.3.220; Pena JDO, 1998, EXP EYE RES, V67, P517, DOI 10.1006/exer.1998.0539; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; Ren RJ, 2014, INVEST OPHTH VIS SCI, V55, P1531, DOI 10.1167/iovs.13-13382; Ritenour RJ, 2009, BRIT J OPHTHALMOL, V93, P838, DOI 10.1136/bjo.2007.135749; Shin HJ, 2014, INVEST OPHTH VIS SCI, V55, P2403, DOI 10.1167/iovs.13-13769; Shoshani Y, 2012, CLIN EXP OPHTHALMOL, V40, P697, DOI 10.1111/j.1442-9071.2012.02778.x; Toprak Ibrahim, 2012, International Ophthalmology, V32, P559, DOI 10.1007/s10792-012-9610-9; van Dijk HW, 2011, VISION RES, V51, P224, DOI 10.1016/j.visres.2010.08.024; 백동원, 2013, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V54, P1261	45	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186229	10.1371/journal.pone.0186229	http://dx.doi.org/10.1371/journal.pone.0186229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040280	Green Submitted, gold, Green Published			2022-12-26	WOS:000413167500027
J	Bauersachs, T; Talbot, HM; Sidgwick, F; Sivonen, K; Schwark, L				Bauersachs, Thorsten; Talbot, Helen M.; Sidgwick, Frances; Sivonen, Kaarina; Schwark, Lorenz			Lipid biomarker signatures as tracers for harmful cyanobacterial blooms in the Baltic Sea	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; TEMPERATURE-INDUCED CHANGES; PROKARYOTIC TRITERPENOIDS; BRANCHED ALKANES; GENERA ANABAENA; BACTERIOHOPANEPOLYOL SIGNATURES; HETEROCYST GLYCOLIPIDS; BACTERIAL-POPULATIONS; EXTRACTABLE LIPIDS; NITROGEN-FIXATION	The recent proliferation of harmful cyanobacterial blooms (cyanoHABs) in the Baltic and other marginal seas poses a severe threat for the health of infested ecosystems as e.g. the massive export and decay of cyanobacterial biomass facilitates the spread of bottom water hypoxia. There is evidence that cyanoHABs occurred repeatedly in the Baltic Sea but knowledge of their spatiotemporal distribution and the cyanobacteria that contributed to them is limited. In this study, we examined representatives of the major bloom-forming heterocystous cyanobacteria (i.e. Aphanizomenon, Dolichospermum (formerly Anabaena) and Nodularia) to establish lipid fingerprints that allow tracking these environmentally important diazotrophs in the modern and past Baltic Sea. The distribution of normal and mid-chain branched alkanes, fatty acid methyl esters, bacteriohopanepolyols and heterocyst glycolipids permitted a clear chemotaxonomic separation of the different heterocystous cyanobacteria but also indicated a close phylogenetic relationship between representatives of the genera Aphanizomenon and Dolichospermum. Compared to the discontinuous nature of phytoplankton surveys studies, the distinct lipid profiles reported here will allow obtaining detailed spatiotemporal information on the frequency and intensity of Baltic Sea cyanoHABs as well as their community composition using the time-integrated biomarker signatures recorded in surface and subsurface sediments. As heterocystous cyanobacteria of the genera Aphanizomenon, Dolichospermum and Nodularia are generally known to form massive blooms in many brackish as well as lacustrine systems worldwide, the chemotaxonomic markers introduced in this study may allow investigating cyanoHABs in a great variety of contemporary environments from polar to tropical latitudes.	[Bauersachs, Thorsten; Schwark, Lorenz] Univ Kiel, Dept Organ Geochem, Kiel, Germany; [Talbot, Helen M.; Sidgwick, Frances] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne, Tyne & Wear, England; [Sivonen, Kaarina] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Schwark, Lorenz] Curtin Univ, Dept Chem, Perth, WA, Australia; [Sidgwick, Frances] Newcastle Univ, NUPPA, Newcastle Upon Tyne, Tyne & Wear, England	University of Kiel; Newcastle University - UK; University of Helsinki; Curtin University; Newcastle University - UK	Bauersachs, T (corresponding author), Univ Kiel, Dept Organ Geochem, Kiel, Germany.	thb@gpi.uni-kiel.de	Schwark, Lorenz/AAF-1902-2021; Bauersachs, Thorsten/AFY-5641-2022	Schwark, Lorenz/0000-0003-0683-0817; Sidgwick, Frances/0000-0001-8792-1096; Sivonen, Kaarina/0000-0002-2904-0458; Bauersachs, Thorsten/0000-0003-4858-9443	German Research Foundation [BA 3841/5-1]; Academy of Finland [1258827]; Land Schleswig-Holstein within the funding program Open Access Publikationsfonds	German Research Foundation(German Research Foundation (DFG)); Academy of Finland(Academy of Finland); Land Schleswig-Holstein within the funding program Open Access Publikationsfonds	The work was funded by a grant of the German Research Foundation (BA 3841/5-1) awarded to TB. KS thanks the Academy of Finland for financial support through grant 1258827. The authors acknowledge financial support by Land Schleswig-Holstein within the funding program Open Access Publikationsfonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MA, 2010, ORG GEOCHEM, V41, P1207, DOI 10.1016/j.orggeochem.2010.07.007; [Anonymous], 2013, BALT SEA ENV P; Barker GLA, 2000, J PHYCOL, V36, P947, DOI 10.1046/j.1529-8817.2000.99146.x; Barker GLA, 1999, J PHYCOL, V35, P931, DOI 10.1046/j.1529-8817.1999.3550931.x; Bauersachs T, 2015, BIOGEOSCIENCES, V12, P3741, DOI 10.5194/bg-12-3741-2015; Bauersachs T, 2009, ORG GEOCHEM, V40, P149, DOI 10.1016/j.orggeochem.2008.11.008; Bauersachs T, 2014, ORG GEOCHEM, V69, P98, DOI 10.1016/j.orggeochem.2014.02.006; Bauersachs T, 2014, PHYTOCHEMISTRY, V98, P145, DOI 10.1016/j.phytochem.2013.11.007; Bauersachs T, 2010, P NATL ACAD SCI USA, V107, P19190, DOI 10.1073/pnas.1007526107; Bauersachs T, 2009, PHYTOCHEMISTRY, V70, P2034, DOI 10.1016/j.phytochem.2009.08.014; Bauersachs T, 2009, RAPID COMMUN MASS SP, V23, P1387, DOI 10.1002/rcm.4009; Berndmeyer C, 2014, BIOGEOSCIENCES, V11, P7009, DOI 10.5194/bg-11-7009-2014; Blumenberg M, 2006, ENVIRON MICROBIOL, V8, P1220, DOI 10.1111/j.1462-2920.2006.01014.x; BRYCE TA, 1972, PHYTOCHEMISTRY, V11, P295, DOI 10.1016/S0031-9422(00)90006-2; Castaneda IS, 2011, QUATERNARY SCI REV, V30, P2851, DOI 10.1016/j.quascirev.2011.07.009; Coates RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085140; COHEN Z, 1995, PHYTOCHEMISTRY, V40, P1155, DOI 10.1016/0031-9422(95)00335-5; Conley DJ, 2012, NATURE, V486, P463, DOI 10.1038/486463a; Conley DJ, 2011, ENVIRON SCI TECHNOL, V45, P6777, DOI 10.1021/es201212r; CRANWELL PA, 1987, ORG GEOCHEM, V11, P513, DOI 10.1016/0146-6380(87)90007-6; DOBSON G, 1988, CHEM GEOL, V68, P155, DOI 10.1016/0009-2541(88)90093-9; Eickhoff M, 2013, ORG GEOCHEM, V58, P107, DOI 10.1016/j.orggeochem.2013.02.013; Fehler SWG, BIOCHEMISTRY, P418; Finni T, 2001, AMBIO, V30, P172, DOI 10.1639/0044-7447(2001)030[0172:THOCBI]2.0.CO;2; FLESCH G, 1989, BIOCHEM J, V262, P673, DOI 10.1042/bj2620673; Galhano V, 2011, HYDROBIOLOGIA, V663, P187, DOI 10.1007/s10750-010-0572-5; Gambacorta A., 1999, CURR TOP PHYTOCHEM, V2, P145; GELPI E, 1970, PHYTOCHEMISTRY, V9, P603, DOI 10.1016/S0031-9422(00)85700-3; Gibson RA, 2014, ORG GEOCHEM, V69, P61, DOI 10.1016/j.orggeochem.2014.02.004; Greenacre M., 2017, CORRES ANAL PRACTICE, V2, DOI [10.1201/9781420011234, DOI 10.1201/9781315369983]; GRIMALT JO, 1992, ORG GEOCHEM, V19, P509, DOI 10.1016/0146-6380(92)90015-P; Gugger M, 2002, INT J SYST EVOL MICR, V52, P1867, DOI 10.1099/ijs.0.02270-0; Gugger M, 2002, INT J SYST EVOL MICR, V52, P1007, DOI 10.1099/00207713-52-3-1007; Halinen K, 2008, FEMS MICROBIOL ECOL, V64, P199, DOI 10.1111/j.1574-6941.2008.00461.x; HAN J, 1969, P NATL ACAD SCI USA, V64, P436, DOI 10.1073/pnas.64.2.436; Handley L, 2010, ORG GEOCHEM, V41, P910, DOI 10.1016/j.orggeochem.2010.04.016; Jahnke LL, 2004, GEOBIOLOGY, V2, P31, DOI 10.1111/j.1472-4677.2004.00021.x; Joyeux C, 2004, FEMS MICROBIOL ECOL, V47, P371, DOI 10.1016/S0168-6496(03)00302-7; Kahru M, 2014, BIOGEOSCIENCES, V11, P3619, DOI 10.5194/bg-11-3619-2014; KAWAMURA K, 1980, CHEM GEOL, V28, P31, DOI 10.1016/0009-2541(80)90033-9; KENIG F, 1995, GEOCHIM COSMOCHIM AC, V59, P2999, DOI 10.1016/0016-7037(95)00190-5; KENYON CN, 1972, ARCH MIKROBIOL, V83, P216, DOI 10.1007/BF00645123; KENYON CN, 1972, J BACTERIOL, V109, P827, DOI 10.1128/JB.109.2.827-834.1972; Kim JH, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003364; KISSIN YV, 1986, J CHROMATOGR SCI, V24, P164, DOI 10.1093/chromsci/24.4.164; KNANI M, 1994, MICROBIOL-UK, V140, P2755, DOI 10.1099/00221287-140-10-2755; KOMAREK J, 1989, ARCH HYDROBIOL, V82, P247; Koster J, 1999, ORG GEOCHEM, V30, P1367, DOI 10.1016/S0146-6380(99)00110-2; Laamanen MJ, 2002, APPL ENVIRON MICROB, V68, P5296, DOI 10.1128/AEM.68.11.5296-5303.2002; Laamanen MJ, 2001, APPL ENVIRON MICROB, V67, P4638, DOI 10.1128/AEM.67.10.4638-4647.2001; Lang IK, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-124; Larsson U, 2001, LIMNOL OCEANOGR, V46, P811, DOI 10.4319/lo.2001.46.4.0811; Lehtimaki J, 2000, INT J SYST EVOL MICR, V50, P1043, DOI 10.1099/00207713-50-3-1043; LEHTIMAKI J, 1994, ARCH HYDROBIOL, V130, P269; Lyra C, 2001, INT J SYST EVOL MICR, V51, P513, DOI 10.1099/00207713-51-2-513; Meyers PA, 2003, ORG GEOCHEM, V34, P261, DOI 10.1016/S0146-6380(02)00168-7; MEYERS PA, 1980, GEOCHIM COSMOCHIM AC, V44, P1215, DOI 10.1016/0016-7037(80)90075-7; Mudimu O, 2015, GEOMICROBIOL J, V32, P291, DOI 10.1080/01490451.2014.889784; MURATA N, 1992, PLANT CELL PHYSIOL, V33, P933; MURATA N, 1987, BIOCH PLANTS, V9, P315; NEUNLIST S, 1988, EUR J BIOCHEM, V171, P245, DOI 10.1111/j.1432-1033.1988.tb13783.x; NICHOLS BW, 1968, NATURE, V217, P767, DOI 10.1038/217767a0; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; OURISSON G, 1987, ANNU REV MICROBIOL, V41, P301, DOI 10.1146/annurev.mi.41.100187.001505; Paerl HW, 2013, MICROB ECOL, V65, P995, DOI 10.1007/s00248-012-0159-y; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Pages A, 2015, MICROB ECOL, V70, P459, DOI 10.1007/s00248-015-0598-3; Pearson A, 2007, ENVIRON MICROBIOL, V9, P2175, DOI 10.1111/j.1462-2920.2007.01331.x; Peters K.E., 2005, BIOMARKER GUIDE; Poutanen EL, 2001, AMBIO, V30, P179, DOI 10.1639/0044-7447(2001)030[0179:CPATOC]2.0.CO;2; PRAHL FG, 1988, GEOCHIM COSMOCHIM AC, V52, P2303, DOI 10.1016/0016-7037(88)90132-9; Rajaniemi P, 2005, INT J SYST EVOL MICR, V55, P11, DOI 10.1099/ijs.0.63276-0; Rashby SE, 2007, P NATL ACAD SCI USA, V104, P15099, DOI 10.1073/pnas.0704912104; RENOUX JM, 1985, EUR J BIOCHEM, V151, P405, DOI 10.1111/j.1432-1033.1985.tb09116.x; RIPPKA R, 1988, METH ENZYMOL, V167, P28; ROBINSON N, 1990, ORG GEOCHEM, V15, P291, DOI 10.1016/0146-6380(90)90007-M; ROHMER M, 1984, J GEN MICROBIOL, V130, P1137; Rutters H, 2002, J MICROBIOL METH, V48, P149, DOI 10.1016/S0167-7012(01)00319-0; Scholz SN, 2017, TOXICOL ENVIRON CHEM, V99, P543, DOI 10.1080/02772248.2016.1269332; SHIEA J, 1991, ORG GEOCHEM, V17, P309, DOI 10.1016/0146-6380(91)90094-Z; SHIEA J, 1990, ORG GEOCHEM, V15, P223, DOI 10.1016/0146-6380(90)90001-G; Sivonen K, 2007, AMBIO, V36, P180, DOI 10.1579/0044-7447(2007)36[180:BDAFIT]2.0.CO;2; Spencer-Jones CL, 2015, ORG GEOCHEM, V89-90, P1, DOI 10.1016/j.orggeochem.2015.09.003; Stal LJ, 1999, AQUAT MICROB ECOL, V18, P165, DOI 10.3354/ame018165; Stal LJ, 2003, CONT SHELF RES, V23, P1695, DOI 10.1016/j.csr.2003.06.001; Steinhoff FS, 2014, ALGAL RES, V5, P42, DOI 10.1016/j.algal.2014.05.005; Summons RE, 1996, CIBA F SYMP, V202, P174; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; SUMMONS RE, 1994, GEOCHIM COSMOCHIM AC, V58, P2853, DOI 10.1016/0016-7037(94)90119-8; SUMMONS RE, 1987, ORG GEOCHEM, V11, P281, DOI 10.1016/0146-6380(87)90039-8; SUMMONS RE, 1990, AM J SCI, V290A, P212; Talbot HM, 2008, ORG GEOCHEM, V39, P232, DOI 10.1016/j.orggeochem.2007.08.006; Talbot HM, 2007, ORG GEOCHEM, V38, P1212, DOI 10.1016/j.orggeochem.2007.04.006; Talbot HM, 2007, RAPID COMMUN MASS SP, V21, P880, DOI 10.1002/rcm.2911; Talbot HM, 2016, ORG GEOCHEM, V96, P77, DOI 10.1016/j.orggeochem.2016.03.006; Talbot HM, 2003, RAPID COMMUN MASS SP, V17, P728, DOI 10.1002/RCM.974; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Vargas MA, 1998, J PHYCOL, V34, P812, DOI 10.1046/j.1529-8817.1998.340812.x; VILCHEZE C, 1994, MICROBIOL-UK, V140, P2749, DOI 10.1099/00221287-140-10-2749; Volkman JK, 1998, ORG GEOCHEM, V29, P1163, DOI 10.1016/S0146-6380(98)00062-X; WADA H, 1990, PLANT PHYSIOL, V92, P1062, DOI 10.1104/pp.92.4.1062; Wasmund N, 2001, MAR ECOL PROG SER, V214, P1, DOI 10.3354/meps214001; WINTERS K, 1969, SCIENCE, V163, P467, DOI 10.1126/science.163.3866.467; Wormer L, 2012, LIMNOL OCEANOGR, V57, P1775, DOI 10.4319/lo.2012.57.06.1775; Wolk C. P., 1982, biology of cyanobacteria [edited by Carr, N.G.; Whitton, B.A.], P359; Xu YP, 2009, ORG GEOCHEM, V40, P79, DOI 10.1016/j.orggeochem.2008.09.003; Zillen L, 2010, BIOGEOSCIENCES, V7, P2567, DOI 10.5194/bg-7-2567-2010; ZUNDEL M, 1985, EUR J BIOCHEM, V150, P35, DOI 10.1111/j.1432-1033.1985.tb08984.x	108	20	21	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							0186360	10.1371/journal.pone.0186360	http://dx.doi.org/10.1371/journal.pone.0186360			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036222	Green Published, Green Submitted, gold			2022-12-26	WOS:000413054800023
J	Kim, JH; Kwon, HY; Ryu, DH; Nam, MH; Shim, BS; Kim, JH; Lee, JY; Kim, SH				Kim, Ju-Ha; Kwon, Hee Young; Ryu, Dong Hoon; Nam, Min-Ho; Shim, Bum Sang; Kim, Jin Han; Lee, Jae Yeol; Kim, Sung-Hoon			Inhibition of CUG-binding protein 1 and activation of caspases are critically involved in piperazine derivative BK10007S induced apoptosis in hepatocellular carcinoma cells	PLOS ONE			English	Article							CALCIUM-CHANNELS; CANCER-CELLS; EXPRESSION; PROLIFERATION; CA2+; THERAPY; UPDATE; CELF1	Though piperazine derivative BK10007S was known to induce apoptosis in pancreatic cancer xenograft model as a T-type CaV3.1 a1G isoform calcium channel blocker, its underlying antitumor mechanism still remains unclear so far. Thus, in the present study, the antitumor mechanism of BK10007S was elucidated in hepatocellular carcinoma cells (HCCs). Herein, BK10007S showed significant cytotoxicity by 3-[4,5-2-yl]-2,5-diphenyltetra-zolium bromide (MTT) assay and anti-proliferative effects by colony formation assay in HepG2 and SKHep1 cells. Also, apoptotic bodies and terminal deoxynucleotidyl transferase (TdT) dUTP Nick End Labeling (TUNEL) positive cells were observed in BK10007S treated HepG2 and SK-Hep1 cells by 4', 6-diamidino-2-phenylinodole (DAPI) staining and TUNEL assay, respectively. Consistently, BK10007S increased sub G1 population in HepG2 and SK-Hep1 cells by cell cycle analysis. Furthermore, Western blotting revealed that BK10007S activated the caspase cascades (caspase 8, 9 and 3), cleaved poly (ADP-ribose) polymerase (PARP), and downregulated the expression of cyclin D1, survivin and for CUG-binding protein 1 (CUGBP1 or CELF1) in HepG2 and SK-Hep1 cells. Conversely, overexpression of CUGBP1 reduced cleavages of PARP and caspase 3, cytotoxicity and subG1 population in BK10007S treated HepG2 cells. Overall, these findings provide scientific evidences that BK10007S induces apoptosis via inhibition of CUGBP1 and activation of caspases in hepatocellular carcinomas as a potent anticancer candidate.	[Kim, Ju-Ha; Ryu, Dong Hoon; Nam, Min-Ho; Shim, Bum Sang; Kim, Sung-Hoon] Kyung Hee Univ, Coll Korean Med, Canc Mol Targeted Herbal Res Ctr, Seoul, South Korea; [Kim, Jin Han; Lee, Jae Yeol] Kyung Hee Univ, Res Inst Basic Sci, Seoul, South Korea; [Kim, Jin Han; Lee, Jae Yeol] Kyung Hee Univ, Dept Chem, Coll Sci, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University	Kim, SH (corresponding author), Kyung Hee Univ, Coll Korean Med, Canc Mol Targeted Herbal Res Ctr, Seoul, South Korea.	sungkim7@khu.ac.kr	Lee, Jae Yeol/N-1621-2018; Nam, Min-Ho/AAF-4287-2020; Shim, Bum-sang/AAH-9081-2020	Lee, Jae Yeol/0000-0001-6622-6692; Nam, Min-Ho/0000-0002-6191-1268; kim, sunghoon/0000-0003-2423-1973	National Research Foundation of Korea (NRF) grant - Korean government [MEST] [2017R1A2A1A17069297]	National Research Foundation of Korea (NRF) grant - Korean government [MEST]	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government [MEST] (No. 2017R1A2A1A17069297). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government [MEST] (No. 2017R1A2A1A17069297).	Beisang D, 2012, J BIOL CHEM, V287, P950, DOI 10.1074/jbc.M111.291658; Chang ET, 2012, BIOCHEM J, V446, P113, DOI 10.1042/BJ20120112; Chang ET, BIOCH J, V446, P113; Covey AM, 2017, AM J ROENTGENOL, V209, P67, DOI 10.2214/AJR.17.17799; Dziegielewska B, 2014, PFLUG ARCH EUR J PHY, V466, P801, DOI 10.1007/s00424-014-1444-z; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Gao CH, 2015, TUMOR BIOL, V36, P4583, DOI 10.1007/s13277-015-3103-1; Garg H, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0326-1; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; House RP, 2015, ONCOTARGET, V6, P43620, DOI 10.18632/oncotarget.6204; Kiraz Y, 2016, TUMOR BIOL, V37, P8471, DOI 10.1007/s13277-016-5035-9; Klungboonkrong V, 2017, J VASC INTERV RADIOL, V28, P949, DOI 10.1016/j.jvir.2017.03.002; Li YJ, 2009, ONCOL REP, V22, P1229, DOI 10.3892/or_00000559; Liu Yong, 2014, Clin Invest Med, V37, pE10; Modok S, 2006, CURR OPIN PHARMACOL, V6, P350, DOI 10.1016/j.coph.2006.01.009; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Petraccia L, 2003, Clin Ter, V154, P325; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Salisbury E, 2008, EXP CELL RES, V314, P2266, DOI 10.1016/j.yexcr.2008.04.018; Sankari SL, 2012, ASIAN PAC J CANCER P, V13, P4873, DOI 10.7314/APJCP.2012.13.10.4873; Talwar S, 2013, RNA BIOL, V10, P277, DOI 10.4161/rna.23315; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Walczak H, 2000, EXP CELL RES, V256, P58, DOI 10.1006/excr.2000.4840; Wang H, INT J CLIN EXPT PATH, V9, P11254; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wang XF, 2016, THORAC CANCER, V7, P32, DOI 10.1111/1759-7714.12268; Wu LN, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-115; Xia L, 2015, INT J BIOL SCI, V11, P1314, DOI 10.7150/ijbs.11344; Zhou Y, 2014, CELL BIOL INT, V38, P1408, DOI 10.1002/cbin.10356	31	5	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186490	10.1371/journal.pone.0186490	http://dx.doi.org/10.1371/journal.pone.0186490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036189	gold, Green Published, Green Submitted			2022-12-26	WOS:000413054800040
J	Lee, H; Kim, J				Lee, Hannah; Kim, Jejoong			Load-sensitive impairment of working memory for biological motion in schizophrenia	PLOS ONE			English	Article							POINT-LIGHT DISPLAYS; BACKWARD-MASKING; SOCIAL COGNITION; INDIVIDUAL-DIFFERENCES; PERCEPTION; DYSFUNCTION; PERFORMANCE; DEFICITS; SALIENCE; MANIA	Impaired working memory (WM) is a core cognitive deficit in schizophrenia. Nevertheless, past studies have reported that patients may also benefit from increasing salience of memory stimuli. Such efficient encoding largely depends upon precise perception. Thus an investigation on the relationship between perceptual processing and WM would be worthwhile. Here, we used biological motion (BM), a socially relevant stimulus that schizophrenics have difficulty discriminating from similar meaningless motions, in a delayed-response task. Non-BM stimuli and static polygons were also used for comparison. In each trial, one of the three types of stimuli was presented followed by two probes, with a short delay in between. Participants were asked to indicate whether one of them was identical to the memory item or both were novel. The number of memory items was one or two. Healthy controls were more accurate in recognizing BM than non-BM regardless of memory loads. Patients with schizophrenia exhibited similar accuracy patterns to those of controls in the Load 1 condition only. These results suggest that information contained in BM could facilitate WM encoding in general, but the effect is vulnerable to the increase of cognitive load in schizophrenia, implying inefficient encoding driven by imprecise perception.	[Lee, Hannah; Kim, Jejoong] Duksung Womens Univ, Dept Psychol, Seoul, South Korea	Duksung Women's University	Kim, J (corresponding author), Duksung Womens Univ, Dept Psychol, Seoul, South Korea.	jejoong@duksung.ac.kr		Lee, Hannah/0000-0001-7033-7264	National Research Foundation of Korea [NRF-2015S1A5A8016885]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by National Research Foundation of Korea (NRF-2015S1A5A8016885; www.nrf.re.kr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Beauchamp MS, 2003, J COGNITIVE NEUROSCI, V15, P991, DOI 10.1162/089892903770007380; BERTENTHAL BI, 1994, PSYCHOL SCI, V5, P221, DOI 10.1111/j.1467-9280.1994.tb00504.x; Bezchlibnyk-Butler K.Z., 1999, CLIN HDB PSYCHOTROPI; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Bledowski C, 2010, BEHAV BRAIN RES, V214, P172, DOI 10.1016/j.bbr.2010.05.041; BRAFF DL, 1991, ARCH GEN PSYCHIAT, V48, P891; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brittain P, 2010, PSYCHIAT RES, V178, P270, DOI 10.1016/j.psychres.2009.09.013; Butler PD, 2001, AM J PSYCHIAT, V158, P1126, DOI 10.1176/appi.ajp.158.7.1126; Cervellione KL, 2007, J AM ACAD CHILD PSY, V46, P867, DOI 10.1097/chi.0b013e318054678d; Chen Y, 1999, ARCH GEN PSYCHIAT, V56, P149, DOI 10.1001/archpsyc.56.2.149; Chen Y, 2003, SCHIZOPHR RES, V61, P215, DOI 10.1016/S0920-9964(02)00222-0; Chen Y, 2009, SCHIZOPHR RES, V107, P92, DOI 10.1016/j.schres.2008.09.010; Cosman D, 2009, J COGN BEHAV PSYCHOT, V9, P21; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Fine MS, 2009, J NEUROSCI, V29, P8016, DOI 10.1523/JNEUROSCI.5503-08.2009; FIRST MB, 1996, STRUCTURED CLIN INTE, V4; Gao ZF, 2009, J VISION, V9, DOI 10.1167/9.7.17; Gold JM, 2010, ARCH GEN PSYCHIAT, V67, P570, DOI 10.1001/archgenpsychiatry.2010.65; GREEN MF, 1994, ARCH GEN PSYCHIAT, V51, P945; GREEN MF, 1994, ARCH GEN PSYCHIAT, V51, P939; Green MF, 2010, CURR DIR PSYCHOL SCI, V19, P243, DOI 10.1177/0963721410377600; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; Haut MW, 1996, PSYCHIAT RES, V65, P15, DOI 10.1016/0165-1781(96)02940-X; Huang J, 2014, PSYCHIAT RES, V220, P96, DOI 10.1016/j.psychres.2014.07.043; Jahshan C, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.303; Javitt DC, 1999, SCHIZOPHRENIA BULL, V25, P763, DOI 10.1093/oxfordjournals.schbul.a033417; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kelemen O, 2005, NEUROPSYCHOLOGY, V19, P494, DOI 10.1037/0894-4105.19.4.494; Kim D., 2011, KOREAN J SCHIZOPHREN, V14, P61; Kim J, 2006, SCHIZOPHR RES, V82, P65, DOI 10.1016/j.schres.2005.10.017; Kim J., 2011, PLOS ONE; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Kim J, 2015, J VISION, V15, DOI 10.1167/15.11.13; Kim J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00391; Kim JJ, 2005, SCHIZOPHR RES, V77, P299, DOI 10.1016/j.schres.2005.04.006; Lee J, 2006, SCHIZOPHR RES, V81, P191, DOI 10.1016/j.schres.2005.08.015; Lee JH, 2005, J ABNORM PSYCHOL, V114, P599, DOI 10.1037/0021-843X.114.4.599; Li CSR, 2002, PROG NEURO-PSYCHOPH, V26, P929, DOI 10.1016/S0278-5846(02)00207-5; Liddle PF, 2000, ACTA PSYCHIAT SCAND, V101, P11, DOI 10.1111/j.0065-1591.2000.007s021[dash]3.x; Loula F, 2005, J EXP PSYCHOL HUMAN, V31, P210, DOI 10.1037/0096-1523.31.1.210; Mayer JS, 2011, VIS COGN, V19, P863, DOI 10.1080/13506285.2011.594459; Mehta UM, 2014, PSYCHIAT RES, V219, P268, DOI 10.1016/j.psychres.2014.05.055; Michels L, 2005, NEUROREPORT, V16, P1037, DOI 10.1097/00001756-200507130-00002; NUECHTERLEIN KH, 1991, HDB SCHIZOPHRENIA, V5; Park S, 1999, BIOL PSYCHIAT, V46, P392, DOI 10.1016/S0006-3223(98)00370-9; PARK S, 1993, SCHIZOPHR RES, V11, P55, DOI 10.1016/0920-9964(93)90038-K; Park S, 2001, SCHIZOPHR RES, V49, P118; PARK S, 1992, ARCH GEN PSYCHIAT, V49, P975; Park S, 2002, PRINCIPLES EXPT PSYC; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Piskulic D, 2007, PSYCHIAT RES, V150, P111, DOI 10.1016/j.psychres.2006.03.018; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Schechter I, 2003, SCHIZOPHR RES, V64, P91, DOI 10.1016/S0920-9964(03)00008-2; Schmidt BK, 2002, PERCEPT PSYCHOPHYS, V64, P754, DOI 10.3758/BF03194742; Sergi MJ, 2003, SCHIZOPHR RES, V59, P233, DOI 10.1016/S0920-9964(01)00405-4; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; van Boxtel JJA, 2013, J VISION, V13, DOI 10.1167/13.12.7; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Yeom T.H., 1992, KOREAN WECHSLER ADUL; 이중서, 2001, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V40, P1090	67	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186498	10.1371/journal.pone.0186498	http://dx.doi.org/10.1371/journal.pone.0186498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ7ZQ	29028821	Green Submitted, Green Published, gold			2022-12-26	WOS:000412980300038
J	Zhang, X; Myers, JMB; Yadagiri, VK; Ulm, A; Chen, XT; Weirauch, MT; Hershey, GKK; Ji, H				Zhang, Xue; Myers, Jocelyn M. Biagini; Yadagiri, Veda K.; Ulm, Ashley; Chen, Xiaoting; Weirauch, Matthew T.; Hershey, Gurjit K. Khurana; Ji, Hong			Nasal DNA methylation differentiates corticosteroid treatment response in pediatric asthma: A pilot study	PLOS ONE			English	Article							COUPLED RECEPTOR 87; CHILDHOOD ASTHMA; GENE-EXPRESSION; LACTATE-DEHYDROGENASE; WIDE ASSOCIATION; CPG-SNPS; OTX2; PROTEIN; IDENTIFICATION; ACTIVATION	Background Treatment response to systemic corticosteroid in asthmatic children is heterogeneous and may be mediated by epigenetic mechanism(s). We aim to identify DNA methylation (DNAm) changes responsive to steroid, and DNAm biomarkers that distinguish treatment response. Materials and methods We followed 33 children (ages 5-18) presenting to the Emergency Department (ED) for asthma exacerbation. Based on whether they met discharge criteria in <= 24 hours, participants were grouped into good and poor responders to steroid treatment. Nasal samples were collected upon presentation to the ED (T0) and 18-24 hours later (T1). Genome-wide DNAm was measured for both time points in 20 subjects, and compared between T0 and T1 in good and poor responders respectively. DNAm at T1 was also compared between two responder groups. DNAm of selected CpGs was verified in the complete cohort, and expression of associated genes was examined. Interactions between DNAm, common single nucleotide polymorphism (SNP) located at the CpG sites and treatment responses were assessed. Results Three CpGs located in the OTX2 promoter showed responder-specific DNAm changes from T0 to T1, in which DNAm decreased in good but not in poor responders. Good and poor responders showed differential DNAm at T1 in 127 CpGs without and 182 CpGs with common SNP co-localization. Negative correlations between DNAm and gene expression were observed at CpGs located within the LDHC promoter, suggesting an impact of DNAm on gene regulation. Interactions between SNPs, DNAm and treatment response were detected. Conclusion Acute systemic steroid treatment modifies nasal DNAm in good responders. Nasal DNAm, dependent or independent of SNPs, can differentiate response to treatment in acute asthmatic children.	[Zhang, Xue] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Zhang, Xue; Yadagiri, Veda K.; Ulm, Ashley; Ji, Hong] Cincinnati Childrens Hosp Med Ctr, Pyrosequencing Lab Genom & Epigen Res, Cincinnati, OH 45229 USA; [Myers, Jocelyn M. Biagini; Yadagiri, Veda K.; Ulm, Ashley; Hershey, Gurjit K. Khurana; Ji, Hong] Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA; [Myers, Jocelyn M. Biagini; Weirauch, Matthew T.; Hershey, Gurjit K. Khurana; Ji, Hong] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Chen, Xiaoting; Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat & Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Ji, H (corresponding author), Cincinnati Childrens Hosp Med Ctr, Pyrosequencing Lab Genom & Epigen Res, Cincinnati, OH 45229 USA.; Ji, H (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA.; Ji, H (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.	Hong.Ji@cchmc.org	Weirauch, Matthew/M-5459-2019	Biagini, Jocelyn/0000-0002-4378-6133; Ji, Hong/0000-0002-9558-0620	NIH/NIAID [R21AI119236, R21AI101375, 2U19AI70235]; NIH [R21HG008186]; Center for Clinical and Translational Science and Training grant [UL1-RR026314-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG008186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070235, R21AI119236, R21AI101375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR070549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099068] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Clinical and Translational Science and Training grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH/NIAID R21AI119236 (HJ), NIH/NIAID R21AI101375 (HJ), NIH R21HG008186 (MTW) and NIH/NIAID 2U19AI70235 (GKKH). REDCap was hosted at Cincinnati Childrens and supported by the Center for Clinical and Translational Science and Training grant UL1-RR026314-01 NCRR/NIH.	Acevedo N, 2015, HUM MOL GENET, V24, P875, DOI 10.1093/hmg/ddu479; Akinbami, 2006, STATE CHILDHOOD ASTH, V381; Al Obaidi AHA, 2009, WORLD ALLERGY ORGAN, V2, P144, DOI 10.1097/WOX.0b013e3181b2fe64; Begin P, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-27; Bernard C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/7931693; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bos SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117403; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; Chen G, 2010, J IMMUNOL, V184, P6133, DOI 10.4049/jimmunol.1000223; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Costello I, 2015, GENE DEV, V29, P2108, DOI 10.1101/gad.268979.115; Dayeh TA, 2013, DIABETOLOGIA, V56, P1036, DOI 10.1007/s00125-012-2815-7; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Feinberg AP, 2010, VIRCHOWS ARCH, V456, P13, DOI 10.1007/s00428-009-0847-2; Gomes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038353; Guajardo JR, 2005, J ALLERGY CLIN IMMUN, V115, P243, DOI 10.1016/j.jaci.2004.10.032; Hashimoto T, 2003, J PHARMACOL SCI, V91, P8, DOI 10.1254/jphs.91.8; Hong XM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7304; Kovacic MB, 2012, PEDIAT ALLER IMM PUL, V25, P104, DOI 10.1089/ped.2011.0116; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P267, DOI 10.1016/j.jaci.2010.05.031; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Modena BD, 2014, AM J RESP CRIT CARE, V190, P1363, DOI 10.1164/rccm.201406-1099OC; Montano C, 2016, JAMA PSYCHIAT; Mortensen AH, 2015, HUM MOL GENET, V24, P939, DOI 10.1093/hmg/ddu506; Murphy TM, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0163-4; Nakano T, 2000, BIOCHEM BIOPH RES CO, V267, P64, DOI 10.1006/bbrc.1999.1872; Nicodemus-Johnson J, 2015, AM J RESP CRITICAL C; Nii K, 2014, MOL CLIN ONCOL, V2, P539, DOI 10.3892/mco.2014.292; Panman L, 2014, CELL REP, V8, P1018, DOI 10.1016/j.celrep.2014.07.016; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rubenfeld J, 2006, AM J PHYSIOL-LUNG C, V290, pL66, DOI 10.1152/ajplung.00473.2004; Saatian B, 2006, BIOCHEM J, V393, P657, DOI 10.1042/BJ20050791; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Sly RM, 1999, ANN ALLERG ASTHMA IM, V82, P233, DOI 10.1016/S1081-1206(10)62603-8; Somineni HK, 2016, J ALLERGY CLIN IMMUN, V137, P797, DOI 10.1016/j.jaci.2015.10.021; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Toews ML, 1997, J APPL PHYSIOL, V83, P1216, DOI 10.1152/jappl.1997.83.4.1216; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; USHER DJ, 1974, THORAX, V29, P685, DOI 10.1136/thx.29.6.685; Vendrell V, 2015, DEVELOPMENT, V142, P2792, DOI 10.1242/dev.122465; Wang L, 2004, CELL SIGNAL, V16, P991, DOI 10.1016/j.cellsig.2004.02.001; Xiao C, 2015, J ALLERGY CLIN IMMUN, V136, P923, DOI 10.1016/j.jaci.2015.01.045; Yang IV, 2016, J ALLERGY CLIN IMMUN; Yang IV, 2017, AM J RESP CRIT CARE, V195, P829, DOI 10.1164/rccm.201608-1558LE; Yang IV, 2015, J ALLERGY CLIN IMMUN, V136, P69, DOI 10.1016/j.jaci.2015.01.025; Yang SH, 2014, CELL REP, V7, P1968, DOI 10.1016/j.celrep.2014.05.037; Zhang HM, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-8; Zhang YH, 2009, CANCER RES, V69, P6049, DOI 10.1158/0008-5472.CAN-09-0621; Zhao YT, 2009, CELL SIGNAL, V21, P367, DOI 10.1016/j.cellsig.2008.10.010; Zhi D, 2013, EPIGENETICS-US, V8, P802, DOI 10.4161/epi.25501; Zielinski D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096788	55	26	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186150	10.1371/journal.pone.0186150	http://dx.doi.org/10.1371/journal.pone.0186150			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028809	Green Published, Green Submitted, gold			2022-12-26	WOS:000412980300020
J	de Oliveira, CM; Ulbrich, AZ; Neves, FS; Dias, FAL; Horimoto, ARVR; Krieger, JE; Alvim, RD; Pereira, AD				de Oliveira, Camila Maciel; Ulbrich, Anderson Zampier; Neves, Felipe Silva; Lavezzo Dias, Fernando Augusto; Vancan Russo Horimoto, Andrea Roseli; Krieger, Jose Eduardo; Alvim, Rafael de Oliveira; Pereira, Alexandre da Costa			Association between anthropometric indicators of adiposity and hypertension in a Brazilian population: Baependi Heart Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BLOOD-PRESSURE; ABDOMINAL OBESITY; INDEX; ADULTS; WAIST; ATHEROSCLEROSIS; MECHANISMS; DISEASE; WOMEN	Background Recently, some studies have evaluated the role of adiposity measures in the prediction of hypertension risk, but the results are conflicting. Thus, the aim of this study was to compare which of the four indicators of adiposity (waist circumference-WC, body mass index-BMI, body adiposity index-BAI, and visceral adiposity index-VAI) were better associated with hypertension in a Brazilian population. Methods and findings For this study, were selected 1627 individuals(both genders, and aged over 18 years) resident in the municipality of Baependi, a city located in the Southeast of Brazil. WC, BMI, BAI and VAI were determined according to a standard protocol. Hypertension was defined as mean systolic blood pressure >= 140 mmHg and/or diastolic blood pressure >= 90 mmHg, and/or antihypertensive drug use. The indicators of adiposity WC, BMI, BAI, and VAI were higher in hypertensive when compared to non-hypertensive individuals. In addition, WC and BMI were most strongly associated with hypertension in men and women, respectively. The area under the curve (AUC) of WC was significantly higher than VAI in men. In women, both AUC of BMI and WC showed higher discriminatory power to predict hypertension than BAI and VAI. Conclusions The indicators of adiposity WC and BMI were better associated with hypertension than BAI and VAI, in both genders, and it could be a useful tools for the screening of hypertensive patients.	[de Oliveira, Camila Maciel; Vancan Russo Horimoto, Andrea Roseli; Krieger, Jose Eduardo; Alvim, Rafael de Oliveira; Pereira, Alexandre da Costa] Univ Sao Paulo, Lab Genet & Mol Cardiol, Heart Inst InCor, Hosp Clin,Fac Med, Sao Paulo, SP, Brazil; [de Oliveira, Camila Maciel; Ulbrich, Anderson Zampier] UFPR, Dept Integrat Med, Ctr Hlth Sci, Curitiba, PR, Brazil; [Neves, Felipe Silva] Univ Fed Juiz de Fora, Dept Nutr, Inst Biol Sci, Juiz de Fora, MG, Brazil; [Lavezzo Dias, Fernando Augusto] UFPR, Dept Physiol, Curitiba, PR, Brazil; [Alvim, Rafael de Oliveira] Univ Fed Espirito Santo, Postgrad Program Publ Hlth, Vitoria, ES, Brazil	Universidade de Sao Paulo; Universidade Federal do Parana; Universidade Federal de Juiz de Fora; Universidade Federal do Parana; Universidade Federal do Espirito Santo	Alvim, RD (corresponding author), Univ Sao Paulo, Lab Genet & Mol Cardiol, Heart Inst InCor, Hosp Clin,Fac Med, Sao Paulo, SP, Brazil.; Alvim, RD (corresponding author), Univ Fed Espirito Santo, Postgrad Program Publ Hlth, Vitoria, ES, Brazil.	r.alvim@hotmail.com	Pereira, Alexandre/HHN-1038-2022; Dias, Fernando AL/D-7126-2013; Ulbrich, Anderson Z/E-2475-2011; Alvim, Rafael/ABA-7823-2021; Neves, Felipe Silva/E-1373-2016	Dias, Fernando AL/0000-0003-3951-2604; Ulbrich, Anderson Z/0000-0001-6602-0010; Alvim, Rafael/0000-0003-3150-4239; Neves, Felipe Silva/0000-0002-3294-5979; Krieger, Jose E/0000-0001-5464-1792	Sao Paulo Research Foundation (FAPESP); Hospital Samaritano Society through Ministry of Health to Support Program Institutional Development of the Unified Health System (SUS-PROADI) [25000.180.664/2011-35]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Hospital Samaritano Society through Ministry of Health to Support Program Institutional Development of the Unified Health System (SUS-PROADI)	This research was supported by grants from Sao Paulo Research Foundation (FAPESP) - JEK. This work has also was supported by Hospital Samaritano Society (Grant 25000.180.664/2011-35), through Ministry of Health to Support Program Institutional Development of the Unified Health System (SUS-PROADI) - JEK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Alvim RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100223; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Amato MC, 2011, HUM REPROD, V26, P1486, DOI 10.1093/humrep/der088; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Chen C, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-108; Chen GP, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0198-0; D'Elia L, 2016, NUTR METAB CARDIOVAS, V26, P630, DOI 10.1016/j.numecd.2016.03.009; de Oliveira Camila M, 2008, BMC Med Genet, V9, P32, DOI 10.1186/1471-2350-9-32; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Ding YN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123414; Elisha B, 2013, APPL PHYSIOL NUTR ME, V38, P892, DOI 10.1139/apnm-2012-0307; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; KAIRISTO V, 1995, SCAND J CLIN LAB INV, V55, P43, DOI 10.3109/00365519509088450; Khosravi A, 2017, J HUM HYPERTENS, V31, P382, DOI 10.1038/jhh.2016.42; Knowles KM, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/931402; Kotchen TA, 2010, AM J HYPERTENS, V23, P1170, DOI 10.1038/ajh.2010.172; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lee JW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1471-5; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lin WY, 2002, INT J OBESITY, V26, P1232, DOI 10.1038/sj.ijo.0802040; Liu PJ, 2016, ANN NUTR METAB, V68, P235, DOI 10.1159/000446121; Malachias Mvb, 2016, Arq Bras Cardiol, V107, P1, DOI 10.5935/abc.20160151; Melmer A, 2013, OBESITY, V21, P775, DOI 10.1002/oby.20289; Moore SC, 2009, AM J CLIN NUTR, V89, P1003, DOI 10.3945/ajcn.2009.27598; Newman TB, 2007, DESIGNING CLIN RES, P109; Park HJ, 2016, ANN MED, V48, P410, DOI 10.1080/07853890.2016.1183258; Sipahi I, 2006, J AM COLL CARDIOL, V48, P833, DOI 10.1016/j.jacc.2006.05.045; Stepien M, 2014, ANGIOLOGY, V65, P333, DOI 10.1177/0003319713485807; Suchanek P, 2012, NEUROENDOCRINOL LETT, V33, P78; Tuan NT, 2010, PUBLIC HEALTH NUTR, V13, P639, DOI 10.1017/S1368980009991479; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Williams B, 2009, J AM COLL CARDIOL, V55, P65, DOI 10.1016/j.jacc.2009.08.037; Yang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104365; Zhang Y, 2006, HYPERTENSION, V47, P410, DOI 10.1161/01.HYP.0000205119.19804.08; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	39	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185225	10.1371/journal.pone.0185225	http://dx.doi.org/10.1371/journal.pone.0185225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023455	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100015
J	Garcia-Garcia, R; Cruz-Gomez, AJ; Mangas-Losada, A; Urios, A; Forn, C; Escudero-Garcia, D; Kosenko, E; Ordono, JF; Tosca, J; Giner-Duran, R; Serra, MA; Avila, C; Belloch, V; Felipo, V; Montoliu, C				Garcia-Garcia, Raquel; Javier Cruz-Gomez, Alvaro; Mangas-Losada, Alba; Urios, Amparo; Forn, Cristina; Escudero-Garcia, Desamparados; Kosenko, Elena; Fermin Ordono, Juan; Tosca, Joan; Giner-Duran, Remedios; Angel Serra, Miguel; Avila, Cesar; Belloch, Vicente; Felipo, Vicente; Montoliu, Carmina			Reduced resting state connectivity and gray matter volume correlate with cognitive impairment in minimal hepatic encephalopathy	PLOS ONE			English	Article							CIRRHOTIC-PATIENTS; FUNCTIONAL CONNECTIVITY; BRAIN ACTIVITY; ATTENTION; NETWORKS; DEFICITS; CORTEX; MEMORY	Background and aims Minimal hepatic encephalopathy (MHE) is associated with cognitive alterations and changes in connectivity. We assessed the relationship of the abnormalities of resting-state functional connectivity (rs-FC) and gray matter (GM) volume with different cognitive alterations and biochemical parameters associated to MHE. Methods Thirty-nine cirrhotic patients (26 without and 13 with MHE) and 24 controls were widely cognitive assessed with a battery of psychometric tests. Atrophy was determined using Voxel-Based Morphometry and rs-FC was assessed by independent component analysis. Receiver operating characteristic (ROC) curves was performed to assess the diagnostic utility of rs-FC and GM reduction for the discrimination of patients with and without MHE. Blood ammonia, cGMP, and levels of pro-inflammatory interleukins were measured. Results MHE patients showed significant decrease of GM volume and lesser degree of rs-FC in different networks related to attention and executive functions as compared to controls and patients without MHE. There is a progressive reduction in rs-FC in the default mode network with the progression of cognitive impairment. MHE patients showed GM reduction in theright frontal lobe, right insula and right cerebellum compared to patients without MHE. Alterations in GM volume and rs-FC correlated with the scores of different cognitive tests. Conclusions Decreased cognitive performance is associated by reduced rs-FC and GM atrophy in MHE patients. These changes could have predictive value for detecting MHE.	[Garcia-Garcia, Raquel; Urios, Amparo; Felipo, Vicente] Ctr Invest Principe Felipe, Valencia, Spain; [Javier Cruz-Gomez, Alvaro; Forn, Cristina; Avila, Cesar] Univ Jaume 1, Dept Psicol Basica Clin & Psicobiol, Castellon de La Plana, Castellon De La, Spain; [Mangas-Losada, Alba; Urios, Amparo; Montoliu, Carmina] Fdn Invest Hosp Clin Valencia, INCLIVA, Valencia, Spain; [Escudero-Garcia, Desamparados; Tosca, Joan; Angel Serra, Miguel] Univ Valencia, Dept Med, Unidad Digest Hosp Clin, Valencia, Spain; [Kosenko, Elena] Inst Theoret & Expt Biophys, Pushchino, Russia; [Fermin Ordono, Juan] Hosp Arnau Vilanova, Serv Neurofisiol, Valencia, Spain; [Fermin Ordono, Juan] CIBERSAM, Paterna Mental Hlth Ctr, Psychopatol & Neurophysiol Unit, Valencia, Spain; [Giner-Duran, Remedios] Hosp Arnau Vilanova, Serv Digest, Valencia, Spain; [Belloch, Vicente] ERESA, Unidad RM, Valencia, Spain; [Montoliu, Carmina] Univ Valencia, Fac Med, Dept Patol, Valencia, Spain	Prince Felipe Research Center; Universitat Jaume I; University of Valencia; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Valencia	Montoliu, C (corresponding author), Fdn Invest Hosp Clin Valencia, INCLIVA, Valencia, Spain.; Montoliu, C (corresponding author), Univ Valencia, Fac Med, Dept Patol, Valencia, Spain.	cmontoliu@incliva.es	Avila, Cesar/B-4370-2011; Escudero-Garcia, Desamparados/ABB-1929-2021; Tosca, Joan/ABG-3723-2020; Felipo, Vicente/A-9265-2014; Montoliu, Carmina/ABB-1904-2021; Urios, Amparo/ABB-1879-2021; Kosenko, Elena A/N-3224-2017; Forn, Cristina/L-6208-2014	Avila, Cesar/0000-0002-5840-605X; Tosca, Joan/0000-0003-1258-9513; Felipo, Vicente/0000-0003-3145-9538; Kosenko, Elena A/0000-0002-3293-652X; Forn, Cristina/0000-0002-6292-5303; Cruz Gomez, Alvaro Javier/0000-0001-9105-5100	Ministerio Ciencia Innovacion [SAF2014-51851-R]; Instituto de Salud Carlos [III-FISPI15/00035]; European Regional Development Funds; Conselleria Educacion Generalitat Valenciana [PROMETEOII/2014/033, ACOMP/2014/026]	Ministerio Ciencia Innovacion; Instituto de Salud Carlos(Instituto de Salud Carlos III); European Regional Development Funds(European Commission); Conselleria Educacion Generalitat Valenciana	Financial support was provided by Ministerio Ciencia Innovacion: SAF2014-51851-R (VF) and Instituto de Salud Carlos III-FISPI15/00035 (CM), co-funded-European Regional Development Funds; Conselleria Educacion Generalitat Valenciana: PROMETEOII/2014/033 (VF) and ACOMP/2014/026 (CM).	Amodio P, 2005, METAB BRAIN DIS, V20, P115, DOI 10.1007/s11011-005-4149-3; Bajaj JS, 2009, HEPATOLOGY, V50, P2014, DOI 10.1002/hep.23216; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen HJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27092; Chen HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089684; Chen HJ, 2012, EUR J RADIOL, V81, P2463, DOI 10.1016/j.ejrad.2011.10.008; Cheng Y, 2017, KOREAN J RADIOL, V18, P370, DOI 10.3348/kjr.2017.18.2.370; Ciaramelli E, 2008, NEUROPSYCHOLOGIA, V46, P1828, DOI 10.1016/j.neuropsychologia.2008.03.022; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Felipo V, 2014, WORLD J GASTROENTERO, V20, P11815, DOI 10.3748/wjg.v20.i33.11815; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; Felipo V, 2012, HEPATOLOGY, V55, P530, DOI 10.1002/hep.24704; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI DOI 10.1053/JHEP.2002.31250; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Gimenez-Garzo C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171211; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Guevara M, 2011, J HEPATOL, V55, P564, DOI 10.1016/j.jhep.2010.12.008; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Joebges EM, 2003, J HEPATOL, V38, P273, DOI 10.1016/S0168-8278(02)00423-3; Kuhn S, 2012, BRAIN STRUCT FUNCT, V217, P523, DOI 10.1007/s00429-011-0365-2; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Montoliu C, 2014, GUT, V63, P1028, DOI 10.1136/gutjnl-2013-306175; Montoliu C, 2012, NEUROIMAGE, V61, P1165, DOI 10.1016/j.neuroimage.2012.03.041; PANDYA DN, 1981, EXP BRAIN RES, V42, P319, DOI 10.1007/BF00237497; Potgieser ARE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00960; Qi RF, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000227; Qi RF, 2013, EUR J RADIOL, V82, P850, DOI 10.1016/j.ejrad.2012.12.016; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Qi RF, 2012, RADIOLOGY, V264, P187, DOI 10.1148/radiol.12111429; Romero-Gomez M, 2001, AM J GASTROENTEROL, V96, P2718, DOI 10.1016/S0002-9270(01)02692-2; Segarra N, 2008, NEUROREPORT, V19, P1513, DOI 10.1097/WNR.0b013e3283108bd8; Shawcross DL, 2004, J HEPATOL, V40, P247, DOI 10.1016/j.jhep.2003.10.016; Timmermann L, 2005, METAB BRAIN DIS, V20, P337, DOI 10.1007/s11011-005-7916-2; Urios A, 2017, LIVER INT, V37, P1013, DOI 10.1111/liv.13345; Weissenborn K, 2005, METAB BRAIN DIS, V20, P359, DOI 10.1007/s11011-005-7919-z; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5; Wilson TW, 2014, NEUROIMAGE, V85, P445, DOI 10.1016/j.neuroimage.2013.04.112; Zhang LJ, 2007, ACTA RADIOL, V48, P577, DOI 10.1080/02841850701308378	41	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186463	10.1371/journal.pone.0186463	http://dx.doi.org/10.1371/journal.pone.0186463			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023586	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100131
J	Murakami, A; Yasuhira, S; Mayama, H; Miura, H; Maesawa, C; Satoh, K				Murakami, Akiko; Yasuhira, Shinji; Mayama, Hisayo; Miura, Hiroyuki; Maesawa, Chihaya; Satoh, Kazuro			Characterization of PAX9 variant P20L identified in a Japanese family with tooth agenesis	PLOS ONE			English	Article							PAIRED DOMAIN; MISSENSE MUTATION; ECTODERMAL DYSPLASIA; WAARDENBURG SYNDROME; OLIGODONTIA; HYPODONTIA; GENE; MORPHOGENESIS; SEQUENCE; MUTANTS	Transcription factors PAX9 and MSX1 play crucial roles in the development of permanent teeth at the bud stage, and their loss-of-function variants have been associated with congenital tooth agenesis. We sequenced the coding regions of the PAX9 and MSX1 genes from nine patients with non-syndromic tooth agenesis, and identified a missense mutation, P20L, of PAX9 in a single familial case involving three patients in two generations. Identical mutation was previously reported by other authors, but has not been characterized in detail. The mutation was located in a highly conserved N-terminal subdomain of the paired domain and co-segregated as a heterozygote with tooth agenesis. The patients showed defects primarily in the first and second molars, which is typical for cases attributable to PAX9 mutation. Luciferase reporter assay using the 2.3-kb promoter region of BMP4 and electrophoretic mobility shift assay using the CD19-2(A-ins) sequence revealed that P20L substitution eliminated most of the transactivation activity and specific DNA binding activity of PAX9 under the experimental conditions we employed, while some residual activity of the mutant was evident in the former assay. The hypomorphic nature of the variant may explain the relatively mild phenotype in this case, as compared with other PAX9 pathogenic variants such as R26W.	[Murakami, Akiko; Mayama, Hisayo; Satoh, Kazuro] Iwate Med Univ, Sch Dent, Dept Dev Oral Hlth Sci, Morioka, Iwate, Japan; [Yasuhira, Shinji; Maesawa, Chihaya] Iwate Med Univ, Inst Biomed Sci, Dept Tumor Biol, Yahaba, Iwate, Japan; [Miura, Hiroyuki] Iwate Med Univ, Sch Dent, Dept Oral Med, Morioka, Iwate, Japan	Iwate Medical University; Iwate Medical University; Iwate Medical University	Yasuhira, S (corresponding author), Iwate Med Univ, Inst Biomed Sci, Dept Tumor Biol, Yahaba, Iwate, Japan.	syasuhir@iwate-med.ac.jp		Yasuhira, Shinji/0000-0003-0041-3545				[Anonymous], 2021, LANG ENV STAT COMP; Arte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073705; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; Bonczek O, 2017, CLIN GENET; Chen YP, 1996, DEVELOPMENT, V122, P3035; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Das P, 2003, AM J MED GENET A, V118A, P35, DOI 10.1002/ajmg.a.10011; Endo T, 2006, AM J ORTHOD DENTOFAC, V129, P29, DOI 10.1016/j.ajodo.2004.09.024; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Jumlongras D, 2004, HUM GENET, V114, P242, DOI 10.1007/s00439-003-1066-6; Kapadia H, 2006, EUR J HUM GENET, V14, P403, DOI 10.1038/sj.ejhg.5201574; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kist R, 2005, HUM MOL GENET, V14, P3605, DOI 10.1093/hmg/ddi388; Kulkarni M, 2011, J CLIN PEDIATR DENT, V36, P65, DOI 10.17796/jcpd.36.1.p74362q544210p33; Lammi L, 2003, EUR J HUM GENET, V11, P866, DOI 10.1038/sj.ejhg.5201060; Mensah JK, 2004, J BIOL CHEM, V279, P5924, DOI 10.1074/jbc.M305648200; Mostowska A, 2003, EUR J ORAL SCI, V111, P272, DOI 10.1034/j.1600-0722.2003.00036.x; Nagasaki M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9018; Nakatomi M, 2010, DEV BIOL, V340, P438, DOI 10.1016/j.ydbio.2010.01.031; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Ogawa T, 2006, J BIOL CHEM, V281, P18363, DOI 10.1074/jbc.M601543200; Pani Sharat Chandra, 2011, J Indian Soc Pedod Prev Dent, V29, P84, DOI 10.4103/0970-4388.84677; Peters H, 1999, TRENDS GENET, V15, P59, DOI 10.1016/S0168-9525(98)01662-X; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shilpa Mohapatra A, 2010, J INDIAN SOC PEDOD P, V28, p319 ; Symons A L, 1993, J Clin Pediatr Dent, V17, P109; THIMMEGOWDA U., 2015, J CLIN DIAGN RES, V9, P8, DOI DOI 10.HTTPS://D0I.0RG/10.7860/JCDR/2015/13173.6049; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Vastardis H, 2000, AM J ORTHOD DENTOFAC, V117, P650, DOI 10.1016/S0889-5406(00)70173-9; Vogan KJ, 1997, J BIOL CHEM, V272, P28289, DOI 10.1074/jbc.272.45.28289; Wang Y, 2009, HUM MOL GENET, V18, P2863, DOI 10.1093/hmg/ddp221; Zhao JL, 2007, AM J MED GENET A, V143A, P2592, DOI 10.1002/ajmg.a.31993	36	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186260	10.1371/journal.pone.0186260	http://dx.doi.org/10.1371/journal.pone.0186260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023497	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100093
J	Vinner, GK; Vladisavljevic, GT; Clokie, MRJ; Malik, DJ				Vinner, Gurinder K.; Vladisavljevic, Goran T.; Clokie, Martha R. J.; Malik, Danish J.			Microencapsulation of Clostridium difficile specific bacteriophages using microfluidic glass capillary devices for colon delivery using pH triggered release	PLOS ONE			English	Article							PHAGE THERAPY; IN-VITRO; MEMBRANE EMULSIFICATION; ALGINATE MICROSPHERES; INTESTINAL DELIVERY; DROPLET FORMATION; DRUG-DELIVERY; INFECTION; MICROPARTICLES; ANTIBIOTICS	The prevalence of pathogenic bacteria acquiring multidrug antibiotic resistance is a global health threat to mankind. This has motivated a renewed interest in developing alternatives to conventional antibiotics including bacteriophages (viruses) as therapeutic agents. The bacterium Clostridium difficile causes colon infection and is particularly difficult to treat with existing antibiotics; phage therapy may offer a viable alternative. The punitive environment within the gastrointestinal tract can inactivate orally delivered phages. C. difficile specific bacteriophage, myovirus CDKM9 was encapsulated in a pH responsive polymer (Eudragit((R)) S100 with and without alginate) using a flow focussing glass microcapillary device. Highly monodispersed core-shell microparticles containing phages trapped within the particle core were produced by in situ polymer curing using 4-aminobenzoic acid dissolved in the oil phase. The size of the generated microparticles could be precisely controlled in the range 80 mu m to 160 mu m through design of the microfluidic device geometry and by varying flow rates of the dispersed and continuous phase. In contrast to free 'naked' phages, those encapsulated within the microparticles could withstand a 3 h exposure to simulated gastric fluid at pH 2 and then underwent a subsequent pH triggered burst release at pH 7. The significance of our research is in demonstrating that C. difficile specific phage can be formulated and encapsulated in highly uniform pH responsive microparticles using a microfluidic system. The microparticles were shown to afford significant protection to the encapsulated phage upon prolonged exposure to an acid solution mimicking the human stomach environment. Phage encapsulation and subsequent release kinetics revealed that the microparticles prepared using Eudragit((R)) S100 formulations possess pH responsive characteristics with phage release triggered in an intestinal pH range suitable for therapeutic purposes. The results reported here provide proof-of-concept data supporting the suitability of our approach for colon targeted delivery of phages for therapeutic purposes.	[Vinner, Gurinder K.; Vladisavljevic, Goran T.; Malik, Danish J.] Loughborough Univ, Chem Engn Dept, Loughborough, Leics, England; [Clokie, Martha R. J.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England	Loughborough University; University of Leicester	Vladisavljevic, GT; Malik, DJ (corresponding author), Loughborough Univ, Chem Engn Dept, Loughborough, Leics, England.	g.vladisavljevic@lboro.ac.uk; d.j.malik@lboro.ac.uk	Vladisavljevic, Goran/D-8962-2011	Vladisavljevic, Goran/0000-0002-8894-975X; Clokie, Martha/0000-0002-6069-8936	EPSRC [EP/M027341/1]; Engineering and Physical Sciences Research Council [EP/M027341/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors would like to acknowledge EPSRC support for this work (Grant no. EP/M027341/1) Tackling Antimicrobial Resistance: An Interdisciplinary Approach.	Abdulamir AS, 2014, ANN CLIN MICROB ANTI, V13, P1; Abedon ST, 2015, PHARMACEUTICALS-BASE, V8, P525, DOI 10.3390/ph8030525; Abedon Stephen T, 2011, Bacteriophage, V1, P66; Abedon ST, 2009, FOODBORNE PATHOG DIS, V6, P807, DOI 10.1089/fpd.2008.0242; Alhnan MA, 2010, J PHARM SCI, V99, P4215; Alisky J, 1998, J INFECTION, V36, P5, DOI 10.1016/S0163-4453(98)92874-2; Allen HK, 2014, ANN NY ACAD SCI, V1323, P91, DOI 10.1111/nyas.12468; Barrow P, 1998, CLIN DIAGN LAB IMMUN, V5, P294, DOI 10.1128/CDLI.5.3.294-298.1998; Barrow PA, 1997, TRENDS MICROBIOL, V5, P268, DOI 10.1016/S0966-842X(97)01054-8; Bean JE, 2014, CHEM MATER, V26, P7201, DOI 10.1021/cm503974g; Biswas B, 2002, INFECT IMMUN, V70, P204, DOI 10.1128/IAI.70.1.204-210.2002; Bouza E, 2012, CLIN MICROBIOL INFEC, V18, P5, DOI 10.1111/1469-0691.12064; Briers Y, 2008, BIOCHEM BIOPH RES CO, V374, P747, DOI 10.1016/j.bbrc.2008.07.102; Brouzes E, 2009, P NATL ACAD SCI USA, V106, P14195, DOI 10.1073/pnas.0903542106; Bruttin A, 2005, ANTIMICROB AGENTS CH, V49, P2874, DOI 10.1128/AAC.49.7.2874-2878.2005; Burke KE, 2014, GUT LIVER, V8, P1, DOI [10.5009/gn1.2014.8.1.1, 10.5009/gnl.2014.8.1.1]; Cairns BJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000253; Cerveny KE, 2002, INFECT IMMUN, V70, P6251, DOI 10.1128/IAI.70.11.6251-6262.2002; Chen S.-H., 2016, PROC ASIA PACIFIC SI, P1; Chibani-Chennoufi S, 2004, ANTIMICROB AGENTS CH, V48, P2558, DOI 10.1128/AAC.48.7.2558-2569.2004; Choinska-Pulit A, 2015, TRENDS FOOD SCI TECH, V45, P212, DOI 10.1016/j.tifs.2015.07.001; Colom J, 2017, SCI REP-UK, V7, DOI 10.1038/srep41441; Connerton PL, 2011, J APPL MICROBIOL, V111, P255, DOI 10.1111/j.1365-2672.2011.05012.x; Czaplewski L, 2016, LANCET INFECT DIS, V16, P239, DOI 10.1016/S1473-3099(15)00466-1; DAVIES JD, 1969, J HYG-CAMB, V67, P573, DOI 10.1017/S0022172400042030; Dini C, 2012, MACROMOL BIOSCI, V12, P1200, DOI 10.1002/mabi.201200109; Duan HG, 2016, COLLOID SURFACE B, V145, P510, DOI 10.1016/j.colsurfb.2016.05.038; Egidi E, 2008, J MEMBRANE SCI, V323, P414, DOI 10.1016/j.memsci.2008.06.047; Ekanem EE, 2015, ACS APPL MATER INTER, V7, P23132, DOI 10.1021/acsami.5b06943; Erb RM, 2011, SOFT MATTER, V7, P8757, DOI 10.1039/c1sm06231j; Fernandez-Nieves A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.157801; Freire-Moran L, 2011, DRUG RESIST UPDATE, V14, P118, DOI 10.1016/j.drup.2011.02.003; Fu TT, 2012, CHEM ENG SCI, V84, P207, DOI 10.1016/j.ces.2012.08.039; Galtier M, 2016, ENVIRON MICROBIOL, V18, P2237, DOI 10.1111/1462-2920.13284; George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017; Gibson PR, 2006, ALIMENT PHARM THER, V23, P1017, DOI 10.1111/j.1365-2036.2006.02861.x; Goh S, 2005, J MED MICROBIOL, V54, P129, DOI 10.1099/jmm.0.45821-0; Governal RA, 1997, J IND MICROBIOL BIOT, V18, P297, DOI 10.1038/sj.jim.2900388; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Housby JN, 2009, DRUG DISCOV TODAY, V14, P536, DOI 10.1016/j.drudis.2009.03.006; Huang S, 2008, BIOTECHNOL BIOENG, V101, P1014, DOI 10.1002/bit.21995; Huttner A, 2013, ANTIMICROBIAL RESIST, P1; Ibekwe VC, 2008, PHARM RES-DORDR, V25, P1828, DOI 10.1007/s11095-008-9580-9; Jain D, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060116; Jonczyk E, 2011, FOLIA MICROBIOL, V56, P191, DOI 10.1007/s12223-011-0039-8; Kietzmann D, 2010, EUR J PHARM BIOPHARM, V76, P290, DOI 10.1016/j.ejpb.2010.06.013; Kim S, 2015, INT J FOOD SCI TECH, V50, P913, DOI 10.1111/ijfs.12736; Knezevic P, 2011, J APPL MICROBIOL, V111, P245, DOI 10.1111/j.1365-2672.2011.05043.x; Kong TT, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4738586; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Lee SW, 2004, NANO LETT, V4, P387, DOI 10.1021/nl034911t; LEIBO SP, 1966, BIOPHYS J, V6, P747, DOI 10.1016/S0006-3495(66)86693-6; Leung SSY, 2016, PHARM RES-DORDR, V33, P1486, DOI 10.1007/s11095-016-1892-6; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; Lu TK, 2011, CURR OPIN MICROBIOL, V14, P524, DOI 10.1016/j.mib.2011.07.028; Ma YS, 2008, APPL ENVIRON MICROB, V74, P4799, DOI 10.1128/AEM.00246-08; Ma YS, 2012, FOOD HYDROCOLLOID, V26, P434, DOI 10.1016/j.foodhyd.2010.11.017; MAHONEY DE, 1985, J CLIN MICROBIOL, V21, P251, DOI 10.1128/JCM.21.2.251-254.1985; Malik DJ, 2017, ADV COLLOID INTERFAC, V249, P100, DOI 10.1016/j.cis.2017.05.014; McConnell EL, 2008, INT J PHARMACEUT, V364, P213, DOI 10.1016/j.ijpharm.2008.05.012; Merabishvili M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068797; Nale JY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01383; Nale JY, 2016, ANTIMICROB AGENTS CH, V60, P968, DOI 10.1128/AAC.01774-15; Navaneethan U, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-7; Nguyen DA, 2005, AICHE J, V51, P415, DOI 10.1002/aic.10329; Pirnay JP, 2015, PHARM RES-DORDR, V32, P2173, DOI 10.1007/s11095-014-1617-7; Puapermpoonsiri U, 2009, EUR J PHARM BIOPHARM, V72, P26, DOI 10.1016/j.ejpb.2008.12.001; Rashid S, 2016, VIRUSES, V8, P1; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Saglam D, 2011, FOOD HYDROCOLLOID, V25, P1139, DOI 10.1016/j.foodhyd.2010.10.011; Samtlebe M, 2016, LWT-FOOD SCI TECHNOL, V68, P334, DOI 10.1016/j.lwt.2015.12.039; Sarker SA, 2016, EBIOMEDICINE, V4, P124, DOI 10.1016/j.ebiom.2015.12.023; Schmelcher Mathias, 2014, Bacteriophage, V4, pe28137; Seo M, 2007, SOFT MATTER, V3, P986, DOI 10.1039/b700687j; Shi LE, 2016, LWT-FOOD SCI TECHNOL, V65, P840, DOI 10.1016/j.lwt.2015.08.071; SMITH HW, 1987, J GEN MICROBIOL, V133, P1111; Sookkasem A, 2015, J DRUG DELIV SCI TEC, V29, P159, DOI 10.1016/j.jddst.2015.07.005; Stanford K, 2010, J FOOD PROTECT, V73, P1304, DOI 10.4315/0362-028X-73.7.1304; Stillwell MT, 2007, IND ENG CHEM RES, V46, P965, DOI 10.1021/ie0611094; Summers WC, 2001, ANNU REV MICROBIOL, V55, P437, DOI 10.1146/annurev.micro.55.1.437; Surh J, 2007, J AGR FOOD CHEM, V55, P175, DOI 10.1021/jf061637q; Tang ZX, 2015, LWT-FOOD SCI TECHNOL, V60, P263, DOI 10.1016/j.lwt.2014.08.012; Tang ZX, 2013, FOOD RES INT, V52, P460, DOI 10.1016/j.foodres.2012.12.037; Vandenheuvel D, 2013, EUR J PHARM BIOPHARM, V84, P578, DOI 10.1016/j.ejpb.2012.12.022; Vardakas KZ, 2012, INT J ANTIMICROB AG, V40, P1, DOI 10.1016/j.ijantimicag.2012.01.004; Vemula SK, 2015, EUR J DRUG METAB PH, V40, P301, DOI 10.1007/s13318-014-0210-0; Viswanathan VK, 2009, NAT REV MICROBIOL, V7, P110, DOI 10.1038/nrmicro2053; Vladisavljevic GT, 2012, LANGMUIR, V28, P12948, DOI 10.1021/la302092f; Vladisavljevic GT, 2012, MICROFLUID NANOFLUID, V13, P151, DOI 10.1007/s10404-012-0948-0; Wall SK, 2010, APPL ENVIRON MICROB, V76, P48, DOI 10.1128/AEM.00785-09; Wills QF, 2005, ANTIMICROB AGENTS CH, V49, P1220, DOI 10.1128/AAC.49.3.1220-1221.2005; Wittaya-areekul S, 2006, INT J PHARMACEUT, V312, P113, DOI 10.1016/j.ijpharm.2006.01.003; Yen MM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14187; Young R, 2015, SCIENCE, V350, P1163, DOI 10.1126/science.aad6791	94	40	41	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186239	10.1371/journal.pone.0186239	http://dx.doi.org/10.1371/journal.pone.0186239			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023522	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100088
J	Dou, JF; Guo, HM; Cheng, F; Huang, HQ; Fu, LY; Li, LN; Yang, C; Ye, L; Wen, LL; Cheng, YY; Tang, LL; Zhu, CH; Zhu, ZW; Wang, WJ; Sheng, YJ; Wang, ZX; Liu, SX; Fan, X; Zuo, XB; Zhou, FS; Sun, LD; Zheng, XD; Zhang, XJ				Dou, Jinfa; Guo, Huimin; Cheng, Fang; Huang, Hequn; Fu, Liying; Li, Longnian; Yang, Chao; Ye, Lei; Wen, Leilei; Cheng, Yuyan; Tang, Lili; Zhu, Caihong; Zhu, Zhengwei; Wang, Wenjun; Sheng, Yujun; Wang, Zaixing; Liu, Shengxiu; Fan, Xing; Zuo, Xianbo; Zhou, Fusheng; Sun, Liangdan; Zheng, Xiaodong; Zhang, Xuejun			Genotype combination contributes to psoriasis: An exhaustive algorithm perspective	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ANALYSIS IDENTIFIES 3; SUSCEPTIBILITY LOCI; DISEASE; POPULATION; VARIANTS	Researchers have learned that nearly all conditions and diseases have a genetic component. With the benefit of technological advances, many single-nucleotide polymorphisms (SNPs) have been found to be associated with the risk of complex disorders by using genome wide association studies (GWASs). Disease-associated SNPs are sometimes shared by healthy controls and cannot clearly distinguish affected individuals from unaffected ones. The combined effects of multiple independent SNPs contribute to the disease process, but revealing the relationship between genotype and phenotype based on the combinations remains a great challenge. In this study, by considering the disease prevalence rate, we conducted an exhaustive process to identify whether a genotype combination pattern would have a decisive effect on complex disorders. Based on genotype data for 68 reported SNPs in 8,372 psoriasis patients and 8,510 healthy controls, we found that putative causal genotype combination patterns (CGCPs) were only present in psoriasis patients, not in healthy subjects. These results suggested that psoriasis might be contributed by combined genotypes, complementing the traditional modest susceptibility of a single variant in a single gene for a complex disease. This work is the first systematic study to analyze genotype combinations based on the reported susceptibility genes, considering each individual among the cases and controls from the Chinese population, and could potentially advance disease-gene mapping and precision medicine due to the causality relationship between the candidate CGCPs and complex diseases.	[Dou, Jinfa; Guo, Huimin; Cheng, Fang; Huang, Hequn; Fu, Liying; Yang, Chao; Ye, Lei; Wen, Leilei; Cheng, Yuyan; Tang, Lili; Zhu, Caihong; Zhu, Zhengwei; Wang, Wenjun; Sheng, Yujun; Wang, Zaixing; Liu, Shengxiu; Fan, Xing; Zuo, Xianbo; Zhou, Fusheng; Sun, Liangdan; Zheng, Xiaodong; Zhang, Xuejun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Dou, Jinfa; Guo, Huimin; Cheng, Fang; Huang, Hequn; Fu, Liying; Yang, Chao; Ye, Lei; Wen, Leilei; Cheng, Yuyan; Tang, Lili; Zhu, Caihong; Zhu, Zhengwei; Wang, Wenjun; Sheng, Yujun; Wang, Zaixing; Liu, Shengxiu; Fan, Xing; Zuo, Xianbo; Zhou, Fusheng; Sun, Liangdan; Zheng, Xiaodong; Zhang, Xuejun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Dou, Jinfa; Guo, Huimin; Cheng, Fang; Huang, Hequn; Fu, Liying; Yang, Chao; Ye, Lei; Wen, Leilei; Cheng, Yuyan; Tang, Lili; Zhu, Caihong; Zhu, Zhengwei; Wang, Wenjun; Sheng, Yujun; Wang, Zaixing; Liu, Shengxiu; Fan, Xing; Zuo, Xianbo; Zhou, Fusheng; Sun, Liangdan; Zheng, Xiaodong; Zhang, Xuejun] Anhui Med Univ, Key Lab Dermatol, Minist Educ, Hefei, Anhui, Peoples R China; [Li, Longnian] Gannan Med Univ, Affiliated Hosp 1, Dept Dermatol, Ganzhou, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Gannan Medical University	Zheng, XD; Zhang, XJ (corresponding author), Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China.; Zheng, XD; Zhang, XJ (corresponding author), Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China.; Zheng, XD; Zhang, XJ (corresponding author), Anhui Med Univ, Key Lab Dermatol, Minist Educ, Hefei, Anhui, Peoples R China.	zhengxiaodong.1234@163.com; ayzxj@vip.sina.com	SHENG, Yu/GXZ-8269-2022		First Affiliated Hospital of Anhui Medical University [2010KJ11]; Natural Science Foundation of Anhui province [1708085QH211]; National Natural Science Foundation of China [81130031]	First Affiliated Hospital of Anhui Medical University; Natural Science Foundation of Anhui province(Natural Science Foundation of Anhui Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Program of the National Natural Science Foundation of China (81130031), Youth Fund of the First Affiliated Hospital of Anhui Medical University (2010KJ11) and the Natural Science Foundation of Anhui province (1708085QH211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-8; Blair DR, 2013, CELL, V155, P70, DOI 10.1016/j.cell.2013.08.030; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Chen HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019454; Ding XL, 2012, EUR J DERMATOL, V22, P663, DOI 10.1684/ejd.2012.1802; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Hemminki K, 2006, NAT REV GENET, V7, P958, DOI 10.1038/nrg2009; Johnson BA, 2013, AM J PSYCHIAT, V170, P1020, DOI 10.1176/appi.ajp.2013.12091163; Knight J, 2012, HUM MOL GENET, V21, P5185, DOI 10.1093/hmg/dds344; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Olden K, 2011, HEALTH AFFAIR, V30, P833, DOI 10.1377/hlthaff.2011.0078; Phillips TJ, 1999, PSYCHOPHARMACOLOGY, V147, P5, DOI 10.1007/s002130051128; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang HY, 2014, NAT GENET, V46, P45, DOI 10.1038/ng.2827; Tsoi LC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8001; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Wu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071934; Yin XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125369; Yin XY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7916; Zakharov S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-569; Zhang SQ, 2012, NAT GENET, V44, P1156, DOI 10.1038/ng.2409; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhang YT, 2014, ANN MATH, V179, P1121, DOI 10.4007/annals.2014.179.3.7	28	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186067	10.1371/journal.pone.0186067	http://dx.doi.org/10.1371/journal.pone.0186067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020033	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400063
J	Montesano, G; Allegrini, D; Colombo, L; Rossetti, LM; Pece, A				Montesano, Giovanni; Allegrini, Davide; Colombo, Leonardo; Rossetti, Luca M.; Pece, Alfredo			Features of the normal choriocapillaris with OCT-angiography: Density estimation and textural properties	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY ANGIOGRAPHY; LIVING HUMAN EYE; IMAGE ARTIFACTS; VASCULATURE	The main objective of our work is to perform an in depth analysis of the structural features of normal choriocapillaris imaged with OCT Angiography. Specifically, we provide an optimal radius for a circular Region of Interest (ROI) to obtain a stable estimate of the subfoveal choriocapillaris density and characterize its textural properties using Markov Random Fields. On each binarized image of the choriocapillaris OCT Angiography we performed simulated measurements of the subfoveal choriocapillaris densities with circular Regions of Interest (ROIs) of different radii and with small random displacements from the center of the Foveal Avascular Zone (FAZ). We then calculated the variability of the density measure with different ROI radii. We then characterized the textural features of choriocapillaris binary images by estimating the parameters of an Ising model. For each image we calculated the Optimal Radius (OR) as the minimum ROI radius required to obtain a standard deviation in the simulation below 0.01. The density measured with the individual OR was 0.52 +/- 0.07 (mean +/- STD). Similar density values (0.51 +/- 0.07) were obtained using a fixed ROI radius of 450 mu m. The Ising model yielded two parameter estimates (beta = 0.34 +/- 0.03; gamma = 0.003 +/- 0.012; mean +/- STD), characterizing pixel clustering and white pixel density respectively. Using the estimated parameters to synthetize new random textures via simulation we obtained a good reproduction of the original choriocapillaris structural features and density. In conclusion, we developed an extensive characterization of the normal subfoveal choriocapillaris that might be used for flow analysis and applied to the investigation pathological alterations.	[Montesano, Giovanni; Rossetti, Luca M.] Univ Milan, Sch Ophthalmol, Milan, Italy; [Montesano, Giovanni; Colombo, Leonardo; Rossetti, Luca M.] ASST Santi Paolo & Carloeye Clin, Milan, Italy; [Montesano, Giovanni] City Univ London, Optometry & Visual Sci, London, England; [Allegrini, Davide] Humanitas Univ, Eye Clin, Humanitas Gavazzeni, Milan, Italy; [Pece, Alfredo] Melegnano Hosp, Eye Clin, Vizzolo, Predabissi, Italy	University of Milan; City University London; Humanitas University; Istituto Clinico Humanitas Gavazzeni	Montesano, G (corresponding author), Univ Milan, Sch Ophthalmol, Milan, Italy.; Montesano, G (corresponding author), ASST Santi Paolo & Carloeye Clin, Milan, Italy.; Montesano, G (corresponding author), City Univ London, Optometry & Visual Sci, London, England.	giovmontesano@gmail.com	Montesano, Giovanni/AAS-9356-2020	Montesano, Giovanni/0000-0002-9148-2804; Colombo, Leonardo/0000-0002-9556-994X	Retina 3000 Foundation	Retina 3000 Foundation	The Retina 3000 Foundation (http://www.fondazioneretina3000.it/ covered the costs for publication. Retina 3000 Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sheikh M, 2017, INVEST OPHTH VIS SCI, V58, P2063, DOI 10.1167/iovs.16-21289; Baierlein R., 1999, THERMAL PHYS, VXIII; Bansal R, 2017, MAGN RESON IMAGING, V35, P98, DOI 10.1016/j.mri.2016.08.002; BESAG J, 1975, J ROY STAT SOC D-STA, V24, P179, DOI 10.2307/2987782; Chan SY, 2016, RETINA-J RET VIT DIS, V36, P2051, DOI 10.1097/IAE.0000000000001064; Chen FK, 2016, CLIN EXP OPHTHALMOL, V44, P388, DOI 10.1111/ceo.12683; Choi W, 2015, OPHTHALMOLOGY, V122, P2532, DOI 10.1016/j.ophtha.2015.08.029; Cole ED, 2016, INVESTIGATIVE OPHTHA, V57; Ferrara D, 2016, PROG RETIN EYE RES, V52, P130, DOI 10.1016/j.preteyeres.2015.10.002; Gorczynska I, 2016, BIOMED OPT EXPRESS, V7, P911, DOI 10.1364/BOE.7.000911; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Huang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125477; Jia YL, 2015, P NATL ACAD SCI USA, V112, pE2395, DOI 10.1073/pnas.1500185112; Kim DY, 2013, P NATL ACAD SCI USA, V110, P14354, DOI 10.1073/pnas.1307315110; Montesano G, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00077; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Odstrcilik J, 2014, COMPUT MED IMAG GRAP, V38, P508, DOI 10.1016/j.compmedimag.2014.05.005; Parisot S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144200; Rodriguez DA, 2016, INVEST OPHTH VIS SCI, V57, P6474, DOI 10.1167/iovs.16-20138; Santos M, 2015, IEEE ENG MED BIO, P8147, DOI 10.1109/EMBC.2015.7320285; Siden P, 2017, NEUROIMAGE, V146, P211, DOI 10.1016/j.neuroimage.2016.11.040; Spaide RF, 2016, AM J OPHTHALMOL, V170, P58, DOI 10.1016/j.ajo.2016.07.023; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2163, DOI 10.1097/IAE.0000000000000765; Vincent T, 2010, IEEE T MED IMAGING, V29, P1059, DOI 10.1109/TMI.2010.2042064; Wang Q, 2016, AM J OPHTHALMOLOGY; Zhang M, 2016, BIOMED OPT EXPRESS, V7, P816, DOI 10.1364/BOE.7.000816	26	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185256	10.1371/journal.pone.0185256	http://dx.doi.org/10.1371/journal.pone.0185256			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020026	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000412754400023
J	Arthurs, C; Murtaza, BN; Thomson, C; Dickens, K; Henrique, R; Patel, HRH; Beltran, M; Millar, M; Thrasivoulou, C; Ahmed, A				Arthurs, Callum; Murtaza, Bibi Nazia; Thomson, Calum; Dickens, Kerry; Henrique, Rui; Patel, Hitendra R. H.; Beltran, Mariana; Millar, Michael; Thrasivoulou, Christopher; Ahmed, Aamir			Expression of ribosomal proteins in normal and cancerous human prostate tissue	PLOS ONE			English	Article							DIAMOND-BLACKFAN ANEMIA; DIFFERENTIAL EXPRESSION; MESSENGER-RNAS; OVEREXPRESS	Few quantifiable tissue biomarkers for the diagnosis and prognosis of prostate cancer exist. Using an unbiased, quantitative approach, this study evaluates the potential of three proteins of the 40S ribosomal protein complex as putative biomarkers of malignancy in prostate cancer. Prostate tissue arrays, constructed from 82 patient samples (245 tissue cores, stage pT3a or pT3b), were stained for antibodies against three ribosomal proteins, RPS19, RPS21 and RPS24. Semi-automated Ox-DAB signal quantification using ImageJ software revealed a significant change in expression of RPS19, RPS21 and RPS24 in malignant vs non-malignant tissue (p < 0.0001). Receiver operating characteristics curves were calculated to evaluate the potential of each protein as a biomarker of malignancy in prostate cancer. Positive likelihood ratios for RPS19, RPS21 and RPS24 were calculated as 2.99, 4.21, and 2.56 respectively, indicating that the overexpression of the protein is correlated with the presence of disease. Triple-labelled, quantitative, immunofluorescence (with RPS19, RPS21 and RPS24) showed significant changes (p < 0.01) in the global intersection coefficient, a measure of how often two fluorophore signals intersect, for RPS19 and RPS24 only. No change was observed in the co-localization of any other permutations of the three proteins. Our results show that RPS19, RPS21 or RPS24 are upregulated in malignant tissue and may serve as putative biomarkers for prostate cancer.	[Arthurs, Callum; Murtaza, Bibi Nazia; Dickens, Kerry; Ahmed, Aamir] Kings Coll London, Prostate Canc Res Ctr, Ctr Stem Cells & Regenerat Med, London, England; [Murtaza, Bibi Nazia; Ahmed, Aamir] UCL, Div Surg, London, England; [Thomson, Calum] Univ Dundee, Dundee Imaging Facil, Coll Life Sci, Dundee, Scotland; [Henrique, Rui] Portuguese Oncol Inst, Dept Pathol, Oporto, Portugal; [Henrique, Rui] Univ Porto, Dept Pathol & Mol Immunol, Abel Salazar Inst Biomed Sci, Oporto, Portugal; [Patel, Hitendra R. H.] Univ Hosp Northern Norway, Div Surg Oncol Urol & Womens Hlth, Tromso, Norway; [Patel, Hitendra R. H.] Princess Alexandra Hosp NHS Trust, Dept Urol, Harlow, Essex, England; [Beltran, Mariana] Aquila Biomed, Edinburgh, Midlothian, Scotland; [Millar, Michael] Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Thrasivoulou, Christopher] UCL, Res Dept Cell & Dev Biol, Ctr Cell & Mol Dynam, Rockefeller Bldg, London, England	University of London; King's College London; University College London; University of London; University College London; University of Dundee; Portuguese Institute of Oncology; Universidade do Porto; UiT The Arctic University of Tromso; University Hospital of North Norway; Princess Alexandra Hospital NHS Trust; University of Edinburgh; University of London; University College London	Ahmed, A (corresponding author), Kings Coll London, Prostate Canc Res Ctr, Ctr Stem Cells & Regenerat Med, London, England.; Ahmed, A (corresponding author), UCL, Div Surg, London, England.	aamir.ahmed@kcl.ac.uk	Henrique, Rui Manuel Ferreira/I-2757-2013; Thrasivoulou, Christopher/F-7087-2010	Henrique, Rui Manuel Ferreira/0000-0003-3171-4666; Thrasivoulou, Christopher/0000-0001-9425-8624; Ahmed, Aamir/0000-0001-7405-5336	Prostate Cancer Research Centre charity [1156027, AA1]; King's College London; Aquila Biomedical	Prostate Cancer Research Centre charity; King's College London(General Electric); Aquila Biomedical	This research was funded by the Prostate Cancer Research Centre charity (registered UK charity no. 1156027), Grant Number AA1. Open access for this article was funded by King's College London. Aquila Biomedical provided support in the form of salaries for author (MB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arya M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124395; BARNARD GF, 1993, CANCER RES, V53, P4048; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bortoluzzi S, 2001, BIOINFORMATICS, V17, P1152, DOI 10.1093/bioinformatics/17.12.1152; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; CHESTER KA, 1989, BIOCHIM BIOPHYS ACTA, V1009, P297, DOI 10.1016/0167-4781(89)90119-X; FernandezPol JA, 1997, ANTICANCER RES, V17, P1519; Giuliano A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161103; HALPERIN DS, 1989, AM J PEDIAT HEMATOL, V11, P380; HENRY JL, 1993, CANCER RES, V53, P1403; KONDOH N, 1992, CANCER RES, V52, P791; Lai MD, 2007, CURR GENOMICS, V8, P43; Leger-Silvestre I, 2005, J BIOL CHEM, V280, P38177, DOI 10.1074/jbc.M506916200; Lopez CD, 2002, CANCER LETT, V180, P195, DOI 10.1016/S0304-3835(02)00024-1; Nariculam J, 2009, ASIAN J ANDROL, V11, P109, DOI 10.1038/aja.2008.22; Presti JC, 2009, UROL ONCOL-SEMIN ORI, V27, P312, DOI 10.1016/j.urolonc.2008.10.029; Rasband W.S., 1997, IMAGEJ; Roehl KA, 2002, J UROLOGY, V167, P2435, DOI 10.1016/S0022-5347(05)64999-3; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Symes AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084295; Vaarala MH, 1998, INT J CANCER, V78, P27, DOI 10.1002/(SICI)1097-0215(19980925)78:1<27::AID-IJC6>3.3.CO;2-A; Wang M, 2017, BIORXIV; Wang Q, 2001, GENE, V263, P205, DOI 10.1016/S0378-1119(00)00570-9; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; Wang Y, 2015, GENE, V571, P286, DOI 10.1016/j.gene.2015.06.084; Yong WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141334; Zhou X, 2015, J MOL CELL BIOL, V7, P92, DOI 10.1093/jmcb/mjv014	28	38	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186047	10.1371/journal.pone.0186047	http://dx.doi.org/10.1371/journal.pone.0186047			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016636	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400050
J	de Jong, RCM; Ewing, MM; de Vries, MR; Karper, JC; Bastiaansen, AJNM; Peters, HAB; Baghana, F; van den Elsen, PJ; Gongora, C; Jukema, JW; Quax, PHA				de Jong, Rob C. M.; Ewing, Mark M.; de Vries, Margreet R.; Karper, Jacco C.; Bastiaansen, Antonius J. N. M.; Peters, Hendrika A. B.; Baghana, Fabiana; van den Elsen, Peter J.; Gongora, Celine; Jukema, J. Wouter; Quax, Paul H. A.			The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development	PLOS ONE			English	Article							FACTOR-KAPPA-B; PERCUTANEOUS CORONARY INTERVENTIONS; ACCELERATED ATHEROSCLEROSIS; ACETYLTRANSFERASE PCAF; HISTONE ACETYLATION; GENETIC-VARIATION; IN-VIVO; DISEASE; INJURY; RESTENOSIS	Objective Genetic P300/CBP-associated factor (PCAF) variation affects restenosis-risk in patients. PCAF has lysine acetyltransferase activity and promotes nuclear factor kappa-beta (NF kappa B)mediated inflammation, which drives post-interventional intimal hyperplasia development. We studied the contributing role of PCAF in post-interventional intimal hyperplasia. Methods and results PCAF contribution to inflammation and intimal hyperplasia was assessed in leukocytes, macrophages and vascular smooth muscle cells (vSMCs) in vitro and in a mouse model for intimal hyperplasia, in which a cuff is placed around the femoral artery. PCAF deficiency downregulate CCL2, IL-6 and TNF-alpha expression, as demonstrated on cultured vSMCs, leukocytes and macrophages. PCAF KO mice showed a 71.8% reduction of vSMC-rich intimal hyperplasia, a 73.4% reduction of intima/media ratio and a 63.7% reduction of luminal stenosis after femoral artery cuff placement compared to wild type (WT) mice. The association of PCAF and vascular inflammation was further investigated using the potent natural PCAF inhibitor garcinol. Garcinol treatment reduced CCL2 and TNF-alpha expression, as demonstrated on cultured vSMCs and leukocytes. To assess the effect of garcinol treatment on vascular inflammation we used hypercholesterolemic ApoE*3-Leiden mice. After cuff placement, garcinol treatment resulted in reduced arterial leukocyte and macrophage adherence and infiltration after three days compared to untreated animals. Conclusions These results identify a vital role for the lysine acetyltransferase PCAF in the regulation of local inflammation after arterial injury and likely the subsequent vSMC proliferation, responsible for intimal hyperplasia.	[de Jong, Rob C. M.; Ewing, Mark M.; de Vries, Margreet R.; Karper, Jacco C.; Bastiaansen, Antonius J. N. M.; Peters, Hendrika A. B.; Baghana, Fabiana; Quax, Paul H. A.] LUMC, Dept Surg, Leiden, Netherlands; [de Jong, Rob C. M.; de Vries, Margreet R.; Karper, Jacco C.; Bastiaansen, Antonius J. N. M.; Peters, Hendrika A. B.; Baghana, Fabiana; Jukema, J. Wouter; Quax, Paul H. A.] LUMC, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Ewing, Mark M.; Jukema, J. Wouter] LUMC, Dept Cardiol, Leiden, Netherlands; [van den Elsen, Peter J.] LUMC, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [van den Elsen, Peter J.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Gongora, Celine] Univ Montpellier 2, Montpellier, France; [Gongora, Celine] Inst Rech Cancerol Montpellier, INSERM, U89, Montpellier, France	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Vrije Universiteit Amsterdam; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Quax, PHA (corresponding author), LUMC, Dept Surg, Leiden, Netherlands.; Quax, PHA (corresponding author), LUMC, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.	P.H.A.Quax@lumc.nl	de Vries, Margreet/Z-5653-2019; Jukema, J. Wouter/ABD-6503-2021; Quax, Paul/ABD-5294-2020; Quax, Paul/W-8520-2019	Jukema, J. Wouter/0000-0002-3246-8359; Quax, Paul/0000-0002-6853-5760; GONGORA, Celine/0000-0001-9034-4031	Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation [CVON2011-19]; Netherlands CardioVascular Research Initiative: Dutch Federation of University Medical Centres [CVON2011-19]; Netherlands CardioVascular Research Initiative: Netherlands Organisation for Health Research and Development [CVON2011-19]; Netherlands CardioVascular Research Initiative: Royal Netherlands Academy of Sciences [CVON2011-19]	Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation; Netherlands CardioVascular Research Initiative: Dutch Federation of University Medical Centres; Netherlands CardioVascular Research Initiative: Netherlands Organisation for Health Research and Development; Netherlands CardioVascular Research Initiative: Royal Netherlands Academy of Sciences	This work was supported by the Netherlands CardioVascular Research Initiative: "the Dutch Heart Foundation, Dutch Federation of University Medical Centres, the Netherlands Organisation for Health Research and Development and the Royal Netherlands Academy of Sciences" for the GENIUS project "Generating the best evidence-based pharmaceutical targets for atherosclerosis" (CVON2011-19).	Ahmad Aamir, 2011, Front Biosci (Elite Ed), V3, P1483; Arif M, 2009, J MED CHEM, V52, P267, DOI 10.1021/jm800657z; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bastiaansen AJNM, 2013, ARTERIOSCL THROM VAS, V33, P1902, DOI 10.1161/ATVBAHA.113.301579; Chen X, 2012, NUTR CANCER, V64, P1211, DOI 10.1080/01635581.2012.718032; de Vries MR, 2013, J MOL CELL CARDIOL, V64, P51, DOI 10.1016/j.yjmcc.2013.08.009; Duclot F, 2010, NEUROSCIENCE, V167, P850, DOI 10.1016/j.neuroscience.2010.02.055; Duclot F, 2010, NEUROSCI LETT, V475, P179, DOI 10.1016/j.neulet.2010.03.077; Egashira K, 2002, CIRC RES, V90, P1167, DOI 10.1161/01.RES.0000020561.03244.7E; Ewing MM, 2013, INT J CARDIOL, V168, P1965, DOI 10.1016/j.ijcard.2012.12.085; Han YS, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0169-6; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Huang J, 2015, EPIGENETICS-US, V10, P62, DOI 10.4161/15592294.2014.990780; Kim WJH, 2003, BIOCHEM BIOPH RES CO, V310, P936, DOI 10.1016/j.bbrc.2003.09.088; Lardenoye JHP, 2000, CIRC RES, V87, P248, DOI 10.1161/01.RES.87.3.248; Lee MS, 2004, J PATHOL, V203, P861, DOI 10.1002/path.1598; Liu CQ, 2015, CANCER LETT, V362, P8, DOI 10.1016/j.canlet.2015.03.019; Matsumoto K, 2003, BIOL PHARM BULL, V26, P569, DOI 10.1248/bpb.26.569; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; Monraats PS, 2005, FASEB J, V19, P1998, DOI 10.1096/fj.05-4634com; Monraats PS, 2005, CIRCULATION, V112, P2417, DOI 10.1161/CIRCULATIONAHA.105.536268; Niida T, 2012, CARDIOVASC RES, V93, P371, DOI 10.1093/cvr/cvr323; Pearson T, 2015, WORKPLACE HEALTH SAF, V63, P376, DOI 10.1177/2165079915593032; Pires NMM, 2006, VASC PHARMACOL, V44, P257, DOI 10.1016/j.vph.2006.01.011; Pons D, 2007, THROMB HAEMOSTASIS, V98, P1323, DOI 10.1160/TH07-04-0301; Pons D, 2011, HEART, V97, P143, DOI 10.1136/hrt.2010.199927; Pons D, 2009, EUR HEART J, V30, P266, DOI 10.1093/eurheartj/ehn603; Schepers A, 2006, ARTERIOSCL THROM VAS, V26, P2063, DOI 10.1161/01.ATV.0000235694.69719.e2; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Shirai T, 2015, AUTOIMMUNITY, V48, P139, DOI 10.3109/08916934.2015.1027815; Shoji M, 2014, J ATHEROSCLER THROMB, V21, P304, DOI 10.5551/jat.19414; Simon DI, 2012, CIRC J, V76, P1811, DOI 10.1253/circj.CJ-12-0801; Simsekyilmaz S, 2015, THROMB HAEMOSTASIS, V113, P464, DOI 10.1160/TH14-07-0599; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yoshida K, 2005, CANCER LETT, V221, P29, DOI 10.1016/j.canlet.2004.08.016; Zimmerman MA, 2002, AM J PHYSIOL-REG I, V283, pR505, DOI 10.1152/ajpregu.00033.2002	41	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185820	10.1371/journal.pone.0185820	http://dx.doi.org/10.1371/journal.pone.0185820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016683	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400031
J	Ellmore, TM; Ng, K; Reichert, CP				Ellmore, Timothy M.; Ng, Kenneth; Reichert, Chelsea P.			Early and late components of EEG delay activity correlate differently with scene working memory performance	PLOS ONE			English	Article							ALPHA-ACTIVITY; BRAIN OSCILLATIONS; GAMMA-ACTIVITY; SHORT-TERM; THETA; DESYNCHRONIZATION; SYNCHRONIZATION; MAINTENANCE; DYNAMICS; CORTEX	Sustained and elevated activity during the working memory delay period has long been considered the primary neural correlate for maintaining information over short time intervals. This idea has recently been reinterpreted in light of findings generated from multiple neural recording modalities and levels of analysis. To further investigate the sustained or transient nature of activity, the temporal-spectral evolution (TSE) of delay period activity was examined in humans with high density EEG during performance of a Sternberg working memory paradigm with a relatively long six second delay and with novel scenes as stimuli. Multiple analyses were conducted using different trial window durations and different baseline periods for TSE computation. Sensor level analyses revealed transient rather than sustained activity during delay periods. Specifically, the consistent finding among the analyses was that high amplitude activity encompassing the theta range was found early in the first three seconds of the delay period. These increases in activity early in the delay period correlated positively with subsequent ability to distinguish new from old probe scenes. Source level signal estimation implicated a right parietal region of transient early delay activity that correlated positively with working memory ability. This pattern of results adds to recent evidence that transient rather than sustained delay period activity supports visual working memory performance. The findings are discussed in relation to synchronous and desynchronous intra-and inter-regional neural transmission, and choosing an optimal baseline for expressing temporal-spectral delay activity change.	[Ellmore, Timothy M.; Ng, Kenneth; Reichert, Chelsea P.] CUNY City Coll, Dept Psychol, New York, NY 10031 USA; [Ellmore, Timothy M.; Reichert, Chelsea P.] CUNY, Grad Ctr, Program Behav & Cognit Neurosci, New York, NY 10016 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Ellmore, TM (corresponding author), CUNY City Coll, Dept Psychol, New York, NY 10031 USA.; Ellmore, TM (corresponding author), CUNY, Grad Ctr, Program Behav & Cognit Neurosci, New York, NY 10016 USA.	tellmore@ccny.cany.edu	Ellmore, Timothy M./I-3760-2019	Ellmore, Timothy M./0000-0001-6125-0044; Reichert, Chelsea/0000-0001-9662-6179	PSC-CUNY [TRAD-45-104]; National Institute of General Medical Sciences of the National Institutes of Health [SC2GM109346]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM109346] Funding Source: NIH RePORTER	PSC-CUNY; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by PSC-CUNY award TRAD-45-104 (to TME). Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number SC2GM109346 (to TME). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bashivan P, 2014, EUR J NEUROSCI, V40, P3774, DOI 10.1111/ejn.12749; Berger Barbara, 2015, Biology-Basel, V4, P1, DOI 10.3390/biology4010001; Brain Products, 2016, PROD APPL; Burke JF, 2013, J NEUROSCI, V33, P292, DOI 10.1523/JNEUROSCI.2057-12.2013; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; DASILVA FHL, 1999, EVENT RELATED DESYNC, V6; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fellner MC, 2013, NEUROIMAGE, V79, P361, DOI 10.1016/j.neuroimage.2013.04.121; Fukuda K, 2010, CURR OPIN NEUROBIOL, V20, P177, DOI 10.1016/j.conb.2010.03.005; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gevins A, 1996, ELECTROEN CLIN NEURO, V98, P327, DOI 10.1016/0013-4694(96)00288-X; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Haegens S, 2010, HUM BRAIN MAPP, V31, P26, DOI 10.1002/hbm.20842; Hanslmayr S, 2016, TRENDS NEUROSCI, V39, P16, DOI 10.1016/j.tins.2015.11.004; Hanslmayr S, 2009, CEREB CORTEX, V19, P1631, DOI 10.1093/cercor/bhn197; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Hsieh LT, 2011, J NEUROSCI, V31, P10803, DOI 10.1523/JNEUROSCI.0828-11.2011; Hussar CR, 2013, J NEUROSCI, V33, P972, DOI 10.1523/JNEUROSCI.4075-12.2013; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Jafarpour A, 2013, NEUROPSYCHOLOGIA, V51, P772, DOI 10.1016/j.neuropsychologia.2012.04.002; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Kaiser J, 2001, NEUROSCI LETT, V312, P149, DOI 10.1016/S0304-3940(01)02217-0; Khader PH, 2010, NEUROSCI LETT, V468, P339, DOI 10.1016/j.neulet.2009.11.028; Khursheed F, 2011, NEUROIMAGE, V56, P1773, DOI 10.1016/j.neuroimage.2011.02.062; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Lisman J, 2010, CURR BIOL, V20, pR490, DOI 10.1016/j.cub.2010.04.011; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Lundqvist M, 2016, NEURON, V90, P152, DOI 10.1016/j.neuron.2016.02.028; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Maris E, 2012, PSYCHOPHYSIOLOGY, V49, P549, DOI 10.1111/j.1469-8986.2011.01320.x; Meeuwissen EB, 2011, HUM BRAIN MAPP, V32, P2045, DOI 10.1002/hbm.21167; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Offen S, 2009, VISION RES, V49, P1352, DOI 10.1016/j.visres.2007.12.022; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Papp N, 1977, Biomed Sci Instrum, V13, P135; Pfurtscheller G, 2001, VISION RES, V41, P1257, DOI 10.1016/S0042-6989(00)00235-2; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; Picton TW, 2000, CLIN NEUROPHYSIOL, V111, P53, DOI 10.1016/S1388-2457(99)00227-8; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Richards JE, 2016, NEUROIMAGE, V124, P1254, DOI 10.1016/j.neuroimage.2015.04.055; Roberts BM, 2013, NEUROPSYCHOLOGIA, V51, P349, DOI 10.1016/j.neuropsychologia.2012.10.009; Rose NS, 2016, SCIENCE, V354, P1136, DOI 10.1126/science.aah7011; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Scherg Michael, 1992, Brain Topography, V5, P103, DOI 10.1007/BF01129037; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Stokes MG, 2015, TRENDS COGN SCI, V19, P394, DOI 10.1016/j.tics.2015.05.004; Teplan M., 2002, MEASUREMENT SCI REV, V2, P1, DOI DOI 10.1021/PR070350L; Tuladhar AM, 2007, HUM BRAIN MAPP, V28, P785, DOI 10.1002/hbm.20306; Wolff MJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00123; Xiao J, 2010, CVPR 2010 IEEE C; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	64	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186072	10.1371/journal.pone.0186072	http://dx.doi.org/10.1371/journal.pone.0186072			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016657	Green Published, gold, Green Submitted			2022-12-26	WOS:000412627400054
J	Wilbers, RHP; van Raaij, DR; Westerhof, LB; Bakker, J; Smant, G; Schots, A				Wilbers, Ruud H. P.; van Raaij, Debbie R.; Westerhof, Lotte B.; Bakker, Jaap; Smant, Geert; Schots, Arjen			Re-evaluation of IL-10 signaling reveals novel insights on the contribution of the intracellular domain of the IL-10R2 chain	PLOS ONE			English	Article							INTERLEUKIN-10 RECEPTOR COMPLEX; HUMAN NEUTROPHILS; T-CELLS; EXPRESSION; MACROPHAGES; MECHANISMS; PATHWAY; BINDING; MODEL; SOCS3	Interleukin-10 (IL-10) is an anti-inflammatory cytokine that plays a key role in maintaining immune homeostasis. IL-10-mediated responses are triggered upon binding to a heterodimeric receptor complex consisting of IL-10 receptor (IL-10R) 1 and IL-10R2. Engagement of the IL-10R complex activates the intracellular kinases Jak1 and Tyk2, but the exact roles of IL-10R2 and IL-10R2-associated signaling via Tyk2 remain unclear. To elucidate the contribution of IL-10R2 and its signaling to IL-10 activity, we re-evaluated IL-10-mediated responses on bone marrow-derived dendritic cells, macrophages and mast cells. By using bone marrow from IL-10R(-/-) mice it was revealed that IL-10-mediated responses depend on both IL-10R1 and IL-10R2 in all three cell types. On the contrary, bone marrow-derived cells from Tyk2(-/-) mice showed similar responses to IL-10 as wild-type cells, indicating that signaling via this IL-10R2-associated kinase only plays a limited role. Tyk2 was shown to control the amplitude of STAT3 activation and the up-regulation of downstream SOCS3 expression. SOCS3 up-regulation was found to be cell-type dependent and correlated with the lack of early suppression of LPS-induced TNF-alpha in dendritic cells. Further investigation of the IL10R complex revealed that both the extracellular and intracellular domains of IL-10R2 influence the conformation of IL-10R1 and that both domains were required for transducing IL10 signals. This observation highlights a novel role for the intracellular domain of IL-10R2 in the molecular mechanisms of IL-10R activation.	[Wilbers, Ruud H. P.; van Raaij, Debbie R.; Westerhof, Lotte B.; Bakker, Jaap; Smant, Geert; Schots, Arjen] Wageningen Univ & Res, Plant Sci Grp, Lab Nematol, Wageningen, Netherlands	Wageningen University & Research	Wilbers, RHP (corresponding author), Wageningen Univ & Res, Plant Sci Grp, Lab Nematol, Wageningen, Netherlands.	ruud.wilbers@wur.nl	Schots, Arjen/U-1839-2017; Wilbers, Ruud/S-8796-2017; Wilbers, Ruud/O-1844-2019; Schots, Arjen/ABF-8014-2020	Schots, Arjen/0000-0002-6036-7088; Wilbers, Ruud/0000-0003-1149-9268; Wilbers, Ruud/0000-0003-1149-9268; Schots, Arjen/0000-0002-6036-7088	Synthon BV, Nijmegen, The Netherlands	Synthon BV, Nijmegen, The Netherlands	This work was partly funded by Synthon BV, Nijmegen, The Netherlands. There was no additional external funding received for this study.	Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Cassatella MA, 1999, BLOOD, V94, P2880, DOI 10.1182/blood.V94.8.2880.420k31_2880_2889; Crepaldi L, 2001, J IMMUNOL, V167, P2312, DOI 10.4049/jimmunol.167.4.2312; Ding YZ, 2001, J IMMUNOL, V167, P6884, DOI 10.4049/jimmunol.167.12.6884; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; HO ASY, 1993, P NATL ACAD SCI USA, V90, P11267, DOI 10.1073/pnas.90.23.11267; HO ASY, 1995, MOL CELL BIOL, V15, P5043; Josephson K, 2000, J BIOL CHEM, V275, P25054; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; Krause CD, 2006, BIOCHEM BIOPH RES CO, V340, P377, DOI 10.1016/j.bbrc.2005.11.182; Krause CD, 2002, MOL CELL PROTEOMICS, V1, P805, DOI 10.1074/mcp.M200065-MCP200; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Masters JR, 2007, NAT PROTOC, V2, P2276, DOI 10.1038/nprot.2007.319; MUI ALF, 1995, J LEUKOCYTE BIOL, V57, P799, DOI 10.1002/jlb.57.5.799; Pang XD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002427; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pils MC, 2010, EUR J IMMUNOL, V40, P443, DOI 10.1002/eji.200939592; Qasimi P, 2006, J BIOL CHEM, V281, P6316, DOI 10.1074/jbc.M508608200; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; Shaw MH, 2006, J IMMUNOL, V176, P7263, DOI 10.4049/jimmunol.176.12.7263; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; TAN JC, 1995, J BIOL CHEM, V270, P12906, DOI 10.1074/jbc.270.21.12906; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; Vogl C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-199; Westerhof LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046460; Wilbers RHP, 2016, PLANT BIOTECHNOL J, V14, P670, DOI 10.1111/pbi.12414; Yoon SI, 2006, J BIOL CHEM, V281, P35088, DOI 10.1074/jbc.M606791200; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089	35	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186317	10.1371/journal.pone.0186317	http://dx.doi.org/10.1371/journal.pone.0186317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016674	Green Submitted, gold, Green Published			2022-12-26	WOS:000412627400066
J	Paraschiv, S; Banica, L; Nicolae, I; Niculescu, I; Abagiu, A; Jipa, R; Pineda-Pena, AC; Pingarilho, M; Neaga, E; Theys, K; Libin, P; Otelea, D; Abecasis, A				Paraschiv, Simona; Banica, Leontina; Nicolae, Ionelia; Niculescu, Iulia; Abagiu, Adrian; Jipa, Raluca; Pineda-Pena, Andrea-Clemencia; Pingarilho, Marta; Neaga, Emil; Theys, Kristof; Libin, Pieter; Otelea, Dan; Abecasis, Ana			Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users	PLOS ONE			English	Article							HEPATITIS-C; MOLECULAR EPIDEMIOLOGY; VIRUS-INFECTION; HIGH PREVALENCE; SUBTYPE F1; PEOPLE; SEQUENCES; GENOTYPES; SPREAD; RISK	Co-infections with HIV and HCV are very frequent among people who inject drugs (PWID). However, very few studies comparatively reconstructed the transmission patterns of both viruses in the same population. We have recruited 117 co-infected PWID during a recent HIV outbreak in Romania. Phylogenetic analyses were performed on HIV and HCV sequences in order to characterize and compare transmission dynamics of the two viruses. Three large HIV clusters (2 subtype F1 and one CRF14_BG) and thirteen smaller HCV transmission networks (genotypes 1a, 1b, 3a, 4a and 4d) were identified. Eighty (65%) patients were both in HIV and HCV transmission chains and 70 of those shared the same HIV and HCV cluster with at least one other patient. Molecular clock analysis indicated that all identified HIV clusters originated around 2006, while the origin of the different HCV clusters ranged between 1980 (genotype 1b) and 2011 (genotypes 3a and 4d). HCV infection preceded HIV infection in 80.3% of cases. Coincidental transmission of HIV and HCV was estimated to be rather low (19.65%) and associated with an outbreak among PWID during detention in the same penitentiary. This study has reconstructed and compared the dispersion of these two viruses in a PWID population.	[Paraschiv, Simona; Banica, Leontina; Nicolae, Ionelia; Neaga, Emil; Otelea, Dan] Natl Inst Infect Dis Matei Bals, Mol Diagnost Lab, Bucharest, Romania; [Niculescu, Iulia; Abagiu, Adrian; Jipa, Raluca] Natl Inst Infect Dis Matei Bals, Clin Dept, Bucharest, Romania; [Niculescu, Iulia] SMZ Sud Kaiser Franz Josef Spital, 4 Med Abt, Vienna, Austria; [Pineda-Pena, Andrea-Clemencia; Pingarilho, Marta; Abecasis, Ana] Univ Nova Lisboa, Inst Higiene & Med Trop, Global Hlth & Trop Med, Lisbon, Portugal; [Pineda-Pena, Andrea-Clemencia] Univ Rosario, Mol Biol & Immunol Dept, Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia; [Pineda-Pena, Andrea-Clemencia] Univ Rosario, Basic Sci Dept, Bogota, Colombia; [Theys, Kristof; Libin, Pieter; Abecasis, Ana] Katholieke Univ Leuven, Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium; [Libin, Pieter] Vrije Univ Brussel, Dept Comp Sci, Artificial Intelligence Iab, Brussels, Belgium	National Institute for Infectious Diseases "Matei Bals"; National Institute for Infectious Diseases "Matei Bals"; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidad del Rosario; Universidad del Rosario; KU Leuven; Vrije Universiteit Brussel	Paraschiv, S (corresponding author), Natl Inst Infect Dis Matei Bals, Mol Diagnost Lab, Bucharest, Romania.	mona_manaila@yahoo.com	Otelea, Dan/AAV-6467-2021; Jipa, Raluca/P-2044-2017; Paraschiv, Simona/AAW-5691-2021; Abecasis, Ana/ABF-6657-2020; Abecasis, Ana/B-6295-2009; Pineda-Peña, Andrea-Clemencia/N-9809-2015; Paraschiv, Simona/N-6991-2015	Abecasis, Ana/0000-0002-3903-5265; Abecasis, Ana/0000-0002-3903-5265; Pineda-Peña, Andrea-Clemencia/0000-0003-1937-0506; Pereira Pingarilho, Marta Sofia/0000-0002-7928-3087; Otelea, Dan/0000-0002-0821-6346; Banica, Leontina/0000-0001-9956-951X; Libin, Pieter/0000-0003-3906-758X; Paraschiv, Simona/0000-0001-6707-3720	Executive Agency for Higher Education, Research, Development and Innovation Funding [BEST-HOPE 4-003/2012, HIV-ID 260/2015]; National Authority for Scientific Research; GreenVac project [5SEE/2014]; POSCCE program CRCBABI project [642/2014]; ational Authority for Scientific Research(ANCS) [POSDRU/1591/1.5/S/135760-CERO]; Fonds Wetenschappelijk Onderzoek Vlaanderen	Executive Agency for Higher Education, Research, Development and Innovation Funding; National Authority for Scientific Research; GreenVac project; POSCCE program CRCBABI project; ational Authority for Scientific Research(ANCS); Fonds Wetenschappelijk Onderzoek Vlaanderen(FWO)	This study was supported by the Executive Agency for Higher Education, Research, Development and Innovation Funding (http:// uefiscdi.gov.ro/) grant BEST-HOPE 4-003/2012 (DO) and project HIV-ID 260/2015 (SP). The National Authority for Scientific Research (http:// research.ro/en) partially supported this work, GreenVac project, 5SEE/2014 (DO) and POSCCE program CRCBABI project (642/2014). EN was supported by National Authority for Scientific Research(ANCS), grant POSDRU/1591/1.5/S/135760-CERO. PL was supported by PhD grant of the Fonds Wetenschappelijk Onderzoek Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abagiu A, 2012, UPDATE COUNTRY SITUA, V11; [Anonymous], 2013, UNAIDS 2013 GLOB REP, P30; [Anonymous], 2014, ROMANIAN HIV AIDS NA, P20; Audelin AM, 2013, JAIDS-J ACQ IMM DEF, V62, P102, DOI 10.1097/QAI.0b013e318276becc; Bartolo I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024130; Bello G, 2012, INFECT GENET EVOL, V12, P1079, DOI 10.1016/j.meegid.2012.03.014; Botescu A, 2012, HIV AIDS INJECTING D, P5; Butler IF, 2007, CURR HIV RES, V5, P23, DOI 10.2174/157016207779316297; Chen JY, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.17; Ciccozzi M, 2012, J MED VIROL, V84, P1613, DOI 10.1002/jmv.23384; de Bruijne J, 2009, J CLIN MICROBIOL, V47, P3832, DOI 10.1128/JCM.01146-09; de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Fernandez-Arcas N, 2006, J MED VIROL, V78, P1429, DOI 10.1002/jmv.20706; Gheorghe L, 2010, J GASTROINTEST LIVER, V19, P373; Grigorescu M, 2009, J GASTROINTEST LIVER, V18, P45; Guide for HIV/ AIDS clinical care, 2014, GUIDE HIV AIDS CLIN; Guimaraes ML, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-39; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Katsoulidou A, 2006, J VIRAL HEPATITIS, V13, P19, DOI 10.1111/j.1365-2893.2005.00649.x; Lin WY, 2013, J INFECT DIS, V207, pS13, DOI 10.1093/infdis/jis926; Maher L, 2007, AUST NZ J PUBL HEAL, V31, P30, DOI 10.1111/j.1753-6405.2007.00007.x; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Matthews GV, 2011, CLIN INFECT DIS, V52, P803, DOI 10.1093/cid/ciq200; Ng KT, 2015, SCI REP-UK, V5, DOI 10.1038/srep15198; Niculescu I, 2015, AIDS RES HUM RETROV, V31, P488, DOI 10.1089/aid.2014.0189; Paraskevis D, 2015, INFECT GENET EVOL, V35, P109, DOI 10.1016/j.meegid.2015.08.004; Perez-Alvarez L, 2014, J ANTIMICROB CHEMOTH, V69, P246, DOI 10.1093/jac/dkt305; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rambaut A., 2016, VIRUS EVOL, V2; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sandres-Saune K, 2003, J VIROL METHODS, V109, P187, DOI 10.1016/S0166-0934(03)00070-3; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Stockman JK, 2010, JAIDS-J ACQ IMM DEF, V55, pS17, DOI 10.1097/QAI.0b013e3181f9c04c; Sultana C, 2011, CENT EUR J MED, V6, P672, DOI 10.2478/s11536-011-0073-6; United Nations Office of Drug Control, 2015, WORLD DRUG REP; Uuskula A, 2007, INT J STD AIDS, V18, P41, DOI 10.1258/095646207779949907; Vallet S, 2011, ANTIVIR THER, V16, P1093, DOI 10.3851/IMP1900; van Asten L, 2004, J INFECT DIS, V189, P292, DOI 10.1086/380821; Walsh N, 2012, CURR OPIN HIV AIDS, V7, P339, DOI 10.1097/COH.0b013e328354131e; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	48	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185866	10.1371/journal.pone.0185866	http://dx.doi.org/10.1371/journal.pone.0185866			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016621	Green Published, gold			2022-12-26	WOS:000412601800024
J	Hsieh, HY; Jou, YC; Tung, CL; Tsai, YS; Wang, YH; Chi, CL; Lin, RI; Hung, SK; Chuang, YM; Wu, SF; Li, C; Shen, CH; Chan, MWY; Hsu, CD				Hsieh, H-Y; Jou, Y-C; Tung, C-L; Tsai, Y-S; Wang, Y-H; Chi, C-L; Lin, R-I; Hung, S-K; Chuang, Y-M; Wu, S-F; Li, C.; Shen, C-H; Chan, M. W. Y.; Hsu, C-D			Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment	ONCOGENE			English	Article							ANGIOPOIETIN-LIKE 4; PROMOTES VENOUS INVASION; LARGE GENE LISTS; BLADDER-CANCER; VASCULAR-PERMEABILITY; KAPOSIS-SARCOMA; ANGIOGENESIS; EXPRESSION; PROTEIN; METASTASIS	Urothelial carcinoma (UC) carcinogenesis has been hypothesized to occur through epigenetic repression of tumor-suppressor genes (TSGs). By quantitative real-time polymerase chain reaction array, we found that one potential TSG, angiopoietin-like 4 (ANGPTL4), was expressed at very low levels in all bladder cancer cell lines we examined. Previous studies had demonstrated that ANGPTL4 is highly expressed in some cancers, but downregulated, by DNA methylation, in others. Consequently, owing to these seemingly conflicting functions in distinct cancers, the precise role of ANGPTL4 in the etiology of UC remains unclear. In this study, using methylation-specific PCR and bisulfite pyrosequencing, we show that ANGPTL4 is transcriptionally repressed by DNA methylation in UC cell lines and primary tumor samples, as compared with adjacent noncancerous bladder epithelium. Functional studies further demonstrated that ectopic expression of ANGPTL4 potently suppressed UC cell proliferation, monolayer colony formation in vitro, and invasion, migration, and xenograft formation in vivo. Surprisingly, circulating ANGPTL4 was significantly higher in plasma samples from UC patients than normal control, suggesting it might be secreted from other cell types. Interestingly, our data also indicated that exogenous cANGPTL4 could promote cell proliferation and cell migration via activation of signaling through the Erk/focal adhesion kinase axis. We further confirmed that mouse xenograft tumor growth could be promoted by administration of exogenous cANGPTL4. Finally, immunohistochemistry demonstrated that ANGPTL4 was downregulated in tumor cells but overexpressed in tumor adjacent stromal tissues of muscle-invasive UC tissue samples. In conclusion, our data support dual roles for ANGPTL4 in UC progression, either as a tumor suppressor or oncogene, in response to microenvironmental context.	[Hsieh, H-Y; Hsu, C-D] Ditmanson Med Fountain Chiayi Christian Hosp, Dept Med Res, Chiayi, Taiwan; [Hsieh, H-Y; Jou, Y-C; Shen, C-H; Hsu, C-D] Ditmanson Med Fdn Chiayi Christian Hosp, Dept Urol, 539 Zhongxiao Rd, Chiayi 600, Taiwan; [Hsieh, H-Y; Chuang, Y-M; Wu, S-F; Li, C.; Chan, M. W. Y.; Hsu, C-D] Natl Chung Cheng Univ, Dept Life Sci, 168 Univ Rd, Chiayi 62102, Taiwan; [Hsieh, H-Y] Natl Museum Nat Sci, Dept Biol, Taichung, Taiwan; [Tung, C-L] Ditmanson Med Fdn Chiayi Christian Hosp, Dept Pathol, Chiayi, Taiwan; [Tsai, Y-S] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Urol, Coll Med, Tainan, Taiwan; [Wang, Y-H] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Wang, Y-H] Taipei Med Univ, Shuang Ho Hosp, Div Gen Surg, Dept Urol, New Taipei, Taiwan; [Chi, C-L] Buddhist Dalin Tzu Chi Gen Hosp, Dept Pathol, Chiayi, Taiwan; [Lin, R-I; Hung, S-K] Buddhist Dalin Tzu Chi Gen Hosp, Dept Radiat Oncol, Chiayi, Taiwan; [Hung, S-K] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chuang, Y-M; Wu, S-F; Li, C.; Chan, M. W. Y.] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi, Taiwan	Chia-Yi Christian Hospital; National Chung Cheng University; Chia-Yi Christian Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; National Chung Cheng University	Hsu, CD (corresponding author), Ditmanson Med Fdn Chiayi Christian Hosp, Dept Urol, 539 Zhongxiao Rd, Chiayi 600, Taiwan.; Chan, MWY (corresponding author), Natl Chung Cheng Univ, Dept Life Sci, 168 Univ Rd, Chiayi 62102, Taiwan.	biowyc@ccu.edu.tw; cdh199712@gmail.com	Chuang, Yu-Ming/AAE-4901-2021; Chan, Michael/F-9615-2018	Chan, Michael/0000-0003-1431-322X; Chan, Michael/0000-0003-0314-2437; Hung, Shih-Kai/0000-0002-4945-528X	Ditmanson Medical Foundation Chiayi Christian Hospital, Taiwan [R101-9]; Ministry of Science and Technology, Taiwan [MOST 104-2314-B-194-001-MY3]	Ditmanson Medical Foundation Chiayi Christian Hospital, Taiwan; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Ditmanson Medical Foundation Chiayi Christian Hospital, Taiwan (grant no. R101-9) and the Ministry of Science and Technology, Taiwan (MOST 104-2314-B-194-001-MY3). The authors would like to thank Dr Curt Balch for English editing.	Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chiodoni C, 2010, CANCER METAST REV, V29, P295, DOI 10.1007/s10555-010-9221-8; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Chong HC, 2012, J ONCOL, V2012, DOI 10.1155/2012/351089; Clement LC, 2014, NAT MED, V20, P37, DOI 10.1038/nm.3396; Costa VL, 2010, EPIGENETICS-US, V5, P343, DOI 10.4161/epi.5.4.11749; Feng S, 2010, ENDOCR-RELAT CANCER, V17, P1021, DOI 10.1677/ERC-10-0073; Foreman JE, 2010, CANCER LETT, V288, P219, DOI 10.1016/j.canlet.2009.07.006; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Girroir EE, 2008, TOXICOLOGY, V243, P236, DOI 10.1016/j.tox.2007.10.023; Goh YY, 2010, AM J PATHOL, V177, P2791, DOI 10.2353/ajpath.2010.100129; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hattori N, 2011, CANCER SCI, V102, P1337, DOI 10.1111/j.1349-7006.2011.01955.x; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsieh HY, 2016, CANCER LETT, V370, P56, DOI 10.1016/j.canlet.2015.09.018; Hu J, 2011, ORAL ONCOL, V47, P371, DOI 10.1016/j.oraloncology.2011.02.018; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang RL, 2011, BLOOD, V118, P3990, DOI 10.1182/blood-2011-01-328716; Ito Y, 2003, CANCER RES, V63, P6651; Kakizoe T, 2006, CANCER SCI, V97, P821, DOI 10.1111/j.1349-7006.2006.00264.x; Kaneda A, 2002, CANCER RES, V62, P6645; Kastritis E, 2009, INT J CANCER, V124, P103, DOI 10.1002/ijc.23917; Katoh Y, 2006, INT J MOL MED, V17, P1145; Kersten S, 2005, BIOCHEM SOC T, V33, P1059, DOI 10.1042/BST0331059; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Kim SH, 2011, CANCER RES, V71, P7010, DOI 10.1158/0008-5472.CAN-11-1262; Kim WJ, 2008, CANCER SCI, V99, P646, DOI 10.1111/j.1349-7006.2008.00735.x; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lin HY, 2015, ONCOTARGET, V6, P915, DOI 10.18632/oncotarget.2821; Ma T, 2010, P NATL ACAD SCI USA, V107, P14363, DOI 10.1073/pnas.1001065107; Muendlein A, 2014, ATHEROSCLEROSIS, V237, P632, DOI 10.1016/j.atherosclerosis.2014.10.028; Nakayama T, 2011, ONCOL REP, V25, P929, DOI 10.3892/or.2011.1176; Nakayama T, 2010, ONCOL REP, V24, P599, DOI 10.3892/or_00000897; Ng KTP, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-196; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; Okochi-Takada E, 2014, ONCOGENE, V33, P2273, DOI 10.1038/onc.2013.174; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pasin Erik, 2008, Rev Urol, V10, P31; Roupret M, 2011, EUR UROL, V59, P584, DOI 10.1016/j.eururo.2010.12.042; Schulz WA, 2006, INT J CANCER, V119, P1513, DOI 10.1002/ijc.21852; Shibata K, 2010, J CLIN PATHOL, V63, P1054, DOI 10.1136/jcp.2010.078600; Shiina H, 2002, J UROLOGY, V168, P2220, DOI 10.1016/S0022-5347(05)64359-5; STUDER UE, 1994, J UROLOGY, V152, P81, DOI 10.1016/S0022-5347(17)32822-7; Swales C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109524; Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519; Tjeerdema N, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000034; Urakami S, 2006, CLIN CANCER RES, V12, P383, DOI 10.1158/1078-0432.CCR-05-1344; Verine J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010421; Wang YH, 2009, TOXICOL APPL PHARM, V241, P111, DOI 10.1016/j.taap.2009.08.008; Wang YH, 2009, UROLOGY, V73, P670, DOI 10.1016/j.urology.2008.09.048; Wang ZM, 2010, BIOMARKERS, V15, P39, DOI 10.3109/13547500903261362; Wu YQ, 2016, EUR REV MED PHARMACO, V20, P44; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776; Yeh CM, 2014, INT J ONCOL, V45, P2101, DOI 10.3892/ijo.2014.2627; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhang H, 2013, EXP THER MED, V5, P119, DOI 10.3892/etm.2012.750; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018; Zordan MD, 2011, CYTOM PART A, V79A, P227, DOI 10.1002/cyto.a.21029	68	16	17	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 1	2018	37	5					673	686		10.1038/onc.2017.375	http://dx.doi.org/10.1038/onc.2017.375			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FU4GT	29035390				2022-12-26	WOS:000423812200012
J	Huynh, DN; Bessi, VL; Menard, L; Piquereau, J; Proulx, C; Febbraio, M; Lubell, WD; Carpentier, AC; Burelle, Y; Ong, H; Marleau, S				Huynh, David N.; Bessi, Valerie L.; Menard, Liliane; Piquereau, Jerome; Proulx, Caroline; Febbraio, Maria; Lubell, William D.; Carpentier, Andre C.; Burelle, Yan; Ong, Huy; Marleau, Sylvie			Adiponectin has a pivotal role in the cardioprotective effect of CP-3(iv), a selective CD36 azapeptide ligand, after transient coronary artery occlusion in mice	FASEB JOURNAL			English	Article						ischemia/reperfusion; reactive oxygen species; PPAR-gamma; Langendorff; hemodynamics	HORMONE-RELEASING PEPTIDE; SCAVENGER RECEPTOR CD36; ISCHEMIA-REPERFUSION INJURY; FATTY-ACID UPTAKE; MYOCARDIAL-ISCHEMIA; CHOLESTEROL EFFLUX; GENE-EXPRESSION; PROTECTS; ISCHEMIA/REPERFUSION; DIFFERENTIATION	CD36 is a multiligand receptor involved in lipid metabolism. We investigated the mechanisms underlying the cardioprotective effect of CP-3(iv), an azapeptide belonging to a new class of selective CD36 ligands. The role of CP-3(iv) in mediating cardioprotection was investigated because CD36 signaling leads to activation of peroxisome proliferator-activated receptor-gamma, a transcriptional regulator of adiponectin. CP-3(iv) pretreatment reduced infarct size by 54% and preserved hemodynamics in C57BL/6mice subjected to 30min coronary ligation and reperfusion but had no effect in CD36-deficient mice. The effects of CP-3(iv) were associated with an increase in circulating adiponectin levels, epididymal fat adiponectin gene expression, and adiponectin transcriptional regulators (Pparg, Cebpb, Sirt1) after 6 h of reperfusion. Reduced myocardial oxidative stress and apoptosis were observed along with an increase in expression of myocardial adiponectin target proteins, including cyclooxygenase-2, phospho-AMPK, and phospho-Akt. Moreover, CP-3(iv) increased myocardial performance in isolated hearts, whereas blockade of adiponectin with an anti-adiponectin antibody abrogated it. CP-3(iv) exerts cardioprotection against myocardial ischemia and reperfusion (MI/R) injury and dysfunction, at least in part, by increasing circulating and myocardial adiponectin levels. Hence, both paracrine and endocrine effects of adiponectin may contribute to reduced reactive oxygen species generation and apoptosis after MI/R, in a CD36-dependent manner.	[Huynh, David N.; Bessi, Valerie L.; Menard, Liliane; Piquereau, Jerome; Burelle, Yan; Ong, Huy; Marleau, Sylvie] Univ Montreal, Fac Pharm, 2940 CP,PO 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Proulx, Caroline; Lubell, William D.] Univ Montreal, Dept Chem, Montreal, PQ, Canada; [Febbraio, Maria] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Carpentier, Andre C.] Univ Sherbrooke, Dept Med, Div Endocrinol, Sherbrooke, PQ, Canada; [Piquereau, Jerome] Univ Paris Sud 11, Orsay, France; [Proulx, Caroline] North Carolina State Univ, Raleigh, NC USA; [Burelle, Yan] Univ Ottawa, Ottawa, ON, Canada	Universite de Montreal; Universite de Montreal; University of Alberta; University of Sherbrooke; UDICE-French Research Universities; Universite Paris Saclay; University of North Carolina; North Carolina State University; University of Ottawa	Bessi, VL; Marleau, S (corresponding author), Univ Montreal, Fac Pharm, 2940 CP,PO 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	valerie.lafreniere.bessi@gmail.com; sylvie.marleau@umontreal.ca	Burelle, Yan/AAF-8104-2021	Burelle, Yan/0000-0001-9379-146X; Piquereau, Jerome/0000-0002-6019-8683	Fonds de Recherche du Quebec-Sante; Groupe de Recherche Universitaire sur le Medicament; GSK Chair in Diabetes of the Universite de Sherbrooke; Heart and Stoke Foundation of Quebec; Canadian Institute of Health Research [MOP 97915]	Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Groupe de Recherche Universitaire sur le Medicament; GSK Chair in Diabetes of the Universite de Sherbrooke; Heart and Stoke Foundation of Quebec; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	V.L.B. and D.N.H. are recipients of the Fonds de Recherche du Quebec-Sante and Groupe de Recherche Universitaire sur le Medicament studentships. A.C.C. is the recipient of the GSK Chair in Diabetes of the Universite de Sherbrooke. This work was supported by grants from the Heart and Stoke Foundation of Quebec and the Canadian Institute of Health Research (Grant MOP 97915). The authors declare no conflicts of interest.	Abraham D, 2015, JOVE-J VIS EXP, DOI 10.3791/52942; Angin Y, 2012, BIOCHEM J, V448, P43, DOI 10.1042/BJ20120060; Ascah A, 2011, AM J PHYSIOL-HEART C, V300, pH144, DOI 10.1152/ajpheart.00522.2010; Avallone R, 2006, MOL ENDOCRINOL, V20, P3165, DOI 10.1210/me.2006-0146; Bessi VL, 2012, CARDIOVASC RES, V96, P99, DOI 10.1093/cvr/cvs225; Braun M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119416; Bujold K, 2009, CARDIOVASC RES, V83, P457, DOI 10.1093/cvr/cvp118; Depre C, 2000, CARDIOVASC RES, V45, P538, DOI 10.1016/S0008-6363(99)00266-7; Fang XP, 2010, AM J PHYSIOL-ENDOC M, V299, pE721, DOI 10.1152/ajpendo.00086.2010; Glatz JFC, 2013, PROSTAG LEUKOTR ESS, V88, P71, DOI 10.1016/j.plefa.2012.04.009; Gonon AT, 2008, CARDIOVASC RES, V78, P116, DOI 10.1093/cvr/cvn017; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Horowitz JD, 2010, CURR OPIN CARDIOL, V25, P329, DOI 10.1097/HCO.0b013e328339f191; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Ibanez B, 2015, J AM COLL CARDIOL, V65, P1455, DOI 10.1016/j.jacc.2015.02.032; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Johnson AR, 2016, MOL METAB, V5, P506, DOI 10.1016/j.molmet.2016.04.005; Kintaka T, 2002, CIRC J, V66, P819, DOI 10.1253/circj.66.819; Koentges C, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0495-4; Lauer MS, 2012, CHEST, V141, P500, DOI 10.1378/chest.11-2521; Lopaschuk Gary D, 2004, Curr Opin Investig Drugs, V5, P290; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Marleau Sylvie, 2005, FASEB J, V19, P1869; Nagendran J, 2013, J MOL CELL CARDIOL, V63, P180, DOI 10.1016/j.yjmcc.2013.07.020; Nanayakkara G, 2012, AM J CARDIOVASC DIS, V2, P253; Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Pineiro R, 2005, FEBS LETT, V579, P5163, DOI 10.1016/j.febslet.2005.07.098; Proulx C, 2012, J MED CHEM, V55, P6502, DOI 10.1021/jm300557t; Qiao LP, 2011, DIABETES, V60, P1519, DOI 10.2337/db10-1017; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Raedschelders K, 2012, PHARMACOL THERAPEUT, V133, P230, DOI 10.1016/j.pharmthera.2011.11.004; Ramasamy R, 2001, AM J PHYSIOL-HEART C, V281, pH290, DOI 10.1152/ajpheart.2001.281.1.H290; Rodrigue-Way A, 2007, ENDOCRINOLOGY, V148, P1009, DOI 10.1210/en.2006-0975; Rodrigue-Way A, 2014, FASEB J, V28, P1910, DOI 10.1096/fj.13-240168; Sabatino D, 2011, J AM CHEM SOC, V133, P12493, DOI 10.1021/ja203007u; Shetty S, 2009, TRENDS PHARMACOL SCI, V30, P234, DOI 10.1016/j.tips.2009.02.004; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Simons PJ, 2007, J ENDOCRINOL, V192, P289, DOI 10.1677/JOE-06-0047; Tao C, 2014, BEST PRACT RES CL EN, V28, P43, DOI 10.1016/j.beem.2013.11.003; Tao L, 2007, CIRCULATION, V115, P1408, DOI 10.1161/CIRCULATIONAHA.106.666941; Tretter L, 2014, METHOD ENZYMOL, V547, P199, DOI 10.1016/B978-0-12-801415-8.00012-6; Verma S, 2002, CIRCULATION, V105, P2332, DOI 10.1161/01.CIR.0000016602.96363.36; Vroegrijk IOCM, 2013, OBESITY, V21, P2037, DOI 10.1002/oby.20354; Xu AM, 2015, AUTOPHAGY, V11, P723, DOI 10.1080/15548627.2015.1034418; Xue P, 2013, DIABETES, V62, P845, DOI 10.2337/db12-0584; Zhang HR, 2010, ARTERIOSCL THROM VAS, V30, P2156, DOI 10.1161/ATVBAHA.110.214700	49	10	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					807	818		10.1096/fj.201700505R	http://dx.doi.org/10.1096/fj.201700505R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29018142	Bronze			2022-12-26	WOS:000425146900023
J	Xiong, Y; Zhang, YX; Xin, N; Yuan, Y; Zhang, Q; Gong, P; Wu, YY				Xiong, Yi; Zhang, Yixin; Xin, Na; Yuan, Ying; Zhang, Qin; Gong, Ping; Wu, Yingying			1,25-Dihydroxyvitamin D-3 promotes bone formation by promoting nuclear exclusion of the FoxO1 transcription factor in diabetic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; diabetes; FOXO; osteoblast; vitamin D; forkhead transcription factor 1; PI3K; Akt pathway; high glucose; osteocalcin	TITANIUM IMPLANT OSSEOINTEGRATION; OXIDATIVE STRESS; VITAMIN-D; LENTIVIRAL VECTOR; G-PROTEIN; INSULIN; OSTEOCALCIN; MELLITUS; TYPE-1; RISK	1,25-Dihydroxyvitamin D-3 (1,25(OH)(2)D-3) is the active form of vitamin D, which is responsible for reducing the risk for diabetes mellitus (DM), decreasing insulin resistance, and improving insulin secretion. Previous studies have shown that 1,25(OH)(2)D-3 inhibited the activity of FoxO1, which has been implicated in the regulation of glucose metabolism. However, its function and mechanism of action in DM-induced energy disorders and also in bone development remains unclear. Here, using in vitro and in vivo approaches including osteoblast-specific, conditional FoxO1-knock-out mice, we demonstrate that 1,25(OH)(2)D-3 ameliorates abnormal osteoblast proliferation in DM-induced oxidative stress conditions and rescues the impaired glucose and bone metabolism through FoxO1 nuclear exclusion resulting from the activation of PI3K/Akt signaling. Using alizarin red staining, alkaline phosphatase assay, Western blot, and real-time qPCR techniques, we found that 1,25(OH)(2)D-3 promotes osteoblast differentiation and expression of osteogenic phenotypic markers (i.e. alkaline phosphatase (1), collagen 1 (COL-1), osteocalcin (OCN), and osteopontin (OPN)) in a high-glucose environment. Moreover, 1,25(OH)(2)D-3 increased both total OCN secretion and levels of uncarboxylated OCN (GluOC) by phosphorylating FoxO1 and promoting its nuclear exclusion, indicated by Western blot and cell immunofluorescence analyses. Taken together, our findings confirm that FoxO1 is a key mediator involved in glucose homeostasis and indicate that 1,25(OH)(2)D-3 improves glucose metabolism and bone development via regulation of PI3K/Akt/FoxO1/OCN pathway.	[Xiong, Yi; Zhang, Yixin; Xin, Na; Yuan, Ying; Zhang, Qin; Gong, Ping; Wu, Yingying] Sichuan Univ, State Key Lab Oral Dis, Natl Clin Res Ctr Oral Dis, West China Hosp Stomatol, Chengdu 610041, Sichuan, Peoples R China; [Xiong, Yi; Xin, Na; Yuan, Ying; Zhang, Qin; Gong, Ping; Wu, Yingying] Sichuan Univ, West China Hosp Stomatol, Dept Implantol, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Yixin] Sichuan Univ, West China Hosp Stomatol, Dept Prosthodont, Chengdu 610041, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Gong, P; Wu, YY (corresponding author), Sichuan Univ, State Key Lab Oral Dis, Natl Clin Res Ctr Oral Dis, West China Hosp Stomatol, 14 Third Sect,Renmin Nan Rd, Chengdu 610041, Sichuan, Peoples R China.; Gong, P; Wu, YY (corresponding author), Sichuan Univ, Dept Implantol, West China Hosp Stomatol, 14 Third Sect,Renmin Nan Rd, Chengdu 610041, Sichuan, Peoples R China.	dentistgong@hotmail.com; yywdentist@163.com	XIONG, Yi/HGU-1217-2022	Xiong, Yi/0000-0002-6676-202X	National Natural Science Foundation of China [NSFC 81400543, NSFC 81571008]; Outstanding Scholars Research Funding of Sichuan University [2017SCU04A21]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Scholars Research Funding of Sichuan University	This work was supported by National Natural Science Foundation of China Grants NSFC 81400543 and NSFC 81571008 and Outstanding Scholars Research Funding of Sichuan University (2017SCU04A21). The authors declare that they have no conflicts of interest with the contents of this article.	Afzal S, 2013, CLIN CHEM, V59, P381, DOI 10.1373/clinchem.2012.193003; Ahmed LA, 2006, OSTEOPOROSIS INT, V17, P495, DOI 10.1007/s00198-005-0013-x; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Botolin S, 2006, J CELL BIOCHEM, V99, P411, DOI 10.1002/jcb.20842; Brotto M, 2015, BONE, V80, P109, DOI 10.1016/j.bone.2015.02.010; Brotto M, 2014, CURR OSTEOPOROS REP, V12, P135, DOI 10.1007/s11914-014-0209-0; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; CANALIS E, 1993, CALCIFIED TISSUE INT, V53, pS90, DOI 10.1007/BF01673411; Carnevale V, 2004, DIABETES-METAB RES, V20, P196, DOI 10.1002/dmrr.449; Chen SC, 2016, J BONE MINER RES, V31, P585, DOI 10.1002/jbmr.2729; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fiorellini JP, 1999, CLIN ORAL IMPLAN RES, V10, P362, DOI 10.1111/j.1600-0501.1999.tb00011.x; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Gao A, 2014, BIOMATERIALS, V35, P4223, DOI 10.1016/j.biomaterials.2014.01.058; Gerritsen M, 2000, J BIOMED MATER RES, V53, P702, DOI 10.1002/1097-4636(2000)53:6<702::AID-JBM13>3.0.CO;2-V; Ghodsi M, 2016, J DIABETES METAB DIS, V15, DOI 10.1186/s40200-016-0275-1; Ghosh P, 2015, ENDOCR REV, V36, P272, DOI 10.1210/er.2014-1099; Hasegawa H, 2008, INT J ORAL MAX IMPL, V23, P237; Huhtakangas JA, 2004, MOL ENDOCRINOL, V18, P2660, DOI 10.1210/me.2004-0116; Iyer S, 2017, J BONE MINER RES, V32, P60, DOI 10.1002/jbmr.2934; Iyer S, 2013, J CLIN INVEST, V123, P3409, DOI 10.1172/JCI68049; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Jehle Sigrid, 2014, Swiss Med Wkly, V144, pw13942, DOI 10.4414/smw.2014.13942; Kanazawa I, 2011, OSTEOPOROSIS INT, V22, P1191, DOI 10.1007/s00198-010-1310-6; Klein GL, 2014, WORLD J DIABETES, V5, P14, DOI 10.4239/wjd.v5.i1.14; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Kousteni S, 2011, J BONE MINER RES, V26, P912, DOI 10.1002/jbmr.306; Kurra S, 2014, ENDOCRIN METAB CLIN, V43, P233, DOI 10.1016/j.ecl.2013.09.004; Lee DH, 2006, CELL BIOL TOXICOL, V22, P39, DOI 10.1007/s10565-006-0018-z; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Littorin B, 2006, DIABETOLOGIA, V49, P2847, DOI 10.1007/s00125-006-0426-x; Liu G, 1998, CALCIFIED TISSUE INT, V62, P286, DOI 10.1007/s002239900432; Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7; Mizokami A, 2017, BIOCHEM PHARMACOL, V132, P1, DOI 10.1016/j.bcp.2017.02.001; O'Loughlin A, 2010, INT J LOW EXTR WOUND, V9, P90, DOI 10.1177/1534734610371600; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; OIKARINEN K, 1995, COMMUNITY DENT ORAL, V23, P114, DOI 10.1111/j.1600-0528.1995.tb00212.x; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Perez-Lopez FR, 2007, MATURITAS, V58, P117, DOI 10.1016/j.maturitas.2007.05.002; Ponugoti B, 2012, EXP DIABETES RES, DOI 10.1155/2012/939751; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Schottker B, 2013, EUR J EPIDEMIOL, V28, P267, DOI 10.1007/s10654-013-9769-z; Schwartz Ann V, 2004, Curr Diab Rep, V4, P364, DOI 10.1007/s11892-004-0039-z; Schwartz AV, 2003, CALCIFIED TISSUE INT, V73, P515, DOI 10.1007/s00223-003-0023-7; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; Strotmeyer Elsa S, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P429, DOI 10.1097/MED.0b013e3282f1cba3; Thomas DM, 1996, J BONE MINER RES, V11, P1312; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vestergaard P, 2009, CALCIFIED TISSUE INT, V84, P45, DOI 10.1007/s00223-008-9195-5; Wasielica-Berger J, 2007, ADV MED SCI-POLAND, V52, P222; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887; Wu YY, 2013, BONE, V52, P1, DOI 10.1016/j.bone.2012.09.005; Wu YK, 2012, ZOOTAXA, P1; Xiang L, 2014, J PERIODONTAL RES, V49, P554, DOI 10.1111/jre.12135; Xiang L, 2017, BONE, V94, P135, DOI 10.1016/j.bone.2015.08.009; Yang JH, 2010, CELL BIOCHEM FUNCT, V28, P334, DOI 10.1002/cbf.1668; Zoch ML, 2016, BONE, V82, P42, DOI 10.1016/j.bone.2015.05.046	63	24	30	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20270	20280		10.1074/jbc.M117.796367	http://dx.doi.org/10.1074/jbc.M117.796367			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29042442	Green Published, hybrid			2022-12-26	WOS:000417696400030
J	Kim, KH; Yoon, HS; Song, W; Choo, HJ; Yoon, H; Chung, WS; Sim, BS; Lee, DH				Kim, Kwang Hyun; Yoon, Hyun Suk; Song, Wan; Choo, Hee Jung; Yoon, Hana; Chung, Woo Sik; Sim, Bong Suk; Lee, Dong Hyeon			Cluster analysis identifies three urodynamic patterns in patients with orthotopic neobladder reconstruction	PLOS ONE			English	Article							QUALITY-OF-LIFE; ILEAL NEOBLADDER; RADICAL CYSTECTOMY; URINARY-DIVERSION; BLADDER-CANCER; NOCTURNAL ENURESIS; CONTINENCE; OUTCOMES; WOMEN; PARAMETERS	Purpose To classify patients with orthotopic neobladder based on urodynamic parameters using cluster analysis and to characterize the voiding function of each group. Materials and methods From January 2012 to November 2015, 142 patients with bladder cancer underwent radical cystectomy and Studer neobladder reconstruction at our institute. Of the 142 patients, 103 with complete urodynamic data and information on urinary functional outcomes were included in this study. K-means clustering was performed with urodynamic parameters which included maximal cystometric capacity, residual volume, maximal flow rate, compliance, and detrusor pressure at maximum flow rate. Three groups emerged by cluster analysis. Urodynamic parameters and urinary function outcomes were compared between three groups. Results Group 1 (n = 44) had ideal urodynamic parameters with a mean maximal bladder capacity of 513.3 ml and mean residual urine volume of 33.1 ml. Group 2 (n = 42) was characterized by small bladder capacity with low compliance. Patients in group 2 had higher rates of daytime incontinence and nighttime incontinence than patients in group 1. Group 3 (n = 17) was characterized by large residual urine volume with high compliance. When we examined gender differences in urodynamics and functional outcomes, residual urine volume and the rate of daytime incontinence were only marginally significant. However, females were significantly more likely to belong to group 2 or 3 (P = 0.003). In multivariate analysis to identify factors associated with group 1 which has the most ideal urodynamic pattern, age (OR 0.95, P = 0.017) and male gender (OR 7.57, P = 0.003) were identified as significant factors. Conclusions While patients with ileal neobladder present with various voiding symptoms, three urodynamic patterns were identified by cluster analysis. Approximately half of patients had ideal urodynamic parameters. The other two groups were characterized by large residual urine and small capacity bladder with low compliance. Young age and male gender appear to have a favorable impact on urodynamic and voiding outcomes in patients undergoing orthotopic neobladder reconstruction.	[Kim, Kwang Hyun; Yoon, Hyun Suk; Song, Wan; Yoon, Hana; Chung, Woo Sik; Sim, Bong Suk; Lee, Dong Hyeon] Ewha Womans Univ, Dept Urol, Coll Med, Seoul, South Korea; [Choo, Hee Jung] Ewha Womans Univ, Dept Urol, Mokdong Hosp, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Lee, DH (corresponding author), Ewha Womans Univ, Dept Urol, Coll Med, Seoul, South Korea.	leedohn@ewha.ac.kr		Yoon, Hyun Suk/0000-0003-1806-3539	Ewha Womans University	Ewha Womans University	This work was supported by the Ewha Womans University Research Grant of 2016.	Ahmadi H, 2013, J UROLOGY, V189, P1782, DOI 10.1016/j.juro.2012.11.078; Anderson CB, 2012, J UROLOGY, V188, P200, DOI 10.1016/j.juro.2012.03.004; Burkhard FC, 2006, J UROLOGY, V175, P2160, DOI DOI 10.1016/S0022-5347(06)00278-3; Charrad M, 2014, J STAT SOFTW, V61, P1; Crozier J, 2016, UROLOGY, V96, P74, DOI 10.1016/j.urology.2016.06.034; El-Bahnasawy MS, 2008, SCAND J UROL NEPHROL, V42, P344, DOI 10.1080/00365590701832726; El-Bahnasawy MS, 2005, BJU INT, V96, P1373, DOI 10.1111/j.1464-410X.2005.05852.x; Finley DS, 2011, J UROLOGY, V186, P1364, DOI 10.1016/j.juro.2011.05.069; GHONEIM MA, 1992, J UROLOGY, V147, P361, DOI 10.1016/S0022-5347(17)37238-5; Gilbert SM, 2007, CANCER-AM CANCER SOC, V109, P1756, DOI 10.1002/cncr.22556; Gilbert SM, 2010, J UROLOGY, V183, P1764, DOI 10.1016/j.juro.2010.01.013; Goldberg H, 2014, BJU INT, V114, P727, DOI 10.1111/bju.12598; Hautmann RE, 2003, J UROLOGY, V169, P834, DOI 10.1097/01.ju.0000029010.97686.eb; Hautmann RE, 2006, WORLD J UROL, V24, P305, DOI 10.1007/s00345-006-0105-z; Hautmann RE, 2013, EUR UROL, V63, P67, DOI 10.1016/j.eururo.2012.08.050; Hoag N, 2016, INT NEUROUROL J, V20, P81, DOI 10.5213/inj.1630380.190; IWAKIRI J, 1993, J UROLOGY, V149, P1072, DOI 10.1016/S0022-5347(17)36299-7; Kretschmer A, 2017, J UROLOGY, V197, P210, DOI 10.1016/j.juro.2016.08.004; Madersbacher S, 2002, J UROLOGY, V167, P2052, DOI 10.1016/S0022-5347(05)65082-3; Novara G, 2010, EUR UROL, V57, P1045, DOI 10.1016/j.eururo.2010.01.007; Sakakibara R, 2007, INT J UROL, V14, P1054, DOI 10.1111/j.1442-2042.2007.01885.x; Santucci RA, 1999, UROLOGY, V54, P252, DOI 10.1016/S0090-4295(99)00098-9; Satkunasivam R, 2016, EUR UROL, V69, P247, DOI 10.1016/j.eururo.2015.06.041; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Schrier BP, 2005, EUR UROL, V47, P679, DOI 10.1016/j.eururo.2004.10.018; Stein JP, 2009, J UROLOGY, V181, P2052, DOI 10.1016/j.juro.2009.01.020; Stein JP, 1998, UROLOGY, V51, P951, DOI 10.1016/S0090-4295(98)00099-5; Studer UE, 2004, BJU INT, V93, P183, DOI 10.1111/j.1464-410X.2004.04641.x; Studer UE, 2006, J UROLOGY, V176, P161, DOI 10.1016/S0022-5347(06)00573-8; Wang D, 2014, ONCOL LETT, V8, P1031, DOI 10.3892/ol.2014.2281; Wu TT, 1996, UROL INT, V57, P213, DOI 10.1159/000282916; Xu K, 2013, J UROLOGY, V190, P928, DOI 10.1016/j.juro.2013.03.072; Zahran MH, 2014, INT J UROL, V21, P887, DOI 10.1111/iju.12452; Zhang ZL, 2013, ONCOL LETT, V6, P1053, DOI 10.3892/ol.2013.1502	34	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0185255	10.1371/journal.pone.0185255	http://dx.doi.org/10.1371/journal.pone.0185255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045422	Green Published, gold, Green Submitted			2022-12-26	WOS:000413168100014
J	Guo, H; Ramos, AMT; Macau, EEN; Zou, Y; Guan, SG				Guo, Heng; Ramos, Antoanio M. T.; Macau, Elbert E. N.; Zou, Yong; Guan, Shuguang			Constructing regional climate networks in the Amazonia during recent drought events	PLOS ONE			English	Article							DYNAMICS; EARTH	Climate networks are powerful approaches to disclose tele-connections in climate systems and to predict severe climate events. Here we construct regional climate networks from precipitation data in the Amazonian region and focus on network properties under the recent drought events in 2005 and 2010. Both the networks of the entire Amazon region and the extreme networks resulted from locations severely affected by drought events suggest that network characteristics show slight difference between the two drought events. Based on network degrees of extreme drought events and that without drought conditions, we identify regions of interest that are correlated to longer expected drought period length. Moreover, we show that the spatial correlation length to the regions of interest decayed much faster in 2010 than in 2005, which is because of the dual roles played by both the Pacific and Atlantic oceans. The results suggest that hub nodes in the regional climate network of Amazonia have fewer long-range connections when more severe drought conditions appeared in 2010 than that in 2005.	[Guo, Heng; Zou, Yong; Guan, Shuguang] East China Normal Univ, Dept Phys, Shanghai, Peoples R China; [Ramos, Antoanio M. T.; Macau, Elbert E. N.] Natl Inst Space Res, Sao Jose Dos Campos, SP, Brazil	East China Normal University; Instituto Nacional de Pesquisas Espaciais (INPE)	Zou, Y; Guan, SG (corresponding author), East China Normal Univ, Dept Phys, Shanghai, Peoples R China.	yzou@phy.ecnu.edu.cn; sgguan@phy.ecnu.edu.cn	Zou, Yong/AHD-3714-2022; Zou, Yong/G-1139-2012; Macau, Elbert Einstein Nehrer/C-5291-2013	Zou, Yong/0000-0002-3241-3139; Zou, Yong/0000-0002-3241-3139; Macau, Elbert Einstein Nehrer/0000-0002-6337-8081	National Natural Science Foundation of China [11305062]; Sao Paulo Research Foundation [FAPESP/DFG-IRTG 1740/TRP, FAPESP/DFG-IRTG, 2015/50122-0, 2014/14229-2, 2015/07373-2, 2015/23607-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was partially supported by the National Natural Science Foundation of China (Grant No. 11305062), and the Sao Paulo Research Foundation (Grant No. FAPESP/DFG-IRTG 1740/TRP, FAPESP/DFG-IRTG, 2015/50122-0, No. 2014/14229-2, No. 2015/07373-2, and No. 2015/23607-3).	Barrat A, 2000, EUR PHYS J B, V13, P547, DOI 10.1007/s100510050067; Bialonski S, 2010, CHAOS, V20, DOI 10.1063/1.3360561; Boers N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6199; Boers N, 2014, CLIM DYN; Boers N, 2013, GEOPHYS RES LETT, V40, P4386, DOI 10.1002/grl.50681; Chen YK, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/186545; Donges JF, 2011, EUR PHYS J B, V84, P635, DOI 10.1140/epjb/e2011-10795-8; Donges JF, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48007; Donges JF, 2009, EUR PHYS J-SPEC TOP, V174, P157, DOI 10.1140/epjst/e2009-01098-2; Donges JF, 2015, CLIM DYNAM, V45, P2407, DOI 10.1007/s00382-015-2479-3; Donges JF, 2011, P NATL ACAD SCI USA, V108, P20422, DOI 10.1073/pnas.1117052108; Ebert-Uphoff I, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053269; Erfanian A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05373-2; Fan JF, 2017, P NATL ACAD SCI USA, V114, P7543, DOI 10.1073/pnas.1701214114; Gozolchiani A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.148501; Heitzig J, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2011-20678-7; Ludescher J, 2014, P NATL ACAD SCI USA, V111, P2064, DOI 10.1073/pnas.1323058111; Ludescher J, 2013, P NATL ACAD SCI USA, V110, P11742, DOI 10.1073/pnas.1309353110; Malik N, 2012, CLIM DYNAM, V39, P971, DOI 10.1007/s00382-011-1156-4; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; Martin EA, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/48003; Marwan N, 2009, PHYS LETT A, V373, P4246, DOI 10.1016/j.physleta.2009.09.042; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Palus M, 2011, NONLINEAR PROC GEOPH, V18, P751, DOI 10.5194/npg-18-751-2011; Panisset JS, 2017, INT J CLIMATOL, p1 ; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Radebach A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052807; Ramos AMdT, 2017, CLIM DYNAM, P1; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Rheinwalt A, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/28002; Scarsoglio S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071129; Schellnhuber HJ, 2009, P NATL ACAD SCI USA, V106, P20561, DOI 10.1073/pnas.0911106106; Sheffield J, 2006, J CLIMATE, V19, P3088, DOI 10.1175/JCLI3790.1; Steinhaeuser K, 2012, CLIM DYNAM, V39, P889, DOI 10.1007/s00382-011-1135-9; Tirabassi G, 2016, SCI REPORTS, V6, P1; Tsonis AA, 2004, PHYSICA A, V333, P497, DOI 10.1016/j.physa.2003.10.045; Tsonis AA, 2006, B AM METEOROL SOC, V87, P585, DOI 10.1175/BAMS-87-5-585; Tsonis AA, 2011, CLIM DYNAM, V37, P933, DOI 10.1007/s00382-010-0874-3; Tsonis AA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228502; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wiedermann M, 2016, GEOPHYS RES LETT, V43, P7176, DOI 10.1002/2016GL069119; Wiedermann M, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.042308; Yamasaki K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228501; Yoon JH, 2010, CLIM DYNAM, V34, P249, DOI 10.1007/s00382-009-0551-6; Zhang R, 2017, COMMUN NONLINEAR SCI, V42, P396, DOI 10.1016/j.cnsns.2016.04.031; Zou Y, 2016, CLIM DYNAM, V46, P3279, DOI 10.1007/s00382-015-2768-x; Zou Y, 2010, CHAOS, V20, DOI 10.1063/1.3523304	50	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186145	10.1371/journal.pone.0186145	http://dx.doi.org/10.1371/journal.pone.0186145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040296	Green Published, gold, Green Submitted			2022-12-26	WOS:000413167500022
J	Li, ZY; Sheth, AB; Sheth, BR				Li, Ziyang; Sheth, Aarohi B.; Sheth, Bhavin R.			What drives slow wave activity during early non-REM sleep: Learning during prior wake or effort?	PLOS ONE			English	Article							MEMORY CONSOLIDATION; LOCAL SLEEP; HOMEOSTASIS; DEPRIVATION; ACTIVATION; VIGILANCE; PATTERNS; REPLAY; SKILLS; FORMS	What is the function of sleep in humans? One claim is that sleep consolidates learning. Slow wave activity (SWA), i.e. slow oscillations of frequency < 4 Hz, has been observed in electroencephalograms (EEG) during sleep; it increases with prior wakefulness and decreases with sleep. Studies have claimed that increase in SWA in specific regions of the sleeping brain is correlated with overnight improved performance, i.e. overnight consolidation, on a demanding motor learning task. We wondered if SWA change during sleep is attributable to overnight consolidation or to metabolic demand. Participants executed out-and-back movements to a target using a pen-like cursor with their dominant hand while the target and cursor position were displayed on a screen. They trained on three different conditions on separate nights, differing in the amount and degree of rotation between the actual hand movement direction and displayed cursor movement direction. In the no-rotation (NR) condition, there was no rotation. In the single rotation (SR) condition, the amount of rotation remained the same throughout, and performance improved both across pre-sleep training and after sleep, i.e. overnight consolidation occurred; in the random rotation (RR) condition, the amount of rotation varied randomly from trial to trial, and no overnight consolidation occurred; SR and RR were cognitively demanding. The average EEG power density of SWA for the first 30 min. of non-rapid eye movement sleep after training was computed. Both SR and RR elicited increase in SWA in the parietal region; furthermore, the topographic distribution of SWA in each was remarkably similar. No correlation was found between the overnight performance improvement on SR and the SWA change in the parietal region on measures of learning. Our results argue that regulation of SWA in early sleep is associated with high levels of cognitive effort during prior wakefulness, and not just overnight consolidation.	[Li, Ziyang; Sheth, Bhavin R.] Univ Houston, Houston, TX 77004 USA; [Sheth, Aarohi B.] Carnegie Vanguard High Sch, Houston, TX USA	University of Houston System; University of Houston	Sheth, BR (corresponding author), Univ Houston, Houston, TX 77004 USA.	brsheth@uh.edu						Anderson C, 2006, SLEEP, V29, P573, DOI 10.1093/sleep/29.4.573; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Borbely A. A., 2000, PRINCIPLES PRACTICE, P377; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gais S, 2004, PSYCHOL BELG, V44, P105; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; Goel N, 2014, SLEEP, V37, P1746, DOI 10.5665/sleep.4164; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; HORNE JA, 1983, SLEEP, V6, P347, DOI 10.1093/sleep/6.4.347; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Landolt HP, 2008, BIOCHEM PHARMACOL, V75, P2070, DOI 10.1016/j.bcp.2008.02.024; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Peigneux P, 2006, PLOS BIOL, V4, P647, DOI 10.1371/journal.pbio.0040100; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Porkka-Heiskanen T, 2011, SLEEP MED REV, V15, P123, DOI 10.1016/j.smrv.2010.06.005; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rauchs G, 2005, J SLEEP RES, V14, P123, DOI 10.1111/j.1365-2869.2005.00450.x; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Sheth BR, 2012, SLEEP, V35, P985, DOI 10.5665/sleep.1966; Sheth BR, 2012, SLEEP, V35, P657, DOI 10.5665/sleep.1826; Sheth BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005496; Sheth BR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003190; Sheth BR, 2005, BEHAV BRAIN SCI, V28, P81, DOI 10.1017/S0140525X05390029; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Vyazovskiy VV, 2004, EUR J NEUROSCI, V20, P1363, DOI 10.1111/j.1460-9568.2004.03583.x; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wu WW, 2013, PSYCHOPHYSIOLOGY, V50, P274, DOI 10.1111/psyp.12011	39	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0185681	10.1371/journal.pone.0185681	http://dx.doi.org/10.1371/journal.pone.0185681			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028805	gold, Green Submitted, Green Published			2022-12-26	WOS:000412980300011
J	Seva, AD; Martcheva, M; Tuncer, N; Fontana, I; Carrillo, E; Moreno, J; Keesling, J				Seva, Anala da Paixao; Martcheva, Maia; Tuncer, Necibe; Fontana, Isabella; Carrillo, Eugenia; Moreno, Javier; Keesling, James			Efficacies of prevention and control measures applied during an outbreak in Southwest Madrid, Spain	PLOS ONE			English	Article							IMPREGNATED DOG COLLARS; LEISHMANIA-INFANTUM; CANINE LEISHMANIASIS; VISCERAL LEISHMANIASIS; INFECTION; CATS; AREA; RESERVOIR; DYNAMICS; DONOVANI	Leishmaniasis is a vector-borne disease of worldwide distribution, currently present in 98 countries. Since late 2010, an unusual increase of human visceral and cutaneous leishmaniasis cases has been observed in the south-western Madrid region, totaling more than 600 cases until 2015. Some hosts, such as human, domestic dog and cat, rabbit (Oryctolagus cuniculus), and hare (Lepus granatensis), were found infected by the parasite of this disease in the area. Hares were described as the most important reservoir due to their higher prevalence, capacity to infect the vector, and presence of the same strains as in humans. Various measures were adopted to prevent and control the disease, and since 2013 there was a slight decline in the human sickness. We used a mathematical model to evaluate the efficacy of each measure in reducing the number of infected hosts. We identified in the present model that culling both hares and rabbits, without immediate reposition of the animals, was the best measure adopted, decreasing the proportion of all infected hosts. Particularly, culling hares was more efficacious than culling rabbits to reduce the proportion of infected individuals of all hosts. Likewise, lowering vector contact with hares highly influenced the reduction of the proportion of infected hosts. The reduction of the vector density per host in the park decreased the leishmaniasis incidence of hosts in the park and the urban areas. On the other hand, the reduction of the vector density per host of the urban area (humans, dogs and cats) decreased only their affected population, albeit at a higher proportion. The use of insecticide-impregnated collar and vaccination in dogs affected only the infected dogs' population. The parameters related to the vector contact with dog, cat or human do not present a high impact on the other hosts infected by Leishmania. In conclusion, the efficacy of each control strategy was determined, in order to direct future actions in this and in other similar outbreaks. The present mathematical model was able to reproduce the leishmaniasis dynamics in the Madrid outbreak, providing theoretical support based on successful experiences, such as the reduction of human cases in Southwest Madrid, Spain.	[Seva, Anala da Paixao; Martcheva, Maia; Keesling, James] Univ Florida, Dept Math, Gainesville, FL 32611 USA; [Tuncer, Necibe] Florida Atlantic Univ, Dept Math Sci, Boca Raton, FL 33431 USA; [Fontana, Isabella] Minist Agr Livestock & Food Supply Brazil, Brasilia, DF, Brazil; [Carrillo, Eugenia; Moreno, Javier] Inst Salud Carlos III, Ctr Nacl Microbiol, WHO Collaborating Ctr Leishmaniasis, Madrid, Spain; [Seva, Anala da Paixao] Univ Sao Paulo, Dept Vet Prevent Med & Anim Hlth, Sao Paulo, Brazil	State University System of Florida; University of Florida; State University System of Florida; Florida Atlantic University; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Universidade de Sao Paulo	Seva, AD (corresponding author), Univ Florida, Dept Math, Gainesville, FL 32611 USA.; Seva, AD (corresponding author), Univ Sao Paulo, Dept Vet Prevent Med & Anim Hlth, Sao Paulo, Brazil.	anaiaps@usp.br	Sevá, Anaiá P/E-9762-2015; Moreno, Javier/AAB-5386-2021; Carrillo, Eugenia/F-2058-2018; Sevá, Anaiá Paixão/J-4538-2013	Sevá, Anaiá P/0000-0001-5203-012X; Carrillo, Eugenia/0000-0002-7869-7915; Sevá, Anaiá Paixão/0000-0001-5203-012X; Moreno, Javier/0000-0003-0087-4659	National Council for Scientific and Technological Development (CNPq); program PDE [205642/2014-4]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); program PDE	The work was supported by funder National Council for Scientific and Technological Development (CNPq), http://cnpq.br/view/-/ journal_content/56_INSTANCE_OoEDL10157/ 515690, program PDE; No 205642/2014-4.	Alvar J, 2001, LEISHMANIASIS BIOL C; Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5; [Anonymous], 2013, COMUNICATION C DE IN, P14; Antoniou M, 2013, EUROSURVEILLANCE, V18, P54, DOI 10.2807/1560-7917.ES2013.18.30.20540; Ruiz EA, 2014, REV SALUD AMBIENT, V14, P39; Arce A, 2013, EUROSURVEILLANCE, V18, P5, DOI 10.2807/1560-7917.ES2013.18.30.20546; Ayllon T, 2008, ANN NY ACAD SCI, V1149, P361, DOI 10.1196/annals.1428.019; Ayllon T, 2012, VECTOR-BORNE ZOONOT, V12, P143, DOI 10.1089/vbz.2011.0729; BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639; Bates PA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0712-x; Bongiorno G, 2013, VET PARASITOL, V197, P691, DOI 10.1016/j.vetpar.2013.05.008; Bouza LG, 2014, CUANTOS VIVIRA NUEST, P1; Brianti E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-327; Buddle BM, 2006, VET MICROBIOL, V112, P191, DOI 10.1016/j.vetmic.2005.11.027; Camargo-Neves VLF, 2004, B EPIDEMIOLOGICO PAU, V12, P7; Cameron MM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1309-8; Carrillo E, 2013, TRENDS PARASITOL, V29, P579, DOI 10.1016/j.pt.2013.10.007; CARVALHO EM, 1992, J INFECT DIS, V165, P535, DOI 10.1093/infdis/165.3.535; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Costa CHN, 2000, J INFECT DIS, V182, P997, DOI 10.1086/315795; Costa DNCC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002355; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P531, DOI 10.1016/j.pt.2012.08.007; David JR, 2001, MEM I OSWALDO CRUZ, V96, P839, DOI 10.1590/S0074-02762001000600018; DECOLMENARES M, 1995, J MED ENTOMOL, V32, P229, DOI 10.1093/jmedent/32.3.229; Desbiez ALJ, 2009, ECOLOGIA POPULAC PAN; EFSA, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4278; Ettinger SJ, 1992, TRATADO MED INT VET; Fisa R, 1999, VET PARASITOL, V83, P87, DOI 10.1016/S0304-4017(99)00074-6; Flux JEC, 1990, HARES JACKRABBITS RA, P177; Foroughi-Parvar Faeze, 2014, Adv Prev Med, V2014, P569193, DOI 10.1155/2014/569193; Gaeta Giovanni B., 1994, Recenti Progressi in Medicina, V85, P340; Galvez R, 2010, VET PARASITOL, V169, P327, DOI 10.1016/j.vetpar.2009.11.025; Garcia AM., 2009, GAZETA M DICA BAHIA, V79, P147; Garcia N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/318254; Garcia-Almagro D, 2005, ACTAS DERMO-SIFILOGR, V96, P1, DOI 10.1016/S0001-7310(05)73027-1; Gibb J.A., 1990, P116; Gonzalez U, 2015, COCHRANE LIB, P103; Goyena E, 2016, PREV VET MED, V124, P78, DOI 10.1016/j.prevetmed.2015.12.009; Hartemink N, 2011, PLOS ONE, P6; HRS, 2016, LONG DOES RABBIT LIV, P1; Jimenez M, 2014, VET PARASITOL, V202, P296, DOI 10.1016/j.vetpar.2014.03.027; Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2; Luz KG, 2004, FORT DODGE SAUDE ANI, P56; Maroli M, 2001, MED VET ENTOMOL, V15, P358, DOI 10.1046/j.0269-283x.2001.00321.x; Maroli M, 2007, VET PARASITOL, V145, P357, DOI 10.1016/j.vetpar.2006.11.009; Martcheva M, 2014, J BIOL SYST, V22, P151, DOI 10.1142/S0218339014500090; Martin-Sanchez J, 2007, VET PARASITOL, V145, P267, DOI 10.1016/j.vetpar.2006.11.005; MARTINSANCHEZ J, 1994, INT J PARASITOL, V24, P405, DOI 10.1016/0020-7519(94)90089-2; Miro G, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-112; Mitchell-Jones AJ, 1999, THA ATLAS EUROPEAN M; MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4; Molina R, 2012, VET PARASITOL, V190, P268, DOI 10.1016/j.vetpar.2012.05.006; Moreno I, 2014, VET PARASITOL, V199, P264, DOI 10.1016/j.vetpar.2013.10.010; Costa CHN, 2011, REV SOC BRAS MED TRO, V44, P232, DOI 10.1590/S0037-86822011005000014; Oliva G, 2014, PLOS NEGL TROP DIS, V8; Otranto D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056374; Ovallos FG, 2011, ESTUDO CAPACIDADE VE; Palatnik-De-Sousai CB, 2004, AN ACAD BRAS CIENC, V76, P583, DOI 10.1590/S0001-37652004000300012; Pennisi MG, 2015, VET PARASITOL, V208, P35, DOI 10.1016/j.vetpar.2014.12.023; Podaliri Vulpiani Michele, 2011, Vet Med Int, V2011, P215964, DOI 10.4061/2011/215964; POZIO E, 1981, ACTA TROP, V38, P383; Rollin BE, 2011, VET CLIN N AM-SMALL, V41, P651, DOI 10.1016/j.cvsm.2011.03.005; Ruiz-Fontes F, 2013, METHODS, V18; Salud Madrid S de P de la S y P, 2014, LEISHMANIASIS COMUNI, P49; Serrano LS, 2009, LEISHMANIASIS EUROPE, P4; Seva AP, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0160058, 10.1371/journal.pone.0162854]; Silva FS., 2007, REV TROP CIENC AGRAR, V1, P20; Silva LD, 2006, AM J TROP MED HYG, V75, P739, DOI 10.4269/ajtmh.2006.75.739; Silveira FT, 2010, T ROY SOC TROP MED H, V104, P529, DOI 10.1016/j.trstmh.2010.05.002; Smith A. T, 2008, IUCN RED LIST THREAT; Solano-Gallego L, 2001, J CLIN MICROBIOL, V39, P560, DOI 10.1128/JCM.39.2.560-563.2001; Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86; Stauch A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001405; Rodriguez BS, 2012, REV ESP SALUD PUBLIC, V86, P555, DOI 10.4321/S1135-57272012000600002; Tarallo VD, 2010, ACTA TROP, V116, P227, DOI 10.1016/j.actatropica.2010.08.013; Viana GMC, 2011, BRAZ J MED BIOL RES, V44, P62, DOI [10.1590/S0100-879X2010007500134, 10.1590/S0100-879X2011000100009]; Vilas F, 2013, ZOONOSIS, P6; WHO, 2010, WHO TECH REP SER, V949, P1; Wylie CE, 2014, PREV VET MED, V117, P7, DOI 10.1016/j.prevetmed.2014.06.015; Xyiang T, 1988, LIVING TREASURES ODY	81	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186372	10.1371/journal.pone.0186372	http://dx.doi.org/10.1371/journal.pone.0186372			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028841	Green Published, Green Submitted, gold			2022-12-26	WOS:000412980300030
J	Shamsuzzaman, M; Bommakanti, A; Zapinsky, A; Rahman, N; Pascual, C; Lindahl, L				Shamsuzzaman, Md; Bommakanti, Ananth; Zapinsky, Aviva; Rahman, Nusrat; Pascual, Clarence; Lindahl, Lasse			Analysis of cell cycle parameters during the transition from unhindered growth to ribosomal and translational stress conditions	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MESSENGER-RNA; TRANSCRIPTION FACTOR; BACTERIAL-RIBOSOMES; FUNCTIONAL-ANALYSIS; G(1)/S TRANSITION; PROTEIN-SYNTHESIS; IN-VIVO; CYTOKINESIS	Abrogation of ribosome synthesis (ribosomal stress) leads to cell cycle arrest. However, the immediate cell response to cessation of ribosome formation and the transition from normal cell proliferation to cell cycle arrest have not been characterized. Furthermore, there are conflicting conclusions about whether cells are arrested in G2/M or G1, and whether the cause is dismantling ribosomal assembly per se, or the ensuing decreased number of translating ribosomes. To address these questions, we have compared the time kinetics of key cell cycle parameters after inhibiting ribosome formation or function in Saccharomyces cerevisiae. Within one-to-two hours of repressing genes for individual ribosomal proteins or Translation Elongation factor 3, configurations of spindles, spindle pole bodies began changing. Actin began depolarizing within 4 hours. Thus the loss of ribosome formation and function is sensed immediately. After several hours no spindles or mitotic actin rings were visible, but membrane ingression was completed in most cells and Ace2 was localized to daughter cell nuclei demonstrating that the G1 stage was reached. Thus cell division was completed without the help of a contractile actin ring. Moreover, cell wall material held mother and daughter cells together resulting in delayed cell separation, suggesting that expression or function of daughter gluconases and chitinases is inhibited. Moreover, cell development changes in very similar ways in response to inhibition of ribosome formation and function, compatible with the notion that decreased translation capacity contributes to arresting the cell cycle after abrogation of ribosome biogenesis. Potential implications for the mechanisms of diseases caused by mutations in ribosomal genes (ribosomopathies) are discussed.	[Shamsuzzaman, Md; Bommakanti, Ananth; Zapinsky, Aviva; Rahman, Nusrat; Pascual, Clarence; Lindahl, Lasse] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA; [Bommakanti, Ananth] Natl Univ Singapore, Trimasek Life Sci Lab, 1 Res Link, Singapore, Singapore; [Pascual, Clarence] Univ Michigan, Life Sci Inst 6036, Ann Arbor, MI 48109 USA	University System of Maryland; University of Maryland Baltimore County; National University of Singapore; University of Michigan System; University of Michigan	Lindahl, L (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA.	lindahl@umbc.edu		Lindahl, Lasse/0000-0001-8418-7885	National Science Foundation [MCB0920578, DBI-0722569]; Provost's Office, University of Maryland Baltimore County	National Science Foundation(National Science Foundation (NSF)); Provost's Office, University of Maryland Baltimore County	This study was supported by the National Science Foundation, https://www.nsf.gov/, MCB0920578; the National Science Foundation, https://www.nsf.gov/, DBI-0722569; and the Provost's Office, University of Maryland Baltimore County to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Aronov S, 2007, MOL CELL BIOL, V27, P3441, DOI 10.1128/MCB.01643-06; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Bernstein KA, 2004, MOL BIOL CELL, V15, P5038, DOI 10.1091/mbc.E04-06-0515; Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; Bhavsar-Jog YP, 2016, SEMIN CELL DEV BIOL; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; Bi EF, 2012, GENETICS, V191, P347, DOI 10.1534/genetics.111.132886; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; de la Cruz J, 2015, ANNU REV BIOCHEM, V84, P93, DOI 10.1146/annurev-biochem-060614-033917; Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Ear J, 2016, J GENET GENOMICS, V43, P307, DOI 10.1016/j.jgg.2016.03.007; Ellis SR, 2014, BBA-MOL BASIS DIS, V1842, P765, DOI 10.1016/j.bbadis.2013.12.013; Fermi B, 2016, CURRENT GENETICS; Fermi B, 2016, NUCLEIC ACIDS RES, V44, P6113, DOI 10.1093/nar/gkw194; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Fumagalli S, 2011, SEMIN HEMATOL, V48, P97, DOI 10.1053/j.seminhematol.2011.02.004; Gamalinda M, 2014, GENE DEV, V28, P198, DOI 10.1101/gad.228825.113; Gomez-Herreros F, 2013, J BIOL CHEM, V288, P31689, DOI 10.1074/jbc.M113.500488; Griffin JN, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005018; Haag C, 2015, ANNU REV MICROBIOL, V69, P265, DOI 10.1146/annurev-micro-091014-104242; Haase SB, 2014, GENETICS, V196, P65, DOI 10.1534/genetics.113.152595; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Hellmuth K, 2000, NUCLEIC ACIDS RES, V28, P4604, DOI 10.1093/nar/28.23.4604; HELSER TL, 1981, MOL CELL BIOL, V1, P51, DOI 10.1128/MCB.1.1.51; Houchens CR, 2008, EUKARYOT CELL, V7, P1433, DOI 10.1128/EC.00119-08; Howell AS, 2012, GENETICS, V190, P51, DOI 10.1534/genetics.111.128314; James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; King L, 1998, CURR GENET, V34, P183, DOI 10.1007/s002940050384; Ko N, 2007, MOL BIOL CELL, V18, P5139, DOI 10.1091/mbc.E07-05-0509; Kovacech B, 1996, MOL CELL BIOL, V16, P3264; Krementsova EB, 2011, J CELL BIOL, V195, P631, DOI 10.1083/jcb.201106146; Lawrence MG, 2016, NUCLEIC ACIDS RES, V44, P5798, DOI 10.1093/nar/gkw493; LEW DJ, 1995, CURR OPIN GENET DEV, V5, P17, DOI 10.1016/S0959-437X(95)90048-9; Li BJ, 1999, MOL CELL BIOL, V19, P5393; Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947; Liu Y, 2014, P NATL ACAD SCI USA, V111, pE2414, DOI 10.1073/pnas.1315605111; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Luo JY, 2004, J CELL BIOL, V165, P843, DOI 10.1083/jcb.200401040; MaalOe O, 1966, CONTROL MACROMOLECUL; Maddox PS, 2000, NAT CELL BIOL, V2, P36, DOI 10.1038/71357; Maurice TC, 1998, YEAST, V14, P1105, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1105::AID-YEA313>3.3.CO;2-P; Mazanka E, 2008, PLOS BIOL, V6, P1778, DOI 10.1371/journal.pbio.0060203; McCann KL, 2016, ELIFE, V5, DOI 10.7554/eLife.16381; Mulet JM, 2006, J BIOL CHEM, V281, P33000, DOI 10.1074/jbc.M604244200; Narla A, 2011, BLOOD, V118, P4300, DOI 10.1182/blood-2011-08-372250; Nerurkar P, 2015, INT REV CEL MOL BIO, V319, P107, DOI 10.1016/bs.ircmb.2015.07.002; Niles BJ, 2014, CELL REP, V6, P541, DOI 10.1016/j.celrep.2013.12.040; Niles BJ, 2012, P NATL ACAD SCI USA, V109, P1536, DOI 10.1073/pnas.1117563109; NOMURA M, 1973, SCIENCE, V179, P864, DOI 10.1126/science.179.4076.864; O'Conallain C, 1999, MOL GEN GENET, V262, P275, DOI 10.1007/s004380051084; Oeffinger M, 2003, EMBO J, V22, P6573, DOI 10.1093/emboj/cdg616; Pelava A, 2016, BIOCHEM SOC T, V44, P1086, DOI 10.1042/BST20160106; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Polymenis M, 2015, MICROB CELL, V2, P94, DOI 10.15698/mic2015.04.198; Provost E, 2012, DEVELOPMENT, V139, P3232, DOI 10.1242/dev.077107; Reja R, 2015, GENE DEV, V29, P1942, DOI 10.1101/gad.268896.115; Robson A, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0138-5; Rosado IV, 2007, NUCLEIC ACIDS RES, V35, P4203, DOI 10.1093/nar/gkm388; Ruggero D., 2013, COLD SPRING HARB PER, V5; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; SHUAI K, 1991, NUCLEIC ACIDS RES, V19, P5059, DOI 10.1093/nar/19.18.5059; Singh SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089098; Sondalle SB, 2014, BBA-MOL BASIS DIS, V1842, P758, DOI 10.1016/j.bbadis.2013.11.004; SPILLMANN S, 1977, J MOL BIOL, V115, P513, DOI 10.1016/0022-2836(77)90168-1; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Thapa M, 2013, MOL BIOL CELL, V24, P3620, DOI 10.1091/mbc.E13-02-0097; Tolliday N, 2003, MOL BIOL CELL, V14, P798, DOI 10.1091/mbc.E02-09-0558; Vilella F, 2005, J BIOL CHEM, V280, P9149, DOI 10.1074/jbc.M411062200; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weiss EL, 2012, GENETICS, V192, P1165, DOI 10.1534/genetics.112.145516; Wloka C, 2012, CYTOSKELETON, V69, P710, DOI 10.1002/cm.21046; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Yamada H, 2007, RNA, V13, P1977, DOI 10.1261/rna.553807; Yelick PC, 2015, RARE DIS, V3, DOI 10.1080/21675511.2015.1025185; Yu L, 2006, MOL BIOL CELL, V17, P4736, DOI 10.1091/mbc.E06-04-0368; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	86	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186494	10.1371/journal.pone.0186494	http://dx.doi.org/10.1371/journal.pone.0186494			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028845	Green Published, Green Submitted, gold			2022-12-26	WOS:000412980300037
J	Hudson, JE; Levia, DF; Hudson, SA; Bais, HP; Legates, DR				Hudson, Janice E.; Levia, Delphis F.; Hudson, Sean A.; Bais, Harsh P.; Legates, David R.			Phenoseasonal subcanopy light dynamics and the effects of light on the physiological ecology of a common understory shrub, Lindera benzoin	PLOS ONE			English	Article							PHOTOSYNTHETICALLY ACTIVE RADIATION; CANOPY STRUCTURE; LEAF-AREA; HERBIVORY; INTERCEPTION; RESPONSES; STANDS	The purpose of this work was to quantify the variation of subcanopy spatiotemporal light dynamics over the course of a year and to link it to the physiological ecology of the understory shrub, Lindera benzoin L. Blume (northern spicebush). Covering all seven phenoseasons of a deciduous forest, this work utilized a line quantum sensor to measure the variation in subcanopy light levels under all sky conditions at different times of the day. A total of 4,592 individual subcanopy measurements of photosynthetic photon flux density (PPFD, mu mol m(-2) s(-1)) were taken as 15-second spatially-integrated one-meter linear averages to better understand the dynamism of light exposure to L. benzoin. Both open (n = 2, one continuous and one instantaneous) and subcanopy location (n = 25) measurements of PPFD were taken on each sampling date in and near the forested plot (Maryland, USA). In addition, we explored the effect of four photointensity-photoperiod combinations on the growth of L. benzoin under controlled conditions to compare to field conditions. On average, understory PPFD was less than 2% of open PPFD during the leafed months and an average of 38.8% of open PPFD during leafless winter months, indicating that: (1) often overlooked woody surfaces intercept large amounts of light; and (2) spicebush within the plot receive limited light even in early spring before canopy leaf-out. Statistical results suggested pheno-season accounted for nearly three-quarters of the variation in incident radiation between the three plant canopy heights. Spicebush under controlled conditions exhibited the highest fitness levels at an intensity of 164.5 mu mol m(-2) s(-1) for 12-hour duration. Similarly, spicebush growth in the field occurred at subcanopy locations receiving higher incidence of PPFD (i.e., >128 mu mol m(-2) s(-1)). Results suggest that the ecological niche for these plants is very specific in terms of light intensity.	[Hudson, Janice E.; Levia, Delphis F.; Hudson, Sean A.; Legates, David R.] Univ Delaware, Dept Geog, Newark, DE 19716 USA; [Levia, Delphis F.; Bais, Harsh P.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA; [Legates, David R.] Univ Delaware, Dept Appl Econ & Stat, Newark, DE USA	University of Delaware; University of Delaware; University of Delaware	Hudson, JE (corresponding author), Univ Delaware, Dept Geog, Newark, DE 19716 USA.	jehudson@udel.edu	Hudson, Janice/AAE-8820-2019	Hudson, Janice/0000-0002-4927-4892	Dr. John "Russ" Mather Graduate Fellows Research Fund	Dr. John "Russ" Mather Graduate Fellows Research Fund	This study was funded in part by the Dr. John "Russ" Mather Graduate Fellows Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON T, 1991, CAN J FOREST RES, V21, P917, DOI 10.1139/x91-127; [Anonymous], 2002, ECOLOGICAL CLIMATOLO; BALDOCCHI D, 1984, AGR FOREST METEOROL, V33, P177, DOI 10.1016/0168-1923(84)90069-8; Ballare CL, 2014, ANNU REV PLANT BIOL, V65, P335, DOI 10.1146/annurev-arplant-050213-040145; Ballare CL, 2012, PLANT PHYSIOL, V160, P145, DOI 10.1104/pp.112.200733; Canham CD, 1999, CAN J FOREST RES, V29, P1775, DOI 10.1139/cjfr-29-11-1775; Chazdon R. L., 1988, Advances in Ecological Research, V18, P1, DOI 10.1016/S0065-2504(08)60179-8; CHAZDON RL, 1991, BIOSCIENCE, V41, P760, DOI 10.2307/1311725; Dietze MC, 2014, PHOTOSYNTH RES, V119, P3, DOI 10.1007/s11120-013-9836-z; Gendron F, 2001, AGR FOREST METEOROL, V106, P23, DOI 10.1016/S0168-1923(00)00174-X; GHOLZ HL, 1991, ECOL MONOGR, V61, P33, DOI 10.2307/1942998; Govind A., 2014, INT J ECOL, DOI [10.1155/2014/712537, DOI 10.1155/2014/712537]; GROSS LJ, 1982, ECOLOGY, V63, P84, DOI 10.2307/1937034; HORN H S, 1971, P144; HUTCHISON BA, 1977, ECOL MONOGR, V47, P185, DOI 10.2307/1942616; Kikuzawa K, 1996, ANN BOT-LONDON, V77, P565, DOI 10.1006/anbo.1996.0071; KINERSON RS, 1973, J APPL ECOL, V10, P657, DOI 10.2307/2402309; Kitajima K, 2003, PLANT CELL ENVIRON, V26, P857, DOI 10.1046/j.1365-3040.2003.01017.x; Lawford R., 2011, WATER RESOURCES PLAN, P3; Leuchner M, 2007, AGR FOREST METEOROL, V142, P35, DOI 10.1016/j.agrformet.2006.10.014; Leuchner M, 2011, AGR FOREST METEOROL, V151, P1226, DOI 10.1016/j.agrformet.2011.04.014; Luken JO, 1997, AM MIDL NAT, V138, P331, DOI 10.2307/2426826; Mooney EH, 2012, ECOLOGY, V93, P2683, DOI 10.1890/11-1620.1; Mooney E, 2010, POPUL ECOL, V52, P417, DOI 10.1007/s10144-010-0197-6; Mooney EH, 2009, OIKOS, V118, P1181, DOI 10.1111/j.1600-0706.2009.17228.x; National Climatic Data Center (NCDC) National Oceanic and Atmospheric Administration, DAT TOOLS 1981 2010; NIESENBAUM RA, 1993, J ECOL, V81, P315, DOI 10.2307/2261501; NIESENBAUM RA, 1992, AM MIDL NAT, V128, P270, DOI 10.2307/2426460; Niesenbaum RA, 2006, ENVIRON ENTOMOL, V35, P600, DOI 10.1603/0046-225X-35.3.600; PERRY TO, 1969, ECOLOGY, V50, P39, DOI 10.2307/1934660; Piayda A, 2015, FOREST ECOL MANAG, V340, P103, DOI 10.1016/j.foreco.2014.12.026; Proe MF, 2002, BIOMASS BIOENERG, V23, P315, DOI 10.1016/S0961-9534(02)00060-0; PUKKALA T, 1991, AGR FOREST METEOROL, V55, P295, DOI 10.1016/0168-1923(91)90067-Z; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Scriber J.M., 1983, P373; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913	36	5	5	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185894	10.1371/journal.pone.0185894	http://dx.doi.org/10.1371/journal.pone.0185894			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023480	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100037
J	Thon, A; Teichgraber, U; Tennstedt-Schenk, C; Hadjidemetriou, S; Winzler, S; Malich, A; Papageorgiou, I				Thon, Anika; Teichgraeber, Ulf; Tennstedt-Schenk, Cornelia; Hadjidemetriou, Stathis; Winzler, Sven; Malich, Ansgar; Papageorgiou, Ismini			Computer aided detection in prostate cancer diagnostics: A promising alternative to biopsy? A retrospective study from 104 lesions with histological ground truth	PLOS ONE			English	Article							MULTIPARAMETRIC MRI; ACTIVE SURVEILLANCE; 3.0 TESLA; B-VALUE; SYSTEM; ADENOCARCINOMA; POPULATION; GRADE; LOCALIZATION; RADIOTHERAPY	Background Prostate cancer (PCa) diagnosis by means of multiparametric magnetic resonance imaging (mpMRI) is a current challenge for the development of computer-aided detection (CAD) tools. An innovative CAD-software (Watson Elementary (TM)) was proposed to achieve high sensitivity and specificity, as well as to allege a correlate to Gleason grade. Aim/Objective To assess the performance of Watson Elementary (TM) in automated PCa diagnosis in our hospital's database of MRI-guided prostate biopsies. Methods The evaluation was retrospective for 104 lesions (47 PCa, 57 benign) from 79, 64.61 +/- 6.64 year old patients using 3T T2-weighted imaging, Apparent Diffusion Coefficient (ADC) maps and dynamic contrast enhancement series. Watson Elementary (TM) utilizes signal intensity, diffusion properties and kinetic profile to compute a proportional Gleason grade predictor, termed Malignancy Attention Index (MAI). The analysis focused on (i) the CAD sensitivity and specificity to classify suspect lesions and (ii) the MAI correlation with the histopathological ground truth. Results The software revealed a sensitivity of 46.80% for PCa classification. The specificity for PCa was found to be 75.43% with a positive predictive value of 61.11%, a negative predictive value of 63.23% and a false discovery rate of 38.89%. CAD classified PCa and benign lesions with equal probability (P 0.06,chi(2) test). Accordingly, receiver operating characteristic analysis suggests a poor predictive value for MAI with an area under curve of 0.65 (P 0.02), which is not superior to the performance of board certified observers. Moreover, MAI revealed no significant correlation with Gleason grade (P 0.60, Pearson's correlation). Conclusion The tested CAD software for mpMRI analysis was a weak PCa biomarker in this dataset. Targeted prostate biopsy and histology remains the gold standard for prostate cancer diagnosis.	[Thon, Anika; Teichgraeber, Ulf] Friedrich Schiller Univ, Jena Univ Hosp, Dept Expt Radiol, Inst Diagnost & Intervent Radiol, Jena, Germany; [Thon, Anika; Winzler, Sven; Malich, Ansgar; Papageorgiou, Ismini] Suedharz Hosp Nordhausen gGmbH, Inst Radiol, Nordhausen, Germany; [Tennstedt-Schenk, Cornelia] Inst Pathol, Muhlhausen Pfafferode, Germany; [Hadjidemetriou, Stathis] Cyprus Univ Technol, Dept Elect Engn & Informat, Limassol, Cyprus	Friedrich Schiller University of Jena; Cyprus University of Technology	Papageorgiou, I (corresponding author), Suedharz Hosp Nordhausen gGmbH, Inst Radiol, Nordhausen, Germany.	ismini.papageorgiou@shk-ndh.de	Teichgräber, med. Ulf/H-8562-2019; Hadjidemetriou, Stathis/B-8283-2009; Papageorgiou, Ismini/AAI-7329-2020	Teichgräber, med. Ulf/0000-0002-4048-3938; Papageorgiou, Ismini/0000-0001-5810-0483				[Anonymous], 2015, PROST CANC SURV STAT; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Bittencourt LK, 2015, RADIOLOGY, V276, P479, DOI 10.1148/radiol.15141412; Bjurlin MA, 2014, J UROLOGY, V192, P648, DOI 10.1016/j.juro.2014.03.117; Bosaily AE, 2016, PROSTATE CANCER P D, V19, P258, DOI 10.1038/pcan.2016.7; Chang AJ, 2014, NAT REV CLIN ONCOL, V11, P308, DOI 10.1038/nrclinonc.2014.68; Filella X, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111784; Giannini V, 2017, EUR RADIOL, V27, P4200, DOI 10.1007/s00330-017-4805-0; Gibbs P, 2009, INVEST RADIOL, V44, P572, DOI 10.1097/RLI.0b013e3181b4c10e; Gottipati S, 2012, AM J SURG PATHOL, V36, P900, DOI 10.1097/PAS.0b013e3182495dee; Haider MA, 2008, INT J RADIAT ONCOL, V70, P425, DOI 10.1016/j.ijrobp.2007.06.029; Hambrock T, 2011, RADIOLOGY, V259, P453, DOI 10.1148/radiol.11091409; Hamoen EHJ, 2015, EUR UROL, V67, P1112, DOI 10.1016/j.eururo.2014.10.033; Harnden P, 2008, CANCER, V112, P971, DOI 10.1002/cncr.23277; Hayes JH, 2014, JAMA-J AM MED ASSOC, V311, P1143, DOI 10.1001/jama.2014.2085; Hegde JV, 2013, J MAGN RESON IMAGING, V37, P1035, DOI 10.1002/jmri.23860; Hugosson J, 2003, BJU INT, V92, P39, DOI 10.1111/j.1465-5101.2003.04396.x; Ilic D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004720.pub3; Kasel-Seibert M, 2016, EUR J RADIOL, V85, P726, DOI 10.1016/j.ejrad.2016.01.011; Kim CK, 2010, AM J ROENTGENOL, V194, pW33, DOI 10.2214/AJR.09.3004; Kim TH, 2015, EUR RADIOL, V25, P1786, DOI 10.1007/s00330-014-3566-2; Kirkham APS, 2006, EUR UROL, V50, P1163, DOI 10.1016/j.eururo.2006.06.025; Klotz L, 2014, NAT REV CLIN ONCOL, V11, P324, DOI 10.1038/nrclinonc.2014.73; Koo IH, 2013, KOREAN J RADIOL, V14, P61, DOI 10.3348/kjr.2013.14.1.61; Kozlowski P, 2006, J MAGN RESON IMAGING, V24, P108, DOI 10.1002/jmri.20626; Litjens G, 2014, IEEE T MED IMAGING, V33, P1083, DOI 10.1109/TMI.2014.2303821; Litjens GJS, 2015, EUR RADIOL, V25, P3187, DOI 10.1007/s00330-015-3743-y; Mahapatra D, 2014, IEEE T BIO-MED ENG, V61, P756, DOI 10.1109/TBME.2013.2289306; Metens T, 2012, EUR RADIOL, V22, P703, DOI 10.1007/s00330-011-2298-9; Moradi M, 2012, J MAGN RESON IMAGING, V35, P1403, DOI 10.1002/jmri.23540; Mottet N, 2016, EUR UROL; Oberlin DT, 2016, ABDOM RADIOL N Y; Parker G J, 1999, Top Magn Reson Imaging, V10, P130, DOI 10.1097/00002142-199904000-00006; Peng YH, 2013, RADIOLOGY, V267, P787, DOI 10.1148/radiol.13121454; Pron G, 2015, Ont Health Technol Assess Ser, V15, P1; Rabah DM, 2010, PROSTATE CANCER P D, V13, P191, DOI 10.1038/pcan.2009.60; Roethke MC, 2014, EUR RADIOL, V24, P344, DOI 10.1007/s00330-013-3017-5; Roethke MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159803; Sadimin ET, 2016, AM J SURG PATHOL, V40, P1686, DOI 10.1097/PAS.0000000000000714; SCHIEBLER ML, 1993, RADIOLOGY, V189, P339, DOI 10.1148/radiology.189.2.8210358; Shah V, 2012, MED PHYS, V39, P4093, DOI 10.1118/1.4722753; Speight JL, 2007, J CLIN ONCOL, V25, P987, DOI 10.1200/JCO.2006.10.3218; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tsivian M, 2016, INT J UROL OFF J JPN; Turkbey B, 2011, RADIOLOGY, V258, P488, DOI 10.1148/radiol.10100667; Vos EK, 2015, INVEST RADIOL, V50, P490, DOI 10.1097/RLI.0000000000000157; Wang S, 2014, BIOMED RES INT, V2014; Winters BR, 2016, UROLOGY, V96, P148, DOI 10.1016/j.urology.2016.04.058; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Zar JH, 2010, BIOSTAT ANAL, P3199; Zelhof B, 2009, BJU INT, V103, P883, DOI 10.1111/j.1464-410X.2008.08130.x	51	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185995	10.1371/journal.pone.0185995	http://dx.doi.org/10.1371/journal.pone.0185995			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023572	gold, Green Submitted, Green Published			2022-12-26	WOS:000412845100050
J	Acharya, P; Adhikari, TB; Neupane, D; Thapa, K; Bhandari, PM				Acharya, Pawan; Adhikari, Tara Ballav; Neupane, Dipika; Thapa, Kiran; Bhandari, Parash Mani			Correlates of institutional deliveries among teenage and non-teenage mothers in Nepal	PLOS ONE			English	Article							PREGNANCY; CARE; SERVICES; HEALTH	Introduction Globally, maternal age is identified as an important predictor of institutional service utilization during delivery. This study aims to assess the correlates of institutional delivery among teenage and non-teenage mothers in Nepal by using the data from Nepal Demographic and Health Survey 2011. Methods The study population consisted of 5391 women of reproductive age (15-49 years) who had given birth to a child within five years before the survey. Out of them, 381 (7.07%) were teenage mothers. The association between the background characteristics and institutional delivery was assessed separately for the teenage and non-teenage mothers using chi-square test and multiple logistic regression analysis. Results After adjusting for background characteristics, teenage mothers were found more likely to deliver at a health facility [AOR: 2.25; 95% CI: 1.10 4.59] in comparison to the non-teenage mothers. Place of residence, occupation, socioeconomic status, and frequency of ANC visits were associated with institutional delivery in both the teenage and non-teenage mothers. However, educational status, parity, birth preparedness and women autonomy had statistically significant association with institutional delivery among the non-teenage mothers only. None of the background characteristics were significantly associated with institutional delivery in teenage mothers only. Conclusions This study identified a significant difference in institutional delivery service utilization among the teenage and non-teenage mothers. While the association of most of the background characteristics with institutional delivery was uniform for both teenage and non-teenage mothers, the association with educational status, parity, birth preparedness and women autonomy was significant only for non-teenage mothers. Considering this difference in the interaction of women's background characteristics with institutional delivery between teenage and non-teenage mothers might help in identifying the pain points and devise targeted interventions to encourage institutional delivery in teenage mothers or non-teenage mothers or both.	[Acharya, Pawan; Adhikari, Tara Ballav; Bhandari, Parash Mani] Young Earth, Kathmandu, Nepal; [Adhikari, Tara Ballav] Univ Southern Denmark, Unit Hlth Promot Res, Esbjerg, Denmark; [Neupane, Dipika; Thapa, Kiran; Bhandari, Parash Mani] Inst Med, Maharajgunj Med Campus, Kathmandu, Nepal	University of Southern Denmark	Acharya, P (corresponding author), Young Earth, Kathmandu, Nepal.	ac.pawan@gmail.com	Adhikari, Tara Ballav/J-7071-2019	Adhikari, Tara Ballav/0000-0002-7654-5483				Acharya J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157746; Acharya P, 2016, J BIOSOC SCI, V48, P249, DOI 10.1017/S0021932015000073; Acharya P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2405-y; Agha S, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-31; Agho KE, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-2; Amano A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-105; Ameyaw EK, 2016, INT J REPROD MED, V2016; Babafemi A. A., 2012, Research Journal of Medical Sciences, V6, P251; Baral YR., 2012, HLTH SCI J, V6, P4; Bayu H, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.28082; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett L., 2008, CASTE ETHNIC REGIONA; Bolam A, 1998, HEALTH POLICY PLANN, V13, P152, DOI 10.1093/heapol/13.2.152; Corcoran J, 2016, SOCIETIES, V6, DOI 10.3390/soc6030021; Dahiru T, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.321.6527; Fikre AA, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-33; Karkee R, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-193; Karkee R, 2013, MIDWIFERY, V29, P1206, DOI 10.1016/j.midw.2013.05.002; Khanal V, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-19; Khanal V, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-9; Lee S, 2012, HEALTH RISK SOC, V14, P511, DOI 10.1080/13698575.2012.701277; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Ministry of Health and Population Nepal, 2007, NEP DEM HLTH SURV 20; Ministry of Health [Nepal] NE, 1996, NEP FAM HLTH SURV 19; Ministry of Health [Nepal] New ERA ORC Macro, 2002, NEP DEM HLTH SURV 20; New ERA, 2010, FAM PLANN MAT NEWB C; Onah HE, 2006, SOC SCI MED, V63, P1870, DOI 10.1016/j.socscimed.2006.04.019; Osamor PE, 2016, INT J WOMENS HEALTH, V8, P191, DOI 10.2147/IJWH.S105483; Pandey A, 2011, J Nepal Health Res Counc, V9, P86; Pradhan R, 2016, PREGNANCY ADOLESCENT; Raj AD, 2010, HLTH SCI J, V4; Rajendra K, 2012, JNMA J NEPAL MED ASS, V52; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; SCHOLL TO, 1994, J ADOLESCENT HEALTH, V15, P444, DOI 10.1016/1054-139X(94)90491-K; Senderowitz J, 1995, ADOLESCENT HLTH REAS; Shah R, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0454-y; Shakya G, 2004, REPROD HEALTH MATTER, V12, P75, DOI 10.1016/S0968-8080(04)24007-1; Sharma G, 2012, HLTH SCI J, V6, P317; Shrestha SK, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-25; Sudhinaraset M, 2016, BMC PREGNANCY CHILDB, V16; Sugathan KS, 2001, PROMOTING I DELIVERI; The DHS Program, 2017, PROT PRIV DHS SURV R; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wagle Rajendra Raj, 2004, BMC Pregnancy Childbirth, V4, P8, DOI 10.1186/1471-2393-4-8; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT	45	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185667	10.1371/journal.pone.0185667	http://dx.doi.org/10.1371/journal.pone.0185667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020047	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400040
J	Joly, B; Perriot, J; d'Athis, P; Chazard, E; Brousse, G; Quantin, C				Joly, Bertrand; Perriot, Jean; d'Athis, Philippe; Chazard, Emmanuel; Brousse, Georges; Quantin, Catherine			Success rates in smoking cessation: Psychological preparation plays a critical role and interacts with other factors such as psychoactive substances	PLOS ONE			English	Article							MENTAL-HEALTH; REDUCTION INTERVENTION; TOBACCO DEPENDENCE; HOSPITAL ANXIETY; QUIT SMOKING; DEPRESSION; SMOKERS; PREDICTORS; ASSOCIATION; WITHDRAWAL	Introduction The aim of this study was to identify factors associated with the results of smoking cessation attempts. Methods Data were collected in Clermont-Ferrand from a smoking cessation clinic between 1999 and 2009 (1,361 patients). Smoking cessation was considered a success when patients were abstinent 6 months after the beginning of cessation. Multivariate logistic regression was used to investigate the association between abstinence and different factors. Results The significant factors were a history of depression (ORadjusted = 0.57, p = 0.003), state of depression at the initial consultation (ORa = 0.64, p = 0.005), other psychoactive substances (ORa = 0.52, p<0.0001), heart, lung and Ear-Nose-Throat diseases (ORa = 0.65, p = 0.005), age (ORa = 1.04, p<0.0001), the Richmond test (p<0.0001; when the patient's motivation went from insufficient to moderate, the frequency of abstinence was twice as high) and the Prochaska algorithm (p<0.0001; when the patient went from the 'pre-contemplation' to the 'contemplation' level, the frequency of success was four times higher). A high score in the Richmond test had a greater impact on success with increasing age (significant interaction: p = 0.01). In exclusive smokers, the contemplation level in the Prochaska algorithm was enough to obtain a satisfactory abstinence rate (65.5%) whereas among consumers of other psychoactive substances, it was necessary to reach the preparation level in the Prochaska algorithm to achieve a success rate greater than 50% (significant interaction: p = 0.02). Conclusion The psychological preparation of the smoker plays a critical role. The management of smoking cessation must be personalized, especially for consumers of other psychoactive substances and/or smokers with a history of depression.	[Joly, Bertrand; d'Athis, Philippe; Quantin, Catherine] Univ Hosp, Biostat & Bioinformat DIM, Dijon, France; [Joly, Bertrand; d'Athis, Philippe; Quantin, Catherine] Bourgogne Franche Comte Univ, Dijon, France; [Perriot, Jean] Ctr Lutte AntiTB CLAT, Ctr Aide Arret Tabagisme IRAAT, Dispensaire Emile Roux, Clermont Ferrand, France; [Chazard, Emmanuel] Univ Lille, CHU Lille, Dept Publ Hlth, Lille, France; [Brousse, Georges] Univ Clermont 1, Psychiat Dept Addictol B, UFR Med, Clermont Ferrand, France; [Brousse, Georges] CHU Clermont Ferrand, Clermont Ferrand, France; [Quantin, Catherine] INSERM, CIC 1432, Dijon, France; [Quantin, Catherine] Dijon Univ Hosp, Clin Invest Ctr, Clin Epidemiol Clin Trials Unit, Dijon, France; [Quantin, Catherine] Univ Paris Saclay, Inst Pasteur, INSERM, UVSQ,Biostat Biomath Pharmacoepidemiol & Infect D, Paris, France	CHU Dijon Bourgogne; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay	Quantin, C (corresponding author), Univ Hosp, Biostat & Bioinformat DIM, Dijon, France.; Quantin, C (corresponding author), Bourgogne Franche Comte Univ, Dijon, France.; Quantin, C (corresponding author), INSERM, CIC 1432, Dijon, France.; Quantin, C (corresponding author), Dijon Univ Hosp, Clin Invest Ctr, Clin Epidemiol Clin Trials Unit, Dijon, France.; Quantin, C (corresponding author), Univ Paris Saclay, Inst Pasteur, INSERM, UVSQ,Biostat Biomath Pharmacoepidemiol & Infect D, Paris, France.	catherine.quantin@chu-dijon.fr		Quantin, Catherine/0000-0001-5134-9411				Abdullah AS, 2015, TOB INDUC DIS, V13, DOI 10.1186/s12971-015-0050-y; [Anonymous], 2001, EXP COLL TAB COMPR A; [Anonymous], LOW NIC DEP HIGH SEL; Aubin D Henri-Jean, NICOTINE TROUBLES NE; Benson Fiona E, 2014, BMC Public Health, V14, P695, DOI 10.1186/1471-2458-14-695; Codern-Bove N, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1225; Cordoba R, 2000, Aten Primaria, V25, P32; Cox LS, 2002, J CLIN ONCOL, V20, P3461, DOI 10.1200/JCO.2002.10.085; d'addictologie Traite, TRAITE DADDICTOLOGIE; Dautzenberg B, 2012, B CANCER, V99, P1007, DOI 10.1684/bdc.2012.1656; Emre N, 2014, TOB INDUC DIS, V12, DOI 10.1186/1617-9625-12-20; Etter JF, 1997, PREV MED, V26, P580, DOI 10.1006/pmed.1997.0179; FAGERSTROM K O, 1990, Ear Nose and Throat Journal, V69, P763; Ghani WMN, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-207; Gillet C, 2007, ALCOOL ADDICTOL, V29, P390; GRITZ ER, 1991, CANCER CAUSE CONTROL, V2, P105, DOI 10.1007/BF00053129; Hall SM, 2015, ADDICT BEHAV, V42, P148, DOI [10.1016/J.addbeh.2014.11.012, 10.1016/j.addbeh.2014.11.012]; Hartmann-Boyce J, 2014, ADDICTION, V109, P1414, DOI 10.1111/add.12633; Hitsman B, 2013, ADDICTION, V108, P294, DOI 10.1111/add.12009; Hollands GJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009164.pub2; Jimenez-Ruiz C A, 2013, Monaldi Arch Chest Dis, V79, P33; Karam-Hage M, 2014, CA-CANCER J CLIN, V64, P273, DOI 10.3322/caac.21231; Kotz D, 2014, MAYO CLIN PROC, V89, P1360, DOI 10.1016/j.mayocp.2014.07.004; Kotz D, 2014, ADDICTION, V109, P491, DOI 10.1111/add.12429; Lam TH, 2015, TOB INDUC DIS, V13, DOI 10.1186/s12971-015-0034-y; Leventhal A, 2014, EVID-BASED MENT HEAL, V17, pE3, DOI 10.1136/eb-2013-101573; Leventhal AM, 2012, PSYCHOL ADDICT BEHAV, V26, P838, DOI 10.1037/a0028449; Lopez-Torrecillas F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1217; Lorencatto F, 2016, ANN BEHAV MED, V50, P310, DOI 10.1007/s12160-015-9755-7; Mackowick KM, 2012, CURR PSYCHIAT REP, V14, P478, DOI 10.1007/s11920-012-0299-2; Mendelsohn CP, 2015, AUSTRALAS PSYCHIATRY, V23, P37, DOI 10.1177/1039856214562076; Moore David, 2009, BMJ, V338, pb1024, DOI 10.1136/bmj.b1024; Navarrete S, 2013, REV MED CHIL MARS, V141, P345; Nayan S, 2013, OTOLARYNG HEAD NECK, V149, P200, DOI 10.1177/0194599813490886; Ostroff J, 2000, J CANCER EDUC, V15, P86; OSTROFF JS, 1995, CANCER-AM CANCER SOC, V75, P569, DOI 10.1002/1097-0142(19950115)75:2<569::AID-CNCR2820750221>3.0.CO;2-I; Perriot J, 2006, REV MAL RESPIR, V23, pS85, DOI 10.1019/200530197; Perriot J, 2003, TABACOLOGIE SEVRAGE; Piper ME, 2011, ADDICTION, V106, P418, DOI 10.1111/j.1360-0443.2010.03173.x; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; RICHMOND RL, 1993, ADDICTION, V88, P1127, DOI 10.1111/j.1360-0443.1993.tb02132.x; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; de Azevedo RCS, 2011, SAO PAULO MED J, V129, P380, DOI 10.1590/S1516-31802011000600003; de Azevedo RCS, 2009, REV ASSOC MED BRAS, V55, P593, DOI 10.1590/S0104-42302009000500025; Stead LF, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009670.pub3; Stolz D, 2014, RESPIRATION, V87, P18, DOI 10.1159/000346646; Tavolacci M-P, 2010, SANTE PUBLIQUE, V21, P583; Taylor G, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2473-z; van der Meer RM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006102.pub2; van Eerd EAM, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0382-y; Wu L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1749-7; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zorick T, 2014, J CLIN PSYCHIAT, V75, pE1433, DOI 10.4088/JCP.14m09012; Zvolensky MJ, 2015, ADDICT BEHAV, V40, P126, DOI 10.1016/j.addbeh.2014.08.012	54	9	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0184800	10.1371/journal.pone.0184800	http://dx.doi.org/10.1371/journal.pone.0184800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020085	Green Published, gold, Green Submitted			2022-12-26	WOS:000412754400017
J	Kampfer, K; Leischnig, A; Ivens, BS; Spence, C				Kampfer, Kristina; Leischnig, Alexander; Ivens, Bjoern Sven; Spence, Charles			Touch-flavor transference: Assessing the effect of packaging weight on gustatory evaluations, desire for food and beverages, and willingness to pay	PLOS ONE			English	Article							HAPTIC CUES; PERCEPTION; PRODUCT; CONSUMER; TASTE; CONTAINER; CONSUMPTION; VOLUME; INFORMATION; INFERENCES	Product packaging serves a number of distinct functions and influences the way in which consumers respond to various product offerings. The research reported here examines whether the haptic characteristics of a non-diagnostic product packaging cue, namely its weight, affects the response of consumers. This article reviews existing research on haptic transference and proposes a conceptual framework to explore how the weight of product packaging affects the flavor of the food or beverages, and, in turn, consumers' desire for consumption and willingness to pay. Two studies demonstrate that an increase in packaging weight affects both desire and willingness to pay for the product. These effects are serially mediated by perceived flavor intensity and overall flavor evaluation. Based on these insights, implications for the design of food and beverages packaging are discussed.	[Kampfer, Kristina; Ivens, Bjoern Sven] Univ Bamberg, Dept Mkt, Feldkirchenstr 21, Bamberg, Germany; [Leischnig, Alexander] Queen Mary Univ London, Sch Business & Management, London, England; [Spence, Charles] Univ Oxford, Dept Expt Psychol, Oxford, England	Otto Friedrich University Bamberg; University of London; Queen Mary University London; University of Oxford	Ivens, BS (corresponding author), Univ Bamberg, Dept Mkt, Feldkirchenstr 21, Bamberg, Germany.	bjoern.ivens@uni-bamberg.de	; Ivens, Bjoern/L-9596-2016	Kampfer, Kristina/0000-0003-4491-734X; Ivens, Bjoern/0000-0001-8510-5212	AHRC [AH/L007053/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/L007053/1] Funding Source: researchfish	AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))		Ackerman JM, 2010, SCIENCE, V328, P1712, DOI 10.1126/science.1189993; Allen MW, 2008, J CONSUM RES, V35, P294, DOI 10.1086/590319; Auvray M, 2008, CONSCIOUS COGN, V17, P1016, DOI 10.1016/j.concog.2007.06.005; Barnett-Cowan M, 2010, PERCEPTION, V39, P1684, DOI 10.1068/p6784; Becker L, 2011, FOOD QUAL PREFER, V22, P17, DOI 10.1016/j.foodqual.2010.06.007; BELLISLE F, 1980, APPETITE, V1, P141, DOI 10.1016/S0195-6663(80)80018-3; Biggs L, 2016, FOOD QUAL PREFER, V50, P129, DOI 10.1016/j.foodqual.2016.02.007; BOBROFF EM, 1986, APPETITE, V7, P85, DOI 10.1016/S0195-6663(86)80044-7; Byron E., 2012, WALL STREET J; Chandon P, 2010, FOUND TRENDS MARKET, V5, P113, DOI 10.1561/1700000016; Cheskin L., 1957, PREDICT WHAT PEOPLE; Deng XY, 2009, J MARKETING RES, V46, P725, DOI 10.1509/jmkr.46.6.725; DICK A, 1990, J CONSUM RES, V17, P82, DOI 10.1086/208539; Gallace A., 2014, TOUCH FUTURE SENSE T; Gatti E, 2014, FOOD QUAL PREFER, V31, P56, DOI 10.1016/j.foodqual.2013.08.004; Hayes A. F., 2012, PROCESS VERSATILE CO; Hilton K., 2015, HARVARD BUS REV; Hine T., 1997, TOTAL PACKAGE SECRET; Hoegg J, 2007, J CONSUM RES, V33, P490, DOI 10.1086/510222; Irmak C, 2011, J CONSUM RES, V38, P390, DOI 10.1086/660044; Kozup JC, 2003, J MARKETING, V67, P19, DOI 10.1509/jmkg.67.2.19.18608; KRISHNA A, 1991, J MARKETING RES, V28, P441, DOI 10.1177/002224379102800406; Krishna A, 2006, J CONSUM RES, V32, P557, DOI 10.1086/500486; Krishna A, 2008, J CONSUM RES, V34, P807, DOI 10.1086/523286; Krishna A, 2012, J CONSUM PSYCHOL, V22, P332, DOI 10.1016/j.jcps.2011.08.003; Krueger L.E., 1989, THE WORLD OF TOUCH; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; LEHRER A, 1975, LANGUAGE, V51, P901, DOI 10.2307/412700; Liang P, 2013, BEHAV BRAIN RES, V253, P42, DOI 10.1016/j.bbr.2013.07.001; Lin HM, 2013, INT J RES MARK, V30, P308, DOI 10.1016/j.ijresmar.2013.03.002; Maggioni E, 2015, J SENS STUD, V30, P395, DOI 10.1111/joss.12166; McCabe DB, 2003, J CONSUM PSYCHOL, V13, P431, DOI 10.1207/S15327663JCP1304_10; MCDANIEL C, 1977, J MARKETING, V41, P57, DOI 10.2307/1250234; Michel C., 2015, FLAVOUR, V4, P1, DOI DOI 10.1186/S13411-015-0036-Y; Orth UR, 2008, J MARKETING, V72, P64, DOI 10.1509/jmkg.72.3.64; Peck J, 2003, J CONSUM RES, V30, P430, DOI 10.1086/378619; Piqueras-Fiszman B, 2012, FOOD QUAL PREFER, V25, P41, DOI 10.1016/j.foodqual.2012.01.001; Piqueras-Fiszman B, 2012, APPETITE, V58, P559, DOI 10.1016/j.appet.2011.12.021; Piqueras-Fiszman B, 2011, FOOD QUAL PREFER, V22, P753, DOI 10.1016/j.foodqual.2011.05.009; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Raghubir P, 1999, J MARKETING RES, V36, P313, DOI 10.2307/3152079; Raghunathan R, 2006, J MARKETING, V70, P170, DOI 10.1509/jmkg.70.4.170; Seiders K, 2004, J PUBLIC POLICY MARK, V23, P153, DOI 10.1509/jppm.23.2.153.51406; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Spence C., 2012, FLAVOUR, V1, P1, DOI DOI 10.1186/2044-7248-1-12; Spence C., 2011, ART SENSES, P207; Spence C, 2014, THEORIA HIST SCI, V10, P207, DOI [DOI 10.2478/THS-2013-0011, 10.12775/ths-2013-0011]; Spence C., 2012, FLAVOUR, V1, P7, DOI [10.1186/2044-7248-1-7, DOI 10.1186/2044-7248-1-7]; Spence C., 2011, P RIGHTWEIGHT, V2, P8; Spence C, 2015, FOOD QUAL PREFER, V39, P131, DOI 10.1016/j.foodqual.2014.07.007; Spence C, 2011, PSYCHOL MARKET, V28, P267, DOI 10.1002/mar.20392; Troye SV, 2012, J MARKETING, V76, P33, DOI 10.1509/jm.10.0205; Tu YJ, 2015, FOOD QUAL PREFER, V39, P124, DOI 10.1016/j.foodqual.2014.07.001; Vartanian LR, 2008, HEALTH PSYCHOL, V27, P533, DOI 10.1037/0278-6133.27.5.533; Velasco C, 2014, FOOD QUAL PREFER, V34, P88, DOI 10.1016/j.foodqual.2013.12.005; Wansink B, 2001, FOOD QUAL PREFER, V12, P69, DOI 10.1016/S0950-3293(00)00031-8; Wansink B., 2003, ADV CONSUM RES, V30, P363; Westerman SJ, 2012, PSYCHOL MARKET, V29, P595, DOI 10.1002/mar.20546; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Zampini M, 2006, NEUROSCI LETT, V400, P235, DOI 10.1016/j.neulet.2006.02.068; Zellner DA, 2003, AM J PSYCHOL, V116, P633, DOI 10.2307/1423663	61	31	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186121	10.1371/journal.pone.0186121	http://dx.doi.org/10.1371/journal.pone.0186121			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020078	Green Published, gold, Green Submitted			2022-12-26	WOS:000412754400070
J	Kim, JH; Chung, I; Kim, KM				Kim, Jin-Hee; Chung, Il Kyung; Kim, Kyung-Min			Construction of a genetic map using EST-SSR markers and QTL analysis of major agronomic characters in hexaploid sweet potato (Ipomoea batatas (L.) Lam)	PLOS ONE			English	Article							LINKAGE MAP; ARBITRARY PRIMERS; AFLP MARKERS; DRY-MATTER; RICE; TRANSFERABILITY; IDENTIFICATION; WHEAT	The Sweet potato, Ipomoea batatas (L.) Lam, is difficult to study in genetics and genomics because it is a hexaploid. The sweet potato study not have been performed domestically or internationally. In this study was performed to construct genetic map and quantitative trait loci (QTL) analysis. A total of 245 EST-SSR markers were developed, and the map was constructed by using 210 of those markers. The total map length was 1508.1 cM, and the mean distance between markers was 7.2 cM. Fifteen characteristics were investigated for QTLs analysis. According to those, the Four QTLs were identified, and The LOD score was 3.0. Further studies need to develop molecular markers in terms of EST-SSR markers for doing to be capable of efficient breeding. The genetic map created here using EST-SSR markers will facilitate planned breeding of sweet potato cultivars with various desirable traits.	[Kim, Jin-Hee; Kim, Kyung-Min] Kyungpook Natl Univ, Coll Agr & Life Sci, Sch Appl Biosci, Daegu, South Korea; [Chung, Il Kyung] Catholic Univ Daegu, Dept Biotechnol, Gyongsan, Gyeongbuk, South Korea	Kyungpook National University; Catholic University of Daegu	Kim, KM (corresponding author), Kyungpook Natl Univ, Coll Agr & Life Sci, Sch Appl Biosci, Daegu, South Korea.	kkm@knu.ac.kr		Kim, Kyung-Min/0000-0003-4812-6297				Cervantes-Flores JC, 2011, MOL BREEDING, V28, P201, DOI 10.1007/s11032-010-9474-5; Cervantes-Flores JC, 2008, MOL BREEDING, V21, P511, DOI 10.1007/s11032-007-9150-6; Eujayl I, 2004, THEOR APPL GENET, V108, P414, DOI 10.1007/s00122-003-1450-6; Gupta P. K., 2004, Functional & Integrative Genomics, V4, P139, DOI 10.1007/s10142-004-0107-0; Kim JH, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0565-9; Kriegner A, 2003, MOL BREEDING, V11, P169, DOI 10.1023/A:1022870917230; MARTIN FW, 1970, BOT GAZ, V131, P139, DOI 10.1086/336524; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; MCCOUCH SR, 1988, THEOR APPL GENET, V76, P815, DOI 10.1007/BF00273666; McCouch SR, 2008, RICE, V1, P72, DOI 10.1007/s12284-008-9004-9; Mukhopadhyay SK, 2011, FOOD SECUR, V3, P283, DOI 10.1007/s12571-011-0134-3; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; TING YC, 1953, J HERED, V44, P207, DOI 10.1093/oxfordjournals.jhered.a106395; TINGEY SV, 1993, PLANT PHYSIOL, V101, P349, DOI 10.1104/pp.101.2.349; Ukoskit K, 1997, J AM SOC HORTIC SCI, V122, P818, DOI 10.21273/JASHS.122.6.818; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Wang ZY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-139; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Zhang LY, 2005, THEOR APPL GENET, V111, P677, DOI 10.1007/s00122-005-2041-5; Zhao N, 2013, MOL BREEDING, V32, P807, DOI 10.1007/s11032-013-9908-y	21	6	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185073	10.1371/journal.pone.0185073	http://dx.doi.org/10.1371/journal.pone.0185073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020092	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400020
J	McCurley, NP; Domi, A; Basu, R; Saunders, KO; LaBranche, CC; Montefiori, DC; Haynes, BF; Robinson, HL				McCurley, Nathanael P.; Domi, Arban; Basu, Rahul; Saunders, Kevin O.; LaBranche, Celia C.; Montefiori, David C.; Haynes, Barton F.; Robinson, Harriet L.			HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site	PLOS ONE			English	Article							DNA/MVA VACCINE; VIRUS; EXPRESSION; BROAD; IMMUNOGENICITY; TYPE-1; INFECTION; DESIGN; VRC01	Here we report the construction, antigenicity and initial immunogenicity testing of DNA and modified vaccinia Ankara (MVA) vaccines expressing virus-like particles (VLPs) displaying sequential clade C Envelopes (Envs) that co-evolved with the elicitation of broadly neutralizing antibodies (bnAbs) to the CD4 binding site (CD4bs) in HIV-infected individual CH0505. The VLP-displayed Envs showed reactivity for conformational epitopes displayed on the receptor-binding form of Env. Two inoculations of the DNA-T/F vaccine, followed by 3 inoculations of the MVA-T/F vaccine and a final inoculation of the MVA-T/F plus a gp120-T/F protein vaccine elicited nAb to the T/F virus in 2 of 4 rhesus macaques (ID50 of similar to 175 and similar to 30). Neutralizing Ab plateaued at 100% neutralization and mapped to the CD4bs like the bnAbs elicited in CH0505. The nAb did not have breadth for other tier 2 viruses. Immunizations with T/F followed by directed-lineage vaccines, both with and without co-delivery of directed-lineage gp120 boosts, failed to elicit tier 2 neutralizing Ab for the CD4bs. Thus, pulsed exposures to DNA and MVA-expressed VLPs plus gp120 protein of a T/F Env can induce autologous tier 2 nAbs to the CD4bs.	[McCurley, Nathanael P.; Domi, Arban; Basu, Rahul; Robinson, Harriet L.] GeoVax Inc, Smyrna, GA USA; [Saunders, Kevin O.; LaBranche, Celia C.; Montefiori, David C.; Haynes, Barton F.] Duke Human Vaccine Inst, Durham, NC USA		Robinson, HL (corresponding author), GeoVax Inc, Smyrna, GA USA.	hrobinson@geovax.com		Robinson, Harriet/0000-0001-6380-3458	NIH [R43A I 120887, UM1 AI100645, HHSN2720100016C]; GeoVax, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GeoVax, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH grants R43A I 120887 to A D, UM1 AI100645 (Duke CHAVI-ID) to BFH and HHSN2720100016C to DCM. GeoVax, Inc. provided support in the form of salary for HLR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Specific roles of these authors are articulated in the "author contributions' section.	Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Chen J, 2015, SCIENCE, V349, P191, DOI 10.1126/science.aaa9804; DAAR ES, 1990, P NATL ACAD SCI USA, V87, P6574, DOI 10.1073/pnas.87.17.6574; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Eroshkin AM, 2014, NUCLEIC ACIDS RES, V42, pD1133, DOI 10.1093/nar/gkt1083; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lynch RM, 2015, J VIROL, V89, P4201, DOI 10.1128/JVI.03608-14; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; Mouquet H, 2012, CELL MOL LIFE SCI, V69, P1435, DOI 10.1007/s00018-011-0872-6; Sarzotti-Kelsoe M, 2013, J IMMUNOL METHODS; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Smith JM, 2004, AIDS RES HUM RETROV, V20, P1335, DOI 10.1089/aid.2004.20.1335; Smith JM, 2004, AIDS RES HUM RETROV, V20, P654, DOI 10.1089/0889222041217419; Sok D, 2016, IMMUNITY, V45, P31, DOI 10.1016/j.immuni.2016.06.026; Wibmer CK, 2015, CURR OPIN HIV AIDS, V10, P135, DOI 10.1097/COH.0000000000000153; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt LS, 2008, VIROLOGY, V372, P260, DOI 10.1016/j.virol.2007.10.033; Wyatt LS, 2008, VACCINE, V26, P486, DOI 10.1016/j.vaccine.2007.11.036; Wyatt LS, 2009, J VIROL, V83, P7176, DOI 10.1128/JVI.00687-09; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zhou T D- RN, 2017, ELL REP IN PRESS; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	27	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0177863	10.1371/journal.pone.0177863	http://dx.doi.org/10.1371/journal.pone.0177863			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020058	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400001
J	Wu, GC; Li, HW; Tey, WG; Lin, CJ; Chang, CF				Wu, Guan-Chung; Li, Hau-Wen; Tey, Wei-Guan; Lin, Chien-Ju; Chang, Ching-Fong			Expression profile of amh/Amh during bidirectional sex change in the protogynous orange-spotted grouper Epinephelus coioides	PLOS ONE			English	Article							PROTANDROUS BLACK PORGY; MULLERIAN-INHIBITING SUBSTANCE; GERM-CELLS; HORMONE; FEMALE; DIFFERENTIATION; FISH; PROLIFERATION; MEDAKA; GENE	Gonadal differentiation is tightly regulated by the initial sex determining gene and the downstream sex-related genes in vertebrates. However, sex change in fish can alter the sexual fate from one sex to the other. Chemical-induced maleness in the protogynous orange-spotted grouper is transient, and a reversible sex change occurs after the chemical treatment is withdrawn. We used these characteristics to study Amh signaling during bi-directional sex change in the grouper. We successfully induced the female-to-male sex change by chemical (aromatase inhibitor, AI, or methyltestosterone, MT) treatment. A dormant gonad (a low proliferation rate of early germ cells and no characteristics of both sexes) was found during the transient phase of reversible male-to-female sex change after the withdrawal of chemical administration. Our results showed that amh (anti-mullerian hormone) and its receptor amhr2 (anti-mullerian hormone receptor type 2) were significantly increased in the gonads during the process of female-to-male sex change. Amh is expressed in the Sertoli cells surrounding the type A spermatogonia in the female-to-male grouper. Male-related gene (dmrt1 and sox9) expression was immediately decreased in MT-terminated males during the reversible male-to-female sex change. However, Amh expression was found in the surrounding cells of type A spermatogonia-like cells during the transient phase of reversible male-to-female sex change. This phenomenon is correlated with the dormancy of type A spermatogonia-like cells. Thus, Amh signaling is suggested to play roles in regulating male differentiation during the female-to-male sex change and in inhibiting type-A spermatogonia-like cell proliferation/ differentiation during the reversible male-to-female sex change. We suggest that Amh signaling might play dual roles during bi-directional sex change in grouper.	[Wu, Guan-Chung; Li, Hau-Wen; Tey, Wei-Guan; Lin, Chien-Ju; Chang, Ching-Fong] Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan; [Wu, Guan-Chung; Chang, Ching-Fong] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan	National Taiwan Ocean University; National Taiwan Ocean University	Wu, GC; Chang, CF (corresponding author), Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan.; Wu, GC; Chang, CF (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan.	gcwu@mail.ntou.edu.tw; B0044@email.ntou.edu.tw		Lin, Chien-Ju/0000-0002-9050-6181	Ministry of Science and Technology [105-2811-B-019-006-MY3, 105-2313-B-019-008MY3]; Ministry of Education, Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by the Ministry of Science and Technology project number 105-2811-B-019-006-MY3 and 105-2313-B-019-008MY3, and Ministry of Education, Taiwan.; The English was edited by the American Journal Experts. This work was supported by the Ministry of Science and Technology Project no. 105-2811-B-019-006-MY3 and no. 105-2313B-019-008-MY3, and the Ministry of Education, Taiwan.	Alam MA, 2006, MOL REPROD DEV, V73, P206, DOI 10.1002/mrd.20393; [Anonymous], 2010, GEN COMP ENDOCR, V165, P352; Bagheri-Fam S, 2008, DEV BIOL, V314, P71, DOI 10.1016/j.ydbio.2007.11.010; Bullejos M, 2005, DEV BIOL, V278, P473, DOI 10.1016/j.ydbio.2004.11.030; CATE RL, 1986, CELL, V45, P685, DOI 10.1016/0092-8674(86)90783-X; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; di Clemente N, 2003, MOL CELL ENDOCRINOL, V211, P9, DOI 10.1016/j.mce.2003.09.005; Eicher EM, 2001, J EXP ZOOL, V290, P322, DOI 10.1002/jez.1072; Hattori RS, 2012, P NATL ACAD SCI USA, V109, P2955, DOI 10.1073/pnas.1018392109; Kamiya T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002798; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Kim Y, 2006, DEV DYNAM, V235, P2292, DOI 10.1002/dvdy.20894; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; Lee YH, 2004, BIOL REPROD, V71, P1270, DOI 10.1095/biolreprod.104.030221; Liu W, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2130-z; Mei J, 2015, SCI CHINA LIFE SCI, V58, P124, DOI 10.1007/s11427-014-4797-9; Miura T, 2002, DEVELOPMENT, V129, P2689; Morinaga C, 2007, P NATL ACAD SCI USA, V104, P9691, DOI 10.1073/pnas.0611379104; Murata R, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.115378; Nakamura S, 2012, DEVELOPMENT, V139, P2283, DOI 10.1242/dev.076307; Nishimura T, 2015, SCIENCE, V349, P328, DOI 10.1126/science.aaa2657; Nozu R, 2013, FISH PHYSIOL BIOCHEM, V39, P47, DOI 10.1007/s10695-012-9632-2; Pfennig F, 2015, GEN COMP ENDOCR, V223, P87, DOI 10.1016/j.ygcen.2015.09.025; POLICANSKY D, 1982, ANNU REV ECOL SYST, V13, P471, DOI 10.1146/annurev.es.13.110182.002351; Ren WY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005180; Rocha A, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137547; de Mitcheson YS, 2008, FISH FISH, V9, P1, DOI 10.1111/j.1467-2979.2007.00266.x; Shiraishi E, 2008, ENDOCRINOLOGY, V149, P1813, DOI 10.1210/en.2007-1535; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Skaar KS, 2011, ENDOCRINOLOGY, V152, P3527, DOI 10.1210/en.2010-1469; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Wu GC, 2016, PLOS ONE, V10; Wu GC, 2017, GEN COMP ENDOCRINOL; Wu GC, 2008, BIOL REPROD, V78, P200, DOI 10.1095/biolreprod.107.062612; Wu GC, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.126953; Wu GC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104398; Wu GC, 2013, FISH PHYSIOL BIOCHEM, V39, P33, DOI 10.1007/s10695-012-9618-0; Wu GC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095695; Wu GC, 2010, BIOL REPROD, V83, P443, DOI 10.1095/biolreprod.110.084681; Xia W, 2007, MOL CELL ENDOCRINOL, V263, P156, DOI 10.1016/j.mce.2006.09.014; Yoshizaki G., 2010, Animal Reproduction, V7, P187; Zhou L, 2010, FISH PHYSIOL BIOCHEM, V36, P181, DOI 10.1007/s10695-008-9219-0	42	20	21	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185864	10.1371/journal.pone.0185864	http://dx.doi.org/10.1371/journal.pone.0185864			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016690	gold, Green Published, Green Submitted			2022-12-26	WOS:000412627400032
J	Chu, Q; Yan, ZX; Zhang, J; Usman, T; Zhang, Y; Liu, H; Wang, HH; Geng, AL; Liu, HG				Chu, Qin; Yan, Zhixun; Zhang, Jian; Usman, Tahir; Zhang, Yao; Liu, Hui; Wang, Haihong; Geng, Ailian; Liu, Huagui			Association of SNP rs80659072 in the ZRS with polydactyly in Beijing You chickens	PLOS ONE			English	Article							TRIPHALANGEAL THUMB; SHH; MUTATION; EXPRESSION; INHERITANCE; FOWL	The Beijing You chicken is a Chinese native breed with superior meat quality and a unique appearance. The G/T mutation of SNP rs80659072 in the Shh long-range regulator of GGA2 is highly associated with the polydactyly phenotype in some chicken breeds. In the present study, this SNP was genotyped using the TaqMan detection method, and its association with the number of toes was analyzed in a flock of 158 birds of the Beijing You population maintained at the Beijing Academy of Agriculture and Forestry Sciences. Furthermore, the skeletal structure of the digits was dissected and assembled in 113 birds. The findings revealed that the toes of Beijing You chickens were rich and more complex than expected. The plausible mutation rs80659072 in the zone of polarizing activity regulatory sequence (ZRS) in chickens was an essential but not sufficient condition for polydactyly and polyphalangy in Beijing You chickens. Several individuals shared the T allele but showed normal four-digit conformations. However, breeding trials demonstrated that the T allele could serve as a strong genetic marker for five-toe selection in Beijing You chickens.	[Chu, Qin; Yan, Zhixun; Zhang, Jian; Zhang, Yao; Liu, Hui; Wang, Haihong; Geng, Ailian; Liu, Huagui] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing, Peoples R China; [Usman, Tahir] Abdul Wali Khan Univ Mardan, Coll Vet Sci & Anim Husb, Garden Campus, Mardan, Pakistan	Beijing Academy of Agriculture & Forestry	Liu, HG (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing, Peoples R China.	liuhuagui66@163.com	Geng, Ailian/GZA-8751-2022; Usman, Tahir/GZB-2259-2022	Geng, Ailian/0000-0002-3721-7356; Usman, Tahir/0000-0002-8192-5800	Youth Program of the National Natural Science Foundation of China [31402060]; Earmarked Fund for Modern Agroindustry Technology Research System [nycytx-41-Z01]; Innovation Program of Beijing Academy of Agriculture and Forestry Sciences [KJCX20170105]	Youth Program of the National Natural Science Foundation of China; Earmarked Fund for Modern Agroindustry Technology Research System; Innovation Program of Beijing Academy of Agriculture and Forestry Sciences	This work was supported by the Youth Program of the National Natural Science Foundation of China (31402060, http:www.nsfc gov.cn/), the Earmarked Fund for Modern Agroindustry Technology Research System (nycytx-41-Z01, http://www.zgrj.org/) and the Innovation Program of Beijing Academy of Agriculture and Forestry Sciences (KJCX20170105, http://www.baafs.net.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuisson J, 2011, CLIN GENET, V79, P371, DOI 10.1111/j.1399-0004.2010.01465.x; [Anonymous], [No title captured]; Bahr C, 2003, DEUT TIERARZTL WOCH, V110, P333; Bouldin CM, 2009, DEV BIOL, V334, P133, DOI 10.1016/j.ydbio.2009.07.009; Brenig B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129208; Bridgham JT, 2016, SCIENCE, V354, P289, DOI 10.1126/science.aai7394; Chu Q, 2012, CHINESE J ANIMAL SCI, V48, P13; Dorshorst B, 2010, J HERED, V101, P339, DOI 10.1093/jhered/esp120; Dunn IC, 2011, DEV DYNAM, V240, P1163, DOI 10.1002/dvdy.22623; Girisha KM, 2014, AM J MED GENET A, V164, P898, DOI 10.1002/ajmg.a.36367; Gorbach D, 2010, J HERED, V101, P469, DOI 10.1093/jhered/esq037; He C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176113; Johnson EJ, 2014, DEV BIOL, V392, P209, DOI 10.1016/j.ydbio.2014.05.025; JOHNSON JL, 1981, J HERED, V72, P205, DOI 10.1093/oxfordjournals.jhered.a109473; Kropatsch R, 2015, PLOS ONE, V10; LANDAUER W, 1948, GENETICS, V33, P133; Laurell T, 2012, HUM MUTAT, V33, P1063, DOI 10.1002/humu.22097; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Liu ZH, 2017, MOL MED REP, V15, P793, DOI 10.3892/mmr.2016.6092; Matsubara H, 2017, DEV DYNAM, V246, P417, DOI 10.1002/dvdy.24493; Metzger J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2844-6; Nie Q, 2002, J HERED, V93, P277, DOI 10.1093/jhered/93.4.277; Norbnop P, 2014, J HUM GENET, V59, P467, DOI 10.1038/jhg.2014.50; Pitel F, 2000, GENET SEL EVOL, V32, P73, DOI 10.1051/gse:2000107; Robb EA, 2012, CYTOGENET GENOME RES, V136, P50, DOI 10.1159/000335005; Sturkle PD, 1943, J EXP ZOOL, V93, P325, DOI 10.1002/jez.1400930302; Sun YF, 2014, G3-GENES GENOM GENET, V4, P1167, DOI 10.1534/g3.114.011338; Wang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep38500; Warren DC, 1944, GENETICS, V29, P217; Yang K, 2013, ANIM GENET, V44, P118, DOI 10.1111/j.1365-2052.2012.02369.x; Yang N, 2005, WORLD POULTRY SCI J, V61, P373, DOI [10.1079/WPS200463, 10.1079/WPS200563]; Zhang LF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099946, 10.1371/journal.pone.0084950]; Zhang R, 2017, G3-GENES GENOM GENET, V7, P851, DOI 10.1534/g3.116.033019; Zhang ZB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149010	34	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185953	10.1371/journal.pone.0185953	http://dx.doi.org/10.1371/journal.pone.0185953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016641	gold, Green Published, Green Submitted			2022-12-26	WOS:000412601800030
J	Jia, YP; Wang, K; Zhang, ZJ; Tong, YN; Han, D; Hu, CY; Li, Q; Xiang, Y; Mao, XH; Tang, B				Jia, Yin-ping; Wang, Kun; Zhang, Zhu-jun; Tong, Ya-nan; Han, Dan; Hu, Chun-yu; Li, Qian; Xiang, Yang; Mao, Xu-hu; Tang, Bin			TLR2/TLR4 activation induces Tregs and suppresses intestinal inflammation caused by Fusobacterium nucleatum in vivo	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; NEGATIVE PERIODONTAL BACTERIA; CYTOKINE PRODUCTION; COLON-CANCER; TOLL-LIKE-RECEPTOR-4; STIMULATION; MICROBIOTA; IMMUNITY; INNATE	Toll-like receptors (TLRs) 2 and 4 play critical roles in intestinal inflammation caused by Fusobacterium nucleatum (F. nucleatum) infection, but the role of TLR2/TLR4 in regulation of proinflammatory cytokines remains unknown. In this study, through microarray analysis and qRT-PCR, we showed that TLR2/TLR4 are involved in the F. nucleatum-induced inflammatory signaling pathway in Caco-2 cells, C57BL/6 mice and human clinical specimens. In TLR2(-/-) and TLR4(-/-) mice, F. nucleatum infection resulted in increased colonization of the bacteria and production of the proinflammatory cytokines IL-8, IL-1 beta and TNF-alpha. In addition, the ratio of Foxp3(+) CD4(+) T cells in the total CD4(+) T cells in TLR2(-/-) and TLR4(-/-) mice was less than that in wild-type mice, and the ratio in hybrid mice was more than that in knockout mice, which suggested that TLR2/TLR4 mediated the number of Tregs. Furthermore, it was observed that inflammatory cytokine levels were reduced in TLR2(-/-) mice after Treg transfer. Thus, these data indicate that TLR2/TLR4 regulate F. nucleatum-induced inflammatory cytokines through Tregs in vivo.	[Jia, Yin-ping; Wang, Kun; Zhang, Zhu-jun; Tong, Ya-nan; Han, Dan; Hu, Chun-yu; Li, Qian; Xiang, Yang; Mao, Xu-hu; Tang, Bin] Third Mil Med Univ, Southwest Hosp, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China; [Jia, Yin-ping; Wang, Kun; Zhang, Zhu-jun; Tong, Ya-nan; Han, Dan; Hu, Chun-yu; Li, Qian; Xiang, Yang; Mao, Xu-hu; Tang, Bin] Third Mil Med Univ, Coll Med Lab Sci, Chongqing, Peoples R China; [Tang, Bin] PLA Rocket Force, Emei Sanat, Emeishan, Peoples R China	Army Medical University; Army Medical University	Tang, B (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China.; Tang, B (corresponding author), Third Mil Med Univ, Coll Med Lab Sci, Chongqing, Peoples R China.; Tang, B (corresponding author), PLA Rocket Force, Emei Sanat, Emeishan, Peoples R China.	tangbin811012@163.com	bin, tang/AAK-9399-2020	bin, tang/0000-0002-1762-3883	National Natural Science Foundation of China (NSFC) [81501796]; project of medical science and technology for training youth scholars of PLA [14QNP054]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); project of medical science and technology for training youth scholars of PLA	This work was supported by Grant Nos. 81501796 (for Q.L.) from National Natural Science Foundation of China (NSFC,), and the project of medical science and technology for training youth scholars of PLA (14QNP054) (for B.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Allen-Vercoe E, 2011, GUT MICROBES, V2, P294, DOI 10.4161/gmic.2.5.18603; Bashir A, 2016, TUMOR BIOL, V37, P2805, DOI 10.1007/s13277-015-4724-0; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Irrazabal T, 2014, MOL CELL, V54, P309, DOI 10.1016/j.molcel.2014.03.039; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Kikkert R, 2007, ORAL MICROBIOL IMMUN, V22, P145, DOI 10.1111/j.1399-302X.2007.00335.x; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; LaRue H, 2013, NAT REV UROL, V10, P537, DOI 10.1038/nrurol.2013.153; Liu HQ, 2007, J IMMUNOL, V179, P2501, DOI 10.4049/jimmunol.179.4.2501; Liu PC, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0106-3; Marcato LG, 2008, ORAL MICROBIOL IMMUN, V23, P353, DOI 10.1111/j.1399-302X.2008.00432.x; Nawijn MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055307; Park SR, 2014, INFECT IMMUN, V82, P1914, DOI 10.1128/IAI.01226-13; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Song JP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20077; Sun Y, 2010, J PERIODONTOL, V81, P1488, DOI 10.1902/jop.2010.100004; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Tang B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165701; Tang B, 2012, AUTOPHAGY, V8, P1045, DOI 10.4161/auto.20159; Tietze K, 2006, J PERIODONTAL RES, V41, P447, DOI 10.1111/j.1600-0765.2006.00890.x; Villalta SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009925; Zhang G, 2011, J PERIODONTAL RES, V46, P558, DOI 10.1111/j.1600-0765.2011.01373.x	25	28	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186179	10.1371/journal.pone.0186179	http://dx.doi.org/10.1371/journal.pone.0186179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016688	Green Published, gold, Green Submitted			2022-12-26	WOS:000412601800044
J	Gharibshahi, L; Saion, E; Gharibshahi, E; Shaari, AH; Matori, KA				Gharibshahi, Leila; Saion, Elias; Gharibshahi, Elham; Shaari, Abdul Halim; Matori, Khamirul Amin			Influence of Poly(vinylpyrrolidone) concentration on properties of silver nanoparticles manufactured by modified thermal treatment method	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; NOBLE-METAL NANOPARTICLES; ELECTROCHEMICAL SYNTHESIS; COLLOIDAL SILVER; GOLD-NANOPARTICLES; OPTICAL-PROPERTIES; PARTICLE-SIZE; NANOCLUSTERS; REDUCTION; CATALYSTS	Very narrow and pure silver nanoparticles were synthesized by modified thermal treatment method via oxygen and nitrogen flow in succession. The structural and optical properties of the calcined silver nanoparticles at 600 degrees C with diverse Poly(vinylpyrrolidone) concentrations varied from 2% to 4% were studied by means of different techniques. Fourier transform infrared spectroscopy was used to monitor the production of pure Ag nanoparticles at a given Poly(vinylpyrrolidone) concentration. The X-ray powder diffraction spectra are evidence for the transformation of the amorphous sample at 30 degrees C to the cubic crystalline nanostructures at the calcination temperatures for all Poly(vinylpyrrolidone) concentrations. The transmission electron microscopy images showed the creation of spherical silver nanoparticles with the average particle size decreased by increasing Poly(vinylpyrrolidone) concentrations from 4.61 nm at 2% to 2.49 nm at 4% Poly(vinylpyrrolidone). The optical properties were investigated by means of UV-vis absorption spectrophotometer, which showed an increase in the conduction band of Ag nanoparticles with increasing Poly(vinylpyrrolidone) concentrations from 2.83 eV at 2% Poly(vinylpyrrolidone) to 2.94 eV at 4% Poly(vinylpyrrolidone) due to decreasing particle size. This was due to less attraction between conduction electrons and metal ions for smaller particle size corresponding to fewer atoms that made up the metal nanoparticles.	[Gharibshahi, Leila; Saion, Elias; Gharibshahi, Elham; Shaari, Abdul Halim; Matori, Khamirul Amin] Univ Putra Malaysia, Fac Sci, Dept Phys, Serdang, Selangor, Malaysia; [Gharibshahi, Elham] Univ Texas San Antonio, Dept Phys & Astron, One UTSA Circle, San Antonio, TX USA	Universiti Putra Malaysia; University of Texas System; University of Texas at San Antonio (UTSA)	Gharibshahi, L (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Phys, Serdang, Selangor, Malaysia.	leila_gsh@yahoo.com		shaari, abdul halim/0000-0001-6729-630X	Research Management Center (RMC), Universiti Putra Malaysia	Research Management Center (RMC), Universiti Putra Malaysia	This work was financially supported by the Research Management Center (RMC), Universiti Putra Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge technical supports from the staff of the Faculty of Science and the Institute of Bioscience (IBS), Universiti Putra Malaysia. This work was financially supported by the Research Management Center (RMC), Universiti Putra Malaysia.	Al-Hada NM, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8040113; Al-Hada NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103134; [Anonymous], 2015, JOURNAL OF NANOMATER; Astruc D, 2005, ANGEW CHEM INT EDIT, V44, P7852, DOI 10.1002/anie.200500766; Avasthi DK, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/12/125604; Baba A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-284; Balu S, 2012, INTERNATIONAL JOURNA; Baptista P, 2008, ANAL BIOANAL CHEM, V391, P943, DOI 10.1007/s00216-007-1768-z; Barone P., 2014, J CHEM, V2014; Blandon L, 2012, PORT ELECTROCHIM ACT, V30, P135, DOI 10.4152/pea.201202135; Bowman MC, 2008, J AM CHEM SOC, V130, P6896, DOI 10.1021/ja710321g; Chimentao RJ, 2005, APPL SURF SCI, V252, P793, DOI 10.1016/j.apsusc.2005.02.064; Chimentao RJ, 2004, CHEM COMMUN, P846, DOI 10.1039/b400762j; Conde J, 2011, JOURNAL OF DRUG DELI, V2012; De Gusseme B, 2010, APPL ENVIRON MICROB, V76, P1082, DOI 10.1128/AEM.02433-09; Dhanya S, 2013, ELECTROCHIM ACTA, V102, P299, DOI 10.1016/j.electacta.2013.04.017; ENUSTUN BV, 1963, J AM CHEM SOC, V85, P3317, DOI 10.1021/ja00904a001; Faried M, 2016, DIG J NANOMATER BIOS, V11, P547; Faulds K, 2004, ANAL CHEM, V76, P412, DOI 10.1021/ac035060c; Ge LP, 2014, INT J NANOMED, V9, P2399, DOI 10.2147/IJN.S55015; Gene SA, 2014, J NANOMATER, V2014, DOI 10.1155/2014/416765; Gharibshahi E, 2017, APPLIED RADIATION AN; Gharibshahi E., 2010, PHYS INT, V1, P57, DOI [10.3844/pisp.2010.57.64, DOI 10.3844/PISP.2010.57.64]; Gharibshahi E, 2012, INT J MOL SCI, V13, P14723, DOI 10.3390/ijms131114723; Gharibshahi L, 2017, MATERIALS, V10, DOI 10.3390/ma10040402; Guzman M. G., 2009, INT J MAT METALLURG, V2, P104; Haes AJ, 2004, J PHYS CHEM B, V108, P6961, DOI 10.1021/jp036261n; Hahm J, 2004, NANO LETT, V4, P51, DOI 10.1021/nl034853b; Hainfeld JF, 2008, J PHARM PHARMACOL, V60, P977, DOI 10.1211/jpp.60.8.0005; Hainfeld JF, 2005, THE USE OF GOLD NANO; Han G, 2007, ADV EXP MED BIOL, V620, P48; He BL, 2004, J MOL CATAL A-CHEM, V221, P121, DOI 10.1016/j.molcata.2004.06.025; Hosseinpour-Mashkani SM, 2014, MATER LETT, V130, P259, DOI 10.1016/j.matlet.2014.05.133; Huang HH, 1996, LANGMUIR, V12, P909, DOI 10.1021/la950435d; Huang MY, 2016, SCI ADV MATER, V8, P1641, DOI 10.1166/sam.2016.2777; Huang X., 2007, GOLD NANOPARTICLES I; Huixiao H, 2012, SOFT NANOSCIENCE LET, V2012; Ider M, 2016, J CLUST SCI, P1; Jain PK, 2007, PLASMONICS, V2, P107, DOI 10.1007/s11468-007-9031-1; Jones MR, 2009, CHEMPHYSCHEM, V10, P1461, DOI 10.1002/cphc.200900269; Keiteb AS, 2016, JOURNAL OF NANOMATER, V2016, P6; Keiteb AS, 2016, APPL SCI-BASEL, V6, DOI 10.3390/app6100295; Koczkur KM, 2015, DALTON T, V44, P17883, DOI 10.1039/c5dt02964c; Kodom T, 2015, J NANOMATER, V2015, DOI 10.1155/2015/210734; Kohler JM, 2008, CHEM ENG SCI, V63, P5048, DOI 10.1016/j.ces.2007.11.038; Kumar M, 2005, RADIAT PHYS CHEM, V73, P21, DOI 10.1016/j.radphyschem.2004.06.006; Kutsenko AS, 2009, THEOR EXP CHEM, V45, P313, DOI 10.1007/s11237-009-9099-0; Lee HJ, 2003, J MATER SCI, V38, P2199, DOI 10.1023/A:1023736416361; Li JG, 2015, NANOSCALE, V7, P7502, DOI 10.1039/c5nr00857c; Li X, 2009, COLLOID SURFACE A, V332, P172, DOI 10.1016/j.colsurfa.2008.09.009; Loria-Bastarrachea MI, 2011, J THERM ANAL CALORIM, V104, P737, DOI 10.1007/s10973-010-1061-9; Mafune F, 2000, J PHYS CHEM B, V104, P8333, DOI 10.1021/jp001803b; Maier S.A., 2007, PLASMONICS FUNDAMENT, DOI DOI 10.1007/0-387-37825-1; Maier SA, 2005, J APPL PHYS, V98, DOI 10.1063/1.1951057; Mallipeddi R, 2010, EXPERT OPIN DRUG DEL, V7, P37, DOI 10.1517/17425240903338055; Manjamadha VP, 2016, BIOPROC BIOSYST ENG, V39, P401, DOI 10.1007/s00449-015-1523-3; Meftah AM, 2014, POLYMERS-BASEL, V6, P2435, DOI 10.3390/polym6092435; Mie G, 1908, ANN PHYS-BERLIN, V25, P377, DOI 10.1002/andp.19083300302; Mishra YK, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/34/345606; Mishra YK, 2007, SCRIPTA MATER, V56, P629, DOI 10.1016/j.scriptamat.2006.12.008; Mishra YK, 2010, J NANOSCI NANOTECHNO, V10, P2833, DOI 10.1166/jnn.2010.1449; NAGATA Y, 1992, J CHEM SOC CHEM COMM, P1620, DOI 10.1039/c39920001620; Naghavi K, 2010, RADIAT PHYS CHEM, V79, P1203, DOI 10.1016/j.radphyschem.2010.07.009; Naseri MG, 2011, J MAGN MAGN MATER, V323, P1745, DOI 10.1016/j.jmmm.2011.01.016; Naseri M Goodarz, 2012, ISRN NANOTECHNOLOGY, V2012; Naseri MG, 2011, SOLID STATE COMMUN, V151, P1031, DOI 10.1016/j.ssc.2011.04.018; Naseri MG, 2010, J NANOMATER, V2010, DOI 10.1155/2010/907686; Nasretdinova GR, 2015, ELECTROCHEM COMMUN, V50, P69, DOI 10.1016/j.elecom.2014.11.016; Pal A, 2009, MATER CHEM PHYS, V114, P530, DOI 10.1016/j.matchemphys.2008.11.056; Pitsillides CM, 2003, BIOPHYS J, V84, P4023, DOI 10.1016/S0006-3495(03)75128-5; Rao GPC, 2010, APPL SPECTROSC, V64, P1094, DOI 10.1366/000370210792973640; REETZ MT, 1994, J AM CHEM SOC, V116, P7401, DOI 10.1021/ja00095a051; Rogers JV, 2008, NANOSCALE RES LETT, V3, P129, DOI 10.1007/s11671-008-9128-2; Roldan Cuenya B, 2010, THIN SOLID FILMS, V518, P3127, DOI 10.1016/j.tsf.2010.01.018; Saion E., 2011, J FUND SCI, V7, P6, DOI DOI 10.11113/MJFAS.V7N1.202; Saion E, 2014, MALAYSIAN JOURNAL OF, V7; Saion E, 2013, INT J MOL SCI, V14, P7880, DOI 10.3390/ijms14047880; Selvan ST, 2010, LANGMUIR, V26, P11631, DOI 10.1021/la903512m; Soltani N, 2012, INT J MOL SCI, V13, P12412, DOI 10.3390/ijms131012412; Song KC, 2009, KOREAN J CHEM ENG, V26, P153, DOI 10.1007/s11814-009-0024-y; Sriram MI, 2010, INT J NANOMED, V5, P753, DOI 10.2147/IJN.S11727; Stamplecoskie KG, 2011, J PHYS CHEM C, V115, P1403, DOI 10.1021/jp106666t; Starowicz M, 2006, ELECTROCHEM COMMUN, V8, P227, DOI 10.1016/j.elecom.2005.11.018; Surudzic R, 2013, J SERB CHEM SOC, V78, P2087, DOI 10.2298/JSC131017124S; Tan XH, 2013, WIRES NANOMED NANOBI, V5, P569, DOI 10.1002/wnan.1237; Tang B, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-1074-1; Tu WX, 2000, CHEM MATER, V12, P564, DOI 10.1021/cm990637l; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055; Uttayarat P, 2015, ADVANCES IN MATERIAL, V2015; Weber M.J., 2014, ATOMIC LAYER DEPOSIT; Yeo SY, 2003, J MATER SCI, V38, P2143, DOI 10.1023/A:1023767828656; Yong NL., 2013, INT J SCI ENG RES, V4, P155; YU Y, 2013, NAT COMMUN, V4; Zaarour M, 2014, LANGMUIR, V30, P6250, DOI 10.1021/la5006743; Zhang JP, 2004, APPL CATAL A-GEN, V266, P49, DOI 10.1016/j.apcata.2004.01.025; Zhang WZ, 2006, J COLLOID INTERF SCI, V302, P370, DOI 10.1016/j.jcis.2006.06.035; Zhang XD, 2014, ADV MATER, V26, P4565, DOI 10.1002/adma.201400866; Zhu SL, 2008, SENSOR ACTUAT B-CHEM, V134, P193, DOI 10.1016/j.snb.2008.04.028	98	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186094	10.1371/journal.pone.0186094	http://dx.doi.org/10.1371/journal.pone.0186094			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KG	29045414	gold, Green Published, Green Submitted			2022-12-26	WOS:000413168100035
J	Dong, ZY; Wang, RF; Fan, MQ; Fu, X				Dong, Zhiyong; Wang, Ranfeng; Fan, Minqiang; Fu, Xiang			Switching and optimizing control for coal flotation process based on a hybrid model	PLOS ONE			English	Article							PREDICTIVE CONTROL; OPTIMIZATION; SELECTION; SYSTEM; SVM	Flotation is an important part of coal preparation, and the flotation column is widely applied as efficient flotation equipment. This process is complex and affected by many factors, with the froth depth and reagent dosage being two of the most important and frequently manipulated variables. This paper proposes a new method of switching and optimizing control for the coal flotation process. A hybrid model is built and evaluated using industrial data. First, wavelet analysis and principal component analysis (PCA) are applied for signal pre-processing. Second, a control model for optimizing the set point of the froth depth is constructed based on fuzzy control, and a control model is designed to optimize the reagent dosages based on expert system. Finally, the least squares-support vector machine (LS-SVM) is used to identify the operating conditions of the flotation process and to select one of the two models (froth depth or reagent dosage) for subsequent operation according to the condition parameters. The hybrid model is developed and evaluated on an industrial coal flotation column and exhibits satisfactory performance.	[Dong, Zhiyong; Wang, Ranfeng; Fan, Minqiang; Fu, Xiang] Taiyuan Univ Technol, Coll Min Engn, Taiyuan, Shanxi, Peoples R China	Taiyuan University of Technology	Wang, RF (corresponding author), Taiyuan Univ Technol, Coll Min Engn, Taiyuan, Shanxi, Peoples R China.	wrf197010@126.com			National Natural Science Foundation of China [50974094]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China. The grant number is '50974094' and was received by MF, URLs: www.nsfcgov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Natural Science Foundation of China (50974094). The authors gratefully acknowledge the Xingtai Coal Preparation Plant of Hebei Province for providing industrial data and the experimental platform.	Aksoy DO, 2016, FUEL, V183, P609, DOI 10.1016/j.fuel.2016.06.111; Beasley CN, 1985, P 3 AUSTR COAL PREP, P87; Bergh LG, 2005, MINER ENG, V18, P721, DOI 10.1016/j.mineng.2004.12.008; Bergh LG, 1998, MINER ENG, V11, P739, DOI 10.1016/S0892-6875(98)00059-4; Bergh L, 2016, IFAC PAPERSONLINE, V49, P155, DOI 10.1016/j.ifacol.2016.10.113; Bruce AG, 1996, BIOMETRIKA, V83, P727, DOI 10.1093/biomet/83.4.727; Bu XN, 2016, INT J MINER PROCESS, V157, P175, DOI 10.1016/j.minpro.2016.11.006; Cubillos FA, 1997, MINER ENG, V10, P707, DOI 10.1016/S0892-6875(97)00050-2; Cui J, 2015, MECHATRONICS, V32, P88, DOI 10.1016/j.mechatronics.2015.10.013; Dong SJ, 2013, MEASUREMENT, V46, P3143, DOI 10.1016/j.measurement.2013.06.038; Dong YJ, 2011, COAL PROCESSING COMP, P17; Dong ZY, 2013, COAL PREPARATION TEC, V1, P75; Ha D, 2016, COMPUT CHEM ENG, V94, P362, DOI 10.1016/j.compchemeng.2016.08.012; Jonsson K, 2002, IMAGE VISION COMPUT, V20, P369, DOI 10.1016/S0262-8856(02)00009-4; Karelovic P, 2015, CONTROL ENG PRACT, V40, P1, DOI 10.1016/j.conengprac.2015.02.006; Katrin S, 2012, J BIOMECH, V45, P2306, DOI 10.1016/j.jbiomech.2012.06.012; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kuo BC, 2014, IEEE J-STARS, V7, P317, DOI 10.1109/JSTARS.2013.2262926; Li B, 2003, SEPAR SCI TECHNOL, V38, P1125, DOI 10.1081/SS-120018127; Liu JT, 2000, US Patent, Patent No. [6, 073, 775, 6073775]; Maldonado M, 2009, INT J MINER PROCESS, V93, P26, DOI 10.1016/j.minpro.2009.05.004; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Mohanty S, 2009, J PROCESS CONTR, V19, P991, DOI 10.1016/j.jprocont.2009.01.001; Ou LM, 2009, SCIENCEPAPER ONLINE, V4, P788; Paul R, 2012, PROCEEDINGS OF THE 2012 INTERNATIONAL CONFERENCE ON COMMUNICATIONS, DEVICES AND INTELLIGENT SYSTEMS (CODLS), P592, DOI 10.1109/CODIS.2012.6422272; Polat M, 2003, INT J MINER PROCESS, V72, P199, DOI 10.1016/S0301-7516(03)00099-1; Putz E, 2015, MINER ENG, V70, P26, DOI 10.1016/j.mineng.2014.08.013; Queiroz Machado F., 2013, IFAC P, V46, P172; [邵良杉 Shao Liangshan], 2012, [煤炭学报, Journal of China Coal Society], V37, P1637; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Vanny Makara, 2013, [Journal of Institute of Control, Robotics and Systems, 제어.로봇.시스템학회 논문지], V19, P364, DOI 10.5302/J.ICROS.2013.13.1879; Vapnik V., 2013, NATURE STAT LAERNING; Wang DH, 2010, MULTIVARIATE STAT AN, P193; Xie YF, 2017, IEEE T IND ELECTRON, V64, P4199, DOI 10.1109/TIE.2016.2613499; Yang T, 2008, CLEAN COAL TECHNOLOG, V14, P12; [张敏 ZHANG Min], 2009, [煤炭学报, Journal of China Coal Society], V34, P823; Zhu JY, 2014, CONTROL ENG PRACT, V29, P1, DOI 10.1016/j.conengprac.2014.02.021	38	5	7	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186553	10.1371/journal.pone.0186553	http://dx.doi.org/10.1371/journal.pone.0186553			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040305	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500056
J	Prall, F; Maletzki, C; Huhns, M; Krohn, M; Linnebacher, M				Prall, Friedrich; Maletzki, Claudia; Huehns, Maja; Krohn, Mathias; Linnebacher, Michael			Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironment	PLOS ONE			English	Article							CANCER; LOCALIZATION; PHENOTYPE	Tumour budding and podia formation are well-appreciated in surgical pathology as an aggressive invasion phenotype of colorectal carcinoma cells that is attained in the microenvironment of the invasive margin. In this study, we addressed how tumour budding and podia formation feature in xenografts. Primary colorectal carcinomas (N = 44) of various molecular types (sporadic standard type, high-degree microsatellite-unstable, CpG island methylator phenotype) were transplanted subcutaneously into T and B cell-deficient NSG mice, making possible immunohistochemistry with routine surgical pathology antibodies. Tumor budding and podia formation were both appreciably present in the xenografts. Quantitative evaluations of cytokeratin immunostains of primaries and their corresponding xenografts showed a reduction of tumour buds in the xenografts. Furthermore, in xenografts tumour cells were completely negative by pSTAT3 immunohistochemistry, indicating absence of cytokine/chemokine signalling, but nuclear beta-catenin and SMAD4 immunostainings as read-out of wnt and BMP pathway activation, respectively, were maintained. Carcinoma cells in most xenografts retained immunostaining of at least some nuclei by immunohistochemistry with antibodies against pERK1/2. K-ras/B-raf mutational status did not correlate with tumour budding or podia formation in the xenografts. Our results indicate that tumour budding and podia formation can be modelled by xenografting, and in NSG mice it can be studied with the same immunohistochemical methods as used for primaries in surgical pathology. Dysregulation of wnt and BMP signalling appears to be transferred into the xenograft microenvironment, but not cytokine/chemokine signalling.	[Prall, Friedrich; Huehns, Maja] Univ Rostock, Inst Pathol, Rostock, Germany; [Maletzki, Claudia; Krohn, Mathias; Linnebacher, Michael] Univ Rostock, Dept Surg, Rostock, Germany	University of Rostock; University of Rostock	Prall, F (corresponding author), Univ Rostock, Inst Pathol, Rostock, Germany.	friedrich.prall@med.uni-rostock.de	Linnebacher, Michael/AAT-3763-2021	Linnebacher, Michael/0000-0001-8054-1402				Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; DINGEMANS KP, 1993, INT J CANCER, V54, P1010, DOI 10.1002/ijc.2910540625; Fukushi S, 2011, BRIT J DERMATOL, V165, P990, DOI 10.1111/j.1365-2133.2011.10498.x; Holck S, 2016, HUM PATHOL, V54, P37, DOI 10.1016/j.humpath.2016.03.001; KYRIAZIS AP, 1978, CANCER RES, V38, P3186; Linnebacher M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-362; Lugli A, 2017, MODERN PATHOLOGY; Montgomery E, 2001, AM J PATHOL, V158, P537, DOI 10.1016/S0002-9440(10)63995-8; Mukaratirwa S, 2005, INT J EXP PATHOL, V86, P219, DOI 10.1111/j.0959-9673.2005.00425.x; Oberlander M, 2013, LANGENBECK ARCH SURG, V398, P251, DOI 10.1007/s00423-012-1043-4; Ostwald C, 2009, INT J ONCOL, V35, P321, DOI 10.3892/ijo_00000343; Prall F, 2007, HISTOPATHOLOGY, V50, P151, DOI 10.1111/j.1365-2559.2006.02551.x; Prall F, 2017, HISTOPATHOLOGY, V71, P366, DOI 10.1111/his.13231; Shultz Leonard D, 2014, Cold Spring Harb Protoc, V2014, P694, DOI 10.1101/pdb.top073585; Theiss AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113608; Zlobec I, 2007, J PATHOL, V212, P260, DOI 10.1002/path.2164	16	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186271	10.1371/journal.pone.0186271	http://dx.doi.org/10.1371/journal.pone.0186271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040282	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500029
J	Osathanunkul, M; Ounjai, S; Osathanunkul, R; Madesis, P				Osathanunkul, Maslin; Ounjai, Sarawut; Osathanunkul, Rossarin; Madesis, Panagiotis			Evaluation of a DNA-based method for spice/herb authentication, so you do not have to worry about what is in your curry, buon appetito!	PLOS ONE			English	Article							IDENTITY	It is long believed that some spices may help protect against certain chronic conditions. Spices are usually parts of plants that have been powdered into small pieces. Have you ever wondered what the curry powder in your dish is made of? The aim of this work was to develop an appropriate DNA-based method for assessment of spice identity. Selecting the best marker for species recognition in the Zingiberaceae family. Six DNA regions were investigated in silico, including ITS, matK, rbcL, rpoC, trnH-psbA and trnL. Then, only four regions (ITS, matK, rbcL and trnH-psbA) were included in the simulated HRM (High-resolution Melting) analysis as the results from previous analysis showed that rpoC and trnL may not be suitable to be used to identify Zingiberaceae species in HRM analysis based on both the percentage of nucleotide variation and GC content. Simulated HRM analysis was performed to test the feasibility of Bar-HRM. We found that ITS2 is the most effective region to be used for identification of the studied species and thus was used in laboratory HRM analysis. All seven tested Zingiberaceae plants were then able to be distinguished using the ITS2 primers in laboratory HRM. Most importantly the melting curves gained from fresh and dried tissue overlapped, which is a crucial outcome for the applicability of the analysis. The method could be used in an authentication test for dried products. In the authentication test, only one of seven store-sold Zingiberaceae products that were tested contained the species listed on their labels, while we found substitution/contamination of the tested purchased products in the rest.	[Osathanunkul, Maslin; Ounjai, Sarawut] Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand; [Osathanunkul, Maslin] Chiang Mai Univ, Ctr Excellence Bioresources Agr Ind & Med, Chiang Mai, Thailand; [Osathanunkul, Rossarin] Chiang Mai Univ, Fac Econ, Chiang Mai, Thailand; [Madesis, Panagiotis] Ctr Res & Technol Hellas CERTH, Inst Appl Biosci, Thessaloniki, Greece	Chiang Mai University; Chiang Mai University; Chiang Mai University; Centre for Research & Technology Hellas	Osathanunkul, M (corresponding author), Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand.; Osathanunkul, M (corresponding author), Chiang Mai Univ, Ctr Excellence Bioresources Agr Ind & Med, Chiang Mai, Thailand.	omaslin@gmail.com	Madesis, Panagiotis/AAL-5980-2020	Madesis, Panagiotis/0000-0003-1447-3514	National Research Council of Thailand	National Research Council of Thailand(National Research Council of Thailand (NRCT))	This work was supported by the National Research Council of Thailand.	Barcaccia G, 2016, GENET RESOUR CROP EV, V63, P639, DOI 10.1007/s10722-015-0273-z; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; de Boer HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084291; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; Ganopoulos I, 2012, FOOD CHEM, V133, P505, DOI 10.1016/j.foodchem.2012.01.015; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Kool A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039459; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, PNAS, V102; Larsen K, 2002, NORD J BOT, V22, P39, DOI 10.1111/j.1756-1051.2002.tb01617.x; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Madesis P, 2012, FOOD CONTROL, V25, P576, DOI 10.1016/j.foodcont.2011.11.034; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Osathanunkul M, 2016, PHYTOMEDICINE, V23, P156, DOI 10.1016/j.phymed.2015.11.018; Osathanunkul M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138888; Osathanunkul M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128476; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; Sarkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043808; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Singh S, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0275-5; Stoeckle MY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00042; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Techen N, 2014, CURR OPIN BIOTECH, V25, P103, DOI 10.1016/j.copbio.2013.09.010	23	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186283	10.1371/journal.pone.0186283	http://dx.doi.org/10.1371/journal.pone.0186283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020084	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400088
J	Rodriguez, J; Waichert, C; von Dohlen, CD; Pitts, JP				Rodriguez, Juanita; Waichert, Cecilia; von Dohlen, Carol D.; Pitts, James P.			The geological record and phylogeny of spider wasps (Hymenoptera: Pompilidae): A revision of fossil species and their phylogenetic placement	PLOS ONE			English	Article							CHUBUTOLITHES-GAIMANENSIS; MOLECULAR PHYLOGENY; OLIGOCENE; DEPOSITS; CTENOCERINAE; ABERNESSIA; BIBIONIDAE; ARGENTINA; COLORADO; INSECTS	Accurate fossil identification has become increasingly relevant with the widespread use of phylogenetic divergence time estimation methods, which rely on fossil data to determine clade hard-minimum ages. Here we revise, diagnose and illustrate known spider wasp (Hymenoptera: Pompilidae) fossil species and place them within the latest Pompilidae phylogenetic hypothesis. Ceropalites infelix Cockerell, from the Florissant Fossil Beds (Priabonian), is no longer recognized as Pompilidae, but as Aulacidae. Agenioideus saxigenus (Cockerell) comb. nov., Deuteragenia wettweri (Statz) comb. nov., Caputelus scudderi (Cockerell, 1906) comb. nov., Pepsinites avitula (Cockerell, 1941) comb. nov., Pepsinites contentus (Theobald, 1937) comb. nov., Pepsinites florissantensis (Cockerell, 1906) comb. nov., Pepsinites laminarum (Rohwer, 1909) comb. nov., Pepsinites scelerosus (Meunier, 1919) comb. nov., Pepsinites cockerellae (Rohwer, 1909) comb. nov., Pompilinites coquandi (Theobald, 1937) comb. nov., Pompilinites depressus (Statz, 1936) comb. nov., Pompilites incertus (Theobald, 1937) comb. nov., Pompilites induratus (Heer, 1849) comb. nov., Pompilites fasciatus (Theobald, 1937) comb. nov., and Pompilites senex comb. nov. are new combinations. Twenty-three fossil species of spider wasps are now recognized in 13 genera. Four new genera are proposed: Caputelus Waichert & Pitts gen. nov., Pompilites Rodriguez gen. nov., Pompilinites Rodriguez & Waichert gen. nov., and Pepsinites Rodriguez & Waichert gen. nov., of which the three latter are collective-group names for fossils with taxonomic uncertainty. One species of fossil spider wasp is described: Deuteragenia catalunyia Rodriguez, Waichert & Pitts sp. nov., from the Bellver deposits in Catalonia, Spain. Five of the 23 known species can be used to determine hard-minimum age for calibrations of genera stem-groups (Agenioideus, Anoplius, Cryptocheilus, Deuteragenia, Priocnemis). The fossil belonging to the stem-group of the tribe Ageniellini (Chubutholites) is not recommended for calibration because of the high uncertainty in its age and taxonomy. The remaining taxa can be assigned to the lineage comprising Pompilinae + Pepsinae (12 species) or crown-group Pompilidae (four species).	[Rodriguez, Juanita] Australian Natl Insect Collect, CSIRO, Acton, ACT, Australia; [Waichert, Cecilia] Univ Fed Espirito Santo, Programa Posgrad Ciencias Biol, Dept Ciencias Biol, Vitoria Es, Brazil; [von Dohlen, Carol D.; Pitts, James P.] Utah State Univ, Dept Biol, Logan, UT 84322 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidade Federal do Espirito Santo; Utah System of Higher Education; Utah State University	Rodriguez, J (corresponding author), Australian Natl Insect Collect, CSIRO, Acton, ACT, Australia.	Juanita.Rodriguez@csiro.au	Waichert, Cecilia/C-5759-2019; Rodriguez, Juanita/M-6973-2016	Waichert, Cecilia/0000-0003-1841-7405; Rodriguez, Juanita/0000-0001-9922-1978; von Dohlen, Carol/0000-0002-3961-251X	Center for Women and Gender, Utah State University; Utah Agricultural Experiment Station, Utah State University UAES [8490]; National Science Foundation [DEB-0743763]; FAPES/CAPES [71026436/15]	Center for Women and Gender, Utah State University; Utah Agricultural Experiment Station, Utah State University UAES; National Science Foundation(National Science Foundation (NSF)); FAPES/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Graduate Student Travel Grant from the Center for Women and Gender, Utah State University supported CW's visit to the MCZ collection. The Utah Agricultural Experiment Station, Utah State University UAES #8490, supported this research. The National Science Foundation award DEB-0743763 to JPP and CDvD also supported this work. FAPES/CAPES (#71026436/15) supported CW's postdoctoral fellowship.	Aleksandrova GN, 2008, STRATIGR GEO CORREL+, V16, P528, DOI 10.1134/S0869593808050067; [Anonymous], 1993, HYMENOPTERA WORLD ID; [Anonymous], 1977, SOVIET GEOLOGY; Arillo Antonio, 2001, Coloquios de Paleontologia, V52, P79; Bellosi E.S., 2010, PALEONTOLOGY GRAN BA, P19; Berger JP, 2005, INT J EARTH SCI, V94, P711, DOI 10.1007/s00531-005-0479-y; BOWN TM, 1988, J PALEONTOL, V62, P163, DOI 10.1017/S0022336000029802; Brady Sean, 2011, American Entomologist, V57, P56; Chateauneuf J.J., 1995, GEOL FR, V2, P43; Cockerell T. D. A., 1906, Bulletin of the Museum of Comparative Zoology at Harvard College, V50; Cockerell TDA, 1941, AM J SCI, V239, P354, DOI 10.2475/ajs.239.5.354; Cockerell TDA, 1914, J GEOL, V22, P714, DOI 10.1086/622186; Collomb FM, 2008, ANN SOC ENTOMOL FR, V44, P161, DOI 10.1080/00379271.2008.10697553; Cookerell TDA, 1908, AM J SCI, V25, P309; Day CM, 1988, R ENTOM SOC LONDON, V6, P1; Engel MS, 2006, J KANSAS ENTOMOL SOC, V79, P359, DOI 10.2317/0604.26.1; Epis R. C., 1974, US GOVT PRINT OFF, P1; Evanoff Emmett, 2001, Proceedings of the Denver Museum of Nature & Science, V4, P1; Evans HE, 1998, J NAT HIST, V32, P1411, DOI 10.1080/00222939800770711; Fikacek M, 2010, ACTA GEOL SIN-ENGL, V84, P732, DOI 10.1111/j.1755-6724.2010.00239.x; FREEMAN BE, 1991, J PALEONTOL, V65, P702, DOI 10.1017/S0022336000030845; Genise JF, 2004, J KANSAS ENTOMOL SOC, V77, P626, DOI 10.2317/E-25.1; Grimaldi David, 2005, pi; Heer O., 1849, ZWEITER THEIL HEUSCH; HIPPOLYTE JC, 1993, TECTONOPHYSICS, V226, P15, DOI 10.1016/0040-1951(93)90108-V; Holbourn A, 2014, GEOLOGY, V42, P19, DOI 10.1130/G34890.1; Huber John T., 1993, Agriculture Canada Publication, V1894E, P13; International Commission on Zoological Nomenclature, 2000, INT CODE ZOOLOGICAL; Iturralde-Vinent MA, 2001, CARIBB J SCI, V37, P141; Kay RF, 1999, P NATL ACAD SCI USA, V96, P13235, DOI 10.1073/pnas.96.23.13235; Kay RF, 2008, J HUM EVOL, V54, P323, DOI 10.1016/j.jhevol.2007.09.002; Kosmowska-Ceranowicz B., 2012, BURSZTYN POLSCE NA S; LELEJ AS, 2012, FAR EAST ENTOMOL NOV, P1; Lutz Herbert, 1997, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V203, P173; Meunier F., 1917, Tijdschrift voor Entomologie, V60; Meunier F., 1915, NOUVELLES RECHERCHES, V18, P1; Nury D., 1987, OLIGOCENE PROVENCE M; Perkovsky EE, 2007, AFR INVERTEBR, V48, P229; Prothero DR, 2008, GEOL S AM S, V435, P71; RITZKOWSKI S., 1997, METALLA BOCHUM, V66, P19; Rodriguez J, 2016, ACTA PALAEONTOL POL, V61, P89, DOI 10.4202/app.00073.2014; Rodriguez J, 2016, MOL PHYLOGENET EVOL, V94, P55, DOI 10.1016/j.ympev.2015.08.014; Rohwer S. A., 1909, Psyche Boston Mass, V16, DOI 10.1155/1909/20351; Schiller W., 1925, AN MUS LA PLATA, V11, P11; Schoberlin E, 1888, SOC ENTOMOLOGICA, V3, P68; Selmeier A, 1990, KLASSISCHE FUNDSTELL, P214; Sharkey MJ, 2002, ZOOL SCR, V31, P57, DOI 10.1046/j.0300-3256.2001.00081.x; Shimizu Akira, 2000, Entomological Science, V3, P499; Shimizu A, 2009, ENTOMOL SCI, V12, P238, DOI 10.1111/j.1479-8298.2009.00327.x; Simpson G. G., 1935, AM MUS NOVIT, V775; Skartveit J, 2017, ZOOTAXA, V4225, P1, DOI 10.11646/zootaxa.4225.1.1; Statz G., 1938, Decheniana Bonn, V98A, P71; Statz G., 1936, Decheniana Bonn, V93, P256; Sustera Oldrieh, 1912, Verhandlungen der Zoologisch-Botanischen Gesellschaft in Wien, V62; Theobald N., 1937, MEM SOC SCI NANCY, V473, P1; Vardy C. R., 2005, Zoologische Mededelingen (Leiden), V79, P1; Wahis R., 1986, CATALOGUE SYSTE MATI; Waichert C, 2011, ANN ENTOMOL SOC AM, V104, P1279, DOI 10.1603/AN11093; Waichert C, 2015, ZOOL J LINN SOC-LOND, V175, P271, DOI 10.1111/zoj.12272; Waichert C, 2013, ZOOKEYS, P71, DOI 10.3897/zookeys.353.6223; Wasbauer MS, 1985, CALIFORNIA SPIDER WA; Wolf H., 1999, BEMERKUNGEN EINIGEN	62	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185379	10.1371/journal.pone.0185379	http://dx.doi.org/10.1371/journal.pone.0185379			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020022	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400029
J	Sato, J; Nakayama, M; Tomita, A; Sonoda, T; Hasumi, M; Miyamoto, T				Sato, Jun; Nakayama, Motokazu; Tomita, Ayumi; Sonoda, Takumi; Hasumi, Motomitsu; Miyamoto, Takahisa			Evaluation of repetitive-PCR and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for rapid strain typing of Bacillus coagulans	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; STAPHYLOCOCCUS-AUREUS; CEREUS GROUP; IDENTIFICATION; SUBTILIS; DNA; EVOLUTION; ANTHRACIS; OPERONS; CASEI	In order to establish rapid and accurate typing method for Bacillus coagulans strains which is important for controlling in some canned foods and tea-based beverages manufacturing because of the high-heat resistance of the spores and high tolerance of the vegetative cells to catechins and chemicals, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and repetitive-PCR (rep-PCR) were evaluated. For this purpose, 28 strains of B. coagulans obtained from various culture collections were tested. DNA sequence analyses of the genes encoding 16S rRNA and DNA gyrase classified the test strains into two and three groups, respectively, regardless of their phenotypes. Both MALDI-TOF MS and rep-PCR methods classified the test strains in great detail. Strains classified in each group showed similar phenotypes, such as carbohydrate utilization determined using API 50CH. In particular, the respective two pairs of strains which showed the same metabolic characteristic were classified into the same group by both MALDI-TOF MS and rep-PCR methods separating from the other strains. On the other hand, the other strains which have the different profiles of carbohydrate utilization were separated into different groups by these methods. These results suggested that the combination of MALDI-TOF MS and rep-PCR analyses was advantageous for the rapid and detailed typing of bacterial strains in respect to both phenotype and genotype.	[Sato, Jun; Tomita, Ayumi; Sonoda, Takumi; Hasumi, Motomitsu] Kao Corp, Safety Sci Res, R&D, Ichikai, Tochigi, Japan; [Sato, Jun] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Hakozaki, Fukuoka, Japan; [Nakayama, Motokazu] Kao Corp, Hlth Care Food Res, R&D, Tokyo, Tokyo, Japan; [Miyamoto, Takahisa] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Higashi Ku,Div Food Sci & Biotechnol, Hakozaki, Fukuoka, Japan	KAO Corporation; Kyushu University; KAO Corporation; Kyushu University	Sato, J (corresponding author), Kao Corp, Safety Sci Res, R&D, Ichikai, Tochigi, Japan.; Sato, J (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Hakozaki, Fukuoka, Japan.	satou.jun5@kao.co.jp		Sato, Jun/0000-0001-5159-2390	Kao Corporation	Kao Corporation	The funder, Kao Corporation, provided support in the form of salaries for authors JS, MN, AT, TS, and MH. The funder made a contract of collaborative study with TM, Kyushu University. TM had a role in review and editing of the manuscript. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerberger F, 1999, J MICROBIOL METH, V35, P237, DOI 10.1016/S0167-7012(99)00025-1; Barbuddhe SB, 2008, APPL ENVIRON MICROB, V74, P5402, DOI 10.1128/AEM.02689-07; Berrazeg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061428; Cosentino S, 1997, INT J FOOD MICROBIOL, V38, P235, DOI 10.1016/S0168-1605(97)00107-4; Daffonchio D, 2003, APPL ENVIRON MICROB, V69, P5128, DOI 10.1128/AEM.69.9.5128-5137.2003; Deschaght P, 2011, RES MICROBIOL, V162, P386, DOI 10.1016/j.resmic.2011.02.002; Fernandez-No IC, 2013, FOOD MICROBIOL, V33, P235, DOI 10.1016/j.fm.2012.09.022; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; Hill KK, 2004, APPL ENVIRON MICROB, V70, P1068, DOI 10.1128/AEM.70.2.1068-1080.2004; Hong HA, 2005, FEMS MICROBIOL REV, V29, P813, DOI 10.1016/j.femsre.2004.12.001; Hotta Y, 2011, J AGR FOOD CHEM, V59, P5222, DOI 10.1021/jf2004095; Ishii S, 2009, ENVIRON MICROBIOL, V11, P733, DOI 10.1111/j.1462-2920.2008.01856.x; Liu PYF, 1997, J CLIN MICROBIOL, V35, P1533, DOI 10.1128/JCM.35.6.1533-1535.1997; MacCannell D, 2013, CLIN LAB MED, V33, P629, DOI 10.1016/j.cll.2013.03.005; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marten P, 2000, J APPL MICROBIOL, V89, P463, DOI 10.1046/j.1365-2672.2000.01136.x; Nigatu A, 2000, J APPL MICROBIOL, V89, P969, DOI 10.1046/j.1365-2672.2000.01202.x; Ojima-Kato T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159730; Ojima-Kato T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113458; Palop A, 1999, INT J FOOD MICROBIOL, V46, P243, DOI 10.1016/S0168-1605(98)00199-8; Pinto B, 2005, SYST APPL MICROBIOL, V28, P340, DOI 10.1016/j.syapm.2005.01.002; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Sachse S, 2014, DIAGN MICR INFEC DIS, V80, P267, DOI 10.1016/j.diagmicrobio.2014.09.005; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato H, 2012, SYST APPL MICROBIOL, V35, P447, DOI 10.1016/j.syapm.2012.08.008; Schoeni JL, 2005, J FOOD PROTECT, V68, P636, DOI 10.4315/0362-028X-68.3.636; Serwecinska Liliana, 1998, Acta Microbiologica Polonica, V47, P313; Shangkuan YH, 2000, J APPL MICROBIOL, V89, P452, DOI 10.1046/j.1365-2672.2000.01134.x; Stephan R, 2011, J MICROBIOL METH, V87, P150, DOI 10.1016/j.mimet.2011.08.016; Tenover FC, 2009, J CLIN MICROBIOL, V47, P2452, DOI 10.1128/JCM.00476-09; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Thorsen L, 2006, APPL ENVIRON MICROB, V72, P5118, DOI 10.1128/AEM.00170-06; Wang LT, 2007, INT J SYST EVOL MICR, V57, P1846, DOI 10.1099/ijs.0.64685-0; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990	34	3	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186327	10.1371/journal.pone.0186327	http://dx.doi.org/10.1371/journal.pone.0186327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020109	Green Published, gold, Green Submitted			2022-12-26	WOS:000412754400092
J	Pedroza-Gutierrez, C; Hernandez, JM				Pedroza-Gutierrez, Carmen; Hernandez, Juan M.			Social networks, market transactions, and reputation as a central resource. The Mercado del Mar, a fish market in central Mexico	PLOS ONE			English	Article							TRUST; MANAGEMENT; COMMITMENT; EVOLUTION; QUALITY	Fish consumption in Mexico is considered low (around 12 kg per person per year) and non-homogeneously distributed across the country. One of the reasons for this situation is the scarcity of wholesale selling sites. In this context, the Mercado del Mar (MM), located in Guadalajara city, Jalisco, is the second biggest wholesale fish market in Mexico, with a distribution of about 500 tons per day and a variety of about 350 different species of fish. In this paper, we argue that MM has accumulated social capital, which is formed from two main resources: buyer and seller relationships, and reputation. Specifically, the MM manages a broad and intensive interaction among business actors and the already achieved reputation allows the MM to adapt to market changes. To validate our hypotheses, an empirical study was conducted in 2015 by means of interviews to fish wholesalers in the MM and a sample of their suppliers and buyers. For simplicity we have only considered fresh water fish. We have followed snow-ball sampling as the survey strategy. Results show that the MM has responded to fish market dynamics organizing a complex network of buyers and suppliers whose relationships can be explained in the form of strong and weak ties. At the same time, reputation has been the central resource to build this social capital and also gives place to market transactions. Additionally, the strategic position of Guadalajara city and the well-connected routes have facilitated fish bulking and distribution in the region.	[Pedroza-Gutierrez, Carmen] Univ Nacl Autonoma Mexico, Coordinac Humanidades, Unidad Acad Estudios Reg, Jiquilpan, Mexico; [Hernandez, Juan M.] Univ Las Palmas Gran Canaria, Dept Quantitat Methods Econ & Management, Inst Tourism & Sustainable Econ Dev TIDES, Las Palmas Gran Canaria, Gran Canaria, Spain	Universidad Nacional Autonoma de Mexico; Universidad de Las Palmas de Gran Canaria	Pedroza-Gutierrez, C (corresponding author), Univ Nacl Autonoma Mexico, Coordinac Humanidades, Unidad Acad Estudios Reg, Jiquilpan, Mexico.	pedrozacarmen@yahoo.com	Hernandez, Juan M./D-7096-2013; Pedroza-Gutiérrez, Carmen/D-1267-2017	Hernandez, Juan M./0000-0001-6897-5179; Pedroza-Gutierrez, Carmen/0000-0002-1048-434X	Universidad Nacional Autonoma de Mexico (UNAM) [PAPIIT IA300215]; Government of Spain [EC02014-59067-P]	Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Government of Spain(Spanish Government)	The study was funded by the Universidad Nacional Autonoma de Mexico (UNAM) under grant PAPIIT IA300215, which financed the field study and part of the travel expenses of both researchers, and the Government of Spain under grant EC02014-59067-P financed part of the travels of Dr. Juan Hernandez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achrol RS, 1997, J ACAD MARKET SCI, V25, P56, DOI 10.1007/BF02894509; Ahuja G, 2000, STRATEGIC MANAGE J, V21, P317, DOI 10.1002/(SICI)1097-0266(200003)21:3<317::AID-SMJ90>3.0.CO;2-B; Anand BN, 2000, STRATEGIC MANAGE J, V21, P295, DOI 10.1002/(SICI)1097-0266(200003)21:3<295::AID-SMJ91>3.0.CO;2-O; BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108; Benjamin BA, 1999, ADMIN SCI QUART, V44, P563, DOI 10.2307/2666962; Bennett R, 2001, J BUS IND MARK, V16, P424, DOI 10.1108/EUM0000000006018; Bestor TC, 2004, TSUKIJI FISH MARKET, V11; BOWERSOX DJ, 1990, HARVARD BUS REV, V68, P36; Braunscheidel MJ, 2009, J OPER MANAG, V27, P119, DOI 10.1016/j.jom.2008.09.006; Burt R. S, 1992, STRUCTURAL HOLES; Casalo LV, 2007, J MARK COMMUN, V13, P1, DOI 10.1080/13527260600951633; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Choi TY, 2001, J OPER MANAG, V19, P351, DOI 10.1016/S0272-6963(00)00068-1; Cuesta J A, 2015, SCI REPORTS; Dasgupta P., 2000, TRUST MAKING BREAKIN, V4, P49; Ding H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162781; Ebbers JJ, 2010, STRATEG ORGAN, V8, P255, DOI 10.1177/1476127010381102; Fluvia M, 2012, FISH RES, V127, P18, DOI 10.1016/j.fishres.2012.04.010; Fombrun Charles., 2004, FAME FORTUNE SUCCESS; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Giulioni G, 2011, J ECON BEHAV ORGAN, V80, P34, DOI 10.1016/j.jebo.2011.01.012; Graddy K, 2006, J ECON PERSPECT, V20, P207, DOI 10.1257/jep.20.2.207; GRADDY K, 1995, RAND J ECON, V26, P75, DOI 10.2307/2556036; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Gray ER, 1998, LONG RANGE PLANN, V31, P695, DOI 10.1016/S0024-6301(98)00074-0; Gulati R., 2007, MANAGING NETWORK RES; Harner J, 2010, GEOGR REV, V100, P494, DOI 10.1111/j.1931-0846.2010.00055.x; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; IBARRA H, 1993, ACAD MANAGE REV, V18, P56, DOI 10.5465/AMR.1993.3997507; INEC,, 2010, CENS POBL VIV; Kim Y, 2011, J OPER MANAG, V29, P194, DOI 10.1016/j.jom.2010.11.001; Lee PM, 2004, J FINANC ECON, V73, P375, DOI 10.1016/j.jfineco.2003.09.003; Michell P, 1998, J MARKET MANAG, V14, P159, DOI DOI 10.1362/026725798784959417; MOORMAN C, 1992, J MARKETING RES, V29, P314, DOI 10.1177/002224379202900303; Moreno JA Islas, 2007, TCPRLA3111 INFOPESCA; Musiolik J, 2012, TECHNOL FORECAST SOC, V79, P1032, DOI 10.1016/j.techfore.2012.01.003; Neville BA, 2005, EUR J MARKETING, V39, P1184, DOI 10.1108/03090560510610798; Newman M.E.J., 2010, NETWORKS INTRO; Pels J., 1992, EUR J MARKETING, V26, P5; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Schweizer T. S., 1999, CORPORATE REPUTATION, V2, P249, DOI DOI 10.1057/palgrave.crr.1540083; Scott J., 2012, SOCIAL NETWORK ANAL; SHAPIRO C, 1983, Q J ECON, V98, P659, DOI 10.2307/1881782; Simatupang T.M., 2002, INT J LOGIST MANAG, V13, P15, DOI [10.1108/09574090210806333, DOI 10.1108/09574090210806333]; Tirole J, 1996, REV ECON STUD, V63, P1, DOI 10.2307/2298112; van Woerkum CMJ, 2007, BRIT FOOD J, V109, P355, DOI 10.1108/00070700710746777; Wang CJ, 2017, APPL MATH COMPUT, V293, P18, DOI 10.1016/j.amc.2016.06.026; Wasserman S, 1994, SOCIAL NETWORK ANAL; Wassmer U., 2008, J MANAGE; WATTERS JK, 1989, SOC PROBL, V36, P416, DOI 10.1525/sp.1989.36.4.03a00070	50	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186063	10.1371/journal.pone.0186063	http://dx.doi.org/10.1371/journal.pone.0186063			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3JE	29016637	Green Published, gold, Green Submitted			2022-12-26	WOS:000412627400053
J	Wang, L; Baser, O; Wells, P; Peacock, WF; Coleman, CI; Fermann, GJ; Schein, J; Crivera, C				Wang, Li; Baser, Onur; Wells, Phil; Peacock, W. Frank; Coleman, Craig I.; Fermann, Gregory J.; Schein, Jeff; Crivera, Concetta			Benefit of early discharge among patients with low-risk pulmonary embolism	PLOS ONE			English	Article							HOSPITAL STAY; OUTPATIENT TREATMENT; SEVERITY INDEX; STRATIFICATION; METAANALYSIS; LENGTH; MORTALITY; COMPLICATIONS; THROMBOSIS; STROKE	Clinical guidelines recommend early discharge of patients with low-risk pulmonary embolism (LRPE). This study measured the overall impact of early discharge of LRPE patients on clinical outcomes and costs in the Veterans Health Administration population. Adult patients with >= 1 inpatient diagnosis for pulmonary embolism (PE) (index date) between 10/2011-06/2015, continuous enrollment for >= 12 months pre-and 3 months post-index date were included. PE risk stratification was performed using the simplified Pulmonary Embolism Stratification Index. Propensity score matching (PSM) was used to compare 90-day adverse PE events (APEs) [recurrent venous thromboembolism, major bleed and death], hospital-acquired complications (HACs), healthcare utilization, and costs among short (<= 2 days) versus long length of stay (LOS). Net clinical benefit was defined as 1 minus the combined rate of APE and HAC. Among 6,746 PE patients, 95.4% were men, 22.0% were African American, and 1,918 had LRPE. Among LRPE patients, only 688 had a short LOS. After 1:1 PSM, there were no differences in APE, but short LOS had fewer HAC (1.5% vs 13.3%, 95% CI: 3.77-19.94) and bacterial pneumonias (5.9% vs 11.7%, 95% CI: 1.24-3.23), resulting in better net clinical benefit (86.9% vs 78.3%, 95% CI: 0.84-0.96). Among long LOS patients, HACs (52) exceeded APEs (14 recurrent DVT, 5 bleeds). Short LOS incurred lower inpatient ($2,164 vs $5,100, 95% CI: $646.8-$5225.0) and total costs ($9,056 vs $12,544, 95% CI: $636.6-$6337.7). LRPE patients with short LOS had better net clinical outcomes at lower costs than matched LRPE patients with long LOS.	[Wang, Li; Baser, Onur] STATinMED Res, Plano, TX 75093 USA; [Baser, Onur] Columbia Univ, Ctr Innovat & Outcomes Res, Dept Surg, New York, NY USA; [Baser, Onur] STATinMED Res, New York, NY USA; [Baser, Onur] MEF Univ, Dept Econ, Istanbul, Turkey; [Wells, Phil] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Wells, Phil] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Peacock, W. Frank] Baylor Coll Med, Emergency Med, Houston, TX 77030 USA; [Coleman, Craig I.] Univ Connecticut, Sch Pharm, Hartford, CT 06112 USA; [Fermann, Gregory J.; Schein, Jeff] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA; [Crivera, Concetta] LLC, Janssen Sci Affairs, Titusville, NJ USA	Columbia University; MEF Universitesi; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Baylor College of Medicine; University of Connecticut; University System of Ohio; University of Cincinnati; Johnson & Johnson; Janssen Pharmaceuticals	Wang, L (corresponding author), STATinMED Res, Plano, TX 75093 USA.	lwang@statinmed.com	Library, MEF/O-1457-2019	Coleman, Craig/0000-0003-4868-7158	Janssen Scientific Affairs, LLC	Janssen Scientific Affairs, LLC	This study was funded by Janssen Scientific Affairs, LLC.	Aujesky D, 2008, ARCH INTERN MED, V168, P706, DOI 10.1001/archinte.168.7.706; Aujesky D, 2009, SWISS MED WKLY, V139, P685, DOI smw-12661; Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; BefElohlavekJ Dytrych V, 2013, EXP CLIN CARDIOL, V18, P129; Berghaus TM, 2010, ADV THER, V27, P648, DOI 10.1007/s12325-010-0058-x; Coleman CI, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009251; Cunningham A, 2011, PHARMACOEPIDEM DR S, V20, P560, DOI 10.1002/pds.2109; Dentali F, 2013, J THROMB HAEMOST, V11, P2103, DOI 10.1111/jth.12420; Donadini MP, 2017, THROMB RES, V156, P155, DOI 10.1016/j.thromres.2017.06.009; Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw rozpoznawania i postepowania w ostrej zatorowosci plucnej, 2014, Kardiol Pol, V72, P997, DOI 10.5603/KP.2014.0211; Hellenkamp K, 2015, INT J CARDIOL, V197, P162, DOI 10.1016/j.ijcard.2015.06.065; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; Jimenez D, 2016, INTERN EMERG MED, V11, P11, DOI 10.1007/s11739-015-1388-0; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Kang DK, 2011, AM J CARDIOL, V108, P133, DOI 10.1016/j.amjcard.2011.03.009; Kearon C, 2003, CAN MED ASSOC J, V168, P183; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; LaMori JC, 2015, CLIN THER, V37, P62, DOI 10.1016/j.clinthera.2014.10.024; Masotti L, 2009, VASC HEALTH RISK MAN, V5, P567; Maynard C, 2004, DIABETES CARE, V27, pB22, DOI 10.2337/diacare.27.suppl_2.B22; Miniati M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030891; Ozsu S, 2014, THROMB RES, V133, P1006, DOI 10.1016/j.thromres.2014.02.032; Piran S, 2013, THROMB RES, V132, P515, DOI 10.1016/j.thromres.2013.08.012; Rali P, 2016, CRIT CARE NURS Q, V39, P131, DOI 10.1097/CNQ.0000000000000106; Research user Guide: Fiscal Year, 2009, VHA MED SAS INPATIEN; Sorbello D, 2009, CEREBROVASC DIS, V28, P378, DOI 10.1159/000230712; Squizzato A, 2012, J THROMB HAEMOST, V10, P1276, DOI 10.1111/j.1538-7836.2012.04739.x; Stamm JA, 2014, SOUTH MED J, V107, P72, DOI 10.1097/SMJ.0000000000000053; Tarbox Abigail K, 2013, Int J Crit Illn Inj Sci, V3, P69, DOI 10.4103/2229-5151.109427; Tirschwell D L, 1999, J Stroke Cerebrovasc Dis, V8, P336, DOI 10.1016/S1052-3057(99)80008-1; VA Information Resource Center, 2009, VIREC RES US GUID VH; VA Information Resource Center, VIREC RES GUID VA DA; Veterans Health Administration, VET HLTH ADM; Zondag W, 2013, EUR RESPIR J, V42, P134, DOI 10.1183/09031936.00093712	34	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185022	10.1371/journal.pone.0185022	http://dx.doi.org/10.1371/journal.pone.0185022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016692	Green Published, gold, Green Submitted			2022-12-26	WOS:000412627400012
J	Gomez, NM; Lu, WN; Lim, JC; Kiselyov, K; Campagno, KE; Grishchuk, Y; Slaugenhaupt, SA; Pfeffer, BA; Fliesler, SJ; Mitchell, CH				Gomez, Nestor Mas; Lu, Wennan; Lim, Jason C.; Kiselyov, Kirill; Campagno, Keith E.; Grishchuk, Yulia; Slaugenhaupt, Susan A.; Pfeffer, Bruce A.; Fliesler, Steven J.; Mitchell, Claire H.			Robust lysosomal calcium signaling through channel TRPML1 is impaired by lysosomal lipid accumulation	FASEB JOURNAL			English	Article						cellular aging; calcium signaling; lysosomal storage disease; RPE; mucolipin	MUCOLIPIDOSIS TYPE-IV; ION CHANNELS; STEM-CELLS; DISEASE; LIPOFUSCIN; RPE; PH; ACTIVATION; AUTOPHAGY; GENE	The transient receptor potential cation channelmucolipin 1 (TRPML1) channel is a conduit for lysosomal calcium efflux, and channel activity may be affected by lysosomal contents. The lysosomes of retinal pigmented epithelial (RPE) cells are particularly susceptible to build-up of lysosomal waste products because they must degrade the outer segments phagocytosed daily from adjacent photoreceptors; incomplete degradation leads to accumulation of lipid waste in lysosomes. This study asks whether stimulation of TRPML1 can release lysosomal calcium in RPE cells and whether such release is affected by lysosomal accumulations. The TRPML agonist ML-SA1 raised cytoplasmic calcium levels in mouse RPE cells, hesRPE cells, and ARPE-19 cells; this increase was rapid, robust, reversible, and reproducible. The increase was not altered by extracellular calcium removal or by thapsigargin but was eliminated by lysosomal rupture with glycyl-L-phenylalanine-beta-naphthylamide. Treatment with desipramine to inhibit acid sphingomyelinase or YM201636 to inhibit PIKfyve also reduced the cytoplasmic calcium increase triggered by ML-SA1, whereas RPE cells from TRPML1(-/-) mice showed no response to ML-SA1. Cotreatment with chloroquine and U18666A induced formation of neutral, autofluorescent lipid in RPE lysosomes and decreased lysosomal Ca2+ release. Lysosomal Ca2+ release was also impaired in RPE cells from the ATP-binding cassette, subfamily A, member 4(-/-) mouse model of Stargardt's retinal dystrophy. Neither TRPML1 mRNA nor total lysosomal calcium levels were altered in these models, suggesting a more direct effect on the channel. In summary, stimulation of TRPML1 elevates cytoplasmic calcium levels in RPE cells, but this response is reduced by lysosomal accumulation.	[Gomez, Nestor Mas; Lu, Wennan; Lim, Jason C.; Campagno, Keith E.; Mitchell, Claire H.] Univ Penn, Dept Anat & Cell Biol, 440 Levy Bldg,240 S 40th St, Philadelphia, PA 19104 USA; [Mitchell, Claire H.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Mitchell, Claire H.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Kiselyov, Kirill] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Grishchuk, Yulia; Slaugenhaupt, Susan A.] Harvard Med Sch, Massachusetts Gen Hosp, Res Inst, Ctr Genom Med, Boston, MA USA; [Grishchuk, Yulia; Slaugenhaupt, Susan A.] Harvard Med Sch, Massachusetts Gen Hosp, Res Inst, Dept Neurol, Boston, MA USA; [Pfeffer, Bruce A.; Fliesler, Steven J.] State Univ New York SUNY Univ, Jacobs Sch Med & Biomed Sci, Ross Eye Inst, Dept Ophthalmol, Buffalo, NY USA; [Pfeffer, Bruce A.; Fliesler, Steven J.] State Univ New York SUNY Univ, Jacobs Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY USA; [Pfeffer, Bruce A.; Fliesler, Steven J.] SUNY Eye Inst, Buffalo, NY USA; [Pfeffer, Bruce A.; Fliesler, Steven J.] Vet Affairs Western New York Healthcare Syst, Res Serv, Buffalo, NY USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Mitchell, CH (corresponding author), Univ Penn, Dept Anat & Cell Biol, 440 Levy Bldg,240 S 40th St, Philadelphia, PA 19104 USA.	chm@upenn.edu	Fliesler, Steven J./AAE-9243-2020	Kiselyov, Kirill/0000-0001-6683-2895; Campagno, Keith/0000-0003-1079-947X; Fliesler, Steven/0000-0002-2557-142X	U.S. National Institutes of Health (NIH) National Eye Institute [EY015537, EY013434, EY001583, EY007361]; NIH National Center for Advancing Translational Science Grant [U54 TR001358]; Jody Sack Fund; Research to Prevent Blindness to the Department of Ophthalmology, SUNY-University at Buffalo; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY015537, R01EY007361, P30EY001583, R01EY013434] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH National Center for Advancing Translational Science Grant; Jody Sack Fund; Research to Prevent Blindness to the Department of Ophthalmology, SUNY-University at Buffalo; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Lincoln Johnson (Laboratory for Stem Cell Biology and Engineering, Neuroscience Research Institute, University of California, Santa Barbara, Santa Barbara, CA, USA) for the generous donation of hesRPE cells. This work was supported by U.S. National Institutes of Health (NIH) National Eye Institute Grants EY015537 and EY013434 and Core Grant EY001583 (to C.H.M.) and EY007361 (to S.J.F.), by NIH National Center for Advancing Translational Science Grant U54 TR001358 to SUNY-University at Buffalo (S.J.F.), by the Jody Sack Fund (to W.L.), and by an Unrestricted Grant from Research to Prevent Blindness to the Department of Ophthalmology, SUNY-University at Buffalo, from Research to Prevent Blindness (to S.J.F.). The opinions expressed herein do not necessarily reflect those of the Veterans Administration or the U.S. Government. The authors declare no conflicts of interest.	Al-Bari MAA, 2015, J ANTIMICROB CHEMOTH, V70, P1608, DOI 10.1093/jac/dkv018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Bargal R, 2001, HUM MUTAT, V17, P397, DOI 10.1002/humu.1115; Cao Q, 2017, J BIOL CHEM, V292, P8424, DOI 10.1074/jbc.M116.772160; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chandra M, 2011, GASTROENTEROLOGY, V140, P857, DOI 10.1053/j.gastro.2010.11.040; Chen CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5681; Cheng XP, 2014, NAT MED, V20, P1187, DOI 10.1038/nm.3611; Christensen KA, 2002, J CELL SCI, V115, P599; Coen K, 2012, J CELL BIOL, V198, P23, DOI 10.1083/jcb.201201076; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Emanuel R, 2014, ARTERIOSCL THROM VAS, V34, P1942, DOI 10.1161/ATVBAHA.114.303342; Frost LS, 2014, EXP EYE RES, V124, P56, DOI 10.1016/j.exer.2014.04.010; Goldin E, 2008, INVEST OPHTH VIS SCI, V49, P3134, DOI 10.1167/iovs.07-1649; Gomez NM, 2013, PFLUG ARCH EUR J PHY, V465, P481, DOI 10.1007/s00424-012-1181-0; GOMEZ NM, 2016, INVEST OPHTHALMOL VI, V57; Grishchuk Y, 2016, AM J PATHOL, V186, P199, DOI 10.1016/j.ajpath.2015.09.017; Guha S, 2014, ADV EXP MED BIOL, V801, P105, DOI 10.1007/978-1-4614-3209-8_14; Guha S, 2013, FASEB J, V27, P4500, DOI 10.1096/fj.13-236166; Guha S, 2012, J NEUROCHEM, V122, P823, DOI 10.1111/j.1471-4159.2012.07804.x; JADOT M, 1984, BIOCHEM J, V219, P965, DOI 10.1042/bj2190965; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Karmakar M, 2015, J IMMUNOL, V194, P1763, DOI 10.4049/jimmunol.1401624; Kawasaki T, 2013, CELL HOST MICROBE, V14, P148, DOI 10.1016/j.chom.2013.07.011; Kellner U, 2008, DOC OPHTHALMOL, V116, P119, DOI 10.1007/s10633-007-9105-6; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kolzer M, 2004, FEBS LETT, V559, P96, DOI 10.1016/S0014-5793(04)00033-X; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; Liu J, 2008, INVEST OPHTH VIS SCI, V49, P772, DOI 10.1167/iovs.07-0675; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2016, J CELL BIOL, V212, P755, DOI 10.1083/jcb.201603037; Lu WN, 2015, INVEST OPHTH VIS SCI, V56; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Ma XC, 2012, AUTOPHAGY, V8, P297, DOI 10.4161/auto.18658; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Melchionda M, 2016, J CELL BIOL, V212, P803, DOI 10.1083/jcb.201510019; Mitter SK, 2014, AUTOPHAGY, V10, P1989, DOI 10.4161/auto.36184; Pfeffer BA, 1991, PROG RETINAL RES, V10, P251; Weiss Norbert, 2012, Commun Integr Biol, V5, P111, DOI [10.4161/cib.21799, 10.4161/cib.20373]; Reigada D, 2005, AM J PHYSIOL-CELL PH, V289, pC617, DOI 10.1152/ajpcell.00542.2004; Rowland TJ, 2013, J TISSUE ENG REGEN M, V7, P642, DOI 10.1002/term.1458; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Sparrow JR, 2013, INVEST OPHTH VIS SCI, V54, P8325, DOI 10.1167/iovs.13-13214; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Strauss O, 2016, ADV EXP MED BIOL, V854, P739, DOI 10.1007/978-3-319-17121-0_98; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Toops KA, 2015, MOL BIOL CELL, V26, P1, DOI 10.1091/mbc.E14-05-1028; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Virador VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005136; Wang WY, 2015, P NATL ACAD SCI USA, V112, pE1373, DOI 10.1073/pnas.1419669112; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; Wu BX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133032; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Zeiger U, 2010, EXP EYE RES, V91, P613, DOI 10.1016/j.exer.2010.07.019; Zhang M, 2010, NEUROCHEM INT, V56, P35, DOI 10.1016/j.neuint.2009.08.011; Zhang XZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10938; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	67	28	28	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					782	794		10.1096/fj.201700220RR	http://dx.doi.org/10.1096/fj.201700220RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29030399	Green Published			2022-12-26	WOS:000425146900021
J	Jindal, GA; Goyal, Y; Humphreys, JM; Yeung, E; Tian, KJ; Patterson, VL; He, HX; Burdine, RD; Goldsmith, EJ; Shvartsman, SY				Jindal, Granton A.; Goyal, Yogesh; Humphreys, John M.; Yeung, Eyan; Tian, Kaijia; Patterson, Victoria L.; He, Haixia; Burdine, Rebecca D.; Goldsmith, Elizabeth J.; Shvartsman, Stanislav Y.			How activating mutations affect MEK1 regulation and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; mitogen-activated protein kinase (MAPK); protein phosphorylation; Raf kinase; zebrafish; MEK1	MAP KINASE KINASE; PROTEIN-KINASE; DUAL PHOSPHORYLATION; RAS PATHWAY; ZEBRAFISH; INHIBITORS; GASTRULATION; RASOPATHIES; COMPLEX; CELLS	The MEK1 kinase directly phosphorylates ERK2, after the activation loop of MEK1 is itself phosphorylated by Raf. Studies over the past decade have revealed a large number of disease-related mutations in the MEK1 gene that lead to tumorigenesis and abnormal development. Several of these mutations result in MEK1 constitutive activity, but how they affect MEK1 regulation and function remains largely unknown. Here, we address these questions focusing on two pathogenic variants of the Phe-53 residue, which maps to the well-characterized negative regulatory region of MEK1. We found that these variants are phosphorylated by Raf faster than the wild-type enzyme, and this phosphorylation further increases their enzymatic activity. However, the maximal activities of fully phosphorylated wild-type and mutant enzymes are indistinguishable. On the basis of available structural information, we propose that the activating substitutions destabilize the inactive conformation of MEK1, resulting in its constitutive activity and making it more prone to Raf-mediated phosphorylation. Experiments in zebrafish revealed that the effects of activating variants on embryonic development reflect the joint control of the negative regulatory region and activating phosphorylation. Our results underscore the complexity of the effects of activating mutations on signaling systems, even at the level of a single protein.	[Jindal, Granton A.; Goyal, Yogesh; Tian, Kaijia; Shvartsman, Stanislav Y.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Jindal, Granton A.; Goyal, Yogesh; Yeung, Eyan; Patterson, Victoria L.; Burdine, Rebecca D.; Shvartsman, Stanislav Y.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Jindal, Granton A.; Goyal, Yogesh; Yeung, Eyan; Tian, Kaijia; Patterson, Victoria L.; Shvartsman, Stanislav Y.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Humphreys, John M.; He, Haixia; Goldsmith, Elizabeth J.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	Princeton University; Princeton University; Princeton University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Shvartsman, SY (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.; Shvartsman, SY (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.; Shvartsman, SY (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.; Goldsmith, EJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.	elizabeth.goldsmith@utsouthwestern.edu; stas@princeton.edu	Shvartsman, Stanislav/GPP-4025-2022; Jindal, Granton/GLU-4486-2022	Shvartsman, Stanislav/0000-0002-9152-9334; Jindal, Granton/0000-0003-2803-9831; Goyal, Yogesh/0000-0003-3502-6465	National Institutes of Health [R01 GM086537]; National Science Foundation Graduate Research Fellowship [DGE 1148900]; Welch Foundation [I1128]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388, R01GM086537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 GM086537 (to J. M. H., H. H., E. J. G., Y. G., K. T., V. L. P., E. Y., R. D. B., and S. Y. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Science Foundation Graduate Research Fellowship Grant DGE 1148900.; Supported by Welch Foundation Grant I1128.	Anastasaki C, 2012, DIS MODEL MECH, V5, P546, DOI 10.1242/dmm.008672; Anastasaki C, 2009, HUM MOL GENET, V18, P2543, DOI 10.1093/hmg/ddp186; Bromberg-White JL, 2012, BRIEF FUNCT GENOMICS, V11, P300, DOI 10.1093/bfgp/els022; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; Couto JA, 2017, AM J HUM GENET, V100, P546, DOI 10.1016/j.ajhg.2017.01.018; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Furthauer M, 1997, DEVELOPMENT, V124, P4253; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Goyal Y, 2017, DIS MODEL MECH, V10, P923, DOI 10.1242/dmm.030163; Goyal Y, 2017, NAT GENET, V49, P465, DOI 10.1038/ng.3780; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Jindal GA, 2017, P NATL ACAD SCI USA, V114, P510, DOI 10.1073/pnas.1615651114; Jindal GA, 2015, DIS MODEL MECH, V8, P769, DOI 10.1242/dmm.020339; Johnson HE, 2017, DEV CELL, V40, P185, DOI 10.1016/j.devcel.2016.12.002; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; Krens SFG, 2008, DEV BIOL, V319, P370, DOI 10.1016/j.ydbio.2008.04.032; Mansour SJ, 1996, BIOCHEMISTRY-US, V35, P15529, DOI 10.1021/bi961854s; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Piala AT, 2014, BIOPHYS J, V107, P2006, DOI 10.1016/j.bpj.2014.09.024; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; RESING KA, 1995, BIOCHEMISTRY-US, V34, P2610, DOI 10.1021/bi00008a027; Runtuwene V, 2011, DIS MODEL MECH, V4, P393, DOI 10.1242/dmm.007112; Schottenfeld J, 2007, DEVELOPMENT, V134, P1605, DOI 10.1242/dev.02827; SEGER R, 1992, J BIOL CHEM, V267, P14373; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Xu H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-436	32	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18814	18820		10.1074/jbc.C117.806067	http://dx.doi.org/10.1074/jbc.C117.806067			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	29018093	Green Published, hybrid			2022-12-26	WOS:000415848000007
J	Liu, JY; Fan, HY; Wang, Y; Zhang, YL; Li, DW; Yu, JL; Han, CG				Liu, Jun-Ying; Fan, Hui-Yan; Wang, Ying; Zhang, Yong-Liang; Li, Da-Wei; Yu, Jia-Lin; Han, Cheng-Gui			Characterization of microRNAs of Beta macrocarpa and their responses to Beet necrotic yellow vein virus infection	PLOS ONE			English	Article							P25 PATHOGENICITY FACTOR; EVOLUTIONARY HISTORY; EXPRESSION; INDUCTION; TARGETS; IDENTIFICATION; SUPPRESSION; BIOGENESIS; DISEASE; VECTOR	Plant microRNAs (miRNAs) are a class of non-coding RNAs that play important roles in plant development, defense, and symptom development. Here, 547 known miRNAs representing 129 miRNA families, and 282 potential novel miRNAs were identified in Beta macrocarpa using small RNA deep sequencing. A phylogenetic analysis was performed, and 8 Beta lineage-specific miRNAs were identified. Through a differential expression analysis, miRNAs associated with Beet necrotic yellow vein virus (BNYVV) infection were identified and confirmed using a microarray analysis and stem-loop RT-qPCR. In total, 103 known miRNAs representing 38 miRNA families, and 45 potential novel miRNAs were differentially regulated, with at least a two-fold change, in BNYVV-infected plants compared with that of the mock-inoculated control. Targets of these differentially expressed miRNAs were also predicted by degradome sequencing. These differentially expressed miRNAs were involved in hormone biosynthesis and signal transduction pathways, and enhanced axillary bud development and plant defenses. This work is the first to describe miRNAs of the plant genus Beta and may offer a reference for miRNA research in other species in the genus. It provides valuable information on the pathogenicity mechanisms of BNYVV.	[Liu, Jun-Ying; Wang, Ying; Zhang, Yong-Liang; Li, Da-Wei; Yu, Jia-Lin; Han, Cheng-Gui] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Liu, Jun-Ying; Wang, Ying; Zhang, Yong-Liang; Li, Da-Wei; Yu, Jia-Lin; Han, Cheng-Gui] China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing, Peoples R China; [Fan, Hui-Yan] Zhejiang Chinese Med Univ, Coll Pharm, Hangzhou, Zhejiang, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Zhejiang Chinese Medical University	Zhang, YL; Han, CG (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China.; Zhang, YL; Han, CG (corresponding author), China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing, Peoples R China.	cauzhangyl@cau.edu.cn; hanchenggui@cau.edu.cn	Li, Dawei/I-8751-2016; Zhang, Yongliang/AAE-7639-2021; Li, Dawei/CAJ-5076-2022	Li, Dawei/0000-0003-4133-1263; Zhang, Yongliang/0000-0002-6790-1044; Liu, Jun-Ying/0000-0002-8388-1557; Han, Chenggui/0000-0002-1584-7170	China Agriculture Research System [CARS-170304]; National Natural Science Foundation of China [31401708, 31470253]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China Agriculture Research System (CARS-170304), www.moa.gov.cn, to CGH, which played a role in the decision to publish and preparation of the manuscript. It was also supported by the National Natural Science Foundation of China (31401708), http://www.nsfc.gov.cn/, to YW, which also participated in the decision to publish. The National Natural Science Foundation of China (31470253), http://www.nsfc.gov.cn/, to YLZ, also played a role in the decision to publish.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Baksa I, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2209-6; Montes RAC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4722; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chiba S, 2011, MOL PLANT MICROBE IN, V24, P207, DOI 10.1094/MPMI-10-10-0241; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Devers EA, 2011, PLANT PHYSIOL, V156, P1990, DOI 10.1104/pp.111.172627; Du ZY, 2014, PLANT PHYSIOL, V164, P1378, DOI 10.1104/pp.113.232090; Eviatar-Ribak T, 2013, CURR BIOL, V23, P1057, DOI 10.1016/j.cub.2013.04.061; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fan GQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2074-3; Fan HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132277; Fornara F, 2009, CELL, V138, P625, DOI 10.1016/j.cell.2009.08.011; Gai YP, 2014, SCI REP-UK, V4, DOI 10.1038/srep05378; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gu WJ, 2012, MOL BIOL EVOL, V29, P3037, DOI 10.1093/molbev/mss109; Jay F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002035; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; Li SB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00047; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; McGrann GRD, 2009, MOL PLANT PATHOL, V10, P129, DOI 10.1111/j.1364-3703.2008.00514.x; Peltier C, 2011, TRANSGENIC RES, V20, P443, DOI 10.1007/s11248-010-9424-3; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; Rahim MD, 2007, J GEN VIROL, V88, P1611, DOI 10.1099/vir.0.82720-0; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; RICHARDS KE, 1992, ANNU REV PHYTOPATHOL, V30, P291, DOI 10.1146/annurev.py.30.090192.001451; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Saminathan T, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0807-3; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Tamada T, 1999, PHYTOPATHOLOGY, V89, P1000, DOI 10.1094/PHYTO.1999.89.11.1000; TAMADA T, 1973, Annals of the Phytopathological Society of Japan, V39, P325, DOI 10.3186/jjphytopath.39.325; TAMADA T, 1989, J GEN VIROL, V70, P3399, DOI 10.1099/0022-1317-70-12-3399; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor RS, 2014, TRENDS PLANT SCI, V19, P175, DOI 10.1016/j.tplants.2013.11.008; Thiel H, 2012, MOL PLANT MICROBE IN, V25, P1058, DOI 10.1094/MPMI-03-12-0057-R; Thiel H, 2009, MOL PLANT MICROBE IN, V22, P999, DOI 10.1094/MPMI-22-8-0999; Varallyay E, 2010, EMBO J, V29, P3507, DOI 10.1038/emboj.2010.215; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang Y, 2011, VIROLOGY J, V8; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Xu MY, 2014, J EXP BOT, V65, P89, DOI 10.1093/jxb/ert353; Yang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146946; Yin HF, 2016, J EXP BOT, V67, P2641, DOI 10.1093/jxb/erw095; Yu S, 2012, PLANT CELL, V24, P3320, DOI 10.1105/tpc.112.101014; Zhang BH, 2015, J CELL PHYSIOL, V230, P1, DOI 10.1002/jcp.24685; Zhang C, 2016, MOL PLANT, V9, P1302, DOI 10.1016/j.molp.2016.06.014; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010	51	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186500	10.1371/journal.pone.0186500	http://dx.doi.org/10.1371/journal.pone.0186500			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036205	Green Published, gold, Green Submitted			2022-12-26	WOS:000413054800042
J	Montemayor, SI; Melo, MC; Scattolini, MC; Pocco, ME; del Rio, MG; Dellape, G; Scheibler, EE; Roig, SA; Cazorla, CG; Dellape, PM				Montemayor, Sara I.; Cecilia Melo, Maria; Celeste Scattolini, Maria; Pocco, Martina E.; Guadalupe del Rio, Maria; Dellape, Gimena; Scheibler, Erica E.; Roig, Sergio A.; Cazorla, Carla G.; Dellape, Pablo M.			The fate of endemic insects of the Andean region under the effect of global warming	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; STABILITY; PATAGONIA; REFUGIA; PHYLOGEOGRAPHY; BIODIVERSITY; PLEISTOCENE; EVOLUTION; PATTERNS; AMERICA	Three independent but complementary lines of research have provided evidence for the recognition of refugia: paleontology, phylogeography and species distributional modelling (SDM). SDM assesses the ecological requirements of a species based on its known occurrences and enables its distribution to be projected on past climatological reconstructions. One advantage over the other two approaches is that it provides an explicit link to environment and geography, thereby enabling the analysis of a large number of taxa in the search for more general refugia patterns. We propose a methodology for using SDM to recognize biogeographical patterns of endemic insects from Southern South America. We built species distributional models for 59 insect species using Maxent. The species analyzed in the study have narrow niche breadth and were classified into four assemblages according to the ecoregion they inhabit. Models were built for the Late Pleistocene, Mid-Holocene and Present. Through the procedure developed for this study we used the models to recognize: Late Pleistocene refugia; areas with high species richness during all three periods; climatically constant areas (in situ refugia); consistent patterns among in situ refugia, Pleistocene refugia and current distribution of endemic species. We recognized two adjacent Pleistocene refugia with distinct climates; four in situ refugia, some of which are undergoing a process of fragmentation and retraction or enlargement. Interestingly, we found a congruent pattern among in situ refugia, Pleistocene refugia and endemic species. Our results seem to be consistent with the idea that long-term climate stability is known to have a key role in promoting persistence of biodiversity in an area. Our Pleistocene and in situ refugia are consistent with refugia identified in studies focusing on different taxa and applying other methodologies, showing that the method developed can be used to identify such areas and prove their importance for conservation.	[Montemayor, Sara I.; Cecilia Melo, Maria; Guadalupe del Rio, Maria; Dellape, Gimena; Dellape, Pablo M.] Univ Nacl La Plata, CONICET, Div Entomol, Museo La Plata, Paseo Bosque S-N B1900FWA, La Plata, Buenos Aires, Argentina; [Celeste Scattolini, Maria; Pocco, Martina E.] UNLP, Ctr Estudios Parasitol & Vectores CEPAVE, CCT La Plata CONICET, Blvd 120 E-60 & 64 S-N, La Plata, Buenos Aires, Argentina; [Scheibler, Erica E.; Roig, Sergio A.] IADIZA CCT CONICET Mendoza, Lab Entomol, Avda,Ruiz Leal S-N,Parque Gral, Mendoza, Argentina; [Cazorla, Carla G.] Univ Nacl La Plata, ANEXO MUSEO, CONICET, Div Entomol,Museo La Plata, Calle 122 & 60, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata	Melo, MC (corresponding author), Univ Nacl La Plata, CONICET, Div Entomol, Museo La Plata, Paseo Bosque S-N B1900FWA, La Plata, Buenos Aires, Argentina.	ceciliamelo@fcnym.unlp.edu.ar	Dellape, Gimena/ADI-6890-2022; Dellapé, Pablo/AAH-6970-2019	Dellape, Gimena/0000-0003-2084-4932; Dellapé, Pablo/0000-0002-6914-1026; Melo, Maria Cecilia/0000-0003-4612-452X; Cazorla, Carla G./0000-0002-3644-8574; Scattolini, Maria Celeste/0000-0002-6613-3186	Fondo para la Investigacion Cientifica y Tecnologica (FONCYT) [PICT-0488]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fondo para la Investigacion Cientifica y Tecnologica (FONCYT)(FONCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The work was funded by Fondo para la Investigacion Cientifica y Tecnologica (FONCYT), PICT-0488, and our main employer Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET).	[Anonymous], 2011, MONOGRAPHS POPULATIO; ASHWORTH AC, 1987, ANN ENTOMOL SOC AM, V80, P865, DOI 10.1093/aesa/80.6.865; Bennett KD, 2008, QUATERNARY SCI REV, V27, P2449, DOI 10.1016/j.quascirev.2008.08.019; Bosso L, 2017, FOREST ECOL MANAG, V400, P655, DOI 10.1016/j.foreco.2017.06.044; Cabrera A. L., 1973, SERIE DE BIOL, V13; Premoli AC, 2012, NAT CONSERVACAO, V10, P160, DOI 10.4322/natcon.2012.036; Chefaoui RM, 2017, SCI REPORTS, V7, P1; Coope GR, 2004, PHILOS T R SOC B, V359, P209, DOI 10.1098/rstb.2003.1393; Cosacov A, 2010, J BIOGEOGR, V37, P1463, DOI 10.1111/j.1365-2699.2010.02307.x; Dellape G, 2016, REV SOC ENTOMOL ARGE, V75, P81; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ponce JF, 2011, BIOL J LINN SOC, V103, P363, DOI 10.1111/j.1095-8312.2011.01653.x; Fois M, 2015, J NAT CONSERV, V24, P42, DOI 10.1016/j.jnc.2015.02.001; Gavin DG, 2014, NEW PHYTOL, V204, P37, DOI 10.1111/nph.12929; Glasser NF, 2008, QUATERNARY SCI REV, V27, P365, DOI 10.1016/j.quascirev.2007.11.011; Grimaldi David, 2005, pi; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOGANSON JW, 1992, QUATERNARY RES, V37, P101, DOI 10.1016/0033-5894(92)90009-8; Montemayor SI, 2016, AUSTRAL ECOL, V41, P983, DOI 10.1111/aec.12392; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Mammola S, 2017, ECOGRAPHY; McCulloch RD, 2000, J QUATERNARY SCI, V15, P409, DOI 10.1002/1099-1417(200005)15:4<409::AID-JQS539>3.0.CO;2-#; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Morrone JJ, 2006, ANNU REV ENTOMOL, V51, P467, DOI 10.1146/annurev.ento.50.071803.130447; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peers MJL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051488; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rabassa J, 2008, DEV QUATER SCI, V11, P151, DOI 10.1016/S1571-0866(07)10008-7; Ramos VA, 2008, DEV QUATER SCI, V11, P57, DOI 10.1016/S1571-0866(07)10004-X; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Sersic AN, 2011, BIOL J LINN SOC, V103, P475, DOI 10.1111/j.1095-8312.2011.01656.x; Shcheglovitova M, 2013, ECOL MODEL, V269, P9, DOI 10.1016/j.ecolmodel.2013.08.011; Spinelli Gustavo R., 2009, Rev. Soc. Entomol. Argent., V68, P201; Terribile LC, 2012, NAT CONSERVACAO, V10, P152, DOI 10.4322/natcon.2012.025; VERGARA O., 2010, REGION DE AYSEN CHIL, V74, P83; VILLAGRAN C, 1988, QUATERNARY RES, V30, P304, DOI 10.1016/0033-5894(88)90006-3; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Werneck FP, 2012, J BIOGEOGR, V39, P1695, DOI 10.1111/j.1365-2699.2012.02715.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	43	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186655	10.1371/journal.pone.0186655	http://dx.doi.org/10.1371/journal.pone.0186655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036214	Green Published, Green Submitted, gold			2022-12-26	WOS:000413054800056
J	Alcala, M; Calderon-Dominguez, M; Serra, D; Herrero, L; Ramos, MP; Viana, M				Alcala, Martin; Calderon-Dominguez, Maria; Serra, Dolors; Herrero, Laura; Ramos, Maria P.; Viana, Marta			Short-term vitamin E treatment impairs reactive oxygen species signaling required for adipose tissue expansion, resulting in fatty liver and insulin resistance in obese mice	PLOS ONE			English	Article							OXIDATION PROTEIN PRODUCTS; METABOLIC PROFILE; E SUPPLEMENTATION; NADPH OXIDASE; STRESS; WEIGHT; ROS; LIPODYSTROPHY; ASSOCIATION; OVERWEIGHT	Objectives The use of antioxidant therapy in the treatment of oxidative stress-related diseases such as cardiovascular disease, diabetes or obesity remains controversial. Our aim is to demonstrate that antioxidant supplementation may promote negative effects if used before the establishment of oxidative stress due to a reduced ROS generation under physiological levels, in a mice model of obesity. Methods C57BL/6J mice were fed with a high-fat diet for 14 weeks, with (OE group) or without (O group) vitamin E supplementation. Results O mice developed a mild degree of obesity, which was not enough to induce metabolic alterations or oxidative stress. These animals exhibited a healthy expansion of retroperitoneal white adipose tissue (rpWAT) and the liver showed no signs of lipotoxicity. Interestingly, despite achieving a similar body weight, OE mice were insulin resistant. In the rpWAT they presented a reduced generation of ROS, even below physiological levels (C: 1651.0 +/- 212.0; O: 3113 +/- 284.7; OE: 917.6 +/- 104.4 RFU/mg protein. C vs OE p<0.01). ROS decay may impair their action as second messengers, which could account for the reduced adipocyte differentiation, lipid transport and adipogenesis compared to the O group. Together, these processes limited the expansion of this fat pad and as a consequence, lipid flux shifted towards the liver, causing steatosis and hepatomegaly, which may contribute to the marked insulin resistance. Conclusions This study provides in vivo evidence for the role of ROS as second messengers in adipogenesis, lipid metabolism and insulin signaling. Reducing ROS generation below physiological levels when the oxidative process has not yet been established may be the cause of the controversial results obtained by antioxidant therapy.	[Alcala, Martin; Calderon-Dominguez, Maria; Ramos, Maria P.; Viana, Marta] Univ San Pablo CEU, CEU Univ, Dept Chem & Biochem, Fac Farm, Madrid, Spain; [Serra, Dolors; Herrero, Laura] Univ Barcelona, Dept Biochem & Physiol, IBUB, Barcelona, Spain; [Serra, Dolors; Herrero, Laura] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain	San Pablo CEU University; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Viana, M (corresponding author), Univ San Pablo CEU, CEU Univ, Dept Chem & Biochem, Fac Farm, Madrid, Spain.	mviana@ceu.es	Viana, Marta/L-4649-2014; Herrero, Laura/D-4011-2014; Ramos-Alvarez, M.Pilar/B-6359-2011; Calderon-Dominguez, Maria/AAU-3721-2020; Serra, Dolors/L-3657-2014; Diaz-Mor, Martín Alcalá/F-1453-2016	Viana, Marta/0000-0003-4718-4145; Herrero, Laura/0000-0003-4244-4673; Ramos-Alvarez, M.Pilar/0000-0002-7727-7783; Calderon-Dominguez, Maria/0000-0003-1797-3450; Serra, Dolors/0000-0002-4936-4206; Diaz-Mor, Martín Alcalá/0000-0003-4678-8860	Ministry of Spain-MINECO [SAF2013-45887-R, SAF2014-56671-R, SAF2014-52223-C2-1-R]; Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN) [CB06/03/0001]; Generalitat de Catalunya [2014SGR465]; Community of Madrid [S2010/BMD-2423]; European Foundation for the Study of Diabetes (EFSD)/Janssen-Rising Star and L'Oreal-UNESCO	Ministry of Spain-MINECO(Ministry of Health-Singapore); Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN); Generalitat de Catalunya(Generalitat de Catalunya); Community of Madrid(Comunidad de Madrid); European Foundation for the Study of Diabetes (EFSD)/Janssen-Rising Star and L'Oreal-UNESCO(L'Oreal Group)	This work was supported by the Ministry of Spain-MINECO (SAF2013-45887-R to LH, SAF2014-56671-R to MPR, SAF2014-52223-C2-1-R to DS (grant cofounded by Fondos Europeos de Desarrollo Regional de la Union Europea (FEDER)), by the Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN) (Grant CB06/03/0001 to DS), by Generalitat de Catalunya (2014SGR465 to DS), by the Community of Madrid (S2010/BMD-2423) to MPR and by the European Foundation for the Study of Diabetes (EFSD)/Janssen-Rising Star and L'Oreal-UNESCO "For Women in Science" research fellowships to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abner Erin L, 2011, Curr Aging Sci, V4, P158; Al-Aubaidy HA, 2011, EUR J ENDOCRINOL, V164, P899, DOI 10.1530/EJE-11-0053; Alcala M, 2015, OBESITY, V23, P1598, DOI 10.1002/oby.21135; Calvisi DF, 2004, J HEPATOL, V41, P815, DOI 10.1016/j.jhep.2004.07.030; Castro JP, 2016, BIOL CHEM, V397, P709, DOI 10.1515/hsz-2015-0305; Chrysohoou C, 2007, NUTR METAB CARDIOVAS, V17, P590, DOI 10.1016/j.numecd.2006.05.007; Contreras-Ferrat A, 2014, J CELL SCI, V127, P1911, DOI 10.1242/jcs.138982; Dandona P, 2001, J CLIN ENDOCR METAB, V86, P355, DOI 10.1210/jc.86.1.355; Cruz MAF, 2015, GASTROENTEROL RES, V8, P260, DOI 10.14740/gr685w; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Hammarstedt A, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-42; Higuchi M, 2012, STEM CELLS DEV; Iwakami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027401; Jiang F, 2011, REDOX REP, V16, P223, DOI 10.1179/174329211X13049558293713; Kanda Y, 2011, LIFE SCI, V89, P250, DOI 10.1016/j.lfs.2011.06.007; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Krzystek-Korpacka M, 2008, CLIN BIOCHEM, V41, P943, DOI 10.1016/j.clinbiochem.2008.04.024; Lackey DE, 2014, AM J PHYSIOL-ENDOC M, V306, pE233, DOI 10.1152/ajpendo.00476.2013; Lancha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098398; Lee PL, 2016, MOL METAB, V5, P422, DOI 10.1016/j.molmet.2016.04.001; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Long EK, 2013, FREE RADIC BIOL MED; Mann JFE, 2004, KIDNEY INT, V65, P1375, DOI 10.1111/j.1523-1755.2004.00513.x; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022; Noeman SA, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-17; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; Patel C, 2007, J CLIN ENDOCR METAB, V92, P4476, DOI 10.1210/jc.2007-0778; Reitman A, 2002, ISRAEL MED ASSOC J, V4, P590; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Ruperez FJ, 1998, J CHROMATOGR A, V823, P483, DOI 10.1016/S0021-9673(98)00206-4; Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002; Slawik M, 2007, GENES NUTR, V2, P41, DOI 10.1007/s12263-007-0014-9; Spencer M, 2011, J CLIN ENDOCR METAB, V96, pE1990, DOI 10.1210/jc.2011-1567; Sutherland WHF, 2007, OBESITY, V15, P386, DOI 10.1038/oby.2007.546; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Viana M, 2000, FREE RADICAL BIO MED, V29, P1115, DOI 10.1016/S0891-5849(00)00397-X; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; World Health Organization, 2016, OB OV; Yang YB, 2014, OBESITY, V22, P2147, DOI 10.1002/oby.20811; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zadeh ES, 2013, J HEPATOL, V59, P131, DOI 10.1016/j.jhep.2013.02.007	48	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186579	10.1371/journal.pone.0186579	http://dx.doi.org/10.1371/journal.pone.0186579			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028831	gold, Green Published, Green Submitted			2022-12-26	WOS:000412980300043
J	Mortensen, JH; Manon-Jensen, T; Jensen, MD; Hagglund, P; Klinge, LG; Kjeldsen, J; Krag, A; Karsdal, MA; Bay-Jensen, AC				Mortensen, Joachim Hog; Manon-Jensen, Tina; Jensen, Michael Dam; Hagglund, Per; Klinge, Lone Gabriels; Kjeldsen, Jens; Krag, Aleksander; Karsdal, Morten Asser; Bay-Jensen, Anne-Christine			Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease	PLOS ONE			English	Article							V COLLAGEN; NEUTROPHIL-ELASTASE; LIVER FIBROSIS; BIGLYCAN; TROPOELASTIN; EXPRESSION; COMPONENTS; CONSENSUS; DECORIN; SIGNALS	Background Increased protease activity is a key pathological feature of inflammatory bowel disease (IBD). However, the differences in extracellular matrix remodelling (ECM) in Crohn's disease (CD) and ulcerative colitis (UC) are not well described. An increased understanding of the inflammatory processes may provide optimized disease monitoring and diagnostics. We investigated the tissue remodelling in IBD and IBS patients by using novel blood-based biomarkers reflecting ECM remodelling. Methods Five ECM biomarkers (VICM, BGM, EL-NE, C5M, Pro-C5) were measured by competitive ELISAs in serum from 72 CD patients, 60 UC patients, 22 patients with irritable bowel syndrome (IBS), and 24 healthy donors. One-way analysis of variance, Mann-Whitney U-test, logistic regression models, and receiver operator characteristics (ROC) curve analysis was carried out to evaluate the diagnostic accuracy of the biomarkers. Results The ECM remodelling was significantly different in UC compared to CD. The best biomarker combination to differentiate UC from CD and colonic CD was BGM and VICM (AUC = 0.98, P< 0.001; AUC = 0.97, P< 0.001), and the best biomarker combination to differentiate IBD from IBS patients were BGM, EL-NE, and Pro-C5 (AUC = 0.8, P< 0.001). When correcting for the use of immunosuppressant and elevated CRP levels (CRP> 5mg/mL), correlation of Pro-C5 (r = 0.36) with CDAI was slightly improved compared to CRP (r = 0.27) corrected for the use of immunosuppressant. Furthermore, BGM and EL-NE biomarkers were highly associated with colon inflammation in CD patients. Conclusion ECM fragments of tissue remodelling in IBD affect UC and CD differently, and may aid in differentiating IBD from IBS (EL-NE, BGM, Pro-C5), and UC from CD patients (BGM, VICM). Formation of type V collagen is related to the level of inflammation in CD and may reflect disease activity in CD.	[Mortensen, Joachim Hog; Manon-Jensen, Tina; Karsdal, Morten Asser; Bay-Jensen, Anne-Christine] Nord Biosci Biomarkers & Res, Herlev, Denmark; [Jensen, Michael Dam] Lillebaelt Hosp Vejle, Dept Internal Med, Vejle, Denmark; [Hagglund, Per] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [Klinge, Lone Gabriels; Kjeldsen, Jens; Krag, Aleksander] Odense Univ Hosp, Dept Gastroenterol, Odense, Denmark	Nordic Bioscience; Technical University of Denmark; University of Southern Denmark; Odense University Hospital	Mortensen, JH (corresponding author), Nord Biosci Biomarkers & Res, Herlev, Denmark.	jhm@nordicbio.com	Hägglund, Per/X-4881-2019; Bay-Jensen, Anne-Christine/AEQ-7281-2022; Kjeldsen, Jens/Q-6894-2019; Krag, Aleksander/ABH-9649-2020	Bay-Jensen, Anne-Christine/0000-0001-7952-9297; Krag, Aleksander/0000-0002-9598-4932; Mortensen, Joachim Hog/0000-0003-0326-7264; Karsdal, Morten/0000-0001-5026-8740; Hagglund, Per/0000-0002-6627-7518; Kjeldsen, Jens/0000-0001-8148-6572	Danish Research Foundation	Danish Research Foundation	This work was funded by the Danish Research Foundation. The funder provided support to the research in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. Joachim H. Mortensen, Tina Manon-Jensen, Morten A. Karsdal and Anne C. Bay-Jensen commercial affiliation with Nordic Bioscience did not play a role in conducting the study, as this study was purely scientific driven and study protocols and design of the study was approved by all authors, including authors not affiliated with Nordic Bioscience. Nordic Bioscience or the Danish Research Foundation did not in any way fund the following authors Michael D. Jensen, Per Hagglund, Lone G. Klinge, Jens Kjeldsen, and Aleksander Krag.with Nordic Bioscience did not play a role in conducting the study, as this study was purely scientific driven and study protocols and design of the study was approved by all authors, including authors not affiliated with Nordic Bioscience. Nordic Bioscience or the Danish Research Foundation did not in any way fund the following authors Michael D. Jensen, Per Hagglund, Lone G. Klinge, Jens Kjeldsen, and Aleksander Krag.	ADEYEMI EO, 1985, GUT, V26, P1306, DOI 10.1136/gut.26.12.1306; Ben- Nun T., 2015, INT C HIGH PERF COMP, P1; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Del Zotto B, 2003, CLIN EXP IMMUNOL, V134, P120, DOI 10.1046/j.1365-2249.2003.02250.x; Douglas T, 2006, BIOMACROMOLECULES, V7, P2388, DOI 10.1021/bm0603746; Genovese F, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-9; Goffin L, 2016, INFLAMM BOWEL DIS, V22, P2041, DOI 10.1097/MIB.0000000000000863; Gouni-Berthold I, 1999, HEPATO-GASTROENTEROL, V46, P2315; GRAHAM MF, 1988, GASTROENTEROLOGY, V94, P257, DOI 10.1016/0016-5085(88)90411-8; Jensen MD, 2015, EUR J GASTROEN HEPAT, V27, P1038, DOI 10.1097/MEG.0000000000000430; Johnson LL, 1998, CURR OPIN CHEM BIOL, V2, P466, DOI 10.1016/S1367-5931(98)80122-1; Karsdal MA, 2013, BIOMARKERS, V18, P375, DOI 10.3109/1354750X.2013.789084; Karsdal MA, 2010, CLIN BIOCHEM, V43, P793, DOI 10.1016/j.clinbiochem.2010.03.015; KONOMI H, 1984, AM J PATHOL, V116, P417; Kristensen JH, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0048-5; Levine AP, 2013, DIGEST DIS, V31, P321, DOI 10.1159/000354686; Magro F, 2013, J CROHNS COLITIS, V7, P827, DOI 10.1016/j.crohns.2013.06.001; Makitalo L, 2012, SCAND J GASTROENTERO, V47, P785, DOI 10.3109/00365521.2012.677954; Mendoza JL, 2009, GASTROEN CLIN BIOL, V33, pS158, DOI 10.1016/S0399-8320(09)73151-3; Mikula M, 2011, FUNCT INTEGR GENOMIC, V11, P215, DOI 10.1007/s10142-010-0200-5; Moreth K, 2010, J CLIN INVEST, V120, P4251, DOI 10.1172/JCI42213; MORTENSEN JH, 2015, J CROHNS COLITIS; Nastase MV, 2012, J HISTOCHEM CYTOCHEM, V60, P963, DOI 10.1369/0022155412456380; Reinboth B, 2002, J BIOL CHEM, V277, P3950, DOI 10.1074/jbc.M109540200; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Shirts B, 2012, AM J GASTROENTEROL, V107, P1760, DOI 10.1038/ajg.2012.238; van Haaften WT, 2017, ALIMENT PHARM THER, V46, P26, DOI 10.1111/apt.14092; Vassiliadis E, 2012, AM J TRANSL RES, V4, P403; Vassiliadis E, 2011, BIOMARKERS, V16, P426, DOI 10.3109/1354750X.2011.584131; Veidal SS, 2012, CLIN BIOCHEM, V45, P541, DOI 10.1016/j.clinbiochem.2012.02.007; Vermeire S, 2006, GUT, V55, P426, DOI 10.1136/gut.2005.069476; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a	37	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0185855	10.1371/journal.pone.0185855	http://dx.doi.org/10.1371/journal.pone.0185855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028807	Green Published, gold, Green Submitted			2022-12-26	WOS:000412980300014
J	Williams, AR; Krych, L; Ahmad, HF; Nejsum, P; Skovgaard, K; Nielsen, DS; Thamsborg, SM				Williams, Andrew R.; Krych, Lukasz; Ahmad, Hajar Fauzan; Nejsum, Peter; Skovgaard, Kerstin; Nielsen, Dennis S.; Thamsborg, Stig M.			A polyphenol-enriched diet and Ascaris suum infection modulate mucosal immune responses and gut microbiota composition in pigs	PLOS ONE			English	Article							DELTA-T-CELLS; SAINFOIN ONOBRYCHIS-VICIIFOLIA; NEMATODE TRICHURIS-SUIS; HELMINTH INFECTION; GRAPE SEED; GASTROINTESTINAL NEMATODES; LYSILOMA-LATISILIQUUM; ESCHERICHIA-COLI; WEANING PIGLETS; PROANTHOCYANIDINS	Polyphenols are a class of bioactive plant secondary metabolites that are thought to have beneficial effects on gut health, such as modulation of mucosal immune and inflammatory responses and regulation of parasite burdens. Here, we examined the interactions between a polyphenol-rich diet supplement and infection with the enteric nematode Ascaris suum in pigs. Pigs were fed either a basal diet or the same diet supplemented with grape pomace (GP), an industrial by-product rich in polyphenols such as oligomeric proanthocyanidins. Half of the animals in each group were then inoculated with A. suum for 14 days to assess parasite establishment, acquisition of local and systemic immune responses and effects on the gut microbiome. Despite in vitro anthelmintic activity of GP-extracts, numbers of parasite larvae in the intestine were not altered by GP-supplementation. However, the bioactive diet significantly increased numbers of eosinophils induced by A. suum infection in the duodenum, jejunum and ileum, and modulated gene expression in the jejunal mucosa of infected pigs. Both GP-supplementation and A. suum infection induced significant and apparently similar changes in the composition of the prokaryotic gut microbiota, and both also decreased concentrations of isobutyric and isovaleric acid (branched-chain short chain fatty acids) in the colon. Our results demonstrate that while a polyphenol-enriched diet in pigs may not directly influence A. suum establishment, it significantly modulates the subsequent host response to helminth infection. Our results suggest an influence of diet on immune function which may potentially be exploited to enhance immunity to helminths.	[Williams, Andrew R.; Thamsborg, Stig M.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg, Denmark; [Krych, Lukasz; Ahmad, Hajar Fauzan; Nielsen, Dennis S.] Univ Copenhagen, Dept Food Sci, Fac Sci, Frederiksberg, Denmark; [Ahmad, Hajar Fauzan] Univ Malaysia Pahang, Dept Ind Biotechnol, Fac Ind Sci & Technol, Pahang, Malaysia; [Nejsum, Peter] Aarhus Univ, Fac Hlth, Dept Clin Med, Aarhus, Denmark; [Skovgaard, Kerstin] Tech Univ Denmark, Sect Immunol & Vaccinol, Frederiksberg, Denmark	University of Copenhagen; University of Copenhagen; Universiti Malaysia Pahang; Aarhus University; Technical University of Denmark	Williams, AR (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg, Denmark.	arw@sund.ku.dk	Ahmad, Hajar Fauzan/AAH-9911-2019; Nielsen, Dennis Sandris/A-9769-2015; Krych, Lukasz/F-4446-2015	Ahmad, Hajar Fauzan/0000-0003-2985-2496; Nejsum, Peter/0000-0002-6673-8505; Nielsen, Dennis Sandris/0000-0001-8121-1114; Williams, Andrew/0000-0002-8231-282X; skovgaard, kerstin/0000-0001-5663-4879; Krych, Lukasz/0000-0003-3224-1346	Danish Council for Independent Research (Technology and Production Sciences) [12-126630]; Lundbeck Foundation [14-3670A]	Danish Council for Independent Research (Technology and Production Sciences)(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by Danish Council for Independent Research (Technology and Production Sciences 12-126630; www.ufm.dk; ARW, SMT) and Lundbeck Foundation (Grant 14-3670A; www.lundbeckfonden.com; ARW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez LRD, 2008, PARASITOLOGY, V135, P1117, DOI 10.1017/S0031182008004563; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brunet S, 2008, VET PARASITOL, V157, P81, DOI 10.1016/j.vetpar.2008.07.013; Canibe N, 2007, LIVEST SCI, V108, P198, DOI 10.1016/j.livsci.2007.01.095; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlier J, 2014, TRENDS PARASITOL, V30, P361, DOI 10.1016/j.pt.2014.04.009; Choy YY, 2014, FOOD FUNCT, V5, P2298, DOI [10.1039/c4fo00325j, 10.1039/C4FO00325J]; Coddens A, 2017, VET MICROBIOL, V202, P64, DOI 10.1016/j.vetmic.2017.01.019; Coop RL, 2001, TRENDS PARASITOL, V17, P325, DOI 10.1016/S1471-4922(01)01900-6; Dawson HD, 2005, INFECT IMMUN, V73, P1116, DOI 10.1128/IAI.73.2.1116-1128.2005; Denis MC, 2015, CLIN SCI, V128, P197, DOI 10.1042/CS20140210; Desrues O, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1617-z; Fiesel A, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0196-5; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Gerwert S, 2002, PARASITOL RES, V88, P63, DOI 10.1007/s004360100507; Gessner DK, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-18; Giacomin P, 2015, SCI REP-UK, V5, DOI 10.1038/srep13797; HALE OM, 1985, J ANIM SCI, V60, P220, DOI 10.2527/jas1985.601220x; Holderness J, 2007, J IMMUNOL, V179, P6468, DOI 10.4049/jimmunol.179.10.6468; Hosseini E, 2011, NUTR REV, V69, P245, DOI 10.1111/j.1753-4887.2011.00388.x; Hoste H, 2012, VET PARASITOL, V186, P18, DOI 10.1016/j.vetpar.2011.11.042; Houlden A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125945; Jankowska-Makosa A, 2015, RES VET SCI, V100, P153, DOI 10.1016/j.rvsc.2015.04.002; Lee SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002880; Li RW, 2016, SCI REP-UK, V6, DOI 10.1038/srep20606; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; MACFARLANE GT, 1992, FEMS MICROBIOL ECOL, V101, P81, DOI 10.1111/j.1574-6968.1992.tb05764.x; Martinez-Micaelo N, 2012, BIOFACTORS, V38, P257, DOI 10.1002/biof.1019; Martinez-Ortiz-de-Montellano C, 2010, VET PARASITOL, V172, P283, DOI 10.1016/j.vetpar.2010.04.040; Masure D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002588; Masure D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002138; Miquel N, 2005, PARASITE IMMUNOL, V27, P79, DOI 10.1111/j.1365-3024.2005.00752.x; Mueller-Harvey I, 2006, J SCI FOOD AGR, V86, P2010, DOI 10.1002/jsfa.2577; Niezen JH, 2002, VET PARASITOL, V105, P229, DOI 10.1016/S0304-4017(02)00014-6; Org E, 2016, GUT MICROBES, V7, P313, DOI 10.1080/19490976.2016.1203502; Park MK, 2011, IMMUNOL LETT, V135, P50, DOI 10.1016/j.imlet.2010.09.011; Plieskatt JL, 2013, FASEB J, V27, P4572, DOI 10.1096/fj.13-232751; Ramanan D, 2016, SCIENCE, V352, P608, DOI 10.1126/science.aaf3229; Ramirez-Restrepo CA, 2010, ANIM FEED SCI TECH, V155, P99, DOI 10.1016/j.anifeedsci.2009.10.006; Ramsay A, 2016, PHYTOCHEMISTRY, V122, P146, DOI 10.1016/j.phytochem.2015.12.005; Ramsay A, 2015, J AGR FOOD CHEM, V63, P9471, DOI 10.1021/acs.jafc.5b04106; REED JD, 1995, J ANIM SCI, V73, P1516; Roepstorff A, 1997, PARASITOLOGY, V115, P443, DOI 10.1017/S0031182097001480; Ropiak HM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170768; Rose C. J., 1984, Proceedings of the Australian Society of Animal Production, V15, P743; Sargison ND, 2012, VET PARASITOL, V189, P79, DOI 10.1016/j.vetpar.2012.03.035; Sehm J, 2007, J ANIM PHYSIOL AN N, V91, P289, DOI 10.1111/j.1439-0396.2006.00650.x; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; STEWART TB, 1988, J ANIM SCI, V66, P1548; Sutherland IA, 2011, TRENDS PARASITOL, V27, P176, DOI 10.1016/j.pt.2010.11.008; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verhelst R, 2014, LIVEST SCI, V160, P138, DOI 10.1016/j.livsci.2013.11.026; Vlaminck J, 2015, VET PARASITOL, V210, P151, DOI 10.1016/j.vetpar.2015.04.012; Williams AR, 2017, VET IMMUNOL IMMUNOP, V189, P43, DOI 10.1016/j.vetimm.2017.06.004; Williams AR, 2017, IMMUNOLOGY, V150, P312, DOI 10.1111/imm.12687; Williams AR, 2016, RES VET SCI, V105, P209, DOI 10.1016/j.rvsc.2016.02.021; Williams AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097053; Witherden DA, 2013, J LEUKOCYTE BIOL, V94, P69, DOI 10.1189/jlb.0213101; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035470; Zaiss MM, 2015, IMMUNITY, V43, P998, DOI 10.1016/j.immuni.2015.09.012	60	42	44	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186546	10.1371/journal.pone.0186546	http://dx.doi.org/10.1371/journal.pone.0186546			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028844	Green Published, Green Submitted, gold			2022-12-26	WOS:000412980300040
J	Radakovic, D; Reboredo, J; Helm, M; Weigel, T; Schurlein, S; Kupczyk, E; Leyh, RG; Walles, H; Hansmann, J				Radakovic, D.; Reboredo, J.; Helm, M.; Weigel, T.; Schuerlein, S.; Kupczyk, E.; Leyh, R. G.; Walles, H.; Hansmann, J.			A multilayered electrospun graft as vascular access for hemodialysis	PLOS ONE			English	Article							COLLAGEN; IMPLANTS; FABRICATION; INFECTIONS; GENTAMICIN; VANCOMYCIN; ELASTIN; BYPASS	Despite medical achievements, the number of patients with end-stage kidney disease keeps steadily raising, thereby entailing a high number of surgical and interventional procedures to establish and maintain arteriovenous vascular access for hemodialysis. Due to vascular disease, aneurysms or infection, the preferred access-an autogenous arteriovenous fistula D is not always available and appropriate. Moreover, when replacing small diameter blood vessels, synthetic vascular grafts possess well-known disadvantages. A continuous multilayered gradient electrospinning was used to produce vascular grafts made of collagen type I nanofibers on luminal and adventitial graft side, and poly-e-caprolactone as medial layer. Therefore, a custom-made electrospinner with robust environmental control was developed. The morphology of electrospun grafts was characterized by scanning electron microscopy and measurement of mechanical properties. Human microvascular endothelial cells were cultured in the graft under static culture conditions and compared to cultures obtained from dynamic continuous flow bioreactors. Immunofluorescent analysis showed that endothelial cells form a continuous luminal layer and functional characteristics were confirmed by uptake of acetylated low-density-lipoprotein. Incorporation of vancomycin and gentamicin to the medial graft layer allowed antimicrobial inhibition without exhibiting an adverse impact on cell viability. Most striking a physiological hemocompatibility was achieved for the multilayered grafts.	[Radakovic, D.; Leyh, R. G.] Univ Hosp Wuerzburg, Dept Thorac & Cardiovasc Surg, Josef Schneider Str 2, Wurzburg, Germany; [Reboredo, J.; Helm, M.; Weigel, T.; Schuerlein, S.; Kupczyk, E.; Walles, H.; Hansmann, J.] Univ Hosp Wuerzburg, Dept Tissue Engn & Regenerat Med, Roentgenring 11, Wurzburg, Germany; [Helm, M.; Walles, H.; Hansmann, J.] Fraunhofer Inst Silicate Res, Neunerpl 2, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; Fraunhofer Gesellschaft	Hansmann, J (corresponding author), Univ Hosp Wuerzburg, Dept Tissue Engn & Regenerat Med, Roentgenring 11, Wurzburg, Germany.; Hansmann, J (corresponding author), Fraunhofer Inst Silicate Res, Neunerpl 2, Wurzburg, Germany.	jan.hansmann@uni-wuerzburg.de	Radakovic, Dejan/AAQ-6041-2020	Weigel, Tobias/0000-0002-6343-0505; Helm, Moritz/0000-0001-7314-146X; Walles, Heike/0000-0002-1512-7448	Interdisciplinary Center for Clinical Research (IZKF Wuerzburg) [Z-2/60]; German Federal Ministry of Education and Research program NanoMatFutur [13N12971 - ETface]	Interdisciplinary Center for Clinical Research (IZKF Wuerzburg); German Federal Ministry of Education and Research program NanoMatFutur	Dejan Radakovic's (DR) research post was funded through Interdisciplinary Center for Clinical Research (IZKF Wuerzburg) as part of Rotation program in a duration of 12 months (Rotation position Z-2/60). The development of the electrospinner was funded by the German Federal Ministry of Education and Research program NanoMatFutur through Grant Agreement No. 13N12971 - ETface.; Dejan Radakovic's research post was funded through Interdisciplinary Center for Clinical Research (IZKF Wuerzburg) as part of Rotation program in a duration of 12 months (Rotation position Z-2/60).	Allon M, 2007, CLIN J AM SOC NEPHRO, V2, P786, DOI 10.2215/CJN.00860207; Birgand G, 2013, INTERACT CARDIOV TH, V16, P134, DOI 10.1093/icvts/ivs449; Bordenave L, 1999, ENDOTHELIUM-J ENDOTH, V6, P267, DOI 10.3109/10623329909078494; Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024; Chudobova D, 2013, INT J MOL SCI, V14, P13592, DOI 10.3390/ijms140713592; Conte MS, 1998, FASEB J, V12, P43, DOI 10.1096/fasebj.12.1.43; Croisier F, 2012, ACTA BIOMATER, V8, P218, DOI 10.1016/j.actbio.2011.08.015; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; DEROSE G, 1984, J CARDIOVASC SURG, V25, P51; DOBRIN PB, 1978, PHYSIOL REV, V58, P397, DOI 10.1152/physrev.1978.58.2.397; Egger D, 2017, CELLS TISSUES ORGANS, V203, P316, DOI 10.1159/000457792; Ethier J, 2008, NEPHROL DIAL TRANSPL, V23, P3219, DOI 10.1093/ndt/gfn261; Feldman HI, 1996, J AM SOC NEPHROL, V7, P523; Fung Y.C., 1981, BIOMECHANICS MECH PR; Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652; GOLDSTEIN JL, 1977, METABOLISM, V26, P1257, DOI 10.1016/0026-0495(77)90119-6; Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003; Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516; Jaganathan SK, 2014, BIOMED RES INT, V2014; Kalicke T, 2006, J ORTHOP RES, V24, P1622, DOI 10.1002/jor.20193; Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247; Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027; KU DN, 1985, ULTRASOUND MED BIOL, V11, P13, DOI 10.1016/0301-5629(85)90003-1; Kumar Vivek A, 2011, Cardiovasc Eng Technol, V2, P137; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; LaPlante KL, 2009, ANTIMICROB AGENTS CH, V53, P3880, DOI 10.1128/AAC.00134-09; Lazarides MK, J VASCULAR SURG, V45, P420; Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032; Lok CE, 2006, J AM SOC NEPHROL, V17, P3204, DOI 10.1681/ASN.2006030190; MAILLOUX LU, 1991, AM J KIDNEY DIS, V18, P326, DOI 10.1016/S0272-6386(12)80091-6; McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8; McClure MJ, 2010, ACTA BIOMATER, V6, P2422, DOI 10.1016/j.actbio.2009.12.029; Moll C, 2013, JOVE-J VIS EXP, DOI 10.3791/50460; Mombelli A, 2011, J CLIN PERIODONTOL, V38, P203, DOI 10.1111/j.1600-051X.2010.01666.x; Mrowczynski W, 2014, J VASC SURG, V59, P210, DOI 10.1016/j.jvs.2013.03.004; Nezarati RM, 2013, TISSUE ENG PART C-ME, V19, P810, DOI [10.1089/ten.tec.2012.0671, 10.1089/ten.TEC.2012.0671]; Rathore A, 2012, WIRES NANOMED NANOBI, V4, P257, DOI 10.1002/wnan.1166; Schmidmaier G, 2006, INJURY, V37, P105, DOI 10.1016/j.injury.2006.04.016; Schmidt D, 2006, ANN THORAC SURG, V82, P1465, DOI 10.1016/j.athoracsur.2006.05.066; Singh C, 2015, J FUNCT BIOMATER, V6, P500, DOI 10.3390/jfb6030500; Solan A, 2009, CELL TRANSPLANT, V18, P915, DOI 10.3727/096368909X471161; Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Ueng SWN, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0386-x; van Almen GC, 2016, MACROMOL BIOSCI, V16, P350, DOI 10.1002/mabi.201500278; Vascular Access Work Group, 2006, AM J KIDNEY DIS, V48, pS248, DOI 10.1053/j.ajkd.2006.04.040; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Wilson S E, 2001, Surg Infect (Larchmt), V2, P171, DOI 10.1089/109629601750469492; Wu T, 2015, COLLOID SURFACE B, V133, P179, DOI 10.1016/j.colsurfb.2015.05.048; Yeager R A, 1992, Ann Vasc Surg, V6, P485; Yin AL, 2013, J BIOMED MATER RES A, V101, P1292, DOI 10.1002/jbm.a.34434; Zhang KH, 2010, J BIOMED MATER RES A, V93A, P984, DOI 10.1002/jbm.a.32504; Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017; Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7	54	25	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185916	10.1371/journal.pone.0185916	http://dx.doi.org/10.1371/journal.pone.0185916			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023551	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100038
J	Barszcz, K; Kupczynska, M; Polguj, M; Kleckowska-Nawrot, J; Janeczek, M; Gozdziewska-Harlajczuk, K; Dzierzecka, M; Janczyk, P				Barszcz, Karolina; Kupczynska, Marta; Polguj, Michal; Kleckowska-Nawrot, Joanna; Janeczek, Maciej; Gozdziewska-Harlajczuk, Karolina; Dzierzecka, Malgorzata; Janczyk, Pawel			Morphometry of the coronary ostia and the structure of coronary arteries in the shorthair domestic cat	PLOS ONE			English	Article							AORTIC-VALVE; HEART; ANATOMY; MACROANATOMY; MORPHOLOGY; PATTERNS; ROOT; DOG	The aim of this study was to measure the area of the coronary ostia, assess their localization in the coronary sinuses and to determine the morphology of the stem of the left and right coronary arteries in the domestic shorthair cat. The study was conducted on 100 hearts of domestic shorthair cats of both sexes, aged 2-18 years, with an average body weight of 4.05 kg. A morphometric analysis of the coronary ostia was carried out on 52 hearts. The remaining 48 hearts were injected with a casting material in order to carry out a morphological assessment of the left and right coronary arteries. In all the studied animals, the surface of the left coronary artery ostium was larger than the surface of the right coronary artery ostium. There were four types of the left main coronary artery: type I (23 animals, 49%)-double-branched left main stem (giving off the left circumflex branch and the interventricular paraconal branch, which in turn gave off the septal branch), type II (12 animals, 26%)-double-branched left main stem (giving off the left circumflex branch and the interventricular paraconal branch without the septal branch), type III (11 animals, 23%)-triple-branched left main stem (giving off the left circumflex branch, interventricular branch and the septal branch, type IV (1 animal, 2%)-double-branched left main stem (giving off the interventricular paraconal branch and the left circumflex branch, which in turn gave off the septal branch). The left coronary artery ostium is greater than the right one. There is considerable diversity in the branches of proximal segment of the left coronary artery, while the right coronary artery is more conservative. These results can be useful in defining the optimal strategies in the endovascular procedures involving the coronary arteries or the aortic valve in the domestic shorthair cat.	[Barszcz, Karolina; Kupczynska, Marta; Dzierzecka, Malgorzata] Warsaw Univ Life Sci, Dept Morphol Sci, Fac Vet Med, 159 Nowoursynowska, Warsaw, Poland; [Polguj, Michal] Med Univ Lodz, Dept Angiol, Interfac Chair Anat & Histol, Narutowicza 60, Lodz, Poland; [Kleckowska-Nawrot, Joanna; Janeczek, Maciej; Gozdziewska-Harlajczuk, Karolina] Wroclaw Univ Environm & Life Sci, Dept Anim Physiol & Biostruct, Fac Vet Med, Kozuchowska 1-3, Wroclaw, Poland; [Janczyk, Pawel] Free Univ Berlin, Inst Vet Anat, Fac Vet Med, Koserstr 20, Berlin, Germany	Warsaw University of Life Sciences; Medical University Lodz; Wroclaw University of Environmental & Life Sciences; Free University of Berlin	Polguj, M (corresponding author), Med Univ Lodz, Dept Angiol, Interfac Chair Anat & Histol, Narutowicza 60, Lodz, Poland.	michal.polguj@umed.lodz.pl	Klećkowska-Nawrot, Joanna/A-5204-2017; Dzierzęcka, Małgorzata/I-6039-2016; Janeczek, Maciej/B-6049-2014; Goździewska-Harłajczuk, Karolina/A-4469-2017	Klećkowska-Nawrot, Joanna/0000-0003-1154-8736; Dzierzęcka, Małgorzata/0000-0002-9521-9093; Janeczek, Maciej/0000-0003-4357-2271; Goździewska-Harłajczuk, Karolina/0000-0003-4412-1966; Polguj, Michal/0000-0003-4146-4998; Barszcz, Karolina/0000-0001-5061-1967				Aksoy G, 2003, ANAT HISTOL EMBRYOL, V32, P129, DOI 10.1046/j.1439-0264.2003.00444.x; [Anonymous], 2004, ACTA VET HUNG, V52, p253 ; Arencibia A, 2016, J VET CARDIOL, V18, P413, DOI 10.1016/j.jvc.2016.06.002; Atalar O, 2003, ANN ANAT, V185, P373, DOI 10.1016/S0940-9602(03)80064-X; Bahar S, 2007, ANAT HISTOL EMBRYOL, V36, P321, DOI 10.1111/j.1439-0264.2007.00770.x; Barszcz K, 2016, ANAT HISTOL EMBRYOL, V45, P81, DOI 10.1111/ahe.12174; Barszcz K, 2016, MED WETER, V72, P186; Barszcz K, 2014, MED WETER, V70, P373; Barszcz K, 2013, MED WETER, V69, P531; Bartyzel BJ, 2009, B VET I PULAWY, V53, P147; BHIMALLI S, 2011, WORLD J SCI TECHNOL, V1, P30; BLAIR E, 1961, CIRC RES, V9, P333, DOI 10.1161/01.RES.9.2.333; BUSS DD, 1982, ANAT REC, V203, P411, DOI 10.1002/ar.1092030311; Cartier R, 2005, CAN J CARDIOL, V21, P1071; Cavalcanti Jennecy Sales, 2003, Arq. Bras. Cardiol., V81, P359, DOI 10.1590/S0066-782X2003001200003; Evans H.E., 2013, MILLERS ANATOMY DOG; Habermehl K. H., 1994, ANATOMIE HUND KATZE; Hauser M, 2005, HEART, V91, P1240, DOI 10.1136/hrt.2004.057299; Islam M N, 2006, Mymensingh Med J, V15, P153; Kaur D., 2012, INT J BIOL MED RES, V3, P2169; Kupczynska M, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0173-4; Longo Büll Marilena, 2002, Rev. chil. anat., V20, P117, DOI 10.4067/S0716-98682002000200001; Loukas M, 2014, CLIN ANAT, V27, P748, DOI 10.1002/ca.22295; Nie Xiao-min, 2006, Zhonghua Yi Xue Za Zhi, V86, P1125; Noestelthaller A, 2007, ANAT HISTOL EMBRYOL, V36, P33, DOI 10.1111/j.1439-0264.2006.00711.x; Ozdemir V, 2008, ANAT HISTOL EMBRYOL, V37, P114, DOI 10.1111/j.1439-0264.2007.00803.x; Ozgel O, 2004, ANAT HISTOL EMBRYOL, V33, P278, DOI 10.1111/j.1439-0264.2004.00548.x; Polguj M, 2009, FOLIA MORPHOL, V68, P271; Polguj M, 2011, J MORPHOL, V272, P497, DOI 10.1002/jmor.10929; Ruvolo Giovanni, 2009, Interact Cardiovasc Thorac Surg, V8, P179, DOI 10.1510/icvts.2008.184200; Sirikonda P., 2012, INT J BIOL MED RES, V3, P2489; Smodlaka H, 2008, ANAT HISTOL EMBRYOL, V37, P30, DOI 10.1111/j.1439-0264.2007.00791.x; Teofilovski-Parapid G, 1993, Srp Arh Celok Lek, V121, P117; Teofilovski-Parapid G, 1998, LAB ANIM-UK, V32, P200, DOI 10.1258/002367798780600007; Tsujino K, 2005, J VET MED SCI, V67, P631, DOI 10.1292/jvms.67.631; Vladova D., 2005, TRAKIA J SCI, V3, P44; Warraich HJ, 2013, AM J CARDIOL, V112, P1445, DOI 10.1016/j.amjcard.2013.06.013; Yuan GQ, 2009, VET RES COMMUN, V33, P367, DOI 10.1007/s11259-008-9185-0	38	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186177	10.1371/journal.pone.0186177	http://dx.doi.org/10.1371/journal.pone.0186177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020103	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400078
J	Binka, C; Doku, DT; Awusabo-Asare, K				Binka, Charity; Doku, David Teye; Awusabo-Asare, Kofi			Experiences of cervical cancer patients in rural Ghana: An exploratory study	PLOS ONE			English	Article							KNOWLEDGE; ILLNESS; COMMUNICATION; PREVENTION; NARRATIVES	Even though cervical cancer is quite a prevalent disease in Ghana, there is hardly any study on this disease. This paper sought to explore the experiences of cervical cancer patients living with the disease with emphasis on their knowledge about the disease before and after the diagnosis. Qualitative data were collected through in-depth interviews with cervical cancer patients undergoing treatment in a specialised cancer treatment health facility in rural Ghana. Cervical cancer patients had inadequate knowledge about the disease, its symptoms, risk factors, treatment and prevention prior to being diagnosed of the disease. These patients were diagnosed late because they usually sought treatment elsewhere before reporting to health facilities. They experienced physical, psychological, economic and social disruptions in their daily lives, which affected their quality of life. It is evident that lack of knowledge about cervical cancer constitutes a threat to its prevention and treatment. Intensive health education through the mass media and community health promotion outreaches can be a sure way of creating adequate knowledge about cervical cancer in Ghana. Treatment and care for cervical cancer patients should incorporate counselling sessions, which should take into consideration the different levels of disruption the women experience and the implications for their wellbeing and management of the condition.	[Binka, Charity] Ghana Inst Management & Publ Adm, Sch Publ Serv & Governance, Accra, Ghana; [Doku, David Teye] Univ Tampere, Sch Hlth Sci, Tampere, Finland; [Doku, David Teye; Awusabo-Asare, Kofi] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana	Tampere University; University of Cape Coast	Binka, C (corresponding author), Ghana Inst Management & Publ Adm, Sch Publ Serv & Governance, Accra, Ghana.	cbinka@gmail.com						Abiodun O. A., 2014, Journal of Public Health and Epidemiology, V6, P119, DOI 10.5897/JPHE2013.0576; Abotchie PN, 2009, INT J GYNECOL CANCER, V19, P412, DOI 10.1111/IGC.0b013e3181a1d6de; Adanu RMK, 2002, J WOMEN HEALTH GEN-B, V11, P487, DOI 10.1089/152460902760277822; Aikins AD, 2005, BMJ-BRIT MED J, V331, P737, DOI 10.1136/bmj.331.7519.737; Aikins ADG, 2003, J HEALTH PSYCHOL, V8, P557, DOI 10.1177/13591053030085007; Andrae B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e900; Atobrah D, 2012, Ghana Med J, V46, P46; Binka C, 2015, J CANCER EDUC, P1; Buki LP, 2005, J COUNS DEV, V83, P470, DOI 10.1002/j.1556-6678.2005.tb00368.x; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; de Graft Aikins A, 2012, Ghana Med J, V46, P59; Domfeh Ab, 2008, Ghana Med J, V42, P71; Downs LS, 2008, GYNECOL ONCOL, V109, pS22, DOI 10.1016/j.ygyno.2008.01.003; Duenas-Gonzalez A, 2014, INT J WOMENS HEALTH, V6, P1023, DOI 10.2147/IJWH.S49471; Ebu NI, 2015, INT J WOMENS HEALTH, V7, P31, DOI 10.2147/IJWH.S71797; Erwin DO, 2010, SOC SCI MED, V71, P693, DOI 10.1016/j.socscimed.2010.05.005; Ezechi OC, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-5; Faircloth CA, 2004, SOCIOL HEALTH ILL, V26, P242, DOI 10.1111/j.1467-9566.2004.00388.x; Francis SA, 2011, VACCINE, V29, P8760, DOI 10.1016/j.vaccine.2011.07.116; International Agency for Research on Cancer, 2012, GLOBOCAN 2012 EST CE; Levealahti H, 2007, PSYCHO-ONCOLOGY, V16, P466, DOI 10.1002/pon.1080; Lingwood RJ, 2008, NAT REV CANCER, V8, P398, DOI 10.1038/nrc2372; Luciani S, 2009, IMMUNOTHERAPY-UK, V1, P795, DOI 10.2217/IMT.09.48; Ministry of Health, 2011, NAT STRAT CANC CONTR; Ndikom CM, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-11; Williams M S, 2012, Ghana Med J, V46, P147; Williams MS, 2014, J CANCER EDUC, V29, P555, DOI 10.1007/s13187-014-0611-4; Williams SJ, 2000, SOCIOL HEALTH ILL, V22, P40, DOI 10.1111/1467-9566.00191	28	17	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185829	10.1371/journal.pone.0185829	http://dx.doi.org/10.1371/journal.pone.0185829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020099	gold, Green Submitted, Green Published			2022-12-26	WOS:000412754400047
J	Le Corvec, M; Jezequel, C; Monbet, V; Fatih, N; Charpentier, F; Tariel, H; Boussard-Pledel, C; Bureau, B; Loreal, O; Sire, O; Bardou-Jacquet, E				Le Corvec, Maena; Jezequel, Caroline; Monbet, Valerie; Fatih, Nadia; Charpentier, Frederic; Tariel, Hugues; Boussard-Pledel, Catherine; Bureau, Bruno; Loreal, Olivier; Sire, Olivier; Bardou-Jacquet, Edouard			Mid-infrared spectroscopy of serum, a promising non-invasive method to assess prognosis in patients with ascites and cirrhosis	PLOS ONE			English	Article							STAGE LIVER-DISEASE; INFRARED-SPECTROSCOPY; HEPATIC-ENCEPHALOPATHY; FTIR SPECTROSCOPY; BREAST-CANCER; MODEL; DIAGNOSIS; SURVIVAL; MORTALITY; PREDICTOR	Background & aims Prognostic tests are critical in the management of patients with cirrhosis and ascites. Biological tests or scores perform poorly in that situation. Mid-infrared fibre evanescent wave spectroscopy (MIR-FEWS) which allows for global serum metabolic profiling may provide more relevant information by measuring a wider range of metabolic parameters in serum. Here we present the accuracy of a MIR-FEWS based predictive model for the prognosis of 6 months survival in patients with ascites and cirrhosis. Methods Patients with ascites were prospectively included and followed up for 6 months. MIR-FEWS spectra were measured in serum samples. The most informative spectral variables obtained by MIR-FEWS were selected by FADA algorithm and then used to build the MIR model. Accuracy of this model was assessed by ROC curves and 90%/10% Monte Carlo cross-validation. MIR model accuracy for 6 months survival was compared to that of the Child-Pugh and MELD scores. Results 119 patients were included. The mean age was 57.36 +/- 13.70, the MELD score was 16.32 +/- 6.26, and the Child-Pugh score was 9.5 +/- 1.83. During follow-up, 23 patients died (20%). The MIR model had an AUROC for 6 months mortality of 0.90 (CI95: 0.88-0.91), the MELD 0.77 (CI95: 0.66-0.89) and Child-Pugh 0.76 (CI95: 0.66-0.88). MELD and Child-Pugh AUROCs were significantly lower than that of the MIR model (p = 0.02 and p = 0.02 respectively). Multivariate logistic regression analysis showed that MELD (p<0.05, OR: 0.86; CI95:0.76-0.97), Beta blockers (p = 0.036; OR:0.20; CI95:0.04-0.90), and the MIR model (p<0.001; OR:0.50; CI95:0.37-0.66), were significantly associated with 6 months mortality. Conclusions In this pilot study MIR-FEWS more accurately assess the 6-month prognosis of patients with ascites and cirrhosis than the MELD or Child-Pugh scores. These promising results, if confirmed by a larger study, suggest that mid infrared spectroscopy could be helpful in the management of these patients.	[Le Corvec, Maena; Sire, Olivier] Univ Bretagne Sud, IRDL, FRE CNRS 3744, Vannes, France; [Le Corvec, Maena; Fatih, Nadia; Charpentier, Frederic; Tariel, Hugues] DIAFIR, Rennes, France; [Jezequel, Caroline; Bardou-Jacquet, Edouard] CHU Rennes, Liver Dis Unit, Rennes, France; [Jezequel, Caroline; Boussard-Pledel, Catherine; Bureau, Bruno] Univ Rennes 1, Inst Sci Chim Rennes, UMR 6226, CNRS,Equipe Verres & Ceram, Rennes, France; [Monbet, Valerie] IRMAR Math Res Inst Rennes, UMR 6625, CNRS, Rennes, France; [Monbet, Valerie] INRIA, ASPI, Rennes, France; [Loreal, Olivier; Bardou-Jacquet, Edouard] Univ Rennes 1, Rennes, France; [Loreal, Olivier; Bardou-Jacquet, Edouard] Univ Rennes 1, Inst NuMeCan, INRA1341, INSERM,U1241, Rennes, France	CHU Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Inria; Universite de Rennes; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Bardou-Jacquet, E (corresponding author), CHU Rennes, Liver Dis Unit, Rennes, France.; Bardou-Jacquet, E (corresponding author), Univ Rennes 1, Rennes, France.; Bardou-Jacquet, E (corresponding author), Univ Rennes 1, Inst NuMeCan, INRA1341, INSERM,U1241, Rennes, France.	edouard.bardou-jacquet@chu-rennes.fr	Loreal, Olivier/G-3366-2013	Loreal, Olivier/0000-0002-7428-3766; Boussard-Pledel, Catherine/0000-0001-6303-648X; Bureau, Bruno/0000-0002-5307-1529	French National Association Research Technology (ANRT); Diafir company	French National Association Research Technology (ANRT); Diafir company	This study was funded the French National Association Research Technology (ANRT). This funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Diafir company provided financial support in the form of salary of authors NF, CC and HT, and provided research material (The Diafir SPIDTM FTIR portable spectrometer used in this study to acquire data). This funder did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Albert JD, 2016, JOINT BONE SPINE, V83, P318, DOI 10.1016/j.jbspin.2015.05.009; Anne ML, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253319; Backhaus J, 2010, VIB SPECTROSC, V52, P173, DOI 10.1016/j.vibspec.2010.01.013; Baker MJ, 2016, CHEM SOC REV, V45, P1803, DOI 10.1039/c5cs00585j; Barlev E, 2016, J GASTROENTEROL, V51, P214, DOI 10.1007/s00535-015-1095-7; Biggins SW, 2006, LIVER TRANSPLANT, V12, pS88, DOI 10.1002/lt.20963; Boursier J, 2009, J CLIN GASTROENTEROL, V43, P580, DOI 10.1097/MCG.0b013e3181889468; Child CG, 1964, LIVER PORTAL HYPERTE, P1964; Cui S, 2013, MOLECULES, V18, P5373, DOI 10.3390/molecules18055373; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Francoz C, 2011, LIVER TRANSPLANT, V17, P1137, DOI 10.1002/lt.22363; Friguet C, 2015, STAT COMPUT; Gautam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045521; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Hands JR, 2014, J BIOPHOTONICS, V7, P189, DOI 10.1002/jbio.201300149; HELM D, 1991, J MICROBIOL METH, V14, P127, DOI 10.1016/0167-7012(91)90042-O; Hinson JA, 1998, CHEM RES TOXICOL, V11, P604, DOI 10.1021/tx9800349; Kallenbach-Thieltges A, 2013, J BIOPHOTONICS, V6, P88, DOI 10.1002/jbio.201200132; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Keirsse J, 2006, APPL SPECTROSC, V60, P584, DOI 10.1366/000370206777670558; Kim Se Yune, 2007, Korean J Gastroenterol, V50, P92; Koo JK, 2013, J GASTROEN HEPATOL, V28, P1209, DOI 10.1111/jgh.12156; Ladep NG, 2014, HEPATOLOGY, V60, P1291, DOI 10.1002/hep.27264; Le Corvec M, 2016, ANALYST, V141, P6259, DOI 10.1039/c6an00136j; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Mantsch H. H., 1996, INFRARED SPECTROSCOP; McPhail MJW, 2016, J HEPATOL, V64, P1058, DOI 10.1016/j.jhep.2016.01.003; Mehmood T, 2012, CHEMOMETR INTELL LAB, V118, P62, DOI 10.1016/j.chemolab.2012.07.010; Merion RM, 2011, TRANSPL INT, V24, P965, DOI 10.1111/j.1432-2277.2011.01274.x; Ollesch J, 2014, J BIOPHOTONICS, V7, P210, DOI 10.1002/jbio.201300163; PENG YC, 2016, MEDICINE, V95; Peuchant E, 2008, TRANSL RES, V152, P103, DOI 10.1016/j.trsl.2008.05.009; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Qi SW, 2012, WORLD J GASTROENTERO, V18, P285, DOI [10.3748/wjg.v18.i3.285, 10.3748/wjg.v17.i3.285]; R Core Team, 2013, R LANG ENV STAT COMP; Rehman S, 2010, APPL SPECTROSC REV, V45, P355, DOI 10.1080/05704928.2010.483674; Said A, 2004, J HEPATOL, V40, P897, DOI 10.1016/j.jhep.2004.02.010; Saxena V, 2006, NMR BIOMED, V19, P521, DOI 10.1002/nbm.1034; Serra MA, 2004, SCAND J GASTROENTERO, V39, P1149, DOI 10.1080/00365520410008024; Serste T, 2012, J HEPATOL, V57, P274, DOI 10.1016/j.jhep.2012.03.018; Simon R, 2007, FUNDAMENTALS DATA MI, P173; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stewart CA, 2007, LIVER TRANSPLANT, V13, P1366, DOI 10.1002/lt.21129; Thumanu K, 2014, J BIOPHOTONICS, V7, P222, DOI 10.1002/jbio.201300183; Travo A, 2014, ANAL BIOANAL CHEM, V406, P2367, DOI 10.1007/s00216-013-7607-5; Trevisan J, 2014, J BIOPHOTONICS, V7, P254, DOI 10.1002/jbio.201300190; Untereiner V, 2014, J BIOPHOTONICS, V7, P241, DOI 10.1002/jbio.201300166; Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210; Zelig U, 2015, BMC CANCER, P15; Zhang XQ, 2013, TRANSL RES, V162, P279, DOI 10.1016/j.trsl.2013.07.007	52	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185997	10.1371/journal.pone.0185997	http://dx.doi.org/10.1371/journal.pone.0185997			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020046	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400057
J	Mei, H; Gonzalez, S; Nakatsu, MN; Baclagon, ER; Chen, FV; Deng, SX				Mei, Hua; Gonzalez, Sheyla; Nakatsu, Martin N.; Baclagon, Elfren R.; Chen, Felix V.; Deng, Sophie X.			Human adipose-derived stem cells support the growth of limbal stem/progenitor cells	PLOS ONE			English	Article							OCULAR SURFACE RECONSTRUCTION; STROMAL CELLS; AMNIOTIC MEMBRANE; EPITHELIAL-CELLS; INTERNATIONAL-SOCIETY; CORNEAL REGENERATION; PROGENITOR CELLS; FEEDER LAYERS; NICHE CELLS; IN-VITRO	The most efficient method to expand limbal stem cells (LSCs) in vitro for clinical transplantation is to culture single LSCs directly on growth-arrested mouse fibroblast 3T3 cells. To reduce possible xenobiotic contamination from 3T3s, primary human adipose-derived stem cells (ASCs) were examined as feeder cells to support the expansion of LSCs in vitro. To optimize the ASC-supported culture, freshly isolated limbal epithelial cells in the form of single cells (SC-ASC) or cell clusters (CC-ASC) were cultured using three different methods: LSCs seeded directly on feeder cells, a 3-dimensional (3D) culture system and a 3D culture system with fibrin (fibrin 3D). The expanded LSCs were examined at the end of a 2-week culture. The standard 3T3 culture served as control. Expansion of SC-ASC showed limited proliferation and exhibited differentiated morphology. CC-ASC generated epithelial cells with undifferentiated morphology in all culture methods, among which CC-ASC in 3D culture supported the highest cell doubling (cells doubled 9.0 times compared to cells doubled 4.9 times in control) while maintained the percentage of putative limbal stem/progenitor cells compared to the control. There were few cell-cell contacts between cultured LSCs and ASCs in 3D CC-ASC. In conclusion, ASCs support the growth of LSCs in the form of cell clusters but not in single cells. 3D CC-ASC could serve as a substitute for the standard 3T3 culture to expand LSCs.	[Mei, Hua; Gonzalez, Sheyla; Nakatsu, Martin N.; Baclagon, Elfren R.; Chen, Felix V.; Deng, Sophie X.] Univ Calif Los Angeles, Stein Eye Inst, Cornea Div, Los Angeles, CA 90095 USA; [Chen, Felix V.] Univ Calif Los Angeles, Coll Letters & Sci, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Deng, SX (corresponding author), Univ Calif Los Angeles, Stein Eye Inst, Cornea Div, Los Angeles, CA 90095 USA.	Deng@jsei.ucla.edu		Nakatsu, Martin/0000-0001-9808-5230	National Eye Institute [5P30EY000331, 1R01EY021797]; California Institute for Regenerative Medicine Early Translational Award [TR2-01768]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY021797, P30EY000331] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); California Institute for Regenerative Medicine Early Translational Award; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute grants (5P30EY000331 and 1R01EY021797), by a California Institute for Regenerative Medicine Early Translational Award (TR2-01768), and an unrestricted grant from Research to Prevent Blindness.	Aksu AE, 2008, ANN PLAS SURG, V60, P306, DOI 10.1097/SAP.0b013e3180621ff0; Ang LPK, 2007, AM J OPHTHALMOL, V143, P178, DOI 10.1016/j.ajo.2006.07.050; Baradaran-Rafii A, 2010, CORNEA, V29, P502, DOI 10.1097/ICO.0b013e3181bd9f60; Baylis O, 2011, J CELL BIOCHEM, V112, P993, DOI 10.1002/jcb.23028; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Chen SY, 2011, TISSUE ENG PART C-ME, V17, P537, DOI [10.1089/ten.TEC.2010.0609, 10.1089/ten.tec.2010.0609]; Chen YT, 2007, STEM CELLS, V25, P1995, DOI 10.1634/stemcells.2006-0677; Corselli M, 2013, BLOOD, V121, P2891, DOI 10.1182/blood-2012-08-451864; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; De Paiva CS, 2005, STEM CELLS, V23, P63, DOI 10.1634/stemcells.2004-0093; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dziasko MA, 2015, EXP EYE RES, V138, P70, DOI 10.1016/j.exer.2015.06.026; EBATO B, 1987, INVEST OPHTH VIS SCI, V28, P1450; Feng YQ, 2014, CURR EYE RES, V39, P541, DOI 10.3109/02713683.2013.853803; Funderburgh JL, 2016, OCUL SURF, V14, P113, DOI 10.1016/j.jtos.2015.12.006; Gonzalez S, 2016, STEM CELL RES, V16, P358, DOI 10.1016/j.scr.2016.02.018; Gonzalez S, 2013, EXP EYE RES, V116, P169, DOI 10.1016/j.exer.2013.08.020; Grueterich M, 2002, OPHTHALMOLOGY, V109, P1547, DOI 10.1016/S0161-6420(02)01105-3; HAUSCHKA PV, 1986, HAEMOSTASIS, V16, P258; Hayashi R, 2007, STEM CELLS, V25, P289, DOI 10.1634/stemcells.2006-0167; Hopkinson A, 2006, INVEST OPHTH VIS SCI, V47, P4316, DOI 10.1167/iovs.05-1415; HUANG AJW, 1991, INVEST OPHTH VIS SCI, V32, P96; Hwang ST, 2010, BIOMATERIALS, V31, P8012, DOI 10.1016/j.biomaterials.2010.07.031; Johnen S, 2011, INVEST OPHTH VIS SCI, V52, P2817, DOI 10.1167/iovs.10-6429; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P645; Kang SK, 2003, DEV BRAIN RES, V145, P141, DOI 10.1016/S0165-3806(03)00224-4; KASPER M, 1988, HISTOCHEMISTRY, V89, P369, DOI 10.1007/BF00500639; Kawakita T, 2008, J CELL MOL MED, V12, P1303, DOI 10.1111/j.1582-4934.2008.00297.x; Kawashima M, 2007, ARCH OPHTHALMOL-CHIC, V125, P1337, DOI 10.1001/archopht.125.10.1337; Kim JY, 2012, ACTA DERM-VENEREOL, V92, P16, DOI 10.2340/00015555-1174; Kim JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069175; Kolli S, 2010, STEM CELLS, V28, P597, DOI 10.1002/stem.276; Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137; Liu JB, 2010, EXPERT REV OPHTHALMO, V5, P645, DOI 10.1586/EOP.10.63; Locke M, 2009, ANZ J SURG, V79, P235, DOI 10.1111/j.1445-2197.2009.04852.x; Maleki Masoud, 2014, International Journal of Stem Cells, V7, P118, DOI 10.15283/ijsc.2014.7.2.118; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Mei H, 2014, TISSUE ENG PART C-ME, V20, P393, DOI [10.1089/ten.TEC.2013.0246, 10.1089/ten.tec.2013.0246]; Meller D, 2009, CORNEA, V28, P233, DOI 10.1097/ICO.0b013e31818526a6; Mendoza R, 2011, J VIROL, V85, P9247, DOI 10.1128/JVI.05137-11; Miyashita H, 2008, TISSUE ENG PT A, V14, P1275, DOI [10.1089/ten.tea.2007.0212, 10.1089/tea.2007.0212]; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Nakamura T, 2006, OPHTHALMOLOGY, V113, P1765, DOI 10.1016/j.ophtha.2006.04.030; Nakatsu MN, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14999; Nakatsu MN, 2011, INVEST OPHTH VIS SCI, V52, P4734, DOI 10.1167/iovs.10-6486; Pellegrini G, 2013, REGEN MED, V8, P553, DOI 10.2217/rme.13.43; Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Satish L, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0119-8; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Shiffman MA, 2001, DERMATOL SURG, V27, P819, DOI 10.1046/j.1524-4725.2001.01062.x; Sousa BR, 2014, CYTOM PART A, V85A, P43, DOI 10.1002/cyto.a.22402; Sugiyama H, 2008, J TISSUE ENG REGEN M, V2, P445, DOI 10.1002/term.111; Tsai, 2000, Am J Ophthalmol, V130, P543, DOI 10.1016/S0002-9394(00)00746-7; TSAI RJF, 1990, OPHTHALMOLOGY, V97, P446, DOI 10.1016/S0161-6420(90)32575-7; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wosnitza M, 2007, DIFFERENTIATION, V75, P12, DOI 10.1111/j.1432-0436.2006.00110.x; Xie HT, 2012, INVEST OPHTH VIS SCI, V53, P279, DOI 10.1167/iovs.11-8441; Zhang XM, 2010, J TISSUE ENG REGEN M, V4, P38, DOI 10.1002/term.216; Zimmerlin L, 2013, CYTOM PART A, V83A, P134, DOI 10.1002/cyto.a.22227; Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813	63	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186238	10.1371/journal.pone.0186238	http://dx.doi.org/10.1371/journal.pone.0186238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020119	gold, Green Published, Green Submitted			2022-12-26	WOS:000412754400083
J	Wickramasinghe, ND; Horton, J; Darshika, I; Galgamuwa, KD; Ranasinghe, WP; Agampodi, TC; Agampodi, SB				Wickramasinghe, Nuwan Darshana; Horton, Jennifer; Darshika, Ishani; Galgamuwa, Kaushila Dinithi; Ranasinghe, Wasantha Pradeep; Agampodi, Thilini Chanchala; Agampodi, Suneth Buddhika			Productivity cost due to postpartum ill health: A cross-sectional study in Sri Lanka	PLOS ONE			English	Article								Objective Even though postpartum morbidity continues to cause high disease burden in maternal morbidity and mortality across the globe, the literature pertaining to resultant productivity loss is scarce. Hence, the present study aimed at determining the productivity loss and associated cost of episodes of postpartum ill health. Methods A cross sectional study was conducted in two Medical Officer of Heath areas in the Anuradhapura district, Sri Lanka in 2011, among 407 women residing in Anuradhapura district with an infant aged between 8 to 24 weeks. Validated interviewer administered questionnaires, including the IMMPACT productivity cost tool, were used to collect data on self-reported episodes of postpartum ill health. The productivity loss was calculated as the sum of days lost due to partial and total incapacitation. The adjusted productivity loss for coping strategies was calculated. Productivity cost, both total and adjusted, were calculated based on the mean daily per capita income of the study sample. Results Of the 407 participants, 161(39.6%) reported at least one episode of postpartum illness. Hospitalisations were reported by 27 (16.8%) of all symptomatic postpartum women. Common symptoms of postpartum ill health were pain/infection at either episiotomy or surgical site (n = 44, 27.3%), lower abdominal pain (n = 40, 24.8%) and backache (n = 27, 16.8%). The mean productivity loss per episode of ill health was 15 days (SD = 7.8 days) and the mean productivity loss per episode after adjusting for coping strategies was 7.9 days (SD = 4.4 days). The mean productivity cost per an episode was US$ 34.2(95% CI US$ 26.7-41.6) and the mean productivity cost per an episode after adjusting for coping strategies was US$ 18.0 (95% CI US$ 14.1-22.0) Conclusions The prevalence of self-reported postpartum ill health, associated productivity loss and cost were high in the study sample and the main contributors were preventable conditions including pain and infection. Thus, effective pain management and proper infection prevention and control measures are important in reducing the burden of postpartum illness and resultant productivity cost.	[Wickramasinghe, Nuwan Darshana; Horton, Jennifer; Darshika, Ishani; Galgamuwa, Kaushila Dinithi; Ranasinghe, Wasantha Pradeep; Agampodi, Thilini Chanchala; Agampodi, Suneth Buddhika] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Community Med, Anuradhapura, Sri Lanka	Rajarata University of Sri Lanka	Wickramasinghe, ND (corresponding author), Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Community Med, Anuradhapura, Sri Lanka.	nuwick74@yahoo.com	Agampodi, Suneth/G-3320-2012; Wickramasinghe, Nuwan Darshana/I-3578-2019; Agampodi, Thilini/AAN-5396-2021	Agampodi, Suneth/0000-0001-7810-1774; Wickramasinghe, Nuwan Darshana/0000-0001-6025-6022; Agampodi, Thilini/0000-0002-7977-6578; Horton, Jennifer/0000-0002-9220-4654	Maternal Health Task Force at EngenderHealth	Maternal Health Task Force at EngenderHealth	The study was funded by Maternal Health Task Force at EngenderHealth, https://www.mhtf.org/mhtf-at-engenderhealth/.	Agampodi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042333; Agampodi Suneth B, 2009, Indian J Community Med, V34, P265, DOI 10.4103/0970-0218.55300; Agampodi SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064214; Agampodi T C, 2011, Ceylon Med J, V56, P183, DOI 10.4038/cmj.v56i4.3907; De Silva WI, 1998, SOC BIOL, V45, P223; Department of Census and Statistics, SRI LANK HOUS INC EX; Department of Census and statistics, SRI LANK DEM HLTH SU; Family Health Bureau Ministry of Health, 2013, SRI LANK ANN REP FAM; Haas DM, 2014, COCHRANE DB SYST REV, V12; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Islam M, 2007, B WORLD HEALTH ORGAN, V85, P735, DOI 10.2471/BLT.07.045963; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mackeen AD, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009516.pub2; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Senanayake Hemantha, 2006, Ceylon Medical Journal, V51, P41; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; United Nations, 2010, KEEP PROM FORW LOOK; University of Aberdeen, 2007, EC COSTS CONS PROD C; Webb DA, 2008, BIRTH-ISS PERINAT C, V35, P179, DOI 10.1111/j.1523-536X.2008.00238.x; World Health Organization, 2008, GLOB BURD DIS 2004 U	21	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185883	10.1371/journal.pone.0185883	http://dx.doi.org/10.1371/journal.pone.0185883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020101	gold, Green Published, Green Submitted			2022-12-26	WOS:000412754400048
J	Bourgeois, D; David, A; Inquimbert, C; Tramini, P; Molinari, N; Carroue, F				Bourgeois, Denis; David, Alexandra; Inquimbert, Camille; Tramini, Paul; Molinari, Nicolas; Carrouel, Florence			Quantification of carious pathogens in the interdental microbiota of young caries-free adults	PLOS ONE			English	Article							REAL-TIME PCR; STREPTOCOCCUS-MUTANS; CANDIDA-ALBICANS; DENTAL-CARIES; PROBIOTIC LACTOBACILLI; ENTEROCOCCUS-FAECALIS; PRESCHOOL-CHILDREN; BIOFILM FORMATION; BACTERIAL DIVERSITY; FUNGAL-INFECTIONS	Background The majority of caries lesions in adults occur on the proximal tooth surfaces of the posterior teeth. A comprehensive study of the composition of the oral microbiota is fundamental for a better understanding of the etiology of interdental caries. Methods Twenty-five caries-free subjects (20-35 years old) were enrolled in the study. The interdental biofilm of four interdental sites were collected. The real-time polymerase chain reaction (PCR) methodology were used to quantify (i) the following bacteria: Streptococcus spp., Streptococcus mutans, Lactobacillus spp., Enterococcus spp., and Enterococcus faecalis; (ii) the fungus Candida albicans; and (iii) total bacteria. Results Streptococcus spp. was the most abundant species, followed by Lactobacillus spp. and Enterococcus spp. Streptococcus spp. and Lactobacillus spp. were detected at all tested sites and Enterococcus spp. at 99% of sites. S. mutans was detected at only 28% of the tested sites and C. albicans was detected at 11% of sites. E. faecalis was never detected. In 54.5% of the biofilm inhabited by C. albicans, S. mutans was present. Moreover, 28% of the ID sites co-expressed S. mutans and Lactobacillus spp. The studied pathogens were organized into two correlated groups of species. Strikingly, the fungus C. albicans and the bacteria Enterococcus spp. cluster together, whereas Streptococcus spp., S. mutans and Lactobacillus spp. form one distinct cluster. Conclusion The interdental biofilm of young caries-free adults is comprised of pathogens that are able to induce interproximal caries. That several of these pathogens are implicated in heart disease or other systemic diseases is an argument for the disruption of interdental biofilms using daily oral hygiene.	[Bourgeois, Denis; David, Alexandra; Inquimbert, Camille; Carrouel, Florence] Univ Lyon 1, Lab System Hlth Care EA4129, Lyon, France; [Bourgeois, Denis] Univ Lyon 1, Fac Dent, Dept Prevent & Publ Hlth, Lyon, France; [Tramini, Paul] Univ Montpellier, Dept Dent Publ Hlth, Montpellier, France; [Molinari, Nicolas] Univ Montpellier, CHU Montpellier, Serv DIM, UMR IMAG 5149, Montpellier, France; [Carrouel, Florence] Univ Lyon 1, Fac Dent, Dept Basic & Clin Biol Sci, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bourgeois, D (corresponding author), Univ Lyon 1, Lab System Hlth Care EA4129, Lyon, France.; Bourgeois, D (corresponding author), Univ Lyon 1, Fac Dent, Dept Prevent & Publ Hlth, Lyon, France.	denis.bourgeois@univ-lyon1.fr	Carrouel, F/X-4952-2019; molinari, nicolas/Y-9681-2019; Bourgeois, Denis/ABI-3060-2020; Bourgeois, Denis/AAH-9280-2020	Carrouel, F/0000-0002-6823-1636; Bourgeois, Denis/0000-0003-4754-2512; 	Institut Clinident SAS (Aix en Provence, France)	Institut Clinident SAS (Aix en Provence, France)	We acknowledge the support of our work by Institut Clinident SAS (Aix en Provence, France).	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Anderson AC, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01534; Arino M, 2006, SCI REP, V6, P29190; Badet C, 2008, Open Microbiol J, V2, P38, DOI 10.2174/1874285800802010038; Barbosa JO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150457; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Bourgeois D, 2015, OPEN DENT J, V9, P431, DOI 10.2174/1874210601509010431; Bourgeois D, 2016, EUR J ORAL SCI, V124, P566, DOI 10.1111/eos.12302; Burley KM, 2012, J ENDODONT, V38, P1511, DOI 10.1016/j.joen.2012.07.004; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Carrouel F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00840; Caufield PW, 2015, J DENT RES, V94, p110S, DOI 10.1177/0022034515576052; Corby PM, 2005, J CLIN MICROBIOL, V43, P5753, DOI 10.1128/JCM.43.11.5753-5759.2005; Dahlen Gunnar, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.10855; Dani S, 2016, CONTEMP CLIN DENT, V7, P529, DOI 10.4103/0976-237X.194114; De-la-Torre J, 2016, MYCOSES, V59, P234, DOI 10.1111/myc.12453; Demirci Mustafa, 2010, Eur J Dent, V4, P270; Dhotre SV, 2017, ARCH PEDIATR INFECT, V5, DOI 10.5812/pedinfect.41067; Dorri M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010431.pub2; Ekstrand KR, 2006, TANDLAEGEBLADET, V110, P788; Falsetta ML, 2014, INFECT IMMUN, V82, P1968, DOI 10.1128/IAI.00087-14; Farah CS, 2010, AUST DENT J, V55, P48, DOI 10.1111/j.1834-7819.2010.01198.x; Faran Ali Syed Muhammad, 2012, J Oral Biol Craniofac Res, V2, P181, DOI 10.1016/j.jobcr.2012.07.001; Fejerskov O, 2015, DENT CARIES DIS ITS, P19; Fouad AF, 2002, J CLIN MICROBIOL, V40, P3223, DOI 10.1128/JCM.40.9.3223-3231.2002; Gao XL, 2014, PEDIATR DENT, V36, P348; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Henne K, 2016, CARIES RES, V50, P480, DOI 10.1159/000448485; Heymann HO, 2012, STURDEVANTS ART SCI, P25; Kanaguchi N, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-36; Keiser-Nielsen S, 1971, Dent Pract (Ewell), V3, ppassim; Keller MK, 2011, ACTA ODONTOL SCAND, V69, P263, DOI 10.3109/00016357.2011.554863; Khalaf H, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0810-8; Kidd E.A.M., 2016, ESSENTIALS DENT CARI; Klinke T, 2011, CARIES RES, V45, P100, DOI 10.1159/000324809; Komiyama EY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163001; Kouidhi B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-155; Kozarov E, 2006, MICROBES INFECT, V8, P687, DOI 10.1016/j.micinf.2005.09.004; Kreth J, 2009, DNA CELL BIOL, V28, P397, DOI 10.1089/dna.2009.0868; Krzysciak W, 2014, EUR J CLIN MICROBIOL, V33, P499, DOI 10.1007/s10096-013-1993-7; Lin X, 2015, ORAL DIS, V21, pE128, DOI 10.1111/odi.12257; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Moraga CPL, 2017, ACTA ODONTOL SCAND, V75, P30, DOI 10.1080/00016357.2016.1244560; Marcenes W, 2013, J DENT RES, V92, P592, DOI 10.1177/0022034513490168; Marsh PD, 2009, ORAL MICROBIOL IMMUN, P8; Mejare I., 2002, CONS C CAR PRIM DENT, P57; Meng H., 2008, THE PERIODONTOLOGY; Metwalli KH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003616; Moalic E, 2001, CARIES RES, V35, P149, DOI 10.1159/000047447; Monteiro-da-Silva F, 2014, MED MYCOL, V52, P496, DOI 10.1093/mmy/myu027; Motisuki C, 2005, ARCH ORAL BIOL, V50, P341, DOI 10.1016/j.archoralbio.2004.08.007; Nakano K, 2008, JPN DENT SCI REV, V44, P29, DOI 10.1016/j.jdsr.2007.09.001; Ott SJ, 2004, J CLIN MICROBIOL, V42, P2566, DOI 10.1128/JCM.42.6.2566-2572.2004; Ozbek SM, 2009, J APPL ORAL SCI, V17, P370, DOI 10.1590/S1678-77572009000500004; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Preza D, 2008, J CLIN MICROBIOL, V46, P2015, DOI 10.1128/JCM.02411-07; Ramesh Krishnan, 2013, J Pharm Bioallied Sci, V5, pS63, DOI 10.4103/0975-7406.113299; Rams TE, 2013, J PERIODONTOL, V84, P1026, DOI 10.1902/jop.2012.120050; Ran SJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00795; Rehman K, 2009, PAKISTAN ORAL DENT J, V29, P119; Ribeiro AA, 2015, CARIES RES, V49, P99, DOI 10.1159/000368562; Richards Derek, 2013, Evid Based Dent, V14, P35, DOI 10.1038/sj.ebd.6400925; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Russell RRB, 2008, CARIES RES, V42, P319, DOI 10.1159/000151326; Salah Randa, 2008, BMC Oral Health, V8, P17, DOI 10.1186/1472-6831-8-17; Sedgley C, 2006, J ENDODONT, V32, P104, DOI 10.1016/j.joen.2005.10.022; Sheth CC, 2016, LETT APPL MICROBIOL, V63, P254, DOI 10.1111/lam.12620; Simon-Soro A, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.25443; Sindhu N, 2013, J PHARMACEUT BIOMED, V31, P1192; Soderling EM, 2011, CURR MICROBIOL, V62, P618, DOI 10.1007/s00284-010-9752-9; Souto R, 2008, ARCH ORAL BIOL, V53, P155, DOI 10.1016/j.archoralbio.2007.08.004; Stecksen-Blicks C, 2009, CARIES RES, V43, P374, DOI 10.1159/000235581; Tanzer J M, 2001, J Dent Educ, V65, P1028; Thenisch NL, 2006, CARIES RES, V40, P366, DOI 10.1159/000094280; Thomas A, 2016, J CLIN DIAGN RES, V10, pZC109, DOI 10.7860/JCDR/2016/19387.8357; Vanderas AP, 2004, PEDIATR DENT, V26, P362; Walter J, 2008, MICROBIOL-SGM, V154, P72, DOI 10.1099/mic.0.2007/010637-0; Willems HM, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw039; Willger SD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-40; Xiao CC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01145; Xie ZJ, 2007, ORAL SURG ORAL MED O, V103, pE44, DOI 10.1016/j.tripleo.2006.12.028; Xu X, 2015, ENVIRON MICROBIOL, V17, P699, DOI 10.1111/1462-2920.12502; Yoshida A, 2003, J CLIN MICROBIOL, V41, P4438, DOI 10.1128/JCM.41.9.4438-4441.2003; Zaremba M L, 2006, Adv Med Sci, V51 Suppl 1, P233; Zheng JS, 2015, ENVIRON MICROBIOL, V17, P2133, DOI 10.1111/1462-2920.12662	90	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185804	10.1371/journal.pone.0185804	http://dx.doi.org/10.1371/journal.pone.0185804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016613	Green Published, gold, Green Submitted			2022-12-26	WOS:000412627400030
J	Liu, Z; Pericak-Vance, MA; Goldschmidt-Clermont, P; Seo, D; Wang, LY; Rundek, T; Beecham, GW				Liu, Zhi; Pericak-Vance, Margaret A.; Goldschmidt-Clermont, Pascal; Seo, David; Wang, Liyong; Rundek, Tatjana; Beecham, Gary W.			Coronary collateralization shows sex and racial-ethnic differences in obstructive artery disease patients	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; DIABETES-MELLITUS; VESSEL DEVELOPMENT; GENETIC-VARIATION; CIRCULATION; ASSOCIATION; HEART; DETERMINANTS; MORTALITY; GENOMES	Background Coronary collateral circulation protects cardiac tissues from myocardial infarction damage and decreases sudden cardiac death. So far, it is unclear how coronary collateralization varies by race-ethnicity groups and by sex. Methods We assessed 868 patients with obstructive CAD. Patients were assessed for collateral grades based on Rentrop grading system, as well as other covariates. DNA samples were genotyped using the Affymetrix 6.0 genotyping array. To evaluate genetic contributions to collaterals, we performed admixture mapping using logistic regression with estimated local and global ancestry. Results Overall, 53% of participants had collaterals. We found difference between sex and racialethnic groups. Men had higher rates of collaterals than women (P-value = 0.000175). White Hispanics/Latinos showed overall higher rates of collaterals than African Americans and non-Hispanic Whites (59%, 50% and 48%, respectively, P-value = 0.017), and especially higher rates in grade 1 and grade 3 collateralization than the other two populations (P-value = 0.0257). Admixture mapping showed Native American ancestry was associated with the presence of collaterals at a region on chromosome 17 (chr17: 35,243,14241,251,931, beta = 0.55, P-value = 0.000127). African ancestry also showed association with collaterals at a different region on chromosome 17 (chr17: 32,266,966-34,463,323, beta = 0.38, P-value = 0.00072). Conclusions In our study, collateralization showed sex and racial-ethnic differences in obstructive CAD patients. We identified two regions on chromosome 17 that were likely to harbor genetic variations that influenced collateralization.	[Liu, Zhi; Pericak-Vance, Margaret A.; Wang, Liyong; Beecham, Gary W.] Univ Miami, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Goldschmidt-Clermont, Pascal; Seo, David] Univ Miami, Miller Sch Med, Div Cardiol, Miami, FL 33136 USA; [Rundek, Tatjana] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Beecham, GW (corresponding author), Univ Miami, John P Hussman Inst Human Genom, Miami, FL 33136 USA.	gbeecham@med.miami.edu			National Institutes of Health/National Heart, Lung and Blood Institute [5R01HL102487-04]	National Institutes of Health/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the grant from the National Institutes of Health/National Heart, Lung and Blood Institute (https://www.nhibi.nih.gov/) 5R01HL102487-04 (GWB/DMS).	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; Benjamin EJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S11; Bhatt H, 2015, ANGIOLOGY, V66, P588, DOI 10.1177/0003319714545342; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; de Marchi SF, 2011, CARDIOLOGY, V118, P198, DOI 10.1159/000328648; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Gloekler S, 2014, HEART, V100, P160, DOI 10.1136/heartjnl-2013-304880; Grobbee DE, 1995, PROGRESSION REGRESSI, P478; Hirtle-Lewis M, 2013, CLIN CARDIOL, V36, P628, DOI 10.1002/clc.22193; Hoffman GS, 2012, INFLAMMATORY DIS BLO, V2nd; Jacobs AK, 2009, CIRC-CARDIOVASC INTE, V2, P69, DOI 10.1161/CIRCINTERVENTIONS.108.847954; Kinnaird T, 2008, CARDIOVASC RES, V78, P257, DOI 10.1093/cvr/cvm116; Koerselman J, 2003, CIRCULATION, V107, P2507, DOI 10.1161/01.CIR.0000065118.99409.5F; Koerselman J, 2007, ATHEROSCLEROSIS, V191, P191, DOI 10.1016/j.atherosclerosis.2006.03.021; Kornowski R, 2003, CORONARY ARTERY DIS, V14, P61, DOI 10.1097/00019501-200302000-00007; la Sala A, 2012, TRENDS MOL MED, V18, P494, DOI 10.1016/j.molmed.2012.06.007; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lee CW, 2004, J AM COLL CARDIOL, V43, P474, DOI 10.1016/j.jacc.2003.09.033; Lewis SL, 2014, NURSING MANAGEMENT C; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lumley T., 2009, PACKAGE LEAPS; Meier P, 2007, CIRCULATION, V116, P975, DOI 10.1161/CIRCULATIONAHA.107.703959; Meier P, 2012, EUR HEART J, V33, P614, DOI 10.1093/eurheartj/ehr308; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Pittman DL, 1998, GENOMICS, V49, P103, DOI 10.1006/geno.1998.5226; Pohl T, 2001, J AM COLL CARDIOL, V38, P1872, DOI 10.1016/S0735-1097(01)01675-8; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Schaper W, 2012, EUR HEART J, V33, P564, DOI 10.1093/eurheartj/ehr385; Seiler C, 2003, HEART, V89, P1352, DOI 10.1136/heart.89.11.1352; Seiler C, 2013, EUR HEART J, V34, P2674, DOI 10.1093/eurheartj/eht195; Tatli Ersan, 2007, Exp Clin Cardiol, V12, P97; Teunissen PFA, 2012, J MOL CELL CARDIOL, V52, P897, DOI 10.1016/j.yjmcc.2011.09.010; Waldecker B, 2002, Z KARDIOL, V91, P243, DOI 10.1007/s003920200018; Wang SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031910; Zbinden R, 2005, HEART, V91, P1289, DOI 10.1136/hrt.2004.041236; Zhang H, 2010, J CEREBR BLOOD F MET, V30, P923, DOI 10.1038/jcbfm.2010.10	41	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0183836	10.1371/journal.pone.0183836	http://dx.doi.org/10.1371/journal.pone.0183836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016599	Green Published, Green Submitted, gold			2022-12-26	WOS:000412627400004
J	Schmidt, MH; Swang, TW; Hamilton, IM; Best, JA				Schmidt, Markus H.; Swang, Theodore W.; Hamilton, Ian M.; Best, Janet A.			State-dependent metabolic partitioning and energy conservation: A theoretical framework for understanding the function of sleep	PLOS ONE			English	Article							DAILY TORPOR; MAMMALIAN SLEEP; TEMPORAL ORGANIZATION; CIRCADIAN RHYTHMICITY; MEMORY CONSOLIDATION; HIBERNATION; HOMEOSTASIS; INTEGRATION; WAKEFULNESS; PLASTICITY	Metabolic rate reduction has been considered the mechanism by which sleep conserves energy, similar to torpor or hibernation. This mechanism of energy savings is in conflict with the known upregulation (compared to wake) of diverse functions during sleep and neglects a potential role in energy conservation for partitioning of biological operations by behavioral state. Indeed, energy savings as derived from state-dependent resource allocations have yet to be examined. A mathematical model is presented based on relative rates of energy deployment for biological processes upregulated during either wake or sleep. Using this model, energy savings from sleep-wake cycling over constant wakefulness is computed by comparing stable limit cycles for systems of differential equations. A primary objective is to compare potential energy savings derived from state-dependent metabolic partitioning versus metabolic rate reduction. Additionally, energy conservation from sleep quota and the circadian system are also quantified in relation to a continuous wake condition. As a function of metabolic partitioning, our calculations show that coupling of metabolic operations with behavioral state may provide comparatively greater energy savings than the measured decrease in metabolic rate, suggesting that actual energy savings derived from sleep may be more than 4-fold greater than previous estimates. A combination of state-dependent metabolic partitioning and modest metabolic rate reduction during sleep may enhance energy savings beyond what is achievable through metabolic partitioning alone; however, the relative contribution from metabolic partitioning diminishes as metabolic rate is decreased during the rest phase. Sleep quota and the circadian system further augment energy savings in the model. Finally, we propose that state-dependent resource allocation underpins both sleep homeostasis and the optimization of daily energy conservation across species. This new paradigm identifies an evolutionary selective advantage for the upregulation of central and peripheral biological processes during sleep, presenting a unifying construct to understand sleep function.	[Schmidt, Markus H.] Univ Bern, Dept Neurol, Inselspital, Bern, Switzerland; [Schmidt, Markus H.] Ohio Sleep Med & Neurosci Inst, Dublin, OH 43017 USA; [Swang, Theodore W.; Hamilton, Ian M.; Best, Janet A.] Ohio State Univ, Dept Math, Columbus, OH 43210 USA; [Hamilton, Ian M.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA	University of Bern; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Schmidt, MH (corresponding author), Univ Bern, Dept Neurol, Inselspital, Bern, Switzerland.; Schmidt, MH (corresponding author), Ohio Sleep Med & Neurosci Inst, Dublin, OH 43017 USA.	mschmidt@sleepmedicine.com	Hamilton, Ian Michael/A-4949-2012	Hamilton, Ian Michael/0000-0002-1198-3431; Schmidt, Markus/0000-0002-3299-1318	NSF CAREER Award [DMS-0956057]; Mathematical Biosciences Institute through NSF [DMS-0931642]; Inselspital; Ohio Sleep Medicine and Neuroscience Institute	NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Mathematical Biosciences Institute through NSF; Inselspital; Ohio Sleep Medicine and Neuroscience Institute	Research was supported by NSF CAREER Award DMS-0956057 to Janet A. Best, by the Mathematical Biosciences Institute through NSF grant DMS-0931642, by Inselspital, and by the Ohio Sleep Medicine and Neuroscience Institute. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Carol Everson, Mark Blumberg, and Howard Roffwarg for reviewing and commenting on the manuscript. Research supported by NSF CAREER Award DMS-0956057, by the Mathematical Biosciences Institute through NSF under grant DMS-0931642, by Inselspital, and by the Ohio Sleep Medicine and Neuroscience Institute.	ALLISON T, 1970, Natural History, V79, P56; Arnardottir ES, 2014, SLEEP, V37, P1589, DOI 10.5665/sleep.4064; Aton SJ, 2009, NEURON, V61, P454, DOI 10.1016/j.neuron.2009.01.007; Aulsebrook AE, 2016, TRENDS ECOL EVOL, V31, P590, DOI 10.1016/j.tree.2016.05.004; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; BERGER RJ, 1995, BEHAV BRAIN RES, V69, P65, DOI 10.1016/0166-4328(95)00002-B; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Everson CA, 2014, SLEEP, V37, P1929, DOI 10.5665/sleep.4244; Froy O, 2011, CLIN SCI, V120, P65, DOI 10.1042/CS20100327; Gallopin T, 2005, NEUROSCIENCE, V134, P1377, DOI 10.1016/j.neuroscience.2005.05.045; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 1998, CLIN EXP PHARMACOL P, V25, P736, DOI 10.1111/j.1440-1681.1998.tb02287.x; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; Home J. A., 1988, WHY WE SLEEP FUNCTIO; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Jung CM, 2011, J PHYSIOL-LONDON, V589, P235, DOI 10.1113/jphysiol.2010.197517; Kortner G, 2000, CHRONOBIOL INT, V17, P103, DOI 10.1081/CBI-100101036; Krueger JM, 2016, SLEEP MED REV, V28, P46, DOI 10.1016/j.smrv.2015.08.005; Krueger JM, 1999, SLEEP MED REV, V3, P119, DOI 10.1016/S1087-0792(99)90019-9; Lesku JA, 2008, SLEEP MED REV, V12, P229, DOI 10.1016/j.smrv.2007.10.003; Lesku JA, 2006, AM NAT, V168, P441, DOI 10.1086/506973; Mackiewicz M, 2009, TRENDS MOL MED, V15, P79, DOI 10.1016/j.molmed.2008.12.002; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; McCauley P, 2009, J THEOR BIOL, V256, P227, DOI 10.1016/j.jtbi.2008.09.012; Mignot E, 2008, PLOS BIOL, V6, P661, DOI 10.1371/journal.pbio.0060106; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; Nijhout HF, 2014, MATH BIOSCI, V257, P104, DOI 10.1016/j.mbs.2014.08.015; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; Ruf T, 2015, BIOL REV, V90, P891, DOI 10.1111/brv.12137; Schmidt MH, 2014, NEUROSCI BIOBEHAV R, V47, P122, DOI 10.1016/j.neubiorev.2014.08.001; Schubert KA, 2010, BIOL LETTERS, V6, P132, DOI 10.1098/rsbl.2009.0569; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; WHITE DP, 1985, J APPL PHYSIOL, V59, P384, DOI 10.1152/jappl.1985.59.2.384; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zepelin, 1989, MAMMALIAN SLEEP; ZEPELIN H, 1974, BRAIN BEHAV EVOLUT, V10, P425, DOI 10.1159/000124330	42	27	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185746	10.1371/journal.pone.0185746	http://dx.doi.org/10.1371/journal.pone.0185746			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016625	Green Published, Green Submitted, gold			2022-12-26	WOS:000412627400028
J	Lee, S; Lee, H; Yoo, S; Kim, H				Lee, Seoeun; Lee, Hunsang; Yoo, Suji; Kim, Hyun			Molecular insights into the m-AAA protease-mediated dislocation of transmembrane helices in the mitochondrial inner membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase associated with diverse cellular activities (AAA); membrane; mitochondria; transmembrane domain; yeast; Yta10; Yta12	CHAPERONE-LIKE ACTIVITY; RHOMBOID PROTEASE; SIGNAL SEQUENCE; IN-VIVO; PROTEINS; YEAST; ATP; DEGRADATION; COMPLEX; MGM1	Protein complexes involved in respiration, ATP synthesis, and protein import reside in the mitochondrial inner membrane; thus, proper regulation of these proteins is essential for cell viability. The m-AAA protease, a conserved hetero-hexameric AAA (ATPase associated with diverse cellular activities) protease, composed of the Yta10 and Yta12 proteins, regulates mitochondrial proteostasis by mediating protein maturation and degradation. It also recognizes and mediates the dislocation of membrane-embedded substrates, including foreign transmembrane (TM) segments, but the molecular mechanism involved in these processes remains elusive. This study investigated the role of the TM domains in the m-AAA protease by systematic replacement of one TM domain at a time in yeast. Our data indicated that replacement of the Yta10 TM2 domain abolishes membrane dislocation for only a subset of substrates, whereas replacement of the Yta12 TM2 domain impairs membrane dislocation for all tested substrates, suggesting different roles of the TM domains in each m-AAA protease subunit. Furthermore, m-AAA protease-mediated membrane dislocation was impaired in the presence of a large downstream hydrophilic moiety in a membrane substrate. This finding suggested that the m-AAA protease cannot dislocate large hydrophilic domains across the membrane, indicating that the membrane dislocation probably occurs in a lipid environment. In summary, this study highlights previously underappreciated biological roles of TM domains of the m-AAA proteases in mediating the recognition and dislocation of membrane-embedded substrates.	[Lee, Seoeun; Lee, Hunsang; Yoo, Suji; Kim, Hyun] Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea; [Lee, Hunsang] Donnelly Ctr, Toronto, ON M5S 3E1, Canada	Seoul National University (SNU); University of Toronto	Kim, H (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea.	joy@snu.ac.kr	Lee, Hunsang/ABC-5697-2020		National Research Foundation of Korea [NRF-2016R1A2B2013459]; Promising-Pioneering Researcher Program through Seoul National University	National Research Foundation of Korea(National Research Foundation of Korea); Promising-Pioneering Researcher Program through Seoul National University	The research was funded by National Research Foundation of Korea Grant NRF-2016R1A2B2013459 and a grant from the Promising-Pioneering Researcher Program through Seoul National University (to H. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Baker MJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007559; Bonn F, 2011, EMBO J, V30, P2545, DOI 10.1038/emboj.2011.169; Botelho SC, 2013, J BIOL CHEM, V288, P4792, DOI 10.1074/jbc.M112.430892; Botelho SC, 2011, EMBO J, V30, P1003, DOI 10.1038/emboj.2011.29; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; Gerdes F, 2012, BBA-MOL CELL RES, V1823, P49, DOI 10.1016/j.bbamcr.2011.09.015; Graef M, 2007, MOL CELL BIOL, V27, P2476, DOI 10.1128/MCB.01721-06; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Janska H, 2013, BBA-MOL CELL RES, V1833, P381, DOI 10.1016/j.bbamcr.2012.03.016; Kihara A, 1999, EMBO J, V18, P2970, DOI 10.1093/emboj/18.11.2970; Kim H, 2000, P NATL ACAD SCI USA, V97, P1516, DOI 10.1073/pnas.040556797; Kim HY, 2015, PROTEIN SCI, V24, P2063, DOI 10.1002/pro.2817; Korbel D, 2004, EMBO REP, V5, P698, DOI 10.1038/sj.embor.7400186; Lee H, 2012, BIOCHEM BIOPH RES CO, V427, P780, DOI 10.1016/j.bbrc.2012.09.138; Lee S, 2011, J BIOL CHEM, V286, P4404, DOI 10.1074/jbc.M110.158741; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Leonhard K, 1999, NATURE, V398, P348, DOI 10.1038/18704; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Paetzel M, 2004, J BIOL CHEM, V279, P30781, DOI 10.1074/jbc.M401686200; Park K, 2013, J BIOL CHEM, V288, P1521, DOI 10.1074/jbc.M112.409748; Rampello AJ, 2017, J MOL BIOL, V429, P873, DOI 10.1016/j.jmb.2017.02.009; Schafer A, 2010, J MOL BIOL, V401, P182, DOI 10.1016/j.jmb.2010.06.014; Shah ZH, 2000, FEBS LETT, V478, P267, DOI 10.1016/S0014-5793(00)01859-7; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; Tatsuta T, 2009, J BIOCHEM, V146, P455, DOI 10.1093/jb/mvp122; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522	32	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20058	20066		10.1074/jbc.M117.796763	http://dx.doi.org/10.1074/jbc.M117.796763			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29030426	Green Published, hybrid			2022-12-26	WOS:000417696400013
J	Goji, T; Takahara, K; Negishi, M; Katoh, H				Goji, Takeo; Takahara, Kazuhiko; Negishi, Manabu; Katoh, Hironori			Cystine uptake through the cystine/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid transport; cell death; glioblastoma; glucose; reactive oxygen species (ROS); cystine	OXIDATIVE STRESS; SYSTEM X(C)(-); GLUTAMINE-METABOLISM; INDUCED CYTOTOXICITY; CANCER; GLIOMA; TRANSPORTER; HOMEOSTASIS; APOPTOSIS; REDUCTASE	Oncogenic signaling in cancer cells alters glucose uptake and utilization to supply sufficient energy and biosynthetic intermediates for survival and sustained proliferation. Oncogenic signaling also prevents oxidative stress and cell death caused by increased production of reactive oxygen species. However, elevated glucose metabolism in cancer cells, especially in glioblastoma, results in the cells becoming sensitive to glucose deprivation (i.e. in high glucose dependence), which rapidly induces cell death. However, the precise mechanism of this type of cell death remains unknown. Here, we report that glucose deprivation alone does not trigger glioblastoma cell death. We found that, for cell death to occur in glucose-deprived glioblastoma cells, cystine and glutamine also need to be present in culture media. We observed that cystine uptake through the cystine/glutamate antiporter xCT under glucose deprivation rapidly induces NADPH depletion, reactive oxygen species accumulation, and cell death. We conclude that although cystine uptake is crucial for production of antioxidant glutathione in cancer cells its transport through xCT also induces oxidative stress and cell death in glucose-deprived glioblastoma cells. Combining inhibitors targeting cancer-specific glucose metabolism with cystine and glutamine treatment may offer a therapeutic approach for glioblastoma tumors exhibiting high xCT expression.	[Goji, Takeo; Negishi, Manabu; Katoh, Hironori] Kyoto Univ, Grad Sch Pharmaceut Sci, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan; [Takahara, Kazuhiko] Kyoto Univ, Dept Anim & Dev & Physiol, Sakyo Ku, Kyoto 6068501, Japan; [Negishi, Manabu; Katoh, Hironori] Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Kyoto University	Katoh, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.	hirokato@pharm.kyoto-u.ac.jp		Katoh, Hironori/0000-0002-8191-8117	Ministry of Education, Science, Sports, and Culture of Japan [15K07043]; Takeda Science Foundation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grant-in-aid for Scientific Research 15K07043 from the Ministry of Education, Science, Sports, and Culture of Japan and a grant from Takeda Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad IM, 2005, J BIOL CHEM, V280, P4254, DOI 10.1074/jbc.M411662200; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Briggs KJ, 2016, CELL, V166, P126, DOI 10.1016/j.cell.2016.05.042; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Graham NA, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.20; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hay N, 2016, NAT REV CANCER, V16, P635, DOI 10.1038/nrc.2016.77; Jelluma N, 2006, MOL CANCER RES, V4, P319, DOI 10.1158/1541-7786.MCR-05-0061; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Katoh Y, 2017, MOL BIOL CELL, V28, P898, DOI 10.1091/mbc.E17-01-0051; Kim JY, 2001, BBA-BIOMEMBRANES, V1512, P335, DOI 10.1016/S0005-2736(01)00338-8; Koppula P, 2017, J BIOL CHEM, V292, P14240, DOI 10.1074/jbc.M117.798405; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Mandal PK, 2010, J BIOL CHEM, V285, P22244, DOI 10.1074/jbc.M110.121327; Muir A, 2017, ELIFE, V6, DOI 10.7554/eLife.27713; Nabeyama A, 2010, P NATL ACAD SCI USA, V107, P6436, DOI 10.1073/pnas.0912827107; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; Pader I, 2014, P NATL ACAD SCI USA, V111, P6964, DOI 10.1073/pnas.1317320111; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; Polewski MD, 2016, MOL CANCER RES, V14, P1229, DOI 10.1158/1541-7786.MCR-16-0028; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Savaskan NE, 2008, NAT MED, V14, P629, DOI 10.1038/nm1772; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Shin CS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15074; Sleire L, 2015, ONCOGENE, V34, P5951, DOI 10.1038/onc.2015.60; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Takeuchi S, 2013, NEUROSURGERY, V72, P33, DOI 10.1227/NEU.0b013e318276b2de; Tsuchihashi K, 2016, CANCER RES, V76, P2954, DOI 10.1158/0008-5472.CAN-15-2121; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yamasaki F, 2003, CANCER CHEMOTH PHARM, V51, P271, DOI 10.1007/s00280-002-0562-z; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zanotto A, 2012, INVEST NEW DRUG, V30, P2252, DOI 10.1007/s10637-012-9804-z	43	41	43	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19721	19732		10.1074/jbc.M117.814392	http://dx.doi.org/10.1074/jbc.M117.814392			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29038291	hybrid, Green Published			2022-12-26	WOS:000416911300017
J	Lee, SY; Kim, EK; Kim, MS; Shin, SH; Chang, H; Jang, SY; Kim, HJ; Kim, DK				Lee, Su Yeon; Kim, Eun Kyoug; Kim, Min Sun; Shin, Sun Hye; Chang, Haseong; Jang, Shin Yi; Kim, Hee-Jin; Kim, Duk-Kyung			The prevalence and clinical manifestation of hereditary thrombophilia in Korean patients with unprovoked venous thromboembolisms	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; FACTOR-V-LEIDEN; PULMONARY-EMBOLISM; ANTITHROMBIN-III; RISK-FACTORS; PROTEIN-C; POPULATION; MANAGEMENT; MUTATION; CARRIERS	Background Hereditary thrombophilia (HT) is a genetic predisposition to thrombosis. Asian mutation spectrum of HT is different from Western ones. We investigated the incidence and clinical characteristics of HT in Korean patients with unprovoked venous thromboembolism (VTE). Methods Among 369 consecutive patients with thromboembolic event who underwent thrombophilia tests, we enrolled 222 patients diagnosed with unprovoked VTE. The presence of HT was confirmed by DNA sequencing of the genes that cause deficits in natural anticoagulants (NAs). Median follow-up duration was 40 +/- 38 months. Results Among the 222 patients with unprovoked VTE, 66 (29.7%) demonstrated decreased NA level, and 33 (14.9%) were finally confirmed to have HT in a genetic molecular test. Antithrombin III deficiency (6.3%) was most frequently detected, followed by protein C deficiency (5.4%), protein S deficiency (1.8%), and dysplasminogenemia (1.4%). The HT group was significantly younger (37 [32-50] vs. 52 [43-65] years; P < 0.001) and had a higher proportion of male (69.7% vs. 47%; P = 0.013), more previous VTE events (57.6% vs. 31.7%; P = 0.004), and a greater family history of VTE (43.8% vs. 1.9%; P < 0.001) than the non-HT group. Age < 45 years and a family history of VTE were independent predictors for unprovoked VTE with HT (odds ratio, 9.435 [2.45-36.35]; P = 0.001 and 92.667 [14.95-574.29]; P < 0.001). Conclusions About 15% of patients with unprovoked VTE had HT. A positive family history of VTE and age <45 years were independent predictors for unprovoked VTE caused by HT.	[Lee, Su Yeon; Kim, Min Sun; Chang, Haseong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Cardiol, Seoul, South Korea; [Kim, Eun Kyoug; Jang, Shin Yi; Kim, Duk-Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Heart Vasc Stroke Inst,Div Cardiol, Seoul, South Korea; [Shin, Sun Hye] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; [Kim, Hee-Jin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, DK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Heart Vasc Stroke Inst,Div Cardiol, Seoul, South Korea.; Kim, HJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea.	hee_jin.kim@samsung.com; dukyung.kim@gmail.com	Kim, Hee Jin/F-4594-2014; Kim, Duk Kyung/F-4613-2014; Kim, Sun/GSN-4867-2022	Kim, Duk-Kyung/0000-0002-2348-8948; Jang, Shin Yi/0000-0003-4319-7029				Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; Chen TY, 2003, ANN HEMATOL, V82, P114, DOI 10.1007/s00277-002-0603-z; Christiansen SC, 2005, JAMA-J AM MED ASSOC, V293, P2352, DOI 10.1001/jama.293.19.2352; Couturaud F, 2009, CHEST, V136, P1537, DOI 10.1378/chest.09-0757; DeStefano V, 1996, BLOOD, V87, P3531, DOI 10.1182/blood.V87.9.3531.bloodjournal8793531; Goodwin AJ, 2002, ARCH PATHOL LAB MED, V126, P1349; Heit JA, 2002, ARCH INTERN MED, V162, P1245, DOI 10.1001/archinte.162.11.1245; Hirsh J, 1996, CIRCULATION, V93, P2212, DOI 10.1161/01.CIR.93.12.2212; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Khan S, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-15; Kim HJ, 2014, HAEMATOLOGICA, V99, P561, DOI 10.3324/haematol.2013.092023; Kim S, 2016, ANN SURG TREAT RES, V90, P340, DOI 10.4174/astr.2016.90.6.340; Kimura R, 2006, J THROMB HAEMOST, V4, P2010, DOI 10.1111/j.1538-7836.2006.02071.x; Lee M, 2012, YONSEI MED J, V53, P571, DOI 10.3349/ymj.2012.53.3.571; Liao S, 2014, J THROMB HAEMOST, V12, P214, DOI 10.1111/jth.12464; Mateo J, 1997, THROMB HAEMOSTASIS, V77, P444; Miyata T, 2009, THROMB RES, V124, P14, DOI 10.1016/j.thromres.2008.08.020; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; Palareti G, 2003, CIRCULATION, V108, P313, DOI 10.1161/01.CIR.0000079162.69615.0F; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Shen MC, 1997, THROMB RES, V87, P377, DOI 10.1016/S0049-3848(97)00141-2; Suehisa E, 2001, BLOOD COAGUL FIBRIN, V12, P95, DOI 10.1097/00001721-200103000-00002; Tang L, 2012, J THROMB HAEMOST, V10, P2019, DOI 10.1111/j.1538-7836.2012.04862.x; Weingarz L, 2013, BRIT J HAEMATOL, V163, P655, DOI 10.1111/bjh.12575; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66	26	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0185785	10.1371/journal.pone.0185785	http://dx.doi.org/10.1371/journal.pone.0185785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040284	Green Submitted, Green Published, gold			2022-12-26	WOS:000413167500011
J	Song, I; Roels, S; Martens, GA; Bouwens, L				Song, Imane; Roels, Sarah; Martens, Geert A.; Bouwens, Luc			Circulating microRNA-375 as biomarker of pancreatic beta cell death and protection of beta cell mass by cytoprotective compounds	PLOS ONE			English	Article							MIR-375; MECHANISMS; STRESS; ACID; MICE	Objective Previous studies demonstrated that circulating microRNA-375 (miR-375) is a suitable plasma biomarker for real-time detection of beta cell death. The present study evaluated the use of this biomarker to assess the beta cytoprotective effect of phenylpropenoic acid glucoside (PPAG), which was previously demonstrated to protect beta cells against various types of injury, and of exendin-4, which is an established antidiabetic drug. Methods PPAG or exendin-4 were administered in mice treated with streptozotocin (STZ) to acutely induce beta cell death. Beta cell mass and apoptotic death were measured in pancreatic tissue sections. Circulating miR-375 was measured in blood plasma by RT-qPCR. The release of miR-375 was also measured in vitro by MIN-6 beta cells. Results Administration of STZ resulted in measurable circulating levels of miR-375, a decrease in beta cell mass and increase in frequency of apoptotic beta cells. In vitro, there was a good correlation between miR-375 release and the extent of beta cell death. Treatment of mice with PPAG or exendin-4 significantly attenuated STZ-induced loss of beta cell mass and beta cell apoptosis, and normalized the blood level of miR-375. Conclusions These findings show the potential use of serological miR-375 measurements to evaluate the beta cytoprotective effect of (potential) antidiabetic drugs in vivo.	[Song, Imane; Bouwens, Luc] VUB, Cell Differentiat Lab, Brussels, Belgium; [Roels, Sarah; Martens, Geert A.] VUB, Diabet Res Ctr, Brussels, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Brussel	Bouwens, L (corresponding author), VUB, Cell Differentiat Lab, Brussels, Belgium.	lucbo@vub.ac.be	Martens, Geert A./F-6920-2015; Martens, Geert/ABA-6297-2020	Martens, Geert A./0000-0003-1208-6289; Martens, Geert/0000-0003-1208-6289; Bouwens, Luc/0000-0001-5767-7002	Research Foundation Flanders [FWO G.0492.12]; Agentschap voor Innovate door Wetenschap en Technologie (IWT) [IWT-SB-141732]; Wetenschappelijk Fonds Willy Gepts from the Universitair Ziekenhuis Brussel; European Foundation for the Study of Diabetes (EFSD/JDRF/Lilly Programme)	Research Foundation Flanders(FWO); Agentschap voor Innovate door Wetenschap en Technologie (IWT); Wetenschappelijk Fonds Willy Gepts from the Universitair Ziekenhuis Brussel; European Foundation for the Study of Diabetes (EFSD/JDRF/Lilly Programme)	This study was supported by research grants from the Research Foundation Flanders (FWO G.0492.12 project grant and Senior Clinical Investigator career support grant to G.A.M.), www. fwo.be; by the Agentschap voor Innovate door Wetenschap en Technologie (IWT) with IWT-SB-141732 (to S.R and G.A.M.), littps://www.iwt.be; by the Wetenschappelijk Fonds Willy Gepts from the Universitair Ziekenhuis Brussel (to G.A.M., S.R. and L.B.) and by the European Foundation for the Study of Diabetes (EFSD/JDRF/Lilly Programme 2015, to G.A.M.), www. europeandiabetesfoundation.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Erener S, 2013, ENDOCRINOLOGY, V154, P603, DOI 10.1210/en.2012-1744; Farr Ryan J, 2013, Pediatr Endocrinol Rev, V11, P14; Gotthardt M, 2014, TRENDS ENDOCRIN MET, V25, P375, DOI 10.1016/j.tem.2014.02.002; Himpe E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157604; Kanak MA, 2015, TRANSPLANTATION, V99, P1568, DOI 10.1097/TP.0000000000000625; Karaca M, 2009, DIABETES METAB, V35, P77, DOI 10.1016/j.diabet.2008.09.007; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Latreille M, 2015, J MOL MED, V93, P1159, DOI 10.1007/s00109-015-1296-9; Lee MS, 2012, CURR MOL MED, V12, P1297, DOI 10.2174/156652412803833553; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Mathijs I, 2014, MOL NUTR FOOD RES, V58, P1980, DOI 10.1002/mnfr.201400211; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; Meier JJ, 2008, DIABETOLOGIA, V51, P703, DOI 10.1007/s00125-008-0936-9; Muller CJF, 2013, MOL NUTR FOOD RES, V57, P2216, DOI 10.1002/mnfr.201300294; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Silva MT, 2010, FEBS LETT, V584, P4491, DOI 10.1016/j.febslet.2010.10.046; Song I, 2015, CURR DRUG TARGETS, V16, P516, DOI 10.2174/1389450116666150204113928; Sun K, 2014, MOL MED REP, V9, P967, DOI 10.3892/mmr.2013.1872; Tamura K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126003; Tortosa F, 2013, ARCH PHYSIOL BIOCHEM, V119, P161, DOI 10.3109/13813455.2013.795175; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Weir GC, 2014, NAT REV DRUG DISCOV, V13, P333; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001	26	18	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186480	10.1371/journal.pone.0186480	http://dx.doi.org/10.1371/journal.pone.0186480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040320	Green Submitted, Green Published, gold			2022-12-26	WOS:000413167500052
J	Schmeltz, MT; Gamble, JL				Schmeltz, Michael T.; Gamble, Janet L.			Risk characterization of hospitalizations for mental illness and/or behavioral disorders with concurrent heat-related illness	PLOS ONE			English	Article							POISSON REGRESSION APPROACH; CAUSE-SPECIFIC MORTALITY; DRUG-USE; WAVES; ADMISSIONS; CLIMATE; TEMPERATURE; MORBIDITY; HEATWAVES; IMPACTS	Background Many studies have found significant associations between high ambient temperatures and increases in heat-related morbidity and mortality. Several studies have demonstrated that increases in heat-related hospitalizations are elevated among individuals with diagnosed mental illnesses and/or behavioral disorders (MBD). However, there are a limited number of studies regarding risk factors associated with specific mental illnesses that contribute, at least in part, to heat-related illnesses (HRI) in the United States. Objective To identify and characterize individual and environmental risk factors associated with MBD hospitalizations with a concurrent HRI diagnosis. Methods This study uses hospitalization data from the Nationwide Inpatient Sample (2001-2010). Descriptive analyses of primary and secondary diagnoses of MBDs with an HRI were examined. Risk ratios (RR) were calculated from multivariable models to identify risk factors for hospitalizations among patients with mental illnesses and/or behavioral disorders and HRI. Results Nondependent alcohol/drug abuse, dementia, and schizophrenia were among the disorders that were associated with increased frequency of HRI hospitalizations among MBD patients. Increased risk of MBD hospitalizations with HRI was observed for Males (RR, 3.06), African Americans (RR, 1.16), Native Americans (RR, 1.70), uninsured (RR, 1.92), and those 40 years and older, compared to MBD hospitalizations alone. Conclusions Previous studies outside the U.S. have found that dementia and schizophrenia are significant risk factors for HRI hospitalizations. Our results suggest that hospitalizations among substance abusers may also be an important risk factor associated with heat morbidity. Improved understanding of these relative risks could help inform future public health strategies.	[Schmeltz, Michael T.] US EPA, ASPPH EPA Environm Hlth Fellowship Program, Off Res & Dev, Natl Ctr Environm Assessment, Washington, DC 20460 USA; [Gamble, Janet L.] US EPA, Off Res & Dev, Natl Ctr Environm Assessment, Washington, DC 20460 USA	United States Environmental Protection Agency; United States Environmental Protection Agency	Schmeltz, MT (corresponding author), US EPA, ASPPH EPA Environm Hlth Fellowship Program, Off Res & Dev, Natl Ctr Environm Assessment, Washington, DC 20460 USA.	mschmeltz@gradcenter.cuny.edu		Schmeltz, Michael/0000-0003-4764-9723	U.S. Environmental Protection Agency (EPA) [X3-83555301]; Association of Schools and Programs of Public Health (ASPPH)	U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency); Association of Schools and Programs of Public Health (ASPPH)	Michael Schmeltz was supported by the Cooperative Agreement Number X3-83555301 from the U.S. Environmental Protection Agency (EPA) and the Association of Schools and Programs of Public Health (ASPPH).	AHRQ (Agency for Healthcare Research and Quality), 2014, MENT HLTH RES FIND; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Bark N, 1998, PSYCHIATR SERV, V49, P1088, DOI 10.1176/ps.49.8.1088; Basagana X, 2011, EPIDEMIOLOGY, V22, P765, DOI 10.1097/EDE.0b013e31823031c5; Berry HL, 2010, INT J PUBLIC HEALTH, V55, P123, DOI 10.1007/s00038-009-0112-0; Bohnert ASB, 2010, ADDICTION, V105, P1049, DOI 10.1111/j.1360-0443.2009.02887.x; Bouchama A, 2007, ARCH INTERN MED, V167, P2170, DOI 10.1001/archinte.167.20.ira70009; Chen P, 2012, J ADOLESCENT HEALTH, V50, P154, DOI 10.1016/j.jadohealth.2011.05.013; Climate Institute, 2011, CLIM SUFF REAL COST; Cotto JH, 2010, GENDER MED, V7, P402, DOI 10.1016/j.genm.2010.09.004; Crimmins A, 2016, IMPACTS CLIMATE CHAN; Crowe AV, 2000, QJM-INT J MED, V93, P147, DOI 10.1093/qjmed/93.3.147; Cusack L, 2011, J ADV NURS, V67, P915, DOI 10.1111/j.1365-2648.2010.05551.x; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; Doherty TJ, 2011, AM PSYCHOL, V66, P265, DOI 10.1037/a0023141; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fritze Jessica G, 2008, Int J Ment Health Syst, V2, P13, DOI 10.1186/1752-4458-2-13; Gasparrini A, 2012, OCCUP ENVIRON MED, V69, P56, DOI 10.1136/oem.2010.059782; Hansen A, 2008, ENVIRON HEALTH PERSP, V116, P1369, DOI 10.1289/ehp.11339; Hansen AL, 2008, INT J EPIDEMIOL, V37, P1359, DOI 10.1093/ije/dyn165; HCUP (Healthcare Cost and Utilization Project), 2016, OV NAT NAT INP SAMPL; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Hess JJ, 2014, ENVIRON HEALTH PERSP, V122, P1209, DOI 10.1289/ehp.1306796; Kaiser R, 2001, AM J FOREN MED PATH, V22, P303, DOI 10.1097/00000433-200109000-00022; Keim ME, 2008, AM J PREV MED, V35, P508, DOI 10.1016/j.amepre.2008.08.022; Kingsley SL, 2016, ENVIRON HEALTH PERSP, V124, P460, DOI 10.1289/ehp.1408826; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Li B, 2012, CLIMATIC CHANGE, V110, P959, DOI [10.1007/s10584-011-0120-y, 10.1007/s10584-011-0120-v]; Li MM, 2015, INT J ENV RES PUB HE, V12, P5256, DOI 10.3390/ijerph120505256; Martin-Latry K, 2007, EUR PSYCHIAT, V22, P335, DOI 10.1016/j.eurpsy.2007.03.007; McKibben B, 2014, NEW YORK REV BOOKS, V61, P46; NIMH (National Institute of Mental Health), 2014, ANY MENT ILLN AMI US; Nitschke M, 2007, MED J AUSTRALIA, V187, P662, DOI 10.5694/j.1326-5377.2007.tb01466.x; Nordon C, 2009, AM J GERIAT PSYCHIAT, V17, P1059, DOI 10.1097/JGP.0b013e3181b7ef6e; Page LA, 2012, BRIT J PSYCHIAT, V200, P485, DOI 10.1192/bjp.bp.111.100404; Peng RD, 2011, ENVIRON HEALTH PERSP, V119, P701, DOI 10.1289/ehp.1002430; Trang PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155609; Ramin B, 2009, J URBAN HEALTH, V86, P654, DOI 10.1007/s11524-009-9354-7; Schmeltz M., 2015, RISK FACTORS COSTS I; Schmeltz MT, 2016, CLIMATIC CHANGE, V138, P567, DOI 10.1007/s10584-016-1747-5; Schmeltz MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118958; Semenza JC, 1999, AM J PREV MED, V16, P269, DOI 10.1016/S0749-3797(99)00025-2; Shiloh R, 2005, EUR PSYCHIAT, V20, P61, DOI 10.1016/j.eurpsy.2004.09.020; Stollberger C, 2009, EUR J NEUROL, V16, P879, DOI 10.1111/j.1468-1331.2009.02581.x; Swim J, 2009, REPORT AM PSYCHOL AS; Wang X, 2014, J AFFECT DISORDERS, V155, P154, DOI 10.1016/j.jad.2013.10.042; Wang XY, 2012, OCCUP ENVIRON MED, V69, P163, DOI 10.1136/oem.2010.062141; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6; Westaway K, 2015, J CLIN PHARM THER, V40, P363, DOI 10.1111/jcpt.12294; Wu LT, 2012, ANN EMERG MED, V60, P172, DOI 10.1016/j.annemergmed.2012.02.003; Wu LT, 2011, ARCH GEN PSYCHIAT, V68, P1176, DOI 10.1001/archgenpsychiatry.2011.120; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	54	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186509	10.1371/journal.pone.0186509	http://dx.doi.org/10.1371/journal.pone.0186509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ8YP	29036206	Green Published, gold, Green Submitted			2022-12-26	WOS:000413054800044
J	Siber-Hoogeboom, R; Schicht, M; Hoogeboom, S; Paulsen, F; Traxdorf, M				Siber-Hoogeboom, Regina; Schicht, Martin; Hoogeboom, Sebastian; Paulsen, Friedrich; Traxdorf, Maximilian			Obstructive sleep apnea and rhonchopathy are associated with downregulation of trefoil factor family peptide 3 (TFF3)-Implications of changes in oral mucus composition	PLOS ONE			English	Article							UPPER AIRWAY; SURFACE-TENSION; CELL-MIGRATION; LINING LIQUID; DOUBLE-BLIND; EXPRESSION; DISEASE; SALIVA; RESISTANCE; TISSUES	Study objectives Trefoil factor family (TFF) peptides belong to the family of mucin-associated peptides and are expressed in most mucosal surfaces. TFF peptides carry out functions such as proliferation and migration enhancement, anti-apoptosis, and wound healing. Moreover, TFFs are associated with mucins and interact with them as "linker peptides", thereby influencing mucus viscosity. To test the hypothesis that in rhonchopathy and obstructive sleep apnea (OSA) changes occur in the expression of TFF3 and -2 that could contribute to changes in mucus viscosity, leading to an increase in upper airway resistance during breathing. Methods RT-PCR, Western-blot, immunohistochemistry and ELISA were performed to detect and quantify TFF3 and -2 in uvula samples. In addition, 99 saliva samples from patients with mild, moderate or severe OSA, as well as samples from rhonchopathy patients and from healthy volunteers, were analyzed by ELISA. Results TFF3 was detected in all uvula samples. Immunohistochemistry revealed a subjectively decreasing antibody reactivity of the uvula epithelia with increasing disease severity. ELISA demonstrated significantly higher TFF3 saliva protein concentrations in the healthy control group compared to cases with rhonchopathy and OSA. Predisposing factors of OSA such as BMI or age showed no correlation with TFF3. No significant changes were observed with regard to TFF2. Conclusions The results suggest the involvement of TFF3 in the pathogenesis of rhonchopathy and OSA and lead to the hypothesis that reduction of TFF3 production by the epithelium and subepithelial mucous glands of the uvula contribute to an increase in breathing resistance due to a change in mucus organization.	[Siber-Hoogeboom, Regina; Schicht, Martin; Hoogeboom, Sebastian; Paulsen, Friedrich] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Anat 2, Erlangen, Germany; [Traxdorf, Maximilian] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Otorhinolaryngol Head & Neck Surg, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Paulsen, F (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Anat 2, Erlangen, Germany.	friedrich.paulsen@fau.de	Traxdorf, Maximilian Thomas/AAB-1094-2020	Traxdorf, Maximilian Thomas/0000-0002-1684-7420; Schicht, Martin/0000-0001-5155-5477; Paulsen, Friedrich/0000-0002-0527-0953	Deutsche Forschungsgemeinschaft (DFG) [PA738/9-2]; Johannes and Frieda Marohn Foundation [FWN/Zo-GEL/2014)]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Johannes and Frieda Marohn Foundation	The work was supported in part by the Deutsche Forschungsgemeinschaft (DFG) grant PA738/9-2 and a grant from the Johannes and Frieda Marohn Foundation (FWN/Zo-GEL/2014).; The work was supported partly by the Deutsche Forschungsgemeinschaft (DFG) grant PA738/9-2 and partly by a grant from the Johannes and Frieda Marohn Foundation (FWN/Zo-GEL/2014). The authors thank Anke Fischer, Jessica Braun, Hong Nguyen and Maike Hemmerlein for excellent technical assistance. The present work was performed in fulfillment of the requirements for obtaining the degree of Dr. med. dent.	Albert TK, 2010, J PROTEOME RES, V9, P3108, DOI 10.1021/pr100020c; Amis TC, 1999, THORAX, V54, P423, DOI 10.1136/thx.54.5.423; ANCH AM, 1982, J APPL PHYSIOL, V53, P1158, DOI 10.1152/jappl.1982.53.5.1158; AUDIE JP, 1993, J HISTOCHEM CYTOCHEM, V41, P1479, DOI 10.1177/41.10.8245407; Aurora RN, 2010, SLEEP, V33, P1408, DOI 10.1093/sleep/33.10.1408; Barnes M, 2009, J CLIN SLEEP MED, V5, P409; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bjornsdottir E, 2015, J SLEEP RES, V24, P328, DOI 10.1111/jsr.12262; Chaiyarit P, 2012, CLIN ORAL INVEST, V16, P1549, DOI 10.1007/s00784-011-0667-z; Chaiyarit P, 2012, J PERIODONTOL, V83, P1129, DOI 10.1902/jop.2011.110431; Chari R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-297; Dieckow J, 2016, INVEST OPHTH VIS SCI, V57, P56, DOI 10.1167/iovs.15-18129; Eliakim R, 2002, EUR J GASTROEN HEPAT, V14, P607, DOI 10.1097/00042737-200206000-00005; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; FUJITA S, 1981, OTOLARYNG HEAD NECK, V89, P923, DOI 10.1177/019459988108900609; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub2; Hakkinen L, 2000, PERIODONTOL 2000, V24, P127, DOI 10.1034/j.1600-0757.2000.2240107.x; Hamans EPPM, 2000, EUR ARCH OTO-RHINO-L, V257, P232, DOI 10.1007/s004050050229; Jokic R, 1998, AM J RESP CRIT CARE, V157, P1522, DOI 10.1164/ajrccm.157.5.9708070; Karimi M, 2015, SLEEP, V38, P341, DOI 10.5665/sleep.4486; KINDON H, 1995, GASTROENTEROLOGY, V109, P516, DOI 10.1016/0016-5085(95)90340-2; Kinoshita K, 2000, MOL CELL BIOL, V20, P4680, DOI 10.1128/MCB.20.13.4680-4690.2000; Kirkness JP, 2003, J APPL PHYSIOL, V95, P1761, DOI 10.1152/japplphysiol.00488.2003; Kirkness JP, 2003, J PHYSIOL-LONDON, V547, P603, DOI 10.1113/jphysiol.2002.031013; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Paulsen FP, 2002, AM J RESP CRIT CARE, V166, P501, DOI 10.1164/rccm.2109099; Paulsen FP, 2008, J BIOL CHEM, V283, P13418, DOI 10.1074/jbc.M800177200; Peker Y, 2002, AM J RESP CRIT CARE, V166, P159, DOI 10.1164/rccm.2105124; Peterson DE, 2009, J CLIN ONCOL, V27, P4333, DOI 10.1200/JCO.2008.21.2381; Poothrikovil Rajesh P, 2012, Sultan Qaboos Univ Med J, V12, P161; Posa A, 2013, ANN ANAT, V195, P137, DOI 10.1016/j.aanat.2012.10.001; Ramar K, 2015, J CLIN SLEEP MED, V11, P773, DOI 10.5664/jcsm.4858; Debata PR, 2007, BIOGERONTOLOGY, V8, P25, DOI 10.1007/s10522-006-9032-z; ROBIN IG, 1968, P ROY SOC MED, V61, P575, DOI 10.1177/003591576806100617; Rosler S, 2010, ARTHRITIS RHEUM-US, V62, P815, DOI 10.1002/art.27295; Samson MH, 2008, SCAND J CLIN LAB INV, V68, P369, DOI 10.1080/00365510701767862; Samson MH, 2011, CLIN CHEM LAB MED, V49, P861, DOI 10.1515/CCLM.2011.123; Sands BE, 1996, ANNU REV PHYSIOL, V58, P253, DOI 10.1146/annurev.ph.58.030196.001345; Schulze U, 2014, INVEST OPHTH VIS SCI, V55, P3037, DOI 10.1167/iovs.13-13423; Silva ED, 2000, J PATHOL, V190, P133; Storesund T, 2009, EUR J ORAL SCI, V117, P636, DOI 10.1111/j.1600-0722.2009.00679.x; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Thim L, 2002, EUR J CLIN INVEST, V32, P519, DOI 10.1046/j.1365-2362.2002.01014.x; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Traxdorf M, 2016, JOVE-J VIS EXP, DOI 10.3791/54739; Verey F, 2011, CLIN CHEM LAB MED, V49, P2051, DOI 10.1515/CCLM.2011.667; Wang YL, 2014, GENET MOL RES, V13, P8596, DOI 10.4238/2014.January.24.16; Wiede A, 1999, AM J RESP CRIT CARE, V159, P1330, DOI 10.1164/ajrccm.159.4.9804149; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	51	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0185200	10.1371/journal.pone.0185200	http://dx.doi.org/10.1371/journal.pone.0185200			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028798	gold, Green Submitted, Green Published			2022-12-26	WOS:000412980300009
J	Biasutti, S; Dart, A; Smith, M; Blaker, C; Clarke, E; Jeffcott, L; Little, C				Biasutti, Sara; Dart, Andrew; Smith, Margaret; Blaker, Carina; Clarke, Elizabeth; Jeffcott, Leo; Little, Christopher			Spatiotemporal variations in gene expression, histology and biomechanics in an ovine model of tendinopathy	PLOS ONE			English	Article							ACHILLES-TENDON RUPTURE; DIGITAL FLEXOR TENDINITIS; ROTATOR CUFF TENDONS; MESSENGER-RNA; MATRIX-METALLOPROTEINASE; COLLAGEN FIBRILLOGENESIS; TISSUE INHIBITORS; NATIONAL HUNT; FOLLOW-UP; INJURY	Flexor tendinopathy is a common problem affecting humans and animals. Tendon healing is poorly understood and the outcomes of conservative and surgical management are often suboptimal. While often considered a localized injury, recent evidence indicates that in the short term, tendinopathic changes are distributed widely throughout the tendon, remote from the lesion itself. Whether these changes persist throughout healing is unknown. The aim of this study was to document gene expression, histopathological and biomechanical changes that occur throughout the superficial digital flexor tendon (SDFT) up to 16 weeks post-injury, using an ovine surgical model of tendinopathy. Partial tendon transection was associated with decreased gene expression for aggrecan, decorin, fibromodulin, tissue inhibitors of metalloproteinases (TIMPS 1, 2 and 3), collagen I and collagen II. Gene expression for collagen III, lumican and matrix metalloproteinase 13 (MMP13) increased locally around the lesion site. Expression of collagen III and MMP13 decreased with time, but compared to controls, collagen III, MMP13 and lumican expression remained regionally high throughout the study. An increase in TIMP3 was observed over time. Histologically, operated tendons had higher pathology scores than controls, especially around the injured region. A chondroid phenotype was observed with increased cellular rounding and marked proteoglycan accumulation which only partially improved with time. Biomechanically, partial tendon transection resulted in a localized decrease in elastic modulus (in compression) but only at 8 weeks postoperatively. This study improves our understanding of tendon healing, demonstrating an early 'peak' in pathology characterized by altered gene expression and notable histopathological changes. Many of these pathological changes become more localized to the region of injury during healing. Collagen III and MMP13 expression levels remained high close to the lesion throughout the study and may reflect the production of tendon tissue with suboptimal biomechanical properties. Further studies evaluating the longterm response of tendon to injury (6-12 months) are warranted to provide additional information on tendon healing and provide further understanding of the mechanisms underlying the pathology observed in this study.	[Biasutti, Sara; Dart, Andrew; Jeffcott, Leo] Univ Sydney, Res & Clin Training Unit, Univ Vet Teaching Hosp, Camden, NSW, Australia; [Smith, Margaret; Little, Christopher] Univ Sydney, Raymond Purves Bone & Joint Res Lab, Kolling Inst, Sydney Med Sch, Sydney, NSW, Australia; [Smith, Margaret; Blaker, Carina; Clarke, Elizabeth; Little, Christopher] Royal North Shore Hosp, Inst Bone & Joint Res, Sydney, NSW, Australia; [Blaker, Carina; Clarke, Elizabeth] Univ Sydney, Murray Maxwell Biomech Lab, Kolling Inst, Sydney Med Sch, Sydney, NSW, Australia	University of Sydney; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney; University of Sydney; Kolling Institute of Medical Research	Biasutti, S (corresponding author), Univ Sydney, Res & Clin Training Unit, Univ Vet Teaching Hosp, Camden, NSW, Australia.	sara.biasutti@sydney.edu.au	Clarke, Elizabeth C/H-3274-2014; Smith, Margaret/E-9633-2010; little, christopher/A-9280-2015; Jeffcott, Leo/S-8887-2017	Clarke, Elizabeth C/0000-0003-2500-5222; Smith, Margaret/0000-0002-2020-0056; little, christopher/0000-0002-0353-7634; Jeffcott, Leo/0000-0002-2855-6946; Blaker, Carina/0000-0003-2264-6702				Albers IS, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0885-2; Alfredson H, 2014, BRIT J SPORT MED, V48, P1421, DOI 10.1136/bjsports-2012-091399; AnandApte B, 1997, INVEST OPHTH VIS SCI, V38, P817; Andersson G, 2011, BRIT J SPORT MED, V45, P399, DOI 10.1136/bjsm.2009.068122; Archambault JM, 2007, J ORTHOP RES, V25, P617, DOI 10.1002/jor.20347; Arnoczky SP, 2007, AM J SPORT MED, V35, P763, DOI 10.1177/0363546506296043; Aroen A, 2004, SCAND J MED SCI SPOR, V14, P30, DOI 10.1111/j.1600-0838.2004.00344.x; ASTROM M, 1995, CLIN ORTHOP RELAT R, P151; Avella CS, 2009, EQUINE VET J, V41, P449, DOI 10.2746/042516409X391042; Ayers Duncan, 2007, BMC Vet Res, V3, P7; Benjamin M., 2004, SOFT TISSUE RHEUMATO; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Cadby JA, 2013, EQUINE VET J, V45, P642, DOI 10.1111/evj.12035; Chakravarti S, 2002, GLYCOCONJUGATE J, V19, P287, DOI 10.1023/A:1025348417078; Chen J, 2011, INVEST OPHTH VIS SCI, V52, P8957, DOI 10.1167/iovs.11-8078; Cho NS, 2011, CLIN ORTHOP RELAT R, V469, P3172, DOI 10.1007/s11999-011-2000-1; Choi RK, 2016, J BIOMECH, V49, P2694, DOI 10.1016/j.jbiomech.2016.06.006; Corps AN, 2012, ANN RHEUM DIS, V71, P746, DOI 10.1136/annrheumdis-2011-200391; Crevier-Denoix N, 1997, Equine Vet J Suppl, P23; Dahlgren LA, 2005, AM J VET RES, V66, P266, DOI 10.2460/ajvr.2005.66.266; Dakin SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032333; De Jonge S, 2014, SCAND J MED SCI SPOR, V24, P773, DOI 10.1111/sms.12072; de Jonge S, 2011, BRIT J SPORT MED, V45, P1026, DOI 10.1136/bjsports-2011-090342; de Mos M, 2007, AM J SPORT MED, V35, P1549, DOI 10.1177/0363546507301885; de Mos M, 2009, AM J SPORT MED, V37, P1214, DOI 10.1177/0363546508331137; Docking SI, 2015, J SCI MED SPORT, V18, P383, DOI 10.1016/j.jsams.2014.06.004; Dyson SJ, 2004, EQUINE VET J, V36, P415, DOI 10.2746/0425164044868422; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Fu SC, 2002, ACTA ORTHOP SCAND, V73, P658, DOI 10.3109/17453670209178031; Gajhede-Knudsen M, 2013, BRIT J SPORT MED, V47, P763, DOI 10.1136/bjsports-2013-092271; Gardner K, 2012, J ORTHOP RES, V30, P1695, DOI 10.1002/jor.22131; Gardner K, 2008, DISABIL REHABIL, V30, P1523, DOI 10.1080/09638280701785395; GELBERMAN R H, 1984, Journal of Orthopaedic Research, V2, P39, DOI 10.1002/jor.1100020107; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; Genovese R. L., 1996, The equine athlete: tendon, ligament and soft tissue injuries. Proceedings Dubai International Equine Symposium 27-30 March, 1996., P187; GENOVESE RL, 1987, COMP CONT EDUC PRACT, V9, P945; Hashimoto T, 2003, CLIN ORTHOP RELAT R, P111, DOI 10.1097/01/blo.0000092974.12414.22; Hosaka Y, 2005, CONNECT TISSUE RES, V46, P9, DOI 10.1080/03008200590935510; Hosaka YZ, 2010, BIOMED RES-TOKYO, V31, P35, DOI 10.2220/biomedres.31.35; Ireland D, 2001, MATRIX BIOL, V20, P159, DOI 10.1016/S0945-053X(01)00128-7; Jacobsen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122220; Jarvinen Tero A H, 2005, Foot Ankle Clin, V10, P255, DOI 10.1016/j.fcl.2005.01.013; Jelinsky SA, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-86; John T, 2010, J ORTHOP RES, V28, P1071, DOI 10.1002/jor.21079; Jones GC, 2006, ARTHRITIS RHEUM-US, V54, P832, DOI 10.1002/art.21672; Juneja SC, 2013, ARTHRITIS, DOI 10.1155/2013/154812; Kajikawa Y, 2007, J CELL PHYSIOL, V210, P684, DOI 10.1002/jcp.20876; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Karousou E, 2008, CLIN ORTHOP RELAT R, V466, P1577, DOI 10.1007/s11999-008-0255-y; Kasashima Y, 2004, EQUINE VET J, V36, P346, DOI 10.2746/0425164044890580; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0; Kujala UM, 2005, CLIN J SPORT MED, V15, P133, DOI 10.1097/01.jsm.0000165347.55638.23; KVIST M, 1994, SPORTS MED, V18, P173, DOI 10.2165/00007256-199418030-00004; LAPIERE C M, 1977, Connective Tissue Research, V5, P21; Lavagnino M, 2006, J BIOMECH, V39, P2355, DOI 10.1016/j.jbiomech.2005.08.008; Le Graverand MPH, 2000, MATRIX BIOL, V19, P431, DOI 10.1016/S0945-053X(00)00093-7; Lee KKH, 2003, CELLS TISSUES ORGANS, V173, P138, DOI 10.1159/000069473; Leppilahti J, 1998, SPORTS MED, V25, P79, DOI 10.2165/00007256-199825020-00002; Leppilahti J, 1996, ACTA ORTHOP SCAND, V67, P277, DOI 10.3109/17453679608994688; Lo IKY, 2004, AM J SPORT MED, V32, P1223, DOI 10.1177/0363546503262200; Longo UG, 2009, SPORTS MED ARTHROSC, V17, P112, DOI 10.1097/JSA.0b013e3181a3d625; Longo UG, 2008, DISABIL REHABIL, V30, P1709, DOI 10.1080/09638280701786922; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Lui PPY, 2010, RHEUMATOLOGY, V49, P231, DOI 10.1093/rheumatology/kep384; Lui PPY, 2009, J HISTOCHEM CYTOCHEM, V57, P91, DOI 10.1369/jhc.2008.952143; Lynch HA, 2003, J BIOMECH ENG-T ASME, V125, P726, DOI 10.1115/1.1614819; Maffulli N, 1999, CLIN J SPORT MED, V9, P157, DOI 10.1097/00042752-199907000-00007; MARR CM, 1993, VET REC, V132, P476, DOI 10.1136/vr.132.19.476; McCurdy R.D., 2008, GENE THER MOL BIOL, V12, P15; Moller A, 1996, ACTA ORTHOP SCAND, V67, P479, DOI 10.3109/17453679608996672; Monfort J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1873; Nakamura N, 2000, J ORTHOPAED RES, V18, P517, DOI 10.1002/jor.1100180402; Nomura M, 2007, J VET MED SCI, V69, P637, DOI 10.1292/jvms.69.637; O'Brien EJO, 2013, J ORTHOP RES, V31, P1520, DOI 10.1002/jor.22404; O'Meara B, 2010, EQUINE VET J, V42, P322, DOI 10.1111/j.2042-3306.2009.00021.x; Oakes B.W., 2003, REHABILITATION SPORT, P56; Ohberg L, 2001, KNEE SURG SPORT TR A, V9, P233, DOI 10.1007/s001670000189; Orchard J, 2008, CLIN ORTHOP RELAT R, V466, P1625, DOI 10.1007/s11999-008-0254-z; Paavola M, 2000, AM J SPORT MED, V28, P634, DOI 10.1177/03635465000280050301; Rees JD, 2009, AM J SPORT MED, V37, P1855, DOI 10.1177/0363546508324283; Riley GP, 2005, SCAND J MED SCI SPOR, V15, P241, DOI 10.1111/j.1600-0838.2005.00456.x; RILEY GP, 1994, ANN RHEUM DIS, V53, P359, DOI 10.1136/ard.53.6.359; Schramme M, 2010, VET COMP ORTHOPAED, V23, P231, DOI 10.3415/VCOT-09-10-0106; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Smith MM, 2008, ARTHRITIS RHEUM-US, V58, P1055, DOI 10.1002/art.23388; Soslowsky L. J., 1999, J SHOULDER ELB SURG, V9, P2000, DOI DOI 10.1067/MSE.2000.101962; Strom AC, 2009, FOOT ANKLE CLIN, V14, P773, DOI 10.1016/j.fcl.2009.08.003; Svensson L, J BIOL CHEM; Tallon C, 2001, MED SCI SPORT EXER, V33, P1983, DOI 10.1097/00005768-200112000-00002; Thornton GM, 2010, BRIT J SPORT MED, V44, P698, DOI 10.1136/bjsm.2008.050575; Tol Johannes L, 2012, Knee Surg Sports Traumatol Arthrosc, V20, P1891; Watts AE, 2012, EQUINE VET J, V44, P576, DOI 10.1111/j.2042-3306.2011.00471.x; Wilkins R, 2012, AM J SPORT MED, V40, P2154, DOI 10.1177/0363546512453293; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	96	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185282	10.1371/journal.pone.0185282	http://dx.doi.org/10.1371/journal.pone.0185282			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023489	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100016
J	Vulfius, CA; Kasheverov, IE; Kryukova, EV; Spirova, EN; Shelukhina, IV; Starkov, VG; Andreeva, TV; Faure, G; Zouridakis, M; Tsetlin, VI; Utkin, YN				Vulfius, Catherine A.; Kasheverov, Igor E.; Kryukova, Elena V.; Spirova, Ekaterina N.; Shelukhina, Irina V.; Starkov, Vladislav G.; Andreeva, Tatyana V.; Faure, Grazyna; Zouridakis, Marios; Tsetlin, Victor I.; Utkin, Yuri N.			Pancreatic and snake venom presynaptically active phospholipases A(2) inhibit nicotinic acetylcholine receptors	PLOS ONE			English	Article							LYMNAEA-STAGNALIS NEURONS; BINDING-SITES; BETA-BUNGAROTOXIN; MEMBRANE-BINDING; ALPHA-CONOTOXIN; NEUROTOXIN-II; CROTOXIN; ENZYMES; PROTEIN; IDENTIFICATION	Phospholipases A(2) (PLA(2)s) are enzymes found throughout the animal kingdom. They hydrolyze phospholipids in the sn-2 position producing lysophospholipids and unsaturated fatty acids, agents that can damage membranes. PLA(2)s from snake venoms have numerous toxic effects, not all of which can be explained by phospholipid hydrolysis, and each enzyme has a specific effect. We have earlier demonstrated the capability of several snake venom PLA(2)s with different enzymatic, cytotoxic, anticoagulant and antiproliferative properties, to decrease acetylcholine-induced currents in Lymnaea stagnalis neurons, and to compete with alpha-bungarotoxin for binding to nicotinic acetylcholine receptors (nAChRs) and acetylcholine binding protein. Since nAChRs are implicated in postsynaptic and presynaptic activities, in this work we probe those PLA(2)s known to have strong presynaptic effects, namely beta-bungarotoxin from Bungarus multicinctus and crotoxin from Crotalus durissus terrificus. We also wished to explore whether mammalian PLA(2)s interact with nAChRs, and have examined non-toxic PLA(2) from porcine pancreas. It was found that porcine pancreatic PLA(2) and presynaptic beta-bungarotoxin blocked currents mediated by nAChRs in Lymnaea neurons with IC(50)s of 2.5 and 4.8 mu M, respectively. Crotoxin competed with radioactive alpha-bungarotoxin for binding to Torpedo and human alpha 7 nAChRs and to the acetylcholine binding protein. Pancreatic PLA(2) interacted similarly with these targets; moreover, it inhibited radioactive alpha-bungarotoxin binding to the water-soluble extracellular domain of human alpha 9 nAChR, and blocked acetylcholine induced currents in human alpha 9 alpha 10 nAChRs heterologously expressed in Xenopus oocytes. These and our earlier results show that all snake PLA(2)s, including presynaptically active crotoxin and beta-bungarotoxin, as well as mammalian pancreatic PLA(2), interact with nAChRs. The data obtained suggest that this interaction may be a general property of all PLA(2)s, which should be proved by further experiments.	[Vulfius, Catherine A.] Russian Acad Sci, Inst Cell Biophys, Pushchino, Moscow Region, Russia; [Kasheverov, Igor E.; Kryukova, Elena V.; Spirova, Ekaterina N.; Shelukhina, Irina V.; Starkov, Vladislav G.; Andreeva, Tatyana V.; Tsetlin, Victor I.; Utkin, Yuri N.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Faure, Grazyna] Inst Pasteur, Unite Recepteurs Canaux, Paris, France; [Zouridakis, Marios] Hellenic Pasteur Inst, Athens, Greece	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Utkin, YN (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	utkin@mx.ibch.ru	Utkin, Yuri/L-2952-2019; Shelukhina, Irina/AHE-5496-2022; Tsetlin, Victor/X-2491-2018	Utkin, Yuri/0000-0002-4609-970X; Shelukhina, Irina/0000-0003-3476-1441; Zouridakis, Marios/0000-0001-9760-1838	Russian Foundation for Basic Research [15-04-01843]; Russian Federation [6216.2016.4]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation)	This work was supported by a grant of Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/eng) No. 15-04-01843 to YU; Grant of the President of the Russian Federation (https://grants.extech.ru/) No. -6216.2016.4 to IS.	BENJAMIN PR, 1972, Z ZELLFORSCH MIK ANA, V128, P564, DOI 10.1007/BF00306989; BON C, 1979, EUR J BIOCHEM, V99, P471, DOI 10.1111/j.1432-1033.1979.tb13278.x; Brazil OV, 2000, J NAT TOXINS, V9, P33; Casais-e-Silva LL, 2016, TOXICOL LETT, V257, P60, DOI 10.1016/j.toxlet.2016.06.005; CHANG CC, 1977, N-S ARCH PHARMACOL, V296, P159, DOI 10.1007/BF00508469; CHEMERIS NK, 1982, J PHYSIOL-LONDON, V323, P1; Copic A, 1999, J BIOL CHEM, V274, P26315, DOI 10.1074/jbc.274.37.26315; Cupillard L, 1999, J BIOL CHEM, V274, P7043, DOI 10.1074/jbc.274.11.7043; daCosta CJB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9057; Del Bufalo A, 2014, CURR PHARM DESIGN, V20, P6042; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Du QS, 2016, TOXICON, V111, P37, DOI 10.1016/j.toxicon.2015.12.017; FAURE G, 1988, BIOCHEMISTRY-US, V27, P730, DOI 10.1021/bi00402a036; Faure G, 2011, J MOL BIOL, V412, P176, DOI 10.1016/j.jmb.2011.07.027; Gaydukov AE, 2014, ACTA NATURAE, V6, P110, DOI 10.32607/20758251-2014-6-4-110-115; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; KOSTYUK PG, 1981, J NEUROSCI METH, V4, P201, DOI 10.1016/0165-0270(81)90032-7; KREIENKAMP HJ, 1992, BIOCHEMISTRY-US, V31, P8239, DOI 10.1021/bi00150a017; Krizaj I, 1997, BIOCHEMISTRY-US, V36, P2779, DOI 10.1021/bi9612374; Krizaj I, 2011, TOXICON, V58, P219, DOI 10.1016/j.toxicon.2011.06.009; Kudryavtsev DS, 2015, J BIOL CHEM, V290, P22747, DOI 10.1074/jbc.M115.648824; KWONG PD, 1995, STRUCTURE, V3, P1109, DOI 10.1016/S0969-2126(01)00246-5; LAMBEAU G, 1990, J BIOL CHEM, V265, P9526; LAMBEAU G, 1989, J BIOL CHEM, V264, P11503; Lesovoy DM, 2009, BIOPHYS J, V97, P2089, DOI 10.1016/j.bpj.2009.07.037; Li D, 2016, TOXINS, V8, DOI 10.3390/toxins8010027; Ma MT, 2010, J CHEM NEUROANAT, V39, P242, DOI 10.1016/j.jchemneu.2010.02.002; Montecucco C, 2009, TOXICON, V54, P561, DOI 10.1016/j.toxicon.2008.12.012; Murakami M, 2013, BIOCHIMIE, V95, P43, DOI 10.1016/j.biochi.2012.09.007; Prasarnpun S, 2004, NEUROPHARMACOLOGY, V47, P304, DOI 10.1016/j.neuropharm.2004.04.012; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; Rigoni M, 2007, J BIOL CHEM, V282, P11238, DOI 10.1074/jbc.M610176200; Romero HK, 2017, P NATL ACAD SCI USA, V114, pE1825, DOI 10.1073/pnas.1621433114; Sampaio SC, 2010, TOXICON, V55, P1045, DOI 10.1016/j.toxicon.2010.01.011; Shenkarev ZO, 2014, ACTA NATURAE, V6, P84, DOI 10.32607/20758251-2014-6-2-84-94; Simonson PD, 2010, BIOPHYS J, V99, pL81, DOI 10.1016/j.bpj.2010.08.076; Subramanian M, 1998, BIOCHEMISTRY-US, V37, P1394, DOI 10.1021/bi9716581; Sundlass NK, 2013, BIOCHEMISTRY-US, V52, P6304, DOI 10.1021/bi400619m; UTKIN YN, 1994, TOXICON, V32, P1153, DOI 10.1016/0041-0101(94)90399-9; Utkin YN, 2015, DOKL BIOCHEM BIOPHYS, V460, P53, DOI 10.1134/S1607672915010159; Vulfius CA, 2005, NEUROSCI LETT, V373, P232, DOI 10.1016/j.neulet.2004.10.010; Vulfius CA, 2001, NEUROSCI LETT, V309, P189, DOI 10.1016/S0304-3940(01)02081-X; Vulfius CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115428; Vulfius CA, 2011, TOXICON, V57, P787, DOI 10.1016/j.toxicon.2011.02.013; Zouridakis M, 2014, NAT STRUCT MOL BIOL, V21, P976, DOI 10.1038/nsmb.2900	45	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186206	10.1371/journal.pone.0186206	http://dx.doi.org/10.1371/journal.pone.0186206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023569	Green Submitted, gold, Green Published			2022-12-26	WOS:000412845100080
J	Billard, MN; De Serres, G; Gariepy, MC; Boulianne, N; Toth, E; Landry, M; Skowronski, DM				Billard, Marie-Noelle; De Serres, Gaston; Gariepy, Marie-Claude; Boulianne, Nicole; Toth, Eveline; Landry, Monique; Skowronski, Danuta M.			Prevalence of risk factors for acquiring measles during the 2011 outbreak in Quebec and impact of the province-wide school-based vaccination campaign on population immunity	PLOS ONE			English	Article								Background A large measles outbreak occurred in Quebec, Canada, in 2011. Although nearly two-thirds of the cases occurred in only two health districts, a mass vaccination campaign targeting all Quebec elementary and high school students without valid two-dose history was undertaken to prevent future outbreaks. We compared rates of non-vaccination and age at first measles vaccine dose among students in the two most-affected districts and the rest of the province and estimated the improvement in overall student measles immunity due to the mass school-based vaccination campaign. Methods Data were extracted from the provincial vaccination registry for students in kindergarten to grade 11 during the 2011/2012 school year. A telephone survey was conducted in three sub-groups: students whose first measles vaccine dose recorded in the vaccination registry was received during the 2011 school vaccination campaign; students with no dose recorded in the registry whose parents refused receipt during the school campaign; and students with no dose recorded in the registry and no information about parental consent/refusal during the school campaign. Results Neither the prevalence of being non-vaccinated nor a younger age at first pediatric dose were higher in the two most-affected districts versus the rest of the province. The school campaign vaccinated nearly 8% of all students including 7% who previously received at least one dose. Before the outbreak, 3% of students were not vaccinated and one-third of these (1%/3%) were vaccinated during the campaign. The campaign likely increased the absolute school population immunity by just 1.7%. Conclusion The concentration of measles cases in the two most-affected health districts during the large Quebec outbreak is not explained by more students who were unvaccinated or who had received their first vaccine dose at a younger age. The vaccination campaign reached one-third of unvaccinated students and only marginally improved population immunity.	[Billard, Marie-Noelle; De Serres, Gaston; Gariepy, Marie-Claude; Boulianne, Nicole] Univ Laval, CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [De Serres, Gaston; Boulianne, Nicole] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Toth, Eveline; Landry, Monique] Minist Sante & Serv Sociaux Quebec, Montreal, PQ, Canada; [Skowronski, Danuta M.] British Columbia Ctr Dis Control, Vancouver, BC, Canada	Laval University; Institut national de sante publique du Quebec (INSPQ)	De Serres, G (corresponding author), Univ Laval, CHU Quebec, Ctr Rech, Quebec City, PQ, Canada.; De Serres, G (corresponding author), Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada.	gaston.deserres@inspq.qc.ca		De Serres, Gaston/0000-0002-1592-5167	Quebec Ministry of Health (Ministere de la Sante et des Services Sociaux de Quebec)	Quebec Ministry of Health (Ministere de la Sante et des Services Sociaux de Quebec)	This work was supported by the Quebec Ministry of Health (Ministere de la Sante et des Services Sociaux de Quebec). The Quebec Ministry of Health provided the database and participated to the preparation of the manuscript.	Auger D., 2013, OPERATION VACCINATIO; Boulianne N., 2015, ENQUETE COUVERTURE V; Boulianne N., 2010, ENQUETE COUVERTURE V; Boulianne N., 2013, 2 ANS QUEBEC 2012 I; Boulianne N, 2007, ENQUETE COUVERTURE V; Boulianne N, 2011, ENQUETE COUVERTURE V; De Serres G, 2013, J INFECT DIS, V207, P990, DOI 10.1093/infdis/jis923; De Serres G, 2012, CLIN INFECT DIS, V55, P394, DOI 10.1093/cid/cis439; Moss WJ, 2017, LANCET; Statistics Canada, 2013, GROUPS SEX POP PRIV	10	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186070	10.1371/journal.pone.0186070	http://dx.doi.org/10.1371/journal.pone.0186070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020069	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400064
J	Giezen, H; Stevens, M; van den Akker-Scheek, I; Reininga, IHF				Giezen, Hilde; Stevens, Martin; van den Akker-Scheek, Inge; Reininga, Inge H. F.			Validity and reliability of the Dutch version of the Copenhagen Hip And Groin Outcome Score (HAGOS-NL) in patients with hip pathology	PLOS ONE			English	Article							QUALITY-OF-LIFE; INTERNATIONAL HIP; HEALTH SURVEY; VALIDATION; DISABILITY; RESPONSIVENESS; COSMIN; SF-36; AGREEMENT; DISEASE	Background and objectives The Copenhagen Hip And Groin Outcome Score (HAGOS) was developed to assess disease- specific consequences in young to middle-aged, physically active hip and/or groin patients. The study aimed to determine validity and reliability of the Dutch version of the HAGOS (HAGOS-NL) for middle-aged patients with hip complaints. Design and methods To assess validity, 117 participants completed five questionnaires: HAGOS-NL, international Hip Outcome Tool (iHOT-12NL), Hip disability and Osteoarthritis Outcome Score (HOOS), RAND-36 Health Survey and Tegner activity scale. Structural validity was determined by conducting confirmatory factor analysis. Construct validity was analyzed by formulating predefined hypotheses regarding relationships between the HAGOS-NL and subscales of the iHOT-12NL, HOOS, RAND-36 and Tegner activity scale. The HAGOS-NL was filled out again by 67 patients to explore test-retest reliability. Reliability was assessed in terms of Cronbach's alpha, Intraclass Correlation Coefficient (ICC), Standard Error of Measurement (SEM) and Minimal Detectable Change (MDC). The Bland and Altman method was used to explore absolute agreement. Results Factor analysis confirmed that the HAGOS-NL consists of six subscales. All hypotheses were confirmed, indicating good construct validity. Internal consistency was good, with Cronbach's alpha values ranging from 0.89 to 0.98. Test-retest reliability was considered good, with ICC values of 0.80 and higher. The SEM ranged from 6.6 to 12.3, and MDC at individual level from 18.3 to 34.1 and at group level from 2.3 to 4.4. Bland and Altman analyses showed no bias. Conclusion The HAGOS-NL is a reliable and valid instrument for measuring pain, physical functioning and quality of life in middle-aged patients with hip complaints.	[Giezen, Hilde; Stevens, Martin; van den Akker-Scheek, Inge] Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands; [Reininga, Inge H. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Trauma Surg, Groningen, Netherlands; [Reininga, Inge H. F.] Martini Hosp Groningen, Dept Orthoped, Groningen, Netherlands	University of Groningen; University of Groningen; Martini Hospital	Stevens, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands.	m.stevens@umcg.nl	Reininga, Inge H.F./H-4250-2013; Stevens, Martin/A-5196-2013	Reininga, Inge H.F./0000-0003-1341-845X; Stevens, Martin/0000-0001-8183-6894; van den Akker-Scheek, Inge/0000-0002-1614-8419				Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Anokye NK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-624; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brans E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148119; de Groot IB, 2007, OSTEOARTHR CARTILAGE, V15, P104, DOI 10.1016/j.joca.2006.06.014; de Vet HCW, 2001, INT J TECHNOL ASSESS, V17, P479, DOI 10.1017/S0266462301107038; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Domholdt E., 2000, PHYS THERAPY RES PRI, V2nd ed.; Griffin DR, 2012, ARTHROSCOPY, V28, P611, DOI 10.1016/j.arthro.2012.02.027; Huch K, 2005, ANN RHEUM DIS, V64, P1715, DOI 10.1136/ard.2004.033266; McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Mohtadi NGH, 2012, ARTHROSCOPY, V28, P595, DOI 10.1016/j.arthro.2012.03.013; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Nilsdotter AK, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-10; Picavet HSJ, 2004, ANN RHEUM DIS, V63, P723, DOI 10.1136/ard.2003.010769; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; PICAVET HSJ, 2000, KLACHTEN BEWEGINGSAP; Slagers AJ, 2017, J SPORT SCI, V35, P393, DOI 10.1080/02640414.2016.1167230; Stevens M, 2015, J ORTHOP SPORT PHYS, V45, P1026, DOI 10.2519/jospt.2015.6178; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Thomee R, 2014, KNEE SURG SPORT TR A, V22, P835, DOI 10.1007/s00167-013-2721-7; Thorborg K, 2011, BRIT J SPORT MED, V45, P478, DOI 10.1136/bjsm.2010.080937; Thorborg K, 2010, BRIT J SPORT MED, V44, P1186, DOI 10.1136/bjsm.2009.060889; Thorborg K, 2015, BR J SPORTS MED; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186064	10.1371/journal.pone.0186064	http://dx.doi.org/10.1371/journal.pone.0186064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020040	gold, Green Published, Green Submitted			2022-12-26	WOS:000412754400062
J	Schlachetzki, JCM; Barth, J; Marxreiter, F; Gossler, J; Kohl, Z; Reinfelder, S; Gassner, H; Aminian, K; Eskofier, BM; Winkler, J; Klucken, J				Schlachetzki, Johannes C. M.; Barth, Jens; Marxreiter, Franz; Gossler, Julia; Kohl, Zacharias; Reinfelder, Samuel; Gassner, Heiko; Aminian, Kamiar; Eskofier, Bjoern M.; Winkler, Juergen; Klucken, Jochen			Wearable sensors objectively measure gait parameters in Parkinson's disease	PLOS ONE			English	Article							CLINICAL VIEW; VARIABILITY; SCALE; TECHNOLOGIES; RHYTHMICITY; RELIABILITY; DISABILITY; STABILITY; DYNAMICS; MOBILITY	Distinct gait characteristics like short steps and shuffling gait are prototypical signs commonly observed in Parkinson's disease. Routinely assessed by observation through clinicians, gait is rated as part of categorical clinical scores. There is an increasing need to provide quantitative measurements of gait, e.g. to provide detailed information about disease progression. Recently, we developed a wearable sensor-based gait analysis system as diagnostic tool that objectively assesses gait parameter in Parkinson's disease without the need of having a specialized gait laboratory. This system consists of inertial sensor units attached laterally to both shoes. The computed target of measures are spatiotemporal gait parameters including stride length and time, stance phase time, heel-strike and toe-off angle, toe clearance, and inter-stride variation from gait sequences. To translate this prototype into medical care, we conducted a cross-sectional study including 190 Parkinson's disease patients and 101 age-matched controls and measured gait characteristics during a 4x10 meter walk at the subjects' preferred speed. To determine intraindividual changes in gait, we monitored the gait characteristics of 63 patients longitudinally. Cross-sectional analysis revealed distinct spatiotemporal gait parameter differences reflecting typical Parkinson's disease gait characteristics including short steps, shuffling gait, and postural instability specific for different disease stages and levels of motor impairment. The longitudinal analysis revealed that gait parameters were sensitive to changes by mirroring the progressive nature of Parkinson's disease and corresponded to physician ratings. Taken together, we successfully show that wearable sensor-based gait analysis reaches clinical applicability providing a high biomechanical resolution for gait impairment in Parkinson's disease. These data demonstrate the feasibility and applicability of objective wearable sensor-based gait measurement in Parkinson's disease reaching high technological readiness levels for both, large scale clinical studies and individual patient care.	[Schlachetzki, Johannes C. M.; Barth, Jens; Marxreiter, Franz; Gossler, Julia; Kohl, Zacharias; Gassner, Heiko; Winkler, Juergen; Klucken, Jochen] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Hosp Erlangen, Dept Mol Neurol, Erlangen, Germany; [Barth, Jens; Reinfelder, Samuel; Eskofier, Bjoern M.] FAU Erlangen Nurnberg, Dept Comp Sci, Pattern Recognit Lab, Digital Sports Grp, Erlangen, Germany; [Barth, Jens] ASTRUM IT GmbH, Wolfsmantel 2, Erlangen, Germany; [Aminian, Kamiar] Ecole Polytech Fed Lausanne, Lab Movement Anal & Measurement, Stn 11, Lausanne, Switzerland	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Klucken, J (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Hosp Erlangen, Dept Mol Neurol, Erlangen, Germany.	jochen.klucken@uk-erlangen.de	Marxreiter, Franz/ABB-6982-2020; Eskofier, Bjoern/ABF-1284-2021	Marxreiter, Franz/0000-0002-5187-4344; Eskofier, Bjoern/0000-0002-0417-0336; Klucken, Jochen/0000-0001-6645-9437; Gassner, Heiko/0000-0003-2037-9460; Schlachetzki, Johannes/0000-0002-7801-9743; Winkler, Jurgen/0000-0003-0630-9204	Bavarian Research Foundation [AZ-974-11]; Emerging Fields Initiative (EFI Moves), Friedrich-Alexander University (FAU) Erlangen-Nurnberg; ASTRUM IT GmbH	Bavarian Research Foundation; Emerging Fields Initiative (EFI Moves), Friedrich-Alexander University (FAU) Erlangen-Nurnberg; ASTRUM IT GmbH	This research study was funded by the Bavarian Research Foundation (AZ-974-11) and the Emerging Fields Initiative (EFI Moves), Friedrich-Alexander University (FAU) Erlangen-Nurnberg. ASTRUM IT GmbH provided support in the form of salary for the thesis project of author J. B., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bjoern M Eskofier reports grants outside the submitted work from Bosch GmbH and Adidas Sport GmbH. Zacharias Kohl reports personal fees outside the submitted work from UCB Pharma GmbH, Actelion Pharmaceuticals, Desitin Arzneimittel GmbH, Ipsen Pharma. Jurgen Winkler reports personal fees outside of the submitted work from Abbvie GmbH & Co. KG. Jochen Klucken reports personal fees outside the submitted work from Teva GmbH, Licher MT GmbH, UCB Pharma GmbH, Ever Pharma GmbH, Desitin Arzneimittel GmbH, Abbvie GmbH & Co. KG, Biogen GmbH, GlaxoSmithKline GmbH & Co. KG. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2013, HORIZON 2020 WORK PR; Baltadjieva R, 2006, EUR J NEUROSCI, V24, P1815, DOI 10.1111/j.1460-9568.2006.05033.x; Barth J, 2015, SENSORS-BASEL, V15, P6419, DOI 10.3390/s150306419; Barth J, 2013, IEEE ENG MED BIO, P6744, DOI 10.1109/EMBC.2013.6611104; BLIN O, 1990, J NEUROL SCI, V98, P91, DOI 10.1016/0022-510X(90)90184-O; Brach JS, 2007, J GERONTOL A-BIOL, V62, P983, DOI 10.1093/gerona/62.9.983; Del Din S, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0154-5; Dewey DC, 2014, J NEUROL SCI, V345, P131, DOI 10.1016/j.jns.2014.07.026; Ebersbach G, 1999, MOVEMENT DISORD, V14, P619, DOI 10.1002/1531-8257(199907)14:4<619::AID-MDS1011>3.0.CO;2-X; Ellis T, 2011, PARKINSONISM RELAT D, V17, P693, DOI 10.1016/j.parkreldis.2011.07.004; Espay AJ, 2016, MOVEMENT DISORD, V31, P1272, DOI 10.1002/mds.26642; Galna B, 2015, MOVEMENT DISORD, V30, P359, DOI 10.1002/mds.26110; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Grieve D.W., 1968, BIOMED ENG, V3, P119; Hass CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042337; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Heldman DA, 2011, MOVEMENT DISORD, V26, P1859, DOI 10.1002/mds.23740; Henderson EJ, 2016, LANCET NEUROL, V15, P249, DOI 10.1016/S1474-4422(15)00389-0; Hobert MA, 2014, ACTA NEUROL SCAND, V130, P139, DOI 10.1111/ane.12248; HOF AL, 1996, GAIT POSTURE, V4, P222; Horak FB, 2013, MOVEMENT DISORD, V28, P1544, DOI 10.1002/mds.25684; Kanzler CM, 2016, IEEE ENG MED BIO, P4979, DOI 10.1109/EMBC.2016.7591845; Kanzler CM, 2015, IEEE ENG MED BIO, P5424, DOI 10.1109/EMBC.2015.7319618; Klucken J, 2015, IEEE J BIOMED HEALTH, V19, P1775, DOI 10.1109/JBHI.2015.2488158; Klucken J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056956; KLUGE F, 2017, SENSORS BASEL, V17, P57587, DOI DOI 10.3390/S17071522; Lindemann U, 2008, GAIT POSTURE, V27, P91, DOI 10.1016/j.gaitpost.2007.02.005; Maetzler W, 2016, MOVEMENT DISORD, V31, P1263, DOI 10.1002/mds.26673; Maetzler W, 2013, MOVEMENT DISORD, V28, P1628, DOI 10.1002/mds.25628; Mancini M, 2015, NEUROREHABILITATION, V37, P3, DOI 10.3233/NRE-151236; Mariani B, 2013, IEEE T BIO-MED ENG, V60, P155, DOI 10.1109/TBME.2012.2227317; Mariani B, 2012, IEEE T BIO-MED ENG, V59, P3162, DOI 10.1109/TBME.2012.2216263; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; Mirelman A, 2015, JAMA-J AM MED ASSOC, V314, P873, DOI 10.1001/jama.2015.8530; MORRIS ME, 1994, BRAIN, V117, P1169, DOI 10.1093/brain/117.5.1169; Najafi B, 2011, IEEE ENG MED BIO, P6507, DOI 10.1109/IEMBS.2011.6091605; Pasluosta CF, 2015, IEEE J BIOMED HEALTH, V19, P1873, DOI 10.1109/JBHI.2015.2461555; Rampp A, 2014, IEEE T BIOMEDICAL EN; Rampp A, 2015, IEEE T BIO-MED ENG, V62, P1089, DOI 10.1109/TBME.2014.2368211; RICHARDS M, 1994, MOVEMENT DISORD, V9, P89, DOI 10.1002/mds.870090114; Rizzo G, 2016, NEUROLOGY, V86, P566, DOI 10.1212/WNL.0000000000002350; Rodriguez-Martin D, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040827; Salarian A, 2004, IEEE T BIO-MED ENG, V51, P1434, DOI 10.1109/TBME.2004.827933; Sanchez-Ferro A, 2016, MOVEMENT DISORD, V31, P1283, DOI 10.1002/mds.26723; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Schulein S, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0228-z; Skog I, 2010, IEEE T BIO-MED ENG, V57, P2657, DOI 10.1109/TBME.2010.2060723; Trojaniello D, 2015, GAIT POSTURE, V42, P310, DOI 10.1016/j.gaitpost.2015.06.008; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Vieregge P, 1997, J NEURAL TRANSM, V104, P237, DOI 10.1007/BF01273184; Weiss A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096675; Weiss A, 2011, NEUROREHAB NEURAL RE, V25, P810, DOI 10.1177/1545968311424869; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	58	163	169	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0183989	10.1371/journal.pone.0183989	http://dx.doi.org/10.1371/journal.pone.0183989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020012	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400009
J	Smith, SG; Harris, SA; Satti, I; Bryan, D; Walker, KB; Dockrell, HM; McShane, H; Ho, MM				Smith, Steven G.; Harris, Stephanie A.; Satti, Iman; Bryan, Donna; Walker, K. Barry; Dockrell, Hazel M.; McShane, Helen; Ho, Mei Mei			Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials	PLOS ONE			English	Article							CYTOKINE STAINING ASSAY; T-CELL RESPONSES; TUBERCULOSIS VACCINE; BCG VACCINATION; ELISPOT ASSAY; IFN-GAMMA; MALAWI; QUALIFICATION; ADULTS; PANEL	Cellular immunological assays are important tools for the monitoring of responses to T-cell-inducing vaccine candidates. As these bioassays are often technically complex and require considerable experience, careful technology transfer between laboratories is critical if high quality, reproducible data that allows comparison between sites, is to be generated. The aim of this study, funded by the European Union Framework Program 7-funded TRANSVAC project, was to optimise Standard Operating Procedures and the technology transfer process to maximise the reproducibility of three bioassays for interferon-gamma responses: enzyme-linked immunosorbent assay (ELISA), ex-vivo enzyme-linked immunospot and intracellular cytokine staining. We found that the initial variability in results generated across three different laboratories reduced following a combination of Standard Operating Procedure harmonisation and the undertaking of side-by-side training sessions in which assay operators performed each assay in the presence of an assay 'lead' operator. Mean inter-site coefficients of variance reduced following this training session when compared with the pre-training values, most notably for the ELISA assay. There was a trend for increased inter-site variability at lower response magnitudes for the ELISA and intracellular cytokine staining assays. In conclusion, we recommend that on-site operator training is an essential component of the assay technology transfer process and combined with harmonised Standard Operating Procedures will improve the quality, reproducibility and comparability of data produced across different laboratories. These data may be helpful in ongoing discussions of the potential risk/benefit of centralised immunological assay strategies for large clinical trials versus decentralised units.	[Smith, Steven G.; Dockrell, Hazel M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London, England; [Harris, Stephanie A.; Satti, Iman; McShane, Helen] Jenner Inst, Oxford, England; [Bryan, Donna; Walker, K. Barry; Ho, Mei Mei] Natl Inst Biol Stand & Controls, Med & Healthcare Prod Regulatory Agcy, Bacteriol Div, Potters Bar, Herts, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Jenner Institute; National Institute for Biological Standards & Control; The Medicines & Healthcare Products Regulatory Agency	Smith, SG (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London, England.	steven.smith@lshtm.ac.uk		McShane, Helen/0000-0002-2126-5142; Smith, Steven/0000-0001-5623-7806; Satti, Iman/0000-0003-4760-4664	EC [FP7-INFRASTRUCTURES-2008-228403, FP7-INFRASTRUCTURES-2012-312661]	EC(European CommissionEuropean Commission Joint Research Centre)	SGS, SAH, IS, DB, KBW, HMD, HM and MH were funded by the EC FP7 TRANSVAC project (FP7-INFRASTRUCTURES-2008-228403). SGS, IS, HMD, HM and MH were also funded by the EC FP7 EURIPRED project (FP7-INFRASTRUCTURES-2012-312661). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Black GF, 2001, INT J TUBERC LUNG D, V5, P664; Britten CM, 2008, CANCER IMMUNOL IMMUN, V57, P289, DOI 10.1007/s00262-007-0378-0; Donaldson MM, 2012, J IMMUNOL METHODS, V386, P10, DOI 10.1016/j.jim.2012.08.011; Geels MJ, 2015, VACCINE, V33, P5481, DOI 10.1016/j.vaccine.2015.01.079; Gomez CE, 2013, J VIROL, V87, P7282, DOI 10.1128/JVI.03246-12; Howles S, 2010, VACCINE, V28, P7306, DOI 10.1016/j.vaccine.2010.08.077; Kagina BM, 2015, J IMMUNOL METHODS, V417, P22, DOI 10.1016/j.jim.2014.12.003; Lalor MK, 2011, J INFECT DIS, V204, P1075, DOI 10.1093/infdis/jir515; McNeil LK, 2013, CYTOM PART A, V83A, P728, DOI [10.1002/cyto.22319, 10.1002/cyto.a.22319]; Mensah VA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167951; Patton K, 2014, CLIN VACCINE IMMUNOL, V21, P628, DOI 10.1128/CVI.00736-13; Shaftr-Weaver K, 2006, J IMMUNOTHER, V29, P328, DOI 10.1097/01.cji.0000203079.35612.c8; Smith SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138042; Smith SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007972; Sow SO, 2009, AM J TROP MED HYG, V80, P1033, DOI 10.4269/ajtmh.2009.80.1033; Spertini F, 2015, LANCET RESP MED, V3, P953, DOI 10.1016/S2213-2600(15)00435-X; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Welters MJP, 2012, CANCER IMMUNOL IMMUN, V61, P967, DOI 10.1007/s00262-012-1282-9	22	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0184391	10.1371/journal.pone.0184391	http://dx.doi.org/10.1371/journal.pone.0184391			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020010	Green Published, Green Accepted, gold			2022-12-26	WOS:000412754400011
J	Zapata-Diomedi, B; Knibbs, LD; Ware, RS; Heesch, KC; Tainio, M; Woodcock, J; Veerman, JL				Zapata-Diomedi, Belen; Knibbs, Luke D.; Ware, Robert S.; Heesch, Kristiann C.; Tainio, Marko; Woodcock, James; Veerman, J. Lennert			A shift from motorised travel to active transport: What are the potential health gains for an Australian city?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; AIR-POLLUTION; IMPACT; BENEFITS; DISEASE; RISK; POLICIES	Introduction An alarmingly high proportion of the Australian adult population does not meet national physical activity guidelines (57%). This is concerning because physical inactivity is a risk factor for several chronic diseases. In recent years, an increasing emphasis has been placed on the potential for transport and urban planning to contribute to increased physical activity via greater uptake of active transport (walking, cycling and public transport). In this study, we aimed to estimate the potential health gains and savings in health care costs of an Australian city achieving its stated travel targets for the use of active transport. Methods Additional active transport time was estimated for the hypothetical scenario of Brisbane (1.1 million population 2013) in Australia achieving specified travel targets. A multi-state life table model was used to estimate the number of health-adjusted life years, life-years, changes in the burden of diseases and injuries, and the health care costs associated with changes in physical activity, fine particle (<2.5 mu m; PM2.5) exposure, and road trauma attributable to a shift from motorised travel to active transport. Sensitivity analyses were conducted to test alternative modelling assumptions. Results Over the life course of the Brisbane adult population in 2013 (860,000 persons), 33,000 health-adjusted life years could be gained if the travel targets were achieved by 2026. This was mainly due to lower risks of physical inactivity-related diseases, with life course reductions in prevalence and mortality risk in the range of 1.5%-6.0%. Prevalence and mortality of respiratory diseases increased slightly (>= 0.27%) due to increased exposure of larger numbers of cyclists and pedestrians to fine particles. The burden of road trauma increased by 30% for mortality and 7% for years lived with disability. We calculated substantial net savings ($AU183 million, 2013 values) in health care costs. Conclusion In cities, such as Brisbane, where over 80% of trips are made by private cars, shifts towards walking, cycling and public transport would cause substantial net health benefits and savings in health care costs. However, for such shifts to occur, investments are needed to ensure safe and convenient travel.	[Zapata-Diomedi, Belen; Knibbs, Luke D.; Ware, Robert S.; Veerman, J. Lennert] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Ware, Robert S.] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia; [Heesch, Kristiann C.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Heesch, Kristiann C.] Sch Publ Hlth & Social Work, Brisbane, Qld, Australia; [Tainio, Marko; Woodcock, James] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Cambridge, Cambs, England; [Tainio, Marko; Woodcock, James] Univ Cambridge, Sch Clin Med, UKCRC Ctr Diet & Act Res CEDAR, Cambridge, Cambs, England; [Tainio, Marko] Polish Acad Sci, Syst Res Inst, Warsaw, Poland; [Veerman, J. Lennert] Canc Council NSW, Sydney, NSW, Australia	University of Queensland; Griffith University; Menzies Health Institute Queensland; Queensland University of Technology (QUT); University of Cambridge; University of Cambridge; Polish Academy of Sciences; Systems Research Institute of the Polish Academy of Sciences; Cancer Council New South Wales	Zapata-Diomedi, B (corresponding author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.	b.zapatadiomedi@uq.edu.au	Knibbs, Luke/C-7865-2012; Woodcock, James/AAH-6753-2021; Heesch, Kristiann C/J-1288-2012; Veerman, Lennert/A-9973-2011; Ware, Robert/B-2024-2014	Heesch, Kristiann C/0000-0003-1931-3683; Knibbs, Luke/0000-0002-0399-2370; Veerman, Lennert/0000-0002-3206-8232; Ware, Robert/0000-0002-6129-6736; Zapata-Diomedi, Belen/0000-0002-9238-0375	Australian Postgraduate Award; NHMRC Early Career (Australian Public Health) Fellowship [APP1036620]; British Heart Foundation; Cancer Research UK; , Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust, under the UK Clinical Research Collaboration; Australian Postgraduate Award; NHMRC Early Career (Australian Public Health) Fellowship [APP1036620]; British Heart Foundation; Cancer Research UK; , Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust, under the UK Clinical Research Collaboration; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1] Funding Source: UKRI	Australian Postgraduate Award(Australian Government); NHMRC Early Career (Australian Public Health) Fellowship(National Health and Medical Research Council (NHMRC) of Australia); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); , Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust, under the UK Clinical Research Collaboration(Wellcome Trust); Australian Postgraduate Award(Australian Government); NHMRC Early Career (Australian Public Health) Fellowship(National Health and Medical Research Council (NHMRC) of Australia); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); , Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust, under the UK Clinical Research Collaboration(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Belen Zapata-Diomedi is supported by an Australian Postgraduate Award. BZD and JLV are part of the NHMRC CRE in Healthy, Liveable Communities (APP1061404). LDK acknowledges an NHMRC Early Career (Australian Public Health) Fellowship (APP1036620). MT and JW undertook the work at the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. MT and JW gratefully acknowledged funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; [Anonymous], 2012, ENV ISSUES WASTE MAN; [Anonymous], 2016, COMP DENS AUSTR EUR; [Anonymous], 2017, SAFETY SCI; [Anonymous], 2013, WALKING RIDING ACCES; [Anonymous], 2016, SHAP SEQ S IN PRESS; [Anonymous], 2001, DIS COSTS IMP STUD D; [Anonymous], 2014, AUSTR MOTOR VEHICLE; [Anonymous], 2016, 2009 12 S E QUEENSLA; [Anonymous], 2016, BRISBANE COMMUNITY P; [Anonymous], 2015, BRISBANE SUBURBS; [Anonymous], 1996, COST EFFECTIVENESS I; [Anonymous], 2004, AIR EM INV S E QUEEN; [Anonymous], 2015, AIR QUAL MON; [Anonymous], 2016, MUCH IS SPENT COPD; [Anonymous], 2016, GLOBAL BURDEN DIS ST; [Anonymous], 2016, AUSTR CANC INCIDENCE; [Anonymous], 2015, AUSTR HLTH SURV PHYS; [Anonymous], 2009, AUSTR HLTH COUNTR 20; [Anonymous], 2014, POPULATION AGE SEX R; [Anonymous], 2012, BRISB LONG TERM INFR; [Anonymous], 2012, BRISBANE ACTIVE TRAN; [Anonymous], 2015, GLOBAL BURDEN DIS GB; [Anonymous], 2016, GLOB AMB AIR POLL; [Anonymous], 2016, DIABETOLOGIA; [Anonymous], 2016, GBD COMP DATA VISUAL; [Anonymous], 2016, GLOBAL REPORT URBAN; [Anonymous], 2016, DEATHS AUSTR; [Anonymous], 2015, HLTH EXP AUSTR 2013; [Anonymous], 2014, CRASH DAT QUEENSL RO; [Anonymous], 2006, 2901 0 CENSUS DICT; [Anonymous], 2011, CONNECTING SEQ 2031; [Anonymous], 2015, QUEENSLAND CYCLE STR; [Anonymous], 2016, ESTIMATED RESIDENT P; [Anonymous], 2009, 2009 S E QUEENSL HOU; [Anonymous], 2016, BICYCLE ROAD RULES S; [Anonymous], 2015, GBD COMPARE; [Anonymous], 2014, ACCIDENT ANAL PREV; [Anonymous], 2016, PROPENSITY CYCLE TOO; [Anonymous], 2015, AUSTR COMM DIST CIT; [Anonymous], 2016, QUEENSL HOUS TRAV SU; Australian Institute of Health and Welfare, 2011, HLTH WELF EXP SER, V46; Barendregt J J, 1998, Math Popul Stud, V7, P29; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Barendregt JJ, 2010, VALUE HEALTH, V13, P388, DOI 10.1111/j.1524-4733.2009.00686.x; Barendregt JJ, 2010, J EPIDEMIOL COMMUN H, V64, P209, DOI 10.1136/jech.2009.090274; Barendregt JJ, 2012, EPIGEAR INT; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; Briggs ADM, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0085-1; Brown V, 2016, TRANSPORT POLICY, V45, P190, DOI 10.1016/j.tranpol.2015.10.003; Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; Cobiac LJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000110; Cook N, 2013, AUST PLAN, V50, P130, DOI 10.1080/07293682.2013.776982; Crane M, 2016, J TRANSP HEALTH, V3, P48, DOI 10.1016/j.jth.2015.10.003; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; de Nazelle A, 2011, ENVIRON INT, V37, P766, DOI 10.1016/j.envint.2011.02.003; Department of Transport and Main Roads (TMR), 2010, S E QUEENSL TR UNPUB; Doberstein C, 2016, LAND USE POLICY, V54, P276, DOI 10.1016/j.landusepol.2016.02.025; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Friend AJ, 2011, ENVIRON CHEM, V8, P569, DOI 10.1071/EN11056; Giles-Corti Billie, 2012, INCREASING DENSITY A; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hamra GB, 2014, ENVIRON HEALTH PERSP, V122, P906, DOI [10.1289/ehp.1408092, 10.1289/ehp/1408092]; Kristensson A, 2004, ATMOS ENVIRON, V38, P657, DOI 10.1016/j.atmosenv.2003.10.030; Kyu HH, 2016, BMJ-BRIT MED J, P354, DOI DOI 10.1136/BMJ.I3857; Maizlish N, 2013, AM J PUBLIC HEALTH, V103, P703, DOI 10.2105/AJPH.2012.300939; Mueller N, 2015, PREV MED, V76, P103, DOI 10.1016/j.ypmed.2015.04.010; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Mytton OT, 2017, EUR J EPIDEMIOL, V32, P235, DOI 10.1007/s10654-017-0235-1; National Heart Foundation of Australia The Australian Local Government Association Bus Industry Confederation Cycling Promotion Fund & International Association of Public Transport, 2010, AUSTR VIS ACT TRANSP; Rojas-Rueda D, 2012, ENVIRON INT, V49, P100, DOI 10.1016/j.envint.2012.08.009; Sa Thiago Herick, 2016, Prev Med Rep, V4, P540; Sallis JF, 2016, LANCET, V388, P2936, DOI 10.1016/S0140-6736(16)30068-X; Stevenson M, 2016, LANCET, V388, P2925, DOI 10.1016/S0140-6736(16)30067-8; Tainio M, 2016, PREV MED, V87, P233, DOI 10.1016/j.ypmed.2016.02.002; Veerman L., 2010, ASSESSING COST EFFEC; Watson A, 2015, ACCIDENT ANAL PREV, V83, P18, DOI 10.1016/j.aap.2015.06.011; WHO, 2014, WHO EXP M METH TOOLS; Woodcock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051462; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; Woodward M, 2003, DIABETES CARE, V26, P360; Xia T, 2015, ENVIRON INT, V74, P281, DOI 10.1016/j.envint.2014.10.004; Yannis G, 2014, EUR TRANSP RES REV, V6, P425, DOI 10.1007/s12544-014-0142-4	83	30	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0184799	10.1371/journal.pone.0184799	http://dx.doi.org/10.1371/journal.pone.0184799			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020093	Green Published, gold, Green Submitted			2022-12-26	WOS:000412754400016
J	Lamb, JJ; Hohmann-Marriott, MF				Lamb, Jacob J.; Hohmann-Marriott, Martin F.			Manganese acquisition is facilitated by PilA in the cyanobacterium Synechocystis sp PCC 6803	PLOS ONE			English	Article							SP STRAIN PCC-6803; EQUATORIAL PACIFIC-OCEAN; IRON TRANSPORT; NANOWIRES; MOTILITY; BINDING; MICROORGANISMS; TRANSFORMATION; ACCUMULATION; CHLOROPHYLL	Manganese is an essential element required by cyanobacteria, as it is an essential part of the oxygen-evolving center of photosystem II. In the presence of atmospheric oxygen, manganese is present as manganese oxides, which have low solubility and consequently provide low bioavailability. It is unknown if cyanobacteria are able to utilize these manganese sources, and what mechanisms may be employed to do so. Recent evidence suggests that type IV pili in non-photosynthetic bacteria facilitate electron donation to extracellular electron acceptors, thereby enabling metal acquisition. Our present study investigates whether PilA1 (major pilin protein of type IV pili) enables the cyanobacterium Synechocystis PCC 6808 to access to Mn from manganese oxides. We present physiological and spectroscopic data, which indicate that the presence of PilA1 enhances the ability of cyanobacteria to grow on manganese oxides. These observations suggest a role of PilA1-containing pili in cyanobacterial manganese acquisition.	[Lamb, Jacob J.; Hohmann-Marriott, Martin F.] NTNU, Dept Biotechnol, Trondheim, Norway; [Lamb, Jacob J.; Hohmann-Marriott, Martin F.] NTNU, PhotoSynLab, Trondheim, Norway; [Lamb, Jacob J.] NTNU, Dept Elect Syst, Trondheim, Norway; [Lamb, Jacob J.] NTNU, ENERSENSE, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Hohmann-Marriott, MF (corresponding author), NTNU, Dept Biotechnol, Trondheim, Norway.; Hohmann-Marriott, MF (corresponding author), NTNU, PhotoSynLab, Trondheim, Norway.	martin.hohmann-marriott@ntnu.no	Lamb, Jacob J./AAQ-4270-2020	Lamb, Jacob J./0000-0002-1019-6655; Hohmann-Marriott, Martin/0000-0002-2957-7052	Norwegian Research Council (Norges Forskningsrad (NO)) [240741]; NTNU; Norwegian Research Council	Norwegian Research Council (Norges Forskningsrad (NO)); NTNU; Norwegian Research Council(Research Council of NorwayEuropean Commission)	We would like to acknowledge NTNU for the PhD fellowship that funded this project, as well as funding from the Norwegian Research Council (Norges Forskningsrad (NO)) grant 240741 to Martin F. Hohmann-Marriott for research into cyanobacterial nanowires. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Thor Bernt Melo for his help and for using his optical laboratory. We would also like to acknowledge NTNU for the PhD fellowship that funded this project, as well as funding from the Norwegian Research Council for research into cyanobacterial nanowires.	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Badarau A, 2008, J BIOL CHEM, V283, P12520, DOI 10.1074/jbc.M709907200; BARTSEVICH VV, 1995, EMBO J, V14, P1845, DOI 10.1002/j.1460-2075.1995.tb07176.x; Bartsevich VV, 1996, J BIOL CHEM, V271, P26057, DOI 10.1074/jbc.271.42.26057; Bhaya D, 2000, MOL MICROBIOL, V37, P941, DOI 10.1046/j.1365-2958.2000.02068.x; Bhaya D, 2001, P NATL ACAD SCI USA, V98, P7540, DOI 10.1073/pnas.131201098; Blankenship RE, 2010, PLANT PHYSIOL, V154, P434, DOI 10.1104/pp.110.161687; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Eaton-Rye JJ, 2004, METH MOL B, V274, P309; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; HANTKE K, 1987, FEMS MICROBIOL LETT, V44, P53, DOI 10.1111/j.1574-6968.1987.tb02241.x; He QF, 1999, PLANT MOL BIOL, V39, P1175, DOI 10.1023/A:1006177103225; Kamei A, 2001, J BACTERIOL, V183, P1505, DOI 10.1128/JB.183.5.1505-1510.2001; Katoh H, 2001, PLANT CELL PHYSIOL, V42, P823, DOI 10.1093/pcp/pce106; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Keren N, 2002, BIOCHEMISTRY-US, V41, P15085, DOI 10.1021/bi026892s; Kranzler C, 2014, ISME J, V8, P409, DOI 10.1038/ismej.2013.161; Kranzler C, 2011, ENVIRON MICROBIOL, V13, P2990, DOI 10.1111/j.1462-2920.2011.02572.x; Kufryk GI, 2002, FEMS MICROBIOL LETT, V206, P215; Lamb J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132258; Lamb JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105761; Lamb JJ, 2013, CURR MICROBIOL, V67, P123, DOI 10.1007/s00284-013-0340-7; Lamb JJ, 2012, PHOTOSYNTH RES, V114, P59, DOI 10.1007/s11120-012-9777-y; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Linhartova M, 2014, MOL MICROBIOL, V93, P1207, DOI 10.1111/mmi.12730; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Morris JN, 2014, NEW ZEAL J BOT, V52, P36, DOI 10.1080/0028825X.2013.846267; Pirbadian S, 2014, P NATL ACAD SCI USA, V111, P12883, DOI 10.1073/pnas.1410551111; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Salomon E, 2011, PLANT PHYSIOL, V155, P571, DOI 10.1104/pp.110.164269; Sure S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01134; Yoshihara S, 2001, PLANT CELL PHYSIOL, V42, P63, DOI 10.1093/pcp/pce007	34	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0184685	10.1371/journal.pone.0184685	http://dx.doi.org/10.1371/journal.pone.0184685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016622	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400010
J	Carlini, DB; Fong, DW				Carlini, David B.; Fong, Daniel W.			The transcriptomes of cave and surface populations of Gammarus minus (Crustacea: Amphipoda) provide evidence for positive selection on cave downregulated transcripts	PLOS ONE			English	Article							GENE-EXPRESSION; EVOLUTION; GENERATION; DROSOPHILA; HEDGEHOG; TOOLKIT	Gammarus minus, a freshwater amphipod living in the cave and surface streams in the eastern USA, is an excellent model for investigating evolutionary adaptation to the subterranean environment. RNA-Seq was conducted on one pair of morphologically distinct sister populations inhabiting surface and cave habitats to identify genes that were differentially expressed in the two populations, as well as to compare levels and patterns of genetic variation within and between populations. Of the 104,630 transcripts identified in the transcriptome assembly, 57% had higher average levels of expression in the cave population. After Benjamini-Hochberg correction for multiple tests, 1517 and 551 transcripts were significantly upregulated or downregulated, respectively, in the cave population, indicating an almost three-fold enrichment of cave-upregulated genes. The average level of nucleotide diversity across all transcripts was significantly lower in the cave population. Within the cave population, where the average nucleotide diversity of cave-downregulated transcripts was 75% that of the cave-upregulated transcripts, a highly significant difference, whereas within the spring population the nucleotide diversities of cave-downregulated and cave-upregulated transcripts was virtually identical. Three lines of evidence suggest that the reduced variation in cave downregulated transcripts is due to positive selection in the cave population: 1) the average neutrality index of cave-downregulated genes was < 1, consistent with positive selection, and significantly less than that of cave-upregulated genes; 2) Tajima's D was positively correlated with the cave: surface expression ratio, and 3) cave-downregulated transcripts were significantly more likely to be highly diverged from their surface homologs than cave-upregulated transcripts. Five transcripts had fixed premature termination codons in the cave population. The expression patterns and sequence variation in one such transcript, encoding the DNA repair protein photolyase, were examined in more detail and provide the first evidence for the relaxation of functional constraint in this light-dependent protein in a subterranean population.	[Carlini, David B.; Fong, Daniel W.] American Univ, Dept Biol, Washington, DC 20016 USA	American University	Carlini, DB (corresponding author), American Univ, Dept Biol, Washington, DC 20016 USA.	carlini@american.edu			Cave Conservancy of the Virginias [36870]	Cave Conservancy of the Virginias	This work was funded by a grant from the Cave Conservancy of the Virginias (award# 36870) awarded to DBC. There was no additional external funding received for this study.; The authors would like to thank Kianna Billman for assistance with qRT-PCR validation of photolyase expression. This work was funded in part by a grant from the Cave Conservancy of the Virginias (award #36870) awarded to DBC. There was no additional external funding received for this study.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1995, ADAPTATION NATURAL S, DOI DOI 10.4159/HARVARD.9780674419070; Aspiras AC, 2012, J EVOLUTION BIOL, V25, P995, DOI 10.1111/j.1420-9101.2012.02481.x; BARR TC, 1985, ANNU REV ECOL SYST, V16, P313, DOI 10.1146/annurev.es.16.110185.001525; Beale A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3769; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Carlini DB, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-89; Carlini DB, 2009, MOL ECOL, V18, P1932, DOI 10.1111/j.1365-294X.2009.04161.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Fong D.W., 2012, ENCY CAVES, P341, DOI DOI 10.1016/B978-0-12-383832-2.00047-5; FONG DW, 1995, ANNU REV ECOL SYST, V26, P249, DOI 10.1146/annurev.es.26.110195.001341; FONG DW, 1989, AM MIDL NAT, V121, P361, DOI 10.2307/2426041; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; GLAZIER DS, 1992, FRESHWATER BIOL, V28, P149, DOI 10.1111/j.1365-2427.1992.tb00572.x; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Holsinger JR, 1970, POSTILLA, V146, P1; Kanai S, 1997, J MOL EVOL, V45, P535, DOI 10.1007/PL00006258; KANE TC, 1992, EVOLUTION, V46, P272, DOI 10.1111/j.1558-5646.1992.tb02002.x; KATO T, 1994, NUCLEIC ACIDS RES, V22, P4119, DOI 10.1093/nar/22.20.4119; KOSTALOS MS, 1979, CRUSTACEANA, V37, P113, DOI 10.1163/156854079X00942; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lucas-Lledo JI, 2009, MOL BIOL EVOL, V26, P1143, DOI 10.1093/molbev/msp029; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meng FW, 2013, MOL BIOL EVOL, V30, P1527, DOI 10.1093/molbev/mst079; POULSON TL, 1969, SCIENCE, V165, P971; Presgraves DC, 2005, CURR BIOL, V15, P1651, DOI 10.1016/j.cub.2005.07.065; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; ROBBINS JH, 1988, JAMA-J AM MED ASSOC, V260, P384; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romero A., 2009, CAVE BIOL; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stoletzki N, 2011, MOL BIOL EVOL, V28, P63, DOI 10.1093/molbev/msq249; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; TAJIMA F, 1989, GENETICS, V123, P585; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tierney SM, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140386; Tobler M, 2008, ENVIRON BIOL FISH, V82, P101, DOI 10.1007/s10641-007-9258-x; VAWTER AT, 1987, STYGOLOGIA, V3, P83	46	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186173	10.1371/journal.pone.0186173	http://dx.doi.org/10.1371/journal.pone.0186173			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016667	gold, Green Published, Green Submitted			2022-12-26	WOS:000412601800043
J	Chen, CL; Mermoud, JC; Paul, LN; Steussy, CN; Stauffacher, CV				Chen, Chun-Liang; Mermoud, James C.; Paul, Lake N.; Steussy, Calvin Nicklaus; Stauffacher, Cynthia V.			Mevalonate 5-diphosphate mediates ATP binding to the mevalonate diphosphate decarboxylase from the bacterial pathogen Enterococcus faecalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; decarboxylase; drug resistance; Enterococcus; enzyme kinetics; enzyme mechanism; isothermal titration calorimetry (ITC); mevalonate pathway	ISOTHERMAL TITRATION CALORIMETRY; SUBSTRATE-BINDING; VANCOMYCIN; RESISTANT; INHIBITION; PYROPHOSPHATE; BIOSYNTHESIS; KINASE; IDENTIFICATION; DAPTOMYCIN	The mevalonate pathway produces isopentenyl diphosphate (IPP), a building block for polyisoprenoid synthesis, and is a crucial pathway for growth of the human bacterial pathogen Enterococcus faecalis. The final enzyme in this pathway, mevalonate diphosphate decarboxylase (MDD), acts on mevalonate diphosphate (MVAPP) to produce IPP while consuming ATP. This essential enzyme has been suggested as a therapeutic target for the treatment of drug-resistant bacterial infections. Here, we report functional and structural studies on the mevalonate diphosphate decarboxylase from E. faecalis (MDDEF). The MDDEF crystal structure in complex with ATP (MDDEF-ATP) revealed that the phosphate-binding loop (amino acids 97-105) is not involved in ATP binding and that the phosphate tail of ATP in this structure is in an outward-facing position pointing away from the active site. This suggested that binding of MDDEF to MVAPP is necessary to guide ATP into a catalytically favorable position. Enzymology experiments show that the MDDEF performs a sequential ordered bi-substrate reaction with MVAPP as the first substrate, consistent with the isothermal titration calorimetry (ITC) experiments. On the basis of ITC results, we propose that this initial prerequisite binding of MVAPP enhances ATP binding. In summary, our findings reveal a substrate-induced substrate-binding event that occurs during the MDDEF-catalyzed reaction. The disengagement of the phosphate-binding loop concomitant with the alternative ATP-binding configuration may provide the structural basis for antimicrobial design against these pathogenic enterococci.	[Chen, Chun-Liang; Mermoud, James C.; Steussy, Calvin Nicklaus; Stauffacher, Cynthia V.] Purdue Univ, Dept Biol Sci, Hockmeyer Hall,Rm 327,240 South Martin Jischke Dr, W Lafayette, IN 47907 USA; [Stauffacher, Cynthia V.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Paul, Lake N.] Purdue Univ, Bindley Biosci Ctr, Biophys Anal Lab, W Lafayette, IN 47906 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Stauffacher, CV (corresponding author), Purdue Univ, Dept Biol Sci, Hockmeyer Hall,Rm 327,240 South Martin Jischke Dr, W Lafayette, IN 47907 USA.	cstauffa@purdue.edu		Chen, Chun-Liang/0000-0003-4625-4340	Purdue Center for Cancer Research; National Institutes of Health [P30 CA 023168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER	Purdue Center for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Purdue Center for Cancer Research and National Institutes of Health Grant P30 CA 023168. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBERTY RA, 1951, J BIOL CHEM, V193, P425; Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P16461, DOI 10.1021/bi048075t; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; BALLARD FJ, 1966, BIOCHEM J, V101, P70, DOI 10.1042/bj1010070; Barrett J F, 2000, Curr Opin Investig Drugs, V1, P181; Barta ML, 2012, BIOCHEMISTRY-US, V51, P5611, DOI 10.1021/bi300591x; Barta ML, 2011, J BIOL CHEM, V286, P23900, DOI 10.1074/jbc.M111.242016; BLOCH K, 1959, J BIOL CHEM, V234, P2595; Boronat A, 2015, ADV BIOCHEM ENG BIOT, V148, P3, DOI 10.1007/10_2014_285; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Burleson BS, 2004, PHARMACOTHERAPY, V24, P1225, DOI 10.1592/phco.24.13.1225.38086; CDC, 2013, ANT RES THREATS US R; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P352; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Eyzaguirre J, 2006, ARCH BIOCHEM BIOPHYS, V454, P189, DOI 10.1016/j.abb.2006.08.002; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GULBINSKY JS, 1968, BIOCHEMISTRY-US, V7, P566, DOI 10.1021/bi00842a009; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Inokoshi J, 2016, J ANTIBIOT, V69, P798, DOI 10.1038/ja.2016.35; JABALQUINTO AM, 1989, BIOCHIM BIOPHYS ACTA, V996, P257, DOI 10.1016/0167-4838(89)90256-2; JABALQUINTO AM, 1987, BIOCHIM BIOPHYS ACTA, V916, P172, DOI 10.1016/0167-4838(87)90105-1; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Johnson AP, 2002, EUR J CLIN MICROBIOL, V21, P751, DOI 10.1007/s10096-002-0807-0; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Krepkiy D, 2004, PROTEIN SCI, V13, P1875, DOI 10.1110/ps.04725204; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; Leskovac V., 2003, COMPREHENSIVE ENZYME, P171; Mermoud J., 2009, THESIS; Munoz-Price LS, 2005, CLIN INFECT DIS, V41, P565, DOI 10.1086/432121; O'Driscoll T, 2015, INFECT DRUG RESIST, V8, P217, DOI 10.2147/IDR.S54125; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; PECORARO VL, 1984, BIOCHEMISTRY-US, V23, P5262, DOI 10.1021/bi00317a026; Qiu YG, 2007, BIOORG MED CHEM LETT, V17, P6164, DOI 10.1016/j.bmcl.2007.09.033; RAMACHANDRAN CK, 1976, BIOCHEM BIOPH RES CO, V69, P42, DOI 10.1016/S0006-291X(76)80269-0; Ruiz Natividad, 2015, Lipid Insights, V8, P21, DOI 10.4137/LPI.S31783; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; SHAMES SL, 1984, ARCH BIOCHEM BIOPHYS, V235, P359, DOI 10.1016/0003-9861(84)90209-1; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; SOLER M, 1979, INT J BIOCHEM, V10, P931, DOI 10.1016/0020-711X(79)90126-5; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Sundsfjord A, 2010, CLIN MICROBIOL INFEC, V16, P525, DOI 10.1111/j.1469-0691.2010.03215.x; UTTLEY AHC, 1988, LANCET, V1, P57; Vilhena C, 2012, MINI-REV MED CHEM, V12, P202, DOI 10.2174/1389557511209030202; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Wilding EI, 2000, J BACTERIOL, V182, P4319, DOI 10.1128/JB.182.15.4319-4327.2000; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization, 2014, ANT RES GLOB REP SUR	52	7	7	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21340	21351		10.1074/jbc.M117.802223	http://dx.doi.org/10.1074/jbc.M117.802223			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29025876	Green Published, hybrid			2022-12-26	WOS:000419013000011
J	Okamoto, A; Hosoda, N; Tanaka, A; Newnam, GP; Chernoff, YO; Hoshino, S				Okamoto, Atsushi; Hosoda, Nao; Tanaka, Anri; Newnam, Gary P.; Chernoff, Yury O.; Hoshino, Shin-ichi			Proteolysis suppresses spontaneous prion generation in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; prion; translation; translation control; translation regulation; translation release factor	TERMINATION FACTOR ERF3; DE-NOVO APPEARANCE; SACCHAROMYCES-CEREVISIAE; RELEASE FACTOR; SUP35 GENE; ACTIN CYTOSKELETON; PROTEASE-B; PSI PRION; INHERITANCE; MECHANISM	Prions are infectious proteins that cause fatal neurodegenerative disorders including Creutzfeldt-Jakob and bovine spongiform encephalopathy (mad cow) diseases. The yeast [PSI+] prion is formed by the translation-termination factor Sup35, is the best-studied prion, and provides a useful model system for studying such diseases. However, despite recent progress in the understanding of prion diseases, the cellular defense mechanism against prions has not been elucidated. Here, we report that proteolytic cleavage of Sup35 suppresses spontaneous de novo generation of the [PSI+] prion. We found that during yeast growth in glucose media, a maximum of 40% of Sup35 is cleaved at its N-terminal prion domain. This cleavage requires the vacuolar proteases PrA-PrB. Cleavage occurs in a manner dependent on translation but independently of autophagy between the glutamine/asparagine-rich (Q/N-rich) stretch critical for prion formation and the oligopeptide-repeat region required for prion maintenance, resulting in the removal of the Q/N-rich stretch from the Sup35 N terminus. The complete inhibition of Sup35 cleavage, by knocking out either PrA (pep4) or PrB (prb1), increased the rate of de novo formation of [PSI+] prion up to approximate to 5-fold, whereas the activation of Sup35 cleavage, by overproducing PrB, inhibited [PSI+] formation. On the other hand, activation of the PrB pathway neither cleaved the amyloid conformers of Sup35 in [PSI+] strains nor eliminated preexisting [PSI+]. These findings point to a mechanism antagonizing prion generation in yeast. Our results underscore the usefulness of the yeast [PSI+] prion as a model system to investigate defense mechanisms against prion diseases and other amyloidoses.	[Okamoto, Atsushi; Hosoda, Nao; Tanaka, Anri; Hoshino, Shin-ichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Nagoya, Aichi 4678603, Japan; [Newnam, Gary P.; Chernoff, Yury O.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Chernoff, Yury O.] St Petersburg State Univ, Lab Amyloid Biol, St Petersburg 199034, Russia	Nagoya City University; University System of Georgia; Georgia Institute of Technology; Saint Petersburg State University	Hoshino, S (corresponding author), 3-1 Tanabe Dori,Mizuho Ku, Nagoya, Aichi 4678603, Japan.	hoshino@phar.nagoya-cu.ac.jp	Chernoff, Yury O/J-2833-2014	Hoshino, Shinichi/0000-0001-6135-7896	Japan Society for the Promotion of Science; Japan Agency for Medical Research and Development; Takeda Science Foundation; National Science Foundation [MCB-1516872]; Russian Science Foundation [14-50-00069]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF)); National Science Foundation(National Science Foundation (NSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported in part by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (to S. H.), the Program on the Innovative Development and the Application of New Drugs for Hepatitis B from the Japan Agency for Medical Research and Development (to S. H), a Grant-in-Aid for Research to Nagoya City University (to S. H.), the Takeda Science Foundation (to S. H), Grant MCB-1516872 from the National Science Foundation (to Y. O. C.), and Grant 14-50-00069 from the Russian Science Foundation (to Y. O. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Bailleul PA, 1999, GENETICS, V153, P81; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Borchsenius AS, 2001, EMBO J, V20, P6683, DOI 10.1093/emboj/20.23.6683; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Chernova TA, 2011, MOL CELL, V43, P242, DOI 10.1016/j.molcel.2011.07.001; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; DOEL SM, 1994, GENETICS, V137, P659; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Geissen M, 2007, VACCINE, V25, P5631, DOI 10.1016/j.vaccine.2007.02.041; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Hashimoto Y, 2012, APOPTOSIS, V17, P1287, DOI 10.1007/s10495-012-0765-7; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Jones EW, 2002, METHOD ENZYMOL, V351, P127; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Manogaran AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001386; MECHLER B, 1987, EMBO J, V6, P2157, DOI 10.1002/j.1460-2075.1987.tb02483.x; MOEHLE CM, 1990, GENETICS, V124, P39; MOEHLE CM, 1987, MOL CELL BIOL, V7, P4390, DOI 10.1128/MCB.7.12.4390; MOEHLE CM, 1987, GENETICS, V115, P255; NEBES VL, 1991, J BIOL CHEM, V266, P22851; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Orij R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r80; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; TUITE MF, 1981, GENETICS, V98, P691; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Turnbaugh JA, 2012, J NEUROSCI, V32, P8817, DOI 10.1523/JNEUROSCI.1103-12.2012; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Wickner RB, 2012, J BIOL CHEM, V287, P14432, DOI 10.1074/jbc.X112.355636; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xue Y., 2014, PLOS ONE, V9, P1; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182	49	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20113	20124		10.1074/jbc.M117.811323	http://dx.doi.org/10.1074/jbc.M117.811323			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29038292	Green Published, hybrid			2022-12-26	WOS:000417696400018
J	Li, Z; Li, XY; Nai, SS; Geng, QZ; Liao, J; Xu, XZ; Li, J				Li, Zhe; Li, Xueyan; Nai, Shanshan; Geng, Qizhi; Liao, Ji; Xu, Xingzhi; Li, Jing			Checkpoint kinase 1-induced phosphorylation of O-linked -N-acetylglucosamine transferase regulates the intermediate filament network during cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; cytokinesis; mitosis; O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc); O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); protein phosphorylation; vimentin	VIMENTIN PHOSPHORYLATION; CROSS-TALK; GLCNACYLATION; CANCER; SEGREGATION; ACTIVATION; ANEUPLOIDY; INVASION; PATHWAY; GLCNAC	Checkpoint kinase 1 (Chk1) is a kinase instrumental for orchestrating DNA replication, DNA damage checkpoints, the spindle assembly checkpoint, and cytokinesis. Despite Chk1's pivotal role in multiple cellular processes, many of its substrates remain elusive. Here, we identified O-linked -N-acetylglucosamine (O-GlcNAc)-transferase (OGT) as one of Chk1's substrates. We found that Chk1 interacts with and phosphorylates OGT at Ser-20, which not only stabilizes OGT, but also is required for cytokinesis. Phospho-specific antibodies of OGT-pSer-20 exhibited specific signals at the midbody of the cell, consistent with midbody localization of OGT as reported previously. Moreover, phospho-deficient OGT (S20A) cells attenuated cellular O-GlcNAcylation levels and also reduced phosphorylation of Ser-71 in the cytoskeletal protein vimentin, a modification critical for severing vimentin filament during cytokinesis. Consequently, elongated vimentin bridges were observed in cells depleted of OGT via an siOGT-based approach. Lastly, expression of plasmids resistant to siOGT efficiently rescued the vimentin bridge phenotype, but the OGT-S20A rescue plasmids did not. Our results suggest a Chk1-OGT-vimentin pathway that regulates the intermediate filament network during cytokinesis.	[Li, Zhe; Li, Xueyan; Nai, Shanshan; Geng, Qizhi; Liao, Ji; Xu, Xingzhi; Li, Jing] Capital Normal Univ, Beijing Key Lab DNA Damage Response, Beijing 100048, Peoples R China; [Li, Zhe; Li, Xueyan; Nai, Shanshan; Geng, Qizhi; Liao, Ji; Xu, Xingzhi; Li, Jing] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China; [Xu, Xingzhi] Shenzhen Univ, Guangdong Key Lab Genome Stabil & Dis Prevent, Sch Med, Shenzhen 518060, Guangdong, Peoples R China	Capital Normal University; Capital Normal University; Shenzhen University	Xu, XZ; Li, J (corresponding author), Capital Normal Univ, Beijing Key Lab DNA Damage Response, Beijing 100048, Peoples R China.; Xu, XZ; Li, J (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China.; Xu, XZ (corresponding author), Shenzhen Univ, Guangdong Key Lab Genome Stabil & Dis Prevent, Sch Med, Shenzhen 518060, Guangdong, Peoples R China.	xingzhi.xu@szu.edu.cn; jing_li@mail.cnu.edu.cn	Xu, Xingzhi/E-8158-2012; Li, Jing/C-2031-2013	Xu, Xingzhi/0000-0002-4459-2082; Li, Jing/0000-0002-3977-1641; July, June/0000-0003-1239-3879	Beijing Nova Program Interdisciplinary Cooperation Project [Z161100004916042]; Capital Normal University (CNU) Interdisciplinary Project; National Natural Science Foundation of China (NSFC) [31461143012, 31530016]; 973 projects [2013CB911002, 2015CB910601]; Shenzhen Science and Technology Innovation Commission [JCYJ20170412113009742]; NSFC [31271446]	Beijing Nova Program Interdisciplinary Cooperation Project; Capital Normal University (CNU) Interdisciplinary Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 projects(National Basic Research Program of China); Shenzhen Science and Technology Innovation Commission; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by Beijing Nova Program Interdisciplinary Cooperation Project Grant Z161100004916042 and Capital Normal University (CNU) Interdisciplinary Project (to J. Li). This work was also supported by National Natural Science Foundation of China (NSFC) funds 31461143012 and 31530016, by the 973 projects 2013CB911002 and 2015CB910601 (X. X.), the Shenzhen Science and Technology Innovation Commission JCYJ20170412113009742 (X. X.), and by NSFC fund 31271446 (J. Liao). The authors declare that they have no conflicts of interest with the contents of this article.	Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; D'Avino PP, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015834; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Jiu Y, 2017, J CELL SCI, V130, P892, DOI 10.1242/jcs.196881; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Kim DH, 2011, BMB REP, V44, P415, DOI 10.5483/BMBRep.2011.44.6.415; Lima VV, 2011, CARDIOVASC RES, V89, P614, DOI 10.1093/cvr/cvq338; Lowery J, 2015, J BIOL CHEM, V290, P17145, DOI 10.1074/jbc.R115.640359; Mackay DR, 2015, MOL BIOL CELL, V26, P2217, DOI 10.1091/mbc.E14-11-1563; Matsuyama M, 2013, J BIOL CHEM, V288, P35626, DOI 10.1074/jbc.M113.514737; Niu YC, 2017, MOL MED REP, V15, P2083, DOI 10.3892/mmr.2017.6244; Pan TL, 2012, J PROTEOMICS, V75, P4676, DOI 10.1016/j.jprot.2012.02.017; Peddibhotla S, 2009, P NATL ACAD SCI USA, V106, P5159, DOI 10.1073/pnas.0806671106; Shi AM, 2016, EUR REV MED PHARMACO, V20, P2603; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Tanaka H, 2015, J BIOL CHEM, V290, P12984, DOI 10.1074/jbc.M114.633891; Tian JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep16722; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Whipple RA, 2008, CANCER RES, V68, P5678, DOI 10.1158/0008-5472.CAN-07-6589; Xu QR, 2014, NUCLEIC ACIDS RES, V42, P5594, DOI 10.1093/nar/gku236; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; Yang Y, 2015, MOL CELL, V58, P47, DOI 10.1016/j.molcel.2015.01.038; Yasui Y, 2001, ONCOGENE, V20, P2868, DOI 10.1038/sj.onc.1204407; Zhong J, 2015, PROTEOMICS, V15, P591, DOI 10.1002/pmic.201400339	31	21	22	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19548	19555		10.1074/jbc.M117.811646	http://dx.doi.org/10.1074/jbc.M117.811646			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29021254	hybrid, Green Published			2022-12-26	WOS:000416911300001
J	Mousa, AA; Roche, DB; Terkawi, MA; Kameyama, K; Kamyingkird, K; Vudriko, P; Salama, A; Cao, SN; Orabi, S; Khalifa, H; Ahmed, M; Attia, M; Elkirdasy, A; Nishikawa, Y; Xuan, XN; Cornillot, E				Mousa, Ahmed Abdelmoniem; Roche, Daniel Barry; Terkawi, Mohamad Alaa; Kameyama, Kyohko; Kamyingkird, Ketsarin; Vudriko, Patrick; Salama, Akram; Cao, Shinuo; Orabi, Sahar; Khalifa, Hanem; Ahmed, Mohamed; Attia, Mabrouk; Elkirdasy, Ahmed; Nishikawa, Yoshifumi; Xuan, Xuenan; Cornillot, Emmanuel			Human babesiosis: Indication of a molecular mimicry between thrombospondin domains from a novel Babesia microti BmP53 protein and host platelets molecules	PLOS ONE			English	Article							INTRINSIC DISORDER PREDICTION; MODEL QUALITY ASSESSMENT; PARASITE IMMUNE EVASION; ANONYMOUS PROTEIN; FOLD RECOGNITION; BINDING-SITE; AUTOIMMUNITY; EXPRESSION; ALDOLASE; DISEASE	Human babesiosis is caused by the apicomplexan parasite Babesia microti, which is of major public health concern in the United States and elsewhere, resulting in malaise and fatigue, followed by a fever and hemolytic anemia. In this paper we focus on the characterization of a novel B. microti thrombospondin domain (TSP1)-containing protein (BmP53) from the new annotation of the B. microti genome (locus 'BmR1_04g09041'). This novel protein (BmP53) had a single TSP1 and a transmembrane domain, with a short cytoplasmic tail containing a sub-terminal glutamine residue, but no signal peptide and Von Willebrand factor type A domains (VWA), which are found in classical thrombospondin-related adhesive proteins (TRAP). Co-localization assays of BmP53 and Babesia microti secreted antigen 1 (BmSA1) suggested that BmP53 might be a non-secretory membranous protein. Molecular mimicry between the TSP1 domain from BmP53 and host platelets molecules was indicated through different measures of sequence homology, phylogenetic analysis, 3D structure and shared epitopes. Indeed, hamster isolated platelets cross-reacted with mouse anti-BmP53-TSP1. Molecular mimicry are used to help parasites to escape immune defenses, resulting in immune evasion or autoimmunity. Furthermore, specific host reactivity was also detected against the TSP1-free part of BmP53 in infected hamster sera. In conclusion, the TSP1 domain mimicry might help in studying the mechanisms of parasite-induced thrombocytopenia, with the TSP1free truncate of the protein representing a potential safe candidate for future vaccine studies.	[Mousa, Ahmed Abdelmoniem; Roche, Daniel Barry; Terkawi, Mohamad Alaa; Cornillot, Emmanuel] Univ Montpellier, CNRS, LIRMM, IBC, Montpellier, France; [Mousa, Ahmed Abdelmoniem; Kameyama, Kyohko; Kamyingkird, Ketsarin; Vudriko, Patrick; Cao, Shinuo] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan; [Mousa, Ahmed Abdelmoniem; Orabi, Sahar; Khalifa, Hanem; Ahmed, Mohamed; Attia, Mabrouk; Elkirdasy, Ahmed; Nishikawa, Yoshifumi; Xuan, Xuenan] Univ Sadat City, Fac Vet Med, Dept Biochem & Chem Nutr, Menoufia, Egypt; [Roche, Daniel Barry] CNRS, UMR 5237, Ctr Rech Biol Cellulaire Montpellier, Montpellier, France; [Kamyingkird, Ketsarin] Kasetsart Univ, Fac Vet Med, Dept Parasitol, Bangkok, Thailand; [Salama, Akram] Univ Sadat City, Fac Vet Med, Dept Anim Med & Infect Dis, Menoufia, Egypt; [Cornillot, Emmanuel] Inst Reg Canc Montpellier ICM, IRCM, INSERM, U1194, Montpellier, France; [Cornillot, Emmanuel] Univ Montpellier, Montpellier, France; [Terkawi, Mohamad Alaa] Hokkaido Univ, Dept Orthoped Surg, Fac Med, Sapporo, Hokkaido, Japan; [Terkawi, Mohamad Alaa] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan	Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier; Obihiro University of Agriculture & Veterinary Medicine; Egyptian Knowledge Bank (EKB); University of Sadat City; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Kasetsart University; Egyptian Knowledge Bank (EKB); University of Sadat City; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Universite de Montpellier; Hokkaido University; Hokkaido University	Cornillot, E (corresponding author), Univ Montpellier, CNRS, LIRMM, IBC, Montpellier, France.; Xuan, XN (corresponding author), Univ Sadat City, Fac Vet Med, Dept Biochem & Chem Nutr, Menoufia, Egypt.; Cornillot, E (corresponding author), Inst Reg Canc Montpellier ICM, IRCM, INSERM, U1194, Montpellier, France.	gen@obihiro.ac.jp; emmanuel.cornillot@umontpellier.fr	Mousa, Ahmed Abdelmoniem/J-5451-2017; Mousa, Ahmed Amin/AAH-2827-2019; Cao, Shinuo/AAD-1027-2020; Mousa, Ahmed Abdelmoniem/AAC-1769-2019; Cornillot, Emmanuel/P-9656-2017; Khalifa, Hanem/ABE-7256-2020; Cao, Shinuo/ABH-3244-2021; orabi, sahar/AAH-1072-2019	Mousa, Ahmed Abdelmoniem/0000-0001-8058-6176; Mousa, Ahmed Abdelmoniem/0000-0001-8058-6176; Cornillot, Emmanuel/0000-0002-1202-1162; Khalifa, Hanem/0000-0002-4893-1117; orabi, sahar/0000-0001-8551-9298; Salama, Akram/0000-0002-8047-8965; Roche, Daniel/0000-0002-9204-1840; Terkawi, Alaa/0000-0002-5481-8516; Vudriko, Patrick/0000-0003-4356-4562; Abd Eldaim, Mabrouk/0000-0001-9842-9777; Ahmed, Mohamed/0000-0001-6106-8947	Ministry of Higher Education-scholarship and mission sector- Egypt; Ministry of Education, Culture, Sports, Science and Technology of Japan; ANR (Investissements d'avenir/Bioinformatique) [ANR-11-BINF-0002]; Grants-in-Aid for Scientific Research [17K10993] Funding Source: KAKEN	Ministry of Higher Education-scholarship and mission sector- Egypt; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ANR (Investissements d'avenir/Bioinformatique)(French National Research Agency (ANR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by a grant from Ministry of Higher Education-scholarship and mission sector- Egypt, for a post-doctoral fellowship at University of Montpellier, France, and a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. DR and EC were supported by the ANR (Investissements d'avenir/Bioinformatique): ANR-11-BINF-0002 (Institut de Biologie Computationnelle).	Akhouri RR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-63; Albert LJ, 1999, NEW ENGL J MED, V341, P2068, DOI 10.1056/NEJM199912303412707; Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; Bosch J, 2007, P NATL ACAD SCI USA, V104, P7015, DOI 10.1073/pnas.0605301104; Buenavista MT, 2012, BIOINFORMATICS, V28, P1851, DOI 10.1093/bioinformatics/bts292; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; Chen MC, 2009, J IMMUNOL, V183, P1797, DOI 10.4049/jimmunol.0800672; Combe A, 2009, INT J PARASITOL, V39, P489, DOI 10.1016/j.ijpara.2008.10.004; Cornillot E, 2012, NUCLEIC ACIDS RES, V40, P9102, DOI 10.1093/nar/gks700; Crow AR, 2001, BRIT J HAEMATOL, V115, P679, DOI 10.1046/j.1365-2141.2001.03136.x; Damian RT, 1997, PARASITOLOGY, V115, pS169, DOI 10.1017/S0031182097002357; Dobbs RJ, 2008, HELICOBACTER, V13, P309, DOI 10.1111/j.1523-5378.2008.00622.x; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Finizio AL, 2011, VET PARASITOL, V176, P132, DOI 10.1016/j.vetpar.2010.11.005; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Fujinami RS, 2006, CLIN MICROBIOL REV, V19, P80, DOI 10.1128/CMR.19.1.80-94.2006; GINSBERG MH, 1981, J SUPRAMOL STR CELL, V17, P91, DOI 10.1002/jsscb.380170111; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Hatcher JC, 2001, CLIN INFECT DIS, V32, P1117, DOI 10.1086/319742; Hurford A, 2013, EVOLUTION, V67, P2889, DOI 10.1111/evo.12171; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kohm AP, 2003, TRENDS MICROBIOL, V11, P101, DOI 10.1016/S0966-842X(03)00006-4; Kuijpers MJE, 2014, ARTERIOSCL THROM VAS, V34, P1187, DOI 10.1161/ATVBAHA.113.302917; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; LEGRAND C, 1992, BLOOD, V79, P1995; Leiby DA, 2011, ANN INTERN MED, V155, P556, DOI 10.7326/0003-4819-155-8-201110180-00363; Lin CF, 2006, VIRAL IMMUNOL, V19, P127, DOI 10.1089/vim.2006.19.127; Lin YS, 2011, EXP BIOL MED, V236, P515, DOI 10.1258/ebm.2011.010339; Luo YZ, 2011, PARASITOL INT, V60, P119, DOI 10.1016/j.parint.2010.11.001; McGuffin LJ, 2008, BIOINFORMATICS, V24, P1798, DOI 10.1093/bioinformatics/btn326; McGuffin LJ, 2015, NUCLEIC ACIDS RES, V43, pW169, DOI 10.1093/nar/gkv236; Michelson S, 2004, HUM IMMUNOL, V65, P465, DOI 10.1016/j.humimm.2004.02.002; Mongui A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-283; Morahan BJ, 2009, TRENDS PARASITOL, V25, P77, DOI 10.1016/j.pt.2008.11.004; Petkova SB, 2000, CARDIOVASC PATHOL, V9, P257, DOI 10.1016/S1054-8807(00)00045-4; Roche DB, 2011, NUCLEIC ACIDS RES, V39, pW171, DOI 10.1093/nar/gkr184; Roche DB, 2016, METHODS MOL BIOL, V1369, P363, DOI 10.1007/978-1-4939-3145-3_23; Schmid-Hempel P, 2008, TRENDS ECOL EVOL, V23, P318, DOI 10.1016/j.tree.2008.02.011; Silva JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep35284; Sorci G, 2013, PATHOGENS, V2, P71, DOI 10.3390/pathogens2010071; Terkawi MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083305; Terkawi MA, 2011, CLIN VACCINE IMMUNOL, V18, P337, DOI 10.1128/CVI.00388-10; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Vannier E, 2008, INFECT DIS CLIN N AM, V22, P469, DOI 10.1016/j.idc.2008.03.010; Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018; Wright I. G., 1988, Babesiosis of domestic animals and man., P99; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou JL, 2006, MOL BIOCHEM PARASIT, V148, P190, DOI 10.1016/j.molbiopara.2006.03.015	50	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0185372	10.1371/journal.pone.0185372	http://dx.doi.org/10.1371/journal.pone.0185372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040286	Green Published, gold, Green Submitted			2022-12-26	WOS:000413167500004
J	Yamada, K; Osakabe, Y; Yamaguchi-Shinozaki, K				Yamada, Kohji; Osakabe, Yuriko; Yamaguchi-Shinozaki, Kazuko			A C-terminal motif contributes to the plasma membrane localization of Arabidopsis STP transporters	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM EXPORT; PROTEIN; ENDOCYTOSIS; DEGRADATION; MECHANISMS; TONOPLAST; THALIANA; RECEPTOR; DEPENDS; SIGNALS	Membrane trafficking is highly organized to maintain cellular homeostasis in any organisms. Membrane-embedded transporters are targeted to various organelles to execute appropriate partition and allocation of their substrates, such as ions or sugars. To ensure the fidelity of targeting and sorting, membrane proteins including transporters have sorting signals that specify the subcellular destination and the trafficking pathway by which the destination is to be reached. Here, we have identified a novel sorting signal (called the tri-aromatic motif) which contains three aromatic residues, two tryptophans and one histidine, for the plasma membrane localization of sugar transporters in the STP family in Arabidopsis. We firstly found that a C-terminal deletion disrupted the sugar uptake activity of STP1 in yeast cells. Additional deletion and mutation analyses demonstrated that the three aromatic residues in the C-terminus, conserved among all Arabidopsis STP transporters, were critical for sugar uptake by not only STP1 but also another STP transporter STP13. We observed that, when the tri-aromatic motif was mutated, STP1 was largely localized at the endomembrane compartments in yeast cells, indicating that this improper subcellular localization led to the loss of sugar absorption. Importantly, our further analyses uncovered that mutations of the triaromatic motif resulted in the endoplasmic reticulum (ER) retention of STP1 and STP13 in plant cells, suggesting that this motif is involved at the step of ER exit of STP transporters to facilitate their plasma membrane localization. Together, we here identified a novel ER export signal, and showed that appropriate sorting via the tri-aromatic motif is important for sugar absorption by STP transporters.	[Yamada, Kohji; Osakabe, Yuriko; Yamaguchi-Shinozaki, Kazuko] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Yamada, Kohji; Osakabe, Yuriko] Tokushima Univ, Grad Sch Technol Ind & Social Sci, Tokushima, Japan	University of Tokyo; Tokushima University	Yamada, K; Yamaguchi-Shinozaki, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.; Yamada, K (corresponding author), Tokushima Univ, Grad Sch Technol Ind & Social Sci, Tokushima, Japan.	kohjiyamada226@gmail.com; akys@mail.ecc.u-tokyo.ac.jp	Yamaguchi-Shinozaki, Kazuko/K-9004-2015; Osakabe, Yuriko/GRI-9818-2022; Osakabe, Yuriko/Y-2507-2019	Yamaguchi-Shinozaki, Kazuko/0000-0002-0249-8258; Osakabe, Yuriko/0000-0001-5503-1427; Osakabe, Yuriko/0000-0001-5503-1427	Japan Society for the Promotion of Science [16K18656]; Mitsubishi Foundation; JSPS KAKENHI [16K18656]; Grants-in-Aid for Scientific Research [15H05955, 16K18656] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science(16K18656; K. Y.) and by the Mitsubishi Foundation (K.Y.).; We thank Dr. Kaido (Kyoto Univ.) for providing the pBIC 35S ER-mCherry vector. This work was supported by JSPS KAKENHI (16K18656; K.Y.) and by the Mitsubishi Foundation (K.Y.)	Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Chen LQ, 2014, NEW PHYTOL, V201, P1150, DOI 10.1111/nph.12445; Gao CJ, 2012, PLANT CELL, V24, P2086, DOI 10.1105/tpc.112.096057; Gonzalez E, 2005, PLANT CELL, V17, P3500, DOI 10.1105/tpc.105.036640; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Jurgens G, 2004, ANNU REV CELL DEV BI, V20, P481, DOI 10.1146/annurev.cellbio.20.082503.103057; Kaido M, 2011, VIROLOGY, V413, P205, DOI 10.1016/j.virol.2011.02.008; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Kitakura S, 2011, PLANT CELL, V23, P1920, DOI 10.1105/tpc.111.083030; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; Mikosch M, 2009, TRAFFIC, V10, P1481, DOI 10.1111/j.1600-0854.2009.00962.x; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Schulze WX, 2012, PLANT J, V69, P529, DOI 10.1111/j.1365-313X.2011.04812.x; Sieben C, 2008, PLANT J, V56, P997, DOI 10.1111/j.1365-313X.2008.03658.x; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Takano J, 2008, TRENDS PLANT SCI, V13, P451, DOI 10.1016/j.tplants.2008.05.007; Wieczorke R, 2003, CELL PHYSIOL BIOCHEM, V13, P123, DOI 10.1159/000071863; Wingenter K, 2011, PLANT J, V68, P890, DOI 10.1111/j.1365-313X.2011.04739.x; Wolfenstetter S, 2012, PLANT CELL, V24, P215, DOI 10.1105/tpc.111.090415; Yamada K, 2016, SCIENCE, V354, P1427, DOI 10.1126/science.aah5692; Yamada K, 2016, EMBO J, V35, P46, DOI 10.15252/embj.201591807; Yamada K, 2011, J BIOL CHEM, V286, P43577, DOI 10.1074/jbc.M111.269712; Yamada K, 2010, J BIOL CHEM, V285, P1138, DOI 10.1074/jbc.M109.054288; Yoshinari A, 2016, PLANT CELL PHYSIOL, V57, P1985, DOI 10.1093/pcp/pcw121	25	10	11	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							0186326	10.1371/journal.pone.0186326	http://dx.doi.org/10.1371/journal.pone.0186326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028820	gold, Green Submitted, Green Published			2022-12-26	WOS:000412980300026
J	Astasov-Frauenhoffer, M; Varenganayil, MM; Decho, AW; Waltimo, T; Braissant, O				Astasov-Frauenhoffer, Monika; Varenganayil, Muth M.; Decho, Alan W.; Waltimo, Tuomas; Braissant, Olivier			Exopolysaccharides regulate calcium flow in cariogenic biofilms	PLOS ONE			English	Article							DETECT MINIMAL AMOUNTS; SUCROSE; MICROORGANISMS; BACTERIA; EROSION; CHANNEL; ENAMEL; MATRIX	Caries-associated biofilms induce loss of calcium from tooth surfaces in the presence of dietary carbohydrates. Exopolysaccharides (EPS) provide a matrix scaffold and an abundance of primary binding sites within biofilms. The role of EPS in binding calcium in cariogenic biofilms is only partially understood. Thus, the aim of the present study is to investigate the relationship between the calcium dissolution rates and calcium tolerance of caries-associated bacteria and yeast as well as to examine the properties of EPS to quantify its binding affinity for dissolved calcium. Calcium dissolution was measured by dissolution zones on Pikovskaya's agar. Calcium tolerance was assessed by isothermal microcalorimetry (IMC) by adding CaCl2 to the bacterial cultures. Acid-base titration and Fourier transform infrared (FTIR) spectroscopy were used to identify possible functional groups responsible for calcium binding, which was assessed by isothermal titration calorimetry (ITC). Lactobacillus spp. and mutans streptococci demonstrated calcium dissolution in the presence of different carbohydrates. All strains that demonstrated high dissolution rates also revealed higher rates of calcium tolerance by IMC. In addition, acidic functional groups were predominantly identified as possible binding sites for calcium ions by acid-base titration and FTIR. Finally, ITC revealed EPS to have a higher binding affinity for calcium compared, for example, to lactic acid. In conclusion, this study illustrates the role of EPS in terms of the calcium tolerance of cariogenic microbiota by determining the ability of EPS to control free calcium concentrations within the biofilms as a self-regulating mode of action in the pathogenesis of dental caries.	[Astasov-Frauenhoffer, Monika; Varenganayil, Muth M.; Waltimo, Tuomas] Univ Basel, Univ Ctr Dent Med, Dept Prevent Dent & Oral Microbiol, Basel, Switzerland; [Decho, Alan W.] Arnold Sch Publ Hlth, Dept Environm Hlth Sci, Columbia, SC USA; [Braissant, Olivier] Univ Basel, Ctr Biomech & Biocalorimetry, Dept Biomed Engn, Allschwil, Switzerland	University of Basel; University of Basel	Astasov-Frauenhoffer, M (corresponding author), Univ Basel, Univ Ctr Dent Med, Dept Prevent Dent & Oral Microbiol, Basel, Switzerland.	m.astasov-frauenhoffer@unibas.ch	Braissant, Olivier/AAO-2371-2020; Decho, Alan W/F-9510-2010	Braissant, Olivier/0000-0003-0659-755X; 	Merian Iselin Stiftung (Basel)	Merian Iselin Stiftung (Basel)	The calorimetry work of O.B. is supported by a grant of the Merian Iselin Stiftung (Basel).	Attin T, 2005, CLIN ORAL INVEST, V9, P203, DOI 10.1007/s00784-005-0313-8; Attin T, 2005, CARIES RES, V39, P432, DOI 10.1159/000086852; Baker MG, 2010, APPL ENVIRON MICROB, V76, P102, DOI 10.1128/AEM.02006-09; BANG J, 1973, J PERIODONTOL, V44, P770, DOI 10.1902/jop.1973.44.12.770; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Braissant O, 2007, GEOBIOLOGY, V5, P401, DOI 10.1111/j.1472-4669.2007.00117.x; Chang YM, 2010, FEBS LETT, V584, P2028, DOI 10.1016/j.febslet.2009.12.035; Fang LC, 2010, BIORESOURCE TECHNOL, V101, P5774, DOI 10.1016/j.biortech.2010.02.075; Featherstone J D B, 2008, Aust Dent J, V53, P286, DOI 10.1111/j.1834-7819.2008.00064.x; Fijan S, 2014, INT J ENV RES PUB HE, V11, P4745, DOI 10.3390/ijerph110504745; Gutierrez T, 2008, APPL ENVIRON MICROB, V74, P4867, DOI 10.1128/AEM.00316-08; Hisano K, 2014, MOL ORAL MICROBIOL, V29, P79, DOI 10.1111/omi.12046; Holland IB, 1999, BIOCHIMIE, V81, P901, DOI 10.1016/S0300-9084(99)00205-9; Kahm M, 2010, J STAT SOFTW, V33, P1; Klein MI, 2013, ORAL MICROBIAL ECOLOGY: CURRENT RESEARCH AND NEW PERSPECTIVES, P63; Koo H, 2013, J DENT RES, V92, P1065, DOI 10.1177/0022034513504218; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Leme AFP, 2004, J DENT RES, V83, P71, DOI 10.1177/154405910408300114; McLaughlin SB, 1999, NEW PHYTOL, V142, P373, DOI 10.1046/j.1469-8137.1999.00420.x; MOHR CD, 1990, MOL MICROBIOL, V4, P2103, DOI 10.1111/j.1365-2958.1990.tb00571.x; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; Patel S, 2012, INDIAN J MICROBIOL, V52, P3, DOI 10.1007/s12088-011-0148-8; Pearce EIF, 2002, CARIES RES, V36, P87, DOI 10.1159/000057865; Pikovskaya RI, 1948, MICROBIOLOGIA, V17; R Core Team, 2021, R LANGUAGE ENV STAT; Rosch JW, 2008, MOL MICROBIOL, V70, P435, DOI 10.1111/j.1365-2958.2008.06425.x; Schlueter N, 2011, CARIES RES, V45, P13, DOI 10.1159/000326819; SEWON LA, 1995, J CLIN PERIODONTOL, V22, P267, DOI 10.1111/j.1600-051X.1995.tb00146.x; Smith B.C., 1996, FUNDAMENTALS FOURIER, P202; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Turner BF, 2006, COMPUT GEOSCI-UK, V32, P1344, DOI 10.1016/j.cageo.2005.12.005; van der Waal SV, 2012, MED HYPOTHESES, V79, P1, DOI 10.1016/j.mehy.2012.03.012; Wiater A, 1999, J BASIC MICROB, V39, P265, DOI 10.1002/(SICI)1521-4028(199909)39:4<265::AID-JOBM265>3.0.CO;2-0; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; Young A, 2006, EUR J ORAL SCI, V114, P180, DOI 10.1111/j.1600-0722.2006.00354.x; Yu QL, 2014, FREE RADICAL BIO MED, V77, P152, DOI 10.1016/j.freeradbiomed.2014.09.011; Zero DT, 2004, CARIES RES, V38, P277, DOI 10.1159/000077767	37	13	13	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186256	10.1371/journal.pone.0186256	http://dx.doi.org/10.1371/journal.pone.0186256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023506	Green Submitted, gold, Green Published			2022-12-26	WOS:000412845100092
J	Huppert, TJ; Karim, H; Lin, CC; Alqahtani, BA; Greenspan, SL; Sparto, PJ				Huppert, Theodore J.; Karim, Helmet; Lin, Chia-Cheng; Alqahtani, Bader A.; Greenspan, Susan L.; Sparto, Patrick J.			Functional imaging of cognition in an old-old population: A case for portable functional near-infrared spectroscopy	PLOS ONE			English	Article							WORKING-MEMORY LOAD; STROOP INTERFERENCE; PREFRONTAL CORTEX; ACTIVATION; BRAIN; PERFORMANCE; IMPAIRMENT; ADULTS; TRAIL; FMRI	In this study, functional near-infrared spectroscopy (fNIRS) was used to record brain activation during cognitive testing in older individuals (88 +/- 6yo; N = 19) living in residential care communities. This population, which is often associated with loss of personal independence due to physical or cognitive decline associated with aging, is also often under-represented in neuroscience research because of a limited means to participate in studies which often take place in large urban or university centers. In this study, we demonstrate the feasibility and initial results using a portable 8-source by 4-detector fNIRS system to measure brain activity from participants within residential care community centers. Using fNIRS, brain signals were recorded during a series of computerized cognitive tests, including a Symbol Digit Coding test (SDC), Stroop Test (ST), and Shifting Attention Test (SAT). The SDC and SAT elicited greater activity in the left middle frontal region of interest. Three components of the ST produced increases in the right middle frontal and superior frontal, and left superior frontal regions. An association between advanced age and increased activation in the right middle frontal region was observed during the incongruent ST. Although none of the participants had clinical dementia based on the short portable mental status questionnaire, the group performance was slightly below age-normed values on these cognitive tests. These results demonstrate the capability for obtaining functional neuroimaging measures in residential settings, which ultimately may aid in prognosis and care related to dementia in older adults.	[Huppert, Theodore J.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Huppert, Theodore J.; Karim, Helmet; Sparto, Patrick J.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Lin, Chia-Cheng] East Carolina Univ, Dept Phys Therapy, Greenville, NC USA; [Alqahtani, Bader A.] Univ Pittsburgh, Dept Elect Engn, Pittsburgh, PA USA; [Greenspan, Susan L.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Sparto, Patrick J.] Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; East Carolina University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Huppert, TJ (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.; Huppert, TJ (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	huppertt@upmc.edu	Alqahtani, Bader/V-8094-2019; Alqahtani, Bader/M-4646-2019; Karim, Helmet/I-6516-2019; Huppert, Theodore/HGB-3534-2022	Alqahtani, Bader/0000-0002-8275-6906; Alqahtani, Bader/0000-0001-7221-5404; Karim, Helmet/0000-0002-9286-0694; Sparto, Patrick/0000-0002-8351-3789; Huppert, Theodore/0000-0001-8426-5759	National Institutes of Health [P30 AG024827]; NATIONAL INSTITUTE ON AGING [P30AG024827, K07AG052668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Institutes of Health (P30 AG024827). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Nancy Beluk and Mary Anne Ferchak for assistance in recruiting study participants and data collection. The authors also thank Ashley C. Whiteman for assistance in manuscript preparation. This work was funded by the National Institutes of Health (P30 AG024827). The authors have no conflicts of interest to disclose related to this work.	Allali G, 2017, CURR TREAT OPTION NE, V19, DOI 10.1007/s11940-017-0466-1; Alqahtani BA, 2016, AGING CLIN EXP RES; Barker JW, 2013, BIOMED OPT EXPRESS, V4, P1366, DOI 10.1364/BOE.4.001366; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Boas DA, 2014, NEUROIMAGE, V85, P1, DOI 10.1016/j.neuroimage.2013.11.033; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2001, SCAND J PSYCHOL, V42, P277, DOI 10.1111/1467-9450.00237; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Ehlis AC, 2005, BIOL PSYCHOL, V69, P315, DOI 10.1016/j.biopsycho.2004.09.003; Espeland MA, 2013, INT J GERIATR PSYCH, V28, P1239, DOI 10.1002/gps.3949; Goldberg TE, 1998, NEUROIMAGE, V7, P296, DOI 10.1006/nimg.1998.0338; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Harris-Kojetin L., 2016, VITAL HLTH STAT, V3, DOI DOI 10.1111/J.1532-5415.2010.02875.X; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Huppert TJ, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.1.010401; Khatutsky G., 2016, RESIDENTIAL CARE COM; Kubo M, 2008, NEUROPSYCHOBIOLOGY, V58, P200, DOI 10.1159/000201717; Langenecker SA, 2004, NEUROIMAGE, V21, P192, DOI 10.1016/j.neuroimage.2003.08.027; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; Makizako H, 2013, GERIATR GERONTOL INT, V13, P314, DOI 10.1111/j.1447-0594.2012.00898.x; Mathis A, 2009, INT J GERIATR PSYCH, V24, P1062, DOI 10.1002/gps.2222; Nakahachi T, 2010, BEHAV BRAIN RES, V215, P21, DOI 10.1016/j.bbr.2010.06.016; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Rosano C, 2010, J GERONTOL A-BIOL, V65, P639, DOI 10.1093/gerona/glq038; Schroeter ML, 2002, HUM BRAIN MAPP, V17, P61, DOI 10.1002/hbm.10052; Shibuya-Tayoshi S, 2007, PSYCHIAT CLIN NEUROS, V61, P616, DOI 10.1111/j.1440-1819.2007.01727.x; Smith GE, 2012, AM PSYCHOL, V67, P1, DOI 10.1037/a0024643; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uemura K, 2016, INT J GERIATR PSYCH, V31, P583, DOI 10.1002/gps.4363; Vermeij A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00303; Vermeij A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046210; Yeung MK, 2016, DEMENT GERIATR COGN, V42, P278, DOI 10.1159/000450993; Zhang L, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.5.057012; Zysset S, 2007, NEUROBIOL AGING, V28, P937, DOI 10.1016/j.neurobiolaging.2006.05.008	37	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0184918	10.1371/journal.pone.0184918	http://dx.doi.org/10.1371/journal.pone.0184918			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ6DU	29023452	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100010
J	Lin, SJ; Kuo, ML; Hsiao, HS; Lee, PT; Chen, JY; Huang, JL				Lin, Syh-Jae; Kuo, Ming-Ling; Hsiao, Hsiu-Shan; Lee, Pei-Tzu; Chen, Ji-Yih; Huang, Jing-Long			Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15	PLOS ONE			English	Article							NK CELLS; DISEASE-ACTIVITY; KILLING DEFECT; GROWTH-FACTOR; EXPRESSION; CD56(BRIGHT); IL-15; CYTOTOXICITY; MOLECULES; TARGET	Natural killer (NK) cells may play an important role in the pathogenesis of SLE. Interleukin (IL)-15, an NK-enhancing cytokine, is over-expressed in SLE patients. In the present study, we examined the effect of IL-15 on NK cytotoxicity of SLE patients, and the expression of various activating and inhibitory NK receptors on NK cells from SLE patients in relation to disease activity. We also sought to determine how IL-15 would affect the NK receptor expression on NK cells from SLE patients. PBMCs were collected from 88 SLE patients with inactive disease activity (SLEDAI score<6) and active disease activity (SLEDAI score >= 6), 26 age-matched healthy adults were used as controls. PBMC were incubated in the presence or absence of IL-15 (10ng/ml) for eighteen hours. CD3(-)CD56(+) lymphoctes were gated using flow cytometry and further divided into CD56(dim) and CD56(bright) subsets according to the MFI of CD56. We observed that 1. Serum IL-15 was elevated in SLE patients, and higher in active disease than in inactive disease; 2. NK cytotoxicity of SLE patients was deficient compared to controls and showed an impaired response to IL-15 compared to controls; 3. CD69, CD94, NKG2A, NKp30, and CD158b on NK cells from SLE patients were higher than controls, and could be further enhanced by IL-15; 4. NKp46 expression from SLE patients was higher than controls, but down-regulated by IL-15; 5. Deficient NKG2D and NKAT-2 expression were found on NK cells from SLE patients, which were enhanced by IL-15; 6. A unique NKp46(-) subset and CD158b(+) subsets were observed in NK cells from SLE patients but not controls. 7. Unlike controls, CD158k on NK cells from SLE patients failed to respond to IL-15. Taken together, we demonstrated the aberrant NCR and iNKR expression on NK cells and their distinct response to IL-15 in SLE patients. As IL-15 predominantly aggravates the aberrant NKR expression found in SLE, IL-15 antagonist may have therapeutic benefits in SLE patients.	[Lin, Syh-Jae; Kuo, Ming-Ling; Hsiao, Hsiu-Shan; Lee, Pei-Tzu; Huang, Jing-Long] Chang Gung Univ Linkou, Chang Gung Mem Hosp, Div Asthma Allergy & Rheumatol, Dept Pediat,Coll Med, Taoyuan, Taiwan; [Kuo, Ming-Ling] Chang Gung Univ, Grad Inst Biomed Sci, Dept Microbiol & Immunol, Coll Med, Taoyuan, Taiwan; [Chen, Ji-Yih] Chang Gung Univ Linkou, Chang Gung Mem Hosp, Div Allergy Immunol & Rheumatol, Dept Med,Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Huang, JL (corresponding author), Chang Gung Univ Linkou, Chang Gung Mem Hosp, Div Asthma Allergy & Rheumatol, Dept Pediat,Coll Med, Taoyuan, Taiwan.; Chen, JY (corresponding author), Chang Gung Univ Linkou, Chang Gung Mem Hosp, Div Allergy Immunol & Rheumatol, Dept Med,Coll Med, Taoyuan, Taiwan.	jychen071688@gmail.com; long@adm.cgmh.org.tw		Huang, Jing-Long/0000-0002-3530-7753; Lin, Syh-Jae/0000-0001-7689-0650; Huang, Jing-Long/0000-0001-9280-920X	Ministry of Science and Technology, R.O.C. [MOST103-2314-6-182A-023-MY3]; Division of Asthma, Allergy, and Rheumatology, Department of Pediatrics, Chang Gung Memory Hospital [CMRPG4D0052, CMRPG3D1933]	Ministry of Science and Technology, R.O.C.; Division of Asthma, Allergy, and Rheumatology, Department of Pediatrics, Chang Gung Memory Hospital	This study was supported partially by grants from Ministry of Science and Technology, R.O.C.: MOST103-2314-6-182A-023-MY3 to SJL. It was also supported by Division of Asthma, Allergy, and Rheumatology, Department of Pediatrics, Chang Gung Memory Hospital: CMRPG4D0052, CMRPG3D1933 to SJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aringer M, 2001, RHEUMATOLOGY, V40, P876, DOI 10.1093/rheumatology/40.8.876; Bai YY, 2014, CLIN LAB, V60, P717, DOI 10.7754/Clin.Lab.2013.130435; Baranda L, 2005, RHEUMATOLOGY, V44, P1507, DOI 10.1093/rheumatology/kei083; Bo H, 2009, SCAND J IMMUNOL, V69, P119, DOI 10.1111/j.1365-3083.2008.02197.x; Boerman GH, 2015, CANCER IMMUNOL IMMUN, V64, P573, DOI 10.1007/s00262-015-1657-9; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Boyiadzis M, 2008, BIOL BLOOD MARROW TR, V14, P290, DOI 10.1016/j.bbmt.2007.12.490; Cheent KS, 2013, P NATL ACAD SCI USA, V110, P16981, DOI 10.1073/pnas.1304366110; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Dai ZP, 2009, J EXP MED, V206, P793, DOI 10.1084/jem.20081648; Eidukaite A, 2004, FERTIL STERIL, V81, P863, DOI 10.1016/j.fertnstert.2003.10.019; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; GIRI JG, 1995, J LEUKOCYTE BIOL, V57, P763, DOI 10.1002/jlb.57.5.763; Gonzalez-Amaro R, 2013, TRENDS MOL MED, V19, P625, DOI 10.1016/j.molmed.2013.07.006; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Green MRJ, 2005, CLIN EXP IMMUNOL, V141, P165, DOI 10.1111/j.1365-2249.2005.02822.x; Halfteck GG, 2009, J IMMUNOL, V182, P2221, DOI 10.4049/jimmunol.0801878; Hervier B, 2011, ARTHRITIS RHEUM-US, V63, P1698, DOI 10.1002/art.30313; Hromadnikova I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151535; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Li WX, 2010, CLIN RHEUMATOL, V29, P315, DOI 10.1007/s10067-009-1322-9; Lin SJ, 2004, PEDIAT ALLERG IMM-UK, V15, P79, DOI 10.1046/j.0905-6157.2003.00103.x; Lin SJ, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9675861; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; McGrath E, 2009, AM J REPROD IMMUNOL, V61, P265, DOI 10.1111/j.1600-0897.2009.00688.x; Miyara M, 2005, J IMMUNOL, V175, P8392, DOI 10.4049/jimmunol.175.12.8392; Naumova E, 2007, CANCER IMMUNOL IMMUN, V56, P95, DOI 10.1007/s00262-006-0151-9; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Petri M, 2005, RHEUM DIS CLIN N AM, V31, P245, DOI 10.1016/j.rdc.2005.01.009; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Popko K, 2015, CENT EUR J IMMUNOL, V40, P470, DOI 10.5114/ceji.2015.56971; Poszepczynska-Guigne E, 2004, J INVEST DERMATOL, V122, P820, DOI 10.1111/j.0022-202X.2004.22326.x; Puxeddu I, 2012, SCAND J RHEUMATOL, V41, P298, DOI 10.3109/03009742.2011.648657; Renaudineau Y, 2004, AUTOIMMUN REV, V3, P516, DOI 10.1016/j.autrev.2004.07.035; Rusakiewicz S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005727; Schepis D, 2009, IMMUNOLOGY, V126, P140, DOI 10.1111/j.1365-2567.2008.02887.x; Shaw J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00339; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Spada R, 2015, J LEUKOCYTE BIOL, V97, P583, DOI 10.1189/jlb.4A0714-326R; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Yabuhara A, 1996, J RHEUMATOL, V23, P171; Zhu HL, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1050-x	44	16	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186223	10.1371/journal.pone.0186223	http://dx.doi.org/10.1371/journal.pone.0186223			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023581	gold, Green Published, Green Submitted			2022-12-26	WOS:000412845100086
J	Sinacore, K; Hall, JS; Potvin, C; Royo, AA; Ducey, MJ; Ashton, MS				Sinacore, Katherine; Hall, Jefferson Scott; Potvin, Catherine; Royo, Alejandro A.; Ducey, Mark J.; Ashton, Mark S.			Unearthing the hidden world of roots: Root biomass and architecture differ among species within the same guild	PLOS ONE			English	Article							ABOVEGROUND BIOMASS; ECOLOGICAL RESTORATION; CARBON SEQUESTRATION; MIXED PLANTATIONS; INDIVIDUAL TREE; EARLY GROWTH; FOREST; ALLOCATION; EQUATIONS; LIDAR	The potential benefits of planting trees have generated significant interest with respect to sequestering carbon and restoring other forest based ecosystem services. Reliable estimates of carbon stocks are pivotal for understanding the global carbon balance and for promoting initiatives to mitigate CO2 emissions through forest management. There are numerous studies employing allometric regression models that convert inventory into aboveground biomass (AGB) and carbon (C). Yet the majority of allometric regression models do not consider the root system nor do these equations provide detail on the architecture and shape of different species. The root system is a vital piece toward understanding the hidden form and function roots play in carbon accumulation, nutrient and plant water uptake, and groundwater infiltration. Work that estimates C in forests as well as models that are used to better understand the hydrologic function of trees need better characterization of tree roots. We harvested 40 trees of six different species, including their roots down to 2 mm in diameter and created species-specific and multi-species models to calculate aboveground (AGB), coarse root belowground biomass (BGB), and total biomass (TB). We also explore the relationship between crown structure and root structure. We found that BGB contributes similar to 27.6% of a tree's TB, lateral roots extend over 1.25 times the distance of crown extent, root allocation patterns varied among species, and that AGB is a strong predictor of TB. These findings highlight the potential importance of including the root system in C estimates and lend important insights into the function roots play in water cycling.	[Sinacore, Katherine; Hall, Jefferson Scott] Smithsonian Trop Res Inst, ForestGEO, Agua Salud Project, Panama City, Panama; [Sinacore, Katherine; Ducey, Mark J.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA; [Potvin, Catherine] McGill Univ, Dept Biol, Montreal, PQ, Canada; [Royo, Alejandro A.] US Forest Serv, Northern Res Stn, Forestry Sci Lab, Irvine, PA USA; [Ashton, Mark S.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	Smithsonian Institution; Smithsonian Tropical Research Institute; University System Of New Hampshire; University of New Hampshire; McGill University; United States Department of Agriculture (USDA); United States Forest Service; Yale University	Sinacore, K (corresponding author), Smithsonian Trop Res Inst, ForestGEO, Agua Salud Project, Panama City, Panama.; Sinacore, K (corresponding author), Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA.	kay467@wildcats.unh.edu			National Secretariat of Science of Panama (SENECYT); Silicon Valley Foundation	National Secretariat of Science of Panama (SENECYT); Silicon Valley Foundation	Field work for this project was paid for by a grant from the National Secretariat of Science of Panama (SENECYT). KS was supported by grants to the Smart Reforestation program of the Smithsonian Tropical Research Institute from Mr. Stanley Motta and the Silicon Valley Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Field work for this project was paid for by a grant from the National Secretariat of Science of Panama (SENECYT). The first author was supported by grants to the Smart Reforestation program of the Smithsonian Tropical Research Institute from Mr. Stanley Motta and the Silicon Valley Foundation. Jose Monteza and Leidy Martinez led field work at the Sardinilla and Soberania sites, respectively. Johanna Balbuena helped with laboratory work and data management. We are grateful to these individuals as well as all the field assistants and students who undertook the messy work of excavating the roots.	Alvarado-Barrientos MS, 2013, AGR FOR; Ashton MS, 2001, FOREST ECOL MANAG, V154, P431, DOI 10.1016/S0378-1127(01)00513-8; Ashton PMS, 2011, ECOLOGY SILVICULTURE, P145; Asner GP, 2002, BIOTROPICA, V34, P483, DOI 10.1111/j.1744-7429.2002.tb00568.x; Asner Gregory P, 2013, Carbon Balance Manag, V8, P7, DOI 10.1186/1750-0680-8-7; Bauhus J, 2000, CAN J FOREST RES, V30, P1886, DOI 10.1139/cjfr-30-12-1886; BONNOR G. M., 1964, FOREST CHRON, V40, P347; BORMANN FH, 1966, ECOL MONOGR, V36, P1, DOI 10.2307/1948486; Burgess SSO, 2001, TREE PHYSIOL, V21, P589, DOI 10.1093/treephys/21.9.589; Cao JX, 2012, ECOL RES, V27, P883, DOI 10.1007/s11284-012-0965-1; Cermak J, 1998, ANN SCI FOREST, V55, P63, DOI 10.1051/forest:19980105; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Cole TG, 2006, FOREST ECOL MANAG, V229, P351, DOI 10.1016/j.foreco.2006.04.017; Coll L, 2008, TREES-STRUCT FUNCT, V22, P585, DOI 10.1007/s00468-008-0219-6; Cordero LDP, 2002, FOREST ECOL MANAG, V165, P1; Dawkins H. C., 1963, Commonwealth Forestry Review, V42, P318; Donoghue DNM, 2007, REMOTE SENS ENVIRON, V110, P509, DOI 10.1016/j.rse.2007.02.032; Drake JB, 2003, GLOBAL ECOL BIOGEOGR, V12, P147, DOI 10.1046/j.1466-822X.2003.00010.x; Ducey Mark Jonathan, 2009, Acta Amaz., V39, P349, DOI 10.1590/S0044-59672009000200013; Dybzinski R, 2015, GLOBAL CHANGE BIOL, V21, P1182, DOI 10.1111/gcb.12783; Dybzinski R, 2011, AM NAT, V177, P153, DOI 10.1086/657992; Farrior CE, 2015, P NATL ACAD SCI USA, V112, P7213, DOI 10.1073/pnas.1506262112; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Fonseca W, 2012, NEW FOREST, V43, P197, DOI 10.1007/s11056-011-9273-9; Griess VC, 2011, NEW FOREST, V41, P13, DOI 10.1007/s11056-010-9207-y; Hall JS, 2011, FOREST ECOL MANAG, V261, P1553, DOI 10.1016/j.foreco.2010.12.011; Hall JS., 2015, MANAGING WATERSHEDS; Holl KD, 2014, FOREST ECOL MANAG, V319, P36, DOI 10.1016/j.foreco.2014.01.024; Ibrahim M, 2007, SISTEMAS SILVOPASTOR; Jackson RBS HJ, 2002, GLOBAL BIOGEOGRAPHY, V72, P311; Jackson ST, 2009, SCIENCE, V325, P567, DOI 10.1126/science.1172977; KEELEY JE, 1988, OIKOS, V52, P364, DOI 10.2307/3565212; Kenzo T, 2009, J TROP ECOL; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; Kraenzel M, 2003, FOREST ECOL MANAG, V173, P213, DOI 10.1016/S0378-1127(02)00002-6; Locatelli B, 2009, FOREST ECOL MANAG, V258, P1864, DOI 10.1016/j.foreco.2009.01.015; Makela A, 2006, ECOLOGY, V87, P2967, DOI 10.1890/0012-9658(2006)87[2967:CRIASI]2.0.CO;2; Malhi Y, 2011, PHILOS T R SOC B, V366, P3225, DOI 10.1098/rstb.2011.0062; Markesteijn L, 2009, J ECOL, V97, P311, DOI 10.1111/j.1365-2745.2008.01466.x; Mart L, 2009, ANTECEDENTES; Meinzer F, 2001, TREE PHYSL; Montagnini F, 2004, AGROFOREST SYST, V61-2, P281, DOI 10.1023/B:AGFO.0000029005.92691.79; Montagnini F, 1998, ENVIRON MANAGE, V22, P459, DOI 10.1007/s002679900119; Moser G, 2011, GLOBAL CHANGE BIOL, V17, P2211, DOI 10.1111/j.1365-2486.2010.02367.x; Murgueitio E, 2011, FOREST ECOL MANAG, V261, P1654, DOI 10.1016/j.foreco.2010.09.027; Nair P.K.R., 1993, CLASSIFICATION AGROF, DOI [10.1007/978-3-030-75358-0, DOI 10.1007/978-3-030-75358-0]; Nicoll B, 2015, FULL SITE CONDITIONS; Niiyama K, 2010, J TROP ECOL, V26, P271, DOI 10.1017/S0266467410000040; Paquette A, 2010, FRONT ECOL ENVIRON, V8, P27, DOI 10.1890/080116; Paul C, 2015, AGROFOREST SYST, V89, P217, DOI 10.1007/s10457-014-9755-9; Pelletier J, 2012, FOREST POLICY ECON, V24, P3, DOI 10.1016/j.forpol.2010.05.005; Pelletier J, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024005; Piotto D, 2008, FOR ECOL MANAGE; Piotto D, 2010, NEW FOREST, V39, P369, DOI 10.1007/s11056-009-9177-0; Popescu SC, 2003, CAN J REMOTE SENS, V29, P564, DOI 10.5589/m03-027; Potvin C, 2011, FOREST ECOL MANAG, V261, P1614, DOI 10.1016/j.foreco.2010.11.015; Redondo-Brenes A, 2007, NEW FOREST, V34, P253, DOI 10.1007/s11056-007-9052-9; Richardson AD, 2003, ANN FOREST SCI, V60, P469, DOI 10.1051/forest:2003040; Rodrigues RR, 2011, FOREST ECOL MANAG, V261, P1605, DOI 10.1016/j.foreco.2010.07.005; Sah JP, 2004, FOREST ECOL MANAG, V203, P319, DOI 10.1016/j.foreco.2004.07.059; Tucker NIJ, 1997, FOREST ECOL MANAG, V99, P133, DOI 10.1016/S0378-1127(97)00200-4; van Breugel M, 2011, FOREST ECOL MANAG, V262, P1648, DOI 10.1016/j.foreco.2011.07.018; van Breugel M, 2011, FOREST ECOL MANAG, V261, P1580, DOI 10.1016/j.foreco.2010.08.019; Vazirabad YF, 2011, BIOMASS - DETECTION, PRODUCTION AND USAGE, P3; Vogt KA, 1996, PLANT SOIL, V187, P159, DOI 10.1007/BF00017088; Wang YY, 2016, ADV ATMOS SCI, V33, P1047, DOI 10.1007/s00376-016-5226-8; Wishnie MH, 2007, FOREST ECOL MANAG, V243, P39, DOI 10.1016/j.foreco.2007.02.001; Yin CY, 2005, ENVIRON EXP BOT, V53, P315, DOI 10.1016/j.envexpbot.2004.04.007; Zeng XB, 2001, J HYDROMETEOROL, V2, P525, DOI 10.1175/1525-7541(2001)002<0525:GVRDFL>2.0.CO;2	70	31	31	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0185934	10.1371/journal.pone.0185934	http://dx.doi.org/10.1371/journal.pone.0185934			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023553	gold, Green Submitted, Green Published			2022-12-26	WOS:000412845100040
J	Bista, D; Shrestha, S; Sherpa, P; Thapa, GJ; Kokh, M; Lama, ST; Khanal, K; Thapa, A; Jnawali, SR				Bista, Damber; Shrestha, Saroj; Sherpa, Peema; Thapa, Gokarna Jung; Kokh, Manish; Lama, Sonam Tashi; Khanal, Kapil; Thapa, Arjun; Jnawali, Shant Raj			Distribution and habitat use of red panda in the Chitwan-Annapurna Landscape of Nepal	PLOS ONE			English	Article							AILURUS-FULGENS; NATIONAL-PARK; CONSERVATION; ECOLOGY; MODELS	In Nepal, the red panda (Ailurus fulgens) has been sparsely studied, although its range covers a wide area. The present study was carried out in the previously untapped Chitwan Annapurna Landscape (CHAL) situated in central Nepal with an aim to explore current distributional status and identify key habitat use. Extensive field surveys conducted in 10 red panda range districts were used to estimate species distribution by presence-absence occupancy modeling and to predict distribution by presence-only modeling. The presence of red pandas was recorded in five districts: Rasuwa, Nuwakot, Myagdi, Baglung and Dhading. The predictive distribution model indicated that 1,904.44 km(2) of potential red panda habitat is available in CHAL with the protected area covering nearly 41% of the total habitat. The habitat suitability analysis based on the probability of occurrence showed only 16.58% (A = 315.81 km(2)) of the total potential habitat is highly suitable. Red Panda occupancy was estimated to be around 0.0667, indicating nearly 7% (218 km(2)) of the total habitat is occupied with an average detection probability of 0.4482 +/- 0.377. Based on the habitat use analysis, altogether eight variables including elevation, slope, aspect, proximity to water sources, bamboo abundance, height, cover, and seasonal precipitation were observed to have significant roles in the distribution of red pandas. In addition, 25 tree species were documented from red panda sign plots out of 165 species recorded in the survey area. Most common was Betula utilis followed by Rhododendron spp. and Abies spectabilis. The extirpation of red pandas in previously reported areas indicates a need for immediate action for the long-term conservation of this species in CHAL.	[Bista, Damber; Shrestha, Saroj; Sherpa, Peema; Lama, Sonam Tashi] Red Panda Network, Kathmandu, Nepal; [Thapa, Gokarna Jung; Khanal, Kapil; Jnawali, Shant Raj] WWF Nepal, Kathmandu, Nepal; [Thapa, Arjun] Small Mammals Conservat & Res Fdn, Kathmandu, Nepal	World Wildlife Fund	Bista, D (corresponding author), Red Panda Network, Kathmandu, Nepal.	damber.bista@redpandanetwork.org	Lama, Sonam Tashi/Z-4025-2019; Lama, Sonam Tashi T/P-3852-2018; Bista, Damber/Y-5758-2018; Bista, Damber/K-1215-2019	Lama, Sonam Tashi/0000-0002-3390-6496; Lama, Sonam Tashi T/0000-0002-3390-6496; Bista, Damber/0000-0003-2699-1642; Bista, Damber/0000-0003-2699-1642; Khanal, Kapil/0000-0001-6468-6353; Sherpa, Ang Phuri/0000-0002-3569-8280	WWF/USAID/Hariyo Ban Program [WU82]; Red Panda Network [13/2014]; Idea Wild; Department of National Parks and Wildlife Conservation; Department of Forest; Red Panda Network; Himali Conservation Forum	WWF/USAID/Hariyo Ban Program(United States Agency for International Development (USAID)); Red Panda Network; Idea Wild; Department of National Parks and Wildlife Conservation; Department of Forest; Red Panda Network; Himali Conservation Forum	We are thankful to the WWF/USAID/Hariyo Ban Program (WU82), Red Panda Network (Ref-13/2014) and Idea Wild (30July, 2015) for financially supporting this work. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the support from the Department of National Parks and Wildlife Conservation; Department of Forest, Red Panda Network and Himali Conservation Forum. We are very thankful to Mr. Ang Phuri Sherpa, Country Director of Red Panda Network whose support remained highly critical in concluding this work. Our sincere thanks also goes to Dr. Angela Glatston, Robert Shepherd, Brian Williams, Terrance Fleming, Shishir Shakya and all the field biologists and local people involved in this work.	AKAIKE H, 1973, BIOMETRIKA, V60, P255, DOI 10.2307/2334537; Bhatta Manoj, 2014, Open Journal of Ecology, V4, P989; BISTA D, 2014, INITIATION, V5, P171, DOI DOI 10.3126/INIT.V5I0.10268; Chalise MK, 2013, BIODIVERS CONSERV, P11; Curtis JT, 1959, VEGETATION WISCONSIN; Dongol B, 2014, HABITAT DISTRI UNPUB; Dorji S, 2012, ORYX, V46, P536, DOI 10.1017/S0030605311000780; Dorji S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026483; Fox J, 1996, CONSERV BIOL, V10, P562, DOI 10.1046/j.1523-1739.1996.10020562.x; Ghose D, 2010, RED PANDA BIOL  1125, V357; Glatston A.R, 1994, STATUS SURVEY CONSER; HU JC, 1991, J SICH NORM COLL, V12, P1; Jnawali S., 2012, RED PANDA AILURUS FU; Kandel K, 2015, BIOL CONSERV, V181, P150, DOI 10.1016/j.biocon.2014.10.007; Lama Sonam Tashi, 2015, Journal of Threatened Taxa, V7, P7460, DOI 10.11609/JoTT.o4208.7460-4; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; Mahato NK, 1825, DISTRIBUTION RED PAN; Ministry of Forests and Soil Conservation, 2015, RED PAND FIELD SURV; Nowak R, 1999, WALKERS MAMMALS WORL, V2, P695; Panthi S, 2012, ZOOLOGICAL STUDIES, V51; Paudel K, 2009, STATUS DISTRIBUTION; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pradhan S, 2001, BIOL CONSERV, V98, P11, DOI 10.1016/S0006-3207(00)00079-3; REID DG, 1991, J ZOOL, V225, P347, DOI 10.1111/j.1469-7998.1991.tb03821.x; ROBERTS M S, 1984, Mammalian Species, P1, DOI 10.2307/3503840; Schaller G. B., 1994, THE LAST PANDA; Sharma HP, 2014, HYSTRIX, V25, P47, DOI 10.4404/hystrix-25.1-9033; Sherpa A, 2015, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2015-4.RLTS.T714A45195924.EN; Stapleton CM, 1994, EDINBURGH J BOT, V51; Steffens E, 2004, RED PANDAS CONSERVAT; Thapa A, 2015, INT J CONSERVATION S, V6; Thapa A, 2014, INITIATION, V5, P43, DOI DOI 10.3126/init.v5i0.10252; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; Wei FW, 2000, J MAMMAL, V81, P448, DOI 10.1644/1545-1542(2000)081<0448:HUASBT>2.0.CO;2; Williams B, 2010, PROJECT PUNDE KUNDO, P393; Williams BH., 2003, CONSERV BIOL ASIA, V16, P236; Williams BH, THESIS; YONZON P, 1991, AMBIO, V20, P285; YONZON PB, 1991, BIOL CONSERV, V57, P1, DOI 10.1016/0006-3207(91)90104-H; YONZON PB, 1991, CONSERV BIOL, V5, P196, DOI 10.1111/j.1523-1739.1991.tb00124.x; Yonzon PB, THESIS; Yonzon PB, 1989, RED PANDA BIOL, V1; Zhang JS, 2008, ECOHEALTH, V5, P6, DOI 10.1007/s10393-007-0139-8	43	29	36	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0178797	10.1371/journal.pone.0178797	http://dx.doi.org/10.1371/journal.pone.0178797			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020020	Green Published, gold, Green Submitted			2022-12-26	WOS:000412754400002
J	Temprana, CF; Prieto, MJ; Igartua, DE; Femia, AL; Amor, MS; Alonso, SD				Facundo Temprana, C.; Jimena Prieto, M.; Igartua, Daniela E.; Lis Femia, A.; Silvia Amor, M.; del Valle Alonso, Silvia			Diacetylenic lipids in the design of stable lipopolymers able to complex and protect plasmid DNA	PLOS ONE			English	Article							IN-VITRO EVALUATION; GENE DELIVERY; DRUG-DELIVERY; CATIONIC LIPOSOMES; POLYMERIZED LIPOSOMES; NONVIRAL VECTORS; DC-CHOL; TRANSFECTION; THERAPY; VIVO	Different viral and non-viral vectors have been designed to allow the delivery of nucleic acids in gene therapy. In general, non-viral vectors have been associated with increased safety for in vivo use; however, issues regarding their efficacy, toxicity and stability continue to drive further research. Thus, the aim of this study was to evaluate the potential use of the polymerizable diacetylenic lipid 1,2-bis(10,12-tricosadiynoyl)-sn-glycero-3-phosphocholine (DC8,9PC) as a strategy to formulate stable cationic lipopolymers in the delivery and protection of plasmid DNA. Cationic lipopolymers were prepared following two different methodologies by using DC8,9PC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), and the cationic lipids (CL) 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP), stearylamine (SA), and myristoylcholine chloride (MCL), in a molar ratio of 1:1:0.2 (DMPC: DC8,9PC:CL). The copolymerization methodology allowed obtaining cationic lipopolymers which were smaller in size than those obtained by the cationic addition methodology although both techniques presented high size stability over a 166-day incubation period at 4 degrees C. Cationic lipopolymers containing DOTAP or MCL were more efficient in complexing DNA than those containing SA. Moreover, lipopolymers containing DOTAP were found to form highly stable complexes with DNA, able to resist serum DNAses degradation. Furthermore, neither of the cationic lipopolymers (with or without DNA) induced red blood cell hemolysis, although metabolic activity determined on the L-929 and Vero cell lines was found to be dependent on the cell line, the formulation and the presence of DNA. The high stability and DNA protection capacity as well as the reduced toxicity determined for the cationic lipopolymer containing DOTAP highlight the potential advantage of using lipopolymers when designing novel non-viral carrier systems for use in in vivo gene therapy. Thus, this work represents the first steps toward developing a cationic lipopolymer-based gene delivery system using polymerizable and cationic lipids.	[Facundo Temprana, C.; Jimena Prieto, M.; Igartua, Daniela E.; Lis Femia, A.; Silvia Amor, M.; del Valle Alonso, Silvia] Univ Nacl Quilmes, Dept Ciencia & Tecnol, Lab Biomembranas LBM, Bernal, Argentina; [Jimena Prieto, M.; Igartua, Daniela E.; del Valle Alonso, Silvia] La Plata CONICET, CCT, CICPBA, Grp Vinculado GBEyB,IMBICE, La Plata, Buenos Aires, Argentina; [Facundo Temprana, C.] Univ Nacl Quilmes, Dept Ciencia & Tecnol, LIV, Bernal, Argentina; [Facundo Temprana, C.; Lis Femia, A.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Lis Femia, A.] CCT Santa Fe, Inst Desarrollo Tecnol Ind Quim, Grp Polimeros & Reactores Polimerizac, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Alonso, SD (corresponding author), Univ Nacl Quilmes, Dept Ciencia & Tecnol, Lab Biomembranas LBM, Bernal, Argentina.; Alonso, SD (corresponding author), La Plata CONICET, CCT, CICPBA, Grp Vinculado GBEyB,IMBICE, La Plata, Buenos Aires, Argentina.	salonso@unq.edu.ar	del V. Alonso, Silvia/A-2064-2017	del V. Alonso, Silvia/0000-0003-4243-2146; Prieto, Maria Jimena/0000-0003-1111-1200; Igartua, Daniela E./0000-0003-2285-5539	CONICET [PIP 5832/05, Res 4845/15]; Universidad Nacional de Quilmes, UNQ [UNQ-MPBio 53/1001-PUNQ0396/07, UNQ-BioNATLP-PUNQ1388/15]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Quilmes, UNQ	This work was supported by grants from the CONICET (PIP 5832/05) and Universidad Nacional de Quilmes, UNQ (UNQ-MPBio 53/1001-PUNQ0396/07 and UNQ-BioNATLP-PUNQ1388/15). Fellowship for D.E. Igartua (CONICET Ph.D. student, D.No Res 4845/15) is acknowledged. Consejo Nacional de Investigaciones Cientificas y Tecnicas: http://www.conicet.gov.ar/. Universidad Nacional de Quilmes: http://www.unq.edu.ar/.	ALBRECHT O, 1982, BIOCHIM BIOPHYS ACTA, V687, P165, DOI 10.1016/0005-2736(82)90542-9; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Alonso-Romanowski S, 2003, CHEM PHYS LIPIDS, V122, P191, DOI 10.1016/S0009-3084(02)00190-1; Baek S, 2016, POLYM J, V48, P457, DOI 10.1038/pj.2015.136; Bandeira E, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00151; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Bishop CJ, 2016, J BIOMED MATER RES A, V104, P707, DOI 10.1002/jbm.a.35610; Bishop CJ, 2013, J AM CHEM SOC, V135, P6951, DOI 10.1021/ja4002376; BLUME A, 1991, CHEM PHYS LIPIDS, V57, P253, DOI 10.1016/0009-3084(91)90080-U; Chen HM, 1996, PHARMACEUT RES, V13, P1378, DOI 10.1023/A:1016030202104; Chen Y, 2013, INT J NANOMED, V8, P1573, DOI 10.2147/IJN.S42800; Chiaramoni NS, 2007, BIOTECHNOL LETT, V29, P1637, DOI 10.1007/s10529-007-9454-y; Chiaramoni NS, 2010, J LIPOSOME RES, V20, P191, DOI 10.3109/08982100903244518; CHILDERS NK, 1989, J IMMUNOL METHODS, V119, P135, DOI 10.1016/0022-1759(89)90390-6; Congiu A, 2004, COLLOID SURFACE B, V36, P43, DOI 10.1016/j.colsurfb.2004.04.006; Daly SM, 2006, LANGMUIR, V22, P1215, DOI 10.1021/la052327p; Dass CR, 2006, J CONTROL RELEASE, V113, P155, DOI 10.1016/j.jconrel.2006.04.009; De Ilarduya CT, 2002, BIOCHIMICA BIOPHYSIC; Elouahabi A, 2005, MOL THER, V11, P336, DOI 10.1016/j.ymthe.2004.12.006; Temprana CF, 2012, CHEM PHYS LIPIDS, V165, P589, DOI 10.1016/j.chemphyslip.2012.06.007; Temprana CF, 2011, J LIPOSOME RES, V21, P141, DOI 10.3109/08982104.2010.492477; Temprana CF, 2010, LANGMUIR, V26, P10084, DOI 10.1021/la100214v; Felnerova D, 2004, CURR OPIN BIOTECH, V15, P518, DOI 10.1016/j.copbio.2004.10.005; Fernandez Ruocco MJ, 2013, LIPID POLYM MEMBRANE; Fujisawa S, 2000, ORAL DIS, V6, P215; Gallagher ES, 2015, J CHROMATOGR A, V1385, P28, DOI 10.1016/j.chroma.2015.01.052; Gasparri J, 2011, J LIPOSOME RES, V21, P124, DOI 10.3109/08982104.2010.491073; Geiger J, 2010, INT J PHARMACEUT, V390, P84, DOI 10.1016/j.ijpharm.2009.10.010; Gregoriadis G, 1995, TRENDS BIOTECHNOL, V13, P527, DOI 10.1016/S0167-7799(00)89017-4; Guo CX, 2010, COLLOID SURFACE B, V76, P362, DOI 10.1016/j.colsurfb.2009.10.009; He CX, 2010, INT J PHARMACEUT, V386, P232, DOI 10.1016/j.ijpharm.2009.11.006; Huang SH, 2013, BIOTECHNOL ADV, V31, P208, DOI 10.1016/j.biotechadv.2012.10.001; Ishiwata H, 2000, J CONTROL RELEASE, V69, P139, DOI 10.1016/S0168-3659(00)00293-5; Jelinek R, 2001, BIOTECHNOL ADV, V19, P109, DOI 10.1016/S0734-9750(00)00064-1; Prieto MJ, 2011, EUR J MED CHEM, V46, P845, DOI 10.1016/j.ejmech.2010.12.021; JOHNSTON DS, 1983, BIOCHEMISTRY-US, V22, P3194, DOI 10.1021/bi00282a024; Ketola TM, 2011, J PHYS CHEM B, V115, P1895, DOI 10.1021/jp109984c; Kshirsagar N.A., 2005, J POSTGRAD MED, V51, P5; Kwon SM, 2008, J CONTROL RELEASE, V128, P89, DOI 10.1016/j.jconrel.2008.02.004; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Majzoub RN, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0129; Mel'nikova YS, 1999, BIOPHYS CHEM, V81, P125, DOI 10.1016/S0301-4622(99)00088-5; Moret I, 2001, J CONTROL RELEASE, V76, P169, DOI 10.1016/S0168-3659(01)00415-1; Morille M, 2008, BIOMATERIALS, V29, P3477, DOI 10.1016/j.biomaterials.2008.04.036; Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mozafari MR, 2005, CELL MOL BIOL LETT, V10, P711; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Neuberg P, 2015, CHEM COMMUN, V51, P11595, DOI 10.1039/c5cc03820k; Nishimura K, 2009, LANGMUIR, V25, P10439, DOI 10.1021/la902237y; OKADA J, 1995, PHARMACEUT RES, V12, P576, DOI 10.1023/A:1016214332030; Oliveira AC, 2009, ACTA BIOMATER, V5, P2142, DOI 10.1016/j.actbio.2009.02.019; Percot A, 2004, INT J PHARMACEUT, V278, P143, DOI 10.1016/j.ijpharm.2004.03.003; Porras G, 2008, EXP NEUROL, V209, P72, DOI 10.1016/j.expneurol.2007.08.003; Poste G, 1984, LIPOSOME TECHNOLOGY, V3, P1; Pouton CW, 1998, ADV DRUG DELIVER REV, V34, P3, DOI 10.1016/S0169-409X(98)00048-9; Radler JO, 1997, SCIENCE, V275, P810, DOI 10.1126/science.275.5301.810; Remaut K, 2006, J CONTROL RELEASE, V115, P335, DOI 10.1016/j.jconrel.2006.08.009; RHODES DG, 1994, BBA-LIPID LIPID MET, V1215, P237, DOI 10.1016/0005-2760(94)90048-5; Riaz M, 1995, Pak J Pharm Sci, V8, P69; Roland I, 2003, INT J PHARM, V263, P85, DOI 10.1016/S0378-5173(03)00364-8; Safari MG, 2013, J LIPOSOME RES, V23, P174, DOI 10.3109/08982104.2013.779703; Schaefer JJ, 2012, J RAMAN SPECTROSC, V43, P351, DOI 10.1002/jrs.3050; Sharma A, 1997, INT J PHARM, V154, P123, DOI 10.1016/S0378-5173(97)00135-X; Silva BFB, 2014, BBA-BIOMEMBRANES, V1838, P398, DOI 10.1016/j.bbamem.2013.09.008; Simonsen JB, 2016, J THROMB HAEMOST, V14, P186, DOI 10.1111/jth.13176; Singh M, 2003, J CONTROL RELEASE, V92, P383, DOI 10.1016/S0168-3659(03)00360-2; Singh M, 2006, INT J PHARMACEUT, V309, P189, DOI 10.1016/j.ijpharm.2005.11.023; Song YK, 1998, BBA-BIOMEMBRANES, V1372, P141, DOI 10.1016/S0005-2736(98)00054-6; Subramaniam V, 2008, LANGMUIR, V24, P11067, DOI 10.1021/la801835g; Svenson S, 1999, LANGMUIR, V15, P4464, DOI 10.1021/la981690b; de Ilarduya CT, 2010, EUR J PHARM SCI, V40, P159, DOI 10.1016/j.ejps.2010.03.019; Vorauer-Uhl K, 2000, CYTOMETRY, V39, P166, DOI 10.1002/(SICI)1097-0320(20000201)39:2<166::AID-CYTO10>3.0.CO;2-M; Wang XL, 2013, ACS MACRO LETT, V2, P1038, DOI 10.1021/mz400500q; Yang SY, 2013, COLLOID SURFACE B, V101, P6, DOI 10.1016/j.colsurfb.2012.05.032; Yang TZ, 2014, J LIPOSOME RES, V24, P270, DOI 10.3109/08982104.2014.907306; Yavlovich A, 2009, J THERM ANAL CALORIM, V98, P97, DOI 10.1007/s10973-009-0228-8; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Zhang SB, 2004, J CONTROL RELEASE, V100, P165, DOI 10.1016/j.jconrel.2004.08.019; Zhang Y, 2012, MOL THER, V20, P1298, DOI 10.1038/mt.2012.79	80	6	6	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186194	10.1371/journal.pone.0186194	http://dx.doi.org/10.1371/journal.pone.0186194			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020107	Green Submitted, Green Published, gold			2022-12-26	WOS:000412754400079
J	Gao, R; Xu, YX; Candresse, T; He, Z; Li, SF; Ma, YX; Lu, MG				Gao, Rui; Xu, Yunxiao; Candresse, Thierry; He, Zhen; Li, Shifang; Ma, Yuxin; Lu, Meiguang			Further insight into genetic variation and haplotype diversity of Cherry virus A from China	PLOS ONE			English	Article							1ST REPORT; SWEET CHERRY; NUCLEOTIDE-SEQUENCE; GENOME SEQUENCES; RECOMBINATION; APPLE; LITTLE-CHERRY-VIRUS-1; CAPILLOVIRUS; POPULATION; HYPOTHESIS	Cherry virus A (CVA) infection appears to be prevalent in cherry plantations worldwide. In this study, the diversity of CVA isolates from 31 cherry samples collected from different orchards around Bohai Bay in northeastern China was analyzed. The complete genome of one of these isolates, ChYT52, was found to be 7,434 nt in length excluding the poly (A) tail. It shares between 79.9-98.7% identity with CVA genome sequences in GenBank, while its RdRp core is more divergent (79.1-90.7% nt identity), likely as a consequence of a recombination event. Phylogenetic analysis of ChYT52 genome with CVA genomes in Genbank resulted in at least 7 major clusters plus additional 5 isolates alone at the end of long branches suggesting the existence of further phylogroups diversity in CVA. The genetic diversity of Chinese CVA isolates from 31 samples and GenBank sequences were analyzed in three genomic regions that correspond to the coat protein, the RNA-dependent RNA polymerase core region, and the movement protein genes. With few exceptions likely representing further recombination impact, the trees various trees are largely congruent, indicating that each region provides valuable phylogenetic information. In all cases, the majority of the Chinese CVA isolates clustering in phylogroup I, together with the X82547 reference sequence from Germany. Statistically significant negative values were obtained for Tajima's D in the three genes for phylogroup I, suggesting that it may be undergoing a period of expansion. There was considerable haplotype diversity in the individual samples and more than half samples contained genetically diverse haplotypes belonging to different phylogroups. In addition, a number of statistically significant recombination events were detected in CVA genomes or in the partial genomic sequences indicating an important contribution of recombination to CVA evolution. This work provides a foundation for elucidation of the epidemiological characteristics and evolutionary history of CVA populations.	[Gao, Rui; Xu, Yunxiao; Li, Shifang; Ma, Yuxin; Lu, Meiguang] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Candresse, Thierry; Ma, Yuxin] Univ Bordeaux, INRA, UMR BFP 1332, Villenave Dornon, France; [He, Zhen] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; INRAE; UDICE-French Research Universities; Universite de Bordeaux; Yangzhou University	Lu, MG (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	mglu@ippcaas.cn	He, Zhen/GYV-6173-2022	Ma, Yuxin/0000-0003-4587-5372; He, Zhen/0000-0003-2460-1583; Candresse, Thierry/0000-0001-9757-1835; li, shifang/0000-0003-4614-1768	National Natural Science Foundation of China [31471752]; Special Fund for Agro-scientific Research in the Public Interest [201203076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the National Natural Science Foundation of China [grant number 31471752] and the Special Fund for Agro-scientific Research in the Public Interest [grant number 201203076] to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Leal R, 2011, PHYTOPATHOLOGY, V101, P1136, DOI 10.1094/PHYTO-01-11-0017; Alabi OJ, 2014, PHYTOPATHOLOGY, V104, P548, DOI 10.1094/PHYTO-06-13-0179-R; Barone M, 2006, PLANT DIS, V90, P1459, DOI 10.1094/PD-90-1459C; Chen H, 2014, ACTA VIROL, V58, P309, DOI 10.4149/av_2014_04_309; Chen SY, 2014, ARCH VIROL, V159, P1431, DOI 10.1007/s00705-013-1927-9; Dhir S, 2013, J PHYTOPATHOL, V161, P704, DOI 10.1111/jph.12121; FU YX, 1993, GENETICS, V133, P693; Gao R, 2016, J INTEGR AGR, V15, P1667, DOI 10.1016/S2095-3119(16)61343-6; Ge BB, 2014, ARCH VIROL, V159, P3197, DOI 10.1007/s00705-014-2180-6; Gibbs A, 2010, ANNU REV PHYTOPATHOL, V48, P205, DOI 10.1146/annurev-phyto-073009-114404; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Nguyen HD, 2013, VIRUS RES, V171, P138, DOI 10.1016/j.virusres.2012.11.008; Isogai Masamichi, 2004, Journal of General Plant Pathology, V70, P288, DOI 10.1007/s10327-004-0129-4; James D, 1998, ACTA HORTIC, P299, DOI 10.17660/ActaHortic.1998.472.35; JELKMANN W, 1995, J GEN VIROL, V76, P2015, DOI 10.1099/0022-1317-76-8-2015; Kesanakurti P, 2017, ARCH VIROL, V162, P2821, DOI 10.1007/s00705-017-3394-1; Kirby MJ, 2001, PLANT PATHOL, V50, P801, DOI 10.1046/j.1365-3059.2001.00624.x; Komorowska B, 2004, PLANT DIS, V88, P909, DOI 10.1094/PDIS.2004.88.8.909C; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; [卢美光 Lu Meiguang], 2015, [植物保护, Plant Protection], V41, P98; Magome H, 1997, PHYTOPATHOLOGY, V87, P389, DOI 10.1094/PHYTO.1997.87.4.389; Mandic B, 2007, J PLANT PATHOL, V89, P103; Marais A, 2008, PLANT DIS, V92, P1589, DOI 10.1094/PDIS-92-11-1589A; Marais A, 2008, ACTA HORTIC, P37, DOI 10.17660/ActaHortic.2008.781.3; Marais A, 2012, PLANT PATHOL, V61, P195, DOI 10.1111/j.1365-3059.2011.02488.x; Marais A., 2011, VIRUS VIRUS LIKE DIS, P147; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Moury B, 2006, ADV VIRUS RES, V67, P49, DOI 10.1016/S0065-3527(06)67002-4; Noorani MS, 2010, ARCH VIROL, V155, P2079, DOI 10.1007/s00705-010-0826-6; Noorani MS, 2015, J PLANT BIOCHEM BIOT, V24, P93, DOI 10.1007/s13562-013-0240-8; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Rao WL, 2009, PLANT DIS, V93, P425, DOI 10.1094/PDIS-93-4-0425B; Sabanadzovic S, 2005, J PLANT PATHOL, V87, P173; Safarova D, 2013, HORTIC SCI, V40, P37, DOI 10.17221/141/2012-HORTSCI; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Sawyer S, 1999, GENECONV COMPUTER PA; SMITH JM, 1992, J MOL EVOL, V34, P126; Svanella-Dumas L, 2005, PLANT DIS, V89, P433, DOI 10.1094/PD-89-0433A; TAJIMA F, 1989, GENETICS, V123, P585; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomitaka Y, 2006, MOL ECOL, V15, P4437, DOI 10.1111/j.1365-294X.2006.03094.x; [王文文 Wang Wenwen], 2013, [植物保护, Plant Protection], V39, P128	44	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186273	10.1371/journal.pone.0186273	http://dx.doi.org/10.1371/journal.pone.0186273			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020049	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400087
J	Ramirez, J; Orini, M; Minchole, A; Monasterio, V; Cygankiewicz, I; de Luna, AB; Martinez, JP; Laguna, P; Pueyo, E				Ramirez, Julia; Orini, Michele; Minchole, Ana; Monasterio, Violeta; Cygankiewicz, Iwona; de Luna, Antonio Bayeas; Martinez, Juan Pablo; Laguna, Pablo; Pueyo, Esther			Sudden cardiac death and pump failure death prediction in chronic heart failure by combining ECG and clinical markers in an integrated risk model	PLOS ONE			English	Article							T-WAVE ALTERNANS; RATE TURBULENCE; POSTINFARCTION PATIENTS; MORTALITY; REPOLARIZATION; EPIDEMIOLOGY; RESTITUTION; DISPERSION; THERAPY; STRATIFICATION	Background Sudden cardiac death (SCD) and pump failure death (PFD) are common endpoints in chronic heart failure (CHF) patients, but prevention strategies are different. Currently used tools to specifically predict these endpoints are limited. We developed risk models to specifically assess SCD and PFD risk in CHF by combining ECG markers and clinical variables. Methods The relation of clinical and ECG markers with SCD and PFD risk was assessed in 597 patients enrolled in the MUSIC (MUerte Subita en Insuficiencia Cardiaca) study. ECG indices included: turbulence slope (TS), reflecting autonomic dysfunction; T-wave alternans (TWA), reflecting ventricular repolarization instability; and T-peak-to-end restitution (Delta alpha(Tpe)) and T-wave morphology restitution (TMR), both reflecting changes in dispersion of repolarization due to heart rate changes. Standard clinical indices were also included. Results The indices with the greatest SCD prognostic impact were gender, New York Heart Association (NYHA) class, left ventricular ejection fraction, TWA, Delta alpha(Tpe) and TMR. For PFD, the indices were diabetes, NYHA class, Delta alpha(Tpe) and TS. Using a model with only clinical variables, the hazard ratios (HRs) for SCD and PFD for patients in the high-risk group (fifth quintile of risk score) with respect to patients in the low-risk group (first and second quintiles of risk score) were both greater than 4. HRs for SCD and PFD increased to 9 and 11 when using a model including only ECG markers, and to 14 and 13, when combining clinical and ECG markers. Conclusion The inclusion of ECG markers capturing complementary pro-arrhythmic and pump failure mechanisms into risk models based only on standard clinical variables substantially improves prediction of SCD and PFD in CHF patients.	[Ramirez, Julia] Queen Mary Univ London, William Harvey Res Inst, John Vane Sci Ctr, Dept Clin Pharmacol, Charterhouse Sq, London, England; [Orini, Michele] UCL, Inst Cardiovasc Sci, London, England; [Orini, Michele] St Bartholomeus Hosp, Barts Heart Ctr, London, England; [Minchole, Ana] Univ Oxford, Dept Comp Sci, Oxford, England; [Monasterio, Violeta] Univ San Jorge, Campus Univ, Villanueva De Gallego, Spain; [Cygankiewicz, Iwona] Med Univ Lodz, Dept Electrocardiol, Sterling Reg Ctr Heart Dis, Lodz, Poland; [de Luna, Antonio Bayeas] Santa Creu & St Pau Hosp, Catalan Inst Cardiovasc Sci, Barcelona, Spain; [Martinez, Juan Pablo; Laguna, Pablo; Pueyo, Esther] Univ Zaragoza, IIS Aragon, Aragon Inst Engn Res, Biomed Signal Interpretat & Computat Simulat BSIC, Zaragoza, Spain; [Martinez, Juan Pablo; Laguna, Pablo; Pueyo, Esther] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza, Spain	University of London; Queen Mary University London; University of London; University College London; University of Oxford; Universidad San Jorge; Medical University Lodz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Ramirez, J (corresponding author), Queen Mary Univ London, William Harvey Res Inst, John Vane Sci Ctr, Dept Clin Pharmacol, Charterhouse Sq, London, England.	j.ramirez@qmul.ac.uk	Monasterio, Violeta/A-4183-2012; Ramírez, Julia/AAB-8153-2019; Pueyo, Esther/C-6945-2009; Martinez, Juan/GXM-4393-2022; Martínez, Juan Pablo/A-2759-2009; Orini, Michele/ABF-6272-2020	Monasterio, Violeta/0000-0001-5343-5671; Ramírez, Julia/0000-0003-4130-5866; Pueyo, Esther/0000-0002-1960-407X; Martínez, Juan Pablo/0000-0002-7503-3339; Orini, Michele/0000-0001-5773-0344; Cygankiewicz, Iwona/0000-0003-3006-311X	Spanish Ministry of Economy and Competitiveness (MINEGO), Spain [TIN2013-41998-R, DPI2016-75458-R]; MULTITOOLS2HEART from GIBER-BBN through Institute de Salud Carlos III, Spain; European Social Fund (EU); Aragon Government through BSICoS group [T96]; European Research Council (ERC) [ERC-2014-StG 638284]	Spanish Ministry of Economy and Competitiveness (MINEGO), Spain; MULTITOOLS2HEART from GIBER-BBN through Institute de Salud Carlos III, Spain; European Social Fund (EU)(European Social Fund (ESF)European Commission); Aragon Government through BSICoS group; European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by projects TIN2013-41998-R to EP, PL, and JR, and DPI2016-75458-R to JPM, EP, and PL from the Spanish Ministry of Economy and Competitiveness (MINEGO), Spain, the MULTITOOLS2HEART from GIBER-BBN through Institute de Salud Carlos III, Spain to JPM, EP, and PL, the European Social Fund (EU) and Aragon Government through BSICoS group (T96) to JPM, EP, and PL, and by the European Research Council (ERC) through project ERC-2014-StG 638284 to EP.	Bauer A, 2009, J ELECTROCARDIOL, V42, P597, DOI 10.1016/j.jelectrocard.2009.07.013; Bauer A, 2009, EUR HEART J, V30, P576, DOI 10.1093/eurheartj/ehn540; Buxton AE, 2005, CIRCULATION, V111, P2537, DOI 10.1161/01.CIR.0000165057.88551.2C; Carey EC, 2008, J AM GERIATR SOC, V56, P68, DOI 10.1111/j.1532-5415.2007.01496.x; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Curtis BM, 2002, MAYO CLIN PROC, V77, P45, DOI 10.4065/77.1.45; Cygankiewicz I, 2008, HEART RHYTHM, V5, P1095, DOI 10.1016/j.hrthm.2008.04.017; DAHLBERG ST, 1990, CARDIOLOGY, V77, P31, DOI 10.1159/000174652; Deo R, 2012, CIRCULATION, V125, P620, DOI 10.1161/CIRCULATIONAHA.111.023838; Dunlay SM, 2017, NAT REV CAR IN PRESS; Figueroa MS, 2006, RESPIR CARE, V51, P403; Fisher JP, 2009, AUTON NEUROSCI-BASIC, V148, P5, DOI 10.1016/j.autneu.2009.02.003; Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Ikeda T, 2006, J AM COLL CARDIOL, V48, P2268, DOI 10.1016/j.jacc.2006.06.075; Klapholz M, 2009, MAYO CLIN PROC, V84, P718, DOI 10.4065/84.8.718; Ky B, 2012, CIRC-HEART FAIL, V5, P183, DOI 10.1161/CIRCHEARTFAILURE.111.965020; La Rovere MT, 2011, CLIN SCI, V121, P279, DOI 10.1042/CS20110063; Lane RE, 2005, HEART, V91, P674, DOI 10.1136/hrt.2003.025254; Mark DB, 2006, CIRCULATION, V114, P135, DOI 10.1161/CIRCULATIONAHA.105.581884; Marynissen T, 2014, EUROPACE, V16, P1069, DOI 10.1093/europace/eut303; Monasterio V, 2012, HEART RHYTHM, V9, P383, DOI 10.1016/j.hrthm.2011.10.027; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Mozaffarian D, 2007, CIRCULATION, V116, P392, DOI 10.1161/CIRCULATIONAHA.106.687103; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Neragi-Miandoab S, 2014, MINERVA CARDIOANGIOL, V62, P481; Ogletree-Hughes ML, 2001, CIRCULATION, V104, P881, DOI 10.1161/hc3301.094911; Pak HN, 2004, J CARDIOVASC ELECTR, V15, P1357, DOI 10.1046/j.1540-8167.2004.03569.x; Qin M, 2013, J CARDIOL, V61, P162, DOI 10.1016/j.jjcc.2012.08.016; Ramirez J, 2016, IEEE T BIOM IN PRESS; Ramirez J, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005310; Ramirez J, 2015, J ELECTROCARDIOL, V48, P551, DOI 10.1016/j.jelectrocard.2015.04.002; Ramirez J, 2014, J ELECTROCARDIOL, V47, P842, DOI 10.1016/j.jelectrocard.2014.08.013; Rang H.P, 2003, PHARMACOLOGY; Selvaraj RJ, 2009, EUROPACE, V11, P1529, DOI 10.1093/europace/eup295; Vazquez R, 2009, EUR HEART J, V30, P1088, DOI 10.1093/eurheartj/ehp032; Verrier RL, 2009, HEART RHYTHM, V6, P416, DOI 10.1016/j.hrthm.2008.11.019; Viles-Gonzalez JF, 2017, HEART RHYTHM, V14, P79, DOI 10.1016/j.hrthm.2016.11.007; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; Zannad F, 2013, EUR J HEART FAIL, V15, P1082, DOI 10.1093/eurjhf/hft095; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	42	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186152	10.1371/journal.pone.0186152	http://dx.doi.org/10.1371/journal.pone.0186152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020031	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400074
J	Kolhe, NV; Fluck, RJ; Taal, MW				Kolhe, Nitin V.; Fluck, Richard J.; Taal, Maarten W.			Effect of weekend admission on mortality associated with severe acute kidney injury in England: A propensity score matched, population-based study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; HOSPITAL EPISODE STATISTICS; REPLACEMENT; CARE	Background Increased in-hospital mortality associated with weekend admission has been reported for many acute conditions, but no study has investigated "weekend effect" for acute kidney injury requiring dialysis (AKI-D). Methods In this large, propensity score matched cohort of AKI-D, we examined the impact of weekend admission and in-centre nephrology services in 53,170 AKI-D admissions between 1st April 2003 and 31st March 2015 using a hospital episode statistic dataset. Propensity score matching (PSM) was performed to match 4284 weekend admissions with AKI-D with 14,788 admissions on weekdays. Results Of the 53,170 admissions with AKI-D in the whole dataset, 12,357 (23%) were at weekends. The unadjusted mortality for weekend admissions was significantly higher compared to admissions on weekdays (40.6% versus 39.6%, p 0.046). However, in multivariable analysis of the PSM cohort, the odds of death for weekend admissions with AKI-D was 1.01 (95% CI 0.93, 1.09). Mortality was higher for weekend admissions in West Midlands (odds ratio (OR) 1.32, 95% confidence interval (CI) 1.05, 1.66) and lower in East of England (OR 0.77, 95% CI 0.59, 1.00) but was not different to weekday admissions in all other regions. In 2003-04, weekend admissions had lower odds of death (OR 0.45, 95% CI 0.21, 0.96) and in 2010-11 higher odds of death (OR 1.28, 95% CI 1.00, 1.63) but in the other ten years observed, there was no significant difference in mortality between weekday and weekend admissions. Provision of in-centre nephrology services was associated with lower odds of death at 0.57 (95% CI 0.54, 0.62). Conclusions Weekend admissions in patients with AKI-D had no effect on mortality. Further research is warranted to elucidate the reasons for the lower mortality in hospitals with in-centre nephrology services.	[Kolhe, Nitin V.; Fluck, Richard J.; Taal, Maarten W.] Royal Derby Hosp, Dept Renal Med, Derby, England; [Kolhe, Nitin V.; Taal, Maarten W.] Univ Nottingham, Div Med Sci & Grad Entry Med, Derby, England	University of Nottingham; University of Nottingham	Kolhe, NV (corresponding author), Royal Derby Hosp, Dept Renal Med, Derby, England.; Kolhe, NV (corresponding author), Univ Nottingham, Div Med Sci & Grad Entry Med, Derby, England.	nitin.kolhe@nhs.net		Taal, Maarten/0000-0002-9065-212X; Kolhe, Nitin/0000-0003-2528-4436				Aldridge C, 2016, LANCET, V388, P178, DOI 10.1016/S0140-6736(16)30442-1; Aylin P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2424; Bray BD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001705; Crooks CJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001437; Dayer MJ, 2014, LANCET; Fotheringham J, 2014, NEPHROL DIAL TRANSPL, V29, P422, DOI 10.1093/ndt/gft363; Freemantle N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4596; James MT, 2010, J AM SOC NEPHROL, V21, P845, DOI 10.1681/ASN.2009070682; Jen MH, 2008, J HOSP INFECT, V70, P321, DOI 10.1016/j.jhin.2008.08.005; Jen MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007103; Kolhe NV, 2016, INT J CLIN PRACT, V70, P330, DOI 10.1111/ijcp.12774; Kolhe NV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162856; Kolhe NV, 2015, KIDNEY INT, V88, P1161, DOI 10.1038/ki.2015.234; Kostis WJ, 2007, NEW ENGL J MED, V350; Ponce D, 2011, NEPHROL DIAL TRANSPL, V26, P3202, DOI 10.1093/ndt/gfr359; Roberts SE, 2015, LANCET, V385, P1829, DOI 10.1016/S0140-6736(15)60580-3; Sibanda N, 2008, PLOS MED, V5, P1398, DOI 10.1371/journal.pmed.0050179; Stewart JAD, 2009, BRIT J HOSP MED, V70, P372, DOI 10.12968/hmed.2009.70.7.43116; Tomlinson LA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-58; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; Wilson FP, 2013, CLIN J AM SOC NEPHRO, V8, P1863, DOI 10.2215/CJN.03540413; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Zhou YF, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003102	24	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186048	10.1371/journal.pone.0186048	http://dx.doi.org/10.1371/journal.pone.0186048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016687	Green Published, gold, Green Submitted			2022-12-26	WOS:000412627400051
J	Echtermeyer, S; Metelmann, PH; Hemprich, A; Dannhauer, KH; Krey, KF				Echtermeyer, Sandra; Metelmann, Philine H.; Hemprich, Alexander; Dannhauer, Karl-Heinz; Krey, Karl-Friedrich			Three-dimensional morphology of first molars in relation to ethnicity and the occurrence of cleft lip and palate	PLOS ONE			English	Article							MORPHOMETRIC-ANALYSIS; TOOTH-SIZE; DIZYGOTIC TWINS; SHAPE-ANALYSIS; ASYMMETRY; DENTITION; CROWNS; TEETH	Objectives This study aims to describe morphological peculiarities of maxillary and mandibular first molars in Europeans, Asians and Europeans with cleft lip and palate. Material and methods Reflex microscopy was used to obtain three-dimensional morphometric landmarks from 40 models (11 Europeans and 13 Asians without cleft lip and palate, 16 Europeans with unilateral cleft lip and palate). The cases were examined using traditional morphometry and geometric morphometry, and visualized using thin-plate splines. Results Classic morphometry showed no right/left differences in the study groups and no significant differences with regard to the cleft side in patients with cleft lip and palate. In Asians, a significantly greater mesiodistal width was found. Geometric morphometry showed an enlarged centroid size in Asians (maxilla and mandible). In cleft patients, the cleft site did not appear to impact the morphology of first molars. Conclusion Unilateral clefting did not affect the size and shape of molars; however, characteristic ethnicity-based differences were in fact identified. The results are relevant for orthodontic treatment with preadjusted appliances, and prosthetic CAD/CAM restorations.	[Echtermeyer, Sandra] Echtermeyer Dent Practice, Leipzig, Germany; [Metelmann, Philine H.; Krey, Karl-Friedrich] Univ Med Greifswald, Ctr Dent Oral & Craniomandibular Sci, Dept Orthodont, Greifswald, Germany; [Hemprich, Alexander] Univ Med Leipzig, Dept Maxillofacial Surg & Plast Surg, Leipzig, Germany; [Dannhauer, Karl-Heinz] Univ Med Greifswald, Ctr Dent Oral & Craniomandibular Sci, Dept Orthodont, Greifswald, Germany	Greifswald Medical School; Leipzig University; Greifswald Medical School	Krey, KF (corresponding author), Univ Med Greifswald, Ctr Dent Oral & Craniomandibular Sci, Dept Orthodont, Greifswald, Germany.	kreyk@un-greifswald.de	Doberschütz, Philine/AAR-7118-2021	Doberschütz, Philine/0000-0002-1120-8398				Akcam MO, 2008, AM J ORTHOD DENTOFAC, V134, P85, DOI 10.1016/j.ajodo.2006.05.048; ANDREWS LF, 1972, AMER J ORTHODONTICS, V62, P296, DOI 10.1016/S0002-9416(72)90268-0; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Ballard M.L., 1944, ANGLE ORTHOD, V14, P67; Bernal V, 2007, HOMO, V58, P279, DOI 10.1016/j.jchb.2006.11.003; BIGGERSTAFF RH, 1970, ARCH ORAL BIOL, V15, P721, DOI 10.1016/0003-9969(70)90036-1; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Bornert Heike, 2002, J Orofac Orthop, V63, P51, DOI 10.1007/s00056-002-0055-z; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Durwald J, 2007, J OROFAC ORTHOP, V68, P183, DOI 10.1007/s00056-007-0648-7; Edgar HJH, 2005, J FORENSIC SCI, V50, P269; Endo T, 2007, ODONTOLOGY, V95, P57, DOI 10.1007/s10266-007-0066-8; ERDBRINK D. P., 1967, Z MORPHOL ANTHROPOL, V59, P40; Ferrario V F, 1999, Int J Adult Orthodon Orthognath Surg, V14, P153; Ferrario VF, 1999, AM J PHYS ANTHROPOL, V108, P281; GARN SM, 1967, J DENT RES, V46, P963, DOI 10.1177/00220345670460055801; Gomez-Robles A, 2011, EVOLUTION, V65, P1772, DOI 10.1111/j.1558-5646.2011.01244.x; Harper DAT, 2001, PALAEONTOLOGIA ELECT; HARTMAN SE, 1988, J HUM EVOL, V17, P489, DOI 10.1016/0047-2484(88)90038-3; HASEGAWA Y, 2007, DENT ANTHR, V20, P1; HELLMAN MILO, 1928, PROC AMER PHIL SOC, V67, P157; Kirchberg A, 2014, CLEFT PALATE-CRAN J, V51, P308, DOI 10.1597/12-106; Kook YA, 2004, AM J ORTHOD DENTOFAC, V126, P680, DOI 10.1016/j.ajodo.2003.10.038; KRAUS BS, 1966, J DENT RES, V45, P1736, DOI 10.1177/00220345660450062601; Krey K, 2012, VJO, V9; Krey KF, 2015, J OROFAC ORTHOP, V76, P213, DOI 10.1007/s00056-015-0290-8; Krey KF, 2009, J OROFAC ORTHOP, V70, P237, DOI 10.1007/s00056-009-8814-8; Krey KF, 2008, J OROFAC ORTHOP, V69, P424, DOI 10.1007/s00056-008-8803-3; LUNDSTROM A, 1963, AM J HUM GENET, V15, P34; Milosevic A, 1994, Community Dent Health, V11, P83; Muhlberg G, 1969, Dtsch Stomatol, V19, P689; NOSS JF, 1983, AM J PHYS ANTHROPOL, V61, P437, DOI 10.1002/ajpa.1330610406; Peretz B, 1998, ARCH ORAL BIOL, V43, P525, DOI 10.1016/S0003-9969(98)00034-X; Polychronis G, 2013, AM J PHYS ANTHROPOL, V152, P186, DOI 10.1002/ajpa.22340; Pretty IA, 2001, BRIT DENT J, V190, P359, DOI 10.1038/sj.bdj.4800972a; Reich U, 1996, GERMANY J OROFAC ORT, V57, P246; SCOTT GR, 1977, HUM BIOL, V49, P453; Singleton M, 2011, ANAT REC, V294, P322, DOI 10.1002/ar.21315; SOFAER JA, 1979, ARCH ORAL BIOL, V24, P141, DOI 10.1016/0003-9969(79)90062-1; SPECULAND B, 1988, BRIT J ORAL MAX SURG, V26, P276, DOI 10.1016/0266-4356(88)90044-7; Stancheva N, 2015, J OROFAC ORTHOP, V76, P391, DOI 10.1007/s00056-015-0299-z; Teaford MF, 1991, P SOC PHOTO-OPT INS, P33; Ungar Peter, 2000, Palaeontologia Electronica, V3, P1; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; WERNER SP, 1989, CLEFT PALATE J, V26, P36; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	46	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185472	10.1371/journal.pone.0185472	http://dx.doi.org/10.1371/journal.pone.0185472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	29016629	Green Submitted, Green Published, gold			2022-12-26	WOS:000412601800018
J	Iida, K; Teng, JF; Cho, T; Yoshikawa-Kimura, S; Iida, H				Iida, Kazuko; Teng, Jinfeng; Cho, Toshihiko; Yoshikawa-Kimura, Sato; Iida, Hidetoshi			Post-translational processing and membrane translocation of the yeast regulatory Mid1 subunit of the Cch1/VGCC/NALCN cation channel family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; calcium transport; membrane protein; membrane transport; N-linked glycosylation; protein translocation; Saccharomyces cerevisiae; signal peptidase; yeast	GATED CALCIUM-CHANNEL; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; ALPHA(2)DELTA SUBUNITS; PROTEIN TRANSLOCATION; NEURONAL EXCITABILITY; SIGNAL PEPTIDES; COMPONENT MID1; LEAK CHANNELS	Saccharomyces cerevisiae Mid1 is composed of 548 amino acids and a regulatory subunit of Cch1, a member of the eukaryotic pore-forming, four-domain cation channel family. The amino acid sequence and voltage insensitivity of Cch1 are more similar to those of Na+ leak channel non-selective (NALCN) than to the (1) subunit of voltage-gated Ca2+ channels (VGCCs). Despite a lack in overall primary sequence similarity, Mid1 resembles in some aspects VGCC (2)/ regulatory subunits and NALCN-associated proteins. Unlike animal (2)/ subunits, Mid1 and NALCN-associated proteins are essential for the function of the pore-forming subunit. We herein investigated the processing and membrane translocation of Mid1. Mid1 was found to have a 20-amino-acid-long N-terminal signal peptide and appeared to be entirely localized extracellularly. A signal peptide-deleted Mid1 protein, Mid1N23, was N-glycosylated and retained Ca2+ influx activity through Cch1. Moreover, an N-terminal truncation analysis revealed that even truncated Mid1 lacking 209 N-terminal amino acid residues was N-glycosylated and maintained Ca2+ influx activity. A 219-amino-acid-truncated Mid1 protein lost this activity but was still N-glycosylated. In the sec71 and sec72 single mutants defective in the post-translational protein transport into the endoplasmic reticulum (ER), Mid1N23 could not mediate Ca2+ influx and did not undergo N-glycosylation, whereas wild-type Mid1 exhibited normal Ca2+ influx activity and N-glycosylation in these mutants. Therefore, the signal peptide-lacking Mid1N23 protein may be translocated to the ER exclusively through the post-translational protein translocation, which typically requires an N-terminal signal peptide. Mid1 may provide a tool for studying mechanisms of protein translocation into the ER.	[Iida, Kazuko] Tokyo Metropolitan Inst Med Sci, Lab Biomembrane, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Teng, Jinfeng; Cho, Toshihiko; Yoshikawa-Kimura, Sato; Iida, Hidetoshi] Tokyo Gakugei Univ, Dept Biol, 4-1-1 Nukui Kita Machi, Koganei, Tokyo 1848501, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Gakugei University	Iida, H (corresponding author), Tokyo Gakugei Univ, Dept Biol, 4-1-1 Nukui Kita Machi, Koganei, Tokyo 1848501, Japan.	iida@u-gakugei.ac.jp	Iida, Hidetoshi/AAO-5506-2020		Japan Society for the Promotion of Science [B 26291026]; Grants-in-Aid for Scientific Research [26291026] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research B 26291026 (to H. I.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Barclay J, 2001, J NEUROSCI, V21, P6095, DOI 10.1523/JNEUROSCI.21-16-06095.2001; Brodbeck J, 2002, J BIOL CHEM, V277, P7684, DOI 10.1074/jbc.M109404200; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cho T, 2017, GENES CELLS, V22, P94, DOI 10.1111/gtc.12458; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; Delic M, 2013, FEMS MICROBIOL REV, V37, P872, DOI 10.1111/1574-6976.12020; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Frank K, 2008, BIOINFORMATICS, V24, P2172, DOI 10.1093/bioinformatics/btn422; Ghezzi A, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00015; GREEN N, 1992, J CELL BIOL, V116, P597, DOI 10.1083/jcb.116.3.597; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hong MP, 2010, J BIOL CHEM, V285, P10951, DOI 10.1074/jbc.M109.056218; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Iida K, 2004, FEBS LETT, V576, P291, DOI 10.1016/j.febslet.2004.09.021; Iida K, 2007, J BIOL CHEM, V282, P25659, DOI 10.1074/jbc.M703757200; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kamano S, 2015, J BIOL CHEM, V290, P30901, DOI 10.1074/jbc.M115.692574; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liebeskind BJ, 2012, MOL BIOL EVOL, V29, P3613, DOI 10.1093/molbev/mss182; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Mandon EC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013342; Martin DC, 2011, J BIOL CHEM, V286, P10744, DOI 10.1074/jbc.M110.177451; Maruoka T, 2002, J BIOL CHEM, V277, P11645, DOI 10.1074/jbc.M111603200; Nacken V, 1996, GENE, V175, P253, DOI 10.1016/0378-1119(96)00171-0; Ozeki-Miyawaki C, 2005, EXP CELL RES, V311, P84, DOI 10.1016/j.yexcr.2005.08.014; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sambrook J., 2001, MOL CLONING LAB MANU; SCOTT JH, 1980, J BACTERIOL, V142, P414, DOI 10.1128/JB.142.2.414-423.1980; Sengstag C, 2000, METHOD ENZYMOL, V327, P175, DOI 10.1016/S0076-6879(00)27275-3; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tada T, 2003, J BIOL CHEM, V278, P9647, DOI 10.1074/jbc.M206993200; Teng J, 2013, MICROBIOL-SGM, V159, P970, DOI 10.1099/mic.0.064030-0; Teng JF, 2008, MICROBIOL-SGM, V154, P3775, DOI 10.1099/mic.0.2008/021089-0; Wakamori M, 1999, J PHYSIOL-LONDON, V517, P659, DOI 10.1111/j.1469-7793.1999.0659s.x; Xie L, 2013, NEURON, V77, P1069, DOI 10.1016/j.neuron.2013.01.018; Yoshimura H, 2004, EXP CELL RES, V293, P185, DOI 10.1016/j.yexcr.2003.09.020; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	50	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20570	20582		10.1074/jbc.M117.810283	http://dx.doi.org/10.1074/jbc.M117.810283			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29042437	Green Published, hybrid			2022-12-26	WOS:000418267000018
J	Wang, T; Cook, I; Leyh, TS				Wang, Ting; Cook, Ian; Leyh, Thomas S.			The NSAID allosteric site of human cytosolic sulfotransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; kinetics; nuclear magnetic resonance (NMR); structural model; sulfotransferase; NSAID; acetylsalicylic; mefenamic; spin label	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROTEIN-LIGAND DOCKING; HUMAN-LIVER; ESTROGEN SULFOTRANSFERASE; CARDIOVASCULAR-DISEASE; MOLECULAR-DYNAMICS; PRIMARY PREVENTION; PROSTATE-CANCER; MEFENAMIC-ACID; BINDING-SITES	Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly prescribed drugs worldwidemore than 111 million prescriptions were written in the United States in 2014. NSAIDs allosterically inhibit cytosolic sulfotransferases (SULTs) with high specificity and therapeutically relevant affinities. This study focuses on the interactions of SULT1A1 and mefenamic acid (MEF)a potent, highly specific NSAID inhibitor of 1A1. Here, the first structure of an NSAID allosteric sitethe MEF-binding site of SULT1A1is determined using spin-label triangulation NMR. The structure is confirmed by site-directed mutagenesis and provides a molecular framework for understanding NSAID binding and isoform specificity. The mechanism of NSAID inhibition is explored using molecular dynamics and equilibrium and pre-steady-state ligand-binding studies. MEF inhibits SULT1A1 turnover through an indirect (helix-mediated) stabilization of the closed form of the active-site cap of the enzyme, which traps the nucleotide and slows its release. Using the NSAID-binding site structure of SULT1A1 as a comparative model, it appears that 11 of the 13 human SULT isoforms harbor an NSAID-binding site. We hypothesize that these sites evolved to enable SULT isoforms to respond to metabolites that lie within their metabolic domains. Finally, the NSAID-binding site structure offers a template for developing isozyme-specific allosteric inhibitors that can be used to regulate specific areas of sulfuryl-transfer metabolism.	[Wang, Ting; Cook, Ian; Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	tom.leyh@einstein.yu.edu			National Institutes of Health [GM121849, GM106158]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121849, R01GM106158] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants GM121849 and GM106158. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKSOY IA, 1994, BIOCHEM BIOPH RES CO, V200, P1621, DOI 10.1006/bbrc.1994.1637; Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker J, 2009, J COMPUT CHEM, V30, P317, DOI 10.1002/jcc.21052; Baron JA, 2000, ANNU REV MED, V51, P511, DOI 10.1146/annurev.med.51.1.511; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Campbell CL, 2007, JAMA-J AM MED ASSOC, V297, P2018, DOI 10.1001/jama.297.18.2018; Cook I, 2017, P NATL ACAD SCI USA, V114, pE5317, DOI 10.1073/pnas.1704500114; Cook I, 2016, P NATL ACAD SCI USA, V113, P14312, DOI 10.1073/pnas.1613913113; Cook I, 2016, CELL CHEM BIOL, V23, P579, DOI 10.1016/j.chembiol.2016.04.009; Cook I, 2015, DRUG METAB DISPOS, V43, P418, DOI 10.1124/dmd.114.061887; Cook I, 2013, J BIOL CHEM, V288, P34494, DOI 10.1074/jbc.M113.510974; Cook I, 2013, J BIOL CHEM, V288, P8619, DOI 10.1074/jbc.M112.445015; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Cook I, 2012, BIOCHEMISTRY-US, V51, P5674, DOI 10.1021/bi300631g; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DUFFEL MW, 1981, J BIOL CHEM, V256, P1123; Eisenhofer G, 1999, CLIN EXP PHARMACOL P, V26, pS41; FALANY CN, 1989, BIOCHEM J, V260, P641, DOI 10.1042/bj2600641; Fuster V, 2011, CIRCULATION, V123, P768, DOI 10.1161/CIRCULATIONAHA.110.963843; Gamage NU, 2005, J BIOL CHEM, V280, P41482, DOI 10.1074/jbc.M508289200; GIRVIN ME, 1995, BIOCHEMISTRY-US, V34, P1635, DOI 10.1021/bi00005a020; Glatt H, 1997, FASEB J, V11, P314, DOI 10.1096/fasebj.11.5.9141497; Glatt H, 2000, CHEM-BIOL INTERACT, V129, P141, DOI 10.1016/S0009-2797(00)00202-7; Guan JY, 2013, J AM CHEM SOC, V135, P5859, DOI 10.1021/ja401323m; Gurpinar E, 2014, CLIN CANCER RES, V20, P1104, DOI 10.1158/1078-0432.CCR-13-1573; Haas J, 2013, DATABASE-OXFORD, V2013, DOI DOI 10.1093/DATABASE/BAT031; Huang WT, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003909; John M, 2006, J AM CHEM SOC, V128, P12910, DOI 10.1021/ja063584z; King RS, 2006, CURR DRUG METAB, V7, P745, DOI 10.2174/138920006778520615; LEVY G, 1971, J PHARM SCI, V60, P215, DOI 10.1002/jps.2600600212; Leyh TS, 2013, DRUG METAB REV, V45, P423, DOI 10.3109/03602532.2013.835625; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; Mora S, 2016, JAMA INTERN MED, V176, P1195, DOI 10.1001/jamainternmed.2016.2648; Nowell S, 2004, CANCER EPIDEM BIOMAR, V13, P270, DOI 10.1158/1055-9965.EPI-03-0047; Patrignani P, 2016, J AM COLL CARDIOL, V68, P967, DOI 10.1016/j.jacc.2016.05.083; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; Richman IB, 2017, MED CLIN N AM, V101, P713, DOI 10.1016/j.mcna.2017.03.004; SCHMITZ U, 1993, J MOL BIOL, V234, P373, DOI 10.1006/jmbi.1993.1593; Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014; Smith CJ, 2017, CANCER EPIDEM BIOMAR, V26, P845, DOI 10.1158/1055-9965.EPI-16-1027; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; Strauch KA, 2011, AAOHN J, V59, P525, DOI 10.3928/08910162-20111123-01; Sun MH, 2010, BIOCHEMISTRY-US, V49, P4779, DOI 10.1021/bi902190r; Teubner W, 2007, BIOCHEM J, V404, P207, DOI 10.1042/BJ20061431; THOMAS BH, 1972, CLIN PHARMACOL THER, V13, P906; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Venkataraman H, 2014, CHEM RES TOXICOL, V27, P2071, DOI 10.1021/tx500288b; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; Verdonk ML, 2004, J CHEM INF COMP SCI, V44, P793, DOI 10.1021/ci034289q; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vietri M, 2000, EUR J CLIN PHARMACOL, V56, P81, DOI 10.1007/s002280050725; Vietri M, 2002, XENOBIOTICA, V32, P587, DOI 10.1080/00498250210131581; Walczak K, 2017, POSTEP HIG MED DOSW, V71, P149; Wang LQ, 2005, J STEROID BIOCHEM, V96, P367, DOI 10.1016/j.jsbmb.2005.05.002; Wang T, 2016, BIOCHEMISTRY-US, V55, P4036, DOI 10.1021/acs.biochem.6b00401; Wang T, 2016, DRUG METAB DISPOS, V44, P481, DOI 10.1124/dmd.115.068205; Wang T, 2014, BIOCHEMISTRY-US, V53, P6893, DOI 10.1021/bi501120p; WHITEHOUSE LW, 1977, J PHARM SCI, V66, P1399, DOI 10.1002/jps.2600661012; WHITEHOUSE LW, 1975, J PHARM SCI, V64, P819, DOI 10.1002/jps.2600640519; Whiteley CG, 1999, BIOCHEM EDUC, V27, P15, DOI 10.1016/S0307-4412(98)00265-9; Zhou YJ, 2014, PHARMACOEPIDEM DR S, V23, P43, DOI 10.1002/pds.3463	65	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20305	20312		10.1074/jbc.M117.817387	http://dx.doi.org/10.1074/jbc.M117.817387			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29038294	Green Published, hybrid			2022-12-26	WOS:000417696400033
J	Cho, JH; Lim, JY; Cho, JY				Cho, Jang Ho; Lim, Jae Yun; Cho, Jae Yong			Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy	PLOS ONE			English	Article							SURGERY; PATTERNS	Aim To compare capecitabine and oxaliplatin (XELOX) with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy. Methods Clinical data from 206 patients who received XELOX or S-1 regimens as adjuvant chemotherapy in stage III gastric cancer were collected. Patients were divided into 2 groups according to regimen; the groups were XELOX (n = 114) and S-1 monotherapy (n = 92). Results 3-year disease-free survival (DFS) was higher in the S-1 group than in the XELOX group (66.6% vs 59.1%; p = 0.636).3-year overall survival (OS) was 75.6% in the S-1 group and 69.6% in the XELOX group (p = 0.495). But, the difference was not statistically significant. Especially, for patients with stage IIIC disease, 3-year overall survival was 55.2% in the XELOX group and 39.0% in the S-1 group (hazard ratio, HR 0.50, 95% confidence interval, CI 0.23-1.10; p = 0.075). In multivariate analysis, N stage (HR, 5.639; 95% CI, 1.297- 24.522; p = 0.021) and cycle completion as planned (HR, 5.734; 95% CI, 3.007-10.936; p<0.001) were independent predictors of overall survival. Conclusion Adjuvant XELOX and S-1 regimen did not prove anything superior for stage III gastric cancer in this study. But, XELOX had a tendency to be superior to S-1 in stage IIIC gastric cancer after D2 gastrectomy although the difference was not statistically significant. N stage and cycle completion as planned were prognostic factors.	[Cho, Jang Ho; Lim, Jae Yun; Cho, Jae Yong] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Div Med Oncol,Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System	Cho, JY (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Div Med Oncol,Dept Internal Med, Seoul, South Korea.	chojy@yuhs.ac		Cho, Jae Yong/0000-0002-0926-1819				Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Deng JY, 2011, SURG TODAY, V41, P210, DOI 10.1007/s00595-009-4251-y; Edge SB, 2010, AJCC CANC STAGING MA; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gallo A, 2006, WORLD J GASTROENTERO, V12, P3237, DOI 10.3748/wjg.v12.i20.3237; Gunderson LL, 2002, SEMIN RADIAT ONCOL, V12, P150, DOI 10.1053/srao.2002.30817; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; NCCN, 2016, GASTRIC CANC; Oh CM, 2016, CANCER RES TREAT, V48, P436, DOI 10.4143/crt.2016.089; Ohtsu A, 2006, J CLIN ONCOL, V24, P2188, DOI 10.1200/JCO.2006.05.9758; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Park Joong-Min, 2006, Cancer Res Treat, V38, P13, DOI 10.4143/crt.2006.38.1.13; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Waddell T, 2013, ANN ONCOL, V24, P57, DOI 10.1093/annonc/mdt344	18	9	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e186362	10.1371/journal.pone.0186362	http://dx.doi.org/10.1371/journal.pone.0186362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040299	gold, Green Submitted, Green Published			2022-12-26	WOS:000413167500039
J	Chen, YT; Lin, CF; Chen, YM; Lo, CE; Chen, WE; Chen, TY				Chen, Yi-Tien; Lin, Chao-Fen; Chen, Young-Mao; Lo, Chih-En; Chen, Wan-Erh; Chen, Tzong-Yueh			Viral infection upregulates myostatin promoter activity in orange-spotted grouper (Epinephelus coioides)	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; PROTEIN-KINASE PKR; FUNCTIONAL-ANALYSIS; DIFFERENTIAL EXPRESSION; ATLANTIC SALMON; CANCER CACHEXIA; SPARUS-AURATA; GENE; BINDING; MYOD	Myostatin is a negative regulator of myogenesis and has been suggested to be an important factor in the development of muscle wasting during viral infection. The objective of this study was to characterize the main regulatory element of the grouper myostatin promoter and to study changes in promoter activity due to viral stimulation. In vitro and in vivo experiments indicated that the E-box E6 is a positive cis-and trans-regulation motif, and an essential binding site for MyoD. In contrast, the E-box E5 is a dominant negative cis-regulatory. The characteristics of grouper myostatin promoter are similar in regulation of muscle growth to that of other species, but mainly through specific regulatory elements. According to these results, we conducted a study to investigate the effect of viral infection on myostatin promoter activity and its regulation. The nervous necrosis virus (NNV) treatment significantly induced myostatin promoter activity. The present study is the first report describing that specific myostatin motifs regulate promoter activity and response to viral infection.	[Chen, Yi-Tien; Lin, Chao-Fen; Chen, Young-Mao; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Coll Biosci & Biotechnol, Lab Mol Genet, Tainan, Taiwan; [Chen, Yi-Tien; Lin, Chao-Fen; Chen, Young-Mao; Lo, Chih-En; Chen, Wan-Erh; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Inst Biotechnol, Coll Biosci & Biotechnol, Lab Mol Genet, Tainan, Taiwan; [Chen, Young-Mao; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Translat Ctr Marine Biotechnol, Tainan, Taiwan; [Chen, Young-Mao; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Agr Biotechnol Res Ctr, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Chen, TY (corresponding author), Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Coll Biosci & Biotechnol, Lab Mol Genet, Tainan, Taiwan.; Chen, TY (corresponding author), Natl Cheng Kung Univ, Inst Biotechnol, Coll Biosci & Biotechnol, Lab Mol Genet, Tainan, Taiwan.; Chen, TY (corresponding author), Natl Cheng Kung Univ, Translat Ctr Marine Biotechnol, Tainan, Taiwan.; Chen, TY (corresponding author), Natl Cheng Kung Univ, Agr Biotechnol Res Ctr, Tainan, Taiwan.	ibcty@mail.ncku.edu.tw		Chen, Yi-Tien/0000-0003-3515-773X; Chen, Tzong-Yueh/0000-0002-5854-2895	Ministry of Science and Technology [MOST 103-2321-B-006-015, MOST 103-2313-B-006-004-MY3]; Headquarters of University Advancement at the National Cheng Kung University - Ministry of Education, Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Headquarters of University Advancement at the National Cheng Kung University - Ministry of Education, Taiwan	This research was supported by the Ministry of Science and Technology (https://www. most.gov.tw/) (MOST 103-2321-B-006-015 and MOST 103-2313-B-006-004-MY3) and the Headquarters of University Advancement at the National Cheng Kung University, which is sponsored by the Ministry of Education (https:// www.edu.tw/), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2007, CLIN CANCER RES, V13, P1356, DOI 10.1158/1078-0432.CCR-06-2307; APONE S, 1995, J BIOL CHEM, V270, P21420, DOI 10.1074/jbc.270.36.21420; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; CATALA F, 1995, MOL CELL BIOL, V15, P4585; Ceccarelli E, 1999, DEV BIOL, V213, P217, DOI 10.1006/dbio.1999.9345; Chen NC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005203; Chen YM, 2007, COMP BIOCHEM PHYS D, V2, P215, DOI 10.1016/j.cbd.2007.04.003; Chen YM, 2008, DEV COMP IMMUNOL, V32, P825, DOI 10.1016/j.dci.2007.12.003; Chi SC, 1999, J FISH DIS, V22, P173, DOI 10.1046/j.1365-2761.1999.00152.x; Chiang YA, 2016, FISH SHELLFISH IMMUN, V48, P212, DOI 10.1016/j.fsi.2015.11.016; Costamagna D, 2015, ROLE INFLAMMATION MU, V2015; Costelli P, 2008, EUR J CLIN INVEST, V38, P531, DOI 10.1111/j.1365-2362.2008.01970.x; Damsgard B, 1998, AQUACULTURE, V163, P185, DOI 10.1016/S0044-8486(98)00242-7; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; De Santis C, 2011, MOL CELL ENDOCRINOL, V335, P158, DOI 10.1016/j.mce.2011.01.011; Deng B, 2012, MOL CELL BIOCHEM, V363, P291, DOI 10.1007/s11010-011-1181-y; Du R, 2007, J BIOCHEM MOL BIOL, V40, P547; Eley HL, 2007, J BIOL CHEM, V282, P7087, DOI 10.1074/jbc.M610378200; Escobar J, 2004, J NUTR, V134, P3047, DOI 10.1093/jn/134.11.3047; FUNKENSTEIN B, 2010, BIOMED CENTRAL, V11, DOI DOI 10.1186/1471-2199-11-37; Funkenstein B, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-37; Garikipati DK, 2006, J ENDOCRINOL, V190, P879, DOI 10.1677/joe.1.06866; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hu YS, 2013, FISH SHELLFISH IMMUN, V35, P1874, DOI 10.1016/j.fsi.2013.09.024; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kerr T, 2005, EVOL DEV, V7, P390, DOI 10.1111/j.1525-142X.2005.05044.x; Kocabas AM, 2002, BBA-GENE STRUCT EXPR, V1575, P99, DOI 10.1016/S0167-4781(02)00289-0; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Ma K, 2001, AM J PHYSIOL-ENDOC M, V281, pE1128, DOI 10.1152/ajpendo.2001.281.6.E1128; Maccatrozzo L, 2001, MAR BIOTECHNOL, V3, P224, DOI 10.1007/s101260000064; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Nadjar-Boger E, 2012, MOL CELL ENDOCRINOL, V361, P51, DOI 10.1016/j.mce.2012.03.017; Neiffer DL, 2009, ILAR J, V50, P343, DOI 10.1093/ilar.50.4.343; Okumura F, 2013, J BIOL CHEM, V288, P2839, DOI 10.1074/jbc.M112.401851; Ostbye TK, 2001, EUR J BIOCHEM, V268, P5249, DOI 10.1046/j.0014-2956.2001.02456.x; Pan JL, 2007, DNA SEQUENCE, V18, P279, DOI 10.1080/10425170701243492; Rescan PY, 2001, J EXP BIOL, V204, P2097; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; Rodgers BD, 2001, COMP BIOCHEM PHYS B, V129, P597, DOI 10.1016/S1096-4959(01)00350-5; Rodgers BD, 2013, ISOLATION CHARACTERI; Salerno MS, 2004, AM J PHYSIOL-CELL PH, V287, pC1031, DOI 10.1152/ajpcell.00492.2003; Spiller MP, 2002, MOL CELL BIOL, V22, P7066, DOI 10.1128/MCB.22.20.7066-7082.2002; Terova G, 2006, DOMEST ANIM ENDOCRIN, V30, P304, DOI 10.1016/j.domaniend.2005.08.003; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Zhu R, 2008, J VIROL, V82, P6889, DOI 10.1128/JVI.02385-07	49	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186506	10.1371/journal.pone.0186506	http://dx.doi.org/10.1371/journal.pone.0186506			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036192	gold, Green Published, Green Submitted			2022-12-26	WOS:000413054800043
J	Leong, IUS; Stuckey, A; Ahanian, T; Cederlof, M; Wikstrom, JD				Leong, Ivone U. S.; Stuckey, Alexander; Ahanian, Tara; Cederlof, Martin; Wikstrom, Jakob D.			Novel mutations in Darier disease and association to self-reported disease severity	PLOS ONE			English	Article							ATP2A2 MUTATIONS; HAILEY-HAILEY; PREDICTION; DISORDERS; SPECTRUM; FEATURES; DATABASE; MUTANTS; SERCA2; PUMP	Darier disease is a rare and severe autosomal dominant skin disease characterised by malodorous keratotic papules in seborrheic areas of the skin. Darier disease affects up to 1 in 30 000 people and is caused by mutations in the ATP2A2 gene, which encodes to the sarco/endoplasmic reticulum calcium-ATPase isoform 2 that pumps calcium into the endoplasmic reticulum. Although many ATP2A2 variants have been described, it is not known if genotype correlates with phenotype, which could be important for prognosis and treatment. This is the first study to use whole exome sequencing to screen the ATP2A2 gene in a cohort of 28 clinically diagnosed Darier disease patients. Twenty-one different disease causing variants were identified and 15 of these were novel. Sixteen of the 21 variants were predicted to be pathogenic using in silico prediction programs. There were seven missense, four intronic/splice-sites, three frameshifts, two in-frame deletions, four nonsense and one synonymous mutations. This study also found ten patients who harbour more than one ATP2A2 variant. The phenotype of the patient cohort was assessed by photography and by patient questionnaires. The genotype-phenotype association was examined for all variants in relation to the patient's disease severity score, and no correlation could be established.	[Leong, Ivone U. S.; Ahanian, Tara; Wikstrom, Jakob D.] Karolinska Inst, Dept Med Solna, Dermatol & Venereol Unit, Stockholm, Sweden; [Stuckey, Alexander] Royal Inst Technol, Sci Life Lab, Sch Biotechnol, Div Gene Technol, Stockholm, Sweden; [Ahanian, Tara; Wikstrom, Jakob D.] Karolinska Univ Hosp, Dermato Venereol Clin, Stockholm, Sweden; [Cederlof, Martin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Wikstrom, JD (corresponding author), Karolinska Inst, Dept Med Solna, Dermatol & Venereol Unit, Stockholm, Sweden.; Wikstrom, JD (corresponding author), Karolinska Univ Hosp, Dermato Venereol Clin, Stockholm, Sweden.	jakob.wikstrom@ki.se		Wikstrom, Jakob/0000-0002-4287-1774; Leong, Ivone/0000-0002-0831-3461	Swedish Research Council; Swedish Society for Medical Research (SSMF); Olle Engkvist stiftelse; Hudfonden; Tore Nilssons stiftelse; Jeanssons stiftelse; Lars Hiertas stiftelse; OE Ostermanns stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research (SSMF); Olle Engkvist stiftelse; Hudfonden; Tore Nilssons stiftelse; Jeanssons stiftelse; Lars Hiertas stiftelse; OE Ostermanns stiftelse	This study was financially supported by the Swedish Research Council, Swedish Society for Medical Research (SSMF), Olle Engkvist stiftelse, Hudfonden, Tore Nilssons stiftelse, Jeanssons stiftelse, Lars Hiertas stiftelse and OE Ostermanns stiftelse to Jakob D Wikstrom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahn W, 2003, J BIOL CHEM, V278, P20795, DOI 10.1074/jbc.M301638200; [Anonymous], 2003, J BIOL CHEM, V278, P47877; Bchetnia M, 2009, ARCH DERMATOL RES, V301, P615, DOI 10.1007/s00403-009-0963-5; Bchetnia M, 2009, ARCH DERMATOL, V145, P654, DOI 10.1001/archdermatol.2009.52; BERG D, 1993, INT J DERMATOL, V32, P397, DOI 10.1111/j.1365-4362.1993.tb02806.x; BURGE SM, 1992, J AM ACAD DERMATOL, V27, P40, DOI 10.1016/0190-9622(92)70154-8; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S6; Cederlof M, 2015, BRIT J DERMATOL, V173, P155, DOI 10.1111/bjd.13740; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Di Palo MT, 1997, ARTHRIT CARE RES, V10, P422, DOI 10.1002/art.1790100610; Dode L, DISSECTION FUNCTIONA; Dodiuk-Gad RP, 2016, BRIT J DERMATOL, V174, P562, DOI 10.1111/bjd.14220; Exome Variant Server, NHLBI GO EX SEQ PROJ; Foggia L, 2004, AM J MED GENET C, V131C, P20, DOI 10.1002/ajmg.c.30031; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Godic A, 2010, EUR J DERMATOL, V20, P271, DOI 10.1684/ejd.2010.0913; Green EK, 2013, J DERMATOL, V40, P259, DOI 10.1111/1346-8138.12082; Jacobsen NJO, 1999, HUM MOL GENET, V8, P1631, DOI 10.1093/hmg/8.9.1631; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kiec-Wilk B, 2007, CLIN CHEM LAB MED, V45, P467, DOI 10.1515/CCLM.2007.092; Klausegger A, 2011, ARCH DERMATOL RES, V303, P371, DOI 10.1007/s00403-011-1148-6; KNAYSI GA, 1968, PLAST RECONSTR SURG, V41, P560, DOI 10.1097/00006534-196806000-00008; Leinonen PT, 2009, J INVEST DERMATOL, V129, P1379, DOI 10.1038/jid.2008.381; Leinonen PT, 2005, BRIT J DERMATOL, V153, P113, DOI 10.1111/j.1365-2133.2005.06623.x; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Leong Ivone U S, 2017, J Clin Med Res, V9, P709, DOI 10.14740/jocmr2894w; Leong IUS, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0176-z; Miyauchi Y, 2006, J BIOL CHEM, V281, P22882, DOI 10.1074/jbc.M601966200; Nellen RGL, 2017, HUM MUTAT, V38, P343, DOI 10.1002/humu.23164; Ringpfeil F, 2001, EXP DERMATOL, V10, P19, DOI 10.1034/j.1600-0625.2001.100103.x; Ruiz-Perez VL, 1999, HUM MOL GENET, V8, P1621, DOI 10.1093/hmg/8.9.1621; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; Sakuntabhai A, 1999, HUM MOL GENET, V8, P1611, DOI 10.1093/hmg/8.9.1611; Sato K, 2004, J BIOL CHEM, V279, P35595, DOI 10.1074/jbc.M404887200; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Takagi A, 2016, J DERMATOL, V43, P275, DOI 10.1111/1346-8138.13230; Tavadia S, 2002, BRIT J DERMATOL, V146, P107, DOI 10.1046/j.1365-2133.2002.04559.x; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; Wang Y, 2011, J CELL SCI, V124, P3568, DOI 10.1242/jcs.084053	41	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186356	10.1371/journal.pone.0186356	http://dx.doi.org/10.1371/journal.pone.0186356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028823	Green Submitted, Green Published, gold			2022-12-26	WOS:000412980300028
J	Mullen, NJ; Price, DH				Mullen, Nicholas J.; Price, David H.			Hydrogen peroxide yields mechanistic insights into human mRNA capping enzyme function	PLOS ONE			English	Article							CARBOXY-TERMINAL DOMAIN; II ELONGATION COMPLEX; POLYMERASE-II; HUMAN CYTOMEGALOVIRUS; CONDITIONAL MUTANTS; IN-VIVO; TRANSCRIPTION; GUANYLYLTRANSFERASE; PROMOTER; REVEALS	Capping of nascent RNA polymerase II (Pol II) transcripts is required for gene expression and the first two steps are catalyzed by separate 50 triphosphatase and guanylyltransferase activities of the human capping enzyme (HCE). The cap is added co-transcriptionally, but how the two activities are coordinated is unclear. Our previous in vitro work has suggested that an unidentified factor modulates the minimum length at which nascent transcripts can be capped. Using the same well-established in vitro system with hydrogen peroxide as a capping inhibitor, we show that this unidentified factor targets the guanylyltransferase activity of HCE. We also uncover the mechanism of HCE inhibition by hydrogen peroxide, and by using mass spectrometry demonstrate that the active site cysteine residue of the HCE triphosphatase domain becomes oxidized. Using recombinant proteins for the two separated HCE domains, we provide evidence that the triphosphatase normally acts on transcripts shorter than can be acted upon by the guanylyltransferase. Our further characterization of the capping reaction dependence on transcript length and its interaction with the unidentified modulator of capping raises the interesting possibility that the capping reaction could be regulated.	[Mullen, Nicholas J.; Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Price, DH (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.	david-price@uiowa.edu		Price, David/0000-0002-5597-385X	National Institutes of Health [R01-GM35500, R01-GM113935]; University of Iowa ICRU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113935, R01GM035500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa ICRU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health R01-GM35500 and R01-GM113935 to DHP and a University of Iowa ICRU fellowships to NJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by National Institutes of Health R01-GM35500 and R01-GM113935 to DHP and a University of Iowa ICRU fellowships to NJM. We thank Marshall Pope for expert assistance with mass spectrometer analysis and Don Luse for comments on the manuscript.	Adamson TE, 2005, J BIOL CHEM, V280, P32262, DOI 10.1074/jbc.M505532200; Andrecka J, 2009, NUCLEIC ACIDS RES, V37, P5803, DOI 10.1093/nar/gkp601; Changela A, 2001, EMBO J, V20, P2575, DOI 10.1093/emboj/20.10.2575; Cheng B, 2009, METHODS, V48, P346, DOI 10.1016/j.ymeth.2009.02.026; Cho EJ, 1998, GENE DEV, V12, P3482, DOI 10.1101/gad.12.22.3482; COPPOLA JA, 1983, P NATL ACAD SCI-BIOL, V80, P1251, DOI 10.1073/pnas.80.5.1251; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; Fresco LD, 1996, RNA, V2, P584; Ghosh A, 2011, MOL CELL, V43, P299, DOI 10.1016/j.molcel.2011.06.001; Ghosh A, 2010, WIRES RNA, V1, P152, DOI 10.1002/wrna.19; Gu MG, 2010, STRUCTURE, V18, P216, DOI 10.1016/j.str.2009.12.009; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Ho CK, 1998, J BIOL CHEM, V273, P9577, DOI 10.1074/jbc.273.16.9577; Isomura H, 2008, J VIROL, V82, P849, DOI 10.1128/JVI.01593-07; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200; Lombardi O, 2016, ONCOTARGET, V7, P82273, DOI 10.18632/oncotarget.12701; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; Mao XD, 1996, MOL CELL BIOL, V16, P475; Martinez-Rucobo FW, 2015, MOL CELL, V58, P1079, DOI 10.1016/j.molcel.2015.04.004; Moteki S, 2002, MOL CELL, V10, P599, DOI 10.1016/S1097-2765(02)00660-3; Nilson KA, 2015, MOL CELL, V59, P576, DOI 10.1016/j.molcel.2015.06.032; Ramanathan A, 2016, NUCLEIC ACIDS RES, V44, P7511, DOI 10.1093/nar/gkw551; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Schwer B, 1996, RNA, V2, P574; Schwer B, 1998, NUCLEIC ACIDS RES, V26, P2050, DOI 10.1093/nar/26.9.2050; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; SHUMAN S, 1995, MOL MICROBIOL, V17, P405, DOI 10.1111/j.1365-2958.1995.mmi_17030405.x; Souliere MF, 2008, BIOCHEMISTRY-US, V47, P3863, DOI 10.1021/bi702054a; STENBERG RM, 1984, J VIROL, V49, P190, DOI 10.1128/JVI.49.1.190-199.1984; Tsukamoto T, 1997, BIOCHEM BIOPH RES CO, V239, P116, DOI 10.1006/bbrc.1997.7439; VENKATESAN S, 1982, P NATL ACAD SCI-BIOL, V79, P340, DOI 10.1073/pnas.79.2.340; Wen YX, 1998, P NATL ACAD SCI USA, V95, P12226, DOI 10.1073/pnas.95.21.12226; Wen YX, 1999, GENE DEV, V13, P1774, DOI 10.1101/gad.13.14.1774; Yue ZY, 1997, P NATL ACAD SCI USA, V94, P12898, DOI 10.1073/pnas.94.24.12898	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186423	10.1371/journal.pone.0186423	http://dx.doi.org/10.1371/journal.pone.0186423			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028835	Green Published, Green Submitted, gold			2022-12-26	WOS:000412980300034
J	Tomida, J; Morita, Y; Shibayama, K; Kikuchi, K; Sawa, T; Akaike, T; Kawamura, Y				Tomida, Junko; Morita, Yuji; Shibayama, Keigo; Kikuchi, Ken; Sawa, Tomohiro; Akaike, Takaaki; Kawamura, Yoshiaki			Diversity and microevolution of CRISPR loci in Helicobacter cinaedi	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; HORIZONTAL GENE-TRANSFER; IDENTIFICATION; INFECTIONS; CELLULITIS; BACTEREMIA; RESISTANCE; EVOLUTION; TOOL	Helicobacter cinaedi is associated with nosocomial infections. The CRISPR-Cas system provides adaptive immunity against foreign genetic elements. We investigated the CRISPR-Cas system in H. cinaedi to assess the potential of the CRISPR-based microevolution of H. cinaedi strains. A genotyping method based on CRISPR spacer organization was carried out using 42 H. cinaedi strains. The results of sequence analysis showed that the H. cinaedi strains used in this study had two CRISPR loci (CRISPR1 and CRISPR2). The lengths of the consensus direct repeat sequences in CRISPR1 and CRISPR2 were both 36 bp-long, and 224 spacers were found in the 42 H. cinaedi strains. Analysis of the organization and sequence similarity of the spacers of the H. cinaedi strains showed that CRISPR arrays could be divided into 7 different genotypes. Each genotype had a different ancestral spacer, and spacer acquisition/deletion events occurred while isolates were spreading. Spacer polymorphisms of conserved arrays across the strains were instrumental for differentiating closely-related strains collected from the same hospital. MLST had little variability, while the CRISPR sequences showed remarkable diversity. Our data revealed the structural features of H. cinaedi CRISPR loci for the first time. CRISPR sequences constitute a valuable basis for genotyping, provide insights into the divergence and relatedness between closelyrelated strains, and reflect the microevolutionary process of H. cinaedi.	[Tomida, Junko; Morita, Yuji; Kawamura, Yoshiaki] Aichi Gakuin Univ, Sch Pharm, Dept Microbiol, Nagoya, Aichi, Japan; [Shibayama, Keigo] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Kikuchi, Ken] Tokyo Womens Med Univ, Dept Infect Dis, Tokyo, Japan; [Sawa, Tomohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Microbiol, Kumamoto, Japan; [Akaike, Takaaki] Tohoku Univ, Grad Sch Med, Dept Environm Hlth Sci & Mol Toxicol, Sendai, Miyagi, Japan	Aichi Gakuin University; National Institute of Infectious Diseases (NIID); Tokyo Women's Medical University; Kumamoto University; Tohoku University	Tomida, J (corresponding author), Aichi Gakuin Univ, Sch Pharm, Dept Microbiol, Nagoya, Aichi, Japan.	jtomida@dpc.agu.ac.jp	Kikuchi, Ken/I-8398-2019	Kikuchi, Ken/0000-0002-3165-8206	JSPS KAKENHI [16K18923]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Number 16K18923 (to JT).	Andersen JM, 2016, GENOME BIOL EVOL, V8, P2841, DOI 10.1093/gbe/evw203; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barros MPS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108353; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Briner AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133661; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; D'Elios MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40515; Devi SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-184; Dewhirst FE, 2005, J BACTERIOL, V187, P6106, DOI 10.1128/JB.187.17.6106-6118.2005; FENNELL CL, 1984, J INFECT DIS, V149, P58, DOI 10.1093/infdis/149.1.58; Garcia-Vallve S, 1999, MOL BIOL EVOL, V16, P1125, DOI 10.1093/oxfordjournals.molbev.a026203; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Goto T, 2012, J BACTERIOL, V194, P3744, DOI 10.1128/JB.00645-12; Gouy M, BIOCHIMIE; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hooton SPT, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00744; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Iwashita H, 2008, CLIN VACCINE IMMUNOL, V15, P513, DOI 10.1128/CVI.00439-07; Kawamura Y, 1999, MICROBIOL-UK, V145, P2605, DOI 10.1099/00221287-145-9-2605; Kawamura Y, 2014, J INFECT CHEMOTHER, V20, P517, DOI 10.1016/j.jiac.2014.06.007; Khan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04680; Khan S, 2012, MICROBIOL IMMUNOL, V56, P145, DOI 10.1111/j.1348-0421.2012.00421.x; KIEHLBAUCH JA, 1994, ANN INTERN MED, V121, P90, DOI 10.7326/0003-4819-121-2-199407150-00002; Kitamura T, 2007, J CLIN MICROBIOL, V45, P31, DOI 10.1128/JCM.01507-06; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Liang JG, 2013, J CLIN MICROBIOL, V51, P920, DOI 10.1128/JCM.02399-12; Mahony J, 2015, CURR OPIN BIOTECH, V32, P8, DOI [10.1016/j.copbio.2014.09.006, 10.1016/j.copbio.2014.09.00]; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Menard A, 2016, SYST APPL MICROBIOL, V39, P77, DOI 10.1016/j.syapm.2015.09.008; Minauchi K, 2010, INTERNAL MED, V49, P1733, DOI 10.2169/internalmedicine.49.3649; Miyoshi-Akiyama T, 2012, J BACTERIOL, V194, P5692, DOI 10.1128/JB.01347-12; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Murakami Hinako, 2003, Journal of Infection and Chemotherapy, V9, P344, DOI 10.1007/s10156-003-0265-3; Oyama K, 2012, J CLIN MICROBIOL, V50, P3893, DOI 10.1128/JCM.01622-12; Pettengill JB, 2014, PEERJ, V2, DOI 10.7717/peerj.340; Rimbara E, 2012, J CLIN MICROBIOL, V50, P2553, DOI 10.1128/JCM.06810-11; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Shimizu S, 2013, ACTA DERM-VENEREOL, V93, P165, DOI 10.2340/00015555-1396; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Belkum A, 2015, MBIO, V6, DOI 10.1128/mBio.01796-15; Yamaoka Y, 2009, CLIN MICROBIOL INFEC, V15, P829, DOI 10.1111/j.1469-0691.2009.02967.x; Zhu DK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3040-4	49	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186241	10.1371/journal.pone.0186241	http://dx.doi.org/10.1371/journal.pone.0186241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028814	Green Submitted, gold, Green Published			2022-12-26	WOS:000412980300024
J	van den Biggelaar, AHJ; Richmond, PC; Fuery, A; Anderson, D; Opa, C; Saleu, G; Lai, M; Francis, JP; Alpers, MP; Pomat, WS; Lehmann, D				van den Biggelaar, Anita H. J.; Richmond, Peter C.; Fuery, Angela; Anderson, Denise; Opa, Christine; Saleu, Gerard; Lai, Mildred; Francis, Jacinta P.; Alpers, Michael P.; Pomat, William S.; Lehmann, Deborah			Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; IMMUNE-RESPONSE; HYPORESPONSIVENESS; IMMUNOGENICITY; DISEASE; PERSISTENCE; 7-VALENT; EFFICACY; BOOSTER	Trial design In an earlier trial, Papua New Guinean (PNG) children at high risk of pneumococcal disease were randomized to receive 0 or 3 doses of 7-valent pneumococcal conjugate vaccine (PCV7), followed by a single dose of 23-valent pneumococcal polysaccharide vaccine (PPV23) at 9 months of age. We here studied in a non-randomized follow-up trial the persistence of pneumococcal immunity in these children at 3-5 years of age (n = 132), and in 121 community controls of a similar age with no prior pneumococcal vaccination. Methods Circulating IgG antibody titers to all PCV7 and PPV23-only serotypes 2, 5 and 7F were measured before and after challenge with 1/5 th of a normal PPV23 dose. Serotype-specific memory B-cells were enumerated at 10 months and 3-5 years of age for a subgroup of study children. Results Serotype-specific IgG antibody titers before and after challenge were similar for children who received PCV7/PPV23, PPV23 only, or no pneumococcal vaccines. Before challenge, at least 89% and 59% of children in all groups had serotype-specific titers similar to 0.35 mu g/ml and similar to 1.0 mu g/ml, respectively. Post-challenge antibody titers were higher or similar to pre-challenge titers for most children independent of pneumococcal vaccination history. The rise in antibody titers was significantly lower when pre-challenge titers were higher. Overall the relative number of serotype-specific memory B-cells remained the same or increased between 10 months and 3-5 years of age, and there were no differences in serotype-specific memory B-cell numbers at 3-5 years of age between the three groups. Conclusions Immunity induced by PCV7 and/or PPV23 immunization in infancy does not exceed that of naturally acquired immunity in 3-5-year-old children living in a highly endemic area. Also, there was no evidence that PPV23 immunization in the first year of life following PCV7 priming induces longer-term hypo-responsiveness.	[van den Biggelaar, Anita H. J.; Anderson, Denise; Lehmann, Deborah] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Richmond, Peter C.; Fuery, Angela] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA, Australia; [Opa, Christine; Saleu, Gerard; Lai, Mildred; Francis, Jacinta P.; Pomat, William S.] Papua New Guinea Inst Med Res, Goroka, Eastern Highlan, Papua N Guinea; [Alpers, Michael P.] Curtin Univ, Sch Hlth Sci, Int Hlth, Perth, WA, Australia; [Fuery, Angela] Baylor Coll Med, Houston, TX 77030 USA	Telethon Kids Institute; University of Western Australia; University of Western Australia; PNG Institute Of Medical Research; Curtin University; Baylor College of Medicine	van den Biggelaar, AHJ (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.; Richmond, PC (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA, Australia.	Anita.vandenBiggelaar@telethonkids.org.au; Peter.Richmond@uwa.edu.au	Richmond, Peter C/G-3379-2012	Richmond, Peter C/0000-0001-7562-7228; Anderson, Denise/0000-0003-0643-4136	Wellcome Trust (United Kingdom) [071613/Z/03/Z]; Australian National Health and Medical Research Council (NHMRC) [303123]; Merck; R. Douglas Wright Biomedical Career Development Award from the Australian National Health and Medical Research Council (NHMRC) [458780]; NHMRC [353514]	Wellcome Trust (United Kingdom)(Wellcome Trust); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Merck(Merck & Company); R. Douglas Wright Biomedical Career Development Award from the Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The initial Neonatal Pneumococcal Conjugate Vaccination trial was funded by an International Collaborative Project Grant of the Wellcome Trust (United Kingdom) (071613/Z/03/Z) and the Australian National Health and Medical Research Council (NHMRC) (303123). Merck sponsored the investigator-initiated follow-up study and Seqirus (formerly bioCSL) donated Pneumovax for the study. A. van den Biggelaar received salary support from an R. Douglas Wright Biomedical Career Development Award from the Australian National Health and Medical Research Council (NHMRC) (458780). D. Lehmann received funding from an NHMRC Program grant (353514). The funders had no role in study design, collection and analysis of data, decision to publish, or writing of the manuscript.	Aho Celestine, 2016, Vaccine Rep, V6, P36, DOI 10.1016/j.vacrep.2016.08.002; Carey VJ, 2012, GEE GEN ESTIMATION E, P181; Clutterbuck EA, 2012, J INFECT DIS, V205, P1408, DOI 10.1093/infdis/jis212; CROSS A, 1994, J INFECT DIS, V170, P834, DOI 10.1093/infdis/170.4.834; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Danilova E, 2005, VACCINE, V23, P4980, DOI 10.1016/j.vaccine.2005.05.028; Danilova E, 2005, VACCINE, V23, P1446, DOI 10.1016/j.vaccine.2004.09.020; De Waroux OL, 2015, PEDIATR INFECT DIS J, V34, P858, DOI 10.1097/INF.0000000000000717; Fuery A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133126; Granoff DM, 2007, PEDIATR INFECT DIS J, V26, P716, DOI 10.1097/INF.0b013e3180cc2c25; Grant LR, 2015, PEDIATR INFECT DIS J, V34, pE138, DOI 10.1097/INF.0000000000000655; Greenhill AR, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1197-0; Hamaluba M, 2015, LANCET INFECT DIS, V15, P405, DOI 10.1016/S1473-3099(15)70007-1; Laferriere C, 2011, VACCINE, V29, P6838, DOI 10.1016/j.vaccine.2011.07.097; Lee LH, 2003, VACCINE, V21, P2190, DOI 10.1016/S0264-410X(03)00025-2; LEHMANN D, 1991, ANN TROP PAEDIATR, V11, P247, DOI 10.1080/02724936.1991.11747510; Licciardi PV, 2016, J ALLERGY CLIN IMMUN, V137, P1772, DOI 10.1016/j.jaci.2015.12.1303; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Phuanukoonnon S., 2010, Papua New Guinea Medical Journal, V53, P191; Pomat WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056698; POMAT WS, 1994, INFECT IMMUN, V62, P1848, DOI 10.1128/IAI.62.5.1848-1853.1994; Poolman J, 2011, EXPERT REV VACCINES, V10, P307, DOI [10.1586/ERV.11.8, 10.1586/erv.11.8]; Quinet B, 2014, PEDIATR INFECT DIS J, V33, P1065, DOI 10.1097/INF.0000000000000459; R Core Team, 2021, R LANGUAGE ENV STAT; RILEY ID, 1986, LANCET, V2, P877; Rohner GB, 2008, J IMMUNOL, V180, P2165, DOI 10.4049/jimmunol.180.4.2165; Russell FM, 2010, VACCINE, V28, P3341, DOI 10.1016/j.vaccine.2010.02.087; Saha SK, 2016, PEDIATR INFECT DIS J, V35, P655, DOI 10.1097/INF.0000000000001037; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Sigurdardottir ST, 2014, VACCINE, V32, P417, DOI 10.1016/j.vaccine.2013.11.029; van den Biggelaar AHJ, 2011, VACCINE, V29, P5414, DOI 10.1016/j.vaccine.2011.05.065; Whitney CG, 2014, PEDIATR INFECT DIS J, V33, pS172, DOI 10.1097/INF.0000000000000076; Yoannes M, 8 INT S PNEUM PNEUM	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0185877	10.1371/journal.pone.0185877	http://dx.doi.org/10.1371/journal.pone.0185877			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028802	gold, Green Published, Green Submitted			2022-12-26	WOS:000412980300015
J	Szatmari, D; Bugyi, B; Ujfalusi, Z; Grama, L; Dudas, R; Nyitrai, M				Szatmari, David; Bugyi, Beata; Ujfalusi, Zoltan; Grama, Laszlo; Dudas, Reka; Nyitrai, Miklos			Cardiac leiomodin2 binds to the sides of actin filaments and regulates the ATPase activity of myosin	PLOS ONE			English	Article							COOPERATIVE CONFORMATIONAL-CHANGES; RESONANCE ENERGY-TRANSFER; THIN-FILAMENTS; POINTED-END; SKELETAL-MUSCLE; F-ACTIN; TROPOMYOSIN; TROPOMODULIN; FLEXIBILITY; CARDIOMYOPATHY	Leiomodin proteins are vertebrate homologues of tropomodulin, having a role in the assembly and maintenance of muscle thin filaments. Leiomodin2 contains an N-terminal tropomodulin homolog fragment including tropomyosin-, and actin-binding sites, and a C-terminal Wiskott-Aldrich syndrome homology 2 actin-binding domain. The cardiac leiomodin2 isoform associates to the pointed end of actin filaments, where it supports the lengthening of thin filaments and competes with tropomodulin. It was recently found that cardiac leiomodin2 can localise also along the length of sarcomeric actin filaments. While the activities of leiomodin2 related to pointed end binding are relatively well described, the potential side binding activity and its functional consequences are less well understood. To better understand the biological functions of leiomodin2, in the present work we analysed the structural features and the activities of Rattus norvegicus cardiac leiomodin2 in actin dynamics by spectroscopic and high-speed sedimentation approaches. By monitoring the fluorescence parameters of leiomodin2 tryptophan residues we found that it possesses flexible, intrinsically disordered regions. Leiomodin2 accelerates the polymerisation of actin in an ionic strength dependent manner, which relies on its N-terminal regions. Importantly, we demonstrate that leiomodin2 binds to the sides of actin filaments and induces structural alterations in actin filaments. Upon its interaction with the filaments leiomodin2 decreases the actin-activated Mg2+-ATPase activity of skeletal muscle myosin. These observations suggest that through its binding to side of actin filaments and its effect on myosin activity leiomodin2 has more functions in muscle cells than it was indicated in previous studies.	[Szatmari, David; Bugyi, Beata; Ujfalusi, Zoltan; Grama, Laszlo; Dudas, Reka; Nyitrai, Miklos] Univ Pecs, Med Sch, Dept Biophys, Pecs, Hungary; [Bugyi, Beata; Nyitrai, Miklos] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary; [Nyitrai, Miklos] Univ Pecs, Hungarian Acad Sci, Nuclear Mitochondrial Interact Res Grp, Pecs, Hungary	University of Pecs; University of Pecs; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Pecs	Nyitrai, M (corresponding author), Univ Pecs, Med Sch, Dept Biophys, Pecs, Hungary.; Nyitrai, M (corresponding author), Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary.; Nyitrai, M (corresponding author), Univ Pecs, Hungarian Acad Sci, Nuclear Mitochondrial Interact Res Grp, Pecs, Hungary.	miklos.nyitrai@aok.pte.hu	Szatmari, David/AAC-4507-2021; Szatmári, Dávid/AAZ-7163-2021	Szatmari, David/0000-0002-7934-6746; Nyitrai, Miklos/0000-0002-6229-4337	National Research, Development and Innovation Office; European Union [GINOP-2.3.3-15-2016-00025, EFOP-3.6.1-16-2016-00004]; Hungarian Science Foundation [K112794, K109689]; Science, Please! Research Team on Innovation [SROP-4.2.2/08/1/2008-0011]; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4A/2-11-1-2012-0001]; New National Excellence Program of the Ministry of Human Capacities; New National Excellence Program of the Ministry of Human Capacities [UNKP-16-4]	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); European Union(European Commission); Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Science, Please! Research Team on Innovation; European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF)); New National Excellence Program of the Ministry of Human Capacities; New National Excellence Program of the Ministry of Human Capacities	This work was supported by grants from the National Research, Development and Innovation Office and the European Union (GINOP-2.3.3-15-2016-00025 and EFOP-3.6.1-16-2016-00004) and the Hungarian Science Foundation (OTKA grant K112794 to MN). This work was also supported by 'Science, Please! Research Team on Innovation' (SROP-4.2.2/08/1/2008-0011), the Hungarian Science Foundation (OTKA Grant K109689 to BB), the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4A/2-11-1-2012-0001 'National Excellence Program' and the New National Excellence Program of the Ministry of Human Capacities (to BB), as well as by the UNKP-16-4 New National Excellence Program of the Ministry of Human Capacities (to BB). The present scientific contribution is dedicated to the 650th anniversary of the foundation of the University of Pecs, Hungary.	Almenar-Queralt A, 1999, J CELL SCI, V112, P1111; Boczkowska M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9314; Bugyi B, 2006, J BIOL CHEM, V281, P10727, DOI 10.1074/jbc.M510252200; Cenik BK, 2015, J CLIN INVEST, V125, P1569, DOI 10.1172/JCI80115; Chen XR, 2015, P NATL ACAD SCI USA, V112, P12687, DOI 10.1073/pnas.1512464112; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Colpan M, 2016, BBA-PROTEINS PROTEOM, V1864, P523, DOI 10.1016/j.bbapap.2016.02.009; Conley CA, 2001, GENOMICS, V73, P127, DOI 10.1006/geno.2000.6501; Conley CA, 2001, AM J PHYSIOL-CELL PH, V280, pC1645, DOI 10.1152/ajpcell.2001.280.6.C1645; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; DeForte S, 2016, MOLECULES, V21, DOI 10.3390/molecules21081090; Dominguez R, 2016, TRENDS BIOCHEM SCI, V41, P478, DOI 10.1016/j.tibs.2016.03.004; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Fowler VM, 2017, BIOPHYS J, V112, P1742, DOI 10.1016/j.bpj.2017.03.034; Fuxreiter M, 2012, MOL BIOSYST, V8, P168, DOI 10.1039/c1mb05234a; Geeves MA, 2015, J MUSCLE RES CELL M, V36, P147, DOI 10.1007/s10974-014-9389-6; Gokhin DS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/103069; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Halim D, 2017, P NATL ACAD SCI USA, V114, pE2739, DOI 10.1073/pnas.1620507114; HIGUCHI H, 1989, J BIOCHEM-TOKYO, V105, P638, DOI 10.1093/oxfordjournals.jbchem.a122717; Hild G, 2002, EUR J BIOCHEM, V269, P842, DOI 10.1046/j.0014-2956.2001.02716.x; Hild G, 1998, BIOPHYS J, V75, P3015, DOI 10.1016/S0006-3495(98)77742-2; Kis-Bicskei N, 2013, CYTOSKELETON, V70, P755, DOI 10.1002/cm.21143; Kostyukova AS, 2007, ARCH BIOCHEM BIOPHYS, V465, P227, DOI 10.1016/j.abb.2007.05.012; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Lehrer SS, 2014, J MUSCLE RES CELL M, V35, P153, DOI 10.1007/s10974-014-9383-z; Li S, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0101-y; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; LOSCALZO J, 1975, P NATL ACAD SCI USA, V72, P3412, DOI 10.1073/pnas.72.9.3412; Ly T, 2016, MOL BIOL CELL, V27, P2565, DOI 10.1091/mbc.E16-03-0200; Nanda V, 2012, J BIOL CHEM, V287, P2459, DOI 10.1074/jbc.M111.302224; Ngo KX, 2016, SCI REP-UK, V6, DOI 10.1038/srep35449; Nworu CU, 2015, J CELL SCI, V128, P239, DOI 10.1242/jcs.152702; Nyitrai M, 1999, J BIOL CHEM, V274, P12996, DOI 10.1074/jbc.274.19.12996; Ono S, 2010, CYTOSKELETON, V67, P677, DOI 10.1002/cm.20476; Oosawa F, 1972, Nihon Seirigaku Zasshi, V34, P96; ORLOVA A, 1995, J MOL BIOL, V245, P598, DOI 10.1006/jmbi.1994.0049; Papp G, 2006, BIOPHYS J, V91, P2564, DOI 10.1529/biophysj.106.087775; Pappas CT, 2015, P NATL ACAD SCI USA, V112, P13573, DOI 10.1073/pnas.1508273112; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Prochniewicz E, 1996, J MOL BIOL, V260, P756, DOI 10.1006/jmbi.1996.0435; Rao JN, 2014, SCIENCE, V345, P463, DOI 10.1126/science.1256159; Sanger JW, 2017, HANDB EXP PHARMACOL, V235, P39, DOI 10.1007/164_2016_53; Skwarek-Maruszewska A, 2010, MOL BIOL CELL, V21, P3352, DOI 10.1091/mbc.E10-02-0109; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; SOMOGYI B, 1984, BIOCHEMISTRY-US, V23, P3403, DOI 10.1021/bi00310a004; Somogyi B, 2000, J PHOTOCH PHOTOBIO B, V59, P26, DOI 10.1016/S1011-1344(00)00130-5; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Tompa P, 2015, CURR OPIN STRUC BIOL, V35, P49, DOI 10.1016/j.sbi.2015.08.009; Toth MA, 2016, J BIOL CHEM, V291, P667, DOI 10.1074/jbc.M115.683904; Tsukada T, 2011, J BIOL CHEM, V286, P2194, DOI 10.1074/jbc.M110.186924; Tsukada T, 2010, J CELL SCI, V123, P3136, DOI 10.1242/jcs.071837; Ujfalusi Z, 2012, J BIOL CHEM, V287, P31894, DOI 10.1074/jbc.M112.341230; Ujfalusi Z, 2009, BIOPHYS J, V96, P162, DOI 10.1529/biophysj.108.138420; Umeki N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20406; WEBER A, 1994, J CELL BIOL, V127, P1627, DOI 10.1083/jcb.127.6.1627; Yuen M, 2014, J CLIN INVEST, V124, P4693, DOI 10.1172/JCI75199	60	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186288	10.1371/journal.pone.0186288	http://dx.doi.org/10.1371/journal.pone.0186288			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023566	Green Published, gold, Green Submitted			2022-12-26	WOS:000412845100098
J	Guarino, K; Voorman, A; Gasteen, M; Stewart, D; Wenger, J				Guarino, Kia; Voorman, Arend; Gasteen, Maxime; Stewart, Donte; Wenger, Jay			Violence, insecurity, and the risk of polio: A systematic analysis	PLOS ONE			English	Article							IMMUNIZATION	Background Since the introduction of polio vaccines in the 1950's and 60's, eradication of poliovirus from the world has been technically feasible. Progress towards this goal, however, has been uneven and influenced by social and political factors that challenge the implementation of robust immunization programs. While violence and insecurity are often cited as barriers to eradication, current global risk models are largely based on virologic and immunologic indicators measured at national levels. In this manuscript, we quantify the relevance of indicators of violence and insecurity on the risk of polio spread. Methods and findings Using logistic regression models and public data sources, we evaluate the relationship between measures of violence and instability and the location of poliomyelitis cases between 2006 and 2015 at the country-level, both individually and after controlling for more proximal determinants of disease, such as nearby circulating poliovirus and vaccination rates. We found that increases in a country's Fragile States Index (FSI) and Global Peace Index (GPI), aggregate indicators of violence and instability, were associated with the occurrence of poliovirus cases in the subsequent year (p<0.01), even after controlling for established risk factors. These effects of violence and insecurity must be mediated through immunity and exposure to poliovirus, coarse measures of which are included in our model. This also implies that in our study, and in risk models in general, the interpretation depends on the quality and granularity of available data. Conclusion National virologic and immunologic indicators understate the risk of poliovirus spread in areas with violence and insecurity, and the inclusion of such factors improves precision. In addition, the link between violence and incidence of disease highlights the broader challenge of implementing health interventions in conflict areas. We discuss practical implications of this work in understanding and measuring the risks to polio eradication and other global health initiatives, and the policy implications of the need to reach vulnerable populations in conflict zones.	[Guarino, Kia] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Voorman, Arend; Gasteen, Maxime; Stewart, Donte; Wenger, Jay] Bill & Melinda Gates Fdn, Seattle, WA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Bill & Melinda Gates Foundation	Voorman, A (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA USA.	Arend.voorman@gatesfoundation.org		Voorman, Arend/0000-0001-6242-7796				Abimbola S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001529; Ahmed MF, 2015, FIELD NOTES COMBATIN, VV, P27; Andre M, 2014, MMWR-MORBID MORTAL W, V63, P756; [Anonymous], 2013, NAT REV MICROBIOL, V11, P67; [Anonymous], 2013, VACCINES; Bloom MM, 2004, POLIT SCI QUART, V119, P61, DOI 10.2307/20202305; Burton A, 2009, B WORLD HEALTH ORGAN, V87, P535, DOI 10.2471/BLT.08.053819; Coupland R, 2007, B WORLD HEALTH ORGAN, V85, P181, DOI 10.2471/BLT.06.037135; Findley M, 2012, BRIT J POLIT SCI, V42, P879, DOI 10.1017/S0007123412000099; IEP, 2014, 2014 GLOB PEAC IND; Kennedy J, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0123-y; Messner J.J., 2015, FRAGILE STATES INDEX; Morrison JS, 2015, HLTH SECURITY TAKES; Norris A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149074; O'Reilly KM, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2443-4; O'Reilly KM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001109; Okeibunor JC, 2015, VACCINE; Pallansch MA, 2006, NEW ENGL J MED, V355, P2508, DOI 10.1056/NEJMp068200; Pettersson T, 2015, J PEACE RES, V52, P536, DOI 10.1177/0022343315595927; R Core Team, 2013, R LANG ENV STAT COMP; Renne EP, 2014, AFRICA, V84, P466, DOI 10.1017/S0001972014000369; Taylor S, 2009, GLOB PUBLIC HEALTH, V4, P546, DOI 10.1080/17441690701727850; The World Bank, 2015, WORLD DEV INDICATORS; United Nations, 2015, ESAPWP241 UN; Voorman A, 2016, VACCINE, V34, P5946, DOI [10.1016/j.vaccine.2016.10.017, 10.1016/j.vaccine.20]; WHO, 2003, B WORLD HEAL ORGAN, V03, P1; World Health Ogranization and others, 1988, HANDB RESOLUT DECIS, V3, P1985	27	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185577	10.1371/journal.pone.0185577	http://dx.doi.org/10.1371/journal.pone.0185577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020086	gold, Green Published, Green Submitted			2022-12-26	WOS:000412754400036
J	Boone, DR; Leek, JM; Falduto, MT; Torres, KEO; Sell, SL; Parsley, MA; Cowart, JC; Uchida, T; Micci, MA; DeWitt, DS; Prough, DS; Hellmich, HL				Boone, Deborah R.; Leek, Jeanna M.; Falduto, Michael T.; Torres, Karen E. O.; Sell, Stacy L.; Parsley, Margaret A.; Cowart, Jeremy C.; Uchida, Tatsuo; Micci, Maria-Adelaide; DeWitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.			Effects of AAV-mediated knockdown of nNOS and GPx-1 gene expression in rat hippocampus after traumatic brain injury	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RNA INTERFERENCE; WORKING-MEMORY; CLINICAL-TRIALS; ISCHEMIC-INJURY; DOWN-REGULATION; NEURODEGENERATION; INHIBITION; WAKEFULNESS; CHALLENGES	Virally mediated RNA interference (RNAi) to knock down injury-induced genes could improve functional outcome after traumatic brain injury (TBI); however, little is known about the consequences of gene knockdown on downstream cell signaling pathways and how RNAi influences neurodegeneration and behavior. Here, we assessed the effects of adeno-associated virus (AAV) siRNA vectors that target two genes with opposing roles in TBI pathogenesis: the allegedly detrimental neuronal nitric oxide synthase (nNOS) and the potentially protective glutathione peroxidase 1 (GPx-1). In rat hippocampal progenitor cells, three siRNAs that target different regions of each gene (nNOS, GPx-1) effectively knocked down gene expression. However, in vivo, in our rat model of fluid percussion brain injury, the consequences of AAV-siRNA were variable. One nNOS siRNA vector significantly reduced the number of degenerating hippocampal neurons and showed a tendency to improve working memory. GPx-1 siRNA treatment did not alter TBI-induced neurodegeneration or working memory deficits. Nevertheless, microarray analysis of laser captured, virus-infected neurons showed that knockdown of nNOS or GPx-1 was specific and had broad effects on downstream genes. Since nNOS knockdown only modestly ameliorated TBI-induced working memory deficits, despite widespread genomic changes, manipulating expression levels of single genes may not be sufficient to alter functional outcome	[Boone, Deborah R.; Leek, Jeanna M.; Sell, Stacy L.; Parsley, Margaret A.; Cowart, Jeremy C.; Uchida, Tatsuo; Micci, Maria-Adelaide; DeWitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Falduto, Michael T.; Torres, Karen E. O.] GenUs Biosyst, Northbrook, IL USA	University of Texas System; University of Texas Medical Branch Galveston	Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	Department of Anesthesiology, University of Texas Medical Branch; GenUs Biosystems;  [R01 NS052532]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052532] Funding Source: NIH RePORTER	Department of Anesthesiology, University of Texas Medical Branch; GenUs Biosystems; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The funder, GenUs Biosystems provided support in the form of salaries for authors [MTF and KEOT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work was supported by R01 NS052532 (HLH) and in part by the Department of Anesthesiology, University of Texas Medical Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The funder, GenUs Biosystems provided support in the form of salaries for authors [MTF and KEOT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Supported by R01 NS052532 (HLH) and in part by the Department of Anesthesiology, University of Texas Medical Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaneya Y, 2010, METHODS MOL BIOL, V623, P313, DOI 10.1007/978-1-60761-588-0_20; [Anonymous], 2004, SAS STATO 9 1 US GUI; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Barthet G, 2013, NEUROBIOL AGING, V34, P499, DOI 10.1016/j.neurobiolaging.2012.02.024; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Boone DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127287; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Boudreau RL, 2011, HUM MOL GENET, V20, pR21, DOI 10.1093/hmg/ddr137; Cabrera GT, 2016, METHODS MOL BIOL, V1382, P67, DOI 10.1007/978-1-4939-3271-9_5; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Cavas M, 2006, PROG NEURO-PSYCHOPH, V30, P56, DOI 10.1016/j.pnpbp.2005.06.013; Chabrier PE, 1999, CELL MOL LIFE SCI, V55, P1029, DOI 10.1007/s000180050353; Chakrabarti S, 2012, J LEUKOCYTE BIOL, V91, P947, DOI 10.1189/jlb.1011513; Cheng MY, 2012, P NATL ACAD SCI USA, V109, P5475, DOI 10.1073/pnas.1113363109; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Christophel TB, 2017, TRENDS COGN SCI, V21, P111, DOI 10.1016/j.tics.2016.12.007; Conte V, 2008, RESTOR NEUROL NEUROS, V26, P45; Davidson BL, 2004, LANCET NEUROL, V3, P145, DOI 10.1016/S1474-4422(04)00678-7; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fei F, 2014, NEUROSCIENCE, V267, P187, DOI 10.1016/j.neuroscience.2014.02.037; Geib BR, 2017, HUM BRAIN MAPP, V38, P2242, DOI 10.1002/hbm.23518; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Greco R, 2017, EUR J PHARMACOL, V16, P30075; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hallock HL, 2016, J NEUROSCI, V36, P8372, DOI 10.1523/JNEUROSCI.0991-16.2016; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hortobagyi T, 2003, NEUROSCIENCE, V121, P983, DOI 10.1016/S0306-4522(03)00482-2; Hu Q, 2011, BRAIN RES, V1367, P347, DOI 10.1016/j.brainres.2010.10.002; Joshi CR, 2017, J NEUROIMMUNE PHARM, V12, P51, DOI 10.1007/s11481-016-9724-3; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Klemm V, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120119; Koch JC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.191; Landegger LD, 2017, NAT BIOTECHNOL, V35, P280, DOI 10.1038/nbt.3781; Ledford H, 2017, CRISPR STUDIES MUDDY; LeVaillant CJ, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.78; Liu M, 2012, MOL BIOL REP, V39, P593, DOI 10.1007/s11033-011-0775-5; Liu PK, 2002, ANN NY ACAD SCI, V962, P226, DOI 10.1111/j.1749-6632.2002.tb04071.x; Lu PY, 2005, ADV GENET, V54, P117, DOI 10.1016/S0065-2660(05)54006-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Mahairaki V, 2009, J NEUROSCI METH, V179, P292, DOI 10.1016/j.jneumeth.2009.02.006; Mandel RJ, 2004, CURR OPIN MOL THER, V6, P482; Masat E, 2013, DISCOV MED, V15, P379; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Miyawaki T, 2009, NAT NEUROSCI, V12, P618, DOI 10.1038/nn.2299; Munkacsy G, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.66; Munoz MF, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00059; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Ojala DS, 2015, NEUROSCIENTIST, V21, P84, DOI 10.1177/1073858414521870; Park SM, 2016, NEURAL REGEN RES, V11, P1081, DOI 10.4103/1673-5374.187039; Park SY, 2016, MOL NEU ROBIOL; Paulson H., 2005, NEUROLOGY; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Sarel A, 2017, SCIENCE, V355, P176, DOI 10.1126/science.aak9589; Scammell TE, 2017, NEURON, V93, P747, DOI 10.1016/j.neuron.2017.01.014; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Sell SL, 2016, J NEUROTRAUMA; Shabestari RM, 2017, BIOMED PHARMACOTHER, V87, P274, DOI 10.1016/j.biopha.2016.12.070; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Steinert JR, 2008, NEURON, V60, P642, DOI 10.1016/j.neuron.2008.08.025; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Torres-Ruiz R, 2017, BRIEF FUNCT GENOMICS, V16, P4, DOI 10.1093/bfgp/elw025; Towne C, 2011, MOL THER, V19, P274, DOI 10.1038/mt.2010.260; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang M, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.151, 10.1038/nplants.2016.151]; Xiong Ye, 2004, J Stroke Cerebrovasc Dis, V13, P129, DOI 10.1016/j.jstrokecerebrovasdis.2004.05.001; Zhang Y, 2003, J GENE MED, V5, P1039, DOI 10.1002/jgm.449; Zhang Z, 2015, NEUROSCIENCE, V300, P219, DOI 10.1016/j.neuroscience.2015.05.025; Zhang Z, 2014, BRAIN RES, V1583, P65, DOI 10.1016/j.brainres.2014.07.037; Zhou L, 2010, NAT MED; Zoubovsky SP, 2011, BIOCHEM BIOPH RES CO, V408, P707, DOI 10.1016/j.bbrc.2011.04.097	78	7	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185943	10.1371/journal.pone.0185943	http://dx.doi.org/10.1371/journal.pone.0185943			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016640	Green Submitted, gold, Green Published			2022-12-26	WOS:000412627400040
J	Gramsch, C; Reuter, I; Kraff, O; Quick, HH; Tanislav, C; Roessler, F; Deuschi, C; Forsting, M; Schlamann, M				Gramsch, Carolin; Reuter, Iris; Kraff, Oliver; Quick, Harald H.; Tanislav, Christian; Roessler, Florian; Deuschi, Cornelius; Forsting, Michael; Schlamann, Marc			Nigrosome 1 visibility at susceptibility weighted 7T MRI-A dependable diagnostic marker for Parkinson's disease or merely an inconsistent, age-dependent imaging finding?	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; DEEP GRAY-MATTER; DORSOLATERAL NIGRAL HYPERINTENSITY; MULTIPLE SYSTEM ATROPHY; SUBSTANTIA-NIGRA; HUMAN BRAIN; IRON DEPOSITION; IN-VIVO; HEALTHY-ADULTS; TESLA MRI	Background Visualisation of nigrosome 1, a substructure of the healthy substantia nigra, was restricted in susceptibility weighted MR imaging in almost all patients with Parkinson's disease studied so far. The purpose of this study was to determine the degree of visibility of this substructure in subjects without Parkinson's disease and to examine the potential link between increasing brain iron accumulation with age and its detectability. Methods In 46 subjects ( 21 women, 25 men; 19 to 75 y; mean age: 44.5; SD: 15.6) examined with susceptibility weighted MR imaging at 7T visibility of nigrosome 1 was rated and classified. We assessed differences related to age and to signal intensities in the substantia nigra, red nucleus and putamen as correlates of the individual iron concentration. Results In 93% nigrosome 1was at least unilaterally clearly present. In 24% at least one-sided limited visibility was observed. Using predefined classification criteria the specificity of the visibility across all age groups reached approximately 94%. We found no correlation with increasing iron concentrations with age. Conclusion Aging with a related increase in iron concentration probably does not affect the visibility of nigrosome 1 at 7T SWI MRI. Our results support the role of this feature as a future differential diagnostic tool but further large-scale prospective studies are needed to better define the extent of a "limited visibility" to which an individual can be considered healthy.	[Gramsch, Carolin; Schlamann, Marc] Univ Hosp Giessen, Dept Neuroradiol, Giessen, Germany; [Gramsch, Carolin; Deuschi, Cornelius; Forsting, Michael; Schlamann, Marc] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Reuter, Iris; Tanislav, Christian; Roessler, Florian] Univ Hosp Giessen, Dept Neurol, Giessen, Germany; [Kraff, Oliver; Quick, Harald H.] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Quick, Harald H.] Univ Hosp Essen, High Field & Hybrid MR Imaging, Essen, Germany	University Hospital of Giessen & Marburg; University of Duisburg Essen; University Hospital of Giessen & Marburg; University of Duisburg Essen; University of Duisburg Essen	Gramsch, C (corresponding author), Univ Hosp Giessen, Dept Neuroradiol, Giessen, Germany.; Gramsch, C (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	Carolin.Gramsch@radiol.med.uni.giessen.de	Kraff, Oliver/AAE-2238-2020	Kraff, Oliver/0000-0002-6006-8934				Aquino D, 2009, RADIOLOGY, V252, P165, DOI 10.1148/radiol.2522081399; Bae YJ, 2016, MOVEMENT DISORD, V31, P684, DOI 10.1002/mds.26584; Bartzokis G, 1997, MAGN RESON IMAGING, V15, P29, DOI 10.1016/S0730-725X(96)00234-2; Bilgic B, 2012, NEUROIMAGE, V59, P2625, DOI 10.1016/j.neuroimage.2011.08.077; Blazejewska AI, 2013, NEUROLOGY, V81, P534, DOI 10.1212/WNL.0b013e31829e6fd2; Brass Steven D, 2006, Top Magn Reson Imaging, V17, P31, DOI 10.1097/01.rmr.0000245459.82782.e4; Cherubini A, 2009, NEUROIMAGE, V48, P29, DOI 10.1016/j.neuroimage.2009.06.035; Cho ZH, 2011, MOVEMENT DISORD, V26, P713, DOI 10.1002/mds.23465; Cosottini M, 2014, RADIOLOGY, V271, P831, DOI 10.1148/radiol.14131448; Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Daugherty A, 2013, NEUROIMAGE, V70, P113, DOI 10.1016/j.neuroimage.2012.12.040; Daugherty AM, 2015, NEUROPSYCHOL REV, V25, P272, DOI 10.1007/s11065-015-9292-y; De Marzi R, 2016, ANN NEUROL, V79, P1026, DOI 10.1002/ana.24646; Dickson DW, 2007, BRAIN PATHOL, V17, P74, DOI 10.1111/j.1750-3639.2007.00054.x; DUGUID JR, 1986, ANN NEUROL, V20, P744, DOI 10.1002/ana.410200618; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gao P, 2015, EUR REV MED PHARMACO, V19, P4603; Gong NJ, 2015, NMR BIOMED, V28, P1267, DOI 10.1002/nbm.3366; Gramsch C, 2013, EUR RADIOL, V23, P2622, DOI 10.1007/s00330-013-2857-3; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P561, DOI 10.1002/jmri.22293; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Hagemeier J, 2013, AM J NEURORADIOL, V34, P2144, DOI 10.3174/ajnr.A3569; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Iranzo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089741; Jankovic J, 2000, ARCH NEUROL-CHICAGO, V57, P369, DOI 10.1001/archneur.57.3.369; Kim JM, 2016, PARKINSONISM RELAT D, V26, P47, DOI 10.1016/j.parkreldis.2016.01.023; Kwon DH, 2012, ANN NEUROL, V71, P267, DOI 10.1002/ana.22592; Lehericy S, 2014, MOVEMENT DISORD, V29, P1574, DOI 10.1002/mds.26043; Li W, 2014, HUM BRAIN MAPP, V35, P2698, DOI 10.1002/hbm.22360; Litvan I, 1996, J NEUROL NEUROSUR PS, V60, P615, DOI 10.1136/jnnp.60.6.615; Mahlknecht P, 2017, MOV DISORD; Mahlknecht P, 2010, NEURODEGENER DIS, V7, P300, DOI 10.1159/000314495; Noh Y, 2015, AM J NEURORADIOL, V36, P2010, DOI 10.3174/ajnr.A4412; Oh SW, 2016, AM J ROENTGENOL, V207, P1089, DOI 10.2214/AJR.16.16092; Persson N, 2015, NEUROIMAGE, V122, P385, DOI 10.1016/j.neuroimage.2015.07.050; Pfefferbaum A, 2009, NEUROIMAGE, V47, P493, DOI 10.1016/j.neuroimage.2009.05.006; Pirpamer L, 2016, NEUROBIOL AGING, V43, P149, DOI 10.1016/j.neurobiolaging.2016.04.002; Ramos P, 2014, J TRACE ELEM MED BIO, V28, P13, DOI 10.1016/j.jtemb.2013.08.001; Reiter E, 2015, MOVEMENT DISORD, V30, P1068, DOI 10.1002/mds.26171; Rodrigue KM, 2011, NEUROIMAGE, V54, P750, DOI 10.1016/j.neuroimage.2010.09.068; Schelhorn J, 2015, ACTA RADIOL, V56, P1501, DOI 10.1177/0284185114559958; Schwarz ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093814; Seppi K, 2005, J NEUROL, V252, P91, DOI 10.1007/s00415-005-0617-2; Sung YH, 2016, RADIOLOGY, V279, P849, DOI 10.1148/radiol.2015151466; THOMAS LO, 1993, AM J NEURORADIOL, V14, P1043; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; von Campenhausen S, 2005, EUR NEUROPSYCHOPHARM, V15, P473, DOI 10.1016/j.euroneuro.2005.04.007; Wallis LI, 2008, J MAGN RESON IMAGING, V28, P1061, DOI 10.1002/jmri.21563; Wang N, 2017, EUR RADIO; Xu X, 2008, NEUROIMAGE, V40, P35, DOI 10.1016/j.neuroimage.2007.11.017	53	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185489	10.1371/journal.pone.0185489	http://dx.doi.org/10.1371/journal.pone.0185489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016618	Green Submitted, Green Published, gold			2022-12-26	WOS:000412627400020
J	Kubo, Y; Imaizumi, T; Ando, M; Nakatochi, M; Yasuda, Y; Honda, H; Kuwatsuka, Y; Kato, S; Kikuchi, K; Kondo, T; Iwata, M; Nakashima, T; Yasui, H; Takamatsu, H; Okajima, H; Yoshida, Y; Maruyama, S				Kubo, Yoko; Imaizumi, Takahiro; Ando, Masahiko; Nakatochi, Masahiro; Yasuda, Yoshinari; Honda, Hiroyuki; Kuwatsuka, Yachiyo; Kato, Sawako; Kikuchi, Kyoko; Kondo, Takaaki; Iwata, Masamitsu; Nakashima, Toru; Yasui, Hiroshi; Takamatsu, Hideki; Okajima, Hiroshi; Yoshida, Yasuko; Maruyama, Shoichi			Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: A cross-sectional study in Japanese male workers	PLOS ONE			English	Article							LIFE-STYLE FACTORS; METABOLIC SYNDROME; FOLLOW-UP; RISK; POPULATION; METAANALYSIS; NEPHROPATHY; OUTCOMES; STROKE; CX3CR1	Background Several single nucleotide polymorphisms (SNPs) have been implicated in the predisposition to chronic kidney disease (CKD). Atherosclerotic disease is deeply involved in the incidence of CKD; however, whether SNPs related to arteriosclerosis are involved in CKD remains unclear. This study aimed to identify SNPs associated with CKD and to examine whether risk allele accumulation is associated with CKD. Methods We conducted a cross-sectional study using data of 4814 male workers to examine the association between estimated glomerular filtration rate (eGFR) and 59 candidate polymorphisms (17 CKD, 42 atherosclerotic diseases). We defined the genetic risk score (GRS) as the total number of risk alleles that showed a significant association in this analysis and examined the relationship with CKD (eGFR < 60 ml/min/1.73m(2)). Multivariate logistic regression, discrimination by area under the receiver operating characteristic curve, integrated discrimination improvement (IDI), and category-free net reclassification improvement (cNRI) were evaluated. Results In total, 432 participants were categorized as having CKD. We found eight candidate SNPs with P value < 0.05 (CX3CR1 rs3732379, SHROOM3 rs17319721, MTP rs1800591, PIP5K1B rs4744712, APOA5 rs662799, BRAP rs3782886, SPATA5L1 rs2467853, and MCP1 rs1024611) in the multivariate linear regression adjusted for age, body mass index, systolic blood pressure, and fasting blood glucose. Among these eight SNPs, BRAP rs3782886 and SPATA5L1 rs2467853 were significantly associated with eGFR (false discovery rate < 0.05). GRS was significantly associated with CKD (odds ratio, 1.17; 95% confidence interval, 1.09-1.26). C-statisics improved from 0.775 to 0.780 but showed no statistical significance. However, adding GRS significantly improved IDI and cNRI (0.0057, P = 0.0028, and 0.212, P < 0.001, respectively). Conclusions After adjustment for clinical factors, kidney function was associated with BRAP rs3782886 and SPATA5L1 rs2467853 and the GRS for CKD that we developed was associated CKD.	[Kubo, Yoko; Ando, Masahiko; Nakatochi, Masahiro; Kuwatsuka, Yachiyo] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Imaizumi, Takahiro; Kato, Sawako; Kikuchi, Kyoko; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi, Japan; [Yasuda, Yoshinari] Nagoya Univ, Grad Sch Med, Dept CKD Initiat, Nagoya, Aichi, Japan; [Honda, Hiroyuki] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Nagoya, Aichi, Japan; [Kondo, Takaaki] Nagoya Univ, Grad Sch Med, Program Radiol & Med Lab Sci, Nagoya, Aichi, Japan; [Iwata, Masamitsu; Nakashima, Toru; Yasui, Hiroshi] Toyota Motor Co Ltd, Safety & Hlth Promot Div, Toyota, Japan; [Takamatsu, Hideki; Okajima, Hiroshi] Toyota Motor Co Ltd, R & D Management Div, Toyota, Japan; [Yoshida, Yasuko] Nagoya Univ, Innovat Res Ctr Preventat Med Engn, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; Nagoya University; Toyota Motor Corporation; Toyota Motor Corporation; Nagoya University	Ando, M (corresponding author), Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan.	mando@med.nagoya-u.ac.jp	Nakatochi, Masahiro/Q-1247-2015; Kato, Sawako/T-2422-2019	Nakatochi, Masahiro/0000-0002-1838-4837; Kato, Sawako/0000-0001-7210-1888	Nagoya University Institute of Innovation for Future Society; government-led Comprehensive Special Zones for Local Revitalization project,; Toyota Motor Corporation Limited	Nagoya University Institute of Innovation for Future Society; government-led Comprehensive Special Zones for Local Revitalization project,; Toyota Motor Corporation Limited	Support for this work was provided by the Center of Innovation Stream Program at the Nagoya University Institute of Innovation for Future Society, government-led Comprehensive Special Zones for Local Revitalization project, and Toyota Motor Corporation Limited. Five authors (Masamitsu Iwata, Toru Nakashima, Hiroshi Yasui, Hideki Takamatsu, and Hiroshi Okajima) have an affiliation to the commercial funders of this research study: Toyota Motor Corporation Limited. We carefully reviewed the contribution of these authors and confirmed that although the funder provided support in the form of salaries for the five authors, it did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292; Brenner D, 2006, STROKE, V37, P1691, DOI 10.1161/01.STR.0000226565.76113.6c; Bruce MA, 2015, ADV CHRONIC KIDNEY D, V22, P46, DOI 10.1053/j.ackd.2014.06.008; Cai GJ, 2015, MOL BIOL REP, V42, P997, DOI 10.1007/s11033-014-3836-8; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Dabrowska-Zamojcin E, 2015, TRANSPL IMMUNOL, V32, P172, DOI 10.1016/j.trim.2015.04.002; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Rios-Gonzalez BE, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/150358; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gorski M, 2015, KIDNEY INT, V87, P1017, DOI 10.1038/ki.2014.361; Hashimoto Y, 2015, CLIN J AM SOC NEPHRO, V10, P578, DOI 10.2215/CJN.08980914; Hishida A, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-162; Hishida A, 2012, ENDOCR J, V59, P589, DOI 10.1507/endocrj.EJ11-0310; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Imaizumi T, 2016, OBES RES CLIN PRACT; Imaizumi T, 2016, CLIN EXP NEPHROL; Iseki Kunitoshi, 2005, Clin Exp Nephrol, V9, P46, DOI 10.1007/s10157-004-0332-9; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Ledmyr H, 2004, CIRCULATION, V109, P2279, DOI 10.1161/01.CIR.0000130070.96758.7b; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Mao S, 2014, RENAL FAILURE, V36, P139, DOI 10.3109/0886022X.2013.832690; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Nakatochi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117591; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pham MHT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049498; Su N, 2015, J RECEPT SIG TRANSD, V35, P94, DOI 10.3109/10799893.2014.936458; Tanaka H, 2006, KIDNEY INT, V69, P369, DOI 10.1038/sj.ki.5000050; Tozawa M, 2007, HYPERTENS RES, V30, P937, DOI 10.1291/hypres.30.937; Wakasugi M, 2013, HYPERTENS RES, V36, P328, DOI 10.1038/hr.2012.186; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yoshida T, 2009, CLIN J AM SOC NEPHRO, V4, P883, DOI 10.2215/CJN.04350808	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185476	10.1371/journal.pone.0185476	http://dx.doi.org/10.1371/journal.pone.0185476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016630	Green Submitted, gold, Green Published			2022-12-26	WOS:000412627400019
J	Magistro, G; Magistro, C; Stief, CG; Schubert, S				Magistro, Giuseppe; Magistro, Christiane; Stief, Christian G.; Schubert, Soeren			The high-pathogenicity island (HPI) promotes flagellum-mediated motility in extraintestinal pathogenic Escherichia coli	PLOS ONE			English	Article							URINARY-TRACT COLONIZATION; YERSINIA-ENTEROCOLITICA; GENE-EXPRESSION; IRON UPTAKE; TRANSCRIPTIONAL REGULATION; SIDEROPHORE PRODUCTION; EPITHELIAL-CELLS; UROTHELIAL CELLS; VIRULENCE; INFECTION	The key of success of extraintestinal pathogenic Escherichia coli (ExPEC) to colonize niches outside the intestinal tract and to establish infection is the coordinated action of numerous virulence and fitness factors. The so-called high-pathogenicity island (HPI), responsible for synthesis, secretion and uptake of the siderophore yersiniabactin, proved to be an important virulence determinant. In this study we investigated the interaction of the flagellum-mediated motility and the HPI. The impairment of yersiniabactin production by deletion of irp2 or ybtA affected significantly motility. The gain of yersiniabactin production improved motility in both pathogenic and non-pathogenic E. coli strains. The loss of flagella expression had no adverse effect on the HPI. Strikingly, external iron abundance was not able to suppress activation of the HPI during motility. The HPI activity of swarming bacteria was comparable to iron deplete conditions, and could even be maximized by supplementing excessive iron. This fact is the first description of a regulatory mechanism, which does not follow the known hierarchical regulation of siderophore systems. Transcriptional reporter fusions of the ybtA promoter demonstrated that the entire promoter region with all YbtA binding sites is necessary for complete induction in both HPI-positive and HPI-negative strains. Altogether, these results suggest that the HPI is part of a complex regulatory network, which orchestrates various virulence mechanisms to optimize the overall fitness of ExPEC.	[Magistro, Giuseppe; Stief, Christian G.] Ludwig Maximilians Univ Munchen, Dept Urol, Munich, Germany; [Magistro, Christiane; Schubert, Soeren] Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany	University of Munich; University of Munich	Magistro, G (corresponding author), Ludwig Maximilians Univ Munchen, Dept Urol, Munich, Germany.	Giuseppe.Magistro@med.uni-muenchen.de						Alteri CJ, 2007, INFECT IMMUN, V75, P2679, DOI 10.1128/IAI.00076-06; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Anisimov R, 2005, FEMS MICROBIOL LETT, V250, P27, DOI 10.1016/j.femsle.2005.06.040; Anisimov R, 2005, INT J MED MICROBIOL, V295, P19, DOI 10.1016/j.ijmm.2004.11.007; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Feldmann F, 2007, INFECT IMMUN, V75, P3183, DOI 10.1128/IAI.00656-06; Fetherston JD, 1996, MOL MICROBIOL, V22, P315, DOI 10.1046/j.1365-2958.1996.00118.x; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gao QQ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-143; Garcia EC, 2011, INFECT IMMUN, V79, P1225, DOI 10.1128/IAI.01222-10; Garenaux A, 2011, VET MICROBIOL, V153, P89, DOI 10.1016/j.vetmic.2011.05.023; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P17104, DOI 10.1021/bi9850524; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hagan EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001187; Hancock V, 2008, MICROBIOL-SGM, V154, P167, DOI 10.1099/mic.0.2007/011981-0; HEESEMANN J, 1993, MOL MICROBIOL, V8, P397, DOI 10.1111/j.1365-2958.1993.tb01583.x; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; HULTGREN SJ, 1986, INFECT IMMUN, V54, P613, DOI 10.1128/IAI.54.3.613-620.1986; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kurabayashi K, 2016, INFECT IMMUN, V84, P3220, DOI 10.1128/IAI.00369-16; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lawlor MS, 2007, INFECT IMMUN, V75, P1463, DOI 10.1128/IAI.00372-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd AL, 2009, J BACTERIOL, V191, P3469, DOI 10.1128/JB.01717-08; Lv HT, 2011, J PROTEOME RES, V10, P5547, DOI 10.1021/pr200756n; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Matilla MA, 2007, ENVIRON MICROBIOL, V9, P1842, DOI 10.1111/j.1462-2920.2007.01286.x; MCCARTER L, 1989, J BACTERIOL, V171, P731, DOI 10.1128/jb.171.2.731-736.1989; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Paauw A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008240; Pelludat C, 2002, INFECT IMMUN, V70, P1832, DOI 10.1128/IAI.70.4.1832-1841.2002; Perry RD, 2011, MICROBES INFECT, V13, P808, DOI 10.1016/j.micinf.2011.04.008; Reigstad CS, 2007, J BIOL CHEM, V282, P21259, DOI 10.1074/jbc.M611502200; Sambrook J., 2001, MOL CLONING LAB MANU; Schubert S, 2004, INT J MED MICROBIOL, V294, P83, DOI 10.1016/j.ijmm.2004.06.026; Schubert S, 2002, INFECT IMMUN, V70, P5335, DOI 10.1128/IAI.70.9.5335-5337.2002; Schubert S, 2000, ADV EXP MED BIOL, V485, P69; Sivick KE, 2009, TRENDS MICROBIOL, V17, P431, DOI 10.1016/j.tim.2009.07.003; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Watts RE, 2012, INFECT IMMUN, V80, P333, DOI 10.1128/IAI.05594-11; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wieser A, 2012, INT J MED MICROBIOL, V302, P10, DOI 10.1016/j.ijmm.2011.09.012; Wieser A, 2010, INFECT IMMUN, V78, P3432, DOI 10.1128/IAI.00174-10; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005	54	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0183950	10.1371/journal.pone.0183950	http://dx.doi.org/10.1371/journal.pone.0183950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016611	Green Published, Green Submitted, gold			2022-12-26	WOS:000412627400005
J	Tiam, A; Gill, MM; Hoffman, HJ; Isavwa, A; Mokone, M; Foso, M; Safrit, JT; Mofenson, LM; Tylleskar, T; Guay, L				Tiam, Appolinaire; Gill, Michelle M.; Hoffman, Heather J.; Isavwa, Anthony; Mokone, Mafusi; Foso, Matokelo; Safrit, Jeffrey T.; Mofenson, Lynne M.; Tylleskar, Thorkild; Guay, Laura			Conventional early infant diagnosis in Lesotho from specimen collection to results usage to manage patients: Where are the bottlenecks?	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV; TRANSMISSION; MORTALITY	Introduction Early infant diagnosis is an important step in identifying children infected with HIV during the perinatal period or in utero. Multiple factors contribute to delayed antiretroviral treatment initiation for HIV-infected children, including delays in the early infant HIV diagnosis cascade. Methods We conducted a retrospective study to evaluate early infant diagnosis turnaround times in Lesotho. Trained staff reviewed records of HIV-exposed infants (aged-6-8 weeks) who received an HIV test during 2011. Study sites were drawn from Highlands, Foothills and Lowlands regions of Lesotho. Central laboratory database data were linked to facility and laboratory register information. Turnaround time geometric means (with 95% CI) were calculated and compared by region using linear mixed models. Results 1,187 individual infant records from 25 facilities were reviewed. Overall, early infant diagnosis turnaround time was 61.7 days (95% CI: 55.3-68.7). Mean time from specimen collection to district laboratory was 14 days (95% CI: 12.1-16.1); from district to central laboratory, 2 days (95% CI 0.8-5.2); results from central laboratory to district hospital, 23.3 days (95% CI: 18.7-29.0); from district hospital to health facility, 3.2 days (95% CI 1.9-5.5); and from health facility to caregiver, 10.4 days (95% CI, 7.9-13.5). Mean times from specimen transfer to the central laboratory and for result transfer from central laboratory to district hospital were significantly shorter in the Lowlands Region (0.9 and 16.2 days, respectively), compared to Highlands Region (6.0 [P = 0.030] and 34.3 days [P = 0.0099]. Turnaround time from blood draw to receipt of results was significantly shorter for HIV infected infants compared to HIV uninfected infants [p = 0.0036] at an average of 47.1 days (95% CI: 38.9-56.9) and 62 days (95% CI: 55.9-68.7) respectively. Of 47 HIV-infected infants, 36 were initiated on antiretroviral therapy at an average of 1.3 days (95% CI: 0.3, 5.7) after caregiver received the result. Conclusion HIV-infected infants received results earlier and were rapidly initiated on antiretroviral therapy once the result was delivered to caregiver. However, average early infant diagnosis turnaround time was two months; the longest period of delay was transfer of results from central laboratory to district hospital. Turnaround time of results based on geographical regions or between hospitals and health centres varied but did not reach statistical significance.	[Tiam, Appolinaire; Tylleskar, Thorkild] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Tiam, Appolinaire; Isavwa, Anthony; Mokone, Mafusi; Foso, Matokelo] Elizabeth Glaser Pediat AIDS Fdn, Med & Sci Affairs, Maseru, Lesotho; [Gill, Michelle M.; Mofenson, Lynne M.; Guay, Laura] Elizabeth Glaser Pediat AIDS Fdn, Res, Washington, DC USA; [Hoffman, Heather J.; Guay, Laura] George Washington Univ, Milken Inst, Sch Publ Hlth, Washington, DC USA; [Safrit, Jeffrey T.] Int AIDS Vaccine Initiat, Res Alliances, New York, NY USA	University of Bergen; George Washington University; International AIDS Vaccine Initiative	Tiam, A (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.; Tiam, A (corresponding author), Elizabeth Glaser Pediat AIDS Fdn, Med & Sci Affairs, Maseru, Lesotho.	atiam@peciaids.org	Tylleskär, Thorkild/S-5529-2017; Mofenson, Lynne/P-9631-2019; Hoffman, Heather/AAF-6429-2020	Tylleskär, Thorkild/0000-0003-4801-4324; Mofenson, Lynne/0000-0002-2818-9808; Tiam, Appolinaire/0000-0002-8045-7590	Pediatric AIDS Coalition Dance Marathon at University of California, Los Angeles, USA; EGPAF	Pediatric AIDS Coalition Dance Marathon at University of California, Los Angeles, USA; EGPAF	This study was funded by grant from the Pediatric AIDS Coalition Dance Marathon at University of California, Los Angeles, USA.; The authors thank the staff from twenty-five EGPAF-supported sites from Butha Buthe, Qacha's Nek, Thaba Tseka, Mokhotlong, Maseru, and Quthing districts that made the study possible. They specifically thank Makhohlisa Matela, Masuoane Mamello.	[Anonymous], 2014, DEM HLTH SURV; [Anonymous], 2016, AIDS FREE WORLD CHIL; Buzdugan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134571; du Plessis E, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-S1-S10; Ekouevi DK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-519; Government of Lesotho Ministry of Health, 2013, NAT GUID PREV MOTH C; Government of Lesotho Ministry of Health, 2016, NAT GUID HIV AIDS CA; Kikuchi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041998; MacPherson P, 2012, TROP MED INT HEALTH, V17, P507, DOI 10.1111/j.1365-3156.2011.02946.x; Mugambi ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078891; Mugasha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115171; Naiwatanakul T, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20511; Namukwaya Z, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1213-5; Pegurri E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124041; PEPFAR, LES COUNTR OP PLAN C; Sloan DJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-490; Sutcliffe CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087028; UNAIDS, LES GAP REP 2015; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wagner A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0325-8; Woldesenbet SA, 2015, JAIDS-J ACQ IMM DEF, V68, pe26, DOI 10.1097/QAI.0000000000000460; World Health Organization, 2013, CONGUID UANT DRU	22	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0184769	10.1371/journal.pone.0184769	http://dx.doi.org/10.1371/journal.pone.0184769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016634	Green Published, Green Submitted, gold			2022-12-26	WOS:000412627400011
J	Yan, YW; Zou, B; Zhu, T; Hozzein, WN; Quan, ZX				Yan, Yong-Wei; Zou, Bin; Zhu, Ting; Hozzein, Wael N.; Quan, Zhe-Xue			Modified RNA-seq method for microbial community and diversity analysis using rRNA in different types of environmental samples	PLOS ONE			English	Article							COMPLETE NITRIFICATION; BACTERIAL COMMUNITIES; MOLECULAR ANALYSIS; BULK WATER; AMPLIFICATION; PHYLLOSPHERE; GENES; CYANOBACTERIA; SEQUENCES; GRADIENT	RNA-seq-based SSU (small subunit) rRNA (ribosomal RNA) analysis has provided a better understanding of potentially active microbial community within environments. However, for RNA-seq library construction, high quantities of purified RNA are typically required. We propose a modified RNA-seq method for SSU rRNA-based microbial community analysis that depends on the direct ligation of a 5' adaptor to RNA before reverse-transcription. The method requires only a low-input quantity of RNA (10-100 ng) and does not require a DNA removal step. The method was initially tested on three mock communities synthesized with enriched SSU rRNA of archaeal, bacterial and fungal isolates at different ratios, and was subsequently used for environmental samples of high or low biomass. For high-biomass salt-marsh sediments, enriched SSU rRNA and total nucleic acid-derived RNA-seq datasets revealed highly consistent community compositions for all of the SSU rRNA sequences, and as much as 46.4%-59.5% of 16S rRNA sequences were suitable for OTU (operational taxonomic unit)-based community and diversity analyses with complete coverage of V1-V2 regions. OTU-based community structures for the two datasets were also highly consistent with those determined by all of the 16S rRNA reads. For low-biomass samples, total nucleic acid-derived RNA-seq datasets were analyzed, and highly active bacterial taxa were also identified by the OTU-based method, notably including members of the previously underestimated genus Nitrospira and phylum Acidobacteria in tap water, members of the phylum Actinobacteria on a shower curtain, and members of the phylum Cyanobacteria on leaf surfaces. More than half of the bacterial 16S rRNA sequences covered the complete region of primer 8F, and non-coverage rates as high as 38.7% were obtained for phylum-unclassified sequences, providing many opportunities to identify novel bacterial taxa. This modified RNA-seq method will provide a better snapshot of diverse microbial communities, most notably by OTU-based analysis, even communities with low-biomass samples.	[Yan, Yong-Wei; Zou, Bin; Zhu, Ting; Quan, Zhe-Xue] Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai, Peoples R China; [Hozzein, Wael N.] King Saud Univ, Coll Sci, Zool Dept, Bioprod Res Chair, Riyadh, Saudi Arabia; [Hozzein, Wael N.] Beni Suef Univ, Fac Sci, Bot & Microbiol Dept, Bani Suwayf, Egypt	Fudan University; King Saud University; Egyptian Knowledge Bank (EKB); Beni Suef University	Quan, ZX (corresponding author), Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai, Peoples R China.	quanzx@fudan.edu.cn	Quan, Zhexue/B-8046-2013; Zhu, Ting/F-3292-2019	Quan, Zhexue/0000-0002-7561-8572; Zhu, Ting/0000-0001-6266-7511	National Natural Science Foundation of China [31170114]; Deanship of Scientific Research at King Saud University [PRG-1436-27]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deanship of Scientific Research at King Saud University(King Saud University)	This work was supported by the National Natural Science Foundation of China (31170114). The authors extend their sincere appreciations to the Deanship of Scientific Research at King Saud University for funding the research group no. PRG-1436-27. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078866, 10.1371/journal.pone.0067861]; [Anonymous], 2011, SICKLE SLIDING WINDO; Berry D, 2006, CURR OPIN BIOTECH, V17, P297, DOI 10.1016/j.copbio.2006.05.007; Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Botero LM, 2005, APPL ENVIRON MICROB, V71, P1267, DOI 10.1128/AEM.71.3.1267-1275.2005; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Daims H, 2015, NATURE, V528, P504, DOI 10.1038/nature16461; Dastager S.G., 2014, PROKARYOTES, P455, DOI DOI 10.1007/978-3-642-30138-4_168; Dojani S, 2007, FLORA, V202, P521, DOI 10.1016/j.flora.2006.12.001; Eichler S, 2006, APPL ENVIRON MICROB, V72, P1858, DOI 10.1128/AEM.72.3.1858-1872.2006; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Goodfellow M., 2014, FAMILY NOCARDIACEAE, P595; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; Henne K, 2012, APPL ENVIRON MICROB, V78, P3530, DOI 10.1128/AEM.06373-11; Holinger EP, 2014, WATER RES, V49, P225, DOI 10.1016/j.watres.2013.11.027; Kelley ST, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-202; Kelley ST, 2004, APPL ENVIRON MICROB, V70, P4187, DOI 10.1128/AEM.70.7.4187-4192.2004; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Li XR, 2014, APPL MICROBIOL BIOT, V98, P3777, DOI 10.1007/s00253-014-5583-0; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Ludemann H, 2000, APPL ENVIRON MICROB, V66, P754, DOI 10.1128/AEM.66.2.754-762.2000; Mannan MAU, 2009, ANAL BIOCHEM, V389, P77, DOI 10.1016/j.ab.2009.03.014; Mao DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-66; Martiny AC, 2005, APPL ENVIRON MICROB, V71, P8611, DOI 10.1128/AEM.71.12.8611-8617.2005; McDonald JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157046; Mizuta K, 2004, BIORESOURCE TECHNOL, V95, P255, DOI 10.1016/j.biortech.2004.02.015; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pinto AJ, 2014, MBIO, V5, DOI 10.1128/mBio.01135-14; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Rigonato J, 2016, CAN J MICROBIOL, P1, DOI DOI 10.1139/CJM2016-0229; Rigonato J, 2012, FEMS MICROBIOL ECOL, V80, P312, DOI 10.1111/j.1574-6941.2012.01299.x; Rosselli R, 2016, SCI REP-UK, V6, DOI 10.1038/srep32165; Salipante SJ, 2014, APPL ENVIRON MICROB, V80, P7583, DOI 10.1128/AEM.02206-14; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Stackebrandt E, 2014, PROKARYOTES, P397; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tomitani A, 2006, P NATL ACAD SCI USA, V103, P5442, DOI 10.1073/pnas.0600999103; Tremblay Julien, 2015, Front Microbiol, V6, P771, DOI 10.3389/fmicb.2015.00771; Tveit AT, 2014, APPL ENVIRON MICROB, V80, P5761, DOI 10.1128/AEM.01030-14; Tveit AT, 2015, P NATL ACAD SCI USA, V112, pE2507, DOI 10.1073/pnas.1420797112; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; van Dijk EL, 2014, EXP CELL RES, V322, P12, DOI 10.1016/j.yexcr.2014.01.008; van Kessel MAHJ, 2015, NATURE, V528, P555, DOI 10.1038/nature16459; Venkatachalam S, 2016, PLANT BIOLOGY, V18, P627, DOI 10.1111/plb.12441; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Walsh P S, 1992, PCR Methods Appl, V1, P241, DOI 10.1101/gr.1.4.241; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WELLER R, 1989, APPL ENVIRON MICROB, V55, P1818, DOI 10.1128/AEM.55.7.1818-1822.1989; Whipps JM, 2008, J APPL MICROBIOL, V105, P1744, DOI 10.1111/j.1365-2672.2008.03906.x; Xiong XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036009; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Youssef N, 2012, APPL ENVIRON MICROB, V78, P2677, DOI 10.1128/AEM.00002-12; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Youssef NH, 2015, J ADV RES, V6, P269, DOI 10.1016/j.jare.2014.10.005; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Zeleke J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00243; Zhang Y, 2009, CRIT REV ENV SCI TEC, V39, P153, DOI 10.1080/10643380701631739; Zifcakova L, 2016, ENVIRON MICROBIOL, V18, P288, DOI 10.1111/1462-2920.13026	73	8	9	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186161	10.1371/journal.pone.0186161	http://dx.doi.org/10.1371/journal.pone.0186161			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016661	Green Published, gold, Green Submitted			2022-12-26	WOS:000412627400057
J	Yang, EH; Rode, J; Howlader, A; Eckermann, M; Santos, JT; Armada, DH; Zheng, RX; Zou, CX; Cairo, CW				Yang, Esther H.; Rode, Julia; Howlader, Amran; Eckermann, Marina; Santos, Jobette T.; Armada, Daniel Hernandez; Zheng, Ruixiang; Zou, Chunxia; Cairo, Christopher W.			Galectin-3 alters the lateral mobility and clustering of beta 1-integrin receptors	PLOS ONE			English	Article							SINGLE-PARTICLE TRACKING; BREAST-CARCINOMA CELLS; HUMAN COLON-CANCER; N-GLYCANS; AFFINITY-CHROMATOGRAPHY; MASS-SPECTROMETRY; TUMOR PROGRESSION; BINDING-PROTEIN; ADHESION; SURFACE	Glycoprotein receptors are influenced by myriad intermolecular interactions at the cell surface. Specific glycan structures may interact with endogenous lectins that enforce or disrupt receptor-receptor interactions. Glycoproteins bound by multivalent lectins may form extended oligomers or lattices, altering the lateral mobility of the receptor and influencing its function through endocytosis or changes in activation. In this study, we have examined the interaction of Galectin-3 (Gal-3), a human lectin, with adhesion receptors. We measured the effect of recombinant Gal-3 added exogenously on the lateral mobility of the alpha 5 beta 1 integrin on HeLa cells. Using single-particle tracking (SPT) we detected increased lateral mobility of the integrin in the presence of Gal-3, while its truncated C-terminal domain (Gal-3C) showed only minor reductions in lateral mobility. Treatment of cells with Gal-3 increased beta 1-integrin mediated migration with no apparent changes in viability. In contrast, Gal-3C decreased both cell migration and viability. Fluorescence microscopy allowed us to confirm that exogenous Gal-3 resulted in reorganization of the integrin into larger clusters. We used a proteomics analysis to confirm that cells expressed endogenous Gal-3, and found that addition of competitive oligosaccharide ligands for the lectin altered the lateral mobility of the integrin. Together, our results are consistent with a Gal-3-integrin lattice model of binding and confirm that the lateral mobility of integrins is natively regulated, in part, by galectins.	[Yang, Esther H.; Rode, Julia; Howlader, Amran; Eckermann, Marina; Santos, Jobette T.; Armada, Daniel Hernandez; Zheng, Ruixiang; Zou, Chunxia; Cairo, Christopher W.] Univ Alberta, Dept Chem, Alberta Glyc Ctr, Edmonton, AB, Canada; [Rode, Julia] Orebro Univ, Orebro, Sweden; [Eckermann, Marina] Ludwig Maximilians Univ Munchen, Munich, Germany; [Santos, Jobette T.] Univ Toronto, Toronto, ON, Canada	University of Alberta; Orebro University; University of Munich; University of Toronto	Cairo, CW (corresponding author), Univ Alberta, Dept Chem, Alberta Glyc Ctr, Edmonton, AB, Canada.	ccairo@ualberta.ca	Rode, Julia/GPF-4088-2022; Cairo, Christopher W/B-5355-2009	Rode, Julia/0000-0001-9402-4756; Cairo, Christopher W/0000-0003-3363-8708	Alberta Glycomics Centre; Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC CGS-D scholarship; University of Alberta Research Experience (UARE) program	Alberta Glycomics Centre; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CGS-D scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Alberta Research Experience (UARE) program	This work was supported by the Alberta Glycomics Centre and the Natural Sciences and Engineering Research Council of Canada (NSERC). MAH acknowledges support from an NSERC CGS-D scholarship. JR and ME were supported by the University of Alberta Research Experience (UARE) program.; The authors would like to thank Caishun Li (UofA) for helpful discussions. This work was supported by the Alberta Glycomics Centre and the Natural Sciences and Engineering Research Council of Canada (NSERC). MAH acknowledges support from an NSERC CGS-D scholarship. JR and ME were supported by the University of Alberta Research Experience (UARE) program.	Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Armada DH, 2015, CARBOHYD RES, V417, P109, DOI 10.1016/j.carres.2015.09.005; Bachhawat-Sikder K, 2001, FEBS LETT, V500, P75, DOI 10.1016/S0014-5793(01)02586-8; Baptiste TA, 2007, EXP CELL RES, V313, P652, DOI 10.1016/j.yexcr.2006.11.005; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; Belardi B, 2012, J AM CHEM SOC, V134, P9549, DOI 10.1021/ja301694s; Berbis MA, 2014, BIOCHEM BIOPH RES CO, V443, P126, DOI 10.1016/j.bbrc.2013.11.063; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Bresalier RS, 1998, GASTROENTEROLOGY, V115, P287, DOI 10.1016/S0016-5085(98)70195-7; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Cairo CW, 2008, BIOPOLYMERS, V89, P409, DOI 10.1002/bip.20898; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Chiasson-MacKenzie C, 2015, J CELL BIOL, V211, P391, DOI 10.1083/jcb.201503081; Das R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000556; de Oliveira JT, 2011, INT J DEV BIOL, V55, P823, DOI 10.1387/ijdb.113359jt; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Diehl C, 2009, J BIOMOL NMR, V45, P157, DOI 10.1007/s10858-009-9356-5; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dong S, 1997, GLYCOCONJUGATE J, V14, P267, DOI 10.1023/A:1018554124545; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Friedrichs J, 2008, J BIOL CHEM, V283, P32264, DOI 10.1074/jbc.M803634200; Fukumori T, 2003, CANCER RES, V63, P8302; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Gao X, 2014, GALECTIN 3 INDUCES C; Garner OB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000993; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x; Han L, 2016, ANAL CHEM; Hernandez JD, 2002, GLYCOBIOLOGY, V12, p127R, DOI 10.1093/glycob/cwf081; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HO MK, 1982, J IMMUNOL, V128, P1221; Hughes RC, 2001, BIOCHIMIE, V83, P667; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Inohara H, 1998, EXP CELL RES, V245, P294, DOI 10.1006/excr.1998.4253; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jia F, 2016, BBA-MOL CELL BIOL L, V1861, P1170, DOI 10.1016/j.bbalip.2016.06.013; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; KUBOTA K, 2009, 2 DIM EL PROT, V519, P483, DOI DOI 10.1007/978-1-59745-281-6_32; Kuwabara I, 1996, J IMMUNOL, V156, P3939; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lakshminarayan R, 2014, NAT CELL BIOL, V16, P592, DOI 10.1038/ncb2970; MacKinnon AC, 2013, GLYCOBIOLOGY; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; Mirandola L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021811; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Nangia-Makker P, 2008, CANCER MICROENVIRON, V1, P43, DOI 10.1007/s12307-008-0003-6; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Noll AJ, 2016, GLYCOBIOLOGY, V26, P655, DOI 10.1093/glycob/cww002; OCHIENG J, 1994, BIOCHEMISTRY-US, V33, P14109, DOI 10.1021/bi00251a020; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Priglinger CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070011; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rao SP, 2007, J IMMUNOL, V179, P7800, DOI 10.4049/jimmunol.179.11.7800; Rotshenker S, 2009, J MOL NEUROSCI, V39, P99, DOI 10.1007/s12031-009-9186-7; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Saraboji K, 2012, BIOCHEMISTRY-US, V51, P296, DOI 10.1021/bi201459p; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Senapati S, 2011, CLIN CANCER RES, V17, P267, DOI 10.1158/1078-0432.CCR-10-1937; Shams-Ud-Doha K, 2017, ANAL CHEM, V89, P4914, DOI 10.1021/acs.analchem.6b05169; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Shirure VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044529; Shoji K, 2012, BIOCHEM BIOPH RES CO, V424, P52, DOI 10.1016/j.bbrc.2012.06.063; Sorme P, 2005, J AM CHEM SOC, V127, P1737, DOI 10.1021/ja043475p; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Suzuki O, 2006, INT J ONCOL, V28, P155; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Vyakarnam A, 1998, EXP CELL RES, V242, P419, DOI 10.1006/excr.1998.4111; WOO HJ, 1990, J BIOL CHEM, V265, P7097; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang RY, 1998, BIOCHEMISTRY-US, V37, P4086, DOI 10.1021/bi971409c; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	89	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0184378	10.1371/journal.pone.0184378	http://dx.doi.org/10.1371/journal.pone.0184378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016609	Green Published, gold, Green Submitted			2022-12-26	WOS:000412627400008
J	Huillet, E; Bridoux, L; Wanapaisan, P; Rejasse, A; Peng, Q; Panbangred, W; Lereclus, D				Huillet, Eugenie; Bridoux, Ludovic; Wanapaisan, Pagakrong; Rejasse, Agnes; Peng, Qi; Panbangred, Watanalai; Lereclus, Didier			The CodY-dependent clhAB2 operon is involved in cell shape, chaining and autolysis in Bacillus cereus ATCC 14579	PLOS ONE			English	Article							PEPTIDOGLYCAN HYDROLASES; STATIONARY-PHASE; GLOBAL REGULATOR; ANTHRACIS; SUBTILIS; VIRULENCE; DEATH; EXPRESSION; PROTEIN; CIDR	The Gram-positive pathogen Bacillus cereus is able to grow in chains of rod-shaped cells, but the regulation of chaining remains largely unknown. Here, we observe that glucose-grown cells of B. cereus ATCC 14579 form longer chains than those grown in the absence of glucose during the late exponential and transition growth phases, and identify that the clhAB(2) operon is required for this chain lengthening phenotype. The clhAB(2) operon is specific to the B. cereus group (i.e., B. thuringiensis, B. anthracis and B. cereus) and encodes two membrane proteins of unknown function, which are homologous to the Staphylococcus aureus CidA and CidB proteins involved in cell death control within glucose-grown cells. A deletion mutant (Delta clhAB(2)) was constructed and our quantitative image analyses show that Delta clhAB(2) cells formed abnormal short chains regardless of the presence of glucose. We also found that glucose-grown cells of Delta clhAB(2) were significantly wider than wild-type cells (1.47 mu m +/- CI95% 0.04 vs 1.19 mu m +/- CI95% 0.03, respectively), suggesting an alteration of the bacterial cell wall. Remarkably, Delta clhAB(2) cells showed accelerated autolysis under autolysis- inducing conditions, compared to wild-type cells. Overall, our data suggest that the B. cereus clhAB2 operon modulates peptidoglycan hydrolase activity, which is required for proper cell shape and chain length during cell growth, and down-regulates autolysin activity. Lastly, we studied the transcription of clhAB(2) using a lacZ transcriptional reporter in wildtype, ccpA and codY deletion-mutant strains. We found that the global transcriptional regulatory protein CodY is required for the basal level of clhAB(2) expression under all conditions tested, including the transition growth phase while CcpA, the major global carbon regulator, is needed for the high-level expression of clhAB(2) in glucose-grown cells.	[Huillet, Eugenie; Bridoux, Ludovic; Wanapaisan, Pagakrong; Rejasse, Agnes; Peng, Qi; Lereclus, Didier] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, Jouy En Josas, France; [Wanapaisan, Pagakrong; Panbangred, Watanalai] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok, Thailand; [Wanapaisan, Pagakrong] Mahidol Univ, Fac Pharm, Dept Microbiol, Bangkok, Thailand; [Peng, Qi] CAAS, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Mahidol University; Mahidol University; Chinese Academy of Agricultural Sciences	Huillet, E (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, Jouy En Josas, France.	eugenie.huillet@inra.fr	Lereclus, Didier/AAD-8293-2019	Wanapaisan, Pagakrong/0000-0002-7682-5936; Lereclus, Didier/0000-0001-9047-9104	Thailand Research Fund	Thailand Research Fund(Thailand Research Fund (TRF))	Pagakrong Wanapaisan was a recipient of the Royal Golden Jubilee program of the Thailand Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Olivier David member of the MIAJ unit (INRA, Jouy-en-Josas) for statistical Anova and Binomial analyses and for many helpful discussions and suggestions. We thank the MIMA2 imaging facility (INRA, Jouy-en-Josas) (ntip://www6.jouy.in.inra.fr.mima2) for the MET images and thank Alexis Canette for excellent technical support. Pagakrong Wanapaisan was a recipient of the Royal Golden Jubilee program of the Thailand Research Fund. We warmly thank Arnaud Chastanet, Marie-Pierre Chapot-Chartier, Romain Briandet, Alexandra Gruss, Isabelle Poquet and Christina Nielsen-Leroux for fruitful discussions. We thank Lindsay Higgins for English correction.	Ababneh QO, 2015, J BACTERIOL, V197, P128, DOI 10.1128/JB.02063-14; Ahn JS, 2006, MOL MICROBIOL, V62, P1158, DOI 10.1111/j.1365-2958.2006.05433.x; Anderson VJ, 2011, MOL MICROBIOL, V81, P192, DOI 10.1111/j.1365-2958.2011.07688.x; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Belitsky BR, 2008, J BACTERIOL, V190, P1224, DOI 10.1128/JB.01780-07; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Chandramohan L, 2009, J BACTERIOL, V191, P4103, DOI 10.1128/JB.00314-09; Chateau A, 2013, J BACTERIOL, V195, P1204, DOI 10.1128/JB.02041-12; Chateau A, 2011, FASEB J, V25, P4445, DOI 10.1096/fj.11-188912; Chaudhari SS, 2016, MOL MICROBIOL, V101, P942, DOI 10.1111/mmi.13433; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dubois T, 2013, MOL MICROBIOL, V88, P48, DOI 10.1111/mmi.12168; Frenzel E, 2012, MOL MICROBIOL, V85, P67, DOI 10.1111/j.1365-2958.2012.08090.x; Frirdich E, 2013, CURR OPIN MICROBIOL, V16, P767, DOI 10.1016/j.mib.2013.09.005; Gohar M, 2005, PROTEOMICS, V5, P3696, DOI 10.1002/pmic.200401225; Hall BG, 2014, MOL BIOL EVOL, V31, P232, DOI 10.1093/molbev/mst187; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Huillet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051047; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Layec S, 2008, J MOL MICROB BIOTECH, V14, P31, DOI 10.1159/000106080; LERECLUS D, 1992, BIO-TECHNOL, V10, P418, DOI 10.1038/nbt0492-418; Lindback T, 2012, ENVIRON MICROBIOL, V14, P2233, DOI 10.1111/j.1462-2920.2012.02766.x; Ludwig H, 2002, J BACTERIOL, V184, P5174, DOI 10.1128/JB.184.18.5174-5178.2002; Majed R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01054; Moreno MS, 2001, MOL MICROBIOL, V39, P1366, DOI 10.1046/j.1365-2958.2001.02328.x; Raddadi N, 2005, J APPL MICROBIOL, V99, P1070, DOI 10.1111/j.1365-2672.2005.02713.x; Rice KC, 2005, J BACTERIOL, V187, P813, DOI 10.1128/JB.187.3.813-821.2005; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Richardson AR, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MBP-0004-2014; Rolain T, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-137; Nguyen-Mau SM, 2012, J BACTERIOL, V194, P3841, DOI 10.1128/JB.00384-12; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Shivers RP, 2006, MOL MICROBIOL, V62, P811, DOI 10.1111/j.1365-2958.2006.05410.x; Shivers RP, 2005, MOL MICROBIOL, V56, P1549, DOI 10.1111/j.1365-2958.2005.04634.x; Shivers RP, 2004, MOL MICROBIOL, V53, P599, DOI 10.1111/j.1365-2958.2004.04135.x; Slamti L, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01501; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; Stenz L, 2011, FEMS IMMUNOL MED MIC, V62, P123, DOI 10.1111/j.1574-695X.2011.00812.x; Thomas VC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004205; Uehara T, 2011, CURR OPIN MICROBIOL, V14, P698, DOI 10.1016/j.mib.2011.10.003; van den Esker MH, 2017, ENVIRON MICROBIOL, V19, P83, DOI 10.1111/1462-2920.13454; van der Voort M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-62; van Schaik W, 2009, INFECT IMMUN, V77, P4437, DOI 10.1128/IAI.00716-09; Verplaetse E, 2015, MBIO, V6, DOI 10.1128/mBio.00138-15; Vilain S, 2006, APPL ENVIRON MICROB, V72, P4970, DOI 10.1128/AEM.03076-05; Vilas-Boas GT, 2007, CAN J MICROBIOL, V53, P673, DOI 10.1139/W07-029; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Yang SJ, 2006, MOL MICROBIOL, V60, P458, DOI 10.1111/j.1365-2958.2006.05105.x	53	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0184975	10.1371/journal.pone.0184975	http://dx.doi.org/10.1371/journal.pone.0184975			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	28991912	Green Published, Green Submitted, gold			2022-12-26	WOS:000412601800011
J	Ito, S; Ogawa, K; Takeuchi, K; Takagi, M; Yoshida, M; Hirokawa, T; Hirayama, S; Shin-ya, K; Shimada, I; Doi, T; Goshima, N; Natsume, T; Nagata, K				Ito, Shinya; Ogawa, Koji; Takeuchi, Koh; Takagi, Motoki; Yoshida, Masahito; Hirokawa, Takatsugu; Hirayama, Shoshiro; Shin-ya, Kazuo; Shimada, Ichio; Doi, Takayuki; Goshima, Naoki; Natsume, Tohru; Nagata, Kazuhiro			A small-molecule compound inhibits a collagen-specific molecular chaperone and could represent a potential remedy for fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; drug screening; endoplasmic reticulum (ER); fibrosis; heat-shock protein (HSP); molecular chaperone; protein-protein interaction; HSP47; serpinH1	STRESS-PROTEIN HSP47; PROLYL 4-HYDROXYLASE INHIBITOR; A-COUPLED LIPOSOMES; HEAT-SHOCK-PROTEIN; RAT-LIVER FIBROSIS; ENDOPLASMIC-RETICULUM; TRIPLE-HELIX; I COLLAGEN; CELLS; PROCOLLAGEN	Fibrosis can disrupt tissue structure and integrity and impair organ function. Fibrosis is characterized by abnormal collagen accumulation in the extracellular matrix. Pharmacological inhibition of collagen secretion therefore represents a promising strategy for the management of fibrotic disorders, such as liver and lung fibrosis. Hsp47 is an endoplasmic reticulum (ER)-resident collagen-specific molecular chaperone essential for correct folding of procollagen in the ER. Genetic deletion of Hsp47 or inhibition of its interaction with procollagen interferes with procollagen triple helix production, which vastly reduces procollagen secretion from fibroblasts. Thus, Hsp47 could be a potential and promising target for the management of fibrosis. In this study, we screened small-molecule compounds that inhibit the interaction of Hsp47 with collagen from chemical libraries using surface plasmon resonance (BIAcore), and we found a molecule AK778 and its cleavage product Col003 competitively inhibited the interaction and caused the inhibition of collagen secretion by destabilizing the collagen triple helix. Structural information obtained with NMR analysis revealed that Col003 competitively binds to the collagen-binding site on Hsp47. We propose that these structural insights could provide a basis for designing more effective therapeutic drugs for managing fibrosis.	[Ito, Shinya; Nagata, Kazuhiro] Kyoto Sangyo Univ, Inst Prot Dynam, Kyoto 6038555, Japan; [Ito, Shinya] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068507, Japan; [Ogawa, Koji; Takeuchi, Koh; Hirokawa, Takatsugu; Shin-ya, Kazuo; Goshima, Naoki; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Tokyo 1350064, Japan; [Takagi, Motoki] JBIC, Tokyo 1350064, Japan; [Yoshida, Masahito; Doi, Takayuki] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Hirayama, Shoshiro] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Tokyo 1130033, Japan; [Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Div Phys Chem, Tokyo 1130033, Japan; [Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kyoto 6038555, Japan; [Nagata, Kazuhiro] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Kyoto 6038555, Japan	Kyoto Sangyo University; Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST); Tohoku University; University of Tokyo; University of Tokyo; Kyoto Sangyo University; Japan Science & Technology Agency (JST)	Nagata, K (corresponding author), Kyoto Sangyo Univ, Inst Prot Dynam, Kyoto 6038555, Japan.; Natsume, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Tokyo 1350064, Japan.; Nagata, K (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kyoto 6038555, Japan.; Nagata, K (corresponding author), Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Kyoto 6038555, Japan.	t-natsume@aist.go.jp; nagata@cc.kyoto-su.ac.jp	Takagi, Motoki/Q-7390-2019; Shin-ya, Kazuo/L-9613-2018; Yoshida, Masahito/K-6636-2019; Doi, Takayuki/U-1009-2019; 直樹, 五島/M-8363-2018; Takeuchi, Koh/B-4971-2010; Natsume, Tohru/M-7627-2018	Shin-ya, Kazuo/0000-0002-4702-0661; Yoshida, Masahito/0000-0002-0252-7637; Takeuchi, Koh/0000-0002-6227-4627; Natsume, Tohru/0000-0002-1510-2582	Japan Society for the Promotion of Science [24227009, 11J05697]; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; ACT-MS from Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [17H06097] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; ACT-MS from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research (S) 24227009 from the Japan Society for the Promotion of Science (to K. N.), by Japan Society for the Promotion of Science Fellowship 11J05697 (to S. I.), and in part by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan and the ACT-MS from Japan Agency for Medical Research and Development (AMED). The authors declare that they have no conflicts of interest with the contents of this article.	Bickel M, 1998, HEPATOLOGY, V28, P404, DOI 10.1002/hep.510280217; Boudko SP, 2012, INT J BIOCHEM CELL B, V44, P21, DOI 10.1016/j.biocel.2011.09.009; Bourhis JM, 2012, NAT STRUCT MOL BIOL, V19, P1031, DOI 10.1038/nsmb.2389; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Goddard T. D., 2014, SPARKY 3; Higashi K, 2011, J BIOL CHEM, V286, P4485, DOI 10.1074/jbc.M110.151936; Hisatomi K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-24; Honzawa Y, 2014, GUT, V63, P1902, DOI 10.1136/gutjnl-2013-305632; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Ishiwatari H, 2013, GUT, V62, P1328, DOI 10.1136/gutjnl-2011-301746; Ito S, 2017, SEMIN CELL DEV BIOL, V62, P142, DOI 10.1016/j.semcdb.2016.11.005; Kawasaki K, 2015, J BIOL CHEM, V290, P3639, DOI 10.1074/jbc.M114.592139; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200; LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642; Liu YQ, 2011, J HEPATOL, V55, P612, DOI 10.1016/j.jhep.2010.11.035; Makareeva E, 2011, TRENDS CELL BIOL, V21, P168, DOI 10.1016/j.tcb.2010.11.007; MASUDA H, 1994, J CLIN INVEST, V94, P2481, DOI 10.1172/JCI117617; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; NAGATA K, 1986, J CELL BIOL, V103, P223, DOI 10.1083/jcb.103.1.223; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; Nordin H, 2005, ANAL BIOCHEM, V340, P359, DOI 10.1016/j.ab.2005.02.027; Ono T, 2012, J BIOL CHEM, V287, P6810, DOI 10.1074/jbc.M111.280248; Raghu G, 1999, AM J RESP CRIT CARE, V159, P1061, DOI 10.1164/ajrccm.159.4.9805017; SAGA S, 1987, J CELL BIOL, V105, P517, DOI 10.1083/jcb.105.1.517; Sakaida I, 1996, HEPATOLOGY, V23, P755, DOI 10.1002/hep.510230416; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Sunamoto M, 1998, LAB INVEST, V78, P967; Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807	34	36	36	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20076	20085		10.1074/jbc.M117.815936	http://dx.doi.org/10.1074/jbc.M117.815936			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29025875	Green Published, hybrid			2022-12-26	WOS:000417696400015
J	Kirschner, KM; Sciesielski, LK; Krueger, K; Scholz, H				Kirschner, Karin M.; Sciesielski, Lina K.; Krueger, Katharina; Scholz, Holger			Wilms tumor protein-dependent transcription of VEGF receptor 2 and hypoxia regulate expression of the testis-promoting gene Sox9 in murine embryonic gonads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin immunoprecipitation (ChiP); development; gene regulation; gene silencing; gene transcription; hypoxia; immunohistochemistry; ovary; testis; transcription factor	ENDOTHELIAL GROWTH-FACTOR; MESONEPHRIC CELL-MIGRATION; SEX DETERMINATION; KIDNEY DEVELOPMENT; FRASIER-SYNDROME; VASCULAR DEVELOPMENT; GRANULOSA-CELLS; MAMMALIAN GONAD; CORD FORMATION; WT1	Wilms tumor protein 1 (WT1) has been implicated in the control of several genes in sexual development, but its function in gonad formation is still unclear. Here, we report that WT1 stimulates expression of Kdr, the gene encoding VEGF receptor 2, in murine embryonic gonads. We found that WT1 and KDR are co-expressed in Sertoli cells of the testes and somatic cells of embryonic ovaries. Vivo-morpholino-mediated WT1 knockdown decreased Kdr transcripts in cultured embryonic gonads at multiple developmental stages. Furthermore, WT1 bound to the Kdr promoter in the chromatin of embryonic testes and ovaries. Forced expression of the WT1(-KTS) isoform, which functions as a transcription factor, increased KDR mRNA levels, whereas the WT1(+KTS) isoform, which acts presumably on the post-transcriptional level, did not. ChIP indicated that WT1(-KTS), but not WT1(+KTS), binds to the KDR promoter. Treatment with the KDR tyrosine kinase inhibitor SU1498 or the KDR ligand VEGFA revealed that KDR signaling represses the testis-promoting gene Sox9 in embryonic XX gonads. WT1 knockdown abrogated the stimulatory effect of SU1498-mediated KDR inhibition on Sox9 expression. Exposure to 1% O-2 to mimic the low-oxygen conditions in the embryo increased Vegfa expression but did not affect Sox9 mRNA levels in gonadal explants. However, incubation in 1% O-2 in the presence of SU1498 significantly reduced Sox9 transcripts in cultured testes and increased Sox9 levels in ovaries. These findings demonstrate that both the local oxygen environment and WT1, which enhances KDR expression, contribute to sex-specific Sox9 expression in developing murine gonads.	[Kirschner, Karin M.; Krueger, Katharina; Scholz, Holger] Charite, Inst Vegetat Physiol, Charitepl 1, D-10117 Berlin, Germany; [Sciesielski, Lina K.] Charite, Klin Neonatol, Charitepl 1, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Scholz, H (corresponding author), Charite, Inst Vegetat Physiol, Charitepl 1, D-10117 Berlin, Germany.	holger.scholz@charite.de	Sciesielski, Lina/G-3716-2017	Sciesielski, Lina/0000-0003-3458-0309; Kirschner, Karin/0000-0003-0226-8636	Deutsche Forschungsgemeinschaft [Scho634/8-1]; Else Kroner-Fresenius-Stiftung [2014_A23]; Verein fur fruhgeborene Kinder an der Charite e.V.; Focus Area "DynAge" at the Free University Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung; Verein fur fruhgeborene Kinder an der Charite e.V.; Focus Area "DynAge" at the Free University Berlin	This work was supported by Deutsche Forschungsgemeinschaft Grant Scho634/8-1 and grants from the Else Kroner-Fresenius-Stiftung (Grant 2014_A23), the "Verein fur fruhgeborene Kinder an der Charite e.V.", and the Focus Area "DynAge" at the Free University Berlin. The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Bott RC, 2006, BIOL REPROD, V75, P56, DOI 10.1095/biolreprod.105.047225; Bott RC, 2010, CELL TISSUE RES, V342, P117, DOI 10.1007/s00441-010-1038-9; Bradford ST, 2009, HUM MOL GENET, V18, P3429, DOI 10.1093/hmg/ddp283; Brill C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43000; Bullejos M, 2001, DEV DYNAM, V221, P201, DOI 10.1002/dvdy.1134; Capel B, 1999, MECH DEVELOP, V84, P127, DOI 10.1016/S0925-4773(99)00047-7; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chassot AA, 2008, SEX DEV, V2, P219, DOI 10.1159/000152038; Chen M, 2017, DEVELOPMENT, V144, P44, DOI 10.1242/dev.144105; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05; Clement TM, 2011, BIOL REPROD, V85, P277, DOI 10.1095/biolreprod.110.090282; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Gao F, 2014, HUM MOL GENET, V23, P333, DOI 10.1093/hmg/ddt423; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; HACKER A, 1995, DEVELOPMENT, V121, P1603; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Hanson J, 2007, FRONT BIOSCI-LANDMRK, V12, P2279, DOI 10.2741/2230; Hartwig S, 2010, DEVELOPMENT, V137, P1189, DOI 10.1242/dev.045732; Jacobi CLJ, 2013, J BIOL CHEM, V288, P18811, DOI 10.1074/jbc.M113.464644; Kikuchi H, 1998, J MED GENET, V35, P45, DOI 10.1136/jmg.35.1.45; Kirschner KM, 2014, J BIOL CHEM, V289, P24452, DOI 10.1074/jbc.M114.564336; Klamt B, 1998, HUM MOL GENET, V7, P709, DOI 10.1093/hmg/7.4.709; Klattig J, 2007, SEX DEV, V1, P238, DOI 10.1159/000104774; Klattig J, 2007, MOL CELL BIOL, V27, P4355, DOI 10.1128/MCB.01780-06; Kobayashi A, 2005, ANN NY ACAD SCI, V1061, P9, DOI 10.1196/annals.1336.003; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Martens LK, 2007, J BIOL CHEM, V282, P14379, DOI 10.1074/jbc.M609857200; McCarty G, 2011, J BIOL CHEM, V286, P43634, DOI 10.1074/jbc.M111.310128; Meschia G, 2011, CLIN CHEST MED, V32, P15, DOI 10.1016/j.ccm.2010.11.007; Morrison AA, 2006, BIOCHEM CELL BIOL, V84, P789, DOI 10.1139/O06-065; Motamedi FJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5444; MUNDLOS S, 1993, DEVELOPMENT, V119, P1329; PELLETIER J, 1991, GENE DEV, V5, P1345, DOI 10.1101/gad.5.8.1345; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; Quinn A, 2012, SEMIN REPROD MED, V30, P351, DOI 10.1055/s-0032-1324718; RICCARDI VM, 1978, PEDIATRICS, V61, P604; Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040; Romereim SM, 2016, RESULTS PROBL CELL D, V58, P67, DOI 10.1007/978-3-319-31973-5_4; Rudigier LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176296; Sciesielski LK, 2010, FEBS LETT, V584, P4665, DOI 10.1016/j.febslet.2010.10.045; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Tilmann C, 1999, DEVELOPMENT, V126, P2883; Toska E, 2014, BIOCHEM J, V461, P15, DOI 10.1042/BJ20131587; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102	53	9	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20281	20291		10.1074/jbc.M117.816751	http://dx.doi.org/10.1074/jbc.M117.816751			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29042436	Green Published, hybrid			2022-12-26	WOS:000417696400031
J	Manthei, KA; Ahn, J; Glukhova, A; Yuan, WM; Larkin, C; Manett, TD; Chang, L; Shayman, JA; Axley, MJ; Schwendeman, A; Tesmer, JJG				Manthei, Kelly A.; Ahn, Joomi; Glukhova, Alisa; Yuan, Wenmin; Larkin, Christopher; Manett, Taylor D.; Chang, Louise; Shayman, James A.; Axley, Milton J.; Schwendeman, Anna; Tesmer, John J. G.			A retractable lid in lecithin:cholesterol acyltransferase provides a structural mechanism for activation by apolipoprotein A-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acyltransferase; apolipoprotein; cholesterol; conformational change; crystallography; high-density lipoprotein (HDL); inhibitor; structural biology; HDX MS; lecithin	LECITHIN-CHOLESTEROL ACYLTRANSFERASE; FISH-EYE DISEASE; HIGH-DENSITY-LIPOPROTEIN; CRYSTAL-STRUCTURE; OPEN CONFORMATION; LCAT DEFICIENCY; INTERFACIAL ACTIVATION; CARDIOVASCULAR-DISEASE; TERMINAL TRUNCATION; VITRO EXPRESSION	Lecithin:cholesterol acyltransferase (LCAT) plays a key role in reverse cholesterol transport by transferring an acyl group from phosphatidylcholine to cholesterol, promoting the maturation of high-density lipoproteins (HDL) from discoidal to spherical particles. LCAT is activated through an unknown mechanism by apolipoprotein A-I (apoA-I) and other mimetic peptides that form a belt around HDL. Here, we report the crystal structure of LCAT with an extended lid that blocks access to the active site, consistent with an inactive conformation. Residues Thr-123 and Phe-382 in the catalytic domain form a latch-like interaction with hydrophobic residues in the lid. Because these residues are mutated in genetic disease, lid displacement was hypothesized to be an important feature of apoA-I activation. Functional studies of site-directed mutants revealed that loss of latch interactions or the entire lid enhanced activity against soluble ester substrates, and hydrogen-deuterium exchange (HDX) mass spectrometry revealed that the LCAT lid is extremely dynamic in solution. Upon addition of a covalent inhibitor that mimics one of the reaction intermediates, there is an overall decrease in HDX in the lid and adjacent regions of the protein, consistent with ordering. These data suggest a model wherein the active site of LCAT is shielded from soluble substrates by a dynamic lid until it interacts with HDL to allow transesterification to proceed.	[Manthei, Kelly A.; Glukhova, Alisa; Manett, Taylor D.; Chang, Louise; Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Manthei, Kelly A.; Glukhova, Alisa; Manett, Taylor D.; Chang, Louise; Tesmer, John J. G.] Univ Michigan, Dept Pharmacol & Biol Chem, Ann Arbor, MI 48109 USA; [Ahn, Joomi; Larkin, Christopher; Axley, Milton J.] MedImmune, Gaithersburg, MD 20878 USA; [Yuan, Wenmin; Schwendeman, Anna] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Yuan, Wenmin; Schwendeman, Anna] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA; [Shayman, James A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Glukhova, Alisa] Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci Biol, Parkville, Vic 3052, Australia; [Glukhova, Alisa] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; AstraZeneca; Medimmune; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Monash University; Monash University	Tesmer, JJG (corresponding author), Purdue Univ, Dept Biol Sci, 240 S Martin Jischke Dr, W Lafayette, IN 47907 USA.	jtesmer@purdue.edu		Manett, Taylor/0000-0001-6315-2712; Yuan, Wenmin/0000-0002-0250-4072; Chang, Louise/0000-0001-5501-4774; Glukhova, Alisa/0000-0003-4146-965X; Manthei, Kelly/0000-0003-3874-8228; Tesmer, John/0000-0003-1125-3727	National Institutes of Health [HL071818, HL122416, AR056991]; F32 Ruth L. Kirschstein NRSA [F32HL131288]; American Heart Association [15POST24870001, 16POST27760002, 13SDG17230049]; University of Michigan Chemical Biology; Veterans Affairs Merit Review Award [1I01BX002021]; MedImmune; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818, R01HL122416, F32HL131288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056991] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F32 Ruth L. Kirschstein NRSA; American Heart Association(American Heart Association); University of Michigan Chemical Biology; Veterans Affairs Merit Review Award(US Department of Veterans Affairs); MedImmune(AstraZenecaMedimmune); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants HL071818 and HL122416 (to J. J. G. T.) and AR056991 (to J. A. S.), F32 Ruth L. Kirschstein NRSA F32HL131288 (to K. A. M.), American Heart Association Postdoctoral Fellowships 15POST24870001 (to K. A. M.) and 16POST27760002 (to W. Y.), American Heart Association Scientist Development Grant 13SDG17230049 (to A. S.), University of Michigan Chemical Biology Postdoctoral Fellowship (to A. G.), Veterans Affairs Merit Review Award 1I01BX002021 (to J. A. S.), and MedImmune. J. A., C. L., and M. J. A. declare that they are employees of MedImmune, the global biologics R&D arm of AstraZeneca, and own stock/stock options in AstraZeneca. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adimoolam S, 1998, J BIOL CHEM, V273, P32561, DOI 10.1074/jbc.273.49.32561; Ahn J, 2012, ANAL CHEM, V84, P7256, DOI 10.1021/ac301749h; Ahsan L., 2014, HDL HDB BIOL FUNCTIO, P159, DOI DOI 10.1016/B978-0-12-407867-3.00007-X; BOLIN DJ, 1994, J BIOL CHEM, V269, P7429; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Calabresi L, 2012, ATHEROSCLEROSIS, V222, P299, DOI 10.1016/j.atherosclerosis.2011.11.034; Charlton-Menys V, 2007, NEPHROL DIAL TRANSPL, V22, P2379, DOI 10.1093/ndt/gfm311; CHEN CH, 1982, BIOCHEM BIOPH RES CO, V107, P1091, DOI 10.1016/0006-291X(82)90633-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christiaens B, 2000, BBA-MOL CELL BIOL L, V1486, P321, DOI 10.1016/S1388-1981(00)00075-5; DASSEUX JL, 1999, Patent No. 6004925; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; Francone OL, 1996, J LIPID RES, V37, P1609; FROHLICH J, 1987, ACTA MED SCAND, V221, P291; FUNKE H, 1991, P NATL ACAD SCI USA, V88, P4855, DOI 10.1073/pnas.88.11.4855; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; GLOMSET JA, 1968, J LIPID RES, V9, P155; Glukhova A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7250; GOTODA T, 1991, LANCET, V338, P778, DOI 10.1016/0140-6736(91)90665-C; Gu XD, 2016, J BIOL CHEM, V291, P6386, DOI 10.1074/jbc.M115.696088; Gunawardane RN, 2016, J BIOL CHEM, V291, P2799, DOI 10.1074/jbc.M115.672790; Hill J. S., 1994, THESIS; Hiraoka M, 2005, J LIPID RES, V46, P2441, DOI 10.1194/jlr.M500248-JLR200; Homan R, 2013, ANAL BIOCHEM, V441, P80, DOI 10.1016/j.ab.2013.06.018; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Iacob RE, 2014, J AM SOC MASS SPECTR, V25, P2093, DOI 10.1007/s13361-014-0973-1; Iacob RE, 2013, J PHARM SCI-US, V102, P4315, DOI 10.1002/jps.23754; Jin LH, 1999, BIOCHEMISTRY-US, V38, P15659, DOI 10.1021/bi9916729; Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KARMIN O, 1993, J LIPID RES, V34, P81; Kim KK, 1997, STRUCTURE, V5, P173, DOI 10.1016/S0969-2126(97)00177-9; KLEIN HG, 1995, J BIOL CHEM, V270, P9443, DOI 10.1074/jbc.270.16.9443; Kuivenhoven JA, 1995, J CLIN INVEST, V96, P2783, DOI 10.1172/JCI118348; Kuivenhoven JA, 1997, J LIPID RES, V38, P191; Lang DA, 1998, EUR J BIOCHEM, V254, P333, DOI 10.1046/j.1432-1327.1998.2540333.x; Lee YP, 1997, BBA-LIPID LIPID MET, V1344, P250, DOI 10.1016/S0005-2760(96)00149-X; Lerch PG, 1996, VOX SANG, V71, P155, DOI 10.1046/j.1423-0410.1996.7130155.x; Li D., 2015, APOLIPOPROTEIN MIMET, P29, DOI [DOI 10.1007/978-3-319-17350-4_3, 10.1007/978-3-319-17350]; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miettinen HE, 1998, ARTERIOSCL THROM VAS, V18, P591, DOI 10.1161/01.ATV.18.4.591; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nanjee MN, 2003, ATHEROSCLEROSIS, V170, P105, DOI 10.1016/S0021-9150(03)00241-7; Nardini M, 2000, J BIOL CHEM, V275, P31219, DOI 10.1074/jbc.M003903200; Peelman F, 1998, PROTEIN SCI, V7, P587, DOI 10.1002/pro.5560070307; Peelman F, 1999, J LIPID RES, V40, P59; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piper DE, 2015, J LIPID RES, V56, P1711, DOI 10.1194/jlr.M059873; Pisciotta L, 2005, ATHEROSCLEROSIS, V182, P153, DOI 10.1016/j.atherosclerosis.2005.01.048; QU SJ, 1995, J LIPID RES, V36, P967; Reshetnyak Y, 2006, J BIOMOL STRUCT DYN, V24, P75, DOI 10.1080/07391102.2006.10507101; Rousset X, 2011, CURR ATHEROSCLER REP, V13, P249, DOI 10.1007/s11883-011-0171-6; Rousset X, 2009, CURR OPIN ENDOCRINOL, V16, P163, DOI 10.1097/MED.0b013e328329233b; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrag JD, 1997, STRUCTURE, V5, P187, DOI 10.1016/S0969-2126(97)00178-0; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P589, DOI 10.1074/mcp.M500321-MCP200; Sorci-Thomas MG, 2009, CLIN LIPIDOL, V4, P113, DOI 10.2217/17584299.4.1.113; Vanloo B, 2000, J LIPID RES, V41, P752; VANTILBEURGH H, 1993, NATURE, V362, P814, DOI 10.1038/362814a0; Vickaryous NK, 2003, BBA-PROTEINS PROTEOM, V1646, P164, DOI 10.1016/S1570-9639(03)00005-0; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhao Y, 2005, BIOCHEMISTRY-US, V44, P1013, DOI 10.1021/bi0481489	67	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20313	20327		10.1074/jbc.M117.802736	http://dx.doi.org/10.1074/jbc.M117.802736			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29030428	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000417696400034
J	Chang, TW; Wei, SY; Wang, SH; Wei, HM; Wang, YJ; Wang, CF; Chen, CP; Liao, YD				Chang, Ting-Wei; Wei, Shu-Yi; Wang, Shih-Han; Wei, Hung-Mu; Wang, Yu-June; Wang, Chiu-Feng; Chen, Chinpan; Liao, You-Di			Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4	PLOS ONE			English	Article							IN-VITRO; MEMBRANE; INFECTION; AMPHIPHILES; NANOTUBES; PROTEINS; MODEL; NMR	Antimicrobial peptides are important components of the host innate defense mechanism against invading pathogens, especially for drug-resistant bacteria. In addition to bactericidal activity, the 25 residue peptide TP4 isolated from Nile tilapia also stimulates cell proliferation and regulates the innate immune system in mice. In this report, TP4 hyperpolarized and depolarized the membrane potential of Pseudomonas aeruginosa at sub-lethal and lethal concentrations. It also inhibited and eradicated biofilm formation. The in vitro binding of TP4 to bacterial outer membrane target protein, OprI, was markedly enhanced by a membranelike surfactant sarkosyl and lipopolysaccharide, which converted TP4 into an alpha-helix. The solution structure of TP4 in dodecylphosphocholine was solved by NMR analyses. It contained a typical alpha-helix at residues Phe10-Arg22 and a distorted helical segment at Ile6-Phe10, as well as a hydrophobic core at the N-terminus and a cationic patch at the C-terminus. Residues Ile16, Leu19 and Ile20 in the hydrophobic face of the main helix were critical for the integrity of amphipathic structure, other hydrophobic residues played important roles in hemolytic and bactericidal activities. A model for the assembly of helical TP4 embedded in sarkosyl vesicle is proposed. This study may provide valuable insight for engineering AMPs to have potent bactericidal activity but low hemolytic activity.	[Chang, Ting-Wei; Wei, Shu-Yi; Wang, Shih-Han; Wei, Hung-Mu; Wang, Yu-June; Wang, Chiu-Feng; Chen, Chinpan; Liao, You-Di] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Academia Sinica - Taiwan	Chen, CP; Liao, YD (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	bmchinp@ibms.sinica.edu.tw; ydliao@ibms.sinica.edu.tw	Wang, Shih-Han/HGA-7092-2022; Chen, Chinpan/O-4202-2018; Liao, You-Di/S-7018-2018	Liao, You-Di/0000-0001-5527-4736	Academia Sinica; Ministry of Science and Technology, Taiwan [105-0210-01-13-01]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from Academia Sinica and Ministry of Science and Technology, Taiwan (105-0210-01-13-01).; The blood samples of C57BL/6JNarl mice were kindly provided by Dr. Chien-Chang Chen in Institute of Biomedical sciences, Academia Sinica, Taiwan. This work was supported by a grant from Academia Sinica and Ministry of Science and Technology, Taiwan (105-0210-01-13-01).	Akter N, 2011, SCI REP-UK, V1, DOI 10.1038/srep00071; ANDLEY UP, 1981, BIOCHEMISTRY-US, V20, P1687, DOI 10.1021/bi00509a043; Andrews JM, 2002, J ANTIMICROB CHEMOTH, V49, P1049, DOI 10.1093/jac/dkf084; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brogden KA, 2001, ANTIMICROB AGENTS CH, V45, P331, DOI 10.1128/AAC.45.1.331-334.2001; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Chang TW, 2015, ANTIMICROB AGENTS CH, V59, P6210, DOI 10.1128/AAC.01406-15; Chang TW, 2012, J BIOL CHEM, V287, P418, DOI 10.1074/jbc.M111.290361; Domenyuk V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054162; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Ghosh S, 2015, J PHYS CHEM B, V119, P7804, DOI 10.1021/acs.jpcb.5b00965; Hancock REW, 2000, EXPERT OPIN INV DRUG, V9, P1723, DOI 10.1517/13543784.9.8.1723; Huang HN, 2015, MAR DRUGS, V13, P2813, DOI 10.3390/md13052813; KIM YM, 1989, J MAGN RESON, V84, P9, DOI 10.1016/0022-2364(89)90003-6; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin YM, 2010, J BIOL CHEM, V285, P8985, DOI 10.1074/jbc.M109.078725; Narayana JL, 2015, ONCOTARGET, V6, P12936; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Peng KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050263; Sanchez E, 2010, APPL ENVIRON MICROB, V76, P6888, DOI 10.1128/AEM.03052-09; Schroder JM, 2006, CELL MOL LIFE SCI, V63, P469, DOI 10.1007/s00018-005-5364-0; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Spindler EC, 2011, ANTIMICROB AGENTS CH, V55, P1706, DOI 10.1128/AAC.01053-10; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Tjabringa GS, 2005, PULM PHARMACOL THER, V18, P321, DOI 10.1016/j.pupt.2005.01.001; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Tseng TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164597; Tsonchev S, 2008, J PHYS CHEM B, V112, P441, DOI 10.1021/jp076273z; Vanhauteghem D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060328; Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599; Wei HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156321; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Yan XH, 2008, CHEM-EUR J, V14, P5974, DOI 10.1002/chem.200800012; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	38	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186442	10.1371/journal.pone.0186442	http://dx.doi.org/10.1371/journal.pone.0186442			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040295	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500046
J	Doi, A; Miyamoto, K; Nakano, YS; Sakasaki, J; Kasae, S; Nishimura, K; Shin, MC; Yoshimura, M				Doi, Atsushi; Miyamoto, Kazuaki; Nakano, Yu-Shin; Sakasaki, Juntaro; Kasae, Syota; Nishimura, Keisuke; Shin, Min-Chul; Yoshimura, Megumu			Sole vibration improves locomotion through the recovery of joint movements in a mouse cast model	PLOS ONE			English	Article							WHOLE-BODY-VIBRATION; IMMOBILIZATION-INDUCED HYPERSENSITIVITY; CRUCIATE LIGAMENT RECONSTRUCTION; HUMAN SKELETAL-MUSCLE; QUADRICEPS FUNCTION; EXERCISE; RATS; BALANCE; HYPERALGESIA; METAANALYSIS	We investigated the effects of a vibratory stimulus on the plantar surface of the hind limb for motor, sensory, and locomotive function using a mouse cast model. The right knee joint of C57BL/6 male mice (7 weeks, 20 g, n = 31) was flexed with aluminum splint and tape for 6 weeks. These mice were randomly divided into 2 groups (control group, n = 11 and vibration group, n = 12). The mice in the vibration group received vibration on the sole of the ankle for 15 minutes per day, 5 days per week. After the knee joint cast was removed, we measured the range of motion (ROM) of both knee and ankle joints and the sensory threshold of the sole. Further, both walking and swimming movements were analyzed with a digital video. The sole vibration did not affect the passive ROM of the knee joint and sensory threshold after cast removal. However, it increased the ankle dorsiflexion range and improved free walking, swimming, and active movement of the knee joint. In conclusion, we show that the vibration recovered both walking and swimming movements, which resulted from improvements in both the passive ankle dorsiflexion and active knee movement.	[Doi, Atsushi; Shin, Min-Chul] Kumamoto Hlth Sci Univ, Dept Rehabil, Kumamoto, Kumamoto, Japan; [Doi, Atsushi; Shin, Min-Chul] Kumamoto Hlth Sci Univ, Grad Sch Hlth Sci, Kumamoto, Kumamoto, Japan; [Miyamoto, Kazuaki] Hitoyoshi Rehabil Hosp, Dept Rehabil, Hitoyoshi, Kumamoto, Japan; [Nakano, Yu-Shin] Okabe Hosp, Dept Rehabil, Umi, Fukuoka, Japan; [Sakasaki, Juntaro] Tokyo Wangan Rehabil Hosp, Dept Rehabil, Narashino, Chiba, Japan; [Kasae, Syota] Shimizu Hosp, Dept Rehabil, Kyoto, Kyoto, Japan; [Nishimura, Keisuke] Iizuka Hosp, Dept Rehabil, Iizuka, Fukuoka, Japan; [Yoshimura, Megumu] Nakamura Hosp, Dept Orthoped Surg, Nogata, Fukuoka, Japan	Kumamoto Health Science University; Kumamoto Health Science University	Doi, A (corresponding author), Kumamoto Hlth Sci Univ, Dept Rehabil, Kumamoto, Kumamoto, Japan.; Doi, A (corresponding author), Kumamoto Hlth Sci Univ, Grad Sch Hlth Sci, Kumamoto, Kumamoto, Japan.	atsushidoi01@gmail.com		Doi, Atsushi/0000-0001-8913-0124	JSPS [26350646]; Kumamoto Health Science University Special Fellowship [25-A-01]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kumamoto Health Science University Special Fellowship	This works was supported by a Grant-in Aid for Scientific Research, JSPS to A.D. (26350646) and Kumamoto Health Science University Special Fellowship Grant to A.D. (No. 25-A-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank to Drs. Taro Matsuzaki and Daisuke Sotobayashi for helping of the technical solution about mouse cast model. This works was supported by a Grant-in Aid for Scientific Research, JSPS to A.D. (26350646) and Kumamoto Health Science University Special Fellowship Grant to A.D. (No. 25-A-01).	Atha J, 1976, Br J Sports Med, V10, P26; Blottner D, 2006, EUR J APPL PHYSIOL, V97, P261, DOI 10.1007/s00421-006-0160-6; Boyd AS, 2009, AM FAM PHYSICIAN, V79, P16; Bush JA, 2015, J STRENGTH COND RES, V29, P1367, DOI 10.1519/JSC.0000000000000709; Choi Eon-Tak, 2016, J Phys Ther Sci, V28, P3149; Choi SJ, 2014, J PHYS THER SCI, V26, P1411, DOI 10.1589/jpts.26.1411; Chuganji S, 2015, NEUROSCI LETT, V584, P66, DOI 10.1016/j.neulet.2014.09.054; Cloak R, 2016, EUR J SPORT SCI, V16, P20, DOI 10.1080/17461391.2014.973912; Coombs Rosalind, 2002, J Sports Sci Med, V1, P56; Dean B J F, 2009, Foot Ankle Surg, V15, P62, DOI 10.1016/j.fas.2008.07.001; Dirks ML, 2014, ACTA PHYSIOL, V210, P628, DOI 10.1111/apha.12200; Falempin M, 1999, J APPL PHYSIOL, V87, P3, DOI 10.1152/jappl.1999.87.1.3; Ferguson SL, 2013, J STRENGTH COND RES, V27, P3329, DOI 10.1519/JSC.0b013e31828f27af; Halanski M, 2008, J AM ACAD ORTHOP SUR, V16, P30, DOI 10.5435/00124635-200801000-00005; Hamaue Y, 2015, PHYS THER, V95, P1015, DOI 10.2522/ptj.20140137; Hamaue Y, 2013, J PHYSIOL SCI, V63, P401, DOI 10.1007/s12576-013-0277-4; Hasegawa S, 2011, J ELECTROMYOGR KINES, V21, P622, DOI 10.1016/j.jelekin.2011.01.005; Houston MN, 2015, J SPORT REHABIL, V24, P77, DOI 10.1123/JSR.2013-0059; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Koga K, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-13; McCormack R, 2015, BRIT J SPORT MED, V49, P1329, DOI 10.1136/bjsports-2015-094935; Morimoto A, 2013, NEUROSCI LETT, V534, P295, DOI 10.1016/j.neulet.2012.11.009; Nakano J, 2012, PHYSIOL RES, V61, P643, DOI 10.33549/physiolres.932362; Ohmichi Y, 2012, EUR J PAIN, V16, P338, DOI 10.1002/j.1532-2149.2011.00026.x; Pamukoff DN, 2016, MUSCLE NERVE, V54, P469, DOI 10.1002/mus.25081; Pamukoff DN, 2016, ARCH PHYS MED REHAB, V97, P1121, DOI 10.1016/j.apmr.2016.01.021; Salanova M, 2011, FASEB J, V25, P4312, DOI 10.1096/fj.11-186049; Sekino Y, 2014, EUR J PAIN, V18, P639, DOI 10.1002/j.1532-2149.2013.00412.x; Spiliopoulou SI, 2010, INT J SPORTS MED, V31, P610, DOI 10.1055/s-0030-1249618; Terkelsen AJ, 2008, ANESTHESIOLOGY, V109, P297, DOI 10.1097/ALN.0b013e31817f4c9d; Yang XT, 2016, CLIN REHABIL, V30, P419, DOI 10.1177/0269215515589202; Yang XT, 2015, CLIN REHABIL, V29, P627, DOI 10.1177/0269215514552829; Yoon KH, 2013, ARTHROSCOPY, V29, P500, DOI 10.1016/j.arthro.2012.10.019	33	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186189	10.1371/journal.pone.0186189	http://dx.doi.org/10.1371/journal.pone.0186189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040289	Green Published, gold, Green Submitted			2022-12-26	WOS:000413167500023
J	Lin, HJ; Huang, CT; Hsiao, HF; Chiang, MC; Jeng, MJ				Lin, Hsin-Ju; Huang, Ching-Tzu; Hsiao, Hsiu-Feng; Chiang, Ming-Chou; Jeng, Mei-Jy			End-tidal carbon dioxide measurement in preterm infants with low birth weight	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INTRAVENTRICULAR HEMORRHAGE; MAINSTREAM	Objective There are conflicting data regarding the use of end-tidal carbon dioxide (PetCO(2)) measurement in preterm infants. The aim of this study was to evaluate the effects of different dead space to tidal volume ratios (VD/VT) on the correlation between PetCO(2) and arterial carbon dioxide pressure (PaCO2) in ventilated preterm infants with respiratory distress syndrome (RDS). Methods We enrolled ventilated preterm infants (with assist control mode or synchronous intermittent mandatory mode) with RDS who were treated with surfactant in this prospective study. Simultaneous PetCO(2) and PaCO2 data pairs were obtained from ventilated neonates monitored using mainstream capnography. Data obtained before and after surfactant treatment were also analyzed. Results One-hundred and one PetCO(2) and PaCO2 pairs from 34 neonates were analyzed. There was a moderate correlation between PetCO(2) and PaCO2 values (r = 0.603, P < 0.01). The correlation was higher in the post-surfactant treatment group (r = 0.786, P < 0.01) than the pre-surfactant treatment group (r = 0.235). The values of PaCO2 and PetCO(2) obtained based on the treatment stage of surfactant therapy were 42.4 +/- 8.6 mmHg and 32.6 +/- 7.2 mmHg, respectively, in pre-surfactant treatment group, and 37.8 +/- 10.3 mmHg and 33.7 +/- 9.3 mmHg, respectively, in the post-surfactant treatment group. Furthermore, we found a significant decrease in VD/VT in the post-surfactant treatment group when compared to the pre-surfactant treatment group (P = 0.003). Conclusions V-D/V-T decreased significantly after surfactant therapy and the correlation between PetCO(2) and PaCO2 was higher after surfactant therapy in preterm infants with RDS.	[Lin, Hsin-Ju; Huang, Ching-Tzu; Hsiao, Hsiu-Feng; Chiang, Ming-Chou] Chang Gung Mem Hosp, Dept Resp Therapy, Taoyuan, Taiwan; [Lin, Hsin-Ju; Huang, Ching-Tzu; Jeng, Mei-Jy] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan; [Huang, Ching-Tzu; Hsiao, Hsiu-Feng; Chiang, Ming-Chou] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chiang, Ming-Chou] Chang Gung Mem Hosp, Div Neonatol, Dept Pediat, Taoyuan, Taiwan; [Jeng, Mei-Jy] Taipei Vet Gen Hosp, Dept Pediat, Childrens Med Ctr, Taipei, Taiwan	Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University; Chang Gung University; Chang Gung Memorial Hospital; Taipei Veterans General Hospital	Chiang, MC (corresponding author), Chang Gung Mem Hosp, Dept Resp Therapy, Taoyuan, Taiwan.; Jeng, MJ (corresponding author), Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan.; Chiang, MC (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Chiang, MC (corresponding author), Chang Gung Mem Hosp, Div Neonatol, Dept Pediat, Taoyuan, Taiwan.; Jeng, MJ (corresponding author), Taipei Vet Gen Hosp, Dept Pediat, Childrens Med Ctr, Taipei, Taiwan.	newborntw@gmail.com; mjjeng@vghtpe.gov.tw			Chang Gung Memorial Hospital [CMRPG3D1021]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was funded by CMRPG3D1021; from Chang Gung Memorial Hospital.; The study was supported partly by Chang Gung Memorial Hospital (CMRPG3D1021). The authors gratefully acknowledge the Center for Big Data Analytics and Statistics at Chang Gung Memorial Hospital for statistical assistance. All of the respiratory therapists and the nursing staff in the neonatal intensive care units do an outstanding job of taking care of the patients and helped to complete this study.	Attar Mohammad Ali, 2002, Semin Neonatol, V7, P353, DOI 10.1053/siny.2002.0129; Balogh AL, 2016, BRIT J ANAESTH, V117, P109, DOI 10.1093/bja/aew127; BARALDI E, 1993, PEDIATR PULM, V15, P157, DOI 10.1002/ppul.1950150306; Bhat YR, 2008, SINGAP MED J, V49, P199; BILLMAN D, 1994, PEDIATR PULM, V18, P279, DOI 10.1002/ppul.1950180503; Bruschettini M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011494.pub2; Cheifetz IM, 2007, RESP CARE, V52, P423; Chung EH, 2001, J KOREAN MED SCI, V16, P51, DOI 10.3346/jkms.2001.16.1.51; Donn SM, 2017, MANUAL OF NEONATAL R; Fabres J, 2007, PEDIATRICS, V119, P299, DOI 10.1542/peds.2006-2434; Garcia Canto E, 1997, An Esp Pediatr, V47, P177; HAND IL, 1990, PEDIATR PULM, V9, P206, DOI 10.1002/ppul.1950090404; Hauspurg AK, 2011, NEONATOLOGY, V99, P104, DOI 10.1159/000308454; Lim WH, 2011, J PERINATOL, V31, P193, DOI 10.1038/jp.2010.86; McSwain SD, 2010, RESP CARE, V55, P288; Niknafs P, 2015, IRAN J MED SCI, V40, P264; Ortega Rafael, 2012, N Engl J Med, V367, pe27, DOI 10.1056/NEJMvcm1105237; Schmalisch G, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0228-4; Singh BS, 2013, PEDIATR PULM, V48, P250, DOI 10.1002/ppul.22593; Siobal MS, 2016, RESP CARE, V61, P1397, DOI 10.4187/respcare.04919; Sullivan KJ, 2005, PEDIATR EMERG CARE, V21, P327, DOI 10.1097/01.pec.0000159064.24820.bd; Sweet DG, 2017, NEONATOLOGY, V111, P107, DOI 10.1159/000448985; Thompson John E, 2005, Respir Care, V50, P100; Trevisanuto D, 2012, PEDIATR PULM, V47, P367, DOI 10.1002/ppul.21558; Urbano J, 2010, PEDIATR PULM, V45, P481, DOI 10.1002/ppul.21203; Verscheure S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1377-3; Walsh BK, 2011, RESP CARE, V56, P503, DOI 10.4187/respcare.01175; WATKINS AMC, 1987, ARCH DIS CHILD, V62, P837, DOI 10.1136/adc.62.8.837; Wu CH, 2003, PEDIATR PULM, V35, P292, DOI 10.1002/ppul.10260	29	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e0186408	10.1371/journal.pone.0186408	http://dx.doi.org/10.1371/journal.pone.0186408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK0KA	29040312	Green Published, Green Submitted, gold			2022-12-26	WOS:000413167500043
J	Taniguchi, M; Tateuchi, H; Ibuki, S; Ichihashi, N				Taniguchi, Masashi; Tateuchi, Hiroshige; Ibuki, Satoko; Ichihashi, Noriaki			Relative mobility of the pelvis and spine during trunk axial rotation in chronic low back pain patients: A case-control study	PLOS ONE			English	Article							LUMBAR SPINE; INTRAABDOMINAL PRESSURE; RISK-FACTORS; KINEMATICS; HIP; MOVEMENTS; MOTION; ASYMMETRY; MUSCLES; THORAX	Background Trunk axial rotation is a risk factor for chronic low back pain (CLBP). The characteristics of rotational mobility in the pelvis and spine among CLBP patients are not fully understood. Purpose The purpose of this study was to examine three-dimensional kinematic changes, and to compare the differences of rotational mobility and coupled motion, in patients with and without CLBP. Methods Fifteen patients with CLBP and 15 age and sex matched healthy subjects participated in this study. Each subject performed trunk rotation to maximum range of motion (ROM) in a standing position. The kinematics data was collected using a three-dimensional motion analysis system. The outcomes measured were the rotational ROM and the spine/pelvis ratio (SPR) in transvers plane at both maximum and 50% rotation position. The coupled angles in sagittal and frontal planes were also measured. Results No significant differences in rotational ROM of the thorax, pelvis, and spine were observed between two groups at maximum rotation position. However, there was a significant interaction between groups and rotational ROM of pelvis and spine (F = 4.57, p = 0.04), and the SPR in CLBP patients was significantly greater than that of the healthy subjects (CLBP; 0.50 +/- 0.10 Control; 0.41 0.12, p = 0.04). The results at 50% rotation position were similar to that at maximum rotation. This indicates a relative increase in spinal rotation in the CLBP patients during trunk rotation. Moreover, the CLBP patients exhibited a significantly higher anterior tilt of the pelvis and extension of the spine in the sagittal plane coupled with rotation. Conclusions CLBP patients had relative hyper rotational mobility of the spine as well as excessive spinal extension coupled with trunk rotation. These results suggest that uncoordinated trunk rotation might be a functional failure associated with CLBP.	[Taniguchi, Masashi] Shiga Univ Med Sci Hosp, Rehabil Units, Div Phys Therapy, Otsu, Shiga, Japan; [Taniguchi, Masashi; Tateuchi, Hiroshige; Ibuki, Satoko; Ichihashi, Noriaki] Kyoto Univ, Grad Sch Med, Dept Phys Therapy, Kyoto, Japan	Shiga University of Medical Science; Kyoto University	Taniguchi, M (corresponding author), Shiga Univ Med Sci Hosp, Rehabil Units, Div Phys Therapy, Otsu, Shiga, Japan.; Taniguchi, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Phys Therapy, Kyoto, Japan.	masa1030@belle.shiga-med.ac.jp	Tateuchi, Hiroshige/GVS-4597-2022	Tateuchi, Hiroshige/0000-0002-7429-8204; Ichihashi, Noriaki/0000-0003-2508-2172; Taniguchi, Masashi/0000-0003-0548-0210				ADAMS MA, 1981, SPINE, V6, P241, DOI 10.1097/00007632-198105000-00006; Al-Eisa E, 2006, SPINE, V31, pE135, DOI 10.1097/01.brs.0000201325.89493.5f; Al-Eisa E, 2006, SPINE, V31, pE71, DOI 10.1097/01.brs.0000197665.93559.04; Armand S, 2014, GAIT POSTURE, V39, P147, DOI 10.1016/j.gaitpost.2013.06.016; Attias M, 2015, CLIN BIOMECH, V30, P28, DOI 10.1016/j.clinbiomech.2014.11.009; Christe G, 2017, J BIOMECH, V60, P211, DOI 10.1016/j.jbiomech.2017.06.042; GOLDISH GD, 1994, ARCH PHYS MED REHAB, V75, P324, DOI 10.1016/0003-9993(94)90037-X; Hodges PW, 2005, J BIOMECH, V38, P1873, DOI 10.1016/j.jbiomech.2004.08.016; Hoogendoorn WE, 2000, SPINE, V25, P3087, DOI 10.1097/00007632-200012010-00018; Lee RYW, 2002, HUM MOVEMENT SCI, V21, P481, DOI 10.1016/S0167-9457(02)00117-3; Lund T, 2002, SPINE, V27, P1865, DOI 10.1097/00007632-200209010-00012; MARRAS WS, 1995, ERGONOMICS, V38, P377, DOI 10.1080/00140139508925111; Masharawi Y, 2004, SPINE, V29, P1755, DOI 10.1097/01.BRS.0000134575.04084.EF; Muller R, 2015, J BIOMECH, V48, P1009, DOI 10.1016/j.jbiomech.2015.01.042; Ng JKF, 2002, J ORTHOPAED RES, V20, P112, DOI 10.1016/S0736-0266(01)00067-5; Ng JKF, 2001, J ORTHOPAED RES, V19, P463, DOI 10.1016/S0736-0266(00)90027-5; Pearcy MJ, 1993, TWISTING MOBILITY HU, V18; Plouvier S, 2014, INT ARCH OCCUP ENV H; Riley PO, 2008, MED SCI SPORT EXER, V40, P1093, DOI 10.1249/MSS.0b013e3181677530; Rohrer M H, 1994, Eur Spine J, V3, P2, DOI 10.1007/BF02428309; Sahrmanns, 2002, DAIGNOSIS TREATMENT; Shmagel A, 2016, ARTHRIT CARE RES, V68, P1688, DOI 10.1002/acr.22890; Sizer PS, 2007, J MANIP PHYSIOL THER, V30, P390, DOI 10.1016/j.jmpt.2007.04.009; Stokes IA, 2011, CLIN BIOMECH; Sung PS, 2012, J SPINAL DISORD TECH, V25, pE74, DOI 10.1097/BSD.0b013e3182404b87; Tateuchi H, 2011, HUM MOVEMENT SCI, V30, P566, DOI 10.1016/j.humov.2010.11.011; Van Dillen LR, 2007, ARCH PHYS MED REHAB, V88, P351, DOI 10.1016/j.apmr.2006.12.021; Wada O, 2014, GAIT POSTURE, V39, P60, DOI 10.1016/j.gaitpost.2013.05.030; Wong TKT, 2004, HUM MOVEMENT SCI, V23, P21, DOI 10.1016/j.humov.2004.03.004; Xu Y, 1997, OCCUP ENVIRON MED, V54, P741, DOI 10.1136/oem.54.10.741	30	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2017	12	10							e186369	10.1371/journal.pone.0186369	http://dx.doi.org/10.1371/journal.pone.0186369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK0KA	29040298	gold, Green Published, Green Submitted			2022-12-26	WOS:000413167500040
J	Han, P; Huang, Y; Xie, YM; Yang, W; Wang, YY; Xiang, WY; Hylands, PJ; Legido-Quigley, C				Han, Pei; Huang, Yong; Xie, Yumin; Yang, Wu; Wang, Yaoyao; Xiang, Wenying; Hylands, Peter J.; Legido-Quigley, Cristina			Metabolic phenotyping in the mouse model of urinary tract infection shows that 3-hydroxybutyrate in plasma is associated with infection	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOMARKERS; DIAGNOSIS; URINALYSIS; MECHANISMS; TRANSPORT; CHILDREN; PROTEIN; LIVER	Urinary tract infection is one of the most common bacterial infections worldwide. Current diagnosis of urinary tract infection chiefly relies on its clinical presentation, urine dipstick tests and urine culture. Small molecules found in bio-fluids related with both infection and recovery would facilitate diagnosis and management of UTI. Mass spectrometry-based fingerprinting of plasma and urine at 3 time points, pre-infection (t = -24h), infection (t = 24h) and post 3-day treatment (t = 112h), were acquired in the following four groups: mice which were healthy, infected but not treated, infected and treated with ciprofloxacin, and infected and treated with Relinqing (R) granules (n = 6 per group). A metabolomics workflow including multivariate analysis and ROC regression was employed to select metabolic features that correlated with UTI and its treatment. Circa 4,000 molecular features were acquired for each sample. The small acid 3-hydroxybutyrate in plasma was found to be differentiated for urinary tract infection, with an area under the curve = 0.97 (95% confidence interval: 0.93-1.00, accuracy = 0.91, sensitivity = 0.92 and specificity = 0.91). The level of 3-hydroxybutyrate in plasma was depleted after infection with a fold change of -22 (q < 0.0001). Correlation between plasma 3-hydroxybutyrate and urine bacterial number in all groups and time points was r = -0.753 (p < 0.0001). The findings show that 3-hydroxybutyrate is depleted in blood and strongly associated with UTI at both infection and post-treatment stage in a UTI mouse model. Further work is envisaged to assess the clinical potential of blood tests to assist with UTI management.	[Han, Pei; Wang, Yaoyao; Hylands, Peter J.; Legido-Quigley, Cristina] Kings Coll London, Inst Pharmaceut Sci, Fac Life Sci & Med, London, England; [Huang, Yong; Xie, Yumin; Yang, Wu; Xiang, Wenying] Guiyang Med Univ, Prov Key Lab Pharmaceut Guizhou Prov, Sch Pharm, Guiyang, Guizhou, Peoples R China	University of London; King's College London; Guizhou Medical University	Hylands, PJ; Legido-Quigley, C (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Fac Life Sci & Med, London, England.	peter.2.hylands@kcl.ac.uk; cristina.legido_quigley@kcl.ac.uk		Legido-Quigley, Cristina/0000-0002-4018-214X	National Natural Science Foundation of China [812606880]; Science and Technology Foundation of Guizhou Province [2012-7040]; National Key Technology RD Program [2013BAI11B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Guizhou Province; National Key Technology RD Program(National Key Technology R&D Program)	YH was supported by National Natural Science Foundation of China (No. 812606880), http://www.nsfc.gov.cn/publish/portal1/; Science and Technology Foundation of Guizhou Province (No. 2012-7040), http://kjt.gzst.gov.cn/; National Key Technology R&D Program (2013BAI11B01), http://www.most.gov.cn/eng/programmes1/200610/t20061009_36224.htm. These funders supported the study design, data collection and analysis. PH was supported by China Scholarship Council, http://en.csc.edu.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdekar S, 2011, CURR MICROBIOL, V63, P484, DOI 10.1007/s00284-011-0006-2; Boonen KJM, 2013, WORLD J UROL, V31, P547, DOI 10.1007/s00345-012-0883-4; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; Chuang FC, 2016, INT NEUROUROL J, V20, P33, DOI 10.5213/inj.1630454.227; Ciragil P, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/269362; Daure E, 2013, RES VET SCI, V95, P1181, DOI 10.1016/j.rvsc.2013.09.002; Finer G, 2004, LANCET INFECT DIS, V4, P631, DOI 10.1016/S1473-3099(04)01147-8; FLEGEL WA, 1991, INFECT IMMUN, V59, P3659, DOI 10.1128/IAI.59.10.3659-3666.1991; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Florkowski Christopher M, 2008, Clin Biochem Rev, V29 Suppl 1, pS83; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; HAGBERG L, 1983, INFECT IMMUN, V40, P273, DOI 10.1128/IAI.40.1.273-283.1983; Han P, 2016, J SEPARATION SCI; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Hooton TM, 2012, NEW ENGL J MED, V367, P185; Ichino M, 2009, J UROLOGY, V181, P2326, DOI 10.1016/j.juro.2009.01.010; Kayalp D, 2013, CLIN BIOCHEM, V46, P1285, DOI 10.1016/j.clinbiochem.2013.06.015; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; KjoivmarK C, 2014, OPEN FORUM INFECT DI, V1; Lam CW, 2015, CLIN CHIM ACTA, V438, P24, DOI 10.1016/j.cca.2014.07.038; Lam CW, 2014, CLIN CHIM ACTA, V436, P217, DOI 10.1016/j.cca.2014.05.014; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lee HY, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/741403; Leroy S, 2013, PEDIATRICS; Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087; Memon RA, 1998, AM J PHYSIOL-ENDOC M, V274, pE210, DOI 10.1152/ajpendo.1998.274.2.E210; Molins CR, 2015, CLIN INFECT DIS, DOI [10.1093/cidiciv185, DOI 10.1093/CIDICIV185]; Nanda N, 2009, BIOMARK INSIGHTS, V4, P111; NEUFELD HA, 1976, METABOLISM, V25, P877, DOI 10.1016/0026-0495(76)90120-7; Nevedomskaya E, 2012, METABOLOMICS, V8, P1227, DOI 10.1007/s11306-012-0411-y; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Nicolle LE, 2008, UROL CLIN N AM, V35, P1, DOI 10.1016/j.ucl.2007.09.004; Price JR, 2017, FEMALE PELVIC MED RE, V23, P101, DOI 10.1097/SPV.0000000000000366; Rahn David D, 2008, Urol Nurs, V28, P333; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Sabbisetti VS, 2012, TOXICOL SCI; SANDERS CC, 1988, REV INFECT DIS, V10, P516; Schappert Susan M, 2006, Vital Health Stat 13, P1; Schrauwen P, 2001, FASEB J, V15, P2497, DOI 10.1096/fj.01-0400hyp; WANNEMACHER RW, 1979, J CLIN INVEST, V64, P1565, DOI 10.1172/JCI109617; Watson JR, 2016, PEDIATR RES, V79, P934, DOI 10.1038/pr.2016.33; Whiley L, 2014, NEUROBIOL AGING, V35, P271, DOI 10.1016/j.neurobiolaging.2013.08.001; Wilson ML, 2004, CLIN INFECT DIS, V38, P1150, DOI 10.1086/383029; Wittenhagen P, 2011, BIOMARK INSIGHTS, V6, P79, DOI 10.4137/BMI.S6876; Yang FM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170896; Yilmaz A, 2009, PEDIATR NEPHROL, V24, P2387, DOI 10.1007/s00467-009-1279-6; Yim HE, 2014, PEDIATR NEPHROL, V29, P2181, DOI 10.1007/s00467-014-2845-0; 기형민, 2014, Childhood Kidney diseases, V18, P36	48	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2017	12	10							e0186497	10.1371/journal.pone.0186497	http://dx.doi.org/10.1371/journal.pone.0186497			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ8YP	29036204	Green Published, Green Submitted, gold			2022-12-26	WOS:000413054800041
J	Fukuhara, T; Kim, J; Hokaiwado, S; Nawa, M; Okamoto, H; Kogiso, T; Watabe, T; Hattori, N				Fukuhara, Takeshi; Kim, Jia; Hokaiwado, Shintaro; Nawa, Makiko; Okamoto, Hayato; Kogiso, Tomohiko; Watabe, Tetsuro; Hattori, Nobutaka			A novel immunotoxin reveals a new role for CD321 in endothelial cells	PLOS ONE			English	Article							JUNCTIONAL ADHESION MOLECULE; MESENCHYMAL TRANSITION; ANTIBODY; MICE; INFLAMMATION; RECRUITMENT; ANTIGEN; GENE	There are currently several antibody therapies that directly target tumors, and antibody-drug conjugates represent a novel moiety as next generation therapeutics. Here, we used a unique screening probe, DT3C, to identify functional antibodies that recognized surface molecules and functional epitopes, and which provided toxin delivery capability. Accordingly, we generated the 90G4 antibody, which induced DT3C-dependent cytotoxicity in endothelial cells. Molecular analysis revealed that 90G4 recognized CD321, a protein localized at tight junctions. Although CD321 plays a pivotal role in inflammation and lymphocyte trans-endothelial migration, little is known about its mechanism of action in endothelial cells. Targeting of CD321 by the 90G4 immunotoxin induced cell death. Moreover, 90G4 immunotoxin caused cytotoxicity primarily in migratory endothelial cells, but not in those forming sheets, suggesting a critical role for CD321 in tumor angiogenesis. We also found that hypoxia triggered redistribution of CD321 to a punctate localization on the basal side of cells, resulting in functional impairment of tight junctions and increased motility. Thus, our findings raise the intriguing possibility that endothelial CD321 presented cellular localization in tight junction as well as multifunctional dynamics in several conditions, leading to illuminate the importance of widely-expressed CD321 as a potential target for antitumor therapy.	[Fukuhara, Takeshi; Hokaiwado, Shintaro; Hattori, Nobutaka] Juntendo Univ, Dept Neurol, Sch Med, Bunkyo Ku, Tokyo, Japan; [Fukuhara, Takeshi; Kim, Jia; Hokaiwado, Shintaro; Okamoto, Hayato; Kogiso, Tomohiko; Watabe, Tetsuro] Tokyo Univ Pharm & Life Sci, Dept Life Sci, Lab Oncol, Hachioji, Tokyo, Japan; [Kim, Jia; Watabe, Tetsuro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Biochem, Bunkyo Ku, Tokyo, Japan; [Nawa, Makiko] Tokyo Med & Dent Univ, Lab Cytometry, Bunkyo Ku, Tokyo, Japan; [Nawa, Makiko] Tokyo Med & Dent Univ, Proteome Res Med Res Inst, Bunkyo Ku, Tokyo, Japan	Juntendo University; Tokyo University of Pharmacy & Life Sciences; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Fukuhara, T (corresponding author), Juntendo Univ, Dept Neurol, Sch Med, Bunkyo Ku, Tokyo, Japan.; Fukuhara, T (corresponding author), Tokyo Univ Pharm & Life Sci, Dept Life Sci, Lab Oncol, Hachioji, Tokyo, Japan.	tfukuha@juntendo.ac.jp	Hattori, Nobutaka/ACR-0069-2022; Fukuhara, Takeshi/GLN-6928-2022		KAKENHI [25830123]; Japan Society for the Promotion of Science (JSPS) [16K07184]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) - Supported Program for the Strategic Research Foundation at Private Universities at Tokyo University of Pharmacy and Life Sciences [S1411014]; Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research [17KT0130] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) - Supported Program for the Strategic Research Foundation at Private Universities at Tokyo University of Pharmacy and Life Sciences; Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by KAKENHI, a Grant-in-Aid for Encouragement of Young Scientists (B) (TF as PI, 25830123), Grant-in-Aid for Scientific research (C) (TF as PI, 16K07184) from Japan Society for the Promotion of Science (JSPS), the Ministry of Education, Culture, Sports, Science and Technology (MEXT)- Supported Program for the Strategic Research Foundation at Private Universities (TF and TW as co-PI, S1411014) at Tokyo University of Pharmacy and Life Sciences, and The Vehicle Racing Commemorative Foundation (TF and TW as PI).; We are grateful to Drs. Hirofumi Hamada for developing the DT3C screening method, and Hiroaki Uchida and Miki Yamaguchi for providing the DT3C expression vector and for helpful support. We thank Drs. Hideo Yagita for a kind gift of F-2 cells, Akemi Koyanagi and Tamami Sakanishi for technical supports, and Drs. Masataka Kasai and Montasir Elahi for manuscript preparation. This study was supported in part by KAKENHI, a Grant-in-Aid for Encouragement of Young Scientists (B) (25830123), a Grant-in-Aid for Scientific research (C) (16K07184) from the Japan Society for the Promotion of Science (JSPS), the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities (S1411014) at Tokyo University of Pharmacy and Life Sciences; and The Vehicle Racing Commemorative Foundation. We thank the laboratory members and the secretaries of the laboratory of Oncology at Tokyo University of Pharmacy and Life Sciences, the Department of Neurology at Juntendo University, and Department of Biochemistry at Tokyo Medical and Dental University.	Azari BM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-98; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Corada M, 2005, P NATL ACAD SCI USA, V102, P10634, DOI 10.1073/pnas.0500147102; Del Maschio A, 1999, J EXP MED, V190, P1351, DOI 10.1084/jem.190.9.1351; Haarmann A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013568; Ikeda M, 2015, BIOCHEM BIOPH RES CO, V458, P877, DOI 10.1016/j.bbrc.2015.02.051; Lechner F, 2000, J INFECT DIS, V182, P978, DOI 10.1086/315765; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; MARUYAMA H, 1993, MICROBIOL IMMUNOL, V37, P895, DOI 10.1111/j.1348-0421.1993.tb01721.x; Mihira H, 2012, J BIOCHEM, V151, P145, DOI 10.1093/jb/mvr121; Naik MU, 2003, BLOOD, V102, P2108, DOI 10.1182/blood-2003-04-1114; Nishii Y, 2015, INT J ONCOL, V46, P1781, DOI 10.3892/ijo.2015.2880; OCONNELL KA, 1990, J IMMUNOL, V144, P521; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Pong WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077571; RAY S, 1994, P NATL ACAD SCI USA, V91, P5548, DOI 10.1073/pnas.91.12.5548; Salifu MO, 2007, J INVEST MED, V55, P115, DOI 10.2310/6650.2007.06041; Severson EA, 2009, CURR OPIN CELL BIOL, V21, P701, DOI 10.1016/j.ceb.2009.06.005; Stamatovic SM, 2012, MOL CELL BIOL, V32, P3414, DOI 10.1128/MCB.06678-11; Tanaka T, 2006, CLIN CANCER RES, V12, P3803, DOI 10.1158/1078-0432.CCR-06-0024; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; WILLIAMS RL, 1989, CELL, V57, P1053, DOI 10.1016/0092-8674(89)90343-7; Yamaguchi M, 2014, BIOCHEM BIOPH RES CO, V454, P600, DOI 10.1016/j.bbrc.2014.10.133; YANAI N, 1991, JPN J CANCER RES, V82, P1344, DOI 10.1111/j.1349-7006.1991.tb01803.x; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zernecke A, 2006, ARTERIOSCL THROM VAS, V26, pE10, DOI 10.1161/01.ATV.0000197852.24529.4f	26	7	7	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0181502	10.1371/journal.pone.0181502	http://dx.doi.org/10.1371/journal.pone.0181502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ7ZQ	29028806	Green Published, gold, Green Submitted			2022-12-26	WOS:000412980300002
J	Horbach, SPJM; Halffman, W				Horbach, Serge P. J. M.; Halffman, Willem			The ghosts of HeLa: How cell line misidentification contaminates the scientific literature	PLOS ONE			English	Article							CROSS-CONTAMINATION; ESTABLISHMENT; FINGERPRINTS; IDENTITY; CULTURES; ALVA-31; CRISIS	While problems with cell line misidentification have been known for decades, an unknown number of published papers remains in circulation reporting on the wrong cells without warning or correction. Here we attempt to make a conservative estimate of this 'contaminated' literature. We found 32,755 articles reporting on research with misidentified cells, in turn cited by an estimated half a million other papers. The contamination of the literature is not decreasing over time and is anything but restricted to countries in the periphery of global science. The decades-old and often contentious attempts to stop misidentification of cell lines have proven to be insufficient. The contamination of the literature calls for a fair and reasonable notification system, warning users and readers to interpret these papers with appropriate care.	[Horbach, Serge P. J. M.; Halffman, Willem] Radboud Univ Nijmegen, Inst Sci Soc, Nijmegen, Netherlands	Radboud University Nijmegen	Halffman, W (corresponding author), Radboud Univ Nijmegen, Inst Sci Soc, Nijmegen, Netherlands.	w.halffman@science.ru.nl	Horbach, Serge P. J. M./AAH-2332-2019; Halffman, Willem/D-3439-2012	Horbach, Serge P. J. M./0000-0003-0406-6261; Halffman, Willem/0000-0002-1800-5884	European Unions Horizon research and innovation program [665926]	European Unions Horizon research and innovation program	The authors received funding from the European Unions Horizon 2020 research and innovation program (https://ec.europa.eu/programmes/horizon2020/en/what-horizon-2020), under grant agreement no. 665926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2016, NATURE, V530, P27, DOI 10.1038/530027a; Artimo P, 2012, EXPASY SIB BIOINFORM; Boonstra JJ, 2010, JNCI-J NATL CANCER I, V102, P271, DOI 10.1093/jnci/djp499; Capes-Davis A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002477; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Casadevall A, 2014, FASEB J, V28, P3847, DOI 10.1096/fj.14-256735; de Oliveira DE, 2016, CANCER LETT, V381, P122, DOI 10.1016/j.canlet.2016.07.031; Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799; Fanelli D, 2016, NATURE, V531, P415, DOI 10.1038/531415a; FERNANDEZ E, 1994, BLOOD, V83, P3245; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Freshney RI, 2002, CYTOTECHNOLOGY, V39, P55, DOI 10.1023/A:1022949730029; Gartler S M, 1967, Natl Cancer Inst Monogr, V26, P167; GARTLER SM, 1968, NATURE, V217, P750, DOI 10.1038/217750a0; GILBERT DA, 1990, AM J HUM GENET, V47, P499; Gold M., 1986, CONSPIRACY CELLS ONE; Grens K., 2016, POPULAR TUMOR CELL L; Grens K, 2015, SCIENTIST, V29, P50; Hall E., 2016, RGC 5 IS NOT RAT RET; Huang YQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170384; Identity crisis, 2009, NATURE, V457, P935; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Lariviere V, 2009, J AM SOC INF SCI TEC, V60, P858, DOI 10.1002/asi.21011; Liang-Chu MMY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116218; Lins MP, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0097-0; LOOP SM, 1993, PROSTATE, V22, P93, DOI 10.1002/pros.2990220202; Lorsch JR, 2014, SCIENCE, V346, P1452, DOI 10.1126/science.1259110; MacLeod RAF, 1999, INT J CANCER, V83, P555; MacLeod RAF, 2002, HUMAN CELL CULTURE C, P371; Masters JR, 2012, NATURE, V492, P186, DOI 10.1038/492186a; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; McElreath R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136088; MURAKI J, 1990, UROLOGY, V36, P79, DOI 10.1016/0090-4295(90)80319-I; Nardone RN, 2007, OPEN LETT REGARDING; National Institutes of Health, 2015, NOTOD15103 NAT I HLT; National Institutes of Health, 2016, NOTOD16011 NAT I HLT; NELSONRE.WA, 1974, SCIENCE, V184, P1093, DOI 10.1126/science.184.4141.1093; NELSONREES WA, 1976, SCIENCE, V191, P96, DOI 10.1126/science.1246601; NELSONREES WA, 1981, SCIENCE, V212, P446, DOI 10.1126/science.6451928; Normile D., 2014, NATURE RETRACTS CONT; OBRIEN SJ, 1980, IN VITRO CELL DEV B, V16, P119; Oransky I., 2017, STUCK LIMBO WHAT HAP; OTOOLE CM, 1983, NATURE, V301, P429, DOI 10.1038/301429a0; Perkel JM, 2011, BIOTECHNIQUES, V51, P85, DOI 10.2144/000113714; Puto LA, 2015, J BIOL CHEM, V290, P15406, DOI 10.1074/jbc.M115.658765; Schulz JB, 2016, J NEUROCHEM, V139, P253, DOI 10.1111/jnc.13844; Singh Chawla D., 2015, NATURE; Stacey GN, 2000, NATURE, V403, P356, DOI 10.1038/35000394; van Bokhoven A, 2001, CANCER RES, V61, P6340; van Bokhoven A, 2001, PROSTATE, V47, P36; Varella-Garcia M, 2001, GENE CHROMOSOME CANC, V31, P303, DOI 10.1002/gcc.1149; Vaughan L, 2017, CANCER RES J; Ye F, 2015, FASEB J, V29, P4268, DOI 10.1096/fj.14-266718; Yu M, 2015, NATURE, V520, P307, DOI 10.1038/nature14397	58	73	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186281	10.1371/journal.pone.0186281	http://dx.doi.org/10.1371/journal.pone.0186281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023500	Green Published, Green Submitted, gold			2022-12-26	WOS:000412845100097
J	Huang, LG; Chen, G; Chen, DY; Hsin-Hua,				Huang, Liang-Gie; Chen, Gin; Chen, Der-Yuan; Chen, Hsin-Hua			Factors associated with the risk of gingival disease in patients with rheumatoid arthritis	PLOS ONE			English	Article							NONSURGICAL PERIODONTAL THERAPY; VITAMIN-C; NATIONAL-HEALTH; PATHOGENESIS; BACTERIA; ADULTS; ALPHA	Gingival disase and rheumatoid arthritis (RA) are linked at both the epidemiologic and pathogenesis levels. In this study, we aimed to identify environmental factors associated with RA and gingival disease and to investigate factors that protect the gingival tissue in RA patients. This retrospective study analyzed 754 RA patients with gingival disease selected from the NHANES database who completed the mobile examination center interview/examination between 1999 and 2004. Data collected included demographics, lifestyle, dietary intake, and biomarkers. The study included 173 RA patients with gingival disease. Multivariate logistic regression analysis showed that the odds of gingival disease were significantly increased with male gender. However, the odds of gingival disease was significantly decreased with increased vitamin C intake (OR = 0.996, p = 0.041), and higher serum vitamin D levels (OR = 0.979, p = 0.011). Given the significant association between the prevalence of gingival disease and RA, identification of risk factors of gingival disease will be useful as a screening tool in national health surveys to improve the management of periodontal disease in patients with RA.	[Huang, Liang-Gie; Chen, Gin] Taichung Vet Gen Hosp, Dept Stomatol, Taichung, Taiwan; [Chen, Gin] Natl Yang Ming Univ, Sch Dent, Taipei, Taiwan; [Chen, Gin] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Hsin-Hua] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Der-Yuan; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Hsin-Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Hsin-Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Hsin-Hua] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, DY (corresponding author), Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan.; Chen, DY; Hsin-Hua, (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chen, DY; Hsin-Hua, (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, DY; Hsin-Hua, (corresponding author), Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.; Chen, DY; Hsin-Hua, (corresponding author), Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.; Chen, DY; Hsin-Hua, (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Hsin-Hua, (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.; Hsin-Hua, (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Hsin-Hua, (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan.	dychen@vghtc.gov.tw; shc5555@hotmail.com		CHEN, GIN/0000-0002-7665-6677	Taichung Veterans General Hospital, Taiwan [TCVGH-1057325D]	Taichung Veterans General Hospital, Taiwan	This study was supported in part by Taichung Veterans General Hospital, Taiwan under Grant (number TCVGH-1057325D).	Abreu OJ, 2016, BMC ORAL HEALTH, V16, DOI 10.1186/s12903-016-0288-7; Adams JS, 2007, ANN NY ACAD SCI, V1117, P94, DOI 10.1196/annals.1402.036; Arajo VMA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/259074; [Anonymous], 2005, J PERIODONTOL, V76, P1406, DOI 10.1902/jop.2005.76.8.1406; Arkema EV, 2010, J RHEUMATOL, V37, P1800, DOI 10.3899/jrheum.091398; Bawadi HA, 2011, J PERIODONTAL RES, V46, P74, DOI 10.1111/j.1600-0765.2010.01314.x; Bellucci E, 2016, CLIN EXP RHEUMATOL, V34, P793; Berthelot JM, 2010, JOINT BONE SPINE, V77, P537, DOI 10.1016/j.jbspin.2010.04.015; Brooks WH, 2010, J AUTOIMMUN, V34, pJ207, DOI 10.1016/j.jaut.2009.12.006; Cekici A, 2014, PERIODONTOL 2000, V64, P57, DOI 10.1111/prd.12002; Chambrone L, 2013, J CLIN PERIODONTOL, V40, P607, DOI 10.1111/jcpe.12106; Daien CI, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/386148; de Pablo P, 2008, J RHEUMATOL, V35, P70; Demmer RT, 2011, J CLIN PERIODONTOL, V38, P998, DOI 10.1111/j.1600-051X.2011.01776.x; Dodington DW, 2015, J NUTR, V145, P2512, DOI 10.3945/jn.115.211524; Eke P. I., 2015, J PERIODONTOL, V86, P611, DOI DOI 10.1902/J0P.2015.140520; Eriksson K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155956; Genco RJ, 2013, PERIODONTOL 2000, V62, P59, DOI 10.1111/j.1600-0757.2012.00457.x; Goh CE, 2016, ARTHRITIS RHEUMATOL, V68, P2384, DOI 10.1002/art.39724; Golub LM, 2006, J DENT RES, V85, P102, DOI 10.1177/154405910608500201; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Ibarnez VS, 2015, REV MED CHILE, V143, P1539, DOI 10.4067/S0034-98872015001200006; Jimenez M, 2014, PUBLIC HEALTH NUTR, V17, P844, DOI 10.1017/S1368980013000177; Johnson CL, 2013, VITAL HLTH STAT, V2, P1; Joseph R, 2013, RHEUMATOL INT, V33, P103, DOI 10.1007/s00296-011-2284-1; Kalden JR, 2016, RHEUMATOL THER, V3, P31, DOI 10.1007/s40744-016-0032-4; Kaur S, 2013, J DENT RES, V92, P399, DOI 10.1177/0022034513483142; Kinane DF, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.38; Klareskog L, 2010, ANN RHEUM DIS, V69, P2062, DOI 10.1136/ard.2010.142109; Koziel J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0408-9; Kuzmanova D, 2012, J CLIN PERIODONTOL, V39, P905, DOI 10.1111/j.1600-051X.2012.01927.x; Leech MT, 2015, BEST PRACT RES CL RH, V29, P189, DOI 10.1016/j.berh.2015.03.001; Lorenzo SM, 2015, CAD SAUDE PUBLICA, V31, P2425, DOI 10.1590/0102-311X00012115; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; MANICOURT DH, 1993, ARTHRITIS RHEUM, V36, P490, DOI 10.1002/art.1780360409; Meyle J, 2015, PERIODONTOL 2000, V69, P7, DOI 10.1111/prd.12104; Mikuls TR, 2014, ARTHRITIS RHEUMATOL, V66, P1090, DOI 10.1002/art.38348; Morita T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162306; Muller K, 1992, CYTOKINE, P4; National Center for Health Statistics, 2010, VITAL HLTH STAT, V1, P1; Nishida M, 2000, J PERIODONTOL, V71, P1215, DOI 10.1902/jop.2000.71.8.1215; Rosenstein ED, 2004, INFLAMMATION, V28, P311, DOI 10.1007/s10753-004-6641-z; Schmickler J, 2016, J PERIODONTOL, P1; Singla Nishu, 2016, J Indian Soc Periodontol, V20, P330, DOI 10.4103/0972-124X.179405; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Valerio MS, 2016, J PERIODONTAL RES; van Hamburg JP, 2011, ARTHRITIS RHEUM-US, V63, P73, DOI 10.1002/art.30093	47	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186346	10.1371/journal.pone.0186346	http://dx.doi.org/10.1371/journal.pone.0186346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023518	gold, Green Published, Green Submitted			2022-12-26	WOS:000412845100111
J	Zinke, F; Bakenecker, P; Hahn, D				Zinke, Fridolin; Bakenecker, Patrick; Hahn, Daniel			Influence of platinum harmonized textile on neuromuscular, systemic and subjective recovery	PLOS ONE			English	Article							NANOPLATINUM LIQUID; MUSCLE; NANODIAMOND; PERFORMANCE; RESISTANCE; STRENGTH; EXERCISE; DPV576; ACTIVATION	The clothing manufacturer Venex Life-Science tracks the strategy to enhance recovery process through implementing platinum harmonized technology (PHT) into their Venex (R) Regeneration Wear. The proposed mechanisms of the regeneration wear are an increase of parasympathetic activity and an increase of the temperature due far-infrared radiation. The purpose of this study was to investigate potential effects of Venex regeneration wear on the recovery of neuromuscular, systemic and subjective parameters following exercise. In a randomized, single-blinded cross-over design, 13 strength-trained male participants performed two exercise sessions in one day. After the first exercise session and for 3 nights following the exercise day participants wore the Venex regeneration wear or a placebo product. Measures of isometric maximum voluntary contraction (MVC), voluntary activation (VA) and potentiated twitch torque (PTT) of the knee extensors, as well as maximum jump height during the Counter-Movement and Drop Jump, creatinkinase (CK) and subjective parameters (perceived pain, recovery condition and sleep quality) were obtained before and after each exercise session and 24, 48, and 72 hours after the first exercise session. MVC, PTT, CK and jump parameters changed over time during the exercise day as well as on the following days, however, there were no significant differences between treatments. Subjective parameters showed strong effect sizes (i.e. Cohen's d > 0.6) in favor for Venex but no significant differences between treatments. Based on these findings, it is concluded that wearing a platinum harmonized textile following exercise did not improve neuromuscular and systemic recovery in a trained male population to a statistical noticeable extent. However, the findings for the subjective parameters suggest some potential for enhanced recovery that requires further research.	[Zinke, Fridolin; Bakenecker, Patrick; Hahn, Daniel] Ruhr Univ Bochum, Fac Sport Sci, Human Movement Sci, Bochum, Germany; [Hahn, Daniel] Univ Queensland, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia	Ruhr University Bochum; University of Queensland	Zinke, F (corresponding author), Ruhr Univ Bochum, Fac Sport Sci, Human Movement Sci, Bochum, Germany.	fridolin.zinke@rub.de	Hahn, Daniel/B-4628-2011	Hahn, Daniel/0000-0002-9401-5478	Venex GmbH	Venex GmbH	The work of FZ has been funded by Venex GmbH. The work of PB has been funded by Venex GmbH. DH declares no potential conflict of interest. http://www.regeneratiorrforyoden/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; Bangsbo J, 2006, J SPORT SCI, V24, P665, DOI 10.1080/02640410500482529; Barnett A, 2006, SPORTS MED, V36, P781, DOI 10.2165/00007256-200636090-00005; BYRNES WC, 1985, J APPL PHYSIOL, V59, P710, DOI 10.1152/jappl.1985.59.3.710; Camm AJ, 1996, CIRCULATION, V93, P1043; Closs SJ, 2004, J PAIN SYMPTOM MANAG, V27, P196, DOI 10.1016/j.jpainsymman.2003.12.010; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davies V, 2009, J STRENGTH COND RES, V23, P1786, DOI 10.1519/JSC.0b013e3181b42589; Debold EP, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00239; Delany NS, 2001, PHYSIOL GENOMICS, V4, P165, DOI 10.1152/physiolgenomics.2001.4.3.165; Elsabahy M, 2013, CHEM SOC REV, V42, P5552, DOI 10.1039/c3cs60064e; Eston R, 1999, J SPORT SCI, V17, P231, DOI 10.1080/026404199366136; Flanagan EP, 2008, STRENGTH COND J, V30, P32, DOI 10.1519/SSC.0b013e318187e25b; Fujimura T, 2008, FIBER CONTAINING NAN; Ghoneum A, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/46/465101; Ghoneum A, 2013, INT J NANOMED, V8, P2567, DOI 10.2147/IJN.S43417; Ghoneum M, 2010, ANTICANCER RES, V30, P4075; Ghoneum M, 2010, IN VIVO, V24, P141; Ghoneum MH, 2017, J BIOMED NANOTECHNOL, V13, P110, DOI 10.1166/jbn.2017.2340; Harridge SDR, 1996, PFLUG ARCH EUR J PHY, V432, P913, DOI 10.1007/s004240050215; Hasegawa H, 2014, EFFECT GARMENT KNEAD; Hecksteden A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148810; Iakoubovskii K, 2000, DIAM RELAT MATER, V9, P861, DOI 10.1016/S0925-9635(99)00354-4; Keller U, 2003, EUR J CLIN NUTR, V57, pS69, DOI 10.1038/sj.ejcn.1601904; KUZNETSOV VL, 1994, CHEM PHYS LETT, V222, P343, DOI 10.1016/0009-2614(94)87072-1; Lieber Richard L, 2002, J Am Acad Orthop Surg, V10, P67; MERTON PA, 1954, J PHYSIOL-LONDON, V123, P553, DOI 10.1113/jphysiol.1954.sp005070; Mika A, 2007, AM J PHYS MED REHAB, V86, P474, DOI 10.1097/PHM.0b013e31805b7c79; Pizzio GA, 2005, EUR J NEUROSCI, V22, P665, DOI 10.1111/j.1460-9568.2005.04247.x; Poppendieck W, 2013, INT J SPORT PHYSIOL, V8, P227, DOI 10.1123/ijspp.8.3.227; Prou E, 1999, J SPORT MED PHYS FIT, V39, P226; Schrand AM, 2007, J PHYS CHEM B, V111, P2, DOI 10.1021/jp066387v; Subramanian A, 2015, BIOTECHNOL ADV, V33, P1897, DOI 10.1016/j.biotechadv.2015.10.002; Weerapong P, 2005, SPORTS MED, V35, P235, DOI 10.2165/00007256-200535030-00004; WESTERBLAD H, 1991, AM J PHYSIOL, V261, pC195, DOI 10.1152/ajpcell.1991.261.2.C195; Wiewelhove T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139801; Young W., 1995, NEW STUD ATHL, V10, P88; Zajac A, 2015, J HUM KINET, V49, P159, DOI 10.1515/hukin-2015-0118	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2017	12	10							e0186162	10.1371/journal.pone.0186162	http://dx.doi.org/10.1371/journal.pone.0186162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6DU	29023563	Green Published, gold			2022-12-26	WOS:000412845100072
J	Cai, CM; Zhou, J; Sun, XQ; Sun, TZ; Xie, WH; Cui, J				Cai, Chunmei; Zhou, Jie; Sun, Xiaoqiang; Sun, Tingzhe; Xie, Weihong; Cui, Jun			Integrated modeling and analysis of intracellular and intercellular mechanisms in shaping the interferon response to viral infection	PLOS ONE			English	Article							VIRUS-REPLICATION; BETA RESPONSE; LAMBDA; GENE; EXPRESSION; DISTINCT; ALPHA; TRANSCRIPTION; REVEALS	The interferons (IFNs) responses to viral infection are heterogeneous, while the underlying mechanisms for variability among cells are still not clear. In this study, we developed a hybrid model to systematically identify the sources of IFN induction heterogeneity. The experiment-integrated simulation demonstrated that the viral dose/type, the diversity in transcriptional factors activation and the intercellular paracrine signaling could strikingly shape the heterogeneity of IFN expression. We further determined that the IFN beta and IFN lambda 1 induced diverse dynamics of IFN-stimulated genes (ISGs) production. Collectively, our findings revealed the intracellular and intercellular mechanisms contributing to cell-to-cell variation in IFN induction, and further demonstrated the significant effects of IFN heterogeneity on antagonizing viruses.	[Cai, Chunmei; Zhou, Jie; Xie, Weihong; Cui, Jun] Sun Yat Sen Univ, Sch Life Sci, Key Lab Gene Engn, Minist Educ,State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Cai, Chunmei; Sun, Xiaoqiang] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China; [Cui, Jun] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Sun, Tingzhe] AnQing Normal Univ, Anqing, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Anqing Normal University	Cui, J (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Key Lab Gene Engn, Minist Educ,State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.; Cui, J (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	cuij5@mail.sysu.edu.cn	Sun, Xiaoqiang/AAU-2148-2020	Sun, Tingzhe/0000-0002-9575-4993	National Natural Science Foundation of China [31522018, 91629101, 61503419]; Guangdong Natural Science Funds for Distinguished Young Scholar [S2013050014772]; Guangdong Innovative Research Team Program [2011Y035, 201001Y0104687244]; Guangzhou Science and Technology Project [201605030012]; Fundamental Research Funds for the Central Universities [15lgjc02]; Training Program for Outstanding Young Teachers in Higher Education institutions of Guangdong Province [YQ2015001]; Guangdong Nature Science Foundation [2014A030310355, 2016A030313234]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Funds for Distinguished Young Scholar; Guangdong Innovative Research Team Program; Guangzhou Science and Technology Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Training Program for Outstanding Young Teachers in Higher Education institutions of Guangdong Province; Guangdong Nature Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by National Natural Science Foundation of China (31522018, 91629101), Guangdong Natural Science Funds for Distinguished Young Scholar (S2013050014772), Guangdong Innovative Research Team Program (NO. 2011Y035 and 201001Y0104687244), Guangzhou Science and Technology Project (201605030012), the Fundamental Research Funds for the Central Universities (15lgjc02), the Training Program for Outstanding Young Teachers in Higher Education institutions of Guangdong Province (YQ2015001), the Guangdong Nature Science Foundation (2014A030310355, 2016A030313234), and the National Natural Science Foundation of China (61503419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajibade AA, 2013, TRENDS IMMUNOL, V34, P307, DOI 10.1016/j.it.2013.03.007; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chen S, 2010, VIROLOGY, V407, P247, DOI 10.1016/j.virol.2010.08.008; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Hicks AL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003838; Hu JZ, 2007, NUCLEIC ACIDS RES, V35, P5232, DOI 10.1093/nar/gkm557; Hwang SY, 2013, J IMMUNOL, V190, P1192, DOI 10.4049/jimmunol.1202326; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kohli A, 2012, J VIRAL HEPATITIS, V19, P843, DOI 10.1111/j.1365-2893.2012.01610.x; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Markiewicz I, 2006, STOCH ENV RES RISK A, V20, P391, DOI 10.1007/s00477-006-0033-x; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Pagliaccetti NE, 2010, VIROLOGY, V401, P197, DOI 10.1016/j.virol.2010.02.022; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Patil S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005728; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Reikine S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00342; Riaz M, 2009, J STAT COMPUT SIM, V79, P1173, DOI 10.1080/00949650802174397; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sun XQ, 2012, BIOMATERIALS, V33, P8265, DOI 10.1016/j.biomaterials.2012.07.041; Timm C, 2015, BIOTECHNOL BIOENG, V112, P1655, DOI 10.1002/bit.25578; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Wu WH, 2008, BMC BIOINFORMATICS, P9; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zhang W, 2015, MATH BIOSCI, V265, P12, DOI 10.1016/j.mbs.2015.04.003; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249; Zinzula L, 2013, ANTIVIR RES, V100, P615, DOI 10.1016/j.antiviral.2013.10.002	41	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186105	10.1371/journal.pone.0186105	http://dx.doi.org/10.1371/journal.pone.0186105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020068	Green Published, Green Submitted, gold			2022-12-26	WOS:000412754400069
J	Anders, S; Schroeter, C				Anders, Sven; Schroeter, Christiane			The impact of nutritional supplement intake on diet behavior and obesity outcomes	PLOS ONE			English	Article							HEALTH PRODUCTION FUNCTION; PROPENSITY-SCORE; LIFE-STYLE; US ADULTS; LABEL USE; VITAMIN; USERS; INFORMATION; PROGRAM; QUALITY	After decades-old efforts to nudge consumers towards healthier lifestyles through dietary guidelines, diet-related diseases are on the rise. In addition, a growing share of U.S. consumers proactively chooses nutritional supplements as an alternative preventative way of maintaining good health, a $25.5 billion industry in the United States. This paper investigates possible linkages between the economics of consumer supplement choices and the relationship to important dietary and health outcomes. We use National Health and Nutrition Examination Survey (NHANES) data to estimate the impact of nutritional supplements intake on respondent's body weight outcomes, controlling for diet quality.: The focus of this article is to determine whether nutritional supplements takers differ from non-takers with regard to their health outcomes when controlling for differences in diet quality, based on individual Healthy Eating Index (HEI-2010) score. The analysis applies treatment effects estimators that account for the selection bias and endogeneity of self-reported behavior and diet-health outcomes. The analysis demonstrates a negative association between supplement intake and BMI but no significant effect on an individual's diet quality. Our findings suggest that individuals proactively invest into their health by taking nutritional supplements instead of improving diet quality through more nutritious food choices. Our results provide important contributions to the literature on a key food policy issue. Knowledge of the determinants of supplement demand in the context of strong diet-health trends should also be helpful to stakeholders in the U.S. produce sector in their competition over consumer market share.	[Anders, Sven] Univ Alberta, Dept Resource Econ & Environm Sociol, Edmonton, AB, Canada; [Schroeter, Christiane] Calif Polytech State Univ San Luis Obispo, Agribusiness Dept, San Luis Obispo, CA 93407 USA	University of Alberta; California State University System; California Polytechnic State University San Luis Obispo	Anders, S (corresponding author), Univ Alberta, Dept Resource Econ & Environm Sociol, Edmonton, AB, Canada.	sven.anders@ualberta.ca		Anders, Sven/0000-0001-8261-6973				Abebaw D, 2010, FOOD POLICY, V35, P286, DOI 10.1016/j.foodpol.2010.01.002; Agudo A, 2005, MEASURING INTAKE FRU; Archer SL, 2005, J AM DIET ASSOC, V105, P1106, DOI 10.1016/j.jada.2005.04.010; Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Balluz LS, 2000, ARCH FAM MED, V9, P258, DOI 10.1001/archfami.9.3.258; Becker GS, 1999, KYKLOS, V45, P327; Becker SO, 2002, STATA J, V2, P358, DOI 10.1177/1536867X0200200403; Beydoun MA, 2008, EUR J CLIN NUTR, V62, P303, DOI 10.1038/sj.ejcn.1602700; Bhatt R, 2014, SOUTH ECON J, V80, P656, DOI 10.4284/0038-4038-2012.102; Black DA, 2004, J ECONOMETRICS, V121, P99, DOI 10.1016/j.jeconom.2003.10.006; Brownie S, 2005, AUSTRALAS J AGEING, V24, P77, DOI 10.1111/j.1741-6612.2005.00088.x; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Campbell BL, 2011, AM J AGR ECON, V93, P1099, DOI 10.1093/ajae/aar031; CDC, 2010, FDN HLTH MEAS GEN HL; CNPP, 2021, VEILL REGL CNPP FR C; Crown WH, 2014, APPL HEALTH ECON HEA, V12, P7, DOI 10.1007/s40258-013-0075-4; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; DeVol R, 2007, UNHEALTHY AM EC BURD; Dickinson A, 2006, MULTIVITAMINS OTHER; Dickinson A, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-14; DiPrete TA, 2004, DISCUSSION PAPERS; Drichoutis AC, 2005, EUR REV AGRIC ECON, V32, P93, DOI 10.1093/erae/jbi003; Drichoutis AC, 2009, KYKLOS, V62, P500, DOI 10.1111/j.1467-6435.2009.00448.x; Ervin RB, 1988, PREVALENCE LEADING T; Ervin RB, 1999, VITAL HLTH STAT SERI, V11; Fayissa B, 2005, APPL ECON, V37, P155, DOI 10.1080/00036840412331313521; Fennell D, 2004, PREV MED, V39, P932, DOI 10.1016/j.ypmed.2004.03.031; Foote JA, 2003, AM J EPIDEMIOL, V157, P888, DOI 10.1093/aje/kwg072; Gahche J, 1988, NCHS DATA BRIEF, V2011, P1; Gleason PM, 2003, AM J AGR ECON, V85, P1047, DOI 10.1111/1467-8276.00507; GOULD BW, 1994, J AGR RESOUR ECON, V19, P349; Grilli L, 2011, PROPENSITY SCORES ES; GROSSMAN M, 1972, J POLIT ECON, V80, P223, DOI 10.1086/259880; Grossman M., 1999, HDB HLTH EC, P347; Guenther PM, 2006, J AM DIET ASSOC, V106, P1371, DOI 10.1016/j.jada.2006.06.002; Harrison RA, 2004, BRIT J NUTR, V91, P617, DOI 10.1079/BJN20031076; Heckman JJ, 1998, REV ECON STUD, V65, P261, DOI 10.1111/1467-937X.00044; Institute of Medicine and National Research Council, 2005, DIET SUPPL FRAM EV S; Irz X, 2015, J HEALTH ECON, V39, P188, DOI 10.1016/j.jhealeco.2014.09.002; Ishihara J, 2003, INT J EPIDEMIOL, V32, P546, DOI 10.1093/ije/dyg091; Kahle L, 2013, CALCULATION MEAN HLT; Kantor ED, 2016, JAMA-J AM MED ASSOC, V316, P1464, DOI 10.1001/jama.2016.14403; KEEN CL, 1994, AM J CLIN NUTR, V59, p532S, DOI 10.1093/ajcn/59.2.532S; KENKEL DS, 1995, HEALTH ECON, V4, P15, DOI 10.1002/hec.4730040103; Kennedy E, 2004, NUTR REV, V62, pS78, DOI 10.1111/j.1753-4887.2004.tb00093.x; Kim SY, 2001, J CONSUM AFF, V35, P346, DOI 10.1111/j.1745-6606.2001.tb00118.x; Kimmons Joel E, 2006, MedGenMed, V8, P3; Klatsky AL, 2010, PHYSIOL BEHAV, V100, P76, DOI 10.1016/j.physbeh.2009.12.019; Lechner M, 1999, J BUS ECON STAT, V17, P74, DOI 10.2307/1392240; Leuven E, 2015, STATA MODULE PERFORM; Li KR, 2010, BRIT J NUTR, V104, P1058, DOI 10.1017/S0007114510001728; Lyle BJ, 1998, J NUTR, V128, P2355, DOI 10.1093/jn/128.12.2355; Mancino L, 2009, FOOD POLICY, V34, P557, DOI 10.1016/j.foodpol.2009.09.003; Mandal B, 2014, ECON HUM BIOL, V14, P50, DOI 10.1016/j.ehb.2014.04.001; Mintel, 2015, MINT AC REP; Mursu J, 2011, ARCH INTERN MED, V171, P1625, DOI 10.1001/archinternmed.2011.445; Nayga R., 1999, FAMILY EC NUTR REV, V12, P43; Park J, 2001, AM J AGR ECON, V83, P840, DOI 10.1111/0002-9092.00213; Perez Claudio E, 2002, Health Rep, V13, P23; Petrovici DA, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-222; Plurphanswat Nantaporn, 2014, BMC Obes, V1, P18, DOI 10.1186/s40608-014-0018-0; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Reinert A, 2007, EUR J NUTR, V46, P165, DOI 10.1007/s00394-007-0650-2; Rock CL, 2007, AM J CLIN NUTR, V85, p277S, DOI 10.1093/ajcn/85.1.277S; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; RUBIN DB, 1991, BIOMETRICS, V47, P1213, DOI 10.2307/2532381; Satia-Abouta J, 2003, AM J EPIDEMIOL, V157, P944, DOI 10.1093/aje/kwg039; Schroeter C, 2013, APPL ECON PERSPECT P, V35, P125, DOI 10.1093/aepp/pps040; Scrinis G., 2013, NUTR SCI POLITICS DI, P352; Stewart H, 2008, REV AGR ECON, V30, P43, DOI 10.1111/j.1467-9353.2007.00391.x; Thornton J, 2002, APPL ECON, V34, P59, DOI 10.1080/00036840010025650; U. S. Department of Agriculture/ U. S. Department of Health and Human Services (USDA/ HHS), 2015, DIET GUID AM 2015; United States Department of Agriculture and United States Department of Health and Human Services, 2010, DIET GUID AM 2010; United States Department of Agriculture-Food and Nutrition Service (USDA-FNS), 2010, DET PROD EL PURCH SN; Van Duyn MS, 2000, J AM DIET ASSOC, V100, P1511, DOI 10.1016/S0002-8223(00)00420-X; Variyam JN, 1999, APPL ECON, V31, P217, DOI 10.1080/000368499324444	76	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185258	10.1371/journal.pone.0185258	http://dx.doi.org/10.1371/journal.pone.0185258			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	28991921	gold, Green Submitted, Green Published			2022-12-26	WOS:000412601800013
